PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	De Donatis, GM; Le Pape, E; Pierron, A; Cheli, Y; Hofman, V; Hofman, P; Allegra, M; Zahaf, K; Bahadoran, P; Rocchi, S; Bertolotto, C; Ballotti, R; Passeron, T				De Donatis, G. M.; Le Pape, E.; Pierron, A.; Cheli, Y.; Hofman, V.; Hofman, P.; Allegra, M.; Zahaf, K.; Bahadoran, P.; Rocchi, S.; Bertolotto, C.; Ballotti, R.; Passeron, T.			NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2	ONCOGENE			English	Article							POLYCOMB GROUP PROTEIN; KAPPA-B ACTIVITY; NEOPLASTIC TRANSFORMATION; CELLULAR SENESCENCE; SIGNALING PATHWAY; EPITHELIAL-CELLS; EXPRESSION; CANCER; GROWTH; DIFFERENTIATION	Enhancer of Zeste homologue 2 (EZH2) belongs to the polycomb repressive complex 2 and catalyzes the methylation of histone H3 lysine 27. These pivotal epigenetic marks are altered in many cancers, including melanoma, as a result of EZH2 overexpression. Here, we show that the non-canonical-NF-kB pathway accounts for most of the NF-kB activity in melanoma cells, in contrast to non-cancer cells. We identify the non-canonical-NF-kB pathway as a key regulator of EZH2 expression in melanoma. We show a striking correlation between NF-kB2 and EZH2 expression in human melanoma metastases. We demonstrate that inhibition of the non-canonical NF-kB pathway by targeting NF-kB2/p52 or the upstream kinase NIK restores the senescence program in melanoma cells through the decrease of EZH2. On the contrary, the overexpression of NF-kB2/p52 in normal human melanocytes prevents stress- and oncogene-induced senescence. Finally, we show in mouse models that the inhibition of the non-canonical NF-kB pathway restores senescence and induces a dramatic reduction in tumor growth compared with controls, thus providing potential drug targets for the re-induction of senescence in melanoma and other cancers where EZH2 is overexpressed.	[De Donatis, G. M.; Le Pape, E.; Pierron, A.; Passeron, T.] C3M, INSERM, U1065, Team 12, Nice, France; [Cheli, Y.; Allegra, M.; Bahadoran, P.; Rocchi, S.; Bertolotto, C.; Ballotti, R.] C3M, INSERM, U1065, Team 1, Nice, France; [Hofman, V.; Hofman, P.; Zahaf, K.] CHU Nice, Human Biobank, F-06202 Nice, France; [Hofman, V.; Hofman, P.; Zahaf, K.] IRCAN CNRS, Inst Res Canc & Aging, Nice, France; [Bahadoran, P.; Ballotti, R.; Passeron, T.] Univ Hosp Nice, Dept Dermatol, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Passeron, T (corresponding author), Univ Hosp Nice, Dept Dermatol, U1065, Archet Hosp 2, 150 Route Ginestiere,Batiment Archimed, F-06200 Nice, France.	passeron@unice.fr	Rocchi, Stephane/O-4152-2016; Hofman, Paul/P-7654-2018; Cheli, Yann/O-5783-2016; Bertolotto, Corine/AAF-6634-2021; BALLOTTI, Robert/F-8825-2013	Rocchi, Stephane/0000-0002-0943-1304; Hofman, Paul/0000-0003-0431-9353; Cheli, Yann/0000-0001-9839-4332; Bertolotto, Corine/0000-0001-6971-7753; Passeron, Thierry/0000-0002-0797-6570; BALLOTTI, Robert/0000-0002-7322-4908; veronique, HOFMAN/0000-0003-0943-1627; Bahadoran, Philippe/0000-0002-2481-0556	Institut National de la Sante et de la Recherche Medicale (INSERM); Fondation ARC; Societe Francaise de Recherche en Dermatologie (SRD)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation ARC; Societe Francaise de Recherche en Dermatologie (SRD)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Fondation ARC, and the Societe Francaise de Recherche en Dermatologie (SRD). The authors would like to thank Professor Robert Weinberg from the MIT Ludiwig Center for Molecular Biology for kindly providing the Mel-ST cells.	Arisan S, 2005, UROL INT, V75, P252, DOI 10.1159/000087804; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Boisvert M, 2008, VIROLOGY, V380, P1, DOI 10.1016/j.virol.2008.07.023; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Ciana P, 1997, ONCOGENE, V14, P1805, DOI 10.1038/sj.onc.1201015; Crea F, 2012, CANCER METAST REV, V31, P753, DOI 10.1007/s10555-012-9387-3; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Dukers DF, 2004, AM J PATHOL, V164, P873, DOI 10.1016/S0002-9440(10)63175-6; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kia SK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-16; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Larribere L, 2004, CELL DEATH DIFFER, V11, P1084, DOI 10.1038/sj.cdd.4401475; Li KX, 2013, BIOORG MED CHEM LETT, V23, P1238, DOI 10.1016/j.bmcl.2013.01.012; McHugh JB, 2007, J CUTAN PATHOL, V34, P597, DOI 10.1111/j.1600-0560.2006.00678.x; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Rovillain E, 2011, ONCOGENE, V30, P2356, DOI 10.1038/onc.2010.611; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Sarkar D, 2015, EPIGENETICS-US, V10, P103, DOI 10.1080/15592294.2014.1003746; Su J, 2015, ONCOL REP, V34, P235, DOI 10.3892/or.2015.3944; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Thu YM, 2012, ONCOGENE, V31, P2580, DOI 10.1038/onc.2011.427; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051	45	29	29	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2735	2745		10.1038/onc.2015.331	http://dx.doi.org/10.1038/onc.2015.331			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26364600				2022-12-26	WOS:000377472700007
J	Hu, F; Shi, XL; Li, BW; Huang, XC; Morelli, X; Shi, N				Hu, Fen; Shi, Xiaoli; Li, Bowen; Huang, Xiaochen; Morelli, Xavier; Shi, Ning			Structural Basis for the Interaction between the Golgi Reassembly-stacking Protein GRASP65 and the Golgi Matrix Protein GM130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICLE-TETHERING PROTEIN; P115; COMPONENTS; CISTERNAE; TRANSPORT; RIBBON; ROLES; PHOSPHORYLATION; FEATURES; GIANTIN	GM130 and GRASP65 are Golgi peripheral membrane proteins that play a key role in Golgi stacking and vesicle tethering. However, the molecular details of their interaction and their structural role as a functional unit remain unclear. Here, we present the crystal structure of the PDZ domains of GRASP65 in complex with the GM130 C-terminal peptide at 1.96-angstrom resolution. In contrast to previous findings proposing that GM130 interacts with GRASP65 at the PDZ2 domain only, our crystal structure of the complex indicates that GM130 binds to GRASP65 at two distinct sites concurrently and that both the PDZ1 and PDZ2 domains of GRASP65 participate in this molecular interaction. Mutagenesis experiments support these structural observations and demonstrate that they are required for GRASP65-GM130 association.	[Hu, Fen; Shi, Xiaoli; Li, Bowen; Huang, Xiaochen; Shi, Ning] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China; [Morelli, Xavier] Aix Marseille Univ, INSERM, CNRS, Inst Paoli Calmettes,UMR7258,U1068,UM105, F-13009 Marseille, France	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Shi, N (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, 155 Yangqiao Rd West, Fuzhou 350002, Peoples R China.	shining@fjirsm.ac.cn	morelli, xavier/A-9218-2016	morelli, xavier/0000-0001-8101-7901	National Natural Science Foundation of China [31370738]; One Hundred Person Project of the Chinese Academy of Sciences; National Science Foundation of Fujian Province [2013J01150]; Campus France (PHC CAI YUANPEI) [26203WD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred Person Project of the Chinese Academy of Sciences; National Science Foundation of Fujian Province; Campus France (PHC CAI YUANPEI)	This work was supported by the National Natural Science Foundation of China Grant 31370738, the One Hundred Person Project of the Chinese Academy of Sciences, the National Science Foundation of Fujian Province (2013J01150) and Campus France (PHC CAI YUANPEI 2013, Project 26203WD). The authors declare that they have no conflict of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; An Y, 2009, J MOL BIOL, V391, P26, DOI 10.1016/j.jmb.2009.04.062; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; CLUETT EB, 1992, J CELL SCI, V103, P773; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Dirac-Svejstrup AB, 2000, J CELL BIOL, V150, P475, DOI 10.1083/jcb.150.3.475; Duran JM, 2008, MOL BIOL CELL, V19, P2579, DOI 10.1091/mbc.E07-10-0998; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARQUHAR MG, 1981, J CELL BIOL, V91, pS77, DOI 10.1083/jcb.91.3.77s; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Feng YB, 2013, J BIOL CHEM, V288, P28418, DOI 10.1074/jbc.M113.478024; Jarvela T, 2014, MOL BIOL CELL, V25, P133, DOI 10.1091/mbc.E13-07-0395; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Klumperman J, 2011, COLD SPRING HARBOR P, V3, P1, DOI DOI 10.1101/CSHPERSPECTA005181; Kodani A, 2008, MOL BIOL CELL, V19, P745, DOI 10.1091/mbc.E07-08-0847; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; Orci L, 1998, P NATL ACAD SCI USA, V95, P2279, DOI 10.1073/pnas.95.5.2279; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; RAMBOURG A, 1990, EUR J CELL BIOL, V51, P189; Ren JQ, 2015, BIOCHEM J, V468, P133, DOI 10.1042/BJ20141473; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Striegl H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004656; Tang DM, 2012, BIOL OPEN, V1, P1204, DOI 10.1242/bio.20122659; Truschel ST, 2012, J BIOL CHEM, V287, P19870, DOI 10.1074/jbc.M111.326256; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xiang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2669; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]	47	24	27	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26373	26382		10.1074/jbc.M115.657940	http://dx.doi.org/10.1074/jbc.M115.657940			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26363069	Green Published, hybrid			2022-12-26	WOS:000364793600003
J	Lussier, A; Bastet, L; Chauvier, A; Lafontaine, DA				Lussier, Antony; Bastet, Laurene; Chauvier, Adrien; Lafontaine, Daniel A.			A Kissing Loop Is Important for btuB Riboswitch Ligand Sensing and Regulatory Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; ESCHERICHIA-COLI; GENETIC-CONTROL; APTAMER DOMAIN; COENZYME B-12; NASCENT RNA; TRANSCRIPTION; BINDING; EXPRESSION; INSIGHTS	RNA-based genetic regulation is exemplified by metabolite-binding riboswitches that modulate gene expression through conformational changes. Crystal structures show that the Escherichia coli btuB riboswitch contains a kissing loop interaction that is in close proximity to the bound ligand. To analyze the role of the kissing loop interaction in the riboswitch regulatory mechanism, we used RNase H cleavage assays to probe the structure of nascent riboswitch transcripts produced by the E. coli RNA polymerase. By monitoring the folding of the aptamer, kissing loop, and riboswitch expression platform, we established the conformation of each structural component in the absence or presence of bound adenosylcobalamin. We found that the kissing loop interaction is not essential for ligand binding. However, we showed that kissing loop formation improves ligand binding efficiency and is required to couple ligand binding to the riboswitch conformational changes involved in regulating gene expression. These results support a mechanism by which the btuB riboswitch modulates the formation of a tertiary structure to perform metabolite sensing and regulate gene expression.	[Lussier, Antony; Bastet, Laurene; Chauvier, Adrien; Lafontaine, Daniel A.] Univ Sherbrooke, Dept Biol, RNA Grp, Fac Sci, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Lafontaine, DA (corresponding author), Univ Sherbrooke, Dept Biol, RNA Grp, Fac Sci, 2500 Blvd Univ, Sherbrooke, PQ J1K 2R1, Canada.	Daniel.Lafontaine@USherbrooke.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	Andersen AA, 2000, MOL CELL, V5, P469, DOI 10.1016/S1097-2765(00)80441-4; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2012, Q REV BIOPHYS, V45, P345, DOI 10.1017/S0033583512000078; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Blouin S, 2011, NUCLEIC ACIDS RES, V39, P3373, DOI 10.1093/nar/gkq1247; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Caron MP, 2012, P NATL ACAD SCI USA, V109, pE3444, DOI 10.1073/pnas.1214024109; Choudhary PK, 2014, RNA, V20, P36, DOI 10.1261/rna.039909.113; Dalgarno PA, 2013, NUCLEIC ACIDS RES, V41, P4253, DOI 10.1093/nar/gkt128; Gallo S, 2008, CHEMBIOCHEM, V9, P1408, DOI 10.1002/cbic.200800099; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Haller A, 2011, NAT CHEM BIOL, V7, P393, DOI [10.1038/NCHEMBIO.562, 10.1038/nchembio.562]; Heppell B, 2011, NAT CHEM BIOL, V7, P384, DOI [10.1038/NCHEMBIO.563, 10.1038/nchembio.563]; Hollands K, 2012, P NATL ACAD SCI USA, V109, P5376, DOI 10.1073/pnas.1112211109; Johnson JE, 2012, NATURE, V492, P133, DOI 10.1038/nature11607; Kalyani BS, 2011, J MOL BIOL, V413, P548, DOI 10.1016/j.jmb.2011.08.053; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Mandin P, 2009, MOL MICROBIOL, V72, P551, DOI 10.1111/j.1365-2958.2009.06665.x; Marsh ENG, 1999, ESSAYS BIOCHEM, V34, P139; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MONFORTE JA, 1990, BIOCHEMISTRY-US, V29, P7882, DOI 10.1021/bi00486a015; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Nou XW, 1998, J BACTERIOL, V180, P6719, DOI 10.1128/JB.180.24.6719-6728.1998; Nou XW, 2000, P NATL ACAD SCI USA, V97, P7190, DOI 10.1073/pnas.130013897; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Perdrizet GA, 2012, P NATL ACAD SCI USA, V109, P3323, DOI 10.1073/pnas.1113086109; Peselis A, 2014, BBA-GENE REGUL MECH, V1839, P908, DOI 10.1016/j.bbagrm.2014.02.012; Peselis A, 2012, NAT STRUCT MOL BIOL, V19, P1182, DOI 10.1038/nsmb.2405; Pleiss JA, 1998, RNA, V4, P1313, DOI 10.1017/S135583829800106X; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Souliere MF, 2013, ANGEW CHEM INT EDIT, V52, P1874, DOI 10.1002/anie.201208167; Treiber DK, 2000, METHOD ENZYMOL, V317, P330; Tremblay R, 2011, J BIOL CHEM, V286, P27406, DOI 10.1074/jbc.M111.229047; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zarrinkar PP, 1996, RNA, V2, P564; ZARRINKAR PP, 1994, SCIENCE, V265, P918, DOI 10.1126/science.8052848	51	9	10	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26739	26751		10.1074/jbc.M115.684134	http://dx.doi.org/10.1074/jbc.M115.684134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370077	hybrid, Green Published			2022-12-26	WOS:000364793600036
J	Okla, M; Wang, W; Kang, I; Pashaj, A; Carr, T; Chung, SY				Okla, Meshail; Wang, Wei; Kang, Inhae; Pashaj, Anjeza; Carr, Timothy; Chung, Soonkyu			Activation of Toll-like Receptor 4 (TLR4) Attenuates Adaptive Thermogenesis via Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; STEM-CELLS; CHRONIC INFLAMMATION; INSULIN-RESISTANCE; OBESITY; FAT; AUTOPHAGY; WHITE; BRITE; COLD	Adaptive thermogenesis is the cellular process transforming chemical energy into heat in response to cold. A decrease in adaptive thermogenesis is a contributing factor to obesity. However, the molecular mechanisms responsible for the compromised adaptive thermogenesis in obese subjects have not yet been elucidated. In this study we hypothesized that Toll-like receptor 4 (TLR4) activation and subsequent inflammatory responses are key regulators to suppress adaptive thermogenesis. To test this hypothesis, C57BL/6 mice were either fed a palmitate-enriched high fat diet or administered with chronic low-dose LPS before cold acclimation. TLR4 stimulation by a high fat diet or LPS were both associated with reduced core body temperature and heat release. Impairment of thermogenic activation was correlated with diminished expression of brown-specific markers and mitochondrial dysfunction in subcutaneous white adipose tissue (sWAT). Defective sWAT browning was concomitant with elevated levels of endoplasmic reticulum (ER) stress and autophagy. Consistently, TLR4 activation by LPS abolished cAMP-induced up-regulation of uncoupling protein 1 (UCP1) in primary human adipocytes, which was reversed by silencing of C/EBP homologous protein (CHOP). Moreover, the inactivation of ER stress by genetic deletion of CHOP or chemical chaperone conferred a resistance to the LPS-induced suppression of adaptive thermogenesis. Collectively, our data indicate the existence of a novel signaling network that links TLR4 activation, ER stress, and mitochondrial dysfunction, thereby antagonizing thermogenic activation of sWAT. Our results also suggest that TLR4/ER stress axis activation may be a responsible mechanism for obesity-mediated defective brown adipose tissue activation.	[Okla, Meshail; Wang, Wei; Kang, Inhae; Pashaj, Anjeza; Carr, Timothy; Chung, Soonkyu] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Chung, SY (corresponding author), Univ Nebraska, Dept Nutr & Hlth Sci, 316G Ruth Leverton Hall,POB 830806, Lincoln, NE 68583 USA.	schung4@unl.edu	Regan, Clinton/E-6250-2012; Okla, Meshail S/E-9317-2017	Chung, Soonkyu/0000-0001-6279-7017	National Institutes of Health [1P20GM104320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P20GM104320 (Project 5; to S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659; Bae JY, 2015, BIOCHEM CELL BIOL, V93, P251, DOI 10.1139/bcb-2014-0139; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Crane JD, 2014, MOL METAB, V3, P490, DOI 10.1016/j.molmet.2014.04.007; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Gawronska-Kozak B, 2014, METHOD ENZYMOL, V538, P1, DOI 10.1016/B978-0-12-800280-3.00001-3; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937; Hotamisligil Gokhan S, 2007, Novartis Found Symp, V286, P86; Jansen HJ, 2012, ENDOCRINOLOGY, V153, P5866, DOI 10.1210/en.2012-1625; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kovsan J, 2011, J CLIN ENDOCR METAB, V96, pE268, DOI 10.1210/jc.2010-1681; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lee YK, 2013, NAT CELL BIOL, V15, P568, DOI 10.1038/ncb2776; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maris M, 2012, DIABETOLOGIA, V55, P1167, DOI 10.1007/s00125-011-2427-7; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nunez CE, 2013, INT J OBESITY, V37, P1473, DOI 10.1038/ijo.2013.27; Okla M, 2015, LIPIDS, V50, P111, DOI 10.1007/s11745-014-3981-9; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Staszkiewicz J, 2010, STEM CELLS DEV, V19, P83, DOI 10.1089/scd.2009.0051; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Valdearcos M, 2015, ANNU REV PHYSIOL, V77, P131, DOI 10.1146/annurev-physiol-021014-071656; Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	49	68	70	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26476	26490		10.1074/jbc.M115.677724	http://dx.doi.org/10.1074/jbc.M115.677724			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370079	Green Published, hybrid			2022-12-26	WOS:000364793600017
J	Rodriguez-Munoz, R; Cardenas-Aguayo, MD; Aleman, V; Osorio, B; Chavez-Gonzalez, O; Rendon, A; Martinez-Rojas, D; Meraz-Rios, MA				Rodriguez-Munoz, Rafael; del Carmen Cardenas-Aguayo, Maria; Aleman, Victor; Osorio, Beatriz; Chavez-Gonzalez, Oscar; Rendon, Alvaro; Martinez-Rojas, Dalila; Antonio Meraz-Rios, Marco			Novel Nuclear Protein Complexes of Dystrophin 71 Isoforms in Rat Cultured Hippocampal GABAergic and Glutamatergic Neurons	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BETA-DYSTROGLYCAN; DP71; GENE; LOCALIZATION; EXPRESSION; DUCHENNE; MATRIX; DOMAIN; CELLS	The precise functional role of the dystrophin 71 in neurons is still elusive. Previously, we reported that dystrophin 71d and dystrophin 71f are present in nuclei from cultured neurons. In the present work, we performed a detailed analysis of the intranuclear distribution of dystrophin 71 isoforms (Dp71d and Dp71f), during the temporal course of 7-day postnatal rats hippocampal neurons culture for lh, 2, 4, 10, 15 and 21 days in vitro (DIV). By immunofluorescence assays, we detected the highest level of nuclear expression of both dystrophin Dp71 isoforms at 10 DIV, during the temporal course of primary culture. Dp71d and Dp7lf were detected mainly in bipolar GABAergic (>= 60%) and multipolar Glutamatergic (<= 40%) neurons, respectively. We also characterized the existence of two nuclear dystrophin-associated protein complexes (DAPC): dystrophin 71d or dystrophin 71f bound to 6-dystroglycan, alpha 1-, beta-, alpha 2-dystrobrevins, a-syntrophin, and syntrophin-associated protein nNOS (Dp71d-DAPC or Dp71f-DAPC, respectively), in the hippocampal neurons. Furthermore, both complexes were localized in interchromatin granule cluster structures (nuclear speckles) of neuronal nucleoskeleton preparations. The present study evinces that each Dp71'5 complexes differ slightly in dystrobrevins composition. The results demonstrated that Dp71d-DAPC was mainly localized in bipolar GABAergic and Dp71f-DAPC in multipolar Glutamatergic hippocampal neurons. Taken together, our results show that dystrophin 71d, dystrophin 71f and DAP integrate protein complexes, and both complexes were associated to nuclear speckles structures.	[Rodriguez-Munoz, Rafael; Aleman, Victor; Osorio, Beatriz; Chavez-Gonzalez, Oscar; Martinez-Rojas, Dalila] CINVESTAV IPN, Natl Polytech Inst, Ctr Res & Adv Studies, Dept Physiol, Mexico City, DF, Mexico; [Rodriguez-Munoz, Rafael; Aleman, Victor; Osorio, Beatriz; Chavez-Gonzalez, Oscar; Martinez-Rojas, Dalila] CINVESTAV IPN, Natl Polytech Inst, Ctr Res & Adv Studies, Dept Biophys & Neurosci, Mexico City, DF, Mexico; [del Carmen Cardenas-Aguayo, Maria; Antonio Meraz-Rios, Marco] CINVESTAV IPN, Natl Polytech Inst, Ctr Res & Adv Studies, Mol Biomed, Mexico City, DF, Mexico; [Rendon, Alvaro] Univ Paris 06, UMR Inserm, Inst Vis, Lab Physiopathol Cellulaire & Mol Retine, Paris, France	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Martinez-Rojas, D (corresponding author), CINVESTAV IPN, Natl Polytech Inst, Ctr Res & Adv Studies, Dept Physiol, Mexico City, DF, Mexico.	damartin@fiso.cinvestav.mx; mmeraz@cinvestav.mx	del Carmen Cardenas-Aguayo, Maria/AAH-5073-2020; MERAZ RIOS, MARCO ANTONIO/F-4194-2016	del Carmen Cardenas-Aguayo, Maria/0000-0001-9156-2161; MERAZ RIOS, MARCO ANTONIO/0000-0001-6748-8117; Rodriguez-Munoz, Rafael/0000-0001-9668-052X	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico City [CB-2013-01 222193]	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico City(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This Study was funded by The Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico City. Grant Number: CB-2013-01 222193 (www.conacyt.mx). Authors who received the funding: MAMR MDCCA. The Founder CONACYT had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman V, 2001, HISTOCHEM CELL BIOL, V115, P243; Aquilano K, 2007, J NEUROCHEM, V101, P1327, DOI 10.1111/j.1471-4159.2006.04431.x; Aquilano K, 2014, J BIOL CHEM, V289, P365, DOI 10.1074/jbc.M113.506733; Aragon J, 2011, J NEUROCHEM, V119, P697, DOI 10.1111/j.1471-4159.2011.07347.x; Artegiani B, 2010, J BIOL CHEM, V285, P24740, DOI 10.1074/jbc.M109.090654; Austin RC, 2000, NEUROMUSCULAR DISORD, V10, P187, DOI 10.1016/S0960-8966(99)00105-4; Baldelli S, 2011, INT J BIOCHEM CELL B, V43, P163, DOI 10.1016/j.biocel.2010.10.016; Benabdesselam R, 2012, J ENDOCRINOL, V213, P239, DOI 10.1530/JOE-12-0066; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; BURRY RW, 1983, BRAIN RES, V261, P261, DOI 10.1016/0006-8993(83)90629-7; Chen YJ, 2003, BIOCHEM J, V375, P329, DOI 10.1042/BJ20030808; Claudepierre T, 1999, INVEST OPHTH VIS SCI, V40, P1520; Claudepierre T, 2000, J CELL SCI, V113, P3409; Daoud F, 2009, HUM MOL GENET, V18, P3779, DOI 10.1093/hmg/ddp320; DIAZBARRIGA F, 1989, TOXICOL IN VITRO, V3, P277, DOI 10.1016/0887-2333(89)90034-9; FABBRIZIO E, 1994, BIOCHEM J, V299, P359, DOI 10.1042/bj2990359; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Fort P, 2005, NEUROSCI RES, V53, P25, DOI 10.1016/j.neures.2005.05.007; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P283, DOI 10.1139/O08-133; Goldman Robert D., 2005, V264, P3, DOI 10.1002/0470093765.ch2; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; GORECKI DC, 1995, NEUROREPORT, V6, P893, DOI 10.1097/00001756-199504190-00017; Greenberg DS, 1996, HUM MOL GENET, V5, P1299, DOI 10.1093/hmg/5.9.1299; Gribbon C, 2002, EUR J CELL BIOL, V81, P557, DOI 10.1078/0171-9335-00275; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Higginson JR, 2005, BIOCHEM SOC T, V33, P1254, DOI 10.1042/BST0331254; Hnia K, 2006, NEUROSCIENCE, V141, P607, DOI 10.1016/j.neuroscience.2006.04.043; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kumeta Masahiro, 2012, Int J Cell Biol, V2012, P494902, DOI 10.1155/2012/494902; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Morales-Lazaro SL, 2010, J NEUROCHEM, V112, P474, DOI 10.1111/j.1471-4159.2009.06467.x; Martinez-Vieyra IA, 2013, BBA-MOL CELL RES, V1833, P698, DOI 10.1016/j.bbamcr.2012.11.019; Mathew G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02792; Meissner M, 2003, EXP CELL RES, V283, P184, DOI 10.1016/S0014-4827(02)00046-0; Miranda R, 2011, NEUROBIOL DIS, V43, P134, DOI 10.1016/j.nbd.2011.02.017; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Muschler J, 2002, CANCER RES, V62, P7102; Nickerson JA, 2001, J CELL SCI, V114, P463; NORTON PA, 1994, J CELL SCI, V107, P1; Oppizzi ML, 2008, TRAFFIC, V9, P2063, DOI 10.1111/j.1600-0854.2008.00822.x; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Rivier F, 1999, HISTOCHEM J, V31, P425, DOI 10.1023/A:1003805905456; Rodriguez-Munoz R, 2008, BIOCHEM BIOPH RES CO, V375, P303, DOI 10.1016/j.bbrc.2008.07.135; Royuela M, 2003, J MUSCLE RES CELL M, V24, P387, DOI 10.1023/A:1027309822007; Royuela M, 2003, EUR J HISTOCHEM, V47, P29; SadouletPuccio HM, 1997, P NATL ACAD SCI USA, V94, P12413, DOI 10.1073/pnas.94.23.12413; SEGAL M, 1983, J NEUROPHYSIOL, V50, P1249, DOI 10.1152/jn.1983.50.6.1249; Sgambato A, 2005, J CELL PHYSIOL, V205, P163, DOI 10.1002/jcp.20411; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Suarez-Sanchez R, 2014, BBA-MOL CELL RES, V1843, P985, DOI 10.1016/j.bbamcr.2014.01.027; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Tadayoni R, 2012, MOL NEUROBIOL, V45, P43, DOI 10.1007/s12035-011-8218-9; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Valtorta F, 2011, SEMIN CELL DEV BIOL, V22, P378, DOI 10.1016/j.semcdb.2011.07.008; Vasquez-Limeta A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090629; Villarreal-Silva M, 2010, NEUROCHEM RES, V35, P366, DOI 10.1007/s11064-009-0064-z; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283	71	14	14	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137328	10.1371/journal.pone.0137328	http://dx.doi.org/10.1371/journal.pone.0137328			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378780	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400014
J	Wakabayashi, K; Soga, K; Hoson, T; Kotake, T; Yamazaki, T; Higashibata, A; Ishioka, N; Shimazu, T; Fukui, K; Osada, I; Kasahara, H; Kamada, M				Wakabayashi, Kazuyuki; Soga, Kouichi; Hoson, Takayuki; Kotake, Toshihisa; Yamazaki, Takashi; Higashibata, Akira; Ishioka, Noriaki; Shimazu, Toru; Fukui, Keiji; Osada, Ikuko; Kasahara, Haruo; Kamada, Motoshi			Suppression of Hydroxycinnamate Network Formation in Cell Walls of Rice Shoots Grown under Microgravity Conditions in Space	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; FERULIC ACID; HYPERGRAVITY CONDITIONS; ARABIDOPSIS SEEDLINGS; WHEAT COLEOPTILES; ELONGATION GROWTH; LIGNIN FORMATION; GENE-EXPRESSION; DIFERULIC ACIDS; CROSS-LINKING	Network structures created by hydroxycinnamate cross-links within the cell wall architecture of gramineous plants make the cell wall resistant to the gravitational force of the earth. In this study, the effects of microgravity on the formation of cell wall-bound hydroxycinnamates were examined using etiolated rice shoots simultaneously grown under artificial 1 g and microgravity conditions in the Cell Biology Experiment Facility on the International Space Station. Measurement of the mechanical properties of cell walls showed that shoot cell walls became stiff during the growth period and that microgravity suppressed this stiffening. Amounts of cell wall polysaccharides, cell wall-bound phenolic acids, and lignin in rice shoots increased as the shoot grew. Microgravity did not influence changes in the amounts of cell wall polysaccharides or phenolic acid monomers such as ferulic acid (FA) and p-coumaric acid, but it suppressed increases in diferulic acid (DFA) isomers and lignin. Activities of the enzymes phenylalanine ammonia-lyase (PAL) and cell wall-bound peroxidase (CW-PRX) in shoots also increased as the shoot grew. PAL activity in microgravity-grown shoots was almost comparable to that in artificial 1 g-grown shoots, while CW-PRX activity increased less in microgravity-grown shoots than in artificial 1 g-grown shoots. Furthermore, the increases in expression levels of some class III peroxidase genes were reduced under microgravity conditions. These results suggest that a microgravity environment modifies the expression levels of certain class III peroxidase genes in rice shoots, that the resultant reduction of CW-PRX activity may be involved in suppressing DFA formation and lignin polymerization, and that this suppression may cause a decrease in cross-linkages within the cell wall architecture. The reduction in intra-network structures may contribute to keeping the cell wall loose under microgravity conditions.	[Wakabayashi, Kazuyuki; Soga, Kouichi; Hoson, Takayuki] Osaka City Univ, Grad Sch Sci, Dept Biol Sci, Sumiyoshi Ku, Osaka 558, Japan; [Kotake, Toshihisa] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Sakura Ku, Saitama 3388570, Japan; [Yamazaki, Takashi; Higashibata, Akira; Ishioka, Noriaki] Japan Aerosp Explorat Agcy JAXA, Tsukuba, Ibaraki, Japan; [Shimazu, Toru; Fukui, Keiji] Japan Space Forum, Chiyoda Ku, Tokyo, Japan; [Osada, Ikuko; Kasahara, Haruo] Japan Manned Space Syst Corp, Tsuchiura, Ibaraki, Japan; [Kamada, Motoshi] Adv Engn Serv Co Ltd, Tsukuba, Ibaraki, Japan	Osaka Metropolitan University; Saitama University; Japan Aerospace Exploration Agency (JAXA); Advanced Engineering Services Co., Ltd. (A.E.S.)	Wakabayashi, K (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol Sci, Sumiyoshi Ku, Osaka 558, Japan.	wakaba@sci.osaka-cu.ac.jp	shimazu, Toru/AAA-5311-2020; KOTAKE, TOSHIHISA/F-1117-2011	shimazu, Toru/0000-0003-0343-8035; KOTAKE, TOSHIHISA/0000-0002-1110-5006	JAXA; Japan Space Forum; Japan Manned Space Systems Corp.; Advanced Engineering Services Co., Ltd.	JAXA; Japan Space Forum; Japan Manned Space Systems Corp.; Advanced Engineering Services Co., Ltd.	The experimental cost for this study was funded by JAXA. Japan Space Forum, Japan Manned Space Systems Corp., and Advanced Engineering Services Co., Ltd. provided support in the form of salaries for authors TS, KF, IO, HK, and MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FRY SC, 1986, ANNU REV PLANT PHYS, V37, P165, DOI 10.1146/annurev.arplant.37.1.165; Gonzalez LF, 1999, PHYTOCHEMISTRY, V50, P711, DOI 10.1016/S0031-9422(98)00611-6; GRABBER JH, 1995, PHYTOCHEMISTRY, V40, P1077, DOI 10.1016/0031-9422(95)00413-2; Hausmann N, 2014, PLANT BIOLOGY, V16, P120, DOI 10.1111/plb.12051; Hoson T, 1996, J EXP BOT, V47, P513, DOI 10.1093/jxb/47.4.513; Hoson T, 2003, INT REV CYTOL, V229, P209, DOI 10.1016/S0074-7696(03)29005-7; Hoson T, 2002, J PLANT RES, V115, P277, DOI 10.1007/s10265-002-0035-9; Hoson T, 2002, PLANT CELL PHYSIOL, V43, P1067, DOI 10.1093/pcp/pcf126; Hoson T, 1999, J PLANT RES, V112, P477, DOI 10.1007/PL00013903; Hoson T., 2006, J GRAVIT PHYSL, V13, P97; Hoson Takayuki, 2000, P137; Hoson T, 2015, PHYTOCHEMISTRY, V112, P84, DOI 10.1016/j.phytochem.2014.08.022; Hossain MT, 2007, J PLANT PHYSIOL, V164, P385, DOI 10.1016/j.jplph.2006.02.003; Jiang JL, 2012, PLANT PHYSIOL BIOCH, V53, P84, DOI 10.1016/j.plaphy.2012.01.017; KAMISAKA S, 1990, PHYSIOL PLANTARUM, V78, P1; Kawamura Y, 2000, J PLANT PHYSIOL, V156, P689, DOI 10.1016/S0176-1617(00)80233-3; Kwon T, 2015, AM J BOT, V102, P21, DOI 10.3732/ajb.1400458; Levine LH, 2001, PHYTOCHEMISTRY, V57, P835, DOI 10.1016/S0031-9422(01)00148-0; Masuda Y, 1990, BOT MAG TOKYO, V103, P103; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Obel N, 2002, PHYTOCHEMISTRY, V60, P603, DOI 10.1016/S0031-9422(02)00148-6; Parr AJ, 1996, J SCI FOOD AGR, V71, P501, DOI 10.1002/(SICI)1097-0010(199608)71:4<501::AID-JSFA608>3.0.CO;2-L; Parvez MM, 1997, PHYSIOL PLANTARUM, V99, P39, DOI 10.1034/j.1399-3054.1997.990106.x; Passardi F, 2004, PHYTOCHEMISTRY, V65, P1879, DOI 10.1016/j.phytochem.2004.06.023; RICHTZENHAIN H, 1949, CHEM BER-RECL, V82, P447, DOI 10.1002/cber.19490820602; SAKURAI N, 1991, BOT MAG TOKYO, V104, P235, DOI 10.1007/BF02489456; Saulnier L, 1999, CARBOHYD RES, V320, P82, DOI 10.1016/S0008-6215(99)00152-4; Saulnier L, 1999, J SCI FOOD AGR, V79, P396, DOI [10.1002/(SICI)1097-0010(19990301)79:3<396::AID-JSFA262>3.0.CO;2-B, 10.1002/(SICI)1097-0010(19990301)79:3&lt;396::AID-JSFA262&gt;3.0.CO;2-B]; SMITH MM, 1983, CARBOHYD RES, V118, P65, DOI 10.1016/0008-6215(83)88036-7; Soga K, 1999, PLANT CELL PHYSIOL, V40, P581, DOI 10.1093/oxfordjournals.pcp.a029580; Tamaoki D, 2006, J PLANT RES, V119, P79, DOI 10.1007/s10265-005-0243-1; Tamaoki D, 2011, J EXP BOT, V62, P5463, DOI 10.1093/jxb/err224; TAN KS, 1992, PLANT CELL PHYSIOL, V33, P103; TAN KS, 1991, PHYSIOL PLANTARUM, V83, P397, DOI 10.1111/j.1399-3054.1991.tb00111.x; Volkmann D, 2006, PROTOPLASMA, V229, P143, DOI 10.1007/s00709-006-0200-4; Wakabayashi K, 1997, PLANT PHYSIOL, V113, P967, DOI 10.1104/pp.113.3.967; Wakabayashi K, 2005, PHYSIOL PLANTARUM, V125, P127, DOI 10.1111/j.1399-3054.2005.00544.x; Wakabayashi K, 2012, J PLANT PHYSIOL, V169, P262, DOI 10.1016/j.jplph.2011.10.002; Wakabayashi K, 2011, J PLANT PHYSIOL, V168, P1997, DOI 10.1016/j.jplph.2011.05.010; Wakabayashi K, 2009, J PLANT PHYSIOL, V166, P947, DOI 10.1016/j.jplph.2008.12.006; Waldron KW, 1996, PHYTOCHEM ANALYSIS, V7, P305, DOI 10.1002/(SICI)1099-1565(199611)7:6&lt;305::AID-PCA320&gt;3.0.CO;2-A; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; YAMAMOTO R, 1970, PLANT CELL PHYSIOL, V11, P947, DOI 10.1093/oxfordjournals.pcp.a074586; Yano S, 2012, BIOL SCI SPACE, V26, P12	47	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137992	10.1371/journal.pone.0137992	http://dx.doi.org/10.1371/journal.pone.0137992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378793	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400042
J	Liu, TR; Xiao, T; Li, XY; Shi, JN				Liu, Tongran; Xiao, Tong; Li, Xiaoyan; Shi, Jiannong			Fluid Intelligence and Automatic Neural Processes in Facial Expression Perception: An Event-Related Potential Study	PLOS ONE			English	Article							VISUAL MISMATCH NEGATIVITY; EMOTIONAL INTELLIGENCE; SOCIOECONOMIC-STATUS; WORKING-MEMORY; MENTAL-ABILITY; FACES; DISCRIMINATION; PERSONALITY; MECHANISMS; PREDICTION	The relationship between human fluid intelligence and social-emotional abilities has been a topic of considerable interest. The current study investigated whether adolescents with different intellectual levels had different automatic neural processing of facial expressions. Two groups of adolescent males were enrolled: a high IQ group and an average IQ group. Age and parental socioeconomic status were matched between the two groups. Participants counted the numbers of the central cross changes while paired facial expressions were presented bilaterally in an oddball paradigm. There were two experimental conditions: a happy condition, in which neutral expressions were standard stimuli (p = 0.8) and happy expressions were deviant stimuli (p = 0.2), and a fearful condition, in which neutral expressions were standard stimuli (p = 0.8) and fearful expressions were deviant stimuli (p = 0.2). Participants were required to concentrate on the primary task of counting the central cross changes and to ignore the expressions to ensure that facial expression processing was automatic. Event-related potentials (ERPs) were obtained during the tasks. The visual mismatch negativity (vMMN) components were analyzed to index the automatic neural processing of facial expressions. For the early vMMN (50-130 ms), the high IQ group showed more negative vMMN amplitudes than the average IQ group in the happy condition. For the late vMMN (320-450 ms), the high IQ group had greater vMMN responses than the average IQ group over frontal and occipito-temporal areas in the fearful condition, and the average IQ group evoked larger vMMN amplitudes than the high IQ group over occipito-temporal areas in the happy condition. The present study elucidated the close relationships between fluid intelligence and pre-attentive change detection on social-emotional information.	[Liu, Tongran; Li, Xiaoyan; Shi, Jiannong] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Xiao, Tong] Northeastern Univ, Coll Informat Sci & Engn, Nat Language Proc Lab, Liaoning 110819, Peoples R China; [Shi, Jiannong] Aalborg Univ, Dept Learning & Philosophy, Aalborg, Denmark	Chinese Academy of Sciences; Institute of Psychology, CAS; Northeastern University - China; Aalborg University	Liu, TR (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	liutr@psych.ac.cn; shijn@psych.ac.cn	Xiao, Tong/AAP-5944-2020		National Natural Science Foundation of China [31370020]; Natural Science Foundation for the Youth of China [31000468]; Scientific Foundation of Institute of Psychology; Chinese Academy of Sciences for Outstanding Doctoral Dissertation; President Award of Chinese Academy of Sciences [Y0CX272B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for the Youth of China; Scientific Foundation of Institute of Psychology; Chinese Academy of Sciences for Outstanding Doctoral Dissertation; President Award of Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (Grant No. 31370020), the Natural Science Foundation for the Youth of China (Grant No. 31000468), the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences for Outstanding Doctoral Dissertation and President Award of Chinese Academy of Sciences (No. Y0CX272B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Astikainen P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00557; Astikainen P, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-30; Austin EJ, 2002, PERS INDIV DIFFER, V32, P1391, DOI 10.1016/S0191-8869(01)00129-5; Barrett LF, 2010, PSYCHOL SCI, V21, P595, DOI 10.1177/0956797610363547; Beauchamp CM, 2006, INTELLIGENCE, V34, P571, DOI 10.1016/j.intell.2006.03.007; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Burnett S, 2011, NEUROSCI BIOBEHAV R, V35, P1654, DOI 10.1016/j.neubiorev.2010.10.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Campanella S, 2002, J COGNITIVE NEUROSCI, V14, P210, DOI 10.1162/089892902317236858; Campanella S, 2012, PSYCHIAT RES, V197, P145, DOI 10.1016/j.psychres.2011.12.026; Casey BJ, 2010, NEURON, V67, P749, DOI 10.1016/j.neuron.2010.08.033; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Chang Y, 2010, NEUROSCI LETT, V472, P33, DOI 10.1016/j.neulet.2010.01.050; Colom R, 2013, NEUROIMAGE, V72, P143, DOI 10.1016/j.neuroimage.2013.01.032; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Coplan Jeremy D, 2011, Front Evol Neurosci, V3, P8, DOI 10.3389/fnevo.2011.00008; Csukly G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075444; Czigler I, 2007, J PSYCHOPHYSIOL, V21, P224, DOI 10.1027/0269-8803.21.34.224; Czigler I, 2010, ADV CONSC RES, V78, P107; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P294, DOI 10.1196/annals.1308.034; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2005, INTELLIGENCE, V33, P455, DOI 10.1016/j.intell.2005.06.003; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Duncan J, 2003, NAT NEUROSCI, V6, P207, DOI 10.1038/nn0303-207; Fiori M, 2012, INTELLIGENCE, V40, P245, DOI 10.1016/j.intell.2012.02.004; Fujimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063703; Gardner Howard, 1983, FRAMES MIND THEORY M; Gayle LC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00334; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Green AE, 2013, CEREB CORTEX, V23, P552, DOI 10.1093/cercor/bhs035; Houlihan M, 2012, INTELLIGENCE, V40, P239, DOI 10.1016/j.intell.2012.02.003; Kimura M, 2012, CEREB CORTEX, V22, P1774, DOI 10.1093/cercor/bhr244; Konstantopoulos S, 2001, AM J EDUC, V109, P344, DOI 10.1086/444275; Kreegipuu K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00714; Li XY, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-7; Liu T, 2011, NEUROSCIENCE, V180, P122, DOI 10.1016/j.neuroscience.2011.02.022; Liu T, 2007, NEUROREPORT, V18, P1571, DOI 10.1097/WNR.0b013e3282ef7640; Liu TR, 2015, NEUROSCI LETT, V592, P22, DOI 10.1016/j.neulet.2015.02.062; Liu TR, 2011, NEUROSCI LETT, V490, P101, DOI 10.1016/j.neulet.2010.12.035; Lubinski D, 2000, AM PSYCHOL, V55, P137, DOI 10.1037/0003-066X.55.1.137; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Mayer JD, 1999, INTELLIGENCE, V27, P267, DOI 10.1016/S0160-2896(99)00016-1; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Raven, 2010, RAVENS PROGRESSIVE M; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Scherf KS, 2011, CORTEX, V21, P1663, DOI DOI 10.1016/J.BANDC.2009.10.003; Schweizer K, 2004, INTELLIGENCE, V32, P329, DOI 10.1016/j.intell.2004.06.006; Sculthorpe LD, 2009, INTELLIGENCE, V37, P405, DOI 10.1016/j.intell.2009.03.006; Spearman C., 1927, ABILITIES MAN; Stefanics G, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01074; Stefanics G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00666; Stefanics G, 2012, NEUROIMAGE, V63, P253, DOI 10.1016/j.neuroimage.2012.06.068; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Sternberg RobertJ., 2000, HDB INTELLIGENCE, DOI [10.1017/CBO9780511807947, DOI 10.1017/CBO9780511807947]; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Susac A, 2004, BRAIN TOPOGR, V16, P265; Terman LM., 1925, MENTAL PHYS TRAITS 1; Todd J, 2010, BRAIN RES, V1310, P113, DOI 10.1016/j.brainres.2009.11.019; Toyomaki A, 2008, PROG NEURO-PSYCHOPH, V32, P95, DOI 10.1016/j.pnpbp.2007.07.020; Troche SJ, 2010, PERS INDIV DIFFER, V49, P228, DOI 10.1016/j.paid.2010.03.040; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; Wartenburger I, 2010, INTELLIGENCE, V38, P193, DOI 10.1016/j.intell.2009.11.001; Zeidner M, 2005, INTELLIGENCE, V33, P369, DOI 10.1016/j.intell.2005.03.001; Zhao L, 2006, NEUROSCI LETT, V410, P126, DOI 10.1016/j.neulet.2006.09.081	68	6	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138199	10.1371/journal.pone.0138199	http://dx.doi.org/10.1371/journal.pone.0138199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26375031	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200086
J	Yao, F; Zhang, C; Du, W; Liu, C; Xu, Y				Yao, Fang; Zhang, Chi; Du, Wei; Liu, Chao; Xu, Ying			Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BIOMARKER; SELECTION; TARGET; SUPPRESSION; PROGNOSIS; INVASION; GROWTH; LEVEL; BASAL	The grade of a cancer is a measure of the cancer's malignancy level, and the stage of a cancer refers to the size and the extent that the cancer has spread. Here we present a computational method for prediction of gene signatures and blood/urine protein markers for breast cancer grades and stages based on RNA-seq data, which are retrieved from the TCGA breast cancer dataset and cover 111 pairs of disease and matching adjacent noncancerous tissues with pathologists-assigned stages and grades. By applying a differential expression and an SVM-based classification approach, we found that 324 and 227 genes in cancer have their expression levels consistently up-regulated vs. their matching controls in a grade-and stage-dependent manner, respectively. By using these genes, we predicted a 9-gene panel as a gene signature for distinguishing poorly differentiated from moderately and well differentiated breast cancers, and a 19-gene panel as a gene signature for discriminating between the moderately and well differentiated breast cancers. Similarly, a 30-gene panel and a 21-gene panel are predicted as gene signatures for distinguishing advanced stage (stages III-IV) from early stage (stages I-II) cancer samples and for distinguishing stage II from stage I samples, respectively. We expect these gene panels can be used as gene-expression signatures for cancer grade and stage classification. In addition, of the 324 grade-dependent genes, 188 and 66 encode proteins that are predicted to be blood-secretory and urine-excretory, respectively; and of the 227 stage-dependent genes, 123 and 51 encode proteins predicted to be blood-secretory and urine-excretory, respectively. We anticipate that some combinations of these blood and urine proteins could serve as markers for monitoring breast cancer at specific grades and stages through blood and urine tests.	[Yao, Fang; Du, Wei; Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China; [Yao, Fang; Zhang, Chi; Du, Wei; Liu, Chao; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Yao, Fang; Zhang, Chi; Du, Wei; Liu, Chao; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Liu, Chao] Shandong Univ, Shandong Prov Hosp, Dept Oral & Maxillofacial Surg, Jinan 250100, Peoples R China; [Yao, Fang] Jilin Teachers Inst Engn & Technol, Changchun, Peoples R China	Jilin University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Du, W (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China.	weidu@jlu.edu.cn; xyn@bmb.uga.edu	Zhang, Chi/AAD-3036-2021	Zhang, Chi/0000-0001-9553-0925	Natural Science Foundation of China [81320108025, 61402194, 61572227]; Ph.D. Program Foundation of MOE of China [20120061120106]; China Postdoctoral Science Foundation [2014T70291]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Program Foundation of MOE of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the Natural Science Foundation of China, 81320108025, http://www.nsfc.gov.cn/ Natural Science Foundation of China, 61402194, http://www.nsfc.gov.cn/, award number: 61572227, recipient: Ying Xu; the Ph.D. Program Foundation of MOE of China, 20120061120106, http://www.cutech.edu.cn/cn/index.htm China Postdoctoral Science Foundation, 2014T70291, http://res.chinapostdoctor.org.cn/BshWeb/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Beltran AS, 2014, ONCOGENE, V33, P4767, DOI 10.1038/onc.2013.422; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigbee W, 2003, CANC MED; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Boelens MC, 2009, J PATHOL, V218, P182, DOI 10.1002/path.2520; Boyle P., 2008, World Cancer Report 2008; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Castro M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-86; Chakrabarti A, 2015, TRENDS PHARMACOL SCI, V36, P481, DOI 10.1016/j.tips.2015.04.013; Chen Jie Qing, 2011, Hormones & Cancer, V2, P132, DOI 10.1007/s12672-011-0067-5; Chen SC, 2012, J PATHOL, V228, P158, DOI 10.1002/path.3988; Chen X, 2015, ONCOL LETT, V9, P2143, DOI 10.3892/ol.2015.3004; Chen X, 2012, CANCER RES, V72, P2294, DOI 10.1158/0008-5472.CAN-11-2181; Crichton N, 2000, J CLIN NURS, V9, P584; Cui J, 2008, BIOINFORMATICS, V24, P2370, DOI 10.1093/bioinformatics/btn418; Cui JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017819; Dijkstra S, 2014, CLIN BIOCHEM, V47, P889, DOI 10.1016/j.clinbiochem.2013.10.023; Dougherty ER, 2012, BIOESSAYS, V34, P277, DOI 10.1002/bies.201200003; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Elston C W, 2002, Histopathology, V41, P154; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gast MCW, 2009, BREAST CANCER RES TR, V116, P17, DOI 10.1007/s10549-008-0263-3; Gauthier TD, 2001, ENVIRON FORENSICS, V2, P359, DOI 10.1006/enfo.2001.0061; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hix LM, 2013, J BIOL CHEM, V288, P11676, DOI 10.1074/jbc.M112.441402; Hong CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016875; Hu LD, 2008, ONCOL REP, V19, P1015; Hudler P, 2014, SCI WORLD J, DOI 10.1155/2014/260348; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Ishizaki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01528; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kelemen LE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2201; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kongkham PN, 2008, CANCER RES, V68, P9945, DOI 10.1158/0008-5472.CAN-08-2169; Leeming DJ, 2006, CANCER EPIDEM BIOMAR, V15, P1392, DOI 10.1158/1055-9965.EPI-05-0909; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; Liu Y, 2013, INT J MOL MED, V31, P855, DOI 10.3892/ijmm.2013.1279; Majid SM, 2006, ONCOGENE, V25, P756, DOI 10.1038/sj.onc.1209107; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Rodriguez-Pinto D, 2009, CANCER IMMUNOL IMMUN, V58, P221, DOI 10.1007/s00262-008-0543-0; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; Sharma S, 2009, INDIAN J MED PAEDIAT, V30, P1, DOI 10.4103/0971-5851.56328; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Souza B, 2004, GENE, V4, P599; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vickers Andrew J, 2005, BMC Med Res Methodol, V5, P35, DOI 10.1186/1471-2288-5-35; Wakefield L, 2008, GENE CHROMOSOME CANC, V47, P118, DOI 10.1002/gcc.20512; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Xu HL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2814; Xu Y, CANC BIOINFORMATICS; Yang ZP, 2006, CLIN CHEM, V52, P1897, DOI 10.1373/clinchem.2005.065862; Zhang C., 2014, QUANT BIOL, V2, P85, DOI [10.1007/s40484-014-0032-8, DOI 10.1007/S40484-014-0032-8]; Zhang C, 2015, J MOL CELL BIOL, V7, P267, DOI 10.1093/jmcb/mjv031; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036	61	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138213	10.1371/journal.pone.0138213	http://dx.doi.org/10.1371/journal.pone.0138213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375396	gold, Green Submitted, Green Published			2022-12-26	WOS:000361610200088
J	Kim, YC; Chen, CC; Bolton, EC				Kim, Young-Chae; Chen, Congcong; Bolton, Eric C.			Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells	PLOS ONE			English	Article							CANCER CELLS; CYCLIN D3; DOWN-REGULATION; LNCAP CELLS; POINT MUTATIONS; APOPTOTIC DEATH; FACTOR-I; PROLIFERATION; EXPRESSION; GENE	The androgen receptor (AR) mediates the developmental, physiologic, and pathologic effects of androgens including 5 alpha-dihydrotestosterone (DHT). However, the mechanisms whereby AR regulates growth suppression and differentiation of luminal epithelial cells in the prostate gland and proliferation of malignant versions of these cells are not well understood, though they are central to prostate development, homeostasis, and neoplasia. Here, we identify androgen-responsive genes that restrain cell cycle progression and proliferation of human prostate epithelial cell lines (HPr-1AR and PC3-Lenti-AR), and we investigate the mechanisms through which AR regulates their expression. DHT inhibited proliferation of HPr-1AR and PC3-Lenti-AR, and cell cycle analysis revealed a prolonged G(1) interval. In the cell cycle, the G(1)/S-phase transition is initiated by the activity of cyclin D and cyclin-dependent kinase (CDK) complexes, which relieve growth suppression. In HPr-1AR, cyclin D1/2 and CDK4/6 mRNAs were androgen-repressed, whereas CDK inhibitor, CDKN1A, mRNA was androgen-induced. The regulation of these transcripts was AR-dependent, and involved multiple mechanisms. Similar AR-mediated down-regulation of CDK4/6 mRNAs and up-regulation of CDKN1A mRNA occurred in PC3-Lenti-AR. Further, CDK4/6 overexpression suppressed DHT-inhibited cell cycle progression and proliferation of HPr-1AR and PC3-Lenti-AR, whereas CDKN1A overexpression induced cell cycle arrest. We therefore propose that AR-mediated growth suppression of HPr-1AR involves cyclin D1 mRNA decay, transcriptional repression of cyclin D2 and CDK4/6, and transcriptional activation of CDKN1A, which serve to decrease CDK4/6 activity. AR-mediated inhibition of PC3-Lenti-AR proliferation occurs through a similar mechanism, albeit without down-regulation of cyclin D. Our findings provide insight into AR-mediated regulation of prostate epithelial cell proliferation.	[Kim, Young-Chae; Chen, Congcong; Bolton, Eric C.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Bolton, EC (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA.	boltonec@life.illinois.edu		Kim, Young-Chae/0000-0002-5130-4413	University of Illinois at Urbana-Champaign	University of Illinois at Urbana-Champaign	This work was supported by University of Illinois at Urbana-Champaign startup funds to ECB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; Bartkova J, 1998, ONCOGENE, V17, P1027, DOI 10.1038/sj.onc.1202016; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; BONKHOFF H, 1993, VIRCHOWS ARCH A, V422, P35, DOI 10.1007/BF01605130; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; CARROLL AG, 1993, PROSTATE, V23, P123, DOI 10.1002/pros.2990230206; Chen Y, 1998, ONCOGENE, V16, P1913, DOI 10.1038/sj.onc.1201719; Choo CK, 1999, PROSTATE, V40, P150, DOI 10.1002/(SICI)1097-0045(19990801)40:3<150::AID-PROS2>3.0.CO;2-7; Claessens F, 2001, J STEROID BIOCHEM, V76, P23, DOI 10.1016/S0960-0760(00)00154-0; D'Antonio JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011475; De Santa F, 2007, MOL CELL BIOL, V27, P7248, DOI 10.1128/MCB.02199-06; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; DELANY AM, 1995, ENDOCRINOLOGY, V136, P4776, DOI 10.1210/en.136.11.4776; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; France KA, 2011, J BIOL CHEM, V286, P22750, DOI 10.1074/jbc.M111.225433; Friedlander TW, 2012, UROL CLIN N AM, V39, P453, DOI 10.1016/j.ucl.2012.07.003; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Galindo CL, 2004, J BIOL CHEM, V279, P37597, DOI 10.1074/jbc.M404641200; Georgieva J, 2001, J CLIN PATHOL, V54, P229, DOI 10.1136/jcp.54.3.229; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; HARPER JW, 1993, CELL, V75, P805; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Heisler LE, 1997, MOL CELL ENDOCRINOL, V126, P59, DOI 10.1016/S0303-7207(96)03970-6; Henderson L, 2013, AM J PHYSIOL-CELL PH, V304, pC927, DOI 10.1152/ajpcell.00006.2013; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; HOSOKAWA Y, 1995, CANCER LETT, V93, P165, DOI 10.1016/0304-3835(95)03805-7; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; ISAACS JT, 1994, SEMIN CANCER BIOL, V5, P391; KIESS M, 1995, ONCOGENE, V10, P159; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kurita T, 2001, CELL DEATH DIFFER, V8, P192, DOI 10.1038/sj.cdd.4400797; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; Lanzino M, 2010, NUCLEIC ACIDS RES, V38, P5351, DOI 10.1093/nar/gkq278; Le H, 2006, AM J PHYSIOL-ENDOC M, V290, pE952, DOI 10.1152/ajpendo.00451.2005; Lee SO, 2012, J ENDOCRINOL, V213, P173, DOI 10.1530/JOE-11-0474; Ling MT, 2001, J ENDOCRINOL, V170, P287, DOI 10.1677/joe.0.1700287; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Lu FM, 2003, CANCER RES, V63, P7056; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Lu S, 1997, CANCER RES, V57, P4511; Lu WQ, 1999, J BIOL CHEM, V274, P12827, DOI 10.1074/jbc.274.18.12827; MARCELLI M, 1995, ENDOCRINOLOGY, V136, P1040, DOI 10.1210/en.136.3.1040; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Mirochnik Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031052; Mirosevich J, 1999, J ENDOCRINOL, V162, P341, DOI 10.1677/joe.0.1620341; Nesslinger NJ, 2003, CANCER RES, V63, P2228; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Ohlson N, 2006, PROSTATE, V66, P1687, DOI 10.1002/pros.20368; Pernicova Z, 2011, NEOPLASIA, V13, P526, DOI 10.1593/neo.11182; Planz B, 1999, PROSTATE, V41, P233; Pozzobon A, 2012, INT J MOL MED, V30, P967, DOI 10.3892/ijmm.2012.1082; Ratliff Timothy L, 2005, J Urol, V174, P1149; Recchia AG, 2009, INT J BIOCHEM CELL B, V41, P603, DOI 10.1016/j.biocel.2008.07.004; REDDY GPV, 1994, J CELL BIOCHEM, V54, P379, DOI 10.1002/jcb.240540404; Rojas P, 2009, MOL CARCINOGEN, V48, P508, DOI 10.1002/mc.20489; RUBIN SJ, 1991, J SURG ONCOL, V46, P31, DOI 10.1002/jso.2930460108; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Srivastava SK, 2012, CARCINOGENESIS, V33, P1149, DOI 10.1093/carcin/bgs134; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899; Taneja SS, 2002, J CELL BIOCHEM, V84, P188, DOI 10.1002/jcb.1278; TILLEY WD, 1995, STEROIDS, V60, P180, DOI 10.1016/0039-128X(94)00031-7; Tzur A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016053; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; Whitacre DC, 2002, CELL GROWTH DIFFER, V13, P1; Wiestner A, 2007, BLOOD, V109, P4599, DOI 10.1182/blood-2006-08-039859; Wikstrom P, 1999, PROSTATE, V38, P268; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; YAN GC, 1992, MOL ENDOCRINOL, V6, P2123, DOI 10.1210/me.6.12.2123; YUAN SX, 1993, CANCER RES, V53, P1304; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhou Y, 2015, J MOL ENDOCRINOL, V54, pR15, DOI 10.1530/JME-14-0203	93	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138286	10.1371/journal.pone.0138286	http://dx.doi.org/10.1371/journal.pone.0138286			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372468	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400062
J	Lee, TY; Huang, JC; Lee, JY; Jien, SH; Zehetner, F; Kao, SJ				Lee, Tsung-Yu; Huang, Jr-Chuan; Lee, Jun-Yi; Jien, Shih-Hao; Zehetner, Franz; Kao, Shuh-Ji			Magnified Sediment Export of Small Mountainous Rivers in Taiwan: Chain Reactions from Increased Rainfall Intensity under Global Warming	PLOS ONE			English	Article							PARTICULATE ORGANIC-CARBON; FLUVIAL SEDIMENT; TRANSPORT; OCEAN; DISCHARGE; EROSION; TRENDS; PRECIPITATION; TEMPERATURE; FLUXES	Fluvial sediment export from small mountainous rivers in Oceania has global biogeochemical significance affecting the turnover rate and export of terrestrial carbon, which might be speeding up at the recognized conditions of increased rainfall intensity. In this study, the historical runoff and sediment export from 16 major rivers in Taiwan are investigated and separated into an early stage (1970-1989) and a recent stage (1990-2010) to illustrate the changes of both runoff and sediment export. The mean daily sediment export from Taiwan Island in the recent stage significantly increased by >80% with subtle increase in daily runoff, indicating more sediment being delivered to the ocean per unit of runoff in the recent stage. The medians of the runoff depth and sediment yield extremes (99.0-99.9 percentiles) among the 16 rivers increased by 6.5%-37% and 62%-94%, respectively, reflecting the disproportionately magnified response of sediment export to the increased runoff. Taiwan is facing increasing event rainfall intensity which has resulted in chain reactions on magnified runoff and sediment export responses. As the globe is warming, rainfall extremes, which are proved to be temperature-dependent, very likely intensify runoff and trigger more sediment associated hazards. Such impacts might occur globally because significant increases of high-intensity precipitation have been observed not only in Taiwan but over most land areas of the globe.	[Lee, Tsung-Yu] Natl Taiwan Normal Univ, Dept Geog, Taipei, Taiwan; [Huang, Jr-Chuan; Lee, Jun-Yi] Natl Taiwan Univ, Dept Geog, Taipei 10764, Taiwan; [Jien, Shih-Hao] Natl Pingtung Univ Sci & Technol, Dept Soil & Water Conservat, Pingtung, Taiwan; [Zehetner, Franz] Univ Nat Resources & Life Sci, Inst Soil Res, Vienna, Austria; [Kao, Shuh-Ji] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	National Taiwan Normal University; National Taiwan University; National Pingtung University Science & Technology; University of Natural Resources & Life Sciences, Vienna; Xiamen University	Lee, TY (corresponding author), Natl Taiwan Normal Univ, Dept Geog, Taipei, Taiwan.	tylee@ntnu.edu.tw	Lee, Jun-Yi/AAL-9645-2021	Lee, Jun-Yi/0000-0002-4442-0264; Huang, Jr-Chuan/0000-0001-6589-4963	Ministry of Science and Technology [102-2923-M-002-001-MY3, 103-2119-M-003-006]; Austrian Science Fund (FWF) [I 1396-B16]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Ministry of Science and Technology (102-2923-M-002-001-MY3, 103-2119-M-003-006)(http://www.most.gov.tw/) and by the Austrian Science Fund (FWF): I 1396-B16 (http://www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey AE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023159; Carey AE, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015690; Carter L., 2009, UNEP WCMC BIODIVERSI, V31; Chen JC, 2014, NAT HAZARD EARTH SYS, V14, P1719, DOI 10.5194/nhess-14-1719-2014; Chen YC, 2012, EARTH SURF PROCESSES, V38, P372; Chen YC, 2013, EARTH SURF PROC LAND, V38, P372, DOI 10.1002/esp.3284; Chien FC, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015092; Chou C, 2013, NAT GEOSCI, V6, P263, DOI [10.1038/NGEO1744, 10.1038/ngeo1744]; Dadson S, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000244; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Dadson SJ, 2004, GEOLOGY, V32, P733, DOI 10.1130/G20639.1; Gabet EJ, 2007, EARTH PLANET SC LETT, V264, P259, DOI 10.1016/j.epsl.2007.09.028; Galy V, 2008, GEOCHIM COSMOCHIM AC, V72, P1767, DOI 10.1016/j.gca.2008.01.027; Goldsmith ST, 2008, GEOLOGY, V36, P483, DOI 10.1130/G24624A.1; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Hilton RG, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004314; Hilton RG, 2011, GEOLOGY, V39, P71, DOI 10.1130/G31352.1; Hilton RG, 2010, GEOCHIM COSMOCHIM AC, V74, P3164, DOI 10.1016/j.gca.2010.03.004; Hovius N, 2000, J GEOL, V108, P73, DOI 10.1086/314387; Hovius N, 2011, EARTH PLANET SC LETT, V304, P347, DOI 10.1016/j.epsl.2011.02.005; Huang JC, 2007, NAT HAZARD EARTH SYS, V7, P781, DOI 10.5194/nhess-7-781-2007; Huang JC, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034008; Kao SJ, 2008, J GEOL, V116, P431, DOI 10.1086/590921; Kao SJ, 2014, EARTH SURF DYNAM, V2, P127, DOI 10.5194/esurf-2-127-2014; Kao SJ, 2006, CONT SHELF RES, V26, P2520, DOI 10.1016/j.csr.2006.07.030; Kao SJ, 2005, TERR ATMOS OCEAN SCI, V16, P653, DOI 10.3319/TAO.2005.16.3.653(T); Kao SJ, 2005, J GEOL, V113, P217, DOI 10.1086/427670; Kao SJ, 1996, LIMNOL OCEANOGR, V41, P1749, DOI 10.4319/lo.1996.41.8.1749; Kao SJ, 2011, IAHS PUBL, V349; Karl TR, 1998, B AM METEOROL SOC, V79, P231, DOI 10.1175/1520-0477(1998)079<0231:STOPAF>2.0.CO;2; Lin CH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044685; Lin GW, 2008, EARTH SURF PROC LAND, V33, P1354, DOI 10.1002/esp.1716; Liu SC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040218; Lyons WB, 2002, GEOLOGY, V30, P443, DOI 10.1130/0091-7613(2002)030<0443:OCFTTO>2.0.CO;2; Manton MJ, 2001, INT J CLIMATOL, V21, P269, DOI 10.1002/joc.610; Milliman J.D., 2013, RIVER DISCHARGE COAS; Milliman JD, 2005, J GEOL, V113, P503, DOI 10.1086/431906; Neil DT, 2002, MAR FRESHWATER RES, V53, P733, DOI 10.1071/MF00151; Rabalais NN, 2007, ECOL APPL, V17, pS129, DOI 10.1890/06-0644.1; Schlunz B, 2000, INT J EARTH SCI, V88, P599, DOI 10.1007/s005310050290; Schmidt JC, 2001, ECOL APPL, V11, P657, DOI 10.1890/1051-0761(2001)011[0657:TCFIGC]2.0.CO;2; Shiu CJ, 2009, J CLIMATE, V22, P5635, DOI 10.1175/2009JCLI2514.1; Steer P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6564; Tank AMGK, 2003, J CLIMATE, V16, P3665, DOI [10.1175/1520-0442(2003)016<3665:TIIODT>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;3665:TIIODT&gt;2.0.CO;2]; Tsai ZX, 2013, EARTH SURF PROC LAND, V38, P661, DOI 10.1002/esp.3309; Tsou CY, 2011, GEOMORPHOLOGY, V127, P166, DOI 10.1016/j.geomorph.2010.12.013; Tu JY, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014023; Tu JY, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034013; Tu JY, 2009, J CLIMATE, V22, P3617, DOI 10.1175/2009JCLI2411.1; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; West AJ, 2011, LIMNOL OCEANOGR, V56, P77, DOI 10.4319/lo.2011.56.1.0077; Wheatcroft RA, 2010, LIMNOL OCEANOGR, V55, P161, DOI 10.4319/lo.2010.55.1.0161	52	38	39	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138283	10.1371/journal.pone.0138283	http://dx.doi.org/10.1371/journal.pone.0138283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372356	gold, Green Published, Green Submitted			2022-12-26	WOS:000361604400061
J	Astudillo-Reyes, C; Fernandez, AC; Cichy, KA				Astudillo-Reyes, Carolina; Fernandez, Andrea C.; Cichy, Karen A.			Transcriptome Characterization of Developing Bean (Phaseolus vulgaris L.) Pods from Two Genotypes with Contrasting Seed Zinc Concentrations	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; GENETIC DIVERSITY; IRON-DEFICIENCY; RNA-SEQ; PROTEIN; FAMILY; NICOTIANAMINE; EXPRESSION; GROWTH	Dry bean (Phaseolus vulgaris L.) seeds are a rich source of dietary zinc, especially for people consuming plant-based diets. Within P. vulgaris there is at least two-fold variation in seed Zn concentration. Genetic studies have revealed seed Zn differences to be controlled by a single gene in two closely related navy bean genotypes, Albion and Voyager. In this study, these two genotypes were grown under controlled fertilization conditions and the Zn concentration of various plant parts was determined. The two genotypes had similar levels of Zn in their leaves and pods but Voyager had 52% more Zn in its seeds than Albion. RNA was sequenced from developing pods of both genotypes. Transcriptome analysis of these genotypes identified 27,198 genes in the developing bean pods, representing 86% of the genes in the P. vulgaris genome (v 1.0 DOE-JGI and USDA- NIFA). Expression was detected in 18,438 genes. A relatively small number of genes (381) were differentially expressed between Albion and Voyager. Differentially expressed genes included three genes potentially involved in Zn transport, including zinc-regulated transporter, iron regulated transporter like (ZIP), zinc-induced facilitator (ZIF) and heavy metal associated (HMA) family genes. In addition 12,118 SNPs were identified between the two genotypes. Of the gene families related to Zn and/or Fe transport, eleven genes were found to contain SNPs between Albion and Voyager.	[Astudillo-Reyes, Carolina; Fernandez, Andrea C.; Cichy, Karen A.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Cichy, Karen A.] USDA ARS, Sugarbeet & Bean Res Unit, E Lansing, MI 48823 USA	Michigan State University; United States Department of Agriculture (USDA)	Cichy, KA (corresponding author), USDA ARS, Sugarbeet & Bean Res Unit, 1066 Bogue St, E Lansing, MI 48823 USA.	Karen.Cichy@ars.usda.gov		Cichy, Karen/0000-0002-4311-0774	USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors received USDA-ARS funding for this work.	Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Assuncao AG, 2010, P NATL ACAD SCI USA; Astudillo C, 2013, FRONT PLANT SCI, P4; BERGER S, 1995, PLANT MOL BIOL, V27, P933, DOI 10.1007/BF00037021; Bhakta MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116822; Blair M, 2009, MOL BREEDING, V23, P197, DOI 10.1007/s11032-008-9225-z; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; BOBB AJ, 1995, PLANT J, V8, P331, DOI 10.1046/j.1365-313X.1995.08030331.x; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; CHAPPELL J, 1986, PLANT PHYSIOL, V81, P50, DOI 10.1104/pp.81.1.50; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Cichy KA, 2005, CROP SCI, V45, P864, DOI 10.2135/cropsci2004.0104; Cichy KA, 2009, CROP SCI, V49, P1742, DOI 10.2135/cropsci2008.10.0605; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; DEBOUCK DG, 1993, ECON BOT, V47, P408, DOI 10.1007/BF02907356; Gelin JP, 2007, CROP SCI, V47, P1361, DOI 10.2135/cropsci2006.08.0510; GEPTS P, 1986, ECON BOT, V40, P469, DOI [10.1007/BF02859659, 10.1007/BF02859660]; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Guo WJ, 2008, PLANT PHYSIOL, V146, P1697, DOI 10.1104/pp.108.115782; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Haydon MJ, 2007, PLANT PHYSIOL, V143, P1705, DOI 10.1104/pp.106.092015; Haydon MJ, 2012, PLANT CELL, V24, P724, DOI 10.1105/tpc.111.095042; Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Islam FMA, 2002, GENET RESOUR CROP EV, V49, P285, DOI 10.1023/A:1015510428026; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SZ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-114; Migocka M, 2014, J EXPT BOT, P459; Moraghan JT, 1999, SOIL SCI SOC AM J, V63, P918, DOI 10.2136/sssaj1999.634918x; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; OLIKER M, 1978, AM J BOT, V65, P366, DOI 10.2307/2442279; Olsen LI, 2014, FRONT PLANT SCI, P5; Pinheiro C, 2010, J FOOD COMPOS ANAL, V23, P319, DOI 10.1016/j.jfca.2010.01.005; Rashid A, 2013, PLANT MOL BIOL REP, V31, P464, DOI 10.1007/s11105-012-0498-3; Ren YJ, 2012, PLANT CELL ENVIRON, V35, P770, DOI 10.1111/j.1365-3040.2011.02450.x; Ricachenevsky FK, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-20; Ricachenevsky FK, 2013, FRONT PLANT SCI, P4; Samardjieva KA, 2015, PROTOPLASMA, V252, P345, DOI 10.1007/s00709-014-0683-3; Sankaran RP, 2009, THEOR APPL GENET, V119, P241, DOI 10.1007/s00122-009-1033-2; SANKARAN RP, 2014, FRONT PLANT SCI, P5, DOI DOI 10.3389/fpls.2014.00149; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schuler M, 2012, PLANT CELL, V24, P2380, DOI 10.1105/tpc.112.099077; Sheokand S, 2005, PLANT SCI, V169, P966, DOI 10.1016/j.plantsci.2005.07.003; STEPHAN UW, 1993, PHYSIOL PLANTARUM, V88, P522, DOI 10.1111/j.1399-3054.1993.tb01367.x; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586; Waters BM, 2011, PLANT SCI, V180, P562, DOI 10.1016/j.plantsci.2010.12.003; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	60	10	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137157	10.1371/journal.pone.0137157	http://dx.doi.org/10.1371/journal.pone.0137157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367119	Green Submitted, gold, Green Published			2022-12-26	WOS:000361601100052
J	Diezmann, S; Leach, MD; Cowen, LE				Diezmann, Stephanie; Leach, Michelle D.; Cowen, Leah E.			Functional Divergence of Hsp90 Genetic Interactions in Biofilm and Planktonic Cellular States	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; CANDIDA-ALBICANS BIOFILMS; DRUG-RESISTANCE; PROTEIN; VIRULENCE; CHAPERONE; REVEALS; STRESS; FORMS; YEAST	Candida albicans is among the most prevalent opportunistic fungal pathogens. Its capacity to cause life-threatening bloodstream infections is associated with the ability to form biofilms, which are intrinsically drug resistant reservoirs for dispersal. A key regulator of biofilm drug resistance and dispersal is the molecular chaperone Hsp90, which stabilizes many signal transducers. We previously identified 226 C. albicans Hsp90 genetic interactors under planktonic conditions, of which 56 are involved in transcriptional regulation. Six of these transcriptional regulators have previously been implicated in biofilm formation, suggesting that Hsp90 genetic interactions identified in planktonic conditions may have functional significance in biofilms. Here, we explored the relationship between Hsp90 and five of these transcription factor genetic interactors: BCR1, MIG1, TEC1, TUP1, and UPC2. We deleted each transcription factor gene in an Hsp90 conditional expression strain, and assessed biofilm formation and morphogenesis. Strikingly, depletion of Hsp90 conferred no additional biofilm defect in the mutants. An interaction was observed in which deletion of BCR1 enhanced filamentation upon reduction of Hsp90 levels. Further, although Hsp90 modulates expression of TEC1, TUP1, and UPC2 in planktonic conditions, it has no impact in biofilms. Lastly, we probed for physical interactions between Hsp90 and Tup1, whose WD40 domain suggests that it might interact with Hsp90 directly. Hsp90 and Tup1 formed a stable complex, independent of temperature or developmental state. Our results illuminate a physical interaction between Hsp90 and a key transcriptional regulator of filamentation and biofilm formation, and suggest that Hsp90 has distinct genetic interactions in planktonic and biofilm cellular states.	[Diezmann, Stephanie; Leach, Michelle D.; Cowen, Leah E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto	Diezmann, S (corresponding author), Univ Bath, Dept Biol & Biochem, Milner Ctr Evolut, Bath BA2 7AY, Avon, England.	s.diezmann@bath.ac.uk; leah.cowen@utoronto.ca		Leach, Michelle/0000-0002-1631-8959; Diezmann, Stephanie/0000-0002-9528-1495	University of Bath; Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust) [096072]; Canada Research Chair in Microbial Genomics and Infectious Disease [303712]; Canadian Institutes of Heath Research Operating Grant [MOP-86452]; Natural Sciences & Engineering Research Council (NSERC) Discovery Grant [355965]; NSERC E.W.R. Steacie Memorial Fellowship [468732]; BBSRC [BB/L007886/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L007886/1] Funding Source: researchfish	University of Bath; Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust); Canada Research Chair in Microbial Genomics and Infectious Disease(Canada Research Chairs); Canadian Institutes of Heath Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences & Engineering Research Council (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC E.W.R. Steacie Memorial Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Prize Fellowship from the University of Bath to SD, a Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust 096072) to MDL, a Canada Research Chair in Microbial Genomics and Infectious Disease (303712) to LEC, a Canadian Institutes of Heath Research Operating Grant (MOP-86452) to LEC, a Natural Sciences & Engineering Research Council (NSERC) Discovery Grant (355965) to LEC, and a NSERC E.W.R. Steacie Memorial Fellowship (468732) to LEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becherelli M, 2013, J MOL MICROB BIOTECH, V23, P396, DOI 10.1159/000351619; Bonhomme J, 2011, MOL MICROBIOL, V80, P995, DOI 10.1111/j.1365-2958.2011.07626.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Brown AJP, 2014, TRENDS MICROBIOL, V22, P614, DOI 10.1016/j.tim.2014.07.001; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Burt ET, 2003, ANN CLIN LAB SCI, V33, P86; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Cho T, 2012, BIOL PHARM BULL, V35, P1371, DOI 10.1248/bpb.b12-00228; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Daniels KJ, 2015, EUKARYOT CELL, V14, P228, DOI 10.1128/EC.00224-14; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Fanning S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002585; Finkel JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002525; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Guan GB, 2013, MOL MICROBIOL, V89, P732, DOI 10.1111/mmi.12310; HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Khurana N, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00100; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Lavoie H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-578; Leach MD, 2014, EUKARYOT CELL, V13, P1077, DOI 10.1128/EC.00138-14; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Leach MD, 2012, NAT REV MICROBIOL, V10, P693, DOI 10.1038/nrmicro2875; Lin CH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003305; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin R, 2011, INT J MED MICROBIOL, V301, P417, DOI 10.1016/j.ijmm.2011.04.009; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Nett JE, 2009, J INFECT DIS, V200, P307, DOI 10.1086/599838; Niklas KJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00008; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; O'Meara TR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7741; Sardi JDO, 2014, REV IBEROAM MICOL, V31, P22, DOI 10.1016/j.riam.2013.09.014; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Senn H, 2012, MOL BIOL CELL, V23, P268, DOI 10.1091/mbc.E11-08-0729; Shapiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044734; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Si HY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003210; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Taff HT, 2012, MED MYCOL, V50, P214, DOI 10.3109/13693786.2011.580016; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Talibi D, 1999, J BACTERIOL, V181, P231, DOI 10.1128/JB.181.1.231-240.1999; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wisplinghoff H, CLIN INFECT DIS, V004, P309; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	67	10	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137947	10.1371/journal.pone.0137947	http://dx.doi.org/10.1371/journal.pone.0137947			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367740	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100181
J	Ding, QF; Zhao, M; Yu, BL; Bai, C; Huang, ZF				Ding, Qingfeng; Zhao, Mei; Yu, Bolan; Bai, Chuan; Huang, Zhaofeng			Identification of Tetraazacyclic Compounds as Novel Potent Inhibitors Antagonizing ROR gamma t Activity and Suppressing Th17 Cell Differentiation	PLOS ONE			English	Article							NUCLEAR RECEPTORS; DERIVATIVES; PROTEIN; GENE; AUTOIMMUNITY; DIGOXIN; IL-17F; TARGET; LIGAND; BETA	CD4(+) T-helper cells that produce interleukin-17 (Th17 cells) are characterized as pathological T-helper cells in autoimmune diseases. Differentiation of human and mouse Th17 cells requires a key transcription regulator, retinoic acid receptor-related orphan receptor gamma t (ROR gamma t), which is a potential therapeutic target for autoimmune diseases. To develop a therapeutic agent for Th17-mediated autoimmune diseases, we have established a highthroughput screening (HTS) assay for candidate screening, in which the luciferase activity in ROR gamma t-LBD positive and negative Jurkat cells were analyzed to evaluate induction of ROR gamma t activity by compounds. This technique was applied to screen a commercially-available drug-like chemical compound library (Enamine) which contains 20155 compounds. The screening identified 17 compounds that can inhibit ROR gamma t function in the HTS screen system. Of these, three tetraazacyclic compounds can potently inhibit ROR gamma t activity, and suppress Th17 differentiation and IL-17 production. These three candidate compounds could significantly attenuate the expression of the Il17a by 65%-90%, and inhibit IL-17A secretion by 47%, 63%, and 74%, respectively. These compounds also exhibited a potent anti-ROR gamma t activity, with EC50 values of 0.25 mu M, 0.67 mu M and 2.6 mu M, respectively. Our data demonstrated the feasibility of targeting the ROR gamma t to inhibit Th17 cell differentiation and function with these tetraazacyclic compounds, and the potential to improve the structure of these compounds for autoimmune diseases therapeutics.	[Ding, Qingfeng; Zhao, Mei; Bai, Chuan; Huang, Zhaofeng] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Ding, Qingfeng; Zhao, Mei; Bai, Chuan; Huang, Zhaofeng] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ China, Guangzhou 510080, Guangdong, Peoples R China; [Yu, Bolan] Guangzhou Med Univ, Key Lab Major Obstet Dis Guangdong Prov, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China; [Huang, Zhaofeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Ministry of Education, China; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University	Huang, ZF (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.	hzhaof@mail.sysu.edu.cn			Natural Science Foundation of China [81370751, 31170831]; Guangdong Recruitment Program of Creative Research Group [2009010058]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Recruitment Program of Creative Research Group	Funds supported by the Natural Science Foundation of China (81370751 and 31170831), and the Guangdong Recruitment Program of Creative Research Group (No. 2009010058).	Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chen YP, 2009, J PHARMACOL EXP THER, V329, P192, DOI 10.1124/jpet.108.148916; Chuang KA, 2010, BRAZ J MED BIOL RES, V43, P931, DOI 10.1590/S0100-879X2010001000003; Fujita-Sato S, 2011, J BIOL CHEM, V286, P31409, DOI 10.1074/jbc.M111.254003; Griffin P, 2012, J EXPT PHARM, P141, DOI [10.2147/jep.s27078, DOI 10.2147/JEP.S27078]; Huang ZF, 2008, J IMMUNOL, V180, P6586, DOI 10.4049/jimmunol.180.10.6586; Huang ZF, 2007, EXPERT OPIN THER TAR, V11, P737, DOI 10.1517/14728222.11.6.737; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kassi E, 2009, CANCER INVEST, V27, P723, DOI 10.1080/07357900802672712; Kumar N, 2011, ACS CHEM BIOL, V6, P218, DOI 10.1021/cb1002762; Kwon MJ, 2012, J IMMUNOL, V188, P5887, DOI 10.4049/jimmunol.1102941; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li YS, 2012, RHEUMATOL INT, V32, P2415, DOI 10.1007/s00296-011-1867-1; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Medvedev A, 1997, GENOMICS, V46, P93, DOI 10.1006/geno.1997.4980; Miossec P, 2009, MICROBES INFECT, V11, P625, DOI 10.1016/j.micinf.2009.04.003; Mongrain V, 2008, GENES CELLS, V13, P1197, DOI 10.1111/j.1365-2443.2008.01237.x; Muhlbauer E, 2013, MOL CELL ENDOCRINOL, V365, P129, DOI 10.1016/j.mce.2012.10.001; Pappu R, 2010, J CLIN IMMUNOL, V30, P185, DOI 10.1007/s10875-010-9369-6; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Solt LA, 2012, ACS CHEM BIOL, V7, P1515, DOI 10.1021/cb3002649; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Xie HM, 2005, J IMMUNOL, V175, P3800, DOI 10.4049/jimmunol.175.6.3800; Xu T, 2011, J BIOL CHEM, V286, P22707, DOI 10.1074/jbc.C111.250407; Yang T, 2014, ACS MED CHEM LETT, V5, P65, DOI 10.1021/ml4003875; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yin Y, 2015, J BIOL CHEM, V290, P35, DOI 10.1074/jbc.M114.598631; Zhong FD, 2015, ORG BIOMOL CHEM, V13, P1792, DOI 10.1039/c4ob02247e	34	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137711	10.1371/journal.pone.0137711	http://dx.doi.org/10.1371/journal.pone.0137711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368822	Green Submitted, gold, Green Published			2022-12-26	WOS:000361601100116
J	Krivokrysenko, VI; Toshkov, IA; Gleiberman, AS; Krasnov, P; Shyshynova, I; Bespalov, I; Maitra, RK; Narizhneva, NV; Singh, VK; Whitnall, MH; Purmal, AA; Shakhov, AN; Gudkov, AV; Feinstein, E				Krivokrysenko, Vadim I.; Toshkov, Ilia A.; Gleiberman, Anatoli S.; Krasnov, Peter; Shyshynova, Inna; Bespalov, Ivan; Maitra, Ratan K.; Narizhneva, Natalya V.; Singh, Vijay K.; Whitnall, Mark H.; Purmal, Andrei A.; Shakhov, Alexander N.; Gudkov, Andrei V.; Feinstein, Elena			The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NF-KAPPA-B; PROINFLAMMATORY GENE-EXPRESSION; TOTAL-BODY IRRADIATION; TUMOR-NECROSIS-FACTOR; PROTECTS MICE; BACTERIAL FLAGELLIN; IMPROVES SURVIVAL; INDUCED APOPTOSIS; CELL-DEATH	There are currently no approved medical radiation countermeasures (MRC) to reduce the lethality of high-dose total body ionizing irradiation expected in nuclear emergencies. An ideal MRC would be effective even when administered well after radiation exposure and would counteract the effects of irradiation on the hematopoietic system and gastrointestinal tract that contribute to its lethality. Entolimod is a Toll-like receptor 5 agonist with demonstrated radioprotective/mitigative activity in rodents and radioprotective activity in nonhuman primates. Here, we report data from several exploratory studies conducted in lethally irradiated non-human primates (rhesus macaques) treated with a single intramuscular injection of entolimod (in the absence of intensive individualized supportive care) administered in a mitigative regimen, 1-48 hours after irradiation. Following exposure to LD50-70/40 of radiation, injection of efficacious doses of entolimod administered as late as 25 hours thereafter reduced the risk of mortality 2-3-fold, providing a statistically significant (P < 0.01) absolute survival advantage of 40-60% compared to vehicle treatment. Similar magnitude of survival improvement was also achieved with drug delivered 48 hours after irradiation. Improved survival was accompanied by predominantly significant (P < 0.05) effects of entolimod administration on accelerated morphological recovery of hematopoietic and immune system organs, decreased severity and duration of thrombocytopenia, anemia and neutropenia, and increased clonogenic potential of the bone marrow compared to control irradiated animals. Entolimod treatment also led to reduced apoptosis and accelerated crypt regeneration in the gastrointestinal tract. Together, these data indicate that entolimod is a highly promising potential life-saving treatment for victims of radiation disasters.	[Krivokrysenko, Vadim I.; Toshkov, Ilia A.; Gleiberman, Anatoli S.; Krasnov, Peter; Shyshynova, Inna; Bespalov, Ivan; Maitra, Ratan K.; Narizhneva, Natalya V.; Purmal, Andrei A.; Shakhov, Alexander N.; Gudkov, Andrei V.; Feinstein, Elena] Cleveland BioLabs Inc CBLI, Buffalo, NY 14203 USA; [Singh, Vijay K.; Whitnall, Mark H.] Armed Forces Radiobiol Res Inst, Bethesda, MD USA; [Gudkov, Andrei V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	United States Department of Defense; Roswell Park Cancer Institute	Gudkov, AV (corresponding author), Cleveland BioLabs Inc CBLI, Buffalo, NY 14203 USA.	andrei.gudkov@roswellpark.org; efeinstein@cbiolabs.com	Singh, Vijay/GWZ-8972-2022	Singh, Vijay/0000-0002-6631-3849; gleiberman, anatoli/0000-0001-8491-0826; Gudkov, Andrei/0000-0003-2548-0154	US Department of Defense (DoD) Chemical Biological Medical Systems (CBMS) [W9113M08C0151, W9113M10C0088]; National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH) [RC1AI080306, RC2AI087616]; US DoD Defense Threat Reduction Agency (DTRA) [HDTRA1-07-C-0021, HDTRA1-11-C-0008]; US Department of Health & Human Services Biomedical Advanced Research and Development Authority (BARDA) [HHSO100200800059C]; Cleveland BioLabs, Inc. (CBLI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080306, RC2AI087616] Funding Source: NIH RePORTER	US Department of Defense (DoD) Chemical Biological Medical Systems (CBMS); National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US DoD Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); US Department of Health & Human Services Biomedical Advanced Research and Development Authority (BARDA); Cleveland BioLabs, Inc. (CBLI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US Department of Defense (DoD) Chemical Biological Medical Systems (CBMS), http://www.jpeocbd.osd.mil/packs/Default.aspx?pg=180 [Grants W9113M08C0151 and W9113M10C0088 to Cleveland BioLabs, Inc.]); the National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH), http://www.niaid.nih.gov/Pages/default.aspx [Grants RC1AI080306 and RC2AI087616 to A.V.G.]; the US DoD Defense Threat Reduction Agency (DTRA), http://www.dtra.mil/ [Grant HDTRA1-07-C-0021 to E.F.], and [Grant HDTRA1-11-C-0008 to V.I.K.]; the US Department of Health & Human Services Biomedical Advanced Research and Development Authority (BARDA), http://www.phe.gov/about/barda/Pages/default.aspx [Grant HHSO100200800059C to A.V.G.]. Cleveland BioLabs, Inc. (CBLI), provided support in the form of salaries for authors VIK, IAT, ASG, PK, IS, IB, RKM, NVN, AAP, ANS, AVG and EF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abtin A, 2010, J INVEST DERMATOL, V130, P2423, DOI 10.1038/jid.2010.158; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Anderson RF, 2001, REDOX REP, V6, P197, DOI 10.1179/135100001101536201; Basile LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030434; Benjamin GC, 2009, ASSESSING MED PREPAR; Bensadoun RJ, 2006, SUPPORT CARE CANCER, V14, P566, DOI 10.1007/s00520-006-0047-4; Bertho JM, 2005, INT J RADIAT ONCOL, V63, P911, DOI 10.1016/j.ijrobp.2005.03.045; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Burdelya LG, 2012, INT J RADIAT ONCOL, V83, P228, DOI 10.1016/j.ijrobp.2011.05.055; Carvalho FA, 2011, MUCOSAL IMMUNOL, V4, P102, DOI 10.1038/mi.2010.57; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; Dainiak N, 2010, HEALTH PHYS, V98, P838, DOI 10.1097/HP.0b013e3181b3fce5; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; DHONDT V, 1995, BLOOD, V85, P2347, DOI 10.1182/blood.V85.9.2347.bloodjournal8592347; DiCarlo AL, 2011, DISASTER MED PUBLIC, V5, pS32, DOI 10.1001/dmp.2011.17; Dorr H, 2014, HEALTH PHYS, V106, P129, DOI 10.1097/HP.0b013e3182a12de0; Dorr H, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-126; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Epperly MW, 2002, RADIAT RES, V157, P568, DOI 10.1667/0033-7587(2002)157[0568:MSDSIR]2.0.CO;2; Farese AM, 2014, HEALTH PHYS, V106, P39, DOI 10.1097/HP.0b013e3182a4dd2c; Farese AM, 2013, RADIAT RES, V179, P89, DOI 10.1667/RR3049.1; Farrell CL, 1998, CANCER RES, V58, P933; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Gao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009351; Garcia-Castro J, 2008, J CELL MOL MED, V12, P2552, DOI 10.1111/j.1582-4934.2008.00516.x; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gluzman-Poltorak Z, 2014, AM J HEMATOL, V89, P868, DOI 10.1002/ajh.23770; Gluzman-Poltorak Z, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-31; Gratwohl A, 1998, BLOOD, V92, P765; Hasan UA, 2005, J BIOL CHEM, V280, P20620, DOI 10.1074/jbc.M500877200; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayon Y, 2012, CNS NEUROL DISORD-DR, V11, P921, DOI 10.2174/1871527311201070921; He Xiao-Xia, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P695; Hedrich CM, 2010, IMMUNOL RES, V47, P185, DOI 10.1007/s12026-009-8150-5; Hendry JH, 1997, INT J RADIAT BIOL, V71, P709, DOI 10.1080/095530097143716; HOLDRINET RSG, 1980, EXP HEMATOL, V8, P103; Janot L, 2009, EUR J IMMUNOL, V39, P1587, DOI 10.1002/eji.200838907; Jones RM, 2011, GUT, V60, P648, DOI 10.1136/gut.2010.223891; Kojouharov BM, 2014, ONCOTARGET, V5, P802, DOI 10.18632/oncotarget.1773; Koller B, 2008, J IMMUNOL, V181, P2753, DOI 10.4049/jimmunol.181.4.2753; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Komarova EA, 2001, BIOCHEM PHARMACOL, V62, P657, DOI 10.1016/S0006-2952(01)00733-X; Krivokrysenko VI, 2012, J PHARMACOL EXP THER, V343, P497, DOI 10.1124/jpet.112.196071; Kumar A, 2010, MICROBES INFECT, V12, P978, DOI 10.1016/j.micinf.2010.06.007; Lee JH, 2004, FREE RADICAL BIO MED, V37, P272, DOI 10.1016/j.freeradbiomed.2004.04.029; Leigh ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085587; Leslie M, 2010, SCIENCE, V328, P562, DOI 10.1126/science.328.5978.562; Luo JL, 2005, J CLIN IMMUNOL, V25, P541, DOI 10.1007/s10875-005-8217-6; MACVITTIE TJ, 1994, BLOOD, V84, P2515; MacVittie TJ, 2000, BLOOD, V95, P837, DOI 10.1182/blood.V95.3.837.003k08_837_845; Maj JG, 2003, CANCER RES, V63, P4338; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Melican K, 2008, CELL MICROBIOL, V10, P1987, DOI 10.1111/j.1462-5822.2008.01182.x; Miller LS, 1996, INT J MICROCIRC, V16, P147, DOI 10.1159/000179165; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; NETA R, 1992, J EXP MED, V175, P689, DOI 10.1084/jem.175.3.689; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; PATCHEN ML, 1993, EXP HEMATOL, V21, P338; PATCHEN ML, 1991, BLOOD, V77, P472; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834, DOI 10.1055/s-0037-1613311; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Rabbani ZN, 2007, INT J RADIAT ONCOL, V67, P573, DOI 10.1016/j.ijrobp.2006.09.053; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Rolland SG, 2010, CURR OPIN CELL BIOL, V22, P852, DOI 10.1016/j.ceb.2010.07.014; ROWE AW, 1994, J MED PRIMATOL, V23, P415, DOI 10.1111/j.1600-0684.1994.tb00130.x; Salamone GV, 2010, LAB INVEST, V90, P1049, DOI 10.1038/labinvest.2010.77; Sasi N, 2009, MOL CANCER THER, V8, P1421, DOI 10.1158/1535-7163.MCT-08-0895; Sergio D, 2008, USING ANIMAL MODELS; Shakhov AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033044; Maia GAS, 2014, ANN HEMATOL, V93, P753, DOI 10.1007/s00277-013-1944-5; Silva SC, 2014, BRAZ J MED BIOL RES, V47, P384, DOI 10.1590/1414-431X20143190; Singh PK, 2011, CYTOKINE, V56, P411, DOI 10.1016/j.cyto.2011.08.016; Singh VK, 2015, EXPERT OPIN BIOL TH, V15, P465, DOI 10.1517/14712598.2015.986453; Singh VK, 2015, CYTOKINE, V71, P22, DOI 10.1016/j.cyto.2014.08.003; Singh VK, 2014, EXPERT OPIN THER PAT, V24, P1229, DOI 10.1517/13543776.2014.964684; Singh VK, 2012, RADIAT RES, V177, P628, DOI 10.1667/RR2657.1; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SRINIVASAN V, 1992, INT J RADIAT ONCOL, V23, P841, DOI 10.1016/0360-3016(92)90657-4; Stickney DR, 2007, INT IMMUNOPHARMACOL, V7, P500, DOI 10.1016/j.intimp.2006.12.005; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; THOMAS J, 1982, CLIN EXP IMMUNOL, V47, P457; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; US Department of Health and Human Services, APPR BIOL PROD HUM E, V21, P601; Van Eeden SF, 2000, LEUKEMIA LYMPHOMA, V37, P259, DOI 10.3109/10428190009089427; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; VANDENBERK LC, 2009, J CELL MOL MED; Vigneulle RM, 2002, DIGEST DIS SCI, V47, P1480, DOI 10.1023/A:1015846514471; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Welters ID, 2010, ANESTH ANALG, V110, P934, DOI 10.1213/ANE.0b013e3181c95cfa; Whitnall MH, 2002, IMMUNOPHARM IMMUNOT, V24, P595, DOI 10.1081/IPH-120016038; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Xiao M, 2007, MOL PHARMACOL, V72, P370, DOI 10.1124/mol.107.035394; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yamazaki R, 2006, BONE MARROW TRANSPL, V38, P377, DOI 10.1038/sj.bmt.1705444; Yu FS, 2010, J IMMUNOL, V185, P1142, DOI 10.4049/jimmunol.1000509; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194; ZEIDLER C, 1992, BLOOD, V80, P2740; Zgair AK, 2012, J MICROBIOL BIOTECHN, V22, P907, DOI 10.4014/jmb.1112.11079; ZSEBO KM, 1992, P NATL ACAD SCI USA, V89, P9464, DOI 10.1073/pnas.89.20.9464	110	35	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0135388	10.1371/journal.pone.0135388	http://dx.doi.org/10.1371/journal.pone.0135388			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367124	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100010
J	Li, YK; Carrillo, JA; Ding, Y; He, YH; Zhao, CP; Liu, JN; Liu, GE; Zan, LS; Song, JZ				Li, Yaokun; Carrillo, Jose A.; Ding, Yi; He, Yanghua; Zhao, Chunping; Liu, Jianan; Liu, George E.; Zan, Linsen; Song, Jiuzhou			Transcriptomic Profiling of Spleen in Grass-Fed and Grain-Fed Angus Cattle	PLOS ONE			English	Article							DAIRY BEEF STEERS; HYPERCHOLESTEROLEMIC MEN; ANTIOXIDANT STATUS; IMMUNE-RESPONSE; VITAMIN-E; PASTURE; DIET; MEAT; IDENTIFICATION; CHOLESTEROL	The grass-fed cattle obtain nutrients directly from pastures containing limited assimilable energy but abundant amount of fiber; by contrast, grain-fed steers receive a diet that is comprised mainly of grains and serves as an efficient source of high-digestible energy. Besides energy, these two types of diet differ in a large number of nutritional components. Additionally, animals maintained on rich-energy regimen are more likely to develop metabolic disorders and infectious diseases than pasture raised individuals. Thus, we hypothesize that spleen-a relevant immune organ-may function differently under disparate regimes. The objective of this study was to find the differentially expressed genes in the spleen of grass-fed and grain-fed steers, and furtherly explore the potential involved biopathways. Through RNA sequencing (RNA-Seq), we detected 123 differentially expressed genes. Based on these genes, we performed an Ingenuity Pathway Analysis (IPA) and identified 9 significant molecular networks and 13 enriched biological pathways. Two of the pathways, Nur77 signaling in T lymphocytes and calcium-induced T lymphocyte apoptosis which are immune related, contain a pair of genes HLA-DRA and NR4A1 with dramatically altered expression level. Collectively, our results provided valuable insights into understanding the molecular mechanism of spleen under varied feeding regimens.	[Li, Yaokun; Zhao, Chunping; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Carrillo, Jose A.; Ding, Yi; He, Yanghua; Liu, Jianan; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Liu, George E.] ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA	Northwest A&F University - China; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	zanlinsen@163.com; songj88@umd.edu	Ding, Yi/U-3314-2019; Liu, George/K-3371-2019; Song, Jiuzhou/AAD-6440-2020	Liu, George/0000-0003-0192-6705; 	China Scholarship Council (CSC); Maryland Agricultural Experiment Station (MAES); Jorgensen Endowment Funds	China Scholarship Council (CSC)(China Scholarship Council); Maryland Agricultural Experiment Station (MAES); Jorgensen Endowment Funds	The work was supported by China Scholarship Council (CSC), Maryland Agricultural Experiment Station (MAES) and Jorgensen Endowment Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz HO, 2007, J CANCER RES CLIN, V133, P107, DOI 10.1007/s00432-006-0149-x; Alfaia CPM, 2009, FOOD CHEM, V114, P939, DOI 10.1016/j.foodchem.2008.10.041; ALTMANN DM, 1993, HUM IMMUNOL, V37, P149, DOI 10.1016/0198-8859(93)90180-9; Andrews S., 2010, FASTQC QUALITY CONTR; Baltes N, 2001, INFECT IMMUN, V69, P472, DOI 10.1128/IAI.69.1.472-478.2001; Beauchesne-Rondeau E, 2003, AM J CLIN NUTR, V77, P587, DOI 10.1093/ajcn/77.3.587; Bjorklund EA, 2014, J DAIRY SCI, V97, P1828, DOI 10.3168/jds.2013-6984; Bjorklund EA, 2014, J DAIRY SCI, V97, P1817, DOI 10.3168/jds.2013-6983; Blanco-Ulate B, 2013, FRONT PLANT SCI, P4; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Brunner FS, 2014, P R SOC B, P281; Cross ML, 1999, IMMUNOL CELL BIOL, V77, P345, DOI 10.1046/j.1440-1711.1999.00834.x; De la Fuente J, 2009, MEAT SCI, V82, P331, DOI 10.1016/j.meatsci.2009.02.002; Descalzo AM, 2007, MEAT SCI, V75, P299, DOI 10.1016/j.meatsci.2006.07.015; Descalzo AM, 2005, MEAT SCI, V70, P35, DOI 10.1016/j.meatsci.2004.11.018; Garcia PT, 2008, MEAT SCI, V79, P500, DOI 10.1016/j.meatsci.2007.10.019; Gatellier P, 2004, MEAT SCI, V67, P385, DOI 10.1016/j.meatsci.2003.11.009; Hoffman BG, 2006, GENES IMMUN, V7, P101, DOI 10.1038/sj.gene.6364270; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA204, DOI 10.1289/ehp.120-a204a; Hunninghake DB, 2000, J AM COLL NUTR, V19, P351, DOI 10.1080/07315724.2000.10718931; Insani EM, 2008, MEAT SCI, V79, P444, DOI 10.1016/j.meatsci.2007.10.017; Lee SO, 2011, EXPERT OPIN THER TAR, V15, P195, DOI 10.1517/14728222.2011.547481; Leheska JM, 2008, J ANIM SCI, V86, P3575, DOI 10.2527/jas.2007-0565; Li RW, 2012, FUNCT INTEGR GENOMIC, V12, P35, DOI 10.1007/s10142-011-0259-7; Ma X, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-168; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Melanson K, 2003, NUTRITION, V19, P409, DOI 10.1016/S0899-9007(02)01080-8; Mitra A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-557; Morita T, 2014, PLOS ONE, P9; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Naeem A, 2014, FUNCT INTEGR GENOMIC, V14, P261, DOI 10.1007/s10142-013-0351-2; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; Rocha-Perugini V, 2014, EUR J IMMUNOL, V44, P1967, DOI 10.1002/eji.201344235; Smith DR, 2002, EXP BIOL MED, V227, P266, DOI 10.1177/153537020222700407; Smith RA, 1998, J ANIM SCI, V76, P272; Wu F, 2012, J FISH BIOL, V81, P1147, DOI 10.1111/j.1095-8649.2012.03299.x; Yang A, 2002, MEAT SCI, V60, P35, DOI 10.1016/S0309-1740(01)00102-4; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	40	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0135670	10.1371/journal.pone.0135670	http://dx.doi.org/10.1371/journal.pone.0135670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367387	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100012
J	Yu, H; Hahn, Y; Yang, I				Yu, Hannah; Hahn, Yoonsoo; Yang, Inchul			Reference Materials for Calibration of Analytical Biases in Quantification of DNA Methylation	PLOS ONE			English	Article							PCR-BIAS; PATTERNS; ASSAY; QUANTITATION; CHALLENGES; GENOME	Most contemporary methods for the quantification of DNA methylation employ bisulfite conversion and PCR amplification. However, many reports have indicated that bisulfite-mediated PCR methodologies can result in inaccurate measurements of DNA methylation owing to amplification biases. To calibrate analytical biases in quantification of gene methylation, especially those that arise during PCR, we utilized reference materials that represent exact bisulfite-converted sequences with 0% and 100% methylation status of specific genes. After determining relative quantities using qPCR, pairs of plasmids were gravimetrically mixed to generate working standards with predefined DNA methylation levels at 10% intervals in terms of mole fractions. The working standards were used as controls to optimize the experimental conditions and also as calibration standards in melting-based and sequencing-based analyses of DNA methylation. Use of the reference materials enabled precise characterization and proper calibration of various biases during PCR and subsequent methylation measurement processes, resulting in accurate measurements.	[Yu, Hannah; Yang, Inchul] Korea Res Inst Stand & Sci, Ctr Bioanal, Div Metrol Qual Life, Taejon 305340, South Korea; [Yu, Hannah; Yang, Inchul] Univ Sci & Technol, Bioanalyt Sci, Taejon 305340, South Korea; [Hahn, Yoonsoo] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea	Korea Research Institute of Standards & Science (KRISS); Chung Ang University	Yang, I (corresponding author), Korea Res Inst Stand & Sci, Ctr Bioanal, Div Metrol Qual Life, Taejon 305340, South Korea.	icy@kriss.re.kr	Yu, Hannah/AAH-6002-2021	HAHN, YOONSOO/0000-0003-4273-9842	Korea Research Institute of Standards and Science [KRISS-GP2015-0008]	Korea Research Institute of Standards and Science	This work was supported by Korea Research Institute of Standards and Science under the project 'Development of Bio and Clinical Measurement Standards (KRISS-GP2015-0008)'.	Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Chhibber A, 2008, ANAL BIOCHEM, V377, P46, DOI 10.1016/j.ab.2008.02.026; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118318; Hernandez HG, 2013, BIOTECHNIQUES, V55, P181, DOI 10.2144/000114087; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Jeong S, 2007, GENOME RES, V17, P1093, DOI 10.1101/gr.6028507; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kit AH, 2012, BIOCHIMIE, V94, P2314, DOI 10.1016/j.biochi.2012.07.014; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Langevin SM, 2012, EPIGENETICS-US, V7, P291, DOI 10.4161/epi.7.3.19134; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Moskalev EA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr213; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312; Smith E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-123; Sriraksa R, 2010, CLIN BIOCHEM, V43, P528, DOI 10.1016/j.clinbiochem.2009.11.005; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Van de Voorde L, 2012, MUTAT RES-REV MUTAT, V751, P304, DOI 10.1016/j.mrrev.2012.06.001; Warnecke PM, 1997, NUCLEIC ACIDS RES, V25, P4422, DOI 10.1093/nar/25.21.4422; White G H, 2004, Clin Biochem Rev, V25, pS1; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wojdacz TK, 2006, BIOTECHNIQUES, V41, P274, DOI 10.2144/000112240; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Wojdacz TK, 2009, EPIGENETICS-US, V4, P231, DOI 10.4161/epi.9020; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang I, 2009, ANAL BIOCHEM, V384, P288, DOI 10.1016/j.ab.2008.09.036; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924	33	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137006	10.1371/journal.pone.0137006	http://dx.doi.org/10.1371/journal.pone.0137006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368560	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100045
J	Cheng, H; Cai, HB; Fu, HT; An, ZW; Fang, JL; Hu, YS; Guo, DJ; Huang, HS				Cheng, Han; Cai, Haibin; Fu, Haitian; An, Zewei; Fang, Jialin; Hu, Yanshi; Guo, Dianjing; Huang, Huasun			Functional Characterization of Hevea brasiliensis CRT/DRE Binding Factor 1 Gene Revealed Regulation Potential in the CBF Pathway of Tropical Perennial Tree	PLOS ONE			English	Article							COLD-ACCLIMATION; LOW-TEMPERATURE; FREEZING TOLERANCE; TRANSCRIPTIONAL ACTIVATORS; SIGNAL-TRANSDUCTION; EXPRESSION; DROUGHT; PLANT; ELEMENT; FAMILY	Rubber trees (Hevea brasiliensis) are susceptible to low temperature and therefore are only planted in the tropical regions. In the past few decades, although rubber trees have been successfully planted in the northern margin of tropical area in China, they suffered from cold injury during the winter. To understand the physiological response under cold stress, we isolated a C-repeat binding factor 1 (CBF1) gene from the rubber tree. This gene (HbCBF1) was found to respond to cold stress but not drought or ABA stress. The corresponding HbCBF1 protein showed CRT/DRE binding activity in gel shift experiment. To further characterize its molecular function, the HbCBF1 gene was overexpressed in Arabidopsis. The HbCBF1 over expression (OE) line showed enhanced cold resistance and relatively slow dehydration, and the expression of Arabidopsis CBF pathway downstream target genes, e.g. AtCOR15a and AtRD29a, were significantly activated under non-acclimation condition. These data suggest HbCBF1 gene is a functional member of the CBF gene family, and may play important regulation function in rubber tree.	[Cheng, Han; Cai, Haibin; An, Zewei; Fang, Jialin; Hu, Yanshi; Huang, Huasun] Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Rubber Biol, Danzhou, Hainan, Peoples R China; [Fu, Haitian] Guangxi Subtrop Crops Res Inst, Nanning, Guangxi, Peoples R China; [Guo, Dianjing] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Guo, Dianjing] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese University of Hong Kong; Chinese University of Hong Kong	Huang, HS (corresponding author), Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Rubber Biol, Danzhou, Hainan, Peoples R China.	forcheng@gmail.com		, Han/0000-0002-1327-8509; , Zewei/0000-0001-8462-4571	National Natural Science Foundation of China [31301072]; Advance Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Human Resources and Social Security of the People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Advance Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Human Resources and Social Security of the People's Republic of China	H. Cheng received the funding of the National Natural Science Foundation of China (grant No.: 31301072); H. Cheng received the funding of Advance Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Human Resources and Social Security of the People's Republic of China (2014-2015).	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; An ZeWei, 2012, African Journal of Biotechnology, V11, P9308; Badawi M, 2007, MOL GENET GENOMICS, V277, P533, DOI 10.1007/s00438-006-0206-9; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Benedict C, 2006, PLANT PHYSIOL, V141, P1219, DOI 10.1104/pp.106.083527; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Champ KI, 2007, PHYSIOL PLANTARUM, V129, P529, DOI 10.1111/j.1399-3054.2006.00826.x; Cheng H, 2013, PLANT OMICS, V6, P240; Cheng Han, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P423; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; El Kayal W, 2006, J EXP BOT, V57, P2455, DOI 10.1093/jxb/erl019; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gray GR, 1997, PLANT PHYSIOL, V114, P467, DOI 10.1104/pp.114.2.467; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; He K., 1987, RUBBER CULTURE NO PA; Hua J, 2009, CURR OPIN PLANT BIOL, V12, P568, DOI 10.1016/j.pbi.2009.07.012; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jeon J, 2013, J PLANT BIOL, V56, P69, DOI 10.1007/s12374-013-0903-y; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kang Liyan, 2009, CHIN AGR SCI B, P251; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Pennycooke JC, 2008, PLANT MOL BIOL, V67, P483, DOI 10.1007/s11103-008-9333-5; Pennycooke JC, 2008, PLANT PHYSIOL, V146, P1242, DOI 10.1104/pp.107.108779; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Roychoudhury A, 2013, PLANT CELL REP, V32, P985, DOI 10.1007/s00299-013-1414-5; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang JM, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-203, 10.1186/1471-2156-15-33, 10.1186/1471-2164-15-415]; Wang Shuming, 2008, TROP AGR SCI TECHNOL, P4; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Xiong YW, 2006, PLANTA, V224, P878, DOI 10.1007/s00425-006-0273-5; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhao TJ, 2006, J BIOL CHEM, V281, P10752, DOI 10.1074/jbc.M510535200; Zhili Zhao, 2012, IEIT Journal of Adaptive & Dynamic Computing, P12, DOI 10.5813/www.ieit-web.org/IJADC/2012.1.3	50	16	26	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137634	10.1371/journal.pone.0137634	http://dx.doi.org/10.1371/journal.pone.0137634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361044	gold, Green Submitted, Green Published			2022-12-26	WOS:000361043100059
J	Chen, J; Bai, M; Ning, C; Xie, B; Zhang, J; Liao, H; Xiong, J; Tao, X; Yan, D; Xi, X; Chen, X; Yu, Y; Bast, RC; Zhang, Z; Feng, Y; Zheng, W				Chen, J.; Bai, M.; Ning, C.; Xie, B.; Zhang, J.; Liao, H.; Xiong, J.; Tao, X.; Yan, D.; Xi, X.; Chen, X.; Yu, Y.; Bast, R. C.; Zhang, Z.; Feng, Y.; Zheng, W.			Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1 alpha/cyclin D1 pathway	ONCOGENE			English	Article							CYCLIN D1; GROWTH-FACTOR; RETINOBLASTOMA PROTEIN; SURVIVIN EXPRESSION; ENDOMETRIAL-CANCER; SURFACE EPITHELIUM; COLORECTAL-CANCER; SIGNALING PATHWAY; RISK REDUCTION; FALLOPIAN-TUBE	Gankyrin is a regulatory subunit of the 26kD proteasome complex. As a novel oncoprotein, gankyrin is expressed aberrantly in cancers from several different sites and has been shown to contribute to oncogenesis in endometrial and cervical carcinomas. Neither gankyrin's contribution to the development of epithelial ovarian cancer nor its interaction with follicle-stimulating hormone (FSH)-driven proliferation in ovarian cancer has been studied. Here we have found that gankyrin is overexpressed in ovarian cancers compared with benign ovarian cystadenomas and that gankyrin regulates FSH upregulation of cyclin D1. Importantly, gankyrin regulates PI3K/AKT signaling by downregulating PTEN. Prolonged AKT activation by FSH stimulation of the FSH receptor (FSHR) promotes gankyrin expression, which, in turn, enhances AKT activation by inhibiting PTEN. Overexpression of gankyrin decreases hypoxia inducible factor-1 alpha (HIF-1 alpha) protein levels, but has little effect on HIF-1 alpha mRNA levels, which could be attributed to gankyrin mediating HIF-1 alpha protein stability via the ubiquitin-proteasome pathway. Reduction in HIF-1 alpha protein stability led to attenuation of the binding with cyclin D1 promoter, resulted in abolishment of the negative regulation of cyclin D1 by HIF-1 alpha, which promotes proliferation of ovarian cancer cells. Our results document that gankyrin regulates HIF-1 alpha protein stability and cyclin D1 expression, ultimately mediating FSH-driven ovarian cancer cell proliferation.	[Chen, J.; Bai, M.; Xie, B.; Zhang, J.; Yan, D.; Xi, X.; Zhang, Z.; Feng, Y.] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Obstet & Gynecol, 100 Haining Rd, Shanghai 200080, Peoples R China; [Ning, C.; Chen, X.; Yu, Y.] Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, Shanghai 200433, Peoples R China; [Liao, H.] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr, Shanghai 200092, Peoples R China; [Xiong, J.] Fudan Univ, Huashan Hosp, Dept Neuropathol, Shanghai 200433, Peoples R China; [Xiong, J.] Fudan Univ, Obstet & Gynecol Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Yu, Y.; Bast, R. C.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Zheng, W.] Univ Arizona, Coll Med, Dept Pathol, Tucson, AZ 85721 USA; [Zheng, W.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	Shanghai Jiao Tong University; Fudan University; Tongji University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center; University of Arizona; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, Z; Feng, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Obstet & Gynecol, 100 Haining Rd, Shanghai 200080, Peoples R China.	zhangzhenbozzb@aliyun.com; Fengyj4806@sohu.com	Bast, Robert C/E-6585-2011	Bast, Robert C/0000-0003-4621-8462; Bai, Mingzhu/0000-0001-6210-4890	National Natural Science Foundation of China [81272883, 81202044, 81370074, 81172478]; Science and Technology Commission of Shanghai Municipality [12ZR1447600]; Shanghai Municipal Public Health Bureau [XYQ2013119]; 'Chenxing Project' from Shanghai Jiao Tong University; National Foundation for Cancer Research; Stuart; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Public Health Bureau; 'Chenxing Project' from Shanghai Jiao Tong University; National Foundation for Cancer Research; Stuart; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Natural Science Foundation of China (grant numbers 81272883, 81202044, 81370074 and 81172478), the Science and Technology Commission of Shanghai Municipality (grant number 12ZR1447600), the Shanghai Municipal Public Health Bureau (grant number XYQ2013119) and the 'Chenxing Project' from Shanghai Jiao Tong University to ZZ. The role of YY in this project was partially supported by The National Foundation for Cancer Research and contributions from Stuart and Gaye Lynn Zarrow.	Bai ZF, 2013, CANCER RES, V73, P4548, DOI 10.1158/0008-5472.CAN-12-4586; Bose CK, 2008, ONCOL RES, V17, P231, DOI 10.3727/096504008786111383; Brekelmans CTM, 2003, CURR OPIN OBSTET GYN, V15, P63, DOI 10.1097/00001703-200302000-00010; Callahan MJ, 2007, J CLIN ONCOL, V25, P3985, DOI 10.1200/JCO.2007.12.2622; Chen XJ, 2009, MODERN PATHOL, V22, P699, DOI 10.1038/modpathol.2009.25; Chen Y, 2007, CELL RES, V17, P1020, DOI 10.1038/cr.2007.99; Choi JH, 2004, J CLIN ENDOCR METAB, V89, P5508, DOI 10.1210/jc.2004-0044; Choi JH, 2007, ENDOCR REV, V28, P440, DOI 10.1210/er.2006-0036; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717; Crum CP, 2009, MOL ONCOL, V3, P165, DOI 10.1016/j.molonc.2009.01.004; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; Dong LW, 2011, CELL RES, V21, P1248, DOI 10.1038/cr.2011.103; Elsheikh S, 2008, BREAST CANCER RES TR, V109, P325, DOI 10.1007/s10549-007-9659-8; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Huang Y, 2008, CELL RES, V18, P780, DOI 10.1038/cr.2008.70; Huang Y, 2011, ENDOCR-RELAT CANCER, V18, P13, DOI 10.1677/ERC-09-0308; Hung WC, 1996, HUM PATHOL, V27, P1324, DOI 10.1016/S0046-8177(96)90345-7; Jia L, 2011, NEOPLASMA, V58, P104, DOI 10.4149/neo_2011_02_104; Konishi I, 2006, INT J GYNECOL CANCER, V16, P16, DOI 10.1111/j.1525-1438.2006.00425.x; Lai YL, 2013, INT J ONCOL, V42, P776, DOI 10.3892/ijo.2012.1743; Li J, 2011, MODERN PATHOL, V24, P1488, DOI 10.1038/modpathol.2011.106; Li Q, 2013, MOL ENDOCRINOL, V27, P1468, DOI 10.1210/me.2013-1082; Li Y, 2007, MOL CELL ENDOCRINOL, V267, P26, DOI 10.1016/j.mce.2006.11.010; Liao H, 2012, ONCOL REP, V27, P1918, DOI 10.3892/or.2012.1700; Liu Yu-Qiang, 2014, J Anal Methods Chem, V2014, P617367, DOI 10.1155/2014/617367; Ludwig AH, 2009, ENDOCR-RELAT CANCER, V16, P1005, DOI 10.1677/ERC-08-0135; Lukanova A, 2005, CANCER EPIDEM BIOMAR, V14, P98; Man JH, 2010, J CLIN INVEST, V120, P2829, DOI 10.1172/JCI42542; Meng Y, 2010, CANCER LETT, V297, P9, DOI 10.1016/j.canlet.2010.04.019; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Nichols GE, 1996, MODERN PATHOL, V9, P418; Ohtani K, 2001, CANCER LETT, V166, P207, DOI 10.1016/S0304-3835(00)00713-8; Ortiz CM, 2008, INT J CANCER, V122, P325, DOI 10.1002/ijc.23106; Qian YW, 2012, GASTROENTEROLOGY, V142, P1547, DOI 10.1053/j.gastro.2012.02.042; Qiu W, 2008, ONCOGENE, V27, P4034, DOI 10.1038/onc.2008.43; Riman T, 1998, CLIN ENDOCRINOL, V49, P695, DOI 10.1046/j.1365-2265.1998.00577.x; Semczuk A, 2004, CANCER LETT, V203, P1, DOI 10.1016/j.canlet.2003.09.012; Song X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-114; Sui L, 1999, GYNECOL ONCOL, V73, P202, DOI 10.1006/gyno.1999.5373; Tang SH, 2010, CANCER BIOL THER, V9, P88, DOI 10.4161/cbt.9.2.10283; Tao X, 2013, ENDOCR-RELAT CANCER, V20, P415, DOI 10.1530/ERC-12-0005; Udhayakumar G, 2007, MOL CARCINOGEN, V46, P807, DOI 10.1002/mc.20311; Umekita Y, 2002, INT J CANCER, V98, P415, DOI 10.1002/ijc.10151; Wang J, 2003, INT J CANCER, V103, P328, DOI 10.1002/ijc.10848; Wen W, 2010, CANCER RES, V70, P2010, DOI 10.1158/0008-5472.CAN-08-4910; WINSTON JT, 1993, MOL BIOL CELL, V4, P1133, DOI 10.1091/mbc.4.11.1133; Zhang JW, 2013, CANCER LETT, V339, P279, DOI 10.1016/j.canlet.2012.10.037; Zhang ZB, 2013, INT J ONCOL, V43, P1194, DOI 10.3892/ijo.2013.2054; Zhang ZB, 2013, ONCOL REP, V29, P1429, DOI 10.3892/or.2013.2278; Zhang ZB, 2012, CANCER LETT, V319, P89, DOI 10.1016/j.canlet.2011.12.033; Zhang ZB, 2009, CANCER LETT, V278, P56, DOI 10.1016/j.canlet.2008.12.024; Zheng TS, 2014, HEPATOLOGY, V59, P935, DOI 10.1002/hep.26705; Zheng WX, 1996, AM J PATHOL, V148, P47	54	68	74	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 12	2016	35	19					2506	2517		10.1038/onc.2015.316	http://dx.doi.org/10.1038/onc.2015.316			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GQ	26364616				2022-12-26	WOS:000376165500009
J	Pini, M; Touch, S; Poirier, H; Dalmas, E; Niot, I; Rouault, C; Druart, C; Delzenne, N; Clement, K; Andre, S; Guerre-Millo, M				Pini, Maria; Touch, Sothea; Poirier, Helene; Dalmas, Elise; Niot, Isabelle; Rouault, Christine; Druart, Celine; Delzenne, Nathalie; Clement, Karine; Andre, Sebastien; Guerre-Millo, Michele			Adipose tissue adaptive response to trans-10, cis-12-conjugated linoleic acid engages alternatively activated M2 macrophages	FASEB JOURNAL			English	Article						lipoatrophy; hyperinsulinemia; fibrosis; lipophagy	CELLS PROMOTE INFLAMMATION; DIET-INDUCED OBESITY; INDUCED WEIGHT-LOSS; INSULIN-RESISTANCE; T-CELLS; IMMUNE-SYSTEM; MICE; FIBROSIS; MOUSE; EXPRESSION	In mice, nutritional supplementation with the trans-10, cis-12 isomer of linoleic acid (t10, c12-CLA) promotes lipoatrophy, hyperinsulinemia, and macrophage infiltration in white adipose tissue (WAT). We explored the dynamics of these interrelated responses over 2 consecutive 7 d periods of t10, c12-CLA administration and withdrawal. t10, c12-CLA down-regulated lipogenic and lipolytic gene expression and increased collagen deposition, but with no evidence of cross-linking. An abundant CD45(+) cell infiltrate, comprising prominently CD206(+)CD11c(-) macrophages, was found in WAT in association with an anti-inflammatory gene signature. Infiltration of natural killer (NK) and dendritic cells contributed to WAT's innate immune response to t10, c12-CLA. Less abundant adaptive immune cells colonized WAT, including B, NK T, gamma delta T, and alpha beta T cells. By contrast, T-regulatory cell abundance was not affected. Interruption of treatment allowed recovery of WAT mass and normalization of insulinemia, coincident with regain of WAT homeostasis owing to a coordinated reversion of genic, structural, and immune deregulations. These data revealed a striking resilience of WAT after a short-term metabolic injury induced by t10, c12-CLA, which relies on alternatively activated M2 macrophage engagement. In addition, the temporal links between variations in WAT alterations and insulinemia upon t10, c12-CLA manipulation strengthen the view that WAT dysfunctional status is critically involved in altered glucose homeostasis.	[Pini, Maria; Touch, Sothea; Dalmas, Elise; Rouault, Christine; Clement, Karine; Andre, Sebastien] Univ Paris 06, Sorbonne Univ, Unite Mixte Rech Sante 1166, Paris, France; [Pini, Maria; Touch, Sothea; Dalmas, Elise; Rouault, Christine; Clement, Karine; Andre, Sebastien; Guerre-Millo, Michele] INSERM, Unite Mixte Rech Sante 1166, Nutri Team 6, Paris, France; [Pini, Maria; Touch, Sothea; Dalmas, Elise; Rouault, Christine; Clement, Karine; Andre, Sebastien; Guerre-Millo, Michele] Hop La Pitie Salpetriere, AP HP, Inst Cardiometabolism & Nutr, Paris, France; [Poirier, Helene; Niot, Isabelle] Univ Bourgogne, AgroSupDijon, INSERM, Unite Mixte Rech U866, Dijon, France; [Druart, Celine; Delzenne, Nathalie] Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Guerre-Millo, M (corresponding author), UMRS 1166, Nutri Team 6, 91 Blvd Hop, F-75013 Paris, France.	michele.guerre-millo@crc.jussieu.fr	Pini, Maria/AAC-2530-2021; Pini, Maria/O-8620-2019; Delzenne, Nathalie/AAC-4628-2019; Guerre-Millo, Michele/G-7253-2017; Pini, Maria/T-6292-2018; Clément, karine/R-1120-2017	Pini, Maria/0000-0002-9995-5370; Delzenne, Nathalie/0000-0003-2115-6082; Pini, Maria/0000-0002-9995-5370; Druart, Celine/0000-0002-7786-9172; ANDRE, Sebastien/0000-0002-7543-153X; Dalmas, Elise/0000-0003-0959-5648	grant (ADIPOFIB) from the National Agency of Research; French Foundation for Medical Research [FRM DEQ20120323701]; Groupe Lipides Nutrition; French government grant [ANR-10-IHU]; Ph.D. fellowship from the EU-Metacardis FP7 program; Association Francaise d'Etude et de Recherche sur l'Obesite; Fonds National de la Recherche Scientifique in Belgium [1.5121.12F]; Institut Danone Belgique	grant (ADIPOFIB) from the National Agency of Research; French Foundation for Medical Research(Fondation pour la Recherche Medicale); Groupe Lipides Nutrition; French government grant; Ph.D. fellowship from the EU-Metacardis FP7 program; Association Francaise d'Etude et de Recherche sur l'Obesite; Fonds National de la Recherche Scientifique in Belgium(Fonds de la Recherche Scientifique - FNRS); Institut Danone Belgique(Danone Nutricia)	The authors thank R. Selleslagh and S. Mutel for expert technical assistance and I. Dugail, D. Lacasa, and C. Caer for helpful discussions. This study was funded by a grant (ADIPOFIB) from the National Agency of Research (to K.C.); by the French Foundation for Medical Research Grant FRM DEQ20120323701(to K.C.); by a grant from Groupe Lipides Nutrition (to M.G.-M.); by a French government grant managed by the National Agency of Research (Institute of Cardiometabolism and Nutrition, reference ANR-10-IHU); by a Ph.D. fellowship from the EU-Metacardis FP7 program (to S.T.); by Association Francaise d'Etude et de Recherche sur l'Obesite (to M.P); by Fonds National de la Recherche Scientifique in Belgium Grant 1.5121.12F Credit aux Chercheurs (to N.D. and C.D.); and by a grant in the form of salary from Institut Danone Belgique (to C.D.). The authors declare no conflicts of interests.	Barbato DL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.404; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Caron-Debarle M, 2010, TRENDS MOL MED, V16, P218, DOI 10.1016/j.molmed.2010.03.002; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Druart C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087560; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Fischer-Posovszky P, 2011, ENDOCRINOLOGY, V152, P3074, DOI 10.1210/en.2011-1031; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Giralt M, 2011, BEST PRACT RES CL EN, V25, P487, DOI 10.1016/j.beem.2010.12.001; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Jan V, 2004, ANTIVIR THER, V9, P555; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kovacikova M, 2011, INT J OBESITY, V35, P91, DOI 10.1038/ijo.2010.112; LaRosa PC, 2006, PHYSIOL GENOMICS, V27, P282, DOI 10.1152/physiolgenomics.00076.2006; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mehta P, 2015, J LEUKOCYTE BIOL, V97, P121, DOI 10.1189/jlb.3A0414-211RR; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pellegrinelli V, 2014, J PATHOL, V233, P183, DOI 10.1002/path.4347; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Poirier H, 2005, DIABETOLOGIA, V48, P1059, DOI 10.1007/s00125-005-1765-8; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Russell JS, 2007, J NUTR, V137, P1200, DOI 10.1093/jn/137.5.1200; Shen W, 2013, J LIPID RES, V54, P909, DOI 10.1194/jlr.M030924; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Vila IK, 2014, CELL REP, V7, P1116, DOI 10.1016/j.celrep.2014.03.062; Villarroya F, 2007, INT J OBESITY, V31, P1763, DOI 10.1038/sj.ijo.0803698; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2012, IMMUNOL CELL BIOL, V90, P755, DOI 10.1038/icb.2011.110; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13	52	11	11	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					241	251		10.1096/fj.15-276675	http://dx.doi.org/10.1096/fj.15-276675			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26362817				2022-12-26	WOS:000367621000024
J	Chen, Q; Yue, F; Li, WJ; Zou, J; Xu, T; Huang, C; Zhang, Y; Song, K; Huang, GQ; Xu, GB; Huang, H; Li, J; Liu, LY				Chen, Qi; Yue, Fei; Li, Wenjiao; Zou, Jing; Xu, Tao; Huang, Cheng; Zhang, Ye; Song, Kun; Huang, Guanqun; Xu, Guibin; Huang, Hai; Li, Jun; Liu, Leyuan			Potassium Bisperoxo(1,10-phenanthroline)oxovanadate (bpV(phen)) Induces Apoptosis and Pyroptosis and Disrupts the P62-HDAC6 Protein Interaction to Suppress the Acetylated Microtubule-dependent Degradation of Autophagosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PEROXOVANADIUM COMPOUNDS; CONJUGATION SYSTEM; P62/SQSTM1; DISEASE; INFLAMMASOMES; MICE; MITOCHONDRIA; PATHOGENESIS; ACTIVATION	Autophagy is a cellular process that controls and executes the turnover of dysfunctional organelles and misfolded or abnormally aggregated proteins. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) activates the initiation of autophagy. Autophagosomes migrate along acetylated microtubules to fuse with lysosomes to execute the degradation of the engulfed substrates that usually bind with sequestosome 1 (SQSTM1, p62). Microtubule-associated protein 1 light chain 3 (LC3) traces the autophagy process by converting from the LC3-I to the LC3-II isoform and serves as a major marker of autophagy flux. Potassium bisperoxo(1,10-phenanthroline) oxovanadate (bpV(phen)) is an insulin mimic and a PTEN inhibitor and has the potential to treat different diseases. Here we show that bpV(phen) enhances the ubiquitination of p62, reduces the stability of p62, disrupts the interaction between p62 and histone deacetylase 6 (HDAC6), activates the deacetylase activity of HDAC6 on alpha-tubulin, and impairs stable acetylated microtubules. Microtubular destabilization leads to the blockade of autophagosome-lysosome fusion and accumulation of autophagosomes. Autophagy defects lead to oxidative stress and lysosomal rupture, which trigger different types of cell death, including apoptosis and pyroptosis. The consistent results from multiple systems, including mouse and different types of mammalian cells, are different from the predicted function of bpV(phen) as a PTEN inhibitor to activate autophagy flux. In addition, levels of p62 are reduced but not elevated when autophagosomal degradation is blocked, revealing a novel function of p62 in autophagy regulation. Therefore, it is necessary to pay attention to the roles of bpV(phen) in autophagy, apoptosis, and pyroptosis when it is developed as a drug.	[Chen, Qi; Xu, Tao; Huang, Cheng; Li, Jun] Anhui Med Univ, Sch Pharm, Hefei 230032, Anhui, Peoples R China; [Chen, Qi; Zhang, Ye] Anhui Med Univ, Hosp 2, Dept Anesthesiol, Hefei 230601, Anhui, Peoples R China; [Chen, Qi; Yue, Fei; Li, Wenjiao; Zou, Jing; Song, Kun; Huang, Guanqun; Xu, Guibin; Huang, Hai; Liu, Leyuan] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA; [Liu, Leyuan] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Anhui Medical University; Anhui Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Li, J (corresponding author), Anhui Med Univ, Inst Liver Dis, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	lj@ahmu.edu.cn; lliu@ibt.tamhsc.edu	Yue, Fei/N-1891-2018; Li, Wenjiao/J-2198-2019	Li, Wenjiao/0000-0003-1308-8489	NCI/National Institutes of Health [CA142862]; Department of Defense New Investigator Award [W81XWH]; NATIONAL CANCER INSTITUTE [R01CA142862] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense New Investigator Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI/National Institutes of Health Grant CA142862 (to L. L.). This work was also supported by Department of Defense New Investigator Award W81XWH (to L. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee J, 2012, J BIOL CHEM, V287, P4033, DOI 10.1074/jbc.M111.280065; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu LY, 2012, AUTOPHAGY, V8, P278, DOI 10.4161/auto.8.2.18939; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Pouliot P, 2009, J IMMUNOL, V182, P1334, DOI 10.4049/jimmunol.182.3.1334; Ryter Stefan W, 2014, Int J Cell Biol, V2014, P502676, DOI 10.1155/2014/502676; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; YALE JF, 1995, DIABETES, V44, P1274, DOI 10.2337/diabetes.44.11.1274; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076016; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094903; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	40	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26051	26058		10.1074/jbc.M115.653568	http://dx.doi.org/10.1074/jbc.M115.653568			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26363065	hybrid, Green Published			2022-12-26	WOS:000363527300026
J	Horniblow, RD; Dowle, M; Iqbal, TH; Latunde-Dada, GO; Palmer, RE; Pikramenou, Z; Tselepis, C				Horniblow, Richard D.; Dowle, Miriam; Iqbal, Tariq H.; Latunde-Dada, Gladys O.; Palmer, Richard E.; Pikramenou, Zoe; Tselepis, Chris			Alginate-Iron Speciation and Its Effect on In Vitro Cellular Iron Metabolism	PLOS ONE			English	Article							OXIDE NANOPARTICLES; ION-BINDING; FERRITIN; ABSORPTION; STABILIZATION; FERRIHYDRITE; IRON(III); WELL	Alginates are a class of biopolymers with known iron binding properties which are routinely used in the fabrication of iron-oxide nanoparticles. In addition, alginates have been implicated in influencing human iron absorption. However, the synthesis of iron oxide nanoparticles employs non-physiological pH conditions and whether nanoparticle formation in vivo is responsible for influencing cellular iron metabolism is unclear. Thus the aims of this study were to determine how alginate and iron interact at gastric-comparable pH conditions and how this influences iron metabolism. Employing a range of spectroscopic techniques under physiological conditions alginate-iron complexation was confirmed and, in conjunction with aberration corrected scanning transmission electron microscopy, nanoparticles were observed. The results infer a nucleation-type model of iron binding whereby alginate is templating the condensation of iron-hydroxide complexes to form iron oxide centred nanoparticles. The interaction of alginate and iron at a cellular level was found to decrease cellular iron acquisition by 37% (p < 0.05) and in combination with confocal microscopy the alginate inhibits cellular iron transport through extracellular iron chelation with the resulting complexes not internalised. These results infer alginate as being useful in the chelation of excess iron, especially in the context of inflammatory bowel disease and colorectal cancer where excess unabsorbed luminal iron is thought to be a driver of disease.	[Horniblow, Richard D.; Iqbal, Tariq H.; Tselepis, Chris] Univ Birmingham, Sch Canc Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Dowle, Miriam; Palmer, Richard E.] Univ Birmingham, Sch Phys, Coll Engn & Phys Sci, Birmingham B15 2TT, W Midlands, England; [Latunde-Dada, Gladys O.] Kings Coll London, Diabet & Nutr Sci, London SE1 9NH, England; [Pikramenou, Zoe] Univ Birmingham, Sch Chem, Coll Engn & Phys Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham; University of London; King's College London; University of Birmingham	Tselepis, C (corresponding author), Univ Birmingham, Sch Canc Sci, Coll Med & Dent Sci, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	c.tselepis@bham.ac.uk	Pikramenou, Zoe/K-3340-2012; Palmer, Richard E/A-5366-2008	Pikramenou, Zoe/0000-0002-6001-1380; Palmer, Richard E/0000-0001-8728-8083; iqbal, tariq/0000-0002-6681-9882	Biotechnology and Biological Sciences Research Council [BB/J500288/1]; Biotechnology and Biological Sciences Research Council [1134509] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E005918/1, EP/K006061/1] Funding Source: researchfish; Medical Research Council [MC_PC_13057] Funding Source: researchfish; EPSRC [EP/K006061/1, EP/E005918/1] Funding Source: UKRI; MRC [MC_PC_13057] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council BB/J500288/1.	Bedford MR, 2013, J CLIN PHARMACOL, V53, P885, DOI 10.1002/jcph.113; BERNER LA, 1983, J FOOD SCI, V48, P755, DOI 10.1111/j.1365-2621.1983.tb14891.x; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Brookes MJ, 2008, ONCOGENE, V27, P966, DOI 10.1038/sj.onc.1210711; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Fang YP, 2007, J PHYS CHEM B, V111, P2456, DOI 10.1021/jp0689870; George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Hampson FC, 2005, INT J PHARMACEUT, V294, P137, DOI 10.1016/j.ijpharm.2005.01.036; HARMUTHHOENE AE, 1980, J NUTR, V110, P1774, DOI 10.1093/jn/110.9.1774; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; Jonathan MC, 2013, J AGR FOOD CHEM, V61, P553, DOI 10.1021/jf304338z; Jones F, 2000, BIOMACROMOLECULES, V1, P556, DOI 10.1021/bm0055089; Karlsen V, 2010, THERMOCHIM ACTA, V501, P119, DOI 10.1016/j.tca.2010.01.007; Kim SW, 2008, B KOREAN CHEM SOC, V29, P1969; Kroll E, 1996, CHEM MATER, V8, P1594, DOI 10.1021/cm960095x; Latunde-Dada GO, 2014, J NUTR, V144, P1896, DOI 10.3945/jn.114.201715; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Llanes F, 2000, INT J BIOL MACROMOL, V27, P35, DOI 10.1016/S0141-8130(99)00115-4; Ma HL, 2007, INT J PHARMACEUT, V333, P177, DOI 10.1016/j.ijpharm.2006.10.006; Maity D, 2007, J MAGN MAGN MATER, V308, P46, DOI 10.1016/j.jmmm.2006.05.001; Pan Y, 2006, MICRON, V37, P403, DOI 10.1016/j.micron.2005.12.009; Pan YH, 2009, J STRUCT BIOL, V166, P22, DOI 10.1016/j.jsb.2008.12.001; Pereira DIA, 2014, NANOMED-NANOTECHNOL, V10, P1877, DOI 10.1016/j.nano.2014.06.012; Pereira DIA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081250; Powell JJ, 2014, NANOMED-NANOTECHNOL, V10, P1529, DOI 10.1016/j.nano.2013.12.011; Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003; SANDBERG AS, 1994, AM J CLIN NUTR, V60, P751, DOI 10.1093/ajcn/60.5.751; Shen F, 2003, BIOTECHNOL BIOENG, V83, P282, DOI 10.1002/bit.10674; Sourty E, 2009, MICROSC MICROANAL, V15, P251, DOI 10.1017/S1431927609090278; Sreeram KJ, 2004, BBA-GEN SUBJECTS, V1670, P121, DOI 10.1016/j.bbagen.2003.11.001; Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577; Thebaudin JY, 1997, TRENDS FOOD SCI TECH, V8, P41, DOI 10.1016/S0924-2244(97)01007-8; TROWELL H, 1976, LANCET, V1, P967; WANG ZY, 1993, BIOPOLYMERS, V33, P703, DOI 10.1002/bip.360330419; Wawer AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112144; Wawer AA, 2012, J AGR FOOD CHEM, V60, P11318, DOI 10.1021/jf3031309; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929	39	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138240	10.1371/journal.pone.0138240	http://dx.doi.org/10.1371/journal.pone.0138240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378798	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400070
J	Williams, AK; McInnes, AS; Rooker, JR; Quigg, A				Williams, Alicia K.; McInnes, Allison S.; Rooker, Jay R.; Quigg, Antonietta			Changes in Microbial Plankton Assemblages Induced by Mesoscale Oceanographic Features in the Northern Gulf of Mexico	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; MISSISSIPPI RIVER PLUME; LOOP CURRENT; EDDY ACTIVITY; E-FLUX; EDDIES; PHYTOPLANKTON; NUTRIENT; ATLANTIC; PICOPLANKTON	Mesoscale circulation generated by the Loop Current in the Northern Gulf of Mexico (NGOM) delivers growth-limiting nutrients to the microbial plankton of the euphotic zone. Consequences of physicochemically driven community shifts on higher order consumers and subsequent impacts on the biological carbon pump remain poorly understood. This study evaluates microbial plankton < 10 mu m abundance and community structure across both cyclonic and anti-cyclonic circulation features in the NGOM using flow cytometry (SYBR Green I and autofluorescence parameters). Non-parametric multivariate hierarchical cluster analyses indicated that significant spatial variability in community structure exists such that stations that clustered together were defined as having a specific 'microbial signature' (i.e. statistically homogeneous community structure profiles based on relative abundance of microbial groups). Salinity and a combination of sea surface height anomaly and sea surface temperature were determined by distance based linear modeling to be abiotic predictor variables significantly correlated to changes in microbial signatures. Correlations between increased microbial abundance and availability of nitrogen suggest nitrogen-limitation of microbial plankton in this open ocean area. Regions of combined coastal water entrainment and mesoscale convergence corresponded to increased heterotrophic prokaryote abundance relative to autotrophic plankton. The results provide an initial assessment of how mesoscale circulation potentially influences microbial plankton abundance and community structure in the NGOM.	[Williams, Alicia K.; McInnes, Allison S.; Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [McInnes, Allison S.] Univ Technol Sydney, Climate Change Cluster, Sydney, NSW 2007, Australia; [Rooker, Jay R.; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Rooker, Jay R.] Texas A&M Univ, Dept Wildlife & Fisheries, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; University of Technology Sydney; Texas A&M University System; Texas A&M University System; Texas A&M University College Station	Williams, AK (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	sheparda@tamug.edu			McDaniel Charitable Foundation; Louisiana Department of Wildlife and Fisheries; Texas Institute of Oceanography; University Libraries; Office of the Vice President for Research	McDaniel Charitable Foundation; Louisiana Department of Wildlife and Fisheries; Texas Institute of Oceanography; University Libraries; Office of the Vice President for Research	The McDaniel Charitable Foundation, Louisiana Department of Wildlife and Fisheries, and the Texas Institute of Oceanography provided funding for this project. Additionally, the open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], ALGAL CULTURING TECH; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baines SB, 2012, NAT GEOSCI, V5, P886, DOI [10.1038/ngeo1641, 10.1038/NGEO1641]; Beaugrand G, 2005, ICES J MAR SCI, V62, P333, DOI 10.1016/j.icesjms.2005.01.002; Benitez-Nelson CR, 2008, DEEP-SEA RES PT II, V55, P1133, DOI 10.1016/j.dsr2.2008.03.001; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bibby TS, 2011, BIOGEOSCIENCES, V8, P657, DOI 10.5194/bg-8-657-2011; Bibby TS, 2008, DEEP-SEA RES PT II, V55, P1310, DOI 10.1016/j.dsr2.2008.01.014; Biggs DC, 1997, FISH B-NOAA, V95, P369; BIGGS DC, 1994, J GEOPHYS RES-OCEANS, V99, P7371, DOI 10.1029/93JC02153; Bouman HA, 2011, ENV MICROBIOL REP, V3, P473, DOI 10.1111/j.1758-2229.2011.00241.x; BROOKS DA, 1982, J GEOPHYS RES-OCEANS, V87, P4195, DOI 10.1029/JC087iC06p04195; Brown SL, 2008, DEEP-SEA RES PT II, V55, P1321, DOI 10.1016/j.dsr2.2008.02.012; Calil PHR, 2008, DEEP-SEA RES PT II, V55, P1179, DOI 10.1016/j.dsr2.2008.01.008; Campbell L, 2001, METHOD MICROBIOL, V30, P317, DOI 10.1016/S0580-9517(01)30051-X; Cherubin LM, 2006, J PHYS OCEANOGR, V36, P569, DOI 10.1175/JPO2871.1; Chistaki CC C., 2011, LIMNOLOGY OCEANOGRAP, V9, P329; Church MJ, 2009, P NATL ACAD SCI USA, V106, P15519, DOI 10.1073/pnas.0908881106; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collier JL, 1999, HYDROBIOLOGIA, V401, P33; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dai A, 2009, J CLIMATE, V22, P2773, DOI 10.1175/2008JCLI2592.1; Dickey TD, 2008, DEEP-SEA RES PT II, V55, P1195, DOI 10.1016/j.dsr2.2008.01.006; Dohan K, 2010, OCEANOGRAPHY, V23, P94, DOI 10.5670/oceanog.2010.08; Dorado S, 2012, MAR ECOL PROG SER, V464, P37, DOI 10.3354/meps09854; DORTCH Q, 1992, CONT SHELF RES, V12, P1293, DOI 10.1016/0278-4343(92)90065-R; DUGDALE RC, 1995, DEEP-SEA RES PT I, V42, P697, DOI 10.1016/0967-0637(95)00015-X; Evans C, 2011, DEEP-SEA RES PT II, V58, P2150, DOI 10.1016/j.dsr2.2011.05.019; Ewart CS, 2008, DEEP-SEA RES PT II, V55, P1334, DOI 10.1016/j.dsr2.2008.02.013; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; Falkowski PG, 2007, AQUATIC PHOTOSYNTHES, pxiii; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Giovannoni SJ, 2014, ISME J, V8, P1553, DOI 10.1038/ismej.2014.60; Hammes F, 2010, ANAL BIOANAL CHEM, V397, P1083, DOI 10.1007/s00216-010-3646-3; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; HURLBURT HE, 1980, J PHYS OCEANOGR, V10, P1611, DOI 10.1175/1520-0485(1980)010<1611:ANSOLC>2.0.CO;2; ICHIYE T, 1959, J GEOPHYS RES, V64, P1109; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Jochem FJ, 2004, MAR BIOL, V145, P1213, DOI 10.1007/s00227-004-1406-7; Kamiya E, 2007, J OCEANOGR, V63, P101, DOI 10.1007/s10872-007-0008-7; Kirchman DL, 2008, MICROBIAL ECOLOGY OF; Koch C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00273; Lamkin J, 1997, FISH B-NOAA, V95, P250; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; LI WKW, 1983, SCIENCE, V219, P292, DOI 10.1126/science.219.4582.292; Liu HB, 2004, ESTUARIES, V27, P147, DOI 10.1007/BF02803568; LOHRENZ SE, 1990, CONT SHELF RES, V10, P639, DOI 10.1016/0278-4343(90)90043-L; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moran XAG, 2001, DEEP-SEA RES PT I, V48, P405, DOI 10.1016/S0967-0637(00)00042-X; Mourino-Carballido B, 2009, DEEP-SEA RES PT I, V56, P1242, DOI 10.1016/j.dsr.2009.03.001; Nencioli F, 2008, DEEP-SEA RES PT II, V55, P1252, DOI 10.1016/j.dsr2.2008.02.003; Qian YR, 2003, CONT SHELF RES, V23, P1, DOI 10.1016/S0278-4343(02)00173-5; Quigg A, 2011, AQUAT GEOCHEM, V17, P519, DOI 10.1007/s10498-011-9134-3; Ressler PH, 2003, CONT SHELF RES, V23, P41, DOI 10.1016/S0278-4343(02)00149-8; Rivas D, 2008, J PHYS OCEANOGR, V38, P2461, DOI 10.1175/2008JPO3755.1; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076080; Sahl LE, 1997, CONT SHELF RES, V17, P117, DOI 10.1016/S0278-4343(96)00017-9; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; SHILLER AM, 1993, ESTUARIES, V16, P541, DOI 10.2307/1352601; Sweeney EN, 2003, DEEP-SEA RES PT II, V50, P3017, DOI 10.1016/j.dsr2.2003.07.008; Thingstad TF, 2008, NATURE, V455, P387, DOI 10.1038/nature07235; Waite AM, 2007, DEEP-SEA RES PT II, V54, P789, DOI 10.1016/j.dsr2.2006.12.008; Walker N, 2009, OCEANS-IEEE, P1484; Wang YY, 2010, TRENDS BIOTECHNOL, V28, P416, DOI 10.1016/j.tibtech.2010.04.006; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zhao Y., 2014, PLOS ONE, V9	77	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138230	10.1371/journal.pone.0138230	http://dx.doi.org/10.1371/journal.pone.0138230			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375709	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200091
J	Bednarska, M; Bajer, A; Drozdowska, A; Mierzejewska, EJ; Tolkacz, K; Welc-Faleciak, R				Bednarska, Malgorzata; Bajer, Anna; Drozdowska, Anna; Mierzejewska, Ewa J.; Tolkacz, Katarzyna; Welc-Faleciak, Renata			Vertical Transmission of Babesia microti in BALB/c Mice: Preliminary Report	PLOS ONE			English	Article							TRANSPLACENTAL TRANSMISSION; CONGENITAL TRANSMISSION; THEILERIA-EQUI; NEW-YORK; INFECTION; DOGS; RESISTANCE; PREGNANCY; MALARIA; GIBSONI	Babesia spp. (Apicomplexa, Piroplasmida) are obligate parasites of many species of mammals, causing a malaria-like infection- babesiosis. Three routes of Babesia infection have been recognized to date. The main route is by a tick bite, the second is via blood transfusion. The third, vertical route of infection is poorly recognized and understood. Our study focused on vertical transmission of B. microti in a well-established mouse model. We assessed the success of this route of infection in BALB/c mice with acute and chronic infections of B. microti. In experimental groups, females were mated on the 1st day of Babesia infection (Group G0); on the 28th day post infection (dpi) in the post-acute phase of the parasite infection (G28); and on the 90th and 150th dpi (G90 and G150 group, respectively), in the chronic phase of the parasite infection. Pups were obtained from 58% of females mated in the post-acute phase (G28) and from 33% of females in groups G90 and G150. Mice mated in the pre-acute phase of infection (G0) did not deliver pups. Congenital B. microti infections were detected by PCR amplification of Babesia 18S rDNA in almost all pups (96%) from the experimental groups G28, G90 and G150. Parasitaemia in the F1 generation was low and varied between 0.01-0.001%. Vertical transmission of B. microti was demonstrated for the first time in BALB/c mice.	[Bednarska, Malgorzata; Bajer, Anna; Drozdowska, Anna; Mierzejewska, Ewa J.; Tolkacz, Katarzyna; Welc-Faleciak, Renata] Univ Warsaw, Dept Parasitol, Inst Zool, Fac Biol, Warsaw, Poland	University of Warsaw	Bednarska, M (corresponding author), Univ Warsaw, Dept Parasitol, Inst Zool, Fac Biol, 1 Miecznikowa St, Warsaw, Poland.	mabed@biol.uw.edu.pl	Bednarska, Małgorzata/ABF-9465-2020; Tołkacz, Katarzyna/AAJ-5452-2021	Tołkacz, Katarzyna/0000-0002-8578-3870; Welc-Faleciak, Renata/0000-0003-2266-1435; Bajer, Anna/0000-0001-6199-8458; Bednarska, Malgorzata/0000-0002-5278-2417	research grant of the National Science Centre Poland [2014/13/B/NZ7/02348]	research grant of the National Science Centre Poland	This study was financially supported by the research grant of the National Science Centre Poland no. 2014/13/B/NZ7/02348.	Aderinboye O, 2010, PEDIATR INFECT DIS J, V29, P188, DOI 10.1097/INF.0b013e3181c3c971; Bajer A, 2006, J ZOOL, V270, P9, DOI 10.1111/j.1469-7998.2006.00089.x; Bajer A, 2014, MICROB ECOL, V68, P196, DOI 10.1007/s00248-014-0390-9; Bednarska M, 2008, EXP PARASITOL, V120, P21, DOI 10.1016/j.exppara.2008.04.007; Bonnet S, 2007, EMERG INFECT DIS, V13, P1208, DOI 10.3201/eid1308.061560; Carlier Y, 2012, ACTA TROP, V121, P55, DOI 10.1016/j.actatropica.2011.10.018; Chaudhry SA, 2014, CAN FAM PHYSICIAN, V60, P334; Chhabra Sushma, 2012, J Parasit Dis, V36, P31, DOI 10.1007/s12639-011-0072-1; Cornett JK, 2012, INFECT DIS CLIN PRAC, V20, P408; Curno O, 2009, P ROY SOC B-BIOL SCI, V276, P1047, DOI 10.1098/rspb.2008.1612; DACOSTAMACEDO LM, 1990, REV I MED TROP, V32, P351, DOI 10.1590/S0036-46651990000500007; De Vos A.J., 1976, Onderstepoort Journal of Veterinary Research, V43, P75; Duffy P, 2001, IMMUNITY MALARIA PRE, P70; ESERNIOJENSSEN D, 1987, J PEDIATR-US, V110, P570, DOI 10.1016/S0022-3476(87)80552-8; Fukumoto S, 2005, INT J PARASITOL, V35, P1031, DOI 10.1016/j.ijpara.2005.03.018; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Hughes VL, 2001, PARASITOLOGY, V123, P365, DOI 10.1017/S0031182001008599; Hughes VL, 2001, J PARASITOL, V87, P49, DOI 10.1645/0022-3395(2001)087[0049:TDIAAR]2.0.CO;2; Jefferies R, 2007, AUST VET J, V85, P459, DOI 10.1111/j.1751-0813.2007.00220.x; Jin ZF, 2008, PARASITOL INT, V57, P495, DOI 10.1016/j.parint.2008.06.006; Joseph JT, 2012, EMERG INFECT DIS, V18, P1318, DOI 10.3201/eid1808.110988; Klinger Y., 1972, Refuah Veterinarith, V29, P73; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10; Luo YZ, 2011, PARASITOL INT, V60, P119, DOI 10.1016/j.parint.2010.11.001; Mierzejewskal EJ, 2014, ANN AGR ENV MED, V21, P500, DOI 10.5604/12321966.1120590; NEITZ WO, 1956, ANN NY ACAD SCI, V64, P56, DOI 10.1111/j.1749-6632.1956.tb36607.x; New DL, 1997, J PEDIATR-US, V131, P163, DOI 10.1016/S0022-3476(97)70143-4; Osorio Y, 2012, AM J TROP MED HYG, V86, P812, DOI 10.4269/ajtmh.2012.11-0458; Phipps LP, 2004, VET REC, V154, P406, DOI 10.1136/vr.154.13.406; Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Sappenfield E, 2013, INFECT DIS OBSTET GY, P752; Sasaki M, 2013, AM J TROP MED HYG, V88, P367, DOI 10.4269/ajtmh.2012.12-0338; SCIMECA PG, 1986, AM J DIS CHILD, V140, P971, DOI 10.1001/archpedi.1986.02140240017009; Sethi S, 2009, EMERG INFECT DIS, V15, P788, DOI 10.3201/eid1505.070808; Shoop WL, 2002, J PARASITOL, V88, P536, DOI 10.1645/0022-3395(2002)088[0536:TTOSSI]2.0.CO;2; Trintis J, 2010, INT J STD AIDS, V21, P606, DOI 10.1258/ijsa.2010.010174; Vannier E, 2004, J INFECT DIS, V189, P1721, DOI 10.1086/382965; VANNIER E, 2009, INTERDISCIP PERSPECT, DOI DOI 10.1155/2009/984568:1-9; Sanchez LV, 2013, PARASITOLOGY, V140, P147, DOI 10.1017/S0031182012001394; Welc-Faleciak R, 2007, ANN AGR ENV MED, V14, P287; White DJ, 1998, ARCH INTERN MED, V158, P2149, DOI 10.1001/archinte.158.19.2149; Yeruham I, 2003, J VET MED B, V50, P60, DOI 10.1046/j.1439-0450.2003.00597.x	44	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137731	10.1371/journal.pone.0137731	http://dx.doi.org/10.1371/journal.pone.0137731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372043	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400028
J	Fu, ZD; Cui, JY; Klaassen, CD				Fu, Zidong Donna; Cui, Julia Yue; Klaassen, Curtis D.			The Role of Sirt1 in Bile Acid Regulation during Calorie Restriction in Mice	PLOS ONE			English	Article							NUCLEAR RECEPTOR; STEROL 12-ALPHA-HYDROXYLASE; DIETARY RESTRICTION; X-RECEPTOR; LIFE-SPAN; METABOLISM; CHOLESTEROL; PROTECTS; EXPRESSION; DELETION	Sirtuin 1 (Sirt1) is an NAD(+)-dependent protein deacetylase that is proposed to mediate many health-promoting effects of calorie restriction (CR). We recently reported that short-term CR increased the bile acid (BA) pool size in mice, likely due to increased BA synthesis in liver. Given the important role of Sirt1 in the regulation of glucose, lipid, as well as BA metabolism, we hypothesized that the CR-induced increase in BAs is Sirt1-dependent. To address this, the present study utilized genetically-modified mice that were Sirt1 loss of function (liver knockout, LKO) or Sirt1 gain of function (whole body-transgenic, TG). Three genotypes of mice (Sirt1-LKO, wild-type, and Sirt1-TG) were each randomly divided into ad libitum or 40% CR feeding for one month. BAs were extracted from various compartments of the enterohepatic circulation, followed by BA profiling by UPLC-MS/MS. CR increased the BA pool size and total BAs in serum, gallbladder, and small intestine. The CR-induced increase in BA pool size correlated with the tendency of increase in the expression of the rate-limiting BA-synthetic enzyme Cyp7a1. However, in contrast to the hypothesis, the CR-induced increase in BA pool size and Cyp7a1 expression was still observed with ablated expression of Sirt1 in liver, and completely suppressed with whole-body overexpression of Sirt1. Furthermore, in terms of BA composition, CR increased the ratio of 12 alpha-hydroxylated BAs regardless of Sirt1 genotypes. In conclusion, the CR-induced alterations in BA pool size, BA profiles, and expression of BA-related genes do not appear to be dependent on Sirt1.	[Fu, Zidong Donna] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Fu, Zidong Donna] Harbin Med Univ, Dept Pharmacol, Harbin 150081, Heilongjiang Pr, Peoples R China; [Cui, Julia Yue] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; Harbin Medical University; University of Washington; University of Washington Seattle; University of Kansas; University of Kansas Medical Center	Klaassen, CD (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA.	curtisklaassenphd@gmail.com	Fu, Zidong/A-2703-2017		National Institutes of Health [ES-019487, ES-025708]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025708, R01ES019487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the National Institutes of Health [Grants ES-019487 and ES-025708].	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Escola-Gil JC, 2013, TRANSL RES, V161, P110, DOI 10.1016/j.trsl.2012.10.008; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen YR, 2010, BIOCHEM CELL BIOL, V88, P715, DOI 10.1139/O10-010; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fu ZD, 2013, TOXICOL APPL PHARM, V273, P680, DOI 10.1016/j.taap.2013.10.020; Geng YQ, 2011, J CELL BIOCHEM, V112, P3755, DOI 10.1002/jcb.23315; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hofmann AF, 2014, J LIPID RES; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kazgan N, 2014, GASTROENTEROLOGY, V146, P1006, DOI 10.1053/j.gastro.2013.12.029; Kemper JK, 2013, VITAM HORM, V91, P385, DOI 10.1016/B978-0-12-407766-9.00016-X; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kir S, 2012, J BIOL CHEM, V287, P41334, DOI 10.1074/jbc.M112.421834; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lettieri Barbato Daniele, 2012, Int J Cell Biol, V2012, P759583, DOI 10.1155/2012/759583; Li TG, 2012, J LIPIDS, V2012, DOI 10.1155/2012/754067; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Pandak WM, 2001, GASTROENTEROLOGY, V120, P1801, DOI 10.1053/gast.2001.24833; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Purushotham A, 2012, MOL CELL BIOL, V32, P1226, DOI 10.1128/MCB.05988-11; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Schwarz M, 2001, J LIPID RES, V42, P1594; Shin DJ, 2008, J BIOL CHEM, V283, P15089, DOI 10.1074/jbc.M710452200; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; TUCHWEBER B, 1987, LIFE SCI, V41, P2091, DOI 10.1016/0024-3205(87)90526-1; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; Wang DQH, 2003, AM J PHYSIOL-GASTR L, V285, pG494, DOI 10.1152/ajpgi.00156.2003; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Yu W, 2014, MOL MED REP, V9, P1218, DOI 10.3892/mmr.2014.1944; Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641	57	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138307	10.1371/journal.pone.0138307	http://dx.doi.org/10.1371/journal.pone.0138307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372644	Green Submitted, Green Published, gold			2022-12-26	WOS:000361604400064
J	Holgate, RGE; Weldon, R; Jones, TD; Baker, MP				Holgate, Robert G. E.; Weldon, Richard; Jones, Timothy D.; Baker, Matthew P.			Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity	PLOS ONE			English	Article							CD52 ANTIGEN; MODEL	Anti-CD52 therapy has been shown to be effective in the treatment of a number of B cell malignancies, hematopoietic disorders and autoimmune diseases (including rheumatoid arthritis and multiple sclerosis); however the current standard of treatment, the humanized monoclonal antibody alemtuzumab, is associated with the development of anti-drug antibodies in a high proportion of patients. In order to address this problem, we have identified a novel murine anti-CD52 antibody which has been humanized using a process that avoids the inclusion within the variable domains of non-human germline MHC class II binding peptides and known CD4+ T cell epitopes, thus reducing its potential for immunogenicity in the clinic. The resultant humanized antibody, ANT1034, was shown to have superior binding to CD52 expressing cells than alemtuzumab and was more effective at directing both antibody dependent and complement dependent cell cytotoxicity. Furthermore, when in the presence of a cross-linking antibody, ANT1034 was more effective at directly inducing apoptosis than alemtuzumab. ANT1034 also showed superior activity in a SCID mouse/human CD52 tumour xenograft model where a single 1 mg/Kg dose of ANT1034 led to increased mouse survival compared to a 10 mg/Kg dose of alemtuzumab. Finally, ANT1034 was compared to alemtuzumab in in vitro T cell assays in order to evaluate its potential to stimulate proliferation of T cells in peripheral blood mononuclear cells derived from a panel of human donors: whereas alemtuzumab stimulated proliferation in a high proportion of the donor cohort, ANT1034 did not stimulate proliferation in any of the donors. Therefore we have developed a candidate therapeutic humanized antibody, ANT1034, that may have the potential to be more efficacious and less immunogenic than the current standard anti-CD52 therapy.	[Holgate, Robert G. E.; Weldon, Richard; Jones, Timothy D.; Baker, Matthew P.] Antitope Ltd, Cambridge, England		Holgate, RGE (corresponding author), Antitope Ltd, Babraham Res Campus, Cambridge, England.	rob.holgate@antitope.com			Antitope Ltd.	Antitope Ltd.	All work was funded by the authors' employer, Antitope Ltd. The funder provided support in the form of salaries for RGEH, RW, TDJ, and MPB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alinari L, 2007, ONCOGENE; Almagro JC, 2012, INT IMMUNOL, V24, P1620, DOI DOI 10.1093/INTIMM/DXS032; Baker MP, 2007, CURR OPIN DRUG DISC, V10, P219; BAUM C, 1994, BIOTECHNIQUES, V17, P1058; Brett SJ, 1996, INT IMMUNOL; Bryson CJ, 2010, BIODRUGS, V24, P1, DOI 10.2165/11318560-000000000-00000; Dearden CE, 2006, BEST PRACT RES CLIN; Enblad G, 2004, BLOOD; Faulkner RD, 2004, BLOOD; Garnock-Jones KP., 2014, DRUGS; Ginaldi L, 1998, LEUK RES; Golay J, 2003, HAEMATOLOGICA; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta V, 2004, BIOL BLOOD MARROW TR; Hale G, 2001, CYTOTHERAPY, V3, P137, DOI 10.1080/146532401753174098; Hale G, 1995, IMMUNOTECHNOLOGY, V1, P175, DOI 10.1016/1380-2933(95)00017-8; Hale G., 1995, IMMUNOTECHNOLOGY; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Hu Y, 2009, IMMUNOLOGY; Isaacs JD, 1992, LANCET; Jones JL, 2014, EXP NEUROL; JONES ST, 1991, BIO-TECHNOL, V9, P88, DOI 10.1038/nbt0191-88; Jones Tim D., 2009, V525, P405, DOI 10.1007/978-1-59745-554-1_21; Jordan M, 1998, CYTOTECHNOLOGY; Kabat E. A., 1991, SEQUENCES PROTEINS I; Keating MJ, 2002, BLOOD, V99, P3554, DOI 10.1182/blood.V99.10.3554; Lapalombella R, 2008, CLIN CANCER RES, V14, P569, DOI 10.1158/1078-0432.CCR-07-1006; Lundin J, 1998, J CLIN ONCOL; Masuyama J, 1999, J EXP MED; Matteson EL, 1995, ARTHRITIS RHEUM; Mone AP, 2006, LEUKEMIA; Osterborg A, 1997, EUR J HAEMATOL; Pawson R, 1997, J CLIN ONCOL; Perry LCA, 2008, DRUGS R D; Riechmann L, 1988, NATURE; Rowan WC, 1995, INT IMMUNOL; Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30; Somerfield J, 2010, J IMMUNOL; Stanglmaier M, 2004, ANN HEMATOL; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Watanabe T, 2006, CLIN IMMUNOL; Weinblatt ME, 1995, ARTHRITIS RHEUM; Xia MQ, 1993, BIOCH J; Zent CS, 2008, LEUK RES	44	22	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138123	10.1371/journal.pone.0138123	http://dx.doi.org/10.1371/journal.pone.0138123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372145	gold, Green Published, Green Submitted			2022-12-26	WOS:000361604400049
J	McNamara, NP; Gregg, R; Oakley, S; Stott, A; Rahman, MT; Murrell, JC; Wardle, DA; Bardgett, RD; Ostle, NJ				McNamara, Niall P.; Gregg, Ruth; Oakley, Simon; Stott, Andy; Rahman, Md. Tanvir; Murrell, J. Colin; Wardle, David A.; Bardgett, Richard D.; Ostle, Nick J.			Soil Methane Sink Capacity Response to a Long-Term Wildfire Chronosequence in Northern Sweden	PLOS ONE			English	Article							BOREAL FOREST; ISLAND AREA; OXIDATION; FIRE; TEMPERATE; EXCHANGE	Boreal forests occupy nearly one fifth of the terrestrial land surface and are recognised as globally important regulators of carbon (C) cycling and greenhouse gas emissions. Carbon sequestration processes in these forests include assimilation of CO2 into biomass and subsequently into soil organic matter, and soil microbial oxidation of methane (CH4). In this study we explored how ecosystem retrogression, which drives vegetation change, regulates the important process of soil CH4 oxidation in boreal forests. We measured soil CH4 oxidation processes on a group of 30 forested islands in northern Sweden differing greatly in fire history, and collectively representing a retrogressive chronosequence, spanning 5000 years. Across these islands the build-up of soil organic matter was observed to increase with time since fire disturbance, with a significant correlation between greater humus depth and increased net soil CH4 oxidation rates. We suggest that this increase in net CH4 oxidation rates, in the absence of disturbance, results as deeper humus stores accumulate and provide niches for methanotrophs to thrive. By using this gradient we have discovered important regulatory controls on the stability of soil CH4 oxidation processes that could not have not been explored through shorter-term experiments. Our findings indicate that in the absence of human interventions such as fire suppression, and with increased wildfire frequency, the globally important boreal CH4 sink could be diminished.	[McNamara, Niall P.; Gregg, Ruth; Oakley, Simon; Ostle, Nick J.] Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lancaster, England; [Stott, Andy] Lancaster Environm Ctr, Ctr Ecol & Hydrol, NERC Life Sci Stable Isotope Facil, Lancaster, England; [Rahman, Md. Tanvir] Bangladesh Agr Univ, Dept Microbiol & Hyg, Mymensingh, Bangladesh; [Murrell, J. Colin] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Bardgett, Richard D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Gregg, Ruth; Bardgett, Richard D.; Ostle, Nick J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Bangladesh Agricultural University (BAU); University of East Anglia; Swedish University of Agricultural Sciences; University of Manchester; Lancaster University	McNamara, NP (corresponding author), Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lancaster, England.	nmcn@ceh.ac.uk	Murrell, John C/B-1443-2012; Rahman, Md.Tanvir, PhD (UK)/C-3110-2009; Oakley, Simon/K-1857-2013; Wardle, David A./F-6031-2011; McNamara, Niall P/B-4907-2008; STOTT, ANDREW/I-7920-2012; Ostle, Nicholas J/E-4847-2014	Rahman, Md.Tanvir, PhD (UK)/0000-0001-5432-480X; Oakley, Simon/0000-0002-5757-7420; Wardle, David A./0000-0002-0476-7335; McNamara, Niall P/0000-0002-5143-5819; Ostle, Nicholas J/0000-0003-3263-3702	UK Natural Environmental Research Council; Swedish research Council (Vetenskapsradet); Natural Environment Research Council [ceh020008, lsmsf010003, NE/I027037/1, NER/A/S/2002/00876, NE/E016855/1, NE/I027037/2] Funding Source: researchfish; NERC [NE/I027037/2, NE/E016855/1, NE/I027037/1, lsmsf010003, ceh020008] Funding Source: UKRI	UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swedish research Council (Vetenskapsradet)(Swedish Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by a UK Natural Environmental Research Council (www.nerc.ac.uk) award to NM, NO and RGB. The contribution from DAW was supported by the Swedish research Council (Vetenskapsradet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSEN APS, 1993, APPL ENVIRON MICROB, V59, P485, DOI 10.1128/AEM.59.2.485-490.1993; Beck PSA, 2011, GLOBAL CHANGE BIOL, V17, P2853, DOI 10.1111/j.1365-2486.2011.02412.x; Bradshaw CJA, 2009, TRENDS ECOL EVOL, V24, P541, DOI 10.1016/j.tree.2009.03.019; Burke RA, 1997, J GEOPHYS RES-ATMOS, V102, P29289, DOI 10.1029/97JD01331; Chan ASK, 2001, J ENVIRON QUAL, V30, P786, DOI 10.2134/jeq2001.303786x; Chuvieco E, 2008, REMOTE SENS ENVIRON, V112, P2381, DOI 10.1016/j.rse.2007.11.007; Gathany MA, 2011, INT J WILDLAND FIRE, V20, P838, DOI 10.1071/WF09135; Girardin MP, 2009, GLOBAL CHANGE BIOL, V15, P2751, DOI 10.1111/j.1365-2486.2009.01869.x; Holland E A, 1999, STANDARD SOIL METHOD; Jaatinen K, 2004, FEMS MICROBIOL ECOL, V50, P195, DOI 10.1016/j.femsec.2004.06.013; Kasischke ES, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002300; Kasischke ES, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000461; Knief C, 2006, ENVIRON MICROBIOL, V8, P321, DOI 10.1111/j.1462-2920.2005.00898.x; Liptay K, 1998, J GEOPHYS RES-ATMOS, V103, P8243, DOI 10.1029/97JD02630; Maxfield PJ, 2008, ENVIRON SCI TECHNOL, V42, P7824, DOI 10.1021/es800544q; McNamara NP, 2008, SOIL USE MANAGE, V24, P1, DOI 10.1111/j.1475-2743.2008.00147.x; Nakano T, 2006, SOIL SCI PLANT NUTR, V52, P77, DOI 10.1111/j.1747-0765.2006.00004.x; Ohlson M, 2009, NAT GEOSCI, V2, P692, DOI 10.1038/NGEO617; Pluchon N, 2014, FUNCT ECOL, V28, P766, DOI 10.1111/1365-2435.12221; Prieme A, 1999, J GEOPHYS RES-ATMOS, V104, P23617, DOI 10.1029/1999JD900427; Reay DS, 2005, SOIL BIOL BIOCHEM, V37, P719, DOI 10.1016/j.soilbio.2004.10.004; Reeburgh WS, 1997, GEOCHIM COSMOCHIM AC, V61, P4761, DOI 10.1016/S0016-7037(97)00277-9; Sjogersten S, 2002, GLOBAL CHANGE BIOL, V8, P885, DOI 10.1046/j.1365-2486.2002.00522.x; Smith KA, 2000, GLOBAL CHANGE BIOL, V6, P791, DOI 10.1046/j.1365-2486.2000.00356.x; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Teh YA, 2005, GLOBAL CHANGE BIOL, V11, P1283, DOI 10.1111/j.1365-2486.2005.00983.x; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; TYLER SC, 1994, GEOCHIM COSMOCHIM AC, V58, P1625, DOI 10.1016/0016-7037(94)90564-9; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA, 2005, NATURE, V435, P806, DOI 10.1038/nature03611; Wardle DA, 2012, J ECOL, V100, P16, DOI 10.1111/j.1365-2745.2011.01907.x; Zhang YH, 2003, REMOTE SENS ENVIRON, V87, P1, DOI 10.1016/S0034-4257(03)00141-X	33	10	10	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0129892	10.1371/journal.pone.0129892	http://dx.doi.org/10.1371/journal.pone.0129892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372346	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000361604400001
J	Behr, J; Gaskin, B; Fu, CL; Dong, C; Kunz, R				Behr, Julie; Gaskin, Byron; Fu, Changliang; Dong, Cheng; Kunz, Robert			Localized Modeling of Biochemical and Flow Interactions during Cancer Cell Adhesion	PLOS ONE			English	Article							DYNAMICS; FORCE; DEFORMATION; SIMULATION; MECHANICS; MOLECULES; CONSTANT; SURFACES; KINETICS	This work focuses on one component of a larger research effort to develop a simulation tool to model populations of flowing cells. Specifically, in this study a local model of the biochemical interactions between circulating melanoma tumor cells (TC) and substrate adherent polymorphonuclear neutrophils (PMN) is developed. This model provides realistic three-dimensional distributions of bond formation and attendant attraction and repulsion forces that are consistent with the time dependent Computational Fluid Dynamics (CFD) framework of the full system model which accounts local pressure, shear and repulsion forces. The resulting full dynamics model enables exploration of TC adhesion to adherent PMNs, which is a known participating mechanism in melanoma cell metastasis. The model defines the adhesion molecules present on the TC and PMN cell surfaces, and calculates their interactions as the melanoma cell flows past the PMN. Biochemical rates of reactions between individual molecules are determined based on their local properties. The melanoma cell in the model expresses ICAM-1 molecules on its surface, and the PMN expresses the beta-2 integrins LFA-1 and Mac-1. In this work the PMN is fixed to the substrate and is assumed fully rigid and of a prescribed shear-rate dependent shape obtained from micro-PIV experiments. The melanoma cell is transported with full six-degrees-of-freedom dynamics. Adhesion models, which represent the ability of molecules to bond and adhere the cells to each other, and repulsion models, which represent the various physical mechanisms of cellular repulsion, are incorporated with the CFD solver. All models are general enough to allow for future extensions, including arbitrary adhesion molecule types, and the ability to redefine the values of parameters to represent various cell types. The model presented in this study will be part of a clinical tool for development of personalized medical treatment programs.	[Behr, Julie; Gaskin, Byron; Fu, Changliang; Dong, Cheng; Kunz, Robert] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Behr, Julie; Gaskin, Byron; Kunz, Robert] Penn State Univ, Appl Res Lab, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kunz, R (corresponding author), Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA.	rfk102@arl.psu.edu	Kunz, Robert/GOV-3020-2022		National Institute of Health [CA-125707]; National Science Foundation [CBET-0729091]; National Natural Science Foundation of China [31170887]; Chinese Scholarship Council; Eric Walker Assistantship at the Pennsylvania State University Applied Research Laboratory	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council); Eric Walker Assistantship at the Pennsylvania State University Applied Research Laboratory	This work was supported by grants from National Institute of Health Grants (CA-125707, to C.D.), National Science Foundation Grant (CBET-0729091, to C.D.), National Natural Science Foundation of China (31170887, to J.W.), and the Fellowship from Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The second author was supported by an Eric Walker Assistantship at the Pennsylvania State University Applied Research Laboratory.	Alberts B, 1998, ESSENTIAL BIOL INTRO, V1; Behr J, 2013, THESIS PENNSYLVANIA; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bongrand P., 1984, CELL SURFACE DYNAMIC, P459; Bongrand P, 1988, PHYS BASIS CELL ADHE, P29; Chang KC, 1996, LANGMUIR, V12, P2271, DOI 10.1021/la950690y; Chtcheglova LA, 2004, BIOPHYS J, V86, P1177, DOI 10.1016/S0006-3495(04)74192-2; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dong Cheng, 2005, Molecular & Cellular Biomechanics, V2, P145; Gaskin BJ, 2014, THESIS; Greenshields CJ, 2005, INT J NUMER METH ENG, V64, P1575, DOI 10.1002/nme.1409; HAMMER DA, 1992, BIOPHYS J, V63, P35, DOI 10.1016/S0006-3495(92)81577-1; Hammer DA, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026402; Hinterdorfer P, 2011, NANOTRIBOLOGY AND NANOMECHANICS: MEASUREMENT TECHNIQUES AND NANOMECHANICS, VOL 1, P355, DOI 10.1007/978-3-642-15283-2_8; Hoskins M, 2008, THESIS PENNSYLVANIA; Hoskins MH, 2009, J FLUID STRUCT, V25, P936, DOI 10.1016/j.jfluidstructs.2009.02.002; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Jamali Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012097; Kan HC, 1998, PHYS FLUIDS, V10, P760, DOI 10.1063/1.869601; Khismatullin DB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1862635; King MR, 2001, BIOPHYS J, V81, P799, DOI 10.1016/S0006-3495(01)75742-6; Kunz R, 2001, AIAA COMP FLUID DYN, V2672; Leyton-Mange J, 2006, J BIOMECH ENG-T ASME, V128, P271, DOI 10.1115/1.2165689; Migliorini C, 2002, BIOPHYS J, V83, P1834, DOI 10.1016/S0006-3495(02)73948-9; Orsello CE, 2001, TRENDS BIOTECHNOL, V19, P310, DOI 10.1016/S0167-7799(01)01692-4; Pawar P, 2008, AM J PHYSIOL-HEART C, V295, pH1439, DOI 10.1152/ajpheart.91536.2007; Simon SI, 2005, ANNU REV BIOMED ENG, V7, P151, DOI 10.1146/annurev.bioeng.7.060804.100423; Slattery MJ, 2003, INT J CANCER, V106, P713, DOI 10.1002/ijc.11297; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Tegenfeldt JO, 2004, P NATL ACAD SCI USA, V101, P10979, DOI 10.1073/pnas.0403849101; Wu QD, 2001, AM J PHYSIOL-CELL PH, V280, pC814, DOI 10.1152/ajpcell.2001.280.4.C814; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604	33	6	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136926	10.1371/journal.pone.0136926	http://dx.doi.org/10.1371/journal.pone.0136926			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366568	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100034
J	Jarde, T; Kass, L; Staples, M; Lescesen, H; Carne, P; Oliva, K; McMurrick, PJ; Abud, HE				Jarde, Thierry; Kass, Lisa; Staples, Margaret; Lescesen, Helen; Carne, Peter; Oliva, Karen; McMurrick, Paul J.; Abud, Helen E.			ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer	PLOS ONE			English	Article							TYROSINE KINASE; EXPRESSION; COLON; PROTEIN; LINES; CD44; APC	Several studies have suggested ERBB3/HER3 may be a useful prognostic marker for colorectal cancer. Tumours with an intestinal stem cell signature have also been shown to be more aggressive. Here, we investigate whether ERBB3 is associated with intestinal stem cell markers in colorectal cancer and if cancer stem cells within tumours are marked by expression of ERBB3. Expression of ERBB3 and intestinal stem cell markers (LGR5, EPHB2, CD44s and CD44v6) was assessed by qRT-PCR in primary colorectal tumours (stages 0 to IV) and matched normal tissues from 53 patients. The localisation of ERBB3, EPHB2 and KI-67 within tumours was investigated using co-immunofluorescence. Expression of ERBB3 and intestinal stem cell markers were significantly elevated in adenomas and colorectal tumours compared to normal tissue. Positive correlations were found between ERBB3 and intestinal stem cell markers. However, co-immunofluorescence analysis showed that ERBB3 and EPHB2 marked specific cell populations that were mutually exclusive within tumours with distinct proliferative potentials, the majority of ERBB3+ve cells being non-proliferative. This pattern resembles cellular organisation within normal colonic epithelium where EPHB2 labelled proliferative cells reside at the crypt base and ERBB3+ve cells mark differentiated cells at the top of crypts. Our results show that ERBB3 and intestinal stem cell markers correlate in colorectal cancers. ERBB3 localises to differentiated cell populations within tumours that are non-proliferative and distinct from cancer stem cells. These data support the concept that tumours contain discrete stem, proliferative and differentiation compartments similar to that present in normal crypts.	[Jarde, Thierry; Kass, Lisa; Lescesen, Helen; Abud, Helen E.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Jarde, Thierry] Hudson Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia; [Staples, Margaret] Cabrini Hlth, Cabrini Inst, Malvern, Vic, Australia; [Carne, Peter; Oliva, Karen; McMurrick, Paul J.] Cabrini Monash Univ, Dept Surg, Malvern, Vic, Australia	Monash University; Hudson Institute of Medical Research; Cabrini Health; Monash University	Abud, HE (corresponding author), Monash Univ, Dept Anat & Dev Biol, Wellington Rd, Clayton, Vic, Australia.	Helen.abud@monash.edu	Jarde, Thierry/H-6781-2019	Jarde, Thierry/0000-0001-7483-8672; Abud, Helen/0000-0003-3792-4023	National Health and Medical Research Council (Australia) [1010429, 1011187]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge support for this work from the National Health and Medical Research Council (Australia) project grants 1010429 to HA and PJM, and 1011187 to HA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurisicchio L, 2012, ONCOTARGET, V3, P744, DOI 10.18632/oncotarget.550; Baiocchi G, 2009, INT J COLORECTAL DIS, V24, P1059, DOI 10.1007/s00384-009-0702-6; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Beji A, 2012, CLIN CANCER RES, V18, P956, DOI 10.1158/1078-0432.CCR-11-1186; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Brunschwig EB, 2003, CANCER RES, V63, P1568; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Emmink BL, 2011, GASTROENTEROLOGY, V141, P269, DOI 10.1053/j.gastro.2011.03.052; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hirsch D, 2014, CARCINOGENESIS, V35, P849, DOI 10.1093/carcin/bgt377; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Ledel F, 2014, EUR J CANCER, V50, P656, DOI 10.1016/j.ejca.2013.11.008; Lee JC, 2002, EUR J CANCER, V38, P1065, DOI 10.1016/S0959-8049(02)00004-7; Ljuslinder I, 2009, ANTICANCER RES, V29, P1489; Lugli A, 2005, CLIN CANCER RES, V11, P6450, DOI 10.1158/1078-0432.CCR-04-2458; Maurer CA, 1998, HUM PATHOL, V29, P771, DOI 10.1016/S0046-8177(98)90444-0; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; RAJKUMAR T, 1993, J PATHOL, V170, P271, DOI 10.1002/path.1711700309; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Uchida H, 2010, CANCER SCI, V101, P1731, DOI 10.1111/j.1349-7006.2010.01571.x; WHITEHEAD RH, 1992, IMMUNOL CELL BIOL, V70, P227, DOI 10.1038/icb.1992.30; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759; Zeilstra J, 2014, ONCOGENE, V33, P665, DOI 10.1038/onc.2012.611; Zhang HH, 2009, INT J CANCER, V125, P297, DOI 10.1002/ijc.24289; Ziskin JL, 2013, GUT, V62, P1012, DOI 10.1136/gutjnl-2011-301195; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	34	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138336	10.1371/journal.pone.0138336	http://dx.doi.org/10.1371/journal.pone.0138336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367378	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100250
J	Moreira-Arce, D; Vergara, PM; Boutin, S				Moreira-Arce, Dario; Vergara, Pablo M.; Boutin, Stan			Diurnal Human Activity and Introduced Species Affect Occurrence of Carnivores in a Human-Dominated Landscape	PLOS ONE			English	Article							FREE-RANGING DOGS; LAND-USE CHANGE; HABITAT USE; SOUTHERN CHILE; ACTIVITY PATTERNS; FOREST LANDSCAPE; PROTECTED AREAS; FELIS-CONCOLOR; SPATIAL SCALE; DARWIN FOX	Diurnal human activity and domestic dogs in agro-forestry mosaics should theoretically modify the diurnal habitat use patterns of native carnivores, with these effects being scale-dependent. We combined intensive camera trapping data with Bayesian occurrence probability models to evaluate both diurnal and nocturnal patterns of space use by carnivores in a mosaic of land-use types in southern Chile. A total of eight carnivores species were recorded, including human-introduced dogs. During the day the most frequently detected species were the culpeo fox and the cougar. Conversely, during the night, the kodkod and chilla fox were the most detected species. The best supported models showed that native carnivores responded differently to landscape attributes and dogs depending on both the time of day as well as the spatial scale of landscape attributes. The positive effect of native forest cover at 250m and 500 m radius buffers was stronger during the night for the Darwin's fox and cougar. Road density at 250m scale negatively affected the diurnal occurrence of Darwin's fox, whereas at 500m scale roads had a stronger negative effect on the diurnal occurrence of Darwin's foxes and cougars. A positive effect of road density on dog occurrence was evidenced during both night and day. Patch size had a positive effect on cougar occurrence during night whereas it affected negatively the occurrence of culpeo foxes and skunks during day. Dog occurrence had a negative effect on Darwin's fox occurrence during day-time and night-time, whereas its negative effect on the occurrence of cougar was evidenced only during day-time. Carnivore occurrences were not influenced by the proximity to a conservation area. Our results provided support for the hypothesis that diurnal changes to carnivore occurrence were associated with human and dog activity. Landscape planning in our study area should be focused in reducing both the levels of diurnal human activity in native forest remnants and the dispersion rates of dogs into these habitats.	[Moreira-Arce, Dario; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Moreira-Arce, Dario; Vergara, Pablo M.] Univ Santiago Chile, Dept Gest Agr, Lab Ecol & Conservac, Santiago, Chile	University of Alberta; Universidad de Santiago de Chile	Moreira-Arce, D (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	moreira.dario@gmail.com	Vergara, Pablo M/F-2519-2010; Moreira-Arce, Dario/ABG-2898-2021; Boutin, Stan/A-2619-2014	Vergara, Pablo M/0000-0002-0024-1678; Moreira-Arce, Dario/0000-0002-1188-496X; Boutin, Stan/0000-0001-6317-038X	Rufford Small Grant Program [10410-1]; Mohammed bin Zayed Conservation Fund [11252508]; Fondo Nacional de Ciencia y Tecnologia [1131133]; NSERC [RGPIN 05874]; Becas-Chile fellowship; Forestal Arauco; Forestal Mininco; University of Alberta; Etica en los Bosques; Environmental Ministry of Chile [NAC-I-008-2012]	Rufford Small Grant Program; Mohammed bin Zayed Conservation Fund; Fondo Nacional de Ciencia y Tecnologia; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Becas-Chile fellowship; Forestal Arauco; Forestal Mininco; University of Alberta(University of Alberta); Etica en los Bosques; Environmental Ministry of Chile	This study was supported by funds derived from an agreement among Forestal Arauco, Forestal Mininco, University of Alberta, Etica en los Bosques and Environmental Ministry of Chile (NAC-I-008-2012). Additional support was provided by Rufford Small Grant Program (10410-1), Mohammed bin Zayed Conservation Fund (11252508), Fondo Nacional de Ciencia y Tecnologia 1131133, and NSERC RGPIN 05874. DMA was funded by a Becas-Chile fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta G, 2008, IUCN RED LIST THREAT; Acosta-Jamett G, 2004, BIODIVERS CONSERV, V13, P1135, DOI 10.1023/B:BIOC.0000018297.93657.7d; Aguayo M, 2009, REV CHIL HIST NAT, V82, P361, DOI 10.4067/S0716-078X2009000300004; Altamirano TA, 2013, REV CHIL HIST NAT, V86, P501, DOI 10.4067/S0716-078X2013000400014; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Besag J, 1995, BIOMETRIKA, V82, P733, DOI 10.2307/2337341; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Burton AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038007; Clarke MF, 1997, BIOL CONSERV, V80, P161, DOI 10.1016/S0006-3207(96)00075-4; Davis ML, 2011, ANIM CONSERV, V14, P56, DOI 10.1111/j.1469-1795.2010.00389.x; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Donadio E, 2001, MAMMALIA, V65, P49, DOI 10.1515/mamm.2001.65.1.49; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Fahrig L, 2009, ECOL SOC, V14; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Franklin WL, 1999, BIOL CONSERV, V90, P33, DOI 10.1016/S0006-3207(99)00008-7; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gelman A., 2003, BAYESIAN DATA ANAL; George SL, 2006, BIOL CONSERV, V133, P107, DOI 10.1016/j.biocon.2006.05.024; Gittleman GL, 2001, CARNIVORE CONSERVATI; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Hels T, 2001, BIOL CONSERV, V99, P331, DOI 10.1016/S0006-3207(00)00215-9; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; JAKSIC FM, 1990, J MAMMAL, V71, P246, DOI 10.2307/1382176; Jim?nez JE., 2004, CANIDS FOXES WOLVES, P50; Klar N, 2009, J WILDLIFE MANAGE, V73, P631, DOI 10.2193/2007-574; Knopff AA, 2014, BIOL CONSERV, V178, P136, DOI 10.1016/j.biocon.2014.07.017; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Lawson A.B, 2013, BAYESIAN DIS MAPPING, Vsecond; Lode T., 2011, INT J ZOOLOGY, DOI [10.1155/2011/15946, DOI 10.1155/2011/15946]; Lyra-Jorge MC, 2010, EUR J WILDLIFE RES, V56, P359, DOI 10.1007/s10344-009-0324-x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marable MK, 2012, BEHAV PROCESS, V91, P119, DOI 10.1016/j.beproc.2012.06.006; MEDEL RG, 1990, BIOL CONSERV, V51, P71, DOI 10.1016/0006-3207(90)90033-L; Munozpedreros A, 1995, REV CHIL HIST NAT, V68, P501; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Ngoprasert D, 2007, ORYX, V41, P343, DOI 10.1017/S0030605307001102; Nichols JD, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P253, DOI 10.1007/978-4-431-99495-4_14; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; Ordiz A, 2013, J APPL ECOL, V50, P306, DOI 10.1111/1365-2664.12047; PATTERSON BD, 1989, J MAMMAL, V70, P67, DOI 10.2307/1381670; Ramesh T, 2012, J ZOOL, V287, P269, DOI 10.1111/j.1469-7998.2012.00908.x; Redford K.H., 1992, MAMMALS NEOTROPICS S, V2; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P1628, DOI 10.2193/2009-571; Sepulveda MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086152; Silva-Rodriguez EA, 2012, BIOL CONSERV, V150, P103, DOI 10.1016/j.biocon.2012.03.008; Silva-Rodriguez EA, 2010, AUSTRAL ECOL, V35, P765, DOI 10.1111/j.1442-9993.2009.02083.x; Simonetti JA, 1997, REV CHIL HIST NAT, V70, P213; Smith-Ramirez C, 2004, BIODIVERS CONSERV, V13, P373, DOI 10.1023/B:BIOC.0000006505.67560.9f; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Takahata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086181; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Lantschner MV, 2012, FOREST ECOL MANAG, V269, P271, DOI 10.1016/j.foreco.2011.12.045; Whittington J, 2004, ECOL SOC, V9; Woodroffe R, 1999, ORYX, V33, P132, DOI 10.1017/S0030605300030398; Zuniga A, THESIS U LOS LAGOS C; Zuniga A, 2009, GAYANA, V73, P200	67	33	33	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137854	10.1371/journal.pone.0137854	http://dx.doi.org/10.1371/journal.pone.0137854			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368395	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100156
J	Sun, ZL; He, JJ; Qiu, SH; Lei, CH; Zhou, Y; Xie, ZL; Zhang, L; Wang, YP; Jin, H				Sun, Zilin; He, Jiajia; Qiu, Shanhu; Lei, Chenghao; Zhou, Yi; Xie, Zuolin; Zhang, Lin; Wang, Yanping; Jin, Hui			Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects	PLOS ONE			English	Article							LIFE-STYLE; GLYCOSYLATION; PREVALENCE; HBA(1C); MELLITUS; INTERVENTION; FRUCTOSAMINE; INDIVIDUALS; POPULATION; TOLERANCE	The efficacy of using fasting plasma glucose (FPG) alone as a preferred screening test for diabetes has been questioned. This study was aimed to evaluate whether the use of serum advanced glycation end products-peptides (sAGEP) would help to improve the efficacy of FPG in diabetes screening among high-risk Chinese subjects with FPG <7.0 mmol/L. FPG, 2-h plasma glucose (2h-PG), serum glycated haemoglobin A1c (HbA1c), and sAGEP were measured in 857 Chinese subjects with risk factors for diabetes. The areas under receiver operating characteristic (ROC) curves generated by logistic regression models were assessed and compared to find the best model for diabetes screening in subjects with FPG <7.0 mmol/L. The optimal critical line was determined by maximizing the sum of sensitivity and specificity. Among the enrolled subjects, 730 of them had FPG <7.0 mmol/L, and only 41.7% new diabetes cases were identified using the 1999 World Health Organization FPG criterion (FPG >= 7.0 mmol/L). The area under ROC curves generated by the model on FPG-sAGEP was the largest compared with that on FPG-HbA1c, sAGEP, HbA1c or FPG in subjects with FPG <7.0 mmol/L. By maximizing the sum of sensitivity and specificity, the optimal critical line was determined as 0.69xFPG + 0.14xsAGEP = 7.03, giving a critical sensitivity of 91.2% in detecting 2h-PG >= 11.1 mmol/L, which was significantly higher than that of FPG-HbA1c or HbA1c. The model on FPG-sAGEP improves the efficacy of using FPG alone in detecting diabetes among high-risk Chinese subjects with FPG <7.0 mmol/L, and is worth being promoted for future diabetes screening.	[Sun, Zilin; He, Jiajia; Qiu, Shanhu; Lei, Chenghao; Zhou, Yi; Xie, Zuolin; Wang, Yanping; Jin, Hui] Southeast Univ, Zhongda Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Sun, Zilin; He, Jiajia; Qiu, Shanhu; Lei, Chenghao; Zhou, Yi; Zhang, Lin; Wang, Yanping] Southeast Univ, Sch Med, Inst Diabet, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Sun, ZL (corresponding author), Southeast Univ, Zhongda Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	sunzilin1963@126.com	Qiu, Shanhu/AAI-1318-2019	Qiu, Shanhu/0000-0003-2597-3856	Key Program of Jiangsu Natural Science Foundation [BK2010087]	Key Program of Jiangsu Natural Science Foundation	This study was supported by the Key Program of Jiangsu Natural Science Foundation (BK2010087, http://www.jstd.gov.cn/kjgz/kjjh/zjjh/jcyj/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drzewoski J, 2001, DIABETIC MED, V18, P29, DOI 10.1046/j.1464-5491.2001.00403.x; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Gradinaru D, 2013, J PROTEOMICS, V92, P313, DOI 10.1016/j.jprot.2013.03.034; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Hu DS, 2009, DIABETES RES CLIN PR, V84, P288, DOI 10.1016/j.diabres.2009.02.021; Jakus V, 2004, PHYSIOL RES, V53, P131; Janssen PGH, 2007, FAM PRACT, V24, P555, DOI 10.1093/fampra/cmm052; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ko GTC, 1998, DIABETES CARE, V21, P1221, DOI 10.2337/diacare.21.8.1221; Lachenbruch PA, 1998, STAT MED, V17, P2207, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2207::AID-SIM920>3.0.CO;2-Y; Li R, 2012, DIABETES CARE, V35, P1028, DOI 10.2337/dc11-1212; Liu NF, 2000, ACTA PHARMACOL SIN, V21, P276; Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; Makita Z, 1996, NEPHROL DIAL TRANSPL, V11, P31; McDonald JH., 2008, HDB BIOL STAT; Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669; Nathan DM, 2007, DIABETIC MED, V24, P137; Nowotny K, 2015, BIOMOLECULES, V5, P194, DOI 10.3390/biom5010194; Perry RC, 2001, DIABETES CARE, V24, P465, DOI 10.2337/diacare.24.3.465; Qiu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109767; Qiu SH, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-36; SCHATZKIN A, 1987, AM J EPIDEMIOL, V125, P672, DOI 10.1093/oxfordjournals.aje.a114580; Shimoike T, 2000, METABOLISM, V49, P1030, DOI 10.1053/meta.2000.7738; Sun ZL, 2001, CLIN CHIM ACTA, V313, P69, DOI 10.1016/S0009-8981(01)00651-9; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Takeuchi M, 1999, MOL MED, V5, P393, DOI 10.1007/BF03402128; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Wang WY, 2002, DIABETES CARE, V25, P1365, DOI 10.2337/diacare.25.8.1365; Wang X, 2015, IN VITRO CELL DEV-AN, V51, P204, DOI 10.1007/s11626-014-9823-5; Wrobel K, 1997, CLIN CHEM, V43, P1563; Xie Zuo-ling, 2012, Zhonghua Yi Xue Za Zhi, V92, P2843; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yanagisawa K, 1998, METABOLISM, V47, P1348, DOI 10.1016/S0026-0495(98)90303-1; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou XH, 2010, DIABETES CARE, V33, P545, DOI 10.2337/dc09-1410	44	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137756	10.1371/journal.pone.0137756	http://dx.doi.org/10.1371/journal.pone.0137756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368827	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100130
J	Yu, B; Wang, XD; Ma, L; Li, L; Li, HF				Yu, Bo; Wang, Xunda; Ma, Lin; Li, Liang; Li, Haifeng			The Complex Pre-Execution Stage of Auditory Cognitive Control: ERPs Evidence from Stroop Tasks	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MISMATCH NEGATIVITY MMN; CONFLICT; INTERFERENCE; PERFORMANCE; FMRI; BRAIN; POTENTIALS; MECHANISMS; TIME	Cognitive control has been extensively studied from Event-Related Potential (ERP) point of view in visual modality using Stroop paradigms. Little work has been done in auditory Stroop paradigms, and inconsistent conclusions have been reported, especially on the conflict detection stage of cognitive control. This study investigated the early ERP components in an auditory Stroop paradigm, during which participants were asked to identify the volume of spoken words and ignore the word meanings. A series of significant ERP components were revealed that distinguished incongruent and congruent trials: two declined negative polarity waves (the N1 and the N2) and three declined positive polarity wave (the P1, the P2 and the P3) over the fronto-central area for the incongruent trials. These early ERP components imply that both a perceptual stage and an identification stage exist in the auditory Stroop effect. A 3-stage cognitive control model was thus proposed for a more detailed description of the human cognitive control mechanism in the auditory Stroop tasks.	[Yu, Bo; Wang, Xunda; Ma, Lin; Li, Haifeng] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150001, Peoples R China; [Yu, Bo] Harbin Univ Sci & Technol, Software Coll, Harbin 150001, Peoples R China; [Li, Liang] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Li, Liang] Peking Univ, Beijing Key Lab Behav & Mental Hlth, PKU IDG McGovern Inst Brain Res,Minist Educ, Speech & Hearing Res Ctr,Key Lab Machine Percept, Beijing 100871, Peoples R China	Harbin Institute of Technology; Harbin University of Science & Technology; Peking University; Peking University	Li, HF (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150001, Peoples R China.	lihaifeng@hit.edu.cn			National Natural Science Foundation of China [61171186, 61271345]; Key Laboratory Opening Funding of MOE-Microsoft Key Laboratory of Natural Language Processing and Speech [HIT.KLOF.20110xx]; Fundamental Research Funds for the Central Universities [HIT.NSRIF.2012047]; Scientific Research Fund [CJN13J004]; Microsoft Research Asia Joint Lab Program (JLP)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory Opening Funding of MOE-Microsoft Key Laboratory of Natural Language Processing and Speech; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Fund; Microsoft Research Asia Joint Lab Program (JLP)	This work was supported by the National Natural Science Foundation of China [61171186], [61271345]; Key Laboratory Opening Funding of MOE-Microsoft Key Laboratory of Natural Language Processing and Speech [HIT.KLOF.20110xx]; Fundamental Research Funds for the Central Universities [HIT.NSRIF.2012047]; Scientific Research Fund CJN13J004. HFL conceived, designed and performed the original experiments. HFL supervised the research activities and made the final approval of the version to be published. Microsoft Research Asia Joint Lab Program (JLP) provided funding towards this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Amenedo E, 1998, BIOL PSYCHOL, V48, P235, DOI 10.1016/S0301-0511(98)00040-4; Ben-Haim MS, 2014, ATTEN PERCEPT PSYCHO, V76, P81, DOI 10.3758/s13414-013-0545-7; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buzzell GA, 2013, INT J PSYCHOPHYSIOL, V90, P265, DOI 10.1016/j.ijpsycho.2013.08.008; Cane JE, 2009, J PSYCHOPHARMACOL, V23, P510, DOI 10.1177/0269881108091253; COHEN G, 1975, PERCEPT PSYCHOPHYS, V17, P79, DOI 10.3758/BF03204002; Cox WM, 2006, PSYCHOL BULL, V132, P443, DOI 10.1037/0033-2909.132.3.443; Donohue SE, 2012, COGN AFFECT BEHAV NE, V12, P1, DOI 10.3758/s13415-011-0060-z; Doucet C, 1999, PSYCHOPHYSIOLOGY, V36, P351, DOI 10.1017/S0048577299980563; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Federmeier KD, 2002, NEUROPSYCHOLOGIA, V40, P730, DOI 10.1016/S0028-3932(01)00193-2; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P601, DOI 10.1111/j.1469-8986.2010.01128.x; Garland EL, 2012, BIOL PSYCHOL, V89, P87, DOI 10.1016/j.biopsycho.2011.09.010; Gootjes L, 2011, INT J PSYCHOPHYSIOL, V79, P356, DOI 10.1016/j.ijpsycho.2010.12.003; HAMERS JF, 1972, J VERB LEARN VERB BE, V11, P303, DOI 10.1016/S0022-5371(72)80091-4; Harrison BJ, 2005, NEUROIMAGE, V24, P181, DOI 10.1016/j.neuroimage.2004.08.033; Henkin Y, 2010, J AM ACAD AUDIOL, V21, P474, DOI 10.3766/jaaa.21.7.6; Herd SA, 2006, J COGNITIVE NEUROSCI, V18, P22, DOI 10.1162/089892906775250012; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; JERGER S, 1988, BRAIN LANG, V35, P86, DOI 10.1016/0093-934X(88)90102-2; Jun C, 2007, PSYCHOL SCI CHINESE, V30, P415; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Klimesch W, 2007, J NEUROPHYSIOL, V97, P1311, DOI 10.1152/jn.00876.2006; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Lefebvre CD, 2005, CLIN NEUROPHYSIOL, V116, P1665, DOI 10.1016/j.clinph.2005.03.015; Lew H, 1997, J Am Acad Audiol, V8, P104; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Luck S.J., 2005, INTRO EVENT RELATED; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mama Y, 2013, COGNITION EMOTION, V27, P589, DOI 10.1080/02699931.2012.726212; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; Martin BA, 2000, J ACOUST SOC AM, V107, P2155, DOI 10.1121/1.428556; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; MCCLAIN L, 1983, PERCEPT PSYCHOPHYS, V33, P266, DOI 10.3758/BF03202864; Meier ME, 2013, J EXP PSYCHOL LEARN, V39, P748, DOI 10.1037/a0029200; Milham MP, 2003, COGNITIVE BRAIN RES, V17, P212, DOI 10.1016/S0926-6410(03)00108-3; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; MORGAN ALR, 1989, BRAIN LANG, V36, P592, DOI 10.1016/0093-934X(89)90088-6; Most SB, 2007, AUDITORY STROOP REVE; Most SB, 2007, J EXP SOC PSYCHOL, V43, P287, DOI 10.1016/j.jesp.2006.02.002; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Peressotti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049099; Qiu J, 2006, BRAIN RES, V1072, P186, DOI 10.1016/j.brainres.2005.12.029; Rebai M, 1997, INT J NEUROSCI, V91, P85, DOI 10.3109/00207459708986367; Redmann A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00363; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Roelofs A, 2002, COGNITIVE BRAIN RES, V15, P85, DOI 10.1016/S0926-6410(02)00218-5; SHOR RE, 1975, J GEN PSYCHOL, V93, P281; SIMSON R, 1977, ELECTROEN CLIN NEURO, V42, P528, DOI 10.1016/0013-4694(77)90216-4; Soutschek A, 2013, PSYCHOL RES-PSYCH FO, V77, P333, DOI 10.1007/s00426-012-0429-9; Soutschek A, 2013, EXP PSYCHOL, V60, P140, DOI 10.1027/1618-3169/a000181; Stafford T, 2007, PHILOS T R SOC B, V362, P1671, DOI 10.1098/rstb.2007.2060; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Swainson R, 2003, J COGNITIVE NEUROSCI, V15, P785, DOI 10.1162/089892903322370717; Thabet MT, 2012, INT J PEDIATR OTORHI, V76, P1712, DOI 10.1016/j.ijporl.2012.08.007; Tome D, 2015, J NEURAL TRANSM, V122, P375, DOI 10.1007/s00702-014-1258-3; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2004, J COGNITIVE NEUROSCI, V16, P103, DOI 10.1162/089892904322755593; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Wolach I, 2001, CLIN NEUROPHYSIOL, V112, P186, DOI 10.1016/S1388-2457(00)00501-0; Wuhr P, 2007, J GEN PSYCHOL, V134, P285, DOI 10.3200/GENP.134.3.285-294; Zhao Y, 2014, NEUROSCIENCE, V262, P92, DOI 10.1016/j.neuroscience.2013.12.052	68	9	9	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137649	10.1371/journal.pone.0137649	http://dx.doi.org/10.1371/journal.pone.0137649			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368570	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100101
J	Meier, D; Lopez, M; Franken, P; Fontana, A				Meier, Daniel; Lopez, Martin; Franken, Paul; Fontana, Adriano			Twist1 Is a TNF-Inducible Inhibitor of Clock Mediated Activation of Period Genes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CIRCADIAN CLOCK; E-BOX; TRANSCRIPTION FACTOR; EXPRESSION; BINDING; ALPHA; PROTEINS; MORPHOGENESIS; INFLAMMATION	Background Activation of the immune system affects the circadian clock. Tumor necrosis factor (TNF) and Interleukin (IL)-1 beta inhibit the expression of clock genes including Period (Per) genes and the PAR-bZip clock-controlled gene D-site albumin promoter-binding protein (Dbp). These effects are due to cytokine-induced interference of E-box mediated transcription of clock genes. In the present study we have assessed the two E-box binding transcriptional regulators Twist1 and Twist2 for their role in cytokine induced inhibition of clock genes. Methods The expression of the clock genes Per1, Per2, Per3 and of Dbp was assessed in NIH-3T3 mouse fibroblasts and the mouse hippocampal neuronal cell line HT22. Cells were treated for 4h with TNF and IL-1 beta. The functional role of Twist1 and Twist2 was assessed by siR-NAs against the Twist genes and by overexpression of TWIST proteins. In luciferase (luc) assays NIH-3T3 cells were transfected with reporter gene constructs, which contain a 3xPer1 E-box or a Dbp E-box. Quantitative chromatin immunoprecipitation (ChIP) was performed using antibodies to TWIST1 and CLOCK, and the E-box consensus sequences of Dbp (CATGTG) and Per1 E-box (CACGTG). Results We report here that siRNA against Twist1 protects NIH-3T3 cells and HT22 cells from down-regulation of Period and Dbp by TNF and IL-1 beta. Overexpression of Twist1, but not of Twist2, mimics the effect of the cytokines. TNF down-regulates the activation of Per1-3xE-box-luc, the effect being prevented by siRNA against Twist1. Overexpression of Twist1, but not of Twist2, inhibits Per1-3xE-box-luc or Dbp-E-Box-luc activity. ChIP experiments show TWIST1 induction by TNF to compete with CLOCK binding to the E-box of Period genes and Dbp. Conclusion Twist1 plays a pivotal role in the TNF mediated suppression of E-box dependent transactivation of Period genes and Dbp. Thereby Twist1 may provide a link between the immune system and the circadian timing system.	[Meier, Daniel; Lopez, Martin; Fontana, Adriano] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Franken, Paul] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	University of Zurich; University of Lausanne	Fontana, A (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	fontana.adriano7@gmail.com	Franken, Paul/A-9633-2018	Franken, Paul/0000-0002-2500-2921; Lopez, Martin/0000-0002-6254-8915	Swiss National Science Foundation [141055]; Baugarten Stiftung; Lotex Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Baugarten Stiftung; Lotex Foundation	The work was supported to A.F. by the Swiss National Science Foundation (Project 141055), the Baugarten Stiftung and the Lotex Foundation. Adriano Fontana is Hertie Senior Research Professor for Neuroscience of the Gemeinnutzige Hertie-Stiftung.	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Chang AT, 2015, GENE DEV, V29, P603, DOI 10.1101/gad.242842.114; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Franken P, 2013, CURR OPIN NEUROBIOL, V23, P864, DOI 10.1016/j.conb.2013.05.002; Gast H, 2012, ANN NY ACAD SCI, V1261, P79, DOI 10.1111/j.1749-6632.2012.06640.x; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Jin-Lu M, 2011, BIOCHEM BIOPH RES CO, V408, P686, DOI 10.1016/j.bbrc.2011.04.089; Kato Y, 2014, CURR TOP DEV BIOL, V110, P339, DOI 10.1016/B978-0-12-405943-6.00010-5; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez M, 2014, J BIOL CHEM, V289, P2736, DOI 10.1074/jbc.M113.508200; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Munoz E, 2002, J BIOL CHEM, V277, P36009, DOI 10.1074/jbc.M203909200; Naidoo N, 2014, AGING CELL, V13, P131, DOI 10.1111/acel.12158; Ohdo S, 2001, NAT MED, V7, P356, DOI 10.1038/85507; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Ripperger JA, 2000, GENE DEV, V14, P679; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Suzuki T, 2008, BIOMED RES-TOKYO, V29, P99, DOI 10.2220/biomedres.29.99; Taraborrelli C, 2011, BRAIN BEHAV IMMUN, V25, P434, DOI 10.1016/j.bbi.2010.11.001; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	39	4	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137229	10.1371/journal.pone.0137229	http://dx.doi.org/10.1371/journal.pone.0137229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361389	Green Submitted, gold, Green Published			2022-12-26	WOS:000361043100026
J	Yashiro, T; Kubo, M; Ogawa, H; Okumura, K; Nishiyama, C				Yashiro, Takuya; Kubo, Masato; Ogawa, Hideoki; Okumura, Ko; Nishiyama, Chiharu			PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells	PLOS ONE			English	Article							IL-4 GENE-EXPRESSION; RESPONSE ELEMENT; MAST-CELLS; DIFFERENTIATION; IDENTIFICATION; REPRESSION; COMPLEX; MOUSE; INVOLVEMENT; PROGENITORS	The transcription factor PU.1 is predominantly expressed in dendritic cells (DCs) and is essential for DC differentiation. Although there are several reports that PU.1 positively regulates the expression of DC-specific genes, whether PU.1 also has a suppressive effect on DCs is largely unknown. Here we demonstrate that PU.1 suppresses the expression of Th2 cytokines including IL-13 and IL-5 in bone marrow-derived DCs (BMDCs), through repression of the expression of GATA3, which is a master regulator of Th2 differentiations. When PU.1 siRNA was introduced into BMDCs, LPS-induced expression of IL-13 and IL-5 was increased along with upregulation of the constitutive expression of GATA2 and GATA3. The additional introduction of GATA3 siRNA but not of GATA2 siRNA abrogated PU.1 siRNAmediated upregulation of IL-13 and IL-5. A chromatin immunoprecipitation assay showed that PU.1 bound to Gata3 proximal promoter region, which is more dominant than the distal promoter in driving GATA3 transcription in DCs. The degree of histone acetylation at the Gata3 promoter was decreased in PU.1 siRNA-introduced DCs, suggesting the involvement of PU.1 in chromatin modification of the Gata3 promoter. Treatment with a histone deacetylase (HDAC) inhibitor, trichostatin A, increased the degree of histone H3 acetylation at the Gata3 promoter and induced the subsequent expression of GATA3. Experiments using HDAC inhibitors and siRNAs showed that HDAC3 suppressed GATA3 expression. The recruitment of HDAC3 to the Gata3 promoter was decreased by PU.1 knockdown. LPSinduced IL-13 expression was dramatically reduced in BMDCs generated from mice lacking the conserved GATA3 response element, termed CGRE, which is an essential site for the binding of GATA3 on the Il-13 promoter. The degree of H3K4me3 at CGRE was significantly increased in PU.1 siRNA-transfected stimulated DCs. Our results indicate that PU.1 plays pivotal roles in DC development and function, serving not only as a transcriptional activator but also as a repressor.	[Yashiro, Takuya; Nishiyama, Chiharu] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, Tokyo 1258585, Japan; [Yashiro, Takuya; Ogawa, Hideoki; Okumura, Ko; Nishiyama, Chiharu] Juntendo Univ, Sch Med, Atopy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Kubo, Masato] RIKEN Yokohama Inst, Integrat Med Sci, Lab Cytokine Regulat, Kanagawa, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Noda, Chiba 2780022, Japan	Tokyo University of Science; Juntendo University; RIKEN; Tokyo University of Science	Nishiyama, C (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	chinishi@rs.tus.ac.jp	yashiro, takuya/Y-1543-2019; Kubo, Masato/A-5918-2016; Nishiyama, Chiharu/GPW-9372-2022		Funding Program for Next Generation World-Leading Researchers from the Ministry of Education, Culture, Sports, Science and Technology of Japan [LS111]; MEXT-Supported Program for the Strategic Research Foundation at Private University (Atopy (Allergy) Research Center, Juntendo University School of Medicine); MEXT-Supported Program for the Strategic Research Foundation at Private University (Translational Research Center, Tokyo University of Science); Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists) [10792]; Grants-in-Aid for Scientific Research [15H01267] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers from the Ministry of Education, Culture, Sports, Science and Technology of Japan; MEXT-Supported Program for the Strategic Research Foundation at Private University (Atopy (Allergy) Research Center, Juntendo University School of Medicine); MEXT-Supported Program for the Strategic Research Foundation at Private University (Translational Research Center, Tokyo University of Science); Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Funding Program for Next Generation World-Leading Researchers from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to CN #LS111), the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Atopy (Allergy) Research Center, Juntendo University School of Medicine; Translational Research Center, Tokyo University of Science). TY has been supported by Research Fellowships of the Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists #10792).	Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Becker C, 2001, J IMMUNOL, V167, P2608, DOI 10.4049/jimmunol.167.5.2608; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chou ST, 2009, BLOOD, V114, P983, DOI 10.1182/blood-2009-03-207944; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Fukai T, 2009, BIOCHEM BIOPH RES CO, V388, P102, DOI 10.1016/j.bbrc.2009.07.126; Gobel F, 2009, BLOOD, V114, P3813, DOI 10.1182/blood-2009-03-210484; Goswami R, 2012, J IMMUNOL, V189, P3026, DOI 10.4049/jimmunol.1201496; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Henkel GW, 1999, BLOOD, V93, P2849; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; Kihara-Negishi F, 2001, ONCOGENE, V20, P6039, DOI 10.1038/sj.onc.1204756; Kitamura N, 2012, J ALLERGY CLIN IMMUN, V129, P814, DOI 10.1016/j.jaci.2011.10.019; Kozuka T, 2011, J IMMUNOL, V187, P5974, DOI 10.4049/jimmunol.1100550; Kwan M, 2005, EUR J IMMUNOL, V35, P1267, DOI 10.1002/eji.200425619; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maeda K, 2006, BLOOD, V108, P262, DOI 10.1182/blood-2005-07-2878; Matsumura I, 2000, BLOOD, V96, P2440; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Nakano N, 2007, BLOOD, V109, P4846, DOI 10.1182/blood-2006-09-045641; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nishiyama C, 2002, J IMMUNOL, V168, P4546, DOI 10.4049/jimmunol.168.9.4546; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Tone Y, 1996, EUR J IMMUNOL, V26, P1222, DOI 10.1002/eji.1830260606; Yamada T, 1998, EXP CELL RES, V245, P186, DOI 10.1006/excr.1998.4251; Yamamoto H, 1999, ONCOGENE, V18, P1495, DOI 10.1038/sj.onc.1202427; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	46	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137699	10.1371/journal.pone.0137699	http://dx.doi.org/10.1371/journal.pone.0137699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361334	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100073
J	Kitatani, K; Usui, T; Sriraman, SK; Toyoshima, M; Ishibashi, M; Shigeta, S; Nagase, S; Sakamoto, M; Ogiso, H; Okazaki, T; Hannun, YA; Torchilin, VP; Yaegashi, N				Kitatani, K.; Usui, T.; Sriraman, S. K.; Toyoshima, M.; Ishibashi, M.; Shigeta, S.; Nagase, S.; Sakamoto, M.; Ogiso, H.; Okazaki, T.; Hannun, Y. A.; Torchilin, V. P.; Yaegashi, N.			Ceramide limits phosphatidylinositol-3-kinase C2 beta-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; SHORT-CHAIN CERAMIDE; ACTIVATED PROTEIN-KINASE; LIPOSOMAL DELIVERY; INDUCED APOPTOSIS; ARACHIDONIC-ACID; EPITHELIAL-CELLS; FACTOR RECEPTOR; OKADAIC ACID; C2 DOMAIN	Targeting cell motility, which is required for dissemination and metastasis, has therapeutic potential for ovarian cancer metastasis, and regulatory mechanisms of cell motility need to be uncovered for developing novel therapeutics. Invasive ovarian cancer cells spontaneously formed protrusions, such as lamellipodia, which are required for generating locomotive force in cell motility. Short interfering RNA screening identified class II phosphatidylinositol 3-kinase C2 beta (PI3KC2 beta) as the predominant isoform of PI3K involved in lamellipodia formation of ovarian cancer cells. The bioactive sphingolipid ceramide has emerged as an antitumorigenic lipid, and treatment with short-chain C-6-ceramide decreased the number of ovarian cancer cells with PI3KC2 beta-driven lamellipodia. Pharmacological analysis demonstrated that long-chain ceramide regenerated from C-6-ceramide through the salvage/recycling pathway, at least in part, mediated the action of C-6-ceramide. Mechanistically, ceramide was revealed to interact with the PIK-catalytic domain of PI3KC2 beta and affect its compartmentalization, thereby suppressing PI3KC2 beta activation and its driven cell motility. Ceramide treatment also suppressed cell motility promoted by epithelial growth factor, which is a prometastatic factor. To examine the role of ceramide in ovarian cancer metastasis, ceramide liposomes were employed and confirmed to suppress cell motility in vitro. Ceramide liposomes had an inhibitory effect on peritoneal metastasis in a murine xenograft model of human ovarian cancer. Metastasis of PI3KC2 beta knocked-down cells was insensitive to treatment with ceramide liposomes, suggesting specific involvement of ceramide interaction with PI3KC2 beta in metastasis suppression. Our study identified ceramide as a bioactive lipid that limits PI3KC2 beta-governed cell motility, and ceramide is proposed to serve as a metastasis-suppressor lipid in ovarian cancer. These findings could be translated into developing ceramide-based therapy for metastatic diseases.	[Kitatani, K.; Usui, T.; Yaegashi, N.] Tohoku Univ, Grad Sch Med, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Kitatani, K.; Toyoshima, M.; Ishibashi, M.; Shigeta, S.; Sakamoto, M.; Yaegashi, N.] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Sriraman, S. K.; Torchilin, V. P.] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Nagase, S.] Yamagata Univ, Dept Obstet & Gynecol, Yamagata 990, Japan; [Ogiso, H.; Okazaki, T.] Kanazawa Med Univ, Dept Life Sci, Med Res Inst, Uchinada, Ishikawa 92002, Japan; [Okazaki, T.] Kanazawa Med Univ, Dept Med, Div Hematol Immunol, Uchinada, Ishikawa 92002, Japan; [Hannun, Y. A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Hannun, Y. A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA	Tohoku University; Tohoku University; Northeastern University; Yamagata University; Kanazawa Medical University; Kanazawa Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kitatani, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Tohoku Med Megabank Org,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9800873, Japan.	kitatani@med.tohoku.ac.jp	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135; Ogiso, Hideo/0000-0002-8241-3006; Nagase, Satoru/0000-0001-5212-1128; xing zhi, shi zhi/0000-0003-3289-5681	JSPS KAKENHI [40539235, 24390375, 23791801]; Health Labour Sciences Research Grant [201221019A]; National Institutes of Health [U54 CA151881, CA087584]; Grants-in-Aid for Scientific Research [26462509, 26670710] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA087584, R01CA172517, U54CA151881] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by JSPS KAKENHI Grants (40539235 to KK, 24390375 to NY and 23791801 to MT), a Health Labour Sciences Research Grant (201221019A to NY), and National Institutes of Health grants (U54 CA151881 to VPT and CA087584 to YAH). We also thank the laboratory members of the Departments of Microbiology and Immunology, and Obstetrics and Gynecology (Tohoku University, Sendai) for critical discussion.	Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Aschrafi A, 2003, BBA-MOL CELL BIOL L, V1634, P30, DOI 10.1016/j.bbalip.2003.08.004; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Banerjee S, 2013, CLIN CANCER RES, V19, P961, DOI 10.1158/1078-0432.CCR-12-2243; Bartlett JMS, 1996, BRIT J CANCER, V73, P301, DOI 10.1038/bjc.1996.53; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boddapati SV, 2008, NANO LETT, V8, P2559, DOI 10.1021/nl801908y; Boller D, 2012, ANTICANCER RES, V32, P3015; Calzolari A, 2007, BLOOD CELL MOL DIS, V39, P82, DOI 10.1016/j.bcmd.2007.02.003; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; Edmond V, 2015, ONCOGENE, V34, P996, DOI 10.1038/onc.2014.55; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Garzotto M, 1998, CANCER RES, V58, P2260; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Huwiler A, 2001, FASEB J, V15, P7; Huwiler A, 1998, BIOCHEMISTRY-US, V37, P14556, DOI 10.1021/bi981401i; Huwiler A, 1996, P NATL ACAD SCI USA, V93, P6959, DOI 10.1073/pnas.93.14.6959; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2007, J BIOL CHEM, V282, P20647, DOI 10.1074/jbc.M609162200; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Koshkaryev A, 2012, CANCER BIOL THER, V13, P50, DOI 10.4161/cbt.13.1.18871; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Meyer AS, 2012, J CELL BIOL, V197, P721, DOI 10.1083/jcb.201201003; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Niikura H, 1997, INT J GYNECOL PATHOL, V16, P60, DOI 10.1097/00004347-199701000-00010; Nitta M, 2001, GYNECOL ONCOL, V81, P10, DOI 10.1006/gyno.2000.6084; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Ogiso H, 2014, METABOLITES, V4, P98, DOI 10.3390/metabo4010098; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Pua TL, 2009, FUTURE ONCOL, V5, P1659, DOI 10.2217/FON.09.120; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Stover T, 2003, J PHARMACOL EXP THER, V307, P468, DOI 10.1124/jpet.103.054056; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Sun Y, 2008, J LEUKOCYTE BIOL, V83, P1512, DOI 10.1189/jlb.0108076; Takeda S, 2006, J BIOCHEM, V139, P255, DOI 10.1093/jb/mvj026; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Tran MA, 2008, CLIN CANCER RES, V14, P3571, DOI 10.1158/1078-0432.CCR-07-4881; van Vlerken LE, 2007, CANCER RES, V67, P4843, DOI 10.1158/0008-5472.CAN-06-1648; WANG E, 1991, J BIOL CHEM, V266, P14486; Wells A, 2013, TRENDS PHARMACOL SCI, V34, P283, DOI 10.1016/j.tips.2013.03.001; Wijesinghe DS, 2005, J LIPID RES, V46, P2706, DOI 10.1194/jlr.M500313-JLR200; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yin XL, 2009, CELL PHYSIOL BIOCHEM, V24, P219, DOI 10.1159/000233248; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568; Zhou HY, 2007, ENDOCRINOLOGY, V148, P5195, DOI 10.1210/en.2007-0361	70	40	40	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2801	2812		10.1038/onc.2015.330	http://dx.doi.org/10.1038/onc.2015.330			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26364609	Green Accepted			2022-12-26	WOS:000377472700013
J	Veya, L; Piguet, J; Vogel, H				Veya, Luc; Piguet, Joachim; Vogel, Horst			Single Molecule Imaging Deciphers the Relation between Mobility and Signaling of a Prototypical G Protein-coupled Receptor in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-COATED-PIT; NEUROKININ 1 RECEPTOR; FLUID-MOSAIC MODEL; TACHYKININ NK1 RECEPTOR; PLASMA-MEMBRANE; SUBSTANCE-P; PARTICLE TRACKING; BIOLOGICAL-MEMBRANES; EPITHELIAL-CELLS; SURFACE PROTEINS	Lateral diffusion enables efficient interactions between membrane proteins, leading to signal transmission across the plasma membrane. An open question is how the spatiotemporal distribution of cell surface receptors influences the transmembrane signaling network. Here we addressed this issue by studying the mobility of a prototypical G protein-coupled receptor, the neurokinin-1 receptor, during its different phases of cellular signaling. Attaching a single quantum dot to individual neurokinin-1 receptors enabled us to follow with high spatial and temporal resolution over long time regimes the fate of individual receptors at the plasma membrane. Single receptor trajectories revealed a very heterogeneous mobility distribution pattern with diffusion constants ranging from 0.0005 to 0.1 mu m(2)/s comprising receptors freely diffusing and others confined in 100-600-nm-sized membrane domains as well as immobile receptors. A two-dimensional representation of mobility and confinement resolved two major, broadly distributed receptor populations, one showing high mobility and low lateral restriction and the other showing low mobility and high restriction. We found that about 40% of the receptors in the basal state are already confined in membrane domains and are associated with clathrin. After stimulation with an agonist, an additional 30% of receptors became further confined. Using inhibitors of clathrin-mediated endocytosis, we found that the fraction of confined receptors at the basal state depends on the quantity of membrane-associated clathrin and is correlated to a significant decrease of the canonical pathway activity of the receptors. This shows that the high plasticity of receptor mobility is of central importance for receptor homeostasis and fine regulation of receptor activity.	[Veya, Luc; Piguet, Joachim; Vogel, Horst] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Piguet, J (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.	joachim.jpiguet@kth.se; horst.vogel@epfl.ch	Piguet, Joachim/E-2329-2011; Vogel, Horst/AAJ-5490-2021	Piguet, Joachim/0000-0002-4762-4887; 	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; National Centre of Competence in Research Chemical Biology; European Community (Project SynSignal) [FP7-KBBE-2013-613879]	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research Chemical Biology; European Community (Project SynSignal)	This work was supported by grants of the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, the National Centre of Competence in Research Chemical Biology, and the European Community (Project SynSignal, Grant FP7-KBBE-2013-613879). The authors declare that they have no conflicts of interest with the contents of this article.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; ALBRECHTBUEHLER G, 1980, P NATL ACAD SCI-BIOL, V77, P6639, DOI 10.1073/pnas.77.11.6639; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Baker A, 2007, EUR BIOPHYS J BIOPHY, V36, P849, DOI 10.1007/s00249-007-0214-7; Bauer B, 2009, ANGEW CHEM INT EDIT, V48, P1656, DOI 10.1002/anie.200803898; Bellve KD, 2006, J BIOL CHEM, V281, P16139, DOI 10.1074/jbc.M511370200; Bouzigues C, 2007, P NATL ACAD SCI USA, V104, P11251, DOI 10.1073/pnas.0702536104; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Cezanne L, 2004, J BIOL CHEM, V279, P45057, DOI 10.1074/jbc.M404811200; Chen PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045322; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; de Keijzer S, 2011, BBA-BIOMEMBRANES, V1808, P1701, DOI 10.1016/j.bbamem.2011.02.009; den Otter WK, 2011, TRAFFIC, V12, P1407, DOI 10.1111/j.1600-0854.2011.01241.x; Destainville N, 2006, BIOPHYS J, V90, pL17, DOI 10.1529/biophysj.105.075176; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ganguly S, 2011, BBA-BIOMEMBRANES, V1808, P1921, DOI 10.1016/j.bbamem.2011.04.001; GARLAND AM, 1994, BIOCHEM J, V303, P177, DOI 10.1042/bj3030177; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; Grasso L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070929; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Grove J, 2014, MOL BIOL CELL, V25, P3581, DOI 10.1091/mbc.E14-06-1154; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Helmuth JA, 2007, J STRUCT BIOL, V159, P347, DOI 10.1016/j.jsb.2007.04.003; Heng BC, 2013, BIOTECHNOL ADV, V31, P1676, DOI 10.1016/j.biotechadv.2013.08.017; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Jaqaman K, 2012, TRENDS CELL BIOL, V22, P515, DOI 10.1016/j.tcb.2012.07.006; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Khawaja AM, 1996, INT J BIOCHEM CELL B, V28, P721, DOI 10.1016/1357-2725(96)00017-9; Kubale V, 2007, CELL TISSUE RES, V330, P231, DOI 10.1007/s00441-007-0462-y; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Kusumi A, 2014, NAT CHEM BIOL, V10, P524, DOI [10.1038/NCHEMBIO.1558, 10.1038/nchembio.1558]; Kusumi A, 2012, ANNU REV CELL DEV BI, V28, P215, DOI 10.1146/annurev-cellbio-100809-151736; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lill Y, 2005, CHEMPHYSCHEM, V6, P1633, DOI 10.1002/cphc.200500111; LIN HC, 1991, J CELL BIOL, V114, P881, DOI 10.1083/jcb.114.5.881; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9; Luttrell LM, 2002, J CELL SCI, V115, P455; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; Meshki J, 2009, J BIOL CHEM, V284, P9280, DOI 10.1074/jbc.M808825200; Meyer BH, 2006, FEBS LETT, V580, P1654, DOI 10.1016/j.febslet.2006.02.007; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; MILLER K, 1991, CELL, V65, P621, DOI 10.1016/0092-8674(91)90094-F; Murphy JE, 2011, AM J PHYSIOL-CELL PH, V301, pC780, DOI 10.1152/ajpcell.00096.2011; Nicolau DV, 2007, BIOPHYS J, V92, P1975, DOI 10.1529/biophysj.105.076869; Nicolson GL, 2014, BBA-BIOMEMBRANES, V1838, P1451, DOI 10.1016/j.bbamem.2013.10.019; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Pick H, 2005, J AM CHEM SOC, V127, P2908, DOI 10.1021/ja044605x; Piguet J, 2011, J BIOL CHEM, V286, P363, DOI 10.1074/jbc.M110.139782; Prummer M, 2006, CHEMBIOCHEM, V7, P908, DOI 10.1002/cbic.200500477; Quartara L, 1998, NEUROPEPTIDES, V32, P1, DOI 10.1016/S0143-4179(98)90015-4; Quartara L, 1997, NEUROPEPTIDES, V31, P537, DOI 10.1016/S0143-4179(97)90001-9; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Roosterman D, 2004, J BIOL CHEM, V279, P30670, DOI 10.1074/jbc.M402479200; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Subtil A, 1997, J CELL SCI, V110, P2441; TAKAHASHI K, 1992, EUR J BIOCHEM, V204, P1025, DOI 10.1111/j.1432-1033.1992.tb16724.x; TANK DW, 1982, J CELL BIOL, V92, P207, DOI 10.1083/jcb.92.1.207; Thurner P, 2014, J BIOL CHEM, V289, P9263, DOI 10.1074/jbc.M113.505685; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Valant C, 2012, ANNU REV PHARMACOL, V52, P153, DOI 10.1146/annurev-pharmtox-010611-134514; VAZ WLC, 1982, BIOCHEMISTRY-US, V21, P5608, DOI 10.1021/bi00265a034; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang XR, 2002, BRAIN RES, V944, P239, DOI 10.1016/S0006-8993(02)02918-9; Weigel AV, 2013, P NATL ACAD SCI USA, V110, pE4591, DOI 10.1073/pnas.1315202110; Zhou HX, 2009, J PHYS CHEM B, V113, P7995, DOI 10.1021/jp8107446	83	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27723	27735		10.1074/jbc.M115.666677	http://dx.doi.org/10.1074/jbc.M115.666677			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26363070	Green Published, hybrid			2022-12-26	WOS:000365757500025
J	Ebrahimi, KH; Hagedoorn, PL; Hagen, WR				Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.			Self-assembly Is Prerequisite for Catalysis of Fe(II) Oxidation by Catalytically Active Subunits of Ferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN H-CHAIN; 4-ALPHA-HELIX BUNDLE PROTEIN; IRON-CORE FORMATION; FERROXIDASE CENTER; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; BINDING SITES; ION CHANNELS; MECHANISM; BACTERIOFERRITIN	Fe(III) storage by ferritin is an essential process of the iron homeostasis machinery. It begins by translocation of Fe(II) from outside the hollow spherical shape structure of the protein, which is formed as the result of self-assembly of 24 subunits, to a di-iron binding site, the ferroxidase center, buried in the middle of each active subunit. The pathway of Fe(II) to the ferroxidase center has remained elusive, and the importance of self-assembly for the functioning of the ferroxidase center has not been investigated. Here we report spectroscopic and metal ion binding studies with a mutant of ferritin from Pyrococcus furiosus (PfFtn) in which self-assembly was abolished by a single amino acid substitution. Weshow that in this mutant metal ion binding to the ferroxidase center and Fe(II) oxidation at this site was obliterated. However, metal ion binding to a conserved third site (site C), which is located in the inner surface of each subunit in the vicinity of the ferroxidase center and is believed to be the path for Fe(II) to the ferroxidase center, was not disrupted. These results are the basis of a new model for Fe(II) translocation to the ferroxidase center: self-assembly creates channels that guide the Fe(II) ions toward the ferroxidase center directly through the protein shell and not via the internal cavity and site C. The results may be of significance for understanding the molecular basis of ferritin-related disorders such as neuroferritinopathy in which the 24-meric structure with 432 symmetry is distorted.	[Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands	Delft University of Technology	Ebrahimi, KH (corresponding author), Delft Univ Technol, Dept Biotechnol, Julianalaan 67, NL-2628 BC Delft, Netherlands.	k.h.ebrahimi@tudelft.nl; w.r.hagen@tudelft.nl	Ebrahimi, Kourosh Honarmand/X-4579-2019; Hagedoorn, Peter-Leon/C-8535-2014; Hagen, Wilfred R./H-8918-2017	Ebrahimi, Kourosh Honarmand/0000-0001-6628-944X; Hagedoorn, Peter-Leon/0000-0001-6342-2022; Hagen, Wilfred R./0000-0002-1609-6671				AROSIO P, 1978, J BIOL CHEM, V253, P4451; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Behera RK, 2015, J BIOL INORG CHEM, V20, P957, DOI 10.1007/s00775-015-1279-x; Behera RK, 2014, P NATL ACAD SCI USA, V111, P7925, DOI 10.1073/pnas.1318417111; Bou-Abdallah F, 2014, BIOCHEMISTRY-US, V53, P483, DOI 10.1021/bi401517f; Bou-Abdallah F, 2003, J BIOL INORG CHEM, V8, P489, DOI 10.1007/s00775-003-0455-6; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Bou-Abdallah F, 2008, J AM CHEM SOC, V130, P17801, DOI 10.1021/ja8054035; BOYD D, 1985, J BIOL CHEM, V260, P1755; Brask J, 2001, BIOORG MED CHEM LETT, V11, P697, DOI 10.1016/S0960-894X(01)00035-X; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; DOUGLAS T, 1995, SCIENCE, V269, P54, DOI 10.1126/science.269.5220.54; Ebrahimi KH, 2015, CHEM REV, V115, P295, DOI 10.1021/cr5004908; Ebrahimi KH, 2013, CHEMBIOCHEM, V14, P1123, DOI 10.1002/cbic.201300149; Ebrahimi KH, 2012, NAT CHEM BIOL, V8, P941, DOI [10.1038/NCHEMBIO.1071, 10.1038/nchembio.1071]; Ebrahimi KH, 2012, J BIOL INORG CHEM, V17, P975, DOI 10.1007/s00775-012-0913-0; Ebrahimi KH, 2010, J BIOL INORG CHEM, V15, P1243, DOI 10.1007/s00775-010-0682-6; Ebrahimi KH, 2009, J BIOL INORG CHEM, V14, P1265, DOI 10.1007/s00775-009-0571-z; Giorgi A, 2008, ARCH BIOCHEM BIOPHYS, V478, P69, DOI 10.1016/j.abb.2008.06.022; GRANICK S, 1946, CHEM REV, V38, P379, DOI 10.1021/cr60121a001; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hem LH, 2003, BIOTECHNOL PROGR, V19, P544, DOI 10.1021/bp0256059; Hosein HA, 2004, LANGMUIR, V20, P10283, DOI 10.1021/la0491100; Jutz G, 2015, CHEM REV, V115, P1653, DOI 10.1021/cr400011b; Kanbak-Aksu S, 2012, CHEM COMMUN, V48, P5745, DOI 10.1039/c2cc31401k; Keyes JD, 2011, J NANOPART RES, V13, P2563, DOI 10.1007/s11051-010-0149-2; Laghaei R, 2013, PROTEINS, V81, P1042, DOI 10.1002/prot.24251; Lee HY, 2006, J AM CHEM SOC, V128, P337, DOI 10.1021/ja0563410; Lee KH, 2004, BIOCHEMISTRY-US, V43, P16277, DOI 10.1021/bi049086p; LEVI S, 1993, FEBS LETT, V336, P309, DOI 10.1016/0014-5793(93)80826-G; LEVI S, 1988, J BIOL CHEM, V263, P18086; Liu HL, 2004, FEBS LETT, V573, P93, DOI 10.1016/j.febslet.2004.07.054; Luscieti S, 2010, J BIOL CHEM, V285, P11948, DOI 10.1074/jbc.M109.096404; OSTERHOUT JJ, 1992, J AM CHEM SOC, V114, P331, DOI 10.1021/ja00027a043; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; Pozzi C, 2015, ACTA CRYSTALLOGR D, V71, P941, DOI 10.1107/S1399004715002333; Rouault TA, 2001, NAT GENET, V28, P299, DOI 10.1038/91036; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; STEIF C, 1993, BIOCHEMISTRY-US, V32, P3867, DOI 10.1021/bi00066a005; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; Treffry A, 1998, J BIOL INORG CHEM, V3, P682, DOI 10.1007/s007750050282; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; TREFFRY A, 1995, BIOCHEMISTRY-US, V34, P15204, DOI 10.1021/bi00046a028; Uchida M, 2010, BBA-GEN SUBJECTS, V1800, P834, DOI 10.1016/j.bbagen.2009.12.005; Ueno T, 2004, ANGEW CHEM INT EDIT, V43, P2527, DOI 10.1002/anie.200353436; Watt RK, 2013, CHEMBIOCHEM, V14, P415, DOI 10.1002/cbic.201200783; Watt RK, 2011, BIOMETALS, V24, P489, DOI 10.1007/s10534-011-9415-8; Weeratunga SK, 2010, BIOCHEMISTRY-US, V49, P1160, DOI 10.1021/bi9015204; Wong SG, 2015, J BIOL CHEM, V290, P3732, DOI 10.1074/jbc.M114.623082; Yao HL, 2015, BIOCHEMISTRY-US, V54, P1611, DOI 10.1021/bi501255r; Yevenes AE, 2011, BIOCHIMIE, V93, P352, DOI 10.1016/j.biochi.2010.10.008	55	10	10	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26801	26810		10.1074/jbc.M115.678375	http://dx.doi.org/10.1074/jbc.M115.678375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370076	Green Published, hybrid			2022-12-26	WOS:000364793600042
J	Cahill, TJ; Leo, V; Kelly, M; Stockenhuber, A; Kennedy, NW; Bao, LY; Cereghetti, G; Harper, AR; Czibik, G; Lao, CY; Bellahcene, M; Steeples, V; Ghaffari, S; Yavari, A; Mayer, A; Poulton, J; Ferguson, DJP; Scorrano, L; Hettiarachchi, NT; Peers, C; Boyle, J; Hill, RB; Simmons, A; Watkins, H; Dear, TN; Ashrafian, H				Cahill, Thomas J.; Leo, Vincenzo; Kelly, Matthew; Stockenhuber, Alexander; Kennedy, Nolan W.; Bao, Leyuan; Cereghetti, Grazia; Harper, Andrew R.; Czibik, Gabor; Lao, Chunyan; Bellahcene, Mohamed; Steeples, Violetta; Ghaffari, Safar; Yavari, Arash; Mayer, Alice; Poulton, Joanna; Ferguson, David J. P.; Scorrano, Luca; Hettiarachchi, Nishani T.; Peers, Chris; Boyle, John; Hill, R. Blake; Simmons, Alison; Watkins, Hugh; Dear, T. Neil; Ashrafian, Houman			Resistance of Dynamin-related Protein 1 Oligomers to Disassembly Impairs Mitophagy, Resulting in Myocardial Inflammation and Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FISSION; AUTOPHAGY; DRP1; FUSION; PROTECTS; STRESS; CELLS; ELIMINATION; DEGRADATION; ACTIVATION	We have reported previously that a missense mutation in the mitochondrial fission gene Dynamin-related protein 1 (Drp1) underlies the Python mouse model of monogenic dilated cardiomyopathy. The aim of this study was to investigate the consequences of the C452F mutation on Drp1 protein function and to define the cellular sequelae leading to heart failure in the Python monogenic dilated cardiomyopathy model. We found that the C452F mutation increased Drp1 GTPase activity. The mutation also conferred resistance to oligomer disassembly by guanine nucleotides and high ionic strength solutions. In a mouse embryonic fibroblast model, Drp1 C452F cells exhibited abnormal mitochondrial morphology and defective mitophagy. Mitochondria in C452F mouse embryonic fibroblasts were depolarized and had reduced calcium uptake with impaired ATP production by oxidative phosphorylation. In the Python heart, we found a corresponding progressive decline in oxidative phosphorylation with age and activation of sterile inflammation. As a corollary, enhancing autophagy by exposure to a prolonged low-protein diet improved cardiac function in Python mice. In conclusion, failure of Drp1 disassembly impairs mitophagy, leading to a downstream cascade of mitochondrial depolarization, aberrant calcium handling, impaired ATP synthesis, and activation of sterile myocardial inflammation, resulting in heart failure.	[Cahill, Thomas J.; Kelly, Matthew; Stockenhuber, Alexander; Harper, Andrew R.; Czibik, Gabor; Bellahcene, Mohamed; Steeples, Violetta; Ghaffari, Safar; Yavari, Arash; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford OX3 9DU, England; [Ferguson, David J. P.] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 9DU, England; [Ashrafian, Houman] Univ Oxford, Radcliffe Dept Med, Expt Therapeut, Oxford OX3 9DU, England; [Bao, Leyuan; Mayer, Alice; Simmons, Alison] Univ Oxford, Nuffield Dept Med, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Lao, Chunyan; Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Leo, Vincenzo; Dear, T. Neil] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Kennedy, Nolan W.; Hill, R. Blake] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Cereghetti, Grazia; Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Hettiarachchi, Nishani T.; Peers, Chris; Boyle, John] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Div Cardiovasc & Diabet Res, Leeds LS2 9JT, W Yorkshire, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Saint James's University Hospital; University of Leeds; Medical College of Wisconsin; University of Geneva; University of Leeds	Ashrafian, H (corresponding author), Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Expt Therapeut, Oxford OX3 9DU, England.	houman.ashrafian@cardiov.ox.ac.uk	Harper, Andrew/B-7044-2017; Regan, Clinton/E-6250-2012; Czibik, Gabor/U-9295-2018; Poulton, Joanna/I-3913-2016; Poulton, Joanna/AAB-4828-2021; Scorrano, Luca/A-6652-2008	Harper, Andrew/0000-0001-5327-0328; Czibik, Gabor/0000-0002-4914-6794; Scorrano, Luca/0000-0002-8515-8928; Kennedy, Nolan/0000-0002-2944-5439; Ashrafian, Houman/0000-0003-3988-378X; Cahill, Thomas/0000-0003-4318-5618; Peers, Chris/0000-0002-8354-346X; Mayer, Alice/0000-0002-6859-0612; Stockenhuber, Alexander/0000-0002-5523-6673; Hill, Blake/0000-0001-6228-3905; Poulton, Joanna/0000-0002-2460-5587	National Institutes for Health Research Academic Clinical Fellowship; Medical Research Council [MR/J010448/1]; Wellcome Trust [0948685/Z/10/Z]; National Institutes of Health [R01-GM067180]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067180] Funding Source: NIH RePORTER; British Heart Foundation [RG/12/16/29939] Funding Source: researchfish; Medical Research Council [MC_UU_12010/7] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-026] Funding Source: researchfish; MRC [MC_UU_12010/7, MR/J010448/1] Funding Source: UKRI	National Institutes for Health Research Academic Clinical Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a National Institutes for Health Research Academic Clinical Fellowship.; Supported by Medical Research Council Project Grant MR/J010448/1 and Wellcome Trust Project Grant 0948685/Z/10/Z.; Supported by National Institutes of Health Grant R01-GM067180.	Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Beraud N, 2009, J BIOENERG BIOMEMBR, V41, P195, DOI 10.1007/s10863-009-9214-x; Cahill TJ, 2013, CIRC RES, V113, P660, DOI 10.1161/CIRCRESAHA.113.300282; Carley AN, 2014, CIRC RES, V114, P717, DOI 10.1161/CIRCRESAHA.114.301863; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Cloonan SM, 2013, CURR OPIN MICROBIOL, V16, P327, DOI 10.1016/j.mib.2013.05.005; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Dorn GW, 2015, CIRC RES, V116, P225, DOI 10.1161/CIRCRESAHA.114.305672; Dorn GW, 2013, BBA-MOL CELL RES, V1833, P233, DOI 10.1016/j.bbamcr.2012.03.008; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hom J, 2010, BBA-BIOENERGETICS, V1797, P913, DOI 10.1016/j.bbabio.2010.03.018; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; James NG, 2014, BBA-GEN SUBJECTS, V1840, P315, DOI 10.1016/j.bbagen.2013.09.001; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Kanamori H, 2009, AM J PATHOL, V174, P1705, DOI 10.2353/ajpath.2009.080875; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Redpath CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069165; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Shintani Y, 2014, EMBO REP, V15, P438, DOI 10.1002/embr.201337945; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang L, 2010, J BIOL CHEM, V285, P22751, DOI 10.1074/jbc.C110.130013; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	42	39	42	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25907	25919		10.1074/jbc.M115.665695	http://dx.doi.org/10.1074/jbc.M115.665695			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26370078	Green Published, hybrid			2022-12-26	WOS:000363527300014
J	Lammers, KM; Chieppa, M; Liu, L; Liu, S; Omatsu, T; Janka-Junttila, M; Casolaro, V; Reinecker, HC; Parent, CA; Fasano, A				Lammers, Karen M.; Chieppa, Marcello; Liu, Lunhua; Liu, Song; Omatsu, Tatsushi; Janka-Junttila, Mirkka; Casolaro, Vincenzo; Reinecker, Hans-Christian; Parent, Carole A.; Fasano, Alessio			Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1	PLOS ONE			English	Article							MUCOSAL GRANULOCYTE ACTIVATION; CELIAC-DISEASE; INTESTINAL PERMEABILITY; BARRIER FUNCTION; GUT PERMEABILITY; CONTROLLED-TRIAL; GENE-EXPRESSION; GLUTEN; ZONULIN; CHEMOTAXIS	Background Gliadin, the immunogenic component within gluten and trigger of celiac disease, is known to induce the production of Interleukin-8, a potent neutrophil-activating and chemoattractant chemokine. We sought to study the involvement of neutrophils in the early immunological changes following gliadin exposure. Methods Utilizing immunofluorescence microscopy and flow cytometry, the redistribution of major tight junction protein, Zonula occludens (ZO)-1, and neutrophil recruitment were assessed in duodenal tissues of gliadin-gavaged C57BL/6 wild-type and Lys-GFP reporter mice, respectively. Intravital microscopy with Lys-GFP mice allowed monitoring of neutrophil recruitment in response to luminal gliadin exposure in real time. In vitro chemotaxis assays were used to study murine and human neutrophil chemotaxis to gliadin, synthetic alpha-gliadin peptides and the neutrophil chemoattractant, fMet-Leu-Phe, in the presence or absence of a specific inhibitor of the fMet-Leu-Phe receptor-1 (FPR1), cyclosporine H. An irrelevant protein, zein, served as a control. Results Redistribution of ZO-1 and an influx of CD11b(+)Lys6G(+) cells in the lamina propria of the small intestine were observed upon oral gavage of gliadin. In vivo intravital microscopy revealed a slowing down of GFP(+) cells within the vessels and influx in the mucosal tissue within 2 hours after challenge. In vitro chemotaxis assays showed that gliadin strongly induced neutrophil migration, similar to fMet-Leu-Phe. We identified thirteen synthetic gliadin peptide motifs that induced cell migration. Blocking of FPR1 completely abrogated the fMet-Leu-Phe-, gliadin- and synthetic peptide-induced migration. Conclusions Gliadin possesses neutrophil chemoattractant properties similar to the classical neutrophil chemoattractant, fMet-Leu-Phe, and likewise uses FPR1 in the process.	[Lammers, Karen M.; Fasano, Alessio] Massachusetts Gen Hosp, Dept Pediat, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Chieppa, Marcello] NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Liu, Lunhua; Janka-Junttila, Mirkka; Parent, Carole A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Liu, Song; Omatsu, Tatsushi; Reinecker, Hans-Christian] Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital	Lammers, KM (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA.	klammers@mgh.harvard.edu	Chieppa, Marcello/I-8447-2018; Casolaro, Vincenzo/E-9144-2010; Chieppa, Marcello/AAG-9835-2019; Fasano, Alessio/K-5486-2016	Chieppa, Marcello/0000-0001-9819-0823; Casolaro, Vincenzo/0000-0001-9810-0488; Chieppa, Marcello/0000-0001-9819-0823; Fasano, Alessio/0000-0002-2134-0261	National Institutes of Health [DK-078699, DK-48373, DK068181, AI113333, DK033506, DK043351, MFAG 10684]; Center for Cancer Research, NCI, NIH; NATIONAL CANCER INSTITUTE [ZIABC011216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078699, P01DK033506, R01DK048373, R01DK068181, P30DK043351] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This research was supported in part by the National Institutes of Health Grants DK-078699 and DK-48373 to AF, DK068181, AI113333, DK033506 and DK043351 to HCR, MFAG 10684 (AIRC) to MC, and the Intramural Research Program of the Center for Cancer Research, NCI, NIH to CAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Beitnes ACR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033556; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Carroccio A, 2012, AM J GASTROENTEROL, V107, P1898, DOI 10.1038/ajg.2012.236; Cascella NG, 2011, SCHIZOPHRENIA BULL, V37, P94, DOI 10.1093/schbul/sbp055; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chladkova B, 2011, J CELL MOL MED, V15, P938, DOI 10.1111/j.1582-4934.2010.01066.x; Cinova J, 2007, J CLIN IMMUNOL, V27, P201, DOI 10.1007/s10875-006-9061-z; de Magistris L, 2010, J PEDIATR GASTR NUTR, V51, P418, DOI 10.1097/MPG.0b013e3181dcc4a5; Diosdado B, 2007, CLIN GASTROENTEROL H, V5, P574, DOI 10.1016/j.cgh.2006.11.014; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; DUNLEVY JR, 1993, J CELL SCI, V105, P489; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; Faust N, 2000, BLOOD, V96, P719; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; HORIKAWA T, 1995, J INVEST DERMATOL, V104, P256, DOI 10.1111/1523-1747.ep12612795; Jelinkova L, 2004, FEBS LETT, V571, P81, DOI 10.1016/j.febslet.2004.06.057; Keet CA, 2009, ANN ALLERG ASTHMA IM, V102, P410, DOI 10.1016/S1081-1206(10)60513-3; Kristjansson G, 2005, SCAND J GASTROENTERO, V40, P662, DOI 10.1080/00365520510015566; Kristjansson G, 2005, GUT, V54, P769, DOI 10.1136/gut.2004.057174; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Lammers KM, 2011, IMMUNOLOGY, V132, P432, DOI 10.1111/j.1365-2567.2010.03378.x; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; Picarelli A, 1999, SCAND J GASTROENTERO, V34, P1099, DOI 10.1080/003655299750024896; RALT D, 1994, BIOL REPROD, V50, P774, DOI 10.1095/biolreprod50.4.774; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Silano M, 2009, CURR MED CHEM, V16, P1489, DOI 10.2174/092986709787909613; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vazquez-Roque MI, 2013, GASTROENTEROLOGY, V144, P903, DOI 10.1053/j.gastro.2013.01.049; Visser JT, 2010, DIABETOLOGIA; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; WENZELSEIFERT K, 1993, J IMMUNOL, V150, P4591; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	41	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138338	10.1371/journal.pone.0138338	http://dx.doi.org/10.1371/journal.pone.0138338			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378785	Green Submitted, gold, Green Published			2022-12-26	WOS:000361769400084
J	Bierle, LA; Reich, KL; Taylor, BE; Blatt, EB; Middleton, SM; Burke, SD; Stultz, LK; Hanson, PK; Partridge, JF; Miller, ME				Bierle, Lindsey A.; Reich, Kira L.; Taylor, Braden E.; Blatt, Eliot B.; Middleton, Sydney M.; Burke, Shawnecca D.; Stultz, Laura K.; Hanson, Pamela K.; Partridge, Janet F.; Miller, Mary E.			DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S-cerevisiae	PLOS ONE			English	Article							RUTHENIUM COMPLEX KP1019; BUDDING YEAST RAD9; MITOTIC SPINDLE; GENE-EXPRESSION; COLORECTAL-CARCINOMA; ANTICANCER AGENT; OXIDATIVE STRESS; MEC1 PATHWAY; CROSS-LINKS; PHASE-I	Careful regulation of the cell cycle is required for proper replication, cell division, and DNA repair. DNA damage-including that induced by many anticancer drugs-results in cell cycle delay or arrest, which can allow time for repair of DNA lesions. Although its molecular mechanism of action remains a matter of debate, the anticancer ruthenium complex KP1019 has been shown to bind DNA in biophysical assays and to damage DNA of colorectal and ovarian cancer cells in vitro. KP1019 has also been shown to induce mutations and induce cell cycle arrest in Saccharomyces cerevisiae, suggesting that budding yeast can serve as an appropriate model for characterizing the cellular response to the drug. Here we use a transcriptomic approach to verify that KP1019 induces the DNA damage response (DDR) and find that KP1019 dependent expression of HUG1 requires the Dun1 checkpoint; both consistent with KP1019 DDR in budding yeast. We observe a robust KP1019 dependent delay in cell cycle progression as measured by increase in large budded cells, 2C DNA content, and accumulation of Pds1 which functions to inhibit anaphase. Importantly, we also find that deletion of RAD9, a gene required for the DDR, blocks drug-dependent changes in cell cycle progression, thereby establishing a causal link between the DDR and phenotypes induced by KP1019. Interestingly, yeast treated with KP1019 not only delay in G2/M, but also exhibit abnormal nuclear position, wherein the nucleus spans the bud neck. This morphology correlates with short, misaligned spindles and is dependent on the dynein heavy chain gene DYN1. We find that KP1019 creates an environment where cells respond to DNA damage through nuclear (transcriptional changes) and cytoplasmic (motor protein activity) events.	[Bierle, Lindsey A.; Miller, Mary E.] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA; [Reich, Kira L.; Taylor, Braden E.; Blatt, Eliot B.; Burke, Shawnecca D.; Miller, Mary E.] Rhodes Coll, Program Biochem & Mol Biol, Memphis, TN 38112 USA; [Middleton, Sydney M.; Hanson, Pamela K.] Birmingham Southern Coll, Dept Biol, Birmingham, AL USA; [Stultz, Laura K.] Birmingham Southern Coll, Dept Chem, Birmingham, AL USA; [Partridge, Janet F.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Miller, ME (corresponding author), Rhodes Coll, Dept Biol, Memphis, TN 38112 USA.	millerm@rhodes.edu	Partridge, Janet/M-9352-2018	Partridge, Janet/0000-0003-1102-6305; Stultz, Laura/0000-0002-2901-5949; Hanson, Pamela/0000-0002-9312-1682	Cancer Center support grant [CCSG 2 P30 CA21765]; ALSAC (American Lebanese Syrian Associated Charities) of St. Jude Children's Research Hospital, Rhodes College J. T. and V. B. Robertson Chair of Biological Sciences; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	Cancer Center support grant; ALSAC (American Lebanese Syrian Associated Charities) of St. Jude Children's Research Hospital, Rhodes College J. T. and V. B. Robertson Chair of Biological Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Cancer Center support grant [CCSG 2 P30 CA21765 to St. Jude] (JFP) and by ALSAC (American Lebanese Syrian Associated Charities) of St. Jude Children's Research Hospital (JFP), Rhodes College J. T. and V. B. Robertson Chair of Biological Sciences (MEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ainsworth WB, 2013, BIOCHEM BIOPH RES CO, V439, P443, DOI 10.1016/j.bbrc.2013.08.089; Alagesan M, 2014, DALTON T, V43, P15829, DOI 10.1039/c4dt01032a; Badin-Larcon AC, 2004, P NATL ACAD SCI USA, V101, P5577, DOI 10.1073/pnas.0307917101; Basrai MA, 1999, MOL CELL BIOL, V19, P7041; Beljanski V, 2004, MOL PHARMACOL, V65, P1496, DOI 10.1124/mol.65.6.1496; BERGER MR, 1989, ANTICANCER RES, V9, P761; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Blankley RT, 2004, J CELL SCI, V117, P601, DOI 10.1242/jcs.00907; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Caba E, 2005, MUTAT RES-FUND MOL M, V575, P34, DOI 10.1016/j.mrfmmm.2005.02.005; Carmelo V, 1997, FEMS MICROBIOL LETT, V149, P85, DOI 10.1016/S0378-1097(97)00059-1; Carter CD, 2005, MOL CELL BIOL, V25, P10273, DOI 10.1128/MCB.25.23.10273-10285.2005; Caydasi AK, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-28; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Cohen-Fix O, 1997, P NATL ACAD SCI USA, V94, P14361, DOI 10.1073/pnas.94.26.14361; Collins ES, 2012, MOL BIOL CELL, V23, P3380, DOI 10.1091/mbc.E12-02-0109; Demeter J, 2000, MOL CELL, V6, P487, DOI 10.1016/S1097-2765(00)00047-2; Dolz-Edo L, 2013, MOL CELL BIOL, V33, P2228, DOI 10.1128/MCB.00240-13; Dotiwala F, 2007, P NATL ACAD SCI USA, V104, P11358, DOI 10.1073/pnas.0609636104; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; ENDOICHIKAWA Y, 1995, BIOCHEM PHARMACOL, V50, P1695, DOI 10.1016/0006-2952(95)02071-3; ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172; Fasullo M, 1999, GENETICS, V152, P909; Finn K, 2012, CELL MOL LIFE SCI, V69, P1447, DOI 10.1007/s00018-011-0875-3; Garay-Arroyo A, 1999, YEAST, V15, P879, DOI 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.3.CO;2-H; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Grossmann KF, 1999, MUTAT RES-DNA REPAIR, V434, P29, DOI 10.1016/S0921-8777(99)00011-7; Grossmann KF, 2000, MUTAT RES-DNA REPAIR, V461, P1, DOI 10.1016/S0921-8777(00)00035-5; Haase Steven B, 2004, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0723s26; Hartinger CG, 2008, CHEM BIODIVERS, V5, P2140, DOI 10.1002/cbdv.200890195; Hartinger CG, 2006, J INORG BIOCHEM, V100, P891, DOI 10.1016/j.jinorgbio.2006.02.013; Heffeter P, 2005, J PHARMACOL EXP THER, V312, P281, DOI 10.1124/jpet.104.073395; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Jaehnig EJ, 2013, CELL REP, V4, P174, DOI 10.1016/j.celrep.2013.05.041; Kapitza S, 2005, CANCER LETT, V226, P115, DOI 10.1016/j.canlet.2005.01.002; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kimura Akiko, 2006, Journal of Toxicological Sciences, V31, P287, DOI 10.2131/jts.31.287; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Klinkenberg LG, 2006, EUKARYOT CELL, V5, P1007, DOI 10.1128/EC.00045-06; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Lentz F, 2009, ANTI-CANCER DRUG, V20, P97, DOI 10.1097/CAD.0b013e328322fbc5; LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096; Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759; Malina J, 2001, J BIOL INORG CHEM, V6, P435, DOI 10.1007/s007750100223; Mialhe A, 2001, CANCER RES, V61, P5024; Moore JK, 2009, CELL MOTIL CYTOSKEL, V66, P546, DOI 10.1002/cm.20364; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.e03-03-0180; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Schluga P, 2006, DALTON T, P1796, DOI 10.1039/b511792e; Schumacher DM, 2006, TOXICOL LETT, V166, P268, DOI 10.1016/j.toxlet.2006.08.002; SEELIG MH, 1992, J CANCER RES CLIN, V118, P195, DOI 10.1007/BF01410134; Sertic S, 2012, CELL CYCLE, V11, P668, DOI 10.4161/cc.11.4.19117; Singh V, 2014, EUR J PHARMACOL, V736, P77, DOI 10.1016/j.ejphar.2014.04.032; Singh V, 2014, FEBS LETT, V588, P1044, DOI 10.1016/j.febslet.2014.02.017; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Soulier J, 1999, CURR BIOL, V9, P551, DOI 10.1016/S0960-9822(99)80242-5; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stevens SK, 2013, MOL PHARMACOL, V83, P225, DOI 10.1124/mol.112.079657; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; SUSEK RE, 1990, MOL CELL BIOL, V10, P6362, DOI 10.1128/MCB.10.12.6362; Suzuki M, 2004, NAT CELL BIOL, V6, P861, DOI 10.1038/ncb1162; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Toh GWL, 2003, BIOCHEM SOC T, V31, P242, DOI 10.1042/bst0310242; van den Bosch M, 2004, CELL CYCLE, V3, P119; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Wang YC, 2003, CELL, V112, P697, DOI 10.1016/S0092-8674(03)00121-1; Warringer J, 2006, YEAST, V23, P389, DOI 10.1002/yea.1363; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949	88	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138085	10.1371/journal.pone.0138085	http://dx.doi.org/10.1371/journal.pone.0138085			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375390	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200075
J	Bordehore, C; Fuentes, VL; Segarra, JG; Acevedo, M; Canepa, A; Raventos, J				Bordehore, Cesar; Fuentes, Veronica L.; Segarra, Jose G.; Acevedo, Melisa; Canepa, Antonio; Raventos, Josep			Use of an Inverse Method for Time Series to Estimate the Dynamics of and Management Strategies for the Box Jellyfish Carybdea marsupialis	PLOS ONE			English	Article							POPULATION-DYNAMICS; PARTIAL-PURIFICATION; CNIDARIA; CUBOZOA; GROWTH; AGE	Frequently, population ecology of marine organisms uses a descriptive approach in which their sizes and densities are plotted over time. This approach has limited usefulness for design strategies in management or modelling different scenarios. Population projection matrix models are among the most widely used tools in ecology. Unfortunately, for the majority of pelagic marine organisms, it is difficult to mark individuals and follow them over time to determine their vital rates and built a population projection matrix model. Nevertheless, it is possible to get time-series data to calculate size structure and densities of each size, in order to determine the matrix parameters. This approach is known as a "demographic inverse problem" and it is based on quadratic programming methods, but it has rarely been used on aquatic organisms. We used unpublished field data of a population of cubomedusae Carybdea marsupialis to construct a population projection matrix model and compare two different management strategies to lower population to values before year 2008 when there was no significant interaction with bathers. Those strategies were by direct removal of medusae and by reducing prey. Our results showed that removal of jellyfish from all size classes was more effective than removing only juveniles or adults. When reducing prey, the highest efficiency to lower the C. marsupialis population occurred when prey depletion affected prey of all medusae sizes. Our model fit well with the field data and may serve to design an efficient management strategy or build hypothetical scenarios such as removal of individuals or reducing prey. TThis This sdfsdshis method is applicable to other marine or terrestrial species, for which density and population structure over time are available.	[Bordehore, Cesar; Segarra, Jose G.; Raventos, Josep] Univ Alicante, Dept Ecol, E-03080 Alicante, Spain; [Bordehore, Cesar; Segarra, Jose G.; Raventos, Josep] Univ Alicante, Multidisciplinary Inst Environm Studies Ramon Mar, E-03080 Alicante, Spain; [Fuentes, Veronica L.; Acevedo, Melisa; Canepa, Antonio] CSIC, Inst Marine Sci, Barcelona, Spain	Universitat d'Alacant; Universitat d'Alacant; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Bordehore, C (corresponding author), Univ Alicante, Dept Ecol, E-03080 Alicante, Spain.	cesar.bordehore@ua.es	Fuentes, Verónica L/K-7589-2014; Bordehore, Cesar/H-2773-2014; Canepa, Antonio/R-5260-2018	Fuentes, Verónica L/0000-0002-6380-0174; Bordehore, Cesar/0000-0002-2816-0538; Canepa, Antonio/0000-0002-0608-2743	European Commission [LIFE 08 NAT ES 0064]; Ministerio de Agricultura, Alimentacion y Medio Ambiente; Direccion General del Agua of the Regional Government of Valencia; Fundacion Biodiversidad; Spanish Ministry of Education and Science; FEDER program [CGL2012-31668]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Agricultura, Alimentacion y Medio Ambiente; Direccion General del Agua of the Regional Government of Valencia; Fundacion Biodiversidad(European Commission); Spanish Ministry of Education and Science(Spanish Government); FEDER program(European Commission)	This research was carried out under contract LIFE 08 NAT ES 0064 (to CB and VLF) co-financed by the European Commission (www.cubomed.eu), the Ministerio de Agricultura, Alimentacion y Medio Ambiente, the Direccion General del Agua of the Regional Government of Valencia and the Fundacion Biodiversidad. This work was also partially supported by Spanish Ministry of Education and Science co-funded by FEDER program (CGL2012-31668) to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MJ, 2012, INT S MAR SCI ISMS; Ballesteros BJ, 2007, DETERMINACION RELACI, P241; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; Boero F., 1986, Bollettino del Museo Civico di Storia Naturale di Venezia, V35, P179; Boero F, 2013, FAO FISHERIES REPORT, V92, P64; Bordehore C, 2011, MAR BIODIVERS REC, V4, P1, DOI [10.1017/S1755267211000650, DOI 10.1017/S1755267211000650]; Bordehore C, 2015, J TRAVEL MED, V22, P61, DOI 10.1111/jtm.12153; Brinkman D, 2008, TOXICON, V51, P853, DOI 10.1016/j.toxicon.2007.12.017; Brinkman DL, 2009, TOXICON, V54, P1162, DOI 10.1016/j.toxicon.2009.02.006; Cantoral-Uiza EA, 2001, LIMNETICA, V20, P159; Carrette T, 2002, TOXICON, V40, P1547, DOI 10.1016/S0041-0101(02)00168-X; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed., P713; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; Erwin S, 2013, J PLANT ECOL, V6, P150, DOI 10.1093/jpe/rts024; Gershwin LA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1168; Gordon M, 2004, HYDROBIOLOGIA, V530, P339, DOI 10.1007/s10750-004-2655-7; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Kingsford MJ, 2012, HYDROBIOLOGIA, V690, P257, DOI 10.1007/s10750-012-1041-0; KOKELJ F, 1992, CONTACT DERMATITIS, V27, P195, DOI 10.1111/j.1600-0536.1992.tb05259.x; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lewis C, 2005, MAR BIOL, V147, P477, DOI 10.1007/s00227-005-1602-0; Lippmann JM, 2011, J TRAVEL MED, V18, P275, DOI 10.1111/j.1708-8305.2011.00531.x; MALEJ A, 1992, OLSEN INT S, P215; Mayo Rios RJ, 2010, OPTIMIZACION ESTACIO, P141; Milla L, 2008, DERMARTOLOGIA REV ME, V44, P167; MOLLER H, 1984, SCIENCE, V224, P621, DOI 10.1126/science.224.4649.621; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Nogueira M, 2008, BRAZ J OCEANOGR, V56, P157, DOI 10.1590/S1679-87592008000300001; Ortiz-Perez S, 2005, ESTUDIO ALTERNATIVO, P48; Palomares MLD, 2009, HYDROBIOLOGIA, V616, P11, DOI 10.1007/s10750-008-9582-y; Perez-Ruzafa A, 2002, HYDROBIOLOGIA, V475, P359, DOI 10.1023/A:1020343510060; Philippart CJM, 2007, ECOSYSTEMS, V10, P95, DOI 10.1007/s10021-006-9006-7; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Sanchez-Rodriguez J, 2006, ARCH TOXICOL, V80, P163, DOI 10.1007/s00204-005-0023-7; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Studebaker JP, 1972, THESIS, P86; Tibballs J, 2006, TOXICON, V48, P830, DOI 10.1016/j.toxicon.2006.07.020; Verity PG, 2002, ENVIRON CONSERV, V29, P207, DOI 10.1017/S0376892902000139; Willcox S, 2008, MAR BIOL, V154, P661, DOI 10.1007/s00227-008-0959-2; Wood S.N., 1997, Population and Community Biology Series, V18, P555	42	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137272	10.1371/journal.pone.0137272	http://dx.doi.org/10.1371/journal.pone.0137272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376483	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200033
J	Grigoriev, P; Andreev, EM				Grigoriev, Pavel; Andreev, Evgeny M.			The Huge Reduction in Adult Male Mortality in Belarus and Russia: Is It Attributable to Anti-Alcohol Measures?	PLOS ONE			English	Article							NATIONAL ALCOHOL POLICY; TIME-SERIES ANALYSIS; PREMATURE MORTALITY; EASTERN-EUROPE; HEART-DISEASE; CONSUMPTION; DRINKING; TRENDS; CRISIS; HEAVY	Background and Aim Harmful alcohol consumption has long been recognized as being the major determinant of male premature mortality in the European countries of the former USSR. Our focus here is on Belarus and Russia, two Slavic countries which continue to suffer enormously from the burden of the harmful consumption of alcohol. However, after a long period of deterioration, mortality trends in these countries have been improving over the past decade. We aim to investigate to what extent the recent declines in adult mortality in Belarus and Russia are attributable to the anti-alcohol measures introduced in these two countries in the 2000s. Data and Methods We rely on the detailed cause-specific mortality series for the period 1980-2013. Our analysis focuses on the male population, and considers only a limited number of causes of death which we label as being alcohol-related: accidental poisoning by alcohol, liver cirrhosis, ischemic heart diseases, stroke, transportation accidents, and other external causes. For each of these causes we computed age-standardized death rates. The life table decomposition method was used to determine the age groups and the causes of death responsible for changes in life expectancy over time. Conclusion Our results do not lead us to conclude that the schedule of anti-alcohol measures corresponds to the schedule of mortality changes. The continuous reduction in adult male mortality seen in Belarus and Russia cannot be fully explained by the anti-alcohol policies implemented in these countries, although these policies likely contributed to the large mortality reductions observed in Belarus and Russia in 2005-2006 and in Belarus in 2012. Thus, the effects of these policies appear to have been modest. We argue that the antialcohol measures implemented in Belarus and Russia simply coincided with fluctuations in alcohol-related mortality which originated in the past. If these trends had not been underway already, these huge mortality effects would not have occurred.	[Grigoriev, Pavel] Max Planck Inst Demog Res, Rostock, Germany; [Andreev, Evgeny M.] New Econ Sch, Moscow, Russia	Max Planck Society; New Economic School	Grigoriev, P (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	Grigoriev@demogr.mpg.de			'From disparities in mortality trends to future health challenges' (DIMOCHA) - 'Deutsche Forschungsgemeinschaft' (DFG); research grant 'Mortality Divergence and Causes of Death' (MODICOD) - AXA Research Fund; Fund 'Dynasty'	'From disparities in mortality trends to future health challenges' (DIMOCHA) - 'Deutsche Forschungsgemeinschaft' (DFG)(German Research Foundation (DFG)); research grant 'Mortality Divergence and Causes of Death' (MODICOD) - AXA Research Fund; Fund 'Dynasty'	PG was partially supported by research grant 'From disparities in mortality trends to future health challenges' (DIMOCHA) funded by 'Deutsche Forschungsgemeinschaft' (DFG) http://gepris.dfg.de/gepris/projekt/228989852?language = en and research grant 'Mortality Divergence and Causes of Death' (MODICOD) funded by AXA Research Fund http://www.axa-research.org/project/france-mesle. EMA was partially supported by the Fund 'Dynasty' http://www.dynastyfdn.com/programs/education/demographic_research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev E, 2013, ALCOHOL ALCOHOLISM, V48, P215, DOI 10.1093/alcalc/ags132; Avdeev A, 1998, Popul, V10, P267; BLUM A, 1989, POP STUD-J DEMOG, V43, P211, DOI 10.1080/0032472031000144096; Brainerd E, 2005, J ECON PERSPECT, V19, P107, DOI 10.1257/0895330053147921; Cornia GA., 2000, MORTALITY CRISIS TRA, P3; Eberstadt Nicholas, 1981, INT J EPIDEMIOL, V35, P1384; Grigoriev P, 2015, EUR J PUBLIC HLTH; Grigoriev P, 2012, THESIS U ROSTOCK GER; Grigoriev P, 2012, WP2012023 M PLANCK I; Grigoriev P, 2014, POPUL DEV REV, V40, P107, DOI 10.1111/j.1728-4457.2014.00652.x; Grigoriev P, 2012, POPULATION, V67, P7; Humphreys DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055581; Khalturina DA, 2006, DEMOSKOP WKLY, V5, P265; Korotaev A, 2015, MNOGO VODKI MNOGO SM; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Leon DA, 2010, INT J EPIDEMIOL, V39, P1279, DOI 10.1093/ije/dyq102; Levintova M, 2007, ALCOHOL ALCOHOLISM, V42, P500, DOI 10.1093/alcalc/agm040; Lozano R, 2001, MISCODING MISCLASSIF; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; McDowall D., 1980, INTERRUPTED TIME SER; McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802; MESLE F, 1992, EUR J POPUL, V8, P281, DOI 10.1007/BF01796624; Nemtsov A., 2010, PREVRATNOSTI PODSCHE; Nemtsov A.V., 2013, DEMOSKOP WKLY, P567; Nemtsov A. V., 2011, CONT HIST ALCOHOL RU; Nemtsov AV, 2015, PRAVOYYE ASPEKTY NAR, V1, P83; Neufeld M, 2013, ALCOHOL ALCOHOLISM, V48, P222, DOI 10.1093/alcalc/ags134; Pridemore WA, 2002, AM J PUBLIC HEALTH, V92, P1921, DOI 10.2105/AJPH.92.12.1921; Pridemore WA, 2006, ALCOHOL CLIN EXP RES, V2014, P257; Pridemore WA, 2013, ADDICTION, V108, P2112, DOI 10.1111/add.12311; Pridemore WA, 2013, AM J PUBLIC HEALTH, V103, P2021, DOI 10.2105/AJPH.2013.301405; Pridemore WA, 2009, AM J PUBLIC HEALTH, V99, P915, DOI 10.2105/AJPH.2008.146183; Radisauskas R, 2011, ALCOHOL ALCOHOLISM, V46, P614, DOI 10.1093/alcalc/agr068; Razvodovsky YE, 2011, VOPROSY ORGANIZATSII, V3, P38; Razvodovsky YE, 2014, J ALCOHOL DRUG DEPEN, V2, P152, DOI [10.4172/2329-6488.1000152, DOI 10.4172/2329-6488.1000152]; Razvodovsky YE, 2003, ALCOHOL MORTALITY CR; Razvodovsky YE, 2009, ADICCIONES, V21, P229, DOI 10.20882/adicciones.233; Rehm J, 2007, INT J EPIDEMIOL, V36, P458, DOI 10.1093/ije/dyl294; Rehn J, 2006, ADDICTION, V101, P1086, DOI 10.1111/j.1360-0443.2006.01491.x; Rossii Naseleniye, 2011, SEMNADTSATYY YEZHEGO, P241; Russian Federation State Statistics Service (Rosstat), 2014, DEM  YB RUSS STAT YB; Shkolnikov VM, 2013, DEMOGR RES, V28, P917, DOI 10.4054/DemRes.2013.28.32; Shkolnikov VM, 2004, HYGIEA INT, V4, P29, DOI DOI 10.3384/HYGIEA.1403-8668.044129; Shkolnikov VM., 1997, PREMATURE DEATH NEW, P120; SKOG OJ, 1985, BRIT J ADDICT, V80, P83; Stickley A, 2007, EUR J PUBLIC HEALTH, P1; Tomkins S, 2007, ADDICTION, V102, P544, DOI 10.1111/j.1360-0443.2006.01693.x; Vishnevski AG, 2002, DEVYATYY YEZHEGODNYY, P70; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; Waterhouse JAH, 1976, CANC INCIDENCE 5 CON, VIII, P454; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160	54	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138021	10.1371/journal.pone.0138021	http://dx.doi.org/10.1371/journal.pone.0138021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26376439	gold, Green Published			2022-12-26	WOS:000361610200071
J	Plotka, M; Kaczorowska, AK; Morzywolek, A; Makowska, J; Kozlowski, LP; Thorisdottir, A; Skirnisdottir, S; Hjorleifsdottir, S; Fridjonsson, OH; Hreggvidsson, GO; Kristjansson, JK; Dabrowski, S; Bujnicki, JM; Kaczorowski, T				Plotka, Magdalena; Kaczorowska, Anna-Karina; Morzywolek, Agnieszka; Makowska, Joanna; Kozlowski, Lukasz P.; Thorisdottir, Audur; Skirnisdottir, Sigurlaug; Hjorleifsdottir, Sigridur; Fridjonsson, Olafur H.; Hreggvidsson, Gudmundur O.; Kristjansson, Jakob K.; Dabrowski, Slawomir; Bujnicki, Janusz M.; Kaczorowski, Tadeusz			Biochemical Characterization and Validation of a Catalytic Site of a Highly Thermostable Ts2631 Endolysin from the Thermus scotoductus Phage vB_Tsc2631	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEINS; BACTERIOPHAGE ENDOLYSINS; CRYSTAL-STRUCTURE; IDENTIFICATION; LYSOZYME; STABILITY; VIRUSES	Phage vB_Tsc2631 infects the extremophilic bacterium Thermus scotoductus MAT2631 and uses the Ts2631 endolysin for the release of its progeny. The Ts2631 endolysin is the first endolysin from thermophilic bacteriophage with an experimentally validated catalytic site. In silico analysis and computational modelling of the Ts2631 endolysin structure revealed a conserved Zn2+ binding site (His(30), Tyr(58), His(131) and Cys(139)) similar to Zn2+ binding site of eukaryotic peptidoglycan recognition proteins (PGRPs). We have shown that the Ts2631 endolysin lytic activity is dependent on divalent metal ions (Zn2+ and Ca2+). The Ts2631 endolysin substitution variants H30N, Y58F, H131N and C139S dramatically lost their antimicrobial activity, providing evidence for the role of the aforementioned residues in the lytic activity of the enzyme. The enzyme has proven to be not only thermoresistant, retaining 64.8% of its initial activity after 2 h at 95 degrees C, but also highly thermodynamically stable (T-m = 99.82 degrees C, Delta Hcal = 4.58 x 10(4) cal mol(-1)). Substitutions of histidine residues (H30N and H131N) and a cysteine residue (C139S) resulted in variants aggregating at temperatures >= 75 degrees C, indicating a significant role of these residues in enzyme thermostability. The substrate spectrum of the Ts2631 endolysin included extremophiles of the genus Thermus but also Gram-negative mesophiles, such as Escherichia coli, Salmonella panama, Pseudomonas fluorescens and Serratia marcescens. The broad substrate spectrum and high thermostability of this endolysin makes it a good candidate for use as an antimicrobial agent to combat Gram-negative pathogens.	[Plotka, Magdalena; Morzywolek, Agnieszka; Kaczorowski, Tadeusz] Univ Gdansk, Dept Microbiol, PL-80952 Gdansk, Poland; [Kaczorowska, Anna-Karina] Univ Gdansk, Collect Plasmids & Microorganisms, PL-80952 Gdansk, Poland; [Makowska, Joanna] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Kozlowski, Lukasz P.; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, Warsaw, Poland; [Thorisdottir, Audur] VESO Vikan, Namsos, Norway; [Skirnisdottir, Sigurlaug; Fridjonsson, Olafur H.; Hreggvidsson, Gudmundur O.] Matis, Reykjavik, Iceland; [Hjorleifsdottir, Sigridur] ORF Genet, Kopavogur, Iceland; [Hreggvidsson, Gudmundur O.] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland; [Kristjansson, Jakob K.] Prokazyme Ehf, Reykjavik, Iceland; [Dabrowski, Slawomir] A&A Biotechnol, Gdynia, Poland; [Bujnicki, Janusz M.] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Lab Bioinformat, Fac Biol, Poznan, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Iceland; Adam Mickiewicz University	Kaczorowski, T (corresponding author), Univ Gdansk, Dept Microbiol, PL-80952 Gdansk, Poland.	tadeusz.kaczorowski@biol.ug.edu.pl	Kozlowski, Lukasz P./E-1765-2013; Kaczorowski, Tadeusz/AAX-2027-2020; Plotka, Magdalena/AAY-3997-2020	Kozlowski, Lukasz P./0000-0001-8187-1980; Makowska, Joanna/0000-0002-5283-159X; Plotka, Magdalena/0000-0002-2871-8060; Hreggvidsson, Gudmundur Oli/0000-0002-4958-1673; Kaczorowska, Anna-Karina/0000-0002-6598-8449	European Union [286556]; VESO Vikan; ORF Genetics; Prokazyme ehf; AA Biotechnology	European Union(European Commission); VESO Vikan; ORF Genetics; Prokazyme ehf; AA Biotechnology	The work described in the manuscript was supported by funding from the European Union's Seventh Framework Programme managed by REA, Research Executive Agency ([FP7/2007-2013] [FP7/2007-2011]) under grant agreement no 286556 to the EXGENOME project (Exgenome Molecular Enzymes). Audur Thorisdottir is employed by VESO Vikan, Namsos, Norway. Sigridur Hjorleifsdottir is employed by ORF Genetics, Kopavogur, Iceland. Jakob K. Kristjansson is employed by Prokazyme ehf, Reykjavik, Iceland. Slawomir Dabrowski is employed by A&A Biotechnology, Gdynia, Poland. VESO Vikan, ORF Genetics, Prokazyme ehf and A&A Biotechnology provided support in the form of salaries for authors AT, SH, JKK and SD respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen HK, 2014, ANN NY ACAD SCI, V1323, P91, DOI 10.1111/nyas.12468; Altschul S.F., 1997, NUCLEIC ACIDS RES, V25, P3389, DOI DOI 10.1093/NAR/25.17; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briers Y, 2006, CELL MOL LIFE SCI, V63, P1899, DOI 10.1007/s00018-006-6183-7; Briers Y, 2015, FUTURE MICROBIOL, V10, P377, DOI [10.2217/FMB.15.8, 10.2217/fmb.15.8]; Bustamante N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046654; CHENG XD, 1994, P NATL ACAD SCI USA, V91, P4034, DOI 10.1073/pnas.91.9.4034; Chowdhury T, 2015, J BIOL INORG CHEM; Claperon M, 2008, BIOCHEM J, V416, P37, DOI 10.1042/BJ20080471; Dalton JAR, 2010, J MOL BIOL, V399, P645, DOI 10.1016/j.jmb.2010.04.047; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Dzwolak W, 2004, PHYS CHEM CHEM PHYS, V6, P1938, DOI 10.1039/b314086e; Farmer RS, 2005, BIOMACROMOLECULES, V6, P1531, DOI 10.1021/bm049216+; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hjorleifsdottir S, 2001, MICROBIAL ECOL, V42, P117; HOLMQUIST B, 1974, J BIOL CHEM, V249, P4601; Jalasvuori M, 2009, J VIROL, V83, P9388, DOI 10.1128/JVI.00869-09; KIDOKORO S, 1987, BIOPOLYMERS, V26, P213, DOI 10.1002/bip.360260205; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lavigne R, 2004, CELL MOL LIFE SCI, V61, P2753, DOI 10.1007/s00018-004-4301-y; Linden SB, 2015, APPL MICROBIOL BIOT, V99, P741, DOI 10.1007/s00253-014-5930-1; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Matsushita I, 2008, BIOCHEM BIOPH RES CO, V377, P89, DOI 10.1016/j.bbrc.2008.09.101; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Nelson DC, 2012, ADV VIRUS RES, V83, P299, DOI 10.1016/B978-0-12-394438-2.00007-4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oliveira H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108376; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; Plotka M, 2014, APPL ENVIRON MICROB, V80, P886, DOI 10.1128/AEM.03074-13; Plotnikov V, 2002, ASSAY DRUG DEV TECHN, V1, P83, DOI 10.1089/154065802761001338; Reiser JB, 2004, J MOL BIOL, V340, P909, DOI 10.1016/j.jmb.2004.04.077; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANZ JM, 1993, J BIOL CHEM, V268, P6125; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/fmb.12.97, 10.2217/FMB.12.97]; Schmelcher M, 2012, APPL MICROBIOL BIOT, V93, P633, DOI 10.1007/s00253-011-3372-6; Stefanska A, 2014, J BIOTECHNOL, V182, P1, DOI 10.1016/j.jbiotec.2014.04.015; Sulakvelidze A, 2013, J SCI FOOD AGR, V93, P3137, DOI 10.1002/jsfa.6222; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yoong P, 2004, J BACTERIOL, V186, P4808, DOI 10.1128/JB.186.14.4808-4812.2004	52	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137374	10.1371/journal.pone.0137374	http://dx.doi.org/10.1371/journal.pone.0137374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375388	gold, Green Submitted, Green Published			2022-12-26	WOS:000361610200036
J	Ribeiro, AP; Joao, SMA; Dinato, RC; Tessutti, VD; Sacco, ICN				Ribeiro, Ana Paula; Amado Joao, Silvia Maria; Dinato, Roberto Casanova; Tessutti, Vitor Daniel; Neves Sacco, Isabel Camargo			Dynamic Patterns of Forces and Loading Rate in Runners with Unilateral Plantar Fasciitis: A Cross-Sectional Study	PLOS ONE			English	Article							FOOT; THICKNESS; INJURIES; SYMPTOMS; PAIN	Aim/Hypothesis The etiology of plantar fasciitis (PF) has been related to several risk factors, but the magnitude of the plantar load is the most commonly described factor. Although PF is the third most-common injury in runners, only two studies have investigated this factor in runners, and their results are still inconclusive regarding the injury stage. Objective Analyze and compare the plantar loads and vertical loading rate during running of runners in the acute stage of PF to those in the chronic stage of the injury in relation to healthy runners. Methods Forty-five runners with unilateral PF (30 acute and 15 chronic) and 30 healthy control runners were evaluated while running at 12 km/h for 40 meters wearing standardized running shoes and Pedar-X insoles. The contact area and time, maximum force, and force-time integral over the rearfoot, midfoot, and forefoot were recorded and the loading rate (20-80% of the first vertical peak) was calculated. Groups were compared by ANOVAs (p<0.05). Results Maximum force and force-time integral over the rearfoot and the loading rate was higher in runners with PF (acute and chronic) compared with controls (p<0.01). Runners with PF in the acute stage showed lower loading rate and maximum force over the rearfoot compared to runners in the chronic stage (p<0.01). Conclusion Runners with PF showed different dynamic patterns of plantar loads during running over the rearfoot area depending on the injury stage (acute or chronic). In the acute stage of PF, runners presented lower loading rate and forces over the rearfoot, possibly due to dynamic mechanisms related to pain protection of the calcaneal area.	[Ribeiro, Ana Paula; Amado Joao, Silvia Maria; Dinato, Roberto Casanova; Tessutti, Vitor Daniel; Neves Sacco, Isabel Camargo] Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, Brazil; [Ribeiro, Ana Paula] Univ Santo Amaro, Phys Therapy Dept, Sch Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Santo Amaro (UNISA)	Ribeiro, AP (corresponding author), Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, Brazil.	apribeiro@usp.br	Ribeiro, Ana Paula/J-6368-2013; Sacco, Isabel/D-7172-2011; Sacco, Isabel/T-2630-2019; João, Sílvia/G-2202-2012	Ribeiro, Ana Paula/0000-0002-1061-3789; Sacco, Isabel/0000-0003-1254-0007; Sacco, Isabel/0000-0003-1254-0007; João, Sílvia/0000-0002-7999-6589	The Agency Coordination of Improvement of Higher Education Personnel (CAPES) [2011/03069-6]; Sao Paulo State Research Foundation (FAPESP) [2010/14044-1]	The Agency Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The Agency Coordination of Improvement of Higher Education Personnel (CAPES) provided support for Ana Paula Ribeiro's scholarship (2011/03069-6) and Sao Paulo State Research Foundation (FAPESP) provided support for Roberto C. Dinato's scholarship (2010/14044-1).	Akfirat M, CLIN IMAGING, V353-7, P353; [Anonymous], 2006, J FAM PRACTICE, V55, P844; Bedi HS, 1998, FOOT ANKLE INT, V19, P153, DOI 10.1177/107110079801900307; CHANDLER TJ, 1993, SPORTS MED, V15, P344, DOI 10.2165/00007256-199315050-00006; Chang R, 2012, CLIN BIOMECH, V27, P500, DOI 10.1016/j.clinbiomech.2011.11.007; Cornwall MW, 1999, J ORTHOP SPORT PHYS, V29, P756, DOI 10.2519/jospt.1999.29.12.756; Crowell HP, 2010, J ORTHOP SPORT PHYS, V40, P206, DOI 10.2519/jospt.2010.3166; Fong DTP, 2012, CLIN BIOMECH, V27, P1072, DOI 10.1016/j.clinbiomech.2012.08.003; Giddings VL, 2000, MED SCI SPORT EXER, V32, P627, DOI 10.1097/00005768-200003000-00012; Grasel RP, 1999, AM J ROENTGENOL, V173, P699, DOI 10.2214/ajr.173.3.10470906; Hong YL, 2012, J SCI MED SPORT, V15, P554, DOI 10.1016/j.jsams.2012.01.004; KIBLER WB, 1991, AM J SPORT MED, V19, P66, DOI 10.1177/036354659101900111; Klein SE, 2012, FOOT ANKLE INT, V33, P693, DOI 10.3113/FAI.2012.0693; Lemont H, 2003, J AM PODIAT MED ASSN, V93, P234, DOI 10.7547/87507315-93-3-234; Lopes AD, 2012, SPORTS MED, V42, P891, DOI [10.2165/11631170-000000000-00000, 10.1007/BF03262301]; Mahowald S, 2011, J AM PODIAT MED ASSN, V101, P385, DOI 10.7547/1010385; Pohl MB, 2009, CLIN J SPORT MED, V19, P372, DOI 10.1097/JSM.0b013e3181b8c270; PRICHASUK S, 1994, CLIN ORTHOP RELAT R, P192; Ribeiro AP, 2011, CLINICS, V66, P1027, DOI 10.1590/S1807-59322011000600018; Ribeiro AP, 2011, CLIN BIOMECH, V26, P194, DOI 10.1016/j.clinbiomech.2010.08.004; Rome K, 2002, FOOT ANKLE INT, V23, P142, DOI 10.1177/107110070202300211; Rome K., 2001, FOOT, V11, P119, DOI 10.1054/foot.2001.0698; Sahin N, 2010, ACTA ORTHOP TRAUMATO, V44, P385, DOI 10.3944/AOTT.2010.2348; SCHEPSIS AA, 1991, CLIN ORTHOP RELAT R, P185; Taunton JE, 2002, PHYS THER SPORT, V3, P57, DOI 10.1054/ptsp.2001.0082; Tessutti V, 2012, J SPORT SCI, V30, P1545, DOI 10.1080/02640414.2012.713975; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Van Middelkoop M, 2008, SCAND J MED SCI SPOR, V18, P691, DOI 10.1111/j.1600-0838.2007.00768.x; VIEL E, 1989, Physiotherapy Practice, V5, P69; WARREN BL, 1990, SPORTS MED, V10, P338, DOI 10.2165/00007256-199010050-00004; WARREN BL, 1984, MED SCI SPORT EXER, V16, P60; Wearing SC, 2003, CLIN ORTHOP RELAT R, P175, DOI 10.1097/01.blo.0000057989.41099.d8; Wearing SC, 2007, PHYS THER, V87, P1002, DOI 10.2522/ptj.20060136; Wearing SC, 2006, SPORTS MED, V36, P585, DOI 10.2165/00007256-200636070-00004; Whittle MW, 1999, GAIT POSTURE, V10, P264, DOI 10.1016/S0966-6362(99)00041-7	35	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136971	10.1371/journal.pone.0136971	http://dx.doi.org/10.1371/journal.pone.0136971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375815	Green Submitted, gold, Green Published			2022-12-26	WOS:000361610200027
J	Martins, MVA; Zaaboub, N; Aleya, L; Frontalini, F; Pereira, E; Miranda, P; Mane, M; Rocha, F; Laut, L; El Bour, M				Martins, Maria Virginia Alves; Zaaboub, Noureddine; Aleya, Lotfi; Frontalini, Fabrizio; Pereira, Egberto; Miranda, Paulo; Mane, Miguel; Rocha, Fernando; Laut, Lazaro; El Bour, Monia			Environmental Quality Assessment of Bizerte Lagoon (Tunisia) Using Living Foraminifera Assemblages and a Multiproxy Approach	PLOS ONE			English	Article							ACID-VOLATILE SULFIDE; SIMULTANEOUSLY EXTRACTED METALS; PEARL RIVER ESTUARY; BENTHIC FORAMINIFERA; AVEIRO PORTUGAL; BIOGEOCHEMICAL INDICATORS; CONTAMINATED AREA; SURFACE SEDIMENTS; HEAVY-METALS; SEM-AVS	This study investigated the environmental quality of the Bizerte Lagoon (Tunisia) through an integrated approach that combined environmental, biogeochemical, and living benthic foraminiferal analyses. Specifically, we analyzed the physicochemical parameters of the water and sediment. The textural, mineralogical, and geochemical characteristics of the sediment, including total organic carbon, total nitrogen, simultaneously extracted metals (SEM), acid volatile sulfides (AVS), chlorophyll a, CaCO3, and changes in bacterial populations and carbon isotopes were measured. The SEM/AVS values indicated the presence of relatively high concentrations of toxic metals in only some areas. Foraminiferal assemblages were dominated by species such as A. parkinsoniana (20-91%), Bolivina striatula (<40%), Hopkinsina atlantica (<17%), and Bolivina ordinaria (<15%) that cannot be considered typical of impacted coastal lagoons both in Mediterranean and northeast Atlantic regions. The results of this work suggest that Bizerte Lagoon is a unique setting. This lagoon is populated by typical marine species that invaded this ecosystem, attracted not only by the prevailing favorable environmental conditions but also by the abundance and quality of food. The results indicate that the metal pollution found in some areas have a negative impact on the assemblages of foraminifera. At present, however, this negative impact is not highly alarming.	[Martins, Maria Virginia Alves; Pereira, Egberto; Mane, Miguel] Univ Estado Rio de Janeiro, Fac Geol, BR-20550013 Rio De Janeiro, RJ, Brazil; [Martins, Maria Virginia Alves] Univ Estado Amazonas, BR-69050010 Manaus, Amazonas, Brazil; [Martins, Maria Virginia Alves; Miranda, Paulo; Rocha, Fernando] Univ Aveiro, Dept Geociencias, P-3810193 Aveiro, Portugal; [Zaaboub, Noureddine; El Bour, Monia] Inst Natl Sci & Technol Mer, Salammbo 19342025, Tunisia; [Aleya, Lotfi] Univ Bourgogne Franche Comte, Lab Chrono Environm, CNRS, UMR 6249, F-25030 Besancon, France; [Frontalini, Fabrizio] Univ Urbino Carlo Bo, Dipartimento Sci Terra Vita & Ambiente, I-61029 Urbino, Italy; [Laut, Lazaro] Univ Fed Estado Rio de Janeiro UNIRIO, Lab Micropaleontol LabMicro, BR-22290240 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Amazonas; Universidade de Aveiro; Institut National des Sciences et Technologies de la Mer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; University of Urbino; Universidade Federal do Estado do Rio de Janeiro	Martins, MVA (corresponding author), Univ Estado Rio de Janeiro, Fac Geol, Ave Sao Francisco Xavier 524, BR-20550013 Rio De Janeiro, RJ, Brazil.	virginia.martins@ua.pt	Laut, Lazaro L.M./K-4782-2012; Mane, Miguel Angelo/AAE-2986-2021; Martins, Maria Virginia Alves/O-2893-2013; Frontalini, Fabrizio/C-4819-2008; Laut, Lazaro/O-4193-2019; Rocha, Fernando/A-4532-2009; Alves Martins, Maria Virginia/AAD-3531-2021	Laut, Lazaro L.M./0000-0002-5637-1930; Martins, Maria Virginia Alves/0000-0001-8348-8862; Frontalini, Fabrizio/0000-0002-0425-9306; Laut, Lazaro/0000-0002-5637-1930; Rocha, Fernando/0000-0002-3636-3933; Alves Martins, Maria Virginia/0000-0001-8348-8862	projects Bilateral of Cooperation Tunisian Portuguese [48/TP/09, PEst-OE/CTE/UI4035/2014]; PROTEC Program of Universidade do Estado do Rio de Janeiro-UERJ; Universidade do Amazonas - UEA	projects Bilateral of Cooperation Tunisian Portuguese; PROTEC Program of Universidade do Estado do Rio de Janeiro-UERJ; Universidade do Amazonas - UEA	This work was partially supported by the projects Bilateral of Cooperation Tunisian Portuguese 48/TP/09 and PEst-OE/CTE/UI4035/2014 and by the fellowship from the PROTEC Program of Universidade do Estado do Rio de Janeiro-UERJ and Universidade do Amazonas - UEA.	Abreu SN, 2000, MAR POLLUT BULL, V40, P293, DOI 10.1016/S0025-326X(99)00187-3; Afli A, 2008, ESTUAR COAST SHELF S, V80, P269, DOI 10.1016/j.ecss.2008.08.010; Allen HE, 1991, EPA821R91100 USEPA O; Alve E, 1999, J FORAMIN RES, V29, P186; Martins MVA, 2015, MAR ENVIRON RES, V109, P52, DOI 10.1016/j.marenvres.2015.06.006; Martins MVA, 2015, ENVIRON SCI POLLUT R, V22, P10019, DOI 10.1007/s11356-015-4185-4; Martins MVA, 2014, ENVIRON MONIT ASSESS, V186, P8875, DOI 10.1007/s10661-014-4052-7; Martins MVA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118077; Amend JP, 2004, 379 SP GEOL SOC AM, V379; Ankley GT, 1996, ENVIRON TOXICOL CHEM, V15, P2056, DOI 10.1002/etc.5620151202; Bejaoui B, 2008, ESTUAR COAST SHELF S, V80, P121, DOI 10.1016/j.ecss.2008.07.011; Bernhard JM, 1999, MODERN FORAMINIFERA, P201; Berry WJ, 1996, ENVIRON TOXICOL CHEM, V15, P2067, DOI 10.1002/etc.5620151203; Bickert T, 2004, S ATLANTIC LATE QUAT, P599; Buchmann N., 1998, STABLE ISOTOPES INTE, P203; Burollet PF, 1951, ANN MINES GEOLOGIE T, V7, P5; Chapman PM, 1998, CAN J FISH AQUAT SCI, V55, P2221, DOI 10.1139/cjfas-55-10-2221; Coccioni R, 2009, MAR POLLUT BULL, V59, P257, DOI 10.1016/j.marpolbul.2009.08.009; Curry WB, 1988, PALEOCEANOGRAPHY, V3, P317, DOI 10.1029/PA003i003p00317; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; Debenay JP, 2001, J FORAMIN RES, V31, P133, DOI 10.2113/0310133; Dellali M, 2001, J RECH OCEANOGR, V26, P18; den Besten Pieter J., 2003, Journal of Soils and Sediments, V3, P144, DOI 10.1065/jss2003.08.084; DITORO DM, 1990, ENVIRON TOXICOL CHEM, V9, P1487; du Chatelet Eric Armynot, 2009, Revue de Micropaleontologie, V52, P75, DOI 10.1016/j.revmic.2008.10.002; ESSID N, 2002, B I NATN SCI TECH ME, V29, P53; Fang T, 2005, ECOTOX ENVIRON SAFE, V61, P420, DOI 10.1016/j.ecoenv.2004.10.004; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Fernex FE, 2001, HYDROBIOLOGIA, V450, P31, DOI 10.1023/A:1017558413882; Frontalini F, 2008, ESTUAR COAST SHELF S, V76, P404, DOI 10.1016/j.ecss.2007.07.024; Frontalini F, 2014, P BIOL SOC WASH, V127, P7, DOI 10.2988/0006-324X-127.1.7; Frontalini F, 2013, ACTA PROTOZOOL, V52, P147, DOI 10.4467/16890027AP.13.0014.1111; Frontalini F, 2010, ENVIRON MONIT ASSESS, V170, P245, DOI 10.1007/s10661-009-1229-6; Frontalini F, 2009, MAR POLLUT BULL, V58, P858, DOI 10.1016/j.marpolbul.2009.01.015; GANOTE CE, 1987, AM J PATHOL, V129, P327; Garali A.B., 2011, J OCEANOGR MAR SCI, V2, P1; Geslin E, 2014, ENVIRON SCI ENG, P163, DOI 10.1007/978-4-431-54388-6_10; GOODAY AJ, 1989, MAR ECOL PROG SER, V58, P53, DOI 10.3354/meps058053; Gooday AJ, 2003, ADV MAR BIOL, V46, P1, DOI 10.1016/S0065-2881(03)46002-1; Gooday AJ, 2012, ANNU REV MAR SCI, V4, P237, DOI 10.1146/annurev-marine-120709-142737; Grami B, 2008, ESTUAR COAST SHELF S, V79, P101, DOI 10.1016/j.ecss.2008.03.009; GROSSMAN EL, 1987, J FORAMIN RES, V17, P48, DOI 10.2113/gsjfr.17.1.48; Harzallah A., 2003, B INSTITUT NATL SCI, V30, P121; Hinkey LM, 2007, MAR POLLUT BULL, V54, P180, DOI 10.1016/j.marpolbul.2006.09.009; Hlaili-Sakka A., 2003, REV FS BIZERTE TUNIS, V2, P37; Ip CCM, 2004, ENVIRON POLLUT, V132, P157, DOI 10.1016/j.envpol.2004.03.028; Kallel M R, 1989, HYDROLOGY LAGOON BIZ; Larpent JP, 1997, TEC DOC LAVOISIER; Lasorsa B, 1996, MAR CHEM, V52, P211, DOI 10.1016/0304-4203(95)00074-7; Li F, 2014, MAR POLLUT BULL, V84, P424, DOI 10.1016/j.marpolbul.2014.04.030; Linshy VN, 2007, INDIAN J MAR SCI, V36, P301; Liu WX, 2003, ENVIRON POLLUT, V121, P377, DOI 10.1016/S0269-7491(02)00234-8; Mackensen A, 2001, GLOBAL PLANET CHANGE, V30, P197, DOI 10.1016/S0921-8181(01)00102-3; Martins V, 2010, ESTUAR COAST SHELF S, V87, P293, DOI 10.1016/j.ecss.2010.01.011; Martins V, 2007, MAR GEOL, V239, P1, DOI 10.1016/j.margeo.2006.11.001; Martins VA, 2013, MAR POLLUT BULL, V70, P18, DOI 10.1016/j.marpolbul.2013.02.003; Mathlouthi S, 1985, THESIS U TUNIS 1 TUN; Maugeri TL, 2000, J APPL MICROBIOL, V89, P261, DOI 10.1046/j.1365-2672.2000.01096.x; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Monterroso P, 2003, ACTA OECOL, V24, pS351, DOI 10.1016/S1146-609X(03)00033-X; Moodley L, 1998, MAR ECOL PROG SER, V169, P77, DOI 10.3354/meps169077; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Murray JW, 2001, MAR MICROPALEONTOL, V41, P1, DOI 10.1016/S0377-8398(00)00057-8; Nigam R, 2005, J COASTAL RES, V21, P853, DOI 10.2112/03-0061.1; Oliveira Leonardo Costa de, 2011, Braz. J. Geol., V41, P447, DOI 10.25249/0375-7536.2011413447462; Ouakad M, 2007, THESIS U TUNIS MANAR; Oueslati W, 2010, SOIL SEDIMENT CONTAM, V19, P696, DOI 10.1080/15320383.2010.515629; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pereira ME, 2009, ENVIRON MONIT ASSESS, V155, P39, DOI 10.1007/s10661-008-0416-1; Pereira ME, 1998, SCI TOTAL ENVIRON, V213, P157, DOI 10.1016/S0048-9697(98)00087-4; Pereira ME, 1998, WATER SCI TECHNOL, V37, P125, DOI 10.2166/wst.1998.0744; Perez-Ruzafa A, 2011, J COAST CONSERV, V15, P369, DOI 10.1007/s11852-010-0095-2; PRAHL FG, 1994, GEOCHIM COSMOCHIM AC, V58, P3035, DOI 10.1016/0016-7037(94)90177-5; Premuzic E.T., 1982, ORG GEOCHEM, V4, P63, DOI [10.1016/0146-6380(82)90009-2., DOI 10.1016/0146-6380(82)90009-2]; Prescott L.M., 1999, MICROBIOLOGY; Ramalhosa E, 2006, WATER RES, V40, P2893, DOI 10.1016/j.watres.2006.05.023; Ravelo AC, 2007, DEV MARINE GEOL, V1, P735, DOI 10.1016/S1572-5480(07)01023-8; Ribeiro AP, 2013, MAR POLLUT BULL, V68, P55, DOI 10.1016/j.marpolbul.2012.12.023; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stanhope JW, 2009, J ENVIRON QUAL, V38, P2070, DOI 10.2134/jeq2008.0358; Tucker M. E., 2001, SEDIMENTARY PETROLOG; Viaroli P, 2004, AQUAT CONSERV, V14, pS19, DOI 10.1002/aqc.647	83	69	70	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137250	10.1371/journal.pone.0137250	http://dx.doi.org/10.1371/journal.pone.0137250			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372655	gold, Green Published, Green Submitted			2022-12-26	WOS:000361604400014
J	Oliveira, D; Ferreira, FS; Atouguia, J; Fortes, F; Guerra, A; Centeno-Lima, S				Oliveira, Dinamene; Ferreira, Filipa Santana; Atouguia, Jorge; Fortes, Filomeno; Guerra, Antonio; Centeno-Lima, Sonia			Infection by Intestinal Parasites, Stunting and Anemia in School-Aged Children from Southern Angola	PLOS ONE			English	Article							NUTRITIONAL-STATUS; HYMENOLEPIS-NANA; RISK-FACTORS; EPIDEMIOLOGY; PREVALENCE; HELMINTHS; MODERATE	Introduction Intestinal parasites are responsible for morbidity in children worldwide, especially in low income countries. In the present study we determine the prevalence of intestinal parasites and explore its association with anemia and stunting in school-aged children. Methods A cross-sectional study was conducted from September to October 2010 enrolling 328 children attending the primary school in Lubango, the second largest city after the capital Luanda. Stool samples were collected for parasite detection through microscopy and molecular identification of Entamoeba histolytica and Entamoeba dispar. Stunting was assessed using the z-scores of height for age and hemoglobin concentration was determined using a portable hemoglobin analyzing system. Results The global prevalence of pathogenic intestinal parasites was 44.2%, the most common being Ascaris lumbricoides (22.0%), Giardia lamblia (20.1%) and Hymenolepis nana (8.8%). Molecular detection revealed that 13.1% of the children carried E. dispar and 0.3% were infected with E. histolytica. The prevalence of stunting (mild to severe) was 41.5%. Stunting was more frequent in older children (p = 0.006, OR = 1.886), while anemia was more frequent in younger children (p = 0.005, OR = 2.210). The prevalence of anemia was 21.6%, and we found a significant association with infection by H. nana (p = 0.031, OR = 2.449). Conclusions This is one of the few published studies reporting intestinal parasites infection, nutritional status and anemia in children from Angola. Furthermore, the present work highlights the importance of regular intestinal parasites screening in children.	[Oliveira, Dinamene] Clin Girassol, Lubango, Angola; [Ferreira, Filipa Santana; Atouguia, Jorge; Centeno-Lima, Sonia] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Clin Trop, Global Hlth & Trop Med, P-1200 Lisbon, Portugal; [Fortes, Filomeno] Minist Saude, Luanda, Angola; [Guerra, Antonio] Univ Porto, Fac Med, Dept Pediat, P-4100 Oporto, Portugal	Clinica Girassol; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade do Porto	Oliveira, D (corresponding author), Clin Girassol, Lubango, Angola.	odinamene@gmail.com	Guerra, António/L-8025-2013; Atouguia, Jorge M/J-2877-2012	Guerra, António/0000-0002-7951-3911; Atouguia, Jorge/0000-0001-9854-0854; Centeno Lima, Sonia/0000-0002-4935-4905; Fortes, Fabiane/0000-0001-6217-3474; Oliveira, Dinamene/0000-0002-7765-5991	Sonangol	Sonangol	All financial expenses were supported by Sonangol through a scholarship assigned to the corresponding author. Sonangol does not attribute numbers to their grants (www.sonangol.co.ao). Sonangol had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Ministry of Health of Angola (www.minsa.gov.ao) contributed with drugs for the treatment of children infected with intestinal parasites.	Ali IKM, 2008, INFECT GENET EVOL, V8, P698, DOI 10.1016/j.meegid.2008.05.004; Augusto G, 2009, AM J TROP MED HYG, V81, P799, DOI 10.4269/ajtmh.2009.08-0344; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Botero-Garces JH, 2009, REV INST MED TROP SP, V51, P155, DOI 10.1590/S0036-46652009000300006; Brito LL, 2006, AM J TROP MED HYG, V75, P939, DOI 10.4269/ajtmh.2006.75.939; Casapia M, 2007, BRIT J NUTR, V98, P1259, DOI 10.1017/S0007114507795272; Casapia M, 2006, INT J PARASITOL, V36, P741, DOI 10.1016/j.ijpara.2006.03.004; Dawood R, 2005, SAUDE VIAJANTES COMO; Dent A.E., 2011, NELSON TXB PEDIAT, V19th; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Ferreira Filipa Santana, 2013, J Parasitol Res, V2013, P252971, DOI 10.1155/2013/252971; Ferreira FS, 2012, PARASITOL RES, V111, P2173, DOI 10.1007/s00436-012-3068-6; Fleming AF, 2009, MANSONS TROPICAL DIS; Hamid MMA, 2015, TRAVEL MED INFECT DI, V13, P172, DOI 10.1016/j.tmaid.2014.12.011; Hamzah Z, 2006, J CLIN MICROBIOL, V44, P3196, DOI 10.1128/JCM.00778-06; Harhay MO, 2010, EXPERT REV ANTI-INFE, V8, P219, DOI [10.1586/eri.09.119, 10.1586/ERI.09.119]; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Jardim-Botelho A, 2008, TROP MED INT HEALTH, V13, P458, DOI 10.1111/j.1365-3156.2008.02022.x; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Magalhaes RJS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002321; Midzi N, 2010, ACTA TROP, V115, P103, DOI 10.1016/j.actatropica.2010.02.010; Mohammad Mahmoud A., 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P877; Nyarango RM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-237; Parija SC, 2007, BMC MICROBIOL, V7; Sharbatkhori Mitra, 2014, Gastroenterol Hepatol Bed Bench, V7, P164; Sousa-Figueiredo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033189; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Tomlinson M, 2010, PUBLIC HEALTH NUTR, V13, P1314, DOI 10.1017/S1368980010000510; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization (WHO), 1994, BENCH AIDS DIAGN INT	31	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137327	10.1371/journal.pone.0137327	http://dx.doi.org/10.1371/journal.pone.0137327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371758	Green Published, gold			2022-12-26	WOS:000361604400016
J	Cheng, Y; Zhang, SW; Chen, Y; Zhao, G				Cheng, Ye; Zhang, Siwen; Chen, Yong; Zhao, Gang			Safe Corridor to Access Clivus for Endoscopic Trans-Sphenoidal Surgery: A Radiological and Anatomical Study	PLOS ONE			English	Article							INTERNAL CAROTID-ARTERY; SELLAR REGION; CLASSIFICATION; TOMOGRAPHY	Purpose Penetration of the clivus is required for surgical access of the brain stem. The endoscopic transclivus approach is a difficult procedure with high risk of injury to important neurovascular structures. We undertook a novel anatomical and radiological investigation to understand the structure of the clivus and neurovascular structures relevant to the extended trans-nasal trans-sphenoid procedure and determine a safe corridor for the penetration of the clivus. Method We examined the clivus region in the computed tomographic angiography (CTA) images of 220 adults, magnetic resonance (MR) images of 50 adults, and dry skull specimens of 10 adults. Multiplanar reconstruction (MPR) of the CT images was performed, and the anatomical features of the clivus were studied in the coronal, sagittal, and axial planes. The data from the images were used to determine the anatomical parameters of the clivus and neurovascular structures, such as the internal carotid artery and inferior petrosal sinus. Results The examination of the CTA and MR images of the enrolled subjects revealed that the thickness of the clivus helped determine the depth of the penetration, while the distance from the sagittal midline to the important neurovascular structures determined the width of the penetration. Further, data from the CTA and MR images were consistent with those retrieved from the examination of the cadaveric specimens. Conclusion Our findings provided certain pointers that may be useful in guiding the surgery such that inadvertent injury to vital structures is avoided and also provided supportive information for the choice of the appropriate endoscopic equipment.	[Cheng, Ye; Chen, Yong; Zhao, Gang] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Jilin Province, Peoples R China; [Zhang, Siwen] Jilin Univ, Hosp 1, Dept Endocrine, Changchun 130023, Jilin Province, Peoples R China	Jilin University; Jilin University	Chen, Y (corresponding author), Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Jilin Province, Peoples R China.	chenyong_jdyy@163.com; zhaogang_jdyy@163.com						Alfieri A, 1999, J Neurosurg Sci, V43, P85; Bouthillier A, 1996, NEUROSURGERY, V38, P425, DOI 10.1097/00006123-199603000-00001; Cheng Y, 2013, SURG RADIOL ANAT, V35, P797, DOI 10.1007/s00276-013-1193-2; Cobb WS, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181fa24f4; Danner C, 2004, OTOL NEUROTOL, V25, P762, DOI 10.1097/00129492-200409000-00019; Fraser JF, 2010, J NEUROSURG, V112, P1061, DOI 10.3171/2009.7.JNS081504; Gondim J, 2003, ARQ NEURO-PSIQUIAT, V61, P836, DOI 10.1590/S0004-282X2003000500024; Guldner C, 2012, ACTA RADIOL, V53, P214, DOI 10.1258/ar.2011.110381; Iyer NG, 2012, HEAD NECK-J SCI SPEC, V34, P1071, DOI 10.1002/hed.21878; Locatelli M, 2013, PITUITARY, V16, P146, DOI 10.1007/s11102-012-0390-z; Mason E, 2014, LARYNGOSCOPE, V124, P628, DOI 10.1002/lary.24378; Natarajan SK, 2007, NEUROSURGERY, V60, P965, DOI 10.1227/01.NEU.0000255472.52882.D6; Ogawa Y, 2012, ACTA NEUROCHIR, V154, P621, DOI 10.1007/s00701-011-1266-0; Rhoton AL, 2007, NEUROSURGERY, V61, P37, DOI 10.1227/01.NEU.0000255490.88321.CE; SEKHAR L N, 1989, Contemporary Neurosurgery, V11, P1; Van Gompel JJ, 2014, J NEUROSURG, V120, P1321, DOI 10.3171/2014.2.JNS131773; Wang CY, 2013, J CRANIOFAC SURG, V24, P1418, DOI 10.1097/SCS.0b013e318292c970; Yilmazlar S, 2012, J CRANIO MAXILL SURG, V40, pE198, DOI 10.1016/j.jcms.2011.10.008; Zhang HJ, 2013, J CRANIOFAC SURG, V24, P1011, DOI 10.1097/SCS.0b013e318287d228	19	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137962	10.1371/journal.pone.0137962	http://dx.doi.org/10.1371/journal.pone.0137962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368821	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100186
J	Du, Y; Ge, MM; Xue, WZ; Yang, QQ; Wang, S; Xu, Y; Wang, HL				Du, Yang; Ge, Meng-Meng; Xue, Weizhen; Yang, Qian-Qian; Wang, Shuang; Xu, Yi; Wang, Hui-Li			Chronic Lead Exposure and Mixed Factors of GenderxAgexBrain Regions Interactions on Dendrite Growth, Spine Maturity and NDR Kinase	PLOS ONE			English	Article							GENDER-DIFFERENCES; CHILDREN; NEUROTOXICITY; RAT; MECHANISMS; BRAIN; INTELLIGENCE; HIPPOCAMPUS; MORPHOLOGY; TOXICITY	NDR1/2 kinase is essential in dendrite morphology and spine formation, which is regulated by cellular Ca2+. Lead (Pb) is a potent blocker of L-type calcium channel and our recent work showed Pb exposure impairs dendritic spine outgrowth in hippocampal neurons in rats. But the sensitivity of Pb-induced spine maturity with mixed factors (genderxagexbrain regions) remains unknown. This study aimed to systematically investigate the effect of Pb exposure on spine maturity in rat brain with three factors (genderxagexbrain regions), as well as the NDR1/2 kinase expression. Sprague-Dawley rats were exposed to Pb from parturition to postnatal day 30, 60, 90, respectively. Golgi-Cox staining was used to examine spine maturity. Western blot assay was applied to measure protein expression and realtime fluorescence quantitative PCR assay was used to examine mRNA levels. The results showed chronic Pb exposure significantly decreased dendritic length and impaired spine maturity in both rat hippocampus and medial prefrontal cortex. The impairment of dendritic length induced by Pb exposure tended to adolescence > adulthood, hippocampus > medial prefrontal cortex and female > male. Pb exposure induced significant damage in spine maturity during adolescence and early adult while little damage during adult in male rat brain and female medial prefrontal cortex. Besides, there was sustained impairment from adolescence to adulthood in female hippocampus. Interestingly, impairment of spine maturity followed by Pb exposure was correlated with NDR1/2 kinase. The reduction of NDR1/2 kinase protein expression after Pb exposure was similar to the result of spine maturity. In addition, NDR2 and their substrate Rabin3 mRNA levels were significantly decreased by Pb exposure in developmental rat brain. Taken together, Pb exposure impaired dendrite growth and maturity which was subject to genderxagexbrain regions effects and related to NDR1/2 signal expression.	[Du, Yang; Ge, Meng-Meng; Xue, Weizhen; Yang, Qian-Qian; Wang, Shuang; Xu, Yi; Wang, Hui-Li] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei 230009, Anhui, Peoples R China	Hefei University of Technology	Wang, HL (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei 230009, Anhui, Peoples R China.	wanghl@hfut.edu.cn		Wang, Hui-Li/0000-0001-6852-8002	National Key Basic Research Program of China (973 Program) [2012CB525003]; National Science Foundation of China [21477031, 31200851, 31401671]; Program for New Century Excellent Talents in University [NCET-12-0835]; Specialized Research Fund for the Doctoral Program of Higher Education [2013011110024]; Anhui University of Chinese Medicine [2015sbgj005]; Huangshan Young Scholar Fund of Hefei University of Technology [407-037030]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Anhui University of Chinese Medicine; Huangshan Young Scholar Fund of Hefei University of Technology	This work was supported by the National Key Basic Research Program of China (973 Program, No. 2012CB525003), the National Science Foundation of China (No. 21477031, 31200851, 31401671), the Program for New Century Excellent Talents in University (NCET-12-0835), Specialized Research Fund for the Doctoral Program of Higher Education (No. 2013011110024), Anhui University of Chinese Medicine (No. 2015sbgj005), the Huangshan Young Scholar Fund of Hefei University of Technology (407-037030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann L, 1998, NEUROTOXICOL TERATOL, V20, P9, DOI 10.1016/S0892-0362(97)00070-6; Andrade V, 2014, NEUROTOXICOLOGY, V45, P168, DOI 10.1016/j.neuro.2014.10.009; Araya R, 2014, P NATL ACAD SCI USA, V111, pE2895, DOI 10.1073/pnas.1321869111; BAGHURST PA, 1992, NEW ENGL J MED, V327, P1279, DOI 10.1056/NEJM199210293271805; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; BELLINGER DC, 1992, PEDIATRICS, V90, P855; Bjorkman L, 2000, ENVIRON HEALTH PERSP, V108, P719, DOI 10.2307/3434724; Bowman RE, 2015, HORM BEHAV, V69, P89, DOI 10.1016/j.yhbeh.2014.12.007; Bressler J, 1999, NEUROCHEM RES, V24, P595, DOI 10.1023/A:1022596115897; BUSSELBERG D, 1994, CELL MOL NEUROBIOL, V14, P711, DOI 10.1007/BF02088679; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Cressey D, 2013, NATURE, V500, P130, DOI 10.1038/500130a; Dall'Oglio A, 2015, J ANAT, V227, P440, DOI 10.1111/joa.12358; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fan GQ, 2013, TOXICOL IN VITRO, V27, P387, DOI 10.1016/j.tiv.2012.06.019; Finkelstein Y, 1998, BRAIN RES REV, V27, P168, DOI 10.1016/S0165-0173(98)00011-3; Florea A-M, 2013, J LOCAL GLOBAL HLTH; Ge MM, 2015, RSC ADV, V5, P31622, DOI 10.1039/c5ra00315f; GRANT LD, 1980, TOXICOL APPL PHARM, V56, P42, DOI 10.1016/0041-008X(80)90130-1; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jedrychowski W, 2009, EARLY HUM DEV, V85, P503, DOI 10.1016/j.earlhumdev.2009.04.006; Jett DA, 1997, PHARMACOL BIOCHEM BE, V57, P271, DOI 10.1016/S0091-3057(96)00350-4; KIRALY E, 1982, EXP NEUROL, V77, P236, DOI 10.1016/0014-4886(82)90158-3; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Liu ZH, 2015, TOXICOL RES-UK, V4, P686, DOI 10.1039/c4tx00093e; Llop S, 2013, TOXICOLOGY, V311, P3, DOI 10.1016/j.tox.2013.04.015; LYNGBYE T, 1990, ACTA PAEDIATR SCAND, V79, P352, DOI 10.1111/j.1651-2227.1990.tb11469.x; Madison JL, 2011, NEUROTOXICOLOGY, V32, P896, DOI 10.1016/j.neuro.2011.05.007; Mason LH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/840547; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; Medvedev NI, 2014, BRAIN STRUCT FUNCT, V219, P407, DOI 10.1007/s00429-012-0488-0; Mendola P, 2002, MENT RETARD DEV D R, V8, P188, DOI 10.1002/mrdd.10033; Millward TA, 1998, EMBO J, V17, P5913, DOI 10.1093/emboj/17.20.5913; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; Paula-Lima AC, 2014, ANTIOXID REDOX SIGN, V21, P892, DOI 10.1089/ars.2013.5796; Peng SQ, 2002, MOL PHARMACOL, V62, P1418, DOI 10.1124/mol.62.6.1418; PETIT TL, 1979, EXP NEUROL, V64, P482, DOI 10.1016/0014-4886(79)90226-7; Rehberg K, 2014, J NEUROSCI, V34, P5342, DOI 10.1523/JNEUROSCI.2728-13.2014; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schneider JS, 2012, TOXICOL SCI, V129, P108, DOI 10.1093/toxsci/kfs189; Seo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105308; Stork O, 2004, J BIOL CHEM, V279, P45773, DOI 10.1074/jbc.M403552200; Tatsuta N, 2014, ENVIRON RES, V133, P321, DOI 10.1016/j.envres.2014.05.024; Tong SL, 2000, ARCH ENVIRON HEALTH, V55, P330, DOI 10.1080/00039890009604025; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; Wang JX, 2014, SCIENCE, V345, P1054, DOI 10.1126/science.1252900; Yang H, 2013, ENVIRON SCI POLLUT R, V20, P4441, DOI 10.1007/s11356-012-1366-2	53	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138112	10.1371/journal.pone.0138112	http://dx.doi.org/10.1371/journal.pone.0138112			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368815	Green Submitted, gold, Green Published			2022-12-26	WOS:000361601100228
J	Ferrer-Mayorga, G; Alvarez-Diaz, S; Valle, N; De Las Rivas, J; Mendes, M; Barderas, R; Canals, F; Tapia, O; Casal, JI; Lafarga, M; Munoz, A				Ferrer-Mayorga, Gemma; Alvarez-Diaz, Silvia; Valle, Noelia; De Las Rivas, Javier; Mendes, Marta; Barderas, Rodrigo; Canals, Francesc; Tapia, Olga; Ignacio Casal, J.; Lafarga, Miguel; Munoz, Alberto			Cystatin D Locates in the Nucleus at Sites of Active Transcription and Modulates Gene and Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER; CYSTEINE CATHEPSINS; POOR-PROGNOSIS; RUNX FAMILY; CELLS; HETEROCHROMATIN; METASTASIS; LOCALIZES; INVASION; ROLES	Cystatin D is an inhibitor of lysosomal and secreted cysteine proteases. Strikingly, cystatin D has been found to inhibit proliferation, migration, and invasion of colon carcinoma cells indicating tumor suppressor activity that is unrelated to protease inhibition. Here, we demonstrate that a proportion of cystatin D locates within the cell nucleus at specific transcriptionally active chromatin sites. Consistently, transcriptomic analysis show that cystatin D alters gene expression, including that of genes encoding transcription factors such as RUNX1, RUNX2, and MEF2C in HCT116 cells. In concordance with transcriptomic data, quantitative proteomic analysis identified 292 proteins differentially expressed in cystatin D-expressing cells involved in cell adhesion, cytoskeleton, and RNA synthesis and processing. Furthermore, using cytokine arrays we found that cystatin D reduces the secretion of several protumor cytokines such as fibroblast growth factor-4, CX3CL1/fractalkine, neurotrophin 4 oncostatin-M, pulmonary and activation-regulated chemokine/CCL18, and transforming growth factor B3. These results support an unanticipated role of cystatin D in the cell nucleus, controlling the transcription of specific genes involved in crucial cellular functions, which may mediate its protective action in colon cancer.	[Ferrer-Mayorga, Gemma; Alvarez-Diaz, Silvia; Valle, Noelia; Munoz, Alberto] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain; [De Las Rivas, Javier] Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, E-37007 Salamanca, Spain; [Mendes, Marta; Barderas, Rodrigo; Ignacio Casal, J.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Canals, Francesc] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol, Prote Lab, E-08035 Barcelona, Spain; [Tapia, Olga; Lafarga, Miguel] Univ Cantabria, Inst Invest Valdecilla, Fac Med, Dept Anat & Biol Celular, E-39011 Santander, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Munoz, A (corresponding author), Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.	amunoz@iib.uam.es	Mendes, Marta L/P-4062-2018; Lafarga, Miguel/K-3733-2014; Miquel, Josep Maria/AAG-3508-2019; Valle, Noelia/AAA-2975-2019; Casal, Ignacio/M-2312-2014; De Las Rivas, Javier/G-5936-2014; Mendes, Marta/AAM-9766-2021; Tapia, Olga/AAH-8651-2020; Alvarez-Diaz, Silvia/P-4948-2018; Barderas, Rodrigo/K-3560-2014; Munoz, Alberto/O-6393-2014; Tapia, Olga/AAN-2427-2020	Mendes, Marta L/0000-0002-3528-7123; Valle, Noelia/0000-0002-3377-5035; Casal, Ignacio/0000-0003-1085-2840; De Las Rivas, Javier/0000-0002-0984-9946; Mendes, Marta/0000-0002-3528-7123; Tapia, Olga/0000-0002-0802-7975; Alvarez-Diaz, Silvia/0000-0002-8897-1893; Barderas, Rodrigo/0000-0003-3539-7469; Munoz, Alberto/0000-0003-3890-4251; Lafarga, Miguel/0000-0003-3402-1152	Spanish Ministry of Economy and Competitiveness-Fondo Europeo de Desarrollo Regional (FEDER) [SAF2013-43468-R]; Comunidad de Madrid Grant Colomics2 [S2010/BMD-2344]; FEDER-Instituto de Salud Carlos III Grant [RD12/0036/0021]	Spanish Ministry of Economy and Competitiveness-Fondo Europeo de Desarrollo Regional (FEDER); Comunidad de Madrid Grant Colomics2(Comunidad de Madrid); FEDER-Instituto de Salud Carlos III Grant	This work was supported by Spanish Ministry of Economy and Competitiveness-Fondo Europeo de Desarrollo Regional (FEDER) Grant SAF2013-43468-R, Comunidad de Madrid Grant Colomics2 S2010/BMD-2344, and FEDER-Instituto de Salud Carlos III Grant RD12/0036/0021. The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal AK, 2010, FOLIA HISTOCHEM CYTO, V48, P323, DOI 10.2478/v10042-10-0067-2; Alvarez-Diaz S, 2009, J CLIN INVEST, V119, P2343, DOI 10.1172/JCI37205; BALBIN M, 1993, HUM GENET, V90, P668; Barderas R, 2012, CANCER RES, V72, P2780, DOI 10.1158/0008-5472.CAN-11-4090; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolin Celeste, 2012, Genes Cancer, V3, P117, DOI 10.1177/1947601912458284; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Carlsson E, 2012, BRIT J CANCER, V106, P517, DOI 10.1038/bjc.2011.553; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Ceru S, 2010, J BIOL CHEM, V285, P10078, DOI 10.1074/jbc.M109.034793; Chimge NO, 2013, ONCOGENE, V32, P2121, DOI 10.1038/onc.2012.328; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Corcione A, 2012, J LEUKOCYTE BIOL, V92, P51, DOI 10.1189/jlb.0112035; Cox JL, 2009, FRONT BIOSCI-LANDMRK, V14, P463, DOI 10.2741/3255; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Fontanillo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024289; FREIJE JP, 1991, J BIOL CHEM, V266, P20538; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; Kim M, 2012, MOL CANCER RES, V10, P11, DOI 10.1158/1541-7786.MCR-11-0256; Kosaka N, 2009, DEV DYNAM, V238, P265, DOI 10.1002/dvdy.21699; Luque-Garcia JL, 2010, PROTEOMICS, V10, P940, DOI 10.1002/pmic.200900441; Maubach G, 2008, MOL BIOL CELL, V19, P4238, DOI 10.1091/mbc.E08-03-0291; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Ochieng J, 2010, J HEALTH CARE POOR U, V21, P51, DOI 10.1353/hpu.0.0257; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Pelaez-Garcia A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063695; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Rivenbark AG, 2009, FRONT BIOSCI-LANDMRK, V14, P453, DOI 10.2741/3254; Scheitz CJF, 2012, EMBO J, V31, P4124, DOI 10.1038/emboj.2012.270; Slattery ML, 2011, CARCINOGENESIS, V32, P318, DOI 10.1093/carcin/bgq245; Traweger A, 2003, J BIOL CHEM, V278, P2692, DOI 10.1074/jbc.M206821200; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu XR, 2012, J SURG ONCOL, V106, P130, DOI 10.1002/jso.23056; Xu XH, 2012, J GASTROINTEST SURG, V16, P1493, DOI 10.1007/s11605-012-1921-7; Yuen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054211	43	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26533	26548		10.1074/jbc.M115.660175	http://dx.doi.org/10.1074/jbc.M115.660175			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26364852	Green Published, hybrid			2022-12-26	WOS:000364793600021
J	Deshpande, RS; Grayson, WL; Spector, AA				Deshpande, Rajiv S.; Grayson, Warren L.; Spector, Alexander A.			A Modeling Insight into Adipose-Derived Stem Cell Myogenesis	PLOS ONE			English	Article							PROCESSED LIPOASPIRATE CELLS; MYOBLAST FUSION; LINEAGE-COMMITMENT; DIFFERENTIATION; TISSUE; FATE; REGENERATION; EXPRESSION; DYNAMICS; RENEWAL	Adipose-derived stem cells (ASCs) are clinically important in regenerative medicine as they are relatively easy to obtain, are characterized by low morbidity, and can differentiate into myogenic progenitor cells. Although studies have elucidated the principal markers, PAX7, Desmin, MyoD, and MHC, the underlying mechanisms are not completely understood. This motivates the application of computational methods to facilitate greater understanding of such processes. In the following, we present a multi-stage kinetic model comprising a system of ordinary differential equations (ODEs). We sought to model ASC differentiation using data from a static culture, where no strain is applied, and a dynamic culture, where 10% strain is applied. The coefficients of the equations have been modulated by those experimental data points. To correctly represent the trajectories, various switches and a feedback factor based on total cell number have been introduced to better represent the biology of ASC differentiation. Furthermore, the model has then been applied to predict ASC fate for strains different from those used in the experimental conditions and for times longer than the duration of the experiment. Analysis of the results reveals unique characteristics of ASC myogenesis under dynamic conditions of the applied strain.	[Deshpande, Rajiv S.; Grayson, Warren L.; Spector, Alexander A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Spector, AA (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	aspector@jhu.edu		Deshpande, Rajiv/0000-0002-1232-0875	Department of Biomedical Engineering of Johns Hopkins University	Department of Biomedical Engineering of Johns Hopkins University	Support was provided by funding from the Department of Biomedical Engineering of Johns Hopkins University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024225; Alon U., 2006, INTRO SYSTEMS BIOL D; Ankam S, 2013, ACTA BIOMATER, V9, P4535, DOI 10.1016/j.actbio.2012.08.018; Ashjian PH, 2003, PLAST RECONSTR SURG, V111, P1922, DOI 10.1097/01.PRS.0000055043.62589.05; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]; Doherty JT, 2011, J BIOL CHEM, V286, P25903, DOI 10.1074/jbc.M111.243030; Duan R, 2012, J CELL BIOL, V199, P169, DOI 10.1083/jcb.201204065; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huri PY, 2013, BIOCHEM BIOPH RES CO, V438, P180, DOI 10.1016/j.bbrc.2013.07.049; Huri PY, 2014, CELL MOL BIOENG, V7, P497, DOI 10.1007/s12195-014-0362-7; Hutton DL, 2012, TISSUE ENG PT A, V18, P1729, DOI [10.1089/ten.tea.2011.0599, 10.1089/ten.TEA.2011.0599]; Hutton DL, 2013, TISSUE ENG PT A, V19, P2076, DOI [10.1089/ten.tea.2012.0752, 10.1089/ten.TEA.2012.0752]; Hwang M, 2009, CELL MOL BIOENG, V2, P285, DOI 10.1007/s12195-009-0078-2; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee WCC, 2007, BIOMECH MODEL MECHAN, V6, P265, DOI 10.1007/s10237-006-0053-y; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Osborne JM, 2010, PHILOS T R SOC A, V368, P5013, DOI 10.1098/rsta.2010.0173; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Wu L, 2013, J CELL PHYSIOL, V228, P938, DOI 10.1002/jcp.24255; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zamir E, 2001, J CELL SCI, V114, P3583; Zandstra PW, 2000, BLOOD, V96, P1215, DOI 10.1182/blood.V96.4.1215.h8001215_1215_1222; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	32	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137918	10.1371/journal.pone.0137918	http://dx.doi.org/10.1371/journal.pone.0137918			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378788	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400035
J	Ilie, G; Boak, A; Mann, RE; Adlaf, EM; Hamilton, H; Asbridge, M; Rehm, J; Cusimano, MD				Ilie, Gabriela; Boak, Angela; Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Asbridge, Mark; Rehm, Juergen; Cusimano, Michael D.			Energy Drinks, Alcohol, Sports and Traumatic Brain Injuries among Adolescents	PLOS ONE			English	Article							EXECUTIVE FUNCTION; UNITED-STATES; CONSUMPTION; RISK; CONSEQUENCES; PATTERNS; BEHAVIOR	Importance The high prevalence of traumatic brain injuries (TBI) among adolescents has brought much focus to this area in recent years. Sports injuries have been identified as a main mechanism. Although energy drinks, including those mixed with alcohol, are often used by young athletes and other adolescents they have not been examined in relation to TBI. Objective We report on the prevalence of adolescent TBI and its associations with energy drinks, alcohol and energy drink mixed in with alcohol consumption. Design, Settings and Participants Data were derived from the Centre for Addiction and Mental Health's 2013 Ontario Student Drug Use and Health Survey (OSDUHS). This population-based cross-sectional school survey included 10,272 7th to 12th graders (ages 11-20) who completed anonymous selfadministered questionnaires in classrooms. Main Outcome Measures Mild to severe TBI were defined as those resulting in a loss of consciousness for at least five minutes, or being hospitalized for at least one night. Mechanism of TBI, prevalence estimates of TBI, and odds of energy drink consumption, alcohol use, and consumption of energy drinks mixed with alcohol are assessed. Results Among all students, 22.4%(95% CI: 20.7, 24.1) reported a history of TBI. Sports injuries remain the main mechanism of a recent (past year) TBI (45.5%, 95% CI: 41.0, 50.1). Multinomial logistic regression showed that relative to adolescents who never sustained a TBI, the odds of sustaining a recent TBI were greater for those consuming alcohol, energy drinks, and energy drinks mixed in with alcohol than abstainers. Odds ratios were higher for these behaviors among students who sustained a recent TBI than those who sustained a former TBI (lifetime but not past 12 months). Relative to recent TBI due to other causes of injury, adolescents who sustained a recent TBI while playing sports had higher odds of recent energy drinks consumption than abstainers. Conclusions and Relevance TBI remains a disabling and common condition among adolescents and the consumption of alcohol, energy drinks, and alcohol mixed with energy drinks further increase the odds of TBI among adolescents. These associations warrant further investigation.	[Ilie, Gabriela] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Boak, Angela; Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen] Ctr Addict & Mental Hlth, Social & Epidemiol Res, Toronto, ON, Canada; [Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Halifax, NS, Canada; [Cusimano, Michael D.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Dalhousie University; University of Toronto	Ilie, G (corresponding author), St Michaels Hosp, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Ilie, Gabriela/AAM-9122-2021; Meijer, Anna/K-5118-2016; Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research [TIR103946]; Ontario Neurotrauma Foundation [AUTO21]; Natural Sciences and Engineering Research Council (NSERC); Canadian Institutes of Health Research (CIHR); Social Sciences and Humanities Research Council (SSHRC); Industry Canada; Ontario Ministry of Health and Long-Term Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Industry Canada; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This work was financially supported by a Team Grant (TIR103946) from Canadian Institutes of Health Research and by funds from the Ontario Neurotrauma Foundation, AUTO21, a member of the Networks of Centres of Excellence (NCE) program that is administered and funded by the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), and the Social Sciences and Humanities Research Council (SSHRC), in partnership with Industry Canada. Drs. RM, HH and JR also acknowledge ongoing funding support from the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Active Healthy Kids Canada, 2014, IS CAN RUNN 2014 ACT; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x; Azagba Sunday, 2013, CMAJ Open, V1, pE19, DOI 10.9778/cmajo.20120017; Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003; Cherpitel CJ, 2007, DRUG ALCOHOL REV, V26, P201, DOI 10.1080/09595230601146686; Cook LG, 2013, J INT NEUROPSYCH SOC, V19, P508, DOI 10.1017/S1355617712001452; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dicker BG, 1989, HEAD TRAUMA REHABIL, V4, P73; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Frances A, DSM 4 CLASSIFICATION; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamilton HA, 2013, CAN J PUBLIC HEALTH, V104, pE496, DOI 10.17269/cjph.104.3998; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Kenny DT, 2007, COMTEMPORARY ISSUES, V107, P1; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; MacDonald N, 2010, CAN MED ASSOC J, V182, P1597, DOI 10.1503/cmaj.100953; Meier B, 2012, NY TIMES; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490; National Center for Injury Prevention & Control, REP C MILD TRAUM BRA; Paglia-Boak A, 2013, CAMH RES DOCUMENT SE; Peacock A, 2013, ALCOHOL CLIN EXP RES, V37, P1234, DOI 10.1111/acer.12086; Pharo H, 2011, BEHAV NEUROSCI, V125, P970, DOI 10.1037/a0025768; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Terry-McElrath YM, 2014, J ADDICT MED, V8, P6, DOI 10.1097/01.ADM.0000435322.07020.53; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Wolk BJ, 2012, CURR OPIN PEDIATR, V24, P243, DOI 10.1097/MOP.0b013e3283506827; Yeates K.O., 2010, PEDIAT NEUROPSYCHOLO, P112	40	19	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0135860	10.1371/journal.pone.0135860	http://dx.doi.org/10.1371/journal.pone.0135860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375286	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200009
J	Namkoong, E; Shin, YH; Bae, JS; Choi, S; Kim, M; Kim, N; Hwang, SM; Park, K				Namkoong, Eun; Shin, Yong-Hwan; Bae, Jun-Seok; Choi, Seulki; Kim, Minkyoung; Kim, Nahyun; Hwang, Sung-Min; Park, Kyungpyo			Role of Sodium Bicarbonate Cotransporters in Intracellular pH Regulation and Their Regulatory Mechanisms in Human Submandibular Glands	PLOS ONE			English	Article							RENAL NA-HCO3 COTRANSPORTER; NA+-HCO3-COTRANSPORTER; RAT-KIDNEY; SALIVARY; TRANSPORTERS; EXPRESSION; ACINAR; NBCE1; NBCN1; DUCT	Sodium bicarbonate cotransporters (NBCs) are involved in the pH regulation of salivary glands. However, the roles and regulatory mechanisms among different NBC isotypes have not been rigorously evaluated. We investigated the roles of two different types of NBCs, electroneutral (NBCn1) and electrogenic NBC (NBCe1), with respect to pH regulation and regulatory mechanisms using human submandibular glands (hSMGs) and HSG cells. Intracellular pH (pH(i)) was measured and the pH(i) recovery rate from cell acidification induced by an NH4Cl pulse was recorded. Subcellular localization and protein phosphorylation were determined using immunohistochemistry and co-immunoprecipitation techniques. We determined that NBCn1 is expressed on the basolateral side of acinar cells and the apical side of duct cells, while NBCe1 is exclusively expressed on the apical membrane of duct cells. The pH(i) recovery rate in hSMG acinar cells, which only express NBCn1, was not affected by pre-incubation with 5 mu M PP2, an Src tyrosine kinase inhibitor. However, in HSG cells, which express both NBCe1 and NBCn1, the pH(i) recovery rate was inhibited by PP2. The apparent difference in regulatory mechanisms for NBCn1 and NBCe1 was evaluated by artificial overexpression of NBCn1 or NBCe1 in HSG cells, which revealed that the pH(i) recovery rate was only inhibited by PP2 in cells overexpressing NBCe1. Furthermore, only NBCe1 was significantly phosphorylated and translocated by NH4Cl, which was inhibited by PP2. Our results suggest that both NBCn1 and NBCe1 play a role in pH(i) regulation in hSMG acinar cells, and also that Src kinase does not regulate the activity of NBCn1.	[Park, Kyungpyo] Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul 110749, South Korea; Dent Res Inst, Seoul 110749, South Korea	Seoul National University (SNU)	Park, K (corresponding author), Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul 110749, South Korea.	kppark@snu.ac.kr			National Research Foundation of Korea, through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea [2014050477]	National Research Foundation of Korea, through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University in Korea	This work was supported by a grant from the National Research Foundation of Korea, through the Oromaxillofacial Dysfunction Research Center for the Elderly (No. 2014050477) at Seoul National University in Korea (EN YS JB SC MK NK SH KP).	Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Bachmann O, 2003, AM J PHYSIOL-GASTR L, V284, pG37, DOI 10.1152/ajpgi.00209.2002; Bae JS, 2013, J BIOL CHEM, V288, P6295, DOI 10.1074/jbc.M112.392001; Bae SH, 2014, FEBS LETT, V588, P86, DOI 10.1016/j.febslet.2013.11.010; Bernardo AA, 2003, J MEMBRANE BIOL, V191, P141, DOI 10.1007/s00232-002-1051-3; Bevensee MO, 2000, AM J PHYSIOL-CELL PH, V278, pC1200, DOI 10.1152/ajpcell.2000.278.6.C1200; Billet A, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.479360; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Catalan MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016549; Chen MM, 2012, J PHYSIOL-LONDON, V590, P3317, DOI 10.1113/jphysiol.2011.226506; DAWES C, 1995, ARCH ORAL BIOL, V40, P699, DOI 10.1016/0003-9969(95)00037-P; Espiritu DJD, 2002, AM J PHYSIOL-RENAL, V283, pF663, DOI 10.1152/ajprenal.00338.2001; Gorbatenko A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00130; Gresz V, 2002, AM J PHYSIOL-GASTR L, V283, pG473, DOI 10.1152/ajpgi.00421.2001; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Gross E, 2003, J PHYSIOL-LONDON, V549, P673, DOI 10.1113/jphysiol.2003.042226; Jin M, 2012, BBA-MOL BASIS DIS, V1822, P161, DOI 10.1016/j.bbadis.2011.11.012; Kurtz I, 2014, PFLUG ARCH EUR J PHY, V466, P1501, DOI 10.1007/s00424-014-1448-8; Kwon TH, 2003, AM J PHYSIOL-RENAL, V285, pF152, DOI 10.1152/ajprenal.00307.2002; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lin AL, 2008, AM J PHYSIOL-CELL PH, V294, pC1454, DOI 10.1152/ajpcell.00151.2007; Luo X, 2001, J BIOL CHEM, V276, P9808, DOI 10.1074/jbc.M008548200; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Muller-Berger S, 2001, PFLUG ARCH EUR J PHY, V442, P718, DOI 10.1007/s004240100592; Park K, 2002, ARCH ORAL BIOL, V47, P1, DOI 10.1016/S0003-9969(01)00098-X; Park M, 2002, J BIOL CHEM, V277, P50503, DOI 10.1074/jbc.M201862200; Parker MD, 2013, PHYSIOL REV, V93, P803, DOI 10.1152/physrev.00023.2012; Perry C, 2007, AM J PHYSIOL-RENAL, V293, pF68, DOI 10.1152/ajprenal.00454.2006; Perry C, 2009, AM J PHYSIOL-CELL PH, V297, pC1409, DOI 10.1152/ajpcell.00028.2009; Perry C, 2008, AM J PHYSIOL-CELL PH, V295, pC1385, DOI 10.1152/ajpcell.00153.2008; Praetorius J, 2004, AM J PHYSIOL-RENAL, V286, pF903, DOI 10.1152/ajprenal.00437.2002; Pushkin A, 1999, AM J PHYSIOL-RENAL, V277, pF974, DOI 10.1152/ajprenal.1999.277.6.F974; Roussa E, 1999, AM J PHYSIOL-GASTR L, V277, pG1288, DOI 10.1152/ajpgi.1999.277.6.G1288; Roussa E, 2001, HISTOCHEM J, V33, P337, DOI 10.1023/A:1012471023913; Roussa E, 2011, CELL TISSUE RES, V343, P263, DOI 10.1007/s00441-010-1089-y; Ruiz OS, 1998, J MEMBRANE BIOL, V162, P201, DOI 10.1007/s002329900357; Ruiz OS, 1999, AM J PHYSIOL-RENAL, V277, pF580, DOI 10.1152/ajprenal.1999.277.4.F580; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schulz E, 2011, CIRCULATION, V124, P1806, DOI 10.1161/CIRCULATIONAHA.111.061226; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Yamaji Y, 1997, AM J PHYSIOL-CELL PH, V272, pC886, DOI 10.1152/ajpcell.1997.272.3.C886	42	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138368	10.1371/journal.pone.0138368	http://dx.doi.org/10.1371/journal.pone.0138368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375462	Green Submitted, gold, Green Published			2022-12-26	WOS:000361610200102
J	Velayutham, B; Thomas, B; Nair, D; Thiruvengadam, K; Prashant, S; Kittusami, S; Vijayakumar, H; Chidambaram, M; Shivakumar, SVBY; Jayabal, L; Jhunjhunwala, A; Swaminathan, S				Velayutham, Banurekha; Thomas, Beena; Nair, Dina; Thiruvengadam, Kannan; Prashant, Suma; Kittusami, Sathyapriya; Vijayakumar, Harivanzan; Chidambaram, Meenachi; Shivakumar, Shri Vijay Bala Yogendra; Jayabal, Lavanya; Jhunjhunwala, Ashok; Swaminathan, Soumya			The Usefulness and Feasibility of Mobile Interface in Tuberculosis Notification (MITUN) Voice Based System for Notification of Tuberculosis by Private Medical Practitioners - A Pilot Project	PLOS ONE			English	Article							RESPONSE SYSTEM; INTERVENTION	Introduction Tuberculosis (TB) is a notifiable disease and health care providers are required to notify every TB case to local authorities. We conducted a pilot study to determine the usefulness and feasibility of mobile interface in TB notification (MITUN) voice based system for notification of TB cases by private medical practitioners. Methodology The study was conducted during September 2013 to October 2014 in three zones of Chennai, an urban setting in South India. Private clinics wherein services are provided by single private medical practitioners were approached. The steps involved in MITUN included: Registration of the practitioners and notification of TB cases by them through voice interactions. Pre and post-intervention questionnaires were administered to collect information on TB notification practices and feasibility of MITUN after an implementation period of 6 months. Results A total of 266 private medical practitioners were approached for the study. Of them, 184 (69%) participated in the study; of whom 11 (6%) practitioners used MITUN for TB notification. Reasons for not using MITUN include lack of time, referral of patients to government facility, issues related to patient confidentiality and technical problems. Suggestions for making mobile phone based TB notification process user-friendly included reducing call duration, including only crucial questions and using missed call or SMS options. Conclusion The performance (feasibility and usefulness) of MITUN voice based system for TB notification in the present format was sub-optimal. Perceived problems, logistical and practical issues preclude scale-up of notification of TB by private practitioners.	[Velayutham, Banurekha; Thomas, Beena; Nair, Dina; Thiruvengadam, Kannan; Vijayakumar, Harivanzan; Chidambaram, Meenachi; Shivakumar, Shri Vijay Bala Yogendra; Swaminathan, Soumya] Natl Inst Res TB, Madras, Tamil Nadu, India; [Prashant, Suma; Kittusami, Sathyapriya; Jhunjhunwala, Ashok] Indian Inst Technol Madras, RTBI, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Swaminathan, S (corresponding author), Natl Inst Res TB, Madras, Tamil Nadu, India.	doctorsoumya@yahoo.com	vijayakumar, harivanzan/T-4968-2019; Thiruvengadam, Kannan/AAQ-8532-2021	Thiruvengadam, Kannan/0000-0002-3758-1094	World Health Organization; United States Agency for International Development (USAID), under the Model DOTS Project [MDP TSA-2013/3130790]	World Health Organization(World Health Organization); United States Agency for International Development (USAID), under the Model DOTS Project(United States Agency for International Development (USAID))	This study was supported by the World Health Organization with financial assistance provided by the United States Agency for International Development (USAID), under the Model DOTS Project (Grant No: MDP TSA-2013/3130790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender BG, 2010, J AM BOARD FAM MED, V23, P159, DOI 10.3122/jabfm.2010.02.090112; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Ganesan M., 2011, Journal of Health Informatics in Developing Countries, V5, P219; Jhunjhunwala A, 2011, INFR HLTH CAR GLOB H, P59; Kaminer Y, 2006, AM J ADDICTION, V15, P122, DOI 10.1080/10550490601006121; Patnaik Somani, 2009, Proceedings of the 2009 International Conference on Information and Communication Technologies and Development (ICTD 2009), P74, DOI 10.1109/ICTD.2009.5426700; Regan S, 2011, NICOTINE TOB RES, V13, P255, DOI 10.1093/ntr/ntq248; Reidel K, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-46; Sachdeva KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022061; Skinner C, 2008, P 619 TEL ASS TECHN; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; World Health Organization, 2011, GLOB OBS EH SER, V3	13	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138274	10.1371/journal.pone.0138274	http://dx.doi.org/10.1371/journal.pone.0138274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376197	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000361610200095
J	Adhikari, RP; Kort, T; Shulenin, S; Kanipakala, T; Ganjbaksh, N; Roghmann, MC; Holtsberg, FW; Aman, MJ				Adhikari, Rajan P.; Kort, Thomas; Shulenin, Sergey; Kanipakala, Tulasikumari; Ganjbaksh, Nader; Roghmann, Mary-Claire; Holtsberg, Frederick W.; Aman, M. Javad			Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; RESISTANT STAPHYLOCOCCUS-AUREUS; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; GAMMA-HEMOLYSIN; VIRULENCE DETERMINANTS; COMMUNITY; TOXINS; PORE; INFECTIONS; LEUCOCIDIN	S. aureus vaccine development has proven particularly difficult. The conventional approach to achieve sterile immunity through opsonophagocytic killing has been largely unsuccessful. S. aureus is highly toxigenic and a great body of evidence suggests that a successful future vaccine for this organism should target extracellular toxins which are responsible for host tissue destruction and immunosuppression. Major staphylococcal toxins are alpha toxin (a single subunit hemolysin) along with a group of bicomponent pore-forming toxins (BCPFT), namely Panton-Valentine leukocidin (PVL), gamma hemolysins (HlgCB and AB), LukAB and LukED. In our previous report, an attenuated mutant of LukS-PV (PVL-S subunit) named as "LukS-mut9" elicited high immunogenic response as well as provided a significant protection in a mouse sepsis model. Recent discovery of PVL receptors shows that mice lack receptors for this toxin, thus the reported protection of mice with the PVL vaccine may relate to cross protective responses against other homologous toxins. This manuscript addresses this issue by demonstrating that polyclonal antibody generated by LukS-mut9 can neutralize other canonical and non-canonical leukotoxin pairs. In this report, we also demonstrated that several potent toxins can be created by non-canonical pairing of subunits. Out of 5 pairs of canonical and 8 pairs of non-canonical toxins tested, anti-LukS-mut9 polyclonal antibodies neutralized all except for LukAB. We also studied the potential hemolytic activities of canonical and noncanonical pairs among biocomponent toxins and discovered that a novel non-canonical pair consisting of HlgA and LukD is a highly toxic combination. This pair can lyse RBC from different species including human blood far better than alpha hemolysin. Moreover, to follow-up our last report, we explored the correlation between the levels of pre-existing antibodies to new sets of leukotoxins subunits and clinical outcomes in adult patients with S. aureus bacteremia. We found that there is an inversed correlation between the antibody titer to sepsis for leukotoxins LukS-mut9, LukF-PV, HlgC, LukE and LukAB, suggesting the risk of sepsis was significantly lower in the patients with higher antibody titer against those toxins.	[Adhikari, Rajan P.; Kort, Thomas; Shulenin, Sergey; Kanipakala, Tulasikumari; Ganjbaksh, Nader; Holtsberg, Frederick W.; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD 20878 USA; [Roghmann, Mary-Claire] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Roghmann, Mary-Claire] VA Maryland Hlth Care Syst, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Adhikari, RP (corresponding author), Integrated Biotherapeut Inc, Gaithersburg, MD 20878 USA.	rajan@integratedbiotherapeutics.com	Adhikari, Rajan/J-7396-2019		National Institute of Allergy and Infectious Diseases (NIAID) [AI106162, AI098232]; Integrated BioTherapeutics, Inc. (IBT) internal RD research fund; Integrated BioTherapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI106162, R56AI111205, R43AI098232, R01AI111205] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Integrated BioTherapeutics, Inc. (IBT) internal RD research fund; Integrated BioTherapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by grants (AI106162 to R.P.A. and AI098232 to M.J.A.) from the National Institute of Allergy and Infectious Diseases (NIAID) and partially from Integrated BioTherapeutics, Inc. (IBT) internal R&D research fund. Integrated BioTherapeutics, Inc. provided support in the form of salaries for authors RPA, TK, SS, FWH and MJA but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adhikari RP, 2012, J INFECT DIS, V206, P915, DOI 10.1093/infdis/jis462; Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Alonzo F, 2012, MOL MICROBIOL, V83, P423, DOI 10.1111/j.1365-2958.2011.07942.x; Aman MJ, 2014, TOXINS, V6, P950, DOI 10.3390/toxins6030950; Arciola CR, 2007, INT J ARTIF ORGANS, V30, P792, DOI 10.1177/039139880703000908; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DuMont AL, 2014, INFECT IMMUN, V82, P1268, DOI 10.1128/IAI.01444-13; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Holzinger D, 2012, J LEUKOCYTE BIOL, V92, P1069, DOI 10.1189/jlb.0112014; Joubert O, 2006, BIOCHEM J, V396, P381, DOI 10.1042/BJ20051878; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Karauzum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065384; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lattar SM, 2014, INFECT IMMUN, V82, P83, DOI 10.1128/IAI.01050-13; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Malachowa N, 2012, J INFECT DIS, V206, P1185, DOI 10.1093/infdis/jis495; Malachowa N, 2011, VIRULENCE, V2, P567, DOI 10.4161/viru.2.6.17732; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Merck, 2012, EFF IMM SAF SINGL DO; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; OZAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1181, DOI 10.1271/bbb.59.1181; Pozzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046648; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Salgado-Pabon W, 2014, NAT REV MICROBIOL, V12, P585, DOI 10.1038/nrmicro3308; Siqueira JA, 1997, J MED MICROBIOL, V46, P486, DOI 10.1099/00222615-46-6-486; Skurnik D, 2012, CLIN INFECT DIS, V55, P1188, DOI 10.1093/cid/cis624; Spaan AN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6438; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Sugawara N, 1999, BIOSCI BIOTECH BIOCH, V63, P884, DOI 10.1271/bbb.63.884; Tristan A, 2007, J HOSP INFECT, V65, P105, DOI 10.1016/S0195-6701(07)60025-5; Varshney AK, 2010, J INFECT DIS, V201, P92, DOI 10.1086/648613; Villaruz AE, 2009, J INFECT DIS, V200, P724, DOI 10.1086/604728; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; WERGELAND HI, 1989, J CLIN MICROBIOL, V27, P1286, DOI 10.1128/JCM.27.6.1286-1291.1989	50	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137874	10.1371/journal.pone.0137874	http://dx.doi.org/10.1371/journal.pone.0137874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367030	Green Published, gold			2022-12-26	WOS:000361601100163
J	Branecky, KL; Niswender, KD; Pendergast, JS				Branecky, Katrina L.; Niswender, Kevin D.; Pendergast, Julie S.			Disruption of Daily Rhythms by High-Fat Diet Is Reversible	PLOS ONE			English	Article							INDUCED OBESITY; LEPTIN RESISTANCE; CIRCADIAN CLOCK; MICE; METABOLISM; WORK	In mammals a network of circadian clocks coordinates behavior and physiology with 24-h environmental cycles. Consumption of high-fat diet disrupts this temporal coordination by advancing the phase of the liver molecular clock and altering daily rhythms of eating behavior and locomotor activity. In this study we sought to determine whether these effects of high-fat diet on circadian rhythms were reversible. We chronically fed mice high-fat diet and then returned them to low-fat chow diet. We found that the phase of the liver PERIOD2:: LUCIFERASE rhythm was advanced (by 4h) and the daily rhythms of eating behavior and locomotor activity were altered for the duration of chronic high-fat diet feeding. Upon diet reversal, the eating behavior rhythm was rapidly reversed (within 2 days) and the phase of the liver clock was restored by 7 days of diet reversal. In contrast, the daily pattern of locomotor activity was not restored even after 2 weeks of diet reversal. Thus, while the circadian system is sensitive to changes in the macronutrient composition of food, the eating behavior rhythm and liver circadian clock are specifically tuned to respond to changes in diet.	[Branecky, Katrina L.; Niswender, Kevin D.; Pendergast, Julie S.] Vanderbilt Univ, Sch Med, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN 37212 USA; [Niswender, Kevin D.] VA Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Pendergast, JS (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.	julie.pendergast@uky.edu			National Institutes of Health [DK098321, DK058404, DK085712, DK064857]; Vanderbilt University Digestive Disease Research Center (National Institutes of Health) [P30 DK058404]; resources of the VA Tennessee Valley Healthcare System; Diabetes Research and Training Center [DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, K08DK064857, R01DK085712, P60DK020593, K01DK098321, P30DK020593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Digestive Disease Research Center (National Institutes of Health); resources of the VA Tennessee Valley Healthcare System; Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health (www.nih.gov) grants DK098321 (to J.S.P.) and DK058404 (Pilot Award to J.S.P.). J.S.P. was supported by a Young Investigator Award from the Vanderbilt University Digestive Disease Research Center (National Institutes of Health grant P30 DK058404). K.D.N. was supported by resources of the VA Tennessee Valley Healthcare System and National Institutes of Health grants (DK085712 and DK064857) and the Diabetes Research and Training Center (DK20593). The authors declare no competing financial or non-financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Eberly R., 2010, IJAHSP, V8, P1; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Kettner NM, 2015, CELL METAB, V22, P448, DOI 10.1016/j.cmet.2015.06.005; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; Pendergast JS, 2013, EUR J NEUROSCI, V37, P1350, DOI 10.1111/ejn.12133; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Suwazono Y, 2009, CHRONOBIOL INT, V26, P926, DOI 10.1080/07420520903044422; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	20	48	49	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137970	10.1371/journal.pone.0137970	http://dx.doi.org/10.1371/journal.pone.0137970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366733	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100189
J	Lin, LZ; Chen, HB; Zhang, YX; Lin, W; Liu, Y; Li, T; Zeng, YP; Chen, JH; Du, HW; Chen, RH; Tan, Y; Liu, N				Lin, Longzai; Chen, Hongbin; Zhang, Yixian; Lin, Wei; Liu, Yong; Li, Tin; Zeng, Yongping; Chen, Jianhao; Du, Houwei; Chen, Ronghua; Tan, Yi; Liu, Nan			IL-10 Protects Neurites in Oxygen-Glucose-Deprived Cortical Neurons through the PI3K/Akt Pathway	PLOS ONE			English	Article							NF-KAPPA-B; GAP-43 NEUROMODULIN; EXPERIMENTAL STROKE; CEREBRAL-ISCHEMIA; PYRAMIDAL NEURONS; BRAIN-INJURY; RAT-BRAIN; IN-VITRO; CELLS; EXPRESSION	IL-10, as a cytokine, has an anti-inflammatory cascade following various injuries, but it remains blurred whether IL-10 protects neurites of cortical neurons after oxygen-glucose deprivation injury. Here, we reported that IL-10, in a concentration-dependent manner, reduced neuronal apoptosis and increased neuronal survival in oxygen-glucose-deprived primary cortical neurons, producing an optimal protective effect at 20ng/ml. After staining NF-H and GAP-43, we found that IL-10 significantly protected neurites in terms of axon length and dendrite number by confocal microscopy. Furthermore, it induced the phosphorylation of AKT, suppressed the activation of caspase-3, and up-regulated the protein expression of GAP-43. In contrast, LY294002, a specific inhibitor of PI3K/AKT, reduced the level of AKT phosphorylation and GAP-43 expression, increased active caspase-3 expression and thus significantly weakened IL-10-mediated protective effect in the OGD-induced injury model. IL-10NA, the IL-10 neutralizing antibody, reduced the level of p-PI3K phosphorylation and increased the expression of active caspase-3. These findings suggest that IL-10 provides neuroprotective effects by protecting neurites through PI3K/AKT signaling pathway in oxygen-glucose-deprived primary cortical neurons.	[Lin, Longzai; Chen, Hongbin; Lin, Wei; Liu, Yong; Li, Tin; Zeng, Yongping; Chen, Jianhao; Du, Houwei; Chen, Ronghua; Liu, Nan] Fujian Med Univ, Affiliated Union Hosp, Dept Neurol, Fuzhou, Fujian, Peoples R China; [Lin, Longzai; Chen, Hongbin; Zhang, Yixian; Lin, Wei; Liu, Yong; Li, Tin; Zeng, Yongping; Chen, Jianhao; Du, Houwei; Chen, Ronghua; Tan, Yi; Liu, Nan] Inst Cerebral Vasc Dis Fujian Prov, Fuzhou, Fujian, Peoples R China; [Zhang, Yixian; Liu, Nan] Fujian Med Univ, Affiliated Union Hosp, Dept Rehabil, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Liu, N (corresponding author), Fujian Med Univ, Affiliated Union Hosp, Dept Neurol, Fuzhou, Fujian, Peoples R China.	xieheliunan1984@sina.com			National Natural Science Foundation of China [81171867, 81472161]; Fujian Provincial Department of Science and Technology [2011Y0027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Department of Science and Technology	This research was supported by National Natural Science Foundation of China (No. 81171867 and No. 81472161) and Fujian Provincial Department of Science and Technology (No. 2011Y0027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Albrecht J, 2005, EUR J NEUROSCI, V22, P2295, DOI 10.1111/j.1460-9568.2005.04398.x; Avwenagha O, 2003, J NEUROCYTOL, V32, P1077, DOI 10.1023/B:NEUR.0000021903.24849.6c; Boyd ZS, 2003, INVEST OPHTH VIS SCI, V44, P5206, DOI 10.1167/iovs.03-0534; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chakravarthy B, 2008, BIOCHEM BIOPH RES CO, V371, P679, DOI 10.1016/j.bbrc.2008.04.119; Cianciulli A, 2015, INT IMMUNOPHARMACOL, V24, P369, DOI 10.1016/j.intimp.2014.12.035; Dent EW, 1998, J NEUROBIOL, V35, P287, DOI 10.1002/(SICI)1097-4695(19980605)35:3<287::AID-NEU6>3.0.CO;2-V; Forgie ML, 2003, BEHAV NEUROSCI, V117, P257, DOI 10.1037/0735-7044.117.2.257; Furutani R, 2012, J NEUROTRAUM, V29, P1266, DOI 10.1089/neu.2010.1630; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Grilli M, 2000, EUR J NEUROSCI, V12, P2265, DOI 10.1046/j.1460-9568.2000.00090.x; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Hendrickson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046918; Hong-Qi Y, 2012, TRANSL NEURODEGENER, V1, DOI [10.1186/2047-9158-1-7, 10.1186/2047-9158-1-21]; Ikeda-Matsuo Y, 2011, J NEUROIMMUNOL, V238, P34, DOI 10.1016/j.jneuroim.2011.06.014; Isele NB, 2007, NEUROCHEM INT, V50, P243, DOI 10.1016/j.neuint.2006.08.007; Kang LH, 2013, NEUROCHEM RES, V38, P311, DOI 10.1007/s11064-012-0922-y; Kriz J, 2009, ACTA NEUROPATHOL, V117, P497, DOI 10.1007/s00401-009-0496-1; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu N, 2011, NEUROSCIENCE, V194, P349, DOI 10.1016/j.neuroscience.2011.07.037; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Liu W, 2013, THEOR APPL MECH LETT, V3, DOI [10.1186/2045-9912-3-3, 10.1063/2.1306201]; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Liu Z, 2012, CELL MOL NEUROBIOL, V32, P191, DOI 10.1007/s10571-011-9746-6; Mao L, 2013, NEUROSCIENCE, V231, P272, DOI 10.1016/j.neuroscience.2012.11.050; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Ooboshi H, 2005, CIRCULATION, V111, P913, DOI 10.1161/01.CIR.0000155622.68580.DC; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Ruan YW, 2009, J NEUROSCI RES, V87, P61, DOI 10.1002/jnr.21816; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Song JQ, 2009, APOPTOSIS, V14, P1061, DOI 10.1007/s10495-009-0382-2; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Tedeschi A, 2009, CELL DEATH DIFFER, V16, P543, DOI 10.1038/cdd.2008.175; Wang XH, 2005, NEUROSCI RES, V51, P129, DOI 10.1016/j.neures.2004.10.001; Wu XM, 2012, NEUROSCI BULL, V28, P509, DOI 10.1007/s12264-012-1273-z; Xiang J, 2010, CAN J PHYSIOL PHARM, V88, P907, DOI [10.1139/Y10-069, 10.1139/y10-069]; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x; Zhou ZY, 2010, J ETHNOPHARMACOL, V131, P154, DOI 10.1016/j.jep.2010.06.023	40	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136959	10.1371/journal.pone.0136959	http://dx.doi.org/10.1371/journal.pone.0136959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366999	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100037
J	Sun, YL; Vedsted, P; Fenger-Gron, M; Sen Wu, C; Bech, BH; Olsen, J; Benros, ME; Vestergaard, M				Sun, Yuelian; Vedsted, Peter; Fenger-Gron, Morten; Sen Wu, Chun; Bech, Bodil Hammer; Olsen, Jorn; Benros, Michael Eriksen; Vestergaard, Mogens			Cancer Mortality in People Treated with Antidepressants before Cancer Diagnosis: A Population Based Cohort Study	PLOS ONE			English	Article							BREAST-CANCER; COLLABORATIVE CARE; SOCIAL-INEQUALITY; DEPRESSION; SURVIVAL; STRESS; CARCINOMA; DENMARK; ANXIETY; HISTORY	Background Depression is common after a cancer diagnosis and is associated with an increased mortality, but it is unclear whether depression occurring before the cancer diagnosis affects cancer mortality. We aimed to study cancer mortality of people treated with antidepressants before cancer diagnosis. Methods and Findings We conducted a population based cohort study of all adults diagnosed with cancer between January 2003 and December 2010 in Denmark (N = 201,662). We obtained information on cancer from the Danish Cancer Registry, on the day of death fromthe Danish Civil Registry, and on redeemed antidepressants from the Danish National Prescription Registry. Current users of antidepressants were defined as those who redeemed the latest prescription of antidepressant 0-4 months before cancer diagnosis (irrespective of earlier prescriptions), and former users as those who redeemed the latest prescription five or more months before cancer diagnosis. We estimated an all-cause one-year mortality rate ratio (MRR) and a conditional five-year MRR for patients who survived the first year after cancer diagnosis and confidence interval (CI) using a Cox proportional hazards regressionmodel. Overall, 33,111 (16.4%) patients redeemed at least one antidepressant prescription in the three years before cancer diagnosis of whom 21,851 (10.8%) were current users at the time of cancer diagnosis. Current antidepressant users had a 32% higher one-year mortality (MRR = 1.32, 95% CI: 1.29-1.35) and a 22% higher conditional five-year mortality (MRR = 1.22, 95% CI: 1.17-1.26) if patients survived the first year after the cancer diagnosis than patients not redeeming antidepressants. The one-year mortality was particularly high for patients who initiated antidepressant treatment within fourmonths before cancer diagnosis (MRR = 1.54, 95% CI: 1.47-1.61). Former users had no increased cancermortality. Conclusions Initiation of antidepressive treatment prior to cancer diagnosis is common and is associated with an increased mortality.	[Sun, Yuelian; Vedsted, Peter; Fenger-Gron, Morten; Bech, Bodil Hammer; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Sun, Yuelian; Sen Wu, Chun; Bech, Bodil Hammer; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Benros, Michael Eriksen] Copenhagen Univ Hosp, Psychiat Res Unit, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; University of Copenhagen	Sun, YL (corresponding author), Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark.	ys@ph.au.dk	Bech, Bodil Hammer/B-9646-2016; Vedsted, Peter/C-2583-2008; Vestergaard, Mogens/M-9333-2014; Sun, Yuelian/AFF-2622-2022; Benros, Michael Eriksen/N-5868-2016	Bech, Bodil Hammer/0000-0002-0287-3687; Vedsted, Peter/0000-0003-2113-5599; Vestergaard, Mogens/0000-0001-8830-2174; Sun, Yuelian/0000-0002-6905-0503; Benros, Michael Eriksen/0000-0003-4939-9465; Fenger-Gron, Morten/0000-0002-6354-5871	Lundbeck Foundation; Novo Nordisk Foundation; Danish Cancer Society [R20-A1028-10-52]; Lundbeck Foundation [R155-2012-11280] Funding Source: researchfish; The Danish Cancer Society [R142-A9081] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); The Danish Cancer Society(Danish Cancer Society)	This study was supported by an unrestricted grant from the Lundbeck Foundation (http://www.lundbeckfoundation.com/) (MV), the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en) (PV), and the Danish Cancer Society (http://www.cancer.dk/) (JO PV) (for project R20-A1028-10-52 and project on 'From symptom to treatment-Research Centre for Cancer Diagnosis in Primary Care'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall-Barbry G, 2012, PSYCHOSOMATICS, V53, P356, DOI 10.1016/j.psym.2012.01.001; Ancoli-Israel S, 2014, SUPPORT CARE CANCER, V22, P2535, DOI 10.1007/s00520-014-2204-5; Andersen TF, 1999, DAN MED BULL, V46, P263; Batty GD, 2012, BRIT J CANCER, V106, P1842, DOI 10.1038/bjc.2012.150; Benros ME, 2009, INT J CANCER, V124, P2917, DOI 10.1002/ijc.24274; Boyd CA, 2012, SURGERY, V152, P403, DOI 10.1016/j.surg.2012.06.010; Chang CK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004295; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen S, 1998, J NATL CANCER I, V90, P3, DOI 10.1093/jnci/90.1.3; Dalton SO, 2008, EUR J CANCER, V44, P2074, DOI 10.1016/j.ejca.2008.06.018; Dalton SO, 2008, EUR J CANCER, V44, P1938, DOI [10.1016/j.ejca.2008.06.010, 10.1016/j.ejca.2008.06.034]; Deleuran Thomas, 2012, Clin Epidemiol, V4 Suppl 2, P39, DOI 10.2147/CLEP.S33315; Forbes LJL, 2014, BRIT J CANCER, V111, P581, DOI 10.1038/bjc.2014.304; FRAS I, 1967, AM J PSYCHIAT, V123, P1553, DOI 10.1176/ajp.123.12.1553; Froslev Trine, 2012, Clin Epidemiol, V4 Suppl 2, P5, DOI 10.2147/CLEP.S32064; Goodwin JS, 2004, J AM GERIATR SOC, V52, P106, DOI 10.1111/j.1532-5415.2004.52018.x; Graber MA, 2000, J GEN INTERN MED, V15, P204, DOI 10.1046/j.1525-1497.2000.04399.x; Hinz A, 2010, EUR J CANCER CARE, V19, P522, DOI 10.1111/j.1365-2354.2009.01088.x; Hjerl K, 2003, PSYCHOSOMATICS, V44, P24, DOI 10.1176/appi.psy.44.1.24; Holland-Bill Louise, 2012, Clin Epidemiol, V4 Suppl 2, P25, DOI 10.2147/CLEP.S31542; Howard LM, 2010, LANCET ONCOL, V11, P797, DOI 10.1016/S1470-2045(10)70085-1; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; JOFFE RT, 1986, GEN HOSP PSYCHIAT, V8, P241, DOI 10.1016/0163-8343(86)90004-6; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kisely S, 2013, JAMA PSYCHIAT, V70, P209, DOI 10.1001/jamapsychiatry.2013.278; Kotwal AA, 2012, MED CARE, V50, P1037, DOI 10.1097/MLR.0b013e318269e096; Ludman EJ, 2010, AM J PREV MED, V38, P303, DOI 10.1016/j.amepre.2009.10.039; Moreno-Smith M, 2010, FUTURE ONCOL, V6, P1863, DOI [10.2217/fon.10.142, 10.2217/FON.10.142]; Nguyen-Nielsen Mary, 2012, Clin Epidemiol, V4 Suppl 2, P17, DOI 10.2147/CLEP.S32004; Ording Anne Gulbech, 2012, Clin Epidemiol, V4 Suppl 2, P11, DOI 10.2147/CLEP.S31574; Ostenfeld Eva Bjerre, 2012, Clin Epidemiol, V4 Suppl 2, P33; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pinquart M, 2010, PSYCHOL MED, V40, P1797, DOI 10.1017/S0033291709992285; Prasad SM, 2014, J CLIN ONCOL, V32, P2471, DOI 10.1200/JCO.2013.51.1048; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Sharpe M, 2014, LANCET, V384, P1099, DOI 10.1016/S0140-6736(14)61231-9; Sogaard Mette, 2012, Clin Epidemiol, V4 Suppl 2, P1; Storm HH, 1997, DAN MED BULL, V44, P535; Watson M, 1999, LANCET, V354, P1331, DOI 10.1016/S0140-6736(98)11392-2	40	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138134	10.1371/journal.pone.0138134	http://dx.doi.org/10.1371/journal.pone.0138134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26367120	Green Submitted, gold, Green Published			2022-12-26	WOS:000361601100234
J	Jiang, N; Zhao, GQ; Lin, J; Hu, LT; Che, CY; Li, C; Wang, Q; Xu, Q; Peng, XD				Jiang, Nan; Zhao, Guiqiu; Lin, Jing; Hu, Liting; Che, Chengye; Li, Cui; Wang, Qian; Xu, Qiang; Peng, Xudong			Indoleamine 2,3-Dioxygenase Is Involved in the Inflammation Response of Corneal Epithelial Cells to Aspergillus fumigatus Infections	PLOS ONE			English	Article							TRYPTOPHAN CATABOLISM; IMMUNE RECOGNITION; RECEPTOR DECTIN-1; FUNGAL KERATITIS; DENDRITIC CELLS; INNATE; TOLERANCE; EXPRESSION; MACROPHAGES; INDUCTION	Indoleamine 2,3-dioxygenase (IDO), which is mainly expressed in activated dendritic cells, is known as a regulator of immune responses. However, the role of IDO in immune responses against fungal corneal infection has not been investigated. To evaluate the regulatory mechanisms of IDO in fungal inflammation, we resorted to human corneal epithelial cells (HCECs), known as the first barrier of cornea against pathogenic microorganisms. We found that IDO was significantly up-regulated in corneal epithelium infected with Aspergillus fumigatus (A. fumigatus) and HCECs incubated with spores of A. fumigatus. Furthermore, IDO inhibitor (1-methyltryptophan, 1-MT) enhanced inflammatory cytokines IL-1 beta and IL-6 expression which were up-regulated by A. fumigatus spores infection. Dectin-1, as one of the important C-type lectin receptors, can identify beta-glucan, and mediate fungal innate immune responses. In the present study, pre-treatment with curdlan, a Dectin-1 agonist, further enhanced IDO expression compared with A. fumigatus stimulation. While laminarin, the Dectin-1 specific inhibitor, partially inhibited IDO expression stimulated by A. fumigatus. Further studies demonstrated inhibition of IDO activity amplified the expressions of inflammatory cytokines IL-1 beta and IL-6 induced by activation of Dectin-1. These results suggested that IDO was involved in the immune responses of fungal keratitis. The activation of Dectin-1 may contribute to A. fumigatus spores-induced up-regulation of IDO.	[Jiang, Nan; Zhao, Guiqiu; Lin, Jing; Hu, Liting; Che, Chengye; Li, Cui; Wang, Qian; Xu, Qiang; Peng, Xudong] Qingdao Univ, Affiliated Hosp, Dept Ophthalmol, Qingdao 266003, Shandong, Peoples R China	Qingdao University	Zhao, GQ (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Ophthalmol, Qingdao 266003, Shandong, Peoples R China.	zhaoguiqiu_good@126.com			National Natural Science Foundation of China [81170825, 81470609]; Specialized Research Fund for the Doctoral Program of Higher Education [20123706110003]; Youth Natural Science Foundation of Shandong Province [ZR2013HQ007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Youth Natural Science Foundation of Shandong Province	This work was supported by grants from National Natural Science Foundation of China (81170825, 81470609), Specialized Research Fund for the Doctoral Program of Higher Education (20123706110003) and grant from the Youth Natural Science Foundation of Shandong Province (ZR2013HQ007).	Agrawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013418; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Bonifazi P, 2010, MUCOSAL IMMUNOL, V3, P193, DOI 10.1038/mi.2009.130; Bozza S, 2005, J IMMUNOL, V174, P2910, DOI 10.4049/jimmunol.174.5.2910; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Carvalho A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00156; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; de Luca A, 2010, CELL MOL IMMUNOL, V7, P459, DOI 10.1038/cmi.2010.43; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fujikawa T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002882; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Guo H, 2009, FEMS IMMUNOL MED MIC, V56, P88, DOI 10.1111/j.1574-695X.2009.00551.x; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jain S, 2014, J CLIN DIAGN RES, V8, pDD01; Karthikeyan RS, 2011, J INFECT DIS, V204, P942, DOI 10.1093/infdis/jir426; Karumuthil-Melethil S, 2014, J IMMUNOL, V193, P3308, DOI 10.4049/jimmunol.1400186; Kredics L, 2015, MYCOSES, V58, P243, DOI 10.1111/myc.12306; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; MacKenzie CR, 1999, EUR J IMMUNOL, V29, P3254, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3254::AID-IMMU3254&gt;3.0.CO;2-0; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Min L, 2012, J IMMUNOL, V188, P1789, DOI 10.4049/jimmunol.1101755; Montagnoli Claudia, 2006, Novartis Found Symp, V279, P66; Romani L, 2006, BLOOD, V108, P2265, DOI 10.1182/blood-2006-02-004762; Ryu YH, 2007, INVEST OPHTH VIS SCI, V48, P4148, DOI 10.1167/iovs.05-1336; Sakurai K, 2002, J NEUROIMMUNOL, V129, P186, DOI 10.1016/S0165-5728(02)00176-5; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sukhithasri V, 2013, MICROBIOL RES, V168, P396, DOI 10.1016/j.micres.2013.02.005; Sun XG, 2007, AM J OPHTHALMOL, V143, P131, DOI 10.1016/j.ajo.2006.09.042; TAKIKAWA O, 1986, J BIOL CHEM, V261, P3648; Tarabishy AB, 2008, J IMMUNOL, V181, P593, DOI 10.4049/jimmunol.181.1.593; Taylor PR, 2014, J IMMUNOL, V192, P3319, DOI 10.4049/jimmunol.1302235; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; Wang LY, 2009, CLIN EXP OPHTHALMOL, V37, P763, DOI 10.1111/j.1442-9071.2009.02155.x; Weindl G, 2010, J DENT RES, V89, P666, DOI 10.1177/0022034510368784; Wu TG, 2003, INVEST OPHTH VIS SCI, V44, P210, DOI 10.1167/iovs.02-0446; Xie LX, 2006, OPHTHALMOLOGY, V113, P1943, DOI 10.1016/j.ophtha.2006.05.035; Yeung AWS, 2012, J LEUKOCYTE BIOL, V91, P657, DOI 10.1189/jlb.1011532; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zelante T, 2009, EUR J IMMUNOL, V39, P645, DOI 10.1002/eji.200839102; Zhong WX, 2009, MOL VIS, V15, P1303	48	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137423	10.1371/journal.pone.0137423	http://dx.doi.org/10.1371/journal.pone.0137423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361229	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100036
J	Koch, A; Maia, A; Janssen, A; Medema, RH				Koch, A.; Maia, A.; Janssen, A.; Medema, R. H.			Molecular basis underlying resistance to Mps1/TTK inhibitors	ONCOGENE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; PROTEIN-KINASES; MITOTIC CHECKPOINT; MYELOID-LEUKEMIA; DRUG-RESISTANCE; AURORA KINASES; CANCER-THERAPY; BCR-ABL; CELLS; KINETOCHORES	Mps1/TTK is a dual-specificity kinase, with an essential role in mitotic checkpoint signaling, which has emerged as a potential target in cancer therapy. Several Mps1/TTK small-molecule inhibitors have been described that exhibit promising activity in cell culture and xenograft models. Here, we investigated whether cancer cells can develop resistance to these drugs. To this end, we treated various cancer cell lines with sublethal concentrations of a potent Mps1/TTK inhibitor in order to isolate inhibitor-resistant monoclonal cell lines. We identified four point mutations in the catalytic domain of Mps1/TTK that gave rise to inhibitor resistance but retained wildtype catalytic activity. Interestingly, cross-resistance of the identified mutations to other Mps1/TTK inhibitors is limited. Our studies predict that Mps1/TTK inhibitor-resistant tumor cells can arise through the acquisition of mutations in the adenosine triphosphate-binding pocket of the kinase that prevent stable binding of the inhibitors. In addition, our results suggest that combinations of inhibitors could be used to prevent acquisition of drug resistance. Interestingly, cross-resistance seems nonspecific for inhibitor scaffolds, a notion that can be exploited in future drug design to evict possible resistance mutations during clinical treatment.	[Koch, A.; Maia, A.; Janssen, A.; Medema, R. H.] Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Janssen, A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA	Netherlands Cancer Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Medema, RH (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.medema@nki.nl		Maia, Ana/0000-0003-1261-7211; Janssen, Aniek/0000-0001-6731-6657; Koch, Andre/0000-0003-3502-382X; Medema, Rene/0000-0002-6754-0381	NWO Gravitation Program (Cancer Genomics Center, CGC.nl); EMBO long-term fellowship [ALTF-425-2013]	NWO Gravitation Program (Cancer Genomics Center, CGC.nl); EMBO long-term fellowship(European Molecular Biology Organization (EMBO))	We thank Geert Kops (UMC Utrecht, The Netherlands) Susanne Lens (UMC Utrecht, The Netherlands) and Anastassis Perrakis (NKI, Amsterdam, The Netherlands) for reagents. Roos Klop, Yoshitaka Hiruma and Mathijs Vleugel for technical help. Bram van den Broek (NKI, Amsterdam, The Netherlands) for providing the ImageJ analysis macro for mitotic index analysis. We thank our colleagues for support and helpful suggestions. The research was funded by the NWO Gravitation Program (Cancer Genomics Center, CGC.nl). AK was supported by an EMBO long-term fellowship (ALTF-425-2013).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Barouch-Bentov R, 2011, EXPERT OPIN INV DRUG, V20, P153, DOI 10.1517/13543784.2011.546344; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Chu MLH, 2010, BIOCHEMISTRY-US, V49, P1689, DOI 10.1021/bi901970c; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Alise AM, 2008, MOL CANCER THER, V7, P1140, DOI 10.1158/1535-7163.MCT-07-2051; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyers PA, 2005, CELL CYCLE, V4, P784, DOI 10.4161/cc.4.6.1693; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jemaa M, 2013, CELL DEATH DIFFER, V20, P1532, DOI 10.1038/cdd.2013.105; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kumar DV, 2012, BIOORG MED CHEM LETT, V22, P4377, DOI 10.1016/j.bmcl.2012.04.131; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marina Caldarelli MA, 2009, Pyrazolo-quinazolines, Patent No. [WO 2009156315 A1, 2009156315]; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Naud S, 2013, J MED CHEM, V56, P10045, DOI 10.1021/jm401395s; Nijenhuis W, 2014, NAT CELL BIOL, V16, P1257, DOI 10.1038/ncb3065; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tannous BA, 2013, JNCI-J NATL CANCER I, V105, P1322, DOI 10.1093/jnci/djt168; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Vleugel M, 2013, J CELL BIOL, V203, P943, DOI 10.1083/jcb.201307016; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515	43	32	33	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 12	2016	35	19					2518	2528		10.1038/onc.2015.319	http://dx.doi.org/10.1038/onc.2015.319			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GQ	26364596	hybrid, Green Published			2022-12-26	WOS:000376165500010
J	Babaeian, A; Bayestehtashk, A; Bandarabadi, M				Babaeian, Amir; Bayestehtashk, Alireza; Bandarabadi, Mojtaba			Multiple Manifold Clustering Using Curvature Constrained Path	PLOS ONE			English	Article							TRACKING; MODEL	The problem of multiple surface clustering is a challenging task, particularly when the surfaces intersect. Available methods such as Isomap fail to capture the true shape of the surface near by the intersection and result in incorrect clustering. The Isomap algorithm uses shortest path between points. The main draw back of the shortest path algorithm is due to the lack of curvature constrained where causes to have a path between points on different surfaces. In this paper we tackle this problem by imposing a curvature constraint to the shortest path algorithm used in Isomap. The algorithm chooses several landmark nodes at random and then checks whether there is a curvature constrained path between each landmark node and every other node in the neighborhood graph. We build a binary feature vector for each point where each entry represents the connectivity of that point to a particular landmark. Then the binary feature vectors could be used as a input of conventional clustering algorithm such as hierarchical clustering. We apply our method to simulated and some real datasets and show, it performs comparably to the best methods such as K-manifold and spectral multi-manifold clustering.	[Babaeian, Amir] Univ Calif San Diego, Dept Math, San Diego, CA 92103 USA; [Bayestehtashk, Alireza] Oregon Hlth & Sci Univ, Dept Comp Sci, Portland, OR 97201 USA; [Bandarabadi, Mojtaba] Univ Coimbra, Dept Informat Engn, Coimbra, Portugal	University of California System; University of California San Diego; Oregon Health & Science University; Universidade de Coimbra	Babaeian, A (corresponding author), Univ Calif San Diego, Dept Math, San Diego, CA 92103 USA.	ababaeian@ucsd.edu	Bandarabadi, Mojtaba/C-5024-2011	Bandarabadi, Mojtaba/0000-0002-4608-1374	National Science Foundation [DMS-0915160]	National Science Foundation(National Science Foundation (NSF))	This work was all supported by a grant from the National Science Foundation (DMS-0915160).	Arias-Castro E, 2011, ELECTRON J STAT, V5, P1537, DOI 10.1214/11-EJS651; Babaeean A, 2008, PROCEEDINGS OF THE 40TH SOUTHEASTERN SYMPOSIUM ON SYSTEM THEORY, P366; Babaeean A, 2008, ICNC 2008: FOURTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 4, PROCEEDINGS, P569, DOI 10.1109/ICNC.2008.584; Babaeian A, 2009, SE SYM SYS THRY, P68, DOI 10.1109/SSST.2009.4806829; Babaeian A, 2009, SE SYM SYS THRY, P59, DOI 10.1109/SSST.2009.4806821; Basri R, 2003, IEEE T PATTERN ANAL, V25, P218, DOI 10.1109/TPAMI.2003.1177153; Bayestehtashk A, 2013, INT CONF ACOUST SPEE, P5750, DOI 10.1109/ICASSP.2013.6638766; Bayestehtashk Alireza, 2013, COMPUTER SPEECH LANG; Beygelzimer A., 2006, P 23 INT C MACH LEAR, P97, DOI [DOI 10.1145/1143844.1143857, 10.1145/1143844.1143857]; Chen GL, 2009, INT J COMPUT VISION, V81, P317, DOI 10.1007/s11263-008-0178-9; de Silva V., 2002, ADV NEURAL INFORM PR, V15, P705; Duc AKH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070059; Epstein R., 1995, Proceedings of the Workshop on Physics-Based Modeling in Computer Vision (Cat. No.95TB8038), P108, DOI 10.1109/PBMCV.1995.514675; Fu ZY, 2005, IEEE IMAGE PROC, P2029; Geman D, 1996, IEEE T PATTERN ANAL, V18, P1, DOI 10.1109/34.476006; Gionis A., 2005, P 11 ACM SIGKDD INT, P51, DOI 10.1145/1081870.1081880; Goldberg A.B., 2009, ARTIF INTELL STAT, V5, P169; Gong D., 2012, P 29 INT C MACH LEAR; Guo QY, 2007, ICMLA 2007: SIXTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P375, DOI 10.1109/ICMLA.2007.43; Hira ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090562; Ho J, 2003, PROC CVPR IEEE, P11, DOI 10.1109/cvpr.2003.1211332; Kushnir D, 2006, PATTERN RECOGN, V39, P1876, DOI 10.1016/j.patcog.2006.04.007; Ma Y, 2008, SIAM REV, V50, P413, DOI 10.1137/060655523; Maier M, 2009, THEOR COMPUT SCI, V410, P1749, DOI 10.1016/j.tcs.2009.01.009; Martinez VJ, 2002, STATISTICS OF THE GA; Ng AY, 2002, ADV NEUR IN, V14, P849; Perona P., 2001, ADV NEURAL INFORM PR, P1255; Rastegar S, 2009, SE SYM SYS THRY, P64, DOI 10.1109/SSST.2009.4806823; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Sapiro, 2007, ADV NEURAL INFORM PR, V19, P553; Shen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084096; Souvenir R, 2005, IEEE I CONF COMP VIS, P648; Tashk ARB, 2007, ICSPC: 2007 IEEE INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING AND COMMUNICATIONS, VOLS 1-3, PROCEEDINGS, P1023; Tauro F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091131; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tipping ME, 1999, NEURAL COMPUT, V11, P443, DOI 10.1162/089976699300016728; Vidal R, 2005, IEEE T PATTERN ANAL, V27, P1945, DOI 10.1109/TPAMI.2005.244; Vidal R, 2006, J MATH IMAGING VIS, V25, P403, DOI 10.1007/s10851-006-8286-z; Wang Y, 2011, IEEE T NEURAL NETWOR, V22, P1149, DOI 10.1109/TNN.2011.2147798; Yang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047406	41	6	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137986	10.1371/journal.pone.0137986	http://dx.doi.org/10.1371/journal.pone.0137986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375819	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200066
J	Biadglegne, F; Merker, M; Sack, U; Rodloff, AC; Niemann, S				Biadglegne, Fantahun; Merker, Matthias; Sack, Ulrich; Rodloff, Arne C.; Niemann, Stefan			Tuberculous Lymphadenitis in Ethiopia Predominantly Caused by Strains Belonging to the Delhi/CAS Lineage and Newly Identified Ethiopian Clades of the Mycobacterium tuberculosis Complex	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANCE; MIRU-VNTRPLUS; PULMONARY	Background Recently, newly defined clades of Mycobacterium tuberculosis complex (MTBC) strains, namely Ethiopia 1-3 and Ethiopia H37Rv-like strains, and other clades associated with pulmonary TB (PTB) were identified in Ethiopia. In this study, we investigated whether these new strain types exhibit an increased ability to cause TB lymphadenitis (TBLN) and raised the question, if particular MTBC strains derived from TBLN patients in northern Ethiopia are genetically adapted to their local hosts and/or to the TBLN. Methods Genotyping of 196 MTBC strains isolated from TBLN patients was performed by spoligotyping and 24-loci mycobacterial interspersed repetitive unit-variable number of tandem repeats (MIRU-VNTR) typing. A statistical analysis was carried out to see possible associations between patient characteristics and phylogenetic MTBC strain classification. Results Among 196 isolates, the majority of strains belonged to the Delhi/CAS (38.8%) lineage, followed by Ethiopia 1 (9.7%), Ethiopia 3 (8.7%), Ethiopia H37RV-like (8.2%), Ethiopia 2 and Haarlem (7.7% each), URAL (3.6%), Uganda l and LAM (2% each), S-type (1.5%), X-type (1%), and 0.5% isolates of TUR, EAI, and Beijing genotype, respectively. Overall, 15 strains (7.7%) could not be allocated to a previously described phylogenetic lineage. The distribution of MTBC lineages is similar to that found in studies of PTB samples. The cluster rate (35%) in this study is significantly lower (P = 0.035) compared to 45% in the study of PTB in northwestern Ethiopia. Conclusion In the studied area, lymph node samples are dominated by Dehli/CAS genotype strains and strains of largely not yet defined clades based on MIRU-VNTR 24-loci nomenclature. We found no indication that strains of particular genotypes are specifically associated with TBLN. However, a detailed analysis of specific genetic variants of the locally contained Ethiopian clades by whole genome sequencing may reveal new insights into the host-pathogen co-evolution and specific features that are related to the local host immune system.	[Biadglegne, Fantahun] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Biadglegne, Fantahun; Rodloff, Arne C.] Univ Leipzig, Univ Hosp, Inst Med Microbiol & Epidemiol Infect Dis, D-04109 Leipzig, Germany; [Biadglegne, Fantahun; Sack, Ulrich] Univ Leipzig, Univ Hosp, Inst Clin Immunol, D-04109 Leipzig, Germany; [Merker, Matthias; Niemann, Stefan] Res Ctr Borstel, Mol Mycobacteriol, Borstel, Germany; [Biadglegne, Fantahun; Sack, Ulrich] Univ Leipzig, Translat Ctr Regenerat Med TRM Leipzig, D-04109 Leipzig, Germany; [Niemann, Stefan] Partner Site Borstel, German Ctr Infect Res, Borstel, Germany	Bahir Dar University; Leipzig University; Leipzig University; Forschungszentrum Borstel; Leipzig University; German Center for Infection Research	Biadglegne, F (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	fantahun.degeneh@gmail.com	Degeneh, Fantahun/AAE-6826-2022; Sack, Ulrich/J-6301-2015; Degeneh, Fantahun/AAC-3138-2022; Niemann, Stefan/C-9327-2011; Merker, Matthias/P-7399-2015	Sack, Ulrich/0000-0002-7813-0492; Merker, Matthias/0000-0003-1386-2331; Niemann, Stefan/0000-0002-6604-0684	German Federal Ministry of Education and Research (BMBF) [1315883]; Institute of Medical Microbiology and Epidemiology of Infectious Diseases; Institute of clinical immunology, University Hospital Leipzig, Germany; Translational Centre for Regenerative Medicine (TRM), University Hospital Leipzig, Germany; Molecular Mycobacteriology, Research Center Borstel, Germany; German Academic Exchange Service (DAAD); University of Bahir Dar, Ethiopia	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Institute of Medical Microbiology and Epidemiology of Infectious Diseases; Institute of clinical immunology, University Hospital Leipzig, Germany; Translational Centre for Regenerative Medicine (TRM), University Hospital Leipzig, Germany; Molecular Mycobacteriology, Research Center Borstel, Germany; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Bahir Dar, Ethiopia	The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF, 1315883), the Institute of Medical Microbiology and Epidemiology of Infectious Diseases, Institute of clinical immunology, University Hospital Leipzig, Germany, Translational Centre for Regenerative Medicine (TRM), University Hospital Leipzig, Germany, Molecular Mycobacteriology, Research Center Borstel, Germany, the German Academic Exchange Service (DAAD) and University of Bahir Dar, Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Hajoj S, 2013, INFECT GENET EVOL, V16, P362, DOI 10.1016/j.meegid.2013.03.019; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Annam V, 2009, INDIAN J PATHOL MICR, V52, P349, DOI 10.4103/0377-4929.54991; [Anonymous], 2011, GLOB TUB CONTR 2011; Belay M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238532; Biadglegne F, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-31; Biadglegne F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106869; Biadglegne F, 2014, TUBERCULOSIS, V94, P502, DOI 10.1016/j.tube.2014.05.002; Biadglegne F, 2014, INDIAN J MED RES, V140, P116; Biadglegne F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081918; Biadglegne F, 2013, INT J MED SCI, V10, P1589, DOI 10.7150/ijms.6806; Bruchfeld J, 2002, J CLIN MICROBIOL, V40, P1636, DOI 10.1128/JCM.40.5.1636-1643.2002; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chatterjee A, 2013, TUBERCULOSIS, V93, P250, DOI 10.1016/j.tube.2012.10.004; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Deribew A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-54; Diriba B, 2013, INT J TUBERC LUNG D, V17, P246, DOI 10.5588/ijtld.12.0195; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Fitzgibbon MM, 2013, EURO SURVEILL, V18; Garedew L, 2013, INT J TUBERC LUNG D, V17, P1076, DOI 10.5588/ijtld.12.0854; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; HERMANS PWM, 1995, J INFECT DIS, V171, P1504, DOI 10.1093/infdis/171.6.1504; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Maeda S, 2014, TUBERCULOSIS, V94, P649, DOI 10.1016/j.tube.2014.09.005; Mbugi EV, 2014, TUBERCULOSIS EDINB, V29; Mihret A, 2012, AFR HEALTH SCI, V12, P339, DOI 10.4314/ahs.v12i3.15; Reyes JF, 2012, INFECT GENET EVOL, V12, P811, DOI 10.1016/j.meegid.2011.05.018; Sulaiman A, 2010, COMPREHENSIVE CYTOL, V16, P707; Supiyaphun P, 2010, ASIAN BIOMED, V4, P787, DOI 10.2478/abm-2010-0102; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tessema B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-131; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2010, GLOB TUB CONTR 2010; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Workalemahu Bereket, 2013, BMC Res Notes, V6, P352, DOI 10.1186/1756-0500-6-352; World Health Organization, 2013, GLOB TUB CONTR 2013	37	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137865	10.1371/journal.pone.0137865	http://dx.doi.org/10.1371/journal.pone.0137865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376441	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200058
J	Hiramatsu, Y; Kimura, D; Kadota, K; Ito, T; Kinoshita, H				Hiramatsu, Yuichi; Kimura, Daisuke; Kadota, Koji; Ito, Taro; Kinoshita, Hiroshi			Control of Precision Grip Force in Lifting and Holding of Low-Mass Objects	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; FINGERTIP FORCES; MEDIAN NERVE; HUMAN HAND; MUSCLE; FLUCTUATIONS; COMPRESSION; INFORMATION; ADJUSTMENTS; PERFORMANCE	Few studies have investigated the control of grip force when manipulating an object with an extremely small mass using a precision grip, although some related information has been provided by studies conducted in an unusual microgravity environment. Grip-load force coordination was examined while healthy adults (N = 17) held a moveable instrumented apparatus with its mass changed between 6 g and 200 g in 14 steps, with its grip surface set as either sandpaper or rayon. Additional measurements of grip-force-dependent finger-surface contact area and finger skin indentation, as well as a test of weight discrimination, were also performed. For each surface condition, the static grip force was modulated in parallel with load force while holding the object of a mass above 30 g. For objects with mass smaller than 30 g, on the other hand, the parallel relationship was changed, resulting in a progressive increase in grip-to-load force (GF/LF) ratio. The rayon had a higher GF/LF force ratio across all mass levels. The proportion of safety margin in the static grip force and normalized moment-to-moment variability of the static grip force were also elevated towards the lower end of the object mass for both surfaces. These findings indicate that the strategy of grip force control for holding objects with an extremely small mass differs from that with a mass above 30 g. The data for the contact area, skin indentation, and weight discrimination suggest that a decreased level of cutaneous feedback signals from the finger pads could have played some role in a cost function in efficient grip force control with low-mass objects. The elevated grip force variability associated with signal-dependent and internal noises, and anticipated inertial force on the held object due to acceleration of the arm and hand, could also have contributed to the cost function.	[Hiramatsu, Yuichi; Kimura, Daisuke; Kadota, Koji; Kinoshita, Hiroshi] Osaka Univ, Grad Sch Med, Dept Biomech & Motor Control, Osaka, Japan; [Ito, Taro] Mukogawa Womens Univ, Dept Hlth & Sports Sci, Nishinomiya, Hyogo, Japan	Osaka University; Mukogawa Women's University	Hiramatsu, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Biomech & Motor Control, Osaka, Japan.	specialeverybody@gmail.com	ITO, TARO/AAP-2580-2020	Kimura, Daisuke/0000-0001-5620-8263	Japan Society for the Promotion of Science KAKENHI [23500675]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	H.K. was supported by the Japan Society for the Promotion of Science KAKENHI (http://www.jsps.go.jp/english/index.html) Grant Number 23500675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0467; Augurelle AS, 2003, EXP BRAIN RES, V148, P533, DOI 10.1007/s00221-002-1322-3; Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; Birznieks I, 2003, THESIS UMEA U; Burstedt MKO, 1999, J NEUROPHYSIOL, V82, P2393, DOI 10.1152/jn.1999.82.5.2393; Cadoret G, 1996, J NEUROPHYSIOL, V75, P1963, DOI 10.1152/jn.1996.75.5.1963; Cole KJ, 2003, EXP BRAIN RES, V148, P150, DOI 10.1007/s00221-002-1283-6; COLE KJ, 1988, J NEUROPHYSIOL, V60, P1513, DOI 10.1152/jn.1988.60.4.1513; Cole KJ, 1999, J NEUROSCI, V19, P3238; COMAISH S, 1971, BRIT J DERMATOL, V84, P37, DOI 10.1111/j.1365-2133.1971.tb14194.x; Crevecoeur F, 2009, NEUROSCIENCE, V161, P589, DOI 10.1016/j.neuroscience.2009.03.025; Delhaye B, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0698; Derler S, 2012, TRIBOL LETT, V45, P1, DOI 10.1007/s11249-011-9854-y; Dideriksen JL, 2012, J NEUROPHYSIOL, V107, P3357, DOI 10.1152/jn.00938.2011; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Engen T., 1971, WOODWORTH SCHLOSBERG, V3rd, P11; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Farina D, 2014, J PHYSIOL-LONDON, V592, P3427, DOI 10.1113/jphysiol.2014.273581; FLANAGAN JR, 1995, EXP BRAIN RES, V105, P455; Flanagan JR, 2001, CAN J EXP PSYCHOL, V55, P87, DOI 10.1037/h0087355; Flanagan JR, 2002, ENCY HUMAN BRAIN, V2, P399, DOI DOI 10.1016/B0-12-227210-2/00157-6; GALGANSKI ME, 1993, J NEUROPHYSIOL, V69, P2108, DOI 10.1152/jn.1993.69.6.2108; Goodwin AW, 1998, J NEUROSCI, V18, P10724; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GREEN DM, 1990, J ACOUST SOC AM, V87, P2662, DOI 10.1121/1.399058; Griffin L, 2009, EXP BRAIN RES, V197, P337, DOI 10.1007/s00221-009-1920-4; HagerRoss C, 1996, EXP BRAIN RES, V110, P131; Hamilton AFD, 2004, EXP BRAIN RES, V157, P417, DOI 10.1007/s00221-004-1856-7; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hermsdorfer J, 1999, EXP BRAIN RES, V126, P205, DOI 10.1007/s002210050730; Hermsdorfer J, 2000, EXP BRAIN RES, V132, P52, DOI 10.1007/s002219900325; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johansson Roland S., 1996, P381, DOI 10.1016/B978-012759440-8/50025-6; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHANSSON RS, 1990, ATTENTION PERFORM, V8, P677; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kawashima N, 2012, EXP BRAIN RES, V218, P579, DOI 10.1007/s00221-012-3050-7; Keen A, 1994, TRAINING RELATED ENH; Kinoshita H, 1996, EUR J APPL PHYSIOL, V74, P450; Kinoshita H, 1999, ERGONOMICS, V42, P1372, DOI 10.1080/001401399185018; Kinoshita H, 1997, J NEUROPHYSIOL, V78, P1619, DOI 10.1152/jn.1997.78.3.1619; Kobylecki S, 1906, PSYCHOL STUDIEN, V1, P219; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; McDonnell MN, 2005, EXP BRAIN RES, V161, P368, DOI 10.1007/s00221-004-2081-0; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Nowak D. A., 2009, SENSORIMOTOR CONTROL; Nowak DA, 2001, EUR J NEUROSCI, V14, P756, DOI 10.1046/j.0953-816x.2001.01697.x; Oberlin KW, 1936, J EXP PSYCHOL, V19, P438, DOI 10.1037/h0056345; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; Schenker M, 2006, J PLAST RECONSTR AES, V59, P706, DOI 10.1016/j.bjps.2005.12.004; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Taylor AM, 2003, J NEUROPHYSIOL, V90, P1350, DOI 10.1152/jn.00056.2003; Thonnard JL, 1999, EXP BRAIN RES, V128, P61, DOI 10.1007/s002210050817; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; WESTLING G, 1984, EXP BRAIN RES, V53, P277; White O, 2005, EXP BRAIN RES, V163, P324, DOI 10.1007/s00221-004-2175-8; Zatsiorsky VM, 2008, J MOTOR BEHAV, V40, P446, DOI 10.3200/JMBR.40.5.446-476; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027715	64	24	24	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138506	10.1371/journal.pone.0138506	http://dx.doi.org/10.1371/journal.pone.0138506			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376484	gold, Green Submitted, Green Published			2022-12-26	WOS:000361610200111
J	Pandya, D; Mariani, M; He, SQ; Andreoli, M; Spennato, M; Dowell-Martino, C; Fiedler, P; Ferlini, C				Pandya, Deep; Mariani, Marisa; He, Shiquan; Andreoli, Mirko; Spennato, Manuela; Dowell-Martino, Candice; Fiedler, Paul; Ferlini, Cristiano			Epstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies	PLOS ONE			English	Article							CERVICAL-CANCER; THERAPY; GENE; CARCINOMA; CELLS; GLYCOLYSIS; MIR-200C; TARGETS; IL-10	The Cancer Genome Atlas (TCGA) microRNA (miRNA) initiative has revealed a pivotal role for miRNAs in cancer. Utilizing the TCGA raw data, we performed the first mapping of viral miRNA sequences within cancer and adjacent normal tissues. Results were integrated with TCGA RNA-seq to link the expression of viral miRNAs to the phenotype. Using clinical data and viral miRNA mapping results we also performed outcome analysis. Three lines of evidence lend credence to an active role of viral miRNAs in solid malignancies. First, expression of viral miRNA is consistently higher in cancerous compared to adjacent noncancerous tissues. Second, viral miRNA expression is associated with significantly worse clinical outcome among patients with early stage malignancy. These patients are also featured by increased expression of PD1/PD-L1, a pathway implicated in tumors escaping immune destruction. Finally, a particular cluster of EBV-miRNA (miR-BART2, miR-BART4, miRBART5, miR-BART18, and miR-BART22) is associated with expression of cytokines known to inhibit host response to cancer. Quantification of specific viral miRNAs may help identify patients who are at risk of poor outcome. These patients may be candidates for novel therapeutic strategies incorporating antiviral agents and/or inhibitors of the PD-1/PD-L1 pathway.	[Pandya, Deep; Mariani, Marisa; He, Shiquan; Andreoli, Mirko; Spennato, Manuela; Dowell-Martino, Candice; Fiedler, Paul; Ferlini, Cristiano] Danbury Hosp, Res Inst, Danbury, CT 06810 USA		Ferlini, C (corresponding author), Danbury Hosp, Res Inst, Danbury, CT 06810 USA.	cristiano.ferlini@danhosp.org			Ruth C. Donovan Cancer Research Program	Ruth C. Donovan Cancer Research Program	This work was partially supported by the Ruth C. Donovan Cancer Research Program and by a liberal donation from Dr. and Mrs. Rudy Ruggles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcocer-Gonzalez JM, 2006, VIRAL IMMUNOL, V19, P481, DOI 10.1089/vim.2006.19.481; Ationu A, 1999, BLOOD, V94, P3193, DOI 10.1182/blood.V94.9.3193.421k26_3193_3198; Bais AG, 2005, J CLIN PATHOL, V58, P1096, DOI 10.1136/jcp.2004.025072; BURKE AP, 1990, MODERN PATHOL, V3, P377; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cortez MA, 2014, MOL THER, V22, P1494, DOI 10.1038/mt.2014.79; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Diaz-Benitez CE, 2009, J CLIN IMMUNOL, V29, P532, DOI 10.1007/s10875-009-9279-7; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Esteban MA, 2012, CURR OPIN GENET DEV, V22, P423, DOI 10.1016/j.gde.2012.09.004; Flores O, 2013, J VIROL, V87, P6589, DOI 10.1128/JVI.00504-13; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Marquitz AR, 2012, P NATL ACAD SCI USA, V109, P9593, DOI 10.1073/pnas.1202910109; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nallamshetty S, 2013, FREE RADICAL BIO MED, V64, P20, DOI 10.1016/j.freeradbiomed.2013.05.022; Pandya D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114750; Prislei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-72; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Torres-Poveda K, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-32; Xiao L, 2014, ONCOGENE, V33, P4568, DOI 10.1038/onc.2014.32; 2014, NATURE, V513, P202, DOI DOI 10.1038/NATURE13480	26	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136058	10.1371/journal.pone.0136058	http://dx.doi.org/10.1371/journal.pone.0136058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375401	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200010
J	Xie, M; Zhang, YJ; Peng, DL; Zhou, J; Zhang, XL; Zhang, ZR; Zhao, JJ; Wu, YH				Xie, Ming; Zhang, Yan-Jun; Peng, De-Liang; Zhou, Jie; Zhang, Xiao-Lin; Zhang, Zhao-Rong; Zhao, Jin-Jin; Wu, Yu-Huan			Persistence and Viability of Lecanicillium lecanii in Chinese Agricultural Soil	PLOS ONE			English	Article							BEAUVERIA-BASSIANA CONIDIA; METARHIZIUM-ANISOPLIAE; PAECILOMYCES-LILACINUS; ENTOMOPATHOGENIC FUNGI; BIOCONTROL AGENTS; SELECTIVE MEDIUM; IN-VITRO; SURVIVAL; BRONGNIARTII; VIRULENCE	The entomopathogenic fungus L. lecanii has been developed as biopesticides and used widely for biological control of several insects in agricultural practice. Due to the lack of isolation/ count methods for L. lecanii in soil, the persistence of this fungus in soil appears to have attracted no attention. A selective medium and count method for L. lecanii in soil based on cetyl trimethyl ammonium bromide (CTAB) was developed, and then the persistence and viability of this fungus in soil were investigated under field conditions between 2012 and 2014. The results showed that the rate of recovery for L. lecanii in soil on the selective CTAB medium was satisfactory. The minimum CFUs for L. lecanii on the selective medium (0.5 g/L CTAB) was about 10(2) conidia/g soil. The L. lecanii density in soil declined quickly in the first month after inoculation with fungal conidia, kept stable for 6 to 10 months, and then decreased gradually until undetectable. L. lecanii could persist for at least 14 months in the agricultural soil of northern China. The colony growth, conidia yield and germination rate on plates, as well as the median lethal concentration or times (LC50 or LT50) to aphids, mycelium growth in aphids and sporulation on aphids of L. lecanii did not change significantly during the persistence in soil. In general, the count method developed here was a very useful tool for monitoring the dynamics of natural or introduced L. lecanii populations in soil, and the data on the persistence of L. lecanii in soil reported here were helpful for biological control and environmental risk assessment.	[Xie, Ming; Zhang, Yan-Jun; Peng, De-Liang; Zhou, Jie; Zhang, Xiao-Lin; Zhang, Zhao-Rong; Zhao, Jin-Jin; Wu, Yu-Huan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Xie, M (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	xiem406@126.com; yjz2100@163.com			National Hightech R& D Program of China [2011AA10A204]; Special Fund for Agri-scientific Research in the Public Interest of China [201503114]; National Natural Science Foundation of China [31201571]; China International Cooperation Project [2012DFR30810, 2011-G4]; Ministry of Science and Technology of China [2012BAD15B03]; Agricultural Science and Technology Innovation Program (ASTIP)	National Hightech R& D Program of China(National High Technology Research and Development Program of China); Special Fund for Agri-scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China International Cooperation Project; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Agricultural Science and Technology Innovation Program (ASTIP)	This work was funded by National Hightech R& D Program of China (Grant 2011AA10A204), Special Fund for Agri-scientific Research in the Public Interest of China (Grant 201503114), National Natural Science Foundation of China (Grant 31201571), China International Cooperation Project (Grants 2012DFR30810 and 2011-G4), Ministry of Science and Technology of China (2012BAD15B03) and Agricultural Science and Technology Innovation Program (ASTIP-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem Z, 2002, NAT BIOTECHNOL, V20, P1035, DOI 10.1038/nbt743; Atkins SD, 2005, FEMS MICROBIOL ECOL, V51, P257, DOI 10.1016/j.femsec.2004.09.002; BEILHARZ VC, 1982, T BRIT MYCOL SOC, V79, P507, DOI 10.1016/S0007-1536(82)80043-0; Bidochka M. J., 2001, Fungi as biocontrol agents: progress, problems and potential, P193, DOI 10.1079/9780851993560.0193; Castrillo LA, 2008, BIOL CONTROL, V45, P163, DOI 10.1016/j.biocontrol.2008.01.005; CHARNLEY A. K., 1997, ENV MICROBIAL RELATI, P185; CHASE AR, 1986, FLA ENTOMOL, V69, P285, DOI 10.2307/3494930; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Enkerli J, 2004, BIOL CONTROL, V29, P115, DOI 10.1016/S1049-9644(03)00131-2; FARGUES J, 1983, J INVERTEBR PATHOL, V41, P131, DOI 10.1016/0022-2011(83)90212-4; Fernandes EKK, 2010, BIOL CONTROL, V54, P197, DOI 10.1016/j.biocontrol.2010.05.009; GILLESPIE AT, 1989, PESTIC SCI, V27, P203, DOI 10.1002/ps.2780270210; Goettel MS, 2008, J INVERTEBR PATHOL, V98, P256, DOI 10.1016/j.jip.2008.01.009; Gu Xinghui, 2015, Chinese Journal of Biological Control, V31, P1; Guerrero-Guerra C, 2013, AEROBIOLOGIA, V29, P249, DOI 10.1007/s10453-012-9277-8; Hajek AE, 1997, ADV MICROB ECOL, V15, P193; HALL RA, 1984, ENTOMOPHAGA, V29, P311, DOI 10.1007/BF02372119; Kessler P, 2004, BIOCONTROL, V49, P563, DOI 10.1023/B:BICO.0000036441.40227.ed; Kessler P, 2003, J INVERTEBR PATHOL, V84, P15, DOI 10.1016/j.jip.2003.08.003; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; LI DP, 1993, J INVERTEBR PATHOL, V62, P273, DOI 10.1006/jipa.1993.1112; LINGG AJ, 1981, J INVERTEBR PATHOL, V38, P191, DOI 10.1016/0022-2011(81)90122-1; Luz C, 2007, MYCOPATHOLOGIA, V164, P39, DOI 10.1007/s11046-007-9020-0; Martinez-Romero E, 2012, EXPERT OPIN ENV BIOL, DOI [10.4172/2325-9655.1000e103, DOI 10.4172/2325-9655.1000E103]; Mensink BJWGH, 2007, BIOCONTROL SCI TECHN, V17, P3, DOI 10.1080/09583150600936982; Paulitz TC, 2000, EUR J PLANT PATHOL, V106, P401, DOI 10.1023/A:1008733927515; Pilz C, 2011, J APPL ENTOMOL, V135, P393, DOI 10.1111/j.1439-0418.2010.01566.x; Posadas JB, 2012, MYCOLOGIA, V104, P974, DOI 10.3852/11-234; Rangel DEN, 2010, BIOCONTROL SCI TECHN, V20, P375, DOI 10.1080/09583150903518370; Rumbos C, 2008, BIOCONTROL SCI TECHN, V18, P1041, DOI 10.1080/09583150802526979; Safavi SA, 2013, J AGR SCI TECH-IRAN, V15, P1; Shah FA, 2005, FEMS MICROBIOL LETT, V251, P259, DOI 10.1016/j.femsle.2005.08.010; St Leger RJ, 2001, FUNGI BIOCONTROL AGE, P219; STOREY GK, 1988, ENVIRON ENTOMOL, V17, P135, DOI 10.1093/ee/17.1.135; STUDDERT JP, 1990, J INVERTEBR PATHOL, V55, P417, DOI 10.1016/0022-2011(90)90086-L; Tseng MN, 2011, APPL ENVIRON MICROB, V77, P4508, DOI 10.1128/AEM.02033-10; Vanninen I, 2000, BIOCONTROL, V45, P201, DOI 10.1023/A:1009998919531; VEEN KH, 1966, J INVERTEBR PATHOL, V8, P268, DOI 10.1016/0022-2011(66)90145-5; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wraight S.P., 2007, FIELD MANUAL TECHNIQ, V2nd, P223; Xie M, 2015, J PEST SCI, V88, P637, DOI 10.1007/s10340-015-0644-4; Zhang YJ, 2014, J MICROBIOL METH, V105, P168, DOI 10.1016/j.mimet.2014.07.033; ZIMMERMANN G, 1986, J APPL ENTOMOL, V102, P213, DOI 10.1111/j.1439-0418.1986.tb00912.x	43	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138337	10.1371/journal.pone.0138337	http://dx.doi.org/10.1371/journal.pone.0138337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375030	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200099
J	Shaikh, S; Nagi, SS; McGlone, F; Mahns, DA				Shaikh, Sumaiya; Nagi, Saad S.; McGlone, Francis; Mahns, David A.			Psychophysical Investigations into the Role of Low-Threshold C Fibres in Non-Painful Affective Processing and Pain Modulation	PLOS ONE			English	Article							HUMAN HAIRY SKIN; UNMYELINATED TACTILE AFFERENTS; CUTANEOUS MECHANORECEPTORS; SOMATOSENSORY CORTEX; ECCENTRIC EXERCISE; INSULAR CORTEX; TOUCH; ALLODYNIA; RESPONSES; NERVE	We recently showed that C low-threshold mechanoreceptors (CLTMRs) contribute to touch-evoked pain (allodynia) during experimental muscle pain. Conversely, in absence of ongoing pain, the activation of CLTMRs has been shown to correlate with a diffuse sensation of pleasant touch. In this study, we evaluated (1) the primary afferent fibre types contributing to positive (pleasant) and negative (unpleasant) affective touch and (2) the effects of tactile stimuli on tonic muscle pain by varying affective attributes and frequency parameters. Psychophysical observations were made in 10 healthy participants. Two types of test stimuli were applied: stroking stimulus using velvet or sandpaper at speeds of 0.1, 1.0 and 10.0 cm/s; focal vibrotactile stimulus at low (20 Hz) or high (200 Hz) frequency. These stimuli were applied in the normal condition (i.e. no experimental pain) and following the induction of muscle pain by infusing hypertonic saline (5%) into the tibialis anterior muscle. These observations were repeated following the conduction block of myelinated fibres by compression of sciatic nerve. In absence of muscle pain, all participants reliably linked velvet-stroking to pleasantness and sandpaper-stroking to unpleasantness (no pain). Likewise, low-frequency vibration was linked to pleasantness and high-frequency vibration to unpleasantness. During muscle pain, the application of previously pleasant stimuli resulted in overall pain relief, whereas the application of previously unpleasant stimuli resulted in overall pain intensification. These effects were significant, reproducible and persisted following the blockade of myelinated fibres. Taken together, these findings suggest the role of low-threshold C fibres in affective and pain processing. Furthermore, these observations suggest that temporal coding need not be limited to discriminative aspects of tactile processing, but may contribute to affective attributes, which in turn predispose individual responses towards excitatory or inhibitory modulation of pain.	[Shaikh, Sumaiya; Nagi, Saad S.; Mahns, David A.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [McGlone, Francis] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England	Western Sydney University; Liverpool John Moores University	Mahns, DA (corresponding author), Univ Western Sydney, Sch Med, Sydney, NSW, Australia.	d.mahns@uws.edu.au	Mahns, David Anthony/GLS-1616-2022; Nagi, Saad/AAM-7928-2021; /AAD-1766-2020; McGlone, Francis Philip/AAA-5058-2022; McGlone, Francis/F-8349-2011	Mahns, David Anthony/0000-0003-2131-9638; Nagi, Saad/0000-0001-8773-8232; /0000-0001-5221-130X; McGlone, Francis/0000-0002-0881-635X	University of Western Sydney Eminent Research Visitors Grant [P00019329]	University of Western Sydney Eminent Research Visitors Grant	This work was supported by the University of Western Sydney Eminent Research Visitors Grant (P00019329) awarded to DAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Cole J, 2006, MUSCLE NERVE, V34, P105, DOI 10.1002/mus.20534; Condon M, 2014, J NEUROPHYSIOL, V111, P1308, DOI 10.1152/jn.00589.2013; CRAIG KD, 1977, PAIN, V3, P127, DOI 10.1016/0304-3959(77)90076-8; Croy I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092975; Delfini MC, 2013, CELL REP, V5, P378, DOI 10.1016/j.celrep.2013.09.013; Essick GK, 1999, NEUROREPORT, V10, P2083, DOI 10.1097/00001756-199907130-00017; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; Fields HL, 1999, PAIN, pS61, DOI 10.1016/S0304-3959(99)00139-6; Francois A, 2015, CELL REP, V10, P370, DOI 10.1016/j.celrep.2014.12.042; Gaillard S, 2014, NEURON, V84, P123, DOI 10.1016/j.neuron.2014.08.056; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; Liljencrantz J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00037; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; MACKENZIE RA, 1975, J NEUROL NEUROSUR PS, V38, P865, DOI 10.1136/jnnp.38.9.865; Mahns DA, 2006, J NEUROPHYSIOL, V95, P1442, DOI 10.1152/jn.00483.2005; Mahns DA, 2006, J NEUROSCI METH, V156, P140, DOI 10.1016/j.jneumeth.2006.02.019; Mahns DA, 2013, EXP BRAIN RES, V227, P457, DOI 10.1007/s00221-013-3521-5; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; MERZENICH MM, 1969, EXP BRAIN RES, V9, P236; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; Nagi SS, 2013, EXP BRAIN RES, V231, P139, DOI 10.1007/s00221-013-3677-z; Nagi SS, 2013, J PAIN, V14, P538, DOI 10.1016/j.jpain.2013.01.009; Nagi SS, 2011, J PHYSIOL-LONDON, V589, P4065, DOI 10.1113/jphysiol.2011.211326; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson HW, 2008, NEUROSCI LETT, V436, P128, DOI 10.1016/j.neulet.2008.03.015; Peckys D, 1999, NEUROSCIENCE, V88, P1093, DOI 10.1016/S0306-4522(98)00251-6; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Sahai V, 2006, J NEUROPHYSIOL, V95, P1451, DOI 10.1152/jn.00485.2005; Samour MS, 2015, PAIN, V156, P1566, DOI 10.1097/j.pain.0000000000000202; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; TOREBJORK HE, 1973, EXP BRAIN RES, V16, P321; Uhelski ML, 2012, PAIN, V153, P885, DOI 10.1016/j.pain.2012.01.018; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; Weerakkody NS, 2003, PAIN, V105, P425, DOI 10.1016/S0304-3959(03)00257-4; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	42	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138299	10.1371/journal.pone.0138299	http://dx.doi.org/10.1371/journal.pone.0138299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372601	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000361604400063
J	Yang, Y; Park, SY; Nguyen, TT; Yu, YH; Nguyen, TV; Sun, EG; Udeni, J; Jeong, MH; Pereira, I; Moon, C; Ha, HH; Kim, KK; Hur, JS; Kim, H				Yang, Yi; Park, So-Yeon; Thanh Thi Nguyen; Yu, Young Hyun; Tru Van Nguyen; Sun, Eun Gene; Udeni, Jayalal; Jeong, Min-Hye; Pereira, Iris; Moon, Cheol; Ha, Hyung-Ho; Kim, Kyung Keun; Hur, Jae-Seoun; Kim, Hangun			Lichen Secondary Metabolite, Physciosporin, Inhibits Lung Cancer Cell Motility	PLOS ONE			English	Article							METASTASIS SUPPRESSOR; SNAIL; PSEUDOCYPHELLARIA; MORPHOGENESIS; STATISTICS; EXPRESSION; MIGRATION; PROTEIN; KITENIN; FAMILY	Lichens produce various unique chemicals that can be used for pharmaceutical purposes. To screen for novel lichen secondary metabolites showing inhibitory activity against lung cancer cell motility, we tested acetone extracts of 13 lichen samples collected in Chile. Physciosporin, isolated from Pseudocyphellaria coriacea (Hook f. & Taylor) D.J. Galloway & P. James, was identified as an effective compound and showed significant inhibitory activity in migration and invasion assays against human lung cancer cells. Physciosporin treatment reduced both protein and mRNA levels of N-cadherin with concomitant decreases in the levels of epithelial-mesenchymal transition markers such as snail and twist. Physciosporin also suppressed KITENIN (KAI1 C-terminal interacting tetraspanin)-mediated AP-1 activity in both the absence and presence of epidermal growth factor stimulation. Quantitative real-time PCR analysis showed that the expression of the metastasis suppressor gene, KAI1, was increased while that of the metastasis enhancer gene, KITENIN, was dramatically decreased by physciosporin. Particularly, the activity of 3'-untranslated region of KITENIN was decreased by physciosporin. Moreover, Cdc42 and Rac1 activities were decreased by physciosporin. These results demonstrated that the lichen secondary metabolite, physciosporin, inhibits lung cancer cell motility through novel mechanisms of action.	[Yang, Yi; Thanh Thi Nguyen; Udeni, Jayalal; Jeong, Min-Hye; Hur, Jae-Seoun] Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon 540950, South Korea; [Park, So-Yeon; Yu, Young Hyun; Tru Van Nguyen; Moon, Cheol; Ha, Hyung-Ho; Kim, Hangun] Sunchon Natl Univ, Coll Pharm, Sunchon 540950, South Korea; [Park, So-Yeon; Yu, Young Hyun; Tru Van Nguyen; Moon, Cheol; Ha, Hyung-Ho; Kim, Hangun] Sunchon Natl Univ, Res Inst Life & Pharmaceut Sci, Sunchon 540950, South Korea; [Thanh Thi Nguyen] Tay Nguyen Univ, Fac Nat Sci & Technol, Buon Ma Thuot, Vietnam; [Sun, Eun Gene; Kim, Kyung Keun] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Gwangju 500872, South Korea; [Pereira, Iris] Univ Talca, Inst Biol Sci, Talca 747721, Chile	Sunchon National University; Sunchon National University; Sunchon National University; Tay Nguyen University; Chonnam National University; Universidad de Talca	Hur, JS (corresponding author), Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon 540950, South Korea.	jshur1@sunchon.ac.kr; hangunkim@sunchon.ac.kr		, Eun-Gene Sun/0000-0002-3396-6966; Moon, Cheol/0000-0003-2342-0860	National Research Foundation of Korea [NRF-2013R1A1A2004677, MRC-2011-0030132]; Korea National Research Resource Center Program [NRF-2014M3A9B8002115]; Sunchon Research Center for Natural Medicine	National Research Foundation of Korea(National Research Foundation of Korea); Korea National Research Resource Center Program; Sunchon Research Center for Natural Medicine	This study was supported by the National Research Foundation of Korea (NRF-2013R1A1A2004677, MRC-2011-0030132) and by the Korea National Research Resource Center Program (NRF-2014M3A9B8002115). This study also received support from a research grant funded by the Sunchon Research Center for Natural Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, LANCET, V382, P659, DOI 10.1016/S0140-6736(13)61759-6; Bae JA, 2014, CLIN CANCER RES, V20, P4115, DOI 10.1158/1078-0432.CCR-13-2863; Brodo I. M., 2001, LICHENS N AM; CULBERSON CF, 1972, J CHROMATOGR, V72, P113, DOI 10.1016/0021-9673(72)80013-X; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Galloway D. J., 2007, FLORA NZ LICHENS INC, V2; GALLOWAY DJ, 1989, LICHENOLOGIST, V21, P88, DOI 10.1017/S0024282989000113; Galloway DJ, 2007, FLORA NZ LICHENS INC, V1; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kawai K.I., 1994, HATTORI BOT LAB, V75, P359; Kim H, 2005, J BIOL CHEM, V280, P22462, DOI 10.1074/jbc.M502769200; Kim H., 2015, RECENT ADV LICHENOLO, P201, DOI DOI 10.1007/978-81-322-2235-4_11; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Lee JH, 2004, CANCER RES, V64, P4235, DOI 10.1158/0008-5472.CAN-04-0275; Liu X, 2014, TISSUE BARRIERS, V2, DOI 10.4161/21688362.2014.969112; MAASS WSG, 1977, CAN J CHEM, V55, P2839, DOI 10.1139/v77-394; McCarthy PM, 2001, FLORA OF AUSTR A, V58A; Murali A, 2014, CELL MOL LIFE SCI, V71, P1703, DOI 10.1007/s00018-013-1519-6; NGUYEN TAD, 2014, BIOSCI BIOTECHNOL RE, V11, P11; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nilsson GMA, 2014, INT J ONCOL, V45, P82, DOI 10.3892/ijo.2014.2424; Orange A., 2001, MICROCHEMICAL METHOD; Park SY, 2014, MOL THER, V22, P1653, DOI 10.1038/mt.2014.105; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prudnikova TY, 2015, CLIN CANCER RES, V21, P24, DOI 10.1158/1078-0432.CCR-14-0827; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stanojkovic T, 2015, INVESTIGATIONS LICHE, P127; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ueda T, 1996, AM J PATHOL, V149, P1435; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; WHITE FJ, 1985, NEW GUIDE MICROCHEMI; WILKINS AL, 1979, LICHENOLOGIST, V11, P271, DOI 10.1017/S0024282979000323; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Yamamoto Y, 2015, LICHEN SUBSTANCES TH, P181; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yui Y, 2010, CLIN EXP METASTAS, V27, P619, DOI 10.1007/s10585-010-9352-x	41	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137889	10.1371/journal.pone.0137889	http://dx.doi.org/10.1371/journal.pone.0137889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371759	Green Published, gold, Green Submitted			2022-12-26	WOS:000361604400036
J	Baranyi, A; Meinitzer, A; Breitenecker, RJ; Amouzadeh-Ghadikolai, O; Stauber, R; Rothenhausler, HB				Baranyi, Andreas; Meinitzer, Andreas; Breitenecker, Robert J.; Amouzadeh-Ghadikolai, Omid; Stauber, Rudolf; Rothenhaeusler, Hans-Bernd			Quinolinic Acid Responses during Interferon-alpha-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis	PLOS ONE			English	Article							QUALITY-OF-LIFE; LIQUID-CHROMATOGRAPHY; TRYPTOPHAN DEPLETION; OXIDATIVE STRESS; HUMAN SERUM; RAT; KYNURENINE; MECHANISM; PATHOPHYSIOLOGY; VULNERABILITY	Background The aim of this exploratory study is to gain for the first time a more comprehensive picture of the impact of changes of quinolinic acid concentrations on depressive symptomatology during and after IFN-alpha therapy. Methods The quinolinic acid concentrations of 35 HCV patients are examined in a prospective survey over the entire period of IFN-a treatment as well as three months later at six different times (baseline, one, three, six and nine months after the beginning of IFN-a treatment, and after the end of treatment). Results During IFN-alpha treatment Hamilton Depression Rating Scale scores rise significantly. At the same time there is greater activity of indoleamine 2,3-dioxygenase, with a resulting increase in plasma kynurenine concentrations. Compared to baseline values quinolinic acid concentrations increase significantly during therapy, reflecting an increased neurotoxic challenge. In addition, patients with higher scores in the Hamilton Depression Rating Scale at six and nine months after starting therapy show significantly higher levels of quinolinic acid concentration. Conclusions The increase of quinolinic acid during IFN-alpha therapy might contribute to depressive symptomatology through the neurotoxic challenge caused by quinolinic acid. Subsequently, our exploratory study results support the inflammatory hypothesis of depression. The awareness of relevant risk factors of IFN-alpha treatment-induced depression is essential to develop preventative treatment strategies.	[Baranyi, Andreas; Rothenhaeusler, Hans-Bernd] Med Univ Graz, Dept Psychiat, Graz, Austria; [Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Breitenecker, Robert J.] Alpen Adria Univ Klagenfurt, Dept Innovat Management & Entrepreneurship, Klagenfurt, Austria; [Amouzadeh-Ghadikolai, Omid] Hosp Bros St John God, Graz, Austria; [Stauber, Rudolf] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria	Medical University of Graz; Medical University of Graz; University of Klagenfurt; Medical University of Graz	Baranyi, A (corresponding author), Med Univ Graz, Dept Psychiat, Graz, Austria.	andreas.baranyi@klinikum-graz.at	Breitenecker, Robert/R-8753-2019; Breitenecker, Robert J/A-5633-2011; Breitenecker, Robert/AAC-8012-2022	Breitenecker, Robert/0000-0003-4485-5388; Breitenecker, Robert J/0000-0003-4485-5388; Breitenecker, Robert/0000-0003-4485-5388; Rothenhausler, Hans-Bernd/0000-0002-8857-8557; Baranyi, Andreas/0000-0003-2389-1945	Pfizer Corporation Austria	Pfizer Corporation Austria	This study was supported by a grant from the Pfizer Corporation Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranyi A, 2013, PSYCHOTHER PSYCHOSOM, V82, P332, DOI 10.1159/000348587; Behan WMH, 1999, BRIT J PHARMACOL, V128, P1754, DOI 10.1038/sj.bjp.0702940; Behan WMH, 2002, BRIT J PHARMACOL, V135, P1435, DOI 10.1038/sj.bjp.0704613; Bonaccorso S, 2002, J AFFECT DISORDERS, V72, P237, DOI 10.1016/S0165-0327(02)00264-1; Bonaccorso S, 2002, J CLIN PSYCHOPHARM, V22, P86, DOI 10.1097/00004714-200202000-00014; Braidy N, 2010, FEBS J, V277, P368, DOI 10.1111/j.1742-4658.2009.07487.x; Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z; Busse M, 2014, EUR ARCH PSYCHIAT CL; Capuron L, 2003, AM J PSYCHIAT, V160, P1342, DOI 10.1176/appi.ajp.160.7.1342; DeCarvalho LP, 1996, NEUROCHEM INT, V28, P445; Dieperink E, 2000, AM J PSYCHIAT, V157, P867, DOI 10.1176/appi.ajp.157.6.867; Dinwiddie SH, 2003, AM J PSYCHIAT, V160, P172, DOI 10.1176/appi.ajp.160.1.172; Eccles J, 2012, EUR NEUROPSYCHOPHARM, V22, P892, DOI 10.1016/j.euroneuro.2012.03.009; Elinos-Calderon D, 2010, J NEURAL TRANSM, V117, P35, DOI 10.1007/s00702-009-0299-5; Fontana RJ, 2001, AM J GASTROENTEROL, V96, P170, DOI 10.1111/j.1572-0241.2001.03473.x; Guillemin GJ, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-16; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Hamilton M., 1967, BR J SOC CLIN PSYCHO, V6, P78; Hauser W, 2004, PSYCHOSOM MED, V66, P954, DOI 10.1097/01.psy.0000145824.82125.a8; Herve C, 1996, J CHROMATOGR B, V675, P157, DOI 10.1016/0378-4347(95)00341-X; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Lee MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014123; Leutscher PDC, 2010, HEPATOLOGY, V52, P430, DOI 10.1002/hep.23699; Malaguarnera M, 2001, J INTERF CYTOK RES, V21, P273, DOI 10.1089/107999001300177457; Mancuso R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130715; Meinitzer A, 2014, CLIN CHIM ACTA, V436, P268, DOI 10.1016/j.cca.2014.06.010; Miyaoka H, 1999, AM J PSYCHIAT, V156, P1120; Moller M, 2012, J CHROMATOGR B, V898, P121, DOI 10.1016/j.jchromb.2012.04.030; Myint AM, 2009, METAB BRAIN DIS, V24, P55, DOI 10.1007/s11011-008-9114-5; Neumeister A, 2005, AM J PSYCHIAT, V162, P805, DOI 10.1176/appi.ajp.162.4.805; PERKINS MN, 1983, J PHARMACOL EXP THER, V226, P551; Pierozan P, 2014, BRAIN RES, V1577, P1, DOI 10.1016/j.brainres.2014.06.024; Pierozan P, 2010, EXP NEUROL, V224, P188, DOI 10.1016/j.expneurol.2010.03.009; POUTIAINEN E, 1994, PHARMACOL BIOCHEM BE, V47, P901, DOI 10.1016/0091-3057(94)90294-1; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; Raison CL, 2005, J CLIN PSYCHIAT, V66, P41, DOI 10.4088/JCP.v66n0106; Russo S, 2003, PSYCHOSOM MED, V65, P665, DOI 10.1097/01.PSY.0000078188.74020.CC; Santamaria A, 2001, NEUROREPORT, V12, P871, DOI 10.1097/00001756-200103260-00049; Schaefer M, 2012, J HEPATOL, V57, P1379, DOI 10.1016/j.jhep.2012.07.037; SCHURR A, 1993, BRAIN RES, V617, P76, DOI 10.1016/0006-8993(93)90615-T; SCHWARCZ R, 1983, NEUROSCI LETT, V38, P85, DOI 10.1016/0304-3940(83)90115-5; Steiner J, 2012, WORLD J BIOL PSYCHIA, V13, P482, DOI 10.3109/15622975.2011.583941; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Sundaram G, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0204-5; Tavares RG, 2002, NEUROCHEM INT, V40, P621, DOI 10.1016/S0197-0186(01)00133-4; Turner EH, 2005, MED HYPOTHESES, V65, P138, DOI 10.1016/j.mehy.2005.01.026; Udina M, 2012, J CLIN PSYCHIAT, V73, P1128, DOI 10.4088/JCP.12r07694; Vandresen-Filho S, 2015, NEUROL SCI; Wichers M, 2002, INT J NEUROPSYCHOPH, V5, P375, DOI 10.1017/S1461145702003103; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Wichers MC, 2004, J PSYCHIATR NEUROSCI, V29, P11; Xiao LD, 2008, CLIN CHIM ACTA, V395, P178, DOI 10.1016/j.cca.2008.05.004	52	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137022	10.1371/journal.pone.0137022	http://dx.doi.org/10.1371/journal.pone.0137022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368809	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100046
J	Korhonova, M; Doricakova, A; Dvorak, Z				Korhonova, Martina; Doricakova, Aneta; Dvorak, Zdenek			Optical Isomers of Atorvastatin, Rosuvastatin and Fluvastatin Enantiospecifically Activate Pregnane X Receptor PXR and Induce CYP2A6, CYP2B6 and CYP3A4 in Human Hepatocytes	PLOS ONE			English	Article							COA REDUCTASE INHIBITORS; DRUG-INTERACTIONS; HEALTHY-VOLUNTEERS; NUCLEAR RECEPTORS; CELL-LINE; PHARMACOKINETICS; EXPRESSION; CONSTRUCTION; ENZYMES; ASSAY	Atorvastatin, fluvastatin and rosuvastatin are drugs used for treatment of hypercholesterolemia. They cause numerous drug-drug interactions by inhibiting and inducing drug-metabolizing cytochromes P450. These three statins exist in four optical forms, but they are currently used as enantiopure drugs, i.e., only one single enantiomer. There are numerous evidences that efficacy, adverse effects and toxicity of drugs may be enantiospecific. Therefore, we investigated the effects of optical isomers of atorvastatin, fluvastatin and rosuvastatin on the expression of drug-metabolizing P450s in primary human hepatocytes, using western blots and RT-PCR for measurement of proteins and mRNAs, respectively. The activity of P450 transcriptional regulators, including pregnane X receptor (PXR), aryl hydrocarbon receptor (AhR) and glucocorticoid receptor (GR), was assessed by gene reporter assays and EMSA. Transcriptional activity of AhR was not influenced by any statin tested. Basal transcriptional activity of GR was not affected by tested statins, but dexamethasoneinducible activity of GR was dose-dependently and enantioselectively inhibited by fluvastatin. Basal and ligand-inducible transcriptional activity of PXR was dose-dependently influenced by all tested statins, and the potency and efficacy between individual optical isomers varied depending on statin and optical isomer. The expression of CYP1A1 and CYP1A2 in human hepatocytes was not influenced by tested statins. All statins induced CYP2A6, CYP2B6 and CYP3A4, and the effects on CYP2C9 were rather modulatory. The effects varied between statins and enantiomers and induction potency decreased in order: atorvastatin (RR>RS = SR>SS) > fluvastatin (SR>RS = SS>RR) >> rosuvastatin (only RS active). The data presented here might be of toxicological and clinical importance.	[Korhonova, Martina; Doricakova, Aneta; Dvorak, Zdenek] Palacky Univ, Dept Cell Biol & Genet, Fac Sci, Olomouc 78371, Czech Republic	Palacky University Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Dept Cell Biol & Genet, Fac Sci, Slechtitelu 27, Olomouc 78371, Czech Republic.	moulin@email.cz	Vrzalová, Aneta/AAL-3571-2021	Vrzalova, Aneta/0000-0002-7923-5851; Dvorak, Zdenek/0000-0002-3938-3585	Czech Science Agency [GACR 13-01809S]; Czech Ministry of Health [IGA NT/13591]; Palacky University [PrF-2015-003]	Czech Science Agency; Czech Ministry of Health(Ministry of Health, Czech Republic); Palacky University	This work was supported by a grant from Czech Science Agency (www.gacr.cz) GACR 13-01809S, a grant from Czech Ministry of Health (www.mzcr.cz) IGA NT/13591, and a student grant from Palacky University PrF-2015-003 (www.upol.cz).	Bellosta S, 2012, EXPERT OPIN DRUG SAF, V11, P933, DOI 10.1517/14740338.2012.712959; Boralli VB, 2009, J CLIN PHARMACOL, V49, P205, DOI 10.1177/0091270008327536; Choi DH, 2008, EUR J CLIN PHARMACOL, V64, P445, DOI 10.1007/s00228-007-0447-5; Cohen LH, 2000, BIOPHARM DRUG DISPOS, V21, P353, DOI 10.1002/bdd.249; Cooper KJ, 2003, CLIN PHARMACOL THER, V73, P322, DOI 10.1016/S0009-9236(02)17633-8; Cooper KJ, 2003, BRIT J CLIN PHARMACO, V55, P94, DOI 10.1046/j.1365-2125.2003.01720.x; Di Pietro G, 2006, J CHROMATOGR B, V832, P256, DOI 10.1016/j.jchromb.2006.01.007; Doricakova A, 2013, ARCH TOXICOL, V87, P291, DOI 10.1007/s00204-012-0937-9; Fischer V, 1999, DRUG METAB DISPOS, V27, P410; Garcia I, 2012, CURR TOP MED CHEM, V12, P895, DOI 10.2174/156802612800166729; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Hoffart E, 2012, BRIT J PHARMACOL, V165, P1595, DOI 10.1111/j.1476-5381.2011.01665.x; Howe K, 2011, XENOBIOTICA, V41, P519, DOI 10.3109/00498254.2011.569773; Hsyu PH, 2001, ANTIMICROB AGENTS CH, V45, P3445, DOI 10.1128/AAC.45.12.3445-3450.2001; Kobayashi K, 2005, DRUG METAB DISPOS, V33, P924, DOI 10.1124/dmd.104.002741; Kocarek TA, 2002, DRUG METAB DISPOS, V30, P1400, DOI 10.1124/dmd.30.12.1400; Lee CK, 2015, PHARMACOL REP, V67, P44, DOI 10.1016/j.pharep.2014.08.005; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Meadowcroft AM, 1999, J CLIN PHARMACOL, V39, P418, DOI 10.1177/00912709922007886; Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003; Novotna A, 2014, PLOS ONE, P9; Novotna A, 2012, EUR J PHARM SCI, V47, P842, DOI 10.1016/j.ejps.2012.10.003; Novotna A, 2011, ENVIRON SCI TECHNOL, V45, P10133, DOI 10.1021/es2029334; Olsson AG, 2002, CARDIOVASC DRUG REV, V20, P303; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Plee-Gautier E, 2012, BIOCHEM PHARMACOL, V84, P571, DOI 10.1016/j.bcp.2012.05.012; Prueksaritanont T, 1999, BRIT J CLIN PHARMACO, V47, P291, DOI 10.1046/j.1365-2125.1999.00903.x; Rulcova A, 2010, J THROMB HAEMOST, V8, P2708, DOI 10.1111/j.1538-7836.2010.04036.x; Scripture CD, 2001, CLIN PHARMACOKINET, V40, P263, DOI 10.2165/00003088-200140040-00003; Sekhar MC, 2012, MOL CELL BIOCHEM, V364, P159, DOI 10.1007/s11010-011-1214-6; Smith SW, 2009, TOXICOL SCI, V110, P4, DOI 10.1093/toxsci/kfp097; Transon C, 1996, EUR J CLIN PHARMACOL, V50, P209, DOI 10.1007/s002280050094; Vavrova A, 2013, ELECTROPHORESIS, V34, P1863, DOI 10.1002/elps.201300079; Vrzal R, 2013, J BIOCHEM MOL TOXIC, V27, P515, DOI 10.1002/jbt.21516; Yamasaki D, 2009, EUR J PHARM SCI, V37, P126, DOI 10.1016/j.ejps.2009.01.009	35	17	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137720	10.1371/journal.pone.0137720	http://dx.doi.org/10.1371/journal.pone.0137720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366873	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100120
J	Kuo, YH; Chen, CW; Chu, Y; Lin, P; Chiang, HM				Kuo, Yueh-Hsiung; Chen, Chien-Wen; Chu, Yin; Lin, Ping; Chiang, Hsiu-Mei			In Vitro and In Vivo Studies on Protective Action of N-Phenethyl Caffeamide against Photodamage of Skin	PLOS ONE			English	Article							FACTOR-KAPPA-B; MATRIX METALLOPROTEINASE-1 EXPRESSION; OXIDATIVE STRESS; INFLAMMATION; PATHWAY; ACTIVATION; RADIATION; DAMAGE; MODEL; AP-1	In our previous study, N-phenethyl caffeamide (K36) was proved to act as an antioxidant and an antiphotoaging agent by inhibiting type I procollagen degradation and stimulating collagen synthesis in human skin fibroblasts. In the present study, in vitro and in vivo experiments were conducted to investigate the mechanism of action and the antiinflammatory and antiphotoaging activity of K36. K36 reduced UVB-induced cyclooxygenase-2 (COX-2) and inducible nitric oxide synthases (iNOS) expression by regulating I kappa B and p-I kappa B expression. K36 also inhibited the nuclear translocation of NF-kappa B. Furthermore, the inhibition of mitogen-activated protein (MAP) kinases by K36 was attributed to the downregulation of COX-2. Topically applying K36 led to efficient antiwrinkle formation and reduced UVB-induced erythema and thickness of epidermis in hairless mice. In addition, K36 penetrated into the skin of hairless mice. Our findings show that K36 has significant beneficial effects on antioxidant, antiinflammatory, and antiphotoaging activity and suggest that K36 can be developed as an antiaging agent for cosmetic and skin care products.	[Kuo, Yueh-Hsiung] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung 404, Taiwan; [Kuo, Yueh-Hsiung] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Chen, Chien-Wen; Chu, Yin; Lin, Ping; Chiang, Hsiu-Mei] China Med Univ, Dept Cosmeceut, Taichung 404, Taiwan	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan	Chiang, HM (corresponding author), China Med Univ, Dept Cosmeceut, Taichung 404, Taiwan.	hmchiang@mail.cmu.edu.tw	Chiang, Hsiu-Mei/L-8150-2013		National Science Council [NSC100-2320-B-039-002-MY3, 99-2622-B-039-001-CC3]; Taipei; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence, Taiwan [MOHW103-TDU-B-212-113002]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence, Taiwan	This study was sponsored by the National Science Council (NSC100-2320-B-039-002-MY3 and 99-2622-B-039-001-CC3), Taipei, and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan, and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), Taiwan.	Afaq F, 2011, MINI-REV MED CHEM, V11, P1200; Bachelor MA, 2004, SEMIN CANCER BIOL, V14, P131, DOI 10.1016/j.semcancer.2003.09.017; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Chiang H-M, 2013, EVIDENCE COMPLEM ALT, V2013, P12, DOI DOI 10.1155/2013/696879; CHIANG HM, 2013, EVID-BASED COMPL ALT, DOI DOI 10.1155/2013/324864; Chiang HM, 2015, J AGR FOOD CHEM, V63, P4551, DOI 10.1021/jf502500t; Chiang HM, 2014, FOOD CHEM TOXICOL, V72, P154, DOI 10.1016/j.fct.2014.07.007; Chiang HM, 2012, FOOD CHEM TOXICOL, V50, P4260, DOI 10.1016/j.fct.2012.08.018; Chiang HM, 2011, FOOD CHEM TOXICOL, V49, P309, DOI 10.1016/j.fct.2010.10.034; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; Filip GA, 2012, J PHYSIOL PHARMACOL, V63, P423; GRUNBERGER D, 1988, EXPERIENTIA, V44, P230, DOI 10.1007/BF01941717; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Hong MJ, 2013, J PHARM PHARMACOL, V65, P142, DOI 10.1111/j.2042-7158.2012.01570.x; Huang GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035922; Hung CF, 2012, J DERMATOL SCI, V68, P135, DOI 10.1016/j.jdermsci.2012.09.005; Hwang YP, 2011, FOOD CHEM TOXICOL, V49, P3374, DOI 10.1016/j.fct.2011.10.002; Kim MS, 2013, PHOTOCHEM PHOTOBIOL, V89, P911, DOI 10.1111/php.12061; Kim YG, 2009, EUR J PHARMACOL, V602, P148, DOI 10.1016/j.ejphar.2008.11.021; Kuo Y-H, 2014, CURRENT PHA IN PRESS; Lee CW, 2012, APPL BIOCHEM BIOTECH, V166, P1137, DOI 10.1007/s12010-011-9500-z; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P142, DOI 10.3390/ijms13010142; Nicolaou A, 2011, CHEM PHYS LIPIDS, V164, P535, DOI 10.1016/j.chemphyslip.2011.04.005; Portugal-Cohen M, 2011, EXP DERMATOL, V20, P749, DOI 10.1111/j.1600-0625.2011.01317.x; Serarslan G, 2007, CLIN EXP DERMATOL, V32, P709, DOI 10.1111/j.1365-2230.2007.02470.x; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; Wen KC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/417346; Wolfle U, 2011, FREE RADICAL BIO MED, V50, P1081, DOI 10.1016/j.freeradbiomed.2011.01.027; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Zhang JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099703	31	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136777	10.1371/journal.pone.0136777	http://dx.doi.org/10.1371/journal.pone.0136777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367260	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100025
J	Nakagawa, H; Koizumi, N; Okumura, N; Suganami, H; Kinoshita, S				Nakagawa, Hiroko; Koizumi, Noriko; Okumura, Naoki; Suganami, Hideki; Kinoshita, Shigeru			Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study	PLOS ONE			English	Article							ROCK INHIBITOR; Y-27632; ENHANCEMENT; DYSTROPHY	Purpose To investigate the effect and safety of a selective Rho kinase inhibitor, ripasudil 0.4% eye drops, on corneal endothelial cells of healthy subjects. Design Prospective, interventional case series. Methods In this study, 6 healthy subjects were administered ripasudil 0.4% in the right eye twice daily for 1 week. Morphological changes and corneal endothelial cell density were examined by noncontact and contact specular microscopy. Central corneal thickness and corneal volume of 5 mm-diameter area of center cornea were analyzed by Pentacam Scheimpflug topography. All the above measurements were conducted in both eyes before administration, 1.5 and 6 hours after the initial administration on day 0; and in the same manner after the final administration on day 7. Results By noncontact specular microscopy, indistinct cell borders with pseudo guttae were observed, but by contact specular microscopy, morphological changes of corneal endothelial cells were mild and pseudo guttae was not observed after single and repeated administration of ripasudil in all subjects. These changes resolved prior to the next administration, and corneal endothelial cell density, central corneal thickness and corneal volume were not changed throughout the study period. Conclusion Transient morphological changes of corneal endothelial cells such as indistinct cell borders with pseudo guttae were observed by noncontact specular microscopy in healthy subjects after ripasudil administration. Corneal edema was not observed and corneal endothelial cell density did not decrease after 1 week repetitive administration. These morphological changes were reversible and corneal endothelial cell morphology returned to normal prior to the next administration.	[Nakagawa, Hiroko; Koizumi, Noriko; Okumura, Naoki; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Kyoto, Japan; [Koizumi, Noriko; Okumura, Naoki] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Kyoto, Japan; [Suganami, Hideki] Kowa Co Ltd, Nagoya, Aichi, Japan	Kyoto Prefectural University of Medicine; Doshisha University; Kowa Company, Ltd.	Koizumi, N (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Kyoto, Japan.	nkoizumi@mail.doshisha.ac.jp			Kowa Company, Ltd, Nagoya, Japan	Kowa Company, Ltd, Nagoya, Japan	This study was sponsored by Kowa Company, Ltd, Nagoya, Japan. The sponsor participated in design, study conduct, data collection, data management, data analysis, interpretation of the data of the study, and preparation, review, and approval of the manuscript.	Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Garnock-Jones K, 2014, DRUGS, V74, P2211, DOI 10.1007/s40265-014-0333-2; HOLDEN BA, 1985, INVEST OPHTH VIS SCI, V26, P1354; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Isobe T, 2014, CURR EYE RES, V39, P813, DOI 10.3109/02713683.2013.874444; Jhanji V, 2012, CURR OPIN OPHTHALMOL, V23, P324, DOI 10.1097/ICU.0b013e32835484a1; Jhanji V, 2010, CURR OPIN OPHTHALMOL, V21, P301, DOI 10.1097/ICU.0b013e32833a8dd3; Kameda T, 2012, INVEST OPHTH VIS SCI, V53, P3092, DOI 10.1167/iovs.11-8018; Koga T, 2006, EXP EYE RES, V82, P362, DOI 10.1016/j.exer.2005.07.006; Koizumi N, 2014, CORNEA, V33, pS25, DOI 10.1097/ICO.0000000000000240; Koizumi N, 2013, CORNEA, V32, P1167, DOI 10.1097/ICO.0b013e318285475d; Nagayama K, 2008, AM J PHYSIOL-CELL PH, V295, pC1569, DOI 10.1152/ajpcell.00098.2008; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P318, DOI 10.1167/iovs.13-12225; Okumura N, 2013, INVEST OPHTH VIS SCI, V54, P2493, DOI 10.1167/iovs.12-11320; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; SHIBUYA M, 1992, J NEUROSURG, V76, P571, DOI 10.3171/jns.1992.76.4.0571; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Tanihara H, 2015, ACTA OPHTHA IN PRESS; Tian B, 2001, CURR EYE RES, V22, P109, DOI 10.1076/ceyr.22.2.109.5529; Wato E, 2014, FUNDAM TOXICOL SCI, V1, P39, DOI DOI 10.2131/fts.1.39; ZANTOS SG, 1977, AM J OPTOM PHYS OPT, V54, P856	23	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136802	10.1371/journal.pone.0136802	http://dx.doi.org/10.1371/journal.pone.0136802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367375	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100026
J	Yamada, K; Gherasim, C; Banerjee, R; Koutmos, M				Yamada, Kazuhiro; Gherasim, Carmen; Banerjee, Ruma; Koutmos, Markos			Structure of Human B-12 Trafficking Protein CblD Reveals Molecular Mimicry and Identifies a New Subfamily of Nitro-FMN Reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN METHIONINE SYNTHASE; COMPLEMENTATION GROUP; VITAMIN-B-12; MMACHC; MUTATIONS; DEFECT; DOMAIN; DEFICIENCY; ACTIVATION; PREDICTION	In mammals, B-12 (or cobalamin) is an essential cofactor required by methionine synthase and methylmalonyl-CoA mutase. A complex intracellular pathway supports the assimilation of cobalamin into its active cofactor forms and delivery to its target enzymes. MMADHC(the methylmalonic aciduria and homocystinuria type D protein), commonly referred to as CblD, is a key chaperone involved in intracellular cobalamin trafficking, and mutations in CblD cause methylmalonic aciduria and/or homocystinuria. Herein, we report the first crystal structure of the globular C-terminal domain of human CblD, which is sufficient for its interaction with MMADHC (the methylmalonic aciduria and homocystinuria type C protein), or CblC, and for supporting the cytoplasmic cobalamin trafficking pathway. CblD contains an alpha+beta fold that is structurally reminiscent of the nitro-FMN reductase superfamily. Two of the closest structural relatives of CblD are CblC, a multifunctional enzyme important for cobalamin trafficking, and the activation domain of methionine synthase. CblD, CblC, and the activation domain of methionine synthase share several distinguishing features and, together with two recently described corrinoid-dependent reductive dehalogenases, constitute a new subclass within the nitro-FMN reductase superfamily. We demonstrate that CblD enhances oxidation of cob(II) alamin bound to CblC and that disease-causing mutations in CblD impair the kinetics of this reaction. The striking structural similarity of CblD to CblC, believed to be contiguous in the cobalamin trafficking pathway, suggests the co-option of molecular mimicry as a strategy for achieving its function.	[Yamada, Kazuhiro; Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20814 USA; [Gherasim, Carmen; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Uniformed Services University of the Health Sciences - USA; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu; markos.koutmos@usuhs.edu	Regan, Clinton/E-6250-2012	Koutmos, Markos/0000-0003-0933-6312	National Institutes of Health [DK45776]; American Heart Association [13SDG14560056]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776 (to R.B.). This work was also supported by American Heart Association Grant 13SDG14560056 (to M.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Bommer M, 2014, SCIENCE, V346, P455, DOI 10.1126/science.1258118; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deme JC, 2012, MOL GENET METAB, V107, P352, DOI 10.1016/j.ymgme.2012.07.001; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Dowling DP, 2012, ANNU REV BIOPHYS, V41, P403, DOI 10.1146/annurev-biophys-050511-102225; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gherasim C, 2013, BIOCHIMIE, V95, P1023, DOI 10.1016/j.biochi.2013.02.003; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; Hannibal L, 2011, MOL GENET METAB, V103, P226, DOI 10.1016/j.ymgme.2011.03.008; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; KOLHOUSE JF, 1977, P NATL ACAD SCI USA, V74, P921, DOI 10.1073/pnas.74.3.921; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; Koutmos M, 2009, P NATL ACAD SCI USA, V106, P18527, DOI 10.1073/pnas.0906132106; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Mah W, 2013, MOL GENET METAB, V108, P112, DOI 10.1016/j.ymgme.2012.11.284; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MELLMAN IS, 1977, P NATL ACAD SCI USA, V74, P916, DOI 10.1073/pnas.74.3.916; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; Plesa M, 2011, MOL GENET METAB, V102, P139, DOI 10.1016/j.ymgme.2010.10.011; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; Stucki M, 2012, HUM MOL GENET, V21, P1410, DOI 10.1093/hmg/ddr579; Suormala T, 2004, J BIOL CHEM, V279, P42742, DOI 10.1074/jbc.M407733200; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolthers KR, 2007, FEBS J, V274, P738, DOI 10.1111/j.1742-4658.2006.05618.x; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022	48	17	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29155	29166		10.1074/jbc.M115.682435	http://dx.doi.org/10.1074/jbc.M115.682435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26364851	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000366613400004
J	Beccari, L; Marco-Ferreres, R; Tabanera, N; Manfredi, A; Souren, M; Wittbrodt, B; Conte, I; Wittbrodt, J; Bovolenta, P				Beccari, Leonardo; Marco-Ferreres, Raquel; Tabanera, Noemi; Manfredi, Anna; Souren, Marcel; Wittbrodt, Beate; Conte, Ivan; Wittbrodt, Jochen; Bovolenta, Paola			A trans-Regulatory Code for the Forebrain Expression of Six3.2 in the Medaka Fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE REGULATORY NETWORKS; RETINAL PROGENITOR CELLS; EYE DEVELOPMENT; NEURAL PLATE; DNA-BINDING; VERTEBRATE RETINA; LENS DEVELOPMENT; BIPOLAR CELLS; MOUSE RETINA; HMG DOMAIN	Background: The transcription factor Six3 is key element of forebrain specification, but its upstream regulators are unknown. Results: A systematic search in medaka fish identifies and functionally characterizes novel Six3 regulators. Conclusion: The spatio-temporal regulation of Six3 depends on a few trans-acting factors. Significance: This study provides new information on how forebrain neuronal diversity is originated.	[Beccari, Leonardo; Marco-Ferreres, Raquel; Tabanera, Noemi; Bovolenta, Paola] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Beccari, Leonardo; Marco-Ferreres, Raquel; Tabanera, Noemi; Bovolenta, Paola] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28049, Spain; [Beccari, Leonardo; Marco-Ferreres, Raquel; Tabanera, Noemi; Manfredi, Anna; Conte, Ivan; Bovolenta, Paola] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Conte, Ivan] Telethon Inst Genet & Med, I-80078 Naples, Italy; [Souren, Marcel; Wittbrodt, Beate; Wittbrodt, Jochen] Heidelberg Univ, Ctr Organismal Studies, D-69120 Heidelberg, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Ruprecht Karls University Heidelberg	Beccari, L (corresponding author), Univ Geneva, Fac Sci, Dept Genet & Evolut, Sci 3,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	leonardo.beccari@unige.ch; pbovolenta@cbm.csic.es	Wittbrodt, Joachim/D-4735-2014; Beccari, Leonardo/AAC-8373-2020; Manfredi, Anna/ABC-8588-2021	Wittbrodt, Joachim/0000-0001-8550-7377; Beccari, Leonardo/0000-0001-6472-5105; Conte, Ivan/0000-0002-8968-9021; Tabanera, Noemi/0000-0002-8815-7728; Bovolenta, Paola/0000-0002-1870-751X; Marco-Ferreres, Raquel/0000-0002-6109-3840	Spanish Ministerio de Economia y Competitividad (MINECO) [BFU2010-16031, BFU2013-43213-P]; FEDER Funds; Comunidad Autonoma de Madrid (CAM) Grant [CELL-DD S2010/BMD-2315]; Fundaluce; Fundacion ONCE; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) del Instituto Carlos III (ISCIII); Fundacion Ramon Areces	Spanish Ministerio de Economia y Competitividad (MINECO); FEDER Funds(European Commission); Comunidad Autonoma de Madrid (CAM) Grant; Fundaluce; Fundacion ONCE; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) del Instituto Carlos III (ISCIII); Fundacion Ramon Areces	This work was supported by Spanish Ministerio de Economia y Competitividad (MINECO) Grants BFU2010-16031 and BFU2013-43213-P, cofounded by FEDER Funds; Comunidad Autonoma de Madrid (CAM) Grant CELL-DD S2010/BMD-2315; Fundaluce; Fundacion ONCE; the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) del Instituto Carlos III (ISCIII); and an Institutional Grant from the Fundacion Ramon Areces. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Ando H, 2005, DEV BIOL, V287, P456, DOI 10.1016/j.ydbio.2005.09.023; Andoniadou CL, 2011, DEVELOPMENT, V138, P4931, DOI 10.1242/dev.066597; Appolloni I, 2008, CEREB CORTEX, V18, P553, DOI 10.1093/cercor/bhm092; Asahara H, 1999, MOL CELL BIOL, V19, P8219; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Beccari L, 2013, MECH DEVELOP, V130, P95, DOI 10.1016/j.mod.2012.10.004; Beccari L, 2012, DEVELOPMENT, V139, P151, DOI 10.1242/dev.067660; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Brzezinski JA, 2013, DEV BIOL, V384, P194, DOI 10.1016/j.ydbio.2013.10.006; Calvo KR, 1999, ONCOGENE, V18, P8033, DOI 10.1038/sj.onc.1203377; Carl M, 2002, DEVELOPMENT, V129, P4057; Chao CH, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-35; Chow RL, 1999, DEVELOPMENT, V126, P4213; Conte I, 2005, DEV DYNAM, V234, P718, DOI 10.1002/dvdy.20463; Conte I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r137; Conte I, 2010, DEVELOPMENT, V137, P2307, DOI 10.1242/dev.045294; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Domene S, 2008, HUM MOL GENET, V17, P3919, DOI 10.1093/hmg/ddn294; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Dyer MA, 2003, CELL CYCLE, V2, P350, DOI 10.4161/cc.2.4.429; Erickson T, 2007, DEV BIOL, V301, P504, DOI 10.1016/j.ydbio.2006.08.022; Ferran JL, 2007, J COMP NEUROL, V505, P379, DOI 10.1002/cne.21493; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Ferri A, 2013, DEVELOPMENT, V140, P1250, DOI 10.1242/dev.073411; Fuhrmann S, 2009, INVEST OPHTH VIS SCI, V50, P432, DOI 10.1167/iovs.08-2270; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Gestri G, 2005, DEVELOPMENT, V132, P2401, DOI 10.1242/dev.01814; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; Goudreau G, 2002, P NATL ACAD SCI USA, V99, P8719, DOI 10.1073/pnas.132195699; Gustavson MD, 2004, MOL CARCINOGEN, V41, P125, DOI 10.1002/mc.20049; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Inbal A, 2007, NEURON, V55, P407, DOI 10.1016/j.neuron.2007.06.037; Inoue M, 2007, GENES CELLS, V12, P1049, DOI 10.1111/j.1365-2443.2007.01114.x; Inoue T, 2002, DEVELOPMENT, V129, P831; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; JOHN A, 1995, DEVELOPMENT, V121, P1801; Kawakami K, 1996, FEBS LETT, V393, P259, DOI 10.1016/0014-5793(96)00899-X; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kobayashi D, 2002, DEVELOPMENT, V129, P83; Kondoh H, 2004, INT J DEV BIOL, V48, P819, DOI 10.1387/ijdb.041868hk; Lacbawan F, 2009, J MED GENET, V46, P389, DOI 10.1136/jmg.2008.063818; Lagutin O, 2001, DEV DYNAM, V221, P342, DOI 10.1002/dvdy.1148; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Laurent A, 2007, MECH DEVELOP, V124, P364, DOI 10.1016/j.mod.2007.01.008; Lavado A, 2008, DEVELOPMENT, V135, P441, DOI 10.1242/dev.010082; Lengler J, 2005, OPHTHALMIC RES, V37, P301, DOI 10.1159/000087774; Lengler J, 2001, BIOCHEM BIOPH RES CO, V287, P372, DOI 10.1006/bbrc.2001.5605; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; Rivas ML, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003252; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Maurya AK, 2011, DEVELOPMENT, V138, P755, DOI 10.1242/dev.062521; McCollum CW, 2007, DEV BIOL, V309, P373, DOI 10.1016/j.ydbio.2007.07.004; Mizutani CM, 2006, PLOS BIOL, V4, P1777, DOI 10.1371/journal.pbio.0040313; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Oliver G, 1995, DEVELOPMENT, V121, P4045; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Paek H, 2009, DEVELOPMENT, V136, P2457, DOI 10.1242/dev.032656; Pasquier L, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023416; Phillips BT, 2006, DEV BIOL, V294, P376, DOI 10.1016/j.ydbio.2006.03.001; Purcell P, 2005, GENE EXPR PATTERNS, V6, P110, DOI 10.1016/j.modgep.2005.04.010; Rodriguez-Seguel E, 2009, DEV BIOL, V329, P258, DOI 10.1016/j.ydbio.2009.02.028; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Schmitt S, 2009, INVEST OPHTH VIS SCI, V50, P5901, DOI 10.1167/iovs.08-3067; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Smith AN, 2009, DEVELOPMENT, V136, P2977, DOI 10.1242/dev.037341; Souren M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r92; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Suh CS, 2010, FEBS J, V277, P1761, DOI 10.1111/j.1742-4658.2010.07599.x; Thiaville MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036054; Tribulo C, 2003, DEVELOPMENT, V130, P6441, DOI 10.1242/dev.00878; Wang S, 2014, DEV CELL, V30, P513, DOI 10.1016/j.devcel.2014.07.018; Wargelius A, 2003, BIOCHEM BIOPH RES CO, V309, P475, DOI 10.1016/j.bbrc.2003.07.010; Zhu CQC, 2002, DEVELOPMENT, V129, P2835; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	84	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26927	26942		10.1074/jbc.M115.681254	http://dx.doi.org/10.1074/jbc.M115.681254			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378230	Green Published, hybrid			2022-12-26	WOS:000364794000005
J	Mohanty, S; Jobichen, C; Chichili, VPR; Velazquez-Campoy, A; Low, BC; Hogue, CWV; Sivaraman, J				Mohanty, Soumya; Jobichen, Chacko; Chichili, Vishnu Priyanka Reddy; Velazquez-Campoy, Adrian; Low, Boon Chuan; Hogue, Christopher W. V.; Sivaraman, J.			Structural Basis for a Unique ATP Synthase Core Complex from Nanoarcheaum equitans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; BINDING CHANGE MECHANISM; V-TYPE; IGNICOCCUS-HOSPITALIS; CRYSTAL-STRUCTURE; F-TYPE; CENTRAL STALK; SUBUNIT B; EVOLUTION; F-1-ATPASE	Background: Structural asymmetry upon nucleotide binding is crucial for catalytic activity of ATP synthases. Results: The structures of apo and bound A(3)B(3) hexamer of N. equitans ATP synthase show conformational inflexibility. Conclusion: The N. equitans A(3)B(3) hexamer is an inactive form. Significance: The structure of inactive form of N. equitans ATP synthase A(3)B(3) is shown for the first time. ATP synthesis is a critical and universal life process carried out by ATP synthases. Whereas eukaryotic and prokaryotic ATP synthases are well characterized, archaeal ATP synthases are relatively poorly understood. The hyperthermophilic archaeal parasite, Nanoarcheaum equitans, lacks several subunits of the ATP synthase and is suspected to be energetically dependent on its host, Ignicoccus hospitalis. This suggests that this ATP synthase might be a rudimentary machine. Here, we report the crystal structures and biophysical studies of the regulatory subunit, NeqB, the apo-NeqAB, and NeqAB in complex with nucleotides, ADP, and adenylyl-imidodiphosphate (non-hydrolysable analog of ATP). NeqB is approximate to 20 amino acids shorter at its C terminus than its homologs, but this does not impede its binding with NeqA to form the complex. The heterodimeric NeqAB complex assumes a closed, rigid conformation irrespective of nucleotide binding; this differs from its homologs, which require conformational changes for catalytic activity. Thus, although N. equitans possesses an ATP synthase core A(3)B(3) hexameric complex, it might not function as a bona fide ATP synthase.	[Mohanty, Soumya; Jobichen, Chacko; Chichili, Vishnu Priyanka Reddy; Low, Boon Chuan; Hogue, Christopher W. V.; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Velazquez-Campoy, Adrian] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit Inst Phys Chem Rocasolano IQFR Spanish, Zaragoza 50018, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Dept Biochem & Mol & Cell Biol, Zaragoza 50018, Spain; [Velazquez-Campoy, Adrian] Govt Aragon, Fdn ARAID, Zaragoza 50018, Spain; [Low, Boon Chuan; Hogue, Christopher W. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore	National University of Singapore; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza; National University of Singapore	Low, BC (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore.	dbslowbc@nus.edu.sg; dbsjayar@nus.edu.sg	Velazquez-Campoy, Adrian/E-7946-2012; Jobichen, Chacko/AAR-7637-2020; Hogue, Christopher W V/AAZ-3934-2020; Low, Boon Chuan/H-8049-2012; Jobichen, Chacko/D-1978-2014; Low, Boon Chuan/AAU-7685-2021	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Hogue, Christopher W V/0000-0002-3107-5246; Low, Boon Chuan/0000-0003-0756-096X; Jobichen, Chacko/0000-0001-5927-1815; Low, Boon Chuan/0000-0003-0756-096X; J, Sivaraman/0000-0001-9781-5326	Academic Research Fund, National University of Singapore [WBS R154000616112]	Academic Research Fund, National University of Singapore(National University of Singapore)	This work was supported in part by Academic Research Fund (WBS R154000616112), National University of Singapore. The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074291; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Burghardt T, 2009, BIOCHEM SOC T, V37, P127, DOI 10.1042/BST0370127; Capaldi RA, 2000, J EXP BIOL, V203, P29; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen C, 2006, J BIOL CHEM, V281, P13777, DOI 10.1074/jbc.M513369200; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Coskun U, 2004, J BIOL CHEM, V279, P22759, DOI 10.1074/jbc.M313741200; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Das S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-186; Deppenmeier Uwe, 2008, V45, P123, DOI 10.1007/400_2006_026; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fillingame RH, 1997, J EXP BIOL, V200, P217; Giannone RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022942; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Grabe M, 2000, BIOPHYS J, V78, P2798, DOI 10.1016/S0006-3495(00)76823-8; Groth G, 2001, J BIOL CHEM, V276, P1345, DOI 10.1074/jbc.M008015200; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; HILARIO E, 1993, BIOSYSTEMS, V31, P111, DOI 10.1016/0303-2647(93)90038-E; Hofmann K., 1996, BOXSHADE VERSION 3 2; Indyk L, 1998, METHOD ENZYMOL, V295, P350; Jahn U, 2004, ARCH MICROBIOL, V182, P404, DOI 10.1007/s00203-004-0725-x; Jahn U, 2008, J BACTERIOL, V190, P1743, DOI 10.1128/JB.01731-07; Kishikawa J, 2014, J BIOL CHEM, V289, P403, DOI 10.1074/jbc.M113.523498; Kuper U, 2010, P NATL ACAD SCI USA, V107, P3152, DOI 10.1073/pnas.0911711107; Kumar A, 2008, ACTA CRYSTALLOGR D, V64, P1110, DOI 10.1107/S090744490802790X; Kumar A, 2010, J MOL BIOL, V396, P301, DOI 10.1016/j.jmb.2009.11.046; Kumar A, 2009, PROTEINS, V75, P807, DOI 10.1002/prot.22289; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Lewalter K, 2006, BBA-BIOENERGETICS, V1757, P437, DOI 10.1016/j.bbabio.2006.04.027; Lingl A, 2003, EXTREMOPHILES, V7, P249, DOI 10.1007/s00792-003-0318-7; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Manimekalai MSS, 2011, J MOL BIOL, V408, P736, DOI 10.1016/j.jmb.2011.03.010; Manimekalai MSS, 2009, J STRUCT BIOL, V166, P38, DOI 10.1016/j.jsb.2008.12.004; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Muller V, 1999, J BIOENERG BIOMEMBR, V31, P15, DOI 10.1023/A:1005451311009; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; NELSON N, 1989, J BIOENERG BIOMEMBR, V21, P553, DOI 10.1007/BF00808113; NELSON N, 1992, BIOCHIM BIOPHYS ACTA, V1100, P109; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Podar M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r158; Rachel Reinhard, 2002, Archaea, V1, P9, DOI 10.1155/2002/307480; SCHAFER G, 1992, BIOCHIM BIOPHYS ACTA, V1101, P232, DOI 10.1016/0005-2728(92)90233-R; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Tellinghuisen J, 2008, ANAL BIOCHEM, V373, P395, DOI 10.1016/j.ab.2007.08.039; Tellinghuisen J, 2012, ANAL BIOCHEM, V424, P211, DOI 10.1016/j.ab.2011.12.035; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Velazquez-Campoy A, 2015, J THERM ANAL CALORIM, V122, P1477, DOI 10.1007/s10973-015-4775-x; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504	71	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27280	27296		10.1074/jbc.M115.677492	http://dx.doi.org/10.1074/jbc.M115.677492			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26370083	Green Published, hybrid			2022-12-26	WOS:000364794000036
J	Agrawal, C; Sen, S; Yadav, S; Rai, S; Rai, LC				Agrawal, Chhavi; Sen, Sonia; Yadav, Shivam; Rai, Shweta; Rai, Lal Chand			A Novel Aldo-Keto Reductase (AKR17A1) of Anabaena sp PCC 7120 Degrades the Rice Field Herbicide Butachlor and Confers Tolerance to Abiotic Stresses in E. coli	PLOS ONE			English	Article							ALDOSE/ALDEHYDE REDUCTASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SP PCC7120; DEGRADATION; EXPRESSION; SOIL; METHYLGLYOXAL; METABOLISM; GENE	Present study deals with the identification of a novel aldo/keto reductase, AKR17A1 from Anabaena sp. PCC7120 and adds on as 17th family of AKR superfamily drawn from a wide variety of organisms. AKR17A1 shares many characteristics of a typical AKR such as-(i) conferring tolerance to multiple stresses like heat, UV-B, and cadmium, (ii) excellent activity towards known AKR substrates (isatin and 2-nitrobenzaldehyde), and (iii) obligate dependence on NADPH as a cofactor for enzyme activity. The most novel attribute of AKR17A1, first reported in this study, is its capability to metabolize butachlor, a persistent rice field herbicide that adversely affects agro-ecosystem and non-target organisms. The AKR17A1 catalyzed-degradation of butachlor resulted into formation of 1,2-benzene dicarboxylic acid and 2,6 bis (1,1, dimethylethyl) 4,-methyl phenol as the major products confirmed by GC-MS analysis.	[Agrawal, Chhavi; Sen, Sonia; Yadav, Shivam; Rai, Shweta; Rai, Lal Chand] Banaras Hindu Univ, Mol Biol Sect, Ctr Adv Study Bot, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Rai, LC (corresponding author), Banaras Hindu Univ, Mol Biol Sect, Ctr Adv Study Bot, Varanasi 221005, Uttar Pradesh, India.	lcrbhu15@gmail.com			Indian Council of Agricultural Research, New Delhi, India [P27/130]	Indian Council of Agricultural Research, New Delhi, India(Indian Council of Agricultural Research (ICAR))	LCR received funds from Indian Council of Agricultural Research, New Delhi, India (Grant no. P27/130).	Agrawal C, 2014, J PROTEOMICS, V96, P271, DOI 10.1016/j.jprot.2013.11.015; Aguilera J, 2001, CURR GENET, V39, P273, DOI 10.1007/s002940100213; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Anees S, 2014, BIOINFORMATION, V10, P365, DOI 10.6026/97320630010365; Ateeq B, 2002, MUTAT RES-GEN TOX EN, V514, P105, DOI 10.1016/S1383-5718(01)00327-8; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; CHANG SS, 1985, J PLANT GROWTH REGUL, V4, P1; Di Luccio E, 2006, BIOCHEM J, V400, P105, DOI 10.1042/BJ20060660; Dwivedi S, 2010, LETT APPL MICROBIOL, V51, P54, DOI 10.1111/j.1472-765X.2010.02854.x; Dwivedi S, 2012, TOXICOLOGY, V302, P77, DOI 10.1016/j.tox.2012.07.014; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ford G, 2002, YEAST, V19, P1087, DOI 10.1002/yea.899; Ford G, 2001, CHEM-BIOL INTERACT, V130, P685, DOI 10.1016/S0009-2797(00)00259-3; Gavidia I, 2002, EUR J BIOCHEM, V269, P2842, DOI 10.1046/j.1432-1033.2002.02931.x; Grant AW, 2003, FEMS MICROBIOL LETT, V218, P93, DOI 10.1111/j.1574-6968.2003.tb11503.x; Hegedus A, 2004, PLANT SCI, V166, P1329, DOI 10.1016/j.plantsci.2004.01.013; Hideg E, 2003, PLANT CELL ENVIRON, V26, P513, DOI 10.1046/j.1365-3040.2003.00982.x; Jayakumar R, 1993, P INT S IND SOC WEED, P123; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Kanayama Y, 2014, PHYTOCHEMISTRY, V104, P30, DOI 10.1016/j.phytochem.2014.04.008; Katoh H, 2004, MICROB ECOL, V47, P164, DOI 10.1007/s00248-003-1043-6; Kim NH, 2013, FEMS MICROBIOL LETT, V344, P114, DOI 10.1111/1574-6968.12163; Kumari N, 2009, CHEMOSPHERE, V77, P1501, DOI 10.1016/j.chemosphere.2009.10.005; Liu HM, 2012, J AGR FOOD CHEM, V60, P12238, DOI 10.1021/jf303936j; Liu WY, 2011, ECOTOXICOLOGY, V20, P377, DOI 10.1007/s10646-010-0589-6; Marino M, 2000, MICROBIOL-SGM, V146, P97, DOI 10.1099/00221287-146-1-97; Nakano M, 1999, J BIOL CHEM, V274, P23185, DOI 10.1074/jbc.274.33.23185; Nei M., 2000, MOL EVOLUTION PHYLOG; Ni Y, 2011, APPL MICROBIOL BIOT, V89, P1111, DOI 10.1007/s00253-010-2941-4; Norbeck J, 1997, J BIOL CHEM, V272, P5544, DOI 10.1074/jbc.272.9.5544; Oberschall A, 2000, PLANT J, V24, P437, DOI 10.1046/j.1365-313x.2000.00885.x; Pal R, 2006, J ENVIRON SCI HEAL B, V41, P1103, DOI 10.1080/03601230600851141; Pandey S, 2012, J PROTEOMICS, V75, P921, DOI 10.1016/j.jprot.2011.10.011; Pandey S, 2013, PLANT MOL BIOL, V83, P417, DOI 10.1007/s11103-013-0100-x; Petrash JM, 2004, CELL MOL LIFE SCI, V61, P737, DOI 10.1007/s00018-003-3402-3; Prakash N. B., 2000, Karnataka Journal of Agricultural Sciences, V13, P575; Rai S, 2014, J PROTEOMICS, V98, P254, DOI 10.1016/j.jprot.2013.12.020; Rai S, 2013, PHOTOSYNTH RES, V118, P105, DOI 10.1007/s11120-013-9931-1; Rajaram H, 2008, MICROBIOL-SGM, V154, P317, DOI 10.1099/mic.0.2007/011064-0; Rao PC, 2012, INDIAN J WEED SCI, V44, P84; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; SETHUNATHAN N, 1973, CAN J MICROBIOL, V19, P873, DOI 10.1139/m73-138; Shobha Sondhia, 2006, Annals of Plant Protection Sciences, V14, P206; Shrivastava AK, 2015, J PROTEOMICS, V127, P122, DOI 10.1016/j.jprot.2015.05.014; Shrivastava AK, 2012, GENE, V511, P248, DOI 10.1016/j.gene.2012.09.033; Simpson PJ, 2009, J MOL BIOL, V392, P465, DOI 10.1016/j.jmb.2009.07.023; Singh PK., 2012, PHYKOS, V42, P39; Singh PK, 2015, J PROTEOMICS, V127, P134, DOI 10.1016/j.jprot.2015.05.019; SMILEY KL, 1982, BIOTECHNOL LETT, V4, P607, DOI 10.1007/BF00127793; Srivastava AK, 2007, J APPL PHYCOL, V19, P373, DOI 10.1007/s10811-006-9144-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turoczy Z, 2011, PLANT MOL BIOL, V75, P399, DOI 10.1007/s11103-011-9735-7; Widmer SK, 1996, ACS SYM SER, V630, P271; Xu DY, 2006, MICROBIOL-SGM, V152, P2013, DOI 10.1099/mic.0.28870-0; Xu HD, 2015, AQUAT TOXICOL, V159, P69, DOI 10.1016/j.aquatox.2014.11.020; Yamamoto K, 2013, ARCH BIOCHEM BIOPHYS, V538, P156, DOI 10.1016/j.abb.2013.08.018; Yang CM, 2011, J ENVIRON SCI, V23, P1437, DOI 10.1016/S1001-0742(10)60604-3; Yu YL, 2003, CHEMOSPHERE, V50, P771, DOI 10.1016/S0045-6535(02)00218-7; Zheng JW, 2012, INT BIODETER BIODEGR, V73, P16, DOI 10.1016/j.ibiod.2012.06.003	62	22	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137744	10.1371/journal.pone.0137744	http://dx.doi.org/10.1371/journal.pone.0137744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372161	Green Submitted, Green Published, gold			2022-12-26	WOS:000361604400029
J	Doucet, CM; Esmery, N; de Saint-Jean, M; Antonny, B				Doucet, Christine M.; Esmery, Nina; de Saint-Jean, Maud; Antonny, Bruno			Membrane Curvature Sensing by Amphipathic Helices Is Modulated by the Surrounding Protein Backbone	PLOS ONE			English	Article							LIPID-PACKING; GOLGI LOCALIZATION; ARFGAP1; MOTIFS; MECHANISMS; SEQUENCES; REQUIRES; DOMAINS; COMPLEX; SENSORS	Membrane curvature is involved in numerous biological pathways like vesicle trafficking, endocytosis or nuclear pore complex assembly. In addition to its topological role, membrane curvature is sensed by specific proteins, enabling the coordination of biological processes in space and time. Amongst membrane curvature sensors are the ALPS (Amphipathic Lipid Packing Sensors). ALPS motifs are short peptides with peculiar amphipathic properties. They are found in proteins targeted to distinct curved membranes, mostly in the early secretory pathway. For instance, the ALPS motif of the golgin GMAP210 binds trafficking vesicles, while the ALPS motif of Nup133 targets nuclear pores. It is not clear if, besides curvature sensitivity, ALPS motifs also provide target specificity, or if other domains in the surrounding protein backbone are involved. To elucidate this aspect, we studied the subcellular localization of ALPS motifs outside their natural protein context. The ALPS motifs of GMAP210 or Nup133 were grafted on artificial fluorescent probes. Importantly, ALPS motifs are held in different positions and these contrasting architectures were mimicked by the fluorescent probes. The resulting chimeras recapitulated the original proteins localization, indicating that ALPS motifs are sufficient to specifically localize proteins. Modulating the electrostatic or hydrophobic content of Nup133 ALPS motif modified its avidity for cellular membranes but did not change its organelle targeting properties. In contrast, the structure of the backbone surrounding the helix strongly influenced targeting. In particular, introducing an artificial coiled-coil between ALPS and the fluorescent protein increased membrane curvature sensitivity. This coiled-coil domain also provided membrane curvature sensitivity to the amphipathic helix of Sar1. The degree of curvature sensitivity within the coiled-coil context remains correlated to the natural curvature sensitivity of the helices. This suggests that the chemistry of ALPS motifs is a key parameter for membrane curvature sensitivity, which can be further modulated by the surrounding protein backbone.	[Doucet, Christine M.; Esmery, Nina; de Saint-Jean, Maud; Antonny, Bruno] CNRS UMR 7275, IPMC, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Doucet, CM (corresponding author), CNRS UMR 5048, CBS, 29 Rue Navacelles, F-34090 Montpellier, France.	christine.doucet@cbs.cnrs.fr	Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; Doucet, Christine/0000-0002-1611-8279	Centre National de la Recherche Scientifique; Marie Curie grant from the 7th Framework Programme for Research [IRG 277018]; European Research Council (ERC) [268888]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Marie Curie grant from the 7th Framework Programme for Research; European Research Council (ERC)(European Research Council (ERC))	CMD is supported by the Centre National de la Recherche Scientifique and by a Marie Curie grant (IRG 277018) from the 7th Framework Programme for Research. BA is supported by an advanced grant from the European Research Council (ERC 268888). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; Antonny B, 2012, DEV CELL; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Cardenas J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-56; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Copic A, 2012, SCIENCE, V335, P1359, DOI 10.1126/science.1215909; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Doucet CM, 2010, CHROMOSOMA, V119, P469, DOI 10.1007/s00412-010-0289-2; Doucet CM, 2010, CELL, V141, P1030, DOI 10.1016/j.cell.2010.04.036; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Dultz E, 2010, J CELL BIOL, V191, P15, DOI 10.1083/jcb.201007076; English AR, 2013, NAT CELL BIOL, V15, P169, DOI 10.1038/ncb2647; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Krabben L, 2011, J NEUROSCI, V31, P18149, DOI 10.1523/JNEUROSCI.4345-11.2011; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Levi S, 2008, J BIOL CHEM, V283, P8564, DOI 10.1074/jbc.M709738200; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Parnis A, 2006, J BIOL CHEM, V281, P3785, DOI 10.1074/jbc.M508959200; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Plomann M, 2010, J MOL BIOL, V400, P129, DOI 10.1016/j.jmb.2010.05.008; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Sato K, 2015, MOL BIOL CELL, V26, P537, DOI 10.1091/mbc.E14-10-1450; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; SIMPSON RJ, 2002, PROTEINS PROTEOMICS; Stachowiak JC, 2013, NAT CELL BIOL, V15, P1019, DOI 10.1038/ncb2832; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; Vanni S, 2013, BIOPHYS J, V104, P575, DOI 10.1016/j.bpj.2012.11.3837; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wong M, 2014, SCIENCE, V346, P601, DOI 10.1126/science.1256898; Woolfson BDN, INTRO PROTEIN DESIGN, V70, P79, DOI [10.1016/S0065-3233(04)70004-2, DOI 10.1016/S0065-3233(04)70004-2]	51	19	19	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137965	10.1371/journal.pone.0137965	http://dx.doi.org/10.1371/journal.pone.0137965			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366573	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100188
J	Torkkeli, PH; Liu, HX; French, AS				Torkkeli, Paeivi H.; Liu, Hongxia; French, Andrew S.			Transcriptome Analysis of the Central and Peripheral Nervous Systems of the Spider Cupiennius salei Reveals Multiple Putative Cys-Loop Ligand Gated Ion Channel Subunits and an Acetylcholine Binding Protein	PLOS ONE			English	Article							X-RAY-STRUCTURE; CHLORIDE CHANNEL; DROSOPHILA-MELANOGASTER; FUNCTIONAL-CHARACTERIZATION; GENE SUPERFAMILY; MOLECULAR CHARACTERIZATION; GLUTAMATE RECEPTORS; RESIDUES CONTRIBUTE; GABA; IDENTIFICATION	Invertebrates possess a diverse collection of pentameric Cys-loop ligand gated ion channel (LGIC) receptors whose molecular structures, evolution and relationships to mammalian counterparts have been intensely investigated in several clinically and agriculturally important species. These receptors are targets for a variety of control agents that may also harm beneficial species. However, little is known about Cys-loop receptors in spiders, which are important natural predators of insects. We assembled de novo transcriptomes from the central and peripheral nervous systems of the Central American wandering spider Cupiennius salei, a model species for neurophysiological, behavioral and developmental studies. We found 15 Cys-loop receptor subunits that are expected to form anion or cation permeable channels, plus a putative acetylcholine binding protein (AChBP) that has only previously been reported in molluscs and one annelid. We used phylogenetic and sequence analysis to compare the spider subunits to homologous receptors in other species and predicted the 3D structures of each protein using the I-Tasser server. The quality of homology models improved with increasing sequence identity to the available high-resolution templates. We found that C. salei has orthologous gamma-aminobutyric acid (GABA), GluCl, pHCl, HisCl and nACha LGIC subunits to other arthropods, but some subgroups are specific to arachnids, or only to spiders. C. salei sequences were phylogenetically closest to gene fragments from the social spider, Stegodyphus mimosarum, indicating high conservation within the Araneomorphae suborder of spiders. C. salei sequences had similar ligand binding and transmembrane regions to other invertebrate and vertebrate LGICs. They also had motifs associated with high sensitivity to insecticides and antiparasitic agents such as fipronil, dieldrin and ivermectin. Development of truly selective control agents for pest species will require information about the molecular structure and pharmacology of Cys-loop receptors in beneficial species.	[Torkkeli, Paeivi H.; Liu, Hongxia; French, Andrew S.] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada	Dalhousie University	Torkkeli, PH (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	Paivi.Torkkeli@dal.ca		French, Andrew/0000-0001-8190-4084; Torkkeli, Paivi/0000-0002-8205-7339	Canadian Institutes of Health Research [MOP-106602]; Natural Sciences and Engineering Research Council of Canada [RGPIN 05565]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding provided by Canadian Institutes of Health Research, Grant number MOP-106602, http://www.cihr.ca/e/193.html (PHT and ASF); Natural Sciences and Engineering Research Council of Canada RGPIN 05565, http://www.nserc-crsng.gc.ca/index_eng.asp (PHT).	Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Barth F.G., 2002, SPIDERS WORLD SENSES; Bartos M, 2009, MOL NEUROBIOL, V40, P236, DOI 10.1007/s12035-009-8084-x; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burrows M., 1996, NEUROBIOLOGY INSECT; Casida JE, 2015, PESTIC BIOCHEM PHYS, V121, P22, DOI 10.1016/j.pestbp.2014.11.006; CHEN RT, 1994, P NATL ACAD SCI USA, V91, P6069, DOI 10.1073/pnas.91.13.6069; Comitani F, 2014, J COMPUT AID MOL DES, V28, P35, DOI 10.1007/s10822-013-9704-0; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Eguchi Y, 2006, INSECT MOL BIOL, V15, P773, DOI 10.1111/j.1365-2583.2006.00680.x; Elliott KJ, 1996, J MOL NEUROSCI, V7, P217, DOI 10.1007/BF02736842; Erkkila BE, 2008, BIOPHYS J, V94, P4299, DOI 10.1529/biophysj.107.118455; Fabian-Fine R, 2002, MICROSC RES TECHNIQ, V58, P283, DOI 10.1002/jemt.10137; Fabian-Fine R, 2015, CELL TISSUE RES; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Foelix R., 2011, BIOL SPIDERS, V3; French AS, 2014, GENE, V539, P203, DOI 10.1016/j.gene.2014.01.079; French Andrew S, 2012, BMC Res Notes, V5, P673, DOI 10.1186/1756-0500-5-673; French AS, 2002, J COMP PHYSIOL A, V188, P739, DOI 10.1007/s00359-002-0363-1; Gisselmann G, 2004, BRIT J PHARMACOL, V142, P409, DOI 10.1038/sj.bjp.0705818; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hope M, 2010, J ECON ENTOMOL, V103, P1355, DOI 10.1603/EC09267; Hosie AM, 2001, NEUROSCIENCE, V102, P709, DOI 10.1016/S0306-4522(00)00483-8; Jones AK, 2010, HEREDITY, V104, P247, DOI 10.1038/hdy.2009.97; Jones AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-327; Jones Andrew K., 2006, Invertebrate Neuroscience, V6, P123, DOI 10.1007/s10158-006-0026-y; Jones Andrew K., 2008, Invertebrate Neuroscience, V8, P41, DOI 10.1007/s10158-008-0068-4; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; Karlin A., 2001, Pharmacogenomics Journal, V1, P221; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kehoe J, 2009, J MOL EVOL, V69, P125, DOI 10.1007/s00239-009-9256-z; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Knipple DC, 2010, PESTIC BIOCHEM PHYS, V97, P140, DOI 10.1016/j.pestbp.2009.09.002; Lansdell SJ, 2000, NEUROPHARMACOLOGY, V39, P2604, DOI 10.1016/S0028-3908(00)00111-8; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lees K, 2014, INT J PARASITOL, V44, P75, DOI 10.1016/j.ijpara.2013.11.002; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ludmerer SW, 2002, BIOCHEMISTRY-US, V41, P6548, DOI 10.1021/bi015920o; Lummis SCR, 2012, ACS CHEM NEUROSCI, V3, P186, DOI 10.1021/cn200103n; Lummis SCR, 2011, J NEUROSCI, V31, P12371, DOI 10.1523/JNEUROSCI.1610-11.2011; Lynagh T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08558; Lynagh T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00060; Lynagh T, 2010, INT J PARASITOL, V40, P1477, DOI 10.1016/j.ijpara.2010.07.010; McCormack T, 2010, BIOCHEMISTRY-US, V49, P2279, DOI 10.1021/bi902023y; McGonigle I, 2010, BIOCHEMISTRY-US, V49, P2897, DOI 10.1021/bi901698c; McGregor AP, 2008, BIOESSAYS, V30, P487, DOI 10.1002/bies.20744; Meng XK, 2015, NEUROSCI LETT, V584, P123, DOI 10.1016/j.neulet.2014.10.013; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mounsey Kate E., 2007, Invertebrate Neuroscience, V7, P149, DOI 10.1007/s10158-007-0050-6; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Nakao T, 2015, PESTIC BIOCHEM PHYS, V121, P39, DOI 10.1016/j.pestbp.2014.09.010; Olsen RW, 2014, ALCOHOL CLIN EXP RES, V38, P595, DOI 10.1111/acer.12283; Ozoe Y, 2013, ADV INSECT PHYSIOL, V44, P211, DOI 10.1016/B978-0-12-394389-7.00004-1; Ozoe Y, 2010, BIOCHEM BIOPH RES CO, V391, P744, DOI 10.1016/j.bbrc.2009.11.131; Panek I, 2005, EUR J NEUROSCI, V22, P636, DOI 10.1111/j.1460-9568.2005.04258.x; Panek I, 2002, EUR J NEUROSCI, V16, P96, DOI 10.1046/j.1460-9568.2002.02065.x; Pantazis A, 2008, J NEUROSCI, V28, P7250, DOI 10.1523/JNEUROSCI.1654-08.2008; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Pfeiffer K, 2009, J NEUROPHYSIOL, V101, P54, DOI 10.1152/jn.91020.2008; Pierleoni A, 2011, NUCLEIC ACIDS RES, V39, pW375, DOI 10.1093/nar/gkr282; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765; Saur M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043685; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Shotkoski F., 1994, Insect Molecular Biology, V3, P283, DOI 10.1111/j.1365-2583.1994.tb00179.x; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Smart TG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009662; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thany SH, 2011, CURR NEUROPHARMACOL, V9, P706, DOI 10.2174/157015911798376343; Tomizawa M, 2011, J AGR FOOD CHEM, V59, P2825, DOI 10.1021/jf1019455; Tomizawa M, 2009, ACCOUNTS CHEM RES, V42, P260, DOI 10.1021/ar800131p; Torkkeli PH, 2012, EUR J NEUROSCI, V36, P3602, DOI 10.1111/j.1460-9568.2012.08275.x; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolff C, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-15; Wolstenholme AJ, 2010, INVERTEBR NEUROSCI, V10, P5, DOI 10.1007/s10158-010-0105-y; Wotring VE, 2003, J PHYSIOL-LONDON, V548, P527, DOI 10.1113/jphysiol.2002.032045; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zemkova H, 2014, PHYSIOL RES, V63, pS215, DOI 10.33549/physiolres.932711; ZHANG HG, 1995, MOL PHARMACOL, V48, P835	95	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138068	10.1371/journal.pone.0138068	http://dx.doi.org/10.1371/journal.pone.0138068			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368804	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100214
J	Wohrle, J; Karakas, M; Trepte, U; Seeger, J; Gonska, B; Koenig, W; Rottbauer, W				Woehrle, Jochen; Karakas, Mahir; Trepte, Ulrike; Seeger, Julia; Gonska, Birgid; Koenig, Wolfgang; Rottbauer, Wolfgang			Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR EVENTS; PROGNOSTIC VALUE; RISK PREDICTION; OPERATIVE RISK; FAILURE; EXPRESSION; SURGERY; SYSTEM	Background It is not known whether biomarkers of hemodynamic stress, myocardial necrosis, and renal function might predict adverse outcome in patients undergoing percutaneous repair of severe mitral valve insufficiency. Thus, we aimed to assess the predictive value of various established and emerging biomarkers for major adverse cardiovascular events (MACE) in these patients. Methods Thirty-four patients with symptomatic severe mitral valve insufficiency with a mean STS-Score for mortality of 12.6% and a mean logistic EuroSCORE of 19.7% undergoing Mitra-Clip therapy were prospectively included in this study. Plasma concentrations of mid regional-proatrial natriuretic peptide (MR-proANP), Cystatin C, high-sensitive C-reactive protein (hsCRP), high-sensitive troponin T (hsTnT), N-terminal B-type natriuretic peptide (NT-proBNP), galectin-3, and soluble ST-2 (interleukin 1 receptor-like 1) were measured directly before procedure. MACE was defined as cardiovascular death and hospitalization for heart failure (HF). Results During a median follow-up of 211 days (interquartile range 133 to 333 days), 9 patients (26.5%) experienced MACE (death: 7 patients, rehospitalization for HF: 2 patients). Thirty day MACE-rate was 5.9% (death: 2 patients, no rehospitalization for HF). Baseline concentrations of hsTnT (Median 92.6 vs 25.2 ng/L), NT-proBNP (Median 11251 vs 1974 pg/mL) and MR-proANP (Median 755.6 vs 318.3 pmol/L, all p<0.001) were clearly higher in those experiencing an event vs event-free patients, while other clinical variables including STS-Score and logistic EuroSCORE did not differ significantly. In Kaplan-Meier analyses, NT-proBNP and in particular hsTnT and MR-proANP above the median discriminated between those experiencing an event vs event-free patients. This was further corroborated by C-statistics where areas under the ROC curve for prediction of MACE using the respective median values were 0.960 for MR-proANP, 0.907 for NT-proBNP, and 0.822 for hsTnT. Conclusions MR-proANP and hsTnT strongly predict cardiovascular death and rehospitalization for HF in patients undergoing percutaneous repair of mitral valve insufficiency. Both markers might be useful components in new scoring systems to better predict short-and potentially long-term mortality and morbidity after MitraClip procedure.	[Woehrle, Jochen; Karakas, Mahir; Trepte, Ulrike; Seeger, Julia; Gonska, Birgid; Koenig, Wolfgang; Rottbauer, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany	Ulm University	Koenig, W (corresponding author), Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany.	wolfgang.koenig@uniklinik-ulm.de		Koenig, Wolfgang/0000-0002-2064-9603				Arjamaa Olli, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P191; Bridgewater B, 1998, HEART, V79, P350, DOI 10.1136/hrt.79.4.350; Dieplinger B, 2014, CLIN CHEM, V60, P530, DOI 10.1373/clinchem.2013.209858; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Karakas M, 2014, CLIN CHEM, V60, P1441, DOI 10.1373/clinchem.2013.220202; Koenig W, 2005, CLIN CHEM, V51, P321, DOI 10.1373/clinchem.2004.041889; Koenig W, 2013, INT J CARDIOL, V168, P5126, DOI 10.1016/j.ijcard.2013.07.113; Koenig W, 2012, CLIN CHEM, V58, P1215, DOI 10.1373/clinchem.2012.183319; Mair J, 2008, CLIN CHEM LAB MED, V46, P1507, DOI 10.1515/CCLM.2008.295; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Mauri L, 2013, J AM COLL CARDIOL, V62, P317, DOI 10.1016/j.jacc.2013.04.030; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; NARUSE M, 1994, HYPERTENSION, V23, pI231, DOI 10.1161/01.HYP.23.1_Suppl.I231; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Neuss M, 2013, EUR J HEART FAIL, V15, P786, DOI 10.1093/eurjhf/hfs214; Pleger ST, 2013, EUR J HEART FAIL, V15, P919, DOI 10.1093/eurjhf/hft046; Rothenbacher D, 2006, ARCH INTERN MED, V166, P2455, DOI 10.1001/archinte.166.22.2455; Sanchez-Mas J, 2014, INT J CARDIOL, V172, pE98, DOI 10.1016/j.ijcard.2013.12.129; TOTH M, 1994, AM J PHYSIOL, V266, pH1572, DOI 10.1152/ajpheart.1994.266.4.H1572; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Xu-Cai YO, 2010, HEART, V96, P419, DOI 10.1136/hrt.2008.164145; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; Zamora E, 2014, CLIN CHEM, V60, P481, DOI 10.1373/clinchem.2013.212951	26	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137464	10.1371/journal.pone.0137464	http://dx.doi.org/10.1371/journal.pone.0137464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368980	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100075
J	Bailey, CC; DeVaux, LB; Farzan, M				Bailey, Charles C.; DeVaux, Lindsey B.; Farzan, Michael			The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; MICROGLIAL RESPONSE; TYPE-4 ALLELE; TREM2; MUTATIONS; RISK; PHAGOCYTOSIS; RECOGNITION; CLEARANCE	The triggering receptor expressed on myeloid cells 2 (TREM2) is an Ig-like V-type receptor expressed by populations of myeloid cells in the central nervous system and periphery. Loss-of-function mutations in TREM2 cause a progressive, fatal neurodegenerative disorder called Nasu-Hakola disease. In addition, a TREM2 R47H coding variant was recently identified as a risk factor for late-onset Alzheimer disease. TREM2 binds various polyanionic molecules but no specific protein ligands have been identified. Here we show that TREM2 specifically binds apolipoprotein E, a well established participant in Alzheimer disease. TREM2-Ig fusions efficiently precipitate ApoE from cerebrospinal fluid and serum. TREM2 also binds recombinant ApoE in solution and immobilized ApoE as detected by ELISA. Furthermore, the Alzheimer disease-associated R47H mutation, and other artificial mutations introduced in the same location, markedly reduced the affinity of TREM2 for ApoE. These findings reveal a link between two Alzheimer disease risk factors and may provide important clues to the pathogenesis of Nasu-Hakola disease and other neurodegenerative disorders.	[Bailey, Charles C.; DeVaux, Lindsey B.; Farzan, Michael] Scripps Res Inst, Dept Immunobiol & Microbial Sci, Jupiter, FL 33458 USA	Scripps Research Institute	Bailey, CC (corresponding author), Scripps Res Inst, Dept Immunobiol & Microbial Sci, Jupiter, FL 33458 USA.	cbailey@scripps.edu		Farzan, Michael/0000-0002-2990-5319; Bailey, Charles/0000-0003-0200-3523	Scripps Research Institute Florida	Scripps Research Institute Florida	This work was supported by startup funds provided by the Scripps Research Institute Florida. The authors declare that they have no conflicts of interest with the contents of this article.	Borroni B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.017; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Lill CM, 2015, ALZHEIMERS DEMENT, V11, P1407, DOI 10.1016/j.jalz.2014.12.009; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Park JS, 2015, TRAFFIC, V16, P510, DOI 10.1111/tra.12264; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Rosenthal SL, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.04.012; Savage JC, 2015, J NEUROSCI, V35, P6532, DOI 10.1523/JNEUROSCI.4586-14.2015; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Ulrich JD, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-20; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	39	170	174	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26033	26042		10.1074/jbc.M115.677286	http://dx.doi.org/10.1074/jbc.M115.677286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26374897	Green Published, hybrid			2022-12-26	WOS:000363527300024
J	Athey, TBT; Auger, JP; Teatero, S; Dumesnil, A; Takamatsu, D; Wasserscheid, J; Dewar, K; Gottschalk, M; Fittipaldi, N				Athey, Taryn B. T.; Auger, Jean-Philippe; Teatero, Sarah; Dumesnil, Audrey; Takamatsu, Daisuke; Wasserscheid, Jessica; Dewar, Ken; Gottschalk, Marcelo; Fittipaldi, Nahuel			Complex Population Structure and Virulence Differences among Serotype 2 Streptococcus suis Strains Belonging to Sequence Type 28	PLOS ONE			English	Article							MURAMIDASE-RELEASED PROTEIN; EXTRACELLULAR PROTEIN; RECOMBINATION EVENTS; DISEASED PIGS; MOUSE MODEL; PATHOGEN; GENOME; IDENTIFICATION; RESISTANCE; ALIGNMENT	Streptococcus suis is a major swine pathogen and a zoonotic agent. Serotype 2 strains are the most frequently associated with disease. However, not all serotype 2 lineages are considered virulent. Indeed, sequence type (ST) 28 serotype 2 S. suis strains have been described as a homogeneous group of low virulence. However, ST28 strains are often isolated from diseased swine in some countries, and at least four human ST28 cases have been reported. Here, we used whole-genome sequencing and animal infection models to test the hypothesis that the ST28 lineage comprises strains of different genetic backgrounds and different virulence. We used 50 S. suis ST28 strains isolated in Canada, the United States and Japan from diseased pigs, and one ST28 strain from a human case isolated in Thailand. We report a complex population structure among the 51 ST28 strains. Diversity resulted from variable gene content, recombination events and numerous genome-wide polymorphisms not attributable to recombination. Phylogenetic analysis using core genome single-nucleotide polymorphisms revealed four discrete clades with strong geographic structure, and a fifth clade formed by US, Thai and Japanese strains. When tested in experimental animal models, strains from this latter clade were significantly more virulent than a Canadian ST28 reference strain, and a closely related Canadian strain. Our results highlight the limitations of MLST for both phylogenetic analysis and virulence prediction and raise concerns about the possible emergence of ST28 strains in human clinical cases.	[Athey, Taryn B. T.; Teatero, Sarah; Fittipaldi, Nahuel] Publ Hlth Ontario, Toronto, ON, Canada; [Auger, Jean-Philippe; Dumesnil, Audrey; Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc, St Hyacinthe, PQ J2S 7C6, Canada; [Takamatsu, Daisuke] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki, Japan; [Takamatsu, Daisuke] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Wasserscheid, Jessica; Dewar, Ken] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Wasserscheid, Jessica; Dewar, Ken] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Fittipaldi, Nahuel] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Universite de Montreal; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University; McGill University; University of Toronto	Fittipaldi, N (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	nahuel.fittipaldi@oahpp.ca	Gottschalk, Marcelo/I-8116-2012	Fittipaldi, Nahuel/0000-0001-9553-3798	Public Health Ontario [PIF 2014-005]; Natural Sciences and Engineering Research Council of Canada [RPGIN-2015-04435]	Public Health Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Public Health Ontario through internal grant PIF 2014-005 to NF and by grants from the Natural Sciences and Engineering Research Council of Canada (RPGIN-2015-04435) to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LEC, 2010, J MOL MED, V88, P371, DOI 10.1007/s00109-009-0566-9; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chang B, 2006, JPN J INFECT DIS, V59, P397; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Chen L, 2013, J VET MED SCI, V75, P583, DOI 10.1292/jvms.12-0279; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Been M, 2013, GENOME BIOL EVOL, V5, P1524, DOI 10.1093/gbe/evt111; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; GOTTSCHALK M, 1989, J CLIN MICROBIOL, V27, P2633, DOI 10.1128/JCM.27.12.2633-2636.1989; Gottschalk M., 2011, DISEASES OF SWINE IN; Gottschalk M, 2013, VET MICROBIOL, V162, P819, DOI 10.1016/j.vetmic.2012.10.028; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; GOTTSCHALK MG, 1995, MICROBIOL-SGM, V141, P189, DOI 10.1099/00221287-141-1-189; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kerdsin A, 2011, EMERG INFECT DIS, V17, P835, DOI 10.3201/eid1705.100754; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Li S, 2013, MICROB PATHOGENESIS, V63, P8, DOI 10.1016/j.micpath.2013.05.011; Marini E, 2015, VET MICROBIOL, V178, P99, DOI 10.1016/j.vetmic.2015.04.013; Marttinen P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-421; Mostowy R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004300; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Okura M, 2011, J BACTERIOL, V193, P822, DOI 10.1128/JB.01555-09; Onishi H, 2012, J VET MED SCI, V74, P1681, DOI 10.1292/jvms.12-0301; Palmieri C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00235; QUESSY S, 1995, INFECT IMMUN, V63, P1975, DOI 10.1128/IAI.63.5.1975-1979.1995; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seitz M, 2012, J MED MICROBIOL, V61, P1311, DOI 10.1099/jmm.0.043885-0; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; Smith HE, 1996, INFECT IMMUN, V64, P4409, DOI 10.1128/IAI.64.10.4409-4412.1996; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; SMITH HE, 1992, INFECT IMMUN, V60, P2361, DOI 10.1128/IAI.60.6.2361-2367.1992; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Suankratay Chusana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P868; Takamatsu D, 2008, EMERG INFECT DIS, V14, P181, DOI 10.3201/eid1401.070568; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Takeuchi D, 2014, J INFECT DIS, V209, P1509, DOI 10.1093/infdis/jit661; Tang YL, 2011, FOLIA MICROBIOL, V56, P541, DOI 10.1007/s12223-011-0077-2; Teatero S, 2014, J CLIN MICROBIOL, V52, P1441, DOI 10.1128/JCM.03554-13; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Weinert LA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7740; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wilson DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002874; Yao XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09835; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang AD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-523; Zhang AD, 2011, VET MICROBIOL, V148, P436, DOI 10.1016/j.vetmic.2010.09.027; Zhang AD, 2010, VET MICROBIOL, V140, P171, DOI 10.1016/j.vetmic.2009.06.034	63	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137760	10.1371/journal.pone.0137760	http://dx.doi.org/10.1371/journal.pone.0137760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375680	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200052
J	Gallego-Delgado, J; Baravian, C; Edagha, I; Ty, MC; Ruiz-Ortega, M; Xu, WY; Rodriguez, A				Gallego-Delgado, Julio; Baravian, Charlotte; Edagha, Innocent; Ty, Maureen C.; Ruiz-Ortega, Marta; Xu, Wenyue; Rodriguez, Ana			Angiotensin II Moderately Decreases Plasmodium Infection and Experimental Cerebral Malaria in Mice	PLOS ONE			English	Article							PATHOGENESIS; RECEPTOR; DISEASE	Angiotensin II, a peptide hormone that regulates blood pressure, has been proposed as a protective factor against cerebral malaria based on a genetic analysis. In vitro studies have documented an inhibitory effect of angiotensin II on Plasmodium growth, while studies using chemical inhibitors of angiotensin II in mice showed protection against experimental cerebral malaria but not major effects on parasite growth. To determine whether the level of angiotensin II affects Plasmodium growth and/or disease outcome in malaria, elevated levels of angiotensin II were induced in mice by intradermal implantation of osmotic mini-pumps providing constant release of this hormone. Mice were then infected with P. berghei and monitored for parasitemia and incidence of cerebral malaria. Mice infused with angiotensin II showed decreased parasitemia seven days after infection. The development of experimental cerebral malaria was delayed and a moderate increase in survival was observed in mice with elevated angiotensin II, as confirmed by decreased number of cerebral hemorrhages compared to controls. The results presented here show for the first time the effect of elevated levels of angiotensin II in an in vivo model of malaria. The decreased pathogenesis observed in mice complements a previous human genetic study, reinforcing the hypothesis of a beneficial effect of angiotensin II in malaria.	[Gallego-Delgado, Julio; Baravian, Charlotte; Edagha, Innocent; Ty, Maureen C.; Xu, Wenyue; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA; [Ruiz-Ortega, Marta] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Cellular Biol Renal Dis Lab, Madrid, Spain; [Xu, Wenyue] Third Mil Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China	New York University; Autonomous University of Madrid; Fundacion Jimenez Diaz; Army Medical University	Rodriguez, A (corresponding author), NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA.	Ana.Rodriguez@nyumc.org	Gallego-Delgado, Julio/AAI-6954-2021; Ruiz-Ortega, Marta/D-3584-2012; Edagha, Innocent/AAM-5344-2020; Rodríguez, Ana/GQR-0554-2022; Ortega, Marta Ruiz/AAN-2136-2020; ruiz-ortega, marta/D-3584-2012	Ruiz-Ortega, Marta/0000-0002-1495-6535; Ortega, Marta Ruiz/0000-0002-1495-6535; Rodriguez, Ana/0000-0002-0060-3405; Xu, Wenyue/0000-0003-3681-5052; Gallego-Delgado, Julio/0000-0002-8914-7740; ruiz-ortega, marta/0000-0002-1403-2690	FECYT (Fundacion Espanola para la Ciencia y la Tecnologia), mobility program, Ministry of Education of Spain; NIH [5T32AI007180-30]; China Scholarship Council; Dana Foundation Program in the Neuroimmunology of Brain Infections and Cancers Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER	FECYT (Fundacion Espanola para la Ciencia y la Tecnologia), mobility program, Ministry of Education of Spain; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Dana Foundation Program in the Neuroimmunology of Brain Infections and Cancers Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by FECYT (Fundacion Espanola para la Ciencia y la Tecnologia), mobility program, Ministry of Education of Spain for JGD; NIH Training Grant 5T32AI007180-30 for MT; China Scholarship Council for WX. This work was supported by a Dana Foundation Program in the Neuroimmunology of Brain Infections and Cancers Grant to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMERANI SAMA, 1978, J PHYSIOL-LONDON, V278, P471, DOI 10.1113/jphysiol.1978.sp012318; Amani V, 1998, INFECT IMMUN, V66, P4093; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Cassis LA, 2004, REGUL PEPTIDES, V117, P107, DOI 10.1016/j.regpep.2003.09.008; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dhangadamajhi G, 2010, INFECT GENET EVOL, V10, P337, DOI 10.1016/j.meegid.2010.01.009; Faiz M A, 1998, Bangladesh Med Res Counc Bull, V24, P35; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Idro R, 2004, ANN TROP PAEDIATR, V24, P17, DOI 10.1179/027249304225013240; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jain V, 2008, AM J TROP MED HYG, V79, P636; Maciel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003296; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; Saraiva VB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017174; Silva JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062999; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Waknine-Grinberg JH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-227; Wang Y, 2010, VASCULAR BIOL PLACEN; World Malaria Report WHO, WORLD MAL REP	21	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138191	10.1371/journal.pone.0138191	http://dx.doi.org/10.1371/journal.pone.0138191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376293	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200083
J	Li, XW; Wang, P; Fail, J; Shelton, AM				Li, Xiao-Wei; Wang, Ping; Fail, Jozsef; Shelton, Anthony M.			Detection of Gene Flow from Sexual to Asexual Lineages in Thrips tabaci (Thysanoptera: Thripidae)	PLOS ONE			English	Article							VENTURIA-CANESCENS HYMENOPTERA; ONION THRIPS; LINDEMAN THYSANOPTERA; REPRODUCTIVE MODES; NEW-YORK; OBLIGATE PARTHENOGENESIS; POPULATIONS; MAINTENANCE; EVOLUTION; FIELDS	Populations of Thrips tabaci are known to have two sympatric but genetically isolated reproductive modes, arrhenotoky (sexual reproduction) and thelytoky (asexual reproduction). Herein, we report behavioral, ecological and genetic studies to determine whether there is gene flow between arrhenotokous and thelytokous T. tabaci. We did not detect significant preference by arrhenotokous males to mate with females of a particular reproductive mode, nor did we detect significant behavioral differences between arrhenotokous males mated with arrhenotokous or thelytokous females in their pre-copulation, copulation duration and mating frequency. Productive gene transfer resulting from the mating between the two modes was experimentally confirmed. Gene transfer from arrhenotokous T. tabaci to thelytokous T. tabaci was further validated by confirmation of the passage of the arrhenotokous male-originated nuclear gene (histone H3 gene) allele to the F-2 generation. These behavioral, ecological and genetic studies confirmed gene transfer from the sexual arrhenotokous mode to the asexual thelytokous mode of T. tabaci in the laboratory. These results demonstrate that asexual T. tabaci populations may acquire genetic variability from sexual populations, which could offset the long-term disadvantage of asexual reproduction.	[Li, Xiao-Wei; Wang, Ping; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Li, Xiao-Wei] Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China; [Fail, Jozsef] Corvinus Univ Budapest, Fac Hort Sci, Dept Entomol, Budapest, Hungary	Cornell University; Northwest A&F University - China; Corvinus University Budapest	Shelton, AM (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	ams5@cornell.edu	Fail, Jozsef/A-5429-2011	Fail, Jozsef/0000-0001-8049-5776	China Scholarship Council (CSC); New York State Cabbage Research Association; Hungarian Scientific Research Fund (OTKA) [MB08A-81156, K 109594]	China Scholarship Council (CSC)(China Scholarship Council); New York State Cabbage Research Association; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	XWL was supported by the China Scholarship Council (CSC) and New York State Cabbage Research Association. PW and AMS were supported by the New York State Cabbage Research Association. JF was supported by the Hungarian Scientific Research Fund (OTKA MB08A-81156 and K 109594) and New York State Cabbage Research Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Hagimori T, 2008, J ECON ENTOMOL, V101, P1510, DOI 10.1603/0022-0493(2008)101[1510:DOAMMT]2.0.CO;2; Allen JKM, 2005, PEST MANAG SCI, V61, P809, DOI 10.1002/ps.1068; Balloux F, 2003, GENETICS, V164, P1635; Bell G, 1982, MASTERPIECE NATURE E; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Brunner PC, 2004, HEREDITY, V93, P364, DOI 10.1038/sj.hdy.6800512; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Chatzivassiliou EK, 2002, PHYTOPATHOLOGY, V92, P603, DOI 10.1094/PHYTO.2002.92.6.603; Chatzivassiliou EK, 1999, PLANT PATHOL, V48, P700, DOI 10.1046/j.1365-3059.1999.00414.x; Copeland CS, 2010, FLA ENTOMOL, V93, P437, DOI 10.1653/024.093.0318; Corley LS, 1999, P ROY SOC B-BIOL SCI, V266, P471, DOI 10.1098/rspb.1999.0661; DAVIS DG, 1969, GENETICS, V61, P577; DAY WH, 1988, ENTOMOPHAGA, V33, P201, DOI 10.1007/BF02372655; Dedryver CA, 2013, HEREDITY, V110, P39, DOI 10.1038/hdy.2012.57; Diaz-Montano J, 2011, J ECON ENTOMOL, V104, P1, DOI 10.1603/EC10269; Dobzhansky T., 1951, COPEIA; Dorit RL, 2001, CURR PROTOC MOL BIOL, V15; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Fekrat L., 2009, Journal of Entomological Society of Iran, V29, P11; Galimov Y, 2011, J EVOLUTION BIOL, V24, P1572, DOI 10.1111/j.1420-9101.2011.02288.x; Glover RH, 2010, MOL ECOL RESOUR, V10, P51, DOI 10.1111/j.1755-0998.2009.02723.x; Goday C, 2001, BIOESSAYS, V23, P242, DOI 10.1002/1521-1878(200103)23:3&lt;242::AID-BIES1034&gt;3.0.CO;2-P; Greeff JM, 1996, HEREDITAS, V124, P99, DOI 10.1111/j.1601-5223.1996.00099.x; Halkett F, 2008, MOL ECOL, V17, P2998, DOI 10.1111/j.1365-294X.2008.03798.x; Herron GA, 2008, AUST J ENTOMOL, V47, P361, DOI 10.1111/j.1440-6055.2008.00669.x; Hoffmann AA, 2008, P ROY SOC B-BIOL SCI, V275, P2473, DOI 10.1098/rspb.2008.0685; Hurst LD, 1996, TRENDS ECOL EVOL, V11, pA46; INNES DJ, 1988, EVOLUTION, V42, P1024, DOI 10.1111/j.1558-5646.1988.tb02521.x; Jacobson AL, 2013, INSECT MOL BIOL, V22, P12, DOI 10.1111/j.1365-2583.2012.01165.x; Jacobson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054484; Judson OP, 1996, TRENDS ECOL EVOL, V11, pA41; Kobayashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03286; Kobayashi K, 2012, J ECON ENTOMOL, V105, P555, DOI 10.1603/EC11320; Lewis T., 1973, THRIPS THEIR BIOL EC; Li XW, 2014, J ECON ENTOMOL, V107, P1526, DOI 10.1603/EC14070; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Maynard S.J, 1978, EVOLUTION SEX; MORI L, 1980, GENETICS, V94, P663; Mound L. A, 1991, 1991 C THRIPS THYS I, P2; Nault BA, 2006, ENVIRON ENTOMOL, V35, P1264, DOI 10.1603/0046-225X(2006)35[1264:RMIOTT]2.0.CO;2; Nemetschke L, 2010, CURR BIOL, V20, P1687, DOI 10.1016/j.cub.2010.08.014; PARKER ED, 1979, AM ZOOL, V19, P753; Schneider MV, 2003, HEREDITY, V90, P260, DOI 10.1038/sj.hdy.6800245; Schneider MV, 2002, J EVOLUTION BIOL, V15, P191, DOI 10.1046/j.1420-9101.2002.00394.x; Shelton AM, 2006, J ECON ENTOMOL, V99, P1798, DOI 10.1603/0022-0493-99.5.1798; Shelton AM, 2003, J ECON ENTOMOL, V96, P1843, DOI 10.1603/0022-0493-96.6.1843; Sogo K, 2014, APPL ENTOMOL ZOOL; STOUTHAMER R, 1993, ENTOMOPHAGA, V38, P3, DOI 10.1007/BF02373133; Tedeschi R, 2001, PHYTOPARASITICA, V29, P37, DOI 10.1007/BF02981812; Toda S, 2007, APPL ENTOMOL ZOOL, V42, P309, DOI 10.1303/aez.2007.309; Westmore GC, 2013, HEREDITY, V111, P210, DOI 10.1038/hdy.2013.39; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069; Wrensch D. L., 1993, EVOLUTION DIVERSITY	53	12	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138353	10.1371/journal.pone.0138353	http://dx.doi.org/10.1371/journal.pone.0138353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375283	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000361610200100
J	Liu, F; Xia, WJ; Hu, JJ; Wang, YZ; Yang, F; Sun, SY; Zhang, J; Jiang, N; Wang, HJ; Tian, WD; Wang, X; Ma, D				Liu, Fei; Xia, Wenjun; Hu, Jiongjiong; Wang, Yingzhi; Yang, Fan; Sun, Shaoyang; Zhang, Jin; Jiang, Nan; Wang, Huijun; Tian, Weidong; Wang, Xu; Ma, Duan			Solute Carrier Family 26 Member a2 (slc26a2) Regulates Otic Development and Hair Cell Survival in Zebrafish	PLOS ONE			English	Article							TRANSPORTER DTDST GENE; GUILT-BY-ASSOCIATION; INNER-EAR; CHONDRODYSPLASIA PHENOTYPE; HEARING IMPAIRMENT; LATERAL-LINE; MUTATIONS; DISEASE; NETWORK; MOUSE	Hearing loss is one of the most prevalent human birth defects. Genetic factors contribute to the pathogenesis of deafness. It is estimated that one-third of deafness genes have already been identified. The current work is an attempt to find novel genes relevant to hearing loss using guilt-by-profiling and guilt-by-association bioinformatics analyses of approximately 80 known non-syndromic hereditary hearing loss (NSHL) genes. Among the 300 newly identified candidate deafness genes, slc26a2 were selected for functional studies in zebrafish. The slc26a2 gene was knocked down using an antisense morpholino (MO), and significant defects were observed in otolith patterns, semicircular canal morphology, and lateral neuromast distributions in morphants. Loss-of-function defects are caused primarily by apoptosis, and morphants are insensitive to sound stimulation and imbalanced swimming behaviours. Morphant defects were found to be partially rescued by co-injection of human SLC26A2 mRNA. All the results suggest that bioinformatics is capable of predicting new deafness genes and this showed slc26a2 is to be a critical otic gene whose dysfunction may induce hearing impairment.	[Liu, Fei; Wang, Yingzhi; Sun, Shaoyang; Zhang, Jin; Jiang, Nan; Wang, Xu; Ma, Duan] Fudan Univ, Sch Basic Med Sci, Key Lab Metab & Mol Med,Minist Educ,Inst Mat Sci, Collaborat Innovat Ctr Genet & Dev,Dept Biochem &, Shanghai 200032, Peoples R China; [Xia, Wenjun; Yang, Fan; Ma, Duan] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Hu, Jiongjiong] Tongji Univ, Shanghai East Hosp, Dept Otorhinolaryngol, Shanghai 200092, Peoples R China; [Wang, Huijun] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Tian, Weidong] Fudan Univ, Sch Life Sci, Inst Biostat, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Tongji University; Fudan University; Fudan University	Wang, X (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Metab & Mol Med,Minist Educ,Inst Mat Sci, Collaborat Innovat Ctr Genet & Dev,Dept Biochem &, Shanghai 200032, Peoples R China.	wangxu2013@fudan.edu.cn; duanma@fudan.edu.cn	wang, hui/GRS-4730-2022; Ma, Duan/I-8330-2014	Wang, Xu/0000-0001-6920-0375	East Raising Sun Talents Program of Shanghai East Hospital, Tongji University [2013DFYY-2]; Foundation for Development of Science and Technology, Pudong new district, Shanghai [2013PKJ2013-Y18]; National Basic Research Program of China [2011CB504502]; Basic Key Program of Shanghai Scientific and Technology Committee [14DJ1400103]; Program of Shanghai Municipal Commission of Health and Family Planning [2013ZYJB0015]	East Raising Sun Talents Program of Shanghai East Hospital, Tongji University; Foundation for Development of Science and Technology, Pudong new district, Shanghai; National Basic Research Program of China(National Basic Research Program of China); Basic Key Program of Shanghai Scientific and Technology Committee; Program of Shanghai Municipal Commission of Health and Family Planning	This study was supported by the East Raising Sun Talents Program of Shanghai East Hospital, Tongji University (2013DFYY-2), the Foundation for Development of Science and Technology, Pudong new district, Shanghai (2013PKJ2013-Y18), National Basic Research Program of China (2011CB504502), Basic Key Program of Shanghai Scientific and Technology Committee (14DJ1400103) and Program of Shanghai Municipal Commission of Health and Family Planning (2013ZYJB0015).	Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Aman A, 2011, DEV BIOL, V349, P470, DOI 10.1016/j.ydbio.2010.10.022; Amigo JD, 2009, BLOOD, V114, P4654, DOI 10.1182/blood-2008-12-189910; Bang PI, 2002, J NEUROSCI METH, V118, P177, DOI 10.1016/S0165-0270(02)00118-8; Bang PI, 2001, J COMP NEUROL, V438, P173, DOI 10.1002/cne.1308; Bever MM, 2002, DEV DYNAM, V223, P536, DOI 10.1002/dvdy.10062; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Jiang LJ, 2014, P NATL ACAD SCI USA, V111, pE1383, DOI 10.1073/pnas.1402898111; Karniski LP, 2001, HUM MOL GENET, V10, P1485, DOI 10.1093/hmg/10.14.1485; Kim MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092984; Kobayashi T, 1997, BIOCHEM BIOPH RES CO, V238, P738, DOI 10.1006/bbrc.1997.7380; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Korf BR, 2013, JAMA-J AM MED ASSOC, V309, P1511, DOI 10.1001/jama.2013.3239; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Liu QW, 2014, DEV BIOL, V390, P93, DOI 10.1016/j.ydbio.2014.03.010; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Mehra S, 2009, OTOLARYNG HEAD NECK, V140, P461, DOI 10.1016/j.otohns.2008.12.022; Meyer J, 2001, HEARING RES, V161, P10, DOI 10.1016/S0378-5955(01)00338-0; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; O'Donoghue G, 2013, NEW ENGL J MED, V369, P1190, DOI 10.1056/NEJMp1310111; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Parente V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053748; Park M, 2014, J BIOL CHEM, V289, P1993, DOI 10.1074/jbc.M113.503466; Pera A, 2008, P NATL ACAD SCI USA, V105, P18608, DOI 10.1073/pnas.0805831105; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Tian WD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s7; Valdivia LE, 2011, DEVELOPMENT, V138, P3931, DOI 10.1242/dev.062695; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; WATERMAN RE, 1984, ANAT REC, V210, P101, DOI 10.1002/ar.1092100113	39	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136832	10.1371/journal.pone.0136832	http://dx.doi.org/10.1371/journal.pone.0136832			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375458	Green Submitted, gold, Green Published			2022-12-26	WOS:000361610200024
J	Malerba, F; Paoletti, F; Ercole, BB; Materazzi, S; Nassini, R; Coppi, E; Patacchini, R; Capsoni, S; Lamba, D; Cattaneo, A				Malerba, Francesca; Paoletti, Francesca; Ercole, Bruno Bruni; Materazzi, Serena; Nassini, Romina; Coppi, Elisabetta; Patacchini, Riccardo; Capsoni, Simona; Lamba, Doriano; Cattaneo, Antonino			Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications	PLOS ONE			English	Article							NERVE-GROWTH-FACTOR; TOPICAL TREATMENT; GUANIDINE-HYDROCHLORIDE; PRESSURE ULCERS; CLINICAL-TRIAL; EXPRESSION; CELLS; RECEPTOR; DIFFERENTIATION; MOUSE	Background Nerve Growth Factor (NGF) holds a great therapeutic promise for Alzheimer's disease, diabetic neuropathies, ophthalmic diseases, dermatological ulcers. However, the necessity for systemic delivery has hampered the clinical applications of NGF due to its potent pro-nociceptive action. A "painless" human NGF (hNGF R100E) mutant has been engineered. It has equal neurotrophic potency to hNGF but a lower nociceptive activity. We previously described and characterized the neurotrophic and nociceptive properties also of the hNGF P61S and P61SR100E mutants, selectively detectable against wild type hNGF. However, the reduced pain-sensitizing potency of the "painless" hNGF mutants has not been quantified. Objectives and Results Aiming at the therapeutic application of the "painless" hNGF mutants, we report on the comparative functional characterization of the precursor and mature forms of the mutants hNGF R100E and hNGF P61SR100E as therapeutic candidates, also in comparison to wild type hNGF and to hNGF P61S. The mutants were assessed by a number of biochemical, biophysical methods and assayed by cellular assays. Moreover, a highly sensitive ELISA for the detection of the P61S-tagged mutants in biological samples has been developed. Finally, we explored the pro-nociceptive effects elicited by hNGF mutants in vivo, demonstrating an expanded therapeutic window with a ten-fold increase in potency. Conclusions This structure-activity relationship study has led to validate the concept of developing painless NGF as a therapeutic, targeting the NGF receptor system and supporting the choice of hNGF P61S R100E as the best candidate to advance in clinical development. Moreover, this study contributes to the identification of the molecular determinants modulating the properties of the hNGF "painless" mutants.	[Malerba, Francesca; Paoletti, Francesca; Ercole, Bruno Bruni; Cattaneo, Antonino] Rita Levi Montalcini Fdn, European Brain Res Inst, Neurotroph Factors & Neurodegenerat Dis Unit, Rome, Italy; [Malerba, Francesca; Paoletti, Francesca; Capsoni, Simona; Cattaneo, Antonino] Scuola Normale Super Pisa, Neurobiol Lab Biol, Pisa, Italy; [Materazzi, Serena; Nassini, Romina; Coppi, Elisabetta] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy; [Patacchini, Riccardo] Chiesi Farmaceut, Dept Pharmacol, Parma, Italy; [Lamba, Doriano] CNR, Ist Cristall, Trieste, Italy	Scuola Normale Superiore di Pisa; University of Florence; Chiesi Pharmaceuticals Inc; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR)	Cattaneo, A (corresponding author), Rita Levi Montalcini Fdn, European Brain Res Inst, Neurotroph Factors & Neurodegenerat Dis Unit, Rome, Italy.	antonino.cattaneo@sns.it	Lamba, Doriano/L-9808-2018; Coppi, Elisabetta/K-6705-2016; Nassini, Romina/AAC-5051-2022; Cattaneo, Antonino/AAA-7252-2019; Cattaneo, Antonino/K-4471-2016; Lamba, Doriano/B-2961-2011	Lamba, Doriano/0000-0001-6859-7868; Coppi, Elisabetta/0000-0003-4434-5919; Nassini, Romina/0000-0002-9223-8395; Cattaneo, Antonino/0000-0002-6975-8923; Lamba, Doriano/0000-0001-6859-7868; Capsoni, Simona/0000-0003-2670-8237	MIUR [2010N8PBAA_006]; ADDF [20120601]; European Union [603191]	MIUR(Ministry of Education, Universities and Research (MIUR)); ADDF; European Union(European Commission)	This work was supported by the following grants: MIUR, project PRIN (#2010N8PBAA_006) to AC (http://prin.miur.it/); ADDF (grant #20120601) to AC (https://www.alzdiscovery.org/); and European Union, project "PAINCAGE" (GA n. 603191) to AC (http://www.paincage.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7; [Anonymous], PYMOL MOL GRAPHICS S; Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; Bernabei R, 1999, LANCET, V354, P307, DOI 10.1016/S0140-6736(99)02784-1; Bernardo A, 2003, J NEUROPATH EXP NEUR, V62, P509, DOI 10.1093/jnen/62.5.509; BISCHOFF SC, 1992, BLOOD, V79, P2662; Bonini S, 2000, OPHTHALMOLOGY, V107, P1347, DOI 10.1016/S0161-6420(00)00163-9; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Capsoni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037555; Capsoni S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017321; CATTANEO A, 1988, J NEUROCHEM, V50, P1003, DOI 10.1111/j.1471-4159.1988.tb10565.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHEVALIER S, 1994, BLOOD, V83, P1479; Coppi E, 2013, GLIA, V61, P1155, DOI 10.1002/glia.22506; Covaceuszach S, 2010, BIOCHEM BIOPH RES CO, V391, P824, DOI 10.1016/j.bbrc.2009.11.146; Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158, DOI 10.2174/156720509787602870; de Andrade DC, 2008, EUR J NEUROL, V15, P712, DOI 10.1111/j.1468-1331.2008.02172.x; DIMARCO E, 1992, CANCER LETT, V65, P189, DOI 10.1016/0304-3835(92)90231-J; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; DREYFUS CF, 1989, TRENDS PHARMACOL SCI, V10, P145, DOI 10.1016/0165-6147(89)90166-1; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; Ferreira J, 2002, NEUROPHARMACOLOGY, V43, P1188, DOI 10.1016/S0028-3908(02)00311-8; Generini S, 2004, EXP CLIN ENDOCR DIAB, V112, P542, DOI 10.1055/s-2004-821313; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; KETTENMANN H, 1991, ANN NY ACAD SCI, V633, P64; Kliemannel M, 2006, BIOCHEMISTRY-US, V45, P3517, DOI 10.1021/bi051896t; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; Lambiase A, 1998, NEW ENGL J MED, V338, P1174, DOI 10.1056/NEJM199804233381702; Lambiase A., 2009, P NATL ACAD SCI US; Lambiase A, 2009, ANN I SUPER SANITA, V45, P439; Landi F, 2003, ANN INTERN MED, V139, P635, DOI 10.7326/0003-4819-139-8-200310210-00006; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Mande SC, 2000, PROTEIN ENG, V13, P133, DOI 10.1093/protein/13.2.133; McAllister AK, 2001, CELL MOL LIFE SCI, V58, P1054, DOI 10.1007/PL00000920; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; OLSON L, 1991, ARCH NEUROL-CHICAGO, V48, P373, DOI 10.1001/archneur.1991.00530160037011; Paoletti F, 2015, BBA-PROTEINS PROTEOM, V1854, P187, DOI 10.1016/j.bbapap.2014.12.005; Paoletti F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022615; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Raychaudhuri SK, 2001, ARCH DERMATOL RES, V293, P291, DOI 10.1007/s004030100224; SONTHEIMER H, 1989, J NEUROSCI RES, V24, P496, DOI 10.1002/jnr.490240406; SONTHEIMER H, 1989, NEURON, V2, P1135, DOI 10.1016/0896-6273(89)90180-3; Tanaka Y, 2004, BIOCHEM BIOPH RES CO, V323, P185, DOI 10.1016/j.bbrc.2004.08.081; Fasulo CTL, 2013, CELL DEATH DIFFER, V20, P1017, DOI 10.1038/cdd.2013.22	49	24	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136425	10.1371/journal.pone.0136425	http://dx.doi.org/10.1371/journal.pone.0136425			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371475	Green Published, gold			2022-12-26	WOS:000361604400005
J	Bedre, R; Rajasekaran, K; Mangu, VR; Timm, LES; Bhatnagar, D; Baisakh, N				Bedre, Renesh; Rajasekaran, Kanniah; Mangu, Venkata Ramanarao; Timm, Luis Eduardo Sanchez; Bhatnagar, Deepak; Baisakh, Niranjan			Genome-Wide Transcriptome Analysis of Cotton (Gossypium hirsutum L.) Identifies Candidate Gene Signatures in Response to Aflatoxin Producing Fungus Aspergillus flavus	PLOS ONE			English	Article							PLANT DEFENSE GENES; BIOLOGICAL-CONTROL; CHITINASE GENE; ABIOTIC STRESS; NITRIC-OXIDE; RESISTANCE; BIOSYNTHESIS; EXPRESSION; PATHOGEN; CONTAMINATION	Aflatoxins are toxic and potent carcinogenic metabolites produced from the fungi Aspergillus flavus and A. parasiticus. Aflatoxins can contaminate cottonseed under conducive pre-harvest and postharvest conditions. United States federal regulations restrict the use of aflatoxin contaminated cottonseed at >20 ppb for animal feed. Several strategies have been proposed for controlling aflatoxin contamination, and much success has been achieved by the application of an atoxigenic strain of A. flavus in cotton, peanut and maize fields. Development of cultivars resistant to aflatoxin through overexpression of resistance associated genes and/ or knocking down aflatoxin biosynthesis of A. flavus will be an effective strategy for controlling aflatoxin contamination in cotton. In this study, genome-wide transcriptome profiling was performed to identify differentially expressed genes in response to infection with both toxigenic and atoxigenic strains of A. flavus on cotton (Gossypium hirsutum L.) pericarp and seed. The genes involved in antifungal response, oxidative burst, transcription factors, defense signaling pathways and stress response were highly differentially expressed in pericarp and seed tissues in response to A. flavus infection. The cell-wall modifying genes and genes involved in the production of antimicrobial substances were more active in pericarp as compared to seed. The genes involved in auxin and cytokinin signaling were also induced. Most of the genes involved in defense response in cotton were highly induced in pericarp than in seed. The global gene expression analysis in response to fungal invasion in cotton will serve as a source for identifying biomarkers for breeding, potential candidate genes for transgenic manipulation, and will help in understanding complex plant-fungal interaction for future downstream research.	[Bedre, Renesh; Mangu, Venkata Ramanarao; Timm, Luis Eduardo Sanchez; Baisakh, Niranjan] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA; [Rajasekaran, Kanniah; Bhatnagar, Deepak] USDA ARS, So Reg Res Ctr, New Orleans, LA 70124 USA	Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA)	Baisakh, N (corresponding author), Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA.	nbaisakh@agcenter.lsu.edu	Sanchez, Eduardo/AAE-8651-2019; Bedre, Renesh/Q-9617-2018	Sanchez, Eduardo/0000-0001-7712-3605; Bedre, Renesh/0000-0001-8874-5100	United States Department of Agriculture-National Institute of Food and Agriculture (SCA) [58-6435-0-529]	United States Department of Agriculture-National Institute of Food and Agriculture (SCA)	Funded by United States Department of Agriculture-National Institute of Food and Agriculture (SCA# 58-6435-0-529).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asano T, 2012, PLANT SIGNAL BEHAV, V7, P817, DOI 10.4161/psb.20351; Baisakh N, 2001, PLANT BIOTECHNOL-NAR, V18, P101, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.101; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BEARDMORE J, 1983, PHYSIOL PLANT PATHOL, V22, P209; Birkenbihl RP, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00076; Bolwell GP, 1997, PHYSIOL MOL PLANT P, V51, P347, DOI 10.1006/pmpp.1997.0129; CARDOSOSILVA CB, 2014, PLOS ONE, V9; CHAPPELL J, 1984, NATURE, V311, P76, DOI 10.1038/311076a0; Chen ZY, 1999, PHYTOPATHOLOGY, V89, P902, DOI 10.1094/PHYTO.1999.89.10.902; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Cleveland TE, 2004, J TOXICOL-TOXIN REV, V23, P345, DOI 10.1081/TXR-200027892; Cleveland TE, 2003, PEST MANAG SCI, V59, P629, DOI 10.1002/ps.724; COLLINGE DB, 1987, PLANT MOL BIOL, V9, P389, DOI 10.1007/BF00014913; COTTY PJ, 1994, PHYTOPATHOLOGY, V84, P1270, DOI 10.1094/Phyto-84-1270; Coumans JVF, 2009, PROTEOMICS, V9, P335, DOI 10.1002/pmic.200800251; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dolezal AL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00384; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Dorner JW, 2008, FOOD ADDIT CONTAM A, V25, P203, DOI 10.1080/02652030701658357; Dorner JW, 2004, J TOXICOL-TOXIN REV, V23, P425, DOI 10.1081/TXR-200027877; Drew DP, 2013, INT J MOL SCI, V14, P9080, DOI 10.3390/ijms14059080; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; ECKER JR, 1987, P NATL ACAD SCI USA, V84, P5202, DOI 10.1073/pnas.84.15.5202; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Ghanashyam C, 2009, PLANT SIGNAL BEHAV, V4, P846, DOI 10.4161/psb.4.9.9376; Goffard N, 2007, NUCLEIC ACIDS RES, V35, pW176, DOI 10.1093/nar/gkm261; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan X, 2011, PROTOPLASMA, V248, P415, DOI 10.1007/s00709-010-0162-4; Guo BZ, 2011, TOXINS, V3, P737, DOI 10.3390/toxins3070737; Guo RY, 2011, MOL BIOL REP, V38, P49, DOI 10.1007/s11033-010-0076-4; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V56, P245; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; Kelley RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036892; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LAWTON MA, 1987, MOL CELL BIOL, V7, P335, DOI 10.1128/MCB.7.1.335; Lee S, 2012, PHYSIOL MOL PLANT P, V80, P35, DOI 10.1016/j.pmpp.2012.08.001; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Lillehoj EB, 1987, P US U CIMMYT MAIZ A; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Luo M, 2011, TOXINS, V3, P766, DOI 10.3390/toxins3070766; Pitt JI, 2006, MYCOPATHOLOGIA, V162, P233, DOI 10.1007/s11046-006-0059-0; Prasad K, 2013, J PLANT BIOCHEM BIOT, V22, P222, DOI 10.1007/s13562-012-0155-9; Pritsch C, 2000, MOL PLANT MICROBE IN, V13, P159, DOI 10.1094/MPMI.2000.13.2.159; Richard J. L., 2003, MYCOTOXINS RISKS PLA; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rohini VK, 2001, PLANT SCI, V160, P889, DOI 10.1016/S0168-9452(00)00462-3; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Sanchez-Vallet A, 2012, PLANT PHYSIOL, V160, P2109, DOI 10.1104/pp.112.200154; Savchenko T, 2010, PLANT CELL, V22, P3193, DOI 10.1105/tpc.110.073858; Siemens J, 2006, MOL PLANT MICROBE IN, V19, P480, DOI 10.1094/MPMI-19-0480; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Todd AT, 2010, PLANT J, V62, P589, DOI 10.1111/j.1365-313X.2010.04186.x; Tohidfar M, 2005, PLANT CELL TISS ORG, V83, P83, DOI 10.1007/s11240-004-6155-2; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; van Egmond HP, 2005, FOOD SCI, V151, P77; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang PC, 2010, PLANT CELL, V22, P2981, DOI 10.1105/tpc.109.072959; Wang SY, 2012, FOOD RES INT, V45, P116, DOI 10.1016/j.foodres.2011.10.010; Wasternack C, 2014, BIOTECHNOL ADV, V32, P31, DOI 10.1016/j.biotechadv.2013.09.009; Wogan GN, 2000, SEMIN CANCER BIOL, V10, P201, DOI 10.1006/scbi.2000.0320; Wright MS, 2000, TOXICON, V38, P1215, DOI 10.1016/S0041-0101(99)00221-4; Yin YN, 2008, J ZHEJIANG UNIV-SC B, V9, P787, DOI 10.1631/jzus.B0860003; Yoshioka H, 2011, NITRIC OXIDE-BIOL CH, V25, P216, DOI 10.1016/j.niox.2010.12.008; Yu JJ, 2012, OMICS TECHNOLOGIES: TOOLS FOR FOOD SCIENCE, P367; Yu JJ, 2012, TOXINS, V4, P1024, DOI 10.3390/toxins4111024	75	23	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138025	10.1371/journal.pone.0138025	http://dx.doi.org/10.1371/journal.pone.0138025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366857	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100204
J	Curtis, KA; Moore, JE; Benson, SR				Curtis, K. Alexandra; Moore, Jeffrey E.; Benson, Scott R.			Estimating Limit Reference Points for Western Pacific Leatherback Turtles (Dermochelys coriacea) in the US West Coast EEZ	PLOS ONE			English	Article							NESTING POPULATION; NATURAL MORTALITY; SEA-TURTLES; CONSERVATION; MANAGEMENT; GROWTH; PAPUA; MODEL	Biological limit reference points (LRPs) for fisheries catch represent upper bounds that avoid undesirable population states. LRPs can support consistent management evaluation among species and regions, and can advance ecosystem-based fisheries management. For transboundary species, LRPs prorated by local abundance can inform local management decisions when international coordination is lacking. We estimated LRPs for western Pacific leatherbacks in the U.S. West Coast Exclusive Economic Zone (WCEEZ) using three approaches with different types of information on local abundance. For the current application, the best-informed LRP used a local abundance estimate derived from nest counts, vital rate information, satellite tag data, and fishery observer data, and was calculated with a Potential Biological Removal estimator. Management strategy evaluation was used to set tuning parameters of the LRP estimators to satisfy risk tolerances for falling below population thresholds, and to evaluate sensitivity of population outcomes to bias in key inputs. We estimated local LRPs consistent with three hypothetical management objectives: allowing the population to rebuild to its maximum net productivity level (4.7 turtles per five years), limiting delay of population rebuilding (0.8 turtles per five years), or only preventing further decline (7.7 turtles per five years). These LRPs pertain to all human-caused removals and represent the WCEEZ contribution to meeting population management objectives within a broader international cooperative framework. We present multi-year estimates, because at low LRP values, annual assessments are prone to substantial error that can lead to volatile and costly management without providing further conservation benefit. The novel approach and the performance criteria used here are not a direct expression of the "jeopardy" standard of the U.S. Endangered Species Act, but they provide useful assessment information and could help guide international management frameworks. Given the range of abundance data scenarios addressed, LRPs should be estimable for many other areas, populations, and taxa.	[Curtis, K. Alexandra] NOAA, Ocean Associates Inc, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Curtis, K. Alexandra; Moore, Jeffrey E.; Benson, Scott R.] NOAA, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Curtis, KA (corresponding author), NOAA, Ocean Associates Inc, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA.	alex.curtis@noaa.gov		Curtis, Katherine Alexandra/0000-0001-7284-944X	Lenfest Ocean Program [2008-000648-009]; National Marine Fisheries Service (NMFS) Office of Science and Technology	Lenfest Ocean Program; National Marine Fisheries Service (NMFS) Office of Science and Technology	This work was supported by grants to KAC and JEM from the Lenfest Ocean Program (grant reference number 2008-000648-009; www.lenfestocean.org) and the National Marine Fisheries Service (NMFS) Office of Science and Technology (https://www.st.nmfs.noaa.gov), through a contract to KAC from Ocean Associates, Inc. Neither the funders nor Ocean Associates, Inc., had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adler D, 2005, VIOPLOT VIOLIN PLOT; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2005, R NEWS; [Anonymous], 2013, IUCN RED LIST THREAT; Avens Larisa, 2009, Endangered Species Research, V8, P165, DOI 10.3354/esr00202; Becker RA, 2014, MAPDATA EXTRA MAP DA; Becker RA, 2014, MAPS DRAW GEOGRAPHIC; Benson SR, 2007, FISH B-NOAA, V105, P337; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Bertalanffy L. v., 1934, ARCH ENTWICKLUNGMECH, V131, P613, DOI DOI 10.1007/BF00650112; Bivand R., 2014, RGEOS INTERFACE GEOM; Bivand R, 2014, RGDAL BINDINGS GEOSP; Caswell, 2000, MATRIX POPULATION MO; Chalmers Matthew, 2003, P UB 2003 WORKSH CRO; Chang W., 2014, EXTRAFONT TOOLS USIN; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Curtis KA, 2013, AQUAT CONSERV, V23, P441, DOI 10.1002/aqc.2308; Curtis KA, MAR POLICY IN PRESS; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Dutton PH, 2007, CHELONIAN CONSERV BI, V6, P47, DOI 10.2744/1071-8443(2007)6[47:SAGSON]2.0.CO;2; Eckert K., 2012, SYNOPSIS BIOL DATA L; Eckert SA, 2002, MAR ECOL PROG SER, V230, P289, DOI 10.3354/meps230289; FAO, 1995, COD COND RESP FISH, P41; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Gallucci VF, 2006, CAN J FISH AQUAT SCI, V63, P931, DOI 10.1139/F05-267; Gaspar P, 2012, MAR ECOL PROG SER, V457, P265, DOI 10.3354/meps09689; Halpin PN, 2009, OCEANOGRAPHY, V22, P104, DOI 10.5670/oceanog.2009.42; Hanan D.A., 1993, CALIF FISH GAME B, V175, P1; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Heppell SS, 2005, DEV ALTERNATIVE QUAN, P35; Hijmans R. J., 2014, GEOSPHERE SPHERICAL; Hitipeuw C., 2002, P W PAC SEA TURTL CO, P161; Hitipeuw C, 2007, CHELONIAN CONSERV BI, V6, P28, DOI 10.2744/1071-8443(2007)6[28:PSAIMO]2.0.CO;2; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Jones TT, 2011, J EXP MAR BIOL ECOL, V399, P84, DOI 10.1016/j.jembe.2011.01.007; Kaplan IC, 2005, CAN J FISH AQUAT SCI, V62, P1710, DOI 10.1139/F05-121; Kenchington TJ, 2014, FISH FISH, V15, P533, DOI 10.1111/faf.12027; Kinan I, 2005, P 2 W PAC SEA TURTL, VI; Koch V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056776; Kot CY, 2014, STATE WORLDS SEA TUR; Lewin-Koh N, 2014, MAPTOOLS TOOLS FOR R; Lontoh, 2014, THESIS SAN JOSE STAT; Martien K. K., 2013, Journal of Cetacean Research and Management, V13, P31; Martin SL, 2015, ECOL APPL, V25, P416, DOI 10.1890/14-0059.1; Moore JE, 2013, ENVIRON CONSERV, V40, P329, DOI 10.1017/S037689291300012X; Moore JE, 2014, RECOMMENDATIONS POLL, P11; *NAT MAR FISH SERV, 1999, HAB APPR IMPL SECT 7; National Marine Fisheries Service, 2014, BIOL OP CONT OP HAW; National Marine Fisheries Service, 2005, REV GUID ASS MAR MAM; National Marine Fisheries Service, 2013, BIOL OP CONT MAN DRI; [National Oceanic and Atmospheric Administration National Marine Fisheries Service West Coast Region U. S. Department of Commerce], 2014, CAL SEA TURTL STRAND; National Research Council, 1990, DECL SEA TURT CAUS P; PAULY D, 1980, J CONSEIL, V39, P175; PETERSON I, 1984, CAN J FISH AQUAT SCI, V41, P1117, DOI 10.1139/f84-131; Plate T., 2011, ABIND COMBINE MULTID; Price E. R., 2006, ENDANGER SPECIES RES, V1, P41, DOI DOI 10.3354/ESR001041; Rafferty AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021038; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; Rohlf Daniel J, 2001, WASHBURN LJ, V41, P114; RStudio Team, 2012, RSTUDIO INT DEV R; Saba VS, 2008, ECOLOGY, V89, P1414, DOI 10.1890/07-0364.1; Saether BE, 2010, BIOL CONSERV, V143, P1970, DOI 10.1016/j.biocon.2010.04.048; Sainsbury K, 2008, R20010999 AUSTR FISH; Tomillo PS, 2007, CHELONIAN CONSERV BI, V6, P54; Seminoff JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037403; Simons RA, 2015, ERDDAP; Snover ML, 2009, ECOL APPL, V19, P774, DOI 10.1890/07-1111.1; Spotila James R., 1996, Chelonian Conservation and Biology, V2, P209; Steering Committee, 2008, STRAT PLANN LONG TER, P79; Stewart K, 2011, ECOL APPL, V21, P263, DOI 10.1890/09-1838.1; Stewart KR, 2007, THESIS DUKE U; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Tapilatu RF, 2007, CHELONIAN CONSERV BI, V6, P154, DOI 10.2744/1071-8443(2007)6[154:LTDCHS]2.0.CO;2; Tapilatu RF, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00348.1; Taylor BL, 2005, MARINE MAMMAL RES CO, P165; Tiwari M., 2013, IUCN RED LIST THREAT, pT46967817A46967821; Turtle Expert Working Group, 2007, NMFSSEFSC555 TURTL E; *US FISH WILDL SER, 1998, REC PLAN US PAC POP; Venables WN., 2002, MODERN APPL STAT S 4; VLIZ, 2014, MAR BOUND GEOD VERS; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Warnes GR, 2014, GTOOLS VARIOUS R PRO; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zug George R., 1996, Chelonian Conservation and Biology, V2, P244	86	13	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136452	10.1371/journal.pone.0136452	http://dx.doi.org/10.1371/journal.pone.0136452			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368557	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100017
J	Le Bloc'h, J; Leray, V; Nazih, H; Gauthier, O; Serisier, S; Magot, T; Krempf, M; Nguyen, P; Ouguerram, K				Le Bloc'h, Jerom; Leray, Veronique; Nazih, Hassan; Gauthier, Olivier; Serisier, Samuel; Magot, Thierry; Krempf, Michel; Nguyen, Patrick; Ouguerram, Khadija			Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; EXTENDED-RELEASE NIACIN; PPAR-GAMMA EXPRESSION; APOLIPOPROTEIN-A-I; TRANSFER PROTEIN; SELECTIVE UPTAKE; PLASMA-LIPOPROTEINS; METABOLISM; BINDING; RECEPTOR	Aim Nicotinic acid (NA) treatment decreases plasma triglycerides and increases HDL cholesterol, but the mechanisms involved in these change are not fully understood. A reduction in cholesteryl ester transfer protein (CETP) activity has been advanced to explain most lipid-modulating effects of NA. However, due to the central role of CETP in reverse cholesterol transport in humans, other effects of NA may have been hidden. As dogs have no CETP activity, we conducted this study to examine the specific effects of extended-release niacin (NA) on lipids and high-density lipoprotein (HDL) cholesteryl ester (CE) turnover in obese Insulin-Resistant dogs with increase plasma triglycerides. Methods HDL kinetics were assessed in fasting dogs before and four weeks after NA treatment through endogenous labeling of cholesterol and apolipoprotein AI by simultaneous infusion of [1,2 C-13(2)] acetate and [5,5,5 H-2(3)] leucine for 8 h. Kinetic data were analyzed by compartmental modeling. In vitro cell cholesterol efflux of serum from NA-treated dogs was also measured. Results NA reduced plasma total cholesterol, low-density lipoprotein cholesterol, HDL cholesterol, triglycerides (TG), and very-low-density lipoprotein TG concentrations (p < 0.05). The kinetic study also showed a higher cholesterol esterification rate (p < 0.05). HDL-CE turnover was accelerated (p < 0.05) via HDL removal through endocytosis and selective CE uptake (p < 0.05). We measured an elevated in vitro cell cholesterol efflux (p < 0.05) with NA treatment in accordance with a higher cholesterol esterification. Conclusion NA decreased HDL cholesterol but promoted cholesterol efflux and esterification, leading to improved reverse cholesterol transport. These results highlight the CETP-independent effects of NA in changes of plasma lipid profile.	[Le Bloc'h, Jerom; Krempf, Michel; Ouguerram, Khadija] INRA, UMR 1280, Physiol Adaptat Nutr, F-44093 Nantes, France; [Le Bloc'h, Jerom; Leray, Veronique; Serisier, Samuel; Nguyen, Patrick] LUNAM Univ, Natl Coll Vet Med Food Sci & Engn, Endocrinol & Nutr Unit, Oniris, F-44307 Nantes, France; [Le Bloc'h, Jerom; Leray, Veronique; Nazih, Hassan; Serisier, Samuel; Magot, Thierry; Krempf, Michel; Nguyen, Patrick; Ouguerram, Khadija] CHU, CRNH, West Human Nutr Res Ctr Nantes, F-44093 Nantes, France; [Nazih, Hassan] IUML Inst Univ Mer & Littoral, CNRS, FR3473, MMS,Mer Mol Sante,EA 2160, Nantes, France; [Gauthier, Olivier] LUNAM Univ, Natl Coll Vet Med Food Sci & Engn, Small Anim Surg Dept, Oniris,Nantes Atlantic, F-44307 Nantes, France	INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Ouguerram, K (corresponding author), INRA, UMR 1280, Physiol Adaptat Nutr, F-44093 Nantes, France.	Khadija.Ouguerram@univ-nantes.fr	Serisier, Samuel/AAI-4608-2020	Nazih, Hassan/0000-0002-3607-295X; Serisier, Samuel/0000-0002-5702-1350; Krempf, Michel/0000-0002-4353-9511				ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Bailhache E, 2003, J ANIM PHYSIOL AN N, V87, P86, DOI 10.1046/j.1439-0396.2003.00419.x; Bailhache E, 2003, METABOLISM, V52, P559, DOI 10.1053/meta.2003.50110; BLUM CB, 1977, J CLIN INVEST, V60, P795, DOI 10.1172/JCI108833; BOBERG J, 1966, CLIN CHIM ACTA, V14, P325, DOI 10.1016/0009-8981(66)90109-4; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399; Czarnecka H, 1996, J BIOL CHEM, V271, P2023, DOI 10.1074/jbc.271.4.2023; DELALLERAMOYA M, 1994, ARTERIOSCLER THROMB, V14, P1056, DOI 10.1161/01.ATV.14.7.1056; Fabbrini E, 2010, J CLIN ENDOCR METAB, V95, P2727, DOI 10.1210/jc.2009-2622; Ferrier L, 2002, J NUTR, V132, p1725S, DOI 10.1093/jn/132.6.1725S; Frenais R, 1997, DIABETOLOGIA, V40, P578, DOI 10.1007/s001250050718; Goldberg A, 2000, AM J CARDIOL, V85, P1100, DOI 10.1016/S0002-9149(00)00703-7; HA YC, 1982, COMP BIOCHEM PHYS B, V71, P265, DOI 10.1016/0305-0491(82)90252-8; HANEDA K, 1986, TOHOKU J EXP MED, V148, P49, DOI 10.1620/tjem.148.49; Hernandez M, 2007, BIOCHEM BIOPH RES CO, V355, P1075, DOI 10.1016/j.bbrc.2007.02.079; KARLIN JB, 1987, J BIOL CHEM, V262, P12557; KHOO JC, 1995, J LIPID RES, V36, P593; KIEFT KA, 1991, J LIPID RES, V32, P859; Knowles HJ, 2006, BIOCHEM PHARMACOL, V71, P646, DOI 10.1016/j.bcp.2005.11.019; Koh Y, 2014, INT J WOMENS HEALTH, V6, P913, DOI 10.2147/IJWH.S69908; Lamon-Fava S, 2008, ARTERIOSCL THROM VAS, V28, P1672, DOI 10.1161/ATVBAHA.108.164541; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Le DSNT, 2009, METABOLISM, V58, P304, DOI 10.1016/j.metabol.2008.09.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Nieland TJF, 2007, J LIPID RES, V48, P1832, DOI 10.1194/jlr.M700209-JLR200; Ouguerram K, 1996, METABOLISM, V45, P4, DOI 10.1016/S0026-0495(96)90193-6; Ouguerram K, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.29006; Ouguerram K, 2004, COMP BIOCHEM PHYS B, V138, P339, DOI 10.1016/j.cbpc.2004.04.011; Pfaffl MW, 2002, DOMEST ANIM ENDOCRIN, V22, P91, DOI 10.1016/S0739-7240(01)00128-X; Piquer BR, 2006, METABOLISM, V55, P980, DOI 10.1016/j.metabol.2006.03.006; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Poynten AM, 2003, METABOLISM, V52, P699, DOI 10.1016/S0026-0495(03)00030-1; Rader DJ, 1996, CURR OPIN LIPIDOL, V7, P117, DOI 10.1097/00041433-199606000-00002; Rubic T, 2004, BIOCHEM PHARMACOL, V67, P411, DOI 10.1016/j.bcp.2003.09.014; SHEPHERD J, 1979, J CLIN INVEST, V63, P858, DOI 10.1172/JCI109385; Siripurkpong P, 2009, J NUTR BIOCHEM, V20, P261, DOI 10.1016/j.jnutbio.2008.02.010; Thacker SG, 2015, J LIPID RES, V56, P1282, DOI 10.1194/jlr.M048629; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; van der Velde AE, 2010, CURR OPIN LIPIDOL, V21, P167, DOI 10.1097/MOL.0b013e3283395e45; Verdoia M, 2015, NUTR METAB CARDIOVAS, V25, P9, DOI 10.1016/j.numecd.2014.09.003; Watts GF, 2008, ARTERIOSCL THROM VAS, V28, P1892, DOI 10.1161/ATVBAHA.108.175224; Wu ZH, 2009, PHARMACOLOGY, V84, P282, DOI 10.1159/000242999; Zhang LH, 2012, J LIPID RES, V53, P941, DOI 10.1194/jlr.M020917; Zhao SP, 2008, INT J CARDIOL, V124, P172, DOI 10.1016/j.ijcard.2006.12.032	46	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136934	10.1371/journal.pone.0136934	http://dx.doi.org/10.1371/journal.pone.0136934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366727	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100035
J	Li, LY; Paz, AC; Wilky, BA; Johnson, B; Galoian, K; Rosenberg, A; Hu, GZ; Tinoco, G; Bodamer, O; Trent, JC				Li, Luyuan; Paz, Ana C.; Wilky, Breelyn A.; Johnson, Britt; Galoian, Karina; Rosenberg, Andrew; Hu, Guozhi; Tinoco, Gabriel; Bodamer, Olaf; Trent, Jonathan C.			Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells	PLOS ONE			English	Article							ISOCITRATE DEHYDROGENASE 1; ACUTE MYELOID-LEUKEMIA; MAFFUCCI SYNDROME; OLLIER DISEASE; CODON 132; MUTATIONS; GLIOMA; HYPERMETHYLATION; GROWTH; GENES	Chondrosarcomas are malignant bone tumors that produce cartilaginous matrix. Mutations in isocitrate dehydrogenase enzymes (IDH1/2) were recently described in several cancers including chondrosarcomas. The IDH1 inhibitor AGI-5198 abrogates the ability of mutant IDH1 to produce the oncometabolite D-2 hydroxyglutarate (D-2HG) in gliomas. We sought to determine if treatment with AGI-5198 would similarly inhibit tumorigenic activity and D-2HG production in IDH1-mutant human chondrosarcoma cells. Two human chondrosarcoma cell lines, JJ012 and HT1080 with endogenous IDH1 mutations and a human chondrocyte cell line C28 with wild type IDH1 were employed in our study. Mutation analysis of IDH was performed by PCR-based DNA sequencing, and D-2HG was detected using tandem mass spectrometry. We confirmed that JJ012 and HT1080 harbor IDH1 R132G and R132C mutation, respectively, while C28 has no mutation. D-2HG was detectable in cell pellets and media of JJ012 and HT1080 cells, as well as plasma and urine from an IDH-mutant chondrosarcoma patient, which decreased after tumor resection. AGI-5198 treatment decreased D-2HG levels in JJ012 and HT1080 cells in a dose-dependent manner, and dramatically inhibited colony formation and migration, interrupted cell cycling, and induced apoptosis. In conclusion, our study demonstrates anti-tumor activity of amutant IDH1 inhibitor in human chondrosarcoma cell lines, and suggests that D-2HG is a potential biomarker for IDH mutations in chondrosarcoma cells. Thus, clinical trials of mutant IDH inhibitors are warranted for patients with IDH-mutant chondrosarcomas.	[Li, Luyuan; Paz, Ana C.; Wilky, Breelyn A.; Hu, Guozhi; Tinoco, Gabriel; Trent, Jonathan C.] Univ Miami, Miller Sch Med, Dept Med, Div Hematol & Oncol, Miami, FL 33136 USA; [Li, Luyuan; Paz, Ana C.; Wilky, Breelyn A.; Hu, Guozhi; Tinoco, Gabriel; Trent, Jonathan C.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Li, Luyuan; Trent, Jonathan C.] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL 33136 USA; [Johnson, Britt; Bodamer, Olaf] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Galoian, Karina] Univ Miami, Miller Sch Med, Dept Orthopaed Surg, Miami, FL 33136 USA; [Rosenberg, Andrew] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Trent, JC (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Hematol & Oncol, Miami, FL 33136 USA.	JTrent@med.miami.edu	Tinoco, Gabriel/ABD-2204-2021; Trent, Jonathan/AAR-7113-2021	Tinoco, Gabriel/0000-0002-2565-6124; Trent, Jonathan/0000-0001-6169-5238; Wilky, Breelyn/0000-0001-5080-497X; Johnson, Britt/0000-0003-1883-5201	Department of Medicine, University of Miami Miller School of Medicine; Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center	Department of Medicine, University of Miami Miller School of Medicine; Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center	This study was supported by Department of Medicine, University of Miami Miller School of Medicine. The authors also acknowledge partial support and assistance from the Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, BLOOD, V116, P2122, DOI 10.1182/blood-2009-11-250878; Aghili M, 2009, J NEURO-ONCOL, V91, P233, DOI 10.1007/s11060-008-9706-2; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Cairns RA, 2011, COLD SH Q B, V76, P299, DOI 10.1101/sqb.2011.76.012856; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Fathi AT, 2014, ONCOLOGIST, V19, P602, DOI 10.1634/theoncologist.2013-0417; Fathi AT, 2012, BLOOD, V120, P4649, DOI 10.1182/blood-2012-06-438267; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guilhamon P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3166; Ho PA, 2010, LEUKEMIA, V24, P909, DOI 10.1038/leu.2010.56; Ichimura K, 2012, BRAIN TUMOR PATHOL, V29, P131, DOI 10.1007/s10014-012-0090-4; Jamil N, 2010, INT J EXP PATHOL, V91, P387, DOI 10.1111/j.1365-2613.2010.00749.x; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kernytsky A, 2015, BLOOD, V125, P296, DOI 10.1182/blood-2013-10-533604; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Ma S, 2015, ONCOTARGET, DOI 10.18632/oncotarget.6284; Murugan AK, 2010, BIOCHEM BIOPH RES CO, V393, P555, DOI 10.1016/j.bbrc.2010.02.095; NYHAN WL, 1995, J CHILD NEUROL, V10, P137, DOI 10.1177/088307389501000216; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Pufe T, 2004, J PATHOL, V202, P367, DOI 10.1002/path.1527; Putiri EL, 2011, CLIN EPIGENETICS, V2, P299, DOI 10.1007/s13148-010-0017-z; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Schaap FG, 2013, ADV ANAT PATHOL, V20, P32, DOI 10.1097/PAP.0b013e31827b654d; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Turkalp Z, 2014, JAMA NEUROL, V71, P1319, DOI 10.1001/jamaneurol.2014.1205; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Waterfall JJ, 2014, BIOCHEM BIOPH RES CO, V455, P16, DOI 10.1016/j.bbrc.2014.08.003; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	43	46	49	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0133813	10.1371/journal.pone.0133813	http://dx.doi.org/10.1371/journal.pone.0133813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368816	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100004
J	Rahman, S; Bruce, N				Rahman, Shafin; Bruce, Neil			Visual Saliency Prediction and Evaluation across Different Perceptual Tasks	PLOS ONE			English	Article							MODEL	Saliency maps produced by different algorithms are often evaluated by comparing output to fixated image locations appearing in human eye tracking data. There are challenges in evaluation based on fixation data due to bias in the data. Properties of eye movement patterns that are independent of image content may limit the validity of evaluation results, including spatial bias in fixation data. To address this problem, we present modeling and evaluation results for data derived from different perceptual tasks related to the concept of saliency. We also present a novel approach to benchmarking to deal with some of the challenges posed by spatial bias. The results presented establish the value of alternatives to fixation data to drive improvement and development of models. We also demonstrate an approach to approximate the output of alternative perceptual tasks based on computational saliency and/or eye gaze data. As a whole, this work presents novel benchmarking results and methods, establishes a new performance baseline for perceptual tasks that provide an alternative window into visual saliency, and demonstrates the capacity for saliency to serve in approximating human behaviour for one visual task given data from another.	[Rahman, Shafin; Bruce, Neil] Univ Manitoba, Dept Comp Sci, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Bruce, N (corresponding author), Univ Manitoba, Dept Comp Sci, Winnipeg, MB R3T 2N2, Canada.	bruce@cs.umanitoba.ca	Rahman, Shafin/N-1939-2019	Rahman, Shafin/0000-0001-7169-0318	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada, NB, http://www.nserc-crsng.gc.ca/ and University of Manitoba, SR NB, http://umanitoba.ca/.	Alpert S, 2007, PROC CVPR IEEE, P359; Borji A, 2013, IEEE T IMAGE PROCESS, V22, P55, DOI 10.1109/TIP.2012.2210727; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruce NDB, 2009, J VISION, V9, DOI 10.1167/9.3.5; Garcia-Diaz A, 2012, IMAGE VISION COMPUT, V30, P51, DOI 10.1016/j.imavis.2011.11.007; HOU X., 2009, DYNAMIC VISUAL ATTEN, P681; Hou X., 2007, P IEEE COMP SOC C CO; Hou XD, 2012, IEEE T PATTERN ANAL, V34, P194, DOI 10.1109/TPAMI.2011.146; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Judd T., 2012, MITCSAILTR2012001; Kanan C, 2009, VIS COGN, V17, P979, DOI 10.1080/13506280902771138; Koehler K, 2014, J VISION, V14, DOI 10.1167/14.3.14; Le Meur O, 2013, BEHAV RES METHODS, V45, P251, DOI 10.3758/s13428-012-0226-9; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Rahman S, 2014, IEEE IMAGE PROC, P4082, DOI 10.1109/ICIP.2014.7025829; Seo HJ, 2009, J VISION, V9, DOI 10.1167/9.12.15; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Torralba A, 2003, J OPT SOC AM A, V20, P1407, DOI 10.1364/JOSAA.20.001407; Yan JC, 2010, IEEE IMAGE PROC, P1089, DOI 10.1109/ICIP.2010.5652280; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32	20	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138053	10.1371/journal.pone.0138053	http://dx.doi.org/10.1371/journal.pone.0138053			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368124	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100211
J	Yamamoto, K; Ito, S; Hanafusa, H; Shimizu, K; Ouchida, M				Yamamoto, Kumiko; Ito, Sachio; Hanafusa, Hiroko; Shimizu, Kenji; Ouchida, Mamoru			Uncovering Direct Targets of MiR-19a Involved in Lung Cancer Progression	PLOS ONE			English	Article							CELL; EXPRESSION; CLUSTER; A20; RNA; MICRORNAS; GENES; FOXP1; IDENTIFICATION; PATHOGENESIS	Micro RNAs (miRNAs) regulate the expression of target genes posttranscriptionally by pairing incompletely with mRNA in a sequence-specific manner. About 30% of human genes are regulated by miRNAs, and a single miRNA is capable of reducing the production of hundreds of proteins by means of incomplete pairing upon miRNA-mRNA binding. Lately, evidence implicating miRNAs in the development of lung cancers has been emerging. In particular, miR-19a, which is highly expressed in malignant lung cancer cells, is considered the key miRNA for tumorigenesis. However, its direct targets remain underreported. In the present study, we focused on six potential miR-19a target genes selected by miRNA target prediction software. To evaluate these genes as direct miR-19a target genes, we performed luciferase, pull-down, and western blot assays. The luciferase activity of plasmids with each miR-19a-binding site was observed to decrease, while increased luciferase activity was observed in the presence of anti-miR-19a locked nucleic acid (LNA). The pull-down assay showed biotinylated miR-19a to bind to AGO2 protein and to four of six potential target mRNAs. Western blot analysis showed that the expression levels of the four genes changed depending on treatment with miR-19a mimic or anti-miR-19a-LNA. Finally, FOXP1, TP53INP1, TNFAIP3, and TUSC2 were identified as miR-19a targets. To examine the function of these four target genes in lung cancer cells, LK79 (which has high miR-19a expression) and A549 (which has low miR-19a expression) were used. The expression of the four target proteins was higher in A549 than in LK79 cells. The four miR-19a target cDNA expression vectors suppressed cell viability, colony formation, migration, and invasion of A549 and LK79 cells, but LK79 cells transfected with FOXP1 and TP53INP1 cDNAs showed no difference compared to the control cells in the invasion assay.	[Yamamoto, Kumiko; Ito, Sachio; Hanafusa, Hiroko; Shimizu, Kenji; Ouchida, Mamoru] Okayama Univ, Dept Mol Genet, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan	Okayama University	Ouchida, M (corresponding author), Okayama Univ, Dept Mol Genet, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008530, Japan.	ouchidam@md.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591905]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 24591905 to M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-840; Asai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056820; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Hao M, 2015, INT J CANCER, V136, P1835, DOI 10.1002/ijc.29199; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Kanayama M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6779; Kanzaki H, 2011, PROTEOMICS, V11, P3531, DOI 10.1002/pmic.201000501; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Langevin SM, 2015, TRANSL RES, V165, P74, DOI 10.1016/j.trsl.2014.03.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lerman MI, 2000, CANCER RES, V60, P6116; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin J, 2011, BIOCHEM BIOPH RES CO, V410, P235, DOI 10.1016/j.bbrc.2011.05.122; Liu FC, 2015, FEBS LETT, V589, P500, DOI 10.1016/j.febslet.2015.01.009; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu M, 2011, INT J ONCOL, V38, P1013, DOI 10.3892/ijo.2011.924; Lu C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034833, 10.1371/journal.pone.0038332]; Lu WD, 2014, INT J CLIN EXP PATHO, V7, P7286; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meng JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077067; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Nonne N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1100; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ouchida M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044095; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Qin J, 2014, GENE, V538, P342, DOI 10.1016/j.gene.2013.12.043; Rutnam ZJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3914; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Takayama K, 2014, MOL ENDOCRINOL, V28, P2012, DOI 10.1210/me.2014-1171; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; Zhang J, 2014, INT J CLIN EXP PATHO, V7, P602; Zhong JF, 2014, INT J MOL SCI, V15, P20355, DOI 10.3390/ijms151120355	49	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137887	10.1371/journal.pone.0137887	http://dx.doi.org/10.1371/journal.pone.0137887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367773	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100167
J	Amano, C; Minematsu, H; Fujita, K; Iwashita, S; Adachi, M; Igarashi, K; Hinuma, S				Amano, Chie; Minematsu, Hideki; Fujita, Kazuyo; Iwashita, Shinki; Adachi, Masaki; Igarashi, Koichi; Hinuma, Shuji			Nanoparticles Containing Curcumin Useful for Suppressing Macrophages In Vivo in Mice	PLOS ONE			English	Article							LARGE UNILAMELLAR VESICLES; LIPOSOME; CELLS; TUMOR; PROLIFERATION; ACCUMULATION; INFLAMMATION; REGION; DRUGS	To explore a novel method using liposomes to suppress macrophages, we screened food constituents through cell culture assays. Curcumin was one of the strongest compounds exhibiting suppressive effects on macrophages. We subsequently tried various methods to prepare liposomal curcumin, and eventually succeeded in preparing liposomes with sufficient amounts of curcumin to suppress macrophages by incorporating a complex of curcumin and bovine serum albumin. The diameter of the resultant nanoparticles, the liposomes containing curcumin, ranged from 60 to 100 nm. Flow cytometric analyses revealed that after intraperitoneal administration of the liposomes containing curcumin into mice, these were incorporated mainly by macrophages positive for F4/80, CD36, and CD11b antigens. Peritoneal cells prepared from mice injected in vivo with the liposomes containing curcumin apparently decreased interleukin-6-producing activities. Major changes in body weight and survival rates in the mice were not observed after administrating the liposomes containing curcumin. These results indicate that the liposomes containing curcumin are safe and useful for the selective suppression of macrophages in vivo in mice.	[Amano, Chie; Minematsu, Hideki; Iwashita, Shinki; Adachi, Masaki; Igarashi, Koichi] Katayama Chem Ind Co Ltd, R&D Div, Minoh City, Osaka, Japan; [Fujita, Kazuyo; Hinuma, Shuji] Senri Kinran Univ, Fac Human Life Sci, Dept Food & Nutr, Suita, Osaka, Japan		Hinuma, S (corresponding author), Katayama Chem Ind Co Ltd, R&D Div, Minoh City, Osaka, Japan.	s-hinuma@cs.kinran.ac.jp			Senri Kinran University; Katayama Chemical Industries, Co., Ltd.; JSPS KAKENHI Grant [23500941]	Senri Kinran University; Katayama Chemical Industries, Co., Ltd.; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Senri Kinran University, Katayama Chemical Industries, Co., Ltd., and JSPS KAKENHI Grant Number 23500941 (http://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors CA, HM, SI and MA but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Barry J, 2009, J AM CHEM SOC, V131, P4490, DOI 10.1021/ja809217u; Ben-Efraim S, 1992, Mediators Inflamm, V1, P295, DOI 10.1155/S0962935192000449; Biskobing DM, 1997, ENDOCRINOLOGY, V138, P4852, DOI 10.1210/en.138.11.4852; Capini C, 2009, J IMMUNOL, V182, P3556, DOI 10.4049/jimmunol.0802972; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; GABIZON AA, 1994, HEMATOL ONCOL CLIN N, V8, P431; Ghosh S, 2010, VASC PHARMACOL, V52, P1, DOI 10.1016/j.vph.2009.10.002; HARRIGAN PR, 1993, BIOCHIM BIOPHYS ACTA, V1149, P329, DOI 10.1016/0005-2736(93)90218-O; HINUMA S, 1989, MICROBIOL IMMUNOL, V33, P761, DOI 10.1111/j.1348-0421.1989.tb00962.x; Hirai M, 2007, BIOCHEM BIOPH RES CO, V353, P553, DOI 10.1016/j.bbrc.2006.12.060; Inokuchi C, 2009, EXP ANIM TOKYO, V58, P383, DOI 10.1538/expanim.58.383; Iwasa S, 2011, YAKUGAKU ZASSHI, V131, P1111, DOI 10.1248/yakushi.131.1111; KUMAGAI K, 1979, J IMMUNOL METHODS, V29, P17, DOI 10.1016/0022-1759(79)90121-2; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Licinska I, 2002, J NUCL MED, V5, P145; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V857, P123, DOI 10.1016/0005-2736(86)90105-7; Naksuriya O, 2014, BIOMATERIALS, V35, P3365, DOI 10.1016/j.biomaterials.2013.12.090; Nicaise P, 1999, EUR CYTOKINE NETW, V10, P365; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Sanders A, 1994, J IMMUNOL METHODS, V174, P83; SCHOOK LB, 1983, J IMMUNOL, V130, P661; Ushio Y, 1996, MICROBIOL IMMUNOL, V40, P489, DOI 10.1111/j.1348-0421.1996.tb01099.x; VazquezTorres A, 1997, MICROBIOL MOL BIOL R, V61, P170; Wang FP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/737264; Yachi K, 1996, BIOPHARM DRUG DISPOS, V17, P589, DOI 10.1002/(SICI)1099-081X(199610)17:7<589::AID-BDD976>3.3.CO;2-4; YAMAZAKI N, 1994, METHOD ENZYMOL, V242, P56; YAMAZAKI N, 1989, J MEMBRANE SCI, V41, P249, DOI 10.1016/S0376-7388(00)82406-0; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	30	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137207	10.1371/journal.pone.0137207	http://dx.doi.org/10.1371/journal.pone.0137207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361331	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100025
J	Geraedts, HAE; Zijlstra, W; Van Keeken, HG; Zhang, W; Stevens, M				Geraedts, Hilde A. E.; Zijlstra, Wiebren; Van Keeken, Helco G.; Zhang, Wei; Stevens, Martin			Validation and User Evaluation of a Sensor-Based Method for Detecting Mobility-Related Activities in Older Adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; AMBULATORY SYSTEM; GAIT; CLASSIFICATION; ACCELEROMETER; POSTURES; FRAIL; RELIABILITY; ACCURACY; BALANCE	Regular physical activity is essential for older adults to stay healthy and independent. However, daily physical activity is generally low among older adults and mainly consists of activities such as standing and shuffling around indoors. Accurate measurement of this low-energy expenditure daily physical activity is crucial for stimulation of activity. The objective of this study was to assess the validity of a necklace-worn sensor-based method for detecting time-on-legs and daily life mobility related postures in older adults. In addition user opinion about the practical use of the sensor was evaluated. Twenty frail and non-frail older adults performed a standardized and free movement protocol in their own home. Results of the sensor-based method were compared to video observation. Sensitivity, specificity and overall agreement of sensor outcomes compared to video observation were calculated. Mobility was assessed based on time-on-legs. Further assessment included the categories standing, sitting, walking and lying. Time-on-legs based sensitivity, specificity and percentage agreement were good to excellent and comparable to laboratory outcomes in other studies. Category-based sensitivity, specificity and overall agreement were moderate to excellent. The necklace-worn sensor is considered an acceptable valid instrument for assessing home-based physical activity based upon time-on-legs in frail and non-frail older adults, but category-based assessment of gait and postures could be further developed.	[Geraedts, Hilde A. E.; Zijlstra, Wiebren; Van Keeken, Helco G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Zijlstra, Wiebren] German Sport Univ Cologne, Inst Movement & Sport Gerontol, Cologne, Germany; [Zhang, Wei] Philips Res Europe, Eindhoven, Netherlands; [Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands	University of Groningen; German Sport University Cologne; Philips; Philips Research; University of Groningen	Geraedts, HAE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	H.A.E.Geraedts@med.umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894; Zhang, Wei/0000-0002-6022-6832	Netherlands Organisation for Health Research and Development (ZonMw) [40-00812-98-09014]; Philips Research Europe	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Philips Research Europe	This study is funded by The Netherlands Organisation for Health Research and Development (ZonMw; website URL http://www.zonmw.nl/en/), funder approval number 40-00812-98-09014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was performed using technology and expertise provided by Philips Research Europe. Philips Research Europe provided support in the form of a salary for author W. Zhang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Aminian K, 2004, GAIT POSTURE, V20, P102, DOI 10.1016/S0966-6362(03)00093-6; Annegarn J, 2011, ARCH PHYS MED REHAB, V92, P1852, DOI 10.1016/j.apmr.2011.06.021; Bagala F, 2013, IEEE T NEUR SYS REH, V21, P624, DOI 10.1109/TNSRE.2012.2230189; Bergmann JHM, 2011, ANN BIOMED ENG, V39, P2299, DOI 10.1007/s10439-011-0339-9; Bergmann JHM, 2012, SENSORS-BASEL, V12, P16695, DOI 10.3390/s121216695; Blikman T, 2013, J ORTHOP SPORT PHYS, V43, P650, DOI 10.2519/jospt.2013.4422; Bussmann JBJ, 1998, PAIN, V74, P153, DOI 10.1016/S0304-3959(97)00161-9; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dijkstra B, 2010, ARCH PHYS MED REHAB, V91, P1272, DOI 10.1016/j.apmr.2010.05.004; Dijkstra B, 2010, AGE AGEING, V39, P259, DOI 10.1093/ageing/afp249; Faber MJ, 2006, ARCH PHYS MED REHAB, V87, P885, DOI 10.1016/j.apmr.2006.04.005; Fleiss JL, 1981, STAT METHODS; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Ganea R, 2012, IEEE T NEUR SYS REH, V20, P688, DOI 10.1109/TNSRE.2012.2202691; Godfrey A, 2011, MED ENG PHYS, V33, P1127, DOI 10.1016/j.medengphy.2011.05.002; Lally F, 2007, POSTGRAD MED J, V83, P16, DOI 10.1136/pgmj.2006.048587; Laufer Y, 2002, CLIN REHABIL, V16, P141, DOI 10.1191/0269215502cr481oa; Lindemann U, 2014, SENSORS-BASEL, V14, P1267, DOI 10.3390/s140101267; Mathie MJ, 2004, MED BIOL ENG COMPUT, V42, P679, DOI 10.1007/BF02347551; Murphy SL, 2009, PREV MED, V48, P108, DOI 10.1016/j.ypmed.2008.12.001; Paraschiv-Ionescu A, 2004, GAIT POSTURE, V20, P113, DOI 10.1016/j.gaitpost.2003.07.005; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rydwik E, 2008, AGING CLIN EXP RES, V20, P159; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Steverink N, 2001, GERONTOLOGIST, V41, P236; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Taraldsen K, 2011, PHYS THER, V91, P277, DOI 10.2522/ptj.20100159; Taylor LM, 2014, ARCH PHYS MED REHAB, V95, P930, DOI 10.1016/j.apmr.2014.01.013; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Tung JY, 2014, GAIT POSTURE, V39, P991, DOI 10.1016/j.gaitpost.2013.11.015; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; World Health Organization, PHYSICAL ACTIVITY AN; Zeng HS, 2011, SENSORS-BASEL, V11, P638, DOI 10.3390/s110100638; Zhang W, 2014, IEEE ENG MED BIO, P1830, DOI 10.1109/EMBC.2014.6943965	36	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137668	10.1371/journal.pone.0137668	http://dx.doi.org/10.1371/journal.pone.0137668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361009	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100071
J	Das, S; Rachagani, S; Sheinin, Y; Smith, LM; Gurumurthy, CB; Roy, HK; Batra, SK				Das, S.; Rachagani, S.; Sheinin, Y.; Smith, L. M.; Gurumurthy, C. B.; Roy, H. K.; Batra, S. K.			Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer	ONCOGENE			English	Article							CELL-SURFACE MUCIN; GENE-EXPRESSION; PROGNOSTIC-FACTOR; INTESTINAL INFLAMMATION; BARRIER; CARCINOMA; DIAGNOSIS; PROTECTS; PATHWAY	MUC4, a large transmembrane mucin normally expressed in the small and large intestine, is differentially expressed during inflammatory and malignant conditions of the colon. However, the expression pattern and the role of MUC4 in colitis and colorectal cancer (CRC) are inconclusive. Therefore, the aim of this study was to understand the role of Muc4 during inflammatory and malignant conditions of the colon. Here, we generated Muc4(-/-) mice and addressed its role in colitis and colitis-associated CRC using dextran sodium sulfate (DSS) and azoxymethane (AOM)-DSS experimental models, respectively. Muc4(-/-) mice were viable, fertile with no apparent defects. Muc4(-/-) mice displayed increased resistance to DSS-induced colitis compared with wild-type (WT) littermates that was evaluated by survival rate, body weight loss, diarrhea and fecal blood score, and histological score. Reduced infiltration of inflammatory cells, that is, CD3(+) lymphocytes and F4/80(+) macrophages was observed in the inflamed mucosa along with reduction in the mRNA levels of inflammatory cytokines interleukin (IL)-1 beta and tumor necrosis factor (TNF)-alpha and anti-microbial genes Lysozyme M and SLPI in the colon of Muc4(-/-) mice compared with WT littermates. Compensatory upregulation of Muc2 and Muc3 mucins under basal and DSS treatment conditions partly explains the resistance observed in Muc4(-/-) mice. Accordingly, Muc4(-/-) mice exhibited significantly reduced tumor burden compared with WT mice assessed in a colitis-induced tumor model using AOM/DSS. An increased percentage of Ki67(+) nuclei was observed in the tumors from WT compared with Muc4(-/-) mice suggesting Muc4 to be critical in intestinal cell proliferation during tumorigenesis. Taken together, we conclusively demonstrate for the first time the role of Muc4 in driving intestinal inflammation and inflammation-associated tumorigenesis using a novel Muc4(-/-) mouse model.	[Das, S.; Rachagani, S.; Batra, S. K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Sheinin, Y.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Smith, L. M.] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE 68198 USA; [Gurumurthy, C. B.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Mouse Genome Engn Core Facil, Omaha, NE 68198 USA; [Roy, H. K.] Boston Univ, Sch Med, Ctr Digest Disorders, Boston, MA 02118 USA; [Batra, S. K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Buffett Canc Ctr, Omaha, NE 68198 USA; [Das, S.] Karolinska Univ Sjukhuset, Dept Med, S-17176 Stockholm, Sweden	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Boston University; University of Nebraska System; University of Nebraska Medical Center	Batra, SK (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Buffett Canc Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	sbatra@unmc.edu	Gurumurthy, Channabasavaiah B/H-8268-2016; Roy, Hemant/AAC-9096-2020; Das, Srustidhar/GVU-1044-2022; Gurumurthy, Channabasavaiah B/E-7205-2011	Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; 	National Institutes of Health [RO1 CA 78590, RO1 CA183459, UO1CA111294, SPORE P50CA127297, TMEN U54CA163120, R03 CA167342]; NATIONAL CANCER INSTITUTE [U54CA163120, R03CA167342, R01CA183459, U01CA111294, R01CA078590, P50CA127297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Don Harms and Rolen Quadros of the mouse genome-engineering core at the University of Nebraska Medical Center (UNMC) for the electroporation, microinjection and generation of chimera for Muc4 knockout mice. We thank UNMC tissue sciences facility for processing of tissues used in the study. We also thank Dr Imayavaramban Lakshmanan and Kavita Mallya for technical assistance. The work in the manuscript, in parts, was supported by the grants from the National Institutes of Health (RO1 CA 78590, RO1 CA183459, UO1CA111294, SPORE P50CA127297, TMEN U54CA163120 and R03 CA167342).	Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Biemer-Huttmann AE, 1999, J HISTOCHEM CYTOCHEM, V47, P1039, DOI 10.1177/002215549904700808; Biemer-Huttmann AE, 2000, CLIN CANCER RES, V6, P1909; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Boltin D, 2013, J CLIN GASTROENTEROL, V47, P106, DOI 10.1097/MCG.0b013e3182688e73; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Buisine MP, 1999, INFLAMM BOWEL DIS, V5, P24, DOI 10.1097/00054725-199902000-00004; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chauhan SC, 2006, MODERN PATHOL, V19, P1386, DOI 10.1038/modpathol.3800646; Dharmani P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025058; Enss ML, 2000, INFLAMM RES, V49, P162, DOI 10.1007/s000110050576; Feagins LA, 2009, NAT REV GASTRO HEPAT, V6, P297, DOI 10.1038/nrgastro.2009.44; Ho SB, 2010, BBA-GEN SUBJECTS, V1800, P629, DOI 10.1016/j.bbagen.2010.03.010; Hoebler C, 2006, DIGEST DIS SCI, V51, P381, DOI 10.1007/s10620-006-3142-y; Iwashita J, 2003, IMMUNOL CELL BIOL, V81, P275, DOI 10.1046/j.1440-1711.2003.t01-1-01163.x; Kim YD, 2002, J KOREAN MED SCI, V17, P765, DOI 10.3346/jkms.2002.17.6.765; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Longman RJ, 2006, J HISTOCHEM CYTOCHEM, V54, P1335, DOI 10.1369/jhc.5A6904.2006; Luu Y, 2010, INT J BIOCHEM CELL B, V42, P996, DOI 10.1016/j.biocel.2010.03.001; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Majhi PD, 2013, J THORAC ONCOL, V8, P398, DOI 10.1097/JTO.0b013e3182829e06; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Miyahara N, 2008, EUR J CANCER, V44, P1048, DOI 10.1016/j.ejca.2008.03.007; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; Myerscough N, 1995, BIOCHEM SOC T, V23, pS536, DOI 10.1042/bst023536s; OGATA S, 1992, CANCER RES, V52, P5971; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Ponnusamy MP, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-7; Resta-Lenert S, 2011, AM J PHYSIOL-GASTR L, V300, pG1144, DOI 10.1152/ajpgi.00138.2010; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Senapati S, 2008, BRIT J CANCER, V99, P949, DOI 10.1038/sj.bjc.6604632; Senapati S, 2010, TRENDS BIOCHEM SCI, V35, P236, DOI 10.1016/j.tibs.2009.10.003; Shanmugam C, 2010, CANCER-AM CANCER SOC, V116, P3577, DOI 10.1002/cncr.25095; Shekels LL, 2003, BBA-GENE STRUCT EXPR, V1627, P90, DOI 10.1016/S0167-4781(03)00081-2; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Sheng YH, 2011, GUT, V60, P1661, DOI 10.1136/gut.2011.239194; Shibahara H, 2004, HEPATOLOGY, V39, P220, DOI 10.1002/hep.20031; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh AP, 2008, LANCET ONCOL, V9, P1076, DOI 10.1016/S1470-2045(08)70277-8; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; VanKlinken BJW, 1995, BIOCHEM SOC T, V23, P814, DOI 10.1042/bst0230814; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Zhang J, 2006, TISSUE CELL, V38, P271, DOI 10.1016/j.tice.2006.06.004	51	44	47	0	31	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 19	2016	35	20					2645	2654		10.1038/onc.2015.327	http://dx.doi.org/10.1038/onc.2015.327			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GS	26364605	Green Accepted			2022-12-26	WOS:000376165700011
J	Silva, IR; Serrao, VHB; Manzine, LR; Faim, LM; da Silva, MTA; Makki, R; Saidemberg, DM; Cornelio, ML; Palma, MS; Thiemann, OH				Silva, Ivan R.; Serrao, Vitor H. B.; Manzine, Livia R.; Faim, Livia M.; da Silva, Marco T. A.; Makki, Raphaela; Saidemberg, Daniel M.; Cornelio, Marinonio L.; Palma, Marrio S.; Thiemann, Otavio H.			Formation of a Ternary Complex for Selenocysteine Biosynthesis in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; ESCHERICHIA-COLI; SECONDARY STRUCTURE; PROTEIN-STRUCTURE; SYNTHASE SELA; TRANSFER-RNA; SELENIUM; IDENTITY	The synthesis of selenocysteine-containing proteins (selenoproteins) involves the interaction of selenocysteine synthase (SelA), tRNA (tRNA(Sec)), selenophosphate synthetase (SelD, SPS), a specific elongation factor (SelB), and a specific mRNA sequence known as selenocysteine insertion sequence (SECIS). Because selenium compounds are highly toxic in the cellular environment, the association of selenium with proteins throughout its metabolism is essential for cell survival. In this study, we demonstrate the interaction of SPS with the SelA-tRNA(Sec) complex, resulting in a 1.3-MDa ternary complex of 27.0 +/- 0.5 nm in diameter and 4.02 +/- 0.05 nm in height. To assemble the ternary complex, SPS undergoes a conformational change. We demonstrated that the glycine-rich N-terminal region of SPS is crucial for the SelA-tRNA(Sec)-SPS interaction and selenoprotein biosynthesis, as revealed by functional complementation experiments. Taken together, our results provide new insights into selenoprotein biosynthesis, demonstrating for the first time the formation of the functional ternary SelA-tRNA(Sec)-SPS complex. We propose that this complex is necessary for proper selenocysteine synthesis and may be involved in avoiding the cellular toxicity of selenium compounds.	[Silva, Ivan R.; Serrao, Vitor H. B.; Manzine, Livia R.; Faim, Livia M.; da Silva, Marco T. A.; Makki, Raphaela; Thiemann, Otavio H.] Univ Sao Paulo, Phys Inst Sao Carlos, Phys & Informat Dept, BR-13563120 Sao Carlos, SP, Brazil; [Serrao, Vitor H. B.] Univ Fed Sao Carlos, Dept Phys, BR-13565905 Sao Carlos, SP, Brazil; [Saidemberg, Daniel M.; Palma, Marrio S.] Sao Paulo State Univ, Biosci Inst Rio Claro, Dept Biol CEIS, BR-13506900 Rio Claro, SP, Brazil; [Cornelio, Marinonio L.] Sao Paulo State Univ, Inst Biosci Letters & Exact Sci IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade Estadual Paulista; Universidade Estadual Paulista	Thiemann, OH (corresponding author), Univ Sao Paulo, Phys Inst Sao Carlos, Phys & Informat Dept, Joao Dagnone Av,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, SP, Brazil.	thiemann@ifsc.usp.br	Palma, Mario Sergio/E-7800-2012; Thiemann, Otavio H/D-9767-2012; Cornelio, Marinonio Lopes/AAC-9215-2020; e Silva, Ivan Rosa/B-5982-2016; Serrao, Vitor Hugo Balasco/AAM-2060-2020; Palma, Mario/N-3903-2019; Manzine, Livia/HDN-9987-2022; Rosa e Silva, Ivan/O-5567-2014	Palma, Mario Sergio/0000-0002-7363-8211; e Silva, Ivan Rosa/0000-0003-4037-2266; Serrao, Vitor Hugo Balasco/0000-0002-9398-2941; Rosa e Silva, Ivan/0000-0003-4732-1517	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57910-0]; CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [550514/2011-2]; FAPESP [2010/04429-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Research Grant 2008/57910-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), CAPES and by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Grant 550514/2011-2). This work was also supported by FAPESP Fellowship 2010/04429-3 (to I. R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Collins R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030581; EHRENREICH A, 1992, EUR J BIOCHEM, V206, P767, DOI 10.1111/j.1432-1033.1992.tb16983.x; ENGELHARDT H, 1992, MOL MICROBIOL, V6, P3461, DOI 10.1111/j.1365-2958.1992.tb01781.x; Figueira ACM, 2011, MOL ENDOCRINOL, V25, P15, DOI 10.1210/me.2010-0202; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; GLASS RS, 1993, BIOCHEMISTRY-US, V32, P12555, DOI 10.1021/bi00210a001; Itoh Y, 2014, J MOL BIOL, V426, P1723, DOI 10.1016/j.jmb.2014.01.003; Itoh Y, 2013, SCIENCE, V340, P75, DOI 10.1126/science.1229521; Itoh Y, 2009, J MOL BIOL, V385, P1456, DOI 10.1016/j.jmb.2008.08.042; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Lacourciere GM, 2000, J BIOL CHEM, V275, P23769, DOI 10.1074/jbc.M000926200; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Manzine LR, 2013, FEBS LETT, V587, P906, DOI 10.1016/j.febslet.2013.02.014; Manzine LR, 2013, PROTEIN EXPRES PURIF, V88, P80, DOI 10.1016/j.pep.2012.12.005; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Muller DJ, 2002, PROG BIOPHYS MOL BIO, V79, P1, DOI 10.1016/S0079-6107(02)00009-3; Noinaj N, 2012, J BACTERIOL, V194, P499, DOI 10.1128/JB.06012-11; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sculaccio SA, 2008, MOL BIOCHEM PARASIT, V162, P165, DOI 10.1016/j.molbiopara.2008.08.009; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Takahata M, 2008, J BIOCHEM, V143, P467, DOI 10.1093/jb/mvm247; TREWHELLA J, 1989, BIOCHEMISTRY-US, V28, P1294, DOI 10.1021/bi00429a052; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Yan Xuguang, 2009, V492, P255, DOI 10.1007/978-1-59745-493-3_15; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010	28	12	13	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29178	U103		10.1074/jbc.M114.613406	http://dx.doi.org/10.1074/jbc.M114.613406			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26378233	Green Published, hybrid			2022-12-26	WOS:000366613400006
J	Huang, HC; Santoso, N; Power, D; Simpson, S; Dieringer, M; Miao, HY; Gurova, K; Giam, CZ; Elledge, SJ; Zhu, J				Huang, Huachao; Santoso, Netty; Power, Derek; Simpson, Sydney; Dieringer, Michael; Miao, Hongyu; Gurova, Katerina; Giam, Chou-Zen; Elledge, Stephen J.; Zhu, Jian			FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNA-POLYMERASE-II; NEGATIVE ELONGATION-FACTOR; P-TEFB; POSTINTEGRATION LATENCY; CHROMATIN DYNAMICS; T-CELLS; TAT; REPLICATION; IDENTIFICATION	Background: FACT proteins SUPT16H and SSRP1 are identified as host factors that restrict HIV-1 replication. Results: Biochemical and genetic evidences that SUPT16H and SSRP1 affect HIV-1/HTLV-1 transcription and latency are provided. Conclusion: SUPT16H and SSRP1 suppress transcription of HIV-1/HTLV-1, and their presence may promote HIV-1 latency. Significance: Identification of host factors necessary for HIV-1 latency is critical, which may benefit the development of novel HIV-1 latency-reversing agents. Our functional genomic RNAi screens have identified the protein components of the FACT (facilitates chromatin transcription) complex, SUPT16H and SSRP1, as top host factors that negatively regulate HIV-1 replication. FACT interacts specifically with histones H2A/H2B to affect assembly and disassembly of nucleosomes, as well as transcription elongation. We further investigated the suppressive role of FACT proteins in HIV-1 transcription. First, depletion of SUPT16H or SSRP1 protein enhances Tat-mediated HIV-1 LTR (long terminal repeat) promoter activity. Second, HIV-1 Tat interacts with SUPT16H but not SSRP1 protein. However, both SUPT16H and SSRP1 are recruited to LTR promoter. Third, the presence of SUPT16H interferes with the association of Cyclin T1 (CCNT1), a subunit of P-TEFb, with the Tat-LTR axis. Removing inhibitory mechanisms to permit HIV-1 transcription is an initial and key regulatory step to reverse post-integrated latent HIV-1 proviruses for purging of reservoir cells. We therefore evaluated the role of FACT proteins in HIV-1 latency and reactivation. Depletion of SUPT16H or SSRP1 protein affects both HIV-1 transcriptional initiation and elongation and spontaneously reverses latent HIV-1 in U1/HIV and J-LAT cells. Similar effects were observed with a primary CD4+ T cell model of HIV-1 latency. FACT proteins also interfere with HTLV-1 Tax-LTR-mediated transcription and viral latency, indicating that they may act as general transcriptional suppressors for retroviruses. We conclude that FACT proteins SUPT16H and SSRP1 play a key role in suppressing HIV-1 transcription and promoting viral latency, which may serve as promising gene targets for developing novel HIV-1 latency-reversing agents.	[Huang, Huachao; Santoso, Netty; Power, Derek; Zhu, Jian] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Zhu, Jian] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Miao, Hongyu] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Simpson, Sydney; Dieringer, Michael] Univ Rochester, Sch Arts & Sci, Rochester, NY 14627 USA; [Gurova, Katerina] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Giam, Chou-Zen] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Elledge, Stephen J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA; [Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Roswell Park Cancer Institute; Uniformed Services University of the Health Sciences - USA; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Zhu, J (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Dept Biochem & Biophys, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	Jian_Zhu@urmc.rochester.edu	Regan, Clinton/E-6250-2012	Simpson, Sydney/0000-0001-5895-3371	National Institutes of Health [R21AI116180, R01GM117838]; University of Rochester Centers for AIDS Research Grant from National Institutes of Health [P30AI078498]; University of Rochester Center for Integrative Bioinformatics and Experimental Mathematics pilot grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498, R21AI116180, R33AI116180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Centers for AIDS Research Grant from National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Center for Integrative Bioinformatics and Experimental Mathematics pilot grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health Grants R21AI116180 and R01GM117838 (to J.Z.) and in part by the University of Rochester Centers for AIDS Research Grant P30AI078498 from National Institutes of Health and the University of Rochester Center for Integrative Bioinformatics and Experimental Mathematics pilot grant. The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2011, J BIOL CHEM, V286, P30504, DOI 10.1074/jbc.M111.264721; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Barton KM, 2013, CLIN PHARMACOL THER, V93, P46, DOI 10.1038/clpt.2012.202; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bosque A, 2011, METHODS, V53, P54, DOI 10.1016/j.ymeth.2010.10.002; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brady J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-69; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cho WK, 2007, J VIROL, V81, P11179, DOI 10.1128/JVI.00408-07; Cho WK, 2010, J VIROL, V84, P12801, DOI 10.1128/JVI.00943-10; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Dinant C, 2013, MOL CELL, V51, P469, DOI 10.1016/j.molcel.2013.08.007; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Easley R, 2010, BBA-GENE REGUL MECH, V1799, P275, DOI 10.1016/j.bbagrm.2009.08.008; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Garcia H, 2013, CELL REP, V4, P159, DOI 10.1016/j.celrep.2013.06.013; Han JH, 2010, GENE DEV, V24, P1485, DOI 10.1101/gad.1887310; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Jadlowsky JK, 2014, MOL CELL BIOL, V34, P1911, DOI 10.1128/MCB.01013-13; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Khan SZ, 2011, J BIOL CHEM, V286, P22943, DOI 10.1074/jbc.M110.201194; Klichko V, 2006, J VIROL, V80, P4570, DOI 10.1128/JVI.80.9.4570-4579.2006; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Larsson M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-31; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Li YP, 2007, J BIOL CHEM, V282, P6936, DOI 10.1074/jbc.M603822200; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Morillo-Huesca M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000964; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Philip S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004040; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Power D, 2015, VIROLOGY, V481, P142, DOI 10.1016/j.virol.2015.02.046; Rafati H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001206; Sanchez-Duffhues G, 2011, CURR DRUG TARGETS, V12, P348, DOI 10.2174/138945011794815266; Schiralli Lester Gillian M, 2012, Mol Biol Int, V2012, P614120, DOI 10.1155/2012/614120; Shan L, 2013, BIOESSAYS, V35, P544, DOI 10.1002/bies.201200170; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Tan BCM, 2004, J BIOL CHEM, V279, P9321, DOI 10.1074/jbc.M311477200; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Van Duyne R, 2011, J MOL BIOL, V411, P581, DOI 10.1016/j.jmb.2011.06.001; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhou MS, 2006, J VIROL, V80, P4781, DOI 10.1128/JVI.80.10.4781-4791.2006; Zhu J, 2014, CELL REP, V9, P752, DOI 10.1016/j.celrep.2014.09.031; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	73	36	37	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27297	27310		10.1074/jbc.M115.652339	http://dx.doi.org/10.1074/jbc.M115.652339			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378236	Green Published, hybrid			2022-12-26	WOS:000364794000037
J	Stanne, T; Narayanan, MS; Ridewood, S; Ling, A; Witmer, K; Kushwaha, M; Wiesler, S; Wickstead, B; Wood, J; Rudenko, G				Stanne, Tara; Narayanan, Mani Shankar; Ridewood, Sophie; Ling, Alexandra; Witmer, Kathrin; Kushwaha, Manish; Wiesler, Simone; Wickstead, Bill; Wood, Jennifer; Rudenko, Gloria			Identification of the ISWI Chromatin Remodeling Complex of the Early Branching Eukaryote Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-I; INDUCIBLE EXPRESSION SYSTEM; AFRICAN TRYPANOSOMES; VSG EXPRESSION; GENE-EXPRESSION; TRANSCRIPTIONAL CONTROL; EPIGENETIC REGULATION; ANTIGENIC VARIATION; SITE CONTROL; DNA-DAMAGE	Background: Eukaryotes typically encode a range of ISWI chromatin remodeling complexes with different functions. Results: We have identified and analyzed three novel ISWI partners in the early branching eukaryote Trypanosoma brucei. Conclusion:T. brucei appears to have a single major ISWI complex. Significance: This unusually simple ISWI configuration could be a consequence of the relative lack of transcriptional regulation in this ancient eukaryote. ISWI chromatin remodelers are highly conserved in eukaryotes and are important for the assembly and spacing of nucleosomes, thereby controlling transcription initiation and elongation. ISWI is typically associated with different subunits, forming specialized complexes with discrete functions. In the unicellular parasite Trypanosoma brucei, which causes African sleeping sickness, TbISWI down-regulates RNA polymerase I (Pol I)-transcribed variant surface glycoprotein (VSG) gene expression sites (ESs), which are monoallelically expressed. Here, we use tandem affinity purification to determine the interacting partners of TbISWI. We identify three proteins that do not show significant homology with known ISWI-associated partners. Surprisingly, one of these is nucleoplasmin-like protein (NLP), which we had previously shown to play a role in ES control. In addition, we identify two novel ISWI partners, regulator of chromosome condensation 1-like protein (RCCP) and phenylalanine/tyrosine-rich protein (FYRP), both containing protein motifs typically found on chromatin proteins. Knockdown of RCCP or FYRP in bloodstream form T. brucei results in derepression of silent variant surface glycoprotein ESs, as had previously been shown for TbISWI and NLP. All four proteins are expressed and interact with each other in both major life cycle stages and show similar distributions at Pol I-transcribed loci. They are also found at Pol II strand switch regions as determined with ChIP. ISWI, NLP, RCCP, and FYRP therefore appear to form a single major ISWI complex in T. brucei (TbIC). This reduced complexity of ISWI regulation and the presence of novel ISWI partners highlights the early divergence of trypanosomes in evolution.	[Stanne, Tara; Narayanan, Mani Shankar; Ridewood, Sophie; Ling, Alexandra; Witmer, Kathrin; Kushwaha, Manish; Wiesler, Simone; Wood, Jennifer; Rudenko, Gloria] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London SW7 2AZ, England; [Wickstead, Bill] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England	Imperial College London; University of Nottingham	Rudenko, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	gloria.rudenko@imperial.ac.uk	Kushwaha, Manish/E-4901-2010	Kushwaha, Manish/0000-0002-8850-3272; Witmer, Kathrin/0000-0002-3159-7386; Ridewood, Sophie/0000-0002-1845-361X; Wickstead, Bill/0000-0002-4620-9091; Rudenko, Gloria/0000-0003-1884-4933	Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/J01477X/1] Funding Source: researchfish; BBSRC [BB/J01477X/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Anosova I, 2015, NUCLEIC ACIDS RES, V43, P5208, DOI 10.1093/nar/gkv365; Aydin OZ, 2014, CELL CYCLE, V13, P3016, DOI 10.4161/15384101.2014.956551; BANGS JD, 1993, J CELL SCI, V105, P1101; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Bartholomew B, 2014, CURR OPIN STRUC BIOL, V24, P150, DOI 10.1016/j.sbi.2014.01.010; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; BRUN R, 1979, ACTA TROP, V36, P289; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Cherry CM, 2010, CELL STEM CELL, V6, P557, DOI 10.1016/j.stem.2010.04.018; Chioda M, 2010, DEVELOPMENT, V137, P3513, DOI 10.1242/dev.048405; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Clayton CE, 2014, MOL BIOCHEM PARASIT, V195, P96, DOI 10.1016/j.molbiopara.2014.06.005; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003680; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Emelyanov AV, 2012, GENE DEV, V26, P603, DOI 10.1101/gad.180604.111; England JR, 2010, J MOL BIOL, V398, P518, DOI 10.1016/j.jmb.2010.03.037; Erdel F, 2011, FEBS J, V278, P3608, DOI 10.1111/j.1742-4658.2011.08282.x; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; Figueiredo LM, 2010, EUKARYOT CELL, V9, P148, DOI 10.1128/EC.00282-09; Figueiredo LM, 2009, NAT REV MICROBIOL, V7, P504, DOI 10.1038/nrmicro2149; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Garcia-Alai MM, 2010, PROTEIN SCI, V19, P1432, DOI 10.1002/pro.404; Glover L, 2013, CELL MICROBIOL, V15, P1984, DOI 10.1111/cmi.12215; Gunzl A, 2015, GENE, V556, P68, DOI 10.1016/j.gene.2014.09.047; Guetg C, 2010, EMBO J, V29, P2135, DOI 10.1038/emboj.2010.17; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Gunzl Arthur, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1919s55; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Hanai K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000011; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Hutchins JRA, 2004, CURR BIOL, V14, P1099, DOI 10.1016/j.cub.2004.05.021; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Klement K, 2014, J CELL BIOL, V207, P717, DOI 10.1083/jcb.201405077; Koster MJE, 2015, CELL, V161, P724, DOI 10.1016/j.cell.2015.04.033; Krajewski WA, 2013, BIOCHEMISTRY-US, V52, P6940, DOI 10.1021/bi400634r; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; Lange M, 2011, EPIGENOMICS-UK, V3, P567, DOI [10.2217/EPI.11.83, 10.2217/epi.11.83]; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Manelyte L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004157; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Narayanan MS, 2013, NUCLEIC ACIDS RES, V41, P2981, DOI 10.1093/nar/gks1469; Narayanan MS, 2011, NUCLEIC ACIDS RES, V39, P2018, DOI 10.1093/nar/gkq950; Narlikar GJ, 2010, CURR OPIN CHEM BIOL, V14, P660, DOI 10.1016/j.cbpa.2010.08.001; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Pepin D, 2007, TRENDS ENDOCRIN MET, V18, P215, DOI 10.1016/j.tem.2007.05.004; Petty E, 2013, TRENDS GENET, V29, P621, DOI 10.1016/j.tig.2013.06.006; Racki LR, 2008, CURR OPIN GENET DEV, V18, P137, DOI 10.1016/j.gde.2008.01.007; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; RUDENKO G, 1990, MOL CELL BIOL, V10, P3492, DOI 10.1128/MCB.10.7.3492; Rudenko G, 2010, ESSAYS BIOCHEM, V48, P201, DOI [10.1042/BSE0480201, 10.1042/bse0480201]; Sadeghifar F, 2015, NUCLEIC ACIDS RES, V43, P4477, DOI 10.1093/nar/gkv312; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Seki T, 1996, J BIOCHEM, V120, P207; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Sheader K, 2004, J BIOL CHEM, V279, P13363, DOI 10.1074/jbc.M312307200; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Stanne TM, 2011, EUKARYOT CELL, V10, P964, DOI 10.1128/EC.05048-11; Stanne TM, 2010, EUKARYOT CELL, V9, P136, DOI 10.1128/EC.00281-09; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Toto M, 2014, CHROMOSOMA, V123, P91, DOI 10.1007/s00412-013-0447-4; Vanolst L, 2005, DEVELOPMENT, V132, P4327, DOI 10.1242/dev.02014; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wright JR, 2010, MOL BIOCHEM PARASIT, V172, P141, DOI 10.1016/j.molbiopara.2010.03.013; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Yokoyama H, 2009, J CELL BIOL, V187, P813, DOI 10.1083/jcb.200906020; Zhu XY, 2012, GENOME, V55, P269, DOI [10.1139/G2012-012, 10.1139/g2012-012]	86	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26954	26967		10.1074/jbc.M115.679019	http://dx.doi.org/10.1074/jbc.M115.679019			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378228	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-26	WOS:000364794000007
J	Yin, Q; El-Ashram, S; Liu, HB; Sun, XM; Zhao, XM; Liu, XY; Suo, X				Yin, Qing; El-Ashram, Saeed; Liu, Hongbin; Sun, Ximeng; Zhao, Xinxin; Liu, Xianyong; Suo, Xun			Interferon-Gamma Release Assay: An Effective Tool to Detect Early Toxoplasma gondii Infection in Mice	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; IMMUNE-RESPONSE; TUBERCULOSIS; DIAGNOSIS; BLOOD; BRADYZOITES; KINETICS; VACCINE; MODEL	Early diagnosis of Toxoplasma gondii infection before the formation of tissue cysts is vital for treatment, as drugs available for toxoplasmosis cannot kill bradyzoites contained in the cysts. However, current methods, such as antibody-based ELISA, are ineffective for detection of early infection. Here, we developed an interferon-gamma release assay (IGRA), measuring the IFN-y released by T lymphocytes stimulated by Toxoplasma antigen peptides in vitro, for the detection of T. gondii infection in mice. Splenocytes isolated from infected mice were stimulated by peptides derived from dense granule proteins GRA4 and GRA6 and rhoptry protein ROP7, and released IFN-y was measured by ELISA. Results showed that both acute and chronic infection could be detected by IGRA. More importantly, IGRA detected infection as early as the third day post infection; while serum IgM and IgG were detected 9 days and 13 days post infection, respectively. Our findings demonstrated that an IGRA-positive and ELISA-negative sample revealed an early infection, indicating the combination of IGRA and ELISA can be employed for the early diagnosis of T. gondii infection in human beings, cats and livestock.	[Yin, Qing; El-Ashram, Saeed; Zhao, Xinxin; Liu, Xianyong; Suo, Xun] China Agr Univ, State Key Lab Agroboitechnol, Beijing 100193, Peoples R China; [Yin, Qing; El-Ashram, Saeed; Zhao, Xinxin; Liu, Xianyong; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100193, Peoples R China; [Yin, Qing; El-Ashram, Saeed; Zhao, Xinxin; Liu, Xianyong; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Liu, Hongbin] Hebei North Univ, Dept Pharmacol, Zhangjiakou 075000, Peoples R China; [Sun, Ximeng] Capital Med Univ, Dept Parasitol, Beijing 100069, Peoples R China; [Suo, Xun] Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100193, Peoples R China; [El-Ashram, Saeed] Kafr El Sheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt	China Agricultural University; China Agricultural University; China Agricultural University; Hebei North University; Capital Medical University; Ministry of Agriculture & Rural Affairs; Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Suo, X (corresponding author), China Agr Univ, State Key Lab Agroboitechnol, Beijing 100193, Peoples R China.	suoxun@cau.edu.cn	El-Ashram, Saeed/AAC-6060-2021; Sun, Ximeng/AAA-8449-2022	El-Ashram, Saeed/0000-0003-0389-1980; LIU, XIANYONG/0000-0001-9425-6784; Zhao, Xin-Xin/0000-0002-1901-1784	Special Fund for Agro-scientific Research in the Public Interest [201303042]; National Natural Science Foundation of China [31172309]; Special Cooperation Funds for Science and Technology of Hainan Province [KJHZ2015-31]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Cooperation Funds for Science and Technology of Hainan Province	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest (No. 201303042), the National Natural Science Foundation of China (No. 31172309), and the Special Cooperation Funds for Science and Technology of Hainan Province (No. KJHZ2015-31).	Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Chapey E, 2010, J CLIN MICROBIOL, V48, P41, DOI 10.1128/JCM.01903-09; CHARDES T, 1990, INFECT IMMUN, V58, P1240; Chirkova TV, 2011, CLIN VACCINE IMMUNOL, V18, P1710, DOI 10.1128/CVI.05116-11; Ciardelli L, 2008, PEDIATR INFECT DIS J, V27, P125, DOI 10.1097/INF.0b013e3181586052; Connell T, 2006, CLIN INFECT DIS, V42, pE82, DOI 10.1086/503910; Corbin GA, 2004, J IMMUNOL, V173, P5679, DOI 10.4049/jimmunol.173.9.5679; Galvan-Ramirez MD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-271; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; DEROUIN F, 1991, EXP PARASITOL, V73, P460, DOI 10.1016/0014-4894(91)90070-D; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Dubey JP, 1997, J EUKARYOT MICROBIOL, V44, P592, DOI 10.1111/j.1550-7408.1997.tb05965.x; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Gilbert R, 2009, MEM I OSWALDO CRUZ, V104, P305, DOI 10.1590/S0074-02762009000200026; John B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000505; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Lyons RE, 2002, TRENDS PARASITOL, V18, P198, DOI 10.1016/S1471-4922(02)02248-1; MCLEOD R, 1984, J INFECT DIS, V149, P234, DOI 10.1093/infdis/149.2.234; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pinon JM, 1996, J CLIN MICROBIOL, V34, P579, DOI 10.1128/JCM.34.3.579-583.1996; Remington JS, 2004, J CLIN MICROBIOL, V42, P941, DOI 10.1128/JCM.42.3.941-945.2004; Richeldi L, 2004, ANN INTERN MED, V140, P709, DOI 10.7326/0003-4819-140-9-200405040-00010; Simner PJ, 2014, J CLIN MICROBIOL, V52, P4414, DOI 10.1128/JCM.00967-14; Streeton JA, 1998, INT J TUBERC LUNG D, V2, P443; SUMYUEN MH, 1995, J PARASITOL, V81, P327, DOI 10.2307/3283948; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Unno A, 2010, BIOCHEM BIOPH RES CO, V391, P477, DOI 10.1016/j.bbrc.2009.11.083; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Yin Q, 2015, EXP PARASITOL; Zou J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-168	31	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137808	10.1371/journal.pone.0137808	http://dx.doi.org/10.1371/journal.pone.0137808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378802	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400028
J	Chen, W; He, SZ; Liu, DG; Patil, GB; Zhai, H; Wang, FB; Stephenson, TJ; Wang, YN; Wang, B; Valliyodan, B; Nguyen, HT; Liu, QC				Chen, Wei; He, Shaozhen; Liu, Degao; Patil, Gunvant B.; Zhai, Hong; Wang, Feibing; Stephenson, Troy J.; Wang, Yannan; Wang, Bing; Valliyodan, Babu; Nguyen, Henry T.; Liu, Qingchang			A Sweetpotato Geranylgeranyl Pyrophosphate Synthase Gene, IbGGPS, Increases Carotenoid Content and Enhances Osmotic Stress Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; PHYTOENE SYNTHASE; DOWN-REGULATION; SALT-STRESS; FUNCTIONAL-ANALYSIS; ENZYME-ACTIVITY; BETA-CAROTENE; EXPRESSION; CLONING; CDNA	Sweetpotato highly produces carotenoids in storage roots. In this study, a cDNA encoding geranylgeranyl phyrophosphate synthase (GGPS), named IbGGPS, was isolated from sweetpotato storage roots. Green fluorescent protein (GFP) was fused to the C-terminus of IbGGPS to obtain an IbGGPS-GFP fusion protein that was transiently expressed in both epidermal cells of onion and leaves of tobacco. Confocal microscopic analysis determined that the IbGGPS-GFP protein was localized to specific areas of the plasma membrane of onion and chloroplasts in tobacco leaves. The coding region of IbGGPS was cloned into a binary vector under the control of 35S promoter and then transformed into Arabidopsis thaliana to obtain transgenic plants. High performance liquid chromatography (HPLC) analysis showed a significant increase of total carotenoids in transgenic plants. The seeds of transgenic and wild-type plants were germinated on an agar medium supplemented with polyethylene glycol (PEG). Transgenic seedlings grew significantly longer roots than wildtype ones did. Further enzymatic analysis showed an increased activity of superoxide dismutase (SOD) in transgenic seedlings. In addition, the level of malondialdehyde (MDA) was reduced in transgenics. qRT-PCR analysis showed altered expressions of several genes involved in the carotenoid biosynthesis in transgenic plants. These data results indicate that IbGGPS is involved in the biosynthesis of carotenoids in sweetpotato storage roots and likely associated with tolerance to osmotic stress.	[Chen, Wei; He, Shaozhen; Liu, Degao; Zhai, Hong; Wang, Feibing; Wang, Yannan; Wang, Bing; Liu, Qingchang] China Agr Univ, Minist Educ, Lab Crop Heterosis & Utilizat, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China; [Patil, Gunvant B.; Stephenson, Troy J.; Valliyodan, Babu; Nguyen, Henry T.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Patil, Gunvant B.; Stephenson, Troy J.; Valliyodan, Babu; Nguyen, Henry T.] Univ Missouri, Natl Ctr Soybean Biotechnol, Columbia, MO USA	China Agricultural University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Liu, QC (corresponding author), China Agr Univ, Minist Educ, Lab Crop Heterosis & Utilizat, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China.	liuqc@cau.edu.cn	Liu, Degao/L-3682-2016; Patil, Gunvant/P-3500-2017	Liu, Degao/0000-0002-0090-9455; Patil, Gunvant/0000-0002-5420-9884; Valliyodan, Babu/0000-0001-9457-9508	China Agriculture Research System [CARS-11]; National High-Tech Research and Development Project of China [2011AA100607]; Beijing Food Crops Innovation Consortium program; Grants-in-Aid for Scientific Research [23659643, 23592747, 26461240, 26304008] Funding Source: KAKEN; EPSRC [EP/I019405/1] Funding Source: UKRI	China Agriculture Research System; National High-Tech Research and Development Project of China(National High Technology Research and Development Program of China); Beijing Food Crops Innovation Consortium program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by China Agriculture Research System Grant No. CARS-11 to QCL, the National High-Tech Research and Development Project of China (Grant No. 2011AA100607) to QCL and Beijing Food Crops Innovation Consortium program (http://219.232.192.143/bpm/main.jsp) to SZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament K, 2006, PLANTA, V224, P1197, DOI 10.1007/s00425-006-0301-5; Cao ZP, 2010, MOL BIOL REP, V37, P1089, DOI 10.1007/s11033-009-9848-0; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Chen W, 2013, J INTEGR AGR, V12, P589, DOI 10.1016/S2095-3119(13)60276-2; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fraser PD, 1999, PLANT MOL BIOL, V40, P687, DOI 10.1023/A:1006256302570; Fu GQ, 2011, PLANT PHYSIOL BIOCH, V49, P792, DOI 10.1016/j.plaphy.2011.01.018; Gao S, 2011, PLANT CELL TISS ORG, V107, P205, DOI 10.1007/s11240-011-9971-1; He SZ, 2009, PLANT CELL TISS ORG, V96, P69, DOI 10.1007/s11240-008-9461-2; Hefner J, 1998, ARCH BIOCHEM BIOPHYS, V360, P62, DOI 10.1006/abbi.1998.0926; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Jassbi AR, 2008, PLANT PHYSIOL, V146, P974, DOI 10.1104/pp.107.108811; Jiang T, 2013, SCI HORTIC-AMSTERDAM, V158, P22, DOI 10.1016/j.scienta.2013.04.027; JOLY A, 1993, J BIOL CHEM, V268, P26983; Kim M, 2010, PLANT CELL REP, V29, P1339, DOI 10.1007/s00299-010-0920-y; Kim SH, 2013, PHYSIOL PLANTARUM, V147, P432, DOI 10.1111/j.1399-3054.2012.01688.x; Kim SH, 2012, PHYTOCHEMISTRY, V74, P69, DOI 10.1016/j.phytochem.2011.11.003; KUNTZ M, 1992, PLANT J, V2, P25; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Lindgren LO, 2003, PLANT PHYSIOL, V132, P779, DOI 10.1104/pp.102.017053; Liu DG, 2014, PLANT CELL TISS ORG, V117, P1, DOI 10.1007/s11240-013-0415-y; MISAWA N, 1994, J BIOCHEM-TOKYO, V116, P980, DOI 10.1093/oxfordjournals.jbchem.a124656; Murashige T., 1962, PHYSIOL PLANTARUM, V15, P474, DOI [10.1111/j.1399-3054.1962.tb08052.x, DOI 10.1111/J.1399-3054.1962.TB08052.X]; Oh SK, 2000, J PLANT PHYSIOL, V157, P535, DOI 10.1016/S0176-1617(00)80109-1; Okada K, 2000, PLANT PHYSIOL, V122, P1045, DOI 10.1104/pp.122.4.1045; Singh M, 2003, PLANT CELL, V15, P874, DOI 10.1105/tpc.010249; Sitthithaworn W, 2001, CHEM PHARM BULL, V49, P197, DOI 10.1248/cpb.49.197; Takaya A, 2003, BBA-GENE STRUCT EXPR, V1625, P214, DOI 10.1016/S0167-4781(02)00602-4; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang YP, 2007, SCI HORTIC-AMSTERDAM, V111, P173, DOI 10.1016/j.scienta.2006.10.007; Xie YJ, 2012, J EXP BOT, V63, P3869, DOI [10.1093/jxb/ers078, 10.1093/jxb/ers201]; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yamamizo C, 2010, J EXP BOT, V61, P709, DOI 10.1093/jxb/erp335; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yu L, 2013, J INTEGR AGR, V12, P773, DOI 10.1016/S2095-3119(13)60299-3; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhu CF, 2002, PLANT MOL BIOL, V48, P277, DOI 10.1023/A:1013383120392; Zhu XF, 1997, PLANT MOL BIOL, V35, P331, DOI 10.1023/A:1005898805326	42	15	17	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137623	10.1371/journal.pone.0137623	http://dx.doi.org/10.1371/journal.pone.0137623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376432	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200045
J	Gonzalez-Bartulos, M; Aceves-Luquero, C; Qualai, J; Cusso, O; Martinez, MA; de Mattos, SF; Menendez, JA; Villalonga, P; Costas, M; Ribas, X; Massaguer, A				Gonzalez-Bartulos, Marta; Aceves-Luquero, Clara; Qualai, Jamal; Cusso, Olaf; Angeles Martinez, Ma; Fernandez de Mattos, Silvia; Menendez, Javier A.; Villalonga, Priam; Costas, Miquel; Ribas, Xavi; Massaguer, Anna			Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells	PLOS ONE			English	Article							DNA CLEAVAGE ACTIVITY; OXIDATIVE STRESS; ANTITUMOR-ACTIVITY; COPPER(II) COMPLEX; SELF-RENEWAL; CHELATORS; ANTICANCER; MECHANISMS; RESISTANCE; DOXORUBICIN	Differential redox homeostasis in normal and malignant cells suggests that pro-oxidant-induced upregulation of cellular reactive oxygen species (ROS) should selectively target cancer cells without compromising the viability of untransformed cells. Consequently, a pro-oxidant deviation well-tolerated by nonmalignant cells might rapidly reach a cell-death threshold in malignant cells already at a high setpoint of constitutive oxidative stress. To test this hypothesis, we took advantage of a selected number of amine-pyridine-based Fe (II) complexes that operate as efficient and robust oxidation catalysts of organic substrates upon reaction with peroxides. Five of these Fe(II)-complexes and the corresponding aminopyridine ligands were selected to evaluate their anticancer properties. We found that the iron complexes failed to display any relevant activity, while the corresponding ligands exhibited significant antiproliferative activity. Among the ligands, none of which were hemolytic, compounds 1, 2 and 5 were cytotoxic in the low micromolar range against a panel of molecularly diverse human cancer cell lines. Importantly, the cytotoxic activity profile of some compounds remained unaltered in epithelial-to-mesenchymal (EMT)-induced stable populations of cancer stem-like cells, which acquired resistance to the well-known ROS inducer doxorubicin. Compounds 1, 2 and 5 inhibited the clonogenicity of cancer cells and induced apoptotic cell death accompanied by caspase 3/7 activation. Flow cytometry analyses indicated that ligands were strong inducers of oxidative stress, leading to a 7-fold increase in intracellular ROS levels. ROS induction was associated with their ability to bind intracellular iron and generate active coordination complexes inside of cells. In contrast, extracellular complexation of iron inhibited the activity of the ligands. Iron complexes showed a high proficiency to cleave DNA through oxidative-dependent mechanisms, suggesting a likely mechanism of cytotoxicity. In summary, we report that, upon chelation of intracellular iron, the pro-oxidant activity of amine-pyrimidine-based iron complexes efficiently kills cancer and cancer stem-like cells, thus providing functional evidence for an efficient family of redox-directed anti-cancer metallodrugs.	[Gonzalez-Bartulos, Marta; Angeles Martinez, Ma; Massaguer, Anna] Univ Girona, Dept Biol, Girona, Catalunya, Spain; [Aceves-Luquero, Clara; Fernandez de Mattos, Silvia; Villalonga, Priam] Univ Illes Balears, Dept Biol Fonamental, Illes Balears, Spain; [Aceves-Luquero, Clara; Fernandez de Mattos, Silvia; Villalonga, Priam] Univ Illes Balears, Inst Univ Invest Ciencies Salut IUNICS, Illes Balears, Spain; [Qualai, Jamal; Cusso, Olaf; Angeles Martinez, Ma; Costas, Miquel; Ribas, Xavi] Univ Girona, Dept Chem, Girona, Catalunya, Spain; [Gonzalez-Bartulos, Marta; Cusso, Olaf; Costas, Miquel; Ribas, Xavi] Univ Girona, IQCC, Girona, Catalunya, Spain; [Menendez, Javier A.] ICO, Translat Res Lab, Girona, Catalunya, Spain; [Menendez, Javier A.] Girona Biomed Res Inst IDIBGI, Girona, Catalunya, Spain	Universitat de Girona; Universitat de les Illes Balears; Universitat de les Illes Balears; Universitat de Girona; Universitat de Girona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI)	Menendez, JA (corresponding author), ICO, Translat Res Lab, Girona, Catalunya, Spain.	jmenendez@idibgi.org; miquel.costas@udg.edu; xavi.ribas@udg.edu; anna.massaguer@udg.edu	Ribas, Xavi/F-3945-2014; Cussó, Olaf/N-3732-2015; martinez lorente, maria angeles/L-4592-2014; Villalonga, Priam/K-4350-2014; de Mattos, Silvia Fernández/K-5153-2014; MENENDEZ, JAVIER A/C-6148-2016; Ribas, Xavi/AAF-4082-2019; Costas, Miquel/H-6920-2012; Massaguer, Anna/L-5993-2014	Ribas, Xavi/0000-0002-2850-4409; Cussó, Olaf/0000-0001-6578-3163; martinez lorente, maria angeles/0000-0002-5696-551X; Villalonga, Priam/0000-0002-7190-6884; de Mattos, Silvia Fernández/0000-0003-4144-3687; MENENDEZ, JAVIER A/0000-0001-8733-4561; Ribas, Xavi/0000-0002-2850-4409; Costas, Miquel/0000-0001-6326-8299; Massaguer, Anna/0000-0003-1312-593X	Spanish Ministerio de Economia y Competitividad (MINECO) [CSD2010-00065]; Ministerio de Ciencia e Innovacion (MICINN) [SAF2012-38914]	Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (MINECO), CONSOLIDER-INGENIO 2010 CSD2010-00065, and from the Ministerio de Ciencia e Innovacion (MICINN), SAF2012-38914, Plan Nacional de I+D+I.	Alexandre J, 2006, INT J CANCER, V119, P41, DOI 10.1002/ijc.21685; AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Barragan F, 2012, BIOCONJUGATE CHEM, V23, P1838, DOI 10.1021/bc300173h; Borras J, 2007, EUR J INORG CHEM, P822, DOI 10.1002/ejic.200600821; Cabantchik ZI, 1996, ANAL BIOCHEM, V233, P221, DOI 10.1006/abio.1996.0032; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Canta M, 2014, ADV SYNTH CATAL, V356, P818, DOI 10.1002/adsc.201300923; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chiarugi P, 2012, INTERNATIONAL JOURNA; Chirino YI, 2009, EXP TOXICOL PATHOL, V61, P223, DOI 10.1016/j.etp.2008.09.003; Company A, 2007, J AM CHEM SOC, V129, P15766, DOI 10.1021/ja077761n; Company A, 2014, J AM CHEM SOC, V136, P4624, DOI 10.1021/ja412059c; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Costas M, 2002, ANGEW CHEM INT EDIT, V41, P2179, DOI 10.1002/1521-3773(20020617)41:12<2179::AID-ANIE2179>3.0.CO;2-F; Cusso O, 2013, J AM CHEM SOC, V135, P14871, DOI 10.1021/ja4078446; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Efferth T, 2005, DRUG RESIST UPDATE, V8, P85, DOI 10.1016/j.drup.2005.04.003; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fang J, 2007, J DRUG TARGET, V15, P475, DOI 10.1080/10611860701498286; Fatfat M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-527; Frau S, 1996, B SOC CHIM FR, V133, P1053; Garcia-Gimenez JL, 2007, INORG CHEM, V46, P7178, DOI 10.1021/ic700751j; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Jungwirth U, 2011, ANTIOXID REDOX SIGN, V15, P1085, DOI 10.1089/ars.2010.3663; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; KIM SK, 1993, FEBS LETT, V315, P61, DOI 10.1016/0014-5793(93)81133-K; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Laurent A, 2005, CANCER RES, V65, P948; Li Q, 2011, INORG CHEM, V50, P8318, DOI 10.1021/ic2008478; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liem Minh Phan, 2014, Cancer Biology Medicine, V11, P1, DOI 10.7497/j.issn.2095-3941.2014.01.001; Liu ZD, 2002, COORDIN CHEM REV, V232, P151, DOI 10.1016/S0010-8545(02)00050-4; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Garcia-Gimenez JL, 2009, J INORG BIOCHEM, V103, P923, DOI 10.1016/j.jinorgbio.2009.04.003; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manoury B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-11; Merlot AM, 2013, ANTIOXID REDOX SIGN, V18, P973, DOI 10.1089/ars.2012.4540; Mojzisova G, 2014, ACTA BIOCHIM POL, V61, P651, DOI 10.18388/abp.2014_1826; Montero AJ, 2012, BREAST CANCER RES TR, V132, P215, DOI 10.1007/s10549-011-1889-0; Montero AJ, 2011, DRUGS, V71, P1385, DOI 10.2165/11592590-000000000-00000; Nguyen LV, 2012, NATURE REV CANC; Oltra AM, 2001, FREE RADICAL BIO MED, V30, P1286, DOI 10.1016/S0891-5849(01)00521-4; Paris M, 1997, ALTERN MED REV, V2, P155; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Richardson DR, 2002, CRIT REV ONCOL HEMAT, V42, P267, DOI 10.1016/S1040-8428(01)00218-9; Shi XK, 2012, ANTIOXID REDOX SIGN, V16, P1215, DOI 10.1089/ars.2012.4529; Sun RWY, 2007, DALTON T, P4884, DOI 10.1039/b705079h; Thomas SR, 2011, EXPERT OPIN DRUG DIS, V6, P195, DOI 10.1517/17460441.2011.546395; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Townsend DM, 2008, CANCER RES, V68, P2870, DOI 10.1158/0008-5472.CAN-07-5957; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.50; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Wu J, 2010, INVEST NEW DRUG, V28, P670, DOI 10.1007/s10637-009-9286-9; Yu Y, 2012, CURR MED CHEM, V19, P2689, DOI 10.2174/092986712800609706; Zhang XS, 1997, FREE RADICAL BIO MED, V23, P980, DOI 10.1016/S0891-5849(97)00126-3; Zhou SY, 2001, TOXICOL LETT, V121, P151, DOI 10.1016/S0378-4274(01)00329-0	72	28	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137800	10.1371/journal.pone.0137800	http://dx.doi.org/10.1371/journal.pone.0137800			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368127	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100141
J	Hryckowian, AJ; Baisa, GA; Schwartz, KJ; Welch, RA				Hryckowian, Andrew J.; Baisa, Gary A.; Schwartz, Kevin J.; Welch, Rodney A.			dsdA Does Not Affect Colonization of the Murine Urinary Tract by Escherichia coli CFT073	PLOS ONE			English	Article							D-SERINE-DEAMINASE; STAPHYLOCOCCUS-SAPROPHYTICUS; PYRIDOXAL 5-PHOSPHATE; POSITIVE CONTROL; MUTANTS; GENES; DEHYDRATASE; ACTIVATOR; STRAINS; TRANSPORTER	The urinary tract environment provides many conditions that deter colonization by microorganisms. D-serine is thought to be one of these stressors and is present at high concentrations in urine. D-serine interferes with L-serine and pantothenate metabolism and is bacteriostatic to many species. Uropathogenic Escherichia coli commonly possess the dsdCXA genetic locus, which allows them to use D-serine as a sole carbon, nitrogen, and energy source. It was previously reported that in the model UPEC strain CFT073, a dsdA mutant outcompetes wild type in the murine model of urinary tract infection. This "hypercolonization" was used to propose a model whereby UPEC strains sense D-serine in the urinary tract and subsequently up-regulate genes necessary for pathogenesis. Here, we show that inactivation of dsdA does not lead to hypercolonization. We suggest that this previously observed effect is due to an unrecognized secondary mutation in rpoS and that some D-serine specific effects described in other studies may be affected by the rpoS status of the strains used. Inactivation of dsdA in the original clinical isolate of CFT073 gives CFT073 Delta dsdA a growth defect in human urine and renders it unable to grow on minimal medium containing D-serine as the sole carbon source. However, CFT073 Delta dsdA is able to colonize the urinary tracts of CBA/J mice indistinguishably from wild type. These findings indicate that D-serine catabolism, though it may play role(s) during urinary tract infection, does not affect the ability of uropathogenic E. coli to colonize the murine urinary tract.	[Hryckowian, Andrew J.; Baisa, Gary A.; Schwartz, Kevin J.; Welch, Rodney A.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Welch, RA (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	rawelch@wisc.edu			National Institutes of Health [R01DK063250]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (http://www.nih.gov/) Grant R01DK063250, awarded to RAW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Anfora AT, 2007, INFECT IMMUN, V75, P5298, DOI 10.1128/IAI.00652-07; Anfora AT, 2006, J BACTERIOL, V188, P6622, DOI 10.1128/JB.00634-06; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; Battaglioli EJ, 2011, APPL ENVIRON MICROB, V77, P6630, DOI 10.1128/AEM.05307-11; BLOOM FR, 1975, J BACTERIOL, V121, P1078, DOI 10.1128/JB.121.3.1078-1084.1975; BLOOM FR, 1975, J BACTERIOL, V121, P1092, DOI 10.1128/JB.121.3.1092-1101.1975; COSLOY SD, 1973, J BACTERIOL, V114, P679, DOI 10.1128/JB.114.2.679-684.1973; COSLOY SD, 1973, J BACTERIOL, V114, P685, DOI 10.1128/JB.114.2.685-694.1973; Danysz W, 1998, PHARMACOL REV, V50, P597; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DOWHAN W, 1970, J BIOL CHEM, V245, P4629; DUPOURQUE D, 1966, J BIOL CHEM, V241, P1233; FEDERIUK CS, 1983, J BIOL CHEM, V258, P5379; FEDERIUK CS, 1983, J BIOL CHEM, V258, P5372; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gunther NW, 2002, INFECT IMMUN, V70, P3344, DOI 10.1128/IAI.70.7.3344-3354.2002; Haugen BJ, 2007, INFECT IMMUN, V75, P278, DOI 10.1128/IAI.01319-06; HEINCZ MC, 1978, P NATL ACAD SCI USA, V75, P1695, DOI 10.1073/pnas.75.4.1695; HEINCZ MC, 1978, J BACTERIOL, V136, P96, DOI 10.1128/JB.136.1.96-103.1978; HENIKOFF S, 1988, P NATL ACAD SCI USA, V85, P6602, DOI 10.1073/pnas.85.18.6602; Hryckowian AJ, 2014, MBIO, V5, DOI [10.1128/mBio.01043-14, DOI 10.1128/MBI0.01043-14]; Hryckowian AJ, 2013, MBIO, V4, DOI 10.1128/mBio.00023-13; Huang Y, 1998, BIOL PHARM BULL, V21, P156, DOI 10.1248/bpb.21.156; Korte-Berwanger M, 2013, INFECT IMMUN, V81, P4525, DOI 10.1128/IAI.00599-13; Kucheria R, 2005, POSTGRAD MED J, V81, P83, DOI 10.1136/pgmj.2004.023036; KUMASHIRO S, 1995, BRAIN RES, V681, P117, DOI 10.1016/0006-8993(95)00307-C; LABOW R, 1966, J BIOL CHEM, V241, P1239; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; MCFALL E, 1983, J BACTERIOL, V153, P872, DOI 10.1128/JB.153.2.872-877.1983; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; MOBLEY HLT, 1993, MOL MICROBIOL, V10, P143, DOI 10.1111/j.1365-2958.1993.tb00911.x; Moritz RL, 2006, J CLIN MICROBIOL, V44, P4038, DOI 10.1128/JCM.01172-06; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; O'Hanley P., 1996, URINARY TRACT INFECT; Patzold R, 2005, BIOMED CHROMATOGR, V19, P466, DOI 10.1002/bmc.515; Peekhaus N, 1997, FEMS MICROBIOL LETT, V147, P233, DOI 10.1111/j.1574-6968.1997.tb10247.x; Putnam D. F., 1971, COMPOSITION CONCENTR; Redford P, 2006, INFECT IMMUN, V74, P4030, DOI 10.1128/IAI.01984-05; Roesch PL, 2003, MOL MICROBIOL, V49, P54, DOI 10.1046/j.1365-2958.2003.03543.x; Sakinc T, 2005, INFECT IMMUN, V73, P6419, DOI 10.1128/IAI.73.10.6419-6428.2005; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Snyder E, 2012, G3-GENES GENOM GENET, V2, P1341, DOI 10.1534/g3.112.003855; Spira B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-248; SU HS, 1991, J BACTERIOL, V173, P2473, DOI 10.1128/jb.173.8.2473-2480.1991; WARGEL RJ, 1970, J BACTERIOL, V103, P778, DOI 10.1128/JB.103.3.778-788.1970; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138121	10.1371/journal.pone.0138121	http://dx.doi.org/10.1371/journal.pone.0138121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366567	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100230
J	Hui, S; Levy, AS; Slack, DL; Burnstein, MJ; Errett, L; Bonneau, D; Latter, D; Rotstein, OD; Bolz, SS; Lidington, D; Voigtlaender-Bolz, J				Hui, Sonya; Levy, Andrew S.; Slack, Daniel L.; Burnstein, Marcus J.; Errett, Lee; Bonneau, Daniel; Latter, David; Rotstein, Ori D.; Bolz, Steffen-Sebastian; Lidington, Darcy; Voigtlaender-Bolz, Julia			Sphingosine-1-Phosphate Signaling Regulates Myogenic Responsiveness in Human Resistance Arteries	PLOS ONE			English	Article							RECEPTOR-NULL MICE; HEART-FAILURE; BLOOD-FLOW; SPHINGOSINE 1-PHOSPHATE; CEREBRAL-ARTERIES; CORONARY-ARTERIES; EXERCISE; MODEL; TONE; VASOCONSTRICTION	We recently identified sphingosine-1-phosphate (S1P) signaling and the cystic fibrosis transmembrane conductance regulator (CFTR) as prominent regulators of myogenic responsiveness in rodent resistance arteries. However, since rodent models frequently exhibit limitations with respect to human applicability, translation is necessary to validate the relevance of this signaling network for clinical application. We therefore investigated the significance of these regulatory elements in human mesenteric and skeletal muscle resistance arteries. Mesenteric and skeletal muscle resistance arteries were isolated from patient tissue specimens collected during colonic or cardiac bypass surgery. Pressure myography assessments confirmed endothelial integrity, as well as stable phenylephrine and myogenic responses. Both human mesenteric and skeletal muscle resistance arteries (i) express critical S1P signaling elements, (ii) constrict in response to S1P and (iii) lose myogenic responsiveness following S1P receptor antagonism (JTE013). However, while human mesenteric arteries express CFTR, human skeletal muscle resistance arteries do not express detectable levels of CFTR protein. Consequently, modulating CFTR activity enhances myogenic responsiveness only in human mesenteric resistance arteries. We conclude that human mesenteric and skeletal muscle resistance arteries are a reliable and consistent model for translational studies. We demonstrate that the core elements of an S1P-dependent signaling network translate to human mesenteric resistance arteries. Clear species and vascular bed variations are evident, reinforcing the critical need for further translational study.	[Hui, Sonya; Levy, Andrew S.; Bolz, Steffen-Sebastian; Lidington, Darcy; Voigtlaender-Bolz, Julia] Univ Toronto, Toronto Ctr Microvasc Med, Toronto, ON, Canada; [Hui, Sonya; Levy, Andrew S.; Bolz, Steffen-Sebastian; Lidington, Darcy; Voigtlaender-Bolz, Julia] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Hui, Sonya; Levy, Andrew S.; Burnstein, Marcus J.; Errett, Lee; Bonneau, Daniel; Latter, David; Rotstein, Ori D.; Bolz, Steffen-Sebastian; Lidington, Darcy; Voigtlaender-Bolz, Julia] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Hui, Sonya; Levy, Andrew S.; Slack, Daniel L.; Bolz, Steffen-Sebastian; Lidington, Darcy; Voigtlaender-Bolz, Julia] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Burnstein, Marcus J.; Errett, Lee; Bonneau, Daniel; Latter, David; Rotstein, Ori D.] St Michaels Hosp, Dept Surg, Toronto, ON M5B 1W8, Canada; [Burnstein, Marcus J.; Errett, Lee; Bonneau, Daniel; Latter, David; Rotstein, Ori D.; Voigtlaender-Bolz, Julia] Univ Toronto, Toronto, ON, Canada; [Bolz, Steffen-Sebastian] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada; [Voigtlaender-Bolz, Julia] St Michaels Hosp, Dept Anaesthesia, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Bolz, SS (corresponding author), Univ Toronto, Toronto Ctr Microvasc Med, Toronto, ON, Canada.	sts.bolz@utoronto.ca		Lidington, Darcy/0000-0001-7582-7924	Canadian Institutes of Health Research [FRN-119345, FRN-37779]; Heart and Stoke Foundation of Canada [NI6581, CI7432]; Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research; St. Michael's Hospital; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research in association with Hypertension Canada [DHY-121263]; University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stoke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research; St. Michael's Hospital(University of Toronto); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Institutes of Health Research in association with Hypertension Canada; University of Toronto(University of Toronto)	Operating Funding: Canadian Institutes of Health Research (FRN-119345 to SSB; FRN-37779 to ODR), Heart and Stoke Foundation of Canada (NI6581 and CI7432 to SSB), seed funding for the Toronto Centre for Microvascular Medicine from the Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research and St. Michael's Hospital (SSB and JVB), Ontario Ministry of Research and Innovation Postdoctoral Fellow Scholarship Program (AL), a Doctoral Research Award from the Canadian Institutes of Health Research in association with Hypertension Canada (DHY-121263 to SH) and Start-Up funding from the University of Toronto (SSB). The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the publication.	Adada M, 2013, FEBS J, V280, P6354, DOI 10.1111/febs.12446; Bidani AK, 2009, HYPERTENSION, V54, P393, DOI 10.1161/HYPERTENSIONAHA.109.133777; Braun OO, 2009, J AM COLL CARDIOL, V54, P1146, DOI 10.1016/j.jacc.2009.06.019; Chadha PS, 2011, J PHARMACOL EXP THER, V336, P701, DOI 10.1124/jpet.110.165795; Gunther A, 2010, LAB CHIP, V10, P2341, DOI 10.1039/c004675b; Hoefer J, 2010, CIRC RES, V107, P923, DOI 10.1161/CIRCRESAHA.110.226464; Jensen BC, 2009, J AM COLL CARDIOL, V54, P1137, DOI 10.1016/j.jacc.2009.05.056; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Just A, 2007, AM J PHYSIOL-REG I, V292, pR1, DOI 10.1152/ajpregu.00332.2006; Keller M, 2006, FASEB J, V20, P702, DOI 10.1096/fj.05-4075fje; Kono M, 2007, J BIOL CHEM, V282, P10690, DOI 10.1074/jbc.M700370200; Lidington D, 2013, CARDIOVASC RES, V97, P404, DOI 10.1093/cvr/cvs345; Lidington D, 2009, ARTERIOSCL THROM VAS, V29, P1916, DOI 10.1161/ATVBAHA.109.194803; Magosso E, 2002, MED BIOL ENG COMPUT, V40, P660, DOI 10.1007/BF02345305; Malik FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130313; Mann DL, 2012, CIRCULATION, V125, P2692, DOI 10.1161/CIRCULATIONAHA.112.107797; Meissner A, 2012, CIRCULATION, V125, P2739, DOI 10.1161/CIRCULATIONAHA.111.047316; METTING PJ, 1989, AM J PHYSIOL, V256, pR98, DOI 10.1152/ajpregu.1989.256.1.R98; METTING PJ, 1989, J CLIN INVEST, V84, P1900, DOI 10.1172/JCI114377; Moien-Afshari F, 2004, CAN J PHYSIOL PHARM, V82, P840, DOI 10.1139/Y04-100; Paulson O. B., 1990, BRAIN METAB REV, V2, P161; PAWELCZYK JA, 1992, J APPL PHYSIOL, V73, P1838, DOI 10.1152/jappl.1992.73.5.1838; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Scherer EQ, 2010, STROKE, V41, P2618, DOI 10.1161/STROKEAHA.110.593327; SULLIVAN MJ, 1989, CIRCULATION, V80, P769, DOI 10.1161/01.CIR.80.4.769; The Criteria Committee of the New York Heart Association, 1994, NOM CRIT DIAGN DIS H; Yagi K, 2015, STROKE, V46, P2260, DOI 10.1161/STROKEAHA.114.006365; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Yang JL, 2012, CIRCULATION, V126, P196, DOI 10.1161/CIRCULATIONAHA.111.039644	30	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138142	10.1371/journal.pone.0138142	http://dx.doi.org/10.1371/journal.pone.0138142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367262	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100235
J	Marchal, PO; Kavvadas, P; Abed, A; Kazazian, C; Authier, F; Koseki, H; Hiraoka, S; Boffa, JJ; Martinerie, C; Chadjichristos, CE				Marchal, Pierre-Olivier; Kavvadas, Panagiotis; Abed, Ahmed; Kazazian, Chantal; Authier, Florence; Koseki, Haruhiko; Hiraoka, Shuichi; Boffa, Jean-Jacques; Martinerie, Cecile; Chadjichristos, Christos E.			Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice	PLOS ONE			English	Article							DOMAIN RECEPTOR 1; HUMAN NOV; URETERAL OBSTRUCTION; WILMS-TUMORS; CCN3 NOV; MODEL; GENE; GLOMERULONEPHRITIS; QUANTIFICATION; REGULATOR	The main hallmark of chronic kidney disease (CKD) is excessive inflammation leading to interstitial tissue fibrosis. It has been recently reported that NOV/CCN3 could be involved in kidney damage but its role in the progression of nephropathies is poorly known. NOV/CCN3 is a secreted multifunctional protein belonging to the CCN family involved in different physiological and pathological processes such as angiogenesis, inflammation and cancers. The purpose of our study was to determine the role of NOV/CCN3 in renal inflammation and fibrosis related to primitive tubulointerstitial injury. After unilateral ureteral obstruction (UUO), renal histology and real-time PCR were performed in NOV/CCN3-/- and wild type mice. NOV/CCN3 mRNA expression was increased in the obstructed kidneys in the early stages of the obstructive nephropathy. Interestingly, plasmatic levels of NOV/CCN3 were strongly induced after 7 days of UUO and the injection of recombinant NOV/CCN3 protein in healthy mice significantly increased CCL2 mRNA levels. Furthermore, after 7 days of UUO NOV/CCN3-/- mice displayed reduced proinflammatory cytokines and adhesion markers expression leading to restricted accumulation of interstitial monocytes, in comparison with their wild type littermates. Consequently, in NOV/CCN3-/- mice interstitial renal fibrosis was blunted after 15 days of UUO. In agreement with our experimental data, NOV/CCN3 expression was highly increased in biopsies of patients with tubulointerstitial nephritis. Thus, the inhibition of NOV/CCN3 may represent a novel target for the progression of renal diseases.	[Marchal, Pierre-Olivier; Kazazian, Chantal; Martinerie, Cecile] Hop St Antoine, INSERM, UMR S938, Ctr Rech St Antoine, F-75571 Paris, France; [Marchal, Pierre-Olivier; Kavvadas, Panagiotis; Abed, Ahmed; Authier, Florence; Boffa, Jean-Jacques; Chadjichristos, Christos E.] Tenon Hosp, INSERM, UMR S1155, Paris, France; [Marchal, Pierre-Olivier; Abed, Ahmed; Martinerie, Cecile; Chadjichristos, Christos E.] Univ Paris 06, Sorbonne Univ, Paris, France; [Koseki, Haruhiko] RIKEN, Yokohama Inst, RCAI, Yokohama, Kanagawa, Japan; [Hiraoka, Shuichi] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 658, Japan; [Boffa, Jean-Jacques] Tenon Hosp, Dept Nephrol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; RIKEN; Kobe Pharmaceutical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Chadjichristos, CE (corresponding author), Tenon Hosp, INSERM, UMR S1155, Paris, France.	christos.chadjichristos@upmc.fr	Koseki, Haruhiko/I-3825-2014; Chadjichristos, Christos E/J-4871-2016	Koseki, Haruhiko/0000-0001-8424-5854; Chadjichristos, Christos E/0000-0001-6657-7900	INSERM and the University Paris VI	INSERM and the University Paris VI	Support for this study was provided by the INSERM and the University Paris VI (CM, CEC). POM is a doctoral fellow of the French Ministry of Education. AA is a doctoral fellow of a UPMC Univ Paris 6- Palestinian Universities cooperation program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed A, 2014, KIDNEY INT, V86, P768, DOI 10.1038/ki.2014.108; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Borkham-Kamphorst E, 2012, LIVER INT, V32, P1342, DOI 10.1111/j.1478-3231.2012.02837.x; Calhabeua F, 2006, EXP CELL RES, V312, P1876, DOI 10.1016/j.yexcr.2006.02.027; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chevalier G, 1998, AM J PATHOL, V152, P1563; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; DIAMOND JR, 1994, AM J PHYSIOL, V266, pF926, DOI 10.1152/ajprenal.1994.266.6.F926; Doghman M, 2007, J CLIN ENDOCR METAB, V92, P3253, DOI 10.1210/jc.2007-0342; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Esteban V, 2003, KIDNEY INT, V64, pS33, DOI 10.1046/j.1523-1755.64.s86.7.x; Guerrot D, 2011, AM J PATHOL, V179, P83, DOI 10.1016/j.ajpath.2011.03.023; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kerroch M, 2012, FASEB J, V26, P4079, DOI 10.1096/fj.11-194902; Kocialkowski S, 2001, ANAT EMBRYOL, V203, P417, DOI 10.1007/s004290100177; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Lafont J, 2005, CELL COMMUN ADHES, V12, P41, DOI 10.1080/15419060500383069; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Le Dreau G, 2010, GLIA, V58, P1510, DOI 10.1002/glia.21025; Le Dreau G, 2010, MOL CELL NEUROSCI, V43, P60, DOI 10.1016/j.mcn.2009.02.011; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Lin ZY, 2010, J CELL COMMUN SIGNAL, V4, P141, DOI 10.1007/s12079-010-0095-x; MARTINERIE C, 1994, ONCOGENE, V9, P2729; Misseri Rosalia, 2005, Curr Urol Rep, V6, P140, DOI 10.1007/s11934-005-0083-5; Niu ZH, 2005, J UROLOGY, V174, P1460, DOI 10.1097/01.ju.0000173008.73741.80; Pakradouni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066788; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Silverstein DM, 2003, KIDNEY INT, V64, P25, DOI 10.1046/j.1523-1755.2003.00067.x; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; van Roeyen CRC, 2012, AM J PATHOL, V180, P1979, DOI 10.1016/j.ajpath.2012.01.031	33	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137876	10.1371/journal.pone.0137876	http://dx.doi.org/10.1371/journal.pone.0137876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367310	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100165
J	Sun, BF; Wang, QQ; Yu, ZJ; Yu, Y; Xiao, CL; Kang, CS; Ge, G; Yan, LH; Zhu, JD; Li, YM; Li, QM; Luo, SP; Yang, D; Li, L; Zhang, WY; Tian, G				Sun, Bao-Fei; Wang, Qing-Qing; Yu, Zi-Jiang; Yu, Yan; Xiao, Chao-Lun; Kang, Chao-Sheng; Ge, Guo; Yan Linghu; Zhu, Jun-De; Li, Yu-Mei; Li, Qiang-Ming; Luo, Shi-Peng; Yang, Dang; Li, Lin; Zhang, Wen-Yan; Tian, Guang			Exercise Prevents Memory Impairment Induced by Arsenic Exposure in Mice: Implication of Hippocampal BDNF and CREB	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; SPATIAL MEMORY; SYNAPTIC-PLASTICITY; NEUROTROPHIC FACTOR; DIETARY RESTRICTION; VOLUNTARY EXERCISE; PROTEIN-SYNTHESIS; GENE-EXPRESSION; RAT; PERFORMANCE	High concentrations of arsenic, which can be occasionally found in drinking water, have been recognized as a global health problem. Exposure to arsenic can disrupt spatial memory; however, the underlying mechanism remains unclear. In the present study, we tested whether exercise could interfere with the effect of arsenic exposure on the long-term memory (LTM) of object recognition in mice. Arsenic (0, 1, 3, and 10 mg/ kg, i.g.) was administered daily for 12 weeks. We found that arsenic at dosages of 1, 3, and 10 mg/kg decreased body weight and increased the arsenic content in the brain. The object recognition LTM (tested 24 h after training) was disrupted by 3 mg/ kg and 10 mg/ kg, but not 1 mg/ kg arsenic exposure. Swimming exercise also prevented LTM impairment induced by 3 mg/kg, but not with 10 mg/ kg, of arsenic exposure. The expression of brain-derived neurotrophic factor (BDNF) and phosphorylated cAMP-response element binding protein (pCREB) in the CA1 and dentate gyrus areas (DG) of the dorsal hippocampus were decreased by 3 mg/ kg and 10 mg/ kg, but not by 1 mg/ kg, of arsenic exposure. The decrease in BDNF and pCREB in the CA1 and DG induced by 3 mg/ kg, but not 10 mg/ kg, of arsenic exposure were prevented by swimming exercise. Arsenic exposure did not affect the total CREB expression in the CA1 or DG. Taken together, these results indicated that swimming exercise prevented the impairment of object recognition LTM induced by arsenic exposure, which may be mediated by BDNF and CREB in the dorsal hippocampus.	[Sun, Bao-Fei; Yu, Zi-Jiang; Yu, Yan; Xiao, Chao-Lun; Kang, Chao-Sheng; Ge, Guo; Yan Linghu; Zhu, Jun-De; Li, Yu-Mei; Li, Qiang-Ming; Luo, Shi-Peng; Yang, Dang; Li, Lin; Zhang, Wen-Yan; Tian, Guang] Guiyang Med Univ, Dept Anat, Guiyang 550004, Peoples R China; [Wang, Qing-Qing] Guiyang Med Univ, Affiliated Hosp, Dept Hosp Infect Management, Guiyang 550004, Peoples R China	Guizhou Medical University; Guizhou Medical University	Yu, ZJ (corresponding author), Guiyang Med Univ, Dept Anat, Guiyang 550004, Peoples R China.	yzj0112@126.com			Natural Science Foundation of China [3066018, 81060108]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Natural Science Foundation of China (no. 3066018 and 81060108), (URL: http://www.nsfc.gov.cn/). The funder supported the whole study, including study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adetutu A, 2013, PHARMACOGN RES, V5, P207, DOI 10.4103/0974-8490.112431; Alomari MA, 2013, BEHAV BRAIN RES, V247, P34, DOI 10.1016/j.bbr.2013.03.007; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Asl Naser Ahmadi, 2008, Pathophysiology, V15, P9, DOI 10.1016/j.pathophys.2007.10.002; Bardullas U, 2009, TOXICOL APPL PHARM, V239, P169, DOI 10.1016/j.taap.2008.12.004; Bechara RG, 2014, BEHAV BRAIN RES, V275, P297, DOI 10.1016/j.bbr.2013.11.015; Bechara RG, 2013, BEHAV BRAIN RES; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Calderon J, 2001, ENVIRON RES, V85, P69, DOI 10.1006/enrs.2000.4106; Chou CT, 2013, AMINO ACIDS, V45, P811, DOI 10.1007/s00726-013-1524-y; Costa MS, 2008, NEUROCHEM INT, V53, P89, DOI 10.1016/j.neuint.2008.06.006; Das AK, 2010, ENVIRON TOXICOL PHAR, V29, P64, DOI 10.1016/j.etap.2009.10.002; Dhar P, 2005, NEUROTOXICOLOGY, V26, P309, DOI 10.1016/j.neuro.2004.10.005; DIESFELDT H F A, 1977, Age and Ageing, V6, P58, DOI 10.1093/ageing/6.1.58; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Dutta M, 2014, FOOD CHEM TOXICOL, V66, P262, DOI 10.1016/j.fct.2014.01.050; Goes ATR, 2014, NEUROSCIENCE, V256, P61, DOI 10.1016/j.neuroscience.2013.09.042; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Gora Ravuri Halley, 2014, Toxicol Int, V21, P78, DOI 10.4103/0971-6580.128807; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hemalatha Pudari, 2013, J Nat Sci Biol Med, V4, P393, DOI 10.4103/0976-9668.116986; Hoveida R, 2011, BEHAV BRAIN RES, V216, P270, DOI 10.1016/j.bbr.2010.08.003; Huo TG, 2014, MOL NEUROBIOL; ITOH T, 1990, TOXICOL LETT, V54, P345; Jiang SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096041; Jing JF, 2012, NEUROTOXICOLOGY, V33, P1230, DOI 10.1016/j.neuro.2012.07.003; Khabour OF, 2013, BRAIN RES BULL, V90, P19, DOI 10.1016/j.brainresbull.2012.08.005; Khabour OF, 2010, HIPPOCAMPUS, V20, P637, DOI 10.1002/hipo.20657; Kim YM, 2013, J EXERC REHABIL, V9, P243, DOI 10.12965/jer.130006; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Lee MC, 2012, J APPL PHYSIOL, V113, P1260, DOI 10.1152/japplphysiol.00869.2012; Luo CX, 2007, J NEUROSCI RES, V85, P1637, DOI 10.1002/jnr.21317; Luo JH, 2012, TOXICOL LETT, V211, P39, DOI 10.1016/j.toxlet.2012.02.021; Luo JH, 2009, TOXICOL LETT, V184, P121, DOI 10.1016/j.toxlet.2008.10.029; Nasehi M, 2014, PHYSIOL BEHAV, V128, P237, DOI 10.1016/j.physbeh.2014.02.011; Noble EE, 2014, NEUROBIOL LEARN MEM, V114, P40, DOI 10.1016/j.nlm.2014.04.006; Owumi SE, 2013, PHARMACOGN RES, V5, P183, DOI 10.4103/0974-8490.112425; Pal S, 2006, DRUG CHEM TOXICOL, V29, P423, DOI 10.1080/01480540600837993; PETRES J, 1977, ENVIRON HEALTH PERSP, V19, P223, DOI 10.2307/3428480; Rahn EJ, 2013, NEUROBIOL LEARN MEM, V105, P133, DOI 10.1016/j.nlm.2013.06.008; Rizwan S, 2014, FOOD CHEM TOXICOL, V68, P99, DOI 10.1016/j.fct.2014.03.011; Rodriguez VM, 2003, TOXICOL LETT, V145, P1, DOI 10.1016/S0378-4274(03)00262-5; Rodriguez VM, 2001, BRAIN RES BULL, V55, P301, DOI 10.1016/S0361-9230(01)00477-4; Rosado JL, 2007, ENVIRON HEALTH PERSP, V115, P1371, DOI 10.1289/ehp.9961; Saadati Hakimeh, 2010, Asian J Sports Med, V1, P137; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; SAMORAJSKI T, 1985, NEUROBIOL AGING, V6, P17, DOI 10.1016/0197-4580(85)90066-1; Tandon Neeraj, 2012, Toxicol Int, V19, P245, DOI 10.4103/0971-6580.103658; Tsai SY, 2003, NEUROTOXICOLOGY, V24, P747, DOI 10.1016/S0161-813X(03)00029-9; Tyler Christina R, 2014, Curr Environ Health Rep, V1, P132; Uygur R, 2013, TOXICOL IND HLTH; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Xi SH, 2009, ARCH TOXICOL, V83, P549, DOI 10.1007/s00204-009-0403-5; Xu Z, 2013, FOOD CHEM TOXICOL, V58, P1, DOI 10.1016/j.fct.2013.03.048; Yadav RS, 2011, NEUROTOXICOLOGY, V32, P760, DOI 10.1016/j.neuro.2011.07.004; Yadav RS, 2010, NEUROTOXICOLOGY, V31, P533, DOI 10.1016/j.neuro.2010.05.001; Yadav RS, 2009, TOXICOL APPL PHARM, V240, P367, DOI 10.1016/j.taap.2009.07.017; Yau SY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/403120	60	23	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137810	10.1371/journal.pone.0137810	http://dx.doi.org/10.1371/journal.pone.0137810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368803	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100144
J	Schnerch, D; Nigg, EA				Schnerch, D.; Nigg, E. A.			Structural centrosome aberrations favor proliferation by abrogating microtubule-dependent tissue integrity of breast epithelial mammospheres	ONCOGENE			English	Article							PROMOTES MAMMARY TUMORIGENESIS; NINEIN-LIKE PROTEIN; CELL POLARITY; CENTRIOLE BIOGENESIS; CANCER; NLP; ORGANIZATION; DUPLICATION; EXPRESSION; CARCINOMA	Structural centrosome aberrations are frequently observed in early stage carcinomas, but their role in malignant transformation is poorly understood. Here, we examined the impact of overexpression of Ninein-like protein (Nlp) on the architecture of polarized epithelia in three-dimensional mammospheres. When Nlp was overexpressed to levels resembling those seen in human tumors, it formed striking centrosome-related bodies (CRBs), which sequestered Ninein and affected the kinetics of microtubule (MT) nucleation and release. In turn, the profound reorganization of the MT cytoskeleton resulted in mislocalization of several adhesion and junction proteins as well as the tumor suppressor Scribble, resulting in the disruption of epithelial polarity, cell-cell interactions and mammosphere architecture. Remarkably, cells harboring Nlp-CRBs displayed an enhanced proliferative response to epidermal growth factor. These results demonstrate that structural centrosome aberrations cause not only the disruption of epithelial polarity but also favor overproliferation, two phenotypes typically associated with human carcinomas.	[Schnerch, D.; Nigg, E. A.] Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	University of Basel	Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	erich.nigg@unibas.ch		nigg, erich/0000-0003-4835-5719	University of Basel; Swiss National Science Foundation [310030B_149641]; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	We thank Tilman Brummer (University of Freiburg), Stefan Zimmermann and Ralph Wasch (University Medical Center Freiburg) as well as Heike Brinkhaus and Mohamed Bentires-Alj (FMI Basel) for cell lines and technical advice, and Cheuk Leung (University of Minnesota) as well as Yi-Ren Hong (Kaohsiung Medical University, Taiwan) for viral vectors. We also thank Alexia Loynton-Ferrand and other members of the Imaging Core Facility (IMCF) for help and Elena Nigg-Martignoni for technical assistance. Finally, we are grateful to Felix B. Engel and the 'Emerging fields Initiative' (EFI) for 'Cell Cycle in Disease and Regeneration (CYDER)' from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) for constructive comments and support, as well as to all members of the Nigg lab for helpful discussions. This work was supported by the University of Basel and the Swiss National Science Foundation (310030B_149641).	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Brito DA, 2012, CURR OPIN CELL BIOL, V24, P4, DOI 10.1016/j.ceb.2012.01.003; Carraway Coralie A Carothers, 2007, Sci STKE, V2007, pre3, DOI 10.1126/stke.3812007re3; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Feigin ME, 2014, CANCER RES, V74, P3180, DOI 10.1158/0008-5472.CAN-13-3415; Fogeron ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2517; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Fujita Y, 2011, CANCER SCI, V102, P1749, DOI 10.1111/j.1349-7006.2011.02011.x; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Guo HQ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1752; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hernandez P, 2010, DIS MODEL MECH, V3, P304, DOI 10.1242/dmm.004507; Hogan C, 2012, CELL MOL LIFE SCI, V69, P203, DOI 10.1007/s00018-011-0806-3; Hotta A, 2010, J CELL BIOL, V189, P901, DOI 10.1083/jcb.200910095; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang F, 2003, INT J CANCER, V106, P661, DOI 10.1002/ijc.11251; Kayser G, 2005, VIRCHOWS ARCH, V447, P61, DOI 10.1007/s00428-004-1191-1; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kronenwett U, 2005, BRIT J CANCER, V92, P389, DOI 10.1038/sj.bjc.6602246; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Li J, 2011, BRIT J CANCER, V104, P1523, DOI 10.1038/bjc.2011.130; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mogensen MM, 2000, J CELL SCI, V113, P3013; MOGENSEN MM, 2004, CENTROSOMES DEV DIS, P299; Moss DK, 2007, J CELL SCI, V120, P3064, DOI 10.1242/jcs.010322; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; NATALI PG, 1992, BRIT J CANCER, V66, P318, DOI 10.1038/bjc.1992.263; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Partanen JI, 2007, P NATL ACAD SCI USA, V104, P14694, DOI 10.1073/pnas.0704677104; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pihan GA, 2003, CANCER RES, V63, P1398; Qu D, 2008, GYNECOL ONCOL, V110, P230, DOI 10.1016/j.ygyno.2008.04.015; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Salisbury JL, 1999, J HISTOCHEM CYTOCHEM, V47, P1265, DOI 10.1177/002215549904701006; Sato N, 1999, CLIN CANCER RES, V5, P963; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Segat D, 2010, HISTOL HISTOPATHOL, V25, P551, DOI 10.14670/HH-25.551; Shao SJ, 2010, J CLIN INVEST, V120, P498, DOI 10.1172/JCI39447; Simpson DR, 2011, CANCER RES, V71, P3822, DOI 10.1158/0008-5472.CAN-10-3782; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Wang Y, 2007, J BIOL CHEM, V282, P17712, DOI 10.1074/jbc.M701350200; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X; Yamauchi H, 2012, CELL RES, V22, P1527, DOI 10.1038/cr.2012.69; Yan J, 2010, J BIOL CHEM, V285, P40230, DOI 10.1074/jbc.M110.140541; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Yu LL, 2009, ONCOL REP, V22, P789, DOI 10.3892/or_00000501; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhao WH, 2012, CANCER BIOL THER, V13, P156, DOI 10.4161/cbt.13.3.18697; Zhao XL, 2010, CANCER BIOL THER, V10, P949, DOI 10.4161/cbt.10.9.13368; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	85	18	19	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2711	2722		10.1038/onc.2015.332	http://dx.doi.org/10.1038/onc.2015.332			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26364601	Green Published, hybrid			2022-12-26	WOS:000377472700005
J	Singh, N; Hassan, A; Bose, K				Singh, Nitu; Hassan, Ali; Bose, Kakoli			Molecular basis of death effector domain chain assembly and its role in caspase-8 activation	FASEB JOURNAL			English	Article						FADD; DED chain; apoptosis; activation; hot spot	CRYSTAL-STRUCTURE; HUMAN FADD; PROTEIN; BINDING; MECHANISM; COMPLEX; LIFE; FLIP; MUTATIONS; APOPTOSIS	Assembly of a death-inducing signaling complex is a key event in the extrinsic apoptotic pathway, enabling activation of the caspase cascade and subsequent cell death. However, the molecular events governing DISC assembly have remained largely elusive because of the lack of information on mechanism and specificity regulating the death effector domain (DED)-DED interaction network. Using molecular modeling, mutagenesis, and biochemical and ex vivo experiments, we identified the precise binding interface and hot spots crucial for intermolecular DED chain assembly. Mutation of key interface residues (Leu42/Phe45) in procaspase-8 DED-A completely abrogated DED chain formation in HEK293 cells and prevented its association with FADD. A significant 2.6-3.6-fold reduction in procaspase-8 activation was observed in functional cell-death assays after substitution of the interfacial residues. Based on our results we propose a new model for DISC formation that refines the current understanding of the activation mechanism. Upon stimulation, FADD selfassociates weakly via reciprocal interaction between helices alpha 1/ alpha 4 and alpha 2/alpha 3 of the DED to form an oligomeric signaling platform that provides a stage for the initial recruitment of procaspase-8 through direct interaction with alpha 1/alpha 4 of DED-A, followed by sequential interaction mediated by helices alpha 2/alpha 5 of DED-B, to form the procaspase-8 DED chain that is crucial for its activation and subsequent cell death.-Singh, N., Hassan, A., Bose, K. Molecular basis of death effector domain chain assembly and its role in caspase-8 activation. FASEB J. 30, 186-200 (2016). www.fasebj.org	[Singh, Nitu; Hassan, Ali; Bose, Kakoli] Adv Ctr Treatment Res & Educ Canc, Integrated Biophys & Struct Biol Lab, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)	Bose, K (corresponding author), Tata Mem Hosp, ACTREC, IBSB Lab, Navi Mumbai 410210, India.	kbose@actrec.gov.in			ACTREC	ACTREC	The authors thank Prof. G. Salvesen (Sanford-Burnham Medical Research Institute, La Jolla, CA, USA) for providing the pcDNA3 caspase-8 wild-type and pET29b FADD constructs, Prof. M. J. Lenardo (U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases) for pEGFP n1 constructs of catalytically inactive caspase-8 and its prodomain, and Dr. D. Bhattacharyya [Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC), Navi Mumbai, India] for the mCherry n1 empty vector. This work was supported by institutional funding from the ACTREC. The authors declare no conflicts of interest.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Ando M, 2013, CANCER SCI, V104, P1002, DOI 10.1111/cas.12191; Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Barnhart BC, 2003, ONCOGENE, V22, P8634, DOI 10.1038/sj.onc.1207103; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Dickens LS, 2012, EXP CELL RES, V318, P1269, DOI 10.1016/j.yexcr.2012.04.005; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Garvey TL, 2002, J VIROL, V76, P697, DOI 10.1128/JVI.76.2.697-706.2002; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Kasibhatla S., 2006, COLD SPRING HARB PRO, V2006; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavrik IN, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.160; Lavrik IN, 2009, ACTA NATURAE, V1, P80, DOI 10.32607/20758251-2009-1-1-80-83; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; Majkut J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4350; Marikar FMMT, 2008, CELL MOL IMMUNOL, V5, P471, DOI 10.1038/cmi.2008.59; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Samali A, 1999, CELL DEATH DIFFER, V6, P495, DOI 10.1038/sj.cdd.4400520; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Shiozaki EN, 2002, P NATL ACAD SCI USA, V99, P4197, DOI 10.1073/pnas.072544399; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Singh N, 2014, FEBS J, V281, P2456, DOI 10.1111/febs.12799; Soung YH, 2005, CANCER RES, V65, P815; Soung YH, 2005, ONCOGENE, V24, P141, DOI 10.1038/sj.onc.1208244; Thierry F, 2008, CELL DEATH DIFFER, V15, P1356, DOI 10.1038/cdd.2008.53; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Tsukumo S, 1999, GENES CELLS, V4, P541, DOI 10.1046/j.1365-2443.1999.00280.x; Walters J, 2009, METHOD ENZYMOL, V455, P1, DOI 10.1016/S0076-6879(08)04201-8; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yao Z, 2007, EMBO J, V26, P1068, DOI 10.1038/sj.emboj.7601571; Yuan RT, 2012, APOPTOSIS, V17, P229, DOI 10.1007/s10495-011-0677-y; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	65	14	17	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					186	200		10.1096/fj.15-272997	http://dx.doi.org/10.1096/fj.15-272997			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26370846				2022-12-26	WOS:000367621000020
J	VanSchouwen, B; Selvaratnam, R; Giri, R; Lorenz, R; Herberg, FW; Kim, C; Melacini, G				VanSchouwen, Bryan; Selvaratnam, Rajeevan; Giri, Rajanish; Lorenz, Robin; Herberg, Friedrich W.; Kim, Choel; Melacini, Giuseppe			Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cell signaling; cyclic AMP (cAMP); cyclic GMP (cGMP); molecular dynamics; nuclear magnetic resonance (NMR); protein kinase G (PKG); agonism	CGMP-SELECTIVE ACTIVATION; NMR CHEMICAL-SHIFTS; CYCLIC-AMP; BINDING DOMAIN; COVARIANCE ANALYSIS; SUBSTRATE-BINDING; REVEALS; AUTOINHIBITION; DYNAMICS; CELLS	Protein kinase G (PKG) is a major receptor of cGMP and controls signaling pathways often distinct from those regulated by cAMP. Hence, the selective activation of PKG by cGMP versus cAMP is critical. However, the mechanism of cGMP-versus-cAMP selectivity is only limitedly understood. Although the C-terminal cyclic nucleotide-binding domain B of PKG binds cGMP with higher affinity than cAMP, the intracellular concentrations of cAMP are typically higher than those of cGMP, suggesting that the cGMP-versus-cAMP selectivity of PKG is not controlled uniquely through affinities. Here, we show that cAMP is a partial agonist for PKG, and we elucidate the mechanism for cAMP partial agonism through the comparative NMR analysis of the apo, cGMP-, and cAMP-bound forms of the PKG cyclic nucleotide-binding domain B. We show that although cGMP activation is adequately explained by a two-state conformational selection model, the partial agonism of cAMP arises from the sampling of a third, partially autoinhibited state.	[VanSchouwen, Bryan; Selvaratnam, Rajeevan; Giri, Rajanish; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Lorenz, Robin; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, D-34132 Kassel, Germany; [Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	McMaster University; McMaster University; Universitat Kassel; Baylor College of Medicine; Baylor College of Medicine	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, 1280 Main St West, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Herberg, Friedrich W/B-5572-2015; Giri, Rajanish/Q-6530-2018	Herberg, Friedrich W/0000-0001-7117-7653; Giri, Rajanish/0000-0002-2046-836X; Selvaratnam, Rajeevan/0000-0003-4457-616X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Kassel University; Federal Ministry of Education and Research [0316177F]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090161] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Kassel University; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Canadian Institutes of Health Research (to G. M.) and by the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the graduate program "Functionomics" at Kassel University.; Supported by Federal Ministry of Education and Research Grant 0316177F No Pain.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Blumenthal DK, 2014, J BIOL CHEM, V289, P28505, DOI 10.1074/jbc.M114.584177; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Boulton S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07306; Boulton S, 2014, BIOCHEM SOC T, V42, P302, DOI 10.1042/BST20130282; Cheng CY, 2009, J BIOL CHEM, V284, P35916, DOI 10.1074/jbc.M109.059493; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; De S, 2012, BIOCHEMISTRY-US, V51, P8583, DOI 10.1021/bi3008214; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Goddard T., 2006, SPARKY NMR ASSIGNMEN; Greenwood AI, 2014, BIOCHEMISTRY-US, V53, P3593, DOI 10.1021/bi500031e; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Huang GY, 2014, BIOCHEMISTRY-US, V53, P6725, DOI 10.1021/bi501012v; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Jayaraman B, 2007, BIOCHEMISTRY-US, V46, P12174, DOI 10.1021/bi701281e; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; Kim J, 2015, P NATL ACAD SCI USA, V112, P3716, DOI 10.1073/pnas.1502299112; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nussinov R, 2014, J AM CHEM SOC, V136, P17692, DOI 10.1021/ja510028c; Nussinov R, 2014, TRENDS PHARMACOL SCI, V35, P256, DOI 10.1016/j.tips.2014.03.006; Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Smith JK, 2000, J BIOL CHEM, V275, P154, DOI 10.1074/jbc.275.1.154; Srivastava AK, 2014, STRUCTURE, V22, P1735, DOI 10.1016/j.str.2014.09.010; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; VanSchouwen B, 2015, J BIOL CHEM, V290, P17642, DOI 10.1074/jbc.M115.651877; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Wolter S, 2011, BIOCHEM BIOPH RES CO, V415, P563, DOI 10.1016/j.bbrc.2011.10.093; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345	51	37	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28631	28641		10.1074/jbc.M115.685305	http://dx.doi.org/10.1074/jbc.M115.685305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26370085	hybrid, Green Published			2022-12-26	WOS:000365762300006
J	Guo, HX; Chen, XH; Tian, RY; Chang, JM; Li, JL; Tan, YH; Xu, ZF; Ren, FG; Zhao, JX; Pan, J; Zhang, N; Wang, XJ; He, JX; Yang, WF; Wang, HW				Guo, Haixiu; Chen, Xiuhua; Tian, Ruiyuan; Chang, Jianmei; Li, Jianlan; Tan, Yanhong; Xu, Zhifang; Ren, Fanggang; Zhao, Junxia; Pan, Jie; Zhang, Na; Wang, Xiaojuan; He, Jianxia; Yang, Wanfang; Wang, Hongwei			Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms	PLOS ONE			English	Article							LEUKOCYTE ALKALINE-PHOSPHATASE; JAK2 EXON-12 MUTATIONS; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; CLINICAL CHARACTERISTICS; CALRETICULIN MUTATIONS; PRIMARY MYELOFIBROSIS; V617F MUTATION; EXPRESSION; DISORDERS	Somatic mutations in the CALR gene have been recently identified as acquired alterations in myeloproliferative neoplasms (MPNs). In this study, we evaluated mutation frequencies, laboratory features, and granulocyte activation in Chinese patients with MPNs. A combination of qualitative allele-specific polymerase chain reaction and Sanger sequencing was used to detect three driver mutations (i.e., CALR, JAK2V617F, and MPL). CALR mutations were identified in 8.4% of cases with essential thrombocythemia (ET) and 5.3% of cases with primary myelofibrosis (PMF). Moreover, 25% of polycythemia vera, 29.5% of ET, and 48.1% of PMF were negative for all three mutations (JAK2V617F, MPL, and CALR). Compared with those patients with JAK2V617F mutation, CALR-mutated ET patients displayed unique hematological phenotypes, including higher platelet counts, and lower leukocyte counts and hemoglobin levels. Significant differences were not found between Chinese PMF patients with mutants CALR and JAK2V617F in terms of laboratory features. Interestingly, patients with CALR mutations showed markedly decreased levels of leukocyte alkaline phosphatase (LAP) expression, whereas those with JAK2V617F mutation presented with elevated levels. Overall, a lower mutant rate of CALR gene and a higher triple-negative rate were identified in the cohort of Chinese patients with MPNs. This result indicates that an undiscovered mutant gene may have a significant role in these patients. Moreover, these pathological features further imply that the disease biology varies considerably between mutants CALR and JAK2V617F.	[Guo, Haixiu; Chen, Xiuhua; Tian, Ruiyuan; Chang, Jianmei; Li, Jianlan; Tan, Yanhong; Xu, Zhifang; Ren, Fanggang; Zhao, Junxia; Pan, Jie; Zhang, Na; Wang, Xiaojuan; He, Jianxia; Yang, Wanfang; Wang, Hongwei] Shanxi Med Univ, Hosp 2, Inst Hematol, Taiyuan, Peoples R China; [Guo, Haixiu] Shanxi Med Univ, Sch Basic Med, Dept Microbiol & Immunol, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi Medical University	Wang, HW (corresponding author), Shanxi Med Univ, Hosp 2, Inst Hematol, Taiyuan, Peoples R China.	wanghw68@hotmail.com		Pan, Jie/0000-0002-1973-8019				Andrikovics H, 2014, HAEMATOLOGICA, V99, P1184, DOI 10.3324/haematol.2014.107482; Basquiera AL, 2007, HAEMATOL-HEMATOL J, V92, P704, DOI 10.3324/haematol.10991; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Brecqueville M, 2012, GENE CHROMOSOME CANC, V51, P743, DOI 10.1002/gcc.21960; Cabagnols X, 2015, LEUKEMIA, V29, P249, DOI 10.1038/leu.2014.270; Chen CC, 2014, ANN HEMATOL, V93, P2029, DOI 10.1007/s00277-014-2151-8; Chen E, 2015, BLOOD, V125, P327, DOI 10.1182/blood-2014-04-567024; Chen XH, 2011, BLOOD CELL MOL DIS, V47, P67, DOI 10.1016/j.bcmd.2011.04.004; Garattini E, 1996, LEUKEMIA LYMPHOMA, V23, P493, DOI 10.3109/10428199609054858; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Li B, 2014, HAEMATOLOGICA, V99, P1697, DOI 10.3324/haematol.2014.109249; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Oku S, 2010, BRIT J HAEMATOL, V150, P334, DOI 10.1111/j.1365-2141.2010.08249.x; Pardanani A, 2007, LEUKEMIA, V21, P1960, DOI 10.1038/sj.leu.2404810; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Passamonti F, 2006, BLOOD, V107, P3676, DOI 10.1182/blood-2005-09-3826; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Qiao C, 2014, HAEMATOLOGICA, V99, pE182, DOI 10.3324/haematol.2014.109199; Rumi E, 2014, BLOOD, V124, P1062, DOI 10.1182/blood-2014-05-578435; Rumi E, 2014, BLOOD, V123, P1544, DOI 10.1182/blood-2013-11-539098; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Shen HJ, 2015, LEUKEMIA LYMPHOMA, V56, P820, DOI 10.3109/10428194.2014.939963; STEWART CA, 1974, PATHOLOGY, V6, P287, DOI 10.3109/00313027409068999; Tefferi A, 2010, JAK2 MPL TET2 ASXL1; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Wu ZY, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0048-6	29	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138250	10.1371/journal.pone.0138250	http://dx.doi.org/10.1371/journal.pone.0138250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375990	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200093
J	Huang, EW; Peng, LY; Zheng, JX; Wang, D; Xu, QY; Huang, L; Wu, QP; Tang, SB; Luo, B; Liu, SP; Liu, XS; Li, ZH; Quan, L; Li, Y; Shi, H; Lv, GL; Zhao, J; Cheng, JD; Liu, C				Huang, Er-Wen; Peng, Long-Yun; Zheng, Jin-Xiang; Wang, Dan; Xu, Qu-Yi; Huang, Lei; Wu, Qiu-Ping; Tang, Shuang-Bo; Luo, Bin; Liu, Shui-Ping; Liu, Xiao-Shan; Li, Zhao-Hui; Quan, Li; Li, Yue; Shi, He; Lv, Guo-Li; Zhao, Jian; Cheng, Jian-Ding; Liu, Chao			Common Variants in Promoter of ADTRP Associate with Early-Onset Coronary Artery Disease in a Southern Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CAROTID ATHEROSCLEROSIS; INSULIN; RISK; POLYMORPHISMS; ANDROGENS; HORMONES; LOCI; MEN	The first genome-wide association study for coronary artery disease (CAD) in the Han Chinese population, we reported recently, had identified rs6903956 in gene ADTRP on chromosome 6p24.1 as a novel susceptibility locus for CAD. The risk allele of rs6903956 was associated with decreased mRNA expression of ADTRP. To further study the correlation of ADTRP expression and CAD, in this study we evaluated the associations of eight common variants in the expression-regulating regions of ADTRP with CAD in the Southern Han Chinese population. Rs169790 in 3'UTR, rs2076189 in 5'UTR, four SNPs (rs2076188, rs7753407, rs11966356 and rs1018383) in promoter, and two SNPs (rs3734273, rs80355771) in the last intron of ADTRP were genotyped in 1716 CAD patients and 1572 controls. The correlations between these loci and total or early-onset CAD were investigated. None of these loci was discovered to associate with total CAD (P > 0.05). However, with early-onset CAD, significant both allelic and genotypic associations of rs7753407, rs11966356 and rs1018383 were identified, after adjustment for risk factors of age, gender, hypertension, diabetes, lipid profiles and smoking (adjusted P < 0.05). A haplotype AGCG (constructed by rs2076188, rs7753407, rs11966356 and rs1018383) was identified to protect subjects from early-onset CAD (OR = 0.332, 95% CI = 0.105-0.879, adjusted P = 0.010). Real-time quantitative reverse transcription polymerase chain reaction assay showed that the risk alleles of the associated loci were significantly associated with decreased expression of ADTRP mRNA. Moreover, the average level of ADTRP mRNA expression in early-onset CAD cases was significantly lower than that in controls. Our results provide new evidence supporting the association of ADTRP with the pathogenesis of early-onset CAD.	[Huang, Er-Wen; Zheng, Jin-Xiang; Huang, Lei; Wu, Qiu-Ping; Tang, Shuang-Bo; Luo, Bin; Liu, Shui-Ping; Liu, Xiao-Shan; Li, Zhao-Hui; Quan, Li; Cheng, Jian-Ding] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Forens Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Er-Wen; Xu, Qu-Yi; Li, Yue; Shi, He; Lv, Guo-Li; Zhao, Jian; Liu, Chao] Guangzhou Forens Sci Inst, Guangzhou, Guangdong, Peoples R China; [Peng, Long-Yun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Dan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, CardioX Inst, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Hubei, Peoples R China; [Wang, Dan] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Hubei, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Cheng, JD (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Forens Pathol, Guangzhou 510275, Guangdong, Peoples R China.	chengjd@mail.sysu.edu.cn; liuchaogzf@163.com	liu, chao/GQZ-6687-2022		National Natural Science Foundation of China [81302616, 81430046, 81172901]; China Postdoctoral Science Foundation [2013M542226]; China National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2012BAK02B02-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	This study was funded by the National Natural Science Foundation of China (81302616, 81430046 and 81172901), the China Postdoctoral Science Foundation (2013M542226), and the China National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAK02B02-3).	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen CH, 2014, NEW ENGL J MED, V370, P119, DOI 10.1056/NEJMoa1212444; Chinetti-Gbaguidi G, 2015, FEBS LETT, V589, P461, DOI 10.1016/j.febslet.2015.01.002; Dechamethakun S, 2014, J ATHEROSCLER THROMB, V21, P680; English KM, 2000, EUR HEART J, V21, P890, DOI 10.1053/euhj.1999.1873; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043732; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Lupu C, 2011, BLOOD, V118, P4463, DOI 10.1182/blood-2011-05-355370; Maddison LA, 2012, DIABETES, V61, P2517, DOI 10.2337/db11-1841; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Muller M, 2004, CIRCULATION, V109, P2074, DOI 10.1161/01.CIR.0000125854.51637.06; Ohta Y, 2011, DIABETES, V60, P3208, DOI 10.2337/db10-1192; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; Tayebi N, 2013, CLIN BIOCHEM, V46, P755, DOI 10.1016/j.clinbiochem.2013.01.004; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; van den Beld AW, 2003, AM J EPIDEMIOL, V157, P25, DOI 10.1093/aje/kwf160; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Wang YH, 2013, MOL CELL, V49, P283, DOI 10.1016/j.molcel.2012.10.028; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yoshida S, 2011, DIABETES OBES METAB, V13, P34, DOI 10.1111/j.1463-1326.2010.01315.x	29	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137547	10.1371/journal.pone.0137547	http://dx.doi.org/10.1371/journal.pone.0137547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375920	gold, Green Submitted, Green Published			2022-12-26	WOS:000361610200041
J	Estrela, AB; Turck, P; Stutz, E; Abraham, WR				Estrela, Andreia Bergamo; Tuerck, Patrick; Stutz, Elaine; Abraham, Wolf-Rainer			Release of Periplasmic Nucleotidase Induced by Human Antimicrobial Peptide in E-coli Causes Accumulation of the Immunomodulator Adenosine	PLOS ONE			English	Article							INTRACELLULAR-LOCALIZATION; PSEUDOMONAS-AERUGINOSA; IMMUNE MODULATION; GUT MICROBIOTA; PANETH CELLS; DISEASE; 5-NUCLEOTIDASE; PURIFICATION; MECHANISMS; DEFENSINS	Previous work by our group described that human beta-defensin-2 induces accumulation of extracellular adenosine (Ado) in E. coli cultures through a non-lytic mechanism causing severe plasmolysis. Here, we investigate the presence of AMP as a direct precursor and the involvement of a bacterial enzyme in the generation of extracellular Ado by treated bacteria. Following hBD-2 treatment, metabolites were quantified in the supernatants using targeted HPLC-MS/MS analysis. Microbial growth was monitored by optical density and cell viability was determined by colony forming units counts. Phosphatase activity was measured using chromogenic substrate pNPP. The results demonstrate that defensin-treated E. coli strainWreleases AMP in the extracellular space, where it is converted to Ado by a bacterial soluble factor. An increase in phosphatase activity in the supernatant was observed after peptide treatment, similar to the effect of sucrose-induced osmotic stress, suggesting that the periplasmic 5'nucleotidase (5'-NT) is released following the plasmolysis event triggered by the peptide. Ado accumulation was enhanced in the presence of Co2+ ion and inhibited by EDTA, further supporting the involvement of a metallo-phosphatase such as 5'-NT in extracellular AMP conversion into Ado. The comparative analysis of hBD-induced Ado accumulation in different E. coli strains and in Pseudomonas aeruginosa revealed that the response is not correlated to the peptide's effect on cell viability, but indicates it might be dependent on the subcellular distribution of the nucleotidase. Taken together, these data shed light on a yet undescribed mechanism of host-microbial interaction: a human antimicrobial peptide inducing selective release of a bacterial enzyme (E. coli 5'-NT), leading to the formation of a potent immunomodulator metabolite (Ado).	[Estrela, Andreia Bergamo; Tuerck, Patrick; Stutz, Elaine; Abraham, Wolf-Rainer] Helmholtz Ctr Infect Res, Chem Microbiol, D-38124 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Estrela, AB (corresponding author), Univ Fed Rio Grande do Norte, Lab Tecnol & Biotecnol Farmaceut, BR-59072970 Natal, RN, Brazil.	estrela.abe@gmail.com; Wolf-Rainer.Abraham@helmholtz-hzi.de	Turck, Patrick/ABE-3969-2021; Abraham, Wolf-Rainer/I-2179-2019; Estrela, Andreia/A-5162-2016	Abraham, Wolf-Rainer/0000-0002-2850-2649; Turck, Patrick/0000-0001-5994-5218	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	A.B.E. and P.T. acknowledge fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and E.S. acknowledges a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), all pertaining to the Brazilian program Science without Borders.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; BHATTI AR, 1976, CAN J MICROBIOL, V22, P1425, DOI 10.1139/m76-211; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; BROAD DF, 1981, J GEN MICROBIOL, V123, P241; Chan ESL, 2002, ARTHRITIS RES, V4, P266, DOI 10.1186/ar419; Crane JK, 2009, FEMS IMMUNOL MED MIC, V57, P214, DOI 10.1111/j.1574-695X.2009.00598.x; Drygiannakis I, 2011, IMMUNOL RES, V50, P69, DOI 10.1007/s12026-011-8207-0; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Estrela AB, 2011, CURR MED CHEM, V18, P2791; Estrela AB, 2013, ANTIMICROB AGENTS CH, V57, P4387, DOI 10.1128/AAC.00820-13; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GLICK J, 1983, J GEN MICROBIOL, V129, P3085; Greenwell-Wild T, 2002, J IMMUNOL, V169, P6286, DOI 10.4049/jimmunol.169.11.6286; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; NEU HC, 1967, J BIOL CHEM, V242, P3896; NEU HC, 1968, BIOCHEMISTRY-US, V7, P3766, DOI 10.1021/bi00850a059; Ochoa-Cortes F, 2014, INFLAMM BOWEL DIS, V20, P1259, DOI 10.1097/MIB.0000000000000047; Okamura S, J BIOCH, V73, P915; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; RINAS U, 1995, APPL ENVIRON MICROB, V61, P4147, DOI 10.1128/AEM.61.12.4147-4151.1995; STROHMEIER GR, 1995, J BIOL CHEM, V270, P2387, DOI 10.1074/jbc.270.5.2387; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; WATANABE K, 1986, BIOCHEM BIOPH RES CO, V134, P527, DOI 10.1016/S0006-291X(86)80452-1; Watanabe K, 2011, BIOSCI BIOTECH BIOCH, V75, P7, DOI 10.1271/bbb.100063; Willyard C, 2011, NATURE, V479, pS5, DOI 10.1038/479S5a; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138033	10.1371/journal.pone.0138033	http://dx.doi.org/10.1371/journal.pone.0138033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371472	gold, Green Published, Green Submitted			2022-12-26	WOS:000361604400045
J	Qu, YY; Zhang, XW; Ma, Q; Deng, J; Deng, Y; Van Nostrand, JD; Wu, LY; He, ZL; Qin, YJ; Zhou, JT; Zhou, JH				Qu, Yuanyuan; Zhang, Xuwang; Ma, Qiao; Deng, Jie; Deng, Ye; Van Nostrand, Joy D.; Wu, Liyou; He, Zhili; Qin, Yujia; Zhou, Jiti; Zhou, Jizhong			Microbial Community Dynamics and Activity Link to Indigo Production from Indole in Bioaugmented Activated Sludge Systems	PLOS ONE			English	Article							RIBOSOMAL-RNA; NAPHTHALENE; GENES; DEGRADATION; STRAIN; WASTE; BIOSYNTHESIS; EXPRESSION; BACTERIUM; OXIDATION	Biosynthesis of the popular dyestuff indigo from indole has been comprehensively studied using pure cultures, but less has been done to characterize the indigo production by microbial communities. In our previous studies, a wild strain Comamonas sp. MQ was isolated from activated sludge and the recombinant Escherichia coli (nagAc) carrying the naphthalene dioxygenase gene (nag) from strain MQ was constructed, both of which were capable of producing indigo from indole. Herein, three activated sludge systems, G1 (non-augmented control), G2 (augmented with Comamonas sp. MQ), and G3 (augmented with recombinant E. coli (nagAc)), were constructed to investigate indigo production. After 132-day operation, G3 produced the highest yields of indigo (99.5 +/- 3.0 mg/l), followed by G2 (27.3 +/- 1.3 mg/l) and G1 (19.2 +/- 1.2 mg/l). The microbial community dynamics and activities associated with indigo production were analyzed by Illumina Miseq sequencing of 16S rRNA gene amplicons. The inoculated strain MQ survived for at least 30 days, whereas E. coli (nagAc) was undetectable shortly after inoculation. Quantitative real-time PCR analysis suggested the abundance of naphthalene dioxygenase gene (nagAc) from both inoculated strains was strongly correlated with indigo yields in early stages (0-30 days) (P < 0.001) but not in later stages (30-132 days) (P > 0.10) of operation. Based on detrended correspondence analysis (DCA) and dissimilarity test results, the communities underwent a noticeable shift during the operation. Among the four major genera (>1% on average), the commonly reported indigo-producing populations Comamonas and Pseudomonas showed no positive relationship with indigo yields (P > 0.05) based on Pearson correlation test, while Alcaligenes and Aquamicrobium, rarely reported for indigo production, were positively correlated with indigo yields (P < 0.05). This study should provide new insights into our understanding of indigo bio-production by microbial communities.	[Qu, Yuanyuan; Zhang, Xuwang; Ma, Qiao; Zhou, Jiti] Dalian Univ Technol, Sch Environm Sci & Technol, Minist Educ, State Key Lab Fine Chem,Key Lab Ind Ecol & Enviro, Dalian 116024, Peoples R China; [Qu, Yuanyuan; Ma, Qiao; Deng, Jie; Deng, Ye; Van Nostrand, Joy D.; Wu, Liyou; He, Zhili; Qin, Yujia; Zhou, Jizhong] Univ Oklahoma, IEG, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China	Dalian University of Technology; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tsinghua University	Qu, YY (corresponding author), Dalian Univ Technol, Sch Environm Sci & Technol, Minist Educ, State Key Lab Fine Chem,Key Lab Ind Ecol & Enviro, Dalian 116024, Peoples R China.	qyy@dlut.edu.cn	Zhang, Xuwang/L-7097-2019; Deng, Ye/X-4358-2019; He, Zhili/C-2879-2012; Van Nostrand, Joy D/F-1740-2016; ma, qiao/AAK-2605-2021	Deng, Ye/0000-0002-7584-0632; He, Zhili/0000-0001-8225-7333; Van Nostrand, Joy D/0000-0001-9548-6450; Ma, Qiao/0000-0003-0614-2192	National Natural Science Foundation of China [21176040]; Program for New Century Excellent Talents in University [NCET-13-0077]; Fundamental Research Funds for the Central Universities [DUT14YQ107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (No. 21176040), the Program for New Century Excellent Talents in University (No. NCET-13-0077), and the Fundamental Research Funds for the Central Universities (No. DUT14YQ107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CCR, 1997, APPL ENVIRON MICROB, V63, P151, DOI 10.1128/AEM.63.1.151-155.1997; Bai YH, 2011, ENVIRON SCI TECHNOL, V45, P1940, DOI 10.1021/es103150v; Bambauer A, 1998, ARCH MICROBIOL, V169, P293, DOI 10.1007/s002030050575; Bechtold T, 2002, BIORESOURCE TECHNOL, V81, P171, DOI 10.1016/S0960-8524(01)00146-8; Bhushan B, 2000, LETT APPL MICROBIOL, V31, P5, DOI 10.1046/j.1472-765x.2000.00754.x; Boon N, 2003, APPL ENVIRON MICROB, V69, P1511, DOI 10.1128/AEM.69.3.1511-1520.2003; Boon N, 2000, APPL ENVIRON MICROB, V66, P2906, DOI 10.1128/AEM.66.7.2906-2913.2000; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Chang YC, 2013, APPL BIOCHEM BIOTECH, V170, P381, DOI 10.1007/s12010-013-0191-5; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; CLAUS G, 1983, SYST APPL MICROBIOL, V4, P169, DOI 10.1016/S0723-2020(83)80046-0; Cosgrove L, 2010, APPL ENVIRON MICROB, V76, P810, DOI 10.1128/AEM.00534-09; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Doukyu N, 2002, APPL MICROBIOL BIOT, V58, P543, DOI 10.1007/s00253-001-0919-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ENSLEY BD, 1983, SCIENCE, V222, P167, DOI 10.1126/science.6353574; Gillam EMJ, 2000, BIOCHEMISTRY-US, V39, P13817, DOI 10.1021/bi001229u; Hai RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107345; Han GH, 2011, PROCESS BIOCHEM, V46, P788, DOI 10.1016/j.procbio.2010.10.015; Iasur-Kruh L, 2011, APPL ENVIRON MICROB, V77, P3734, DOI 10.1128/AEM.00691-11; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ma Q, 2015, BIORESOURCE TECHNOL, V179, P436, DOI 10.1016/j.biortech.2014.12.041; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marshall CW, 2013, CURR OPIN BIOTECH, V24, P391, DOI 10.1016/j.copbio.2013.03.016; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; MURDOCK D, 1993, BIO-TECHNOL, V11, P381, DOI 10.1038/nbt0393-381; O'Connor KE, 1998, BIOTECHNOL LETT, V20, P219, DOI 10.1023/A:1005361415496; OConnor KE, 1997, APPL ENVIRON MICROB, V63, P4287, DOI 10.1128/AEM.63.11.4287-4291.1997; Pathak H, 2010, APPL BIOCHEM BIOTECH, V160, P1616, DOI 10.1007/s12010-009-8638-4; Philp JC, 2013, TRENDS BIOTECHNOL, V31, P219, DOI 10.1016/j.tibtech.2012.12.007; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Qu YY, 2015, ENVIRON SCI TECHNOL, V49, P4627, DOI 10.1021/es5053045; Qu YY, 2012, J BASIC MICROB, V52, P687, DOI 10.1002/jobm.201100516; Qu YY, 2012, BIOTECHNOL LETT, V34, P353, DOI 10.1007/s10529-011-0778-2; Qu YY, 2010, BIORESOURCE TECHNOL, V101, P4527, DOI 10.1016/j.biortech.2010.01.033; Qu YY, 2012, PLOS ONE, V7, DOI [10. 1371/ journal. pone. 0044313, DOI 10.1371/J0URNAL.P0NE.0044313]; Rhee SK, 2004, APPL ENVIRON MICROB, V70, P4303, DOI 10.1128/AEM.70.7.4303-4317.2004; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Vinas M, 2005, APPL ENVIRON MICROB, V71, P7008, DOI 10.1128/AEM.71.11.7008-7018.2005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138820; Zhang XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125732; Zhang XW, 2013, PROCESS BIOCHEM, V48, P581, DOI 10.1016/j.procbio.2013.02.008; Zhou JZ, 2015, MBIO, V6, DOI 10.1128/mBio.02288-14; Zhou JZ, 2014, P NATL ACAD SCI USA, V111, pE836, DOI 10.1073/pnas.1324044111; Zhou JZ, 2013, MBIO, V4, DOI 10.1128/mBio.00584-12	48	6	6	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138455	10.1371/journal.pone.0138455	http://dx.doi.org/10.1371/journal.pone.0138455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372223	gold, Green Submitted, Green Published			2022-12-26	WOS:000361604400070
J	Skaaby, T; Husemoen, LLN; Thuesen, BH; Jorgensen, T; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Jorgensen, Torben; Linneberg, Allan			Lifestyle-Related Factors and Atopy in Seven Danish Population-Based Studies from Different Time Periods	PLOS ONE			English	Article							SERUM IMMUNOGLOBULIN-E; ALLERGIC RESPIRATORY-DISEASE; NUTRITION EXAMINATION SURVEY; BODY-MASS INDEX; ALCOHOL-CONSUMPTION; COPENHAGEN-ALLERGY; AEROALLERGEN SENSITIZATION; AIRWAY INFLAMMATION; CHOLESTEROL LEVELS; NATIONAL-HEALTH	Background The prevalence of allergic respiratory disease tends to increase in populations that adopt the so-called Westernized lifestyle. We investigated the association between atopy and several possible lifestyle-related factors in seven Danish population-based studies. Methods A total of 20048 persons participated in the seven studies. We used logistic regression to analyse the associations between possible determinants and atopy defined as serum specific IgE or skin prick test positivity against inhalant allergens. Associations were expressed as odds ratios (ORs) with 95% confidence intervals (95% CIs). In addition, individual participant data meta-analyses were performed. Results Atopy was significantly associated with younger age (OR per 1 year increase in age: 0.97; 95% CI: 0.97, 0.98); male sex (OR for males versus females: 1.34; 95% CI: 1.24, 1.45), heavy drinking (OR for heavy drinkers versus light drinkers: 1.15; 95% CI: 1.04, 1.27), never smoking (OR for current versus never smokers: 0.73; 95% CI: 0.67, 0.80), and higher educational level (OR for educated versus uneducated: 1.27; 95% CI: 1.15, 1.41). Atopy was not associated with blood pressure, serum total cholesterol, physical activity or body mass except in women only, where we found a positive association (OR for obese vs. normal weight: 1.18; 95% CI: 1.00, 1.39) with ptrend = 0.032. Conclusions Of interest for preventive purposes, we found that atopy was associated with some of the reversible lifestyle-related factors that characterize a Westernized lifestyle.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Jorgensen, Torben; Linneberg, Allan] Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben; Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark	University of Copenhagen; Aalborg University; University of Copenhagen	Skaaby, T (corresponding author), Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Jørgensen, Torben/Z-1335-2018	Linneberg, Allan/0000-0002-0994-0184; Thuesen, Betina/0000-0001-9772-4344; Jorgensen, Torben/0000-0001-9453-2830; Skaaby, Tea/0000-0003-0031-5726	Lundbeck Foundation [R165-2013-15410, R108-A10225]	Lundbeck Foundation(Lundbeckfonden)	Tea Skaaby was supported by a grant from the Lundbeck Foundation (Grant number R165-2013-15410). Betina Heinsbaek Thuesen was supported by a grant from the Lundbeck Foundation (Grant number R108-A10225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2014, AM J PREV MED, V47, P576, DOI 10.1016/j.amepre.2014.06.020; Aadahl M, 2013, EUR J PREV CARDIOL, V20, P1088, DOI 10.1177/2047487312462825; Assing K, 2007, ANN ALLERG ASTHMA IM, V98, P70, DOI 10.1016/S1081-1206(10)60862-9; Berg ND, 2012, J ALLERGY CLIN IMMUN, V129, P374, DOI 10.1016/j.jaci.2011.08.045; Bergeron C, 2005, J ALLERGY CLIN IMMUN, V115, P1102, DOI 10.1016/j.jaci.2005.03.018; Boulet LP, 2014, CLIN EXP ALLERGY; Bruno A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607192; Byberg S, 2012, DIABETIC MED, V29, pE354, DOI 10.1111/j.1464-5491.2012.03711.x; Castro-Rodriguez LA, 2001, AM J RESP CRIT CARE, V163, P1344, DOI 10.1164/ajrccm.163.6.2006140; Chen W, 2008, ALLERGY, V63, P1418, DOI 10.1111/j.1398-9995.2008.01880.x; Chen Y, 2010, INT ARCH ALLERGY IMM, V153, P372, DOI 10.1159/000316348; Chen Y, 2009, J AGROMEDICINE, V14, P222, DOI 10.1080/10599240902724051; Drivsholm T, 2006, SCAND J PUBLIC HEALT, V34, P623, DOI 10.1080/14034940600607616; Ferraz E, 2011, J PEDIAT-BRAZIL, V87, P336, DOI [10.2223/JPED.2114, 10.1590/S0021-75572011000400011]; Fessler MB, 2010, ALLERGY, V65, P859, DOI 10.1111/j.1398-9995.2009.02287.x; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Flexeder C, 2011, INT ARCH ALLERGY IMM, V156, P117, DOI 10.1159/000322296; GERGEN PJ, 1991, ARCH INTERN MED, V151, P487, DOI 10.1001/archinte.151.3.487; Gonzalez-Quintela A, 2008, CLIN EXP ALLERGY, V38, P152, DOI 10.1111/j.1365-2222.2007.02863.x; Gonzalez-Quintela A, 2004, ADDICT BIOL, V9, P195, DOI 10.1080/13556210412331292235; Gonzalez-Quintela A, 2003, CLIN EXP ALLERGY, V33, P199, DOI 10.1046/j.1365-2222.2003.01582.x; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hancox RJ, 2005, AM J RESP CRIT CARE, V171, P440, DOI 10.1164/rccm.200405-623OC; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; Husemoen LLN, 2008, ALCOHOL CLIN EXP RES, V32, P1984, DOI 10.1111/j.1530-0277.2008.00780.x; Jahn-Schmid B, 2003, CLIN EXP ALLERGY, V33, P1443, DOI 10.1046/j.1365-2222.2003.01784.x; Jarvis D, 2002, CLIN EXP ALLERGY, V32, P831, DOI 10.1046/j.1365-2222.2002.01380.x; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lee YW, 2009, CLIN CHIM ACTA, V401, P25, DOI 10.1016/j.cca.2008.10.034; Linneberg A, 2007, CLIN EXP ALLERGY, V37, P1137, DOI 10.1111/j.1365-2222.2007.02760.x; Linneberg A, 2006, ALLERGY, V61, P344, DOI 10.1111/j.1398-9995.2006.00968.x; Linneberg A, 2003, CLIN EXP ALLERGY, V33, P192, DOI 10.1046/j.1365-2222.2003.01515.x; Linneberg A, 2002, CLIN EXP ALLERGY, V32, P1702, DOI 10.1046/j.1365-2222.2002.01537.x; Linneberg A, 2010, INT ARCH ALLERGY IMM, V151, P142, DOI 10.1159/000236004; Linneberg A, 2001, CLIN EXP ALLERGY, V31, P1409, DOI 10.1046/j.1365-2222.2001.01178.x; Linneberg A, 2001, RESP MED, V95, P258, DOI 10.1053/rmed.2001.1031; Linneberg A, 2001, ALLERGY, V56, P328, DOI 10.1034/j.1398-9995.2000.00509.x-i1; Linneberg A, 2008, INT ARCH ALLERGY IMM, V147, P93, DOI 10.1159/000135695; Osler M, 2011, INT J EPIDEMIOL, V40, P602, DOI 10.1093/ije/dyq041; Petersen AB, 2004, CLIN BIOCHEM, V37, P882, DOI 10.1016/j.clinbiochem.2004.06.010; Ring J, 2001, CURR OPIN IMMUNOL, V13, P701, DOI 10.1016/S0952-7915(01)00282-5; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Salam MT, 2006, J ALLERGY CLIN IMMUN, V117, P1001, DOI 10.1016/j.jaci.2006.02.004; Santamaria F, 2007, J ALLERGY CLIN IMMUN, V120, P965, DOI 10.1016/j.jaci.2007.06.002; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Schachter LM, 2003, THORAX, V58, P1031, DOI 10.1136/thorax.58.12.1031; Schachter LM, 2001, THORAX, V56, P4, DOI 10.1136/thorax.56.1.4; Schafer T, 2003, CLIN EXP ALLERGY, V33, P1360, DOI 10.1046/j.1365-2222.2003.01780.x; Silverberg JI, 2012, BRIT J DERMATOL, V166, P498, DOI 10.1111/j.1365-2133.2011.10694.x; Skaaby T, 2014, CLIN EXP ALLERGY, V44, P1361, DOI 10.1111/cea.12408; Skaaby T, 2014, ENDOCRINE; Skaaby T, 2014, JACI PRACTICE; Skaaby T, 2015, ENDOCRINE; Skaaby T, 2015, AUTOIMMUNITY, V48, P282, DOI 10.3109/08916934.2014.1003640; Thuesen BH, 2010, ALLERGY, V65, P1446, DOI 10.1111/j.1398-9995.2010.02378.x; van Gent R, 2007, J ALLERGY CLIN IMMUN, V119, P591, DOI 10.1016/j.jaci.2006.11.007; van Veen IH, 2008, ALLERGY, V63, P570, DOI 10.1111/j.1398-9995.2007.01597.x; Vidal C, 2002, ALCOHOL CLIN EXP RES, V26, P59, DOI 10.1111/j.1530-0277.2002.tb02432.x; Vieira VJ, 2005, AM J CLIN NUTR, V82, P504, DOI 10.1093/ajcn/82.3.504; Visness CM, 2010, J ASTHMA, V47, P822, DOI 10.3109/02770903.2010.489388; Wuthrich B, 1996, INT ARCH ALLERGY IMM, V111, P396, DOI 10.1159/000237398; Xu BZ, 2002, EUR J PUBLIC HEALTH, V12, P166, DOI 10.1093/eurpub/12.3.166; Yeh YF, 2004, J BIOMED SCI, V11, P599, DOI 10.1007/BF02256124	63	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137406	10.1371/journal.pone.0137406	http://dx.doi.org/10.1371/journal.pone.0137406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372449	Green Published, gold, Green Submitted			2022-12-26	WOS:000361604400022
J	Varenhorst, AJ; McCarville, MT; O'Neal, ME				Varenhorst, Adam J.; McCarville, Michael T.; O'Neal, Matthew E.			Reduced Fitness of Virulent Aphis glycines (Hemiptera: Aphididae) Biotypes May Influence the Longevity of Resistance Genes in Soybean	PLOS ONE			English	Article							HOST-PLANT RESISTANCE; SEED TRAITS; SINGLE-GENE; RAG1; MANAGEMENT; INSECTICIDES; POPULATIONS; RESPONSES; REFUGE; IMPACT	Sustainable use of insect resistance in crops require insect resistance management plans that may include a refuge to limit the spread of virulence to this resistance. However, without a loss of fitness associated with virulence, a refuge may not prevent virulence from becoming fixed within a population of parthenogenetically reproducing insects like aphids. Aphid-resistance in soybeans (i.e., Rag genes) prevent outbreaks of soybean aphid (Aphis glycines), yet four biotypes defined by their capacity to survive on aphid-resistant soybeans (e.g., biotype-2 survives on Rag1 soybean) are found in North America. Although fitness costs are reported for biotype-3 on aphid susceptible and Rag1 soybean, it is not clear if virulence to aphid resistance in general is associated with a decrease in fitness on aphid susceptible soybeans. In laboratory assays, we measured fitness costs for biotype 2, 3 and 4 on an aphid-susceptible soybean cultivar. In addition, we also observed negative cross-resistance for biotype-2 on Rag3, and biotype-3 on Rag1 soybean. We utilized a simple deterministic, single-locus, four compartment genetic model to account for the impact of these findings on the frequency of virulence alleles. When a refuge of aphid susceptible was included within this model, fitness costs and negative cross-resistance delayed the increase of virulence alleles when virulence was inherited recessively or additively. If virulence were inherited additively, fitness costs decreased the frequency of virulence. Combined, these results suggest that a refuge may prevent virulent A. glycines biotypes from overcoming Rag genes if this aphid-resistance were used commercially in North America.	[Varenhorst, Adam J.; McCarville, Michael T.; O'Neal, Matthew E.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA	Iowa State University	O'Neal, ME (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	oneal@iastate.edu		Varenhorst, Adam/0000-0001-6239-9860	North Central Soybean Research Program USDA National Institute of Food and Agriculture [233507]	North Central Soybean Research Program USDA National Institute of Food and Agriculture	North Central Soybean Research Program USDA National Institute of Food and Agriculture, Hatch Project #233507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt J, 2013, CROP SCI, V53, P1491, DOI 10.2135/cropsci2012.11.0672; Bansal R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-972; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Brace RC, 2012, CROP SCI, V52, P2070, DOI 10.2135/cropsci2011.12.0637; Chirumamilla A, 2014, CROP SCI, V54, P2557, DOI 10.2135/cropsci2014.05.0393; Crowder DW, 2009, J THEOR BIOL, V261, P423, DOI 10.1016/j.jtbi.2009.08.017; Donaldson JR, 2007, BIOL CONTROL, V43, P111, DOI 10.1016/j.biocontrol.2007.06.004; Enders L, 2014, ENVIRON ENTOMOL, V43, P47, DOI 10.1603/EN13135; FEHR W. R., 1971, Crop science, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Hesler LS, 2013, ENTOMOL EXP APPL, V147, P201, DOI 10.1111/eea.12073; Hill CB, 2010, J ECON ENTOMOL, V103, P509, DOI 10.1603/EC09179; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Johnson KD, 2009, J ECON ENTOMOL, V102, P2101, DOI 10.1603/029.102.0613; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Kim KS, 2013, CROP SCI, V53, P1326, DOI 10.2135/cropsci2012.09.0558; Kim KS, 2009, CROP SCI, V49, P1726, DOI 10.2135/cropsci2008.10.0588; Mardorf JL, 2010, CROP SCI, V50, P1891, DOI 10.2135/cropsci2010.02.0079; McCarville MT, 2014, J ECON ENTOMOL, V107, P1680, DOI 10.1603/EC14047; McCarville MT, 2012, J ECON ENTOMOL, V105, P1835, DOI 10.1603/EC12043; McCarville M. T, 2012, SOYBEAN APHID RESIST, V92; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Michel AP, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P355; Michel AP, 2010, J ECON ENTOMOL, V103, P949, DOI 10.1603/EC09337; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; [NASS/USDA] National Agricultural Statistics Service/U.S. Department of Agriculture, 2005, AGR CHEM US 2005 FIE; [NASS/USDA] National Agricultural Statistics Service/U.S. Department of Agriculture, 1999, PEST MAN PRACT; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Ohnesorg WJ, 2009, J ECON ENTOMOL, V102, P1816, DOI 10.1603/029.102.0512; Olson K.D., 2008, FARMERS AWARENESS US; Pittendrigh B. R., 2008, INSECT RESISTANCE MA, P108; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Richardson ML, 2012, J APPL ENTOMOL, V136, P641, DOI 10.1111/j.1439-0418.2011.01692.x; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Varenhorst AJ, 2015, ENVIRON ENTOMOL, V44, P658, DOI 10.1093/ee/nvv051; Varenhorst AJ, 2012, ENVIRON ENTOMOL, V41, P1565, DOI 10.1603/EN12068; Wenger J, 2014, J ECON ENTOMOL, V107, P1599, DOI 10.1603/EC13545; Whalen R, 2015, ARTHROPOD-PLANT INTE, V9, P233, DOI 10.1007/s11829-015-9366-z; Wiarda SL, 2012, J ECON ENTOMOL, V105, P252, DOI 10.1603/EC11020	39	27	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138252	10.1371/journal.pone.0138252	http://dx.doi.org/10.1371/journal.pone.0138252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372106	Green Published, gold, Green Submitted			2022-12-26	WOS:000361604400059
J	Babitha, KC; Vemanna, RS; Nataraja, KN; Udayakumar, M				Babitha, K. C.; Vemanna, Ramu S.; Nataraja, Karaba N.; Udayakumar, M.			Overexpression of EcbHLH57 Transcription Factor from Eleusine coracana L. in Tobacco Confers Tolerance to Salt, Oxidative and Drought Stress	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; ATYPICAL BHLH PROTEIN; LOOP-HELIX PROTEINS; ABSCISIC-ACID; FUNCTIONAL-ANALYSIS; ABIOTIC STRESS; DESICCATION TOLERANCE; LIPID-PEROXIDATION; FACTOR FAMILY; GENOME-WIDE	Basic helix-loop-helix (bHLH) transcription factors constitute one of the largest families in plants and are known to be involved in various developmental processes and stress tolerance. We report the characterization of a stress responsive bHLH transcription factor from stress adapted species finger millet which is homologous to OsbHLH57 and designated as EcbHLH57. The full length sequence of EcbHLH57 consisted of 256 amino acids with a conserved bHLH domain followed by leucine repeats. In finger millet, EcbHLH57 transcripts were induced by ABA, NaCl, PEG, methyl viologen (MV) treatments and drought stress. Overexpression of EcbHLH57 in tobacco significantly increased the tolerance to salinity and drought stress with improved root growth. Transgenic plants showed higher photosynthetic rate and stomatal conductance under drought stress that resulted in higher biomass. Under long-term salinity stress, the transgenic plants accumulated higher seed weight/pod and pod number. The transgenic plants were also tolerant to oxidative stress and showed less accumulation of H(2)0(2) and MDA levels. The overexpression of EcbHLH57 enhanced the expression of stress responsive genes such as LEA14, rd29A, rd29B, SOD, APX, ADH1, HSP70 and also PP2C and hence improved tolerance to diverse stresses.	[Babitha, K. C.; Vemanna, Ramu S.; Nataraja, Karaba N.; Udayakumar, M.] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India	University of Agricultural Sciences Bangalore	Udayakumar, M (corresponding author), Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India.	udayakumar_m@yahoo.com		Nataraja, Karaba N./0000-0002-9766-3622; Vemanna, Ramu/0000-0002-9729-8768	Department of Biotechnology, Centre of Excellence programme [BT/01/COE/05/03]; Indian Council of Agricultural Research Niche area of Excellence programme [10-(6)/2005 EPD]; Department of Biotechnology-University of Agricultural Sciences Biotech HUB [BT/INF/UAS Bangalore/2011]	Department of Biotechnology, Centre of Excellence programme; Indian Council of Agricultural Research Niche area of Excellence programme; Department of Biotechnology-University of Agricultural Sciences Biotech HUB	This work was supported by the Department of Biotechnology, Centre of Excellence programme support (BT/01/COE/05/03), the Indian Council of Agricultural Research Niche area of Excellence programme (F.No. 10-(6)/2005 EP&D), and the Department of Biotechnology-University of Agricultural Sciences Biotech HUB (Ref No. BT/INF/UAS Bangalore/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca D, 2001, J EXP BOT, V52, P1417, DOI 10.1093/jexbot/52.360.1417; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Anjum F., 2003, Pakistan Journal of Agricultural Sciences, V40, P45; Aroca R, 2008, MICROB ECOL, V56, P704, DOI 10.1007/s00248-008-9390-y; Ashraf M, 1996, INT J PLANT SCI, V157, P729, DOI 10.1086/297395; Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; Badawi M, 2008, PLANT CELL PHYSIOL, V49, P1237, DOI 10.1093/pcp/pcn100; Bartels D, 2001, PLANT PHYSIOL, V127, P1346, DOI 10.1104/pp.010765; Casaretto J, 2003, PLANT CELL, V15, P271, DOI 10.1105/tpc.007096; Chandler JW, 2009, PLANT MOL BIOL, V69, P57, DOI 10.1007/s11103-008-9405-6; CHAZEN O, 1995, PLANT CELL ENVIRON, V18, P727, DOI 10.1111/j.1365-3040.1995.tb00575.x; Chen J., 1994, MAIZE SCI, V2, P36; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Demidchik V, 2014, J EXP BOT, V65, P1259, DOI 10.1093/jxb/eru004; Du YL, 2013, FUNCT PLANT BIOL, V40, P494, DOI 10.1071/FP12250; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; Fairchild CD, 2000, GENE DEV, V14, P2377; Feng XM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-22; Fisher R.A., 1960, DESIGN EXPT, V7th; Fu XZ, 2011, ENVIRON EXP BOT, V74, P106, DOI 10.1016/j.envexpbot.2011.05.006; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Goding CR, 2000, GENE DEV, V14, P1712; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Heang D, 2012, BREEDING SCI, V62, P133, DOI 10.1270/jsbbs.62.133; Heang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031325; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hossain MA, 2010, PLANT MOL BIOL, V72, P557, DOI 10.1007/s11103-009-9592-9; Huang XS, 2013, PLANT PHYSIOL, V162, P1178, DOI 10.1104/pp.112.210740; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kirschbaum MUF, 2011, PLANT PHYSIOL, V155, P117, DOI 10.1104/pp.110.166819; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Li B, 2008, PLANT BIOTECHNOL J, V6, P146, DOI 10.1111/j.1467-7652.2007.00301.x; Li CY, 2004, ENVIRON EXP BOT, V51, P237, DOI 10.1016/j.envexpbot.2003.11.001; Li F, 2010, PLANT CELL REP, V29, P977, DOI 10.1007/s00299-010-0883-z; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lv S, 2008, PLANT CELL PHYSIOL, V49, P1150, DOI 10.1093/pcp/pcn090; MARCHETTI A, 1995, J MOL BIOL, V248, P541, DOI 10.1006/jmbi.1995.0241; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Meng L, 2010, MOL PLANT, V3, P760, DOI 10.1093/mp/ssq021; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nazarbeygi E., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P70; Negi NP, 2015, PLANT CELL REP, V34, P1109, DOI 10.1007/s00299-015-1770-4; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Noreen Z, 2009, ENVIRON EXP BOT, V67, P395, DOI 10.1016/j.envexpbot.2009.05.011; Payne CT, 2000, GENETICS, V156, P1349; Pillitteri LJ, 2007, BIOESSAYS, V29, P861, DOI 10.1002/bies.20625; Ramegowda HV, 2009, THESIS U AGR SCI BAN; Ramegowda V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040397; Rao RCN, 2001, J AGRON CROP SCI, V186, P175, DOI 10.1046/j.1439-037X.2001.00472.x; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sakamoto W, 2001, PLANT CELL PHYSIOL, V42, P982, DOI 10.1093/pcp/pce128; Senthil-Kumar M, 2007, J PLANT PHYSIOL, V164, P111, DOI 10.1016/j.jplph.2006.09.009; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; SHEN QX, 1993, J BIOL CHEM, V268, P23652; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; UMA S, 1995, ANN BOT-LONDON, V76, P43, DOI 10.1006/anbo.1995.1076; Wang W, 2004, TRENDS PLANT SCI, V9, P1360; Wang YJ, 2003, THEOR APPL GENET, V107, P1402, DOI 10.1007/s00122-003-1378-x; Wang YC, 2010, J PLANT PHYSIOL, V167, P222, DOI 10.1016/j.jplph.2009.09.008; Whittaker A, 2001, J EXP BOT, V52, P961, DOI 10.1093/jexbot/52.358.961; Ye NH, 2012, RICE, V5, DOI 10.1186/1939-8433-5-1; Zhou J, 2009, J PLANT PHYSIOL, V166, P1296, DOI 10.1016/j.jplph.2009.02.007	78	58	64	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137098	10.1371/journal.pone.0137098	http://dx.doi.org/10.1371/journal.pone.0137098			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366726	Green Submitted, gold, Green Published			2022-12-26	WOS:000361601100049
J	Cutler, T; Sarkar, A; Moran, M; Steffensmeier, A; Puli, OR; Mancini, G; Tare, M; Gogia, N; Singh, A				Cutler, Timothy; Sarkar, Ankita; Moran, Michael; Steffensmeier, Andrew; Puli, Oorvashi Roy; Mancini, Greg; Tare, Meghana; Gogia, Neha; Singh, Amit			Drosophila Eye Model to Study Neuroprotective Role of CREB Binding Protein (CBP) in Alzheimer's Disease	PLOS ONE			English	Article							PHOTORECEPTOR AXON GUIDANCE; RUBINSTEIN-TAYBI-SYNDROME; TRANSCRIPTIONAL COACTIVATOR; BETA OLIGOMERS; CELL; P300; ACETYLATION; CHROMATIN; TOXICITY; RETINA	Background The progressive neurodegenerative disorder Alzheimer's disease (AD) manifests as loss of cognitive functions, and finally leads to death of the affected individual. AD may result from accumulation of amyloid plaques. These amyloid plaques comprising of amyloid-beta 42 (A beta 42) polypeptides results from the improper cleavage of amyloid precursor protein (APP) in the brain. The A beta 42 plaques have been shown to disrupt the normal cellular processes and thereby trigger abnormal signaling which results in the death of neurons. However, the molecular-genetic mechanism(s) responsible for A beta 42 mediated neurodegeneration is yet to be fully understood. Methodology/Principal Findings We have utilized Gal4/UAS system to develop a transgenic fruit fly model for A beta 42 mediated neurodegeneration. Targeted misexpression of human A beta 42 in the differentiating photoreceptor neurons of the developing eye of transgenic fly triggers neurodegeneration. This progressive neurodegenerative phenotype resembles Alzheimer's like neuropathology. We identified a histone acetylase, CREB Binding Protein (CBP), as a genetic modifier of A beta 42 mediated neurodegeneration. Targeted misexpression of CBP along with A beta 42 in the differentiating retina can significantly rescue neurodegeneration. We found that gain-of-function of CBP rescues A beta 42 mediated neurodegeneration by blocking cell death. Misexpression of A beta 42 affects the targeting of axons from retina to the brain but misexpression of full length CBP along with A beta 42 can restore this defect. The CBP protein has multiple domains and is known to interact with many different proteins. Our structure function analysis using truncated constructs lacking one or more domains of CBP protein, in transgenic flies revealed that Bromo, HAT and polyglutamine (BHQ) domains together are required for the neuroprotective function of CBP. This BHQ domain of CBP has not been attributed to promote survival in any other neurodegenerative disorders. Conclusions/Significance We have identified CBP as a genetic modifier of A beta 42 mediated neurodegeneration. Furthermore, we have identified BHQ domain of CBP is responsible for its neuroprotective function. These studies may have significant bearing on our understanding of genetic basis of AD.	[Cutler, Timothy; Steffensmeier, Andrew; Mancini, Greg; Singh, Amit] Univ Dayton, Premed Program, Dayton, OH 45469 USA; [Sarkar, Ankita; Moran, Michael; Puli, Oorvashi Roy; Tare, Meghana; Gogia, Neha; Singh, Amit] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Singh, Amit] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA	University of Dayton; University of Dayton; University of Dayton	Singh, A (corresponding author), Univ Dayton, Premed Program, Dayton, OH 45469 USA.	asingh1@udayton.edu	Puli, Oorvashi G./N-7671-2017; Sarkar, Ankita/AAC-8549-2020; Singh, Amit/T-5619-2019; Gogia, Neha/S-4777-2019	Puli, Oorvashi G./0000-0003-0358-7428; Singh, Amit/0000-0002-2962-2255; Gogia, Neha/0000-0002-0544-1265	University of Dayton	University of Dayton	This work was supported by University of Dayton startup Support; University of Dayton Honors Program; and University of Dayton Graduate Program.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Akimaru H, 1997, NAT GENET, V17, P211, DOI 10.1038/ng1097-211; Anderson J, 2005, GENETICS, V171, P1655, DOI 10.1534/genetics.105.045450; [Anonymous], [No title captured]; Arensman MD, 2014, MOL CANCER THER, V13, P2303, DOI 10.1158/1535-7163.MCT-13-1005; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bantignies F, 2000, MOL CELL BIOL, V20, P9317, DOI 10.1128/MCB.20.24.9317-9330.2000; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barnes DE, 2011, ARCH NEUROL-CHICAGO, V68, P268, DOI 10.1001/archneurol.2011.4; Beduer A, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/2/024001; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Cauchi RJ, 2006, NEURODEGENER DIS, V3, P338, DOI 10.1159/000097303; Chan HM, 2001, J CELL SCI, V114, P2363; Chan KC, 2015, SCI REP-UK, V5, DOI 10.1038/srep09979; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Claeysen S, 2012, CELL SIGNAL, V24, P1831, DOI 10.1016/j.cellsig.2012.05.008; Cowan CM, 2010, BIOCHEM SOC T, V38, P988, DOI 10.1042/BST0380988; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Crowther DC, 2006, METHOD ENZYMOL, V412, P234, DOI 10.1016/S0076-6879(06)12015-7; Deng Z, 2003, MOL CELL BIOL, V23, P2633, DOI 10.1128/MCB.23.8.2633-2644.2003; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Goldman PS, 1997, RECENT PROG HORM RES, V52, P103; Goodman RH, 2000, GENE DEV, V14, P1553; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Iijima K, 2008, J ALZHEIMERS DIS, V15, P523; Iijima-Ando K, 2010, BRAIN STRUCT FUNCT, V214, P245, DOI 10.1007/s00429-009-0234-4; Janknecht R, 2002, HISTOL HISTOPATHOL, V17, P657, DOI 10.14670/HH-17.657; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kumar JP, 2004, GENETICS, V168, P877, DOI 10.1534/genetics.104.029850; Kumar JP, 2012, DEV DYNAM, V241, P136, DOI 10.1002/dvdy.23707; Kumar JP, 2011, DEV NEUROBIOL, V71, P1133, DOI 10.1002/dneu.20921; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; League GP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021218; Lee JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122628; Lilja T, 2003, DEV BIOL, V262, P294, DOI 10.1016/S0012-1606(03)00392-0; Ludlam WH, 2002, MOL CELL BIOL, V22, P3832, DOI 10.1128/MCB.22.11.3832-3841.2002; Mallik M, 2010, GENETICS, V184, P927, DOI 10.1534/genetics.109.113696; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Marek KW, 2000, NEURON, V25, P537, DOI 10.1016/S0896-6273(00)81058-2; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Meinertzhagen Ian A., 1993, P1363; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Moran MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080829; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Newsome TP, 2000, DEVELOPMENT, V127, P851; NORDHEIM A, 1994, NATURE, V370, P177, DOI 10.1038/370177a0; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Pena-Ortega F, 2015, PROTEIN AND PEPTIDE; Petrij F, 2000, AM J MED GENET, V92, P47, DOI 10.1002/(SICI)1096-8628(20000501)92:1<47::AID-AJMG8>3.0.CO;2-H; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Richardson ECN, 2010, DEVELOPMENT, V137, P641, DOI 10.1242/dev.041913; RINCONLIMAS DE, 2012, CURR PHARM DES; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Singh A, 2002, DEVELOPMENT, V129, P4271; Singh A, 2005, AD DEV BIOL, V14, P59, DOI 10.1016/S1574-3349(04)14004-0; Singh A, 2006, DEVELOPMENT, V133, P4771, DOI 10.1242/dev.02686; Singh A, 2012, DEV DYNAM, V241, P1, DOI 10.1002/dvdy.23712; Steffensmeier AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078717; Stronach B, 2005, DEV DYNAM, V232, P575, DOI 10.1002/dvdy.20283; Tare M., 2013, **DROPPED REF**, P37; Tare M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024361; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; Treisman JE, 1999, BIOESSAYS, V21, P843, DOI 10.1002/(SICI)1521-1878(199910)21:10<843::AID-BIES6>3.3.CO;2-A; Valor LM, 2013, CURR PHARM DESIGN, V19, P5051, DOI 10.2174/13816128113199990382; van Genderen MM, 2000, BRIT J OPHTHALMOL, V84, P1177, DOI 10.1136/bjo.84.10.1177; Vinters HV, 2015, ANNU REV PATHOL-MECH, V10, P291, DOI 10.1146/annurev-pathol-020712-163927; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Waltzer L, 1999, EMBO J, V18, P1630, DOI 10.1093/emboj/18.6.1630; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wolff Tanya, 1993, P1277; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	88	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137691	10.1371/journal.pone.0137691	http://dx.doi.org/10.1371/journal.pone.0137691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367392	gold, Green Submitted, Green Published			2022-12-26	WOS:000361601100110
J	Gomez-Laich, A; Yoda, K; Zavalaga, C; Quintana, F				Gomez-Laich, Agustina; Yoda, Ken; Zavalaga, Carlos; Quintana, Flavio			Selfies of Imperial Cormorants (Phalacrocorax atriceps): What Is Happening Underwater?	PLOS ONE			English	Article							FORAGING BEHAVIOR; GREAT CORMORANTS; DIVING PATTERNS; VISUAL-FIELDS; TOP PREDATOR; SHAGS; EYE; ATTACHMENT; STRATEGIES; MOVEMENTS	During the last few years, the development of animal-borne still cameras and video recorders has enabled researchers to observe what a wild animal sees in the field. In the present study, we deployed miniaturized video recorders to investigate the underwater foraging behavior of Imperial cormorants (Phalacrocorax atriceps). Video footage was obtained from 12 animals and 49 dives comprising a total of 8.1 h of foraging data. Video information revealed that Imperial cormorants are almost exclusively benthic feeders. While foraging along the seafloor, animals did not necessarily keep their body horizontal but inclined it downwards. The head of the instrumented animal was always visible in the videos and in the majority of the dives it was moved constantly forward and backward by extending and contracting the neck while travelling on the seafloor. Animals detected prey at very short distances, performed quick capture attempts and spent the majority of their time on the seafloor searching for prey. Cormorants foraged at three different sea bottom habitats and the way in which they searched for food differed between habitats. Dives were frequently performed under low luminosity levels suggesting that cormorants would locate prey with other sensory systems in addition to sight. Our video data support the idea that Imperial cormorants' efficient hunting involves the use of specialized foraging techniques to compensate for their poor underwater vision.	[Gomez-Laich, Agustina; Quintana, Flavio] Consejo Nacl Invest Cient & Tecn, Inst Biol Organismos Marinos IBIOMAR CENPAT, Puerto Madryn, Chubut, Argentina; [Yoda, Ken; Zavalaga, Carlos] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Zavalaga, Carlos] Univ Cient Sur, Fac Ciencias Ambientales, Lima 42, Peru; [Quintana, Flavio] Wildlife Conservat Soc, Buenos Aires, DF, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Nagoya University; Universidad Cientifica del Sur (CIENTIFICA)	Gomez-Laich, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol Organismos Marinos IBIOMAR CENPAT, Blvd Brown 2915,U9120ACD, Puerto Madryn, Chubut, Argentina.	agomezlaich@cenpat-conicet.gob.ar		Quintana, Flavio/0000-0003-0696-2545	Wildlife Conservation Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica; Japan Society for Promotion of Science	Wildlife Conservation Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by grants from the Wildlife Conservation Society, Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET) and Agencia Nacional de Promocion Cientifica y Tecnologica to F. Quintana, and by the Japan Society for Promotion of Science to C. Zavalaga and K. Yoda.	BANNASCH R, 1994, J EXP BIOL, V194, P83; Bannasch R, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P141; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Charrassin JB, 2001, MAR ECOL PROG SER, V221, P285, DOI 10.3354/meps221285; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; Cronin TW, 2007, J ORNITHOL, V148, pS563, DOI 10.1007/s10336-007-0199-0; CROXALL JP, 1991, J ZOOL, V225, P177, DOI 10.1111/j.1469-7998.1991.tb03810.x; Davis RW, 2001, COMP BIOCHEM PHYS A, V129, P759, DOI 10.1016/S1095-6433(01)00345-2; Davis RW, 2004, POLAR RES E, V58, P148; Dmytryk R, 2012, WILDLIFE SEARCH RESC; FRIEDMAN MB, 1975, NATURE, V255, P67, DOI 10.1038/255067a0; FROST BJ, 1978, J EXP BIOL, V74, P187; Fujita M, 2006, J COMP PHYSIOL A, V192, P481, DOI 10.1007/s00359-005-0083-4; Laich AG, 2012, J ORNITHOL, V153, P139, DOI 10.1007/s10336-011-0714-1; Gomez-Laich A, 2013, MAR BIOL, V160, P1697, DOI 10.1007/s00227-013-2222-8; Gremillet D, 2005, BIOL LETTERS, V1, P469, DOI 10.1098/rsbl.2005.0356; Gremillet D, 2012, AQUAT BIOL, V15, P187, DOI 10.3354/ab00430; Gunji M, 2013, J COMP PHYSIOL A, V199, P703, DOI 10.1007/s00359-013-0828-4; Harris S, 2014, EMU, V114, P222, DOI 10.1071/MU13059; Harris S, 2013, MAR BIOL, V160, P1249, DOI 10.1007/s00227-013-2177-9; Irigoyen AJ, 2011, BIOL INVASIONS, V13, P17, DOI 10.1007/s10530-010-9780-1; Johnson C, 2007, PRACTICAL ZONE SYSTE; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kokubun N, 2010, AQUAT BIOL, V8, P289, DOI 10.3354/ab00243; Malacalza Viviana E., 1995, Ornitologia Neotropical, V5, P91; MARTIN GR, 1991, BRAIN BEHAV EVOLUT, V37, P65, DOI 10.1159/000114347; MARTIN GR, 1984, PROC R SOC SER B-BIO, V223, P197, DOI 10.1098/rspb.1984.0090; Martin GR, 2008, IBIS, V150, P485, DOI 10.1111/j.1474-919X.2008.00808.x; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Moll RJ, 2009, COMPUT ELECTRON AGR, V66, P133, DOI 10.1016/j.compag.2009.01.001; Parker G., 1997, MAR ARGENTINO SUS RE, V1, P65; Pelletier D, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031768, DOI 10.1371/J0URNAL.P0NE.0031768]; Ponganis PJ, 2000, J EXP BIOL, V203, P3275; Quillfeldt P, 2011, MAR ECOL PROG SER, V428, P271, DOI 10.3354/meps09058; Quintana F, 2011, OIKOS, V120, P350, DOI 10.1111/j.1600-0706.2010.18387.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007322; Shepard ELC, 2010, AQUAT BIOL, V8, P259, DOI 10.3354/ab00232; Strod T, 2004, CURR BIOL, V14, pR376, DOI 10.1016/j.cub.2004.05.009; Svagelj WS, 2007, WATERBIRDS, V30, P97, DOI 10.1675/1524-4695(2007)030[0097:SSDASD]2.0.CO;2; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Tremblay Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088424; Troje NF, 2000, J EXP BIOL, V203, P935; VOSLAMBER B, 1995, ARDEA, V83, P213; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Watanuki Y, 2004, MAR BIOL, V145, P427, DOI 10.1007/s00227-004-1345-3; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; White CR, 2008, IBIS, V150, P231, DOI 10.1111/j.1474-919X.2008.00837.x; White CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000639; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 2002, ANIM BEHAV, V63, P85, DOI 10.1006/anbe.2001.1883; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Wilson RP, 1986, J WILDLIFE MANAGE, V54, P447; Yoda K, 2012, MAR ECOL PROG SER, V466, P249, DOI 10.3354/meps09939; Yoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019602	59	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136980	10.1371/journal.pone.0136980	http://dx.doi.org/10.1371/journal.pone.0136980			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367384	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100040
J	Martins, VT; Chavez-Fumagalli, MA; Lage, DP; Duarte, MC; Garde, E; Costa, LE; da Silva, VG; Oliveira, JS; de Magalhaes-Soares, DF; Teixeira, SMR; Fernandes, AP; Soto, M; Tavares, CAP; Coelho, EAF				Martins, Vivian Tamietti; Chavez-Fumagalli, Miguel Angel; Lage, Daniela Pagliara; Duarte, Mariana Costa; Garde, Esther; Costa, Lourena Emanuele; da Silva, Viviane Gomes; Oliveira, Jamil Silvano; de Magalhaes-Soares, Danielle Ferreira; Ribeiro Teixeira, Santuza Maria; Fernandes, Ana Paula; Soto, Manuel; Pereira Tavares, Carlos Alberto; Ferraz Coelho, Eduardo Antonio			Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; T-CELL RESPONSE; IMMUNE-RESPONSES; CUTANEOUS LEISHMANIASIS; BALB/C MICE; CANINE LEISHMANIASIS; BRAZILIAN DOGS; VACCINE; INFECTION; CHAGASI	In the present study, two Leishmania infantum hypothetical proteins present in the amastigote stage, LiHyp1 and LiHyp6, were combined with a promastigote protein, IgE-dependent histamine-releasing factor (HRF); to compose a polyproteins vaccine to be evaluated against L. infantum infection. Also, the antigenicity of the three proteins was analyzed, and their use for the serodiagnosis of canine visceral leishmaniasis (CVL) was evaluated. The LiHyp1, LiHyp6, and HRF DNA coding sequences were cloned in prokaryotic expression vectors and the recombinant proteins were purified. When employed in ELISA assays, all proteins were recognized by sera from visceral leishmaniasis (VL) dogs, and presented no cross-reactivity with either sera from dogs vaccinated with a Brazilian commercial vaccine, or sera of Trypanosoma cruzi-infected or Ehrlichia canis-infected animals. In addition, the antigens were not recognized by antibodies from non-infected animals living in endemic or non-endemic areas for leishmaniasis. The immunogenicity and protective efficacy of the three proteins administered in the presence of saponin, individually or in combination (composing a polyproteins vaccine), were evaluated in a VL murine model: BALB/c mice infected with L. infantum. Spleen cells from mice inoculated with the individual proteins or with the polyproteins vaccine plus saponin showed a protein-specific production of IFN-gamma, IL-12, and GM-CSF after an in vitro stimulation, which was maintained after infection. These animals presented significant reductions in the parasite burden in different evaluated organs, when compared to mice inoculated with saline or saponin. The decrease in parasite burden was associated with an IL-12-dependent production of IFN-gamma against parasite total extracts (produced mainly by CD4(+) T cells), correlated to the induction of parasite proteins-driven NO production. Mice inoculated with the recombinant protein-based vaccines showed also high levels of parasite-specific IgG2a antibodies. The polyproteins vaccine administration induced a more pronounced Th1 response before and after challenge infection than individual vaccines, which was correlated to a higher control of parasite dissemination to internal organs.	[Martins, Vivian Tamietti; da Silva, Viviane Gomes; Oliveira, Jamil Silvano; Ribeiro Teixeira, Santuza Maria; Pereira Tavares, Carlos Alberto] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Chavez-Fumagalli, Miguel Angel; Duarte, Mariana Costa; Costa, Lourena Emanuele; Ferraz Coelho, Eduardo Antonio] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil; [Lage, Daniela Pagliara; Duarte, Mariana Costa; Ferraz Coelho, Eduardo Antonio] Univ Fed Minas Gerais, COLTEC, Dept Patol Clin, Belo Horizonte, MG, Brazil; [Garde, Esther; Soto, Manuel] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [de Magalhaes-Soares, Danielle Ferreira] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Belo Horizonte, MG, Brazil; [Fernandes, Ana Paula] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Coelho, EAF (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.	eduardoferrazcoelho@yahoo.com.br	COELHO, EA/V-7926-2017; Fumagalli, Miguel Angel Chávez/AAI-9413-2020; Chávez Fumagalli, Miguel Angel/I-6756-2016; Álvarez, Manuel Soto/Q-5234-2018	COELHO, EA/0000-0002-6681-9014; Fumagalli, Miguel Angel Chávez/0000-0002-8394-4802; Chávez Fumagalli, Miguel Angel/0000-0002-8394-4802; Álvarez, Manuel Soto/0000-0001-6825-841X	Pro-Reitoria de Pesquisa from UFMG [Edital 01/2014]; Instituto Nacional de Ciencia e Tecnologia em Nanobiofarmaceutica (INCT-Nanobiofar); FAPEMIG [CBB-APQ-00819-12]; CNPq [APQ-472090/2011-9, APQ-482976/2012-8, APQ-488237/2013-0]; FAPEMIG/CAPES; CNPq; Ministerio de Ciencia e Innovacion [FIS PI14/00366]	Pro-Reitoria de Pesquisa from UFMG; Instituto Nacional de Ciencia e Tecnologia em Nanobiofarmaceutica (INCT-Nanobiofar); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from Pro-Reitoria de Pesquisa from UFMG (Edital 01/2014), Instituto Nacional de Ciencia e Tecnologia em Nanobiofarmaceutica (INCT-Nanobiofar), FAPEMIG (CBB-APQ-00819-12), and CNPq (APQ-472090/2011-9, APQ-482976/2012-8, APQ-488237/2013-0). MACF is a grant recipient of FAPEMIG/CAPES. EAFC, APF and SMRT are grant recipient of CNPq. This study was also, in part, supported in Spain by grants from Ministerio de Ciencia e Innovacion (FIS PI14/00366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; Agallou M, 2012, VACCINE, V30, P5086, DOI 10.1016/j.vaccine.2012.05.075; Alves Waneska Alexandre, 2004, Cad. Saúde Pública, V20, P259, DOI 10.1590/S0102-311X2004000100043; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Baharia RK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003557; Balaraman S, 2004, BIOCHEM BIOPH RES CO, V317, P639, DOI 10.1016/j.bbrc.2004.03.097; Barbieri CL, 2006, PARASITE IMMUNOL, V28, P329, DOI 10.1111/j.1365-3024.2006.00840.x; Bayih AG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003391; Beaumier CM, 2013, TRANSL RES, V162, P144, DOI 10.1016/j.trsl.2013.03.006; Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrion J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-150; Cerpa-Cruz SS, 2013, IMMUNOL RES, V56, P299, DOI 10.1007/s12026-013-8400-4; Chavez-Fumagalli MA, 2010, MICROBES INFECT, V12, P967, DOI 10.1016/j.micinf.2010.06.008; Ciaramella P, 1997, VET REC, V141, P539, DOI 10.1136/vr.141.21.539; Coelho EAF, 2003, INFECT IMMUN, V71, P3988, DOI 10.1128/IAI.71.7.3988-3994.2003; Coelho VTS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001430; Costa LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110014; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Das A, 2012, EXPERT REV VACCINES, V11, P783, DOI [10.1586/ERV.12.50, 10.1586/erv.12.50]; Pereira NCD, 2015, EXP PARASITOL, V153, P180, DOI 10.1016/j.exppara.2015.03.027; Dumas C, 2003, INFECT IMMUN, V71, P6499, DOI 10.1128/IAI.71.11.6499-6509.2003; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Fernandes AP, 2012, CURR OPIN MICROBIOL, V15, P476, DOI 10.1016/j.mib.2012.05.002; Figueiredo FB, 2010, REV INST MED TROP SP, V52, P193, DOI 10.1590/S0036-46652010000400005; Follador I, 2002, VACCINE, V20, P1365, DOI 10.1016/S0264-410X(01)00469-8; Galli V, 2013, CLIN VACCINE IMMUNOL, V20, P1370, DOI 10.1128/CVI.00140-13; GarciaAlonso M, 1996, PARASITE IMMUNOL, V18, P539, DOI 10.1046/j.1365-3024.1996.d01-28.x; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GREEN SJ, 1990, IMMUNOL LETT, V25, P15, DOI 10.1016/0165-2478(90)90083-3; Iborra S, 2008, MICROBES INFECT, V10, P1133, DOI 10.1016/j.micinf.2008.06.002; Joshi J, 2014, PARASITOLOGY, V141, P554, DOI 10.1017/S0031182013001959; Kang HS, 2001, J IMMUNOL, V166, P6545, DOI 10.4049/jimmunol.166.11.6545; Kang JA, 2014, IMMUNOLOGY, V143, P550, DOI 10.1111/imm.12333; Kaur S, 2008, PARASITOL RES, V103, P1413, DOI 10.1007/s00436-008-1150-x; Kharazmi A, 1999, IMMUNOL LETT, V65, P105, DOI 10.1016/S0165-2478(98)00132-1; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Martins VT, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002148, 10.1371/annotation/427655ac-c278-41f5-95ca-6279c562752f]; Mettler M, 2005, J CLIN MICROBIOL, V43, P5515, DOI 10.1128/JCM.43.11.5515-5519.2005; Minodier Philippe, 2007, Travel Med Infect Dis, V5, P150, DOI 10.1016/j.tmaid.2006.09.004; Miro G, 2007, PARASITOL RES, V101, P253, DOI 10.1007/s00436-007-0497-8; Miro G, 2008, TRENDS PARASITOL, V24, P371, DOI 10.1016/j.pt.2008.05.003; Murphy ML, 2001, EUR J IMMUNOL, V31, P2848, DOI 10.1002/1521-4141(2001010)31:10&lt;2848::AID-IMMU2848&gt;3.0.CO;2-T; MURRAY HW, 1995, J CLIN INVEST, V95, P1183, DOI 10.1172/JCI117767; Murray HW, 2002, INFECT IMMUN, V70, P6284, DOI 10.1128/IAI.70.11.6284-6293.2002; Mutiso JM, 2013, J BIOMED RES, V27, P85, DOI [10.7555/BR.27.20120064, 10.7555/JBR.27.20120064]; Oliveira DM, 2012, PARASITOL RES, V110, P1277, DOI 10.1007/s00436-011-2628-5; Oliveira LF, 2011, ACTA TROP, V118, P87, DOI 10.1016/j.actatropica.2011.02.007; Palatnik-de-Sousa CB, 2008, EXPERT REV VACCINES, V7, P833, DOI 10.1586/14760584.7.6.833; RACHAMIM N, 1993, J IMMUNOL, V150, P2322; Ramirez L, 2013, VACCINE, V31, P1312, DOI 10.1016/j.vaccine.2012.12.071; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Resende DM, 2008, VACCINE, V26, P4585, DOI 10.1016/j.vaccine.2008.05.091; Saljoughian N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002174; Pereira BAS, 2008, VET PARASITOL, V158, P239, DOI 10.1016/j.vetpar.2008.09.015; Soudi S, 2011, PARASITE IMMUNOL, V33, P561, DOI 10.1111/j.1365-3024.2011.01318.x; Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Strauss-Ayali D, 2004, J INFECT DIS, V189, P1729, DOI 10.1086/383281; Tavares CAP, 2003, EXPERT REV MOL DIAGN, V3, P657, DOI 10.1586/14737159.3.5.657; Tsenova L, 2006, INFECT IMMUN, V74, P2392, DOI 10.1128/IAI.74.4.2392-2401.2006; Weiss WR, 1998, J IMMUNOL, V161, P2325; Wenzel UA, 2012, FASEB J, V26, P29, DOI 10.1096/fj.11-184895; WHO, 2010, WHO TECH REP SER, V949, P1; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Zahedifard F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002751; Zanin FHC, 2007, MICROBES INFECT, V9, P1070, DOI 10.1016/j.micinf.2007.05.012	70	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137683	10.1371/journal.pone.0137683	http://dx.doi.org/10.1371/journal.pone.0137683			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367128	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100108
J	Zhang, PF				Zhang, Peifeng			Spatiotemporal Features of the Three-Dimensional Architectural Landscape in Qingdao, China	PLOS ONE			English	Article							URBAN LAND EXPANSION; LIDAR DATA; DYNAMICS; IMAGERY; EXTRACTION; FUSION; SCENES; SAR; GIS	The evolution and development of the three-dimensional (3D) architectural landscape is the basis of proper urban planning, eco-environment construction and the improvement of environmental quality. This paper presents the spatiotemporal characteristics of the 3D architectural landscape of the Shinan and Shibei districts in Qingdao, China, based on buildings' 3D information extracted from Quickbird images from 2003 to 2012, supported by Barista, landscape metrics and GIS. The results demonstrated that: (1) Shinan and Shibei districts expanded vertically and urban land use intensity increased noticeably from year to year. (2) Significant differences in the 3D architectural landscape existed among the western, central and eastern regions, and among the 26 sub-districts over the study period. The differentiation was consistent with the diverse development history, function and planning of the two districts. Finally, we found that population correlates positively with the variation in the 3D architectural landscape. This research provides an important reference for related studies, urban planning and eco-city construction.	China Univ Petr, Coll Pipeline & Civil Engn, Qingdao, Shandong, Peoples R China	China University of Petroleum	Zhang, PF (corresponding author), China Univ Petr, Coll Pipeline & Civil Engn, Qingdao, Shandong, Peoples R China.	windzpf@163.com			Projects of National Natural Science Foundation of China [41301198]; Fundamental Research Funds for the Central Universities [14CX02081A]	Projects of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the Projects of National Natural Science Foundation of China (41301198) and the Fundamental Research Funds for the Central Universities (14CX02081A).	Aguilera F, 2011, LANDSCAPE URBAN PLAN, V99, P226, DOI 10.1016/j.landurbplan.2010.10.004; Awrangjeb M, 2010, ISPRS J PHOTOGRAMM, V65, P457, DOI 10.1016/j.isprsjprs.2010.06.001; Baillard C, 1999, COMPUT VIS IMAGE UND, V76, P244, DOI 10.1006/cviu.1999.0793; Chen JF, 2014, HABITAT INT, V43, P61, DOI 10.1016/j.habitatint.2014.01.004; Cici A, 2009, COMPUTERS ENV URBAN, V33, P285; Dell'Acqua F, 2009, ISPRS J PHOTOGRAMM, V64, P482, DOI 10.1016/j.isprsjprs.2008.09.006; Giilch E., 1999, INT ARCH PHOTOGRAMME, V32, P177, DOI 10.1.1.115.8061; Hanley H., 2004, PROC 20 ISPRS C, P24; Haregeweyn N, 2012, LANDSCAPE URBAN PLAN, V106, P149, DOI 10.1016/j.landurbplan.2012.02.016; Jiang L, 2012, LANDSCAPE URBAN PLAN, V108, P131, DOI 10.1016/j.landurbplan.2012.08.008; Kim J, 2011, INT J REMOTE SENS, V32, P2245, DOI 10.1080/01431161003698237; Li L, 2003, LANDSCAPE URBAN PLAN, V64, P67, DOI 10.1016/S0169-2046(02)00201-3; Li XW, 2010, PROCEDIA ENVIRON SCI, V2, P1139, DOI 10.1016/j.proenv.2010.10.123; Li YF, 2014, REG ENVIRON CHANGE, V14, P1175, DOI 10.1007/s10113-013-0552-1; Li YF, 2010, LANDSCAPE URBAN PLAN, V94, P218, DOI 10.1016/j.landurbplan.2009.10.006; Liu ZF, 2012, LANDSCAPE URBAN PLAN, V106, P62, DOI 10.1016/j.landurbplan.2012.02.013; Ma YL, 2010, HABITAT INT, V34, P228, DOI 10.1016/j.habitatint.2009.09.007; Nassar AK, 2014, COMPUT ENVIRON URBAN, V45, P50, DOI 10.1016/j.compenvurbsys.2014.02.005; Rottensteiner F, 2002, INT ARCH PHOTOGRAMM, DOI DOI 10.3390/S120506347; Soergel U, 2009, ISPRS J PHOTOGRAMM, V64, P490, DOI 10.1016/j.isprsjprs.2008.10.007; Sohn G, 2007, ISPRS J PHOTOGRAMM, V62, P43, DOI 10.1016/j.isprsjprs.2007.01.001; Suveg I, 2002, P SPIE INT SOC OPTIC; Trisirisatayawong I, 2004, ISPRS 20 C 12 23 JUL; Tupin F, 2003, ISPRS J PHOTOGRAMM, V58, P71, DOI 10.1016/S0924-2716(03)00018-2; VOSSELMAN G, 2001, INT ARCH PHOTOGRAMME, V34, P37; Vozikis G, 2003, PUBLIKATIONEN DTSCH, V12, P179; Willneff J., 2006, 13 AUSTR REM SENS PH; WILLNEFF J., INT ARCH PHOTOGRAMME, V36; Xiao JY, 2006, LANDSCAPE URBAN PLAN, V75, P69, DOI 10.1016/j.landurbplan.2004.12.005; Xu XL, 2013, CITIES, V35, P104, DOI 10.1016/j.cities.2013.05.002; Yang XM, 2006, DYNAM CONT DIS SER A, V13, P1418; Yu BL, 2010, LANDSCAPE URBAN PLAN, V98, P210, DOI 10.1016/j.landurbplan.2010.08.004; Zhang PF, 2014, J INDIAN SOC REMOTE, V42, P409, DOI 10.1007/s12524-013-0315-y	33	10	12	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137853	10.1371/journal.pone.0137853	http://dx.doi.org/10.1371/journal.pone.0137853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361016	gold, Green Published			2022-12-26	WOS:000361043100095
J	Sanchez-Lopez, E; Flashner-Abramson, E; Shalapour, S; Zhong, Z; Taniguchi, K; Levitzki, A; Karin, M				Sanchez-Lopez, E.; Flashner-Abramson, E.; Shalapour, S.; Zhong, Z.; Taniguchi, K.; Levitzki, A.; Karin, M.			Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling	ONCOGENE			English	Article							FACTOR-I RECEPTOR; COLITIS-ASSOCIATED CANCER; ADENOMATOUS POLYPS; CIRCULATING LEVELS; MOUSE MODEL; GROWTH; TUMORIGENESIS; METASTASIS; ACTIVATION; CELLS	The tumor microenvironment (TME) exerts critical pro-tumorigenic effects through cytokines and growth factors that support cancer cell proliferation, survival, motility and invasion. Insulin-like growth factor-1 (IGF-1) and signal transducer and activator of transcription 3 (STAT3) stimulate colorectal cancer development and progression via cell autonomous and microenvironmental effects. Using a unique inhibitor, NT157, which targets both IGF-1 receptor (IGF-1R) and STAT3, we show that these pathways regulate many TME functions associated with sporadic colonic tumorigenesis in CPC-APC mice, in which cancer development is driven by loss of the Apc tumor suppressor gene. NT157 causes a substantial reduction in tumor burden by affecting cancer cells, cancer-associated fibroblasts (CAF) and myeloid cells. Decreased cancer cell proliferation and increased apoptosis were accompanied by inhibition of CAF activation and decreased inflammation. Furthermore, NT157 inhibited expression of protumorigenic cytokines, chemokines and growth factors, including IL-6, IL-11 and IL-23 as well as CCL2, CCL5, CXCL7, CXCL5, ICAM1 and TGF beta; decreased cancer cell migratory activity and reduced their proliferation in the liver. NT157 represents a new class of anticancer drugs that affect both the malignant cell and its supportive microenvironment.	[Sanchez-Lopez, E.; Shalapour, S.; Zhong, Z.; Taniguchi, K.; Karin, M.] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Sanchez-Lopez, E.; Shalapour, S.; Zhong, Z.; Taniguchi, K.; Karin, M.] Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Flashner-Abramson, E.; Levitzki, A.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel; [Taniguchi, K.] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Hebrew University of Jerusalem; Keio University	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Sanchez-Lopez, Elsa/A-7131-2017	Sanchez-Lopez, Elsa/0000-0002-4236-1985; Zhong, Zhenyu/0000-0002-9441-7645	Sara Borrell fellowship ISCIII/MICINN program; ERC Advanced Grant [249898]; NIH grants [AI043477, CA118165]; NATIONAL CANCER INSTITUTE [R01CA118165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER	Sara Borrell fellowship ISCIII/MICINN program; ERC Advanced Grant(European Research Council (ERC)); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	ESL was supported by Sara Borrell fellowship ISCIII/MICINN program. SS and ZZ are CRI Irvington postdoctoral fellows. KT is Uehara Memorial Foundation Fellow. AL and EFA were supported by ERC Advanced Grant (249898) to AL. Research was supported by NIH grants (AI043477 and CA118165) to MK, who is an American Cancer Society Research Professor and holds the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases.	Albanell J, 2001, JNCI-J NATL CANCER I, V93, P1830, DOI 10.1093/jnci/93.24.1830; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chan B, 2008, J MAMMARY GLAND BIOL, V13, P415, DOI 10.1007/s10911-008-9101-9; Chang Q, 2002, CANCER RES, V62, P6035; Esposito DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036190; Feng QY, 2014, WORLD J GASTROENTERO, V20, P4263, DOI 10.3748/wjg.v20.i15.4263; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Heron-Milhavet L, 2002, J BIOL CHEM, V277, P15600, DOI 10.1074/jbc.M111142200; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Huang F, 2012, CLIN CANCER RES, V18, P1156, DOI 10.1158/1078-0432.CCR-11-1135; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103551; Lee KW, 2015, CANCER RES, V75, P73, DOI 10.1158/0008-5472.CAN-14-0350; Maeda S, 2009, HEPATOLOGY, V50, P1851, DOI 10.1002/hep.23199; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Ollberding NJ, 2012, CANCER EPIDEM BIOMAR, V21, P810, DOI 10.1158/1055-9965.EPI-11-1105; Peretz S, 2001, P NATL ACAD SCI USA, V98, P1676, DOI 10.1073/pnas.041416598; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Prager GW, 2012, HAMOSTASEOLOGIE, V32, P105, DOI 10.5482/ha-1163; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ramocki NM, 2008, ENDOCRINOLOGY, V149, P261, DOI 10.1210/en.2007-0869; Reuveni H, 2013, CANCER RES, V73, P4383, DOI 10.1158/0008-5472.CAN-12-3385; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Ryan PD, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.2007-0199; Schlussel AT, 2014, J GASTROINTEST ONCOL, V5, P326, DOI 10.3978/j.issn.2078-6891.2014.069; Shiratsuchi I, 2011, ANTICANCER RES, V31, P2541; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Soubry A, 2012, INT J CANCER, V131, P512, DOI 10.1002/ijc.26393; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Surmacz E, 2003, ONCOGENE, V22, P6589, DOI 10.1038/sj.onc.1206772; Tang Z, 2008, AM J SURG, V196, P690, DOI 10.1016/j.amjsurg.2008.08.001; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Woodson K, 2004, JNCI-J NATL CANCER I, V96, P407, DOI 10.1093/jnci/djh042; Xiong H, 2014, INT J CANCER, V134, P2030, DOI 10.1002/ijc.28539; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006; Zhou SL, 2014, CARCINOGENESIS, V35, P597, DOI 10.1093/carcin/bgt397; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200	50	95	104	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 19	2016	35	20					2634	2644		10.1038/onc.2015.326	http://dx.doi.org/10.1038/onc.2015.326			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GS	26364612	Green Submitted, Green Accepted			2022-12-26	WOS:000376165700010
J	Atagi, Y; Liu, CC; Painter, MM; Chen, XF; Verbeeck, C; Zheng, HH; Li, X; Rademakers, R; Kang, SS; Xu, HX; Younkin, S; Das, P; Fryer, JD; Bu, GJ				Atagi, Yuka; Liu, Chia-Chen; Painter, Meghan M.; Chen, Xiao-Fen; Verbeeck, Christophe; Zheng, Honghua; Li, Xia; Rademakers, Rosa; Kang, Silvia S.; Xu, Huaxi; Younkin, Steven; Das, Pritam; Fryer, John D.; Bu, Guojun			Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; TYPE-4 ALLELE; R47H VARIANT; RISK-FACTOR; A-BETA; BRAIN; ASSOCIATION; CLEARANCE; APOE	Several heterozygous missense mutations in the triggering receptor expressed on myeloid cells 2 (TREM2) have recently been linked to risk for a number of neurological disorders including Alzheimer disease (AD), Parkinson disease, and frontotemporal dementia. These discoveries have re-ignited interest in the role of neuroinflammation in the pathogenesis of neurodegenerative diseases. TREM2 is highly expressed in microglia, the resident immune cells of the central nervous system. Along with its adaptor protein, DAP12, TREM2 regulates inflammatory cytokine release and phagocytosis of apoptotic neurons. Here, we report apolipoprotein E (apoE) as a novel ligand for TREM2. Using a biochemical assay, we demonstrated high-affinity binding of apoE to human TREM2. The functional significance of this binding was highlighted by increased phagocytosis of apoE-bound apoptotic N2a cells by primary microglia in a manner that depends on TREM2 expression. Moreover, when the AD-associated TREM2-R47H mutant was used in biochemical assays, apoE binding was vastly reduced. Our data demonstrate that apoE-TREM2 interaction in microglia plays critical roles in modulating phagocytosis of apoE-bound apoptotic neurons and establish a critical link between two proteins whose genes are strongly linked to the risk for AD.	[Atagi, Yuka; Liu, Chia-Chen; Painter, Meghan M.; Verbeeck, Christophe; Li, Xia; Rademakers, Rosa; Kang, Silvia S.; Younkin, Steven; Das, Pritam; Fryer, John D.; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Fryer, John D.; Bu, Guojun] Mayo Clin, Neurobiol Dis Grad Program, Jacksonville, FL 32224 USA; [Liu, Chia-Chen; Chen, Xiao-Fen; Zheng, Honghua; Xu, Huaxi; Bu, Guojun] Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China	Mayo Clinic; Mayo Clinic; Xiamen University	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu	Xu, Huaxi/AAV-7177-2021; Regan, Clinton/E-6250-2012		National Institutes of Health [R01AG027924, R01AG035355, R01AG046205, P01AG30128, P01NS074969, P50AG016574]; Alzheimer's Association; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128, RF1AG051504, R01AG027924, P50AG016574, R01AG035355, R01AG046205, RF1AG046205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG027924, R01AG035355, R01AG046205, P01AG30128, P01NS074969, and P50AG016574 (to G. B.), and grants from the Alzheimer's Association and Cure Alzheimer's Fund (to G. B.). We declare no competing financial interests.	Benitez BA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.018; Borroni B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.017; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Casey CS, 2015, J BIOL CHEM, V290, P14208, DOI 10.1074/jbc.M114.625251; Chaussenot A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.022; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Giraldo M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.02.016; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jin SC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0016-9; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kondo T, 2002, NEUROLOGY, V59, P1105, DOI 10.1212/WNL.59.7.1105; Korvatska O, 2015, JAMA NEUROL, V72, P920, DOI 10.1001/jamaneurol.2015.0979; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Neumann H, 2013, NEW ENGL J MED, V368, P182, DOI 10.1056/NEJMe1213157; Ortega-Cubero S, 2015, PARKINSONISM RELAT D, V21, P306, DOI 10.1016/j.parkreldis.2014.12.010; Page KJ, 1998, NEUROSCIENCE, V85, P1161, DOI 10.1016/S0306-4522(97)00661-1; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Petegnief V, 2001, NEUROSCIENCE, V104, P223, DOI 10.1016/S0306-4522(01)00046-X; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Rosenthal SL, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.04.012; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986; Zhu W, 2010, J NEUROCHEM, V114, P386, DOI 10.1111/j.1471-4159.2010.06763.x	53	269	274	4	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26043	26050		10.1074/jbc.M115.679043	http://dx.doi.org/10.1074/jbc.M115.679043			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26374899	hybrid, Green Published			2022-12-26	WOS:000363527300025
J	Reddy, A; Growney, JD; Wilson, NS; Emery, CM; Johnson, JA; Ward, R; Monaco, KA; Korn, J; Monahan, JE; Stump, MD; Mapa, FA; Wilson, CJ; Steiger, J; Ledell, J; Rickles, RJ; Myer, VE; Ettenberg, SA; Schlegel, R; Sellers, WR; Huet, HA; Lehar, J				Reddy, Anupama; Growney, Joseph D.; Wilson, Nick S.; Emery, Caroline M.; Johnson, Jennifer A.; Ward, Rebecca; Monaco, Kelli A.; Korn, Joshua; Monahan, John E.; Stump, Mark D.; Mapa, Felipa A.; Wilson, Christopher J.; Steiger, Janine; Ledell, Jebediah; Rickles, Richard J.; Myer, Vic E.; Ettenberg, Seth A.; Schlegel, Robert; Sellers, William R.; Huet, Heather A.; Lehar, Joseph			Gene Expression Ratios Lead to Accurate and Translatable Predictors of DR5 Agonism across Multiple Tumor Lineages	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MEDIATED APOPTOSIS; CANCER; CELLS; OVEREXPRESSION; APO2L/TRAIL; SENSITIVITY; CLASSIFIER; RESISTANCE; CLEAVAGE	Death Receptor 5 (DR5) agonists demonstrate anti-tumor activity in preclinical models but have yet to demonstrate robust clinical responses. A key limitation may be the lack of patient selection strategies to identify those most likely to respond to treatment. To overcome this limitation, we screened a DR5 agonist Nanobody across >600 cell lines representing 21 tumor lineages and assessed molecular features associated with response. High expression of DR5 and Casp8 were significantly associated with sensitivity, but their expression thresholds were difficult to translate due to low dynamic ranges. To address the translational challenge of establishing thresholds of gene expression, we developed a classifier based on ratios of genes that predicted response across lineages. The ratio classifier outperformed the DR5+Casp8 classifier, as well as standard approaches for feature selection and classification using genes, instead of ratios. This classifier was independently validated using 11 primary patient-derived pancreatic xenograft models showing perfect predictions as well as a striking linearity between prediction probability and anti-tumor response. A network analysis of the genes in the ratio classifier captured important biological relationships mediating drug response, specifically identifying key positive and negative regulators of DR5 mediated apoptosis, including DR5, CASP8, BID, cFLIP, XIAP and PEA15. Importantly, the ratio classifier shows translatability across gene expression platforms (from Affymetrix microarrays to RNA-seq) and across model systems (in vitro to in vivo). Our approach of using gene expression ratios presents a robust and novel method for constructing translatable biomarkers of compound response, which can also probe the underlying biology of treatment response.	[Reddy, Anupama; Growney, Joseph D.; Wilson, Nick S.; Emery, Caroline M.; Johnson, Jennifer A.; Ward, Rebecca; Monaco, Kelli A.; Korn, Joshua; Monahan, John E.; Stump, Mark D.; Mapa, Felipa A.; Wilson, Christopher J.; Myer, Vic E.; Ettenberg, Seth A.; Schlegel, Robert; Sellers, William R.; Huet, Heather A.; Lehar, Joseph] Novartis Inst Biomed Res, Cambridge, MA USA; [Steiger, Janine; Ledell, Jebediah; Rickles, Richard J.] Horizon CombinatoRx, Cambridge, MA USA	Novartis	Reddy, A (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	anupamar@gmail.com		Wilson, Christopher/0000-0002-9146-522X; Monahan, John/0000-0002-3125-8704	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	This study was funded by Novartis Institutes for Biomedical Research. All authors were employed by Novartis Institutes for Biomedical Research during the course of the study. Novartis Institutes for Biomedical Research provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Al-Harbi S, 2011, BLOOD, V118, P3579, DOI 10.1182/blood-2011-03-340364; Araki S, 2010, CANCER LETT, V292, P269, DOI 10.1016/j.canlet.2009.12.007; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Bellail AC, 2010, J CELL MOL MED, V14, P1303, DOI 10.1111/j.1582-4934.2009.00777.x; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Herbst RS, 2010, CLIN CANCER RES, V16, P5883, DOI 10.1158/1078-0432.CCR-10-0631; Herbst RS, 2010, J CLIN ONCOL, V28, P2839, DOI 10.1200/JCO.2009.25.1991; Huet HA, 2014, MABS IN PRESS; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lomberk Gwen A, 2011, J Gastrointest Cancer, V42, P93, DOI 10.1007/s12029-011-9256-2; Mao ZG, 2010, APOPTOSIS, V15, P1211, DOI 10.1007/s10495-010-0513-9; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Motoki K, 2005, CLIN CANCER RES, V11, P3126, DOI 10.1158/1078-0432.CCR-04-1867; Natoni A, 2007, BRIT J HAEMATOL, V139, P568, DOI 10.1111/j.1365-2141.2007.06852.x; Nurtdinov RN, 2010, NUCLEIC ACIDS RES, V38, pD726, DOI 10.1093/nar/gkp969; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Pitts TM, 2010, CLIN CANCER RES, V16, P3193, DOI 10.1158/1078-0432.CCR-09-3191; Price ND, 2007, P NATL ACAD SCI USA, V104, P3414, DOI 10.1073/pnas.0611373104; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yang X, 2005, AM J PATHOL, V167, P705, DOI 10.1016/S0002-9440(10)62045-7	33	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138486	10.1371/journal.pone.0138486	http://dx.doi.org/10.1371/journal.pone.0138486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378449	Green Published, gold			2022-12-26	WOS:000361769400104
J	McGlynn, N; Kirsh, VA; Cotterchio, M; Harris, MA; Nadalin, V; Kreiger, N				McGlynn, Natalie; Kirsh, Victoria A.; Cotterchio, Michelle; Harris, M. Anne; Nadalin, Victoria; Kreiger, Nancy			Shift Work and Obesity among Canadian Women: A Cross-Sectional Study Using a Novel Exposure Assessment Tool	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; RISK-FACTORS; WEIGHT-GAIN; LIFE-STYLE; OVERWEIGHT; NURSES; ASSOCIATION; CANCER; HEALTH	Background/Objectives It has been suggested that the association between shift work and chronic disease is mediated by an increase in obesity. However, investigations of the relationship between shift work and obesity reveal mixed findings. Using a recently developed exposure assessment tool, this study examined the association between shift work and obesity among Canadian women from two studies: a cohort of university alumni, and a population-based study. Methods Self-administered questionnaire data were used from healthy, currently employed females in a population-based study, the Ontario Women's Diet and Health case-control study (n = 1611 controls), and from a subset of a of university alumni from the Canadian Study of Diet, Lifestyle, and Health (n = 1097) cohort study. Overweight was defined as BMI >= 25 to < 30, and obesity as BMI >= 30. Reported occupation was converted to occupational codes and linked to a probability of shift work value derived from Survey of Labour and Income Dynamics data. Regular evenings, nights, or rotating work comprised shift work. Polytomous logistic regression estimated the association between probability of shift work, categorized as near nil, low, medium, and high probability of shift work, on overweight and obesity, controlling for detected confounders. Results In the population-based sample, high probability of shift work was associated with obesity (reference = near nil probability of shift work, OR: 1.88, 95% CI: 1.01-3.51, p = 0.047). In the alumni cohort, no significant association was detected between shift work and overweight or obesity. Conclusions As these analyses found a positive association between high probability of shift work exposure and obesity in a population-based sample, but not in an alumni cohort, it is suggested that the relationship between shift work and obesity is complex, and may be particularly susceptible to occupational and education-related factors within a given population.	[McGlynn, Natalie] Toronto Publ Hlth, Surveillance & Epidemiol Unit, Performance & Stand, Toronto, ON, Canada; [Kirsh, Victoria A.; Cotterchio, Michelle; Kreiger, Nancy] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cotterchio, Michelle; Nadalin, Victoria] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Harris, M. Anne] Ryerson Univ, Sch Occupat & Publ Hlth, Toronto, ON, Canada	University of Toronto; Cancer Care Ontario; Toronto Metropolitan University	McGlynn, N (corresponding author), Toronto Publ Hlth, Surveillance & Epidemiol Unit, Performance & Stand, Toronto, ON, Canada.	nmcglynn@alumni.uwo.ca			Canadian Institutes for Health Information; Canadian Breast Cancer Research Alliance; Cancer Care Ontario	Canadian Institutes for Health Information(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance; Cancer Care Ontario	The Canadian Institutes for Health Information funded the Canadian Study of Diet, Lifestyle and Health. The Canadian Breast Cancer Research Alliance funded the Ontario Women's Diet and Health Study. Support for this research project was provided by Cancer Care Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbadoro P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063289; BOUYER J, 1995, SCAND J WORK ENV HEA, V21, P265, DOI 10.5271/sjweh.36; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chee HL, 2004, ASIA PAC J CLIN NUTR, V13, P248; Cotterchio M, 2008, CANCER CAUSE CONTROL, V19, P259, DOI 10.1007/s10552-007-9089-2; Demers PA, 2010, SCI S HLTH EFF SHIFT; Devaux M, 2011, OCED J EC STUD, V2011, P121, DOI DOI 10.1787/19952856; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; Human Resources and Skills Development Canada (HRSDC), 2013, INTR ED 2001 NAT OCC; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Katzmarzyk PT, 2002, CAN MED ASSOC J, V166, P1039; Kim MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1204; Kivimaki M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001138; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Ko GTC, 2007, INT J OBESITY, V31, P254, DOI 10.1038/sj.ijo.0803389; Kouvonen A, 2005, PSYCHOSOM MED, V67, P577, DOI 10.1097/01.psy.0000170330.08704.62; Le Moual N, 2000, OCCUP ENVIRON MED, V57, P126, DOI 10.1136/oem.57.2.126; Luckhaupt SE, 2014, AM J PREV MED, V46, P237, DOI 10.1016/j.amepre.2013.11.002; Miller SK, 2008, J AM ACAD NURSE PRAC, V20, P259, DOI 10.1111/j.1745-7599.2008.00319.x; Niedhammer I, 1996, INT J OBESITY, V20, P625; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Parkes KR, 2002, SCAND J WORK ENV HEA, V28, P64, DOI 10.5271/sjweh.648; Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96, DOI 10.5271/sjweh.2894; Rohan TE, 2007, CANCER DETECT PREV, V31, P12, DOI 10.1016/j.cdp.2006.12.006; SAS Institute Inc, 2009, SAS 9 2; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Shields M, 1999, Health Rep, V11, P33; Shields Margot, 2011, NCHS Data Brief, P1; Smith P, 2013, APPL NURS RES, V26, P24, DOI 10.1016/j.apnr.2012.10.001; Statistics Canada, 2014, HLTH FACT SHEETS BOD; Thaler JP, 2013, DIABETES, V62, P2629, DOI 10.2337/db12-1605; Truong KD, 2005, AM J PUBLIC HEALTH, V95, P1602, DOI 10.2105/AJPH.2004.043935; van Amelsvoort LGPM, 2004, J OCCUP ENVIRON MED, V46, P699, DOI 10.1097/01.jom.0000131794.83723.45; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; Viswanathan AN, 2007, CANCER RES, V67, P10618, DOI 10.1158/0008-5472.CAN-07-2485; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Watari M, 2006, PREV MED, V43, P107, DOI 10.1016/j.ypmed.2006.04.012; WHO, 2014, OB OV; Williams C, 2008, PERSPECT LABOUR INCO, V9, P5; Wilsgaard T, 2005, AM J EPIDEMIOL, V162, P1179, DOI 10.1093/aje/kwi328; Wong IS, 2011, SCAND J WORK ENV HEA, V37, P54, DOI 10.5271/sjweh.3124; World Health Organization, 2000, WHO TECHN REP SER, V894; World Health Organization International Agency for Research on Canada (IARC), 2010, IARC MONOGR EVAL CAR, V98, P563; Wright SM, 2012, ABDOM IMAGING, V37, P730, DOI 10.1007/s00261-012-9862-x	46	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137561	10.1371/journal.pone.0137561	http://dx.doi.org/10.1371/journal.pone.0137561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26376050	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200042
J	Nishijima, T; Yashiro, S; Teruya, K; Kikuchi, Y; Katai, N; Oka, S; Gatanaga, H				Nishijima, Takeshi; Yashiro, Shigeko; Teruya, Katsuji; Kikuchi, Yoshimi; Katai, Naomichi; Oka, Shinichi; Gatanaga, Hiroyuki			Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /mu L	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; CYTOMEGALOVIRUS RETINITIS; RETINAL MICROANGIOPATHY; ANTIRETROVIRAL THERAPY; RISK-FACTORS; DISEASE; AIDS; ERA; INITIATION	Objective To investigate whether routine eye screening by an ophthalmologist in patients with HIV-1 infection is clinically useful. Methods A single-center, retrospective study in Tokyo, Japan. HIV-1-infected patients aged over 17 years who visited our clinic for the first time between January 2004 and December 2013 and underwent full ophthalmologic examination were enrolled. At our clinic, ophthalmologic examination, including dilated retinal examination by indirect ophthalmoscopy was routinely conducted by ophthalmologists on the first visit. The prevalence of ophthalmologic diseases and associated factors including the existence of ocular symptoms were analyzed. Results Of the 1,515 study patients, cytomegalovirus retinitis (CMV-R) was diagnosed in 24 (2%) patients, HIV retinopathy (HIV-R) in 127 (8%), cataract in 31 (2%), ocular syphilis in 4 (0.3%), and uveitis with unknown cause in 8 (0.5%). Other ocular diseases were diagnosed in 14 patients. The CD4 count was <200 /mu L in all CMV-R cases and 87% of HIV-R. The prevalence of any ocular diseases, CMV-R, and HIV-R in patients with CD4 <200 /mu L were 22%, 3%, and 15%, respectively, whereas for those with CD4 >= 200 /mu L were 5%, 0%, and 2%, respectively. No ocular symptoms were reported by 71% of CMV-R cases and 82% of patients with any ocular diseases. Conclusions Routine ophthalmologic screening is recommended for HIV-1-infected patients with CD4 <200/mu L in resource-rich settings based on the high prevalence of ocular diseases within this CD4 count category and because most patients with ocular diseases, including those with CMV-R, were free of ocular symptoms.	[Nishijima, Takeshi; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Yashiro, Shigeko; Katai, Naomichi] Natl Ctr Global Hlth & Med, Dept Ophthalmol, Tokyo, Japan; [Nishijima, Takeshi; Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp		Oka, Shinichi/0000-0002-9283-2167	Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001, H24-AIDS-003]	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grant-in-Aids for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001; H24-AIDS-003).	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Cunningham ET, 2001, AM J OPHTHALMOL, V132, P727, DOI 10.1016/S0002-9394(01)01217-X; Curtis JR, 2006, ARTHRIT RHEUM-ARTHR, V55, P420, DOI 10.1002/art.21984; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Furrer H, 2003, OPHTHALMOLOGY, V110, P432, DOI 10.1016/S0161-6420(02)01750-5; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Goldberg DE, 2005, RETINA-J RET VIT DIS, V25, P633, DOI 10.1097/00006982-200507000-00015; Gomez ML, 2009, OPHTHALMOLOGY, V116, P2407, DOI 10.1016/j.ophtha.2009.05.012; Hall HI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077763; Heiden D, 2007, PLOS MED, V4, P1845, DOI 10.1371/journal.pmed.0040334; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Hodge WG, 2004, OPHTHALMOLOGY, V111, P1326, DOI 10.1016/j.ophtha.2004.03.001; Holland GN, 2008, AM J OPHTHALMOL, V145, P397, DOI 10.1016/j.ajo.2007.12.001; Iragui VJ, 1996, NEUROLOGY, V47, P1452, DOI 10.1212/WNL.47.6.1452; Iwasaki Y, 2013, JPN J OPHTHALMOL, V57, P372, DOI 10.1007/s10384-013-0247-7; Jabs D A, 1995, Trans Am Ophthalmol Soc, V93, P623; Jabs DA, 2005, OPHTHALMOLOGY, V112, P771, DOI 10.1016/j.ophtha.2004.10.049; Jabs DA, 2007, OPHTHALMOLOGY, V114, P780, DOI 10.1016/j.ophtha.2006.11.008; Jacobson MA, 1997, LANCET, V349, P1443, DOI 10.1016/S0140-6736(96)11431-8; KALEEM MA, 2012, INT OPHTHALMOL, V32, P145, DOI DOI 10.1007/S10792-012-9543-3; Kestelyn PG, 2001, B WORLD HEALTH ORGAN, V79, P208; Kiss Szilard, 2005, Semin Ophthalmol, V20, P161, DOI 10.1080/08820530500232092; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lindblad BE, 2008, OPHTHALMOLOGY, V115, P1687, DOI 10.1016/j.ophtha.2008.04.004; Mizushima D, 2015, JAIDS-J ACQ IMM DEF, V68, P140, DOI 10.1097/QAI.0000000000000410; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Rasmussen LD, 2011, CLIN INFECT DIS, V53, P1156, DOI 10.1093/cid/cir675; Stewart MW, 2012, INFECT DIS REP, V4, P92, DOI [10.4081/idr.2012.3853, 10.4081/idr.2012.e25]; Sugar EA, 2012, AM J OPHTHALMOL, V153, P1016, DOI 10.1016/j.ajo.2011.11.014; Thorne JE, 2006, OPHTHALMOLOGY, V113, P1441, DOI 10.1016/j.ophtha.2006.03.022; Tucker JD, 2011, SEX TRANSM INFECT, V87, P4, DOI 10.1136/sti.2010.043042; Vrabec TR, 2004, SURV OPHTHALMOL, V49, P131, DOI 10.1016/j.survophthal.2003.12.008; Wohl DA, 2009, HIV CLIN TRIALS, V10, P143, DOI 10.1310/hct1003-143	33	16	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136747	10.1371/journal.pone.0136747	http://dx.doi.org/10.1371/journal.pone.0136747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375282	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200022
J	Ruzzenenti, F; Joseph, A; Ticci, E; Vozzella, P; Gabbi, G				Ruzzenenti, Franco; Joseph, Andreas; Ticci, Elisa; Vozzella, Pietro; Gabbi, Giampaolo			Interactions between Financial and Environmental Networks in OECD Countries	PLOS ONE			English	Article							RECIPROCITY; DYNAMICS; FDI	We analysed a multiplex of financial and environmental networks between OECD countries from 2002 to 2010. Foreign direct investments and portfolio investment showing the flows in equity securities, short-term, long-term and total debt, these securities represent the financial layers; emissions of NOx, PM10, SO2, CO2 equivalent and the water footprint associated with international trade represent the environmental layers. We present a new measure of cross-layer correlations between flows in different layers based on reciprocity. For the assessment of results, we implement a null model for this measure based on the exponential random graph theory. We find that short-term financial flows are more correlated with environmental flows than long-term investments. Moreover, the correlations between reverse financial and environmental flows (i.e. the flows of different layers going in opposite directions) are generally stronger than correlations between synergic flows (flows going in the same direction). This suggests a trade-off between financial and environmental layers, where, more financialised countries display higher correlations between outgoing financial flows and incoming environmental flows than from lower financialised countries. Five countries are identified as hubs in this finance-environment multiplex: The United States, France, Germany, Belgium-Luxembourg and United Kingdom.	[Ruzzenenti, Franco] Univ Siena, Dept Biotechnol Chem & Pharm, IT-53100 Siena, Italy; [Joseph, Andreas] Bank England, Adv Analyt, London EC2R 8AH, England; [Ticci, Elisa] Univ Siena, Dept Econ & Stat, IT-53100 Siena, Italy; [Vozzella, Pietro; Gabbi, Giampaolo] Univ Siena, Dept Business & Law, IT-53100 Siena, Italy	University of Siena; Bank of England; University of Siena; University of Siena	Ruzzenenti, F (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Via Aldo Moro 1, IT-53100 Siena, Italy.	ruzzenenti@gmail.com		GABBI, GIAMPAOLO/0000-0001-8137-233X				Aichele R, 2014, REV EC STAT; Aizenman J., 2004, 10496 NBER; Aizenman J, 2006, Q REV ECON FINANC, V46, P317, DOI 10.1016/j.qref.2006.02.004; Albuquerque R, 2005, J INT ECON, V66, P267, DOI 10.1016/j.jinteco.2004.07.002; Aviat A, 2007, J INT ECON, V71, P22, DOI 10.1016/j.jinteco.2006.02.002; Barigozzi M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046104; Battiston S, 2003, PHYSICA A, V322, P567, DOI 10.1016/S0378-4371(02)01930-1; Battiston S, 2013, NAT PHYS, V9, P123, DOI 10.1038/nphys2575; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Blonigen B. A., 2005, 11299 NBER; Broner F, 2012, NAT BUREAU EC RES; Catanzaro M, 2013, NAT PHYS, V9, P121, DOI 10.1038/nphys2570; Chung S, 2014, J DEV ECON, V108, P222, DOI 10.1016/j.jdeveco.2014.01.003; Coeurdacier N, 2009, J INT ECON, V77, P86, DOI 10.1016/j.jinteco.2008.10.005; Delpini D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01626; Galbiati M, 2013, NAT PHYS, V9, P126, DOI 10.1038/nphys2581; Galstyan V, 2013, EUR ECON REV, V57, P63, DOI 10.1016/j.euroecorev.2012.10.002; Garlaschelli D, 2005, PHYSICA A, V350, P491, DOI 10.1016/j.physa.2004.11.040; Gemmetto V, 2015, SCI REP-UK, V5, DOI 10.1038/srep09120; Gemmetto V, 2014, ARXIV14111282PHYSICS; Hanna R, 2010, AM ECON J-APPL ECON, V2, P158, DOI 10.1257/app.2.3.158; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; Joseph A, ARXIV14030848QFINGN; Joseph AC, 2014, PHYSICA D, V267, P58, DOI 10.1016/j.physd.2013.08.005; Joseph AC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03991; Kaushik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061815; Lane PR, 2008, REV ECON STAT, V90, P538, DOI 10.1162/rest.90.3.538; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; Levinson A, 2008, INT ECON REV, V49, P223, DOI 10.1111/j.1468-2354.2008.00478.x; Mulatu A, 2010, ENVIRON RESOUR ECON, V45, P459, DOI 10.1007/s10640-009-9323-3; Nicosia V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058701; Ruzzenenti F, 2010, SYMMETRY-BASEL, V2, P1710, DOI 10.3390/sym2031710; Squartini T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03357; Squartini T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02729; Wilde O, 1998, EPIGRAMS OSCAR WILDE	36	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136767	10.1371/journal.pone.0136767	http://dx.doi.org/10.1371/journal.pone.0136767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26375393	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200023
J	Da Silva, S; Robbe-Masselot, C; Raymond, A; Mercade-Loubiere, M; Salvador-Cartier, C; Ringot, B; Leonard, R; Fourquaux, I; Ait-Belgnaoui, A; Loubiere, P; Theodorou, V; Mercier-Bonin, M				Da Silva, Stephanie; Robbe-Masselot, Catherine; Raymond, Arthur; Mercade-Loubiere, Myriam; Salvador-Cartier, Christel; Ringot, Belinda; Leonard, Renaud; Fourquaux, Isabelle; Ait-Belgnaoui, Afifa; Loubiere, Pascal; Theodorou, Vassilia; Mercier-Bonin, Muriel			Spatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; LACTIC-ACID BACTERIA; GASTROINTESTINAL-TRACT; RHAMNOSUS GG; PHYLOGENETIC ANALYSIS; HELICOBACTER-PYLORI; FUNCTIONAL-ANALYSIS; ULCERATIVE-COLITIS; REUTERI ATCC-55730; MICROBIAL ECOLOGY	The present study aimed at detecting the exogenously applied probiotic Lactobacillus farciminis in rats, after exposure to IBS-like chronic stress, based on 4-day Water Avoidance Stress (WAS). The presence of L. farciminis in both ileal and colonic mucosal tissues was demonstrated by FISH and qPCR, with ileum as the preferential niche, as for the SFB population. A different spatial distribution of the probiotic was observed: in the ileum, bacteria were organized in micro-colonies more or less close to the epithelium whereas, in the colon, they were mainly visualized far away from the epithelium. When rats were submitted to WAS, the L. farciminis population substantially decreased in both intestinal regions, due to a stress-induced increase in colonic motility and defecation, rather than a modification of bacterial binding to the intestinal mucin Muc2.	[Da Silva, Stephanie; Raymond, Arthur; Mercade-Loubiere, Myriam; Loubiere, Pascal; Mercier-Bonin, Muriel] Univ Toulouse, LISBP, INP, INSA,UPS, F-31077 Toulouse, France; [Da Silva, Stephanie; Raymond, Arthur; Mercade-Loubiere, Myriam; Loubiere, Pascal; Mercier-Bonin, Muriel] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Da Silva, Stephanie; Raymond, Arthur; Mercade-Loubiere, Myriam; Loubiere, Pascal; Mercier-Bonin, Muriel] CNRS, UMR5504, F-31400 Toulouse, France; [Da Silva, Stephanie; Salvador-Cartier, Christel; Ait-Belgnaoui, Afifa; Theodorou, Vassilia; Mercier-Bonin, Muriel] UPS, INRA, INPT, Equipe NeuroGastroenterol & Nutr,TOXALIM,UMR 1331, F-31027 Toulouse 9, France; [Robbe-Masselot, Catherine; Ringot, Belinda; Leonard, Renaud] Univ Lille Nord France, USTL, Unite Glycobiol Struct & Fonct, IFR 147, F-59650 Villeneuve Dascq, France; [Robbe-Masselot, Catherine; Ringot, Belinda; Leonard, Renaud] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Fourquaux, Isabelle] CMEAB, Fac Med Rangueil, F-31062 Toulouse, France; [Ait-Belgnaoui, Afifa] Lallemand SA, F-31702 Blagnac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Lallemand - France	Theodorou, V (corresponding author), UPS, INRA, INPT, Equipe NeuroGastroenterol & Nutr,TOXALIM,UMR 1331, 180 Chemin Tournefeuille, F-31027 Toulouse 9, France.	vtheodor@toulouse.inra.fr	MERCIER-BONIN, Muriel/AAO-5286-2021	DA SILVA-HEIL, Stephanie/0000-0001-8817-6403; Robbe Masselot, Catherine/0000-0001-6266-6033; Leonard, Renaud/0000-0001-5023-1032	INRA (CEPIA Division); CNRS (INSIS Institute); Lallemand SA	INRA (CEPIA Division); CNRS (INSIS Institute); Lallemand SA	This work was supported by INRA (CEPIA Division; http://www.inra.fr) and CNRS (INSIS Institute; www.cnrs.fr) through the doctoral grant of Stephanie Da Silva (2010-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Lallemand SA provided support in the form of salary for author (Afifa Ait-Belgnaoui), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. No additional external funding was received for this study.	Agostini S, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01865.x; Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; Ait-Belgnaoui A, 2006, GUT, V55, P1090, DOI 10.1136/gut.2005.084194; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bergonzelli GE, 2006, INFECT IMMUN, V74, P425, DOI 10.1128/IAI.74.1.425-434.2006; Blasco L, 2003, FEMS MICROBIOL LETT, V225, P115, DOI 10.1016/S0378-1097(03)00501-9; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Brenner DM, 2009, AM J GASTROENTEROL, V104, P1033, DOI 10.1038/ajg.2009.25; Bron PA, 2013, CURR OPIN MICROBIOL, V16, P262, DOI 10.1016/j.mib.2013.06.001; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Brooks SPJ, 2003, CAN J MICROBIOL, V49, P589, DOI 10.1139/W03-075; Buck BL, 2005, APPL ENVIRON MICROB, V71, P8344, DOI 10.1128/AEM.71.12.8344-8351.2005; Da Silva S, 2014, AM J PHYSIOL-GASTR L, V307, pG420, DOI 10.1152/ajpgi.00290.2013; Dalby AB, 2006, APPL ENVIRON MICROB, V72, P6707, DOI 10.1128/AEM.00378-06; Del Piano M, 2010, J CLIN GASTROENTEROL, V44, pS42, DOI 10.1097/MCG.0b013e3181ed0e71; Distrutti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063893; Le DTL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079850; Doan TLL, 2011, BIOPHYS J, V101, P2843, DOI 10.1016/j.bpj.2011.10.034; Ducrotte P, 2012, WORLD J GASTROENTERO, V18, P4012, DOI 10.3748/wjg.v18.i30.4012; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Greenwood-Van Meerveld B, 2015, AM J PHYSIOL-GASTR L, V308, pG885, DOI 10.1152/ajpgi.00463.2014; Guyonnet D, 2007, ALIMENT PHARM THER, V26, P475, DOI 10.1111/j.1365-2036.2007.03362.x; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kerckhoffs APM, 2009, WORLD J GASTROENTERO, V15, P2887, DOI 10.3748/wjg.15.2887; Kim HJ, 2005, NEUROGASTROENT MOTIL, V17, P687, DOI 10.1111/j.1365-2982.2005.00695.x; King TS, 1998, LANCET, V352, P1187, DOI 10.1016/S0140-6736(98)02146-1; Kinoshita H, 2008, J APPL MICROBIOL, V104, P1667, DOI 10.1111/j.1365-2672.2007.03679.x; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; KOOPMAN JP, 1987, LAB ANIM-UK, V21, P48, DOI 10.1258/002367787780740743; Lamine F, 2004, SCAND J GASTROENTERO, V39, P1250, DOI 10.1080/00365520410007953; Lamine F, 2004, SCAND J GASTROENTERO, V39, P37, DOI 10.1080/00365520310007152; Larauche M, 2012, EXP NEUROL, V233, P49, DOI 10.1016/j.expneurol.2011.04.020; Lebeer S, 2011, LETT APPL MICROBIOL, V52, P220, DOI 10.1111/j.1472-765X.2010.02994.x; Lebeer S, 2010, BENEF MICROBES, V1, P335, DOI 10.3920/BM2010.0032; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Macfarlane S, 2004, CLIN INFECT DIS, V38, P1690, DOI 10.1086/420823; MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Mare L, 2006, J APPL MICROBIOL, V100, P838, DOI 10.1111/j.1365-2672.2006.02835.x; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Niv E, 2005, CLIN NUTR, V24, P925, DOI 10.1016/j.clnu.2005.06.001; Odenbreit S, 2009, INFECT IMMUN, V77, P3782, DOI 10.1128/IAI.00364-09; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Quigley EMM, 2011, GASTROENTEROL CLIN N, V40, P207, DOI 10.1016/j.gtc.2010.12.009; Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d; Rojas M, 2002, APPL ENVIRON MICROB, V68, P2330, DOI 10.1128/AEM.68.5.2330-2336.2002; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; Saxami G, 2012, ANAEROBE, V18, P417, DOI 10.1016/j.anaerobe.2012.04.002; Schmulson M, 2011, ALIMENT PHARM THER, V33, P1071, DOI 10.1111/j.1365-2036.2011.04637.x; SNEL J, 1995, INT J SYST BACTERIOL, V45, P780, DOI 10.1099/00207713-45-4-780; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; STAHL DA, 1988, APPL ENVIRON MICROB, V54, P1079, DOI 10.1128/AEM.54.5.1079-1084.1988; Tobin Jacinta M, 2013, BMC Res Notes, V6, P252, DOI 10.1186/1756-0500-6-252; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wang B, 2009, INT J FOOD MICROBIOL, V132, P59, DOI 10.1016/j.ijfoodmicro.2009.03.016; Yoon JS, 2014, J GASTROEN HEPATOL, V29, P52, DOI 10.1111/jgh.12322; Zareie M, 2006, GUT, V55, P1553, DOI 10.1136/gut.2005.080739	66	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136048	10.1371/journal.pone.0136048	http://dx.doi.org/10.1371/journal.pone.0136048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367538	Green Published, gold			2022-12-26	WOS:000361601100013
J	Gomez, H; Kautza, B; Escobar, D; Nassour, I; Luciano, J; Botero, AM; Gordon, L; Martinez, S; Holder, A; Ogundele, O; Loughran, P; Rosengart, MR; Pinsky, M; Shiva, S; Zuckerbraun, BS				Gomez, Hernando; Kautza, Benjamin; Escobar, Daniel; Nassour, Ibrahim; Luciano, Jason; Botero, Ana Maria; Gordon, Lisa; Martinez, Silvia; Holder, Andre; Ogundele, Olufunmilayo; Loughran, Patricia; Rosengart, Matthew R.; Pinsky, Michael; Shiva, Sruti; Zuckerbraun, Brian S.			Inhaled Carbon Monoxide Protects against the Development of Shock and Mitochondrial Injury following Hemorrhage and Resuscitation	PLOS ONE			English	Article							HEME OXYGENASE-1; TRANSCRIPTIONAL CONTROL; CELLULAR RESPIRATION; LUNG INJURY; BIOGENESIS; LIVER; INHALATION; MODEL; INHIBITION; MECHANISM	Aims Currently, there is no effective resuscitative adjunct to fluid and blood products to limit tissue injury for traumatic hemorrhagic shock. The objective of this study was to investigate the role of inhaled carbon monoxide (CO) to limit inflammation and tissue injury, and specifically mitochondrial damage, in experimental models of hemorrhage and resuscitation. Results Inhaled CO (250 ppm for 30 minutes) protected against mortality in severe murine hemorrhagic shock and resuscitation (HS/R) (20% vs. 80%; P < 0.01). Additionally, CO limited the development of shock as determined by arterial blood pH (7.25 +/- 0.06 vs. 7.05 +/- 0.05; P < 0.05), lactate levels (7.2 +/- 5.1 vs 13.3 +/- 6.0; P < 0.05), and base deficit (13 +/- 3.0 vs 24 +/- 3.1; P < 0.05). A dose response of CO (25-500 ppm) demonstrated protection against HS/R lung and liver injury as determined by MPO activity and serum ALT, respectively. CO limited HS/R-induced increases in serum tumor necrosis factor-alpha and interleukin-6 levels as determined by ELISA (P < 0.05 for doses of 100-500ppm). Furthermore, inhaled CO limited HS/R induced oxidative stress as determined by hepatic oxidized glutathione: reduced glutathione levels and lipid peroxidation. In porcine HS/R, CO did not influence hemodynamics. However, CO limited HS/R-induced skeletal muscle and platelet mitochondrial injury as determined by respiratory control ratio (muscle) and ATP-linked respiration and mitochondrial reserve capacity (platelets). Conclusion These preclinical studies suggest that inhaled CO can be a protective therapy in HS/R; however, further clinical studies are warranted.	[Gomez, Hernando; Gordon, Lisa; Holder, Andre; Ogundele, Olufunmilayo; Rosengart, Matthew R.; Pinsky, Michael] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Gomez, Hernando; Rosengart, Matthew R.; Zuckerbraun, Brian S.] Univ Pittsburgh, Ctr Crit Care Nephrol, Pittsburgh, PA 15260 USA; [Kautza, Benjamin; Escobar, Daniel; Nassour, Ibrahim; Luciano, Jason; Botero, Ana Maria; Martinez, Silvia; Loughran, Patricia; Zuckerbraun, Brian S.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Shiva, Sruti; Zuckerbraun, Brian S.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA; [Zuckerbraun, Brian S.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Zuckerbraun, BS (corresponding author), Univ Pittsburgh, Ctr Crit Care Nephrol, Pittsburgh, PA 15260 USA.	zuckerbraunbs@upmc.edu	Nassour, Ibrahim/J-5807-2019; Gomez, Hernando/ABB-4589-2020; Loughran, Patricia/AAB-1184-2021	Nassour, Ibrahim/0000-0002-9845-1074; 	National Institutes of Health [R01GM082830, UM1 HL120877-01, 1K12HL109068-02]; Veterans Affairs Merit Award [1I01BX000566]; Department of Defense [DM102439]; Hemophilia Center of Western Pennsylvania; UPMC Military Medicine Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007820, UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082830] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); Hemophilia Center of Western Pennsylvania; UPMC Military Medicine Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by National Institutes of Health grants R01GM082830 (BSZ), UM1 HL120877-01 (BSZ), 1K12HL109068-02 (HG), Veterans Affairs Merit Award 1I01BX000566 (BSZ), Department of Defense DM102439 (BSZ), Hemophilia Center of Western Pennsylvania (SS) and UPMC Military Medicine Center (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BO, 1991, J APPL PHYSIOL, V71, P1862, DOI 10.1152/jappl.1991.71.5.1862; Bauer I, 1998, HEPATOLOGY, V27, P829, DOI 10.1002/hep.510270327; Bauer M, 1996, AM J PHYSIOL-GASTR L, V271, pG929, DOI 10.1152/ajpgi.1996.271.5.G929; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Carrico CJ, 2002, SHOCK, V17, P165, DOI 10.1097/00024382-200203000-00001; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; ECKSTEIN RW, 1946, AM J PHYSIOL, V147, P685, DOI 10.1152/ajplegacy.1946.147.4.685; Kaczorowski DJ, 2007, CURR MED CHEM, V14, P2720, DOI 10.2174/092986707782023181; Kanagawa F, 2010, J TRAUMA, V69, P185, DOI 10.1097/TA.0b013e3181bbd516; Kawanishi S, 2013, MOL MED REP, V7, P3, DOI 10.3892/mmr.2012.1173; Kubulus D, 2008, SHOCK, V29, P583, DOI 10.1097/SHK.0b013e318157e526; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pannen BHJ, 1998, J CLIN INVEST, V102, P1220, DOI 10.1172/JCI3428; Paxian M, 2001, SHOCK, V15, P438, DOI 10.1097/00024382-200115060-00005; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P532, DOI 10.1016/j.bbagen.2012.01.003; Sakai H, 2009, SHOCK, V31, P507, DOI 10.1097/SHK.0b013e318188f83d; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Shah NS, 1998, SHOCK, V10, P343, DOI 10.1097/00024382-199811000-00006; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Vallabhaneni R, 2010, SHOCK, V33, P274, DOI 10.1097/SHK.0b013e3181b0f566; WEST MA, 1985, INFECT IMMUN, V49, P563, DOI 10.1128/IAI.49.3.563-570.1985; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003; Zuckerbraun BS, 2005, SHOCK, V23, P527, DOI 10.1097/01.shk.0000163206.22032.a1	33	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0135032	10.1371/journal.pone.0135032	http://dx.doi.org/10.1371/journal.pone.0135032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366865	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000361601100008
J	Hampel, A; Huber, C; Geffers, R; Spona-Friedl, M; Eisenreich, W; Bange, FC				Hampel, Annegret; Huber, Claudia; Geffers, Robert; Spona-Friedl, Marina; Eisenreich, Wolfgang; Bange, Franz-Christoph			Mycobacterium tuberculosis Is a Natural Ornithine Aminotransferase (rocD) Mutant and Depends on Rv2323c for Growth on Arginine	PLOS ONE			English	Article							NITRITE REDUCTASE NIRBD; BOVIS BCG; BACILLUS-SUBTILIS; HUMAN MACROPHAGES; OXIDE SYNTHASE; METABOLISM; BIOSYNTHESIS; SMEGMATIS; AMIDINOTRANSFERASE; CATABOLISM	Mycobacterium tuberculosis (Mtb) possesses a genetic repertoire for metabolic pathways, which are specific and fit to its intracellular life style. Under in vitro conditions, Mtb is known to use arginine as a nitrogen source, but the metabolic pathways for arginine utilization have not been identified. Here we show that, in the presence of arginine, Mtb upregulates a gene cluster which includes an ornithine aminotransferase (rocD) and Rv2323c, a gene of unknown function. Isotopologue analysis by using C-13-or N-15-arginine revealed that in Mtb arginine is not only used as nitrogen source but also as carbon source for the formation of amino acids, in particular of proline. Surprisingly, rocD, which is widespread in other bacteria and is part of the classical arginase pathway turned out to be naturally deleted in Mtb, but not in non-tuberculous mycobacteria. Mtb lacking Rv2323c showed a growth defect on arginine, did not produce proline from arginine, and incorporated less nitrogen derived from arginine in its core nitrogen metabolism. We conclude that the highly induced pathway for arginine utilization in Mtb differs from that of other bacteria including non-tuberculous mycobacteria, probably reflecting a specific metabolic feature of intracellular Mtb.	[Hampel, Annegret; Bange, Franz-Christoph] Hannover Med Sch, Dept Med Microbiol & Hosp Epidemiol, D-30625 Hannover, NH, Germany; [Huber, Claudia; Spona-Friedl, Marina; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, Garching, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Res Grp Genome Analyt, D-38124 Braunschweig, Germany	Hannover Medical School; Technical University of Munich; Helmholtz Association; Helmholtz-Center for Infection Research	Bange, FC (corresponding author), Hannover Med Sch, Dept Med Microbiol & Hosp Epidemiol, D-30625 Hannover, NH, Germany.	bange.franz@mh-hannover.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [Sonderforschungsbereich 587, 900]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) through the grant Sonderforschungsbereich 587 and 900 to AH and FCB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAL AT, 1979, ANNU REV MICROBIOL, V33, P139, DOI 10.1146/annurev.mi.33.100179.001035; Akhtar S, 2013, J BACTERIOL, V195, P4592, DOI 10.1128/JB.00698-13; Bange F.-C., 1999, Tubercle and Lung Disease, V79, P171, DOI 10.1054/tuld.1998.0201; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cunningham-Bussel A, 2013, P NATL ACAD SCI USA, V110, pE4256, DOI 10.1073/pnas.1316894110; DARBRE A, 1968, BIOCHEM J, V106, P923, DOI 10.1042/bj1060923; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fritsche E, 1998, BIOCHEMISTRY-US, V37, P17664, DOI 10.1021/bi981949p; GARDAN R, 1995, J MOL BIOL, V249, P843, DOI 10.1006/jmbi.1995.0342; Gordhan BG, 2002, INFECT IMMUN, V70, P3080, DOI 10.1128/IAI.70.6.3080-3084.2002; Gouzy A, 2014, NAT REV MICROBIOL; Gouzy A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003928; Harper CJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-138; Hernandez-Guzman G, 2001, MOL PLANT MICROBE IN, V14, P545, DOI 10.1094/MPMI.2001.14.4.545; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; Jenkins VA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-301; JeSSberger Nadja, 2013, BMC Res Notes, V6, P482, DOI 10.1186/1756-0500-6-482; Jung JY, 2013, INFECT IMMUN, V81, P3198, DOI 10.1128/IAI.00611-13; Kwon O. Jung, 1997, Journal of Korean Medical Science, V12, P481; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Muenchhoff J, 2010, FEBS J, V277, P3844, DOI 10.1111/j.1742-4658.2010.07788.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Peteroy-Kelly MA, 2003, INFECT IMMUN, V71, P1011, DOI 10.1128/IAI.71.2.1011-1015.2003; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; Scanga CA, 2001, INFECT IMMUN, V69, P7711, DOI 10.1128/IAI.69.12.7711-7717.2001; Schneider BL, 1998, J BACTERIOL, V180, P4278, DOI 10.1128/JB.180.16.4278-4286.1998; Seth A, 2000, J BACTERIOL, V182, P919, DOI 10.1128/JB.182.4.919-927.2000; SHAIBE E, 1985, J BACTERIOL, V163, P933, DOI 10.1128/JB.163.3.933-937.1985; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Surken M, 2008, INT J MED MICROBIOL, V298, P657, DOI 10.1016/j.ijmm.2007.09.003; Talaue MT, 2006, J BACTERIOL, V188, P4830, DOI 10.1128/JB.01687-05; Tiffert Y, 2008, MOL MICROBIOL, V67, P861, DOI 10.1111/j.1365-2958.2007.06092.x; Townsend DE, 1996, MICROBIOL-SGM, V142, P1491, DOI 10.1099/13500872-142-6-1491; World Health Organization, 2015, GLOB TUB REP 2014; Zaprasis A, 2014, ENVIRON MICROBIOL, V16, P701, DOI 10.1111/1462-2920.12193	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136914	10.1371/journal.pone.0136914	http://dx.doi.org/10.1371/journal.pone.0136914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368558	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100031
J	Hoevenaren, IA; Meulstee, J; Krikken, E; Berge, SJ; Ulrich, DJO; Maal, TJJ				Hoevenaren, Inge A.; Meulstee, J.; Krikken, E.; Berge, S. J.; Ulrich, D. J. O.; Maal, Thomas J. J.			Development of a Three-Dimensional Hand Model Using Three-Dimensional Stereophotogrammetry: Assessment of Image Reproducibility	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RECONSTRUCTION; PRECISION; SYSTEM; PHOTOGRAMMETRY; SIMULATIONS; RELIABILITY; DISSECTION; ACCURACY; FLAP	Purpose Using three-dimensional (3D) stereophotogrammetry precise images and reconstructions of the human body can be produced. Over the last few years, this technique is mainly being developed in the field of maxillofacial reconstructive surgery, creating fusion images with computed tomography (CT) data for precise planning and prediction of treatment outcome. Though, in hand surgery 3D stereophotogrammetry is not yet being used in clinical settings. Methods A total of 34 three-dimensional hand photographs were analyzed to investigate the reproducibility. For every individual, 3D photographs were captured at two different time points (baseline T0 and one week later T1). Using two different registration methods, the reproducibility of the methods was analyzed. Furthermore, the differences between 3D photos of men and women were compared in a distance map as a first clinical pilot testing our registration method. Results The absolute mean registration error for the complete hand was 1.46 mm. This reduced to an error of 0.56 mm isolating the region to the palm of the hand. When comparing hands of both sexes, it was seen that the male hand was larger (broader base and longer fingers) than the female hand. Conclusions This study shows that 3D stereophotogrammetry can produce reproducible images of the hand without harmful side effects for the patient, so proving to be a reliablemethod for soft tissue analysis. Its potential use in everyday practice of hand surgery needs to be further explored.	[Hoevenaren, Inge A.; Ulrich, D. J. O.] Radboud Univ Nijmegen, Med Ctr, Dept Plast Reconstruct & Hand Surg, NL-6525 ED Nijmegen, Netherlands; [Meulstee, J.; Krikken, E.; Berge, S. J.; Maal, Thomas J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Krikken, E.] Univ Twente, Tech Med, NL-7500 AE Enschede, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Twente	Hoevenaren, IA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Plast Reconstruct & Hand Surg, NL-6525 ED Nijmegen, Netherlands.	inge.hoevenaren@radboudumc.nl	Bergé, S.J./H-8011-2014; Berge, Stefaan/AAP-3708-2020; Ulrich, D.J.O./H-8099-2014; Meulstee, Jene/F-3723-2016; Meulstee, Jene/AAE-1903-2019; Maal, Thomas JJ/L-4497-2015	Meulstee, Jene/0000-0002-1285-6602; Maal, Thomas JJ/0000-0002-1702-4733				Adamczyk C, 2009, ANN ANAT, V191, P339, DOI 10.1016/j.aanat.2009.03.003; Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Ayoub AF, 1998, BRIT J ORAL MAX SURG, V36, P353, DOI 10.1016/S0266-4356(98)90646-5; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bugaighis I, 2012, EUR J ORTHODONT, P8, DOI [10.1093/ejo/cjs060, DOI 10.1093/EJ0/CJS060]; COOMBES AM, 1991, EUR J ORTHODONT, V13, P95, DOI 10.1093/ejo/13.2.95; Crossingham JL, 2009, HPB, V11, P523, DOI 10.1111/j.1477-2574.2009.00097.x; Gacto-Sanchez P, 2010, J SURG RES, V162, P140, DOI 10.1016/j.jss.2009.01.025; Gacto-Sanchez P, 2010, PLAST RECONSTR SURG, V125, P24, DOI 10.1097/PRS.0b013e3181c4948b; Gerlach NL, 2010, J ORAL MAXIL SURG, V68, P811, DOI 10.1016/j.joms.2009.09.059; Giunta RE, 2010, HANDCHIR MIKROCHIR P, V42, P143, DOI 10.1055/s-0030-1249039; Hammond P, 2004, AM J MED GENET A, V126A, P339, DOI 10.1002/ajmg.a.20665; Henseler H, 2012, J PLAST RECONSTR AES, V65, P1209, DOI 10.1016/j.bjps.2012.03.043; Hoehnke C, 2007, J PLAST RECONSTR AES, V60, P1138, DOI 10.1016/j.bjps.2007.01.068; Hoevenaren IA, 2015, J PLAST RECONSTR AES, V68, P709, DOI 10.1016/j.bjps.2014.12.025; Ibrahim AE, 2012, EUR J PLAST SURG, V35, P571, DOI 10.1007/s00238-012-0737-8; Jastrow H, 2003, CLIN ANAT, V16, P44, DOI 10.1002/ca.10062; Johnston DJ, 2003, CLEFT PALATE-CRAN J, V40, P291, DOI 10.1597/1545-1569(2003)040<0291:AFER>2.0.CO;2; Jones DG, 1997, CLIN ANAT, V10, P123, DOI 10.1002/(SICI)1098-2353(1997)10:2<123::AID-CA9>3.0.CO;2-W; Kau CH, 2005, AM J ORTHOD DENTOFAC, V128, P424, DOI 10.1016/j.ajodo.2004.06.037; Kimoto K, 2007, J ORAL REHABIL, V34, P201, DOI 10.1111/j.1365-2842.2006.01663.x; Kovacs L, 2005, BURNS, V31, P85, DOI 10.1016/j.burns.2004.07.010; Kovacs L, 2007, BREAST, V16, P137, DOI 10.1016/j.breast.2006.08.001; Kovacs L, 2012, AESTHET PLAST SURG, V36, P879, DOI 10.1007/s00266-012-9892-3; Kowalczuk J, 2012, SURG ENDOSC, V26, P3413, DOI 10.1007/s00464-012-2355-8; Krimmel M, 2005, BIOMED TECH, V50, P45, DOI 10.1515/BMT.2005.008; Lane C, 2008, AM J ORTHOD DENTOFAC, V133, P612, DOI 10.1016/j.ajodo.2007.03.023; Lee Samson, 2004, Arch Facial Plast Surg, V6, P410, DOI 10.1001/archfaci.6.6.410; Lefevre P, 2007, INT J LEGAL MED, V121, P511, DOI 10.1007/s00414-007-0204-4; Levine MG, 1999, CLIN ANAT, V12, P191, DOI 10.1002/(SICI)1098-2353(1999)12:3<191::AID-CA8>3.0.CO;2-5; Lin EC, 2010, MAYO CLIN PROC, V85, P1142, DOI 10.4065/mcp.2010.0260; Littlefield TR, 2004, J CRANIOFAC SURG, V15, P175, DOI 10.1097/00001665-200401000-00042; Ma LL, 2009, COMPUT METH PROG BIO, V94, P290, DOI 10.1016/j.cmpb.2009.01.010; Maal TJJ, 2010, J ORAL MAXIL SURG, V68, P2391, DOI 10.1016/j.joms.2009.10.017; Mozzo P, 1998, EUR RADIOL, V8, P1558, DOI 10.1007/s003300050586; Okada E, 2001, J CRANIOFAC SURG, V12, P167, DOI 10.1097/00001665-200103000-00014; Plooij JM, 2009, INT J ORAL MAX SURG, V38, P267, DOI 10.1016/j.ijom.2008.12.009; Pommert A, 2001, MED IMAGE ANAL, V5, P221, DOI 10.1016/S1361-8415(01)00044-5; Reeves RE, 2004, CLIN ANAT, V17, P337, DOI 10.1002/ca.10245; Schittek M, 2001, Eur J Dent Educ, V5, P93, DOI 10.1034/j.1600-0579.2001.050301.x; Sierra R, 2006, MED IMAGE ANAL, V10, P275, DOI 10.1016/j.media.2005.11.003; Silen C, 2008, MED TEACH, V30, pE115, DOI 10.1080/01421590801932228; Small KH, 2010, J PLAST RECONSTR AES, V63, P346, DOI 10.1016/j.bjps.2008.11.023; Smith-Bindman R, 2013, JAMA; Trunk P, 2007, COMPUT BIOL MED, V37, P1398, DOI 10.1016/j.compbiomed.2006.11.003; Weinberg SM, 2006, J CRANIOFAC SURG, V17, P477, DOI 10.1097/00001665-200605000-00015; Weinberg SM, 2005, J CRANIOFAC SURG, V16, P847, DOI 10.1097/01.SCS.0000164330.96675.0C; Zhang YZ, 2007, MICROSURG, V27, P553, DOI 10.1002/micr.20410	49	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136710	10.1371/journal.pone.0136710	http://dx.doi.org/10.1371/journal.pone.0136710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366860	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100022
J	Hynson, NA; Allison, SD; Treseder, KK				Hynson, Nicole A.; Allison, Steven D.; Treseder, Kathleen K.			Quantum Dots Reveal Shifts in Organic Nitrogen Uptake by Fungi Exposed to Long-Term Nitrogen Enrichment	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITY; HOME-FIELD ADVANTAGE; FUNCTIONAL-SIGNIFICANCE; MYCORRHIZAL FUNGI; DECOMPOSITION; LITTER; CARBON; NANOCRYSTALS; DIVERSITY; STOICHIOMETRY	Anthropogenic nitrogen (N) enrichment can alter N dynamics associated with decomposing plant litter. However, it is unclear to what extent these alterations occur via microbial effects (e.g., changes in gene regulation, physiology, or community composition) versus plant litter effects (e.g., changes in composition of N and C compounds). To isolate microbial effects from plant litter effects, we collected plant litter from long-term N fertilized and control plots, reciprocally inoculated it with microbes from the two treatments, and incubated it in a common field setting for three months. We used quantum dots (QDs) to track fungal uptake of glycine and chitosan. Glycine is a relatively simple organic N compound; chitosan is more complex. We found that microbial and litter origins each contributed to a shift in fungal uptake capacities under N fertilization. Specifically, N fungi preferred glycine over chitosan, but control fungi did not. In comparison, litter effects were more subtle, and manifested as a three-way interaction between litter origin, microbial origin, and type of organic N (glycine versus chitosan). In particular, control fungi tended to target chitosan only when incubated with control litter, while N fungi targeted glycine regardless of litter type. Overall, microbial effects may mediate how N dynamics respond to anthropogenic N enrichment in ecosystems.	[Hynson, Nicole A.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Allison, Steven D.; Treseder, Kathleen K.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Irvine	Hynson, NA (corresponding author), Univ Hawaii Manoa, Dept Bot, 3190 Maile Way, Honolulu, HI 96822 USA.	nhynson@hawaii.edu	Allison, Steven D./E-2978-2010; Treseder, Kathleen K/E-5148-2011	Allison, Steven D./0000-0003-4629-7842; Treseder, Kathleen K/0000-0003-2847-6935; Hynson, Nicole/0000-0001-7098-9641	Office of Science (BER), US Department of Energy (Program in Microbial Communities and Carbon Cycling); NSF [DEB-1256896, EAR-1411942]; Direct For Biological Sciences [1457160] Funding Source: National Science Foundation; Directorate For Geosciences [1411942] Funding Source: National Science Foundation; Division Of Environmental Biology [1256896] Funding Source: National Science Foundation	Office of Science (BER), US Department of Energy (Program in Microbial Communities and Carbon Cycling)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Office of Science (BER), US Department of Energy (Program in Microbial Communities and Carbon Cycling), NSF DEB-1256896, and NSF EAR-1411942.	Allison SD, 2005, ECOL LETT, V8, P626, DOI 10.1111/j.1461-0248.2005.00756.x; Allison SD, 2010, SOIL ENZYMOLOGY, P245; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Allison SD, 2013, ECOLOGY, V94, P714, DOI 10.1890/12-1243.1; Alster CJ, 2013, SOIL BIOL BIOCHEM, V64, P68, DOI 10.1016/j.soilbio.2013.03.034; Ayres E, 2009, J ECOL, V97, P901, DOI 10.1111/j.1365-2745.2009.01539.x; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Cleveland CC, 2014, OECOLOGIA, V174, P283, DOI 10.1007/s00442-013-2758-9; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Dighton J, 2016, FUNGI ECOSYSTEM PROC, DOI DOI 10.1201/9781315371528; Edwards IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020421; Egerton-Warburton LM, 2000, ECOL APPL, V10, P484, DOI 10.1890/1051-0761(2000)010[0484:SIAMCA]2.0.CO;2; Entwistle EM, 2013, SOIL SCI SOC AM J, V77, P1648, DOI 10.2136/sssaj2013.05.0179; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Freschet GT, 2012, J ECOL, V100, P619, DOI 10.1111/j.1365-2745.2011.01943.x; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Gooday Graham W., 1994, P279; GOODAY GW, 1990, ADV MICROB ECOL, V11, P387; Gustafsson FS, 2014, SCI REP-UK, V4, DOI 10.1038/srep06971; Hanson CA, 2008, ECOSYSTEMS, V11, P1157, DOI 10.1007/s10021-008-9186-4; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Kagata H, 2013, POPUL ECOL, V55, P69, DOI 10.1007/s10144-012-0342-5; Kivlin SN, 2015, MICROB ECOL, V69, P748, DOI 10.1007/s00248-014-0509-z; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; LeBauer DS, 2010, CAN J FOREST RES, V40, P1076, DOI 10.1139/X10-054; Lin Z, 2004, RUSS CHEM B+, V53, P2690, DOI 10.1007/s11172-005-0176-9; Madigan MT, 2009, BROCK BIOL MICROORGA; Matulich KL, 2015, ISME J; Matulich KL, 2015, ECOLOGY, V96, P154, DOI 10.1890/14-0357.1; McGuire KL, 2010, ECOLOGY, V91, P2324, DOI 10.1890/09-0654.1; Mohan JE, 2014, FUNGAL ECOL, V10, P3, DOI 10.1016/j.funeco.2014.01.005; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Potts DL, 2012, J ARID ENVIRON, V81, P59, DOI 10.1016/j.jaridenv.2012.01.007; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Reed HE, 2013, ISME J, V7, P868, DOI 10.1038/ismej.2012.154; ROSSWALL T, 1982, PLANT SOIL, V67, P15, DOI 10.1007/BF02182752; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Schlesinger W.H., 2013, BIOGEOCHEMISTRY; Setala H, 2004, OECOLOGIA, V139, P98, DOI 10.1007/s00442-003-1478-y; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; SPSS, 2009, SYST 13 VERS 13 00 0; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Treseder KK, 2015, MICROBIOL MOL BIOL R, V79, P243, DOI 10.1128/MMBR.00001-15; Treseder KK, 2012, BIOGEOCHEMISTRY, V109, P7, DOI 10.1007/s10533-011-9636-5; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Wardle D., 2002, COMMUNITIES ECOSYSTE; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Whiteside MD, 2012, SOIL BIOL BIOCHEM, V55, P7, DOI 10.1016/j.soilbio.2012.06.001; Whiteside MD, 2009, ECOLOGY, V90, P100, DOI 10.1890/07-2115.1	64	7	7	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138158	10.1371/journal.pone.0138158	http://dx.doi.org/10.1371/journal.pone.0138158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367868	Green Published, gold			2022-12-26	WOS:000361601100238
J	Nalluri, S; Ghoshal-Gupta, S; Kutiyanawalla, A; Gayatri, S; Lee, BR; Jiwani, S; Rojiani, AM; Rojiani, MV				Nalluri, Srilatha; Ghoshal-Gupta, Sampa; Kutiyanawalla, Ammar; Gayatri, Sitaram; Lee, Byung Rho; Jiwani, Shahanawaz; Rojiani, Amyn M.; Rojiani, Mumtaz V.			TIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2	PLOS ONE			English	Article							BREAST EPITHELIAL-CELLS; TISSUE INHIBITOR; METALLOPROTEINASES-1 TIMP-1; SIGNALING PATHWAY; CARCINOMA CELLS; CANCER; PHOSPHORYLATION; ANGIOGENESIS; PROGNOSIS; SURVIVAL	Tissue inhibitors of metalloproteinases (TIMPs) are multifaceted molecules that exhibit properties beyond their classical proteinase inhibitory function. Although TIMP-1 is a known inhibitor of apoptosis in mammalian cells, the mechanisms by which it exerts its effects are not well-established. Our earlier studies using H2009 lung adenocarcinoma cells, implanted in the CNS, showed that TIMP-1 overexpressing H2009 cells (HB-1), resulted in more aggressive tumor kinetics and increased vasculature. The present study was undertaken to elucidate the role of TIMP-1 in the context of apoptosis, using the same lung cancer cell lines. Overexpressing TIMP-1 in a lung adenocarcinoma cell line H2009 resulted in an approximately 3-fold increased expression of Bcl-2, with a marked reduction in apoptosis upon staurosporine treatment. This was an MMP-independent function as a clone expressing TIMP-1 mutant T2G, lacking MMP inhibition activity, inhibited apoptosis as strongly as TIMP1 overexpressing clones, as determined by inhibition of PARP cleavage. Immunoprecipitation of Bcl-2 from cell lysates also co-immunoprecipitated TIMP-1, indicative of an interaction between these two proteins. This interaction was specific for TIMP-1 as TIMP-2 was not present in the Bcl-2 pull-down. Additionally, we show a co-dependency of TIMP-1 and Bcl-2 RNA and protein levels, such that abrogating Bcl-2 causes a downregulation of TIMP-1 but not TIMP-2. Finally, we demonstrate that TIMP-1 dependent inhibition of apoptosis occurs through p90RSK, with phosphorylation of the pro-apoptotic protein BAD at serine 112, ultimately reducing Bax levels and increasing mitochondrial permeability. Together, these studies define TIMP-1 as an important cancer biomarker and demonstrate the potential TIMP-1 as a crucial therapeutic target.	[Nalluri, Srilatha; Ghoshal-Gupta, Sampa; Kutiyanawalla, Ammar; Gayatri, Sitaram; Lee, Byung Rho; Jiwani, Shahanawaz; Rojiani, Amyn M.; Rojiani, Mumtaz V.] Georgia Regents Univ, Med Coll Georgia, Dept Pathol, Augusta, GA USA	University System of Georgia; Augusta University	Rojiani, MV (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Med, Augusta, GA 30912 USA.	mrojiani@GRU.edu	Gayatri, Sitaram/GLT-7340-2022	Lee, Byung Rho/0000-0002-2729-1616; Rojiani, Amyn/0000-0001-5621-3724; nalluri, srilatha/0000-0002-7265-8165; Gayatri, Sitaram/0000-0002-0773-6278	Georgia Research Alliance [GCC0059]; Georgia Regents University	Georgia Research Alliance; Georgia Regents University	This study was funded by Research Award GCC0059 from the Georgia Research Alliance to AMR and intramural research funds from the Georgia Regents University to MVR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A. C. S, 2014, CANC FACTS FIG; Aljada IS, 2004, J CLIN ONCOL, V22, P3218, DOI 10.1200/JCO.2004.02.110; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Ashutosh, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.54; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Davidsen ML, 2006, BRIT J CANCER, V95, P1114, DOI 10.1038/sj.bjc.6603378; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Fong KM, 1996, CLIN CANCER RES, V2, P1369; Gao M, 2012, ONCOL REP, V27, P585, DOI 10.3892/or.2011.1527; Gonzalez-Puertos VY, 2010, J GASTROEN HEPATOL, V25, P1306, DOI 10.1111/j.1440-1746.2009.06175.x; Gouyer V, 2005, CANCER-AM CANCER SOC, V103, P1676, DOI 10.1002/cncr.20965; Grunnet M, 2013, SCAND J GASTROENTERO, V48, P899, DOI 10.3109/00365521.2013.812235; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; Guo LJ, 2006, CALCIFIED TISSUE INT, V78, P285, DOI 10.1007/s00223-005-0092-x; Guo YH, 2004, LIFE SCI, V75, P2483, DOI 10.1016/j.lfs.2004.07.007; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Hoetelmans RWM, 2000, CELL DEATH DIFFER, V7, P384, DOI 10.1038/sj.cdd.4400664; Ikenaka Y, 2003, INT J CANCER, V105, P340, DOI 10.1002/ijc.11094; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Jiang YF, 2001, CANCER RES, V61, P2365; Jin ZH, 2004, J BIOL CHEM, V279, P40209, DOI 10.1074/jbc.M404056200; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Lee JH, 2011, J GASTROINTEST LIVER, V20, P287; Lee SJ, 2003, BIOCHEM BIOPH RES CO, V312, P1196, DOI 10.1016/j.bbrc.2003.11.050; Li GY, 1999, CANCER RES, V59, P6267; Liu XW, 2005, CANCER RES, V65, P898; Liu XW, 2003, J BIOL CHEM, V278, P40364, DOI 10.1074/jbc.M302999200; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Park JS, 2012, INT J ONCOL, V40, P1210, DOI 10.3892/ijo.2011.1310; Pesta M, 2011, ANTICANCER RES, V31, P4031; Phelps RM, 1996, J CELL BIOCHEM, P32; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Ritter LM, 1999, BIOCHEM BIOPH RES CO, V257, P494, DOI 10.1006/bbrc.1999.0408; Rojiani MV, 2015, J NEUROPATH EXP NEUR, V74, P293, DOI 10.1097/NEN.0000000000000175; Rooswinkel RW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.109; Stilley JAW, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094680; Sun Jun, 2009, J Mol Signal, V4, P4, DOI 10.1186/1750-2187-4-4; Tsagaraki I, 2010, CELL TISSUE RES, V342, P87, DOI 10.1007/s00441-010-1025-1; Van Geest RJ, 2013, J CELL COMMUN SIGNAL, V7, P1, DOI 10.1007/s12079-012-0178-y; Wang T, 2002, BIOCHEM BIOPH RES CO, V296, P201, DOI 10.1016/S0006-291X(02)00741-6; Wu TY, 2014, INT J CLIN EXP PATHO, V7, P56; Wurtz SO, 2008, ACTA ONCOL, V47, P580, DOI 10.1080/02841860802022976; Wurtz SO, 2005, ENDOCR-RELAT CANCER, V12, P215, DOI 10.1677/erc.1.00719; Yamada E, 2001, HISTOL HISTOPATHOL, V16, P87, DOI 10.14670/HH-16.87; Ye DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027637; Zhao WQ, 1998, J CELL SCI, V111, P1147	53	26	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137673	10.1371/journal.pone.0137673	http://dx.doi.org/10.1371/journal.pone.0137673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366732	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100105
J	Nahas, GR; Murthy, RG; Patel, SA; Ganta, T; Greco, SJ; Rameshwar, P				Nahas, George R.; Murthy, Raghav G.; Patel, Shyam A.; Ganta, Teja; Greco, Steven J.; Rameshwar, Pranela			The RNA-binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth	FASEB JOURNAL			English	Article						miRNA; neurokinin-1; REST; substance P; cancer stem cell	TRUNCATED NEUROKININ-1 RECEPTOR; MESENCHYMAL STEM-CELLS; BONE-MARROW STROMA; SUBSTANCE-P; TACHYKININ RECEPTORS; TUMOR PROGRESSION; KAPPA-B; EXPRESSION; ACTIVATION; GENE	Substance P and its truncated receptor exert oncogenic effects. The high production of substance P in breast cancer cells (BCCs) is caused by the enhancement of tachykinin (TAC) 1 translation by cytosolic factor. In vitro translational studies and mRNA stabilization analyses indicate that BCCs contain the factor needed to increase TAC1 translation and to stabilize the mRNA. Prediction of protein folding, RNA-shift analysis, and proteomic analysis identified a 40 kDa molecule that interacts with the non-coding exon 7. Western blot analysis and RNA supershift identified Musashi 1 (Msi1) as the binding protein. Ectopic expression of TAC1 in nontumorigenic breast cells (BCs) indicates that TAC1 regulates its stability by increasing Msi1. Using a reporter gene system, we showed that Msi1 competes with microRNA (miR) 130a and -206 for the 3 ' UTR of exon 7/TAC1. In the absence of Msi1 and miR130a and -206, reporter gene activity decreased, indicating that Msi1 expression limits TAC1 expression. Tumor growth was significantly decreased when nude BALB/c mice were injected with Msi1-knockdown BCCs. In summary, the RNA-binding protein Msi1 competes with miR130a and -206 for interaction with TAC1 mRNA, to stabilize and increase its translation. Consequently, these interactions increase tumor growth.-Nahas, G. R., Murthy, R. G., Patel, S. A., Ganta, T., Greco, S. J., Rameshwar P. The RNA-binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth. FASEB J. 30, 149-159 (2016). www.fasebj.org	[Nahas, George R.; Murthy, Raghav G.; Patel, Shyam A.; Ganta, Teja; Greco, Steven J.; Rameshwar, Pranela] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Rameshwar, P (corresponding author), Rutgers New Jersey Med Sch, 185 South Orange Ave,MSB E-585, Newark, NJ 07103 USA.	rameshwa@njms.rutgers.edu		Ganta, Teja/0000-0003-2441-4104	New Jersey Cancer Commission	New Jersey Cancer Commission	This study was funded by the New Jersey Cancer Commission. The authors declare no conflicts of interest.	Aalto Y, 1998, PEPTIDES, V19, P231, DOI 10.1016/S0196-9781(97)00323-9; Ansquer C, 2009, CURR PHARM DESIGN, V15, P2453, DOI 10.2174/138161209788682262; Bandari PS, 2002, NEUROPEPTIDES, V36, P13, DOI 10.1054/npep.2002.0869; Baou M, 2011, BLOOD, V118, P5732, DOI 10.1182/blood-2011-07-347237; Castano Z, 2011, INT J DEV BIOL, V55, P889, DOI 10.1387/ijdb.113366zc; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Corcoran KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002563; Eberhardt W, 2012, CURR PROTEIN PEPT SC, V13, P380, DOI 10.2174/138920312801619439; Garcia-Recio S, 2013, CANCER RES, V73, P6424, DOI 10.1158/0008-5472.CAN-12-4573; Gillespie E, 2011, P NATL ACAD SCI USA, V108, P17420, DOI 10.1073/pnas.1114275108; Glazer RI, 2008, CELL CYCLE, V7, P2635, DOI 10.4161/cc.7.17.6522; Greco SJ, 2007, J BIOL CHEM, V282, P30039, DOI 10.1074/jbc.M703026200; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; Greco SJ, 2007, J IMMUNOL, V179, P3342, DOI 10.4049/jimmunol.179.5.3342; Klassert TE, 2008, J NEUROIMMUNOL, V196, P27, DOI 10.1016/j.jneuroim.2008.02.010; Klassert TE, 2010, J RECEPT LIGAND CH R, V3, P51; Lagadec C, 2014, STEM CELLS, V32, P135, DOI 10.1002/stem.1537; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Lu XY, 2011, HISTOL HISTOPATHOL, V26, P1127, DOI 10.14670/HH-26.1127; Mancino M, 2011, BBA-REV CANCER, V1816, P105, DOI 10.1016/j.bbcan.2011.04.005; Mayordomo C, 2012, J CELL PHYSIOL, V227, P1358, DOI 10.1002/jcp.22848; Moharita AL, 2006, BLOOD, V108, P3245, DOI 10.1182/blood-2006-01-017459; Navarro P, 2012, EXP CELL RES, V318, P2604, DOI 10.1016/j.yexcr.2012.09.002; Nikpour P, 2011, J CELL MOL MED, V15, P1210, DOI 10.1111/j.1582-4934.2010.01090.x; Nowicki M, 2008, LEUKEMIA RES, V32, P97, DOI 10.1016/j.leukres.2007.05.006; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Page NM, 2005, PEPTIDES, V26, P1356, DOI 10.1016/j.peptides.2005.03.030; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Patel HJ, 2005, P NATL ACAD SCI USA, V102, P17436, DOI 10.1073/pnas.0506351102; Patel SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00906; Pavlovic S, 2011, J IMMUNOL, V186, P848, DOI 10.4049/jimmunol.0903878; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; Pinto FM, 2004, EUR J PHARMACOL, V494, P233, DOI 10.1016/j.ejphar.2004.05.016; Rameshwar Pranela, 2012, Recent Pat CNS Drug Discov, V7, P173; Ramkissoon SH, 2006, EXPERT OPIN BIOL TH, V6, P109, DOI 10.1517/14712598.6.2.109; Ramkissoon SH, 2007, CANCER RES, V67, P1653, DOI 10.1158/0008-5472.CAN-06-3813; Rao G, 2004, CANCER RES, V64, P2874, DOI 10.1158/0008-5472.CAN-03-3121; Reddy Bobby Y, 2008, Curr Drug Discov Technol, V5, P15; Rodriguez PL, 2014, INT J CANCER, V134, P1034, DOI 10.1002/ijc.28433; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Sugiyama-Nakagiri Y, 2006, AM J PATHOL, V168, P80, DOI 10.2353/ajpath.2006.050469; Todd AJ, 2002, EXP PHYSIOL, V87, P245, DOI 10.1113/eph8702351; Tuluc F, 2009, TRENDS IMMUNOL, V30, P271, DOI 10.1016/j.it.2009.03.006; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Zhou YL, 2013, BREAST CANCER RES TR, V140, P49, DOI 10.1007/s10549-013-2599-6	48	18	19	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					149	159		10.1096/fj.15-278770	http://dx.doi.org/10.1096/fj.15-278770			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26373800				2022-12-26	WOS:000367621000017
J	Foster, AJ; Pelletier, G; Tanguay, P; Seguin, A				Foster, Adam J.; Pelletier, Gervais; Tanguay, Philippe; Seguin, Armand			Transcriptome Analysis of Poplar during Leaf Spot Infection with Sphaerulina spp.	PLOS ONE			English	Article							HYBRID POPLAR; EXPRESSION ANALYSIS; INDUCED DEFENSES; SEPTORIA-MUSIVA; DATA SETS; POPULUS; ARABIDOPSIS; SEQUENCE; GENOMICS; RESISTANCE	Diseases of poplar caused by the native fungal pathogen Sphaerulina musiva and related species are of growing concern, particularly with the increasing interest in intensive poplar plantations to meet growing energy demands. Sphaerulina musiva is able to cause infection on leaves, resulting in defoliation and canker formation on stems. To gain a greater understanding of the different responses of poplar species to infection caused by the naturally co-evolved Sphaerulina species, RNA-seq was conducted on leaves of Populus deltoides, P. balsamifera and P. tremuloides infected with S. musiva, S. populicola and a new undescribed species, Ston1, respectively. The experiment was designed to contain the pathogen in a laboratory environment, while replicating disease development in commercial plantations. Following inoculation, trees were monitored for disease symptoms, pathogen growth and host responses. Genes involved in phenylpropanoid, terpenoid and flavonoid biosynthesis were generally upregulated in P. balsamifera and P. tremuloides, while cell wall modification appears to play an important role in the defense of P. deltoides. Poplar defensive genes were expressed early in P. balsamifera and P. tremuloides, but their expression was delayed in P. deltoides, which correlated with the rate of disease symptoms development. Also, severe infection in P. balsamifera led to leaf abscission. This data gives an insight into the large differences in timing and expression of genes between poplar species being attacked by their associated Sphaerulina pathogen.	[Foster, Adam J.; Pelletier, Gervais; Tanguay, Philippe; Seguin, Armand] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada	Natural Resources Canada; Canadian Forest Service	Seguin, A (corresponding author), Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada.	Armand.Seguin@RNCan-NRCan.ca			Genomics R&D Initiative of Canada; Natural Sciences and Engineering Research Council of Canada	Genomics R&D Initiative of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this research was provided by the Genomics R&D Initiative of Canada (http://grdiirdg.collaboration.gc.ca/eng/) and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) Discovery Grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2008, EUPHYTICA, V159, P167, DOI 10.1007/s10681-007-9469-4; Azaiez A, 2009, MOL PLANT MICROBE IN, V22, P190, DOI 10.1094/MPMI-22-2-0190; Bao H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-359; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BIER J. E., 1939, CANADIAN JOUR RES SECT C BOT SCI, V17, P195; Borem A, 2014, OMICS IN PLANT BREEDING, P1, DOI 10.1002/9781118820971; Busby PE, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00127.1; Busby PE, 2012, FUNGAL BIOL-UK, V116, P792, DOI 10.1016/j.funbio.2012.04.012; Christopher ME, 2004, PLANTA, V219, P936, DOI 10.1007/s00425-004-1297-3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cossu RM, 2014, TREE GENET GENOMES, V10, P53, DOI 10.1007/s11295-013-0661-5; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Feau N, 2005, MYCOL RES, V109, P1015, DOI 10.1017/S0953756205003242; Feau N, 2007, J MOL EVOL, V64, P489, DOI 10.1007/s00239-005-0309-7; Feau N, 2006, MOL PHYLOGENET EVOL, V40, P808, DOI 10.1016/j.ympev.2006.03.029; Feau N, 2010, CAN J PLANT PATHOL, V32, P122, DOI 10.1080/07060661003740009; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; Isabel N, 2013, TREE GENET GENOMES, V9, P621, DOI 10.1007/s11295-012-0569-5; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Kelleher CT, 2007, PLANT J, V50, P1063, DOI 10.1111/j.1365-313X.2007.03112.x; Kim JY, 2005, BIOCHEM BIOPH RES CO, V330, P921, DOI 10.1016/j.bbrc.2005.03.057; Kombrink A, 2011, MICROBES INFECT, V13, P1168, DOI 10.1016/j.micinf.2011.07.010; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Li ZH, 2012, J INTEGR PLANT BIOL, V54, P526, DOI 10.1111/j.1744-7909.2012.01136.x; Liang HY, 2014, PLANT SCI, V223, P69, DOI 10.1016/j.plantsci.2014.03.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; LONG R, 1986, CAN J FOREST RES, V16, P405, DOI 10.1139/x86-072; Major IT, 2006, NEW PHYTOL, V172, P617, DOI 10.1111/j.1469-8137.2006.01877.x; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Ojiambo PS, 2005, PHYTOPATHOLOGY, V95, P108, DOI 10.1094/PHYTO-95-0108; OSTRY ME, 1988, PLANT DIS, V72, P497, DOI 10.1094/PD-72-0497; Petre B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044408; Polle A, 2013, APPL MICROBIOL BIOT, V97, P5669, DOI 10.1007/s00253-013-4940-8; Qin RQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103477; Ralph S, 2006, MOL ECOL, V15, P1275, DOI 10.1111/j.1365-294X.2006.02824.x; RIDE JP, 1975, PHYSIOL PLANT PATHOL, V5, P125, DOI 10.1016/0048-4059(75)90016-8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Royle DJ, 1995, BIOMASS BIOENERG, V9, P69, DOI 10.1016/0961-9534(95)00080-1; Somssich IE, 1996, P NATL ACAD SCI USA, V93, P14199, DOI 10.1073/pnas.93.24.14199; SPIELMAN LJ, 1986, PLANT DIS, V70, P968, DOI 10.1094/PD-70-968; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tuskan GA, 2005, SCIENCE, V313, P1596, DOI [10.1007/s00425-005-1498-4, DOI 10.1007/S00425-005-1498-4]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weiland JE, 2007, PLANT DIS, V91, P1524, DOI 10.1094/PDIS-91-12-1524; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhu S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-382	51	21	23	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138162	10.1371/journal.pone.0138162	http://dx.doi.org/10.1371/journal.pone.0138162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378446	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400062
J	Bairlein, F; Fritz, J; Scope, A; Schwendenwein, I; Stanclova, G; van Dijk, G; Meijer, HAJ; Verhulst, S; Dittami, J				Bairlein, Franz; Fritz, Johannes; Scope, Alexandra; Schwendenwein, Ilse; Stanclova, Gabriela; van Dijk, Gertjan; Meijer, Harro A. J.; Verhulst, Simon; Dittami, John			Energy Expenditure and Metabolic Changes of Free-Flying Migrating Northern Bald Ibis	PLOS ONE			English	Article							DOUBLY LABELED WATER; LONG-DISTANCE MIGRATION; WIND-TUNNEL; HEART-RATE; OXYGEN-CONSUMPTION; OXIDATIVE STRESS; FLIGHT DURATION; PIGEON FLIGHT; BODY-MASS; LACTATE	Many migrating birds undertake extraordinary long flights. How birds are able to perform such endurance flights of over 100-hour durations is still poorly understood. We examined energy expenditure and physiological changes in Northern Bald Ibis Geronticus eremite during natural flights using birds trained to follow an ultra-light aircraft. Because these birds were tame, with foster parents, we were able to bleed them immediately prior to and after each flight. Flight duration was experimentally designed ranging between one and almost four hours continuous flights. Energy expenditure during flight was estimated using doublylabelled- water while physiological properties were assessed through blood chemistry including plasma metabolites, enzymes, electrolytes, blood gases, and reactive oxygen compounds. Instantaneous energy expenditure decreased with flight duration, and the birds appeared to balance aerobic and anaerobic metabolism, using fat, carbohydrate and protein as fuel. This made flight both economic and tolerable. The observed effects resemble classical exercise adaptations that can limit duration of exercise while reducing energetic output. There were also in-flight benefits that enable power output variation from cruising to manoeuvring. These adaptations share characteristics with physiological processes that have facilitated other athletic feats in nature and might enable the extraordinary long flights of migratory birds as well.	[Bairlein, Franz] Inst Avian Res Vogelwarte Helgoland, D-26386 Wilhelmshaven, Germany; [Fritz, Johannes; Dittami, John] Univ Vienna, Ctr Organism Syst Biol, Dept Anthropol, A-1090 Vienna, Austria; [Fritz, Johannes; Dittami, John] Univ Vienna, Ctr Organism Syst Biol, Dept Behav Biol, A-1090 Vienna, Austria; [Scope, Alexandra; Stanclova, Gabriela] Univ Vet Med Vienna, Clin Avian Reptile & Fish Med, A-1210 Vienna, Austria; [Schwendenwein, Ilse] Univ Vet Med Vienna, Cent Lab, A-1210 Vienna, Austria; [van Dijk, Gertjan; Verhulst, Simon] Univ Groningen, CBN, NL-9747 AG Groningen, Netherlands; [van Dijk, Gertjan; Meijer, Harro A. J.] Univ Groningen, CIO, NL-9747 AG Groningen, Netherlands; [Fritz, Johannes] Waldrappteam, A-6162 Mutters, Austria; [Fritz, Johannes] Konrad Lorenz Res Stn, A-4645 Grunau, Austria	University of Vienna; University of Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Groningen; University of Groningen	Bairlein, F (corresponding author), Inst Avian Res Vogelwarte Helgoland, Vogelwarte 21, D-26386 Wilhelmshaven, Germany.	franz.bairlein@ifv-vogelwarte.de	Verhulst, Simon/B-1613-2009; Verhulst, Simon/S-3404-2019; Meijer, Harro A J/A-5787-2012	Verhulst, Simon/0000-0002-1143-6868; Verhulst, Simon/0000-0002-1143-6868; Meijer, Harro A.J./0000-0001-8744-5632; Fritz, Johannes/0000-0003-4691-2892	Austrian Science Fund (FWF) [P20633]; Forderverein Waldrappteam; Heinz Sielmann Foundation; HIT Umweltstiftung; City Council of Burghausen	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Forderverein Waldrappteam; Heinz Sielmann Foundation; HIT Umweltstiftung; City Council of Burghausen	This work was supported by an Austrian Science Fund (FWF P20633) grant to J.D., Forderverein Waldrappteam, Heinz Sielmann Foundation, HIT Umweltstiftung and the City Council of Burghausen.	Adams NJ, 1997, J COMP PHYSIOL B, V167, P444, DOI 10.1007/s003600050095; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Arora K. L., 2010, International Journal of Poultry Science, V9, P828; BAIRLEIN F, 1994, ANNU REV NUTR, V14, P187, DOI 10.1146/annurev.nu.14.070194.001155; BAIRLEIN F, 1992, ORNIS SCAND, V23, P244, DOI 10.2307/3676645; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; BERGER M, 1970, Z VERGL PHYSIOL, V66, P201, DOI 10.1007/BF00297779; Berthold P, 1996, CONTROL BIRD MIGRATI; BIESEL W, 1987, J COMP PHYSIOL B, V157, P117, DOI 10.1007/BF00702736; Billat VL, 2003, SPORTS MED, V33, P407, DOI 10.2165/00007256-200333060-00003; Bordel R, 2000, J COMP PHYSIOL B, V170, P51, DOI 10.1007/s003600050007; BORDEL R, 1993, J COMP PHYSIOL B, V163, P219, DOI 10.1007/BF00261668; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Butler PJ, 2000, COMP BIOCHEM PHYS A, V126, P379, DOI 10.1016/S1095-6433(00)00221-X; BUTLER PJ, 1977, J EXP BIOL, V71, P7; CARMI N, 1995, ISRAEL J ZOOL, V41, P369; CARMI N, 1992, AUK, V109, P268; Costantini D, 2006, J COMP PHYSIOL B, V176, P329, DOI 10.1007/s00360-005-0055-6; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2008, J COMP PHYSIOL B, V178, P829, DOI 10.1007/s00360-008-0270-z; COSTILL DL, 1977, J APPL PHYSIOL, V43, P695, DOI 10.1152/jappl.1977.43.4.695; Eckert R, 2002, ANIMAL PHYSL 2002 TH; Engel S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P763, DOI 10.1086/504610; Engel S, 2006, J COMP PHYSIOL B, V176, P415, DOI 10.1007/s00360-006-0063-1; Fair J, 2007, IBIS, V149, P535, DOI 10.1111/j.1474-919X.2007.00680.x; Fritz J, 2004, WAZA MAGAZINE, V5, P16; Gehre M, 2004, RAPID COMMUN MASS SP, V18, P2650, DOI 10.1002/rcm.1672; Gerson AR, 2013, J COMP PHYSIOL B, V183, P983, DOI 10.1007/s00360-013-0767-y; Gerson AR, 2011, SCIENCE, V333, P1434, DOI 10.1126/science.1210449; Giladi I, 1999, J COMP PHYSIOL B, V169, P311, DOI 10.1007/s003600050226; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Guglielmo C, 2001, J EXP BIOL, V204, P2683; Guglielmo CG, 2002, AUK, V119, P437, DOI 10.1642/0004-8038(2002)119[0437:EAISOV]2.0.CO;2; Guglielmo CG, 2002, J COMP PHYSIOL B, V172, P409, DOI 10.1007/s00360-002-0266-z; Guglielmo CG, 1998, COMP BIOCHEM PHYS B, V119, P549, DOI 10.1016/S0305-0491(98)00016-9; Guidotti S, 2013, RAPID COMMUN MASS SP, V27, P1055, DOI 10.1002/rcm.6540; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; Jenni L, 2000, AM J PHYSIOL-REG I, V278, pR1182, DOI 10.1152/ajpregu.2000.278.5.R1182; Jenni L, 1998, BIOL CONSERV FAUNA, V102, P312; Jenni L, 2006, J ORNITHOL, V147, P531, DOI 10.1007/s10336-006-0076-2; Jenni-Eiermann S, 2003, AVIAN MIGRATION, P293; Jenni-Eiermann S, 2002, J EXP BIOL, V205, P2453; Jenni-Eiermann S, 2001, PHYSIOL BIOCHEM ZOOL, V74, P90, DOI 10.1086/319306; Jenni-Eiermann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097650; Jenni-Eiermann Susanne, 1999, Biologia e Conservazione della Fauna, V102, P312; JenniEiermann S, 1996, FUNCT ECOL, V10, P62, DOI 10.2307/2390263; JENNIEIERMANN S, 1992, PHYSIOL ZOOL, V65, P112, DOI 10.1086/physzool.65.1.30158242; JENNIEIERMANN S, 1991, J COMP PHYSIOL B, V161, P465; JENNIEIERMANN S, 1994, AUK, V111, P888, DOI 10.2307/4088821; Kasprzak M, 2006, J ORNITHOL, V147, P599, DOI 10.1007/s10336-006-0084-2; Klaassen M, 2000, CONDOR, V102, P444, DOI 10.1650/0010-5422(2000)102[0444:FCAFCO]2.0.CO;2; Klaassen M, 1995, AUK, V112, P260, DOI 10.2307/4088789; Klaassen M, 1996, J EXP BIOL, V199, P57; KLASING K. C., 1998, COMP AVIAN NUTR; Landys MM, 2005, P ROY SOC B-BIOL SCI, V272, P295, DOI 10.1098/rspb.2004.2952; LIFSON N, 1966, J THEOR BIOL, V12, P46, DOI 10.1016/0022-5193(66)90185-8; Lindsell JA, 2009, ORYX, V43, P329, DOI 10.1017/S0030605309001963; Lindstrom A, 1999, FUNCT ECOL, V13, P352, DOI 10.1046/j.1365-2435.1999.00320.x; LUMEIJ JT, 1985, AVIAN PATHOL, V14, P257, DOI 10.1080/03079458508436227; Lyons JE, 2008, OECOLOGIA, V155, P417, DOI 10.1007/s00442-007-0921-x; Martin MP, 2010, AVIAN DIS, V54, P1016, DOI 10.1637/9223-122209-Reg.1; MASMAN D, 1987, AUK, V104, P603, DOI 10.1093/auk/104.4.603; McArdle W.D., 2009, EXERCISE PHYSL NUTR, V7th; McCain SL, 2010, VET CLIN PATH, V39, P474, DOI 10.1111/j.1939-165X.2010.00258.x; Michaeli G, 2001, J EXP BIOL, V204, P3803; Moniello G, 2005, S AFR J ANIM SCI, V35, P268; Myers J, 1997, CHEST, V111, P787, DOI 10.1378/chest.111.3.787; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Norberg U., 1990, VERTEBRATE FLIGHT ME; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Penzlin H, 2005, LEHRBUCH TIERPHYSIOL; ROTHE HJ, 1987, J COMP PHYSIOL B, V157, P99, DOI 10.1007/BF00702734; Schmidt-Wellenburg CA, 2008, J COMP PHYSIOL B, V178, P767, DOI 10.1007/s00360-008-0267-7; Schwilch R, 1996, J COMP PHYSIOL B, V166, P77, DOI 10.1007/BF00301171; Scope A, 2006, VET REC, V159, P839; Scope A, 2002, J AVIAN MED SURG, V16, P10, DOI 10.1647/1082-6742(2002)016[0010:STVOBP]2.0.CO;2; Scope A, 2000, AVIAN DIS, V44, P885, DOI 10.2307/1593061; Speakman J.R., 1997, DOUBLY LABELLED WATE; Steinmetz HW, 2007, J VET DIAGN INVEST, V19, P382, DOI 10.1177/104063870701900407; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Van Hall G, 2000, ACTA PHYSIOL SCAND, V168, P643, DOI 10.1046/j.1365-201x.2000.00716.x; Visser GH, 2000, J COMP PHYSIOL B, V170, P365, DOI 10.1007/s003600000112; Visser GH, 1999, PHYSIOL BIOCHEM ZOOL, V72, P740, DOI 10.1086/316713; Ward S, 2004, J EXP BIOL, V207, P4291, DOI 10.1242/jeb.01281; Ward S, 2002, J EXP BIOL, V205, P3347; Wasserman K., 2012, PRINCIPLES EXERCISE, V1, P8; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a	93	32	33	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0134433	10.1371/journal.pone.0134433	http://dx.doi.org/10.1371/journal.pone.0134433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376193	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200004
J	Skrzypek, G; Wojtun, B; Richter, D; Jakubas, D; Wojczulanis-Jakubas, K; Samecka-Cymerman, A				Skrzypek, Grzegorz; Wojtun, Bronislaw; Richter, Dorota; Jakubas, Dariusz; Wojczulanis-Jakubas, Katarzyna; Samecka-Cymerman, Aleksandra			Diversification of Nitrogen Sources in Various Tundra Vegetation Types in the High Arctic	PLOS ONE			English	Article							PLANT-COMMUNITIES; NITRATE; SEABIRD; DEPOSITION; ISOTOPES; CARBON; VARIABILITY; ACQUISITION; PATTERNS; HORNSUND	Low nitrogen availability in the high Arctic represents a major constraint for plant growth, which limits the tundra capacity for carbon retention and determines tundra vegetation types. The limited terrestrial nitrogen (N) pool in the tundra is augmented significantly by nesting seabirds, such as the planktivorous Little Auk (Alle alle). Therefore, N delivered by these birds may significantly influence the N cycling in the tundra locally and the carbon budget more globally. Moreover, should these birds experience substantial negative environmental pressure associated with climate change, this will adversely influence the tundra N-budget. Hence, assessment of bird-originated N-input to the tundra is important for understanding biological cycles in polar regions. This study analyzed the stable nitrogen composition of the three main N-sources in the High Arctic and in numerous plants that access different N-pools in ten tundra vegetation types in an experimental catchment in Hornsund (Svalbard). The percentage of the total tundra N-pool provided by birds, ranged from 0-21% in Patterned-ground tundra to 100% in Ornithocoprophilous tundra. The total N-pool utilized by tundra plants in the studied catchment was built in 36% by birds, 38% by atmospheric deposition, and 26% by atmospheric N2-fixation. The stable nitrogen isotope mixing mass balance, in contrast to direct methods that measure actual deposition, indicates the ratio between the actual N-loads acquired by plants from different N-sources. Our results enhance our understanding of the importance of different N-sources in the Arctic tundra and the used methodological approach can be applied elsewhere.	[Skrzypek, Grzegorz] Univ Western Australia, Sch Plant Biol, West Australian Biogeochem Ctr, Crawley, WA, Australia; [Wojtun, Bronislaw; Samecka-Cymerman, Aleksandra] Univ Wroclaw, Dept Ecol Biogeochem & Environm Protect, PL-50138 Wroclaw, Poland; [Richter, Dorota] Wroclaw Univ Environm & Life Sci, Dept Bot & Plant Ecol, Wroclaw, Poland; [Jakubas, Dariusz; Wojczulanis-Jakubas, Katarzyna] Univ Gdansk, Dept Vertebrate Ecol & Zool, PL-80952 Gdansk, Poland	University of Western Australia; University of Wroclaw; Wroclaw University of Environmental & Life Sciences; Fahrenheit Universities; University of Gdansk	Skrzypek, G (corresponding author), Univ Western Australia, Sch Plant Biol, West Australian Biogeochem Ctr, Crawley, WA, Australia.	grzegorz.skrzypek@uwa.edu.au	Wojczulanis-Jakubas, Katarzyna/AAO-4126-2021; Skrzypek, Grzegorz/B-4202-2008; Jakubas, Dariusz/N-3680-2019; Richter, Dorota/S-8850-2016; Jakubas, Dariusz/L-9660-2015	Wojczulanis-Jakubas, Katarzyna/0000-0001-6230-0509; Jakubas, Dariusz/0000-0002-1879-4342; Richter, Dorota/0000-0003-3024-9766; Jakubas, Dariusz/0000-0002-1879-4342; Wojtun, Bronislaw/0000-0003-1029-1078; Skrzypek, Grzegorz/0000-0002-5686-2393; Samecka-Cymerman, Aleksandra/0000-0002-5421-0092	Polish National Science Centre [N N304 410139]; ARC Future Fellowship [FT110100352]	Polish National Science Centre; ARC Future Fellowship(Australian Research Council)	This research was supported by the Polish National Science Centre to B.W. (Grant no. N N304 410139), https://www.ncn.gov.pl/? language = en. G. S.'s participation was supported by ARC Future Fellowship (FT110100352), http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari AH, 2013, BIOGEOCHEMISTRY, V113, P341, DOI 10.1007/s10533-012-9761-9; Arroniz-Crespo M, 2014, PLOS ONE, V9, DOI [10.1371/ journal. pone. 0096081, DOI 10.1371/J0URNAL.P0NE.0096081]; Asada T, 2005, AQUAT BOT, V82, P297, DOI 10.1016/j.aquabot.2005.05.005; Atkin OK, 1996, PLANT CELL ENVIRON, V19, P695, DOI 10.1111/j.1365-3040.1996.tb00404.x; Ayres E, 2006, BIOL LETT-UK, V2, P286, DOI 10.1098/rsbl.2006.0455; Bjork RG, 2007, NEW PHYTOL, V176, P862, DOI 10.1111/j.1469-8137.2007.02231.x; BUCH H, 1947, COMMENTATIONES BIOL, V9, P1; Buck WR, 2000, BRYOPHYTE BIOL, P71, DOI DOI 10.1017/CBO9781139171304; Burke Chantelle M., 2014, Marine Ornithology, V42, P17; Casciotti KL, 2007, ANAL CHEM, V79, P2427, DOI 10.1021/ac061598h; Caut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039125; Chapin DM, 1992, ARCTIC ECOSYSTEMS CH, P301, DOI DOI 10.1016/B978-0-12-168250-7.50020-1; Climate change, 2007, SUMM POL MAK; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Davey ML, 2009, MYCOL RES, V113, P1254, DOI 10.1016/j.mycres.2009.08.001; DODDS WK, 1995, J PHYCOL, V31, P2, DOI 10.1111/j.0022-3646.1995.00002.x; Elliott EM, 2007, ENVIRON SCI TECHNOL, V41, P7661, DOI 10.1021/es070898t; Elven R, 1996, CATALOGUE SVALBARD P, V198, P9; EUROLA S, 1977, Aquilo Ser Botanica, V15, P1; Evans RD, 1996, PLANT CELL ENVIRON, V19, P1317, DOI 10.1111/j.1365-3040.1996.tb00010.x; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; Fort J, 2010, MAR ECOL PROG SER, V414, P293, DOI 10.3354/meps08721; Fritz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079991; Gersper P. L., 1980, An Arctic ecosystem. The coastal tundra at Barrow, Alaska., P219; Glime JM, 2017, BRYOPHYTE ECOLOGY; Goffinet B., 2008, BRYOPHYTE BIOL; Graham LE, 2000, ALGAE; Heaton THE, 2004, ATMOS ENVIRON, V38, P5611, DOI 10.1016/j.atmosenv.2004.06.028; Hill MO, 2006, J BRYOL, V28, P198, DOI 10.1179/174328206X119998; Hobbie EA, 2009, BIOGEOCHEMISTRY, V95, P355, DOI 10.1007/s10533-009-9328-6; Hubner H., 1986, HDB ENV ISOTOPE GEOC, P361, DOI DOI 10.1016/B978-0-444-42225-5.50014-0; Ininbergs K, 2011, NEW PHYTOL, V192, P507, DOI 10.1111/j.1469-8137.2011.03809.x; Jakubas D, 2008, POL POLAR RES, V29, P45; Jakubas D, 2011, MAR ECOL PROG SER, V432, P277, DOI 10.3354/meps09082; Kendall C., 1998, ISOTOPE TRACERS CATC, P517; Kendall C, 2007, ECOL METHOD CONCEPT, P375, DOI 10.1002/9780470691854.ch12; Koba K, 2003, ECOSYSTEMS, V6, P457, DOI 10.1007/s10021-002-0132-6; Kohzu A, 2003, ECOL RES, V18, P257, DOI 10.1046/j.1440-1703.2003.00552.x; Kolb G.S., 2011, P212; Kolondra L, 2002, CARTOGRAPHER ORTHO; Kuhnel R, 2011, ADV METEOROL, V2011, DOI 10.1155/2011/406508; Lindo Z, 2013, GLOBAL CHANGE BIOL, V19, P2022, DOI 10.1111/gcb.12175; Liu XY, 2012, FUNCT PLANT BIOL, V39, P598, DOI 10.1071/FP12014; Mariotti A., 1980, Catena, V7, P293, DOI 10.1016/0341-8162(80)90014-4; Marshall JD, 2007, ECOL METHOD CONCEPT, P22, DOI 10.1002/9780470691854.ch2; Matula Jan, 2007, Polish Polar Research, V28, P283; Migala K, 2014, CATENA, V116, P10, DOI [10.1016/j.catena.2013.12.007, 10.1016/j.catena2013.12.007]; Minet E, 2011, J ENVIRON MONITOR, V13, P2062, DOI 10.1039/c1em10289c; Mulvaney RL, 1996, METHODS SOIL ANAL, P1123, DOI DOI 10.2136/SSSAB00KSER5.3.C38; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; SCHUMACKER R, 2000, IDENTIFICATION KEYS; Shearer G, 1992, ISOTOPES ORGANIC CHE, P133; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Skrzypek G, 2006, RAPID COMMUN MASS SP, V20, P2915, DOI 10.1002/rcm.2688; Skrzypek G, 2013, ANAL BIOANAL CHEM, V405, P2815, DOI 10.1007/s00216-012-6517-2; Solheim B, 2002, CYANOBACTERIA IN SYMBIOSIS, P137; Solheim B, 2006, PLANT ECOL, V182, P109, DOI 10.1007/s11258-005-9034-y; STEMPNIEWICZ L, 1990, COLON WATERBIRD, V13, P62, DOI 10.2307/1521421; Stempniewicz L, 1992, LANDSCAPE LIFE WORLD, P255; Stempniewicz L, 2007, DEEP-SEA RES PT II, V54, P2934, DOI 10.1016/j.dsr2.2007.08.012; Stempniewicz Lech, 2001, BWP Update, V3, P175; Stewart KJ, 2014, SOIL BIOL BIOCHEM, V70, P96, DOI 10.1016/j.soilbio.2013.12.005; Szymanski W, 2013, POL POLAR RES, V34, P289, DOI 10.2478/popore-2013-0017; Turetsky MR, 2003, BRYOLOGIST, V106, P395, DOI 10.1639/05; Vankoughnett MR, 2014, BIOGEOCHEMISTRY, V118, P291, DOI 10.1007/s10533-013-9930-5; Vare H., 1992, Mycorrhiza, V1, P93, DOI 10.1007/BF00203256; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; WIRTH V., 2013, FLECHTEN DEUTSCHLAND; Wojczulanis-Jakubas K, 2014, POLAR BIOL, V37, P621, DOI 10.1007/s00300-014-1462-5; Wold A, 2011, POLAR BIOL, V34, P1147, DOI 10.1007/s00300-011-0975-4; Yano Y, 2010, BIOGEOCHEMISTRY, V97, P183, DOI 10.1007/s10533-009-9365-1; ZELICKMAN EA, 1972, MAR BIOL, V17, P265, DOI 10.1007/BF00366302; Zwolicki A, 2015, POLAR BIOL, V38, P1645, DOI 10.1007/s00300-015-1730-z; Zwolicki A, 2013, POLAR BIOL, V36, P363, DOI 10.1007/s00300-012-1265-5	75	40	41	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136536	10.1371/journal.pone.0136536	http://dx.doi.org/10.1371/journal.pone.0136536			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376204	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200017
J	Marshall, KLA; Philpot, KE; Damas-Moreira, I; Stevens, M				Marshall, Kate L. A.; Philpot, Kate E.; Damas-Moreira, Isabel; Stevens, Martin			Intraspecific Colour Variation among Lizards in Distinct Island Environments Enhances Local Camouflage	PLOS ONE			English	Article							PODARCIS-ERHARDII SQUAMATA; VISUAL PIGMENTS; ULTRAVIOLET SENSITIVITY; CROTAPHYTUS-COLLARIS; OIL DROPLETS; POPULATIONS; VISION; EVOLUTION; ECOLOGY; SELECTION	Within-species colour variation is widespread among animals. Understanding how this arises can elucidate evolutionary mechanisms, such as those underlying reproductive isolation and speciation. Here, we investigated whether five island populations of Aegean wall lizards (Podarcis erhardii) have more effective camouflage against their own (local) island substrates than against other (non-local) island substrates to avian predators, and whether this was linked to island differences in substrate appearance. We also investigated whether degree of local substrate matching varied among island populations and between sexes. In most populations, both sexes were better matched against local backgrounds than against non-local backgrounds, particularly in terms of luminance (perceived lightness), which usually occurred when local and non-local backgrounds were different in appearance. This was found even between island populations that historically had a land connection and in populations that have been isolated relatively recently, suggesting that isolation in these distinct island environments has been sufficient to cause enhanced local background matching, sometimes on a rapid evolutionary time-scale. However, heightened local matching was poorer in populations inhabiting more variable and unstable environments with a prolonged history of volcanic activity. Overall, these results show that lizard coloration is tuned to provide camouflage in local environments, either due to genetic adaptation or changes during development. Yet, the occurrence and extent of selection for local matching may depend on specific conditions associated with local ecology and biogeographic history. These results emphasize how anti-predator adaptations to different environments can drive divergence within a species, which may contribute to reproductive isolation among populations and lead to ecological speciation.	[Marshall, Kate L. A.] Univ Cambridge, Dept Zool, Behav Ecol Grp, Cambridge, England; [Philpot, Kate E.; Stevens, Martin] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Damas-Moreira, Isabel] Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Vila Do Conde, Portugal	University of Cambridge; University of Exeter; Universidade do Porto	Marshall, KLA (corresponding author), Univ Cambridge, Dept Zool, Behav Ecol Grp, Cambridge, England.	km547@cam.ac.uk		Stevens, Martin/0000-0001-7768-3426	Biotechnology and Biological Sciences Research Council; British Herpetological Society; Cambridge Philosophical Society; Magdalene College, Cambridge; David Philips Research Fellowship [BB/G022887/1]; BBSRC [BB/G022887/1, BB/G022887/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G022887/2, 1088693, BB/G022887/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Herpetological Society; Cambridge Philosophical Society; Magdalene College, Cambridge; David Philips Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council studentship (www.BBSRC.com), the British Herpetological Society (www.thebhs.org), the Cambridge Philosophical Society (http://www.cambridgephilosophicalsociety.org) and Magdalene College, Cambridge (to KLAM), and a Biotechnology and Biological Sciences Research Council and David Philips Research Fellowship (grant number BB/G022887/1) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, IUCN RED LIST THREAT; ARNOLD NE, 2002, FIELD GUIDE REPTILES; Bergman TJ, 2008, BIOL J LINN SOC, V94, P231, DOI 10.1111/j.1095-8312.2008.00981.x; Brock KM, 2015, EVOLUTION, V69, P216, DOI 10.1111/evo.12555; Castilla AM, 1998, ACTA OECOL, V19, P107, DOI 10.1016/S1146-609X(98)80014-3; Castilla AM, 1999, HERPETOLOGICA, V55, P530; CASTILLA AM, 1991, OECOLOGIA, V85, P366, DOI 10.1007/BF00320612; CHONDROPOULOS B P, 1986, Amphibia-Reptilia, V7, P217, DOI 10.1163/156853886X00028; CLARKE B, 1962, HEREDITY, V17, P319, DOI 10.1038/hdy.1962.35; COLLAR N., 2005, HDB BIRDS WORLD, V10, P514; Cooper W.E. Jr, 1992, P298; Cuthill Innes C., 2006, P3; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Fan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111504; Fitze PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005111; Foufopoulos J, 1999, AM NAT, V153, P1, DOI 10.1086/303149; Garcia JE, 2013, J EXP BIOL, V216, P4290, DOI 10.1242/jeb.094045; Garcia-Munoz E, 2010, ACTA HERPETOL, V5, P259; Grimm A, 2014, NAT CONSERV-BULGARIA, P45, DOI 10.3897/natureconservation.9.8908; Hamilton PS, 2008, AMPHIBIA-REPTILIA, V29, P473, DOI 10.1163/156853808786230488; Handrinos G., 1997, THE BIRDS OF GREECE; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hart NS, 2002, J EXP BIOL, V205, P3925; Hawlena D, 2006, BEHAV ECOL, V17, P889, DOI 10.1093/beheco/arl023; Hemmi JM, 2006, J EXP BIOL, V209, P4140, DOI 10.1242/jeb.02483; Hernandez-Gallegos O, 2012, REV BIOL TROP, V60, P405; Higgins MD, 1996, GEOLOGICAL COMPANION; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Houston AI, 2007, BEHAV ECOL, V18, P769, DOI 10.1093/beheco/arm039; Hurston H, 2009, MOL PHYLOGENET EVOL, V52, P395, DOI 10.1016/j.ympev.2009.03.028; Husak JF, 2006, ETHOLOGY, V112, P572, DOI 10.1111/j.1439-0310.2005.01189.x; Huyghe K, 2007, INTEGR COMP BIOL, V47, P211, DOI 10.1093/icb/icm043; Jones CD, 2004, VISION RES, V44, P83, DOI 10.1016/j.visres.2003.08.014; Jordan MA, 2008, MOL ECOL, V17, P1224, DOI 10.1111/j.1365-294X.2007.03658.x; Jordan MA, 2005, MOL ECOL, V14, P859, DOI 10.1111/j.1365-294X.2005.02452.x; Kalogeropoulos S, 1990, P 3 INT C, P164; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; KETTLEWELL H D, 1961, ANNU REV ENTOMOL, V6, P245; KETTLEWELL HBD, 1956, PROC R SOC SER B-BIO, V145, P297, DOI 10.1098/rspb.1956.0037; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Lind O, 2013, J EXP BIOL, V216, P1819, DOI 10.1242/jeb.082834; Macedonia JM, 2002, BIOL J LINN SOC, V77, P67, DOI 10.1046/j.1095-8312.2002.00092.x; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; Marshall KLA, 2014, BEHAV ECOL, V25, P1325, DOI 10.1093/beheco/aru126; Martin J, 1996, COPEIA, P722, DOI 10.2307/1447538; Martin J, 1990, AMPHIBIANS REPTILES; McLean CA, 2014, J EVOLUTION BIOL, V27, P2654, DOI 10.1111/jeb.12521; Merilaita S, 1999, BIOL J LINN SOC, V67, P151, DOI 10.1111/j.1095-8312.1999.tb01858.x; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Odeen A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-36; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Perissoratis C, 2003, MAR GEOL, V196, P145, DOI 10.1016/S0025-3227(03)00047-1; Photiades A., 2003, BULL GEOL SOC GREECE, V35, P35; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; Poulakakis N, 2005, MOL ECOL NOTES, V5, P549, DOI 10.1111/j.1471-8286.2005.00986.x; Poulakakis N, 2003, MOL PHYLOGENET EVOL, V28, P38, DOI 10.1016/S1055-7903(03)00037-X; Poulakakis N, 2015, J ZOOL SYST EVOL RES, V53, P18, DOI 10.1111/jzs.12071; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Rowe MH, 2002, NEWS PHYSIOL SCI, V17, P93, DOI 10.1152/nips.01376.2001; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Sazima I, 2011, REV BRAS ORNITOL, V19, P450; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Spottiswoode CN, 2011, P ROY SOC B-BIOL SCI, V278, P3566, DOI 10.1098/rspb.2011.0401; Steiner CC, 2008, PLOS BIOL, V6, P418, DOI 10.1371/journal.pbio.0060036; Stevens M, 2013, SENSORY ECOLOGY, BEHAVIOUR, AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199601776.001.0001; Stevens M, 2007, BIOSCIENCE, V57, P501, DOI 10.1641/B570607; Stevens M, 2007, P ROY SOC B-BIOL SCI, V274, P1457, DOI 10.1098/rspb.2007.0220; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00014; Stevens M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110325; Stevens M, 2013, BIOL J LINN SOC, V109, P257, DOI 10.1111/bij.12039; Stevens M, 2009, INT J PRIMATOL, V30, P893, DOI 10.1007/s10764-009-9356-z; Stevens M, 2009, PHILOS T R SOC B, V364, P481, DOI 10.1098/rstb.2008.0216; Stuart-Fox D, 2006, BIOL J LINN SOC, V88, P437, DOI 10.1111/j.1095-8312.2006.00631.x; Stuart-Fox DM, 2004, EVOLUTION, V58, P1549; Stuart-Fox DM, 2003, ANIM BEHAV, V66, P541, DOI 10.1006/anbe.2003.2235; VALAKOS E, 1986, HERPETOL J, V1, P118; Valakos Efstratios D., 1999, Herpetological Review, V30, P52; VANDAMME R, 1990, ACTA OECOL, V11, P503; Verwaijen D, 2008, ZOOLOGY, V111, P37, DOI 10.1016/j.zool.2007.04.001; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x; VON BEDRIAGA J., 1882, B SOC IMP NAT MOSC, V56, P43; VON BEDRIAGA J., 1882, B SOC IMPERIALE NATU, V56, P278; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286	93	25	25	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0135241	10.1371/journal.pone.0135241	http://dx.doi.org/10.1371/journal.pone.0135241			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372454	Green Published, gold			2022-12-26	WOS:000361604400002
J	Ndu, U; Barkay, T; Mason, RP; Schartup, AT; Al-Farawati, R; Liu, J; Reinfelder, JR				Ndu, Udonna; Barkay, Tamar; Mason, Robert P.; Schartup, Amina Traore; Al-Farawati, Radwan; Liu, Jie; Reinfelder, John R.			The Use of a Mercury Biosensor to Evaluate the Bioavailability of Mercury-Thiol Complexes and Mechanisms of Mercury Uptake in Bacteria	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; ELEMENTAL MERCURY; ESCHERICHIA-COLI; TRANSPORT; OXIDATION; METHYLATION; RESISTANCE; REDUCTION; MATTER; HG(II)	As mercury (Hg) biosensors are sensitive to only intracellular Hg, they are useful in the investigation of Hg uptake mechanisms and the effects of speciation on Hg bioavailability to microbes. In this study, bacterial biosensors were used to evaluate the roles that several transporters such as the glutathione, cystine/cysteine, and Mer transporters play in the uptake of Hg from Hg-thiol complexes by comparing uptake rates in strains with functioning transport systems to strains where these transporters had been knocked out by deletion of key genes. The Hg uptake into the biosensors was quantified based on the intracellular conversion of inorganic mercury (Hg(II)) to elemental mercury (Hg(0)) by the enzyme MerA. It was found that uptake of Hg from Hg-cysteine (Hg(CYS)(2)) and Hg-glutathione (Hg(GSH)(2)) complexes occurred at the same rate as that of inorganic complexes of Hg(II) into Escherichia coli strains with and without intact Mer transport systems. However, higher rates of Hg uptake were observed in the strain with a functioning Mer transport system. These results demonstrate that thiol-bound Hg is bioavailable to E. coli and that this bioavailability is higher in Hg-resistant bacteria with a complete Mer system than in non-resistant strains. No difference in the uptake rate of Hg from Hg(GSH)(2) was observed in E. coli strains with or without functioning glutathione transport systems. There was also no difference in uptake rates between a wildtype Bacillus subtilis strain with a functioning cystine/cysteine transport system, and a mutant strain where this transport system had been knocked out. These results cast doubt on the viability of the hypothesis that the entire Hg-thiol complex is taken up into the cell by a thiol transporter. It is more likely that the Hg in the Hg-thiol complex is transferred to a transport protein on the cell membrane and is subsequently internalized.	[Ndu, Udonna; Reinfelder, John R.] Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08903 USA; [Barkay, Tamar; Liu, Jie] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA; [Mason, Robert P.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Schartup, Amina Traore] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Al-Farawati, Radwan] King Abdulaziz Univ, Marine Chem Dept, Jeddah 21413, Saudi Arabia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Connecticut; Harvard University; Harvard T.H. Chan School of Public Health; King Abdulaziz University	Ndu, U (corresponding author), Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08903 USA.	udonna.ndu@duke.edu	Reinfelder, John/C-7214-2016; Al-Farawati, Radwan K/J-5813-2012; /AAB-2984-2020	Reinfelder, John/0000-0002-3737-604X; Mason, Robert/0000-0002-7443-4931; Schartup, Amina/0000-0002-9289-8107	NSF-EAR (Geobiology & Low Temperature Geochemistry) [EAR-0952291]; U.S. Department of Energy, Office of Science (BER) [DE-SC0007051]	NSF-EAR (Geobiology & Low Temperature Geochemistry)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); U.S. Department of Energy, Office of Science (BER)(United States Department of Energy (DOE))	This project was supported by grants from NSF-EAR (Geobiology & Low Temperature Geochemistry, EAR-0952291) and the U.S. Department of Energy, Office of Science (BER, DE-SC0007051).	Al-Farawati R, 2001, ENVIRON SCI TECHNOL, V35, P1902, DOI 10.1021/es000073i; Barkay T, 1997, APPL ENVIRON MICROB, V63, P4267, DOI 10.1128/AEM.63.11.4267-4271.1997; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Benoit JM, 2001, APPL ENVIRON MICROB, V67, P51, DOI 10.1128/AEM.67.1.51-58.2001; BERGER EA, 1972, J BIOL CHEM, V247, P7684; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.15.4875-4884.2004; Chien MF, 2010, J BIOSCI BIOENG, V110, P94, DOI 10.1016/j.jbiosc.2010.01.010; Christine A, 1998, ATLANTIC, V45, P1903, DOI DOI 10.1016/S0967-0637(98)00042-9; Crespo-Medina M, 2009, LIMNOL OCEANOGR, V54, P41, DOI 10.4319/lo.2009.54.1.0041; Deng GF, 2013, CHINESE SCI BULL, V58, P256, DOI 10.1007/s11434-012-5514-3; DYRSSEN D, 1986, ANAL CHIM ACTA, V180, P473, DOI 10.1016/0003-2670(86)80026-5; Endo G, 2003, ACTA BIOTECHNOL, V23, P123, DOI 10.1002/abio.200390018; French TD, 2014, ENVIRON SCI TECHNOL, V48, P3162, DOI 10.1021/es403849d; Fu YJ, 2008, APPL MICROBIOL BIOT, V79, P363, DOI 10.1007/s00253-008-1442-1; Golding GR, 2002, LIMNOL OCEANOGR, V47, P967, DOI 10.4319/lo.2002.47.4.0967; Gu BH, 2011, P NATL ACAD SCI USA, V108, P1479, DOI 10.1073/pnas.1008747108; HAMLETT NV, 1992, J BACTERIOL, V174, P6377, DOI 10.1128/JB.174.20.6377-6385.1992; Han SH, 2006, MAR CHEM, V98, P156, DOI 10.1016/j.marchem.2005.07.004; Hansen LH, 2000, FEMS MICROBIOL LETT, V193, P123; Kiyono M, 2000, BIOL PHARM BULL, V23, P279; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LUTHER GW, 1986, SCIENCE, V232, P746, DOI 10.1126/science.232.4751.746; Mason RP, 1996, ENVIRON SCI TECHNOL, V30, P1835, DOI 10.1021/es950373d; MORBY AP, 1995, MOL MICROBIOL, V17, P25, DOI 10.1111/j.1365-2958.1995.mmi_17010025.x; Morelli E, 2009, SCI TOTAL ENVIRON, V408, P286, DOI 10.1016/j.scitotenv.2009.09.047; NAKAHARA H, 1979, J BACTERIOL, V140, P161, DOI 10.1128/JB.140.1.161-166.1979; Ndu U, 2011, THESIS, P1; Ndu U, 2012, APPL ENVIRON MICROB, V78, P7276, DOI 10.1128/AEM.00362-12; Pernet-Coudrier B, 2013, SCI TOTAL ENVIRON, V463, P997, DOI 10.1016/j.scitotenv.2013.06.053; Poulain AJ, 2007, APPL ENVIRON MICROB, V73, P2230, DOI 10.1128/AEM.02701-06; Priyadarshi H, 2012, J ENVIRON SCI-CHINA, V24, P963, DOI 10.1016/S1001-0742(11)60820-6; Rasmussen LD, 1997, APPL ENVIRON MICROB, V63, P3291, DOI 10.1128/AEM.63.8.3291-3293.1997; Schaefer JK, 2011, P NATL ACAD SCI USA, V108, P8714, DOI 10.1073/pnas.1105781108; Schaefer JK, 2009, NAT GEOSCI, V2, P123, DOI 10.1038/NGEO412; SELIFONOVA O, 1993, APPL ENVIRON MICROB, V59, P3083, DOI 10.1128/AEM.59.9.3083-3090.1993; Simmons-Willis TA, 2002, BIOCHEM J, V367, P239, DOI 10.1042/BJ20020841; Smith T, 1998, APPL ENVIRON MICROB, V64, P1328; Sone Y, 2010, J HEALTH SCI, V56, P123; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; Whalin L, 2007, MAR CHEM, V107, P278, DOI 10.1016/j.marchem.2007.04.002; YAMAMOTO M, 1995, B ENVIRON CONTAM TOX, V54, P409; Zheng W, 2013, ENVIRON SCI TECHNOL, V47, P12827, DOI 10.1021/es402697u; Zheng W, 2012, ENVIRON SCI TECHNOL, V46, P292, DOI 10.1021/es203402p	43	24	24	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138333	10.1371/journal.pone.0138333	http://dx.doi.org/10.1371/journal.pone.0138333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371471	Green Submitted, gold, Green Published			2022-12-26	WOS:000361604400065
J	Cho, S; Kim, T; Woo, HM; Lee, J; Kim, Y; Um, Y				Cho, Sukhyeong; Kim, Taeyeon; Woo, Han Min; Lee, Jinwon; Kim, Yunje; Um, Youngsoon			Enhanced 2,3-Butanediol Production by Optimizing Fermentation Conditions and Engineering Klebsiella oxytoca M1 through Overexpression of Acetoin Reductase	PLOS ONE			English	Article							ALPHA-ACETOLACTATE DECARBOXYLASE; MESO-2,3-BUTANEDIOL DEHYDROGENASE; ACID; BIOSYNTHESIS; DELETION; LACTATE; PATHWAY; GLUCOSE	Microbial production of 2,3-butanediol (2,3-BDO) has been attracting increasing interest because of its high value and various industrial applications. In this study, high production of 2,3-BDO using a previously isolated bacterium Klebsiella oxytoca M1 was carried out by optimizing fermentation conditions and overexpressing acetoin reductase (AR). Supplying complex nitrogen sources and using NaOH as a neutralizing agent were found to enhance specific production and yield of 2,3-BDO. In fed-batch fermentations, 2,3-BDO production increased with the agitation speed (109.6 g/L at 300 rpm vs. 118.5 g/L at 400 rpm) along with significantly reduced formation of by-product, but the yield at 400 rpm was lower than that at 300 rpm (0.40 g/g vs. 0.34 g/g) due to acetoin accumulation at 400 rpm. Because AR catalyzing both acetoin reduction and 2,3-BDO oxidation in K. oxytoca M1 revealed more than 8-fold higher reduction activity than oxidation activity, the engineered K. oxytoca M1 overexpressing the budC encoding AR was used in fed-batch fermentation. Finally, acetoin accumulation was significantly reduced by 43% and enhancement of 2,3-BDO concentration (142.5 g/L), yield (0.42 g/g) and productivity (1.47 g/L/h) was achieved compared to performance with the parent strain. This is by far the highest titer of 2,3-BDO achieved by K. oxytoca strains. This notable result could be obtained by finding favorable fermentation conditions for 2,3-BDO production as well as by utilizing the distinct characteristic of AR in K. oxytoca M1 revealing the nature of reductase.	[Cho, Sukhyeong; Kim, Taeyeon; Woo, Han Min; Kim, Yunje; Um, Youngsoon] Korea Inst Sci & Technol, Clean Energy Res Ctr, Seoul, South Korea; [Kim, Taeyeon] Seoul Natl Univ, Coll Agr & Life Sci, Interdisciplinary Program Agr Biotechnol, Seoul, South Korea; [Woo, Han Min; Um, Youngsoon] Korea Univ Sci & Technol, Clean Energy & Chem Engn, Daejeon, South Korea; [Lee, Jinwon] Sogang Univ, Dept Chem & Biomol Engn, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Seoul National University (SNU); University of Science & Technology (UST); Sogang University	Um, Y (corresponding author), Korea Inst Sci & Technol, Clean Energy Res Ctr, Seoul, South Korea.	yum@kist.re.kr	Woo, Han Min/J-1847-2015	Woo, Han Min/0000-0002-8797-0477; um, youngsoon/0000-0003-1695-1874; Lee, Jinwon/0000-0003-4153-0609	R&D Program of MOTIE/KEIT [10035578]; Creative Allied Project (CAP) of the Korea Research Council of Fundamental Science and Technology (KRCF)/Korea Institute of Science and Technology (KIST)	R&D Program of MOTIE/KEIT; Creative Allied Project (CAP) of the Korea Research Council of Fundamental Science and Technology (KRCF)/Korea Institute of Science and Technology (KIST)	This work was supported by the R&D Program of MOTIE/KEIT (No. 10035578, Development of 2,3-Butanediol and Derivative Production Technology for C-Zero Bio-Platform Industry). This work was also supported by Creative Allied Project (CAP) of the Korea Research Council of Fundamental Science and Technology (KRCF)/Korea Institute of Science and Technology (KIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho JH, 2012, BIOPROC BIOSYST ENG, V35, P1081, DOI 10.1007/s00449-012-0691-7; Cho S, 2013, APPL BIOCHEM BIOTECH, V170, P1922, DOI 10.1007/s12010-013-0291-2; Choi O, 2012, BIOTECHNOL BIOENG, V109, P2494, DOI 10.1002/bit.24520; GARG SK, 1995, BIORESOURCE TECHNOL, V51, P103, DOI 10.1016/0960-8524(94)00136-O; GoupilFeuillerat N, 1997, J BACTERIOL, V179, P6285, DOI 10.1128/JB.179.20.6285-6293.1997; Jantama K, 2015, METAB ENG, V30, P16, DOI 10.1016/j.ymben.2015.04.004; Ji XJ, 2008, BIOTECHNOL LETT, V30, P731, DOI 10.1007/s10529-007-9599-8; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; Ji XJ, 2010, APPL MICROBIOL BIOT, V85, P1751, DOI 10.1007/s00253-009-2222-2; Ji XJ, 2009, BIORESOURCE TECHNOL, V100, P3410, DOI 10.1016/j.biortech.2009.02.031; Jung MY, 2012, APPL MICROBIOL BIOT, V95, P461, DOI 10.1007/s00253-012-3883-9; Kim B, 2012, J MICROBIOL BIOTECHN, V22, P1258, DOI 10.4014/jmb.1201.01044; Li LX, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-123; Liu Z, 2011, BIORESOURCE TECHNOL, V102, P10741, DOI 10.1016/j.biortech.2011.08.110; Lu M, 2014, BIOPROC BIOSYST ENG, V37, P343, DOI 10.1007/s00449-013-0999-y; Ma CQ, 2009, APPL MICROBIOL BIOT, V82, P49, DOI 10.1007/s00253-008-1732-7; Monnet C, 2003, LETT APPL MICROBIOL, V36, P399, DOI 10.1046/j.1472-765X.2003.01326.x; Moon C, 2010, APPL BIOCHEM BIOTECH, V161, P502, DOI 10.1007/s12010-009-8859-6; Nakashimada Y, 2000, J BIOSCI BIOENG, V90, P661, DOI 10.1263/jbb.90.661; Nicholson WL, 2008, APPL ENVIRON MICROB, V74, P6832, DOI 10.1128/AEM.00881-08; Okino S, 2005, APPL MICROBIOL BIOT, V68, P475, DOI 10.1007/s00253-005-1900-y; Park JM, 2013, J IND MICROBIOL BIOT, V40, P1057, DOI 10.1007/s10295-013-1298-y; Park JM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-20; Petrov K, 2009, APPL MICROBIOL BIOT, V84, P659, DOI 10.1007/s00253-009-2004-x; Qi GF, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-16; QURESHI N, 1989, J FERMENT BIOENG, V67, P415, DOI 10.1016/0922-338X(89)90147-5; Sangproo M, 2012, BIORESOURCE TECHNOL, V119, P191, DOI 10.1016/j.biortech.2012.05.114; Seo JK, 1998, J IND ENG CHEM, V4, P215; Syu MJ, 2001, APPL MICROBIOL BIOT, V55, P10, DOI 10.1007/s002530000486; van Haveren J, 2008, BIOFUEL BIOPROD BIOR, V2, P41, DOI 10.1002/bbb.43; Yang TH, 2014, J BIOTECHNOL, V172, P59, DOI 10.1016/j.jbiotec.2013.12.007; Zhang GL, 2012, BIOTECHNOL LETT, V34, P1519, DOI 10.1007/s10529-012-0933-4; Zhang LY, 2010, J IND MICROBIOL BIOT, V37, P857, DOI 10.1007/s10295-010-0733-6; Zhang X, 2011, WORLD J MICROB BIOT, V27, P2785, DOI 10.1007/s11274-011-0754-y; Zhang XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087788	36	51	54	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138109	10.1371/journal.pone.0138109	http://dx.doi.org/10.1371/journal.pone.0138109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368397	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100226
J	Du, SS; Zhao, MM; Zhang, Y; Zhang, P; Hu, Y; Wang, LS; Zhou, Y; Li, QH; Li, Y; Du, YK; He, X; Li, N; Yin, ZF; Wei, YR; Weng, D; Li, HP				Du, Shan-Shan; Zhao, Meng-Meng; Zhang, Yuan; Zhang, Peng; Hu, Yang; Wang, Liu-Sheng; Zhou, Ying; Li, Qiu-Hong; Li, Yan; Du, Yu-Kui; He, Xian; Li, Nan; Yin, Zhao-Fang; Wei, Ya-Ru; Weng, Dong; Li, Hui-Ping			Screening for Differentially Expressed Proteins Relevant to the Differential Diagnosis of Sarcoidosis and Tuberculosis	PLOS ONE			English	Article							SOLUBLE ICAM-1; PULMONARY TUBERCULOSIS; LEPTIN; SERUM; MARKERS; INFLAMMATION; VCAM-1; SYSTEM; SPUTUM; ALPHA	Background In this study, we sought to identify differentially expressed proteins in the serum of patients with sarcoidosis or tuberculosis and to evaluate these proteins as markers for the differential diagnosis of sarcoidosis and sputum-negative tuberculosis. Methods Using protein microarrays, we identified 3 proteins exhibiting differential expression between patients with sarcoidosis and tuberculosis. Elevated expression of these proteins was verified using the enzyme-linked immunosorbent assay (ELISA) and was further confirmed by immunohistochemistry. Receiver operating characteristic (ROC) curve, logistic regression analysis, parallel, and serial tests were used to evaluate the diagnostic efficacy of the proteins. Results Intercellular Adhesion Molecule 1(ICAM-1) and leptin were screened for differentially expressed proteins relevant to sarcoidosis and tuberculosis. Using ROC curves, we found that ICAM-1 (cutoff value: 57740 pg/mL) had an area under the curve (AUC), sensitivity, and specificity of 0.718, 62.3%, and 79.5% respectively, while leptin (cutoff value: 1193.186 pg/mL) had an AUC, sensitivity, and specificity of 0.763, 88.3%, and 65.8%, respectively. Logistic regression analysis revealed that the AUC, sensitivity, and specificity of combined leptin and ICAM-1 were 0.787, 89.6%, and 65.8%, respectively, while those of combined leptin, ICAM-1, and body mass index (BMI) were 0.837, 90.9%, and 64.4%, respectively, which had the greatest diagnostic value. Parallel and serial tests indicated that the BMI-leptin parallel with the ICAM-1 serial was the best diagnostic method, achieving a sensitivity and specificity of 86.5% and 73.1%, respectively. Thus, our results identified elevated expression of ICAM-1 and leptin in serum and granulomas of sarcoidosis patients. Conclusions ICAM-1 and leptin were found to be potential markers for the diagnosis of sarcoidosis and differential diagnosis of sarcoidosis and sputum-negative tuberculosis.	[Du, Shan-Shan; Zhao, Meng-Meng; Zhang, Yuan; Hu, Yang; Wang, Liu-Sheng; Zhou, Ying; Li, Qiu-Hong; Li, Yan; Du, Yu-Kui; Li, Nan; Wei, Ya-Ru; Weng, Dong; Li, Hui-Ping] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Resp Med, Shanghai 200092, Peoples R China; [Zhang, Peng] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Chest Surg, Shanghai 200092, Peoples R China; [He, Xian; Yin, Zhao-Fang] Soochow Univ, Sch Med, Shanghai Pulm Hosp, Dept Resp Med, Suzhou, Peoples R China	Tongji University; Tongji University; Soochow University - China	Weng, D (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Resp Med, Shanghai 200092, Peoples R China.	cruise00@gmail.com; liw2013@126.com			National Science Foundation of China [91442103, 81170011, 81200045]; Science and Technology Commission of Shanghai Municipality [12DJ1400103, 124119a9000, 12DZ1942500, 12411950105]; Health Bureau Program of Shanghai Municipality [SHDC12014120, 2013SY047]; Tongji University [1511219020]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Health Bureau Program of Shanghai Municipality; Tongji University	The study was funded by grants from the National Science Foundation of China (No: 91442103, 81170011, and 81200045), the Science and Technology Commission of Shanghai Municipality (12DJ1400103, 124119a9000, 12DZ1942500 and 12411950105), the Health Bureau Program of Shanghai Municipality (SHDC12014120, 2013SY047), and Tongji University (1511219020).	Arakelyan A, 2009, CLIN EXP IMMUNOL, V155, P457, DOI 10.1111/j.1365-2249.2008.03832.x; Bargagli E, 2008, CLIN CHEST MED, V29, P445, DOI 10.1016/j.ccm.2008.03.004; Baughman RP, 2011, AM J RESP CRIT CARE, V183, P573, DOI 10.1164/rccm.201006-0865CI; Baughman RP, 2003, LANCET, V361, P1111, DOI 10.1016/S0140-6736(03)12888-7; Braun J, 1999, LUNG, V177, P139, DOI 10.1007/PL00007635; Cakir B, 1999, HORM RES, V52, P279, DOI 10.1159/000023495; Calikoglu M, 2004, RESPIRATION, V71, P45, DOI 10.1159/000075648; Costabel U, 1999, EUR RESPIR J, V14, P735, DOI 10.1034/j.1399-3003.1999.14d02.x; DUANMU HJ, 2002, CHIN J TUBERC RESP D, V25, P3; Figeys D, 2002, PROTEOMICS, V2, P373, DOI 10.1002/1615-9861(200204)2:4<373::AID-PROT373>3.0.CO;2-I; Hamzaoui A, 1996, MEDIAT INFLAMM, V5, P276, DOI 10.1155/S0962935196000403; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; ISHII Y, 1995, CHEST, V107, P1636, DOI 10.1378/chest.107.6.1636; Kim DS, 1999, CHEST, V115, P1059, DOI 10.1378/chest.115.4.1059; Kruit A, 2007, RESP MED, V101, P510, DOI 10.1016/j.rmed.2006.06.025; Li QH, 2012, SARCOIDOSIS VASC DIF, V29, P11; MAFFEI M, 1995, P NATL ACAD SCI USA, V92, P6957, DOI 10.1073/pnas.92.15.6957; Martin-Romero C, 2000, CELL IMMUNOL, V199, P15, DOI 10.1006/cimm.1999.1594; Miyoshi S, 2010, CHEST, V137, P1391, DOI 10.1378/chest.09-1975; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Sun ZH, 2004, ANTICANCER RES, V24, P1159; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; VANDINTHERJANSSEN ACHM, 1993, J PATHOL, V170, P157, DOI 10.1002/path.1711700210; Yurt S, 2013, CLIN BIOCHEM, V46, P40, DOI 10.1016/j.clinbiochem.2012.09.008; Zandvoort A, 2006, EUR RESPIR J, V28, P113, DOI 10.1183/09031936.06.00116205; Zhang Y, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-18; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou Y, 2008, SARCOIDOSIS VASC DIF, V25, P93	31	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0132466	10.1371/journal.pone.0132466	http://dx.doi.org/10.1371/journal.pone.0132466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368286	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100001
J	Hursel, R; Martens, EAP; Gonnissen, HKJ; Hamer, HM; Senden, JMG; van Loon, LJC; Westerterp-Plantenga, MS				Hursel, Rick; Martens, Eveline A. P.; Gonnissen, Hanne K. J.; Hamer, Henrike M.; Senden, Joan M. G.; van Loon, Luc J. C.; Westerterp-Plantenga, Margriet S.			Prolonged Adaptation to a Low or High Protein Diet Does Not Modulate Basal Muscle Protein Synthesis Rates - A Substudy	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; AMINO-ACIDS; BODY-WEIGHT; ENERGY-EXPENDITURE; MEN; MAINTENANCE; METABOLISM; KINETICS; LEUCINE	Background Based on controlled 36 h experiments a higher dietary protein intake causes a positive protein balance and a negative fat balance. A positive net protein balance may support fat free mass accrual. However, few data are available on the impact of more prolonged changes in habitual protein intake on whole-body protein metabolism and basal muscle protein synthesis rates. Objective To assess changes in whole-body protein turnover and basal muscle protein synthesis rates following 12 weeks of adaptation to a low versus high dietary protein intake. Methods A randomized parallel study was performed in 40 subjects who followed either a high protein (2.4 g protein/kg/d) or low protein (0.4 g protein/kg/d) energy-balanced diet (30/35/35% or 5/60/35% energy from protein/carbohydrate/fat) for a period of 12 weeks. A subgroup of 7 men and 8 women (body mass index: 22.8 +/- 2.3 kg/m(2), age: 24.3 +/- 4.9 y) were selected to evaluate the impact of prolonged adaptation to either a high or low protein intake on whole body protein metabolism and basal muscle protein synthesis rates. After the diet, subjects received continuous infusions with L-[ring-H-2(5)]phenylalanine and L-[ring-H-2(2)]tyrosine in an overnight fasted state, with blood samples and muscle biopsies being collected to assess post-absorptive whole-body protein turnover and muscle protein synthesis rates in vivo in humans. Results After 12 weeks of intervention, whole-body protein balance in the fasted state was more negative in the high protein treatment when compared with the low protein treatment (-4.1 +/- 0.5 vs -2.7 +/- 0.6 mu mol phenylalanine/kg/h; P<0.001). Whole-body protein breakdown (43.0 +/- 4.4 vs 37.8 +/- 3.8 mu mol phenylalanine/kg/h; P<0.03), synthesis (38.9 +/- 4.2 vs 35.1 +/- 3.6 mu mol phenylalanine/kg/h; P<0.01) and phenylalanine hydroxylation rates (4.1 +/- 0.6 vs 2.7 +/- 0.6 mu mol phenylalanine/kg/h; P<0.001) were significantly higher in the high vs low protein group. Basal muscle protein synthesis rates were maintained on a low vs high protein diet (0.042 +/- 0.01 vs 0.045 +/- 0.01%/h; P = 0.620). Conclusions In the overnight fasted state, adaptation to a low-protein intake (0.4 g/kg/d) does not result in a more negative whole-body protein balance and does not lower basal muscle protein synthesis rates when compared to a high-protein intake.	[Hursel, Rick; Martens, Eveline A. P.; Gonnissen, Hanne K. J.; Westerterp-Plantenga, Margriet S.] Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands; [Hamer, Henrike M.; Senden, Joan M. G.; van Loon, Luc J. C.] Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Human Movement Sci, Maastricht, Netherlands	Maastricht University; Maastricht University	Hursel, R (corresponding author), Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands.	rick.hursel@maastrichtuniversity.nl	van Loon, Luc J.C./ABG-9158-2020; van Loon, Luc J C/G-5920-2010	van Loon, Luc J.C./0000-0002-6768-9231; van Loon, Luc J C/0000-0002-6768-9231	European Union Seventh Framework Programme (FP7) [266408]	European Union Seventh Framework Programme (FP7)	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 266408. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NN, 1981, METABOLISM, V30, P936, DOI 10.1016/0026-0495(81)90074-3; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Boirie Y, 1996, AM J PHYSIOL-ENDOC M, V271, pE1083, DOI 10.1152/ajpendo.1996.271.6.E1083; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Burd NA, 2013, EXERC SPORT SCI REV, V41, P169, DOI 10.1097/JES.0b013e318292f3d5; Cermak NM, 2012, AM J CLIN NUTR, V96, P1454, DOI 10.3945/ajcn.112.037556; Dangin M, 2003, J PHYSIOL-LONDON, V549, P635, DOI 10.1113/jphysiol.2002.036897; Dideriksen K, 2013, NUTRIENTS, V5, P852, DOI 10.3390/nu5030852; Fujita S, 2007, AM J PHYSIOL-ENDOC M, V292, pE77, DOI 10.1152/ajpendo.00173.2006; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; HEGSTED DM, 1976, J NUTR, V106, P307; Henderson GC, 2009, FASEB J, V23, P631, DOI 10.1096/fj.08-117200; HUSEK P, 1991, FEBS LETT, V280, P354, DOI 10.1016/0014-5793(91)80330-6; Jahn LA, 1999, J CLIN ENDOCR METAB, V84, P1007, DOI 10.1210/jc.84.3.1007; Koopman R, 2006, AM J CLIN NUTR, V84, P623, DOI 10.1093/ajcn/84.3.623; Koopman R, 2009, AM J CLIN NUTR, V90, P106, DOI 10.3945/ajcn.2009.27474; Martens EA, 2015, CLIN NUTR, V34, P968, DOI 10.1016/j.clnu.2014.10.007; Matthews DE, 2007, J NUTR, V137, p1549S, DOI 10.1093/jn/137.6.1549S; MILLWARD DJ, 1991, P NUTR SOC, V50, P197, DOI 10.1079/PNS19910030; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Smith GI, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-11; Smith GI, 2009, J APPL PHYSIOL, V107, P1308, DOI 10.1152/japplphysiol.00348.2009; Soenen S, 2013, J NUTR, V143, P591, DOI 10.3945/jn.112.167593; Soenen S, 2010, PHYSIOL BEHAV, V101, P635, DOI 10.1016/j.physbeh.2010.09.014; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Symons TB, 2009, J AM DIET ASSOC, V109, P1582, DOI 10.1016/j.jada.2009.06.369; van Loon LJC, 2011, NESTLE NUTR WORKS SE, V69, P79, DOI 10.1159/000329287; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; WESTERTERP KR, 1995, BRIT J NUTR, V73, P337, DOI 10.1079/BJN19950037; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Westerterp-Plantenga MS, 2012, BRIT J NUTR, V108, pS105, DOI 10.1017/S0007114512002589; Wolfe R.R., 2005, ISOTOPE TRACERMETA, Vsecond; Wolfe RR, 2002, J NUTR, V132, p3219S, DOI 10.1093/jn/131.10.3219S; YOUNG V R, 1986, Journal of Nutrition, V116, P700; YOUNG VR, 1987, HUM NUTR-CLIN NUTR, V41C, P1	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137183	10.1371/journal.pone.0137183	http://dx.doi.org/10.1371/journal.pone.0137183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367529	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100055
J	Iscla, I; Wray, R; Eaton, C; Blount, P				Iscla, Irene; Wray, Robin; Eaton, Christina; Blount, Paul			Scanning MscL Channels with Targeted Post-Translational Modifications for Functional Alterations	PLOS ONE			English	Article							MECHANOSENSITIVE ION-CHANNEL; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GATING MECHANISM; SINGLE RESIDUE; PORE-SIZE; MEMBRANE; PROTEIN; DOMAINS; TRAAK	Mechanosensitive channels are present in all living organisms and are thought to underlie the senses of touch and hearing as well as various important physiological functions like osmoregulation and vasoregulation. The mechanosensitive channel of large conductance (MscL) from Escherichia coli was the first protein shown to encode mechanosensitive channel activity and serves as a paradigm for how a channel senses and responds to mechanical stimuli. MscL plays a role in osmoprotection in E. coli, acting as an emergency release valve that is activated by membrane tension due to cell swelling after an osmotic down-shock. Using an osmotically fragile strain in an osmotic down-shock assay, channel functionality can be directly determined in vivo. In addition, using thiol reagents and expressed MscL proteins with a single cysteine substitution, we have shown that targeted post-translational modifications can be performed, and that any alterations that lead to dysfunctional proteins can be identified by this in vivo assay. Here, we present the results of such a scan performed on 113 MscL cysteine mutants using five different sulfhydryl-reacting probes to confer different charges or hydrophobicity to each site. We assessed which of these targeted modifications affected channel function and the top candidates were further studied using patch clamp to directly determine how channel activity was affected. This comprehensive screen has identified many residues that are critical for channel function as well as highlighted MscL domains and residues that undergo the most drastic environmental changes upon gating.	[Iscla, Irene; Wray, Robin; Eaton, Christina; Blount, Paul] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Blount, P (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Paul.Blount@utsouthwestern.edu		Iscla, Irene/0000-0001-8936-430X	Welch Foundation [I-1420]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP100146]; U.S. National Institutes of Health [GM061028]; National American Heart Association [12SDG8740012]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061028] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas (CPRIT); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by grant I-1420 of the Welch Foundation (http://www.welch1.org/), grant RP100146 from the Cancer Prevention and Research Institute of Texas (CPRIT; http://www.cprit.state.tx.us/), and grant GM061028 from the U.S. National Institutes of Health (http://www.nih.gov/). I.I. is supported by Grant 12SDG8740012 from the National American Heart Association (http://www.heart.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Bartlett JL, 2006, BIOPHYS J, V91, P3684, DOI 10.1529/biophysj.106.088062; Bartlett JL, 2004, P NATL ACAD SCI USA, V101, P10161, DOI 10.1073/pnas.0402040101; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Blount P, 1997, J BIOL CHEM, V272, P32150, DOI 10.1074/jbc.272.51.32150; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Corry B, 2010, J GEN PHYSIOL, V136, P483, DOI 10.1085/jgp.200910376; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Epstein W, 1970, J BACTERIOL, V101, P836, DOI 10.1128/JB.101.3.836-843.1970; Hase CC, 1997, J MEMBRANE BIOL, V157, P17, DOI 10.1007/s002329900212; Iscla I, 2004, BIOPHYS J, V87, P3172, DOI 10.1529/biophysj.104.049833; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2007, BIOPHYS J, V92, P1224, DOI 10.1529/biophysj.106.090316; Iscla I, 2013, BIOSENSORS-BASEL, V3, P171, DOI 10.3390/bios3010171; Iscla I, 2012, CHANNELS, V6, P255, DOI 10.4161/chan.20756; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Iscla I, 2011, FASEB J, V25, P694, DOI 10.1096/fj.10-170878; Jeon J, 2008, BIOPHYS J, V94, P3497, DOI 10.1529/biophysj.107.109850; Kumanovics A, 2002, FASEB J, V16, P1623, DOI 10.1096/fj.02-0238hyp; Levin G, 2004, BIOPHYS J, V86, P2862, DOI 10.1016/S0006-3495(04)74338-6; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li YZ, 2009, FASEB J, V23, P2197, DOI 10.1096/fj.09-129296; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Park KH, 2004, BIOPHYS J, V86, P2129, DOI 10.1016/S0006-3495(04)74272-1; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Tsai IJ, 2005, EUR BIOPHYS J BIOPHY, V34, P403, DOI 10.1007/s00249-005-0476-x; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Yang LM, 2013, CELL REP, V3, P520, DOI 10.1016/j.celrep.2013.01.018; Yang LM, 2012, ACS NANO, V6, P1134, DOI 10.1021/nn203703j; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2004, BIOPHYS J, V86, P2113, DOI 10.1016/S0006-3495(04)74270-8; Zhong DL, 2014, FASEB J, V28, P5234, DOI 10.1096/fj.14-259309; Zhou XL, 2007, P NATL ACAD SCI USA, V104, P15555, DOI 10.1073/pnas.0704039104	48	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137994	10.1371/journal.pone.0137994	http://dx.doi.org/10.1371/journal.pone.0137994			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368283	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100197
J	Meier, ER; Byrnes, C; Weissman, M; Lee, YT; Miller, JL				Meier, Emily Riehm; Byrnes, Colleen; Weissman, Maxine; Lee, Y. Terry; Miller, Jeffery L.			Absolute Reticulocyte Count Acts as a Surrogate for Fetal Hemoglobin in Infants and Children with Sickle Cell Anemia	PLOS ONE			English	Article							RED-BLOOD-CELLS; F-CELLS; ERYTHROPOIESIS; ERYTHROCYTES; EXPRESSION; SURVIVAL; DISEASE; RISK	Hemoglobin switching is largely complete in humans by six months of age. Among infants with sickle cell anemia (HbSS, SCA), reticulocytosis begins early in life as fetal hemoglobin (HbF) is replaced by sickle hemoglobin (HbS). The objective of this study was to determine if absolute reticulocyte count (ARC) is related to HbF levels in a cohort of pediatric SCA patients. A convenience sample of 106 children with SCA between the ages of 1 month and 20 years who were not receiving hydroxyurea or monthly blood transfusions were enrolled in this observational study. Hematologic data, including ARC and HbF levels, were measured at steady state. F-cells were enumerated by flow cytometry. Initial studies compared infants with ARC greater than or equal to 200 K/mu L (ARC >= 200) based upon the previously reported utility of this threshold as a predictive marker for SCA severity. Mean HbF and F-cell levels were significantly lower in the ARC >= 200 group when compared to the ARC < 200 group. Both HbF and F-cell percentages were negatively correlated to ARC in infants and in children between the ages of 1 and 9 years. However, the inverse relationship was lost after the age of 10 years. Overall, decreased expression and distribution of HbF during childhood SCA is well-correlated with increased reticulocyte production and release into the peripheral blood. As such, these data further support the clinical use of reticulocyte enumeration as a disease severity biomarker for childhood sickle cell anemia.	[Meier, Emily Riehm; Byrnes, Colleen; Lee, Y. Terry; Miller, Jeffery L.] NIDDKD, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Meier, Emily Riehm] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA; [Weissman, Maxine] NIH, Dept Lab Med, Hematol Serv, Bethesda, MD 20892 USA; [Meier, Emily Riehm] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's National Health System; National Institutes of Health (NIH) - USA; George Washington University	Miller, JL (corresponding author), NIDDKD, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	jm7f@nih.gov			Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; NIH National Center for Advancing Translational Sciences [UL1TR000075, KL2TR000076]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075, KL2TR000076] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases supported this work. Dr. Meier is supported by Award Numbers UL1TR000075 and KL2TR000076 from the NIH National Center for Advancing Translational Sciences. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. The authors have no conflicts of interest to disclose.	ALTER BP, 1976, BLOOD, V48, P843; Bhanu NV, 2004, BLOOD, V103, P1929, DOI 10.1182/blood-2003-05-1624; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; CROUCH JY, 1985, ARCH PATHOL LAB MED, V109, P325; DOVER GJ, 1978, NEW ENGL J MED, V299, P1428, DOI 10.1056/NEJM197812282992603; Franco RS, 2006, BLOOD, V108, P1073, DOI 10.1182/blood-2005-09-008318; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Marcus SJ, 1997, AM J HEMATOL, V54, P40, DOI 10.1002/(SICI)1096-8652(199701)54:1<40::AID-AJH6>3.0.CO;2-4; Meier ER, 2014, AM J HEMATOL, V89, P904, DOI 10.1002/ajh.23777; Meier ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070794; Meier ER, 2011, PEDIATR BLOOD CANCER, V56, P103, DOI 10.1002/pbc.22643; NAGEL RL, 1993, BLOOD, V81, P9; Navenot JM, 1998, CYTOMETRY, V32, P186, DOI 10.1002/(SICI)1097-0320(19980701)32:3<186::AID-CYTO4>3.3.CO;2-D; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; Oneal PA, 2006, BLOOD, V108, P2081, DOI 10.1182/blood-2006-04-015859; PAPAYANNOPOULOU T, 1980, BRIT J HAEMATOL, V44, P535, DOI 10.1111/j.1365-2141.1980.tb08707.x; Perrine SP, 2008, PEDIATR ANN, V37, P339, DOI 10.3928/00904481-20080501-10; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; RODGERS GP, 1990, NEW ENGL J MED, V322, P1037, DOI 10.1056/NEJM199004123221504; STAMATOYANNOPOULOS G, 1985, ANN NY ACAD SCI, V445, P188, DOI 10.1111/j.1749-6632.1985.tb17188.x	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136672	10.1371/journal.pone.0136672	http://dx.doi.org/10.1371/journal.pone.0136672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366562	gold, Green Submitted, Green Published			2022-12-26	WOS:000361601100020
J	Unlu, ES; Gordon, DM; Telli, M				Unlu, Ercan Selcuk; Gordon, Donna M.; Telli, Murat			Small RNA Sequencing Based Identification of MiRNAs in Daphnia magna	PLOS ONE			English	Article							GASTRIC-CANCER; PREDICTION; DISCOVERY; MICRORNA; GROWTH	Small RNA molecules are short, non-coding RNAs identified for their crucial role in post-transcriptional regulation. A well-studied example includes miRNAs (microRNAs) which have been identified in several model organisms including the freshwater flea and planktonic crustacean Daphnia. A model for epigenetic-based studies with an available genome database, the identification of miRNAs and their potential role in regulating Daphnia gene expression has only recently garnered interest. Computational-based work using Daphnia pulex, has indicated the existence of 45 miRNAs, 14 of which have been experimentally verified. To extend this study, we took a sequencing approach towards identifying miRNAs present in a small RNA library isolated from Daphnia magna. Using Perl codes designed for comparative genomic analysis, 815,699 reads were obtained from 4 million raw reads and run against a database file of known miRNA sequences. Using this approach, we have identified 205 putative mature miRNA sequences belonging to 188 distinct miRNA families. Data from this study provides critical information necessary to begin an investigation into a role for these transcripts in the epigenetic regulation of Daphnia magna.	[Unlu, Ercan Selcuk] Abant Izzet Baysal Univ, Fac Art & Sci, Dept Chem, Bolu, Turkey; [Gordon, Donna M.] Mississippi State Univ, Dept Biol Sci, Starkville, MS USA; [Telli, Murat] Abant Izzet Baysal Univ, Fac Art & Sci, Dept Biol, Bolu, Turkey	Abant Izzet Baysal University; Mississippi State University; Abant Izzet Baysal University	Telli, M (corresponding author), Abant Izzet Baysal Univ, Fac Art & Sci, Dept Biol, Bolu, Turkey.	tellim@ibu.edu.tr	Telli, Murat/U-3821-2019; Ünlü, Ercan Selçuk/AAG-8127-2019	Telli, Murat/0000-0001-5546-0379; Ünlü, Ercan Selçuk/0000-0003-0097-1125	Council of Higher Education of Turkey	Council of Higher Education of Turkey(Ministry of National Education - Turkey)	This work was supported by the Council of Higher Education of Turkey (http://www.yok.gov.tr/en/web/uluslararasi-iliskiler/anasayfa) to MT.	Alon S, 2015, BIOINFORMATICS, V31, P2568, DOI 10.1093/bioinformatics/btv187; Bai J, 2015, PROTEIN CELL, V6, P397, DOI 10.1007/s13238-015-0159-z; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang L, 2015, ONCOL LETT, V9, P2317, DOI 10.3892/ol.2015.3028; Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.553; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Gomes Clarissa P. C., 2013, Frontiers in Genetics, V4, P81, DOI 10.3389/fgene.2013.00081; Griffiths-Jones S, NUCLEIC ACIDS RES, V36, pD154, DOI [10.1093/nar/gkm952.2008, DOI 10.1093/NAR/GKM952.2008]; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; Kou YW, 2015, TUMOR BIOL, V36, P2249, DOI 10.1007/s13277-014-2832-x; Lampert W, 2006, POL J ECOL, V54, P607; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meester L, 1999, ECOLOGY EVOLUTION IN; Niu SY, 2016, MOL GENET GENOMICS, V291, P181, DOI 10.1007/s00438-015-1102-y; Orellana EA, 2015, CANCERS, V7, P1388, DOI 10.3390/cancers7030842; Price C, 2014, GENES DIS, V1, P53, DOI 10.1016/j.gendis.2014.06.004; Reynolds C., 2011, FRESHW REV, V4, P85, DOI [10.1608/FRJ-4.1.425, DOI 10.1608/FRJ-4.1.425]; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134899; Wang YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133491; Weick EM, 2014, DEVELOPMENT, V141, P3458, DOI 10.1242/dev.094037; Xiao L., 2014, ABSTR APPL ANAL, V1-8, DOI DOI 10.1371/J0URNAL.P0NE.0083708; Yoo JK, 2012, STEM CELLS DEV, V21, P2049, DOI 10.1089/scd.2011.0500; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137617	10.1371/journal.pone.0137617	http://dx.doi.org/10.1371/journal.pone.0137617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367422	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100096
J	Wei, K; Wang, LY; Zhang, CC; Wu, LY; Li, HL; Zhang, F; Cheng, H				Wei, Kang; Wang, Liyuan; Zhang, Chengcai; Wu, Liyun; Li, Hailin; Zhang, Fen; Cheng, Hao			Transcriptome Analysis Reveals Key Flavonoid 3 '-Hydroxylase and Flavonoid 3 ',5 '-Hydroxylase Genes in Affecting the Ratio of Dihydroxylated to Trihydroxylated Catechins in Camellia sinensis	PLOS ONE			English	Article							L. O.-KUNTZE; GREEN TEA; BIOSYNTHESIS; EXPRESSION; COLOR; DELPHINIDIN; CULTIVAR; PLANTS; SHADE	The ratio of dihydroxylated to trihydroxylated catechins (RDTC) is an important indicator of tea quality and biochemical marker for the study of genetic diversity. It is reported to be under genetic control but the underlying mechanism is not well understood. Flavonoid 3'-hydroxylase (F3'H) and flavonoid 3',5'-hydroxylase (F3'5'H) are key enzymes involved in the formation of dihydroxylated and trihydroxylated catechins. The transcriptome and HPLC analysis of tea samples from Longjing43 and Zhonghuang2 under control and shading treatment were performed to assess the F3'H and F3'5'H genes that might affect RDTC. A total of 74.7 million reads of mRNA seq (2x101bp) data were generated. After de novo assembly, 109,909 unigenes were obtained, and 39,982 of them were annotated using 7 public databases. Four key F3'H and F3'5'H genes (including CsF3'5'H1, CsF3'H1, CsF3'H2 and CsF3'H3) were identified to be closely correlated with RDTC. Shading treatment had little effect on RDTC, which was attributed to the stable expression of these key F3'H and F3'5'H genes. The correlation of the coexpression of four key genes and RDTC was further confirmed among 13 tea varieties by real time PCR and HPLC analysis. The coexpression of three F3'H genes and a F3'5'H gene may play a key role in affecting RDTC in Camellia sinensis. The current results may establish valuable foundation for further research about the mechanism controlling catechin composition in tea.	[Wei, Kang; Wang, Liyuan; Zhang, Chengcai; Wu, Liyun; Li, Hailin; Zhang, Fen; Cheng, Hao] Chinese Acad Agr Sci, Tea Res Inst, Natl Ctr Tea Improvement, Hangzhou 310008, Zhejiang, Peoples R China; [Wei, Kang; Wang, Liyuan; Zhang, Chengcai; Wu, Liyun; Li, Hailin; Zhang, Fen; Cheng, Hao] Minist Agr, Key Lab Tea Plant Biol & Resources Utilizat, Hangzhou 310008, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Cheng, H (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Natl Ctr Tea Improvement, 9 Meiling South Rd, Hangzhou 310008, Zhejiang, Peoples R China.	chenghao@mail.tricaas.com			National Natural Science Foundation of China [31470396]; Natural Science Foundation of Zhejiang Province [LY14C020001]; Earmarked Fund for China Agriculture Research System [CARS-23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Earmarked Fund for China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (31470396), the Natural Science Foundation of Zhejiang Province (LY14C020001) and the Earmarked Fund for China Agriculture Research System (CARS-23). The Natural Science Foundation of Zhejiang Province (LY14C020001) and the Earmarked Fund for China Agriculture Research System (CARS-23) had roles in study design, data collection and analysis. The National Natural Science Foundation of China (31470396) had a role in preparation of the manuscript and publication.	Ashihara H, 2010, PHYTOCHEMISTRY, V71, P559, DOI 10.1016/j.phytochem.2010.01.010; Boase MR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-107; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Castellarin SD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-12; Chen L, 2012, PREP BIOCHEM BIOTECH, V42, P87, DOI 10.1080/10826068.2011.566297; Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Eungwanichayapant PD, 2009, PLANT PHYSIOL BIOCH, V47, P94, DOI 10.1016/j.plaphy.2008.11.002; GERATS AM, 1992, PHENOLIC METABOLISM, P167; Guo Q, 1999, BBA-GEN SUBJECTS, V1427, P13, DOI 10.1016/S0304-4165(98)00168-8; Guryev V, 2009, FEBS LETT, V583, P1668, DOI 10.1016/j.febslet.2009.04.020; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jiang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062315; Jin JQ, 2014, J AGR FOOD CHEM, V62, P9436, DOI 10.1021/jf5024559; Katiyar SK, 1996, INT J ONCOL, V8, P221; Katsumoto Y, 2007, PLANT CELL PHYSIOL, V48, P1589, DOI 10.1093/pcp/pcm131; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nakagawa T, 2002, FOOD CHEM TOXICOL, V40, P1745, DOI 10.1016/S0278-6915(02)00169-2; Nanjo F, 1999, BIOSCI BIOTECH BIOCH, V63, P1621, DOI 10.1271/bbb.63.1621; Owuor PO, 2007, FOOD CHEM, V100, P873, DOI 10.1016/j.foodchem.2005.10.030; Rani A, 2012, GENE, V495, P205, DOI 10.1016/j.gene.2011.12.029; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; SAIJO R, 1980, PLANT CELL PHYSIOL, V21, P989; Saravanan M, 2005, PHYTOCHEMISTRY, V66, P561, DOI 10.1016/j.phytochem.2004.06.024; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; Tijburg LBM, 1997, CRIT REV FOOD SCI, V37, P771, DOI 10.1080/10408399709527802; Toda K, 2002, PLANT MOL BIOL, V50, P187, DOI 10.1023/A:1016087221334; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Wang L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0352-x; Wang YS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0347-7; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V141, P7, DOI 10.1016/j.scienta.2012.04.013; Wei K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107201; Wei K, 2011, FOOD CHEM, V125, P44, DOI 10.1016/j.foodchem.2010.08.029; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Wu K, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0274-7, 10.1186/s12870-014-0277-4]; Xiong LG, 2013, PLANT PHYSIOL BIOCH, V71, P132, DOI 10.1016/j.plaphy.2013.06.019; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515	39	34	36	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137925	10.1371/journal.pone.0137925	http://dx.doi.org/10.1371/journal.pone.0137925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367395	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100180
J	Yousefi, M; Ahmadi, M; Nourani, E; Behrooz, R; Rajabizadeh, M; Geniez, P; Kaboli, M				Yousefi, Masoud; Ahmadi, Mohsen; Nourani, Elham; Behrooz, Roozbeh; Rajabizadeh, Mehdi; Geniez, Philippe; Kaboli, Mohammad			Upward Altitudinal Shifts in Habitat Suitability of Mountain Vipers since the Last Glacial Maximum	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CLIMATE-CHANGE; CONSERVATION; DISTRIBUTIONS; VERTEBRATES; PREDICTION; AUSTRALIA; IMPACT; AREAS	We determined the effects of past and future climate changes on the distribution of the Montivipera raddei species complex (MRC) that contains rare and endangered viper species limited to Iran, Turkey and Armenia. We also investigated the current distribution of MRC to locate unidentified isolated populations as well as to evaluate the effectiveness of the current network of protected areas for their conservation. Present distribution of MRC was modeled based on ecological variables and model performance was evaluated by field visits. Some individuals at the newly identified populations showed uncommon morphological characteristics. The distribution map of MRC derived through modeling was then compared with the distribution of protected areas in the region. We estimated the effectiveness of the current protected area network to be 10%, which would be sufficient for conserving this group of species, provided adequate management policies and practices are employed. We further modeled the distribution of MRC in the past (21,000 years ago) and under two scenarios in the future (to 2070). These models indicated that climatic changes probably have been responsible for an upward shift in suitable habitats of MRC since the Last Glacial Maximum, leading to isolation of allopatric populations. Distribution will probably become much more restricted in the future as a result of the current rate of global warming. We conclude that climate change most likely played a major role in determining the distribution pattern of MRC, restricting allopatric populations to mountaintops due to habitat alterations. This long-term isolation has facilitated unique local adaptations among MRC populations, which requires further investigation. The suitable habitat patches identified through modeling constitute optimized solutions for inclusion in the network of protected areas in the region.	[Yousefi, Masoud; Ahmadi, Mohsen; Nourani, Elham; Kaboli, Mohammad] Univ Tehran, Fac Nat Resources, Dept Environm Sci, Tehran, Iran; [Ahmadi, Mohsen] Isfahan Univ Technol, Dept Nat Resources, Esfahan, Iran; [Nourani, Elham] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 852, Japan; [Behrooz, Roozbeh; Geniez, Philippe] Univ Montpellier 3, Univ Montpellier, CNRS, CEFE UMR 5175,EPHE,Lab Biogeog & Ecol Vertebres, F-34293 Montpellier 5, France; [Rajabizadeh, Mehdi] Univ Ghent, Evolutionary Morphol Vertebrates, B-9000 Ghent, Belgium; [Rajabizadeh, Mehdi] Grad Univ Adv Technol, Inst Sci & High Technol & Environm Sci, Dept Biodivers, Kerman, Iran; [Rajabizadeh, Mehdi] Razi Univ, Fac Sci, Iranian Plateau Herpetol Res Grp IPHRG, Kermanshah, Iran	University of Tehran; Isfahan University of Technology; Nagasaki University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Universite Paul-Valery; Ghent University; Graduate University of Advanced Technology; Razi University	Kaboli, M (corresponding author), Univ Tehran, Fac Nat Resources, Dept Environm Sci, Tehran, Iran.	mkaboli@ut.ac.ir	Ahmadi, Mohsen/AAW-7357-2021; Yousefi, Masoud/L-4131-2019; Nourani, Elham/E-2623-2016; Ahmadi, Mohsen/J-7360-2017; Yousefi, Masoud/R-2895-2016	Ahmadi, Mohsen/0000-0002-9657-699X; Nourani, Elham/0000-0003-4420-3902; Ahmadi, Mohsen/0000-0002-9657-699X; Yousefi, Masoud/0000-0002-1465-4027				Ahmadi H., 2006, QUATERNARY FORMATION; Ahmadzadeh F, 2013, ZOOL ANZ, V252, P141, DOI 10.1016/j.jcz.2012.05.002; [Anonymous], 2004, K 1 COUPLED GCM MIRO; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Behruz R, 2009, 15 EUR C HERP KUS TU; Bergl RA, 2007, BIOL CONSERV, V134, P195, DOI 10.1016/j.biocon.2006.08.013; Boettger O, 1890, P ZOOL SOC LOND, V314, P424; BRERETON R, 1995, BIOL CONSERV, V72, P339, DOI 10.1016/0006-3207(94)00016-J; Brito JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014734; Chunco AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059853; Ehlers J, 2004, QUATERNARY GLACIAT 3; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gaston K.J., 1994, RARITY POPULATION CO, V13; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IONIA, 2009, GLOBC LAND COV; IUCN, 2013, IUCN RED LIST THREAT; Kian Najmeh, 2011, Herpetological Review, V42, P535; Kiehl JT, 2004, J CLIMATE, V17, P3666, DOI 10.1175/1520-0442(2004)017<3666:TCCSMV>2.0.CO;2; Latifi M, 2000, SNAKES IRAN, V3rd; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lesbarreres D, 2009, HEREDITY, V102, P213, DOI 10.1038/hdy.2008.121; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Martinez-Freiria F, 2013, NATURWISSENSCHAFTEN, V100, P877, DOI 10.1007/s00114-013-1088-4; Martinez-Meyer Enrique, 2005, Biodiversity Informatics, V2, P42; MERTENS ROBERT, 1967, SENCKENBERG BIOL, V48, P161; Meyneeke JO, 2004, ECOL MODEL, V174, P347, DOI 10.1016/j.ecolmodel.2003.07.012; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nagelkerke Kees, 2003, Levende Natuur, V104, P114; NILSON G, 1985, Amphibia-Reptilia, V6, P207, DOI 10.1163/156853885X00119; Nilson G., 2009, IUCN RED LIST THREAT; Nilson Goran, 1996, Symposia of the Zoological Society of London, V70, P31; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parra-Quijano M, 2012, BIODIVERS CONSERV, V21, P79, DOI 10.1007/s10531-011-0167-0; Penman TD, 2010, DIVERS DISTRIB, V16, P109, DOI 10.1111/j.1472-4642.2009.00619.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rajabizadeh M, 2013, THESIS GHENT U GHENT; Rajabizadeh M, 2007, THESIS SHAHID BEHESH; Rajabizadeh Mehdi, 2011, Russian Journal of Herpetology, V18, P235; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Rodder D, 2010, BIODIVERS CONSERV, V19, P2651, DOI 10.1007/s10531-010-9865-2; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ruddiman W.F., 2000, EARTHS CLIMATE FUTUR; Santos X, 2006, BIOL CONSERV, V130, P416, DOI 10.1016/j.biocon.2006.01.003; SCHNEIDER SH, 1998, STATUS TRENDS NATION, P89; Teixeira J, 2002, BIODIVERS CONSERV, V11, P2167, DOI 10.1023/A:1021342611769; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x	60	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138087	10.1371/journal.pone.0138087	http://dx.doi.org/10.1371/journal.pone.0138087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367126	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100220
J	Zhou, YY; Dong, HY; Zhong, YJ; Huang, J; Lv, JL; Li, JX				Zhou, Yanyan; Dong, Haiyun; Zhong, Yanjun; Huang, Jia; Lv, Jianlei; Li, Jinxiu			The Cold-Inducible RNA-Binding Protein (CIRP) Level in Peripheral Blood Predicts Sepsis Outcome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GENE-EXPRESSION; APACHE-II; PROCALCITONIN; HYPOTHERMIA; LIVER	Objectives Sepsis is a lethal and complex clinical syndrome caused by infection or suspected infection. Cold-inducible RNA-binding protein (CIRP) is a widely distributed cold-shock protein that plays a proinflammatory role in sepsis and that may induce organ damage. However, clinical studies regarding the use of CIRP for the prognostic evaluation of sepsis are lacking. The purpose of this research was to investigate the prognostic significance of peripheral blood concentrations of CIRP in sepsis. Sepsis was assessed using several common measures, including the Acute Physiology and Chronic Health Evaluation II (APACHE II) score; the Sepsis-related Organ Failure Assessment (SOFA) score; the lactate, serum creatinine, and procalcitonin (PCT) levels; the white blood cell (WBC) count; and the neutrophil ratio (N%). Design Sixty-nine adult patients with sepsis were enrolled in this study. According to the mortality data from the hospital, 38 patients were survivors, and 31 were nonsurvivors. The plasma levels of the biomarkers were measured and the APACHE II and SOFA scores were calculated within 24 hours of patient enrollment into our study. The CIRP level was measured via ELISA. Results The plasma level of CIRP was significantly higher in the nonsurvivors than in the survivors (median (IQR) 4.99 (2.37-30.17) ng/mL and 1.68 (1.41-13.90) ng/mL, respectively; p = 0.013). The correlations of the CIRP level with the APACHE II score (r = 0.248, p = 0.040, n = 69), the SOFA score (r = 0.323, p = 0.007, n = 69), the serum creatinine level (r = 0.316, p = 0.008, n = 69), and the PCT level (r = 0.282, p = 0.019, n = 69) were significant. Receiver operator characteristic (ROC) curve analysis showed that the area under the ROC curve (AUC) for the CIRP level was 0.674 (p = 0.013). According to Cox proportional hazards models, the CIRP level independently predicts sepsis mortality. When the CIRP level in the peripheral blood increased by 10 ng/mL, the mortality risk increased by 1.05-fold (p = 0.012). Thus, the CIRP level reflects the degree of renal injury but does not predict the severity of sepsis or organ damage. Conclusion An elevated plasma concentration of CIRP was significantly associated with poor prognosis among patients with sepsis. Therefore, CIRP is a potential predictor of sepsis prognosis.	[Zhou, Yanyan; Dong, Haiyun; Zhong, Yanjun; Huang, Jia; Lv, Jianlei; Li, Jinxiu] Cent South Univ, Xiangya Hosp 2, Intens Care Unit, Changsha, Hunan, Peoples R China	Central South University	Li, JX (corresponding author), Cent South Univ, Xiangya Hosp 2, Intens Care Unit, Changsha, Hunan, Peoples R China.	LJX669025@163.com						Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Asfar P, 2014, NEW ENGL J MED, V370, P1583, DOI 10.1056/NEJMoa1312173; Brochu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057426; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Cheng B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/846935; Das U, 2014, ARCH MED SCI, V10, P325, DOI 10.5114/aoms.2014.42586; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Godwin A, 2015, SHOCK, V43, P24, DOI 10.1097/SHK.0000000000000251; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Jiang D, 2014, MOL BIOL REP, V41, P1015, DOI 10.1007/s11033-013-2946-z; Jiang L, 2015, J INT MED RES, V43, P188, DOI 10.1177/0300060514561136; Kim H, 2014, CLIN LAB, V60, P2015, DOI 10.7754/Clin.Lab.2014.140528; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Na YR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118203; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Pop-Began V, 2014, J Med Life, V7 Spec No. 2, P38; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Sakurai T, 2015, CANCER SCI, V106, P352, DOI 10.1111/cas.12611; Sakurai T, 2014, CANCER RES, V74, P6119, DOI 10.1158/0008-5472.CAN-14-0471; Sakurai T, 2013, DIGEST DIS, V31, P440, DOI 10.1159/000355242; Tang C, 2015, CELL BIOL INT, V39, P678, DOI 10.1002/cbin.10438; Tong G, 2013, BRAIN RES, V1504, P74, DOI 10.1016/j.brainres.2013.01.041; Umberger R, 2015, DIMENS CRIT CARE NUR, V34, P100, DOI 10.1097/DCC.0000000000000098; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Xia ZP, 2012, ASIAN J ANDROL, V14, P884, DOI 10.1038/aja.2012.71; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Zhou M, 2014, BBA-GEN SUBJECTS, V1840, P2253, DOI 10.1016/j.bbagen.2014.02.027	32	47	49	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137721	10.1371/journal.pone.0137721	http://dx.doi.org/10.1371/journal.pone.0137721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361390	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100074
J	Koukourakis, MI; Kalamida, D; Giatromanolaki, A; Zois, CE; Sivridis, E; Poulilioul, S; Mitrakas, A; Gatter, KC; Harris, AL				Koukourakis, Michael I.; Kalamida, Dimitra; Giatromanolaki, Alexandra; Zois, Christos E.; Sivridis, Efthimios; Poulilioul, Stamatia; Mitrakas, Achilleas; Gatter, Kevin C.; Harris, Adrian L.			Autophagosome Proteins LC3A, LC3B and LC3C Have Distinct Subcellular Distribution Kinetics and Expression in Cancer Cell Lines	PLOS ONE			English	Article							LIPIDATION; MEMBRANES	LC3s (MAP1-LC3A, B and C) are structural proteins of autophagosomal membranes, widely used as biomarkers of autophagy. Whether these three LC3 proteins have a similar biological role in autophagy remains obscure. We examine in parallel the subcellular expression patterns of the three LC3 proteins in a panel of human cancer cell lines, as well as in normal MRC5 fibroblasts and HUVEC, using confocal microscopy and western blot analysis of cell fractions. In the cytoplasm, there was a minimal co-localization between LC3A, B and C staining, suggesting that the relevant autophagosomes are formed by only one out of the three LC3 proteins. LC3A showed a perinuclear and nuclear localization, while LC3B was equally distributed throughout the cytoplasm and localized in the nucleolar regions. LC3C was located in the cytoplasm and strongly in the nuclei (excluding nucleoli), where it extensively co-localized with the LC3A and the Beclin-1 autophagy initiating protein. Beclin 1 is known to contain a nuclear trafficking signal. Blocking nuclear export function by Leptomycin B resulted in nuclear accumulation of all LC3 and Beclin-1 proteins, while lvermectin that blocks nuclear import showed reduction of accumulation, but not in all cell lines. Since endogenous LC3 proteins are used as major markers of autophagy in clinical studies and cell lines, it is essential to check the specificity of the antibodies used, as the kinetics of these molecules are not identical and may have distinct biological roles. The distinct subcellular expression patterns of LC3s provide a basis for further studies.	[Koukourakis, Michael I.; Kalamida, Dimitra; Zois, Christos E.; Poulilioul, Stamatia; Mitrakas, Achilleas] Democritus Univ Thrace, Sch Med, Univ Gen Hosp Alexandroupolis, Dept Radiotherapy Oncol, Alexandroupolis, Greece; [Giatromanolaki, Alexandra; Sivridis, Efthimios] Democritus Univ Thrace, Sch Med, Univ Gen Hosp Alexandroupolis, Dept Pathol, Alexandroupolis, Greece; [Gatter, Kevin C.] John Radcliffe Hosp, Nuffield Dept Cellular Sci, Oxford 0X3 9DU, England; [Zois, Christos E.; Harris, Adrian L.] Univ Oxford, Weatherall Inst Mol Med, Canc Res United Kingdom Mol Oncol Labs, Oxford 0X3 9DU, England	Democritus University of Thrace; Democritus University of Thrace; University of Oxford	Koukourakis, MI (corresponding author), Democritus Univ Thrace, Sch Med, Univ Gen Hosp Alexandroupolis, Dept Radiotherapy Oncol, Alexandroupolis, Greece.	targ@her.forthnet.gr	Mitrakas, Achilleas/GPC-8600-2022; Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409; Mitrakas, Achilleas/0000-0002-9980-7773; Pouliliou, Stamatia/0000-0001-8900-2202	"TRAINING AND LIFELONG LEARNING - ARISTEIA" project [520, 12605/26.09.2012]; Cancer Research UK [11359, 16466] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	"TRAINING AND LIFELONG LEARNING - ARISTEIA" project; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The study has been funded by the "TRAINING AND LIFELONG LEARNING - ARISTEIA" project, code no 520, ESPA 2007-2013, GGET decision number 12605/26.09.2012 (URL: http://www.espa.gr/el/pages/proclamationsfs.aspx?item=1736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668; Bai H, 2012, ONCOGENE, V31, P4397, DOI 10.1038/onc.2011.613; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Drake KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009806; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; He W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113089; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karim MR, 2007, AUTOPHAGY, V3, P553, DOI 10.4161/auto.4615; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Liang XH, 2001, CANCER RES, V61, P3443; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Zois CE, 2011, AUTOPHAGY, V7, P1371, DOI 10.4161/auto.7.11.16664	19	101	107	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137675	10.1371/journal.pone.0137675	http://dx.doi.org/10.1371/journal.pone.0137675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378792	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400021
J	Sriramula, S; Francis, J				Sriramula, Srinivas; Francis, Joseph			Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress	PLOS ONE			English	Article							CARDIAC RESTRICTED OVEREXPRESSION; BLOOD-PRESSURE; NADPH OXIDASE; TRANSGENIC MICE; NITRIC-OXIDE; INDUCED HYPERTENSION; XANTHINE-OXIDASE; NAD(P)H OXIDASE; GENE-EXPRESSION; CTGF EXPRESSION	The functional crosstalk between angiotensin II (Ang II) and tumor necrosis factor (TNF)-alpha has been shown to cause adverse left ventricular remodeling and hypertrophy in hypertension. Previous studies from our lab showed that mice lacking TNF-alpha (TNF-alpha(-/-)) have attenuated hypertensive response to Ang II; however, the signaling mechanisms involved are not known. In this study, we investigated the signaling pathways involved in the Ang II and TNF-alpha interaction. Chronic Ang II infusion (1 mu g/kg/min, 14 days) significantly increased cardiac collagen I, collagen III, CTGF and TGF-beta mRNA and protein expression in wild-type (WT) mice, whereas these changes were decreased in TNF-alpha(-/-) mice. TNF-alpha(-/-) mice with Ang II infusion showed reduced myocardial perivascular and interstitial fibrosis compared to WT mice with Ang II infusion. In WT mice, Ang II infusion increased reactive oxygen species formation and the expression of NADPH oxidase subunits, indicating increased oxidative stress, but not in TNF-alpha(-/-) mice. In addition, treatment with etanercept (8 mg/kg, every 3 days) for two weeks blunted the Ang II-induced hypertension (133 +/- 4 vs 154 +/- 3 mmHg, p<0.05) and cardiac hypertrophy (heart weight to body weight ratio, 4.8 +/- 0.2 vs 5.6 +/- 0.3, p<0.05) inWT mice. Furthermore, Ang II-induced activation of NF-kappa B, p38 MAPK, and JNK were reduced in both TNF-alpha(-/-) mice and mice treated with etanercept. Together, these findings indicate that TNF-alpha contributes to Ang II-induced hypertension and adverse cardiac remodeling, and that these effects are associated with changes in the oxidative stress dependent MAPK/TGF-beta/NF-kappa B pathway. These results may provide new insight into the mechanisms of Ang II and TNF-alpha interaction.	[Sriramula, Srinivas; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Sriramula, Srinivas] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Sriramula, S (corresponding author), Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	ssrira@lsuhsc.edu; jfrancis@lsu.edu	Sriramula, Srinivas/N-1297-2019	Sriramula, Srinivas/0000-0001-9937-1589	National Heart, Lung, and Blood Institute [HL-80544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080544] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute Grant HL-80544 to JF.	Brandes RP, 2002, FREE RADICAL BIO MED, V32, P1116, DOI 10.1016/S0891-5849(02)00789-X; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Chou DHI, 1996, J IMMUNOL, V156, P4354; Cifuentes ME, 2000, AM J PHYSIOL-HEART C, V279, pH2234, DOI 10.1152/ajpheart.2000.279.5.H2234; Dobrian AD, 2001, HYPERTENSION, V38, P361, DOI 10.1161/01.HYP.38.3.361; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Elmarakby AA, 2006, HYPERTENSION, V47, P557, DOI 10.1161/01.HYP.0000198545.01860.90; Flesch M, 2003, CIRCULATION, V108, P598, DOI 10.1161/01.CIR.0000081768.13378.BF; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gu J, 2012, EXP CELL RES, V318, P2105, DOI 10.1016/j.yexcr.2012.06.015; Gurantz D, 1999, CIRC RES, V85, P272, DOI 10.1161/01.RES.85.3.272; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Kakishita M, 2003, J CARDIOVASC PHARM, V42, pS67, DOI 10.1097/00005344-200312001-00015; Kalra D, 2000, CIRCULATION, V102, P1302, DOI 10.1161/01.CIR.102.11.1302; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Li JM, 2002, CIRC RES, V90, P143, DOI 10.1161/hh0202.103615; Mariappan N, 2010, CARDIOVASC RES, V85, P473, DOI 10.1093/cvr/cvp305; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; Marvar PJ, 2010, CIRC RES, V107, P263, DOI 10.1161/CIRCRESAHA.110.217299; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; NAKAZONO K, 1991, P NATL ACAD SCI USA, V88, P10045, DOI 10.1073/pnas.88.22.10045; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Schnackenberg CG, 1998, HYPERTENSION, V32, P59, DOI 10.1161/01.HYP.32.1.59; Sekiguchi K, 2004, CARDIOVASC RES, V63, P433, DOI 10.1016/j.cardiores.2004.02.005; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; Sriramula S, 2008, HYPERTENSION, V51, P1345, DOI 10.1161/HYPERTENSIONAHA.107.102152; Sriramula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063847; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Suzuki H, 1998, P NATL ACAD SCI USA, V95, P4754, DOI 10.1073/pnas.95.8.4754; Touyz Rhian M, 2003, Expert Rev Cardiovasc Ther, V1, P91, DOI 10.1586/14779072.1.1.91; Tran LT, 2009, MOL CELL BIOCHEM, V330, P219, DOI 10.1007/s11010-009-0136-z; Venegas-Pont M, 2010, HYPERTENSION, V56, P643, DOI 10.1161/HYPERTENSIONAHA.110.157685; VILLARREAL FJ, 1992, AM J PHYSIOL, V262, pH1861, DOI 10.1152/ajpheart.1992.262.6.H1861; Xiao L, 2002, AM J PHYSIOL-CELL PH, V282, pC926, DOI 10.1152/ajpcell.00254.2001; Zhang CH, 2006, ARTERIOSCL THROM VAS, V26, P475, DOI 10.1161/01.ATV.0000201932.32678.7e; Zhang CH, 2006, J MOL CELL CARDIOL, V40, P247, DOI 10.1016/j.yjmcc.2005.11.010	43	63	67	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138372	10.1371/journal.pone.0138372	http://dx.doi.org/10.1371/journal.pone.0138372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378790	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400091
J	Cancarini, I; Krogh, V; Agnoli, C; Grioni, S; Matullo, G; Pala, V; Pedraglio, S; Contiero, P; Riva, C; Muti, P; Sieri, S				Cancarini, Ilaria; Krogh, Vittorio; Agnoli, Claudia; Grioni, Sara; Matullo, Giuseppe; Pala, Valeria; Pedraglio, Samuele; Contiero, Paolo; Riva, Cristina; Muti, Paola; Sieri, Sabina			Micronutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer Subtypes	PLOS ONE			English	Article							DIETARY-FOLATE INTAKE; ESTROGEN-RECEPTOR GENE; B-VITAMINS; METHYLATION; DNA; ALCOHOL; WOMEN; CARCINOGENESIS; LYMPHOCYTES; DEFICIENCY	Background Vitamins involved in one-carbon metabolism are hypothesized to influence breast cancer (BC) risk. However, epidemiologic studies that examined associations between B vitamin intake and BC risk have provided inconsistent results. We prospectively examined, in the Italian ORDET cohort, whether B vitamin consumption was associated with risk of BC and BC subtypes. Methods After a mean follow-up of 16.5 years, 391 BCs were diagnosed among 10,786 cohort women. B vitamin intakes were estimated from food frequency questionnaires. Cox proportional hazard models adjusted for energy intake and confounders, estimated hazard ratios (HR) with 95% confidence intervals (CIs) for BC according to intake. Results RRs were 0.61 (95% CI 0.38-0.97 highest vs. lowest quartile; P trend 0.025) for thiamine; 0.48 (95% CI 0.32-0.71; P trend <0.001) for riboflavin; 0.59 (95% CI 0.39-0.90; P trend 0.008) for vitamin B6, and 0.65 (95% CI 0.44-0.95; P trend 0.021) for folate. As regards risk of BC subtypes, high riboflavin and folate were significantly associated with lower risk of estrogen receptor positive (ER+) and progesterone receptor positive (PR+) cancers, and high thiamine was associated with lower risk of ER-PR-cancers. High riboflavin was associated with lower risk of both HER2+ and HER2-cancers, high folate with lower risk of HER2-disease, and high thiamine with HER2+ disease. Conclusions These findings support protective effects of thiamine and one-carbon metabolism vitamins (folate, riboflavin, and vitamin B6) against BC in general; while folate may also protect against ER+PR+ and HER2-disease; and thiamine against ER-PR-, and HER2+ disease.	[Cancarini, Ilaria; Krogh, Vittorio; Agnoli, Claudia; Grioni, Sara; Pala, Valeria; Pedraglio, Samuele; Sieri, Sabina] Fdn IRCSS Ist Nazl Tumori, Dept Prevent & Predict Med, Epidemiol & Prevent Unit, Milan, Italy; [Matullo, Giuseppe] Univ Turin, Dept Med Sci, Turin, Italy; [Matullo, Giuseppe] Human Genet Fdn, Turin, Italy; [Contiero, Paolo] Fdn IRCSS Ist Nazl Tumori, Environm Epidemiol Unit, Dept Prevent & Predict Med, Turin, Italy; [Riva, Cristina] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Muti, Paola] McMaster Univ, Fac Hlth Sci, Dept Oncol, Hamilton, ON, Canada	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Turin; University of Insubria; McMaster University	Sieri, S (corresponding author), Fdn IRCSS Ist Nazl Tumori, Dept Prevent & Predict Med, Epidemiol & Prevent Unit, Milan, Italy.	sabina.sieri@istitutotumori.mi.it	Agnoli, Claudia/K-5916-2016; Krogh, Vittorio/K-2628-2016; Krogh, Vittorio/AAA-9171-2019; Grioni, Sara/K-5320-2016; Muti, Paola/AAD-9108-2020; Matullo, Giuseppe/K-6383-2016; Contiero, Paolo/F-6721-2016; Sieri, Sabina/K-4667-2016; Pala, Valeria/K-4738-2016; RIVA, CRISTINA/K-5063-2016	Agnoli, Claudia/0000-0003-4472-1179; Krogh, Vittorio/0000-0003-0122-8624; Krogh, Vittorio/0000-0003-0122-8624; Grioni, Sara/0000-0002-5891-8426; Matullo, Giuseppe/0000-0003-0674-7757; Contiero, Paolo/0000-0001-6760-3605; Sieri, Sabina/0000-0001-5201-172X; Pala, Valeria/0000-0001-5438-970X; RIVA, CRISTINA/0000-0001-9884-038X	Italian Ministry of Public Health	Italian Ministry of Public Health(Ministry of Health, Italy)	This study was funded by the Italian Ministry of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames BN, 2001, MUTAT RES-FUND MOL M, V475, P7, DOI 10.1016/S0027-5107(01)00070-7; Bassett JK, 2013, CANCER CAUSE CONTROL, V24, P1555, DOI 10.1007/s10552-013-0232-y; Chen P, 2014, BRIT J CANCER, V110, P2327, DOI 10.1038/bjc.2014.155; Cho EY, 2007, CANCER EPIDEM BIOMAR, V16, P2787, DOI 10.1158/1055-9965.EPI-07-0683; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Chou YC, 2007, BREAST CANCER RES TR, V101, P199, DOI 10.1007/s10549-006-9278-9; Contiero P, 2008, J BIOMED INFORM, V41, P24, DOI 10.1016/j.jbi.2007.03.003; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Batlle J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju367; de Kruijf EM, 2014, MOL ONCOL; Doke S, 1998, BIOSCI BIOTECH BIOCH, V62, P1008, DOI 10.1271/bbb.62.1008; Duffy CM, 2009, BREAST CANCER RES TR, V116, P551, DOI 10.1007/s10549-008-0167-2; Duthie SJ, 1998, FASEB J, V12, P1491, DOI 10.1096/fasebj.12.14.1491; Ericson U, 2007, AM J CLIN NUTR, V86, P434, DOI 10.1093/ajcn/86.2.434; FERGUSON AT, 1995, CANCER RES, V55, P2279; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Kwak HK, 2002, J NUTR, V132, P3308, DOI 10.1093/jn/132.11.3308; Lajous M, 2006, CANCER EPIDEM BIOMAR, V15, P443, DOI 10.1158/1055-9965.EPI-05-0532; Lajous M, 2006, CANCER CAUSE CONTROL, V17, P1209, DOI 10.1007/s10552-006-0053-3; Lapidus RG, 1998, CANCER RES, V58, P2515; Lapidus RG, 1996, CLIN CANCER RES, V2, P805; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Larsson SC, 2008, CANCER EPIDEM BIOMAR, V17, P3444, DOI 10.1158/1055-9965.EPI-08-0692; Layfield Lester J., 2000, Breast J, V6, P189, DOI 10.1046/j.1524-4741.2000.99097.x; Levi F, 2001, INT J CANCER, V91, P260, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1041&gt;3.3.CO;2-R; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Liu SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085702; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Ma E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-122; Maruti SS, 2009, AM J CLIN NUTR, V89, P624, DOI 10.3945/ajcn.2008.26568; Mason J B, 1996, Oncology (Williston Park), V10, P1727; Mason JB, 2003, J NUTR, V133, p941S, DOI 10.1093/jn/133.3.941S; Mason JB, 2000, ADV ENZYME REGUL, V40, P127, DOI 10.1016/S0065-2571(99)00037-0; MCCORMICK DB, 1989, PHYSIOL REV, V69, P1170, DOI 10.1152/physrev.1989.69.4.1170; Negri E, 1996, INT J CANCER, V65, P140, DOI 10.1002/(SICI)1097-0215(19960117)65:2&lt;140::AID-IJC3&gt;3.0.CO;2-Z; OTTAVIANO YL, 1994, CANCER RES, V54, P2552; Paul L, 2013, NUTR REV, V71, P239, DOI 10.1111/nure.12014; PIVA R, 1990, BRIT J CANCER, V61, P270, DOI 10.1038/bjc.1990.50; Rohan TE, 2000, J NATL CANCER I, V92, P266, DOI 10.1093/jnci/92.3.266; Roswall N, 2010, EUR J CANCER PREV, V19, P360, DOI 10.1097/CEJ.0b013e32833ade68; Salvini S, 1998, BANCA DATI DI COMPOS; Sellers TA, 2002, CANCER EPIDEM BIOMAR, V11, P1104; Sellers TA, 2001, EPIDEMIOLOGY, V12, P420, DOI 10.1097/00001648-200107000-00012; Shrubsole MJ, 2011, AM J EPIDEMIOL, V173, P1171, DOI 10.1093/aje/kwq491; Shrubsole MJ, 2001, CANCER RES, V61, P7136; Sieri S, 2002, NUTR CANCER, V42, P10, DOI 10.1207/S15327914NC421_2; Taherian-Fard A, 2014, BRIEF BIOINFORM; Tio M, 2014, BREAST CANC RES TREA; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Zastre JA, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-16; Zhang SM, 2005, CANCER EPIDEM BIOMAR, V14, P2004, DOI 10.1158/1055-9965.EPI-05-0083; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632; Zhang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100044	59	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138318	10.1371/journal.pone.0138318	http://dx.doi.org/10.1371/journal.pone.0138318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376452	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200097
J	Travenzoli, NM; Silva, PC; Santos, U; Zanuncio, JC; Oliveira, C; Dergam, JA				Travenzoli, Natalia Martins; Silva, Priscilla Caroline; Santos, Udson; Zanuncio, Jose Cola; Oliveira, Claudio; Dergam, Jorge Abdala			Cytogenetic and Molecular Data Demonstrate that the Bryconinae (Ostariophysi, Bryconidae) Species from Southeastern Brazil Form a Phylogenetic and Phylogeographic Unit	PLOS ONE			English	Article							PROCHILODUS-LINEATUS CHARACIFORMES; HOPLIAS-MALABARICUS; ERYTHRINIDAE FISH; EASTERN BRAZIL; CHARACIDAE; PISCES; DNA; BIOGEOGRAPHY; KARYOTYPE; TELEOSTEI	Brycon spp. occur in Neotropical watersheds to the west and east of the Andes, and as they are sensitive to anthropogenic changes, many these species are endangered in southeastern Brazil. Coastal rivers in southeastern Brazil are characterized by the presence of relatively few freshwater fish species and high endemism of this fauna. The objective of this study was to examine whether Brycon spp. occurring in the coastal basins of southeastern Brazil are monophyletic, using cytogenetic data, mitochondrial, and nuclear molecular markers. All the species showed a diploid number of 50 chromosomes, a conserved number within the subfamily Bryconinae. However, the karyotypic formulas were unique to most species, including Brycon devillei (26m+22sm+2st), Brycon ferox (26m+12sm+12st), Brycon insignis (22m+20sm+8st), Brycon opalinus, and Brycon vermelha (24m+20sm+6st), indicating the prevalence of pericentric and paracentric inversions in the chromosomal evolution of these species. All of them had nucleolar organizer regions in the first pair of subtelocentric chromosomes and no equilocal distribution of heterochromatin in the first pair of chromosomes of the karyotype. These two features, not seen in any other Brycon spp. examined to date, indicate that Bryconinae species from the Brazilian southeastern coastal basins, including the monotypic genus Henochilus, are monophyletic. Also, this is the first study that reports NOR location and C-banding patterns as synapomorphies for a Neotropical fish species group. The monophyly was also supported by a phylogenetic analysis of 16S rDNA (16S), cytochrome oxidase subunit I (COI), alpha-myosin (MYH6) genes and S72 intron molecular data. Our results partially corroborate the "Brycon acuminatus" group proposed by Howes in 1982: our proposed clade keeps B. devillei, B. ferox, and B. insignis; but it also includes B. opalinus, B. vermelha, and H. weatlandii whereas it excludes B. nattereri. The phylogeographic unit formed by Bryconinae species in southeastern Brazil reflects the long and isolated paleohydrological history of these coastal basins relative to the continental watersheds.	[Travenzoli, Natalia Martins; Silva, Priscilla Caroline; Santos, Udson; Zanuncio, Jose Cola; Dergam, Jorge Abdala] Univ Fed Vicosa, Dept Biol Anim, Lab Sistemat Mol Beagle, BR-36570000 Vicosa, MG, Brazil; [Oliveira, Claudio] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Morfol, BR-18618970 Botucatu, SP, Brazil	Universidade Federal de Vicosa; Universidade Estadual Paulista	Dergam, JA (corresponding author), Univ Fed Vicosa, Dept Biol Anim, Lab Sistemat Mol Beagle, BR-36570000 Vicosa, MG, Brazil.	jdergam@gmail.com	Fapesp, Biota/F-8655-2017; Oliveira, Claudio/D-7713-2012	Fapesp, Biota/0000-0002-9887-8449; Oliveira, Claudio/0000-0002-7010-8880	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Pesquisa (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Pesquisa (CNPq), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG).	Abe KT, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-152; Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Albert JS, 2011, MAJOR BIOGEOGRAFIC P, P45; AlmeidaToledo LF, 1996, CARYOLOGIA, V49, P35, DOI 10.1080/00087114.1996.10797348; Artoni RF, 2006, NEOTROP ICHTHYOL, V4, P197, DOI 10.1590/S1679-62252006000200005; Artoni RF, 2009, REV FISH BIOL FISHER, V19, P393, DOI 10.1007/s11160-009-9109-2; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bertollo LAC, 2000, CHROMOSOME RES, V8, P603, DOI 10.1023/A:1009233907558; Bertollo LAC., 1978, BRAZIL J GENET, V1, P103; Bizerril CRSF, 1994, ACTA BIOL LEOPOLDENS, V16, P51; Botero-Botero A, 2011, REV MVZ CORDOBA, V16, P2349; BOYCE TM, 1989, GENETICS, V123, P825; Buckup PA, 2011, BIOGEOGRAPHY NEOTROP; Buckup PA, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P203; Carvalho ML, 2002, GENET MOL BIOL, V25, P49, DOI 10.1590/S1415-47572002000100010; Carvalho T. P., 2007, DARWINIANA, V45, P65; Castro RMC, 2004, COPEIA, P496, DOI 10.1643/CI-03-202R2; Cioffi MD, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-28; Cooke GM, 2007, J FISH BIOL, V71, P132, DOI 10.1111/j.1095-8649.2007.01478.x; Lopez DD, 2008, REV BIOL TROP, V56, P1619; de Barros LC, 2015, ZEBRAFISH, V12, P102, DOI 10.1089/zeb.2014.1030; De Rosa LVS, 2007, Braz. J. Biol., V67, P333, DOI 10.1590/S1519-69842007000200020; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia Caroline, 2005, Neotrop. ichthyol., V3, P285, DOI 10.1590/S1679-62252005000200006; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Howes G., 1982, Bulletin of the British Museum (Natural History) Zoology, V43, P1; Ingenito LFS, 2007, J BIOGEOGR, V34, P1173, DOI 10.1111/j.1365-2699.2007.01686.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jacobina UP, 2009, NEOTROP ICHTHYOL, V7, P617, DOI 10.1590/S1679-62252009000400009; Kavalco KF, 2005, GENETICA, V124, P85, DOI 10.1007/s10709-005-0176-6; Kowsmann RO, 1979, SERIE PROJETO REMAC, V8; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Lima F.C.T., 2003, CHECK LIST FRESHWATE, P174; Lima Flavio C.T., 2000, Ichthyological Exploration of Freshwaters, V11, P155; Lucena CAS, 2013, B SOC BRAS ICTIOL, V105, P20; Margarido Vladimir P., 1996, Cytobios, V85, P219; Margarido VP, 1999, GENET MOL BIOL, V22, P357, DOI 10.1590/S1415-47571999000300012; Mariguela TC, 2010, COMP CYTOGENET, V4, P185, DOI 10.3897/compcytogen.v4i2.49; Menezes N.A., 1988, P295; Miller M.A., 2010, P GAT COMP ENV WORKS; Molina WF, 2004, J EXP MAR BIOL ECOL, V309, P109, DOI 10.1016/j.jembe.2004.03.011; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Oliveira Claudio, 2003, Neotrop. ichthyol., V1, P47, DOI 10.1590/S1679-62252003000100005; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Palumbi Stephen R., 1996, P205; Parada S, 2003, ORINOQUIA, V7, P42; Pereira TL, 2013, J BIOGEOGR, V40, P905, DOI 10.1111/jbi.12044; Rambaut A., 2007, TRACER V1 4; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Santos U, 2009, J FISH BIOL, V75, P2326, DOI 10.1111/j.1095-8649.2009.02489.x; Sessions SK, 2008, CHROMOSOME RES, V16, P183, DOI 10.1007/s10577-007-1205-3; Hilsdorf AWS, 2008, GENET MOL BIOL, V31, P366; Silva PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042278; Souza IL, 2008, MICRON, V39, P1036, DOI 10.1016/j.micron.2007.09.007; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vicari MR, 2006, GENET MOL BIOL, V29, P621, DOI 10.1590/S1415-47572006000400008; Voltolin TA, 2010, GENETICA, V138, P281, DOI 10.1007/s10709-009-9420-9; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wasko AP, 2000, GENET MOL BIOL, V23, P135, DOI 10.1590/S1415-47572000000100025; Wasko AP, 2001, GENOME, V44, P893, DOI 10.1139/gen-44-5-893; Weitzman S.H., 1988, P379; White BJ, 2009, GENETICS, V183, P275, DOI 10.1534/genetics.109.105817; Zander R. H., 2004, PHYLOINFORMATICS, V2, P1	70	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137843	10.1371/journal.pone.0137843	http://dx.doi.org/10.1371/journal.pone.0137843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372558	Green Published, gold, Green Submitted			2022-12-26	WOS:000361604400033
J	Yang, L; Shi, GF; Zhou, T; Li, Y; Li, Y				Yang, Li; Shi, Gaofeng; Zhou, Tao; Li, Yang; Li, Yong			Quantification of the Iodine Content of Perigastric Adipose Tissue by Dual-Energy CT: A Novel Method for Preoperative Diagnosis of T4-Stage Gastric Cancer	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ACCURACY	This study investigated the utility of quantifying iodine concentration (IC) in perigastric adipose tissue, using dual-energy computed tomography (DECT), for the detection of T4astage gastric cancer. Fifty-four patients with gastric cancer were enrolled at the Fourth Hospital of Hebei Medical University between January and June 2013. Patients were imaged preoperatively with conventional computed tomography (CT) scans and DECT, and the IC in perigastric fat adjacent to the tumor calculated from arterial phase (AP) and portal venous phase (PVP) images. The patients subsequently received surgical treatment (gastrectomy), and histologic analysis of resected specimens was used as a 'gold standard' reference for cancer staging. Receiver operating characteristic (ROC) curve analysis was employed to assess the utility of DECT for identifying T4a-stage gastric cancer, with optimal IC thresholds determined from the area under the ROC curve (AUC). Postoperative histology revealed that 32 patients had serosal invasion (group A), and 22 did not (group B). The accuracy of conventional CT for distinguishing stage T4 from non-T4 stages was 68.5% (37/54). IC was significantly higher in group A than in group B (AP: 0.60 +/- 0.34 vs. 0.09 +/- 0.19 mg/mL, p < 0.001; PVP: 0.83 +/- 0.41 vs. 0.27 +/- 0.21 mg/mL, p < 0.001). The sensitivity, specificity and AUC for detecting serosal invasion were 77.1%, 79.2% and 0.89 at an IC threshold of 0.25 mg/mL for AP images; and 80.0%, 79.2% and 0.90 at an IC threshold of 0.45 mg/mL for PVP images. These results indicated that Iodine quantification in perigastric fat using DECT is an accurate method for detecting serosal invasion by gastric cancer.	[Yang, Li; Shi, Gaofeng; Li, Yang] Hebei Med Univ, Hosp 4, Dept CT, Shijiazhuang, Hebei Province, Peoples R China; [Zhou, Tao; Li, Yong] Hebei Med Univ, Hosp 4, Dept Surg, Shijiazhuang, Hebei Province, Peoples R China	Hebei Medical University; Hebei Medical University	Shi, GF (corresponding author), Hebei Med Univ, Hosp 4, Dept CT, Shijiazhuang, Hebei Province, Peoples R China.	yangli8008@hotmail.com						Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Bauer RW, 2011, EUR RADIOL, V21, P2139, DOI 10.1007/s00330-011-2162-y; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; Edge SB, 2009, AJCC CANC STAGING MA, P648; Ho LM, 2012, AM J ROENTGENOL, V198, P840, DOI 10.2214/AJR.11.7316; Hur J, 2006, J COMPUT ASSIST TOMO, V30, P372, DOI 10.1097/00004728-200605000-00005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim AY, 2005, ABDOM IMAGING, V30, P465, DOI 10.1007/s00261-004-0273-5; Kim JH, 2012, ABDOM IMAGING, V37, P541, DOI 10.1007/s00261-011-9823-9; Kim YH, 2009, RADIOLOGY, V250, P767, DOI 10.1148/radiol.2502071872; Kumano S, 2005, RADIOLOGY, V237, P961, DOI 10.1148/radiol.2373041380; Li MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107061; Lin XZ, 2012, EUR J RADIOL, V81, P2487, DOI 10.1016/j.ejrad.2011.10.028; Lv PJ, 2012, EUR RADIOL, V22, P2117, DOI 10.1007/s00330-012-2485-3; Makino T, 2011, SURGERY, V149, P672, DOI 10.1016/j.surg.2010.12.003; Park SR, 2010, ANN SURG, V251, P428, DOI 10.1097/SLA.0b013e3181ca69a7; Schmid-Bindert G, 2012, EUR RADIOL, V22, P93, DOI 10.1007/s00330-011-2230-3; Seevaratnam R, 2012, GASTRIC CANCER, V15, pS3, DOI 10.1007/s10120-011-0069-6; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Yang DM, 2007, J COMPUT ASSIST TOMO, V31, P98, DOI 10.1097/01.rct.0000234072.16209.ab	20	9	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136871	10.1371/journal.pone.0136871	http://dx.doi.org/10.1371/journal.pone.0136871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372042	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400008
J	Gooding, S; Lau, IJ; Sheikh, M; Roberts, P; Wong, JL; Dickens, E; Bullement, A; Elvidge, J; Lee, D; Ramasamy, K				Gooding, Sarah; Lau, I-Jun; Sheikh, Mimi; Roberts, Pamela; Wong, Julia; Dickens, Emmy; Bullement, Ash; Elvidge, Jamie; Lee, Dawn; Ramasamy, Karthik			Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs	PLOS ONE			English	Article							THERAPIES; SURVIVAL; ERA	Double relapsed and/or refractory multiple myeloma (DRMM), MM that is relapsed and/or refractory to bortezomib and lenalidomide, carries a poor prognosis. The healthcare costs of DRMM have not previously been reported. We analyzed detailed medical resource utilization (MRU) costs, drug costs and outcomes for 39 UK patients receiving standard DRMM therapy. Median OS in this cohort was 5.6 months. The mean cost of DRMM treatment plus MRU until death was 23,472 pound [range: 1,411- pound 90,262] pound, split between drug costs 11,191 pound and other resource use costs 12,281 pound. The cost per assumed quality-adjusted life year (QALY) during DRMM was 66,983 pound. These data provide a standard of care comparison when evaluating the cost-effectiveness of new drugs in DRMM.	[Gooding, Sarah; Lau, I-Jun; Sheikh, Mimi; Roberts, Pamela; Wong, Julia; Dickens, Emmy; Ramasamy, Karthik] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Haematol, Oxford OX3 7LE, England; [Gooding, Sarah; Lau, I-Jun; Sheikh, Mimi; Dickens, Emmy; Ramasamy, Karthik] Oxford Univ Hosp NHS Trust, Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford OX3 7LE, England; [Gooding, Sarah] Univ Oxford, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England; [Sheikh, Mimi] Univ Oxford, Dept Oncol, Oxford OX3 7LH, England; [Bullement, Ash; Elvidge, Jamie; Lee, Dawn] BresMed Hlth Solut, Sheffield S1 2DW, S Yorkshire, England; [Ramasamy, Karthik] Royal Berkshire Hosp NHS Trust, Reading RG1 5AN, Berks, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Oxford; Royal Berkshire Hospital	Ramasamy, K (corresponding author), Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Haematol, Old Rd, Oxford OX3 7LE, England.	karthik.ramasamy@ouh.nhs.uk	lee, dawn/GRJ-7459-2022; Bullement, Ash/AEO-3423-2022	Bullement, Ash/0000-0001-7091-0972; Ramasamy, Karthik/0000-0003-3385-3707; Lau, I-Jun/0000-0003-1727-3243	Wellcome Trust [102341/Z/13/Z]; Medical Research Council Clinical Research Training Fellowship [MR/M003221/1]; Oxford Cancer Research Centre Clinical Research Training Fellowship [OCRC-CRF14-MW]; MRC [MR/M003221/1] Funding Source: UKRI; Medical Research Council [MR/M003221/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Cancer Research Centre Clinical Research Training Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SG was supported by Wellcome Trust Research Training Fellowship 2013-2016. Grant code 102341/Z/13/Z (http://www.wellcome.ac.uk/Funding/Biomedical-science/Fundingschemes/Fellowships/Clinical-fellowships/wtd004435.htm). IL was supported by Medical Research Council Clinical Research Training Fellowship 2014-2017. Grant code MR/M003221/1 (http://www.mrc.ac.uk/skillscareers/fellowships/clinical-fellowships/clinical-research-training-fellowship-crtf/). MS was supported by Oxford Cancer Research Centre Clinical Research Training Fellowship 2014-2017. Grant code OCRC-CRF14-MW (http://www.cancercentre.ox.ac.uk/graduate-studies/clinical-research-trainingfellowships/). BresMed Health Solutions provided support in the form of salaries for authors AB, JE and DL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Brown RE, 2013, EUR J HEALTH ECON, V14, P507, DOI 10.1007/s10198-012-0395-6; Durie Brian, 2013, J Med Econ, V16, P614, DOI 10.3111/13696998.2012.760159; Gaultney JG, 2013, J CLIN PHARM THER, V38, P41, DOI 10.1111/jcpt.12020; Gaultney JG, 2013, ONCOLOGIST, V18, P5, DOI 10.1634/theoncologist.2012-0484; Jordan K, 2014, SUPPORT CARE CANCER, V22, P417, DOI 10.1007/s00520-013-1991-4; Kantarjian HM, 2013, J CLIN ONCOL, V31, P3600, DOI 10.1200/JCO.2013.49.1845; Kumar SK, 2012, LEUKEMIA, V26, P149, DOI 10.1038/leu.2011.196; Lau IJ, 2014, ANN HEMATOLOGY; Lee Hans C, 2013, Am Soc Clin Oncol Educ Book, DOI 10.1200/EdBook_AM.2013.33.e302; Meadows JP, 2013, CURR HEMATOL MALIG R, V8, P253, DOI 10.1007/s11899-013-0173-2; National Institute for Health and Care Excellence, 2013, GUIDE TO THE METHODS; Palumbo A, 2013, LYMPH MYEL 2013 INT; Pozzi S, 2013, BRIT J HAEMATOL, V163, P40, DOI 10.1111/bjh.12465; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Teitelbaum A, 2013, ONCOLOGIST, V18, P37, DOI 10.1634/theoncologist.2012-0113	15	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136207	10.1371/journal.pone.0136207	http://dx.doi.org/10.1371/journal.pone.0136207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367874	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000361601100014
J	Gruber, T; Balbach, J				Gruber, Tobias; Balbach, Jochen			Protein Folding Mechanism of the Dimeric AmphiphysinII/Bin1 N-BAR Domain	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PROLYL ISOMERIZATION; MEMBRANE CURVATURE; ENERGY LANDSCAPES; CRYSTAL-STRUCTURE; ON-PATHWAY; INTERMEDIATE; ASSOCIATION; STABILITY; KINETICS	The human AmphyphisinII/Bin1 N-BAR domain belongs to the BAR domain superfamily, whose members sense and generate membrane curvatures. The N-BAR domain is a 57 kDa homodimeric protein comprising a six helix bundle. Here we report the protein folding mechanism of this protein as a representative of this protein superfamily. The concentration dependent thermodynamic stability was studied by urea equilibrium transition curves followed by fluorescence and far-UV CD spectroscopy. Kinetic unfolding and refolding experiments, including rapid double and triple mixing techniques, allowed to unravel the complex folding behavior of N-BAR. The equilibrium unfolding transition curve can be described by a two-state process, while the folding kinetics show four refolding phases, an additional burst reaction and two unfolding phases. All fast refolding phases show a rollover in the chevron plot but only one of these phases depends on the protein concentration reporting the dimerization step. Secondary structure formation occurs during the three fast refolding phases. The slowest phase can be assigned to a proline isomerization. All kinetic experiments were also followed by fluorescence anisotropy detection to verify the assignment of the dimerization step to the respective folding phase. Based on these experiments we propose for NBAR two parallel folding pathways towards the homodimeric native state depending on the proline conformation in the unfolded state.	[Gruber, Tobias; Balbach, Jochen] Univ Halle Wittenberg, Inst Phys, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Balbach, J (corresponding author), Univ Halle Wittenberg, Inst Phys, Betty Heimann Str 7, D-06120 Halle, Germany.	jochen.balbach@physik.uni-halle.de			Deutsche Forschungsgemeinschaft [BA 1821/5-2]; Bundesministerium fur Forschung un Bildung (ZIK HALOMem); European Regional Development Fund; State Saxony-Anhalt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Forschung un Bildung (ZIK HALOMem); European Regional Development Fund(European Commission); State Saxony-Anhalt	This work was supported by Deutsche Forschungsgemeinschaft (BA 1821/5-2) (www.dfg.de) (TG and JB); Bundesministerium fur Forschung un Bildung (ZIK HALOMem) (http://www.unternehmen-region.de/de/350.php) (JB); European Regional Development Fund (http://www.foerderdatenbank.de) (JB); and State Saxony-Anhalt (http://www.exzellenznetzwerk-biowissenschaften.uni-halle.de/) (TG and JB).	Bachmann A, 2002, BIOPHYS CHEM, V96, P141, DOI 10.1016/S0301-4622(02)00020-0; Bachmann A, 2005, PROTEIN FOLDING HANDBOOK, P379; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Beitlich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078384; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; CHAZIN WJ, 1989, P NATL ACAD SCI USA, V86, P2195, DOI 10.1073/pnas.86.7.2195; DeVries I, 2011, J MOL BIOL, V408, P163, DOI 10.1016/j.jmb.2011.02.021; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Doyle SM, 2004, J MOL BIOL, V341, P199, DOI 10.1016/j.jmb.2004.06.021; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; Fernandes FM, 2008, BIOPHYS J IN PRESS; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gloss LM, 2001, J MOL BIOL, V312, P1121, DOI 10.1006/jmbi.2001.4974; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; GRANT SK, 1992, BIOCHEMISTRY-US, V31, P9491, DOI 10.1021/bi00154a023; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Jakob RP, 2009, J MOL BIOL, V387, P1017, DOI 10.1016/j.jmb.2009.02.021; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lorenz T, 2008, J MOL BIOL, V381, P443, DOI 10.1016/j.jmb.2008.06.001; Low C, 2008, BIOPHYS J, V95, P4315, DOI 10.1529/biophysj.108.134155; Mallam AL, 2006, J MOL BIOL, V359, P1420, DOI 10.1016/j.jmb.2006.04.032; Martin A, 2003, J MOL BIOL, V331, P1131, DOI 10.1016/S0022-2836(03)00864-7; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011; Mok YK, 1996, NAT STRUCT BIOL, V3, P711, DOI 10.1038/nsb0896-711; Mukaiyama A, 2013, J MOL BIOL, V425, P257, DOI 10.1016/j.jmb.2012.11.004; Najera H, 2003, BIOCHEM J, V370, P785, DOI 10.1042/BJ20021439; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Placek BJ, 2005, J MOL BIOL, V345, P827, DOI 10.1016/j.jmb.2004.11.006; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Rumfeldt JAO, 2008, PROG BIOPHYS MOL BIO, V98, P61, DOI 10.1016/j.pbiomolbio.2008.05.004; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; Schmid F X, 1986, Methods Enzymol, V131, P70; Schmid F, 2005, PROTEIN FOLDING HANDBOOK, P916, DOI 10.1002/9783527619498.ch25; Schmid Franz X., 1992, P197; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Schulenburg C, 2009, BIOCHEMISTRY-US, V48, P8449, DOI 10.1021/bi900596j; STARK GR, 1965, BIOCHEMISTRY-US, V4, P1030, DOI 10.1021/bi00882a008; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128; Topping TB, 2004, J MOL BIOL, V342, P247, DOI 10.1016/j.jmb.2004.07.045; Topping TB, 2004, J MOL BIOL, V335, P1065, DOI 10.1016/j.jmb.2003.11.013; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P2142, DOI 10.1021/bi00174a022; WARREN JR, 1966, J PHYS CHEM-US, V70, P297, DOI 10.1021/j100873a507; Weininger U, 2009, P NATL ACAD SCI USA, V106, P12335, DOI 10.1073/pnas.0902102106; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030; Zeeb M, 2004, J MOL BIOL, V336, P227, DOI 10.1016/j.jmb.2003.12.003	58	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136922	10.1371/journal.pone.0136922	http://dx.doi.org/10.1371/journal.pone.0136922			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368922	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100033
J	Hartley, SW; Coon, SL; Savastano, LE; Mullikin, JC; Fu, C; Klein, DC				Hartley, Stephen W.; Coon, Steven L.; Savastano, Luis E.; Mullikin, James C.; Fu, Cong; Klein, David C.		NISC Comparative Sequencing	Neurotranscriptomics: The Effects of Neonatal Stimulus Deprivation on the Rat Pineal Transcriptome	PLOS ONE			English	Article							SEROTONIN N-ACETYLTRANSFERASE; PARAVENTRICULAR NUCLEUS AREA; CYCLIC-AMP MECHANISM; RNA-SEQ; MELATONIN SYNTHESIS; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; CIRCADIAN EXPRESSION; NEUROPEPTIDE-Y; GLAND	The term neurotranscriptomics is used here to describe genome-wide analysis of neural control of transcriptomes. In this report, next-generation RNA sequencing was using to analyze the effects of neonatal (5-days-of-age) surgical stimulus deprivation on the adult rat pineal transcriptome. In intact animals, more than 3000 coding genes were found to exhibit differential expression (adjusted-p < 0.001) on a night/day basis in the pineal gland (70% of these increased at night, 376 genes changed more than 4-fold in either direction). Of these, more than two thousand genes were not previously known to be differentially expressed on a night/day basis. The night/day changes in expression were almost completely eliminated by neonatal removal (SCGX) or decentralization (DCN) of the superior cervical ganglia (SCG), which innervate the pineal gland. Other than the loss of rhythmic variation, surgical stimulus deprivation had little impact on the abundance of most genes; of particular interest, expression levels of the melatonin-synthesis-related genes Tph1, Gch1, and Asmt displayed little change (less than 35%) following DCN or SCGX. However, strong and consistent changes were observed in the expression of a small number of genes including the gene encoding Serpina1, a secreted protease inhibitor that might influence extracellular architecture. Many of the genes that exhibited night/day differential expression in intact animals also exhibited similar changes following in vitro treatment with norepinephrine, a superior cervical ganglia transmitter, or with an analog of cyclic AMP, a norepinephrine second messenger in this tissue. These findings are of significance in that they establish that the pineal-defining transcriptome is established prior to the neonatal period. Further, this work expands our knowledge of the biological process under neural control in this tissue and underlines the value of RNA sequencing in revealing how neurotransmission influences cell biology.	[Hartley, Stephen W.; Mullikin, James C.] NHGRI, Comparat Genom Anal Unit, Canc Genet & Comparat Genom Branch, NIH, Bethesda, MD 20892 USA; [Coon, Steven L.; Fu, Cong; Klein, David C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Savastano, Luis E.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [NISC Comparative Sequencing] NHGRI, NIH, Intramural Sequencing Ctr, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Klein, DC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Off Sci Director, NIH, Bethesda, MD 20892 USA.	kleind@mail.nih.gov		Klein, David/0000-0002-1792-5806	Intramural Research Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD008958] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER	Intramural Research Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892; and, the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.	ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; BALER R, 1995, J BIOL CHEM, V270, P27319, DOI 10.1074/jbc.270.45.27319; BERG GR, 1972, J NEUROCHEM, V19, P2519, DOI 10.1111/j.1471-4159.1972.tb01311.x; BOWERS CW, 1982, J PHYSIOL-LONDON, V330, P279, DOI 10.1113/jphysiol.1982.sp014341; BOWERS CW, 1984, NEUROSCIENCE, V13, P87, DOI 10.1016/0306-4522(84)90261-6; Bustos DM, 2011, CELL TISSUE RES, V344, P1, DOI 10.1007/s00441-010-1094-1; Coon SL, 2012, P NATL ACAD SCI USA, V109, P13319, DOI 10.1073/pnas.1207748109; DeMeo DL, 2004, THORAX, V59, P259, DOI 10.1136/thx.2003.006502; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Savastano LE, 2010, J NEUROSCI METH, V192, P22, DOI 10.1016/j.jneumeth.2010.07.007; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fukuhara C, 2008, NEUROSCI RES, V60, P192, DOI 10.1016/j.neures.2007.10.011; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hartley SW, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0670-5; Hernandez SC, 2004, MOL PHARMACOL, V66, P978, DOI 10.1124/mol.104.002345; HO AK, 1990, PROG CLIN BIOL RES, V342, P139; Ho AK, 2010, J NEUROCHEM, V112, P321, DOI 10.1111/j.1471-4159.2009.06457.x; Humphries A, 2004, J NEUROCHEM, V91, P946, DOI 10.1111/j.1471-4159.2004.02777.x; Humphries A, 2002, J NEUROENDOCRINOL, V14, P101, DOI 10.1046/j.0007-1331.2001.00738.x; Karolczak M, 2005, ENDOCRINE, V27, P89, DOI 10.1385/ENDO:27:2:089; Kim JS, 2010, MOL CELL ENDOCRINOL, V314, P128, DOI 10.1016/j.mce.2009.05.013; Klein DC, 2010, MOL CELL ENDOCRINOL, V314, P170, DOI 10.1016/j.mce.2009.07.010; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; KLEIN DC, 1971, P NATL ACAD SCI USA, V68, P3107, DOI 10.1073/pnas.68.12.3107; KLEIN DC, 1985, CIBA F SYMP, V117, P38; KLEIN DC, 1983, BRAIN RES BULL, V10, P647, DOI 10.1016/0361-9230(83)90033-3; KLEIN DC, 1979, BRAIN RES, V174, P245, DOI 10.1016/0006-8993(79)90848-5; KLEIN DC, 1983, P NATL ACAD SCI-BIOL, V80, P599, DOI 10.1073/pnas.80.2.599; KLEIN DC, 1991, SUPRACHIASMATIC NUCL, V16; LINGAPPA JR, 1987, NEUROSCIENCE, V21, P893, DOI 10.1016/0306-4522(87)90045-5; Maronde E, 1999, ADV EXP MED BIOL, V460, P109; Maronde E, 1997, BIOL CELL, V89, P505, DOI 10.1016/S0248-4900(98)80006-3; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; Mikkelsen JD, 1999, ADV EXP MED BIOL, V460, P95; Miranda E, 2006, CELL MOL LIFE SCI, V63, P709, DOI 10.1007/s00018-005-5077-4; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; MOORE RY, 1974, BRAIN RES, V71, P17, DOI 10.1016/0006-8993(74)90188-7; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; PARFITT A, 1976, NEUROPHARMACOLOGY, V15, P353, DOI 10.1016/0028-3908(76)90083-6; PARFITT AG, 1976, ENDOCRINOLOGY, V99, P840, DOI 10.1210/endo-99-3-840; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; ROSEBOOM PH, 1995, MOL PHARMACOL, V47, P439; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; SUGDEN D, 1985, NATURE, V314, P359, DOI 10.1038/314359a0; SUGDEN LA, 1987, J BIOL CHEM, V262, P741; TAMOTSU S, 1995, CELL TISSUE RES, V282, P219, DOI 10.1007/s004410050474; VACAS MI, 1987, CELL MOL NEUROBIOL, V7, P309, DOI 10.1007/BF00711307; VANECEK J, 1985, ENDOCRINOLOGY, V116, P2167, DOI 10.1210/endo-116-6-2167; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; YANOVSKI J, 1987, BRAIN RES BULL, V19, P129, DOI 10.1016/0361-9230(87)90175-4; ZATZ M, 1985, J NEUROCHEM, V45, P95, DOI 10.1111/j.1471-4159.1985.tb05479.x	56	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137548	10.1371/journal.pone.0137548	http://dx.doi.org/10.1371/journal.pone.0137548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367423	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100082
J	Moreau, CS; Hugall, AF; McDonald, KR; Jamieson, BGM; Moritz, C				Moreau, Corrie S.; Hugall, Andrew F.; McDonald, Keith R.; Jamieson, Barrie G. M.; Moritz, Craig			An Ancient Divide in a Contiguous Rainforest: Endemic Earthworms in the Australian Wet Tropics	PLOS ONE			English	Article							COMPARATIVE PHYLOGEOGRAPHY; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENY; GEOGRAPHIC RANGE; CLIMATE-CHANGE; DIVERSITY; EVOLUTION; SPECIATION; DYNAMICS; DIVERSIFICATION	Understanding the factors that shape current species diversity is a fundamental aim of ecology and evolutionary biology. The Australian Wet Tropics (AWT) are a system in which much is known about how the rainforests and the rainforest-dependent organisms reacted to late Pleistocene climate changes, but less is known about how events deeper in time shaped speciation and extinction in this highly endemic biota. We estimate the phylogeny of a species-rich endemic genus of earthworms (Terrisswalkerius) from the region. Using DEC and DIVA historical biogeography methods we find a strong signal of vicariance among known biogeographical sub-regions across the whole phylogeny, congruent with the phylogeography of less diverse vertebrate groups. Absolute dating estimates, in conjunction with relative ages of major biogeographic disjunctions across Australia, indicate that diversification in Terrisswalkerius dates back before the mid-Miocene shift towards aridification, into the Paleogene era of isolation of mesothermal Gondwanan Australia. For the Queensland endemic Terrisswalkerius earthworms, the AWT have acted as both a museum of biological diversity and as the setting for continuing geographically structured diversification. These results suggest that past events affecting organismal diversification can be concordant across phylogeographic to phylogenetic levels and emphasize the value of multi-scale analysis, from intra-to interspecies, for understanding the broad-scale processes that have shaped geographic diversity.	[Moreau, Corrie S.] Field Museum Nat Hist, Dept Sci & Educ, Chicago, IL 60605 USA; [Hugall, Andrew F.] Museum Victoria, Melbourne, Vic 3001, Australia; [McDonald, Keith R.] Queensland Parks & Wildlife Serv, Atherton, Qld 4883, Australia; [Jamieson, Barrie G. M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Moritz, Craig] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Moritz, Craig] Australian Natl Univ, Ctr Biodivers Anal, Canberra, ACT 2601, Australia	Field Museum of Natural History (Chicago); Museum Victoria; University of Queensland; Australian National University; Australian National University	Moreau, CS (corresponding author), Field Museum Nat Hist, Dept Sci & Educ, 1400 South Lake Shore Dr, Chicago, IL 60605 USA.	cmoreau@fieldmuseum.org		Moreau, Corrie/0000-0003-1139-5792	Australian Research Council; Department of Science and Education; Field Museum of Natural History; Miller Institute for Basic Research in Science, University of California Berkeley	Australian Research Council(Australian Research Council); Department of Science and Education; Field Museum of Natural History; Miller Institute for Basic Research in Science, University of California Berkeley(University of California System)	B.G.M.J. thanks the Australian Research Council for grants supporting collection of Wet Tropics earthworms and K.R.M. for making this possible. C.S.M. would like to thank the Department of Science and Education, Field Museum of Natural History and the Miller Institute for Basic Research in Science, University of California Berkeley for support during the analyzing and writing of this research.	[Anonymous], 1878, TROPICAL NATURE OTHE; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Baldwin SL, 2012, ANNU REV EARTH PL SC, V40, P495, DOI 10.1146/annurev-earth-040809-152540; Beaulieu JM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-80; Bell KL, 2007, MOL ECOL, V16, P4984, DOI 10.1111/j.1365-294X.2007.03533.x; Bell KL, 2004, MOL PHYLOGENET EVOL, V31, P741, DOI 10.1016/j.ympev.2003.09.010; Bell RC, 2012, P ROY SOC B-BIOL SCI, V279, P991, DOI 10.1098/rspb.2011.1229; Bell RC, 2010, MOL ECOL, V19, P2531, DOI 10.1111/j.1365-294X.2010.04676.x; BERMINGHAM E, 2005, TROPICAL RAINFORESTS; BOWLER JM, 1982, EVOLUTION FLORA FAUN, P35; Buckley TR, 2011, MOL PHYLOGENET EVOL, V58, P85, DOI 10.1016/j.ympev.2010.09.024; Bush MB, 2004, J QUATERNARY SCI, V19, P677, DOI 10.1002/jqs.883; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Chacon J, 2014, J BIOGEOGR, V41, P1414, DOI 10.1111/jbi.12301; Chang CH, 2008, MOL PHYLOGENET EVOL, V49, P958, DOI 10.1016/j.ympev.2008.08.025; Dobzhansky T., 1941, GENETICS ORIGIN SPEC; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyne Geoffrey R., 1994, Memoirs of the Queensland Museum, V36, P59; ENDLER JA, 1982, AM ZOOL, V22, P441; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fernandez R, 2012, MOL PHYLOGENET EVOL, V64, P368, DOI 10.1016/j.ympev.2012.04.011; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Greenwood D. R., 2005, Tropical rainforests: past, present and future, P336; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hilbert DW, 2007, PALAEOGEOGR PALAEOCL, V251, P104, DOI 10.1016/j.palaeo.2007.02.020; Hocknull SA, 2007, EARTH PLANET SC LETT, V264, P317, DOI 10.1016/j.epsl.2007.10.004; Hoskin CJ, 2003, AUST J ZOOL, V51, P153, DOI 10.1071/ZO02072; Hoskin CJ, 2004, AUST J ZOOL, V52, P237, DOI 10.1071/ZO03056; Hoskin CJ, 2011, AM NAT, V178, P561, DOI 10.1086/662164; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall A, 2003, SM S COMP E, P270; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; James SW, 2012, INVERTEBR SYST, V26, P213, DOI 10.1071/IS11012; Jamieson B. G. M., 1994, Memoirs of the Queensland Museum, V37, P157; Jamieson B. G. M., 1981, ECOLOGICAL BIOGEOGRA, P885; Jamieson Barrie G.M., 2006, P235; Jamieson Barrie G. M., 2013, Memoirs of the Queensland Museum, V58, P15; Jamieson Barrie G. M., 2002, Zoosystema, V24, P707; Jamieson BGM, 2000, NATIVE EARTHWORMS AU; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kershaw A. P., 2005, Tropical rainforests: past, present and future, P374; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Loader SP, 2007, BIOL LETTERS, V3, P505, DOI 10.1098/rsbl.2007.0266; MAYR E, 1986, EVOLUTION, V40, P55, DOI 10.1111/j.1558-5646.1986.tb05717.x; McGowran B, 2004, AUST J EARTH SCI, V51, P459, DOI 10.1111/j.1400-0952.2004.01078.x; Minamiya Y, 2009, EUR J SOIL BIOL, V45, P423, DOI 10.1016/j.ejsobi.2009.06.004; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Moritz C, 2005, CONSERV BIOL SER, V8, P243; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Nix HA, 1991, RAINFOREST ANIMALS A, P11; Novo M, 2011, MOL PHYLOGENET EVOL, V61, P125, DOI 10.1016/j.ympev.2011.05.018; Perez-Losada M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028153; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Ponniah M, 2004, EVOLUTION, V58, P1073; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ricklefs Robert E., 2005, P16; Ricklefs Robert E., 1993, P215; Rossetto M, 2007, AUST J BOT, V55, P416, DOI 10.1071/BT06195; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Santos JC, 2009, PLOS BIOL, V7, P448, DOI 10.1371/journal.pbio.1000056; Schneider CJ, 1998, MOL ECOL, V7, P487, DOI 10.1046/j.1365-294x.1998.00334.x; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Sharma A, 2011, ZOOL SCI, V28, P25, DOI 10.2108/zsj.28.25; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shull HC, 2005, MOL PHYLOGENET EVOL, V37, P249, DOI 10.1016/j.ympev.2005.04.034; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Sturzenbaum SR, 2009, P ROY SOC B-BIOL SCI, V276, P789, DOI 10.1098/rspb.2008.1510; Swofford DL, 2001, PAUP STAR VER 4 0B10; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; Vanzolini P. E, 1970, Archos Zool. S. Paulo, V19, P1; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Voelker G, 2010, GLOBAL ECOL BIOGEOGR, V19, P111, DOI 10.1111/j.1466-8238.2009.00500.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Williams S. E., 1996, Pacific Conservation Biology, V2, P327; Williams SE, 1997, P ROY SOC B-BIOL SCI, V264, P709, DOI 10.1098/rspb.1997.0101; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zwickl DJ., 2006, THESIS	85	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136943	10.1371/journal.pone.0136943	http://dx.doi.org/10.1371/journal.pone.0136943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366862	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100036
J	Zhang, YJ; Zhang, SY; Yang, J; Yan, Y; Fu, XP; Lu, SB				Zhang, Yan-Jie; Zhang, Su-Yan; Yang, Jie; Yan, Yue; Fu, Xiang-ping; Lu, Shun-Bao			Patterns and Drivers of Soil Respiration under Long-Term Citrus reticulate in Southern China	PLOS ONE			English	Article							MICROBIAL BIOMASS; CARBON-CYCLE; LAND; ORCHARD; AREA; DECOMPOSITION; TERRESTRIAL; FERTILITY; PROVINCE; FORESTS	Soil respiration (Rs) is a major source of carbon emission in terrestrial ecosystems. Despite the fact that the influence of land use practice on Rs has been widely studied, the patterns and drivers on Rs of Citrus reticulata cultivation, a worldwide land use practice are unclear. In this current study, we investigated the influence of long-term cultivation of Citrus reticulata (CO) and of CO intercropped with soybean (CB) on soil nutrients, water availability, and Rs in southern China. Results indicated that after 21 years of cultivation, CO and CB significantly increased total soil carbon (TC), total soil nitrogen (TN), and soil organic matter (OM) at 0-20 cm and 20-40 cm, both at upslope and downslope compared with bare soil (CK). However, soil moisture (SM), dissolved organic carbon (DOC), and microbial biomass carbon (MBC) decreased under CB. In addition, no significant variation was found in soil pH between CK, CO, and CB. Across incubation time (56 days), Rs decreased exponentially with incubation time and CB showed the highest Rs rate irrespective of soil depth or topography. Linear regression further showed TC and TN as the two major factors influencing Rs upslope, while DOC was the dominant factor in regulating Rs downslope. These findings demonstrated that long-term cultivation of citrus significantly changed soil nutrients, water availability, and Rs rate.	[Zhang, Yan-Jie; Zhang, Su-Yan; Yan, Yue; Lu, Shun-Bao] Jiangxi Normal Univ, Coll Life Sci, Key Lab Protect & Utilizat Subtrop Plant Resource, Minist Educ,Key Lab Poyang Lake Wetland & Watersh, Nanchang 330022, Peoples R China; [Yang, Jie] Jiangxi Res Inst Soil & Water Conservat, Nanchang 330029, Peoples R China; [Fu, Xiang-ping] Jiangxi Agr Univ, Coll Foreign Languages, Nanchang 330022, Peoples R China	Jiangxi Normal University; Jiangxi Agricultural University	Lu, SB (corresponding author), Jiangxi Normal Univ, Coll Life Sci, Key Lab Protect & Utilizat Subtrop Plant Resource, Minist Educ,Key Lab Poyang Lake Wetland & Watersh, Nanchang 330022, Peoples R China.	luxunbao8012@126.com			National Natural Science Foundation of China [31360136]; China Postdoctoral Science Foundation [2013M541080, 2014T70139]; open foundation of Jiangxi Province Key Lab of Protection and Utilization of Subtropical Plant Resources, Key Laboratory of Poyang Lake Wetland and Watershed Research, Ministry of Education, Jiangxi Normal University [PK2014002]; Jiangxi Research Institute for Soil and Water Conservation [201105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); open foundation of Jiangxi Province Key Lab of Protection and Utilization of Subtropical Plant Resources, Key Laboratory of Poyang Lake Wetland and Watershed Research, Ministry of Education, Jiangxi Normal University; Jiangxi Research Institute for Soil and Water Conservation	This work was funded by The work has been funded by National Natural Science Foundation of China (31360136), China Postdoctoral Science Foundation (2013M541080 and 2014T70139), open foundation of Jiangxi Province Key Lab of Protection and Utilization of Subtropical Plant Resources, Key Laboratory of Poyang Lake Wetland and Watershed Research, Ministry of Education (PK2014002), Jiangxi Normal University and Jiangxi Research Institute for Soil and Water Conservation (201105).	Allen AS, 2004, SOIL BIOL BIOCHEM, V36, P581, DOI 10.1016/j.soilbio.2003.12.002; China NBoSo, 2006, STAT CHIN AGR 1949 2; China Soil Census Office, 1998, CHIN SOIL; Ekblad A, 2002, PLANT SOIL, V242, P115, DOI 10.1023/A:1019698108838; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; [韩庆忠 HAN Qingzhong], 2008, [土壤, Soils], V40, P602; Iqbal J, 2010, AGR ECOSYST ENVIRON, V137, P294, DOI 10.1016/j.agee.2010.02.015; Li YL, 2008, PEDOSPHERE, V18, P273, DOI 10.1016/S1002-0160(08)60017-X; [林清山 Lin Qingshan], 2010, [生态学报, Acta Ecologica Sinica], V30, P309; Liu H, 2008, AGR ECOSYST ENVIRON, V124, P125, DOI 10.1016/j.agee.2007.09.002; Loecke TD, 2009, SOIL BIOL BIOCHEM, V41, P228, DOI 10.1016/j.soilbio.2008.10.017; Lu SB, 2012, GEODERMA, V170, P136, DOI 10.1016/j.geoderma.2011.11.023; Luo XX, 2015, CROP RES, V29, P284; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Postgate J., 1998, NITROGEN FIXATION; Raizada A, 2013, TROP ECOL, V54, P251; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Sheng H, 2010, GLOBAL CHANGE BIOL, V16, P1107, DOI 10.1111/j.1365-2486.2009.01988.x; Soil Survey Staff, 1975, HANDBOOK; Srivastava AK, 2002, J SUSTAIN AGR, V19, P5, DOI 10.1300/J064v19n03_03; Wang Chao, 2012, Yingyong Shengtai Xuebao, V23, P1469; Wu DM, 2011, PEDOSPHERE, V21, P782, DOI 10.1016/S1002-0160(11)60182-3; Wu Zhi-dan, 2010, Journal of Ecology and Rural Environment, V26, P231; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Yang Jie, 2012, Yingyong Shengtai Xuebao, V23, P468; ZHANG Ting, 2013, J JIANGXI NORMAL U N, V37, P93	26	0	0	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137574	10.1371/journal.pone.0137574	http://dx.doi.org/10.1371/journal.pone.0137574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368561	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100087
J	Owen, CD; Lukacik, P; Potter, JA; Sleator, O; Taylor, GL; Walsh, MA				Owen, C. David; Lukacik, Petra; Potter, Jane A.; Sleator, Olivia; Taylor, Garry L.; Walsh, Martin A.			Streptococcus pneumoniae NanC STRUCTURAL INSIGHTS INTO THE SPECIFICITY AND MECHANISM OF A SIALIDASE THAT PRODUCES A SIALIDASE INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; CRYSTAL-STRUCTURE; INFLUENZA-VIRUS; TRANS-SIALIDASE; NEURAMINIDASE; BACTERIAL; ACID; COLONIZATION; OSELTAMIVIR; INHIBITION	Streptococcus pneumoniae is an important human pathogen that causes a range of disease states. Sialidases are important bacterial virulence factors. There are three pneumococcal sialidases: NanA, NanB, and NanC. NanC is an unusual sialidase in that its primary reaction product is 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (Neu5Ac2en, also known as DANA), a nonspecific hydrolytic sialidase inhibitor. The production of Neu5Ac2en from alpha 2-3-linked sialosides by the catalytic domain is confirmed within a crystal structure. A covalent complex with 3-fluoro-beta-N-acetylneuraminic acid is also presented, suggesting a common mechanism with other sialidases up to the final step of product formation. A conformation change in an active site hydrophobic loop on ligand binding constricts the entrance to the active site. In addition, the distance between the catalytic acid/base (Asp-315) and the ligand anomeric carbon is unusually short. These features facilitate a novel sialidase reaction in which the final step of product formation is direct abstraction of the C3 proton by the active site aspartic acid, forming Neu5Ac2en. NanC also possesses a carbohydrate-binding module, which is shown to bind alpha 2-3- and alpha 2-6-linked sialosides, as well as N-acetylneuraminic acid, which is captured in the crystal structure following hydration of Neu5Ac2en by NanC. Overall, the pneumococcal sialidases show remarkable mechanistic diversity while maintaining a common structural scaffold.	[Owen, C. David; Potter, Jane A.; Taylor, Garry L.] Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland; [Lukacik, Petra; Walsh, Martin A.] Harwell Sci & Innovat Campus, Diamond Light Source, Didcot OX11 0FA, Oxon, England; [Lukacik, Petra] Harwell Sci & Innovat Campus, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Sleator, Olivia; Walsh, Martin A.] European Synchrotron Radiat Facil, Med Res Council France, F-38043 Grenoble, France	University of St Andrews; Diamond Light Source; European Synchrotron Radiation Facility (ESRF)	Taylor, GL (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	glt2@st-andrews.ac.uk; martin.walsh@diamond.ac.uk	Lukacik, Petra/AAY-3775-2021; Walsh, Martin A/I-1566-2013	Lukacik, Petra/0000-0002-3179-7273; Walsh, Martin A/0000-0001-5683-1151; Taylor, Garry/0000-0001-9486-566X; Owen, David/0000-0001-5774-8202	Biotechnology and Biological Sciences Research Council (UK); Medical Research Council (UK); Biotechnology and Biological Sciences Research Council [1099850] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (UK) and the Medical Research Council (UK). The authors declare that they have no conflicts of interest with the contents of this article.	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Brittan JL, 2012, MOL ORAL MICROBIOL, V27, P270, DOI 10.1111/j.2041-1014.2012.00658.x; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Connaris H, 2009, J BIOL CHEM, V284, P7339, DOI 10.1074/jbc.M807398200; Cornick JE, 2012, MICROBES INFECT, V14, P573, DOI 10.1016/j.micinf.2012.01.012; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gut H, 2008, FEBS LETT, V582, P3348, DOI 10.1016/j.febslet.2008.08.026; Gut H, 2011, J MOL BIOL, V409, P496, DOI 10.1016/j.jmb.2011.04.016; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Hayre JK, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-19; HOLZER CT, 1993, GLYCOCONJUGATE J, V10, P40, DOI 10.1007/BF00731185; Hsiao YS, 2009, BIOCHEM BIOPH RES CO, V380, P467, DOI 10.1016/j.bbrc.2009.01.108; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Janapatla RP, 2013, CLIN MICROBIOL INFEC, V19, P480, DOI 10.1111/j.1469-0691.2012.03894.x; Jefferson T, 2010, COCHRANE DB SYST REV; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Long JP, 2004, INFECT IMMUN, V72, P4309, DOI 10.1128/IAI.72.7.4309-4313.2004; Luo Y, 1998, STRUCTURE, V6, P521, DOI 10.1016/S0969-2126(98)00053-7; Magesh S, 2008, BIOORG MED CHEM LETT, V18, P532, DOI 10.1016/j.bmcl.2007.11.084; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullers JA, 2004, J INFECT DIS, V190, P519, DOI 10.1086/421525; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Muchmore EA, 1998, AM J PHYS ANTHROPOL, V107, P187, DOI 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.3.CO;2-M; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; Olarte L, 2015, CLIN INFECT DIS, V61, P767, DOI 10.1093/cid/civ368; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park KH, 2013, BBA-PROTEINS PROTEOM, V1834, P1510, DOI 10.1016/j.bbapap.2013.04.028; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Parker RB, 2012, ACS CHEM BIOL, V7, P1509, DOI 10.1021/cb300241v; Pettigrew MM, 2006, INFECT IMMUN, V74, P3360, DOI 10.1128/IAI.01442-05; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Rennie Robert P, 2012, Handb Exp Pharmacol, P45, DOI 10.1007/978-3-642-28951-4_4; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Seki M, 2004, CLIN EXP IMMUNOL, V137, P35, DOI 10.1111/j.1365-2249.2004.02481.x; Smutova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106320; Stierand K, 2007, CHEMMEDCHEM, V2, P853, DOI 10.1002/cmdc.200700010; Tailford LE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8624; Tanaka A, 2015, ANTIVIR THER, V20, P11, DOI 10.3851/IMP2744; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Uchiyama S, 2009, J EXP MED, V206, P1845, DOI 10.1084/jem.20090386; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Walther E, 2015, INT J MED MICROBIOL, V305, P289, DOI 10.1016/j.ijmm.2014.12.004; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wolfe S, 2015, EPIDEMIOLOGY PREVENT; Word JM, 2000, PROTEIN SCI, V9, P2251, DOI 10.1110/ps.9.11.2251; Xu GG, 2008, ACTA CRYSTALLOGR F, V64, P772, DOI 10.1107/S1744309108024044; Xu GG, 2011, J AM CHEM SOC, V133, P1718, DOI 10.1021/ja110733q; Xu GG, 2008, J MOL BIOL, V384, P436, DOI 10.1016/j.jmb.2008.09.032	77	30	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27736	27748		10.1074/jbc.M115.673632	http://dx.doi.org/10.1074/jbc.M115.673632			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26370075	Green Published, hybrid			2022-12-26	WOS:000365757500026
J	Pusparini, W; Sievert, PR; Fuller, TK; Randhir, TO; Andayani, N				Pusparini, Wulan; Sievert, Paul R.; Fuller, Todd K.; Randhir, Timothy O.; Andayani, Noviar			Rhinos in the Parks: An Island-Wide Survey of the Last Wild Population of the Sumatran Rhinoceros	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; DICERORHINUS-SUMATRENSIS; EXTINCTION	In the 200 years since the Sumatran rhinoceros was first scientifically described (Fisher 1814), the range of the species has contracted from a broad region in Southeast Asia to three areas on the island of Sumatra and one in Kalimantan, Indonesia. Assessing population and spatial distribution of this very rare species is challenging because of their elusiveness and very low population number. Using an occupancy model with spatial dependency, we assessed the fraction of the total landscape occupied by Sumatran rhinos over a 30,345-km(2) survey area and the effects of covariates in the areas where they are known to occur. In the Leuser Landscape (surveyed in 2007), the model averaging result of conditional occupancy estimate was (psi) over cap (SE[(psi) over cap]) = 0.151(0.109) or 2,371.47 km(2), and the model averaging result of replicated level detection probability (p) over cap (SE[(p) over cap]) = 0.252(0.267); in Way Kambas National Park-2008: (psi) over cap (SE[(psi) over cap]) = 0.468(0.165) or 634.18 km(2), and (p) over cap (SE[(p) over cap]) = 0.138(0.571); and in Bukit Barisan Selatan National Park-2010. (psi) over cap (SE[(psi) over cap]) = 0.322(0.049) or 819.67 km(2), and (p) over cap (SE[(p) over cap]) = 0.365(0.42). In the Leuser Landscape, rhino occurrence was positively associated with primary dry land forest and rivers, and negatively associated with the presence of a road. In Way Kambas, occurrence was negatively associated with the presence of a road. In Bukit Barisan Selatan, occurrence was negatively associated with presence of primary dry-land forest and rivers. Using the probabilities of site occupancy, we developed spatially explicit maps that can be used to outline intensive protection zones for in-situ conservation efforts, and provide a detailed assessment of conserving Sumatran rhinos in the wild. We summarize our core recommendation in four points: consolidate small population, strong protection, determine the percentage of breeding females, and recognize the cost of doing nothing. To reduce the probability of poaching, here we present only the randomized location of site level occupancy in our result while retaining the overall estimation of occupancy for a given area.	[Pusparini, Wulan; Sievert, Paul R.; Fuller, Todd K.; Randhir, Timothy O.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Pusparini, Wulan; Andayani, Noviar] Wildlife Conservat Soc Indonesia Program, Bogor, Indonesia	University of Massachusetts System; University of Massachusetts Amherst; Wildlife Conservation Society - Indonesia	Pusparini, W (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	wpusparini@wcs.org	Randhir, Timothy O/A-7145-2009	Randhir, Timothy O/0000-0002-1084-9716; Pusparini, Wulan/0000-0001-9909-0920; Andayani, Noviar/0000-0002-1888-193X	Rhinoceros-Tiger Conservation Fund; Asian Elephant Conservation Fund of the USFWS	Rhinoceros-Tiger Conservation Fund; Asian Elephant Conservation Fund of the USFWS	The funding for field work was provided by the Rhinoceros-Tiger Conservation Fund and the Asian Elephant Conservation Fund of the USFWS.	Ahmad A.H., 2013, J INDONES NAT HIST, V1, P11; Andriansyah, 2013, J ZOO WILDLIFE MED, V44, P280, DOI 10.1638/2012-0046R2.1; [Anonymous], 1989, ANIMAL KINGDOM, V92, P2; Borner MA, 1979, THESIS U BASEL; BPS (Badan Pusat Statistik), 2013, TRENDS SEL SOC IND I; Brook SM, 2014, BIOL CONSERV, V174, P21, DOI 10.1016/j.biocon.2014.03.014; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clements R, 2010, BIODIVERS CONSERV, V19, P1115, DOI 10.1007/s10531-009-9775-3; Ditjen PHKA Kemenhut RI (Direktorat Jenderal Perlindungan Hutan dan Konservasi Alam Kementrian Kehutanan Republik Indonesia), 2012, TAM NAS BUK BAR SEL; Doherty JG, 1992, ZOO VIEW, V26, P24; Evans JS, TOOLBOX SURFAC UNPUB; Foose T. J., 1997, ASIAN RHINOS STATUS; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Hance J, 2015, MONGABAY; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines J. E., 2006, PRESENCE4 SOFTWARE E; HUTCHINS M, 1995, CONSERV BIOL, V9, P977, DOI 10.1046/j.1523-1739.1995.9050977_1.x; Hutchins Michael, 1995, International Zoo Yearbook, V34, P117, DOI 10.1111/j.1748-1090.1995.tb00669.x; Karanth KU, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P241; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M., 2010, INTRO WINBUGS ECOLOG; Laumonier Y., 1997, GEOBOTANY, P22; Lessee J, 1995, REALLY RHINOS, V9, P1; MacKenzie D.I., 2004, SAMPLING RARE ELUSIV; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, AUST NZ J STAT, V47, P65, DOI 10.1111/j.1467-842X.2005.00372.x; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; McDonald-Madden E, 2008, CONSERV BIOL, V22, P656, DOI 10.1111/j.1523-1739.2008.00918.x; McGarigal K, 2009, LANDSCAPE ECOL, V24, P433, DOI 10.1007/s10980-009-9327-y; Meijaard E, 2014, BIOL CONSERV, V175, P21, DOI 10.1016/j.biocon.2014.03.021; Merz A, 1997, REF J, V11, P4; Miller PS, 2015, POPULATION VIABILITY, P65; MoF RI (Ministry of Forestry Republic of Indonesia), 2007, STRAT ACT PLAN CONS, P1; Nicholls H, 2012, NATURE, V485, P566, DOI 10.1038/485566a; O'Brien JK, 2000, J REPROD FERTIL, V118, P263, DOI 10.1530/reprod/118.2.263; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Payne J, 2012, COMMENT SEX SINGLE R; Pusparini W, 2010, THESIS U INDONESIA; Pusparini W, 2013, PACHYDERM, P59; RABINOWITZ A, 1995, CONSERV BIOL, V9, P482, DOI 10.1046/j.1523-1739.1995.09030482.x; Reilly J, 1997, ORYX, V31, P143, DOI 10.1046/j.1365-3008.1997.d01-8.x; Roth TL, 2004, ZOO BIOL, V23, P219, DOI 10.1002/zoo.10131; Roth TL, 2003, BIOL REPROD, V68, P95; ROTH TL, 2002, P AZA ANN C, P63; Royle J. A., 2008, HIERARCHICAL MODELIN; Stauffer HB, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P357; Stoops MA, 2011, J ZOO WILDLIFE MED, V42, P723, DOI 10.1638/2010-0186.1; Strategic Asia, 2012, IMPL IND EC MAST PLA; Talukdar BK, 2010, P AS RHIN SPEC GROUP, P30; van Strien N. J., 1986, SUMATRAN RHINOCEROS; vanStrien N. J., 2008, IUCN RED LIST THREAT; WCS-IP, 2012, ACC CONS MON SUM TIG, P31; Wibisono HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025931; Wibisono HT, 2008, SURVEY PROTOCOL SUMA; Wibisono HT, 2012, MANAGING TIGER CONSE, P14; Wich S. A., 2011, ORANGUTANS EC SUSTAI; Zafir AWA, 2011, ORYX, V45, P225, DOI 10.1017/S0030605310000864	63	7	7	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136643	10.1371/journal.pone.0136643	http://dx.doi.org/10.1371/journal.pone.0136643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376453	gold, Green Published			2022-12-26	WOS:000361610200019
J	Stewart, L; MacLean, EL; Ivy, D; Woods, V; Cohen, E; Rodriguez, K; McIntyre, M; Mukherjee, S; Call, J; Kaminski, J; Miklosi, A; Wrangham, RW; Hare, B				Stewart, Laughlin; MacLean, Evan L.; Ivy, David; Woods, Vanessa; Cohen, Eliot; Rodriguez, Kerri; McIntyre, Matthew; Mukherjee, Sayan; Call, Josep; Kaminski, Juliane; Miklosi, Adam; Wrangham, Richard W.; Hare, Brian			Citizen Science as a New Tool in Dog Cognition Research	PLOS ONE			English	Article							CANIS-FAMILIARIS; DOMESTIC DOG; SOCIAL DOG; WOLVES; TRAITS; COMPREHENSION; VALIDATION; HYPOTHESIS; BEHAVIOR; STATE	Family dogs and dog owners offer a potentially powerful way to conduct citizen science to answer questions about animal behavior that are difficult to answer with more conventional approaches. Here we evaluate the quality of the first data on dog cognition collected by citizen scientists using the Dognition. com website. We conducted analyses to understand if data generated by over 500 citizen scientists replicates internally and in comparison to previously published findings. Half of participants participated for free while the other half paid for access. The website provided each participant a temperament questionnaire and instructions on how to conduct a series of ten cognitive tests. Participation required internet access, a dog and some common household items. Participants could record their responses on any PC, tablet or smartphone from anywhere in the world and data were retained on servers. Results from citizen scientists and their dogs replicated a number of previously described phenomena from conventional lab-based research. There was little evidence that citizen scientists manipulated their results. To illustrate the potential uses of relatively large samples of citizen science data, we then used factor analysis to examine individual differences across the cognitive tasks. The data were best explained by multiple factors in support of the hypothesis that nonhumans, including dogs, can evolve multiple cognitive domains that vary independently. This analysis suggests that in the future, citizen scientists will generate useful datasets that test hypotheses and answer questions as a complement to conventional laboratory techniques used to study dog psychology.	[Stewart, Laughlin; Ivy, David; Woods, Vanessa; Cohen, Eliot; Hare, Brian] Canines Inc, Canine Res Dept, Durham, NC 27701 USA; [MacLean, Evan L.; Woods, Vanessa; Rodriguez, Kerri; Hare, Brian] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [MacLean, Evan L.] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [McIntyre, Matthew] 23 & Me Inc, Dept Stat, Mountain View, CA USA; [Mukherjee, Sayan] Duke Univ, Dept Stat Sci, Durham, NC USA; [Mukherjee, Sayan] Duke Univ, Dept Comp Sci, Durham, NC USA; [Mukherjee, Sayan] Duke Univ, Dept Math, Durham, NC USA; [Call, Josep] Univ St Andrews, Dept Psychol & Neurosci, St Andrews, Fife, Scotland; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Psychol, Leipzig, Germany; [Kaminski, Juliane] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England; [Miklosi, Adam] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary; [Wrangham, Richard W.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Hare, Brian] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; University of Arizona; Duke University; Duke University; Duke University; University of St Andrews; Max Planck Society; University of Portsmouth; MTA-ELTE Comparative Ethology Research Group; Harvard University; Duke University	Hare, B (corresponding author), Canines Inc, Canine Res Dept, Durham, NC 27701 USA.	b.hare@duke.edu	Rodriguez, Kerri E/AAF-6893-2020; Miklosi, Adam/N-5147-2017	Rodriguez, Kerri E/0000-0002-3395-4818; Call Balaguer, Josep/0000-0002-8597-8336; MacLean, Evan/0000-0001-7595-662X; Kaminski, Juliane/0000-0002-3437-3484; Miklosi, Adam/0000-0003-4831-8985	Hungarian Academy of Sciences [MTA 01 031]; 23 and me, Inc.	Hungarian Academy of Sciences(Hungarian Academy of Sciences); 23 and me, Inc.	The work of A.M. was supported by the Hungarian Academy of Sciences (MTA 01 031). Co-authors Laughlin Stewart, David Ivy, Vanessa Woods, and Eliot Cohen are employed by Canines, Inc. Co-author Matthew McIntyre is employed by 23 and me, Inc. Canines, Inc., and 23 and me, Inc., provided support in the form of salaries for authors LS, DI, VW, EC and MM respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aust U, 2008, ANIM COGN, V11, P587, DOI 10.1007/s10071-008-0149-0; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Burghardt GM, 2012, ETHOLOGY, V118, P511, DOI 10.1111/j.1439-0310.2012.02040.x; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Cooper CB, 2007, ECOL SOC, V12; Cooper JJ, 2003, APPL ANIM BEHAV SCI, V81, P229, DOI 10.1016/S0168-1591(02)00284-8; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Erdohegyi A, 2007, ANIM BEHAV, V74, P725, DOI 10.1016/j.anbehav.2007.03.004; Gacsi M, 2009, ANIM COGN, V12, P471, DOI 10.1007/s10071-008-0208-6; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2002, COGNITIVE ANIMAL, P363; Hare B., 2013, GENIUS DOGS DISCOVER; Hare B, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2009.06.031; Hauser MD, 2011, BEHAV PROCESS, V86, P7, DOI 10.1016/j.beproc.2010.07.011; Hecht J, 2015, BEHAV PROCESS, V110, P125, DOI 10.1016/j.beproc.2014.10.014; Hegedus D, 2013, BEHAVIOUR, V150, P427, DOI 10.1163/1568539X-00003060; Herrmann E, 2009, PSYCHOL SCI; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Joly-Mascheroni RM, 2008, BIOL LETTERS, V4, P446, DOI 10.1098/rsbl.2008.0333; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kaminski J., 2014, SOCIAL DOG BEHAV COG; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; MacLean EL, 2014, J COMP PSYCHOL, V128, P285, DOI 10.1037/a0035742; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A., 2014, DOG BEHAV EVOLUTION; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; O'Hara SJ, 2011, ANIM BEHAV, V81, P335, DOI 10.1016/j.anbehav.2010.11.005; Osthaus B, 2010, ANIM COGN, V13, P881, DOI 10.1007/s10071-010-0331-z; Romero T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071365; Schmidjell T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00558; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Silvertown J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018927; Stevens J. P., 2012, APPL MULTIVARIATE ST; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Tempelmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091014; Tomasello M, 1997, PRIMATE COGNITION; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; Wobber V, 2009, BEHAV PROCESS, V81, P423, DOI 10.1016/j.beproc.2009.04.003	51	34	34	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0135176	10.1371/journal.pone.0135176	http://dx.doi.org/10.1371/journal.pone.0135176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376443	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200006
J	Zhang, XL; Liu, RH; Su, ZX; Zhang, YC; Zhang, WF; Liu, XY; Wang, FW; Guo, YJ; Li, CG; Hao, J				Zhang, Xiaoli; Liu, Ruihua; Su, Zhongxue; Zhang, Yuecun; Zhang, Wenfang; Liu, Xinyu; Wang, Fuwu; Guo, Yuji; Li, Chuangang; Hao, Jing			Immunohistochemical Study of Expression of Sohlh1 and Sohlh2 in Normal Adult Human Tissues	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; SPERMATOGONIAL DIFFERENTIATION; NONOBSTRUCTIVE AZOOSPERMIA; TRANSCRIPTIONAL REGULATORS; GERM; GENE; FOLLICULOGENESIS; SPERMATOGENESIS; VARIANTS; CELLS	The expression pattern of Sohlh1 (spermatogenesis and oogenesis specific basic helix-loop-helix 1) and Sohlh2 in mice has been reported in previous studies. Sohlh1 and Sohlh2 are specifically expressed in spermatogonia, prespermatogonia in male mice and oocytes of primordial and primary follicles in female mice. In this report, we studied the expression pattern of Sohlh1 and Sohlh2 in human adult tissues. Immunohistochemical staining of Sohlh1 and Sohlh2 was performed in 5 samples of normal ovaries and testes, respectively. The results revealed that Sohlh genes are not only expressed in oocytes and spermatogonia, but also in granular cells, theca cells, Sertoli cells and Leydig cells, and in smooth muscles of blood vessel walls. To further investigate the expression of Sohlh genes in other adult human tissues, we collected representative normal adult tissues developed from three embryonic germ layers. Compared with the expression in mice, Sohlhs exhibited a much more extensive expression pattern in human tissues. Sohlhs were detected in testis, ovary and epithelia developed from embryonic endoderm, ectoderm and tissues developed from embryonic mesoderm. Sohlh signals were found in spermatogonia, Sertoli cells and also Leydig cells in testis, while in ovary, the expression was mainly in oocytes of primordial and primary follicles, granular cells and theca cells of secondary follicles. Compared with Sohlh2, the expression of Sohlh1 was stronger and more extensive. Our study explored the expression of Sohlh genes in human tissues and might provide insights for functional studies of Sohlh genes.	[Zhang, Xiaoli; Zhang, Wenfang; Liu, Xinyu; Wang, Fuwu; Guo, Yuji; Hao, Jing] Shandong Univ, Dept Histol & Embryol, Minist Educ Expt Teratol, Key Lab,Sch Med, Jinan 250100, Peoples R China; [Liu, Ruihua] Yantai Yuhuangding Hosp, Dept Ultrasound, Yantai, Peoples R China; [Su, Zhongxue] Shandong Univ, Dept Hepatobiliary Surg, Shandong Prov Hosp, Jinan 250100, Peoples R China; [Zhang, Yuecun] Dongnan Univ, Sch Med, Nanjing Tongren Hosp, Dept Gynecol & Obstet, Nanjing, Jiangsu, Peoples R China; [Li, Chuangang] Shandong Univ, Affiliated Hosp 2, Dept Anesthesiol, Jinan 250100, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Southeast University - China; Shandong University	Hao, J (corresponding author), Shandong Univ, Dept Histol & Embryol, Minist Educ Expt Teratol, Key Lab,Sch Med, Jinan 250100, Peoples R China.	haojing@sdu.edu.cn			Natural Science Foundation 1 of Shandong Province [ZR2014HM082]; Shandong Department of Science and Technology Plan Project [2014GSF118085]; Shandong Province Outstanding Young Scientist Research Award Fund Project [2011BSE27084]	Natural Science Foundation 1 of Shandong Province; Shandong Department of Science and Technology Plan Project; Shandong Province Outstanding Young Scientist Research Award Fund Project	This study was supported by the Natural Science Foundation 1 of Shandong Province (NO. ZR2014HM082), the Shandong Department of Science and Technology Plan Project (NO. 2014GSF118085), and the Shandong Province Outstanding Young Scientist Research Award Fund Project (2011BSE27084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Ballow DJ, 2006, GENE EXPR PATTERNS, V6, P1014, DOI 10.1016/j.modgep.2006.04.007; Barrios F, 2012, J CELL SCI, V125, P1455, DOI 10.1242/jcs.092593; Bonnet A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-417; Choi Y, 2010, HUM MUTAT, V31, P788, DOI 10.1002/humu.21264; Choi Y, 2008, BIOL REPROD, V79, P1176, DOI 10.1095/biolreprod.108.071217; Hao J, 2008, STEM CELLS, V26, P1587, DOI 10.1634/stemcells.2007-0502; Jagarlamudi K, 2012, MOL CELL ENDOCRINOL, V356, P31, DOI 10.1016/j.mce.2011.07.049; Lim Eun-Jin, 2012, Clin Exp Reprod Med, V39, P127, DOI 10.5653/cerm.2012.39.4.127; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Pan B, 2011, MOL HUM REPROD, V17, P550, DOI 10.1093/molehr/gar017; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Qin YY, 2014, FERTIL STERIL, V101, P1104, DOI 10.1016/j.fertnstert.2014.01.001; Rajkovic A, 2001, FERTIL STERIL, V76, P550, DOI 10.1016/S0015-0282(01)01966-5; Ramaswamy S, 2014, MOL HUM REPROD, V20, P350, DOI 10.1093/molehr/gat093; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Song B, 2015, EUR J OBSTET GYN R B, V184, P48, DOI 10.1016/j.ejogrb.2014.11.003; Song HW, 2014, SEMIN CELL DEV BIOL, V30, P14, DOI 10.1016/j.semcdb.2014.02.005; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; Suzumori N, 2007, CURR MED CHEM, V14, P353, DOI 10.2174/092986707779941087; Toyoda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101681; Toyoda S, 2009, DEV BIOL, V325, P238, DOI 10.1016/j.ydbio.2008.10.019; Woloszynska-Read A, 2011, CLIN CANCER RES, V17, P2170, DOI 10.1158/1078-0432.CCR-10-2315; Zhang HY, 2014, CARCINOGENESIS, V35, P1863, DOI 10.1093/carcin/bgu113; Zhang T, 2014, DEVELOPMENT, V141, P3662, DOI 10.1242/dev.113936; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	27	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137431	10.1371/journal.pone.0137431	http://dx.doi.org/10.1371/journal.pone.0137431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375665	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200039
J	Bakhchane, A; Charif, M; Salime, S; Boulouiz, R; Nahili, H; Roky, R; Lenaers, G; Barakat, A				Bakhchane, Amina; Charif, Majida; Salime, Sara; Boulouiz, Redouane; Nahili, Halima; Roky, Rachida; Lenaers, Guy; Barakat, Abdelhamid			Recessive TBC1D24 Mutations Are Frequent in Moroccan Non-Syndromic Hearing Loss Pedigrees	PLOS ONE			English	Article							GENE	Mutations in the TBC1D24 gene are responsible for four neurological presentations: infantile epileptic encephalopathy, infantile myoclonic epilepsy, DOORS (deafness, onychodystrophy, osteodystrophy, mental retardation and seizures) and NSHL (non-syndromic hearing loss). For the latter, two recessive (DFNB86) and one dominant (DFNA65) mutations have so far been identified in consanguineous Pakistani and European/Chinese families, respectively. Here we report the results of a genetic study performed on a large Moroccan cohort of deaf patients that identified three families with compound heterozygote mutations in TBC1D24. Four novel mutations were identified, among which, one c.641G>A (p.Arg214His) was present in the three families, and has a frequency of 2% in control Moroccan population with normal hearing, suggesting that it acts as an hypomorphic variant leading to restricted deafness when combined with another recessive severe mutation. Altogether, our results show that mutations in TBC1D24 gene are a frequent cause (>2%) of NSHL in Morocco, and that due to its possible compound heterozygote recessive transmission, this gene should be further considered and screened in other deaf cohorts.	[Bakhchane, Amina; Charif, Majida; Salime, Sara; Boulouiz, Redouane; Nahili, Halima; Barakat, Abdelhamid] Inst Pasteur Maroc, Lab Genet Mol Humaine, Dept Rech Sci, Casablanca, Morocco; [Roky, Rachida] Univ Hassan II Ain Chock, Lab Physiol & Genet Mol, Casablanca 20100, Morocco; [Charif, Majida; Salime, Sara; Lenaers, Guy] Univ Montpellier, Inst Neurosci Montpellier, INSERM, U1051, F-34091 Montpellier 05, France; [Charif, Majida; Lenaers, Guy] Univ Angers, Mitochondrial Med Res Ctr, PREMMi, CHU Bat IRIS IBS, F-49933 Angers 9, France	Hassan II University of Casablanca; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite d'Angers	Barakat, A (corresponding author), Inst Pasteur Maroc, Lab Genet Mol Humaine, Dept Rech Sci, Casablanca, Morocco.	hamid.barakat@pasteur.ma	Lenaers, guy/X-4727-2019; LENAERS, Guy/K-2421-2015	LENAERS, Guy/0000-0003-2736-3349; BOULOUIZ, Redouane/0000-0003-4430-3612	Pasteur Institute of Morocco; French National Institute of Health and Medical research (INSERM); Moroccan National center of Technical research (CNRST); Region Pays de la Loire, Angers Loire Metropole, Angers University and Hospital	Pasteur Institute of Morocco; French National Institute of Health and Medical research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Moroccan National center of Technical research (CNRST); Region Pays de la Loire, Angers Loire Metropole, Angers University and Hospital(Region Pays de la Loire)	This work was supported by Pasteur Institute of Morocco and the collaborative project between the French National Institute of Health and Medical research (INSERM) and the Moroccan National center of Technical research (CNRST). GL acknowledges the support from the Region Pays de la Loire, Angers Loire Metropole, Angers University and Hospital.	Abidi O, 2007, INT J PEDIATR OTORHI, V71, P1239, DOI 10.1016/j.ijporl.2007.04.019; Azaiez H, 2014, HUM MUTAT, V35, P819, DOI 10.1002/humu.22557; Boulouiz R, 2008, AM J MED GENET A, V146A, P3086, DOI 10.1002/ajmg.a.32525; Campeau PM, 2014, LANCET NEUROL, V13, P44, DOI 10.1016/S1474-4422(13)70265-5; Charif M, 2013, GENE, V523, P103, DOI 10.1016/j.gene.2013.03.123; Charif M, 2012, BIOCHEM BIOPH RES CO, V419, P643, DOI 10.1016/j.bbrc.2012.02.066; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Falace A, 2010, AM J HUM GENET, V87, P365, DOI 10.1016/j.ajhg.2010.07.020; Guven A, 2013, J MED GENET, V50, P199, DOI 10.1136/jmedgenet-2012-101313; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; Nahili H, 2010, INT J PEDIATR OTORHI, V74, P1071, DOI 10.1016/j.ijporl.2010.06.008; Rehman AU, 2014, AM J HUM GENET, V94, P144, DOI 10.1016/j.ajhg.2013.12.004; Zhang LP, 2014, HUM MUTAT, V35, P814, DOI 10.1002/humu.22558	13	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138072	10.1371/journal.pone.0138072	http://dx.doi.org/10.1371/journal.pone.0138072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371875	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400047
J	Gonzalez, JEH; Garcia-Fernandez, R; Valiente, PA				Hernandez Gonzalez, Jorge Enrique; Garcia-Fernandez, Rossana; Alberto Valiente, Pedro			Polar Desolvation and Position 226 of Pancreatic and Neutrophil Elastases Are Crucial to their Affinity for the Kunitz-Type Inhibitors ShPI-1 and ShPI-1/K13L	PLOS ONE			English	Article							FREE-ENERGY DECOMPOSITION; GENERALIZED BORN MODELS; MOLECULAR-DYNAMICS; TRYPSIN-INHIBITOR; SUBSTRATE-SPECIFICITY; PROTEINASE-INHIBITORS; CRYSTAL-STRUCTURES; HUMAN-LEUKOCYTE; LIGAND-BINDING; SOLVATION	The Kunitz-type protease inhibitor ShPI-1 inhibits human neutrophil elastase (HNE, K-i = 2.35.10(-8) M) but does not interact with the porcine pancreatic elastase (PPE); whereas its P1 site variant, ShPI-1/K13L, inhibits both HNE and PPE (K-i = 1.3.10(-9) M, and K-i = 1.2.10(-8) M, respectively). By employing a combination of molecular modeling tools, e.g., structural alignment, molecular dynamics simulations and Molecular Mechanics Generalized-Born/Poisson-Boltzmann Surface Area free energy calculations, we showed that D226 of HNE plays a critical role in the interaction of this enzyme with ShPI-1 through the formation of a strong salt bridge and hydrogen bonds with K13 at the inhibitor's P1 site, which compensate the unfavorable polar-desolvation penalty of the latter residue. Conversely, T226 of PPE is unable to establish strong interactions with K13, thereby precluding the insertion of K13 side-chain into the S1 subsite of this enzyme. An alternative conformation of K13 site-chain placed at the entrance of the S1 subsite of PPE, similar to that observed in the crystal structure of ShPI-1 in complex with chymotrypsin (PDB:3T62), is also unfavorable due to the lack of stabilizing pair-wise interactions. In addition, our results suggest that the higher affinity of ShPI-1/K13L for both elastases mainly arises from the lower polar-desolvation penalty of L13 compared to that of K13, and not from stronger pair-wise interactions of the former residue with those of each enzyme. These results provide insights into the PPE and HNE inhibition and may contribute to the design of more potent and/or specific inhibitors toward one of these proteases.	[Hernandez Gonzalez, Jorge Enrique; Garcia-Fernandez, Rossana; Alberto Valiente, Pedro] Univ La Habana, Fac Biol, Ctr Estudios Prot, Havana, Cuba	Universidad de la Habana	Gonzalez, JEH (corresponding author), Univ La Habana, Fac Biol, Ctr Estudios Prot, Havana, Cuba.	jehg@fbio.uh.cu; valiente@fbio.uh.cu	García-Fernández, Rossana/A-8920-2011; González, Jorge Enrique Hernández/AAB-2705-2019; , pedro/AAK-9885-2020	, pedro/0000-0002-4776-6017; Hernandez Gonzalez, Jorge Enrique/0000-0002-4770-8677				Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; ANTUCH W, 1993, EUR J BIOCHEM, V212, P675, DOI 10.1111/j.1432-1033.1993.tb17705.x; Bachovchin WW, 2001, MAGN RESON CHEM, V39, pS199, DOI 10.1002/mrc.951; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biela A, 2012, J MOL BIOL, V418, P350, DOI 10.1016/j.jmb.2012.01.054; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case DA, 2012, AMBER 12; Chughtai B, 2004, J AEROSOL MED, V17, P289, DOI 10.1089/jam.2004.17.289; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delfin J, 1996, TOXICON, V34, P1367, DOI 10.1016/S0041-0101(96)00114-6; Delfin J, 1994, Arch Med Res, V25, P199; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fulle S, 2013, J CHEM INF MODEL, V53, P573, DOI 10.1021/ci300581z; Garcia-Fernandez R, 2015, J BIOL CHEM, V290, P14154, DOI 10.1074/jbc.M115.647586; Genheden S, 2011, J CHEM THEORY COMPUT, V7, P3768, DOI 10.1021/ct200163c; Genheden S, 2010, J COMPUT CHEM, V31, P837, DOI 10.1002/jcc.21366; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gonzalez Y, 2007, BIOL CHEM, V388, P1183, DOI 10.1515/BC.2007.129; HAKANSSON HO, 1993, SCAND J CLIN LAB INV, V53, P17, DOI 10.3109/00365519309092527; Hayes J.M., 2012, MOL DYNAMICS STUDIES, P171; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Alvarez LH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003759; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Humphris EL, 2008, STRUCTURE, V16, P1777, DOI 10.1016/j.str.2008.09.012; Jayaram B, 1998, J PHYS CHEM B, V102, P9571, DOI 10.1021/jp982007x; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kiczak L, 2001, BBA-PROTEIN STRUCT M, V1550, P153, DOI 10.1016/S0167-4838(01)00282-5; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kraunsoe JAE, 1996, BIOCHEMISTRY-US, V35, P9090, DOI 10.1021/bi953013b; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Laskowski Jr M, 2000, INTERACTION STANDARD; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Ley AC, 2003, US patent, Patent No. [003/0175919 A1, 0030175919]; Lindahl Erik R., 2008, V443, P3, DOI 10.1007/978-1-59745-177-2_1; Lu WY, 1997, J MOL BIOL, V266, P441, DOI 10.1006/jmbi.1996.0781; MARK AE, 1994, J MOL BIOL, V240, P167, DOI 10.1006/jmbi.1994.1430; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Moroy G, 2012, ANTI-CANCER AGENT ME, V12, P565, DOI 10.2174/187152012800617696; Nguyen H, 2013, J CHEM THEORY COMPUT, V9, P2020, DOI 10.1021/ct3010485; Norberg J, 2003, Q REV BIOPHYS, V36, P257, DOI 10.1017/S0033583503003895; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oehme DP, 2012, J COMPUT CHEM, V33, P2566, DOI 10.1002/jcc.23095; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Onufriev AV, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3578686; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaefer M, 1996, J PHYS CHEM-US, V100, P1578, DOI 10.1021/jp9521621; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; TSCHESCHE H, 1987, BIOCHIM BIOPHYS ACTA, V913, P97, DOI 10.1016/0167-4838(87)90238-X; van der Spoel D., 2010, GROMACS USER MANUAL; Wang JM, 2012, J CHEM INF MODEL, V52, P1199, DOI 10.1021/ci300064d; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Wodak SJ, 2004, CURR OPIN STRUC BIOL, V14, P242, DOI 10.1016/j.sbi.2004.02.003; Wolfram Research Inc., 2008, MATH VERS 7 0; Yang TY, 2011, PROTEINS, V79, P1940, DOI 10.1002/prot.23018; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395; Zou XQ, 1999, J AM CHEM SOC, V121, P8033, DOI 10.1021/ja984102p	78	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137787	10.1371/journal.pone.0137787	http://dx.doi.org/10.1371/journal.pone.0137787			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372354	Green Submitted, Green Published, gold			2022-12-26	WOS:000361604400031
J	Hurford, A; Lin, AL; Wu, JH				Hurford, Amy; Lin, Alice L.; Wu, Jianhong			Determinants of the Final Size and Case Rate of Nosocomial Outbreaks	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INTENSIVE-CARE UNITS; HEALTH-CARE; TRANSMISSION; INFECTIONS; HOSPITALS; COMMUNITY; DYNAMICS; ROUTES	Different nosocomial pathogen species have varying infectivity and durations of infectiousness, while the transmission route determines the contact rate between pathogens and susceptible patients. To determine if the pathogen species and transmission route affects the size and spread of outbreaks, we perform a meta-analysis that examines data from 933 outbreaks of hospital-acquired infection representing 14 pathogen species and 8 transmission routes. We find that the mean number of cases in an outbreak is best predicted by the pathogen species and the mean number of cases per day is best predicted by the species-transmission route combination. Our fitted model predicts the largest mean number of cases for Salmonella outbreaks (22.3) and the smallest mean number of cases for Streptococci outbreaks (8.5). The largest mean number of cases per day occurs during Salmonella outbreaks spread via the environment (0.33) and the smallest occurs for Legionella outbreaks spread by multiple transmission routes (0.005). When combined with information on the frequency of outbreaks these findings could inform the design of infection control policies in hospitals.	[Hurford, Amy] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Hurford, Amy] Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada; [Lin, Alice L.] Queens Univ, Life Sci Program, Kingston, ON, Canada; [Wu, Jianhong] York Univ, Dept Math & Stat, York Inst Hlth Res, Ctr Dis Modelling, Toronto, ON M3J 2R7, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Queens University - Canada; York University - Canada	Hurford, A (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	ahurford@mun.ca	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 2014-05413]; Canadian Institutes for Health Research (CIHR); NSERC [CHRP 446610-13]; Canada Research Chairs Program [950230720]; Public Health Agency of Canada; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, KL2TR001118] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); Public Health Agency of Canada; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	AH was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC; RGPIN 2014-05413). JW and AH were supported by funding jointly from the Canadian Institutes for Health Research (CIHR) and NSERC (CHRP 446610-13). JH was supported by CIHR, NSERC, the Canada Research Chairs Program (950230720), and the Public Health Agency of Canada. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Bolker B, 2008, ECOLOGICAL MODELS DA; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Cook AR, 2007, P NATL ACAD SCI USA, V104, P20392, DOI 10.1073/pnas.0706461104; Cooper BS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002454; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; de Celles MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045758; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Gastmeier P, 2006, AM J INFECT CONTROL, V34, P603, DOI 10.1016/j.ajic.2006.01.014; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Hetem DJ, 2013, EMERG INFECT DIS, V19, P1797, DOI 10.3201/eid1911.121085; Hetem DJ, 2012, J ANTIMICROB CHEMOTH, V67, P1775, DOI 10.1093/jac/dks125; Kiss IZ, 2006, MATH BIOSCI, V203, P124, DOI 10.1016/j.mbs.2006.03.002; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; KREGER BE, 1980, AM J MED, V68, P332, DOI 10.1016/0002-9343(80)90101-1; Lankford MG, 2006, AM J INFECT CONTROL, V34, P258, DOI 10.1016/j.ajic.2005.10.008; Lanzas C, 2011, INFECT CONT HOSP EP, V32, P553, DOI 10.1086/660013; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Pelupessy I, 2002, P NATL ACAD SCI USA, V99, P5601, DOI 10.1073/pnas.082412899; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Ueno T, 2008, J THEOR BIOL, V254, P655, DOI 10.1016/j.jtbi.2008.07.001; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wisplinghoff H, 2005, CLIN INFECT DIS, V40, P1077	24	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138216	10.1371/journal.pone.0138216	http://dx.doi.org/10.1371/journal.pone.0138216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371880	gold, Green Published, Green Submitted			2022-12-26	WOS:000361604400057
J	Richard, V; Viallon, J; Cao-Lormeau, VM				Richard, Vaea; Viallon, Jerome; Cao-Lormeau, Van-Mai			Use of Centrifugal Filter Devices to Concentrate Dengue Virus in Mosquito per os Infection Experiments	PLOS ONE			English	Article							AEDES-ALBOPICTUS; GENE-TRANSFER; SUSCEPTIBILITY; TRANSMISSION; AEGYPTI; ISLAND	Dengue virus (DENV) is an arbovirus transmitted to humans by the bite of infected Aedes mosquitoes. Experimental per os infection of mosquitoes with DENV is usually a preliminary step in virus/vector studies but it requires being able to prepare artificial blood-meals with high virus titers. We report here the convenient use of centrifugal filter devices to quickly concentrate DENV particles in cell-culture supernatants. The median viral titer in concenntrated-supernatants was 8.50 log(10) TCID50/mL. By using these DENV concentrated-supernatants to prepare infectious blood-meals in Aedes aegypti per os infection experiments, we obtained a mean mosquito-infection rate of 94%. We also evaluated the use of centrifugal filter devices to recover DENV particles from non-infectious blood-meals presented to infected mosquitoes through a feeding membrane to collect their saliva.	[Richard, Vaea; Viallon, Jerome; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Papeete, France		Richard, V (corresponding author), Inst Louis Malarde, Papeete, France.	vrichard@ilm.pf	Cao-Lormeau, Van-Mai/H-4879-2018	Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Richard, Vaea/0000-0001-8132-0740				AITKEN THG, 1977, MOSQ NEWS, V37, P130; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P108, DOI 10.2987/09-5935.1; Aubry M, 2012, J CLIN VIROL, V55, P23, DOI 10.1016/j.jcv.2012.05.010; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Chu THT, 1997, J VIROL, V71, P720, DOI 10.1128/JVI.71.1.720-725.1997; Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12; Doggett S.L., 2001, Arbovirus Research in Australia, V8, P126; GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045; Huang KJ, 2008, AM J INFECT DIS, V4, P50, DOI 10.3844/ajidsp.2008.50.59; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11; Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188; Russell BJ, 2007, J VIROL METHODS, V145, P62, DOI 10.1016/j.jviromet.2007.05.008; SAHA K, 1994, J VIROL METHODS, V46, P349, DOI 10.1016/0166-0934(94)90005-1; Van den Hurk AF, 2007, J MED ENTOMOL, V44, P845, DOI 10.1603/0022-2585(2007)44[845:EOFDSF]2.0.CO;2; Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; WHO, DENG SEV DENG	26	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138161	10.1371/journal.pone.0138161	http://dx.doi.org/10.1371/journal.pone.0138161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372347	Green Submitted, Green Published, gold			2022-12-26	WOS:000361604400051
J	Addabbo, M; Longhi, E; Bolognini, N; Senna, I; Tagliabue, P; Cassia, VM; Turati, C				Addabbo, Margaret; Longhi, Elena; Bolognini, Nadia; Senna, Irene; Tagliabue, Paolo; Cassia, Viola Macchi; Turati, Chiara			Seeing Touches Early in Life	PLOS ONE			English	Article							HAND-MOUTH COORDINATION; SOMATOSENSORY ACTIVATIONS; FACE PREFERENCE; BODY PERCEPTION; SENSE; FETAL; SELF	The sense of touch provides fundamental information about the surrounding world, and feedback about our own actions. Although touch is very important during the earliest stages of life, to date no study has investigated infants' abilities to process visual stimuli implying touch. This study explores the developmental origins of the ability to visually recognize touching gestures involving others. Looking times and orienting responses were measured in a visual preference task, in which participants were simultaneously presented with two videos depicting a touching and a no-touching gesture involving human body parts (face, hand) and/or an object (spoon). In Experiment 1, 2-day-old newborns and 3-month-old infants viewed two videos: in one video a moving hand touched a static face, in the other the moving hand stopped before touching it. Results showed that only 3-month-olds, but not newborns, differentiated the touching from the no-touching gesture, displaying a preference for the former over the latter. To test whether newborns could manifest a preferential visual response when the touched body part is different from the face, in Experiment 2 newborns were presented with touching/no-touching gestures in which a hand or an inanimate object -i.e., a spoon-moved towards a static hand. Newborns were able to discriminate a hand-to-hand touching gesture, but they did not manifest any preference for the object-to-hand touch. The present findings speak in favour of an early ability to visually recognize touching gestures involving the interaction between human body parts.	[Addabbo, Margaret; Longhi, Elena; Bolognini, Nadia; Senna, Irene; Cassia, Viola Macchi; Turati, Chiara] Univ Milano Bicocca, Dept Psychol, I-20126 Milan, Italy; [Addabbo, Margaret; Bolognini, Nadia; Cassia, Viola Macchi; Turati, Chiara] Milan Ctr Neurosci, NeuroMi, Milan, Italy; [Longhi, Elena] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Bolognini, Nadia] Ist Auxol Italiano, Neuropsychol Lab, Milan, Italy; [Senna, Irene] Univ Bielefeld, Cognit Neurosci Dept, D-33615 Bielefeld, Germany; [Senna, Irene] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany; [Tagliabue, Paolo] San Gerardo Hosp, MBBM Fdn, Neonatol & Intens Care Unit, I-20900 Monza, Italy	University of Milano-Bicocca; University of London; University College London; IRCCS Istituto Auxologico Italiano; University of Bielefeld; University of Bielefeld; San Gerardo Hospital	Addabbo, M (corresponding author), Univ Milano Bicocca, Dept Psychol, Piazza Ateneo Nuovo 1 U6, I-20126 Milan, Italy.	m.addabbo2@campus.unimib.it	BOLOGNINI, NADIA/J-5746-2016; addabbo, margaret/ABD-5240-2020; Macchi Cassia, Viola/HCI-2058-2022	BOLOGNINI, NADIA/0000-0002-2921-8658; addabbo, margaret/0000-0002-8414-6853; Senna, Irene/0000-0002-3237-8193; macchi cassia, viola/0000-0002-9983-8254	ERC-Starting Grant [241176]	ERC-Starting Grant	Research was supported by an ERC-Starting Grant to CT ODMIR No. 241176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrick LE, 2013, CURR BIOL, V23, pR1039, DOI 10.1016/j.cub.2013.10.060; Biro S, 2007, DEVELOPMENTAL SCI, V10, P379, DOI 10.1111/j.1467-7687.2006.00544.x; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Bolognini N, 2014, CURR BIOL, V24, P1513, DOI 10.1016/j.cub.2014.05.025; Bolognini N, 2013, CURR BIOL, V23, pR436, DOI 10.1016/j.cub.2013.03.036; Bolognini N, 2013, J NEUROSCI, V33, P4201, DOI 10.1523/JNEUROSCI.4498-12.2013; Bolognini N, 2012, CEREB CORTEX, V22, P2055, DOI 10.1093/cercor/bhr283; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; BUTTERWORTH G, 1988, BRIT J DEV PSYCHOL, V6, P303, DOI 10.1111/j.2044-835X.1988.tb01103.x; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; Cassia VM, 2001, DEVELOPMENTAL SCI, V4, P101; Castiello U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013199; COHEN LB, 1972, CHILD DEV, V43, P869, DOI 10.2307/1127638; COHEN LB, 1973, MERRILL PALMER QUART, V19, P157; Craighero L, 2011, COGNITION, V120, P26, DOI 10.1016/j.cognition.2011.02.011; Ebisch SJH, 2008, J COGNITIVE NEUROSCI, V20, P1611, DOI 10.1162/jocn.2008.20111; Ebisch SJH, 2011, J COGNITIVE NEUROSCI, V23, P1808, DOI 10.1162/jocn.2010.21551; Field T, 2001, TOUCH; Filippetti ML, 2013, CURR BIOL, V23, P2413, DOI 10.1016/j.cub.2013.10.017; Hertenstein MJ, 2002, HUM DEV, V45, P70, DOI 10.1159/000048154; Johnson MH, 1991, BIOL COGNITIVE DEV C; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kuehn E, 2014, BRAIN STRUCT FUNCT, V219, P119, DOI 10.1007/s00429-012-0489-z; Kurjak A, 2005, CROAT MED J, V46, P772; LEW AR, 1995, DEV PSYCHOL, V31, P456, DOI 10.1037/0012-1649.31.3.456; Longhi E, 2015, CHILD DEV, V86, P632, DOI 10.1111/cdev.12329; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Meyer K, 2011, CEREB CORTEX, V21, P2113, DOI 10.1093/cercor/bhq289; Montagu A., 1971, TOUCHING HUMAN SIGNI; Myowa-Yamakoshi M, 2006, INFANCY, V10, P289, DOI 10.1207/s15327078in1003_5; Nagy E, 2014, DEVELOPMENTAL SCI, V17, P841, DOI 10.1111/desc.12163; Reissland N, 2014, DEV PSYCHOBIOL, V56, P955, DOI 10.1002/dev.21172; Rochat P, 1997, EARLY DEV PARENTING, V6, P105; Rossetti A, 2012, EUR J NEUROSCI, V36, P2317, DOI 10.1111/j.1460-9568.2012.08137.x; Saxe R, 2007, DEV PSYCHOL, V43, P149, DOI 10.1037/0012-1649.43.1.149; Schaefer M, 2009, HUM BRAIN MAPP, V30, P2722, DOI 10.1002/hbm.20701; Sparling Joyce W., 1993, Physical and Occupational Therapy in Pediatrics, V12, P97, DOI 10.1300/J006v12n02_06; Sparling JW, 1999, PHYS THER, V79, P24, DOI 10.1093/ptj/79.1.24; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7; Zmyj N, 2011, COGNITION, V120, P82, DOI 10.1016/j.cognition.2011.03.001; Zoia S, 2007, EXP BRAIN RES, V176, P217, DOI 10.1007/s00221-006-0607-3	44	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0134549	10.1371/journal.pone.0134549	http://dx.doi.org/10.1371/journal.pone.0134549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26366563	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100006
J	Butler, MW; Ligon, RA				Butler, Michael W.; Ligon, Russell A.			Interactions between Biliverdin, Oxidative Damage, and Spleen Morphology after Simulated Aggressive Encounters in Veiled Chameleons	PLOS ONE			English	Article							HISTORY TRADE-OFFS; ANTIOXIDANT CAPACITY; ACUTE STRESS; BEHAVIOR; PROTEIN; REPRODUCTION; STIMULATION; MECHANISMS; CORTISOL; ECOLOGY	Stressors frequently increase oxidative damage-unless organisms simultaneously mount effective antioxidant responses. One putative mitigative mechanism is the use of biliverdin, an antioxidant produced in the spleen during erythrocyte degradation. We hypothesized that both wild and captive-bred male veiled chameleons (Chamaeleo calyptratus), which are highly aggressive to conspecifics, would respond to agonistic displays with increased levels of oxidative damage, but that increased levels of biliverdin would limit this increase. We found that even just visual exposure to a potential combatant resulted in decreased body mass during the subsequent 48-hour period, but that hematocrit, biliverdin concentration in the bile, relative spleen size, and oxidative damage in plasma, liver, and spleen were unaffected. Contrary to our predictions, we found that individuals with smaller spleens exhibited greater decreases in hematocrit and higher bile biliverdin concentrations, suggesting a revision to the idea of spleen-dependent erythrocyte processing. Interestingly, individuals with larger spleens had reduced oxidative damage in both the liver and spleen, demonstrating the spleen's importance in modulating oxidative damage. We also uncovered differences in spleen size and oxidative damage between wild and captive-bred chameleons, highlighting environmentally dependent differences in oxidative physiology. Lastly, we found no relationship between oxidative damage and biliverdin concentration, calling into question biliverdin's antioxidant role in this species.	[Butler, Michael W.] Lafayette Coll, Dept Biol, Easton, PA 18042 USA; [Ligon, Russell A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Lafayette College; Arizona State University; Arizona State University-Tempe	Butler, MW (corresponding author), Lafayette Coll, Dept Biol, Easton, PA 18042 USA.	butlermw@lafayette.edu	Ligon, Russell/M-1233-2013	Ligon, Russell/0000-0002-0195-8275; Butler, Michael/0000-0002-8390-2960	Lafayette College	Lafayette College	Funding provided to MWB by Lafayette College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakovic D, 2013, J PHYSIOL PHARMACOL, V64, P649; Berlec A, 2014, J VET DIAGN INVEST, V26, P521, DOI 10.1177/1040638714535403; Bonkovsky HL, 2013, COMPR PHYSIOL, V3, P365, DOI 10.1002/cphy.c120006; Brenes A, 2010, SPAN J AGRIC RES, V8, P326, DOI 10.5424/sjar/2010082-1199; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2008, J COMP PHYSIOL B, V178, P829, DOI 10.1007/s00360-008-0270-z; Costantini D, 2008, J EXP BIOL, V211, P377, DOI 10.1242/jeb.012856; Costantini D, 2008, BIOL LETTERS, V4, P119, DOI 10.1098/rsbl.2007.0513; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Cuadrado M, 2000, HERPETOLOGICA, V56, P387; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Davies S, 2013, PHYSIOL BIOCHEM ZOOL, V86, P47, DOI 10.1086/667990; Dickens MJ, 2009, GEN COMP ENDOCR, V160, P76, DOI 10.1016/j.ygcen.2008.10.023; Douxfils J, 2011, FISH SHELLFISH IMMUN, V31, P1113, DOI 10.1016/j.fsi.2011.10.001; Fan YP, 2014, INT J BIOL MACROMOL, V65, P200, DOI 10.1016/j.ijbiomac.2014.01.041; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Fernandez-Llario P, 2004, EUR J WILDLIFE RES, V50, P13, DOI 10.1007/s10344-003-0028-6; Foller M, 2010, FASEB J, V24, P3351, DOI 10.1096/fj.10-159483; Hamalainen A, 2012, BEHAV ECOL SOCIOBIOL, V66, P1577, DOI 10.1007/s00265-012-1411-7; Hardy ICW, 2013, ANIMAL CONTESTS, P1, DOI 10.1017/CBO9781139051248; HILLENIUS D., 1966, BEAUFORTIA SEE MISC PUBLICATIONS ZOOL MUS AMSTERDAM, V13, P91; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Isaksson C, 2011, BEHAVIOUR, V148, P713, DOI 10.1163/000579511X574204; Jennings DJ, 2010, ANIM BEHAV, V79, P1293, DOI 10.1016/j.anbehav.2010.02.031; Jiang SZ, 2011, J ANIM SCI, V89, P3008, DOI 10.2527/jas.2010-3658; Juttner F, 2013, EUR FOOD RES TECHNOL, V236, P943, DOI 10.1007/s00217-013-1932-y; Laguerre M, 2007, PROG LIPID RES, V46, P244, DOI 10.1016/j.plipres.2007.05.002; Ligon RA, 2014, BEHAV ECOL SOCIOBIOL, V68, P1007, DOI 10.1007/s00265-014-1713-z; Ligon RA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0892; Mancuso C, 2012, NEUROSCI LETT, V518, P101, DOI 10.1016/j.neulet.2012.04.062; Mateo R, 2004, J CHROMATOGR B, V810, P305, DOI 10.1016/j.jchromb.2004.08.019; McDonagh A. F., 1979, PORPHYRINS, VVI; MCDONAGH AF, 1980, BIOCHEM J, V189, P193, DOI 10.1042/bj1890193; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; McGraw KJ, 2011, J COMP PHYSIOL A, V197, P683, DOI 10.1007/s00359-011-0631-z; McGraw KJ, 2010, FUNCT ECOL, V24, P947, DOI 10.1111/j.1365-2435.2010.01772.x; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Molzer C, 2012, FREE RADICAL RES, V46, P1369, DOI 10.3109/10715762.2012.715371; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Moore IT, 2003, HORM BEHAV, V43, P39, DOI 10.1016/S0018-506X(02)00038-7; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Necas P, 1999, CHAMELEONS NATURES H; Oishi K, 1999, ACTA PHYSIOL SCAND, V165, P65; Orr AL, 2009, COMP BIOCHEM PHYS A, V153, P213, DOI 10.1016/j.cbpa.2009.02.016; Page MM, 2009, COMP BIOCHEM PHYS A, V152, P115, DOI 10.1016/j.cbpa.2008.09.032; Pennacchio M, 2003, HERPETOL J, V13, P161; Rammal H, 2010, EUR J PHARMACOL, V627, P173, DOI 10.1016/j.ejphar.2009.11.001; Ros AFH, 2014, J EXP BIOL, V217, P1768, DOI 10.1242/jeb.093666; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schoech SJ, 2011, CURR ZOOL, V57, P514, DOI 10.1093/czoolo/57.4.514; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Sharma S, 2009, ENVIRON TOXICOL, V24, P1, DOI 10.1002/tox.20383; Small TW, 2015, J COMP PHYSIOL B, V185, P119, DOI 10.1007/s00360-014-0866-4; Summers CH, 2005, EUR J PHARMACOL, V526, P21, DOI 10.1016/j.ejphar.2005.09.059; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; Turkan H, 2004, BIOL TRACE ELEM RES, V102, P105, DOI 10.1385/BTER:102:1-3:105; Wilhelm D, 2007, COMP BIOCHEM PHYS C, V146, P214, DOI 10.1016/j.cbpc.2006.11.015; Williams RB, 2005, AVIAN PATHOL, V34, P29, DOI 10.1080/03079450400025430; Wolff JO, 1998, OIKOS, V83, P529, DOI 10.2307/3546680	64	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138007	10.1371/journal.pone.0138007	http://dx.doi.org/10.1371/journal.pone.0138007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368930	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100201
J	Campagna, D; Gasparini, F; Franchi, N; Manni, L; Telatin, A; Vitulo, N; Ballarin, L; Valle, G				Campagna, Davide; Gasparini, Fabio; Franchi, Nicola; Manni, Lucia; Telatin, Andrea; Vitulo, Nicola; Ballarin, Loriano; Valle, Giorgio			SATRAP: SOLiD Assembler TRAnslation Program	PLOS ONE			English	Article							SEQUENCES; GENOME	SOLiD DNA sequences are typically analyzed using a reference genome, while they are not recommended for de novo assembly of genomes or transcriptomes. This is mainly due to the difficulty in translating the SOLiD color-space data into normal base-space sequences. In fact, the nature of color-space is such that any misinterpreted color leads to a chain of further translation errors, producing totally wrong results. Here we describe SATRAP, a computer program designed to efficiently translate de novo assembled color-space sequences into a base-space format. The program was tested and validated using simulated and real transcriptomic data; its modularity allows an easy integration into more complex pipelines, such as Oases for RNA-seq de novo assembly. SATRAP is available at http://satrap.cribi.unipd.it, either as a multi-step pipeline incorporating several tools for RNA-seq assembly or as an individual module for use with the Oases package.	[Campagna, Davide; Telatin, Andrea; Valle, Giorgio] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Campagna, Davide; Gasparini, Fabio; Franchi, Nicola; Manni, Lucia; Vitulo, Nicola; Ballarin, Loriano; Valle, Giorgio] Univ Padua, Dept Biol, Padua, Italy	University of Padua; University of Padua	Campagna, D (corresponding author), Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy.	davide@cribi.unipd.it	Telatin, Andrea/I-7438-2013; Gasparini, Fabio/F-4485-2011; Vitulo, Nicola/GVT-2319-2022; Ballarin, Loriano/D-7106-2011	Telatin, Andrea/0000-0001-7619-281X; Gasparini, Fabio/0000-0002-7574-0834; Ballarin, Loriano/0000-0002-3287-8550; VALLE, GIORGIO/0000-0003-4377-5685; Manni, Lucia/0000-0003-4257-8946; Vitulo, Nicola/0000-0002-9571-0747	Universita degli Studi di Padova, Progetto Strategico BIOINFOGEN; Consiglio Nazionale delle Ricerche, Progetto EPIGEN; Fondazione Cassa di Risparmio di Padova e Rovigo, Progetti di eccellenza	Universita degli Studi di Padova, Progetto Strategico BIOINFOGEN; Consiglio Nazionale delle Ricerche, Progetto EPIGEN; Fondazione Cassa di Risparmio di Padova e Rovigo, Progetti di eccellenza	This work was funded by Universita degli Studi di Padova, Progetto Strategico 2011 BIOINFOGEN (to GV) (http://www.unipd.it/ricerca/finanziamenti/finanziamenti-ateneo/progetti-strategiciateneo); Consiglio Nazionale delle Ricerche, Progetto EPIGEN (to GV) (http://www.epigen.it/); and Fondazione Cassa di Risparmio di Padova e Rovigo, Progetti di eccellenza 2008 (to LB) (http://www.fondazionecariparo.net/).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Dayarian A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-345; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Umemura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063673; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11	9	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137436	10.1371/journal.pone.0137436	http://dx.doi.org/10.1371/journal.pone.0137436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368549	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100072
J	Hu, XY; Li, JX; Hong, YL; Wang, L				Hu, Xiaoyue; Li, Jing Xian; Hong, Youlian; Wang, Lin			Characteristics of Plantar Loads in Maximum Forward Lunge Tasks in Badminton	PLOS ONE			English	Article							PLAYERS	Background Badminton players often perform powerful and long-distance lunges during such competitive matches. The objective of this study is to compare the plantar loads of three one-step maximum forward lunges in badminton. Methods Fifteen right-handed male badminton players participated in the study. Each participant performed five successful maximum lunges at three directions. For each direction, the participant wore three different shoe brands. Plantar loading, including peak pressure, maximum force, and contact area, was measured by using an insole pressure measurement system. Two-way ANOVA with repeated measures was employed to determine the effects of the different lunge directions and different shoes, as well as the interaction of these two variables, on the measurements. Results The maximum force (MF) on the lateral midfoot was lower when performing left-forward lunges than when performing front-forward lunges (p = 0.006, 95% CI = -2.88 to -0.04% BW). The MF and peak pressures (PP) on the great toe region were lower for the front-forward lunge than for the right-forward lunge (MF, p = 0.047, 95% CI = -3.62 to -0.02% BW; PP, p = 0.048, 95% CI = -37.63 to -0.16 KPa) and left-forward lunge (MF, p = 0.015, 95% CI = -4.39 to -0.38% BW; PP, p = 0.008, 95% CI = -47.76 to -5.91 KPa). Conclusions These findings indicate that compared with the front-forward lunge, left and right maximum forward lunges induce greater plantar loads on the great toe region of the dominant leg of badminton players. The differences in the plantar loads of the different lunge directions may be potential risks for injuries to the lower extremities of badminton players.	[Hu, Xiaoyue; Hong, Youlian; Wang, Lin] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Li, Jing Xian] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada	Shanghai University of Sport; University of Ottawa	Wang, L (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.	wanglin@sus.edu.cn	WANG, LIN/AAD-6960-2021	Wang, Lin/0000-0003-3057-3742	Shanghai Municipal Education Commission [14ZZ149]; National Natural Science Fund of China [11572202]	Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Shanghai Municipal Education Commission (14ZZ149) and the National Natural Science Fund of China (11572202).	Abian-Vicen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037821; Castanedo JAVA, 2014, INT J SPORT PHYSIOL, V9, P689, DOI [10.1123/ijspp.2013-0269, 10.1123/IJSPP.2013-0269]; Badminton Grice T., 1992, BADMINTON STEPS SUCC; Boesen MI, 2006, AM J SPORT MED, V34, P2013, DOI 10.1177/0363546506290188; Dowling AV, 2010, AM J SPORT MED, V38, P478, DOI 10.1177/0363546509348374; Hong Y., 2013, ROUTLEDGE HDB ERGONO, P376; Hong YL, 2014, J APPL BIOMECH, V30, P113, DOI 10.1123/jab.2012-0151; Hong YL, 2012, J SCI MED SPORT, V15, P554, DOI 10.1016/j.jsams.2012.01.004; Kroner K, 1990, Br J Sports Med, V24, P169; Kuntze G, 2010, J SPORT SCI, V28, P183, DOI 10.1080/02640410903428533; Phomsoupha M, 2015, SPORTS MED, V45, P473, DOI 10.1007/s40279-014-0287-2; RAMANATHAN AK, 2010, FOOT ANKLE SURG, V16, P70, DOI DOI 10.1016/J.FAS.2009.05.006; Robinson G., 2008, INT J PERF ANAL SPOR, V8, P127; Singh R, 2012, FOOTWEAR SCI, V1, P166, DOI DOI 10.1080/19424280903063630; Wang L, 2012, RES SPORTS MED, V20, P75, DOI 10.1080/15438627.2012.660816; Wei Y, 2009, J MED BIOL ENG, V29, P172; Wiegerinck JI, 2009, GAIT POSTURE, V29, P514, DOI 10.1016/j.gaitpost.2008.12.001; Winge S, 1990, SPORTS MED, V10, P169	18	13	13	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137558	10.1371/journal.pone.0137558	http://dx.doi.org/10.1371/journal.pone.0137558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367741	gold, Green Submitted, Green Published			2022-12-26	WOS:000361601100083
J	Lee, JE; Walsh, MC; Hoehn, KL; James, DE; Wherry, EJ; Choi, Y				Lee, Jang Eun; Walsh, Matthew C.; Hoehn, Kyle L.; James, David E.; Wherry, E. John; Choi, Yongwon			Acetyl CoA Carboxylase 2 Is Dispensable for CD8(+) T Cell Responses	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; MEMORY; COENZYME; REGULATOR; OXIDATION	Differentiation of T cells is closely associated with dynamic changes in nutrient and energy metabolism. However, the extent to which specific metabolic pathways and molecular components are determinative of CD8(+) T cell fate remains unclear. It has been previously established in various tissues that acetyl CoA carboxylase 2 (ACC2) regulates fatty acid oxidation (FAO) by inhibiting carnitine palmitoyltransferase 1 (CPT1), a rate-limiting enzyme of FAO in mitochondria. Here, we explore the cell-intrinsic role of ACC2 in T cell immunity in response to infections. We report here that ACC2 deficiency results in a marginal increase of cellular FAO in CD8(+) T cells, but does not appear to influence antigen-specific effector and memory CD8(+) T cell responses during infection with listeria or lymphocytic choriomeningitis virus. These results suggest that ACC2 is dispensable for CD8(+) T cell responses.	[Lee, Jang Eun; Walsh, Matthew C.; Choi, Yongwon] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Lee, Jang Eun; Walsh, Matthew C.; Wherry, E. John; Choi, Yongwon] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Hoehn, Kyle L.] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; [James, David E.] Univ Sydney, Charles Perkins Ctr Res & Educ Hub, Sydney, NSW 2006, Australia	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Virginia; University of Sydney	Choi, Y (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	ychoi3@mail.med.upenn.edu	Wherry, John/ABI-1280-2020	James, David/0000-0001-5946-5257; Hoehn, Kyle/0000-0002-0214-3238	National Institutes of Health [AI064909, AI105343, AI112521, AI082630, AI095608, HHSN266200500030C]; Korea Institute of Oriental Medicine, Ministry of Education, Science and Technology, Korea [K13050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105343, P01AI112521, U01AI095608, U19AI082630, R21AI108627, R01AI064909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Institute of Oriental Medicine, Ministry of Education, Science and Technology, Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health AI064909 to YC, the National Institutes of Health AI105343, AI112521, AI082630, AI095608, and HHSN266200500030C to EJW, and the Korea Institute of Oriental Medicine, Ministry of Education, Science and Technology, Korea Grant K13050 to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Byersdorfer CA, 2013, BLOOD, V122, P3230, DOI 10.1182/blood-2013-04-495515; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Kolwicz SC, 2012, CIRC RES, V111, P728, DOI 10.1161/CIRCRESAHA.112.268128; Lee JE, 2008, J IMMUNOL, V181, P6201, DOI 10.4049/jimmunol.181.9.6201; Lee J, 2014, J IMMUNOL, V192, P3190, DOI 10.4049/jimmunol.1302985; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	20	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137776	10.1371/journal.pone.0137776	http://dx.doi.org/10.1371/journal.pone.0137776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367121	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100136
J	Nowacki, A; Fiechter, M; Fichtner, J; Debove, I; Lachenmayer, L; Schupbach, M; Oertel, MF; Wiest, R; Pollo, C				Nowacki, Andreas; Fiechter, Michael; Fichtner, Jens; Debove, Ines; Lachenmayer, Lenard; Schuepbach, Michael; Oertel, Markus Florian; Wiest, Roland; Pollo, Claudio			Using MDEFT MRI Sequences to Target the GPi in DBS Surgery	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; INVERSION-RECOVERY SEQUENCE; GLOBUS-PALLIDUS-INTERNUS; HIGH-RESOLUTION; SUBTHALAMIC STIMULATION; PARKINSON-DISEASE; DYSTONIA; LOCALIZATION; ELECTRODES; LOCATION	Objective Recent advances in different MRI sequences have enabled direct visualization and targeting of the Globus pallidus internus (GPi) for DBS surgery. Modified Driven Equilibrium Fourier Transform (MDEFT) MRI sequences provide high spatial resolution and an excellent contrast of the basal ganglia with low distortion. In this study, we investigate if MDEFT sequences yield accurate and reliable targeting of the GPi and compare direct targeting based on MDEFT sequences with atlas-based targeting. Methods 13 consecutive patients considered for bilateral GPi-DBS for dystonia or PD were included in this study. Preoperative targeting of the GPi was performed visually based on MDEFT sequences as well as by using standard atlas coordinates. Postoperative CT imaging was performed to calculate the location of the implanted leads as well as the active electrode(s). The coordinates of both visual and atlas based targets were compared. The stereotactic coordinates of the lead and active electrode(s) were calculated and projected on the segmented GPi. Results On MDEFT sequences the GPi was well demarcated in most patients. Compared to atlas-based planning the mean target coordinates were located significantly more posterior. Subgroup analysis showed a significant difference in the lateral coordinate between dystonia (LAT = 19.33 +/- 0.90) and PD patients (LAT = 20.67 +/- 1.69). Projected on the segmented preoperative GPi the active contacts of the DBS electrode in both dystonia and PD patients were located in the inferior and posterior part of the structure corresponding to the motor part of the GPi. Conclusions MDEFT MRI sequences provide high spatial resolution and an excellent contrast enabling precise identification and direct visual targeting of the GPi. Compared to atlas-based targeting, it resulted in a significantly different mean location of our target. Furthermore, we observed a significant variability of the target among the PD and dystonia subpopulation suggesting accurate targeting for each individual patient.	[Nowacki, Andreas; Fiechter, Michael; Fichtner, Jens; Oertel, Markus Florian; Pollo, Claudio] Univ Hosp Bern, Dept Neurosurg, Inselspital, CH-3010 Bern, Switzerland; [Nowacki, Andreas; Fiechter, Michael; Fichtner, Jens; Debove, Ines; Lachenmayer, Lenard; Schuepbach, Michael; Oertel, Markus Florian; Wiest, Roland; Pollo, Claudio] Univ Bern, Bern, Switzerland; [Debove, Ines; Lachenmayer, Lenard; Schuepbach, Michael] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Wiest, Roland] Univ Hosp Bern, Inselspital, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Nowacki, A (corresponding author), Univ Hosp Bern, Dept Neurosurg, Inselspital, CH-3010 Bern, Switzerland.	neuro.nowacki@gmail.com						Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; COFFEY CE, 1992, NEUROLOGY, V42, P527, DOI 10.1212/WNL.42.3.527; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Elias WJ, 2007, J NEUROSURG, V107, P983, DOI 10.3171/JNS-07/11/0983; Hamani C, 2008, NEUROSURGERY, V63, P217, DOI [10.1227/01.NEU.0000297026.98243.68, 10.1227/01.neu.0000317396.16089.bc]; Hemm S, 2009, ACTA NEUROCHIR, V151, P823, DOI 10.1007/s00701-009-0393-3; Karas PJ, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.9.FOCUS13383; Kern DS, 2007, NEUROLOGIST, V13, P237, DOI 10.1097/NRL.0b013e3181492c48; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Menuel C, 2005, J NEUROSURG, V103, P256, DOI 10.3171/jns.2005.103.2.0256; Mordasini L, 2012, J UROLOGY, V188, P2233, DOI 10.1016/j.juro.2012.08.043; Norris DG, 1999, MAGN RESON MATER PHY, V9, P92; O'Gorman RL, 2009, STEREOT FUNCT NEUROS, V87, P205, DOI 10.1159/000225973; Petersen EA, 2010, NEUROSURGERY, V67, P213, DOI 10.1227/01.NEU.0000380991.23444.08; Pinsker MO, 2008, ZBL NEUROCHIR, V69, P144, DOI 10.1055/s-2008-1077075; Pinsker MO, 2008, ZBL NEUROCHIR, V69, P71, DOI 10.1055/s-2007-1004583; Pinsker MO, 2009, ACTA NEUROCHIR, V151, P751, DOI 10.1007/s00701-009-0375-5; Reich CA, 2000, AM J NEURORADIOL, V21, P928; Sako W, 2014, J NEUROL NEUROSURG P; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Soria G, 2011, ANAT REC, V294, P1035, DOI 10.1002/ar.21383; Sudhyadhom A, 2009, NEUROIMAGE, V47, pT44, DOI 10.1016/j.neuroimage.2009.04.018; Tisch S, 2007, J NEUROL NEUROSUR PS, V78, P1314, DOI 10.1136/jnnp.2006.109694; Vayssiere N, 2004, J NEUROSURG, V101, P181, DOI 10.3171/jns.2004.101.2.0181; Vayssiere N, 2002, J NEUROSURG, V96, P673, DOI 10.3171/jns.2002.96.4.0673; Welter ML, 2014, NEUROLOGY, V82, P1352, DOI 10.1212/WNL.0000000000000315	26	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137868	10.1371/journal.pone.0137868	http://dx.doi.org/10.1371/journal.pone.0137868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366574	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100160
J	Radowsky, JS; Caruso, JD; Luthra, R; Bradley, MJ; Elster, EA; Forsberg, JA; Crane, NJ				Radowsky, Jason S.; Caruso, Joseph D.; Luthra, Rajiv; Bradley, Matthew J.; Elster, Eric A.; Forsberg, Jonathan A.; Crane, Nicole J.			Noninvasive Multimodal Imaging to Predict Recovery of Locomotion after Extended Limb Ischemia	PLOS ONE			English	Article							POSTOCCLUSIVE REACTIVE HYPEREMIA; PERIPHERAL VASCULAR-DISEASE; ARTERIAL OCCLUSIVE DISEASE; SPINAL-CORD-INJURY; SKIN MICROCIRCULATION; INDOCYANINE GREEN; TISSUE OXYGENATION; HEALTHY-VOLUNTEERS; NITRIC-OXIDE; PERFUSION	Acute limb ischemia is a common cause of morbidity and mortality following trauma both in civilian centers and in combat related injuries. Rapid determination of tissue viability and surgical restoration of blood flow are desirable, but not always possible. We sought to characterize the response to increasing periods of hind limb ischemia in a porcine model such that we could define a period of critical ischemia (the point after which irreversible neuromuscular injury occurs), evaluate non-invasive methods for characterizing that ischemia, and establish a model by which we could predict whether or not the animal's locomotion would return to baselines levels post-operatively. Ischemia was induced by either application of a pneumatic tourniquet or vessel occlusion (performed by clamping the proximal iliac artery and vein at the level of the inguinal ligament). The limb was monitored for the duration of the procedure with both 3-charge coupled device (3CCD) and infrared (IR) imaging for tissue oxygenation and perfusion, respectively. The experimental arms of this model are effective at inducing histologically evident muscle injury with some evidence of expected secondary organ damage, particularly in animals with longer ischemia times. Noninvasive imaging data shows excellent correlation with post-operative functional outcomes, validating its use as a non-invasive means of viability assessment, and directly monitors postocclusive reactive hyperemia. A classification model, based on partial-least squares discriminant analysis (PLSDA) of imaging variables only, successfully classified animals as "returned to normal locomotion" or "did not return to normal locomotion" with 87.5% sensitivity and 66.7% specificity after cross-validation. PLSDA models generated from non-imaging data were not as accurate (AUC of 0.53) compared the PLSDA model generated from only imaging data (AUC of 0.76). With some modification, this limb ischemia model could also serve as a means on which to test therapies designed to prolong the time before critical ischemia.	[Radowsky, Jason S.; Bradley, Matthew J.; Elster, Eric A.; Forsberg, Jonathan A.; Crane, Nicole J.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Caruso, Joseph D.; Bradley, Matthew J.; Elster, Eric A.] Walter Reed Natl Mil Med Ctr, Gen Surg, Bethesda, MD USA; [Luthra, Rajiv; Bradley, Matthew J.; Forsberg, Jonathan A.; Crane, Nicole J.] Naval Med Res Ctr, Regenerat Med Dept, Silver Spring, MD USA; [Forsberg, Jonathan A.] Walter Reed Natl Mil Med Ctr, Orthopaed & Rehabil, Bethesda, MD USA; [Crane, Nicole J.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center; Naval Medical Research Center (NMRC); Walter Reed National Military Medical Center; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Crane, NJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA.	nicole.j.crane@gmail.com	Radowsky, Jason/ABX-5157-2022; Elster, Eric/ABG-6091-2021	Elster, Eric/0000-0002-0981-2748	Congressionally Directed Medical Research Program [W81XWH-10-2-0162];  [602115HP.3720.001.A1015]	Congressionally Directed Medical Research Program(United States Department of Defense); 	This work was supported/funded by work unit number 602115HP.3720.001.A1015. Funding support includes Congressionally Directed Medical Research Program award number W81XWH-10-2-0162.	Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Burkhardt GE, 2010, J TRAUMA, V69, pS146, DOI 10.1097/TA.0b013e3181e6a09b; Cadeddu JA, 2001, J ENDOUROL, V15, P111, DOI 10.1089/08927790150501033; Cheng R, 2013, APPL OPTICS, V52, P7324, DOI 10.1364/AO.52.007324; Cheng XF, 2004, CLIN HEMORHEOL MICRO, V31, P11; Cracowski JL, 2006, TRENDS PHARMACOL SCI, V27, P503, DOI 10.1016/j.tips.2006.07.008; Crane NJ, 2008, J AM COLL SURGEONS, V206, P1159, DOI 10.1016/j.jamcollsurg.2008.01.013; Crane NJ, 2007, APPL SPECTROSC, V61, P797, DOI 10.1366/000370207781540204; Crane NJ, 2010, J UROLOGY, V184, P1279, DOI 10.1016/j.juro.2010.06.010; Crane Nicole J, 2008, BMC Surg, V8, P8, DOI 10.1186/1471-2482-8-8; CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510; Favazza CP, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3536522; Forsberg JA, 2014, CLIN ORTHOP RELAT R, V472, P2845, DOI 10.1007/s11999-014-3694-7; FRONEK A, 1973, CIRCULATION, V48, P149, DOI 10.1161/01.CIR.48.1.149; Gifford SM, 2009, J TRAUMA, V67, P259, DOI 10.1097/TA.0b013e3181a5e99b; Gorbach AM, 2003, ANN NEUROL, V54, P297, DOI 10.1002/ana.10646; Gurley K, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.075010; HAGISAWA S, 1994, J REHABIL RES DEV, V31, P1; HOPEROSS M, 1994, OPHTHALMOLOGY, V101, P529; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; Isenberg JS, 2005, MICROSURG, V25, P442, DOI 10.1002/micr.20168; Jarm T, 2003, ADV EXP MED BIOL, V530, P661; Joyal Christian C, 2013, Open Neuroimag J, V7, P1, DOI 10.2174/1874440001307010001; Kiyatkin EA, 2002, EUR J NEUROSCI, V16, P164, DOI 10.1046/j.1460-9568.2002.02066.x; Kragelj R, 2001, ANN BIOMED ENG, V29, P311, DOI 10.1114/1.1359451; Liu DZ, 2011, J RECONSTR MICROSURG, V27, P355, DOI 10.1055/s-0031-1281515; Love TJ, 1980, ANN NY ACAD SCI, V335, P429; MALAN E, 1963, J CARDIOVASC SURG, V4, P212; Millendez MB, 2012, J PEDIATR SURG, V47, P142, DOI 10.1016/j.jpedsurg.2011.10.033; Moyer HR, 2012, PLAST RECONSTR SURG, V129, P1043, DOI 10.1097/PRS.0b013e31824a2b02; Nguyen JT, 2012, J SURG RES, V178, pE43, DOI 10.1016/j.jss.2012.05.014; Rizk M, 2004, WORLD J SURG, V28, P301, DOI 10.1007/s00268-003-7396-7; Roustit M, 2013, TRENDS PHARMACOL SCI, V34, P373, DOI 10.1016/j.tips.2013.05.007; Roustit M, 2012, MICROCIRCULATION, V19, P47, DOI 10.1111/j.1549-8719.2011.00129.x; Sae-Sia W, 2007, ARCH PHYS MED REHAB, V88, P1673, DOI 10.1016/j.apmr.2007.07.037; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; SCHUBERT V, 1991, SCAND J REHABIL MED, V23, P33; SCULLY RE, 1956, AM J PATHOL, V32, P805; TARLOV IM, 1953, AMA ARCH NEUROL PSY, V70, P813, DOI 10.1001/archneurpsyc.1953.02320360128010; Thomas KN, 2015, ULTRASOUND MED BIOL, V41, P26, DOI 10.1016/j.ultrasmedbio.2014.06.012; WAHLBERG E, 1990, VASA-J VASCULAR DIS, V19, P301; Watson JC, 2002, J NEUROSURG, V96, P918, DOI 10.3171/jns.2002.96.5.0918; Wu C, 2013, ANN PLAS SURG, V70, P613, DOI 10.1097/SAP.0b013e31827565f3	43	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137430	10.1371/journal.pone.0137430	http://dx.doi.org/10.1371/journal.pone.0137430			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368024	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100070
J	Shi, JR; Yang, W; Zheng, XY				Shi, Jiarong; Yang, Wei; Zheng, Xiuyun			Robust Generalized Low Rank Approximations of Matrices	PLOS ONE			English	Article								In recent years, the intrinsic low rank structure of some datasets has been extensively exploited to reduce dimensionality, remove noise and complete the missing entries. As a well-known technique for dimensionality reduction and data compression, Generalized Low Rank Approximations of Matrices (GLRAM) claims its superiority on computation time and compression ratio over the SVD. However, GLRAM is very sensitive to sparse large noise or outliers and its robust version does not have been explored or solved yet. To address this problem, this paper proposes a robust method for GLRAM, named Robust GLRAM (RGLRAM). We first formulate RGLRAM as an l(1)-norm optimization problem which minimizes the l(1)-norm of the approximation errors. Secondly, we apply the technique of Augmented Lagrange Multipliers (ALM) to solve this l(1)-norm minimization problem and derive a corresponding iterative scheme. Then the weak convergence of the proposed algorithm is discussed under mild conditions. Next, we investigate a special case of RGLRAM and extend RGLRAM to a general tensor case. Finally, the extensive experiments on synthetic data show that it is possible for RGLRAM to exactly recover both the low rank and the sparse components while it may be difficult for previous state-of-the-art algorithms. We also discuss three issues on RGLRAM: the sensitivity to initialization, the generalization ability and the relationship between the running time and the size/number of matrices. Moreover, the experimental results on images of faces with large corruptions illustrate that RGLRAM obtains the best denoising and compression performance than other methods.	[Shi, Jiarong; Yang, Wei; Zheng, Xiuyun] Xian Univ Architecture & Technol, Sch Sci, Xian, Peoples R China	Xi'an University of Architecture & Technology	Shi, JR (corresponding author), Xian Univ Architecture & Technol, Sch Sci, Xian, Peoples R China.	jiarongs3@163.com		Shi, Jiarong/0000-0002-4315-8655	National Natural Science Foundation of China [61403298, 11401457]; Natural Science Basic Research Plan In Shaanxi Province of China [2014JQ8323, 2014JQ1019]; Shaanxi Provincial Education Department [2013JK0587]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan In Shaanxi Province of China; Shaanxi Provincial Education Department	This work is partially supported by National Natural Science Foundation of China under Grant No. 61403298 and No. 11401457, the Natural Science Basic Research Plan In Shaanxi Province of China under Grant No. 2014JQ8323 and No. 2014JQ1019, and by Shaanxi Provincial Education Department under Grant No. 2013JK0587.	[Anonymous], P VLSM; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Candes EJ, 2010, IEEE T INFORM THEORY, V56, P2053, DOI 10.1109/TIT.2010.2044061; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; Ding C, 2005, SIAM PROC S, P32; Edelman A, 1998, SIAM J MATRIX ANAL A, V20, P303, DOI 10.1137/S0895479895290954; Golub G. H., 2012, MATRIX COMPUTATIONS; Jiarong Shi, 2014, ICIC Express Letters, Part B: Applications, V5, P1619; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Ke Q., 2005, P IEEE C COMP VIS PA; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Kwak N, 2008, IEEE T PATTERN ANAL, V30, P1672, DOI 10.1109/TPAMI.2008.114; Li, 2004, P ADV NEUR INF PROC, P1569; Lin Z., 2009, UILUENG092215; Liu G., 2010, P INT C MACH LEARN, P663, DOI DOI 10.1109/ICDMW.2010.64; Liu GC, 2013, IEEE T PATTERN ANAL, V35, P171, DOI 10.1109/TPAMI.2012.88; Liu J, 2010, IEEE T NEURAL NETWOR, V21, P621, DOI 10.1109/TNN.2010.2040290; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Shen Y., 2012, OPTIMIZATION METHODS, V29, P1; Wright J., 2009, P ADV NEURAL INFORM, V22, DOI DOI 10.5555/2984093.2984326; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Ye JP, 2005, MACH LEARN, V61, P167, DOI 10.1007/s10994-005-3561-6; Zhang DQ, 2005, NEUROCOMPUTING, V69, P224, DOI 10.1016/j.neucom.2005.06.004	25	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138028	10.1371/journal.pone.0138028	http://dx.doi.org/10.1371/journal.pone.0138028			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367116	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100206
J	Song, ZL; Zhang, C; Liu, GB; Qu, D; Xue, S				Song, Zilin; Zhang, Chao; Liu, Guobin; Qu, Dong; Xue, Sha			Fractal Feature of Particle-Size Distribution in the Rhizospheres and Bulk Soils during Natural Recovery on the Loess Plateau, China	PLOS ONE			English	Article							LAND-USE PATTERNS; MICROBIAL COMMUNITIES; MOISTURE; SUCCESSION; CATCHMENT; REGION; RIVER	The application of fractal geometry to describe soil structure is an increasingly useful tool for better understanding the performance of soil systems. Only a few studies, however, have focused on the structure of rhizospheric zones, where energy flow and nutrient recycling most frequently occur. We used fractal dimensions to investigate the characteristics of particle-size distribution (PSD) in the rhizospheres and bulk soils of six croplands abandoned for 1, 5, 10, 15, 20, and 30 years on the Loess Plateau of China and evaluated the changes over successional time. The PSDs of the rhizospheres and the fractal dimensions between rhizosphere soil and bulk soils during the natural succession differed significantly due to the influence of plant roots. The rhizospheres had higher sand (0.05-1.00 mm) contents, lower silt (<0.002 mm) contents, and lower fractal dimensions than the bulk soils during the early and intermediate successional stages (1-15 years). The fractal dimensions of the rhizosphere soil and bulk soil ranged from 2.102 to 2.441 and from 2.214 to 2.459, respectively, during the 30-year restoration. Rhizospheric clay and silt contents and fractal dimension tended to be higher and sand content tended to be lower as abandonment age increased, but the bulk soils had the opposite trend. Linear regression analysis indicated that the fractal dimensions of both the rhizospheres and bulk soils were significantly linearly correlated with clay, sand, organic-carbon, and total-nitrogen contents, with R-2 ranging from 0.526 to 0.752 (P<0.001). In conclusion, PSD differed significantly between the rhizosphere soil and bulk soil. The fractal dimension was a sensitive and useful index for quantifying changes in the properties of the different soil zones. This study will greatly aid the application of the fractal method for describing soil structure and nutrient status and the understanding of the performance of rhizospheric zones during ecological restoration.	[Song, Zilin; Qu, Dong] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Peoples R China; [Zhang, Chao; Liu, Guobin; Xue, Sha] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Zhang, C (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	zhangchaolynn@163.com						An SS, 2008, PEDOSPHERE, V18, P809, DOI 10.1016/S1002-0160(08)60077-6; Bird N, 2006, J HYDROL, V322, P211, DOI 10.1016/j.jhydrol.2005.02.039; Cutler NA, 2014, SOIL BIOL BIOCHEM, V69, P359, DOI 10.1016/j.soilbio.2013.11.022; Delgado-Baquerizo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059807; Du F, 2007, COLLOID SURFACE B, V58, P278, DOI 10.1016/j.colsurfb.2007.04.002; Falconer K. J., 2003, FRACTAL GEOMETRY MAT; Fu BJ, 2003, CATENA, V54, P197, DOI 10.1016/S0341-8162(03)00065-1; Gao GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088559; Hinsinger P, 2009, PLANT SOIL, V321, P117, DOI 10.1007/s11104-008-9885-9; Jin K, SOIL TILLAGE RES, V104, P115; Ladygina N, 2010, SOIL BIOL BIOCHEM, V42, P162, DOI 10.1016/j.soilbio.2009.10.009; Liu X, 2009, GEODERMA, V154, P123, DOI 10.1016/j.geoderma.2009.10.005; MANDELBORT B. B., 1982, FRACTAL GEOMETRY NAT, P45; Marriott CA, 1997, PLANT SOIL, V196, P151, DOI 10.1023/A:1004288610550; Peng G, 2014, J SOIL SEDIMENT, V14, P1116, DOI 10.1007/s11368-014-0876-6; PERFECT E, 1991, SOIL SCI SOC AM J, V55, P1552, DOI 10.2136/sssaj1991.03615995005500060009x; RIEU M, 1991, SOIL SCI SOC AM J, V55, P1231, DOI 10.2136/sssaj1991.03615995005500050006x; Rosenvald K, 2011, ECOL ENG, V37, P1027, DOI 10.1016/j.ecoleng.2010.05.011; Su YZ, 2004, GEODERMA, V122, P43, DOI 10.1016/j.geoderma.2003.12.003; Tscherko D, 2004, SOIL BIOL BIOCHEM, V36, P1685, DOI 10.1016/j.soilbio.2004.07.004; TURCOTTE DL, 1986, J GEOPHYS RES-SOLID, V91, P1921, DOI 10.1029/JB091iB02p01921; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Uren NC, 2007, RHIZOSPHERE BIOCH OR, P1, DOI [10.1201/9781420005585.ch1, DOI 10.1201/9781420005585.CH1]; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang B, 2011, ENVIRON EARTH SCI, V62, P915, DOI 10.1007/s12665-010-0577-4; Wang XD, 2006, GEODERMA, V134, P56, DOI 10.1016/j.geoderma.2005.08.014; Wang YQ, 2009, GEODERMA, V150, P141, DOI 10.1016/j.geoderma.2009.01.021; [吴彩霞 WU Cai-xia], 2009, [草业科学, Pratacultural Science], V26, P24; Xu GC, 2013, CATENA, V101, P17, DOI 10.1016/j.catena.2012.09.013; Yang P.L, 1993, CHINESE SCI BULL, V38, P1896, DOI DOI 10.1360/csb1993-38-20-1896; Zhang C, 2012, EUR J SOIL BIOL, V50, P127, DOI 10.1016/j.ejsobi.2012.01.002; Zhang Chao, 2011, Scientia Agricultura Sinica, V44, P507; Zhang C, 2011, GEODERMA, V161, P115, DOI 10.1016/j.geoderma.2010.12.003; Zhao QO, 2010, APPL SOIL ECOL, V46, P341, DOI 10.1016/j.apsoil.2010.10.007; Zheng FL, 2006, PEDOSPHERE, V16, P420, DOI 10.1016/S1002-0160(06)60071-4; Zhou Ping, 2008, Acta Agrestia Sinica, V16, P396; Zhu BB, 2010, ECOL RES, V25, P531, DOI 10.1007/s11284-009-0683-5; Zhu YJ, 2008, GEODERMA, V147, P185, DOI 10.1016/j.geoderma.2008.08.012	38	16	16	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138057	10.1371/journal.pone.0138057	http://dx.doi.org/10.1371/journal.pone.0138057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368339	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100212
J	Valenza, E; Otsuka, Y; Bulf, H; Ichikawa, H; Kanazawa, S; Yamaguchi, MK				Valenza, Eloisa; Otsuka, Yumiko; Bulf, Hermann; Ichikawa, Hiroko; Kanazawa, So; Yamaguchi, Masami K.			Face Orientation and Motion Differently Affect the Deployment of Visual Attention in Newborns and 4-Month-Old Infants	PLOS ONE			English	Article							RECOGNITION; PREFERENCE; PERCEPTION; EXPERIENCE; SPECIALIZATION; STIMULI; LOOKING; SYSTEM; DISENGAGEMENT; 3-MONTH-OLDS	Orienting visual attention allows us to properly select relevant visual information from a noisy environment. Despite extensive investigation of the orienting of visual attention in infancy, it is unknown whether and how stimulus characteristics modulate the deployment of attention from birth to 4 months of age, a period in which the efficiency in orienting of attention improves dramatically. The aim of the present study was to compare 4-month-old infants' and newborns' ability to orient attention from central to peripheral stimuli that have the same or different attributes. In Experiment 1, all the stimuli were dynamic and the only attribute of the central and peripheral stimuli to be manipulated was face orientation. In Experiment 2, both face orientation and motion of the central and peripheral stimuli were contrasted. The number of valid trials and saccadic latency were measured at both ages. Our results demonstrated that the deployment of attention is mainly influenced by motion at birth, while it is also influenced by face orientation at 4-month of age. These findings provide insight into the development of the orienting visual attention in the first few months of life and suggest that maturation may be not the only factor that determines the developmental change in orienting visual attention from birth to 4 months.	[Valenza, Eloisa] Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, I-35131 Padua, Italy; [Valenza, Eloisa] Univ Padua, Interdept Ctr Cognit Sci CISC, I-35131 Padua, Italy; [Otsuka, Yumiko] UNSW Australia, Sch Psychol, Sydney, NSW 2052, Australia; [Bulf, Hermann] Univ Milano Bicocca, Dept Psychol, I-20126 Milan, Italy; [Bulf, Hermann] Milan Ctr Neurosci NeuroMI, Milan, Italy; [Ichikawa, Hiroko; Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Hachioji, Tokyo 1920393, Japan; [Ichikawa, Hiroko] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa 2148565, Japan	University of Padua; University of Padua; University of New South Wales Sydney; University of Milano-Bicocca; Chuo University; Japan Society for the Promotion of Science; Japan Womens University	Otsuka, Y (corresponding author), Ehime Univ, Fac Law & Letters, Bunkyo Cho 3, Matsuyama, Ehime 7908577, Japan.	otsuka.yumiko.wf@ehime-u.ac.jp			Progetti di Eccellenza CARIPARO [1873/2012]; JSPS [26285167, 196068]; MEXT [20119002]	Progetti di Eccellenza CARIPARO(Fondazione Cariparo); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The present research was supported by a grant from 'Progetti di Eccellenza CARIPARO' (rep. no. 1873/2012). The research was also supported by a Grant-in-Aid for Scientific Research (B) (26285167 to M.K.Y) and by Excellent Young Researcher Overseas Visit Program (196068 to Y.O.) from JSPS, and by a Grant-in-Aid for Scientific Research on Innovative Areas, 'Face perception and recognition' from MEXT KAKENHI (20119002 to M. K. Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON J, 1988, PERCEPTION, V17, P367; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Bertin E, 2004, DEVELOPMENTAL SCI, V7, P431, DOI 10.1111/j.1467-7687.2004.00363.x; Bhatt RS, 2005, CHILD DEV, V76, P169, DOI 10.1111/j.1467-8624.2005.00837.x; Blaga OA, 2006, DEV PSYCHOL, V42, P1069, DOI 10.1037/0012-1649.42.6.1069; Bulf H, 2010, VIS COGN, V18, P504, DOI 10.1080/13506280903272037; Butcher PR, 2000, INFANT BEHAV DEV, V23, P3, DOI 10.1016/S0163-6383(00)00031-X; Cassia VM, 2008, CHILD DEV, V79, P807, DOI 10.1111/j.1467-8624.2008.01160.x; Cassia VM, 2011, BRIT J PSYCHOL, V102, P816, DOI 10.1111/j.2044-8295.2011.02046.x; Cassia VM, 2009, PSYCHOL SCI, V20, P853, DOI 10.1111/j.1467-9280.2009.02376.x; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; Cassia VM, 2001, DEVELOPMENTAL SCI, V4, P101; Cohen LB, 2001, INFANT CHILD DEV, V10, P83, DOI 10.1002/icd.250; Coulon M, 2011, INT J BEHAV DEV, V35, P282, DOI 10.1177/0165025410396765; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; de Haan M, 2001, COGNITIVE DEV, V16, P659, DOI 10.1016/S0885-2014(01)00051-X; de Schonen S, 2002, PSYCHOL TURN MILLENN; Easterbrook MA, 1999, CAN J EXP PSYCHOL, V53, P231, DOI 10.1037/h0087312; Elman JL, 1996, RETHINKING INNATENES; Farroni T, 1999, DEVELOPMENTAL SCI, V2, P174, DOI 10.1111/1467-7687.00066; FINLAY D, 1984, DEV PSYCHOL, V20, P29, DOI 10.1037/0012-1649.20.1.29; Frick JE, 1999, CHILD DEV, V70, P537, DOI 10.1111/1467-8624.00039; Gallay M, 2006, CHILD DEV, V77, P984, DOI 10.1111/j.1467-8624.2006.00914.x; GOREN CC, 1975, PEDIATRICS, V56, P544; Guellai B, 2011, VIS COGN, V19, P1212, DOI 10.1080/13506285.2011.620578; Halit H, 2003, NEUROIMAGE, V19, P1180, DOI 10.1016/S1053-8119(03)00076-4; HOOD B, 1990, DEV MED CHILD NEUROL, V32, P1067; Hood B. M., 1995, ADV INFANCY RES, V10, P163; HOOD BM, 1993, INFANT BEHAV DEV, V16, P405, DOI 10.1016/0163-6383(93)80001-O; Hunnius S, 2004, INFANT BEHAV DEV, V27, P397, DOI 10.1016/j.infbeh.2004.02.003; Ichikawa H, 2013, JPN PSYCHOL RES, V55, P254, DOI 10.1111/j.1468-5884.2012.00540.x; Johnson M H, 1990, J Cogn Neurosci, V2, P81, DOI 10.1162/jocn.1990.2.2.81; JOHNSON MH, 1991, J COGNITIVE NEUROSCI, V3, P335, DOI 10.1162/jocn.1991.3.4.335; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Johnson MH, 1991, BIOL COGNITIVE DEV C; JOHNSON MH, 1993, BRAIN DEV COGNITION; Kelly DJ, 2007, INFANCY, V11, P87, DOI 10.1207/s15327078in1101_4; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; KLEINER KA, 1993, NATO ADV SCI INST SE, V69, P103; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Lee K, 2013, J VIS, V13, P985; Leo I, 2009, DEVELOPMENTAL SCI, V12, P492, DOI 10.1111/j.1467-7687.2008.00791.x; Lewis TL, 1996, INVEST OPHTH VIS SCI, V37, pS1067; Libertus K, 2014, INT J BEHAV DEV, V38, P529, DOI 10.1177/0165025414535122; Libertus K, 2011, DEVELOPMENTAL SCI, V14, P1355, DOI 10.1111/j.1467-7687.2011.01084.x; MACFARLANE A, 1976, J EXP CHILD PSYCHOL, V21, P532, DOI 10.1016/0022-0965(76)90080-1; Matsuzawa M, 1997, INFANT BEHAV DEV, V20, P449, DOI 10.1016/S0163-6383(97)90035-7; MAURER D, 1981, CHILD DEV, V52, P196, DOI 10.2307/1129230; MICHEL GF, 1995, DEV PSYCHOBIOLOGY IN; Nelson C.A., 2001, HDB DEV COGNITIVE NE; Nelson CA, 2001, INFANT CHILD DEV, V10, P3, DOI 10.1002/icd.239; Otsuka Y, 2012, J EXP CHILD PSYCHOL, V111, P164, DOI 10.1016/j.jecp.2010.10.014; Otsuka Y, 2009, CHILD DEV, V80, P1259, DOI 10.1111/j.1467-8624.2009.01330.x; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Peltola MJ, 2008, DEVELOPMENTAL SCI, V11, P60, DOI 10.1111/j.1467-7687.2007.00659.x; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Rafal Robert, 1995, P625; REGAL DM, 1981, VISION RES, V21, P549, DOI 10.1016/0042-6989(81)90100-0; ROTHBART MK, 1994, DEV PSYCHOPATHOL, V6, P635, DOI 10.1017/S0954579400004715; Sale A, 2004, NEUROPHARMACOLOGY, V47, P649, DOI 10.1016/j.neuropharm.2004.07.008; Shirai N, 2010, JPN PSYCHOL RES, V52, P78, DOI 10.1111/j.1468-5884.2010.00426.x; Simion F, 2002, DEVELOPMENTAL SCI, V5, P427, DOI 10.1111/1467-7687.00237; Simion F, 2001, INFANT CHILD DEV, V10, P59, DOI 10.1002/icd.247; Simion F, 2007, PROG BRAIN RES, V164, P169, DOI 10.1016/S0079-6123(07)64009-6; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; TRONICK E, 1972, PERCEPT PSYCHOPHYS, V11, P373, DOI 10.3758/BF03206270; Turati C, 2004, INFANCY, V6, P275, DOI 10.1207/s15327078in0602_8; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; Turati C, 2005, J EXP CHILD PSYCHOL, V90, P255, DOI 10.1016/j.jecp.2004.11.001; Turati C, 2004, CURR DIR PSYCHOL SCI, V13, P5, DOI 10.1111/j.0963-7214.2004.01301002.x; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Valenza E, 2007, DEVELOPMENTAL SCI, V10, P492, DOI 10.1111/j.1467-7687.2007.00602.x; Valenza E, 2006, CHILD DEV, V77, P1810, DOI 10.1111/j.1467-8624.2006.00975.x; Valenza E, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00027; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; [No title captured]	77	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136965	10.1371/journal.pone.0136965	http://dx.doi.org/10.1371/journal.pone.0136965			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26367122	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100038
J	Castillo, V; Onate, M; Woehlbier, U; Rozas, P; Andreu, C; Medinas, D; Valdes, P; Osorio, F; Mercado, G; Vidal, RL; Kerr, B; Court, FA; Hetz, C				Castillo, Valentina; Onate, Maritza; Woehlbier, Ute; Rozas, Pablo; Andreu, Catherine; Medinas, Danilo; Valdes, Pamela; Osorio, Fabiola; Mercado, Gabriela; Vidal, Rene L.; Kerr, Bredford; Court, Felipe A.; Hetz, Claudio			Functional Role of the Disulfide Isomerase ERp57 in Axonal Regeneration	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOPLASMIC-RETICULUM STRESS; PARKINSONS-DISEASE; SCHWANN-CELLS; NEURODEGENERATIVE DISEASES; MISFOLDED PROTEINS; NERVE REGENERATION; SENSOR IRE1-ALPHA; PERIPHERAL-NERVE	ERp57 (also known as grp58 and PDIA3) is a protein disulfide isomerase that catalyzes disulfide bonds formation of glycoproteins as part of the calnexin and calreticulin cycle. ERp57 is markedly upregulated in most common neurodegenerative diseases downstream of the endoplasmic reticulum (ER) stress response. Despite accumulating correlative evidence supporting a neuroprotective role of ERp57, the contribution of this foldase to the physiology of the nervous system remains unknown. Here we developed a transgenic mouse model that overexpresses ERp57 in the nervous system under the control of the prion promoter. We analyzed the susceptibility of ERp57 transgenic mice to undergo neuro-degeneration. Unexpectedly, ERp57 overexpression did not affect dopaminergic neuron loss and striatal denervation after injection of a Parkinson's disease-inducing neurotoxin. In sharp contrast, ERp57 transgenic animals presented enhanced locomotor recovery after mechanical injury to the sciatic nerve. These protective effects were associated with enhanced myelin removal, macrophage infiltration and axonal regeneration. Our results suggest that ERp57 specifically contributes to peripheral nerve regeneration, whereas its activity is dispensable for the survival of a specific neuronal population of the central nervous system. These results demonstrate for the first time a functional role of a component of the ER proteostasis network in peripheral nerve regeneration.	[Castillo, Valentina; Onate, Maritza; Woehlbier, Ute; Rozas, Pablo; Andreu, Catherine; Medinas, Danilo; Valdes, Pamela; Mercado, Gabriela; Vidal, Rene L.; Hetz, Claudio] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago, Chile; [Castillo, Valentina; Onate, Maritza; Woehlbier, Ute; Rozas, Pablo; Andreu, Catherine; Medinas, Danilo; Valdes, Pamela; Mercado, Gabriela; Hetz, Claudio] Univ Chile, Inst Biomed Sci, Ctr Mol Studies Cell, Program Cellular & Mol Biol, Santiago, Chile; [Onate, Maritza; Court, Felipe A.] Pontificia Univ Catolica Chile, Fac Biol, Millenium Nucl Regenerat Biol, Santiago, Chile; [Osorio, Fabiola] Univ Chile, Inst Biomed Sci, Program Immunol, Santiago, Chile; [Vidal, Rene L.] Neuroun Biomed Fdn, CENPAR, Santiago, Chile; [Kerr, Bredford] Ctr Estudios Cient, Valdivia, Chile; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Universidad de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Harvard University; Harvard T.H. Chan School of Public Health	Hetz, C (corresponding author), Univ Chile, Inst Biomed Sci, Independencia 1027, Santiago, Chile.	chetz@med.uchile.cl	Andreu, Catherine/AAV-6825-2021; Hetz, Claudio/ABD-7514-2021; Medinas, Danilo/ABA-1182-2021; Vidal, Rene Luis/S-7154-2019; Osorio, Fabiola/H-4529-2014	Andreu, Catherine/0000-0003-2402-0252; Bilches Medinas, Danilo/0000-0002-1822-1974; Osorio, Fabiola/0000-0001-5306-7856; Court, Felipe/0000-0002-9394-7601; Kerr, Bredford/0000-0001-8714-8726; vidal, rene/0000-0002-4305-7387; Woehlbier, Ute/0000-0003-3114-9708; Mercado, Gabriela/0000-0002-3346-5758	FONDEF [D11I1007]; Millennium Institute [P09-015-F]; Frick Foundation; FONDECYT [1140549]; Michael J Fox Foundation for Parkinson Research; Alzheimer's Association; Muscular Dystrophy Association; COPEC-UC Foundation; CONICYT [USA2013-0003]; ECOS-CONICYT [C13S02]; ALS Therapy Alliance; Millennium Nucleus [P-07-011-F]; CONICYT PAI [82130031];  [ACT1109]	FONDEF; Millennium Institute(Takeda Pharmaceutical Company Ltd); Frick Foundation; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Michael J Fox Foundation for Parkinson Research; Alzheimer's Association(Alzheimer's Association); Muscular Dystrophy Association(Muscular Dystrophy Association); COPEC-UC Foundation; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); ECOS-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); ALS Therapy Alliance; Millennium Nucleus; CONICYT PAI; 	This work was funded by Ring Initiative ACT1109 (FC and CH), FONDEF D11I1007, Millennium Institute No. P09-015-F, the Frick Foundation, FONDECYT no. 1140549, Michael J Fox Foundation for Parkinson Research, the Alzheimer's Association, the Muscular Dystrophy Association, COPEC-UC Foundation, CONICYT grant USA2013-0003, ECOS-CONICYT C13S02, and ALS Therapy Alliance (CH). Millennium Nucleus P-07-011-F, FONDECYT no. 1110987 (FC), FONDECYT no. 1150608 (RV). FONDECYT no. 3130351 (DM), FONDECYT no. 3120146 (GM), CONICYT PAI No 82130031. VC, PR and MO are postgraduate fellows supported by a CONICYT fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu CI, 2012, FEBS LETT, V586, P2826, DOI 10.1016/j.febslet.2012.07.023; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Bernard-Marissal N, 2015, NEUROBIOL DIS, V73, P130, DOI 10.1016/j.nbd.2014.09.009; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; Bradford BM, 2009, J NEUROSCI, V29, P15445, DOI 10.1523/JNEUROSCI.4195-09.2009; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Coleman M, 2011, ADV GENET, V73, P185, DOI 10.1016/B978-0-12-380860-8.00005-7; Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026; Court F, 2000, BRAIN RES, V867, P1, DOI 10.1016/S0006-8993(00)02140-5; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Egawa N, 2011, J BIOL CHEM, V286, P7947, DOI 10.1074/jbc.M110.156430; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Filezac de LEtang A, 2015, NATURE NEUROSCIENCE; Follet J, 2002, J VIROL, V76, P2434, DOI 10.1128/JVI.76.5.2434-2439.2002; Garbi N, 2007, CURR OPIN IMMUNOL, V19, P99, DOI 10.1016/j.coi.2006.11.013; Geuna S, 2009, INT REV NEUROBIOL, V87, P27, DOI 10.1016/S0074-7742(09)87003-7; Gonzalez-Perez P, 2015, GENE, V566, P158, DOI 10.1016/j.gene.2015.04.035; Gorbatyuk MS, 2012, MOL THER, V20, P1327, DOI 10.1038/mt.2012.28; Grek C, 2014, ENDOPLASMIC RETICULU, V1, P4, DOI 10.2478/ersc-2013-0001; Grubb S, 2012, MOL BIOL CELL, V23, P520, DOI 10.1091/mbc.E11-08-0704; Hashida K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047950; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hirsch I, 2014, APOPTOSIS, V19, P801, DOI 10.1007/s10495-013-0961-0; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Hosoda A, 2010, BIOCHEM J, V425, P117, DOI 10.1042/BJ20091269; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z; Jin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112837; Jung J, 2011, FASEB J, V25, P3929, DOI 10.1096/fj.11-184911; Kim K, 2013, BLOOD, V122, P1052, DOI 10.1182/blood-2013-03-492504; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Kraus A, 2010, J BIOL CHEM, V285, P18928, DOI 10.1074/jbc.M110.107201; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Lu X, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-17; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Mantuano E, 2011, J NEUROSCI, V31, P13376, DOI 10.1523/JNEUROSCI.2850-11.2011; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Nardo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025545; Nemere I, 2010, J BIOL CHEM, V285, P31859, DOI 10.1074/jbc.M110.116954; Niforou K, 2014, REDOX BIOL, V2, P323, DOI 10.1016/j.redox.2014.01.017; NOEL F, 1995, J NEUROSCI, V15, P6926; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Penas C, 2011, NEUROSCIENCE, V178, P33, DOI 10.1016/j.neuroscience.2011.01.012; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rodriguez DA, 2012, EMBO J, V31, P2322, DOI 10.1038/emboj.2012.84; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Valdes P, 2014, P NATL ACAD SCI USA, V111, P6804, DOI 10.1073/pnas.1321845111; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Villegas R, 2014, J NEUROSCI, V34, P7179, DOI 10.1523/JNEUROSCI.4784-13.2014; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wu XF, 2014, TOXICOL LETT, V230, P19, DOI 10.1016/j.toxlet.2014.07.026; Yang Qi-rui, 2015, Instrument Technique and Sensor, P1; Yao M, 1998, LARYNGOSCOPE, V108, P1141, DOI 10.1097/00005537-199808000-00007; Ying ZX, 2014, P NATL ACAD SCI USA, V111, P16142, DOI 10.1073/pnas.1407462111; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620	84	36	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136620	10.1371/journal.pone.0136620	http://dx.doi.org/10.1371/journal.pone.0136620			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361352	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100013
J	Liu, PF; Xiao, L; Zhang, J				Liu, Pengfei; Xiao, Liang; Zhang, Jun			Fast Second Degree Total Variation Method for Image Compressive Sensing	PLOS ONE			English	Article							SIGNAL RECOVERY; MINIMIZATION; ALGORITHMS	This paper presents a computationally efficient algorithm for image compressive sensing reconstruction using a second degree total variation (HDTV2) regularization. Firstly, a preferably equivalent formulation of the HDTV2 functional is derived, which can be formulated as a weighted L-1-L-2 mixed norm of second degree image derivatives under the spectral decomposition framework. Secondly, using the equivalent formulation of HDTV2, we introduce an efficient forward-backward splitting (FBS) scheme to solve the HDTV2-based image reconstruction model. Furthermore, from the averaged non-expansive operator point of view, we make a detailed analysis on the convergence of the proposed FBS algorithm. Experiments on medical images demonstrate that the proposed method outperforms several fast algorithms of the TV and HDTV2 reconstruction models in terms of peak signal to noise ratio (PSNR), structural similarity index (SSIM) and convergence speed.	[Liu, Pengfei; Xiao, Liang] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, Jun] Nanjing Univ Sci & Technol, Sch Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology; Nanjing University of Science & Technology	Xiao, L (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China.	xiaoliang@mail.njust.edu.cn	xiao, liang/G-2968-2010; xiao, liang/V-2280-2019	xiao, liang/0000-0003-0178-9384; xiao, liang/0000-0003-0178-9384	Fundamental Research Funds for the Central Universities [30915012204]; National Nature Science Foundation of China [61171165, 11431015, 61101198]; Nature Science Foundation of Jiangsu Province [BK2012800]; National Scientific Equipment Developing Project of China [2012YQ050250]; Six Top Talents Project of Jiangsu Province [2012DZXX-036]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Scientific Equipment Developing Project of China; Six Top Talents Project of Jiangsu Province	This research is supported by the Fundamental Research Funds for the Central Universities (30915012204), the National Nature Science Foundation of China (61171165, 11431015, 61101198), Nature Science Foundation of Jiangsu Province (BK2012800), National Scientific Equipment Developing Project of China (2012YQ050250) and Six Top Talents Project of Jiangsu Province (2012DZXX-036).	Beck A, 2009, IEEE T IMAGE PROCESS, V18, P2419, DOI 10.1109/TIP.2009.2028250; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bredies K, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/1/015005; Byrne C, 2004, INVERSE PROBL, V20, P103, DOI 10.1088/0266-5611/20/1/006; Byrne C., 2007, APPL ITERATIVE METHO; Candes E, 2005, PROC SPIE, V5674, P76, DOI 10.1117/12.600722; Chan T, 2000, SIAM J SCI COMPUT, V22, P503, DOI 10.1137/S1064827598344169; Combettes PL, 2011, SPRINGER SER OPTIM A, V49, P185, DOI 10.1007/978-1-4419-9569-8_10; Combettes PL, 2005, MULTISCALE MODEL SIM, V4, P1168, DOI 10.1137/050626090; Hu Y, 2012, IEEE T IMAGE PROCESS, V21, P2559, DOI 10.1109/TIP.2012.2183143; Lefkimmiatis S, 2012, IEEE T IMAGE PROCESS, V21, P983, DOI 10.1109/TIP.2011.2168232; Li F, 2007, J VIS COMMUN IMAGE R, V18, P322, DOI 10.1016/j.jvcir.2007.04.005; Lysaker M, 2006, INT J COMPUT VISION, V66, P5, DOI 10.1007/s11263-005-3219-7; Lysaker M, 2003, IEEE T IMAGE PROCESS, V12, P1579, DOI 10.1109/TIP.2003.819229; Ma S., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587391; Nesterov Y., 1983, SOV MATH DOKL, V27, P372; Oliveira JP, 2009, SIGNAL PROCESS, V89, P1683, DOI 10.1016/j.sigpro.2009.03.018; Schnabel RB, 1983, NUMERICAL METHODS UN; Sluder G, 2007, METHOD CELL BIOL, V81, P1; Sra S, 2011, LECT NOTES ARTIF INT, V6913, P305, DOI 10.1007/978-3-642-23808-6_20; Vogel C. R., 2002, FRONT APPL MATH, DOI DOI 10.1137/1.9780898717570; Wen YW, 2008, SIAM J SCI COMPUT, V30, P2655, DOI 10.1137/070683374; Yang JF, 2010, IEEE J-STSP, V4, P288, DOI 10.1109/JSTSP.2010.2042333; You YL, 2000, IEEE T IMAGE PROCESS, V9, P1723, DOI 10.1109/83.869184	24	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137115	10.1371/journal.pone.0137115	http://dx.doi.org/10.1371/journal.pone.0137115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361008	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100023
J	Zhu, T; Wang, J; Pei, Y; Wang, Q; Wu, Y; Qiu, G; Zhang, D; Lv, M; Li, W; Zhang, J				Zhu, T.; Wang, J.; Pei, Y.; Wang, Q.; Wu, Y.; Qiu, G.; Zhang, D.; Lv, M.; Li, W.; Zhang, J.			Neddylation controls basal MKK7 kinase activity in breast cancer cells	ONCOGENE			English	Article							PROTEIN-KINASE; NEDD8-ACTIVATING ENZYME; UBIQUITIN LIGASE; ACTIVATION; JNK; NEDD8; APOPTOSIS; IDENTIFICATION; INHIBITOR; STABILITY	The c-Jun NH2-terminal protein kinase (JNK) pathway has been implicated in mammary tumor development. However, the molecular mechanisms regulating JNK activity in breast cancer cells remain unclear. Here, we report that the inhibition of ubiquitination-like post-translational modification neddylation through different strategies results in enhanced basal JNK phosphorylation in human breast cancer cells. The upregulation of basal JNK phosphorylation upon neddylation inhibition is independent of the deneddylation of Cullins, the well-characterized neddylation substrates. Since augmented basal JNK phosphorylation via ectopic MKK7 expression impedes proliferation and the epithelial-to-mesenchymal transition (EMT) phenotype, the neddylation system might contribute to mammary tumor development partially through limiting basal JNK phosphorylation. Further exploration reveals that MKK7, a JNK-specific MAP2K, undergoes neddylation in human breast cancer cells. MKK7 coprecipitates with a fragment of Ran-binding protein 2 (RanBP2), a large multimodular and pleiotropic protein that has been recognized as a SUMO E3 ligase. Knockdown of RanBP2 attenuates MKK7 neddylation and augments basal JNK phosphorylation without affecting the neddylation of Cullins, whereas ectopic expression of a RanBP2 fragment possessing SUMO E3 activity (RanBP2 Delta FG) manifests the opposite effects. In vitro neddylation assays confirm that RanBP2 Delta FG works as the neddylation E3 ligase for MKK7. The basal kinase activity of endogenous MKK7 increases upon RanBP2 knockdown but decreases upon the ectopic expression of RanBP2 Delta FG. Furthermore, purified MKK7 shows reduced basal kinase activity after in vitro neddylation by RanBP2 Delta FG. Consistently, RanBP2 knockdown leads to reduced proliferation and impaired EMT phenotype in human breast cancer cells and the effects of RanBP2 knockdown are reversed by simultaneous MKK7 knockdown. Taken together, our data suggest that MKK7 undergoes neddylation in human breast cancer cells, which limits its basal kinase activity.	[Zhu, T.; Wang, J.; Pei, Y.; Wang, Q.; Wu, Y.; Qiu, G.; Zhang, D.; Lv, M.; Li, W.; Zhang, J.] Inst Basic Med Sci, Dept Mol Immunol, 27 Taiping Rd, Beijing 100850, Peoples R China		Zhang, J (corresponding author), Inst Basic Med Sci, Dept Mol Immunol, 27 Taiping Rd, Beijing 100850, Peoples R China.	zhangjy@nic.bmi.ac.cn	Z, D/AFG-4813-2022	, DALIN/0000-0002-6553-7373; Zhang, Jiyan/0000-0001-8011-8719	National Natural Science Foundation of China [81472736, 31270960]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Professors Ming Shi, Ning Guo, Ailing Li and Xuemin Zhang for providing reagents. This work was supported by grants from National Natural Science Foundation of China (81472736, 31270960).	Aoki I, 2013, ONCOGENE, V32, P3954, DOI 10.1038/onc.2012.428; Broemer M, 2010, MOL CELL, V40, P810, DOI 10.1016/j.molcel.2010.11.011; Cellurale C, 2012, CANCER RES, V72, P472, DOI 10.1158/0008-5472.CAN-11-1628; Cellurale C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012469; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Collier-Hyams LS, 2005, J IMMUNOL, V175, P4194, DOI 10.4049/jimmunol.175.7.4194; Cui J, 2009, MOL CANCER THER, V8, P3214, DOI 10.1158/1535-7163.MCT-09-0408; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Embade N, 2012, HEPATOLOGY, V55, P1237, DOI 10.1002/hep.24795; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Godbersen JC, 2014, CLIN CANCER RES, V20, P1576, DOI 10.1158/1078-0432.CCR-13-0987; Guo YY, 2013, HEPATOLOGY, V57, P140, DOI 10.1002/hep.25978; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Pelham CJ, 2012, CELL METAB, V16, P462, DOI 10.1016/j.cmet.2012.08.011; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Wang J, 2011, MOL BIOL CELL, V22, P117, DOI 10.1091/mbc.E10-06-0492; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang J, 2008, CELL DEATH DIFFER, V15, P1654, DOI 10.1038/cdd.2008.87; Zhang JY, 2010, J IMMUNOL, V185, P3554, DOI 10.4049/jimmunol.1000431; Zhang Z, 2014, ONCOGENE, V33, P3374, DOI 10.1038/onc.2013.337	36	12	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 19	2016	35	20					2624	2633		10.1038/onc.2015.323	http://dx.doi.org/10.1038/onc.2015.323			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GS	26364603				2022-12-26	WOS:000376165700009
J	Wang, CP; Hascall, VC; Zhang, FM; Linhardt, RJ; Abbadi, A; Wang, AM				Wang, Christina P.; Hascall, Vincent C.; Zhang, Fuming; Linhardt, Robert J.; Abbadi, Amina; Wang, Aimin			The Responses of Hyperglycemic Dividing Mesangial Cells to Heparin Are Mediated by the Non-reducing Terminal Trisaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; diabetic nephropathy; endoplasmic reticulum stress (ER stress); glucose metabolism; heparanase; heparin; hyaluronan; inflammation; monocyte adhesive hyaluronan matrix; trisaccharide	CARBOHYDRATE ELECTROPHORESIS FACE; C-FOS INDUCTION; HYALURONAN MATRIX; SULFATE; GLYCOSAMINOGLYCANS; MICROANALYSIS; SPECIFICITY; ADHESIVE; LYASES	Our previous studies showed: (i) that growth-arrested G(0)/G(1) rat mesangial cells stimulated to divide in hyperglycemic medium initiate intracellular hyaluronan synthesis that induces autophagy and the cyclin D3-induced formation of a monocyte-adhesive extracellular hyaluronan matrix after completing cell division; and (ii) that heparin inhibits the intracellular hyaluronan and autophagy responses, but after completing division, induces hyaluronan synthesis at the plasma membrane with the formation of a larger monocyte-adhesive hyaluronan matrix. This study shows: (i) that the non-terminal trisaccharide of heparin is sufficient to initiate the same responses as intact heparin, (ii) that a fully sulfated tetrasaccharide isolated from bacterial heparin lyase 1 digests of heparin that contains a -2S-iduronate on the non-reducing end does not initiate the same responses as intact heparin, and (iii) that removal of the -2S-iduronate to expose the fully sulfated trisaccharide (GlcNS(6S)-IdoUA(2S)-GlcNS(6S)) does initiate the same responses as intact heparin. These results provide evidence that mammalian heparanase digestion of heparin and heparan sulfate exposes a cryptic motif on the non-reducing termini that is recognized by a receptor on dividing cells.	[Wang, Christina P.; Hascall, Vincent C.; Abbadi, Amina; Wang, Aimin] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem, Troy, NY 12180 USA	Cleveland Clinic Foundation; Rensselaer Polytechnic Institute	Wang, AM (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, ND20, Cleveland, OH 44195 USA.	wanga@ccf.org			NHLBI, National Institutes of Health [P01 HL107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062934] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Hyaluronan Matrices in Vascular Pathologies Program is funded in its entirety by the NHLBI, National Institutes of Health, Grant P01 HL107147.	Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Calabro A, 2001, OSTEOARTHR CARTILAGE, V9, pS16, DOI 10.1053/joca.2001.0439; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DESAI UR, 1993, BIOCHEMISTRY-US, V32, P8140, DOI 10.1021/bi00083a012; GAMBARO G, 1992, KIDNEY INT, V42, P285, DOI 10.1038/ki.1992.288; GAMBARO G, 1994, KIDNEY INT, V46, P797, DOI 10.1038/ki.1994.335; HEGELE RG, 1989, CLIN INVEST MED, V12, P181; Lauer ME, 2007, J BIOL CHEM, V282, P843, DOI 10.1074/jbc.M608823200; LINDAHL U, 1991, THROMB HAEMOSTASIS, V66, P44; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; MERCHANT ZM, 1985, BIOCHEM J, V229, P369, DOI 10.1042/bj2290369; Miralem T, 1996, J BIOL CHEM, V271, P17100, DOI 10.1074/jbc.271.29.17100; Miralem T, 1996, AM J PHYSIOL-RENAL, V270, pF960, DOI 10.1152/ajprenal.1996.270.6.F960; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; TEMPLETON DM, 1990, J BIOL CHEM, V265, P21764; Wang A, 1999, METABOLISM, V48, P1220, DOI 10.1016/S0026-0495(99)90259-7; Wang A, 2015, MATRIX BIOL, V48, P36, DOI 10.1016/j.matbio.2015.04.003; Wang AM, 2014, J BIOL CHEM, V289, P9418, DOI 10.1074/jbc.M113.541441; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang AM, 1996, KIDNEY INT, V49, P437, DOI 10.1038/ki.1996.63; WANG AM, 1994, J CELL PHYSIOL, V159, P295, DOI 10.1002/jcp.1041590213; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3	26	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29045	29050		10.1074/jbc.M115.677401	http://dx.doi.org/10.1074/jbc.M115.677401			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26378235	hybrid, Green Published			2022-12-26	WOS:000365762300042
J	Clarke, MW; Boddington, KF; Warnica, JM; Atkinson, J; McKenna, S; Madge, J; Barker, CH; Graether, SP				Clarke, Matthew W.; Boddington, Kelly F.; Warnica, Josephine M.; Atkinson, John; McKenna, Sarah; Madge, Jeffrey; Barker, Christine H.; Graether, Steffen P.			Structural and Functional Insights into the Cryoprotection of Membranes by the Intrinsically Disordered Dehydrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; EMPIRICAL PARAMETERS; FOLDING PROBLEM; STRESS-PROTEIN; SECONDARY STRUCTURE; CHILLING TOLERANCE; COLD-ACCLIMATION; NMR-SPECTROSCOPY; PHASE-TRANSITION; PLASMA-MEMBRANE	Background: Genetic evidence supports a protective role for plant dehydrins against drought and cold. Results: Dehydrins prevent membrane fusion and lower the transition temperature without altering membrane accessibility and fluidity. Conclusion: The lysine-rich segments are important for protecting membranes from freeze-thaw damage. Significance: An amphipathic helix with positively charged residues flanking the hydrophobic face may be a common motif for disordered stress proteins.	[Clarke, Matthew W.; Boddington, Kelly F.; Warnica, Josephine M.; Atkinson, John; McKenna, Sarah; Madge, Jeffrey; Barker, Christine H.; Graether, Steffen P.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Graether, SP (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	graether@uoguelph.ca	Graether, Steffen P./AFU-0892-2022; Graether, Steffen P./AAR-8849-2021	Graether, Steffen P./0000-0002-2356-3936; Graether, Steffen P./0000-0002-2356-3936	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by an Natural Sciences and Engineering Research Council of Canada Discovery Grant and by infrastructure support from the Canadian Foundation for Innovation and the Ontario Innovation Trust (to S. P. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Al Kayal T, 2012, SOFT MATTER, V8, P4524, DOI 10.1039/c2sm06906g; Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; ARNOLD K, 1992, BIOCHIM BIOPHYS ACTA, V1124, P88, DOI 10.1016/0005-2760(92)90130-N; BAKALTCHEVA I, 1994, BBA-BIOMEMBRANES, V1189, P38, DOI 10.1016/0005-2736(94)90277-1; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Buchko GW, 1998, BBA-LIPID LIPID MET, V1392, P101, DOI 10.1016/S0005-2760(98)00028-9; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; CARRIER D, 1985, BIOCHIM BIOPHYS ACTA, V820, P131, DOI 10.1016/0005-2736(85)90224-X; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P679, DOI 10.1016/B978-012164491-8/50010-5; CEVC G, 1981, BIOCHEMISTRY-US, V20, P4955, DOI 10.1021/bi00520a023; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Eriksson SK, 2011, ECOL STUD-ANAL SYNTH, V215, P289, DOI 10.1007/978-3-642-19106-0_14; Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Findlater EE, 2009, BIOMOL NMR ASSIGN, V3, P273, DOI 10.1007/s12104-009-9192-2; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; GODAY A, 1994, PLANT CELL, V6, P351, DOI 10.1105/tpc.6.3.351; GOMES AV, 1993, BIOCHEMISTRY-US, V32, P5365, DOI 10.1021/bi00071a011; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hara M, 2003, PLANTA, V217, P290, DOI 10.1007/s00425-003-0986-7; Hara M, 2009, PLANT CELL ENVIRON, V32, P532, DOI 10.1111/j.1365-3040.2009.01947.x; HARRIGAN PR, 1990, CHEM PHYS LIPIDS, V52, P139, DOI 10.1016/0009-3084(90)90157-M; HEISE H, 1991, BIOCHIM BIOPHYS ACTA, V1061, P121, DOI 10.1016/0005-2736(91)90276-E; HOUDE M, 1995, PLANT J, V8, P583, DOI 10.1046/j.1365-313X.1995.8040583.x; Hughes S, 2011, PROTEIN SCI, V20, P42, DOI 10.1002/pro.534; Hughes SL, 2013, PLANT PHYSIOL, V163, P1376, DOI 10.1104/pp.113.226803; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Ismail AM, 1999, PLANT PHYSIOL, V120, P237, DOI 10.1104/pp.120.1.237; Ismail AM, 1997, CROP SCI, V37, P1270, DOI 10.2135/cropsci1997.0011183X003700040041x; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Kosova K, 2007, BIOL PLANTARUM, V51, P601, DOI 10.1007/s10535-007-0133-6; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; LENTZ BR, 1993, CHEM PHYS LIPIDS, V64, P99, DOI 10.1016/0009-3084(93)90060-G; Li SH, 2004, BIOPHYS CHEM, V109, P149, DOI 10.1016/j.bpc.2003.10.025; LIN CT, 1992, BIOCHEM BIOPH RES CO, V183, P1103, DOI 10.1016/S0006-291X(05)80304-3; Livernois AM, 2009, ANAL BIOCHEM, V392, P70, DOI 10.1016/j.ab.2009.05.023; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3; Petersen J, 2012, J EXP BOT, V63, P4919, DOI 10.1093/jxb/ers173; Rahman LN, 2010, BIOCHEM CELL BIOL, V88, P791, DOI [10.1139/O10-026, 10.1139/o10-026]; Rinne PLH, 1999, PLANTA, V209, P377, DOI 10.1007/s004250050740; Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029; Tompa P, 2006, BIOPHYS J, V91, P2243, DOI 10.1529/biophysj.106.084723; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsunoda T, 2001, COLLOID SURFACE B, V20, P155, DOI 10.1016/S0927-7765(00)00188-0; Tulumello DV, 2009, BIOCHEMISTRY-US, V48, P12096, DOI 10.1021/bi9013819; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YZ, 2014, PLANT SCI, V214, P113, DOI 10.1016/j.plantsci.2013.10.005; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xie C, 2012, NEW PHYTOL, V195, P124, DOI 10.1111/j.1469-8137.2012.04136.x	68	40	41	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26900	26913		10.1074/jbc.M115.678219	http://dx.doi.org/10.1074/jbc.M115.678219			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26370084	hybrid, Green Published			2022-12-26	WOS:000364794000003
J	Fukui, K; Ferris, HA; Kahn, CR				Fukui, Kenji; Ferris, Heather A.; Kahn, C. Ronald			Effect of Cholesterol Reduction on Receptor Signaling in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; INTRANASAL INSULIN; ALZHEIMERS-DISEASE; BRAIN CHOLESTEROL; A-BETA; AUTOPHAGY; METABOLISM; PROTEINS; ROLES; CELLS	Diabetes mellitus is associated with a variety of complications, including alterations in the central nervous system (CNS). We have recently shown that diabetes results in a reduction of cholesterol synthesis in the brain due to decreased insulin stimulation of SREBP2-mediated cholesterol synthesis in neuronal and glial cells. In the present study, we explored the effects of the decrease in cholesterol on neuronal cell function using GT1-7 hypothalamic cells subjected to cholesterol depletion in vitro using three independent methods: 1) exposure to methyl-beta-cyclodextrin, 2) treatment with the HMG-CoA reductase inhibitor simvastatin, and 3) shRNA-mediated knockdown of SREBP2. All three methods produced 20-31% reductions in cellular cholesterol content, similar to the decrease in cholesterol synthesis observed in diabetes. All cholesterol-depleted neuron-derived cells, independent of the method of reduction, exhibited decreased phosphorylation/activation of IRS-1 and AKT following stimulation by insulin, insulin-like growth factor-1, or the neurotrophins (NGF and BDNF). ERK phosphorylation/activation was also decreased after methyl-beta-cyclodextrin and statin treatment but increased in cells following SREBP2 knockdown. In addition, apoptosis in the presence of amyloid-beta was increased. Reduction in cellular cholesterol also resulted in increased basal autophagy and impairment of induction of autophagy by glucose deprivation. Together, these data indicate that a reduction in neuron-derived cholesterol content, similar to that observed in diabetic brain, creates a state of insulin and growth factor resistance that could contribute to CNS-related complications of diabetes, including increased risk of neurodegenerative diseases, such as Alzheimer disease.	[Fukui, Kenji; Ferris, Heather A.; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Kahn, CR (corresponding author), Joslin Diabet Ctr, One Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021; Regan, Clinton/E-6250-2012; Ferris, Heather/L-4697-2019	Kahn, Ronald/0000-0002-7583-9228; Ferris, Heather/0000-0002-6321-3447	National Institutes of Health [5K08 DK097293, R01 DK031036, R01 DK033201, P30DK036836]; Sunstar Foundation, Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R37DK031036, R01DK033201, K08DK097293, R01DK031036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sunstar Foundation, Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5K08 DK097293 (to H. A. F.), R01 DK031036 and R01 DK033201 (to C. R. K.), and P30DK036836 (to the Joslin Diabetes and Endocrinology Research Center Flow Cytometry Core). This work was also supported by a research fellowship, Hiroo Kaneda Scholarship from Sunstar Foundation, Japan (to K. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Air EL, 2002, PHARMACOL BIOCHEM BE, V72, P423, DOI 10.1016/S0091-3057(01)00780-8; Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Benedict C, 2011, EXP GERONTOL, V46, P112, DOI 10.1016/j.exger.2010.08.026; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Biondi E, 2011, NEUROL SCI, V32, P195, DOI 10.1007/s10072-010-0440-0; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P839, DOI 10.1016/j.bbalip.2010.03.010; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Fox TE, 2011, AM J PHYSIOL-ENDOC M, V300, pE600, DOI 10.1152/ajpendo.00641.2010; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; Linetti A, 2010, J CELL SCI, V123, P595, DOI 10.1242/jcs.060681; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Perez-Sala D, 2007, FRONT BIOSCI-LANDMRK, V12, P4456, DOI 10.2741/2401; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Solomon CS, 2002, BIOCHEM BIOPH RES CO, V291, P458, DOI 10.1006/bbrc.2002.6471; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Suzuki R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001532; Suzuki R, 2010, CELL METAB, V12, P567, DOI 10.1016/j.cmet.2010.11.006; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; TERZI E, 1994, BIOCHEMISTRY-US, V33, P7434, DOI 10.1021/bi00189a051; Toth C, 2006, NEUROSCIENCE, V139, P429, DOI 10.1016/j.neuroscience.2005.11.065; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Uchiyama Y, 2009, METHOD ENZYMOL, V453, P33, DOI 10.1016/S0076-6879(08)04003-2; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Xu QG, 2004, EXP NEUROL, V188, P43, DOI 10.1016/j.expneurol.2004.03.008; Xu XQ, 1996, ARCH BIOCHEM BIOPHYS, V326, P233, DOI 10.1006/abbi.1996.0070; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Zhang J, 2009, BIOPHYS J, V97, P1371, DOI 10.1016/j.bpj.2009.06.025; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045	46	33	36	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26383	26392		10.1074/jbc.M115.664367	http://dx.doi.org/10.1074/jbc.M115.664367			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370080	Green Published, hybrid			2022-12-26	WOS:000364793600004
J	Neve, EPA; Kofeler, H; Hendriks, DFG; Nordling, A; Gogvadze, V; Mkrtchian, S; Naslund, E; Ingelman-Sundberg, M				Neve, Etienne P. A.; Koefeler, Harald; Hendriks, Delilah F. G.; Nordling, Asa; Gogvadze, Vladimir; Mkrtchian, Souren; Naslund, Erik; Ingelman-Sundberg, Magnus			Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran	PLOS ONE			English	Article							INDUCED LIVER-INJURY; MASS-SPECTROMETRY; AMIDOXIME; PATHOGENESIS; THIOREDOXIN; REDUCTASE; PROTEIN; STRESS; SYSTEM; CELLS	Recently two novel enzymes were identified in the outer mitochondrial membrane, mARC1 and mARC2. These molybdenum containing enzymes can reduce a variety of N-hydroxylated compounds, such as N-hydroxy-guanidines and sulfohydroxamic acids, as well as convert nitrite into nitric oxide (NO). However, their endogenous functions remain unknown. Here we demonstrate a specific developmental pattern of expression of these enzymes. mARC1, but not mARC2, was found to be expressed in fetal human liver, whereas both, in particular mARC2, are abundant in adult liver and also expressed in omental and subcutaneous fat. Caloric diet restriction of obese patients caused a decreased expression of mARC2 in liver, similar to that seen in the livers of starved rats. Knock down of mARC2 expression by siRNA in murine adipocytes had statistically significant effect on the level of diglycerides and on the fatty acid composition of some triglycerides, concomitantly a clear trend toward the reduced formation of most of triglyceride and phospholipid species was observed. The involvement of mARC2 in the metabolism of the hepatotoxic drug ximelagatran was evaluated in hepatocytes and adipocytes. Ximelagatran was shown to cause oxidative stress and knock down of mARC2 in adipocytes prevented ximelagatran induced inhibition of mitochondrial respiration. In conclusion, our data indicate that mARC1 and mARC2 have different developmental expression profiles, and that mARC2 is involved in lipogenesis, is regulated by nutritional status and responsible for activation of ximelagatran into a mitotoxic metabolite(s).	[Neve, Etienne P. A.; Hendriks, Delilah F. G.; Nordling, Asa; Mkrtchian, Souren; Ingelman-Sundberg, Magnus] Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, Stockholm, Sweden; [Koefeler, Harald] Med Univ Graz, Ctr Med Res ZMF, Graz, Austria; [Gogvadze, Vladimir] Karolinska Inst, Inst Environm Med, Sect Toxicol, S-10401 Stockholm, Sweden; [Naslund, Erik] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden	Karolinska Institutet; Medical University of Graz; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet	Ingelman-Sundberg, M (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, Stockholm, Sweden.	magnus.ingelman-sundberg@ki.se	Ingelman-Sundberg, Magnus/ABD-9302-2021; Gogvadze, Vladimir/A-4392-2014	Hendriks, Delilah/0000-0003-1159-5946; Kofeler, Harald/0000-0002-2725-9616; Mkrtchian, Souren/0000-0001-9801-2736	IMI MIP-DILI project [115336]; Swedish Research Council; Stockholm County Council (ALF)	IMI MIP-DILI project; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF)(Stockholm County Council)	This work was supported by the IMI MIP-DILI project (Grant Agreement number 115336), The Swedish Research Council and Stockholm County Council (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2005, DRUG METAB DISPOS, V33, P570, DOI 10.1124/dmd.104.002972; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Clement B, 2003, DRUG METAB DISPOS, V31, P645, DOI 10.1124/dmd.31.5.645; Du YT, 2013, J BIOL CHEM, V288, P32241, DOI 10.1074/jbc.M113.495150; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; Fontana RJ, 2014, GASTROENTEROLOGY, V146, P914, DOI 10.1053/j.gastro.2013.12.032; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Goldkind L, 2006, PHARMACOEPIDEM DR S, V15, P213, DOI 10.1002/pds.1207; Jakobs HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105371; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Krompholz N, 2012, CHEM RES TOXICOL, V25, P2443, DOI 10.1021/tx300298m; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mkrtchian S, 1998, EUR J BIOCHEM, V251, P304, DOI 10.1046/j.1432-1327.1998.2510304.x; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Plitzko B, 2015, J BIOL CHEM, V290, P10126, DOI 10.1074/jbc.M115.640052; Sparacino-Watkins CE, 2014, J BIOL CHEM, V289, P10345, DOI 10.1074/jbc.M114.555177; Stephens C, 2014, CURR OPIN ALLERGY CL, V14, P286, DOI 10.1097/ACI.0000000000000070; Testa L, 2007, EXPERT OPIN DRUG SAF, V6, P397, DOI 10.1517/14740338.6.4.397; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532	21	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138487	10.1371/journal.pone.0138487	http://dx.doi.org/10.1371/journal.pone.0138487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378779	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400105
J	Zhang, L; Morrison, AJ; Thibodeau, PH				Zhang, Liang; Morrison, Anneliese J.; Thibodeau, Patrick H.			Interdomain Contacts and the Stability of Serralysin Protease from Serratia marcescens	PLOS ONE			English	Article							AERUGINOSA ALKALINE PROTEASE; ADENYLATE-CYCLASE TOXIN; PSEUDOMONAS-AERUGINOSA; ERWINIA-CHRYSANTHEMI; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; EXTRACELLULAR PROTEINS; SECRETION SYSTEM; METALLOPROTEASE; METZINCINS	The serralysin family of bacterial metalloproteases is associated with virulence in multiple modes of infection. These extracellular proteases are members of the Repeats-in-ToXin (RTX) family of toxins and virulence factors, which mediated virulence in E. coli, B. pertussis, and P. aeruginosa, as well as other animal and plant pathogens. The serralysin proteases are structurally dynamic and their folding is regulated by calcium binding to a C-terminal domain that defines the RTX family of proteins. Previous studies have suggested that interactions between N-terminal sequences and this C-terminal domain are important for the high thermal and chemical stabilities of the RTX proteases. Extending from this, stabilization of these interactions in the native structure may lead to hyperstabilization of the folded protein. To test this hypothesis, cysteine pairs were introduced into the N-terminal helix and the RTX domain and protease folding and activity were assessed. Under stringent pH and temperature conditions, the disulfide-bonded mutant showed increased protease activity and stability. This activity was dependent on the redox environment of the refolding reaction and could be blocked by selective modification of the cysteine residues before protease refolding. These data demonstrate that the thermal and chemical stability of these proteases is, in part, mediated by binding between the RTX domain and the N-terminal helix and demonstrate that stabilization of this interaction can further stabilize the active protease, leading to additional pH and thermal tolerance.	[Zhang, Liang; Morrison, Anneliese J.; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.	thibodea@pitt.edu			National Institutes of Health, National Institutes of Diabetes, Digestive and Kidney Diseases [DK083284]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK083284, R01DK083284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Diabetes, Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health, National Institutes of Diabetes, Digestive and Kidney Diseases, DK083284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIYAPPA PS, 1976, MOL CELL BIOCHEM, V13, P95, DOI 10.1007/BF01837059; Angkawidjaja C, 2007, FEBS LETT, V581, P5060, DOI 10.1016/j.febslet.2007.09.048; Balaban NP, 2012, BIOCHEMISTRY-MOSCOW+, V77, P119, DOI 10.1134/S0006297912020010; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; BAUMANN U, 1995, J MOL BIOL, V248, P653, DOI 10.1006/jmbi.1995.0249; Butterworth MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100313; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; GENTSCHEV I, 1992, MOL GEN GENET, V232, P40, DOI 10.1007/BF00299135; HASE CC, 1993, MICROBIOL REV, V57, P823; Hege T, 2001, J MOL BIOL, V314, P187, DOI 10.1006/jmbi.2001.5124; HESS J, 1990, MOL GEN GENET, V224, P201, DOI 10.1007/BF00271553; HINES DA, 1988, J BACTERIOL, V170, P4141, DOI 10.1128/jb.170.9.4141-4146.1988; Hobden JA, 2002, DNA CELL BIOL, V21, P391, DOI 10.1089/10445490260099674; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; KREGER AS, 1986, INVEST OPHTH VIS SCI, V27, P932; Kuwahara K, 2008, PROTEIN ENG DES SEL, V21, P737, DOI 10.1093/protein/gzn057; LAZDUNSKI A, 1990, BIOCHIMIE, V72, P147, DOI 10.1016/0300-9084(90)90140-C; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; LETOFFE S, 1991, J BACTERIOL, V173, P2160; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; LYERLY D, 1981, INFECT IMMUN, V33, P927, DOI 10.1128/IAI.33.3.927-932.1981; LYERLY DM, 1983, INFECT IMMUN, V40, P113, DOI 10.1128/IAI.40.1.113-119.1983; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Motyan JA, 2013, BIOMOLECULES, V3, P923, DOI 10.3390/biom3040923; Palacios JL, 2001, J BACTERIOL, V183, P1346, DOI 10.1128/JB.183.4.1346-1358.2001; PARMELY M, 1990, INFECT IMMUN, V58, P3009, DOI 10.1128/IAI.58.9.3009-3014.1990; Petersen LM, 2013, CAN J MICROBIOL, V59, P627, DOI 10.1139/cjm-2013-0343; SEBO P, 1993, MOL MICROBIOL, V9, P999, DOI 10.1111/j.1365-2958.1993.tb01229.x; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; STOCKER W, 1995, PROTEIN SCI, V4, P823; SUH YS, 1992, J BACTERIOL, V174, P2361, DOI 10.1128/JB.174.7.2361-2366.1992; Zhang L, 2014, BIOCHEMISTRY-US, V53, P6452, DOI 10.1021/bi5007546; Zhang L, 2012, J BIOL CHEM, V287, P4311, DOI 10.1074/jbc.M111.310300	38	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138419	10.1371/journal.pone.0138419	http://dx.doi.org/10.1371/journal.pone.0138419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378460	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400097
J	Farris, ZJ; Golden, CD; Karpanty, S; Murphy, A; Stauffer, D; Ratelolahy, F; Andrianjakarivelo, V; Holmes, CM; Kelly, MJ				Farris, Zach J.; Golden, Christopher D.; Karpanty, Sarah; Murphy, Asia; Stauffer, Dean; Ratelolahy, Felix; Andrianjakarivelo, Vonjy; Holmes, Christopher M.; Kelly, Marcella J.			Hunting, Exotic Carnivores, and Habitat Loss: Anthropogenic Effects on a Native Carnivore Community, Madagascar	PLOS ONE			English	Article							EASTERN RAIN-FORESTS; ACTIVITY PATTERNS; EXTINCTION RISK; DOMESTIC DOGS; FRAGMENTATION; BIODIVERSITY; CONSERVATION; IMPACTS; DENSITY; DEFORESTATION	The wide-ranging, cumulative, negative effects of anthropogenic disturbance, including habitat degradation, exotic species, and hunting, on native wildlife has been well documented across a range of habitats worldwide with carnivores potentially being the most vulnerable due to their more extinction prone characteristics. Investigating the effects of anthropogenic pressures on sympatric carnivores is needed to improve our ability to develop targeted, effective management plans for carnivore conservation worldwide. Utilizing photographic, line-transect, and habitat sampling, as well as landscape analyses and village-based bushmeat hunting surveys, we provide the first investigation of how multiple forms of habitat degradation (fragmentation, exotic carnivores, human encroachment, and hunting) affect carnivore occupancy across Madagascar's largest protected area: the Masoala-Makira landscape. We found that as degradation increased, native carnivore occupancy and encounter rates decreased while exotic carnivore occupancy and encounter rates increased. Feral cats (Felis species) and domestic dogs (Canis familiaris) had higher occupancy than half of the native carnivore species across Madagascar's largest protected landscape. Bird and small mammal encounter rates were negatively associated with exotic carnivore occupancy, but positively associated with the occupancy of four native carnivore species. Spotted fanaloka (Fossa fossana) occupancy was constrained by the presence of exotic feral cats and exotic small Indian civet (Viverricula indica). Hunting was intense across the four study sites where hunting was studied, with the highest rates for the small Indian civet ((x) over bar = 90 individuals consumed/year), the ring-tailed vontsira (Galidia elegans) ((x) over bar = 58 consumed/year), and the fosa (Cryptoprocta ferox) ((x) over bar = 31 consumed/year). Our modeling results suggest hunters target intact forest where carnivore occupancy, abundance, and species richness, are highest. These various anthropogenic pressures and their effects on carnivore populations, especially increases in exotic carnivores and hunting, have wide-ranging, global implications and demand effective management plans to target the influx of exotic carnivores and unsustainable hunting that is affecting carnivore populations across Madagascar and worldwide.	[Farris, Zach J.; Karpanty, Sarah; Murphy, Asia; Stauffer, Dean; Kelly, Marcella J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Golden, Christopher D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Golden, Christopher D.] Wildlife Conservat Soc, Wildlife Hlth & Hlth Policy Program, HEAL, New York, NY USA; [Ratelolahy, Felix; Andrianjakarivelo, Vonjy] Wildlife Conservat Soc Madagascar Program, Antananarivo, Madagascar; [Holmes, Christopher M.] Wildlife Conservat Soc Asia Program, Viangchan, Laos	Virginia Polytechnic Institute & State University; Harvard University; Harvard T.H. Chan School of Public Health; Wildlife Conservation Society	Farris, ZJ (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	zjfarris@vt.edu	Farris, Zach J./AAW-6579-2020; Kelly, Marcella/B-4891-2011	Kelly, Marcella/0000-0001-9044-3873; Karpanty, Sarah/0000-0003-3831-8914; Golden, Christopher/0000-0002-2258-7493; Golden, Christopher/0000-0002-0358-4625	Cleveland Metroparks Zoo African Seed Grant; Mohammed bin Zayed Species Conservation Fund [1025935]; National Geographic Society-Waitts grant [W96-10]; National Geographic Society Conservation Trust [C135-08]; National Science Foundation [1011714]; National Science Foundation Coupled Human Natural Systems grant [NSF-GEO 1115057]	Cleveland Metroparks Zoo African Seed Grant; Mohammed bin Zayed Species Conservation Fund; National Geographic Society-Waitts grant(National Geographic Society); National Geographic Society Conservation Trust(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Coupled Human Natural Systems grant	Cleveland Metroparks Zoo African Seed Grant (http://www.clevelandmetroparks.com/Zoo/Grants/Africa-Seed-Grants-Program-3.aspx): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. European Association for Zoos and Aquariums (www.eaza.net): Idea Wild (www.ideawild.org): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Margot Marsh Biodiversity Fund (grant #023815) (http://www.conservation.org/Pages/default.aspx): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mohammed bin Zayed Species Conservation Fund (grant #1025935) (http://www.speciesconservation.org/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Geographic Society-Waitts grant (#W96-10) (http://www.nationalgeographic.com/explorers/grantsprograms/waitt-grants-application/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Geographic Society Conservation Trust (grant #C135-08) (http://www.nationalgeographic.com/explorers/grants-programs/conservation-trust/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Science Foundation Doctoral Dissertation Improvement grant (#1011714) (http://www.nsf.gov/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Science Foundation Coupled Human Natural Systems grant (NSF-GEO 1115057) (www.nsf.gov): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. People's Trust for Endangered Species (http://ptes.org/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Virginia Tech Chapter of Sigma Xi (http://www.vtnews.vt.edu/articles/2010/04/2010-266.html): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Virginia Tech McGinnes fellowship (http://fishwild.vt.edu/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Virginia Tech Mosby fellowship (www.fishwild.vt.edu): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; Angerbjorn A, 2013, J APPL ECOL, V50, P59, DOI 10.1111/1365-2664.12033; [Anonymous], 2015, IUCN IUCN RED LIST T; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Becker M, 2013, BIOL CONSERV, V158, P26, DOI 10.1016/j.biocon.2012.08.017; Brockman DK, 2008, INT J PRIMATOL, V29, P135, DOI 10.1007/s10764-007-9145-5; Brooke ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093195; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Campbell K.J., 2011, Occasional Papers of the IUCN Species Survival Commission, V42, P37; Carbone C, 2011, BIOL LETTERS, V7, P312, DOI 10.1098/rsbl.2010.0996; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Davis ML, 2011, ANIM CONSERV, V14, P56, DOI 10.1111/j.1469-1795.2010.00389.x; Dehgan A, 2003, BEHAV EXTINCTION PRE; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Farris ZJ, 2015, J ZOOL, V296, P45, DOI 10.1111/jzo.12216; Farris Z. J., 2012, Small Carnivore Conservation, V47, P82; Farris ZJ, 2014, INT J PRIMATOL, V35, P859, DOI 10.1007/s10764-014-9786-0; Farris ZJ, ANIM CONSER IN PRESS; Farris ZJ, 2014, THESIS VIRGINIA POLY; Forero-Medina German, 2009, Biota Neotrop., V9, P45, DOI 10.1590/S1676-06032009000200004; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Garbutt N, 2007, MAMMALS MADAGASCAR C; Gardner CJ, 2014, HUM ECOL, V42, P21, DOI 10.1007/s10745-013-9629-1; Gerber BD, 2011, THESIS; Gerber B, 2010, ORYX, V44, P219, DOI 10.1017/S0030605309991037; Gerber BD, 2012, ORYX, V46, P414, DOI 10.1017/S0030605311001116; Gerber BD, 2012, J MAMMAL, V93, P667, DOI 10.1644/11-MAMM-A-265.1; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Godfrey LR, 2007, FOLIA PRIMATOL, V78, P405, DOI 10.1159/000105152; Golden CD, 2014, CONSERV BIOL, V28, P234, DOI 10.1111/cobi.12174; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P1; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 2003, NATURAL HIST MADAGAS, P1351; Goodman SM, 2012, CARNIVORA MADAGASCAR; Goodrich JM, 2008, J ZOOL, V276, P323, DOI 10.1111/j.1469-7998.2008.00458.x; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hawkins CE, 2005, ORYX, V39, P35, DOI 10.1017/S0030605305000074; Hines J. E., 2006, PROGRAM PRESENCE; Holmes C., 2007, LINKING LIVELIHOODS; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; Kelly M. J., 2011, ASSESSING CARN UNPUB; Kerridge F, 2003, NATURAL HIST MADAGAS, P1363; Kolby JE, 2014, NATURE, V509, P563, DOI 10.1038/509563a; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kremen C, 1999, CONSERV BIOL, V13, P1055, DOI 10.1046/j.1523-1739.1999.98374.x; Kremen C., 2003, NATURAL HIST MADAGAS, P1459; Logan MK, 2015, ANIM CONSERV, V18, P82, DOI 10.1111/acv.12137; Longcore T, 2009, CONSERV BIOL, V23, P887, DOI 10.1111/j.1523-1739.2009.01174.x; Lowry E, 2013, ECOL EVOL, V3, P182, DOI 10.1002/ece3.431; Luhrs ML, 2013, BEHAV ECOL SOCIOBIOL, V67, P1731, DOI 10.1007/s00265-013-1581-y; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McGarigal K., 2012, TECH REP; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Mudappa D, 2007, SMALL CARNIVORE CONS, V36, P18; Oehler JD, 1996, CAN J ZOOL, V74, P2070, DOI 10.1139/z96-235; Palmer C, 2014, VALUE CONFLICTS FERA; POLLARD JH, 1971, BIOMETRICS, V27, P991, DOI 10.2307/2528833; Rakotomanana H, 2013, CONSERVATION BIOLOGY: VOICES FROM THE TROPICS, P33; Randriamanalina Malatatiana H., 2000, Lemur News, V5, P11; Randrianandrianina FH, 2010, ORYX, V44, P411, DOI 10.1017/S003060531000044X; Ray JC, 2001, OECOLOGIA, V127, P395, DOI 10.1007/s004420000604; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schwitzer C., 2013, LEMURS MADAGASCAR ST; Silva-Rodriguez EA, 2012, BIOL CONSERV, V150, P103, DOI 10.1016/j.biocon.2012.03.008; Tilman D, 1995, BIOL CONSERV, V72, P409; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Winter L, 2004, JAVMA-J AM VET MED A, V225, P1369, DOI 10.2460/javma.2004.225.1369; Woodroffe R, 2001, CONSERV BIOL SER, V5, P61; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Young JK, 2011, BIOSCIENCE, V61, P125, DOI 10.1525/bio.2011.61.2.7	89	50	53	3	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136456	10.1371/journal.pone.0136456	http://dx.doi.org/10.1371/journal.pone.0136456			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375991	Green Submitted, Green Published, gold			2022-12-26	WOS:000361610200015
J	Ishizawa, J; Kojima, K; McQueen, T; Ruvolo, V; Chachad, D; Nogueras-Gonzalez, GM; Huang, XL; Pierceall, WE; Dettman, EJ; Cardone, MH; Shacham, S; Konopleva, M; Andreeff, M				Ishizawa, Jo; Kojima, Kensuke; McQueen, Teresa; Ruvolo, Vivian; Chachad, Dhruv; Nogueras-Gonzalez, Graciela M.; Huang, Xuelin; Pierceall, William E.; Dettman, E. J.; Cardone, Michael H.; Shacham, Sharon; Konopleva, Marina; Andreeff, Michael			Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; BCL-2; AML; SENSITIVITY; PROTEINS; ABT-199; MDM2; INHIBITION; MECHANISMS; DEPENDENCE	BH3 profiling measures the propensity of transformed cells to undergo intrinsic apoptosis and is determined by exposing cells to BH3-mimicking peptides. We hypothesized that basal levels of prosurvival BCL-2 family proteins may modulate the predictive power of BH3 profiling and termed it mitochondrial profiling. We investigated the correlation between cell sensitivity to apoptogenic agents and mitochondrial profiling, using a panel of acute myeloid leukemias induced to undergo apoptosis by exposure to cytarabine, the BH3 mimetic ABT-199, the MDM2 inhibitor Nutlin-3a, or the CRM1 inhibitor KPT-330. We found that the apoptogenic efficacies of ABT-199 and cytarabine correlated well with BH3 profiling reflecting BCL2, but not BCL-XL or MCL-1 dependence. Baseline BCL-2 protein expression analysis increased the ability of BH3 profiling to predict resistance mediated by MCL-1. By utilizing engineered cells with overexpression or knockdown of BCL-2 family proteins, Ara-C was found to be independent, while ABT-199 was dependent on BCL-XL. BCL-2 and BCL-XL overexpression mediated resistance to KPT-330 which was not reflected in the BH3 profiling assay, or in baseline BCL-2 protein levels. In conclusion, mitochondrial profiling, the combination of BH3 profiling and prosurvival BCL-2 family protein analysis, represents an improved approach to predict efficacy of diverse agents in AML and may have utility in the design of more effective drug combinations.	[Ishizawa, Jo; Kojima, Kensuke; McQueen, Teresa; Ruvolo, Vivian; Chachad, Dhruv; Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Nogueras-Gonzalez, Graciela M.; Huang, Xuelin] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Dept Biostat, Houston, TX 77030 USA; [Pierceall, William E.; Dettman, E. J.; Cardone, Michael H.] Eutrop Pharmaceut, Cambridge, MA USA; [Shacham, Sharon] Karyopharm Therapeut, Boston, MA USA; [Kojima, Kensuke] Saga Univ, Dept Med, Hematol Resp Med & Oncol, Saga 840, Japan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Saga University	Andreeff, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA.	mandreef@mdanderson.org		Dettman, E.J./0000-0002-0059-836X; Chachad, Dhruv/0000-0003-3131-7679	Japan Society for the Promotion of Science Postdoctoral Fellowship; Ministry of Education, Culture, Sports, Science and Technology in Japan [26461425]; Princess Takamatsu Cancer Research Fund [14-24610]; National Institutes of Health USA [CA49639, 100632, CA136411, CA16672]; Paul and Mary Haas Chair in Genetics; NATIONAL CANCER INSTITUTE [P50CA136411, P30CA016672, P01CA049639, P50CA100632] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Cancer Research Fund; National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Mary Haas Chair in Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by grants from the Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad Award (to JI); the Ministry of Education, Culture, Sports, Science and Technology in Japan (26461425) and the Princess Takamatsu Cancer Research Fund (14-24610) (to KK); and the National Institutes of Health USA (CA49639, 100632, CA136411, and CA16672), and the Paul and Mary Haas Chair in Genetics (to MA).	Andreeff M, 2011, BLOOD; Bogenberger JM, 2014, LEUKEMIA, V28, P1657, DOI 10.1038/leu.2014.44; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chonghaile TN, 2014, CANCER DISCOV, V4, P1074, DOI 10.1158/2159-8290.CD-14-0353; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Kojima K, 2010, LEUKEMIA, V24, P33, DOI 10.1038/leu.2009.212; Kojima K, 2006, CELL CYCLE, V5, P2778, DOI 10.4161/cc.5.23.3520; Kojima K, 2013, BLOOD, V121, P4166, DOI 10.1182/blood-2012-08-447581; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Konopleva M, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.118.118; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Long JT, 2010, BLOOD, V116, P71, DOI 10.1182/blood-2010-01-261628; Mau-Soerensen M, 2014, ASCO M, V32, P482, DOI DOI 10.1200/JCO.2013.53.3448; Pan R, 2014, BLOOD; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Pierceall WE, 2014, LEUKEMIA RES, V38, P564, DOI 10.1016/j.leukres.2014.02.007; Pierceall WE, 2013, MOL CANCER THER, V12, P2940, DOI 10.1158/1535-7163.MCT-13-0692; Ryan J, 2013, METHODS, V61, P156, DOI 10.1016/j.ymeth.2013.04.006; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Seymour JF DM, 2014, J CLIN ONCOL S, V32, p5s; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038	26	21	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138377	10.1371/journal.pone.0138377	http://dx.doi.org/10.1371/journal.pone.0138377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375587	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200103
J	Nakase, K; Kita, K; Kyo, T; Ueda, T; Tanaka, I; Katayama, N				Nakase, Kazunori; Kita, Kenkichi; Kyo, Taiichi; Ueda, Takanori; Tanaka, Isao; Katayama, Naoyuki			Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor alpha-Chain (CD25) Expression Predicts a Poor Prognosis	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; MAINTENANCE INTENSIFICATION THERAPY; INDIVIDUALIZED INDUCTION THERAPY; HEMATOPOIETIC GROWTH-FACTORS; SOLUBLE INTERLEUKIN-2-RECEPTOR; CONSOLIDATION THERAPY; CLINICAL IMPORTANCE; GM-CSF; CELLS; PROLIFERATION	A variety of cytokine/cytokine receptor systems affect the biological behavior of acute leukemia cells. However, little is known about the clinical relevance of cytokine receptor expression in acute myeloid leukemia (AML). We quantitatively examined the expression of interleukin-2 receptor alpha-chain (IL-2R alpha, also known as CD25), IL-2R beta, IL-3R alpha, IL-4R alpha, IL5R alpha, IL-6R alpha, IL-7R alpha, the common beta-chain (beta c), gamma c, granulocyte-macrophage colony-stimulating factor (GM-CSF)R alpha, G-CSFR, c-fms, c-mpl, c-kit, FLT3, and GP130 in leukemia cells from 767 adult patients with AML by flow cytometry and determined their prevalence and clinical significance. All cytokine receptors examined were expressed at varying levels, whereas the levels of IL-3R alpha, GM-CSFR alpha, IL-2R alpha, gamma c, c-kit, and G-CSFR exhibited a wide spectrum of >= 10,000 sites/cell. In terms of their French-American-British classification types, GM-CSFR alpha and c-fms were preferentially expressed in M4/M5 patients, G-CSF in M3 patients, and IL-2R alpha in non-M3 patients. Elevated levels of IL-3R alpha, GM-CSFR alpha, and IL-2R alpha correlated with leukocytosis. In patients <= 60 years old, higher levels of these 3 receptors correlated with poor responses to conventional chemotherapy, but only IL-2R alpha was associated with a shorter overall survival. By incorporating IL-2R alpha status into cytogenetic risk stratification, we could sort out a significantly adverse-risk cohort from the cytogenetically intermediate-risk group. Analyses with various phenotypical risk markers revealed the expression of IL-2R alpha as an independent prognostic indicator in patients with intermediaterisk cytogenetics. These findings were not observed in patients >60 years old. Our results indicate that several cytokine receptors were associated with certain cellular and clinical features, but IL-2R alpha alone had prognostic value that provides an additional marker to improve current risk evaluation in AML patients <= 60 years old.	[Nakase, Kazunori] Mie Univ Hosp, Ctr Canc, Tsu, Mie, Japan; [Kita, Kenkichi] Japan Baptist Hosp, Dept Internal Med, Kyoto, Japan; [Kita, Kenkichi] Hiroshima Red Cross & Atom Bomb Survivors Hosp, Dept Internal Med 4, Hiroshima, Japan; [Ueda, Takanori] Univ Fukui, Sch Med, Dept Internal Med 1, Fukui 910, Japan; [Tanaka, Isao] Suzuka Kaisei Hosp, Dept Internal Med, Suzuka, Japan; [Nakase, Kazunori; Kita, Kenkichi; Katayama, Naoyuki] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 514, Japan	Mie University; University of Fukui; Mie University	Nakase, K (corresponding author), Mie Univ Hosp, Ctr Canc, Tsu, Mie, Japan.	k2nakase@clin.medic.mie-u.ac.jp			Japan Society for the promotion of Science [63570570, 06454346]	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the promotion of Science (Grant 63570570 and 06454346)(www.jsps.go.jp/j-grantsinaid/). KK received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE RJ, 1986, BRIT J HAEMATOL, V64, P799, DOI 10.1111/j.1365-2141.1986.tb02242.x; BRADSTOCK K, 1994, BLOOD, V84, P1220; CARRON JA, 1989, BRIT J HAEMATOL, V73, P168, DOI 10.1111/j.1365-2141.1989.tb00248.x; Cerny J, 2013, BRIT J HAEMATOL, V160, P262, DOI 10.1111/bjh.12109; Derolf AR, 2014, SCAND J IMMUNOL, V80, P424, DOI 10.1111/sji.12223; Djunic I, 2012, MED ONCOL, V29, P2077, DOI 10.1007/s12032-011-0104-9; DUBREUIL P, 1988, BLOOD, V72, P1081; Engelhardt M, 2002, LEUKEMIA, V16, P1603, DOI 10.1038/sj.leu.2402620; ERBER WN, 1988, AM J CLIN PATHOL, V89, P645, DOI 10.1093/ajcp/89.5.645; Feller N, 2004, LEUKEMIA, V18, P1380, DOI 10.1038/sj.leu.2403405; FOA R, 1990, BRIT J HAEMATOL, V75, P34, DOI 10.1111/j.1365-2141.1990.tb02613.x; Gonen M, 2012, BLOOD, V120, P2297, DOI 10.1182/blood-2012-02-414425; Graf M, 2004, EUR J HAEMATOL, V72, P89, DOI 10.1046/j.0902-4441.2003.00184.x; Greenwood MJ, 2006, LEUKEMIA LYMPHOMA, V47, P1245, DOI 10.1080/10428190600572673; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hoshino S, 1990, BLOOD, V7; Ikegawa S, 2015, LEUKEMIA LYMPHOMA, V56, P1874, DOI 10.3109/10428194.2014.974044; Katayama N, 1998, AM J HEMATOL, V58, P31, DOI 10.1002/(SICI)1096-8652(199805)58:1<31::AID-AJH6>3.0.CO;2-1; KITA K, 1993, BLOOD, V81, P2399; Kobayashi T, 1996, J CLIN ONCOL, V14, P204, DOI 10.1200/JCO.1996.14.1.204; Koubek K, 1998, NEOPLASMA, V45, P198; KYO T, 1988, ACTA HAEMATOL JAPON, V51, P1641; Lanza F, 1997, LEUKEMIA, V11, P1700, DOI 10.1038/sj.leu.2400794; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lotem J, 2002, ONCOGENE, V21, P3284, DOI 10.1038/sj.onc.1205319; LOWENBERG B, 1993, BLOOD, V81, P281; Maegawa S, 2014, GENOME RES, V24, P580, DOI 10.1101/gr.157529.113; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Miwa H, 1998, LEUKEMIA, V12, P44, DOI 10.1038/sj.leu.2400877; Miyawaki S, 2005, CANCER-AM CANCER SOC, V104, P2726, DOI 10.1002/cncr.21493; Miyawaki S, 1999, INT J HEMATOL, V70, P97; Moon Y, 2004, ANN CLIN LAB SCI, V34, P410; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nakase K, 2007, LEUKEMIA, V21, P326, DOI 10.1038/sj.leu.2404497; NAKASE K, 1993, LEUKEMIA RES, V17, P17, DOI 10.1016/0145-2126(93)90136-9; NAKASE K, 1992, BRIT J HAEMATOL, V80, P317, DOI 10.1111/j.1365-2141.1992.tb08139.x; Nakase K, 2000, LEUKEMIA, V14, P163, DOI 10.1038/sj.leu.2401638; Nakase K, 2006, IMMUNOLOGY, V2, P64; Nakase K, 2012, CANCER EPIDEMIOL, V36, pE306, DOI 10.1016/j.canep.2012.03.011; OHNO R, 1993, CANCER, V71, P3888, DOI 10.1002/1097-0142(19930615)71:12<3888::AID-CNCR2820711216>3.0.CO;2-G; Ohtake S, 2010, INT J HEMATOL, V91, P276, DOI 10.1007/s12185-009-0480-5; PADROS MR, 1989, EUR J HAEMATOL, V42, P436; Paietta E, 1997, LEUKEMIA, V11, P1887, DOI 10.1038/sj.leu.2400836; PARK LS, 1989, BLOOD, V74, P56; Riaz W, 2014, CANCER CONTROL, V21, P279, DOI 10.1177/107327481402100404; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Terwijn M, 2009, EUR J CANCER, V45, P1692, DOI 10.1016/j.ejca.2009.02.021; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; Tsuzuki M, 1997, LEUKEMIA, V11, P2125, DOI 10.1038/sj.leu.2400870; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; WEIDMANN E, 1995, LEUKEMIA RES, V19, P469, DOI 10.1016/0145-2126(95)00012-D; Yanada M, 2005, LEUKEMIA, V19, P1345, DOI 10.1038/sj.leu.2403838; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885	56	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0128998	10.1371/journal.pone.0128998	http://dx.doi.org/10.1371/journal.pone.0128998			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375984	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200002
J	Sanchez, DJ; Miranda, D; Marsden, MD; Dizon, TMA; Bontemps, JR; Davila, SJ; Del Mundo, LE; Ha, T; Senaati, A; Zack, JA; Cheng, GH				Sanchez, David Jesse; Miranda, Daniel, Jr.; Marsden, Matthew D.; Dizon, Thomas Michael A.; Bontemps, Johnny R.; Davila, Sergio J.; Del Mundo, Lara E.; Thai Ha; Senaati, Ashkon; Zack, Jerome A.; Cheng, Genhong			Disruption of Type I Interferon Induction by HIV Infection of T Cells	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; ANTIVIRAL SIGNALING PROTEIN; TOLL-LIKE RECEPTORS; ADAPTER PROTEIN; GENE; DNA; IDENTIFICATION; ACTIVATION; TRAF3; NEF	Our main objective of this study was to determine how Human Immunodeficiency Virus (HIV) avoids induction of the antiviral Type I Interferon (IFN) system. To limit viral infection, the innate immune system produces important antiviral cytokines such as the IFN. IFN set up a critical roadblock to virus infection by limiting further replication of a virus. Usually, IFN production is induced by the recognition of viral nucleic acids by innate immune receptors and subsequent downstream signaling. However, the importance of IFN in the defense against viruses has lead most pathogenic viruses to evolve strategies to inhibit host IFN induction or responses allowing for increased pathogenicity and persistence of the virus. While the adaptive immune responses to HIV infection have been extensively studied, less is known about the balance between induction and inhibition of innate immune defenses, including the antiviral IFN response, by HIV infection. Here we show that HIV infection of T cells does not induce significant IFN production even IFN I Interferon production. To explain this paradox, we screened HIV proteins and found that two HIV encoded proteins, Vpu and Nef, strongly antagonize IFN induction, with expression of these proteins leading to loss of expression of the innate immune viral RNA sensing adaptor protein, IPS-1 (IFN-beta promoter stimulator-1). We hypothesize that with lower levels of IPS-1 present, infected cells are defective inmounting antiviral responses allowing HIV to replicate without the normal antiviral actions of the host IFN response. Using cell lines as well as primary human derived cells, we show that HIV targeting of IPS-1 is key to limiting IFN induction. These findings describe how HIV infection modulates IFN induction providing insight into the mechanisms by which HIV establishes infection and persistence in a host.	[Sanchez, David Jesse; Dizon, Thomas Michael A.; Del Mundo, Lara E.] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA; [Miranda, Daniel, Jr.; Bontemps, Johnny R.; Davila, Sergio J.; Thai Ha; Senaati, Ashkon; Zack, Jerome A.; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Miranda, Daniel, Jr.; Marsden, Matthew D.; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Marsden, Matthew D.; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA	Western University of Health Sciences; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sanchez, DJ (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA.	sanchezd@westernu.edu		Sanchez, David/0000-0002-6032-4600	NIH [AI069120-03, AI70010]; UCLA Center for AIDS Research (CFAR); UCLA CFAR [NIH/NIAID AI028697]; UCLA AIDS Institute; Western University of Health Sciences College of Pharmacy startup funding; UCLA Interdisciplinary Training in Virology and Gene Therapy grant [NIH 5T32AI060567-05]; UCLA Tumor Cell Biology Training grant [NIH 5T32CA009056-29]; UCLA Clinical Immunology and Allergy Training grant [NIH 5T32AI007126-30]; NATIONAL CANCER INSTITUTE [T32CA009056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007126, P30AI028697, R01AI069120, T32AI060567, R01AI070010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008563, R25GM055052] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Center for AIDS Research (CFAR); UCLA CFAR; UCLA AIDS Institute; Western University of Health Sciences College of Pharmacy startup funding; UCLA Interdisciplinary Training in Virology and Gene Therapy grant; UCLA Tumor Cell Biology Training grant; UCLA Clinical Immunology and Allergy Training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH Grants AI069120-03 (G.C.) and AI70010 (J.A.Z.) as well as by the UCLA Center for AIDS Research (CFAR) including a Seed grant by the UCLA CFAR (NIH/NIAID AI028697) and UCLA AIDS Institute (D.J.S.) as well as the Western University of Health Sciences College of Pharmacy startup funding (D.J.S.). Additional support was provided by UCLA Interdisciplinary Training in Virology and Gene Therapy grant (NIH 5T32AI060567-05) (D.J.S.), UCLA Tumor Cell Biology Training grant (NIH 5T32CA009056-29) (D.J.S.), and UCLA Clinical Immunology and Allergy Training grant (NIH 5T32AI007126-30) (D.M.). A.S. was a Van Trees Scholar and T.H. was a Boyer Scholar through the UCLA Undergraduate Research Scholars Program. J.R.B. was a Maximizing Student Diversity Scholar (NIH 5R25GM055052-10) and S.J.D. was a Minority Access to Research Careers Scholar (NIH 5T34GM008563-13) though the UCLA Center for Academic and Research Excellence.	Alonso K, 1997, IMMUNOL INVEST, V26, P341, DOI 10.3109/08820139709022691; An DS, 1999, J VIROL, V73, P7671, DOI 10.1128/JVI.73.9.7671-7677.1999; Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; Burke B, 2007, J VIROL, V81, P7424, DOI 10.1128/JVI.02838-06; Chang JJ, 2010, J INFECT DIS, V202, pS297, DOI 10.1086/655657; Doehle BP, 2009, J VIROL, V83, P10395, DOI 10.1128/JVI.00849-09; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Havlir D, 2012, NEW ENGL J MED, V367, P685, DOI 10.1056/NEJMp1207138; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kamga I, 2005, J INFECT DIS, V192, P303, DOI 10.1086/430931; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lindwasser OW, 2007, CURR MOL MED, V7, P171; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Marsden MD, 2007, J VIROL, V81, P6146, DOI 10.1128/JVI.00203-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437	49	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137951	10.1371/journal.pone.0137951	http://dx.doi.org/10.1371/journal.pone.0137951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375588	Green Submitted, gold, Green Published			2022-12-26	WOS:000361610200064
J	de Lange, MJ; Razzaq, L; Versluis, M; Verlinde, S; Dogrusoz, M; Bohringer, S; Marinkovic, M; Luyten, GPM; de Keizer, RJW; de Gruijl, FR; Jager, MJ; van der Velden, PA				de Lange, Mark J.; Razzaq, Lubna; Versluis, Mieke; Verlinde, Sven; Dogrusoz, Mehmet; Bohringer, Stefan; Marinkovic, Marina; Luyten, Gregorius P. M.; de Keizer, Rob J. W.; de Gruijl, Frank R.; Jager, Martine J.; van der Velden, Pieter A.			Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; OCULAR MELANOMA; DNA; BRAF; SKIN; MELANOGENESIS; PATTERNS; RISK	Uveal melanomas (UM) originate from melanocytes in the interior wall of the eye, namely from the iris, ciliary body and the choroid with marked differences in light exposure (from dark anterior to illuminated posterior). In contrast to UV radiation, focused or converging visible light readily reaches the retina and can damage DNA which possibly contributes to UM development. In this report choroidal, ciliochoroidal and iridociliary melanomas were analyzed for GNAQ and GNA11 mutations which were subsequently correlated to the location of tumor origin. Hotspot mutations in GNAQ and GNA11 can be divided in A>T and in A>C mutation signatures. The GNAQ A626C mutation (Q209P) was almost exclusively observed in choroidal melanomas from the illuminated posterior side. On the other hand, ciliochoroidal UM from the dark anterior side with mostly A>T mutations were clearly associated with light-colored eyes. Combined these data suggest a light and a pigment dependent etiology in UM development.	[de Lange, Mark J.; Razzaq, Lubna; Versluis, Mieke; Verlinde, Sven; Dogrusoz, Mehmet; Marinkovic, Marina; Luyten, Gregorius P. M.; de Keizer, Rob J. W.; Jager, Martine J.; van der Velden, Pieter A.] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands; [Bohringer, Stefan] Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands; [de Gruijl, Frank R.] Leiden Univ, Dept Dermatol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Velden, PA (corresponding author), Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands.	velden@lumc.nl	Jager, Martine/AAR-3525-2020	Jager, Martine/0000-0003-2261-3820; van der Velden, Pieter/0000-0002-5710-9256	KWF kankerbestrijding [UL2011-4991]	KWF kankerbestrijding(KWF Kankerbestrijding)	This work was supported by KWF kankerbestrijding grant no.: UL2011-4991, received by PAvdV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2009, DEVELOPMENT, V136, P2511, DOI 10.1242/dev.037168; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Cruz F, 2003, CANCER RES, V63, P5761; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; Guenel P, 2001, CANCER CAUSE CONTROL, V12, P451, DOI 10.1023/A:1011271420974; Janssen CS, 2008, BRIT J CANCER, V99, P1673, DOI 10.1038/sj.bjc.6604731; KAMIYA H, 1995, NUCLEIC ACIDS RES, V23, P2893, DOI 10.1093/nar/23.15.2893; Krohn J, 2008, BRIT J OPHTHALMOL, V92, P751, DOI 10.1136/bjo.2007.133025; Li WJ, 2000, CANCER RES, V60, P3757; Maat W, 2008, INVEST OPHTH VIS SCI, V49, P23, DOI 10.1167/iovs.07-0722; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; RAIVIO I, 1977, ACTA OPHTHALMOL, P1; Rimoldi D, 2003, CANCER RES, V63, P5712; RONES B, 1958, ARCH OPHTHALMOL-CHIC, V60, P193; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P981, DOI 10.1001/archophthalmol.2009.151; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SOPARKER CN, 1993, INVEST OPHTH VIS SCI, V34, P2203; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; STRICKLAND D, 1981, AM J EPIDEMIOL, V113, P700, DOI 10.1093/oxfordjournals.aje.a113150; Vajdic CM, 2002, INT J CANCER, V101, P175, DOI 10.1002/ijc.10579; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586	30	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138002	10.1371/journal.pone.0138002	http://dx.doi.org/10.1371/journal.pone.0138002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368812	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100200
J	DeAmicis, S; Foggo, A				DeAmicis, Stacey; Foggo, Andrew			Long-Term Field Study Reveals Subtle Effects of the Invasive Alga Sargassum muticum upon the Epibiota of Zostera marina	PLOS ONE			English	Article							SEAGRASS POSIDONIA-OCEANICA; EPIPHYTIC ALGAE; INTRODUCED SEAWEED; PHENOLIC-COMPOUNDS; CAULERPA-RACEMOSA; MOBILE EPIFAUNA; HABITAT; EELGRASS; ASSEMBLAGES; COMMUNITIES	Invasive species can alter coastal ecosystems both directly, e.g. through competition for substratum and nutrients, and indirectly. Indirect effects may be mediated by creation of dissimilar or inimical habitats, changes in predator and/or prey assemblages, alterations in associated biota, and perturbations of water movement and thermal regimes. Previous studies have shown that invasive algae can modify native habitat architecture, disrupt intricately linked food webs and alter epibiotic assemblages. In the UK, the seagrass Zostera marina supports a diverse epibiotic assemblage, influencing key factors such as sediment dynamics, depositional regime and trophic linkages. Increasing encroachment of the invasive alga Sargassum muticum into seagrass meadows changes the physical and chemical characteristics of the local environment and creates the potential for changes in the epibionts associated with the seagrass blades, threatening the integrity of the seagrass ecosystem. We investigated the effects of S. muticum invasion upon the epibiota of Z. marina in a drowned river valley in SW England seasonally from spring to autumn over four years in an in-situ manipulative experiment, comparing permanent quadrats with and without artificially introduced S. muticum. Epibiota were weighed, identified to the most detailed operational taxonomic unit (OTU) possible, and unitary organisms were enumerated. Multivariate PERMANOVA+ analysis revealed significant differences in epibiont assemblages between Sargassum treatments. Linear mixed effects models indicated that differences in epibiota assemblage composition were not reflected as significant differences in mean biomass per sample, or number of epibiont OTUs per sample. We conclude that S. muticum invasion into Z. marina meadows may significantly alter the species composition and abundance distribution of epibiotic assemblages found on the blades of the seagrass. Thus S. muticum invasion could have more wide-reaching effects on processes within coastal ecosystems than predicted purely by direct effects.	[DeAmicis, Stacey; Foggo, Andrew] Univ Plymouth, Sch Marine Sci & Engn, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	University of Plymouth	DeAmicis, S (corresponding author), Univ Plymouth, Sch Marine Sci & Engn, Marine Biol & Ecol Res Ctr, 620 Davy Bldg, Plymouth PL4 8AA, Devon, England.	stacey.deamicis@plymouth.ac.uk	DeAmicis, Stacey/F-3553-2015	DeAmicis, Stacey/0000-0002-3447-5085	Jack Kent Cooke Graduate Scholarship; Jack Kent Cooke Foundation	Jack Kent Cooke Graduate Scholarship; Jack Kent Cooke Foundation	This study was funded by (SD) Jack Kent Cooke Graduate Scholarship, Jack Kent Cooke Foundation: http://www.jkcf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2014, R LANG ENV STAT COMP; Attrill MJ, 2000, ECOGRAPHY, V23, P114, DOI 10.1034/j.1600-0587.2000.230112.x; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Bell JD., 1989, BIOL SEAGRASSES TREA, P565; Bologna PAX, 1999, J EXP MAR BIOL ECOL, V242, P21, DOI 10.1016/S0022-0981(99)00092-1; BRAITHWAITE RW, 1989, BIOL CONSERV, V48, P189, DOI 10.1016/0006-3207(89)90118-3; Britton-Simmons KH, 2004, MAR ECOL PROG SER, V277, P61, DOI 10.3354/meps277061; Buschbaum C, 2006, MAR BIOL, V148, P743, DOI 10.1007/s00227-005-0128-9; Castejon-Silvo I, 2012, ESTUAR COAST SHELF S, V112, P225, DOI 10.1016/j.ecss.2012.07.028; Christie H, 2009, MAR ECOL PROG SER, V396, P221, DOI 10.3354/meps08351; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CRITCHLEY AT, 1986, BIOL CONSERV, V35, P313, DOI 10.1016/0006-3207(86)90092-3; Cuny P, 1995, AQUAT BOT, V52, P237, DOI 10.1016/0304-3770(95)00504-8; De Falco G, 2000, GEO-MAR LETT, V20, P50, DOI 10.1007/s003670000030; DeAmicis S, 2012, LONG TERM EFFECTS SA; Drouin A, 2012, OECOLOGIA, V168, P491, DOI 10.1007/s00442-011-2086-x; Dumay O, 2004, PHYTOCHEMISTRY, V65, P3211, DOI 10.1016/j.phytochem.2004.09.003; Fagundez J, 2013, ANN BOT-LONDON, V111, P151, DOI 10.1093/aob/mcs257; Gartner A, 2013, J EXP MAR BIOL ECOL, V439, P143, DOI 10.1016/j.jembe.2012.11.009; Gestoso I, 2011, HELGOLAND MAR RES, V66, P1; Gestoso I, 2010, MAR FRESHWATER RES, V61, P724, DOI 10.1071/MF09251; GORHAM J, 1984, MAR BIOL, V80, P103, DOI 10.1007/BF00393133; HACKER SD, 1990, ECOLOGY, V71, P2269, DOI 10.2307/1938638; HALL MO, 1988, J MAR RES, V46, P613, DOI 10.1357/002224088785113531; HARRISON PG, 1989, AQUAT BOT, V35, P409, DOI 10.1016/0304-3770(89)90012-0; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; Hauxwell J, 2001, ECOLOGY, V82, P1007, DOI 10.2307/2679899; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hirst JA, 2008, ESTUAR COAST SHELF S, V78, P811, DOI 10.1016/j.ecss.2008.02.020; Jackson EL, 2006, J EXP MAR BIOL ECOL, V330, P38, DOI 10.1016/j.jembe.2005.12.016; JACOBS RPWM, 1983, AQUAT BOT, V15, P157, DOI 10.1016/0304-3770(83)90026-8; Jaschinski S, 2008, MAR BIOL, V154, P475, DOI 10.1007/s00227-008-0942-y; Jones E, 2010, MAR ECOL PROG SER, V400, P87, DOI 10.3354/meps08391; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; KLUMPP DW, 1992, AQUAT BOT, V43, P327, DOI 10.1016/0304-3770(92)90046-L; Lee SY, 2001, J EXP MAR BIOL ECOL, V259, P23, DOI 10.1016/S0022-0981(01)00221-0; Lewis III R. R., 1982, CREATION RESTORATION; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lutz ML, 2010, MAR BIOL, V157, P1095, DOI 10.1007/s00227-010-1391-y; McClintock JB, 2001, MARINE CHEM ECOLOGY; McGlathery KJ, 2001, J PHYCOL, V37, P453, DOI 10.1046/j.1529-8817.2001.037004453.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mittermayr A, 2014, MAR ECOL PROG SER, V505, P95, DOI 10.3354/meps10797; Moncreiff CA, 2001, MAR ECOL PROG SER, V215, P93, DOI 10.3354/meps215093; Monteiro CA, 2009, MAR BIOL, V156, P2505, DOI 10.1007/s00227-009-1275-1; NORTON TA, 1977, J EXP MAR BIOL ECOL, V26, P41, DOI 10.1016/0022-0981(77)90079-X; NORTON TA, 1983, MAR BIOL, V75, P169, DOI 10.1007/BF00405999; NOVAK R, 1984, MAR ECOL-P S Z N I, V5, P143, DOI 10.1111/j.1439-0485.1984.tb00313.x; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Parker JD, 2001, MAR ECOL PROG SER, V224, P55, DOI 10.3354/meps224055; Pergent Gerard, 2008, BMC Ecology, V8, P20, DOI 10.1186/1472-6785-8-20; Plouguerne E, 2006, AQUAT BOT, V85, P337, DOI 10.1016/j.aquabot.2006.06.011; Polte P, 2008, AQUAT BIOL, V3, P11, DOI 10.3354/ab00071; Raniello R, 2007, BIOL INVASIONS, V9, P361, DOI 10.1007/s10530-006-9044-2; Ruesink JL, 2006, MAR ECOL PROG SER, V311, P203, DOI 10.3354/meps311203; Saunders JE, 2003, MAR ECOL PROG SER, V249, P107, DOI 10.3354/meps249107; Scheibling RE, 2006, BOT MAR, V157, P1095; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Strong JA, 2006, MAR ECOL PROG SER, V321, P87, DOI 10.3354/meps321087; TAYLOR RB, 1994, MAR ECOL PROG SER, V115, P271, DOI 10.3354/meps115271; Thomsen MS, 2011, J EXP MAR BIOL ECOL, V400, P322, DOI 10.1016/j.jembe.2011.02.033; THURSBY G B, 1984, Florida Scientist, V47, P130; Tomas F, 2005, MAR ECOL PROG SER, V287, P115, DOI 10.3354/meps287115; Tweedley JR, 2008, MAR ECOL PROG SER, V354, P305, DOI 10.3354/meps07242; Valentine JF, 2002, B MAR SCI, V71, P1361; Vazquez-Luis M, 2008, MAR ENVIRON RES, V65, P416, DOI 10.1016/j.marenvres.2008.01.006; Verges A, 2007, MAR ECOL PROG SER, V343, P107, DOI 10.3354/meps06885; Viejo RM, 1999, AQUAT BOT, V64, P131, DOI 10.1016/S0304-3770(99)00011-X; Wikstrom SA, 2004, BIOL INVASIONS, V6, P141, DOI 10.1023/B:BINV.0000022132.00398.14	73	7	7	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137861	10.1371/journal.pone.0137861	http://dx.doi.org/10.1371/journal.pone.0137861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368805	gold, Green Submitted, Green Published			2022-12-26	WOS:000361601100158
J	Hallstrom, T; Uhde, M; Singh, B; Skerka, C; Riesbeck, K; Zipfel, PF				Hallstroem, Teresia; Uhde, Melanie; Singh, Birendra; Skerka, Christine; Riesbeck, Kristian; Zipfel, Peter F.			Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; ALKALINE PROTEASE; IMMUNE EVASION; FACTOR-H; SURFACE; ACTIVATION; INTERACTS; DOMAIN	The opportunistic human pathogen Pseudomonas aeruginosa controls host innate immune and complement attack. Here we identify Dihydrolipoamide dehydrogenase (Lpd), a 57 kDa moonlighting protein, as the first P. aeruginosa protein that binds the two human terminal pathway inhibitors vitronectin and clusterin. Both human regulators when bound to the bacterium inhibited effector function of the terminal complement, blocked C5b-9 deposition and protected the bacterium from complement damage. P. aeruginosa when challenged with complement active human serum depleted from vitronectin was severely damaged and bacterial survival was reduced by over 50%. Similarly, when in human serum clusterin was blocked by a mAb, bacterial survival was reduced by 44%. Thus, demonstrating that Pseudomonas benefits from attachment of each human regulator and controls complement attack. The Lpd binding site in vitronectin was localized to the C-terminal region, i.e. to residues 354-363. Thus, Lpd of P. aeruginosa is a surface exposed moonlighting protein that binds two human terminal pathway inhibitors, vitronectin and clusterin and each human inhibitor when attached protected the bacterial pathogen from the action of the terminal complement pathway. Our results showed insights into the important function of Lpd as a complement regulator binding protein that might play an important role in virulence of P. aeruginosa.	[Hallstroem, Teresia; Uhde, Melanie; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Singh, Birendra; Riesbeck, Kristian] Lund Univ, Skane Univ Hosp, Dept Translat Med Malmo, Med Microbiol, Malmo, Sweden; [Zipfel, Peter F.] Univ Jena, Fac Biol, Jena, Germany	Hans Knoll Institute (HKI); Lund University; Skane University Hospital; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany.	peter.zipfel@hki-jena.de	; Singh, Birendra/H-3592-2011	Riesbeck, Kristian/0000-0001-6274-6965; Singh, Birendra/0000-0002-7246-1442				Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; ARKO RJ, 1991, J CLIN MICROBIOL, V29, P70, DOI 10.1128/JCM.29.1.70-75.1991; Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bubeck D, 2014, BIOCHEMISTRY-US, V53, P1908, DOI 10.1021/bi500157z; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; CHOI NH, 1989, MOL IMMUNOL, V26, P835; ENGELS W, 1985, J IMMUNOL METHODS, V81, P43, DOI 10.1016/0022-1759(85)90120-6; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; Guo W, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/293637; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; Hallstrom T, 2012, J IMMUNOL, V189, P4939, DOI 10.4049/jimmunol.1200386; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; HONG YQ, 1992, CLIN IMMUNOL IMMUNOP, V62, P133, DOI 10.1016/0090-1229(92)90065-V; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; KOSTRZYNSKA M, 1992, MICROBIOS, V71, P179; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; Laarman AJ, 2012, J IMMUNOL, V188, P386, DOI 10.4049/jimmunol.1102162; Leroy-Dudal J, 2004, MICROBES INFECT, V6, P875, DOI 10.1016/j.micinf.2004.05.004; Li DQ, 2001, CURR MICROBIOL, V42, P361, DOI 10.1007/s002840010230; Li DQ, 2001, FEMS IMMUNOL MED MIC, V31, P197; LIANG OD, 1995, BBA-PROTEIN STRUCT M, V1250, P110, DOI 10.1016/0167-4838(95)00076-7; Liang OD, 1997, FEBS LETT, V407, P169, DOI 10.1016/S0014-5793(97)00330-X; Liszewski MK, 2015, J INTERN MED, V277, P294, DOI 10.1111/joim.12338; Lopez CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090796; MCCULLY V, 1986, BIOCHEM J, V233, P737, DOI 10.1042/bj2330737; Millis AJT, 2001, J CELL PHYSIOL, V186, P210, DOI 10.1002/1097-4652(200102)186:2<210::AID-JCP1019>3.0.CO;2-N; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Partridge SR, 1996, INFECT IMMUN, V64, P4324, DOI 10.1128/IAI.64.10.4324-4329.1996; Pier GB, 2005, PSEUDOMONAS AERUGINO; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P123; PREISSNER KT, 1985, J IMMUNOL, V135, P445; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; SCHILLER NL, 1986, INFECT IMMUN, V54, P689, DOI 10.1128/IAI.54.3.689-694.1986; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SHEEHAN M, 1995, CLIN EXP IMMUNOL, V101, P136; Silkensen JR, 1995, J CLIN INVEST, V96, P2646, DOI 10.1172/JCI118330; Singh B, 2011, MOL MICROBIOL, V81, P80, DOI 10.1111/j.1365-2958.2011.07678.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Styriak I, 2003, CURR MICROBIOL, V46, P435, DOI 10.1007/s00284-002-3879-2; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Zipfel PF, 2014, INT J MED MICROBIOL, V304, P188, DOI 10.1016/j.ijmm.2013.11.004; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	51	18	19	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137630	10.1371/journal.pone.0137630	http://dx.doi.org/10.1371/journal.pone.0137630			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368530	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100100
J	Relja, B; Weber, R; Maraslioglu, M; Wagner, N; Borsello, T; Jobin, C; Marzi, I; Lehnert, M				Relja, Borna; Weber, Roxane; Maraslioglu, Miriam; Wagner, Nils; Borsello, Tiziana; Jobin, Christian; Marzi, Ingo; Lehnert, Mark			Differential Relevance of NF-kappa B and JNK in the Pathophysiology of Hemorrhage/Resususcitation-Induced Liver Injury after Chronic Ethanol Feeding	PLOS ONE			English	Article							TERMINAL KINASE PROTECTS; C-JUN; PEPTIDE INHIBITOR; HEMORRHAGIC-SHOCK; INFLAMMATORY RESPONSE; HEPATIC-INJURY; CASPASE-3 ACTIVATION; SIGNAL-TRANSDUCTION; REPERFUSION INJURY; CEREBRAL-ISCHEMIA	Background Chronic ethanol (EtOH) abuse worsens pathophysiological derangements after hemorrhagic shock and resuscitation (H/R) that induce hepatic injury and strong inflammatory changes via JNK and NF-kappa B activation. Inhibiting JNK with a cell-penetrating, proteaseresistant peptide D-JNKI-1 after H/R in mice with healthy livers ameliorated these effects. Here, we studied if JNK inhibition by D-JNKI-1 in chronically EtOH-fed mice after hemorrhagic shock prior to the onset of resuscitation also confers protection. Methods Male mice were fed a Lieber-DeCarli diet containing EtOH or an isocaloric control (ctrl) diet for 4 weeks. Animals were hemorrhaged for 90 min (32 +/- 2 mm Hg) and randomly received either D-JNKI-1 (11 mg/kg, intraperitoneally, i.p.) or sterile saline as vehicle (veh) immediately before the onset of resuscitation. Sham animals underwent surgical procedures without H/R and were either D-JNKI-1 or veh treated. Two hours after resuscitation, blood samples and liver tissue were harvested. Results H/R induced hepatic injury with increased systemic interleukin (IL)-6 levels, and enhanced local gene expression of NF-kappa B-controlled genes such as intercellular adhesion molecule (ICAM)-1 and matrix metallopeptidase (MMP) 9. c-Jun and NF-kappa B phosphorylation were increased after H/R. These effects were further increased in EtOH-fed mice after H/R. D-JNKI-1 application inhibited the proinflammatory changes and reduced significantly hepatic injury after H/R in ctrl-fed mice. Moreover, D-JNKI-1 reduces in ctrl-fed mice the H/R-induced c-Jun and NF-kappa B phosphorylation. However, in chronically EtOH-fed mice, JNK inhibition did not prevent the H/R-induced hepatic damage and proinflammatory changes nor c-Jun and NF-kappa B phosphorylation after H/R. Conclusions These results indicate, that JNK inhibition is protective only in not pre-harmed liver after H/R. In contrast, the pronounced H/R-induced liver damage in mice being chronically fed with ethanol cannot be prevented by JNK inhibition after H/R and seems to be under the control of NF-kappa B.	[Relja, Borna; Weber, Roxane; Maraslioglu, Miriam; Wagner, Nils; Marzi, Ingo; Lehnert, Mark] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60054 Frankfurt, Germany; [Borsello, Tiziana] Ist Ric Farmacol Mario Negri, Neuronal Death & Neuroprotect Unit, Milan, Italy; [Jobin, Christian] Univ Florida, Dept Med, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; State University System of Florida; University of Florida	Relja, B (corresponding author), Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60054 Frankfurt, Germany.	info@bornarelja.com	Borsello, Tiziana/ABG-7759-2020; Maraslioglu, M./I-8306-2019; Relja, Borna/B-6642-2016; Borsello, Tiziana/J-8232-2016	Maraslioglu, M./0000-0002-2071-2801; Relja, Borna/0000-0002-5625-8823; Borsello, Tiziana/0000-0002-9729-7642	Deutsche Forschungsgemeinschaft (DE) [LE 1346/2-1]	Deutsche Forschungsgemeinschaft (DE)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DE) grant nr. LE 1346/2-1.	Aroor AR, 2011, ALCOHOL CLIN EXP RES, V35, P2128, DOI 10.1111/j.1530-0277.2011.01577.x; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Benakis C, 2010, BRAIN BEHAV IMMUN, V24, P800, DOI 10.1016/j.bbi.2009.11.001; Bertelsen M, 2005, ASSAY DRUG DEV TECHN, V3, P261, DOI 10.1089/adt.2005.3.261; Bogner V, 2009, EUR J MED RES, V14, P284, DOI 10.1186/2047-783X-14-7-284; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Bradford BU, 2008, TOXICOL APPL PHARM, V232, P236, DOI 10.1016/j.taap.2008.06.022; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Davoli E, 2014, J PHARMACOL TOX MET, V70, P55, DOI 10.1016/j.vascn.2014.04.001; DECARLI LM, 1967, J NUTR, V91, P331, DOI 10.1093/jn/91.3_Suppl.331; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dietz GPH, 2005, BRAIN RES BULL, V68, P103, DOI 10.1016/j.brainresbull.2005.08.015; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Eshraghi AA, 2007, HEARING RES, V226, P168, DOI 10.1016/j.heares.2006.09.008; Fan CG, 2004, J CLIN INVEST, V113, P746, DOI 10.1172/JCI200417337; Greiffenstein P, 2007, ALCOHOL CLIN EXP RES, V31, P704, DOI 10.1111/j.1530-0277.2007.00355.x; Koteish A, 2002, J BIOL CHEM, V277, P13037, DOI 10.1074/jbc.M101632200; Lehnert M, 2008, SHOCK, V30, P159, DOI 10.1097/SHK.0b013e31815dd623; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Maraslioglu M, 2013, BRIT J PHARMACOL, V170, P506, DOI 10.1111/bph.12224; Maraslioglu M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/808695; Meng ZH, 2001, AM J PHYSIOL-CELL PH, V280, pC343, DOI 10.1152/ajpcell.2001.280.2.C343; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Nau C, 2012, INJURY; Ono M, 2004, SHOCK, V21, P519, DOI 10.1097/01.shk.0000126905.75237.07; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Peden M, 2002, BRIT MED J, V324, P1153, DOI 10.1136/bmj.324.7346.1153; Reinecke K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030985; Relja B, 2012, BRIT J PHARMACOL, V165, P1188, DOI 10.1111/j.1476-5381.2011.01595.x; Relja B, 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/781519; Relja B, 2010, PLANT POLYPHENOLS AT; Relja B, 2013, SCAND J GASTROENTERO, V48, P448, DOI 10.3109/00365521.2013.772228; Relja B, 2011, BRIT J NUTR, V105, P1791, DOI 10.1017/S000711451000560X; Relja B, 2010, SHOCK, V34, P46, DOI 10.1097/SHK.0b013e3181cd8d05; Relja B, 2009, SHOCK, V32, P509, DOI 10.1097/SHK.0b013e3181a2530d; Rensing H, 2001, CRIT CARE MED, V29, P1962, DOI 10.1097/00003246-200110000-00019; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; Rushing GD, 2008, ANN SURG, V247, P929, DOI 10.1097/SLA.0b013e31816757f7; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sakran JV, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-64; Shimizu T, 2007, J HEPATOL, V46, P1047, DOI 10.1016/j.jhep.2007.01.019; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Touchard E, 2010, INVEST OPHTH VIS SCI, V51, P4683, DOI 10.1167/iovs.09-4733; van Meurs M, 2008, SHOCK, V29, P291, DOI 10.1097/shk.0b013e318145a7c1; Wang J, 2003, J NEUROSCI, V23, P8596; Wang XD, 2009, FREE RADICAL BIO MED, V47, P518, DOI 10.1016/j.freeradbiomed.2009.05.021; Wetzel G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/930419	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137875	10.1371/journal.pone.0137875	http://dx.doi.org/10.1371/journal.pone.0137875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367181	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100164
J	Wu, P; Wang, LP; Cowling, BJ; Yu, JX; Fang, VJ; Li, F; Zeng, LJ; Wu, JT; Li, ZJ; Leung, GM; Yu, HJ				Wu, Peng; Wang, Liping; Cowling, Benjamin J.; Yu, Jianxing; Fang, Vicky J.; Li, Fu; Zeng, Lingjia; Wu, Joseph T.; Li, Zhongjie; Leung, Gabriel M.; Yu, Hongjie			Live Poultry Exposure and Public Response to Influenza A(H7N9) in Urban and Rural China during Two Epidemic Waves in 2013-2014	PLOS ONE			English	Article							A H7N9 VIRUS; BEHAVIORAL-RESPONSES; HUMAN INFECTIONS; HONG-KONG; MARKETS	Background The novel influenza A(H7N9) virus has caused 2013 spring and 2013-2014 winter waves of human infections since its first emergence in China in March 2013. Exposure to live poultry is a risk factor for H7N9 infection. Public psychobehavioral responses often change during progression of an epidemic. Methods We conducted population-based surveys in southern China to examine human exposure to live poultry, and population psychological response and behavioral changes in the two waves. In Guangzhou, an urban area of Guangdong province, we collected data using telephone surveys with random digit dialing in May-June 2013 and again in December 2013 to January 2014. In Zijin county, a rural area of the same province, we used door-to-door surveys under a stratified sampling design in July 2013 and again in December 2013 to January 2014. All responses were weighted by age and sex to the respective adult populations. Findings Around half of the urban respondents (53.8%) reported having visited LPMs in the previous year in the first survey, around double that reported in the second survey (27.7%). In the rural surveys, around half of the participants reported raising backyard poultry in the past year in the first survey, increasing to 83.2% participants in the second survey. One third of urban subjects supported the permanent closure of LPMs in the first and second surveys, and factors associated with support for closure included female sex, higher level of worry towards H7N9, and worry induced by a hypothetical influenza-like illness. Conclusions Our study indicated high human exposure to live poultry and low support for permanent closure of markets in both urban and rural residents regardless of increased worry during the epidemic.	[Wu, Peng; Cowling, Benjamin J.; Fang, Vicky J.; Wu, Joseph T.; Leung, Gabriel M.] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Hong Kong, Peoples R China; [Wang, Liping; Yu, Jianxing; Li, Fu; Zeng, Lingjia; Li, Zhongjie; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China	University of Hong Kong; World Health Organization; Chinese Center for Disease Control & Prevention	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	yuhj@chinacdc.cn	Yu, Hongjie/GZK-5351-2022; Wu, Joseph/ABD-5880-2021; Cowling, Benjamin John/C-4263-2009; Wu, Joseph Tsz Kei/C-4450-2009	Cowling, Benjamin John/0000-0002-6297-7154; YU, Jianxing/0000-0002-9696-2460; Wu, Peng/0000-0003-1157-9401; Leung, Gabriel/0000-0002-2503-6283; Wu, Joseph Tsz Kei/0000-0002-3155-5987	US National Institutes of Health [U19 AI51915)]; China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases, grants from the Ministry of Science and Technology, China [2012 ZX10004-201]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region [HKU-13-06-01]; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases, grants from the Ministry of Science and Technology, China; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; Area of Excellence Scheme of the Hong Kong University Grants Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the US National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915), the China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases, grants from the Ministry of Science and Technology, China (2012 ZX10004-201), the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558), the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (grant no. HKU-13-06-01), and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Peng ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095430; Wang LP, 2014, EMERG INFECT DIS, V20, P1296, DOI 10.3201/eid2008.131821; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2	10	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137831	10.1371/journal.pone.0137831	http://dx.doi.org/10.1371/journal.pone.0137831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367002	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100149
J	Yin, L; Bian, XH; Wang, X; Chen, M; Wu, J; Xu, JH; Qian, PD; Guo, WJ; Jiang, XS; Zhu, HF; Gu, JJ; Wu, JF; Zhang, YW; He, X				Yin, Li; Bian, Xiu-Hua; Wang, Xue; Chen, Meng; Wu, Jing; Xu, Jian-Hua; Qian, Pu-Dong; Guo, Wen-Jie; Jiang, Xue-Song; Zhu, Huan-Feng; Gu, Jia-Jia; Wu, Jian-Feng; Zhang, Ye-wei; He, Xia			Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; PHASE-II TRIAL; NECK-CANCER; TREATMENT OUTCOMES; RANDOMIZED-TRIALS; RADIATION-THERAPY; CHEMOTHERAPY; NEDAPLATIN; HEAD; METAANALYSIS	Background N-stage is related to distant metastasis in nasopharyngeal carcinoma (NPC) patients. The purpose of this study was to evaluate the efficacy and toxicity of different nedaplatin-based chemotherapy regimens in advanced N2-3 stage NPC patients treated with intensity modulated radiation therapy (IMRT). Patients and Methods Between April 2005 and December 2009, a total of 128 patients with N2-3 advanced NPC were retrospectively analyzed. Patients were treated with IMRT concurrent with 2 cycles of chemotherapy consisting of either nedaplatin plus paclitaxel (NP group, n = 67) or nedaplatin plus fluorouracil and paclitaxel (NFP group, n = 61). Two to four cycles of adjuvant chemotherapy were then administered every 21 days following concurrent chemoradiotherapy. Results With a median follow-up of 60 months, the 5-year overall survival (OS), progression-free survival (PFS), local-regional recurrence-free survival (LRRFS), and distant metastasis-free survival (DMFS) for all patients were 81.4%, 71.5%, 87.8% and 82.0%, respectively. No significant difference in PFS (66.6% vs. 76.7%, P = 0.212) and LRRFS rates (89.0% vs. 86.3%, P = 0.664) was observed between the NP and NFP groups. The 5-year OS (75.4% vs. 88.5%, P = 0.046) and DMFS (75.1% vs. 89.0%, P = 0.042) rate were superior in the NFP group compared with the NP group. The NFP group had a higher incidence of grade 3-4 acute toxicities including bone marrow suppression (leukopenia: chi(2) = 3.935, P = 0.047; anemia: chi(2) = 9.760, P = 0.002; thrombocytopenia: chi(2) = 8.821, P = 0.003), and both liver and renal dysfunction (chi(2) = 5.206, P = 0.023) compared with the NP group. Late toxicities were moderate and no difference was observed between the two groups. Conclusion IMRT concurrent with nedaplatin-based chemotherapy is an advocated regimen for patients with advanced N2-3 stage NPC. Patients with advanced N2-3 stage may be better candidates for the NFP regimen although this regimen was associated with a high acute toxicity rate.	[Yin, Li; Bian, Xiu-Hua; Chen, Meng; Wu, Jing; Xu, Jian-Hua; Qian, Pu-Dong; Guo, Wen-Jie; Jiang, Xue-Song; Zhu, Huan-Feng; Gu, Jia-Jia; Wu, Jian-Feng; He, Xia] Nanjing Med Univ, Affiliated Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China; [Yin, Li; Bian, Xiu-Hua; Chen, Meng; Wu, Jing; Xu, Jian-Hua; Qian, Pu-Dong; Guo, Wen-Jie; Jiang, Xue-Song; Zhu, Huan-Feng; Gu, Jia-Jia; Wu, Jian-Feng; Zhang, Ye-wei; He, Xia] Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China; [Wang, Xue] Jilin Canc Hosp, Dept Radiat Oncol, Changchun, Peoples R China; [Zhang, Ye-wei] Nanjing Med Univ, Affiliated Jiangsu Canc Hosp, Dept Hepatobiliary & Pancreat Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	He, X (corresponding author), Nanjing Med Univ, Affiliated Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China.	hexia200302@tom.com	Qian, Pu/GZM-2400-2022		JiangSu Clinical medicine Science and Technology Special Fund [BL2014091]; JiangSu Provincial Commission of Health and Family Planning Young Scholars Award [Q201501]	JiangSu Clinical medicine Science and Technology Special Fund; JiangSu Provincial Commission of Health and Family Planning Young Scholars Award	This research was supported by grants from the JiangSu Clinical medicine Science and Technology Special Fund (No:BL2014091, http://www.jstd.gov.cn/), the JiangSu Provincial Commission of Health and Family Planning Young Scholars Award (Q201501, http://www.jswst.gov.cn/jsswshjhsywyh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Argiris A, 2011, ANN ONCOL, V22, P773, DOI 10.1093/annonc/mdq426; Bae WK, 2010, CANCER CHEMOTH PHARM, V65, P589, DOI 10.1007/s00280-009-1152-0; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Ji XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056208; Kalogera-Fountzila A, 2006, STRAHLENTHER ONKOL, V182, P458, DOI 10.1007/s00066-006-1538-4; Kodaira T, 2006, ANTICANCER RES, V26, P2265; Kong Lin, 2010, Chin J Cancer, V29, P551; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Lee AWM, 2010, JNCI-J NATL CANCER I, V102, P1188, DOI 10.1093/jnci/djq258; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; Li XX, 2013, 2013 SEVENTH INTERNATIONAL CONFERENCE ON INTERNET COMPUTING FOR ENGINEERING AND SCIENCE (ICICSE 2013), P48, DOI 10.1109/ICICSE.2013.17; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Ma J, 2001, INT J RADIAT ONCOL, V50, P1181, DOI 10.1016/S0360-3016(01)01537-1; Ohashi T, 2011, JPN J CLIN ONCOL, V41, P348, DOI 10.1093/jjco/hyq196; Shen ZT, 2013, WORLD J GASTROENTERO, V19, P9447, DOI 10.3748/wjg.v19.i48.9447; Shenouda G, 2015, INT J RADIAT ONCOL, V91, P907, DOI 10.1016/j.ijrobp.2014.12.018; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Sun XM, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-265; Wong FCS, 2010, INT J RADIAT ONCOL, V76, P138, DOI 10.1016/j.ijrobp.2009.01.084; Wu F, 2014, RADIOTHER ONCOL, V112, P106, DOI 10.1016/j.radonc.2014.05.005; Xu JH, 2013, CANCER RADIOTHER, V17, P297, DOI 10.1016/j.canrad.2013.03.006; Xu JH, 2014, HEAD NECK-J SCI SPEC, V36, P1474, DOI 10.1002/hed.23487; Zhang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-558	29	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137383	10.1371/journal.pone.0137383	http://dx.doi.org/10.1371/journal.pone.0137383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367317	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100067
J	Molza, AE; Mangat, K; Le Rumeur, E; Hubert, JF; Menhart, N; Delalande, O				Molza, Anne-Elisabeth; Mangat, Khushdeep; Le Rumeur, Elisabeth; Hubert, Jean-Fracnois; Menhart, Nick; Delalande, Olivier			Structural Basis of Neuronal Nitric-oxide Synthase Interaction with Dystrophin Repeats 16 and 17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; X-RAY; DOMAIN; NNOS; GENE; FLEXIBILITY; SCATTERING; PHENOTYPE; SEVERITY	Duchenne muscular dystrophy is a lethal genetic defect that is associated with the absence of dystrophin protein. Lack of dystrophin protein completely abolishes muscular nitric-oxide synthase (NOS) function as a regulator of blood flow during muscle contraction. In normal muscles, nNOS function is ensured by its localization at the sarcolemma through an interaction of its PDZ domain with dystrophin spectrin-like repeats R16 and R17. Early studies suggested that repeat R17 is the primary site of interaction but ignored the involved nNOS residues, and the R17 binding site has not been described at an atomic level. In this study, we characterized the specific amino acids involved in the binding site of nNOS-PDZ with dystrophin R16-17 using combined experimental biochemical and structural in silico approaches. First, 32 alanine-scanning mutagenesis variants of dystrophin R16-17 indicated the regions where mutagenesis modified the affinity of the dystrophin interaction with the nNOS-PDZ. Second, using small angle x-ray scattering-based models of dystrophin R16-17 and molecular docking methods, we generated atomic models of the dystrophin R16-17 center dot nNOS-PDZ complex that correlated well with the alanine scanning identified regions of dystrophin. The structural regions constituting the dystrophin interaction surface involve the A/B loop and the N-terminal end of helix B of repeat R16 and the N-terminal end of helix A' and a small fraction of helix B' and a large part of the helix C' of repeat R17. The interaction surface of nNOS-PDZ involves its main beta-sheet and its specific C-terminal beta-finger.	[Molza, Anne-Elisabeth; Le Rumeur, Elisabeth; Hubert, Jean-Fracnois; Delalande, Olivier] Univ Rennes 1, F-35043 Rennes, France; [Molza, Anne-Elisabeth; Le Rumeur, Elisabeth; Hubert, Jean-Fracnois; Delalande, Olivier] IGDR, UMR CNRS 6290, Rennes, France; [Mangat, Khushdeep; Menhart, Nick] IIT, Chicago, IL 60616 USA	Universite de Rennes; Illinois Institute of Technology	Delalande, O (corresponding author), Univ Rennes 1, Fac Sci Pharmaceut & Biol, IGDR, UMR CNRS 6290,Equipe SIM,Platforme PRISM, 2 Av Pr Leon Bernard CS 34317, F-35043 Rennes, France.	olivier.delalande@univ-rennes1.fr	Mangat, Khushdeep/AAE-6593-2022		Association Francaise Contre les Myopathies; AFM-Telethon; Rennes Metropole; Grand Equipement National de Calcul Intensif-GENCI program (DARI DYSIM); Muscular Dystrophy Association, USA [217640]	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); AFM-Telethon(Association Francaise contre les Myopathies); Rennes Metropole(Region Bretagne); Grand Equipement National de Calcul Intensif-GENCI program (DARI DYSIM); Muscular Dystrophy Association, USA(Muscular Dystrophy Association)	This work was supported in part by the Association Francaise Contre les Myopathies, AFM-Telethon, Rennes Metropole, the Grand Equipement National de Calcul Intensif-GENCI program (projet DARI DYSIM), and Muscular Dystrophy Association, USA Grant 217640.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Campbell MG, 2014, P NATL ACAD SCI USA, V111, pE3614, DOI 10.1073/pnas.1413763111; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Ferey N, 2012, PROTEIN-PROTEIN INTERACTIONS - COMPUTATIONAL AND EXPERIMENTAL TOOLS, P27; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Gentil C, 2012, HUM MOL GENET, V21, P3449, DOI 10.1093/hmg/dds176; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Giudice E, 2013, BIOCHEMISTRY-US, V52, P7777, DOI 10.1021/bi400794p; Harper SQ, 2013, P NATL ACAD SCI USA, V110, P387, DOI 10.1073/pnas.1220256110; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1990, J BIOL CHEM, V265, P4560; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Lai Y, 2013, P NATL ACAD SCI USA, V110, P525, DOI 10.1073/pnas.1211431109; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Le Rumeur E, 2010, BBA-PROTEINS PROTEOM, V1804, P1713, DOI 10.1016/j.bbapap.2010.05.001; Mirza A, 2010, BBA-PROTEINS PROTEOM, V1804, P1796, DOI 10.1016/j.bbapap.2010.03.009; Molza AE, 2014, FARADAY DISCUSS, V169, P45, DOI 10.1039/c3fd00134b; Nicolas A, 2015, HUM MOL GENET, V24, P1267, DOI 10.1093/hmg/ddu537; Nicolas A, 2012, ORPHANET J RARE DIS, V7, DOI [10.1186/1750-1172-7-45, 10.1186/1750-1172-7-42]; Perez J, 2012, CURR OPIN STRUC BIOL, V22, P670, DOI 10.1016/j.sbi.2012.07.014; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Sato K, 2008, Acta Myol, V27, P30; Schneider S, 2012, METHODS MOL BIOL, V819, P221, DOI 10.1007/978-1-61779-465-0_15; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Tengan CH, 2012, INT J MOL SCI, V13, P17160, DOI 10.3390/ijms131217160; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Wang Y, 1999, CRIT REV NEUROBIOL, V13, P21, DOI 10.1615/CritRevNeurobiol.v13.i1.20; Wein N, 2015, PEDIATR CLIN N AM, V62, P723, DOI 10.1016/j.pcl.2015.03.008; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	43	18	18	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29531	29541		10.1074/jbc.M115.680660	http://dx.doi.org/10.1074/jbc.M115.680660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26378238	Green Published, hybrid			2022-12-26	WOS:000366613400035
J	Erikson, E; Wratil, PR; Frank, M; Ambiel, I; Pahnke, K; Pino, M; Azadi, P; Izquierdo-Useros, N; Martinez-Picado, J; Meier, C; Schnaar, RL; Crocker, PR; Reutter, W; Keppler, OT				Erikson, Elina; Wratil, Paul R.; Frank, Martin; Ambiel, Ina; Pahnke, Katharina; Pino, Maria; Azadi, Parastoo; Izquierdo-Useros, Nuria; Martinez-Picado, Javier; Meier, Chris; Schnaar, Ronald L.; Crocker, Paul R.; Reutter, Werner; Keppler, Oliver T.			Mouse Siglec-1 Mediates trans-Infection of Surface-bound Murine Leukemia Virus in a Sialic Acid N-Acyl Side Chain-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCAPSULAR SINUS MACROPHAGES; DC-SIGN; B-CELL; GLYCOLYLNEURAMINIC ACID; DENDRITIC CELLS; FORCE-FIELD; T-CELLS; SIALOADHESIN; BINDING; RECEPTOR	Background: Human Siglec-1 mediates HIV trans-infection by interaction with virion-associated sialylated gangliosides. Results: Here, Siglec-1 on mouse macrophages mediated trans-infection of surface-bound MLV. This could be inhibited by biosynthetic modification of sialic acids' N-acyl side chain in virus-producer cells. Conclusion: The N-acyl side chain is a critical determinant of Siglec-1-dependent MLV trans-infection. Significance: Glycoengineering allows manipulation of sialic acid-dependent virus/receptor interactions. Siglec-1 (sialoadhesin, CD169) is a surface receptor on human cells that mediates trans-enhancement of HIV-1 infection through recognition of sialic acid moieties in virus membrane gangliosides. Here, we demonstrate that mouse Siglec-1, expressed on the surface of primary macrophages in an interferon-alpha -responsive manner, captures murine leukemia virus (MLV) particles and mediates their transfer to proliferating lymphocytes. The MLV infection of primary B-cells was markedly more efficient than that of primary T-cells. The major structural protein of MLV particles, Gag, frequently co-localized with Siglec-1, and trans-infection, primarily of surface-bound MLV particles, efficiently occurred. To explore the role of sialic acid for MLV trans-infection at a submolecular level, we analyzed the potential of six sialic acid precursor analogs to modulate the sialylated ganglioside-dependent interaction of MLV particles with Siglec-1. Biosynthetically engineered sialic acids were detected in both the glycolipid and glycoprotein fractions of MLV producer cells. MLV released from cells carrying N-acyl-modified sialic acids displayed strikingly different capacities for Siglec-1-mediated capture and trans-infection; N-butanoyl, N-isobutanoyl, N-glycolyl, or N-pentanoyl side chain modifications resulted in up to 92 and 80% reduction of virus particle capture and trans-infection, respectively, whereas N-propanoyl or N-cyclopropylcarbamyl side chains had no effect. In agreement with these functional analyses, molecular modeling indicated reduced binding affinities for non-functional N-acyl modifications. Thus, Siglec-1 is a key receptor for macrophage/lymphocyte trans-infection of surface-bound virions, and the N-acyl side chain of sialic acid is a critical determinant for the Siglec-1/MLV interaction.	[Erikson, Elina; Ambiel, Ina; Keppler, Oliver T.] Goethe Univ Frankfurt, Inst Med Virol, Natl Reference Ctr Retroviruses, D-60596 Frankfurt, Germany; [Erikson, Elina; Keppler, Oliver T.] Heidelberg Univ, Dept Infect Dis, Virol, D-69120 Heidelberg, Germany; [Wratil, Paul R.; Reutter, Werner] Charite, Inst Lab Med, Klin Chem & Pathobiochem, D-12200 Berlin, Germany; [Frank, Martin] Biognos AB, S-40274 Gothenburg, Sweden; [Pahnke, Katharina; Meier, Chris] Univ Hamburg, Dept Chem, Fac Sci, Organ Chem, D-20146 Hamburg, Germany; [Pino, Maria; Izquierdo-Useros, Nuria; Martinez-Picado, Javier] Univ Autonoma Barcelona, AIDS Res Inst IrsiCaixa, Inst Invest Ciencies Salut Germans Trias & Pujol, Barcelona 08916, Spain; [Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Martinez-Picado, Javier] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21218 USA; [Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA; [Crocker, Paul R.] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; University System of Georgia; University of Georgia; ICREA; Johns Hopkins University; Johns Hopkins University; University of Dundee	Keppler, OT (corresponding author), Goethe Univ Frankfurt, Inst Med Virol, Natl Reference Ctr Retroviruses, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	oliver.keppler@kgu.de	Schnaar, Ronald L/S-8967-2016; Meier, Chris/X-6105-2019; Izquierdo-Useros, Nuria/G-2534-2016; Regan, Clinton/E-6250-2012; Martinez-Picado, Javier/G-5507-2012	Schnaar, Ronald L/0000-0002-7701-5484; Izquierdo-Useros, Nuria/0000-0002-1039-1821; Martinez-Picado, Javier/0000-0002-4916-2129; Pino Claveria, Maria/0000-0003-4954-5215; Frank, Martin/0000-0002-1006-6746	National Institutes of Health [P41GM10349010, HL107151]; Robert Koch-Institute; Sonnenfeld-Stiftung Berlin; Spanish Secretariat for Research Grant [SAF2013-49042-R]; Goethe University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Koch-Institute; Sonnenfeld-Stiftung Berlin; Spanish Secretariat for Research Grant; Goethe University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	This work was supported, in whole or in part, by National Institutes of Health Grant P41GM10349010 (Research Resource for Biomedical Glycomics to Complex Carbohydrate Research Center, University of Georgia) to P. A. and HL107151 to R. L. S. This work was also supported by the Robert Koch-Institute to the National Reference Center for Retroviruses (to O. T. K.), the Sonnenfeld-Stiftung Berlin (to W. R.), Spanish Secretariat for Research Grant SAF2013-49042-R (to N. I. U. and J. M. P.), and Goethe University (to O. T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004751; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8633, DOI 10.1074/jbc.275.12.8633; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; COUTINHO A, 1973, NATURE-NEW BIOL, V245, P12, DOI 10.1038/newbio245012a0; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1990, BLOOD, V76, P1131; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DWYER JM, 1981, CLIN EXP IMMUNOL, V46, P237; Gagiannis D, 2007, BBA-GEN SUBJECTS, V1770, P297, DOI 10.1016/j.bbagen.2006.09.023; Galuska SP, 2010, ANAL CHEM, V82, P4591, DOI 10.1021/ac100627e; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Goffinet C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-53; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Horstkorte R, 2004, FEBS LETT, V571, P99, DOI 10.1016/j.febslet.2004.06.067; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Inoue S, 2003, METHOD ENZYMOL, V362, P543; Izquierdo-Useros N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004146; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001315; Izquierdo-Useros N, 2011, TRAFFIC, V12, P1702, DOI 10.1111/j.1600-0854.2011.01281.x; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jin J, 2011, J VIROL, V85, P7672, DOI 10.1128/JVI.00409-11; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; KAYSER H, 1992, J BIOL CHEM, V267, P16934; Kelm S, 1998, EUR J BIOCHEM, V255, P663, DOI 10.1046/j.1432-1327.1998.2550663.x; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Keppler OT, 1998, BIOCHEM BIOPH RES CO, V253, P437, DOI 10.1006/bbrc.1998.9650; KEPPLER OT, 1995, J BIOL CHEM, V270, P1308, DOI 10.1074/jbc.270.3.1308; Klaas M, 2012, SEMIN IMMUNOPATHOL, V34, P353, DOI 10.1007/s00281-012-0310-3; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kuka M, 2014, ANN NY ACAD SCI, V1319, P38, DOI 10.1111/nyas.12387; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Luchansky SJ, 2004, CHEMBIOCHEM, V5, P1706, DOI 10.1002/cbic.200400148; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Naito-Matsui Y, 2014, J BIOL CHEM, V289, P1564, DOI 10.1074/jbc.M113.523753; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Oetke C, 2001, EUR J BIOCHEM, V268, P4553, DOI 10.1046/j.1432-1327.2001.02379.x; Pino M, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0160-x; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Posch W, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005005; Prather RS, 2013, J VIROL, V87, P9538, DOI 10.1128/JVI.00177-13; Puryear WB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003291; Puryear WB, 2012, P NATL ACAD SCI USA, V109, P7475, DOI 10.1073/pnas.1201104109; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Rosenberg N., 1997, P475; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Schneider N, 2013, J COMPUT AID MOL DES, V27, P15, DOI 10.1007/s10822-012-9626-2; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Smith D. F., 2001, CURR PROTOC MOL BIOL; Sonnenburg JL, 2004, GLYCOBIOLOGY, V14, P339, DOI 10.1093/glycob/cwh039; Vinson M, 1996, J BIOL CHEM, V271, P9267, DOI 10.1074/jbc.271.16.9267; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wieser JR, 1996, FEBS LETT, V395, P170, DOI 10.1016/0014-5793(96)01029-0; Wratil PR, 2014, J BIOL CHEM, V289, P32056, DOI 10.1074/jbc.M114.608398; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134	67	28	28	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27345	27359		10.1074/jbc.M115.681338	http://dx.doi.org/10.1074/jbc.M115.681338			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26370074	Green Published, hybrid			2022-12-26	WOS:000364794000041
J	Chang, CW; Tran, ENH; Ericsson, DJ; Casey, LW; Lonhienne, T; Benning, F; Morona, R; Kobe, B				Chang, Chiung-Wen; Tran, Elizabeth N. H.; Ericsson, Daniel J.; Casey, Lachlan W.; Lonhienne, Thierry; Benning, Friederike; Morona, Renato; Kobe, Bostjan			Structural and Biochemical Analysis of a Single Amino-Acid Mutant of WzzB(SF) That Alters Lipopolysaccharide O-Antigen Chain Length in Shigella flexneri	PLOS ONE			English	Article							POLYSACCHARIDE CO-POLYMERASES; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CROSS-LINKING; WZZ; PROTEIN; BIOSYNTHESIS; MUTAGENESIS; DETERMINANT; VIRULENCE	Lipopolysaccharide (LPS), a surface polymer of Gram-negative bacteria, helps bacteria survive in different environments and acts as a virulence determinant of host infection. The O-antigen (Oag) component of LPS exhibits a modal chain-length distribution that is controlled by polysaccharide co-polymerases (PCPs). The molecular basis of the regulation of Oag chain-lengths remains unclear, despite extensive mutagenesis and structural studies of PCPs from Escherichia coli and Shigella. Here, we identified a single mutation (A107P) of the Shigella flexneri WzzB(SF), by a random mutagenesis approach, that causes a shortened Oag chain-length distribution in bacteria. We determined the crystal structures of the penplasmic domains domains of wild-type WzzBsF and the A107P mutant. Both structures form a highly similar open trimeric assembly in the crystals, and show a similar tendency to self-associate in solution. Binding studies by bio-layer interferometry reveal cooperative binding of very short (VS)-core-plus-O-antigen polysaccharide (COPS) to the periplasmic domains of both proteins, but with decreased affinity for the A107P mutant. Our studies reveal that subtle and localized structural differences in PCPs can have dramatic effects on LPS chain-length distribution in bacteria, for example by altering the affinity for the substrate, which supports the role of the structure of the growing Oag polymer in this process.	[Chang, Chiung-Wen; Ericsson, Daniel J.; Casey, Lachlan W.; Lonhienne, Thierry; Benning, Friederike; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Chang, Chiung-Wen; Ericsson, Daniel J.; Casey, Lachlan W.; Benning, Friederike; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Chang, Chiung-Wen; Ericsson, Daniel J.; Casey, Lachlan W.; Benning, Friederike; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Tran, Elizabeth N. H.; Morona, Renato] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA 5005, Australia	University of Queensland; University of Queensland; University of Queensland; University of Adelaide	Morona, R (corresponding author), Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA 5005, Australia.	renato.morona@adelaide.edu.au; b.kobe@uq.edu.au	Morona, Renato/B-7746-2013; Casey, Lachlan/N-3396-2015; Kobe, Bostjan/D-1292-2009; Ericsson, Daniel/F-7458-2011	Morona, Renato/0000-0001-7009-7440; Casey, Lachlan/0000-0002-4458-0137; Kobe, Bostjan/0000-0001-9413-9166; Ericsson, Daniel/0000-0001-5101-9244; Benning, Friederike/0000-0002-1002-4204; Tran, Elizabeth Ngoc Hoa/0000-0003-1644-2287	National Health and Medical Research Council (NHMRC) [565526, 1071659]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	As listed in the "Funding information" section online, this work was supported by the National Health and Medical Research Council (NHMRC) Program grants 565526 to R.M. and B.K. and 1071659 to B.K. B.K. is a NHMRC Senior Research Fellow (1003326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniels C, 2002, ENVIRON MICROBIOL, V4, P883, DOI 10.1046/j.1462-2920.2002.00288.x; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; Edelstein SJ, 2013, J MOL BIOL, V425, P1424, DOI 10.1016/j.jmb.2013.03.011; Tran ENH, 2014, MICROBIOL-SGM, V160, P589, DOI 10.1099/mic.0.074955-0; Tran ENH, 2013, MICROBIOL-SGM, V159, P701, DOI 10.1099/mic.0.065631-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson DJ, 2012, CURR DRUG TARGETS, V13, P1421; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; Guo H, 2008, CURR TOP MED CHEM, V8, P141; Guo H, 2006, PROTEIN EXPRES PURIF, V48, P49, DOI 10.1016/j.pep.2006.01.015; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; Hong M, 1997, MOL MICROBIOL, V24, P779, DOI 10.1046/j.1365-2958.1997.3731744.x; Islam ST, 2014, CAN J MICROBIOL, V60, P697, DOI 10.1139/cjm-2014-0595; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalynych S, 2015, PROTEIN SCI, V24, P58, DOI 10.1002/pro.2586; Kalynych S, 2014, FEMS MICROBIOL REV, V38, P1048, DOI 10.1111/1574-6976.12070; Kalynych S, 2012, PROTEIN ENG DES SEL, V25, P797, DOI 10.1093/protein/gzs075; Kalynych S, 2012, J BIOL CHEM, V287, P15696, DOI 10.1074/jbc.M112.354837; Kalynych S, 2011, J BACTERIOL, V193, P3710, DOI 10.1128/JB.00059-11; Kintz EN, 2011, J BIOL CHEM, V286, P44277, DOI 10.1074/jbc.M111.273979; Larue K, 2009, J BIOL CHEM, V284, P7395, DOI 10.1074/jbc.M809068200; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Marolda CL, 2008, J BACTERIOL, V190, P2128, DOI 10.1128/JB.01746-07; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; MORONA R, 1995, MOL MICROBIOL, V18, P209, DOI 10.1111/j.1365-2958.1995.mmi_18020209.x; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Newman J, 2004, ACTA CRYSTALLOGR D, V60, P610, DOI 10.1107/S0907444903029640; Papadopoulos M, 2010, J BACTERIOL, V192, P3385, DOI 10.1128/JB.01134-09; Purins L, 2008, MICROBIOL-SGM, V154, P1104, DOI 10.1099/mic.0.2007/014225-0; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Smajs D, 1997, J BACTERIOL, V179, P4919, DOI 10.1128/jb.179.15.4919-4928.1997; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; STEVENSON G, 1995, FEMS MICROBIOL LETT, V125, P23, DOI 10.1016/0378-1097(94)00485-A; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang KH, 2007, BIOCHEMISTRY-US, V46, P11744, DOI 10.1021/bi701181r; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; Van Den Bosch L, 2003, MICROB PATHOGENESIS, V35, P11, DOI 10.1016/S0882-4010(03)00064-0; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351	51	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138266	10.1371/journal.pone.0138266	http://dx.doi.org/10.1371/journal.pone.0138266			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378781	gold, Green Submitted, Green Published			2022-12-26	WOS:000361769400077
J	Crossa, A; Kessler, J; Harris, TG				Crossa, Aldo; Kessler, Jason; Harris, Tiffany G.			Enhanced Tuberculosis Infection Treatment Outcomes after Implementation of QuantiFERON (R)-Gold Testing	PLOS ONE			English	Article							LATENT TUBERCULOSIS; UNITED-STATES; SKIN-TEST; COST-EFFECTIVENESS; HEALTH; GOLD; COMPLETION; ACCEPTANCE; PREDICTORS; ADHERENCE	Background Use of the tuberculin skin test (TST) for diagnosis of latent tuberculosis infection (LTBI) among individuals who received the Bacille Calmette-Guerin (BCG) vaccine is complicated by its potential cross-reaction with TST antigens which may cause false-positive results and lead to patient and physician reluctance to initiate LTBI treatment. QuantiFERON (R)-TB Gold (QFT-G) lacks this cross-reaction. We sought to study the impact of implementing QFT-G testing in 2006 on LTBI treatment initiation and completion at NYC chest clinics. Methods QFT-G results from 10/2006-12/2008 in NYC Department of Health and Mental Hygiene chest clinics were obtained from the electronic medical record system. The proportions of patients who initiated and completed treatment among patients tested with QFT-G were compared to those tested with TST from 10/2004-9/2006. Results Among 36,167 patients tested with QFT-G, 2,300 (6%) tested positive, 33,327 (93%) tested negative, and 540 (1%) had an indeterminate result. Among those who had a positive QFT-G test and deemed eligible, 985 (80%) initiated LTBI treatment and 490 (40%) completed treatment. Historically, among patients tested with TST, 7,073 (19%) tested positive (p<0.0001 compared to QFT-G); 3,182 (79%) of those eligible initiated LTBI treatment and 1,210 (30%) completed treatment (p<0.0001 compared to QFT-G). Conclusions QFT-G implementation increased the proportion of patients completing LTBI treatment. Additional studies are needed in more settings to determine whether using QFT-G leads to a sustained increase in treatment completion.	[Crossa, Aldo; Kessler, Jason; Harris, Tiffany G.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; [Kessler, Jason] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	New York City Department of Health & Mental Hygiene; Columbia University	Crossa, A (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.	acrossa@health.nyc.gov		Harris, Tiffany/0000-0003-2212-0874	New York City Department of Health and Mental Hygiene program funds; T32 training grant [5T32AI049821]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049821] Funding Source: NIH RePORTER	New York City Department of Health and Mental Hygiene program funds; T32 training grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by New York City Department of Health and Mental Hygiene program funds. JK was supported by a T32 training grant (5T32AI049821) during the period of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GOLD QUANT TB IN TUB; Banach DB, 2011, INT J TUBERC LUNG D, V15, P1623, DOI 10.5588/ijtld.11.0017; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Carvalho ACC, 2007, J INFECTION, V55, P164, DOI 10.1016/j.jinf.2007.02.004; Deuffic-Burban S, 2010, INT J TUBERC LUNG D, V14, P471; Dobler CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048900; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Goswami ND, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-468; Grinsdale JA, 2011, INT J TUBERC LUNG D, V15, P1614, DOI 10.5588/ijtld.11.0102; Hardy AB, 2010, THORAX, V65, P178, DOI 10.1136/thx.2009.119677; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Hirsch-Moverman Y, 2015, INT J TUBERC LUNG D, V19, P31, DOI 10.5588/ijtld.14.0373; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; Katapodi MC, 2004, PREV MED, V38, P388, DOI 10.1016/j.ypmed.2003.11.012; Landry J, 2008, INT J TUBERC LUNG D, V12, P1352; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; Li JH, 2010, INT J INFECT DIS, V14, pE292, DOI 10.1016/j.ijid.2009.05.007; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; McGinnis B, 2007, ANN PHARMACOTHER, V41, P1805, DOI 10.1345/aph.1K209; NYC Bureau of Tuberculosis Control, 1999, CLIN POL PROT; NYC Bureau of Tuberculosis Control, 2006, TEST TREATM LAT TUB; NYC Bureau of Tuberculosis Control, 2008, CLIN POL PROT; NYC Bureau of Tuberculosis Control, 2000, TEST TREATM LAT TUB; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; Sahni R, 2009, INFECT CONT HOSP EP, V30, P197, DOI 10.1086/593965; Salazar-Schicchi J, 2004, INT J TUBERC LUNG D, V8, P1443; Schousboe JT, 2010, OSTEOPOROSIS INT, V21, P1899, DOI 10.1007/s00198-009-1141-5; Seyhan EC, 2010, TRANSPL INFECT DIS, V12, P98, DOI 10.1111/j.1399-3062.2009.00469.x; Shabaro J, 2006, HIST TB CONTROL TUBE; Shah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036551; Sharma Surendra K, 2014, Evid Based Child Health, V9, P169, DOI 10.1002/ebch.1962; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Vinton P, 2009, INFECT CONT HOSP EP, V30, P215, DOI 10.1086/595695	39	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138349	10.1371/journal.pone.0138349	http://dx.doi.org/10.1371/journal.pone.0138349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371760	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400066
J	Deng, PC; Wang, L; Cui, LC; Feng, KW; Liu, FY; Du, XH; Tong, W; Nie, XJ; Ji, WQ; Weining, S				Deng, Pingchuan; Wang, Le; Cui, Licao; Feng, Kewei; Liu, Fuyan; Du, Xianghong; Tong, Wei; Nie, Xiaojun; Ji, Wanquan; Weining, Song			Global Identification of MicroRNAs and Their Targets in Barley under Salinity Stress	PLOS ONE			English	Article							HORDEUM-VULGARE L.; SMALL RNA; PLANT-RESPONSES; SALT STRESS; MIRNAS; EXPRESSION; DROUGHT; WHEAT; ADAPTATION; GENES	Salinity is a major limiting factor for agricultural production worldwide. A better understanding of the mechanisms of salinity stress response will aid efforts to improve plant salt tolerance. In this study, a combination of small RNA and mRNA degradome sequencing was used to identify salinity responsive-miRNAs and their targets in barley. A total of 152 miRNAs belonging to 126 families were identified, of which 44 were found to be salinity responsive with 30 up-regulated and 25 down-regulated respectively. The majority of the salinity-responsive miRNAs were up-regulated at the 8h time point, while down-regulated at the 3h and 27h time points. The targets of these miRNAs were further detected by degradome sequencing coupled with bioinformatics prediction. Finally, qRT-PCR was used to validate the identified miRNA and their targets. Our study systematically investigated the expression profile of miRNA and their targets in barley during salinity stress phase, which can contribute to understanding how miRNAs respond to salinity stress in barley and other cereal crops.	[Deng, Pingchuan; Wang, Le; Cui, Licao; Feng, Kewei; Liu, Fuyan; Du, Xianghong; Tong, Wei; Nie, Xiaojun; Ji, Wanquan; Weining, Song] Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Deng, Pingchuan; Wang, Le; Cui, Licao; Feng, Kewei; Liu, Fuyan; Du, Xianghong; Tong, Wei; Nie, Xiaojun; Ji, Wanquan; Weining, Song] Northwest A&F Univ, China Wheat Improvement Ctr, Yangling Branch, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Du, XH (corresponding author), Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Du, XH (corresponding author), Northwest A&F Univ, China Wheat Improvement Ctr, Yangling Branch, Yangling, Shaanxi, Peoples R China.	xianghongdu@nwsuaf.edu.cn; sweining2002@yahoo.com	Wang, Le/AAX-2622-2020; Nie, Xiaojun/ABE-2666-2021	Nie, Xiaojun/0000-0002-4787-7550	National Natural Science Foundation of China [31571647, 31401373]; 863 program from the Chinese of Ministry of Science Technology [2012AA10A308]; 948 Program from the Chinese Ministry of Agriculture [2010-S1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 program from the Chinese of Ministry of Science Technology; 948 Program from the Chinese Ministry of Agriculture; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was mainly funded by the National Natural Science Foundation of China (31571647 and 31401373), and partially supported by the 863 program (2012AA10A308) from the Chinese of Ministry of Science & Technology and the 948 Program (2010-S1) from the Chinese Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Cui LY, 2006, NUCLEIC ACIDS RES, V34, pD692, DOI 10.1093/nar/gkj055; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Deng PC, 2014, PLANT MOL BIOL REP, V32, P487, DOI 10.1007/s11105-013-0669-x; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Dryanova A, 2008, GENOME, V51, P433, DOI 10.1139/G08-025; Eren H, 2015, ANN APPL BIOL; Fedoroff Nina V, 2002, Sci STKE, V2002, pre10, DOI 10.1126/stke.2002.140.re10; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Grondin M, 2015, BIOTECHNOL J, V10, P801, DOI 10.1002/biot.201400562; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hackenberg M, 2015, PLANT BIOTECHNOL J, V13, P2, DOI 10.1111/pbi.12220; Jain R, 2007, BIOCHEM BIOPH RES CO, V359, P486, DOI 10.1016/j.bbrc.2007.05.142; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; KONING AJ, 1992, PLANT PHYSIOL, V100, P801, DOI 10.1104/pp.100.2.801; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Munns R, 1999, AUST J PLANT PHYSIOL, V26, P459, DOI 10.1071/PP99049; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Ozhuner E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059543; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Shannon MC, 1997, ADV AGRON, V60, P75, DOI 10.1016/S0065-2113(08)60601-X; Si JN, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S1-S6; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Walia Harkamal, 2006, Functional & Integrative Genomics, V6, P143, DOI 10.1007/s10142-005-0013-0; Wang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-289; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Witzel K, 2009, J EXP BOT, V60, P3545, DOI 10.1093/jxb/erp198; Xie FL, 2015, J EXP BOT, V66, P789, DOI 10.1093/jxb/eru437; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yin ZJ, 2012, MOL BIOL REP, V39, P4961, DOI 10.1007/s11033-011-1292-2; Zhang BH, 2015, J EXP BOT, V66, P1749, DOI 10.1093/jxb/erv013; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	45	48	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137990	10.1371/journal.pone.0137990	http://dx.doi.org/10.1371/journal.pone.0137990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372557	gold, Green Submitted, Green Published			2022-12-26	WOS:000361604400043
J	Gras, R; Golestani, A; Hendry, AP; Cristescu, ME				Gras, Robin; Golestani, Abbas; Hendry, Andrew P.; Cristescu, Melania E.			Speciation without Pre-Defined Fitness Functions	PLOS ONE			English	Article							SEXUAL SELECTION; MODELS; EVOLUTION; PATTERNS; ORIGIN; SIMULATION	The forces promoting and constraining speciation are often studied in theoretical models because the process is hard to observe, replicate, and manipulate in real organisms. Most models analyzed to date include pre-defined functions influencing fitness, leaving open the question of how speciation might proceed without these built-in determinants. To consider the process of speciation without pre-defined functions, we employ the individual-based ecosystem simulation platform EcoSim. The environment is initially uniform across space, and an evolving behavioural model then determines how prey consume resources and how predators consume prey. Simulations including natural selection (i.e., an evolving behavioural model that influences survival and reproduction) frequently led to strong and distinct phenotypic/genotypic clusters between which hybridization was low. This speciation was the result of divergence between spatially-localized clusters in the behavioural model, an emergent property of evolving ecological interactions. By contrast, simulations without natural selection (i.e., behavioural model turned off) but with spatial isolation (i.e., limited dispersal) produced weaker and overlapping clusters. Simulations without natural selection or spatial isolation (i.e., behaviour model turned off and high dispersal) did not generate clusters. These results confirm the role of natural selection in speciation by showing its importance even in the absence of pre-defined fitness functions.	[Gras, Robin; Golestani, Abbas] Univ Windsor, Sch Comp Sci, Windsor, ON N9B 3P4, Canada; [Gras, Robin] Univ Windsor, Dept Biol, Windsor, ON N9B 3P4, Canada; [Gras, Robin] Great Lakes Inst Environm Res, Windsor, ON, Canada; [Hendry, Andrew P.; Cristescu, Melania E.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Hendry, Andrew P.; Cristescu, Melania E.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Windsor; University of Windsor; McGill University; McGill University	Gras, R (corresponding author), Univ Windsor, Sch Comp Sci, Windsor, ON N9B 3P4, Canada.	rgras@uwindsor.ca		Cristescu, Melania/0000-0002-0854-4040	Natural Sciences and Engineering Research Council of Canada [ORGPIN 341854]; Canada Research Chairs [9502-3617]; Canada Foundation for Innovation grant [203617]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Canada Foundation for Innovation grant(Canada Foundation for Innovation)	RG funded by Natural Sciences and Engineering Research Council of Canada grant ORGPIN 341854 (http://www.nserc-crsng.gc.ca/index_eng.asp), Canada Research Chairs grant 9502-3617 (http://www.chairs-chaires.gc.ca/homeaccueil-eng.aspx), and Canada Foundation for Innovation grant 203617 (http://www.innovation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspinall A, 2010, LECT NOTES COMPUT SC, V6335, P318, DOI 10.1007/978-3-642-15470-6_33; Bascompte J, 1997, J THEOR BIOL, V187, P213, DOI 10.1006/jtbi.1997.0430; Biktashev VN, 2004, CHAOS, V14, P988, DOI 10.1063/1.1793751; Clune J, 2011, P ROY SOC B-BIOL SCI, V278, P666, DOI 10.1098/rspb.2010.1557; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; Coyne J.A., 2004, SPECIATION; de Aguiar MAM, 2009, NATURE, V460, P384, DOI 10.1038/nature08168; Devaurs D, 2010, SIMUL MODEL PRACT TH, V18, P100, DOI 10.1016/j.simpat.2009.09.012; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U., 2004, ADAPTIVE SPECIATION; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Duckworth RA, 2009, EVOLUTION, V63, P968, DOI 10.1111/j.1558-5646.2009.00625.x; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gavrilets S, 2014, J HERED, V105, P743, DOI 10.1093/jhered/esu045; Gavrilets Sergey, 2000, EVOLUTION, V54; Golestani A, 2012, INT C MOD SIM CONTR, P1275; Golestani A, 2011, INT C ART INT ICAI, P991; Golestani A, 2012, P ROY SOC B-BIOL SCI, V279, P3055, DOI 10.1098/rspb.2012.0466; Golestani A, 2010, CHAOS, V20, DOI 10.1063/1.3514011; Gras R, 2009, ARTIF LIFE, V15, P423, DOI 10.1162/artl.2009.Gras.012; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hughes BD, 1995, RANDOM WALKS RANDOM, V1, DOI [10.1079/PNS19950063, DOI 10.1079/PNS19950063]; Kantz H., 1997, NONLINEAR TIME SERIE; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; KOSKO B, 1986, INT J MAN MACH STUD, V24, P65, DOI 10.1016/S0020-7373(86)80040-2; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Lotka AJ, 1910, J PHYS CHEM-US, V14, P271, DOI 10.1021/j150111a004; MacPherson B, 2015, J THEOR BIOL UNPUB; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Nosil P, 2011, P ROY SOC B-BIOL SCI, V278, P399, DOI 10.1098/rspb.2010.1215; Price T, 2007, SPECIATION BIRDS; Ray T.S., 1991, SANTA FE I STUDIES S, VXI, P371; Rohani P, 1997, TRENDS ECOL EVOL, V12, P70, DOI 10.1016/S0169-5347(96)20103-X; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Servedio MR, 2014, P NATL ACAD SCI USA, V111, P8113, DOI 10.1073/pnas.1316484111; Seuront L, 1996, GEOPHYS RES LETT, V23, P3591, DOI 10.1029/96GL03473; Thibert-Plante X, 2009, J EVOLUTION BIOL, V22, P109, DOI 10.1111/j.1420-9101.2008.01627.x; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; VOLTERRA V, 1928, J CONS INT EXPLOR ME, V3, P3, DOI DOI 10.1093/ICESJMS/3.1.3; Volterra V., 1927, VARIAZIONI FLUTTUAZI; Yaeger L, 1992, SANTA FE I STUDIES S, V17, P263	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137838	10.1371/journal.pone.0137838	http://dx.doi.org/10.1371/journal.pone.0137838			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372462	gold, Green Submitted, Green Published			2022-12-26	WOS:000361604400032
J	Suzuki, M; Takahashi, S; Kondo, T; Dohra, H; Ito, Y; Kiriiwa, Y; Hayashi, M; Kamiya, S; Kato, M; Fujiwara, M; Fukao, Y; Kobayashi, M; Nagata, N; Motohashi, R				Suzuki, Miho; Takahashi, Sachiko; Kondo, Takanori; Dohra, Hideo; Ito, Yumihiko; Kiriiwa, Yoshikazu; Hayashi, Marina; Kamiya, Shiori; Kato, Masaya; Fujiwara, Masayuki; Fukao, Yoichiro; Kobayashi, Megumi; Nagata, Noriko; Motohashi, Reiko			Plastid Proteomic Analysis in Tomato Fruit Development	PLOS ONE			English	Article							CAROTENOID-ASSOCIATED PROTEIN; CHROMOPLAST DIFFERENTIATION; SOLANUM-LYCOPERSICON; ARABIDOPSIS-THALIANA; MOLECULAR-BIOLOGY; PROVIDES INSIGHTS; INDUCED LIPOCALIN; GENE-EXPRESSION; SWEET ORANGE; MICRO-TOM	To better understand the mechanism of plastid differentiation from chloroplast to chromoplast, we examined proteome and plastid changes over four distinct developmental stages of 'Micro-Tom' fruit. Additionally, to discover more about the relationship between fruit color and plastid differentiation, we also analyzed and compared 'Micro-Tom' results with those from two other varieties, 'Black' and 'White Beauty'. We confirmed that proteins related to photosynthesis remain through the orange maturity stage of 'Micro-Tom', and also learned that thylakoids no longer exist at this stage. These results suggest that at a minimum there are changes in plastid morphology occurring before all related proteins change. We also compared 'Micro-Tom' fruits with 'Black' and 'White Beauty' using twodimensional gel electrophoresis. We found a decrease of CHRC (plastid-lipid-associated protein) and HrBP1 (harpin binding protein-1) in the 'Black' and 'White Beauty' varieties. CHRC is involved in carotenoid accumulation and stabilization. HrBP1 in Arabidopsis has a sequence similar to proteins in the PAP/fibrillin family. These proteins have characteristics and functions similar to lipocalin, an example of which is the transport of hydrophobic molecules. We detected spots of TIL (temperature-induced lipocalin) in 2D-PAGE results, however the number of spots and their isoelectric points differed between 'Micro-Tom' and 'Black'/'White Beauty'. Lipocalin has various functions including those related to environmental stress response, apoptosis induction, membrane formation and fixation, regulation of immune response, cell growth, and metabolism adjustment. Lipocalin related proteins such as TIL and HrBP1 could be related to the accumulation of carotenoids, fruit color and the differentiation of chromoplast.	[Suzuki, Miho; Takahashi, Sachiko; Kondo, Takanori; Ito, Yumihiko; Kiriiwa, Yoshikazu; Hayashi, Marina; Kamiya, Shiori; Kato, Masaya; Motohashi, Reiko] Shizuoka Univ, Fac Agr, Shizuoka, Shizuoka 4228529, Japan; [Dohra, Hideo] Shizuoka Univ, Res Inst Green Sci & Technol, Instrumental Res Support Off, Shizuoka, Shizuoka, Japan; [Fujiwara, Masayuki; Fukao, Yoichiro] Nara Inst Sci & Technol, Plant Sci Educ Unit, Ikoma City, Nara, Japan; [Kobayashi, Megumi; Nagata, Noriko] Japan Womens Univ, Fac Sci, Bunkyo Ku, Tokyo, Japan	Shizuoka University; Shizuoka University; Nara Institute of Science & Technology; Japan Womens University	Motohashi, R (corresponding author), Shizuoka Univ, Fac Agr, Shizuoka, Shizuoka 4228529, Japan.	armotoh@ipc.shizuoka.ac.jp		Nagata, Noriko/0000-0002-0894-2049; Dohra, Hideo/0000-0002-3919-3538	Japanese Ministry of Education [20510190, 23580039]	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was made possible by the Grant-in-Aid for Scientific Research, a program administered by the Japanese Ministry of Education (No. 20510190 and 23580039 to RM), http://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2004, TRENDS PLANT SCI, V9, P331, DOI 10.1016/j.tplants.2004.05.004; Adato A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000777; Akerstrom B, 2006, BIOCHIM BIOPHYS ACTA, V163, P895; Aoki K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-210; Baginsky S, 2004, J PROTEOME RES, V3, P1128, DOI 10.1021/pr0499186; Balmer Y, 2006, J EXP BOT, V57, P1591, DOI 10.1093/jxb/erj156; Barsan C, 2012, PLANT PHYSIOL, V160, P708, DOI 10.1104/pp.112.203679; Barsan C, 2010, J EXP BOT, V61, P2413, DOI 10.1093/jxb/erq070; Behrens C, 2013, J PROTEOMICS, V91, P73, DOI 10.1016/j.jprot.2013.07.001; BLANKE MM, 1989, PLANT CELL ENVIRON, V12, P31, DOI 10.1111/j.1365-3040.1989.tb01914.x; Borisjuk L, 2009, NEW PHYTOL, V182, P17, DOI 10.1111/j.1469-8137.2008.02752.x; Camara B, 1995, INT REV CYTOL, V163, P175, DOI 10.1016/S0074-7696(08)62211-1; Carrara S, 2001, PHOTOSYNTHETICA, V39, P75, DOI 10.1023/A:1012495903093; Charron JBF, 2005, PLANT PHYSIOL, V139, P2017, DOI 10.1104/pp.105.070466; Charron JBF, 2002, FEBS LETT, V517, P129, DOI 10.1016/S0014-5793(02)02606-6; Charron JBF, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-86; Chi WT, 2009, PLANT CELL ENVIRON, V32, P917, DOI 10.1111/j.1365-3040.2009.01972.x; Egea I, 2010, PLANT CELL PHYSIOL, V51, P1601, DOI 10.1093/pcp/pcq136; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Flower DR, 1996, BIOCHEM J, V318, P1; FRAY RG, 1993, PLANT MOL BIOL, V22, P589, DOI 10.1007/BF00047400; Fujiwara M, 2009, PLANT CELL PHYSIOL, V50, P1191, DOI 10.1093/pcp/pcp077; Gady ALF, 2012, MOL BREEDING, V29, P801, DOI 10.1007/s11032-011-9591-9; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; HUNT GM, 1980, PHYTOCHEMISTRY, V19, P1415, DOI 10.1016/0031-9422(80)80185-3; Iijima Y, 2008, PLANT J, V54, P949, DOI 10.1111/j.1365-313X.2008.03434.x; Jones AME, 2006, PROTEOMICS, V6, P4155, DOI 10.1002/pmic.200500172; Joyard J, 2009, MOL PLANT, V2, P1154, DOI 10.1093/mp/ssp088; Kahlau S, 2008, PLANT CELL, V20, P856, DOI 10.1105/tpc.107.055202; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; Kalachanis D, 2010, PHYSIOL PLANTARUM, V139, P313, DOI 10.1111/j.1399-3054.2010.01362.x; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Kato M, 2004, PLANT PHYSIOL, V134, P824, DOI 10.1104/pp.103.031104; Kilambi HV, 2013, PLANT PHYSIOL, V161, P2085, DOI 10.1104/pp.112.212191; Kleffmann T, 2006, PLANT CELL PHYSIOL, V47, P432, DOI 10.1093/pcp/pcj005; Komatsu S, 2003, MOL CELL PROTEOMICS, V2, P2, DOI 10.1074/mcp.R200008-MCP200; Leitner-Dagan Y, 2006, PLANT PHYSIOL, V142, P233, DOI 10.1104/pp.106.082404; LIVNE A, 1988, PLANT PHYSIOL, V87, P239, DOI 10.1104/pp.87.1.239; LORD JM, 1973, J CELL BIOL, V57, P659, DOI 10.1083/jcb.57.3.659; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marti E, 2006, J EXP BOT, V57, P2037, DOI 10.1093/jxb/erj154; Marti MC, 2009, PLANT BIOLOGY, V11, P613, DOI 10.1111/j.1438-8677.2008.00149.x; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Mintz-Oron S, 2008, PLANT PHYSIOL, V147, P823, DOI 10.1104/pp.108.116004; Motohashi R, 2007, PLANT MOL BIOL, V64, P481, DOI 10.1007/s11103-007-9166-7; Motohashi R, 2012, PLANT PHYSIOL, V160, P2189, DOI 10.1104/pp.112.204032; Mueller LA, 2005, COMP FUNCT GENOM, V6, P153, DOI 10.1002/cfg.468; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poole Rebecca L., 2007, V406, P179; RAY PM, 1969, P NATL ACAD SCI USA, V64, P605, DOI 10.1073/pnas.64.2.605; Ruuska SA, 2004, PLANT PHYSIOL, V136, P2700, DOI 10.1104/pp.104.047977; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Siddique MA, 2006, PLANT CELL PHYSIOL, V47, P1663, DOI 10.1093/pcp/pcl033; Simkin AJ, 2007, PHYTOCHEMISTRY, V68, P1545, DOI 10.1016/j.phytochem.2007.03.014; Stensballe A, 2008, FEBS J, V275, P1723, DOI 10.1111/j.1742-4658.2008.06332.x; Tetlow IJ, 2003, PLANT SCI, V165, P383, DOI 10.1016/S0168-9452(03)00199-7; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Vasquez-Caicedo AL, 2006, J AGR FOOD CHEM, V54, P5769, DOI 10.1021/jf060747u; Vishnevetsky M, 1996, PLANT J, V10, P1111, DOI 10.1046/j.1365-313X.1996.10061111.x; Vishnevetsky M, 1999, PLANT J, V20, P423, DOI 10.1046/j.1365-313x.1999.00615.x; Vogel JT, 2010, J SCI FOOD AGR, V90, P2233, DOI 10.1002/jsfa.4076; von Zychlinski A, 2005, MOL CELL PROTEOMICS, V4, P1072, DOI 10.1074/mcp.M500018-MCP200; Wang YQ, 2013, J EXP BOT, V64, P949, DOI 10.1093/jxb/ers375; You JJ, 2010, ELECTROPHORESIS, V31, P1853, DOI 10.1002/elps.200900755; Zeng YL, 2014, PHYSIOL PLANTARUM, V150, P252, DOI 10.1111/ppl.12080; Zeng YL, 2011, J EXP BOT, V62, P5297, DOI 10.1093/jxb/err140	67	27	28	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137266	10.1371/journal.pone.0137266	http://dx.doi.org/10.1371/journal.pone.0137266			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371478	Green Submitted, Green Published, gold			2022-12-26	WOS:000361604400015
J	Barron, EV; Roman-Bassaure, E; Sanchez-Sandoval, AL; Espinosa, AM; Guardado-Estrada, M; Medina, I; Juarez, E; Alfaro, A; Bermudez, M; Zamora, R; Garcia-Ruiz, C; Gomora, JC; Kofman, S; Perez-Armendariz, EM; Berumen, J				Valeria Barron, Eira; Roman-Bassaure, Edgar; Laura Sanchez-Sandoval, Ana; Maria Espinosa, Ana; Guardado-Estrada, Mariano; Medina, Ingrid; Juarez, Eligia; Alfaro, Ana; Bermudez, Miriam; Zamora, Ruben; Garcia-Ruiz, Carlos; Carlos Gomora, Juan; Kofman, Susana; Martha Perez-Armendariz, E.; Berumen, Jaime			CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; PROTEIN PHOSPHATASE; HEPATOCELLULAR-CARCINOMA; NEOADJUVANT CHEMOTHERAPY; CELL-PROLIFERATION; AMPLIFICATION; QUADRIVALENT; INHIBITION; VACCINE; GENE	The cyclin-dependent kinase inhibitor 3 (CDKN3) gene, involved in mitosis, is upregulated in cervical cancer (CC). We investigated CDKN3 mRNA as a survival biomarker and potential therapeutic target for CC. CDKN3 mRNA was measured in 134 CC and 25 controls by quantitative PCR. A 5-year survival study was conducted in 121 of these CC patients. Furthermore, CDKN3-specific siRNAs were used to investigate whether CDKN3 is involved in proliferation, migration, and invasion in CC-derived cell lines (SiHa, CaSki, HeLa). CDKN3 mRNA was on average 6.4-fold higher in tumors than in controls (p = 8 x 10(-6), Mann-Whitney). A total of 68.2% of CC patients over expressing CDKN3 gene (fold change >= 17) died within two years of diagnosis, independent of the clinical stage and HPV type (Hazard Ratio = 5.0, 95% CI: 2.5-10, p = 3.3 x 10(-6), Cox proportional-hazards regression). In contrast, only 19.2% of the patients with lower CDKN3 expression died in the same period. In vitro inactivation of CDKN3 decreased cell proliferation on average 67%, although it had no effect on cell migration and invasion. CDKN3 mRNA may be a good survival biomarker and potential therapeutic target in CC.	[Valeria Barron, Eira; Maria Espinosa, Ana; Guardado-Estrada, Mariano; Medina, Ingrid; Juarez, Eligia; Alfaro, Ana; Bermudez, Miriam; Garcia-Ruiz, Carlos; Berumen, Jaime] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Med Genom, Mexico City 04510, DF, Mexico; [Valeria Barron, Eira; Martha Perez-Armendariz, E.; Berumen, Jaime] Univ Nacl Autonoma Mexico, Dept Med Expt, Fac Med, Mexico City 04510, DF, Mexico; [Roman-Bassaure, Edgar] Hosp Gen Mexico City, Serv Oncol, Mexico City, DF, Mexico; [Laura Sanchez-Sandoval, Ana; Carlos Gomora, Juan] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neuropatol Mol, Mexico City 04510, DF, Mexico; [Zamora, Ruben] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Zamora, Ruben] Mexico Hosp Dr Luis Sanchez Bulnes, Asociac Evitar Ceguera, Lab Biol Mol, Mexico City, DF, Mexico; [Kofman, Susana] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Serv Genet, Mexico City 04510, DF, Mexico	Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico	Berumen, J (corresponding author), Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Med Genom, Mexico City 04510, DF, Mexico.	jaimeberumen@hotmail.com	Sanchez-Sandoval, Ana Laura/GPK-6264-2022; Berumen, Jaime/AAL-5577-2020; Berumen, Jaime/F-7914-2018	Sanchez-Sandoval, Ana Laura/0000-0002-9478-4779; Berumen, Jaime/0000-0001-6707-3317; Berumen, Jaime/0000-0001-6707-3317; ESPINOSA GARCIA, ANA MARIA/0000-0003-3255-4051; Gomora, Juan Carlos/0000-0002-9871-1307; Barron, Eira Valeria/0000-0001-7901-4947	National Council of Science and Technology (CONACYT) [8135/A1, 24341]; National University of Mexico [SDI.PTID.05.2]; National Council of Science and Technology (CONACYT), scholarship	National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National University of Mexico; National Council of Science and Technology (CONACYT), scholarship	This work was supported by the National Council of Science and Technology (CONACYT, www.conacyt.mx), grant numbers 8135/A1, 24341 (to JB), National University of Mexico (www.unam.mx), grant number SDI.PTID.05.2 (to JB), and National Council of Science and Technology (CONACYT, www.conacyt.mx), scholarship (to EVB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e900; Berumen J, 2014, EXPERT OPIN THER TAR, V18, P1149, DOI 10.1517/14728222.2014.941808; Bruni L, ICO INFORM CTR HPV C; Bryant C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-147; Cao TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103793; Chen QH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111611; Chhavi, 2010, J CANCER RES THER, V6, P167, DOI 10.4103/0973-1482.65242; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Cuzick J, 2010, GYNECOL ONCOL, V117, pS11, DOI 10.1016/j.ygyno.2010.01.025; Feng MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108502; Ferlay J., 2013, IARC CANCERBASE, V11; Gavrilov Kseniya, 2012, Yale Journal of Biology and Medicine, V85, P187; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Guardado-Estrada M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109406; Guardado-Estrada M, 2012, J HUM GENET, V57, P269, DOI 10.1038/jhg.2012.17; Hu Q, 2014, INT J CLIN EXP PATHO, V7, P5057; Hunter KD, 2006, CANCER RES, V66, P7405, DOI 10.1158/0008-5472.CAN-06-0186; Hwang SJ, 2012, J ONCOL, V2012, DOI 10.1155/2012/507286; Jackson MW, 2014, ONCOTARGETS THER, V7, P751, DOI 10.2147/OTT.S49429; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Lai MW, 2012, UROL ONCOL-SEMIN ORI, V30, P871, DOI 10.1016/j.urolonc.2010.09.010; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Lee SW, 2000, MOL CELL BIOL, V20, P1723, DOI 10.1128/MCB.20.5.1723-1732.2000; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Li TR, 2014, ONCOL REP, V31, P1825, DOI 10.3892/or.2014.3045; Lin WR, 2013, ONCOL REP, V29, P903, DOI 10.3892/or.2012.2208; Liu L, 2014, INT J NANOMED, V9, P3509, DOI 10.2147/IJN.S63717; MacDermed DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-16; Espinosa AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055975; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Mathew M, 2013, APOPTOSIS, V18, P882, DOI 10.1007/s10495-013-0840-8; McCormack M, 2013, BRIT J CANCER, V108, P2464, DOI 10.1038/bjc.2013.230; Medina-Martinez I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097842; Nalepa G, 2013, J CELL BIOL, V201, P997, DOI 10.1083/jcb.201205125; Natunen Kari, 2011, Infect Dis Obstet Gynecol, V2011, P675858, DOI 10.1155/2011/675858; Nogueira-Rodrigues A, 2014, CANCER-AM CANCER SOC, V120, P1187, DOI 10.1002/cncr.28471; Pappano WN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-430; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Saxena R, 2012, MED RES REV, V32, P166, DOI 10.1002/med.20209; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Schimmack S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-15; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Shen SN, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-69; Singh RB, 2013, GYNECOL ONCOL, V129, P124, DOI 10.1016/j.ygyno.2013.01.011; Suh DH, 2014, J GYNECOL ONCOL, V25, P236, DOI 10.3802/jgo.2014.25.3.236; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Tsai CJ, 2013, GYNECOL ONCOL, V131, P645, DOI 10.1016/j.ygyno.2013.04.056; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Wan HY, 2014, CANCER LETT, V355, P148, DOI 10.1016/j.canlet.2014.09.005; Weaver BA, 2014, MOL BIOL CELL, V25, P2677, DOI 10.1091/mbc.E14-04-0916; Wen XX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0092-7; Wu Z, 2013, INT J GYNECOL CANCER, V23, P906, DOI 10.1097/IGC.0b013e318292da82; Xing CY, 2012, BIOCHEM BIOPH RES CO, V420, P29, DOI 10.1016/j.bbrc.2012.02.107; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yeh CT, 2000, CANCER RES, V60, P4697; Yeh CT, 2003, BIOCHEM BIOPH RES CO, V305, P311, DOI 10.1016/S0006-291X(03)00757-5; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524, DOI 10.1111/j.1349-7006.1991.tb01882.x; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478; Yu Y, 2014, CARCINOGENESIS, V35, P1416, DOI 10.1093/carcin/bgu065	64	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137397	10.1371/journal.pone.0137397	http://dx.doi.org/10.1371/journal.pone.0137397			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372210	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400020
J	Wood, JP; Meyer, KM; Kelly, TJ; Choi, YW; Rogers, JV; Riggs, KB; Willenberg, ZJ				Wood, Joseph P.; Meyer, Kathryn M.; Kelly, Thomas J.; Choi, Young W.; Rogers, James V.; Riggs, Karen B.; Willenberg, Zachary J.			Environmental Persistence of Bacillus anthracis and Bacillus subtilis Spores	PLOS ONE			English	Article							GEOBACILLUS-STEAROTHERMOPHILUS SPORES; SOLAR ULTRAVIOLET-RADIATION; ARTIFICIAL UV-C; HYDROGEN-PEROXIDE; INACTIVATION; RESISTANCE; SURVIVAL; LIGHT; EFFICACY; REPAIR	There is a lack of data for how the viability of biological agents may degrade over time in different environments. In this study, experiments were conducted to determine the persistence of Bacillus anthracis and Bacillus subtilis spores on outdoor materials with and without exposure to simulated sunlight, using ultraviolet (UV)-A/B radiation. Spores were inoculated onto glass, wood, concrete, and topsoil and recovered after periods of 2, 14, 28, and 56 days. Recovery and inactivation kinetics for the two species were assessed for each surface material and UV exposure condition. Results suggest that with exposure to UV, decay of spore viability for both Bacillus species occurs in two phases, with an initial rapid decay, followed by a slower inactivation period. The exception was with topsoil, in which there was minimal loss of spore viability in soil over 56 days, with or without UV exposure. The greatest loss in viable spore recovery occurred on glass with UV exposure, with nearly a four log(10) reduction after just two days. In most cases, B. subtilis had a slower rate of decay than B. anthracis, although less B. subtilis was recovered initially.	[Wood, Joseph P.] US EPA, Off Res & Dev, Natl Homeland Secur Res Ctr, Res Triangle Pk, NC 27711 USA; [Meyer, Kathryn M.] Oak Ridge Inst Sci & Educ, Res Triangle Pk, NC USA; [Kelly, Thomas J.; Choi, Young W.; Rogers, James V.; Riggs, Karen B.; Willenberg, Zachary J.] Battelle Mem Inst, Columbus, OH 43201 USA	United States Environmental Protection Agency; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Battelle Memorial Institute	Wood, JP (corresponding author), US EPA, Off Res & Dev, Natl Homeland Secur Res Ctr, Res Triangle Pk, NC 27711 USA.	wood.joe@epa.gov		Wood, Joseph/0000-0001-6316-9418	Battelle Memorial Institute [GS23F001L-3]; Oak Ridge Institute for Science and Education	Battelle Memorial Institute; Oak Ridge Institute for Science and Education(General Electric)	The US EPA funded Battelle Memorial Institute to perform this work via contract GS23F001L-3. Kathryn Meyer was funded as a postdoc through the Oak Ridge Institute for Science and Education. Joseph Wood of the EPA was the sponsor and technical director of the study, and was involved in the study design, data analysis, decision to publish, and preparation of manuscript.	[Anonymous], UV B MON RES PROGR; Balasaraswathy P, 2002, INDIAN J DERMATOLVEN, V68, P201; Blatchley ER, 2005, J ENVIRON ENG, V131, P1245, DOI 10.1061/(ASCE)0733-9372(2005)131:9(1245); Block S.S., 2001, DISINFECTION STERILI, P65; Brown GS, 2007, APPL ENVIRON MICROB, V73, P706, DOI 10.1128/AEM.01082-06; Coohill TP, 2008, PHOTOCHEM PHOTOBIOL, V84, P1084, DOI 10.1111/j.1751-1097.2008.00387.x; Coohill TP, 2009, PHOTOCHEM PHOTOBIOL, V85, P1043, DOI 10.1111/j.1751-1097.2009.00586.x; DIETZ P, 1980, ZBL BAKT MIK HYG B, V171, P455; Gardner DWM, 1998, J APPL MICROBIOL, V84, P633, DOI 10.1046/j.1365-2672.1998.00391.x; JEANMOUGIN M, 1987, ANN DERMATOL VENER, V114, P671; KNUDSON GB, 1986, APPL ENVIRON MICROB, V52, P444, DOI 10.1128/AEM.52.3.444-449.1986; KOLARI PJ, 1986, PHOTODERMATOLOGY, V3, P340; Lee SD, 2011, APPL ENVIRON MICROB, V77, P1638, DOI 10.1128/AEM.02237-10; MANCHEE RJ, 1994, APPL ENVIRON MICROB, V60, P4167, DOI 10.1128/AEM.60.11.4167-4171.1994; Mattle MJ, 2012, ENVIRON SCI TECHNOL, V46, P10022, DOI 10.1021/es302058v; McKenzie RL, 2003, PHOTOCH PHOTOBIO SCI, V2, P5, DOI 10.1039/b211155c; Moeller R, 2011, J APPL MICROBIOL, V110, P1485, DOI 10.1111/j.1365-2672.2011.05004.x; Moeller R, 2009, APPL ENVIRON MICROB, V75, P5202, DOI 10.1128/AEM.00789-09; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL, 2003, APPL ENVIRON MICROB, V69, P1327, DOI 10.1128/AEM.69.2.1327-1330.2003; Rentschler HC, 1941, J BACTERIOL, V41, P745, DOI 10.1128/JB.41.6.745-774.1941; Riesenman PJ, 2000, APPL ENVIRON MICROB, V66, P620, DOI 10.1128/AEM.66.2.620-626.2000; Rogers JV, 2007, J APPL MICROBIOL, V103, P1104, DOI 10.1111/j.1365-2672.2007.03332.x; Rogers JV, 2005, J APPL MICROBIOL, V99, P739, DOI 10.1111/j.1365-2672.2005.02686.x; Rose LJ, 2009, APPL ENVIRON MICROB, V75, P2987, DOI 10.1128/AEM.02180-08; Ryan SP, 2014, WORLD J MICROB BIOT, V30, P2609, DOI 10.1007/s11274-014-1684-2; Sagripanti JL, 2011, ARCH VIROL, V156, P489, DOI 10.1007/s00705-010-0847-1; Setlow P, 2001, ENVIRON MOL MUTAGEN, V38, P97, DOI 10.1002/em.1058; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Slieman TA, 2001, APPL ENVIRON MICROB, V67, P1274, DOI 10.1128/AEM.67.3.1274-1279.2001; Slieman TA, 2000, APPL ENVIRON MICROB, V66, P199, DOI 10.1128/AEM.66.1.199-205.2000; Stuart AL, 2005, ENVIRON SCI TECHNOL, V39, P2736, DOI 10.1021/es048705e; The United States Department of Justice, 2010, AM INV SUMM; Tomasino SF, 2006, J AOAC INT, V89, P1373; U.S. Environmental Protection Agency, 2013, EPA600R13110; Whitney EAS, 2003, EMERG INFECT DIS, V9, P623; Wood JP, 2011, J APPL MICROBIOL, V110, P1262, DOI 10.1111/j.1365-2672.2011.04980.x; Wood JP, 2010, ENVIRON SCI TECHNOL, V44, P7515, DOI 10.1021/es1016153; Xue YM, 1996, APPL ENVIRON MICROB, V62, P2221, DOI 10.1128/AEM.62.7.2221-2227.1996	39	22	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138083	10.1371/journal.pone.0138083	http://dx.doi.org/10.1371/journal.pone.0138083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372011	Green Submitted, Green Published, gold			2022-12-26	WOS:000361604400048
J	Cunningham, TJ; Brade, T; Sandell, LL; Lewandoski, M; Trainor, PA; Colas, A; Mercola, M; Duester, G				Cunningham, Thomas J.; Brade, Thomas; Sandell, Lisa L.; Lewandoski, Mark; Trainor, Paul A.; Colas, Alexandre; Mercola, Mark; Duester, Gregg			Retinoic Acid Activity in Undifferentiated Neural Progenitors Is Sufficient to Fulfill Its Role in Restricting Fgf8 Expression for Somitogenesis	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; BODY AXIS EXTENSION; MOUSE EMBRYO; FATE SPECIFICATION; SIGNALING PATHWAYS; MESODERM FORMATION; PRIMITIVE STREAK; LIMB DEVELOPMENT; SEGMENTATION; RECEPTOR	Bipotent axial stem cells residing in the caudal epiblast during late gastrulation generate neuroectodermal and presomitic mesodermal progeny that coordinate somitogenesis with neural tube formation, but the mechanism that controls these two fates is not fully understood. Retinoic acid (RA) restricts the anterior extent of caudal fibroblast growth factor 8 (Fgf8) expression in both mesoderm and neural plate to control somitogenesis and neurogenesis, however it remains unclear where RA acts to control the spatial expression of caudal Fgf8. Here, we found that mouse Raldh2-/- embryos, lacking RA synthesis and displaying a consistent small somite defect, exhibited abnormal expression of key markers of axial stem cell progeny, with decreased Sox2+ and Sox1+ neuroectodermal progeny and increased Tbx6+ presomitic mesodermal progeny. The Raldh2-/- small somite defect was rescued by treatment with an FGF receptor antagonist. Rdh10 mutants, with a less severe RA synthesis defect, were found to exhibit a small somite defect and anterior expansion of caudal Fgf8 expression only for somites 1-6, with normal somite size and Fgf8 expression thereafter. Rdh10 mutants were found to lack RA activity during the early phase when somites are small, but at the 6-somite stage RA activity was detected in neural plate although not in presomitic mesoderm. Expression of a dominant-negative RA receptor in mesoderm eliminated RA activity in presomitic mesoderm but did not affect somitogenesis. Thus, RA activity in the neural plate is sufficient to prevent anterior expansion of caudal Fgf8 expression associated with a small somite defect. Our studies provide evidence that RA restriction of Fgf8 expression in undifferentiated neural progenitors stimulates neurogenesis while also restricting the anterior extent of the mesodermal Fgf8 mRNA gradient that controls somite size, providing new insight into the mechanism that coordinates somitogenesis with neurogenesis.	[Cunningham, Thomas J.; Brade, Thomas; Colas, Alexandre; Mercola, Mark; Duester, Gregg] Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA; [Trainor, Paul A.] Stowers Inst Med Res, Kansas City, MO USA; [Trainor, Paul A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Sandell, Lisa L.] Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Louisville, KY 40292 USA; [Lewandoski, Mark] NCI, Lab Canc & Dev Biol, NIH, Frederick, MD 21701 USA; [Colas, Alexandre; Mercola, Mark] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Louisville; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego	Duester, G (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA.	duester@SBPdiscovery.org	Sandell, Lisa L/M-4238-2013	Sandell, Lisa L/0000-0002-1735-8223; Duester, Gregg/0000-0003-4335-3650; Cunningham, Thomas/0000-0002-4751-3140; Trainor, Paul/0000-0003-2774-3624; Lewandoski, Mark/0000-0002-1066-3735	National Institutes of Health [GM062848, DE016082]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [ZIABC010338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM062848 (GD) and DE016082 (PT) (www.nih.gov), and the Stowers Institute for Medical Research (PT) (www.stowers.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bard JBL, 1999, DEVELOPMENT, P103; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Boulet AM, 2012, DEV BIOL, V371, P235, DOI 10.1016/j.ydbio.2012.08.017; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; Chambers D, 2007, DEVELOPMENT, V134, P1369, DOI 10.1242/dev.02815; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chatzi C, 2013, DEV DYNAM, V242, P1056, DOI 10.1002/dvdy.23999; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; Cunningham TJ, 2013, CELL REP, V3, P1503, DOI 10.1016/j.celrep.2013.03.036; DELCORRAL RD, 2003, NEURON, V40, P65, DOI DOI 10.1016/S0896-6273(03)00565-8; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HORTON C, 1995, DEV DYNAM, V202, P312, DOI 10.1002/aja.1002020310; Jurberg AD, 2014, DEV BIOL, V394, P253, DOI 10.1016/j.ydbio.2014.08.012; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; Martin BL, 2009, CURR BIOL, V19, pR215, DOI 10.1016/j.cub.2009.01.052; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Oginuma M, 2008, DEVELOPMENT, V135, P2555, DOI 10.1242/dev.019877; Olivera-Martinez I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001415; Patel NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003614; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Rajaii F, 2008, DEV BIOL, V316, P371, DOI 10.1016/j.ydbio.2008.01.041; Ribes V, 2009, DEVELOPMENT, V136, P665, DOI 10.1242/dev.016204; Rochette-Egly C, 2015, BBA-MOL CELL BIOL L, V1851, P66, DOI 10.1016/j.bbalip.2014.04.003; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sheikh BN, 2014, STEM CELLS, V32, P1451, DOI 10.1002/stem.1604; Shifley ET, 2008, DEVELOPMENT, V135, P899, DOI 10.1242/dev.006742; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Szeto DP, 2006, GENE DEV, V20, P1923, DOI 10.1101/gad.1435306; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yoshida M, 2014, MECH DEVELOP, V132, P59, DOI 10.1016/j.mod.2014.01.003; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	56	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137894	10.1371/journal.pone.0137894	http://dx.doi.org/10.1371/journal.pone.0137894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368825	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100172
J	Gourand, F; Amini, N; Jia, ZS; Stone-Elander, S; Guilloteau, D; Barre, L; Halldin, C				Gourand, Fabienne; Amini, Nahid; Jia, Zhisheng; Stone-Elander, Sharon; Guilloteau, Denis; Barre, Louisa; Halldin, Christer			[C-11]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET)	PLOS ONE			English	Article							SEROTONIN TRANSPORTER; LIVER-MICROSOMES; HUMANS; BRAIN; SPECT; CYTOCHROME-P450; QUANTIFICATION; IDENTIFICATION; I-123-ADAM	In quantitative PET measurements, the analysis of radiometabolites in plasma is essential for determining the exact arterial input function. Diphenyl sulfide compounds are promising PET and SPECT radioligands for in vivo quantification of the serotonin transporter (SERT) and it is therefore important to investigate their radiometabolism. We have chosen to explore the radiometabolic profile of [C-11] MADAM, one of these radioligands widely used for in vivo PET-SERT studies. The metabolism of [C-11]MADAM/MADAM was investigated using rat and human liver microsomes (RLM and HLM) in combination with radio-HPLC or UHPLC/Q-ToF-MS for their identification. The effect of carrier on the radiometabolic rate of the radioligand [C-11]MADAM in vitro and in vivo was examined by radio-HPLC. RLM and HLM incubations were carried out at two different carrier concentrations of 1 and 10 mu M. Urine samples after perfusion of [C-11]MADAM/ MADAM in rats were also analysed by radio-HPLC. Analysis by UHPLC/Q-ToF-MS identified the metabolites produced in vitro to be results of N-demethylation, S-oxidation and benzylic hydroxylation. The presence of carrier greatly affected the radiometabolism rate of [C-11]MADAM in both RLM/HLM experiments and in vivo rat studies. The good concordance between the results predicted by RLM and HLM experiments and the in vivo data obtained in rat studies indicate that the kinetics of the radiometabolism of the radioligand [C-11]MADAM is dose-dependent. This issue needs to be addressed when the diarylsulfide class of compounds are used in PET quantifications of SERT.	[Gourand, Fabienne; Amini, Nahid; Jia, Zhisheng; Halldin, Christer] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, S-17176 Stockholm, Sweden; [Gourand, Fabienne; Barre, Louisa] CEA, DSV I2BM, LDM TEP Grp, GIP Cyceron, F-14074 Caen, France; [Gourand, Fabienne; Barre, Louisa] Univ Caen Basse Normandie, Caen, France; [Gourand, Fabienne; Barre, Louisa] CNRS, UMR ISTCT 6301, LDM TEP Grp, GIP Cyceron, Caen, France; [Stone-Elander, Sharon] Karolinska Inst, Karolinska Univ Hosp, MicroPET & Clin Neurosci, Neuroradiol, S-17176 Stockholm, Sweden; [Guilloteau, Denis] Univ Tours, CHRU Tours, INSERM, U930, F-37044 Tours, France	Karolinska Institutet; CEA; Universite de Caen Normandie; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Karolinska Institutet; Karolinska University Hospital; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Gourand, F (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, S-17176 Stockholm, Sweden.	gourand@cyceron.fr		Guilloteau, Denis/0000-0002-4545-3068	European programme DiMI: WP3; Commissariat a l'energie atomique et aux energies alternatives (CEA)	European programme DiMI: WP3; Commissariat a l'energie atomique et aux energies alternatives (CEA)(French Atomic Energy Commission)	This project was partially funded by the European programme DiMI: WP3 and the Commissariat a l'energie atomique et aux energies alternatives (CEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton PD, 2001, J NUCL MED, V42, P1556; Amini N, 2013, ANAL BIOANAL CHEM, V405, P1303, DOI 10.1007/s00216-012-6541-2; Catafau AM, 2005, J NUCL MED, V46, P1301; Frankle WG, 2006, J NUCL MED, V47, P815; Frokjaer VG, 2008, J NUCL MED, V49, P247, DOI 10.2967/jnumed.107.046102; Gourand F, 2014, NUCL MED BIOL, V41, P501, DOI 10.1016/j.nucmedbio.2014.03.022; Halldin C, 2005, SYNAPSE, V58, P173, DOI 10.1002/syn.20189; HALLDIN C, 1995, DEV NUC MED, V26, P55; Lundberg J, 2005, J NUCL MED, V46, P1505; Meyer JH, 2004, AM J PSYCHIAT, V161, P826, DOI 10.1176/appi.ajp.161.5.826; Nnane IP, 2003, LIFE SCI, V73, P359, DOI 10.1016/S0024-3205(03)00290-X; Nnane IP, 2002, J PHARMACEUT BIOMED, V27, P315, DOI 10.1016/S0731-7085(01)00551-9; Schou M, 2009, MOL IMAGING BIOL, V11, P23, DOI 10.1007/s11307-008-0175-y; Shetty HU, 2007, EUR J NUCL MED MOL I, V34, P667, DOI 10.1007/s00259-006-0277-1	14	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137160	10.1371/journal.pone.0137160	http://dx.doi.org/10.1371/journal.pone.0137160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367261	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100053
J	Ishibashi, D; Homma, T; Nakagaki, T; Fuse, T; Sano, K; Takatsuki, H; Atarashi, R; Nishida, N				Ishibashi, Daisuke; Homma, Takujiro; Nakagaki, Takehiro; Fuse, Takayuki; Sano, Kazunori; Takatsuki, Hanae; Atarashi, Ryuichiro; Nishida, Noriyuki			Strain-Dependent Effect of Macroautophagy on Abnormally Folded Prion Protein Degradation in Infected Neuronal Cells	PLOS ONE			English	Article							AGGREGATE-PRONE PROTEINS; REGULATES AUTOPHAGY; SIGNALING PATHWAYS; ALZHEIMER-DISEASE; ALPHA-SYNUCLEIN; CLEARANCE; PRPSC; NEURODEGENERATION; POLYGLUTAMINE; ACTIVATION	Prion diseases are neurodegenerative disorders caused by the accumulation of abnormal prion protein (PrPSc) in the central nervous system. With the aim of elucidating the mechanism underlying the accumulation and degradation of PrPSc, we investigated the role of autophagy in its degradation, using cultured cells stably infected with distinct prion strains. The effects of pharmacological compounds that inhibit or stimulate the cellular signal transduction pathways that mediate autophagy during PrPSc degradation were evaluated. The accumulation of PrPSc in cells persistently infected with the prion strain Fukuoka-1 (FK), derived from a patient with Gerstmann-Straussler-Scheinker syndrome, was significantly increased in cultures treated with the macroautophagy inhibitor 3-methyladenine (3MA) but substantially reduced in those treated with the macroautophagy inducer rapamycin. The decrease in FK-derived PrPSc levels was mediated, at least in part, by the phosphatidylinositol 3-kinase/MEK signalling pathway. By contrast, neither rapamycin nor 3MA had any apparently effect on PrPSc from either the 22L or the Chandler strain, indicating that the degradation of PrPSc in host cells might be strain-dependent.	[Ishibashi, Daisuke; Homma, Takujiro; Nakagaki, Takehiro; Fuse, Takayuki; Sano, Kazunori; Takatsuki, Hanae; Atarashi, Ryuichiro; Nishida, Noriyuki] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan	Nagasaki University	Ishibashi, D (corresponding author), Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	dishi@nagasaki-u.ac.jp	Homma, Takujiro/AAH-7386-2019	Homma, Takujiro/0000-0003-3886-7411; Nakagaki, Takehiro/0000-0003-1960-8326	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591482]; Takeda Science Foundation; Japan Intractable Disease Research Foundation; Tokyo Biochemical Research Foundation; Ichiro Kanehara Foundation; Research Committee of Molecular Pathogenesis and Therapies for Prion Disease and Slow Virus Infection; Research Committee of Prion Disease and Slow Virus Infection, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Commissions, The Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [25461514] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Intractable Disease Research Foundation; Tokyo Biochemical Research Foundation; Ichiro Kanehara Foundation; Research Committee of Molecular Pathogenesis and Therapies for Prion Disease and Slow Virus Infection; Research Committee of Prion Disease and Slow Virus Infection, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Commissions, The Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	D. I. received research support from a grant-in aid for science research (C; grant no. 24591482) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a grant from Takeda Science Foundation; a grant from the Japan Intractable Disease Research Foundation; a grant-in-aid from the Tokyo Biochemical Research Foundation and a grant provided by The Ichiro Kanehara Foundation. This study was supported by Grants-in-Aid from the Research Committee of Molecular Pathogenesis and Therapies for Prion Disease and Slow Virus Infection and from the Research Committee of Prion Disease and Slow Virus Infection, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Commissions, The Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Allard EK, 2013, NEUROBIOL DIS, V58, P116, DOI 10.1016/j.nbd.2013.05.014; Atarashi R, 2006, J VIROL, V80, P7854, DOI 10.1128/JVI.00424-06; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Cortes Constanza J, 2013, Int J Cell Biol, V2013, P560421, DOI 10.1155/2013/560421; Cortes CJ, 2012, J NEUROSCI, V32, P12396, DOI 10.1523/JNEUROSCI.6189-11.2012; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; Heiseke A, 2010, CURR ISSUES MOL BIOL, V12, P87; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Homma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04504; Ishibashi D, 2012, J VIROL, V86, P4947, DOI 10.1128/JVI.06326-11; Ishibashi D, 2011, VACCINE, V29, P9321, DOI 10.1016/j.vaccine.2011.10.017; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Karapetyan YE, 2013, P NATL ACAD SCI USA, V110, P7044, DOI 10.1073/pnas.1303510110; Kawasaki Y, 2007, J VIROL, V81, P12889, DOI 10.1128/JVI.01563-07; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Marzo L, 2013, J CELL SCI, V126, P1345, DOI 10.1242/jcs.114801; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakagaki T, 2013, AUTOPHAGY, V9, P1386, DOI 10.4161/auto.25381; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qiang YW, 2004, BLOOD, V103, P301, DOI 10.1182/blood-2003-06-2066; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029; Shindoh R, 2009, J VIROL, V83, P3852, DOI 10.1128/JVI.01740-08; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Weissmann C, 2002, ACTA NEUROBIOL EXP, V62, P153; Xu XH, 2013, CARDIOVASC RES, V99, P412, DOI 10.1093/cvr/cvt116; Xu Y, 2016, MOL NEUROBIOL, V53, P706, DOI 10.1007/s12035-014-9028-7; Xu Y, 2012, AUTOPHAGY, V8, P1604, DOI 10.4161/auto.21482; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0	47	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137958	10.1371/journal.pone.0137958	http://dx.doi.org/10.1371/journal.pone.0137958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368533	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100184
J	Melgar-Rojas, P; Alvarado, JC; Fuentes-Santamaria, V; Gabaldon-Ull, MC; Juiz, JM				Melgar-Rojas, Pedro; Carlos Alvarado, Juan; Fuentes-Santamaria, Veronica; Cruz Gabaldon-Ull, Maria; Juiz, Jose M.			Validation of Reference Genes for RT-qPCR Analysis in Noise-Induced Hearing Loss: A Study in Wistar Rat	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; MESSENGER-RNA EXPRESSION; REAL-TIME PCR; PIG INNER-EAR; IMPULSE NOISE; HAIR-CELLS; INTENSE NOISE; FREE-RADICALS; RESPONSE ABR; GLUTATHIONE-PEROXIDASE	The reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) requires adequate normalization in order to ensure accurate results. The use of reference genes is the most common method to normalize RT-qPCR assays; however, many studies have reported that the expression of frequently used reference genes is more variable than expected, depending on experimental conditions. Consequently, proper validation of the stability of reference genes is an essential step when performing new gene expression studies. Despite the fact that RT-qPCR has been widely used to elucidate molecular correlates of noise-induced hearing loss (NIHL), up to date there are no reports demonstrating validation of reference genes for the evaluation of changes in gene expression after NIHL. Therefore, in this study we evaluated the expression of some commonly used reference genes (Arbp, b-Act, b2m, CyA, Gapdh, Hprt1, Tbp, Tfrc and UbC) and examined their suitability as endogenous control genes for RT-qPCR analysis in the adult Wistar rat in response to NIHL. Four groups of rats were noise-exposed to generate permanent cochlear damage. Cochleae were collected at different time points after noise exposure and the expression level of candidate reference genes was evaluated by RT-qPCR using geNorm, NormFinder and BestKeeper software to determine expression stability. The three independent applications revealed Tbp as the most stably expressed reference gene. We also suggest a group of top-ranked reference genes that can be combined to obtain suitable reference gene pairs for the evaluation of the effects of noise on gene expression in the cochlea. These findings provide essential basis for further RT-qPCR analysis in studies of NIHL using Wistar rats as animal model.	[Melgar-Rojas, Pedro; Carlos Alvarado, Juan; Fuentes-Santamaria, Veronica; Cruz Gabaldon-Ull, Maria; Juiz, Jose M.] Univ Castilla La Mancha, Sch Med, Inst Invest Discapacidades Neurol IDINE, Albacete, Spain	Universidad de Castilla-La Mancha	Melgar-Rojas, P (corresponding author), Univ Castilla La Mancha, Sch Med, Inst Invest Discapacidades Neurol IDINE, Campus Albacete, Albacete, Spain.	pedro.melgar@uclm.es	Alvarado, Juan C./G-3379-2015; juiz, jose m/G-3025-2015; juiz, jose/ABF-8752-2020	Alvarado, Juan C./0000-0002-3623-4090; juiz, jose m/0000-0002-9668-8983; juiz, jose/0000-0002-9668-8983	European Commission [FP7-HEALTH-2012-INNOVATION 304925]; Spain's MINECO [BFU2012-39982-C02-02]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spain's MINECO	This work was supported by the European Commission, FP7-HEALTH-2012-INNOVATION 304925 (PROHEARING) (ec.europa.eu/research/fp7) and by Spain's MINECO BFU2012-39982-C02-02 (http://www.idi.mineco.gob.es/portal/site/MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00029; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; AXELSSON A, 1987, HEARING RES, V31, P183, DOI 10.1016/0378-5955(87)90125-0; Bas E, 2009, ACTA OTO-LARYNGOL, V129, P385, DOI 10.1080/00016480802566279; Bottger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006; BOHNE BA, 1976, EFFECTS NOISE HEARIN, P41; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai QF, 2012, NEUROBIOL DIS, V45, P723, DOI 10.1016/j.nbd.2011.10.018; Alvarado JC, 2012, NEUROSCI RES, V73, P302, DOI 10.1016/j.neures.2012.05.001; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen GD, 2003, HEARING RES, V177, P81, DOI 10.1016/S0378-5955(02)00802-X; Chen GD, 2006, HEARING RES, V222, P54, DOI 10.1016/j.heares.2006.08.011; Chen J, 2009, ACTA OTO-LARYNGOL, V129, P644, DOI 10.1080/00016480802311015; Cho YS, 2004, MOL BRAIN RES, V130, P134, DOI 10.1016/j.molbrainres.2004.07.017; Church MW, 2012, NEUROTOXICOL TERATOL, V34, P196, DOI 10.1016/j.ntt.2011.09.004; Church MW, 2010, NEUROTOXICOL TERATOL, V32, P171, DOI 10.1016/j.ntt.2009.09.006; Church MW, 2013, HEARING RES, V302, P96, DOI 10.1016/j.heares.2013.05.007; Church MW, 2012, ALCOHOL CLIN EXP RES, V36, P83, DOI 10.1111/j.1530-0277.2011.01594.x; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Fetoni AR, 2015, FREE RADICAL BIO MED, V85, P269, DOI 10.1016/j.freeradbiomed.2015.04.021; Fetoni AR, 2013, J NEUROSCI, V33, P4011, DOI 10.1523/JNEUROSCI.2282-12.2013; Fetoni AR, 2012, ACTA OTO-LARYNGOL, V132, P391, DOI 10.3109/00016489.2011.652307; Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764; Garcia-Pino E, 2010, J COMP NEUROL, V518, P1301, DOI 10.1002/cne.22276; Gourevitch B, 2009, BRAIN RES, V1304, P66, DOI 10.1016/j.brainres.2009.09.041; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Gurgen O, 2014, ANAL QUANT CYTOPATHO, V36, P213; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HAMERNIK RP, 1984, HEARING RES, V13, P229, DOI 10.1016/0378-5955(84)90077-7; Han Y, 2012, GENE, V499, P318, DOI 10.1016/j.gene.2012.02.042; Han Y, 2011, NEUROSCI LETT, V491, P79, DOI 10.1016/j.neulet.2011.01.010; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; HENDERSON D, 1986, J ACOUST SOC AM, V80, P569, DOI 10.1121/1.394052; HENDERSON D, 1994, HEARING RES, V76, P101, DOI 10.1016/0378-5955(94)90092-2; Henderson Donald, 2008, V31, P195; Hu BH, 2009, NEUROSCIENCE, V161, P915, DOI 10.1016/j.neuroscience.2009.03.072; Hu BH, 2006, HEARING RES, V211, P16, DOI 10.1016/j.heares.2005.08.006; Hu BH, 2000, ACTA OTO-LARYNGOL, V120, P19, DOI 10.1080/000164800760370774; Hu BH, 2002, HEARING RES, V166, P62, DOI 10.1016/S0378-5955(02)00286-1; Hu BH, 2012, J NEUROSCI, V32, P14927, DOI 10.1523/JNEUROSCI.1588-12.2012; Hu BH, 2010, J NEUROSCI RES, V88, P1812, DOI 10.1002/jnr.22333; Hu BH, 2012, SPRINGER HANDB AUDIT, V40, P57, DOI 10.1007/978-1-4419-9523-0_5; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ishii N, 1996, BRAIN RES, V726, P123, DOI 10.1016/0006-8993(96)00305-8; Jamesdaniel S, 2008, J PROTEOME RES, V7, P3516, DOI 10.1021/pr8002479; Jamesdaniel S, 2009, J PROTEOME RES, V8, P3520, DOI 10.1021/pr900222c; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; Kil J, 2007, HEARING RES, V226, P44, DOI 10.1016/j.heares.2006.08.006; Kireev RA, 2013, BIOGERONTOLOGY, V14, P431, DOI 10.1007/s10522-013-9443-6; Kirkegaard M, 2006, NEUROSCIENCE, V142, P425, DOI 10.1016/j.neuroscience.2006.06.037; Le Prell CG, 2012, SPRINGER HANDB AUDIT, V40, P1, DOI 10.1007/978-1-4419-9523-0_1; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Mazurek B, 2007, HEARING RES, V231, P73, DOI 10.1016/j.heares.2007.05.008; Nakao R, 2015, MUSCLE NERVE, V51, P276, DOI 10.1002/mus.24310; Nicotera TM, 2003, JARO-J ASSOC RES OTO, V4, P466, DOI 10.1007/s10162-002-3038-2; Niu XZ, 2003, NEUROREPORT, V14, P1025, DOI 10.1097/01.wnr.0000070830.57864.32; Ohinata Y, 2000, BRAIN RES, V878, P163, DOI 10.1016/S0006-8993(00)02733-5; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; OVERBECK GW, 1992, HEARING RES, V59, P129, DOI 10.1016/0378-5955(92)90110-9; Patel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058471; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pilati N, 2012, P NATL ACAD SCI USA, V109, P8292, DOI 10.1073/pnas.1116981109; Pirvola U, 2000, J NEUROSCI, V20, P43, DOI 10.1523/JNEUROSCI.20-01-00043.2000; Rarey KE, 1996, ACTA OTO-LARYNGOL, V116, P833, DOI 10.3109/00016489609137935; SAUNDERS JC, 1985, J ACOUST SOC AM, V78, P833, DOI 10.1121/1.392915; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sha SH, 2001, HEARING RES, V155, P1, DOI 10.1016/S0378-5955(01)00224-6; Singer W, 2013, MOL NEUROBIOL, V47, P261, DOI 10.1007/s12035-012-8372-8; SLEPECKY N, 1986, HEARING RES, V22, P307, DOI 10.1016/0378-5955(86)90107-3; SUBRAMANIAM M, 1992, HEARING RES, V58, P57, DOI 10.1016/0378-5955(92)90008-B; Tagoe T, 2014, J NEUROSCI, V34, P2684, DOI 10.1523/JNEUROSCI.3977-13.2014; Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043; Usami S, 1996, BRAIN RES, V743, P337, DOI 10.1016/S0006-8993(96)01090-6; Vandesompele J., 2011, GENORM DISCUSSION GR; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Vicente-Torres MA, 2006, J NEUROSCI RES, V83, P1564, DOI 10.1002/jnr.20832; Vlajkovic SM, 2013, HEARING RES, V304, P145, DOI 10.1016/j.heares.2013.07.012; Vlajkovic SM, 2010, J NEUROSCI RES, V88, P2598, DOI 10.1002/jnr.22421; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Wong ACY, 2010, HEARING RES, V260, P81, DOI 10.1016/j.heares.2009.12.004; Wong CC, 2000, DEV BRAIN RES, V119, P187, DOI 10.1016/S0165-3806(99)00173-X; Wu HP, 2010, HEARING RES, V267, P71, DOI 10.1016/j.heares.2010.03.082; Yamane H, 1995, EUR ARCH OTO-RHINO-L, V252, P504, DOI 10.1007/BF02114761; Yamashita D, 2004, BRAIN RES, V1019, P201, DOI 10.1016/j.brainres.2004.05.104; Yamashita D, 2008, J NEUROSCI RES, V86, P920, DOI 10.1002/jnr.21533; Yamasoba T, 1998, BRAIN RES, V804, P72, DOI 10.1016/S0006-8993(98)00660-X; Yang WP, 2004, HEARING RES, V196, P69, DOI 10.1016/j.heares.2004.04.015; Ying YLM, 2009, HEARING RES, V253, P116, DOI 10.1016/j.heares.2009.04.006	94	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138027	10.1371/journal.pone.0138027	http://dx.doi.org/10.1371/journal.pone.0138027			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366995	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100205
J	Mitra, A; Ruhnow, F; Nitzsche, B; Diez, S				Mitra, Aniruddha; Ruhnow, Felix; Nitzsche, Bert; Diez, Stefan			Impact-Free Measurement of Microtubule Rotations on Kinesin and Cytoplasmic-Dynein Coated Surfaces	PLOS ONE			English	Article							MOTOR PROTEIN; TORQUE GENERATION; PROCESSIVITY; MOVEMENTS; MOLECULE; PROTOFILAMENTS; PRECISION; TRANSPORT; DOMAIN; FORCE	Knowledge about the three-dimensional stepping of motor proteins on the surface of microtubules (MTs) as well as the torsional components in their power strokes can be inferred from longitudinal MT rotations in gliding motility assays. In previous studies, optical detection of these rotations relied on the tracking of rather large optical probes present on the outer MT surface. However, these probes may act as obstacles for motor stepping and may prevent the unhindered rotation of the gliding MTs. To overcome these limitations, we devised a novel, impact-free method to detect MT rotations based on fluorescent speckles within the MT structure in combination with fluorescence-interference contrast microscopy. We (i) confirmed the rotational pitches of MTs gliding on surfaces coated by kinesin-1 and kinesin-8 motors, (ii) demonstrated the superiority of our method over previous approaches on kinesin-8 coated surfaces at low ATP concentration, and (iii) identified MT rotations driven by mammalian cytoplasmic dynein, indicating that during collective motion cytoplasmic dynein side-steps with a bias in one direction. Our novel method is easy to implement on any state-of-the-art fluorescence microscope and allows for high-throughput experiments.	[Mitra, Aniruddha; Ruhnow, Felix; Diez, Stefan] Tech Univ Dresden, CUBE Ctr Mol Bioengn B, D-01062 Dresden, Germany; [Nitzsche, Bert; Diez, Stefan] Max Plank Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Max Planck Society	Diez, S (corresponding author), Tech Univ Dresden, CUBE Ctr Mol Bioengn B, D-01062 Dresden, Germany.	diez@bcube-dresden.de	Diez, Stefan/E-8172-2010	Diez, Stefan/0000-0002-0750-8515; Mitra, Aniruddha/0000-0002-6623-2918; Ruhnow, Felix/0000-0002-0856-5511	European Research Council [242933]; European Social Funds [100111059]; German Research Foundation [DI 1226/4, SFG 877, DI 1226/5]; Max Planck Society; Technische Universitat Dresden	European Research Council(European Research Council (ERC)European Commission); European Social Funds(European Social Fund (ESF)); German Research Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Technische Universitat Dresden	The authors acknowledge financial support from the European Research Council (starting grant 242933, NanoTrans, to SD), the European Social Funds (grant 100111059, MindNano), the German Research Foundation (Cluster of Excellence Center for Advancing Electronics Dresden, Heisenberg programme grant DI 1226/4 and research unit SFG 877 grant DI 1226/5) as well as the Max Planck Society and the Technische Universitat Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bormuth V, 2012, BIOPHYS J, V103, pL04, DOI 10.1016/j.bpj.2012.05.024; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Brunnbauer M, 2012, MOL CELL, V46, P147, DOI 10.1016/j.molcel.2012.04.005; Bugiel M, 2015, BIOPHYS J, V108, P2019, DOI 10.1016/j.bpj.2015.03.022; Can S, 2014, ELIFE, V3, DOI 10.7554/eLife.03205; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Crevenna AH, 2008, BIOPHYS J, V95, P5216, DOI 10.1529/biophysj.108.132449; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Furuta K, 2013, P NATL ACAD SCI USA, V110, P501, DOI 10.1073/pnas.1201390110; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Jannasch A, 2013, BIOPHYS J, V104, P2456, DOI 10.1016/j.bpj.2013.02.040; Kerssemakers J, 2006, P NATL ACAD SCI USA, V103, P15812, DOI 10.1073/pnas.0510400103; Korten T, 2011, METHODS MOL BIOL, V783, P121, DOI 10.1007/978-1-61779-282-3_7; Mayr MI, 2011, PLOS ONE, P6, DOI [10.1371/journal.pone.0027471, DOI 10.1371/J0URNAL.P0NE.0027471]; MIMORI Y, 1995, CELL MOTIL CYTOSKEL, V30, P17, DOI 10.1002/cm.970300104; NISHIZAKA T, 1993, NATURE, V361, P269, DOI 10.1038/361269a0; Nitzsche B, 2008, NAT NANOTECHNOL, V3, P552, DOI 10.1038/nnano.2008.216; Nitzsche B, 2010, METHOD CELL BIOL, V95, P247, DOI 10.1016/S0091-679X(10)95014-0; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Peters C, 2010, EMBO J, V29, P3437, DOI 10.1038/emboj.2010.220; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Schneider R, 2015, BIOPHYS J, V108, P2249, DOI 10.1016/j.bpj.2015.03.048; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; VALE RD, 1988, CELL, V52, P459, DOI 10.1016/S0092-8674(88)80038-2; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Yajima J, 2005, NAT CHEM BIOL, V1, P338, DOI 10.1038/nchembio740; Yamaguchi S, 2015, BIOPHYS J, V108, P872, DOI 10.1016/j.bpj.2014.12.038; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	41	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136920	10.1371/journal.pone.0136920	http://dx.doi.org/10.1371/journal.pone.0136920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368807	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100032
J	Petruccelli, E; Lansdon, P; Kitamoto, T				Petruccelli, Emily; Lansdon, Patrick; Kitamoto, Toshihiro			Exaggerated Nighttime Sleep and Defective Sleep Homeostasis in a Drosophila Knock-In Model of Human Epilepsy	PLOS ONE			English	Article							FEBRILE SEIZURES PLUS; REDUCED SLEEP; MOUSE MODEL; PDF CELLS; DEPRIVATION; NEURONS; SCN1A; AROUSAL; FLIES	Despite an established link between epilepsy and sleep behavior, it remains unclear how specific epileptogenic mutations affect sleep and subsequently influence seizure susceptibility. Recently, Sun et al. (2012) created a fly knock-in model of human generalized epilepsy with febrile seizures plus (GEFS+), a wide-spectrum disorder characterized by fever-associated seizing in childhood and lifelong affliction. GEFS+ flies carry a disease-causing mutation in their voltage-gated sodium channel (VGSC) gene and display semidominant heat-induced seizing, likely due to reduced GABAergic inhibitory activity at high temperature. Here, we show that at room temperature the GEFS+ mutation dominantly modifies sleep, with mutants exhibiting rapid sleep onset at dusk and increased nighttime sleep as compared to controls. These characteristics of GEFS+ sleep were observed regardless of sex, mating status, and genetic background. GEFS+ mutant sleep phenotypes were more resistant to pharmacologic reduction of GABA transmission by carbamazepine (CBZ) than controls, and were mitigated by reducing GABA(A) receptor expression specifically in wake-promoting pigment dispersing factor (PDF) neurons. These findings are consistent with increased GABAergic transmission to PDF neurons being mainly responsible for the enhanced nighttime sleep of GEFS+ mutants. Additionally, analyses under other light conditions suggested that the GEFS+ mutation led to reduced buffering of behavioral responses to light on and off stimuli, which contributed to characteristic GEFS+ sleep phenotypes. We further found that GEFS+ mutants had normal circadian rhythms in free-running dark conditions. Interestingly, the mutants lacked a homeostatic rebound following mechanical sleep deprivation, and whereas deprivation treatment increased heat-induced seizure susceptibility in control flies, it unexpectedly reduced seizure activity in GEFS+ mutants. Our study has revealed the sleep architecture of a Drosophila VGSC mutant that harbors a human GEFS+ mutation, and provided unique insight into the relationship between sleep and epilepsy.	[Petruccelli, Emily; Lansdon, Patrick; Kitamoto, Toshihiro] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Kitamoto, Toshihiro] Univ Iowa, Dept Anesthesia, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Kitamoto, T (corresponding author), Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	toshi-kitamoto@uiowa.edu		Petruccelli, Emily/0000-0002-6911-7157; Kitamoto, Toshihiro/0000-0003-0863-8466	National Institutes of Health; Iowa Center for Research by Undergraduates; NIAAA [F31AA021625]; NINDS [T32NS045549]; NIMH [R01 MH085081]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA021625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa Center for Research by Undergraduates; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding provided by National Institutes of Health (http://www.nih.gov/), Iowa Center for Research by Undergraduates (http://www.uiowa.edu/icru/), NIAAA F31AA021625 (EP), NINDS T32NS045549 (PL), NIMH R01 MH085081 (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil B, 2001, NEUROLOGY, V57, P2265, DOI 10.1212/WNL.57.12.2265; Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; Derry CP, 2013, EPILEPSY BEHAV, V26, P394, DOI 10.1016/j.yebeh.2012.10.033; Donlea JM, 2014, NEURON, V81, P860, DOI 10.1016/j.neuron.2013.12.013; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; ELLINGSON RJ, 1984, J CLIN NEUROPHYSIOL, V1, P83, DOI 10.1097/00004691-198401000-00005; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Giorelli Andre S, 2013, Epilepsy Res Treat, V2013, P629469, DOI 10.1155/2013/629469; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hawkins NA, 2011, NEUROBIOL DIS, V41, P655, DOI 10.1016/j.nbd.2010.11.016; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Jain SV, 2014, EPILEPSIA, V55, P26, DOI 10.1111/epi.12478; Kalume F, 2015, NEUROBIOL DIS, V77, P141, DOI 10.1016/j.nbd.2015.02.016; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Li Y, 2013, J NEUROSCI, V33, P15545, DOI 10.1523/JNEUROSCI.0819-13.2013; Liu S, 2014, NEURON, V82, P151, DOI 10.1016/j.neuron.2014.01.040; Liu ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105678; Lucey BP, 2015, SLEEP, V38, P777, DOI 10.5665/sleep.4674; Malow Beth A, 2004, Epilepsy Curr, V4, P193, DOI 10.1111/j.1535-7597.2004.04509.x; Martin MS, 2010, J BIOL CHEM, V285, P9823, DOI 10.1074/jbc.M109.078568; Matos G, 2011, PROG NEUROBIOL, V95, P396, DOI 10.1016/j.pneurobio.2011.09.006; Neiman ES, 2010, SLEEP MED, V11, P799, DOI 10.1016/j.sleep.2010.04.006; Papale LA, 2010, J BIOL CHEM, V285, P16553, DOI 10.1074/jbc.M109.090084; Papale LA, 2013, EPILEPSIA, V54, P625, DOI 10.1111/epi.12060; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Parker L, 2011, INT REV NEUROBIOL, V99, P1, DOI 10.1016/B978-0-12-387003-2.00001-X; Potdar S, 2013, J NEUROGENET, V27, P23, DOI 10.3109/01677063.2013.791692; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sinha SR, 2011, J CLIN NEUROPHYSIOL, V28, P103, DOI 10.1097/WNP.0b013e3182120d41; Song J, 2008, PROG NEUROBIOL, V84, P182, DOI 10.1016/j.pneurobio.2007.10.006; Steiger SS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1016; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Sun L, 2012, J NEUROSCI, V32, P14145, DOI 10.1523/JNEUROSCI.2932-12.2012; Tabuchi M, 2015, CURR BIOL, V25, P702, DOI 10.1016/j.cub.2015.01.016; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Wu MN, 2009, J NEUROSCI, V29, P11029, DOI 10.1523/JNEUROSCI.1653-09.2009; Xu Xiao-jing, 2012, Zhonghua Er Ke Za Zhi, V50, P580	48	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137758	10.1371/journal.pone.0137758	http://dx.doi.org/10.1371/journal.pone.0137758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361221	gold, Green Published			2022-12-26	WOS:000361043100084
J	Zahid, MSH; Awasthi, SP; Asakura, M; Chatterjee, S; Hinenoya, A; Faruque, SM; Yamasaki, S				Zahid, M. Shamim Hasan; Awasthi, Sharda Prasad; Asakura, Masahiro; Chatterjee, Shruti; Hinenoya, Atsushi; Faruque, Shah M.; Yamasaki, Shinji			Suppression of Virulence of Toxigenic Vibrio cholerae by Anethole through the Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System	PLOS ONE			English	Article							TOXIN-COREGULATED PILUS; EL-TOR VARIANT; GENE-EXPRESSION; INDUCTION; REGULATOR; ACTIVATOR; STRAINS; APHA; DEGRADATION; INHIBITOR	Use of natural compounds as antivirulence drugs could be an alternative therapeutic approach to modify the outcome of bacterial infections, particularly in view of growing resistance to available antimicrobials. Here, we show that sub-bactericidal concentration of anethole, a component of sweet fennel seed, could suppress virulence potential in O1 El Tor biotype strains of toxigenic Vibrio cholerae, the causative agent of the ongoing 7th cholera pandemic. The expression of cholera toxin (CT) and toxin coregulated pilus (TCP), the major virulence factors of V. cholerae, is controlled through a regulatory cascade involving activation of ToxT with synergistic coupling interaction of ToxR/ToxS with TcpP/TcpH. We present evidence that anethole inhibits in vitro expression of CT and TCP in a toxT-dependent but toxR/toxS-independent manner and through repression of tcpP/tcpH, by using bead-ELISA, western blotting and quantitative real-time RT-PCR assays. The cyclic AMP (cAMP)-cAMP receptor protein (CRP) is a well-studied global signaling system in bacterial pathogens, and this complex is known to suppress expression of tcpP/tcpH in V. cholerae. We find that anethole influences the virulence regulatory cascade by over-expressing cyaA and crp genes. Moreover, suppression of toxigenic V. cholerae-mediated fluid accumulation in ligated ileum of rabbit by anethole demonstrates its potentiality as an antivirulence drug candidate against the diseases caused by toxigenic V. cholerae. Taken altogether, these results revealing a mechanism of virulence inhibition in V. cholerae by the natural compound anethole, may have relevance in designing antivirulence compounds, particularly against multiple antibiotic resistant bacterial pathogens.	[Zahid, M. Shamim Hasan; Awasthi, Sharda Prasad; Asakura, Masahiro; Chatterjee, Shruti; Hinenoya, Atsushi; Yamasaki, Shinji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan; [Faruque, Shah M.] Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, Dhaka 1000, Bangladesh	Osaka Metropolitan University; International Centre for Diarrhoeal Disease Research (ICDDR)	Yamasaki, S (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan.	shinji@vet.osakafu-u.ac.jp		Awasthi, Sharda Prasad/0000-0003-1606-3543; Faruque, Shah/0000-0002-7006-622X	Yamazaki Spice Promotion Foundation, Osaka Prefecture University	Yamazaki Spice Promotion Foundation, Osaka Prefecture University	Funding provided by Yamazaki Spice Promotion Foundation, Osaka Prefecture University.	Abuaita BH, 2011, MOL MICROBIOL, V81, P1640, DOI 10.1111/j.1365-2958.2011.07798.x; Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Bax R, 2000, INT J ANTIMICROB AG, V16, P51, DOI 10.1016/S0924-8579(00)00189-8; Beck NA, 2004, J BACTERIOL, V186, P8309, DOI 10.1128/JB.186.24.8309-8316.2004; Behari J, 2001, J BACTERIOL, V183, P178, DOI 10.1128/JB.183.1.178-188.2001; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; Chatterjee E, 2013, INFECT IMMUN, V81, P3935, DOI 10.1128/IAI.00722-13; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Chatterjee S, 2010, FEMS MICROBIOL LETT, V306, P54, DOI 10.1111/j.1574-6968.2010.01931.x; Corrigan D, 2001, NATURAL REMEDIES THE, P124; De M, 2002, PHYTOTHER RES, V16, P94, DOI 10.1002/ptr.989; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; DiRita VJ, 2013, MBIO, V4, DOI [10.1128/mBio.00403-13, DOI 10.1128/MBI0.00403-13]; Dog TL, 2006, EXPLORE-NY, V2, P446, DOI 10.1016/j.explore.2006.06.010; Faruque SM, 2007, P NATL ACAD SCI USA, V104, P5151, DOI 10.1073/pnas.0700365104; Ghosh-Banerjee J, 2010, J CLIN MICROBIOL, V48, P4283, DOI 10.1128/JCM.00799-10; Hagihara K, 2004, BIOCHEM BIOPH RES CO, V314, P363, DOI 10.1016/j.bbrc.2003.12.096; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; HIGGINS DE, 1994, MOL MICROBIOL, V14, P17, DOI 10.1111/j.1365-2958.1994.tb01263.x; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Kovacikova G, 1999, J BACTERIOL, V181, P4250, DOI 10.1128/JB.181.14.4250-4256.1999; Kovacikova G, 2001, MOL MICROBIOL, V41, P393, DOI 10.1046/j.1365-2958.2001.02518.x; Krukonis ES, 2000, MOL MICROBIOL, V38, P67, DOI 10.1046/j.1365-2958.2000.02111.x; Kubo I, 2008, J SCI FOOD AGR, V88, P242, DOI 10.1002/jsfa.3079; Lin W, 2007, MOL MICROBIOL, V64, P953, DOI 10.1111/j.1365-2958.2007.05693.x; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; Matson JS, 2005, P NATL ACAD SCI USA, V102, P16403, DOI 10.1073/pnas.0505818102; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Medrano AI, 1999, INFECT IMMUN, V67, P2178, DOI 10.1128/IAI.67.5.2178-2183.1999; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Nye MB, 2000, J BACTERIOL, V182, P4295, DOI 10.1128/JB.182.15.4295-4303.2000; OKU Y, 1988, MICROBIOL IMMUNOL, V32, P807, DOI 10.1111/j.1348-0421.1988.tb01442.x; Pratt JT, 2010, MOL MICROBIOL, V77, P1595, DOI 10.1111/j.1365-2958.2010.07310.x; Ramamurthy T, 2003, MICROBES INFECT, V5, P329, DOI 10.1016/S1286-4579(03)00035-2; Sanchez J, 2011, INDIAN J MED RES, V133, P153; Sanmugam D, 2007, NATURALLY SPEAKING I, P79; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Yamasaki S, 2011, INDIAN J MED RES, V133, P232; Yu RR, 1999, J BACTERIOL, V181, P2584, DOI 10.1128/JB.181.8.2584-2592.1999; Zahid MSH, 2015, J VET MED SCI, V77, P535, DOI 10.1292/jvms.14-0664	47	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137529	10.1371/journal.pone.0137529	http://dx.doi.org/10.1371/journal.pone.0137529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361388	Green Submitted, gold, Green Published			2022-12-26	WOS:000361043100050
J	McIntyre, J; McLenigan, MP; Frank, EG; Dai, XX; Yang, W; Wang, YS; Woodgate, R				McIntyre, Justyna; McLenigan, Mary P.; Frank, Ekaterina G.; Dai, Xiaoxia; Yang, Wei; Wang, Yinsheng; Woodgate, Roger			Posttranslational Regulation of Human DNA Polymerase i	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; LYSINE ACETYLTRANSFERASE KAT3B/P300; TRANSLESION SYNTHESIS; Y-FAMILY; STRUCTURAL BASIS; UBIQUITINATION SITES; OXIDATIVE STRESS; MAMMALIAN-CELLS; IOTA; ETA	Background: Many proteins are subject to posttranslational regulation, such as ubiquitination. Results: Human DNA polymerase iota (pol iota) can be monoubiquitinated at >27 unique sites, and exposure to naphthoquinones results in polyubiquitination of pol iota. Conclusion: Ubiquitination sites are located across the entire pol iota polypeptide as well as various structural motifs. Significance: Ubiquitination at these sites is likely to alter cellular functions of pol iota in vivo. Human DNA polymerases (pols) eta and i are Y-family DNA polymerase paralogs that facilitate translesion synthesis past damaged DNA. Both pol eta and poli can be monoubiquitinated in vivo. Pol eta has been shown to be ubiquitinated at one primary site. When this site is unavailable, three nearby lysines may become ubiquitinated. In contrast, mass spectrometry analysis of monoubiquitinated poli revealed that it is ubiquitinated at over 27 unique sites. Many of these sites are localized in different functional domains of the protein, including the catalytic polymerase domain, the proliferating cell nuclear antigen-interacting region, the Rev1-interacting region, and its ubiquitin binding motifs UBM1 and UBM2. Poli monoubiquitination remains unchanged after cells are exposed to DNA-damaging agents such as UV light (generating UV photoproducts), ethyl methanesulfonate (generating alkylation damage), mitomycin C (generating interstrand cross-links), or potassium bromate (generating direct oxidative DNA damage). However, when exposed to naphthoquinones, such as menadione and plumbagin, which cause indirect oxidative damage through mitochondrial dysfunction, poli becomes transiently polyubiquitinated via Lys(11)- and Lys(48)-linked chains of ubiquitin and subsequently targeted for degradation. Polyubiquitination does not occur as a direct result of the perturbation of the redox cycle as no polyubiquitination was observed after treatment with rotenone or antimycin A, which both inhibit mitochondrial electron transport. Interestingly, polyubiquitination was observed after the inhibition of the lysine acetyltransferase KATB3/p300. We hypothesize that the formation of polyubiquitination chains attached to poli occurs via the interplay between lysine acetylation and ubiquitination of ubiquitin itself at Lys(11) and Lys(48) rather than oxidative damage per se.	[Woodgate, Roger] NICHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA; [McIntyre, Justyna] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Dai, Xiaoxia; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Yang, Wei] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Woodgate, R (corresponding author), NICHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA.	woodgate@nih.gov	McIntyre, Justyna/M-9186-2014; Regan, Clinton/E-6250-2012; Yang, Wei/ABB-4785-2020	McIntyre, Justyna/0000-0002-0382-4799; Yang, Wei/0000-0002-3591-2195; Dai, Xiaoxia/0000-0002-3514-5061	NICHD, National Institutes of Health Intramural Research Program; NIDDK, National Institutes of Health Intramural Research Program; Foundation for Polish Science [HOMING PLUS/2013-7/10]; National Institutes of Health [R01 DK082779]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER	NICHD, National Institutes of Health Intramural Research Program; NIDDK, National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NICHD, National Institutes of Health Intramural Research Program (to R.W.); the NIDDK, National Institutes of Health Intramural Research Program (to W.Y.); the Foundation for Polish Science HOMING PLUS/2013-7/10 (to J.M.); and National Institutes of Health Grant R01 DK082779 (to Y.W.). The authors declare that they have no conflicts of interest with the contents of this article.	BALLMAIER D, 1995, CARCINOGENESIS, V16, P335, DOI 10.1093/carcin/16.2.335; Bebenek K, 2001, SCIENCE, V291, P2156, DOI 10.1126/science.1058386; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Burschowsky D, 2011, J BIOL CHEM, V286, P1364, DOI 10.1074/jbc.M110.135038; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Cui GF, 2010, BIOCHEMISTRY-US, V49, P10198, DOI 10.1021/bi101303t; Dai XX, 2013, J PROTEOME RES, V12, P4167, DOI 10.1021/pr400498y; Danielsen J. M., 2011, MOL CELL PROTEOMICS, V10, pM110, DOI DOI 10.1074/mcp.M110.003590; Frank EG, 2002, NUCLEIC ACIDS RES, V30, P5284, DOI 10.1093/nar/gkf643; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Haracska L, 2005, MOL CELL BIOL, V25, P1183, DOI 10.1128/MCB.25.3.1183-1190.2005; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; JABUSCH JR, 1985, ARCH BIOCHEM BIOPHYS, V238, P170, DOI 10.1016/0003-9861(85)90153-5; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kanao R, 2015, DNA REPAIR, V29, P139, DOI 10.1016/j.dnarep.2015.02.006; Kannouche P, 2002, EMBO J, V21, P6246, DOI 10.1093/emboj/cdf618; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kayashima T, 2009, CANCER LETT, V278, P34, DOI 10.1016/j.canlet.2008.12.020; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirouac KN, 2009, EMBO J, V28, P1644, DOI 10.1038/emboj.2009.122; Klaus V, 2010, ARCH BIOCHEM BIOPHYS, V496, P93, DOI 10.1016/j.abb.2010.02.002; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Li L, 1999, MOL CELL BIOL, V19, P5619; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Matsubara K, 2008, INT J MOL MED, V22, P381, DOI 10.3892/ijmm_00000034; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; McIntyre J, 2015, DNA REPAIR, V29, P166, DOI 10.1016/j.dnarep.2015.02.011; McIntyre J, 2013, NUCLEIC ACIDS RES, V41, P1649, DOI 10.1093/nar/gks1277; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Neuberger MS, 2007, J EXP MED, V204, P7, DOI 10.1084/jem.20062409; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Prasad R, 2003, J BIOL CHEM, V278, P29649, DOI 10.1074/jbc.M305399200; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; Sabbioneda S, 2008, MOL BIOL CELL, V19, P5193, DOI 10.1091/mbc.E08-07-0724; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; SEGA GA, 1984, MUTAT RES, V134, P113, DOI 10.1016/0165-1110(84)90007-1; Seung SA, 1998, CHEM-BIOL INTERACT, V113, P133, DOI 10.1016/S0009-2797(98)00024-6; Temviriyanukul P, 2012, TOXICOL SCI, V127, P130, DOI 10.1093/toxsci/kfs074; Tissier A, 2000, GENE DEV, V14, P1642; Tissier A, 2004, DNA REPAIR, V3, P1503, DOI 10.1016/j.dnarep.2004.06.015; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Vasudevarao MD, 2014, J BIOL CHEM, V289, P7702, DOI 10.1074/jbc.M113.486522; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; Wagner S. A., 2011, MOL CELL PROTEOMICS, V10, pM111, DOI DOI 10.1074/MCP.M111.013284; Warren AJ, 1998, CANCER RES, V58, P453; Washington MT, 2004, MOL CELL BIOL, V24, P936, DOI 10.1128/MCB.24.2.936-943.2004; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	70	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27332	27344		10.1074/jbc.M115.675769	http://dx.doi.org/10.1074/jbc.M115.675769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26370087	Green Published, hybrid			2022-12-26	WOS:000364794000040
J	Nighot, MP; Nighot, PK; Ma, TY; Malinowska, DH; Shull, GE; Cuppoletti, J; Blikslager, AT				Nighot, Meghali P.; Nighot, Prashant K.; Ma, Thomas Y.; Malinowska, Danuta H.; Shull, Gary E.; Cuppoletti, John; Blikslager, Anthony T.			Genetic Ablation of the ClC-2 Cl-Channel Disrupts Mouse Gastric Parietal Cell Acid Secretion	PLOS ONE			English	Article							APICAL CANALICULAR MEMBRANE; MUCOSAL BARRIER FUNCTION; RECOMBINANT HUMAN CLC-2; MURINE SMALL-INTESTINE; KIR2.1 K+ CHANNELS; CHLORIDE CHANNEL; ARACHIDONIC-ACID; PORCINE ILEUM; BETA-SUBUNIT; PKA	The present studies were designed to examine the effects of ClC-2 ablation on cellular morphology, parietal cell abundance, H/K ATPase expression, parietal cell ultrastructure and acid secretion using WT and ClC-2(-/-) mouse stomachs. Cellular histology, morphology and proteins were examined using imaging techniques, electron microscopy and western blot. The effect of histamine on the pH of gastric contents was measured. Acid secretion was also measured using methods and secretagogues previously established to give maximal acid secretion and morphological change. Compared to WT, ClC-2(-/-) gastric mucosal histological organization appeared disrupted, including dilation of gastric glands, shortening of the gastric gland region and disorganization of all cell layers. Parietal cell numbers and H/K ATPase expression were significantly reduced by 34% (P<0.05) and 53% (P<0.001) respectively and cytoplasmic tubulovesicles appeared markedly reduced on electron microscopic evaluation without evidence of canalicular expansion. In WT parietal cells, ClC-2 was apparent in a similar cellular location as the H/K ATPase by immunofluorescence and appeared associated with tubulovesicles by immunogold electron microscopy. Histamine-stimulated [ H+] of the gastric contents was significantly (P<0.025) lower by 9.4 fold (89%) in the ClC-2(-/-) mouse compared to WT. Histamine/carbachol stimulated gastric acid secretion was significantly reduced (range 84-95%, P<0.005) in ClC-2(-/-) compared to WT, while pepsinogen secretion was unaffected. Genetic ablation of ClC-2 resulted in reduced gastric gland region, reduced parietal cell number, reduced H/K ATPase, reduced tubulovesicles and reduced stimulated acid secretion.	[Nighot, Meghali P.; Nighot, Prashant K.; Blikslager, Anthony T.] N Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Malinowska, Danuta H.; Shull, Gary E.; Cuppoletti, John] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Ma, Thomas Y.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA	University of North Carolina; North Carolina State University; University System of Ohio; University of Cincinnati; University of New Mexico	Blikslager, AT (corresponding author), N Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.	anthony_blikslager@ncsu.edu		Blikslager, Anthony/0000-0002-0867-7310	Sucampo Pharmaceuticals Inc., Bethesda MD, USA; NIH NIDDK [DK43816]; Sucampo AG, Zug Switzerland; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043816] Funding Source: NIH RePORTER	Sucampo Pharmaceuticals Inc., Bethesda MD, USA; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Sucampo AG, Zug Switzerland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a grant to Anthony Blikslager from Sucampo Pharmaceuticals Inc., Bethesda MD, USA; by NIH NIDDK DK43816 grant to John Cuppoletti and Danuta H. Malinowska; and a grant to John Cuppoletti from Sucampo AG, Zug Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson ML, 1932, J GEN PHYSIOL, V16, P59, DOI 10.1085/jgp.16.1.59; Aoyama F, 2011, BIOL PHARM BULL, V34, P813, DOI 10.1248/bpb.34.813; Bali MZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1588, DOI 10.1152/ajpcell.2001.280.6.C1588; Beil W, 1998, PROSTAG LEUKOTR ESS, V59, P119, DOI 10.1016/S0952-3278(98)90090-4; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Cuppoletti J, 2004, AM J PHYSIOL-CELL PH, V287, pC1173, DOI 10.1152/ajpcell.00528.2003; Cuppoletti J, 2004, J BIOL CHEM, V279, P21849, DOI 10.1074/jbc.M312567200; CUPPOLETTI J, 1993, AM J PHYSIOL, V264, pC1609, DOI 10.1152/ajpcell.1993.264.6.C1609; Cuppoletti J, 2001, AM J PHYSIOL-CELL PH, V281, pC46, DOI 10.1152/ajpcell.2001.281.1.C46; Cuppoletti J, 2014, AM J PHYSIOL-CELL PH, V307, pC479, DOI 10.1152/ajpcell.00077.2014; Cuppoletti J, 2013, CELL BIOCHEM BIOPHYS, V66, P53, DOI 10.1007/s12013-012-9406-6; Dykstra MJ, 1993, MANUAL APPL TECHNIQU; Forte JG, 2004, AM J PHYSIOL-CELL PH, V286, pC478, DOI 10.1152/ajpcell.00531.2003; Forte JG, 2010, ANNU REV PHYSIOL, V72, P273, DOI 10.1146/annurev-physiol-021909-135744; Franic TV, 2001, AM J PHYSIOL-GASTR L, V281, pG1502, DOI 10.1152/ajpgi.2001.281.6.G1502; Fujii T, 2009, J BIOL CHEM, V284, P619, DOI 10.1074/jbc.M806562200; Gyomorey K, 2000, AM J PHYSIOL-CELL PH, V279, pC1787, DOI 10.1152/ajpcell.2000.279.6.C1787; Gyomorey K, 2001, PFLUG ARCH EUR J PHY, V443, pS103, DOI 10.1007/s004240100654; ITO S, 1974, J CELL BIOL, V63, P364, DOI 10.1083/jcb.63.2.364; Jain RN, 2008, J CLIN INVEST, V118, P2459, DOI 10.1172/JCI33569; Jordt SE, 1997, EMBO J, V16, P1582, DOI 10.1093/emboj/16.7.1582; Lipecka J, 2002, AM J PHYSIOL-CELL PH, V282, pC805, DOI 10.1152/ajpcell.00291.2001; Malinowska DH, 2004, AM J PHYSIOL-CELL PH, V286, pC495, DOI 10.1152/ajpcell.00386.2003; MALINOWSKA DH, 1990, AM J PHYSIOL, V259, pG536, DOI 10.1152/ajpgi.1990.259.4.G536; MALINOWSKA DH, 1995, AM J PHYSIOL-CELL PH, V268, pC191, DOI 10.1152/ajpcell.1995.268.1.C191; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG647, DOI 10.1152/ajpgi.00183.2006; Moeser AJ, 2004, GASTROENTEROLOGY, V127, P802, DOI 10.1053/j.gastro.2004.06.004; Murray CB, 1996, AM J PHYSIOL-LUNG C, V271, pL829, DOI 10.1152/ajplung.1996.271.5.L829; MURRAY CB, 1995, AM J RESP CELL MOL, V12, P597, DOI 10.1165/ajrcmb.12.6.7766424; Nehrke K, 2002, J BIOL CHEM, V277, P23604, DOI 10.1074/jbc.M202900200; Nighot M, 2012, WORLD J GASTROENTERO, V18, P4684, DOI 10.3748/wjg.v18.i34.4684; Nighot PK, 2010, AM J PHYSIOL-GASTR L, V299, pG449, DOI 10.1152/ajpgi.00520.2009; Nighot PK, 2009, EXP CELL RES, V315, P110, DOI 10.1016/j.yexcr.2008.10.001; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Olsen ML, J NEUROSCI, V23, P5572; Scarff KL, 1999, GASTROENTEROLOGY, V117, P605, DOI 10.1016/S0016-5085(99)70453-1; SCHOFIELD GC, 1979, J ANAT, V128, P669; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Sherry AM, 1997, AM J PHYSIOL-CELL PH, V273, pC384, DOI 10.1152/ajpcell.1997.273.2.C384; Sherry AM, 2001, AM J PHYSIOL-CELL PH, V280, pC1599, DOI 10.1152/ajpcell.2001.280.6.C1599; Sidani SM, 2007, J BIOL CHEM, V282, P6068, DOI 10.1074/jbc.M608427200; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Takahashi Y, 2014, BIOL OPEN, V3, P12, DOI 10.1242/bio.20136205; Tewari KP, 2000, AM J PHYSIOL-CELL PH, V279, pC40, DOI 10.1152/ajpcell.2000.279.1.C40; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; WOLOSIN JM, 1985, J MEMBRANE BIOL, V83, P261, DOI 10.1007/BF01868700; WOLOSIN JM, 1984, AM J PHYSIOL, V246, pC537, DOI 10.1152/ajpcell.1984.246.5.C537; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105	48	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138174	10.1371/journal.pone.0138174	http://dx.doi.org/10.1371/journal.pone.0138174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378782	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400063
J	Takagi, Y; Kinoshita, K; Ozaki, N; Seino, Y; Murata, Y; Oshida, Y; Hayashi, Y				Takagi, Yusuke; Kinoshita, Keita; Ozaki, Nobuaki; Seino, Yusuke; Murata, Yoshiharu; Oshida, Yoshiharu; Hayashi, Yoshitaka			Mice Deficient in Proglucagon-Derived Peptides Exhibit Glucose Intolerance on a High-Fat Diet but Are Resistant to Obesity	PLOS ONE			English	Article							RECEPTOR KNOCKOUT MICE; GLP-1 RECEPTOR; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; GLUCAGON; HYPERGLUCAGONEMIA; THERMOGENESIS; HYPERGLYCEMIA; ANTAGONISM	Homozygous glucagon-GFP knock-in mice (Gcg(gfp/gfp)) lack proglucagon derived-peptides including glucagon and GLP-1, and are normoglycemic. We have previously shown that Gcg(gfp/gfp) show improved glucose tolerance with enhanced insulin secretion. Here, we studied glucose and energy metabolism in Gcg(gfp/gfp) mice fed a high-fat diet (HFD). Male Gcg(gfp/gfp) and Gcg(gfp/+) mice were fed either a normal chow diet (NCD) or an HFD for 15-20 weeks. Regardless of the genotype, mice on an HFD showed glucose intolerance, and Gcg(gfp/gfp) mice on HFD exhibited impaired insulin secretion whereas Gcg(gfp/+) mice on HFD exhibited increased insulin secretion. A compensatory increase in b-cell mass was observed in Gcg(gfp/+) mice on HFD, but not in Gcg(gfp/gfp) mice on the same diet. Weight gain was significantly lower in Gcg(gfp/gfp) mice than in Gcg(gfp/+) mice. Oxygen consumption was enhanced in Gcg(gfp/gfp) mice compared to Gcg(gfp/+) mice on an HFD. HFD feeding significantly increased uncoupling protein 1 mRNA expression in brown adipose and inguinal white adipose tissues of Gcg(gfp/gfp) mice, but not of Gcg(gfp/+) mice. Treatment with the glucagon-like peptide-1 receptor agonist liraglutide (200 mg/kg) improved glucose tolerance in Gcg(gfp/gfp) mice and insulin content in Gcg(gfp/gfp) and Gcg(gfp/+) mice was similar after liraglutide treatment. Our findings demonstrate that Gcg(gfp/gfp) mice develop diabetes upon HFD-feeding in the absence of proglucagon-derived peptides, although they are resistant to diet-induced obesity.	[Takagi, Yusuke; Kinoshita, Keita; Ozaki, Nobuaki; Oshida, Yoshiharu] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan; [Takagi, Yusuke; Kinoshita, Keita; Murata, Yoshiharu; Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Div Stress Adaptat & Recognit, Dept Genet, Nagoya, Aichi 4648601, Japan; [Seino, Yusuke] Nagoya Univ, Sch Med, Dept Metab Med, Nagoya, Aichi 466, Japan	Nagoya University; Nagoya University; Nagoya University	Ozaki, N (corresponding author), Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan.	n-ozaki@med.nagoya-u.ac.jp	Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303; Kinoshita, Keita/0000-0001-8373-1789	Japan Society for the Promotion of Science [22590974, 24659451]; Ministry of Education, Culture, Sports, Science, and Technology [23122507, 25122708]; Grants-in-Aid for Scientific Research [15K15356] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (22590974 to NO and 24659451 to YH), and by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (23122507 and 25122708 to YH).	Abegg K, 2013, PHYSIOL BEHAV, V121, P70, DOI 10.1016/j.physbeh.2013.03.027; Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Ayala JE, 2010, ENDOCRINOLOGY, V151, P4678, DOI 10.1210/en.2010-0289; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Basu A, 1996, J CLIN INVEST, V97, P2351, DOI 10.1172/JCI118678; Bradley DP, 2012, APPL PHYSIOL NUTR ME, V37, P893, DOI [10.1139/H2012-068, 10.1139/h2012-068]; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; BUTLER PC, 1991, DIABETES, V40, P73, DOI 10.2337/diabetes.40.1.73; Chatzigeorgiou A, 2014, OBES REV; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; Fukami A, 2013, DIABETES, V62, P510, DOI 10.2337/db12-0294; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hansotia T, 2004, DIABETES, V53, P1326, DOI 10.2337/diabetes.53.5.1326; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Heppner KM, 2010, PHYSIOL BEHAV, V100, P545, DOI 10.1016/j.physbeh.2010.03.019; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; JOHNSON DG, 1982, SCIENCE, V215, P1115, DOI 10.1126/science.6278587; Jun LS, 2015, DIABETES, V64, P819, DOI 10.2337/db14-1052; Kanoski SE, 2011, ENDOCRINOLOGY, V152, P3103, DOI 10.1210/en.2011-0174; Kinoshita K, 2014, ENDOCRINOLOGY, V155, P3484, DOI 10.1210/en.2014-1175; Knauf C, 2008, ENDOCRINOLOGY, V149, P4768, DOI 10.1210/en.2008-0180; Lamont BJ, 2012, J CLIN INVEST, V122, P388, DOI 10.1172/JCI42497; Larsson H, 2000, DIABETES CARE, V23, P650, DOI 10.2337/diacare.23.5.650; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Li XC, 2013, CURR HYPERTENS REP, V15, P522, DOI 10.1007/s11906-013-0383-y; Lo KA, 2013, BIOSCIENCE REP, V33, P711, DOI 10.1042/BSR20130046; Lockie SH, 2013, ADIPOCYTE, V2, P196, DOI 10.4161/adip.25417; Mu J, 2011, DIABETOLOGIA, V54, P2381, DOI 10.1007/s00125-011-2217-2; Omar BA, 2014, DIABETES, V63, P101, DOI 10.2337/db13-0710; Osaka T, 2005, PEPTIDES, V26, P1623, DOI 10.1016/j.peptides.2005.02.016; Parker JC, 2002, BIOCHEM BIOPH RES CO, V290, P839, DOI 10.1006/bbrc.2001.6265; Peschechera A, 2013, ARCH PHYSIOL BIOCHEM, V119, P151, DOI 10.3109/13813455.2013.796995; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Sakamoto E, 2012, J DIABETES INVEST, V3, P432, DOI 10.1111/j.2040-1124.2012.00208.x; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; VanTine BA, 1996, ENDOCRINOLOGY, V137, P3316, DOI 10.1210/en.137.8.3316; Watanabe C, 2012, DIABETES, V61, P74, DOI 10.2337/db11-0739; Winzell MS, 2007, DIABETOLOGIA, V50, P1453, DOI 10.1007/s00125-007-0675-3	42	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138322	10.1371/journal.pone.0138322	http://dx.doi.org/10.1371/journal.pone.0138322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378455	Green Submitted, gold, Green Published			2022-12-26	WOS:000361769400083
J	Alt, KW; Benz, M; Vach, W; Simmons, TL; Goring-Morris, AN				Alt, Kurt W.; Benz, Marion; Vach, Werner; Simmons, Tal L.; Goring-Morris, A. Nigel			Insights into the Social Structure of the PPNB Site of Kfar HaHoresh, Israel, Based on Dental Remains	PLOS ONE			English	Article							VARIABILITY; AGE	One of the central questions of the transition from mobile hunter-gatherers to sedentary farming communities concerns the establishment of new social structures and group identities. Along with other important factors, such as territory, ideology or economy, biological relationships might have played a decisive role in defining social groups. We therefore systematically analyzed teeth and jaw remains from nine sites in the Near East dating from the Natufian to the Late PPNB as primary proxy data for the reconstruction of familial relationships. This paper presents the results of morphological analyses on the teeth of the individuals from Kfar HaHoresh, one of the investigated Pre-Pottery Neolithic B sites. Kfar HaHoresh is located in the Nazareth hills of Galilee (32 degrees 42'20 '' N 35 degrees 16'28 '' E), Israel. Different statistical methods were applied to our data of epigenetic traits with the aim of determining biological relationships within the community, whereby the data of the eight other sites were used as cross-references. Our comparison of the traits of all individuals from Kfar HaHoresh indicates a rather heterogeneous community, but clearly shows one cluster belonging to a quite homogenous group, suggesting close biological relations between females and sub-adults. Interestingly, none of the male individuals belongs to this cluster, although their number outweighs that of the female individuals. This might suggest matrilocal residence patterns. However, due to the incomplete preservation of the teeth along with several other uncertainties, our conclusion must be seen as preliminary. A cross-examination of the results on skeletons excavated after our investigation should also be taken into consideration.	[Alt, Kurt W.] Danube Private Univ, Ctr Nat & Cultural Hist Teeth, Krems Stein, Austria; [Alt, Kurt W.] Univ Basel, IPAS, Basel, Switzerland; [Alt, Kurt W.] Saxony Anhalt & Heritage Museum, State Off Heritage Management & Archaeol, Halle, Germany; [Benz, Marion] Univ Freiburg, Dept Near Eastern Archaeol, D-79106 Freiburg, Germany; [Vach, Werner] Univ Freiburg, Univ Med Ctr, Ctr Med Biometry & Med Informat, D-79106 Freiburg, Germany; [Simmons, Tal L.] Hebrew Univ Jerusalem, Inst Adv Studies, Jerusalem, Israel; [Goring-Morris, A. Nigel] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel	University of Basel; University of Freiburg; University of Freiburg; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Alt, KW (corresponding author), Danube Private Univ, Ctr Nat & Cultural Hist Teeth, Krems Stein, Austria.	kurt.alt@dp-uni.ac.at	Simmons, Tal/AAD-9780-2019; Vach, Werner/F-2512-2011	Vach, Werner/0000-0003-1865-8399; Goring-Morris, Adrian Nigel/0000-0003-1673-7747	Eliteprogramme for Postdocs; Baden-Wurttemberg Stiftung; Irene Levi-Sala CARE Foundation; National Geographic Society [8625/09]; Israel Science Foundation (Israel Academy of Sciences and Humanities) [840/01, 558/04, 755/07, 1161/10]	Eliteprogramme for Postdocs; Baden-Wurttemberg Stiftung; Irene Levi-Sala CARE Foundation; National Geographic Society(National Geographic Society); Israel Science Foundation (Israel Academy of Sciences and Humanities)(Israel Science Foundation)	The SIGN-Project ("Social Identities of Neolithic Groups in the Near East") was funded by the "Eliteprogramme for Postdocs" (2007-2009). MB is indebted to the Baden-Wurttemberg Stiftung for this generous support (http://www.bwstiftung.de). Investigations at Kfar HaHoresh have been funded by generous grants (to ANGM) from the Irene Levi-Sala CARE Foundation (http://prehistory.org.il/?page_id=894), the National Geographic Society (Grant #8625/09) (www.nationalgeographic.com) and the Israel Science Foundation (Israel Academy of Sciences and Humanities Grants #840/01, #558/04, #755/07 and #1161/10) (www.isf.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen V., 1988, ACTA REGIAE SOC HUMA, V79, P106; Alt K. W., 1997, ODONTOLOGISCHE VERWA; Alt KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065649; ALT KW, 1995, FORENSIC SCI INT, V74, P99, DOI 10.1016/0379-0738(95)01740-A; Alt KW, 1998, DENTAL ANTHROPOLOGY, P537; Alt KW, 1996, HOMO, V46, P256; Alt KW, 2004, BASLER HEFTE ARCHAOL, V3; Alt KW, 1997, CAHIERS ASS PROMOTIO, P1; [Anonymous], 2004, MONOGRAPH FACULTY AR; Arensburg B., 1989, BAR INT SERIES, V508, P115; Belfer-Cohen A., 1988, PALEORIENT, V14, P297, DOI DOI 10.3406/PALE0.1988.4476; Belfer-Cohen A, 2013, NATUFIAN CULTURE LEV, VII, P554; Bentley AR, 2012, P NATL ACAD SCI USA, V109, DOI [10.1073/pnas, DOI 10.1073/PNAS]; Benz M., 2010, STUDIES EARLY NEAR E, V14, P249; Bienert H. D., 1991, J PREHISTORIC RELIG, V5, P9; Birkenfeld M, 2015, ARCHAEOLOGICAL REV C, V30, P95; Biton R, 2014, J ARCHAEOL SCI, V41, P740, DOI 10.1016/j.jas.2013.10.005; Bonogofsky M, 2006, BAR INT SERIES, V1539; Bouwman AS, 2009, ANNU BRIT SCH ATHENS, V104, P291; Boyd B, 2006, WORLD ARCHAEOL, V38, P164, DOI 10.1080/00438240600688398; Buikstra J, 1994, ARKAN; Cucina A., 2014, ARCHAEOLOGY BIOARCHA; Diaz E, 2014, COLOMB MEDICA, V45, P15; Dunbar Robin I. M., 2013, NEOLITHICS, V2, P25; Fernandez E, 2013, MEMORIA CIENTIFICA, P470; Fernandez E, 2006, ANALISIS GENETICO PO, V83, P07; Finlayson B., 2011, PALE ORIENT, V37, P123; Flannery KV, 2002, AM ANTIQUITY, V67, P417, DOI 10.2307/1593820; FLANNERY KV, 1972, MAN SETTLEMENT URBAN, P23; Garfinkel Y., 2006, J ISRAEL PREHISTORIC, V36, P109; Gebel HGK., 2002, THESIS U LIB FREIBUR; Gopher A., 1990, J ISRAEL PREHISTORIC, V23, P9; Goren Y, 2001, J ARCHAEOL SCI, V28, P671, DOI 10.1006/jasc.1999.0573; Goring-Morris, 2008, PALEORIENT, V34, P91; Goring-Morris A. N., 1998, NEOLITHICS, V3, P1; Goring-Morris A.N., 2014, NEOLITHIC TRANSITION, P59; Goring-Morris A.N., 2000, LIFE NEOLITHIC FARMI, P103, DOI DOI 10.1007/0-306-47166-3_5; Goring-Morris A. N., 2008, NEW ENCY ARCHAEOLOGI, V5, P1907; Goring-Morris A. N., 2008, ANTIQUITY, V82; Goring-Morris A.N., 2005, ARCHAEOLOGICAL PERSP, P89; Goring-Morris AN, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P239, DOI 10.1007/978-1-4020-8539-0_10; Goring-Morris AN, 2008, NEOLITHICS, V2, P17; Goring-Morris AN, 2007, ANTIQUITY, V81, P1; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Hanihara K., 1997, OROFACIAL GROWTH DEV, P195; Hauser G., 1989, EPIGENETIC VARIANTS; Hughes T., 2013, ANTHR PERSPECTIVES T, P31, DOI [10.1017/CBO9780511984464.003, DOI 10.1017/CBO9780511984464.003]; Kuijt I, 1996, J ANTHROPOL ARCHAEOL, V15, P313, DOI 10.1006/jaar.1996.0012; Kuijt I., 2001, LIFE NEOLITHIC FARMI, P311; Leroux H, 2012, THESIS LEIDEN U LEID; Lukacs J R, 1987, Anthropol Anz, V45, P97; Meyer C, 2012, BAR INT SER, V2325, P11; MIZOGUCHI Y, 1977, J ANTHROPOL SOC NIP, V85, P301; Molleson TI, 2000, VILLAGE EUPHRATES, P533; NICHOL CR, 1989, AM J PHYS ANTHROPOL, V78, P37, DOI 10.1002/ajpa.1330780106; Nirmala SVSG, 2013, CONTEMP CLIN DENT, V4, P349, DOI 10.4103/0976-237X.118338; PILLOUD MA, 2009, THESIS OHIO STATE U; Pilloud MA, 2011, AM J PHYS ANTHROPOL, V145, P519, DOI 10.1002/ajpa.21520; Renfrew Colin, 2013, NEOLITHICS, V13, P30; Rohrer-Ertl O, 1978, NEOLITHISCHE REVOLUT; Rollefson G. O., 1983, PALEORIENT, V9, P29, DOI [DOI 10.3406/paleo.1983.4339, DOI 10.3406/PALE0.1983.4339]; Rollefson G. O., 1986, PALEORIENT, V12, P45, DOI DOI 10.3406/paleo.1986.4397; Rollefson G. O., 2000, LIFE NEOLITHIC FARMI, P165; Rollefson GO., 2010, STUDIES EARLY NEAR E, V14, P182; Rosing F, 1990, QUBBET HAWA ELEPHANT; Saunders S.R., 1989, RECONSTRUCTION LIFE, P95; Saunders SR, 1998, RECONSTRUCTION LIFE, P95; Schulze C., 1987, ANOMALIEN MISSBILDUN; Scott GR, 2013, ANTHR PERSPECTIVE TO; Scott GR, 2008, BIOL ANTHR HUMAN SKE, P265, DOI DOI 10.1002/9780470245842; Scott GR, 1973, THEISS TEMPE; SCOTT GR, 1982, TEETH FORM FUNCTION, P259; Scott GR., 1984, ANTHROPOLOGIE, V22, P223, DOI [10.1080/03014460.2022.2032339, DOI 10.1080/03014460.2022.2032339]; Simmons AH, 2007, NEOLITHIC REVOLUTION; Simmons T., 2007, BAR INT SERIES, V1603, P1; Slon V, PLOS ONE, V9, DOI DOI 10.1371/J0URNAL.P0NE.0089242; Stojanowski CM, 2006, YEARB PHYS ANTHROPOL, V49, P49, DOI 10.1002/ajpa.20517; Stordeur D., 2007, SYRIA, V84, P5, DOI DOI 10.4000/SYRIA.321; TOWNSEND G, 1990, AM J PHYS ANTHROPOL, V82, P267, DOI 10.1002/ajpa.1330820305; VACH W, 1993, COMPUTING PAST, P287; Van Tuinen M, 2005, BRIT I ARCHAEOLOGY A, V38, P307; Verhoeven M., 2002, PALEORIENT, V28, P5, DOI DOI 10.3406/PALEO.2002.4735; Watkins T., 2010, LEVANT SUPPLEMENTARY, V8, P106; Wiltschke-Schrotta K, 1988, THESIS U VIENNA	84	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0134528	10.1371/journal.pone.0134528	http://dx.doi.org/10.1371/journal.pone.0134528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CR8NH	26376321	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200005
J	Garlapow, ME; Huang, W; Yarboro, MT; Peterson, KR; Mackay, TFC				Garlapow, Megan E.; Huang, Wen; Yarboro, Michael T.; Peterson, Kara R.; Mackay, Trudy F. C.			Quantitative Genetics of Food Intake in Drosophila melanogaster	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; ADIPOSE-TISSUE DEVELOPMENT; INSULIN-PRODUCING CELLS; SHORT NEUROPEPTIDE-F; FEEDING-BEHAVIOR; DEVELOPMENTAL STABILITY; TRANSCRIPTION FACTORS; DIABETIC-NEPHROPATHY	Food intake is an essential animal activity, regulated by neural circuits that motivate food localization, evaluate nutritional content and acceptance or rejection responses through the gustatory system, and regulate neuroendocrine feedback loops that maintain energy homeostasis. Excess food consumption in people is associated with obesity and metabolic and cardiovascular disorders. However, little is known about the genetic basis of natural variation in food consumption. To gain insights in evolutionarily conserved genetic principles that regulate food intake, we took advantage of a model system, Drosophila melanogaster, in which food intake, environmental conditions and genetic background can be controlled precisely. We quantified variation in food intake among 182 inbred, sequenced lines of the Drosophila melanogaster Genetic Reference Panel (DGRP). We found significant genetic variation in the mean and within-line environmental variance of food consumption and observed sexual dimorphism and genetic variation in sexual dimorphism for both food intake traits (mean and variance). We performed genome wide association (GWA) analyses for mean food intake and environmental variance of food intake (using the coefficient of environmental variation, CVE, as the metric for environmental variance) and identified molecular polymorphisms associated with both traits. Validation experiments using RNAi-knockdown confirmed 24 of 31 (77%) candidate genes affecting food intake and/or variance of food intake, and a test cross between selected DGRP lines confirmed a SNP affecting mean food intake identified in the GWA analysis. The majority of the validated candidate genes were novel with respect to feeding behavior, and many had mammalian orthologs implicated in metabolic diseases.	[Garlapow, Megan E.; Huang, Wen; Mackay, Trudy F. C.] N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA; [Garlapow, Megan E.; Huang, Wen; Yarboro, Michael T.; Peterson, Kara R.; Mackay, Trudy F. C.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Garlapow, Megan E.; Huang, Wen; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Mackay, TFC (corresponding author), N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu		Huang, Wen/0000-0001-6788-8364	National Institute of General Medical Sciences [R01 GM45146]; National Institute on Alcohol Abuse and Alcoholism [R01 AA016560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016560] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institute of General Medical Sciences R01 GM45146 to TFCM, and by the National Institute on Alcohol Abuse and Alcoholism R01 AA016560 to TFCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI H, 1995, J ENDOCRINOL, V146, P381, DOI 10.1677/joe.0.1460381; Aguilera CM, 2015, INT J MOL SCI, V16, P7723, DOI 10.3390/ijms16047723; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Andres SF, 2015, AM J PHYSIOL-GASTR L, V308, pG100, DOI 10.1152/ajpgi.00287.2014; Ansel J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000049; Ayroles JF, 2015, P NATL ACAD SCI USA, V112, P6706, DOI 10.1073/pnas.1503830112; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Azadbakht L, 2013, INT J FOOD SCI NUTR, V64, P392, DOI 10.3109/09637486.2012.753039; Baltzer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006935; Barrett AL, 2008, DEV BIOL, V317, P234, DOI 10.1016/j.ydbio.2008.02.025; BASIOTIS PP, 1987, J NUTR, V117, P1638, DOI 10.1093/jn/117.9.1638; Beavis W. D., 1994, P 49 ANN CORN SORGH, P250; Beavis William D., 1998, P145; Bharucha KN, 2009, PEDIATR RES, V65, P132, DOI 10.1203/PDR.0b013e318191fc68; BIRD AR, 1994, J NUTR, V124, P231, DOI 10.1093/jn/124.2.231; Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Brankatschk M, 2014, ELIFE, V3, DOI 10.7554/eLife.02862; Bray GA, 2008, AM J CLIN NUTR, V88, P1504, DOI 10.3945/ajcn.2008.26289; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Buti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092682; Carvalho GB, 2006, CURR BIOL, V16, P692, DOI 10.1016/j.cub.2006.02.064; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Champagne CM, 2013, J ACAD NUTR DIET, V113, P1532, DOI 10.1016/j.jand.2013.07.001; Chen KL, 2013, ENDOCR RES, V38, P59, DOI 10.3109/07435800.2012.681824; Chung AWY, 2009, EUR J PHARMACOL, V613, P114, DOI 10.1016/j.ejphar.2009.04.029; Clemente-Postigo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024783; Constantinou C, 2014, J LIPID RES, V55, P1434, DOI 10.1194/jlr.M050047; DEBELLE JS, 1989, GENETICS, V123, P157; Delgado-Lista J, 2014, J CLIN ENDOCR METAB, V99, pE384, DOI 10.1210/jc.2013-3165; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dionisio N, 2012, CURR MOL MED, V12, P1319, DOI 10.2174/156652412803833616; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Du ZJ, 2007, OPHTHALMIC RES, V39, P224, DOI 10.1159/000104831; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Do DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071509; Estella E, 2006, DIABETES, V55, P2212, DOI 10.2337/db06-0129; Flood TF, 2013, NATURE, V499, P83, DOI 10.1038/nature12208; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Frazier-Wood AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030732; Gasque Gabriel, 2013, Sci Rep, V3, psrep02120, DOI 10.1038/srep02120; Geiger-Thornsberry GL, 2002, GENET RES, V79, P211, DOI 10.1017/S0016672302005621; Goergen P, 2014, BEHAV GENET, V44, P155, DOI 10.1007/s10519-014-9643-0; Goncalves Helen, 2012, J Adolesc Health, V51, pS46, DOI 10.1016/j.jadohealth.2012.08.015; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Hall MC, 2007, P NATL ACAD SCI USA, V104, P13717, DOI 10.1073/pnas.0701936104; Harbison ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-281; Harris DT, 2015, NEURON, V86, P1449, DOI 10.1016/j.neuron.2015.05.026; Harris RH, 2013, INT J EAT DISORDER, V46, P369, DOI 10.1002/eat.22073; He F, 2014, DIABETOLOGIA, V57, P1726, DOI 10.1007/s00125-014-3282-0; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Hirota Y, 2002, MECH DEVELOP, V119, pS279, DOI 10.1016/S0925-4773(03)00129-1; Hodin CM, 2011, J PATHOL, V225, P276, DOI 10.1002/path.2917; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Huetteroth W, 2015, CURR BIOL, V25, P751, DOI 10.1016/j.cub.2015.01.036; Iijima K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008498; Itskov PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5560; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jaeken J, 2015, EUR J HUM GENET, V23, pE1, DOI 10.1038/ejhg.2015.9; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Jordan KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038722; Joseph BK, 2015, J BIOL CHEM, V290, P10588, DOI 10.1074/jbc.M114.626259; Jumbo-Lucioni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-297; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaczkowski CH, 2000, J NUTR, V130, P802, DOI 10.1093/jn/130.4.802; Kapan N, 2012, CELL MOL LIFE SCI, V69, P4051, DOI 10.1007/s00018-012-1097-z; Kato M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003389; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; KIM W W, 1984, American Journal of Clinical Nutrition, V40, P1333, DOI 10.1093/ajcn/40.6.1333; Konieczna J, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0366-2; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Kubrak OI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113051; Kulyte A, 2014, DIABETES, V63, P1248, DOI 10.2337/db13-0702; KURACHI H, 1993, AM J PHYSIOL, V265, pE323, DOI 10.1152/ajpendo.1993.265.2.E323; Lai CQ, 2009, OBESITY, V17, P593, DOI 10.1038/oby.2008.561; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lerner IM, 1954, GENETIC HOMEOSTASIS; LEWONTIN RC, 1964, GENETICS, V50, P757; Li AJ, 2006, ENDOCRINOLOGY, V147, P3428, DOI 10.1210/en.2006-0235; Li SY, 2015, J AM SOC NEPHROL, V26, P3072, DOI 10.1681/ASN.2014100989; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Liu QA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000575; Liu YT, 2015, J COMP NEUROL, V523, P1840, DOI 10.1002/cne.23768; Locke JM, 2015, DIABETES, V64, P1484, DOI 10.2337/db14-0957; Luo JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099732; Lushchak OV, 2015, CELL MOL LIFE SCI, V72, P3143, DOI 10.1007/s00018-015-1884-4; Mackay TFC, 2005, PHILOS T R SOC B, V360, P1513, DOI 10.1098/rstb.2005.1672; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2010, PHILOS T R SOC B, V365, P1229, DOI 10.1098/rstb.2009.0315; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Manzo A, 2012, P NATL ACAD SCI USA, V109, P6307, DOI 10.1073/pnas.1120305109; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Masek P, 2015, CURR BIOL, V25, P1535, DOI 10.1016/j.cub.2015.04.027; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; McNeill H, 2008, GENETICS, V179, P843, DOI 10.1534/genetics.107.083097; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Memon AA, 2015, J DIABETES, V7, P369, DOI 10.1111/1753-0407.12184; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Mita M, 2010, CLIN EXP PHARMACOL P, V37, P670, DOI 10.1111/j.1440-1681.2010.05373.x; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Morava E, 2012, PEDIATRICS, V130, pE1034, DOI 10.1542/peds.2011-2711; Morgante F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09785; Mueller LD, 2015, GENETICA, V143, P93, DOI 10.1007/s10709-015-9818-5; Mukherjee T, 2012, G3-GENES GENOM GENET, V2, P23, DOI 10.1534/g3.111.001495; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Naja F, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-111; Nassel DR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00252; Neckameyer WS, 2010, DEV NEUROSCI-BASEL, V32, P217, DOI 10.1159/000304888; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Ohta H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00018; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Ordas B, 2008, GENET RES, V90, P385, DOI 10.1017/S0016672308009762; Ostojic I, 2014, P NATL ACAD SCI USA, V111, P8143, DOI 10.1073/pnas.1315466111; Ozawa T, 2003, J GASTROENTEROL, V38, P844, DOI 10.1007/s00535-003-1159-y; Padilla J, 2013, PHYSIOL GENOMICS, V45, P434, DOI 10.1152/physiolgenomics.00038.2013; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Pool AH, 2014, NEURON, V83, P164, DOI 10.1016/j.neuron.2014.05.006; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Potdar S, 2013, J NEUROGENET, V27, P23, DOI 10.3109/01677063.2013.791692; Potes CS, 2010, AM J PHYSIOL-REG I, V299, pR623, DOI 10.1152/ajpregu.00791.2009; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Ramanathan G, 2012, J THROMB HAEMOST, V10, P419, DOI 10.1111/j.1538-7836.2011.04596.x; Ribeiro C, 2010, CURR BIOL, V20, P1000, DOI 10.1016/j.cub.2010.03.061; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Ritter S, 2006, PHYSIOL BEHAV, V89, P490, DOI 10.1016/j.physbeh.2006.05.036; Rodenfels J, 2014, GENE DEV, V28, P2636, DOI 10.1101/gad.249763.114; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Ryuda M, 2011, J BIOL CHEM, V286, P38417, DOI 10.1074/jbc.M111.267344; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Scheiner R, 2014, J INSECT PHYSIOL, V69, P107, DOI 10.1016/j.jinsphys.2014.03.011; SCHOELLER DA, 1995, METABOLISM, V44, P18, DOI 10.1016/0026-0495(95)90204-X; SCHOELLER DA, 1990, NUTR REV, V48, P373, DOI 10.1111/j.1753-4887.1990.tb02882.x; Schoofs A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001893; Schubert ML, 2008, GASTROENTEROLOGY, V134, P1842, DOI 10.1053/j.gastro.2008.05.021; Seale JL, 2002, NUTRITION, V18, P568, DOI 10.1016/S0899-9007(02)00804-3; Seeger FH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004529; Singh H, 2013, BIOINFORMATION, V9, P37, DOI 10.6026/97320630009037; Smith CE, 2013, INT J OBESITY, V37, P1211, DOI 10.1038/ijo.2012.215; Smith CE, 2013, OBESITY, V21, P602, DOI 10.1002/oby.20001; Soderberg Jeannette A E, 2012, Front Endocrinol (Lausanne), V3, P109, DOI 10.3389/fendo.2012.00109; Strumia R, 2013, CLIN DERMATOL, V31, P80, DOI 10.1016/j.clindermatol.2011.11.011; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Swarup S, 2014, CHEM SENSES, V39, P125, DOI 10.1093/chemse/bjt061; Thomas HE, 2010, CELL DEATH DIFFER, V17, P577, DOI 10.1038/cdd.2009.165; Thomas HE, 2011, DIABETES-METAB RES, V27, P790, DOI 10.1002/dmrr.1253; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Toshima N, 2014, J INSECT PHYSIOL, V69, P89, DOI 10.1016/j.jinsphys.2014.06.019; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; Unckless RL, 2015, G3-GENES GENOM GENET, V5, P417, DOI 10.1534/g3.114.016477; Vairaktaris E, 2007, IN VIVO, V21, P615; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Vemana HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125764; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036059; Wang YH, 2013, CELL REP, V3, P820, DOI 10.1016/j.celrep.2013.02.003; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Whitaker R, 2014, AGING-US, V6, P355, DOI 10.18632/aging.100662; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Xu J, 2008, NAT NEUROSCI, V11, P676, DOI 10.1038/nn.2119; Xu SZ, 2003, GENETICS, V165, P2259; Yan L, 2012, BIOCHEM J, V444, P239, DOI 10.1042/BJ20111606; Yang Z, 2015, P NATL ACAD SCI USA, V112, P5219, DOI 10.1073/pnas.1417838112; Zbidi H, 2009, BLOOD CELL MOL DIS, V43, P211, DOI 10.1016/j.bcmd.2009.04.005; Zeng CY, 2011, FLY, V5, P174, DOI 10.4161/fly.5.3.15572; Zhang CF, 2014, CURR VASC PHARMACOL; Zhang D, 2009, AM J NEPHROL, V29, P244, DOI 10.1159/000157627; Zhang LF, 2014, INT J BIOL SCI, V10, P236, DOI 10.7150/ijbs.7744; Zhang T, 2013, P NATL ACAD SCI USA, V110, P15431, DOI 10.1073/pnas.1308816110; Zhang W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002429; Zhang YV, 2013, NAT NEUROSCI, V16, P1468, DOI 10.1038/nn.3513; Zhang YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7704; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	190	57	57	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138129	10.1371/journal.pone.0138129	http://dx.doi.org/10.1371/journal.pone.0138129			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375667	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200078
J	Hwang, SH; Cho, HK; Park, SH; Lee, W; Lee, HJ; Lee, DC; Park, SH; Lim, MH; Back, SA; Yun, BG; Sun, DI; Kang, JM; Kim, SW				Hwang, Se Hwan; Cho, Hye Kyung; Park, Sang Hi; Lee, WeonSun; Lee, Hee Jin; Lee, Dong Chang; Park, Sun Hwa; Lim, Mi Hyun; Back, Sang A.; Yun, Byeong Gon; Sun, Dong Il; Kang, Jun Myung; Kim, Sung Won			Characteristics of Human Turbinate-Derived Mesenchymal Stem Cells Are Not Affected by Allergic Condition of Donor	PLOS ONE			English	Article							INFERIOR TURBINATE; STROMAL CELLS; UP-REGULATION; RHINITIS; TISSUE; DIFFERENTIATION; MULTIPOTENT; EXPRESSION; MUCOSA	The characteristics of mesenchymal stem cells (MSCs) derived from human turbinates (hTMSCs) have not been investigated in allergic rhinitis. We evaluated the influence of allergic state of the donor on the characteristics, proliferation, and differentiation potential of hTMSCs, compared with hTMSCs derived from non-allergic patients. hTMSCs were isolated from five non-allergic and five allergic patients. The expression of toll-like receptors (TLRs) in hTMSCs was measured by FACS, and cell proliferation was measured using a cell counting kit. Cytokine secretion was analyzed using multiplex immunoassays. The osteogenic, chondrogenic, and adipogenic differentiation potentials of hTMSCs were evaluated by histology and gene expression analysis. In allergic patients, FACS analysis showed that TLR3 and TLR4 were more highly expressed on the surface of hTMSCs than TLR2 and TLR5. The proliferation of hTMSCs was not influenced by the presence of TLR priming. The expression of IL-6, IL-8, IL-12, IP-10, and RANTES was upregulated after the TLR4 priming. The differentiation potential of hTMSCs was not influenced by TLR priming. These characteristics of hTMSCs were similar to those of hTMSCs from non-allergic patients. We conclude that the allergic condition of the donor does not influence TLR expression, proliferation, or immunomodulatory potential of hTMSCs.	[Hwang, Se Hwan; Lee, Dong Chang; Park, Sun Hwa; Lim, Mi Hyun; Back, Sang A.; Yun, Byeong Gon; Sun, Dong Il; Kang, Jun Myung; Kim, Sung Won] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Cho, Hye Kyung] Gachon Univ, Grad Sch Med, Dept Pediat, Inchon, South Korea; [Park, Sang Hi; Lee, WeonSun; Lee, Hee Jin] Catholic Univ Korea, Coll Med, Inst Clin Med Res, Seoul, South Korea; [Park, Sun Hwa; Lim, Mi Hyun; Yun, Byeong Gon] Catholic Univ Korea, Coll Med, Dept Biomed Sci, Seoul, South Korea	Catholic University of Korea; Gachon University; Catholic University of Korea; Catholic University of Korea	Kang, JM (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	entkjm@catholic.ac.kr; kswent@catholic.ac.kr		Hwang, Se Hwan/0000-0002-2838-7820	Catholic Medical Center Research Foundation; Institute of Clinical Medicine Research of Bucheon St. Mary's Hospital, Research Fund; National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2014R1A2A2A01004325]; Korea Health Industry Development Institute - Ministry of Health and Welfare [HI14C3228]	Catholic Medical Center Research Foundation; Institute of Clinical Medicine Research of Bucheon St. Mary's Hospital, Research Fund; National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Korea Health Industry Development Institute - Ministry of Health and Welfare	The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2014, the Institute of Clinical Medicine Research of Bucheon St. Mary's Hospital, Research Fund, 2015 and the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, and Future Planning (2014R1A2A2A01004325), and the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare (HI14C3228). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auletta JJ, 2012, BLOOD, V119, P1801, DOI 10.1182/blood-2011-10-384354; Berger G, 2003, LARYNGOSCOPE, V113, P1192, DOI 10.1097/00005537-200307000-00015; Businco LD, 2014, AM J RHINOL ALLERGY, V28, P164, DOI 10.2500/ajra.2014.28.3990; Cho KS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/436476; Deenadayal DS, 2014, INDIAN J OTOLARYNGOL, V66, pS231, DOI 10.1007/s12070-011-0445-x; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Egeli E, 2004, LARYNGOSCOPE, V114, P113, DOI 10.1097/00005537-200401000-00020; Fransson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-100; Gao ZW, 2010, APPL CLIN GENET, V3, P109, DOI 10.2147/TACG.S8380; Hwang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101558; Hwang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074330; Hwang SH, 2012, OTOLARYNG HEAD NECK, V147, P568, DOI 10.1177/0194599812447172; Hwang SH, 2011, TISSUE ENG REGEN MED, V8, P544; Hwang SH, 2011, TISSUE ENG REGEN MED, V8, P536; Kafle P, 2007, Kathmandu Univ Med J (KUMJ), V5, P501; Kim SW, 2008, OTOLARYNG HEAD NECK, V139, P143, DOI 10.1016/j.otohns.2008.04.015; Leong SC, 2010, CURR OPIN OTOLARYNGO, V18, P54, DOI 10.1097/MOO.0b013e328334db14; Liu YC, 2014, BIOSCI TRENDS, V8, P138, DOI 10.5582/bst.2014.01047; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Makihara S, 2014, ALLERGY RHINOL, V5, pE22, DOI 10.2500/ar.2014.5.0078; Najar M, 2012, STEM CELL REV REP, V8, P1188, DOI 10.1007/s12015-012-9408-1; PAWANKAR RU, 1995, AM J RESP CRIT CARE, V152, P2049, DOI 10.1164/ajrccm.152.6.8520775; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Renkonen J, 2015, APMIS, V123, P716, DOI 10.1111/apm.12408; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wei HQ, 2014, ULTRASOUND MED BIOL, V40, P2425, DOI 10.1016/j.ultrasmedbio.2014.05.016; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138041	10.1371/journal.pone.0138041	http://dx.doi.org/10.1371/journal.pone.0138041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376485	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200072
J	Kudo, N; Arai, Y; Suhara, Y; Ishii, T; Nakayama, T; Osakabe, N				Kudo, Naoto; Arai, Yasunori; Suhara, Yoshitomo; Ishii, Takeshi; Nakayama, Tsutomu; Osakabe, Naomi			A Single Oral Administration of Theaflavins Increases Energy Expenditure and the Expression of Metabolic Genes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DIETARY POLYPHENOLS; BLACK TEA; PROANTHOCYANIDINS; FLAVAN-3-OLS; CHOLESTEROL; CATECHINS; REDUCE; LEAVES; MICE	Theaflavins are polyphenols found in black tea, whose physiological activities are not well understood. This study on mice evaluated the influence of a single oral administration of theaflavins on energy metabolism by monitoring the initial metabolic changess in skeletal muscle and brown adipose tissue (BAT). Oxygen consumption (VO2) and energy expenditure (EE) were increased significantly in mice treated with theaflavin rich fraction (TF) compared with the group administered vehicle alone. There was no difference in locomotor activity. Fasting mice were euthanized under anesthesia before and 2 and 5, 20-hr after treatment with TF or vehicle. The mRNA levels of uncoupling protein-1 (UCP-1) and peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) in BAT were increased significantly 2-hr after administration ofTF. The levels of UCP-3 and PGC-1 alpha in the gastrocnemius muscle were increased significantly 2 and 5-hr after administration of TF. The concentration of phosphorylated AMP-activated protein kinase (AMPK) 1 alpha was also increased significantly in the gastrocnemius 2 and 5-hr after treatment with TF. These results indicate that TF significantly enhances systemic energy expenditure, as evidenced by an increase in expression of metabolic genes.	[Kudo, Naoto; Arai, Yasunori; Suhara, Yoshitomo; Osakabe, Naomi] Shibaura Inst Technol, Dept Biosci & Engn, Munuma Ku, Saitama 3378570, Japan; [Ishii, Takeshi] Univ Shizuoka, Dept Food & Nutr Sci, Suruga Ku, Shizuoka 4228526, Japan; [Nakayama, Tsutomu] Nippon Vet & Life Sci Univ, Sch Food Sci & Technol, Tokyo 1808602, Japan	Shibaura Institute of Technology; University of Shizuoka; Nippon Veterinary & Life Science University	Osakabe, N (corresponding author), Shibaura Inst Technol, Dept Biosci & Engn, Munuma Ku, 307 Fukasaku, Saitama 3378570, Japan.	nao-osa@sic.shibaura-it.ac.jp		Suhara, Yoshitomo/0000-0002-4770-2910	Japan Science and Technology Agency (JST) under the Broader Collaboration of Regional Entities for the Advancement of Technological Excellence (CREATE) Program; National Agriculture and Food Research Organization (NARO); Grant of Cross-Ministerial Strategic Innovation Promotion Program (SIP), Council for Science, Technology and Innovation, Cabinet Office, Government of Japan	Japan Science and Technology Agency (JST) under the Broader Collaboration of Regional Entities for the Advancement of Technological Excellence (CREATE) Program; National Agriculture and Food Research Organization (NARO); Grant of Cross-Ministerial Strategic Innovation Promotion Program (SIP), Council for Science, Technology and Innovation, Cabinet Office, Government of Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Science and Technology Agency (JST) under the Broader Collaboration of Regional Entities for the Advancement of Technological Excellence (CREATE) Program, the Research Project on Development of Agricultural Products and Foods with Health-promoting Benefits from the National Agriculture and Food Research Organization (NARO), and the Grant of Cross-Ministerial Strategic Innovation Promotion Program (SIP), Council for Science, Technology and Innovation, Cabinet Office, Government of Japan. CREAT: http://www.shizuoka-tiikikesshu.jp/outline/index.html. SIP: http://www8.cao.go.jp/cstp/gaiyo/sip/. NARO: http://www.naro.affrc.go.jp/project/f_foodpro/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braicu C, 2013, FOOD CHEM, V141, P3282, DOI 10.1016/j.foodchem.2013.05.122; Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024; Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j; Hartley L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009934.pub2; Haslam E, 2003, PHYTOCHEMISTRY, V64, P61, DOI 10.1016/S0031-9422(03)00355-8; Islam Mohammed A, 2012, Recent Pat Cardiovasc Drug Discov, V7, P88; Li SM, 2013, FOOD FUNCT, V4, P10, DOI 10.1039/c2fo30093a; Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Maron DJ, 2003, ARCH INTERN MED, V163, P1448, DOI 10.1001/archinte.163.12.1448; Matsumura Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112180; Matsuura K, 2014, J CLIN BIOCHEM NUTR, V55, P103, DOI 10.3164/jcbn.13-101; Miyata Y, 2013, J AGR FOOD CHEM, V61, P9366, DOI 10.1021/jf400123y; Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231; Neilson AP, 2006, J CHROMATOGR A, V1132, P132, DOI 10.1016/j.chroma.2006.07.059; Nishimura M, 2007, J AGR FOOD CHEM, V55, P7252, DOI 10.1021/jf070312m; Sanchez AMJ, 2012, AM J PHYSIOL-CELL PH, V303, pC475, DOI 10.1152/ajpcell.00125.2012; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Santesso Nancy, 2014, Glob Adv Health Med, V3, P66, DOI 10.7453/gahmj.2014.003; Sawada K, 2014, MOL CELL ENDOCRINOL, V393, P99, DOI 10.1016/j.mce.2014.06.009; Tamaru S, 2013, J AGR FOOD CHEM, V61, P5817, DOI 10.1021/jf400938h; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; Torronen R, 2013, J NUTR, V143, P430, DOI 10.3945/jn.112.169771; Vermeer MA, 2008, J AGR FOOD CHEM, V56, P12031, DOI 10.1021/jf8022035; Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9; Vogiatzoglou A, 2014, BRIT J NUTR, V111, P1463, DOI 10.1017/S0007114513003930; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1090, DOI [10.1017/S0007114511001437, 10.1017/S0007114511006386]	28	29	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137809	10.1371/journal.pone.0137809	http://dx.doi.org/10.1371/journal.pone.0137809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375960	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200054
J	Ragavan, ND; Kumar, S; Chye, TT; Mahadeva, S; Shiaw-Hooi, H				Ragavan, Nanthiney Devi; Kumar, Suresh; Chye, Tan Tian; Mahadeva, Sanjiv; Shiaw-Hooi, Ho			Blastocystis sp. in Irritable Bowel Syndrome (IBS) - Detection in Stool Aspirates during Colonoscopy	PLOS ONE			English	Article							HOMINIS; CLASSIFICATION; RELEVANCE	Blastocystis is one of the most common gut parasites found in the intestinal tract of humans and animals. Its' association with IBS is controversial, possibly as a result of irregular shedding of parasites in stool and variation in stool detection. We aimed to screen for Blastocystis in colonic stool aspirate samples in adult patients with and without IBS undergoing colonoscopy for various indications and measure the interleukin levels (IL-8, IL-3 and IL-5). In addition to standard stool culture techniques, polymerase chain reaction (PCR) techniques were employed to detect and subtype Blastocystis. All the serum samples collected were subjected for ELISA studies to measure the interleukin levels (IL-8, IL-3 and IL-5). Among 109 (IBS n = 35 and non-IBS n = 74) adults, direct stool examination and culture of colonic aspirates were initially negative for Blastocystis. However, PCR analysis detected Blastocystis in 6 (17%) IBS and 4 (5.5%) non-IBS patients. In the six positive IBS patients by PCR method, subtype 3 was shown to be the most predominant (3/6: 50%) followed by subtype 4 (2/6; 33.3%) and subtype 5 (1/6; 16.6%). IL-8 levels were significantly elevated in the IBS Blasto group and IBS group (p<0.05) compared to non-IBS and non-IBS Blasto group. The level of IL-3 in were seen to be significantly higher in than IBS Blasto group and IBS group (p<0.05) compared to non-IBS. Meanwhile, the IL-5 levels were significantly higher in IBS Blasto group (p<0.05) compared to non-IBS and non-IBS Blasto group. This study implicates that detecting Blastosystis by PCR method using colonic aspirate samples during colonoscopy, suggests that this may be a better method for sample collection due to the parasite's irregular shedding in Blastocystis-infected stools. Patients with IBS infected with parasite showed an increase in the interleukin levels demonstrate that Blastocystis does have an effect in the immune system.	[Ragavan, Nanthiney Devi; Kumar, Suresh; Chye, Tan Tian] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia; [Mahadeva, Sanjiv; Shiaw-Hooi, Ho] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Kumar, S (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia.	suresh@um.edu.my	TAN, TIAN CHYE/B-9920-2010; Mahadeva, Sanjiv/E-1711-2011; Ho, Shiaw-Hooi/B-1606-2017	Mahadeva, Sanjiv/0000-0001-5824-0590; Ho, Shiaw-Hooi/0000-0003-4992-7627	High Impact Research (HIR) [UM.C/625/1/HIR/044]; Postgraduate Research Grant (PPP) [PG108-2012B]	High Impact Research (HIR); Postgraduate Research Grant (PPP)	The study would not have been possible without the support of High Impact Research (HIR) grant UM.C/625/1/HIR/044 and Postgraduate Research Grant (PPP) PG108-2012B.	Al Funda Dogruman, 2007, Turkiye Parazitoloji Dergisi, V31, P28; Chan KH, 2012, PARASITOL RES, V110, P2475, DOI 10.1007/s00436-011-2788-3; Chandramathi S, 2010, PARASITOL RES, V106, P1459, DOI 10.1007/s00436-010-1825-y; Chandramathi S, 2010, PARASITOLOGY, V137, P605, DOI 10.1017/S0031182009991351; Chandramathi S, 2012, T ROY SOC TROP MED H, V106, P267, DOI 10.1016/j.trstmh.2011.12.008; Chandramathi S, 2010, PARASITOL RES, V106, P941, DOI 10.1007/s00436-010-1764-7; Graczyk TK, 2005, PARASITOL RES, V98, P38, DOI 10.1007/s00436-005-0003-0; Gwee KA, 2003, GUT, V52, P523, DOI 10.1136/gut.52.4.523; Gwee KA, 2005, NEUROGASTROENT MOTIL, V17, P1; Jones MS, 2009, PARASITOL RES, V104, P341, DOI 10.1007/s00436-008-1198-7; Kollmar O, 2006, WORLD J GASTROENTERO, V12, P858, DOI 10.3748/wjg.v12.i6.858; Kumarasamy V, 2013, PARASITOL RES, V112, P3551, DOI 10.1007/s00436-013-3538-5; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; NANTHINEY DR, 2014, J PARASITES VECTORS, V7, P404; Oppenheim JJ, 2010, MED IMMUNOLOGY, P148; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Simren M, 2006, CLIN GASTROENTEROL H, V4, P187, DOI 10.1016/S1542-3565(05)00981-X; Singh BN, 2009, GLYCOCONJUGATE J, V26, P3, DOI 10.1007/s10719-008-9157-1; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Surangsrirat Surapon, 2010, J Med Assoc Thai, V93 Suppl 6, pS119; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan TC, 2007, PARASITOL RES, V101, P1521, DOI 10.1007/s00436-007-0670-0; Tungtrongchitr Anchalee, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P705; van Gool T, 2003, EUR J CLIN MICROBIOL, V22, P284, DOI 10.1007/s10096-003-0919-1; Vennila GD, 1999, PARASITOL RES, V85, P162, DOI 10.1007/s004360050528; WINDSOR JJ, 2007, BRIT J BIOMED SCI, V64, P524; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Yan YM, 2006, PARASITOL RES, V99, P597, DOI 10.1007/s00436-006-0186-z; Yoshikawa H, 2004, PARASITOL RES, V92, P22, DOI 10.1007/s00436-003-0995-2	29	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0121173	10.1371/journal.pone.0121173	http://dx.doi.org/10.1371/journal.pone.0121173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375823	Green Published, gold			2022-12-26	WOS:000361610200001
J	Seemann, S; Lupp, A				Seemann, Semjon; Lupp, Amelie			Administration of a CXCL12 Analog in Endotoxemia Is Associated with Anti-Inflammatory, Anti- Oxidative and Cytoprotective Effects In Vivo	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; CELL-DERIVED FACTOR-1; NECROSIS-FACTOR-ALPHA; NADPH OXIDASE; LIPOPOLYSACCHARIDE INHIBITION; HEPATIC CYTOCHROME-P-450; SENSITIVE ASSAY; GLUTATHIONE; EXPRESSION; CXCR4	Background The chemokine receptor CXCR4 is a multifunctional receptor which is activated by its natural ligand C-X-C motif chemokine 12 (CXCL12). As CXCR4 is part of the lipopolysaccharide sensing complex and CXCL12 analogs are not well characterized in inflammation, we aimed to uncover the systemic effects of a CXCL12 analog in severe systemic inflammation and to evaluate its impact on endotoxin induced organ damages by using a sublethal LPS dose. Methods The plasma stable CXCL12 analog CTCE-0214D was synthesized and administered subcutaneously shortly before LPS treatment. After 24 hours, mice were sacrificed and blood was obtained for TNF alpha, IFN gamma and blood glucose evaluation. Oxidative stress in the liver and spleen was assessed and liver biotransformation capacity was determined. Finally, CXCR4, CXCL12 and TLR4 expression patterns in liver, spleen and thymus tissue as well as the presence of different markers for apoptosis and oxidative stress were determined by means of immunohistochemistry. Results CTCE-0214D distinctly reduced the LPS mediated effects on TNF alpha, IFN gamma, ALAT and blood glucose levels. It attenuated oxidative stress in the liver and spleen tissue and enhanced liver biotransformation capacity unambiguously. Furthermore, in all three organs investigated, CTCE-0214D diminished the LPS induced expression of CXCR4, CXCL12, TLR4, NF-.B, cleaved caspase-3 and gp91 phox, whereas heme oxygenase 1 expression and activity was induced above average. Additionally, TUNEL staining revealed anti-apoptotic effects of CTCE-0214D. Conclusions In summary, CTCE-0214D displayed anti-inflammatory, anti-oxidative and cytoprotective features. It attenuated reactive oxygen species, induced heme oxygenase 1 activity and mitigated apoptosis. Thus, the CXCR4/CXCL12 axis seems to be a promising target in the treatment of acute systemic inflammation, especially when accompanied by a hepatic dysfunction and an excessive production of free radicals.	[Seemann, Semjon; Lupp, Amelie] Univ Jena, Jena Univ Hosp, Inst Pharmacol & Toxicol, Jena, Germany	Friedrich Schiller University of Jena	Seemann, S (corresponding author), Univ Jena, Jena Univ Hosp, Inst Pharmacol & Toxicol, Jena, Germany.	semjon.seemann@yahoo.com						AITIO A, 1978, ANAL BIOCHEM, V85, P488, DOI 10.1016/0003-2697(78)90245-2; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Bach HH, 2012, MOL MED, V18, P1056, DOI 10.2119/molmed.2011.00497; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; CASTELEIJN E, 1988, J BIOL CHEM, V263, P6953; Chang Thomas K H, 2006, Methods Mol Biol, V320, P127; Choi SH, 1998, BIOCHEM PHARMACOL, V56, P1427, DOI 10.1016/S0006-2952(98)00204-4; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Dalton TP, 2004, FREE RADICAL BIO MED, V37, P1511, DOI 10.1016/j.freeradbiomed.2004.06.040; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; De Cruz Sharon J, 2009, Expert Rev Respir Med, V3, P511, DOI 10.1586/ers.09.39; Delano MJ, 2011, J IMMUNOL, V187, P911, DOI 10.4049/jimmunol.1100588; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fan HK, 2014, AM J RESP CRIT CARE, V189, P1509, DOI 10.1164/rccm.201312-2163OC; Fan HK, 2012, INFLAMMATION, V35, P130, DOI 10.1007/s10753-011-9297-5; Garnica MR, 2002, IMMUNOL LETT, V83, P47, DOI 10.1016/S0165-2478(02)00067-6; Glawe JD, 2013, DIABETOLOGIA, V56, P2222, DOI 10.1007/s00125-013-2978-x; Gonnert FA, 2011, J SURG RES, V170, pE123, DOI 10.1016/j.jss.2011.05.019; Guan SW, 2015, IMMUNOLOGY, V144, P405, DOI 10.1111/imm.12382; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Huang XQ, 2003, BIOPHYS J, V84, P171, DOI 10.1016/S0006-3495(03)74840-1; Jacob A, 2009, INT J CLIN EXP MED, V2, P203; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kishore SP, 2005, FEBS LETT, V579, P699, DOI 10.1016/j.febslet.2004.12.047; KLEEBERG U, 1982, J PHARMACOL METHOD, V8, P19, DOI 10.1016/0160-5402(82)90004-3; KLINGER W, 1974, Z VERSUCHSTIERKD, V16, P149; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; LUBET RA, 1985, ARCH BIOCHEM BIOPHYS, V238, P43, DOI 10.1016/0003-9861(85)90138-9; Lupp A, 2001, TOXICOLOGY, V161, P53, DOI 10.1016/S0300-483X(01)00333-X; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; MCMANUS JFA, 1948, STAIN TECHNOL, V23, P99, DOI 10.3109/10520294809106232; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Muyderman H, 2007, J NEUROCHEM, V102, P1369, DOI 10.1111/j.1471-4159.2007.04641.x; Nanki T, 2001, CELL IMMUNOL, V214, P145, DOI 10.1006/cimm.2001.1890; Novoa B, 2009, FISH SHELLFISH IMMUN, V26, P326, DOI 10.1016/j.fsi.2008.12.004; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Perez LE, 2004, EXP HEMATOL, V32, P300, DOI 10.1016/j.exphem.2003.12.005; POHL RJ, 1980, ANAL BIOCHEM, V107, P150, DOI 10.1016/0003-2697(80)90505-9; Raetzsch CF, 2009, HEPATOLOGY, V50, P592, DOI 10.1002/hep.22999; Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12; SHOJI Y, 1995, IMMUNOLOGY, V84, P543; Tamamura H, 2004, FEBS LETT, V569, P99, DOI 10.1016/j.febslet.2004.05.056; Tamion F, 2006, J TRAUMA, V61, P1078, DOI 10.1097/01.ta.0000239359.41464.ef; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2008, EUR J IMMUNOL, V38, P192, DOI 10.1002/eji.200636821; Tunc T, 2014, J MATERN-FETAL NEO M, V22, P1; Vabulas RM, 2002, CURR TOP MICROBIOL, V270, P169; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Xu L, 2013, MOL BIOSYST, V9, P2107, DOI 10.1039/c3mb70120d; YAGI T, 1987, MUTAT RES, V184, P223, DOI 10.1016/0167-8817(87)90020-4; Yan ZQ, 2006, ARTERIOSCL THROM VAS, V26, P2582, DOI 10.1161/01.ATV.0000250933.92917.dd; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; YOSHIDA T, 1974, FEBS LETT, V48, P256, DOI 10.1016/0014-5793(74)80481-3; Zhou M, 2008, INT J MOL MED, V21, P423	63	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138389	10.1371/journal.pone.0138389	http://dx.doi.org/10.1371/journal.pone.0138389			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375818	gold, Green Submitted, Green Published			2022-12-26	WOS:000361610200105
J	Chen, F; Zhang, XF; Zhang, N; Wang, SS; Yin, GH; Dong, ZD; Cui, DQ				Chen, Feng; Zhang, Xiangfen; Zhang, Ning; Wang, Shasha; Yin, Guihong; Dong, Zhongdong; Cui, Dangqun			Combined Small RNA and Degradome Sequencing Reveals Novel MiRNAs and Their Targets in the High-Yield Mutant Wheat Strain Yunong 3114	PLOS ONE			English	Article							MICRORNA REGULATION; PLANT MICRORNAS; GENE-EXPRESSION; MESSENGER-RNA; ARABIDOPSIS-THALIANA; FLOWERING TIME; IDENTIFICATION; STRESS; ARCHITECTURE; RESPONSES	Wheat is one of the main food sources worldwide; large amount studies have been conducted to improve wheat production. MicroRNAs (miRNAs) with about 20-30 nucleotide are a class of regulatory small RNAs (sRNAs), which could regulate gene expression through sequence-specific base pairing with target mRNAs, playing important roles in plant growth. An ideal plant architecture (IPA) is crucial to enhance yield in bread wheat. In this study, the high-yield wheat strain Yunong 3114 was EMS-mutagenesis from the wild-type strain Yunong 201, exhibiting a preferable plant structure compared with the wild-type strain. We constructed small RNA and degradome libraries from Yunong 201 and Yunong 3114, and performed small RNA sequencing of these libraries in order identify miRNAs and their targets related to IPA in wheat. Totally, we identified 488 known and 837 novel miRNAs from Yunong 3114 and 391 known and 533 novel miRNAs from Yunong 201. The number of miRNAs in the mutant increased. A total of 37 known and 432 putative novel miRNAs were specifically expressed in the mutant strain; furthermore, 23 known and 159 putative novel miRNAs were specifically expressed in the wild-type strain. A total of 150 known and 100 novel miRNAs were differentially expressed between mutant and wild-type strains. Among these differentially expressed novel miRNAs, 4 and 8 predict novel miRNAs were evidenced by degradome sequencing and showed up-regulated and down-regulated expressions in the mutant strain Yunong 3114, respectively. Targeted gene annotation and previous results indicated that this set of miRNAs is related to plant structure. Our results further suggested that miRNAs may be necessary to obtain an optimal wheat structure.	[Chen, Feng; Zhang, Xiangfen; Zhang, Ning; Wang, Shasha; Dong, Zhongdong; Cui, Dangqun] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Collaborat Innovat Ctr Henan Grain Crops, Agron Coll, Zhengzhou, Peoples R China; [Yin, Guihong] Zhoukou Acad Agr Sci, Zhoukou, Peoples R China	Henan Agricultural University	Chen, F (corresponding author), Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Collaborat Innovat Ctr Henan Grain Crops, Agron Coll, Zhengzhou, Peoples R China.	chf0088@163.com; cdq62@sohu.com			973 project [2014CB138105, 2014CB160303]; National Natural Science Foundation [31370031]; Program for New Century Excellent Talents in University in the University of China [NCET-13-0776]	973 project(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University in the University of China(Program for New Century Excellent Talents in University (NCET))	This project was funded by the 973 project (2014CB138105 and 2014CB160303), the National Natural Science Foundation (31370031), and the Program for New Century Excellent Talents in University (NCET-13-0776) in the University of China.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Curaba J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-120; Feng H, 2014, MOL PLANT PATHOL, V15, P284, DOI 10.1111/mpp.12089; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gutierrez L, 2012, PLANT CELL, V24, P2515, DOI 10.1105/tpc.112.099119; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jover-Gil S, 2005, INT J DEV BIOL, V49, P733, DOI 10.1387/ijdb.052015sj; Kang MM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-360; Kato Y, 2004, PLANTA, V220, P97, DOI 10.1007/s00425-004-1328-0; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kurtoglu KY, 2014, FUNCT INTEGR GENOMIC, V14, P363, DOI 10.1007/s10142-013-0357-9; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Li YF, 2013, PLANT SCI, V203, P17, DOI 10.1016/j.plantsci.2012.12.014; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZF, 2013, PLANT CELL, V25, P3743, DOI 10.1105/tpc.113.113639; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Malone Colin, 2012, Cold Spring Harb Protoc, V2012, P1067, DOI 10.1101/pdb.prot071431; Meng FR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-140; Meng YJ, 2013, NEW PHYTOL, V197, P441, DOI 10.1111/nph.12018; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Nakano T, 1997, PLANT CELL, V9, P1673, DOI 10.1105/tpc.9.9.1673; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pandey B, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23932; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Pei HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064290; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Shao CG, 2013, GENE, V515, P123, DOI 10.1016/j.gene.2012.11.015; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tang Hai-Ming, 2012, Yichuan, V34, P784, DOI 10.3724/SP.J.1005.2012.00784; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Vidal EA, 2010, WIRES SYST BIOL MED, V2, P683, DOI 10.1002/wsbm.87; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wang YH, 2005, PLANT MOL BIOL, V59, P75, DOI 10.1007/s11103-004-4038-x; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048445; Wang Y, 2012, NEW PHYTOL, V196, P914, DOI 10.1111/j.1469-8137.2012.04304.x; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yamaguchi K, 2003, EUR J BIOCHEM, V270, P190, DOI 10.1046/j.1432-1033.2003.03359.x; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032; Yuan C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-511; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81; Zhao YP, 2013, ANN BOT-LONDON, V112, P633, DOI 10.1093/aob/mct133; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhu C, 2011, PHYSIOL PLANTARUM, V143, P1, DOI 10.1111/j.1399-3054.2011.01477.x; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	76	10	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137773	10.1371/journal.pone.0137773	http://dx.doi.org/10.1371/journal.pone.0137773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372220	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400030
J	Scherzer, MT; Waigel, S; Donninger, H; Arumugam, V; Zacharias, W; Clark, G; Siskind, LJ; Soucy, P; Beverly, L				Scherzer, Michael T.; Waigel, Sabine; Donninger, Howard; Arumugam, Vennila; Zacharias, Wolfgang; Clark, Geoffrey; Siskind, Leah J.; Soucy, Patricia; Beverly, Levi			Fibroblast-Derived Extracellular Matrices: An Alternative Cell Culture System That Increases Metastatic Cellular Properties	PLOS ONE			English	Article							LUNG-CANCER; TUMOR PROGRESSION; GROWTH; COMPLEMENT; THERAPY	Poor survival rates from lung cancer can largely be attributed to metastatic cells that invade and spread throughout the body. The tumor microenvironment (TME) is composed of multiple cell types, as well as non-cellular components. The TME plays a critical role in the development of metastatic cancers by providing migratory cues and changing the properties of the tumor cells. The Extracellular Matrix (ECM), a main component of the TME, has been shown to change composition during tumor progression, contributing to cancer cell invasion and survival away from the primary cancer site. Although the ECM is well-known to influence the fate of tumor progression, little is known about the molecular mechanisms that are affected by the cancer cell-ECM interactions. It is imperative that these mechanisms are elucidated in order to properly understand and prevent lung cancer dissemination. However, common in vitro studies do not incorporate these interactions into everyday cell culture assays. We have adopted a model that examines decellularized human fibroblast-derived ECM as a 3-dimensional substrate for growth of lung adenocarcinoma cell lines. Here, we have characterized the effect of fibroblast-derived matrices on the properties of various lung-derived epithelial cell lines, including cancerous and non-transformed cells. This work highlights the significance of the cell-ECM interaction and its requirement for incorporation into in vitro experiments. Implementation of a fibroblast-derived ECM as an in vitro technique will provide researchers with an important factor to manipulate to better recreate and study the TME.	[Scherzer, Michael T.; Waigel, Sabine; Donninger, Howard; Arumugam, Vennila; Zacharias, Wolfgang; Clark, Geoffrey; Siskind, Leah J.; Beverly, Levi] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Scherzer, Michael T.; Soucy, Patricia; Beverly, Levi] Univ Louisville, Dept Bioengn, Louisville, KY 40202 USA; [Donninger, Howard; Zacharias, Wolfgang; Beverly, Levi] Univ Louisville, Dept Med, Louisville, KY 40202 USA; [Zacharias, Wolfgang; Clark, Geoffrey; Siskind, Leah J.; Beverly, Levi] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Beverly, L (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA.	Levi.Beverly@Louisville.edu	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660; Siskind, Leah/0000-0001-5026-5187	National Institutes of Health, National Institute of General Medicine [1P30GM106396]; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01DK093462]; National Institutes of Health, National Cancer Institute [R01CA133171, R01CA193220]; NATIONAL CANCER INSTITUTE [R01CA193220, R01CA133171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WZ was supported by National Institutes of Health, National Institute of General Medicine, #1P30GM106396; LJS by National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, #R01DK093462; GC by National Institutes of Health, National Cancer Institute, #R01CA133171; LJB by National Institutes of Health, National Cancer Institute, #R01CA193220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, NONSM CELL LUNG CANC; Blaauboer ME, 2014, MATRIX BIOL, V34, P170, DOI 10.1016/j.matbio.2013.11.002; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Caccavari F, 2010, CELL ADHES MIGR, V4, P124, DOI 10.4161/cam.4.1.10976; Copland IB, 2007, J CELL PHYSIOL, V210, P133, DOI 10.1002/jcp.20840; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Hadler-Olsen E, 2013, TUMOR BIOL, V34, P2041, DOI 10.1007/s13277-013-0842-8; Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; IHDE DC, 1992, NEW ENGL J MED, V327, P1434; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Oskarsson T, 2013, BREAST, V22, pS66, DOI 10.1016/j.breast.2013.07.012; Pasqualato A, 2013, CELL ADHES MIGR, V7, P450, DOI 10.4161/cam.26765; Pio R, 2014, ADV EXP MED BIOL, V772, P229, DOI 10.1007/978-1-4614-5915-6_11; Pio R, 2013, SEMIN IMMUNOL, V25, P54, DOI 10.1016/j.smim.2013.04.001; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Soucy PA, 2015, ACTA BIOMATER, V11, P264, DOI 10.1016/j.actbio.2014.08.037; Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005; Xiao Dakai, 2010, J Thorac Dis, V2, P154, DOI 10.3978/j.issn.2072-1439.2010.02.03.7; Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764	27	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138065	10.1371/journal.pone.0138065	http://dx.doi.org/10.1371/journal.pone.0138065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371754	Green Submitted, gold, Green Published			2022-12-26	WOS:000361604400046
J	Barden, HE; Behnsen, J; Bergmann, U; Leng, MJ; Manning, PL; Withers, PJ; Wogelius, RA; van Dongen, BE				Barden, Holly E.; Behnsen, Julia; Bergmann, Uwe; Leng, Melanie J.; Manning, Phillip L.; Withers, Philip J.; Wogelius, Roy A.; van Dongen, Bart E.			Geochemical Evidence of the Seasonality, Affinity and Pigmenation of Solenopora jurassica	PLOS ONE			English	Article							ISOTOPIC DISEQUILIBRIUM; GROWTH BANDS; RED; GLOUCESTERSHIRE	Solenopora jurassica is a fossil calcareous alga that functioned as an important reef-building organism during the Palaeozoic. It is of significant palaeobiological interest due to its distinctive but poorly understood pink and white banding. Though widely accepted as an alga there is still debate over its taxonomic affinity, with recent work arguing that it should be reclassified as a chaetetid sponge. The banding is thought to be seasonal, but there is no conclusive evidence for this. Other recent work has, however demonstrated the presence of a unique organic boron-containing pink/red pigment in the pink bands of S. jurassica. We present new geochemical evidence concerning the seasonality and pigmentation of S. jurassica. Seasonal growth cycles are demonstrated by X-ray radiography, which shows differences in calcite density, and by varying delta C-13 composition of the bands. Temperature variation in the bands is difficult to constrain accurately due to conflicting patterns arising from Mg/Ca molar ratios and delta O-18 data. Fluctuating chlorine levels indicate increased salinity in the white bands, when combined with the isotope data this suggests more suggestive of marine conditions during formation of the white band and a greater freshwater component (lower chlorinity) during pink band precipitation (delta O-18). Increased photosynthesis is inferred within the pink bands in comparison to the white, based on delta C-13. Pyrolysis Gas Chromatography Mass Spectrometry (Py-GCMS) and Fourier Transform Infrared Spectroscopy (FTIR) show the presence of tetramethyl pyrrole, protein moieties and carboxylic acid groups, suggestive of the presence of the red algal pigment phycoerythrin. This is consistent with the pink colour of S. jurassica. As phycoerythrin is only known to occur in algae and cyanobacteria, and no biomarker evidence of bacteria or sponges was detected we conclude S. jurassica is most likely an alga. Pigment analysis may be a reliable classification method for fossil algae.	[Barden, Holly E.; Manning, Phillip L.; Wogelius, Roy A.; van Dongen, Bart E.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England; [Behnsen, Julia; Withers, Philip J.] Univ Manchester, Sch Mat Sci, Manchester M13 9PL, Lancs, England; [Bergmann, Uwe] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Leng, Melanie J.] British Geol Survey, NERC Isotope Geosci Facil, Keyworth NG12 5GG, Notts, England; [Leng, Melanie J.] Univ Nottingham, Sch Geog, Ctr Environm Geochem, Nottingham NG7 2RD, England	University of Manchester; University of Manchester; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Nottingham	Barden, HE (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England.	holly.barden@manchester.ac.uk	Manning, Phillip/F-9966-2011; Wogelius, Roy/C-4917-2008; Withers, Phil/A-6760-2009	Manning, Phillip/0000-0002-7161-6246; Withers, Phil/0000-0002-1946-5647; van Dongen, Bart/0000-0003-1189-142X; Leng, Melanie/0000-0003-1115-5166	Natural Environment Research Council (NERC); Engineering and Physical Sciences Research Council for the Henry Moseley X-ray Imaging Facility [EP/F007906/1, EP/F028431/1, EP/F001452, EP/I02249X]; Engineering and Physical Sciences Research Council [EP/J021229/1, EP/M010619/1, EP/F007906/1, EP/F028431/1] Funding Source: researchfish; Natural Environment Research Council [nigl010001, NE/J023426/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/M001814/1] Funding Source: researchfish; EPSRC [EP/F028431/1, EP/F007906/1, EP/M010619/1, EP/J021229/1] Funding Source: UKRI; NERC [NE/J023426/1, nigl010001] Funding Source: UKRI; STFC [ST/M001814/1] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council for the Henry Moseley X-ray Imaging Facility(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	A Natural Environment Research Council (NERC, http://www.nerc.ac.uk/) PhD studentship funded HEB to complete the work as part of her PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge funding from the Engineering and Physical Sciences Research Council for the Henry Moseley X-ray Imaging Facility under EP/F007906/1, EP/F028431/1, EP/F001452 and EP/I02249X (http://www.epsrc.ac.uk/).	Barnes DJ, 1996, GLOBAL CHANGE BIOL, V2, P569, DOI 10.1111/j.1365-2486.1996.tb00068.x; Brown A, 1894, GEOL MAG, V1, P145, DOI 10.1017/S0016756800140762; CHAPMAN DJ, 1967, J AM CHEM SOC, V89, P5976, DOI 10.1021/ja00999a058; Craig H., 1965, STABLE ISOTOPES OCEA, P161; DODGE RE, 1974, EARTH PLANET SC LETT, V23, P313, DOI 10.1016/0012-821X(74)90121-6; Edwards NP, 2014, METALLOMICS, V6, P774, DOI 10.1039/c3mt00242j; EMRY RJ, 1973, SMITHSONIAN CONTRIBU, V18, P1, DOI DOI 10.5479/SI.00810266.18.1; Faulk H, 1994, MIKROCHIM ACTA, V117, P1, DOI [10.1007/BF01243010, DOI 10.1007/BF01243010]; Ferguson JE, 2008, EARTH PLANET SC LETT, V265, P153, DOI 10.1016/j.epsl.2007.10.011; FICNER R, 1993, EUR J BIOCHEM, V218, P103, DOI 10.1111/j.1432-1033.1993.tb18356.x; Fujiwara BYT, 1936, J BIOCH, V43, P195; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gornitz V, 2009, ENCY PALEOCLIMATOLOG, P719; Gupta NS, 2007, ORG GEOCHEM, V38, P499, DOI 10.1016/j.orggeochem.2006.06.011; HARLAND TL, 1982, PALAEONTOLOGY, V25, P905; Insalaco E, 1996, PALAEONTOLOGY, V39, P413; KLEIN R, 1990, NATURE, V345, P145, DOI 10.1038/345145a0; KLEIN R, 1992, MAR BIOL, V112, P259, DOI 10.1007/BF00702470; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; KOLESAR PT, 1978, J SEDIMENT PETROL, V48, P815; Lear CH, 2002, GEOCHIM COSMOCHIM AC, V66, P3375, DOI 10.1016/S0016-7037(02)00941-9; Lee D, 2001, CHEM GEOL, V172, P307, DOI 10.1016/S0009-2541(00)00258-8; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; McConnaughey TA, 2008, GEO-MAR LETT, V28, P287, DOI 10.1007/s00367-008-0116-4; Peters K.E., 2005, BIOMARKER GUIDE 1, V1; Riding R, 2004, PALAEONTOLOGY, V47, P117, DOI 10.1111/j.0031-0239.2004.00351.x; Russell J.D., 1987, HDB DETERMINATIVE ME, P133; Sharp Z., 2007, PRINCIPLES STABLE IS; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Toole CM, 2003, ADV PHOTO RESPIRAT, V14, P305; WEBER JN, 1975, NATURE, V255, P697, DOI 10.1038/255697a0; Wolkenstein K, 2010, P NATL ACAD SCI USA, V107, P19374, DOI 10.1073/pnas.1007973107; Wray JL, 1977, CALCAREOUS ALGAE, P28; WRIGHT VP, 1985, J PALEONTOL, V59, P721	35	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138305	10.1371/journal.pone.0138305	http://dx.doi.org/10.1371/journal.pone.0138305			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367117	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000361601100248
J	Chen, B; Xu, JG; He, XM; Xu, HP; Li, GH; Du, HL; Nie, QH; Zhang, XQ				Chen, Biao; Xu, Jiguo; He, Xiaomei; Xu, Haiping; Li, Guihuan; Du, Hongli; Nie, Qinghua; Zhang, Xiquan			A Genome-Wide mRNA Screen and Functional Analysis Reveal FOXO3 as a Candidate Gene for Chicken Growth	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; TRANSCRIPTION FACTOR FOXO3A; SKELETAL-MUSCLE; UBIQUITIN LIGASES; EXPRESSION; MYOD; DIFFERENTIATION; IDENTIFICATION; CELLS; ASSOCIATION	Chicken growth performance provides direct economic benefits to the poultry industry. However, the underlying genetic mechanisms are unclear. The objective of this study was to identify candidate genes associated with chicken growth and investigate their potential mechanisms. We used RNA-Seq to study the breast muscle transcriptome in high and low tails of Recessive White Rock (WRRh, WRRl) and Xinghua chickens (XHh, XHl). A total of 60, 23, 153 and 359 differentially expressed genes were detected in WRRh vs. WRRl, XHh vs. XHl, WRRh vs. XHh and WRRl vs. XHl, respectively. GO, KEGG pathway and gene network analyses showed that CEBPB, FBXO32, FOXO3 and MYOD1 played key roles in growth. The functions of FBXO32 and FOXO3 were validated. FBXO32 was predominantly expressed in leg muscle, heart and breast muscle. After decreased FBXO32 expression, growth-related genes such as PDK4, IGF2R and IGF2BP3 were significantly downregulated (P < 0.05). FBXO32 was significantly (P < 0.05) associated with carcass and meat quality traits, but not growth traits. FOXO3 was predominantly expressed in breast and leg muscle. In both of these tissues, the FOXO3 mRNA level in XH was significantly higher than that in WRR chickens with normal body weight (P < 0.05). In DF-1 cells, siRNA knockdown of FOXO3 significantly (P < 0.01) inhibited the MYOD expression and significantly upregulated (P < 0.01 or P < 0.05) the expression of growth- related genes including CEBPB, FBXO32, GH, GHR, IGF1R, IGF2R, IGF2BP1, IGF2BP3, INSR, PDK1 and PDK4. Moreover, 18 SNPs were identified in FOXO3. G66716193A was significantly (P < 0.05) associated with growth traits. The sites C66716002T, C66716195T and A66716179G were significantly (P < 0.05) associated with growth or carcass traits. These results demonstrated that FOXO3 is a candidate gene influencing chicken growth. Our observations provide new clues to understand the molecular basis of chicken growth.	[Chen, Biao; Xu, Jiguo; He, Xiaomei; Xu, Haiping; Li, Guihuan; Nie, Qinghua; Zhang, Xiquan] South China Agr Univ, Dept Anim Genet Breeding & Reprod, Guangzhou 510642, Guangdong, Peoples R China; [Chen, Biao; Xu, Jiguo; He, Xiaomei; Xu, Haiping; Li, Guihuan; Nie, Qinghua; Zhang, Xiquan] Minist Agr, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou 510642, Guangdong, Peoples R China; [Chen, Biao; Xu, Jiguo; He, Xiaomei; Xu, Haiping; Li, Guihuan; Nie, Qinghua; Zhang, Xiquan] Minist Agr, Key Lab Chicken Genet,Breeding & Reprod, Guangzhou 510642, Guangdong, Peoples R China; [Du, Hongli] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China	South China Agricultural University; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; South China University of Technology	Du, HL (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China.	hldu@scut.edu.cn; nqinghua@scau.edu.cn	Chen, Biao/HGC-3146-2022; xu, haiping/GSJ-1374-2022	Chen, Biao/0000-0003-1852-5289; 	National Natural Science Foundation of China [31172200, 31472090]; Program for New Century Excellent Talents in University [NCET-13-0803]; Key Technology Research and Development Program of Guangdong Emerging Strategic Industries [2012A020800005]; Foundation for High-level Talents in Higher Education of Guangdong, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Technology Research and Development Program of Guangdong Emerging Strategic Industries; Foundation for High-level Talents in Higher Education of Guangdong, China	This research was supported by the National Natural Science Foundation of China (31172200; 31472090), the Program for New Century Excellent Talents in University (NCET-13-0803), the Key Technology Research and Development Program of Guangdong Emerging Strategic Industries (2012A020800005), and the Foundation for High-level Talents in Higher Education of Guangdong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan Muhammad, 2013, Frontiers in Genetics, V4, P226, DOI 10.3389/fgene.2013.00226; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blum R, 2014, J CELL BIOCHEM, V115, P1855, DOI 10.1002/jcb.24854; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Cui TX, 2011, MOL ENDOCRINOL, V25, P681, DOI 10.1210/me.2010-0232; D'Andre HC, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-43; Flisar T, 2014, POULTRY SCI, V93, P16, DOI 10.3382/ps.2013-03464; Henriksen Tora, 2012, Recent Pat Biotechnol, V6, P167; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Hu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056411; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Jiang CD, 2010, INT J BIOL SCI, V6, P627, DOI 10.7150/ijbs.6.627; Kim JR, 2006, OBESITY, V14, P188, DOI 10.1038/oby.2006.24; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lei MM, 2005, POULTRY SCI, V84, P1191, DOI 10.1093/ps/84.8.1191; Liang SS, 2015, DOMEST ANIM ENDOCRIN, V50, P65, DOI 10.1016/j.domaniend.2014.09.006; Mallinson JE, 2012, J PHYSIOL-LONDON, V590, P6389, DOI 10.1113/jphysiol.2012.238022; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marchildon F, 2012, STEM CELLS, V30, P2619, DOI 10.1002/stem.1248; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Morosetti R, 2006, P NATL ACAD SCI USA, V103, P16995, DOI 10.1073/pnas.0603386103; Murphy BA, 2014, VET J, V201, P39, DOI 10.1016/j.tvjl.2014.03.028; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Niarami MD, 2014, ANIM BIOTECHNOL, V25, P13, DOI 10.1080/10495398.2013.803478; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmidt A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004476; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Teng S, 2008, CURR PHARM BIOTECHNO, V9, P123, DOI 10.2174/138920108783955164; Thomas K, 2015, CONNECT TISSUE RES, V56, P1, DOI 10.3109/03008207.2014.947369; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Wang Mingfeng, 2013, Evid Based Complement Alternat Med, V2013, P285489, DOI 10.1155/2013/285489; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Yin H, 2014, POULTRY SCI, V93, P147, DOI 10.3382/ps.2013-03612; Yu LH, 2013, EUR J HUM GENET, V21, P731, DOI 10.1038/ejhg.2012.239; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	50	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137087	10.1371/journal.pone.0137087	http://dx.doi.org/10.1371/journal.pone.0137087			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366565	Green Submitted, gold, Green Published			2022-12-26	WOS:000361601100048
J	Donner, DG; Elliott, GE; Beck, BR; Bulmer, AC; Du Toit, EF				Donner, Daniel G.; Elliott, Grace E.; Beck, Belinda R.; Bulmer, Andrew C.; Du Toit, Eugene F.			Impact of Diet-Induced Obesity and Testosterone Deficiency on the Cardiovascular System: A Novel Rodent Model Representative of Males with Testosterone-Deficient Metabolic Syndrome (TDMetS)	PLOS ONE			English	Article							ANDROGEN-DEPRIVATION THERAPY; BODY-FAT PERCENTAGE; MIDDLE-AGED MEN; HORMONE-BINDING GLOBULIN; LATE-ONSET HYPOGONADISM; CORONARY-HEART-DISEASE; PROSTATE-CANCER; INSULIN-RESISTANCE; ISCHEMIA-REPERFUSION; RISK-FACTORS	Introduction Currentmodels of obesity utilise normogonadic animals and neglect the strong relationships between obesity-associated metabolic syndrome (MetS) and male testosterone deficiency (TD). The joint presentation of these conditions has complex implications for the cardiovascular system that are not well understood. We have characterised and investigated three models in male rats: one of diet-induced obesity with the MetS; a second using orchiectomised rats mimicking TD; and a third combining MetS with TD which we propose is representative of males with testosterone deficiency and the metabolic syndrome (TDMetS). Methods Male Wistar rats (n = 24) were randomly assigned to two groups and provided ad libitum access to normal rat chow (CTRL) or a high fat/high sugar/low protein "obesogenic" diet (OGD) for 28 weeks (n = 12/group). These groups were further sub-divided into sham-operated or orchiectomised (ORX) animals to mimic hypogonadism, with and without diet-induced obesity (n = 6/group). Serum lipids, glucose, insulin and sex hormone concentrations were determined. Body composition, cardiovascular structure and function; and myocardial tolerance to ischemia-reperfusion were assessed. Results OGD-fed animals had 72% greater fat mass; 2.4-fold greater serum cholesterol; 2.3-fold greater serum triglycerides and 3-fold greater fasting glucose (indicative of diabetes mellitus) compared to CTRLs (all p<0.05). The ORX animals had reduced serum testosterone and left ventricle mass (p<0.05). In addition to the combined differences observed in each of the isolated models, the OGD, ORX and OGD+ORX models each had greater CK-MB levels following in vivo cardiac ischemia-reperfusion insult compared to CTRLs (p<0.05). Conclusion Our findings provide evidence to support that the MetS and TD independently impair myocardial tolerance to ischemia-reperfusion. The combined OGD+ORX phenotype described in this study is a novel animal model with associated cardiovascular risk factors and complex myocardial pathology which may be representative of male patients presenting with TDMetS.	[Donner, Daniel G.; Elliott, Grace E.; Bulmer, Andrew C.; Du Toit, Eugene F.] Griffith Univ, Menzies Hlth Inst Queensland, Heart Fdn Res Ctr, Gold Coast, Qld, Australia; [Beck, Belinda R.] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University	Donner, DG (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Heart Fdn Res Ctr, Gold Coast, Qld, Australia.	d.donner@griffith.edu.au	Beck, Belinda/B-9079-2008	Beck, Belinda/0000-0003-1295-6395; Bulmer, Andrew/0000-0002-2994-7893; Donner, Daniel G./0000-0003-4924-720X	Menzies Health Institute Queensland, Griffith University; EFDT	Menzies Health Institute Queensland, Griffith University; EFDT	Funding for this project was provided by the Menzies Health Institute Queensland, Griffith University and was received by EFDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2002, J CLIN ENDOCR METAB, V87, P4522, DOI 10.1210/jc.2002-020567; Alibhai SMH, 2009, J CLIN ONCOL, V27, P3452, DOI 10.1200/JCO.2008.20.0923; Sanchez-Garrido MA, 2014, ENDOCRINOLOGY, V155, P1067, DOI 10.1210/en.2013-1584; Bell JR, 2011, ENDOCRINOLOGY, V152, P4937, DOI 10.1210/en.2011-1212; Bertelli DF, 2013, J ENDOCRINOL, V217, P131, DOI 10.1530/JOE-12-0562; Bhasin S, 2011, J CLIN ENDOCR METAB, V96, P2430, DOI 10.1210/jc.2010-3012; Bouhidel O, 2008, AM J PHYSIOL-HEART C, V295, pH1580, DOI 10.1152/ajpheart.00379.2008; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Clark C, 2011, PHYSIOL RES, V60, P291, DOI 10.33549/physiolres.931999; Corona G, 2011, J ENDOCRINOL INVEST, V34, P557, DOI 10.3275/7806; Corona G, 2013, ARCH ESP UROL, V66, P711; Dockery F, 2003, CLIN SCI, V104, P195, DOI 10.1042/CS20020209; Donner D, 2013, DIS MODEL MECH, V6, P457, DOI 10.1242/dmm.010959; Donner DG, 2012, MYOCARDIAL INSULIN R, V2012, P12; du Toit EF, 2005, BASIC RES CARDIOL, V100, P346, DOI 10.1007/s00395-005-0528-5; du Toit EF, 2008, AM J PHYSIOL-HEART C, V294, pH2336, DOI 10.1152/ajpheart.00481.2007; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Emmelot-Vonk MH, 2008, JAMA-J AM MED ASSOC, V299, P39, DOI 10.1001/jama.2007.51; English KM, 2000, CIRCULATION, V102, P1906, DOI 10.1161/01.CIR.102.16.1906; ERI LM, 1995, J UROLOGY, V154, P100, DOI 10.1016/S0022-5347(01)67239-2; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Goodman-Gruen D, 2000, DIABETES CARE, V23, P912, DOI 10.2337/diacare.23.7.912; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Habib SS, 2013, BIOMED ENVIRON SCI, V26, P94, DOI 10.3967/0895-3988.2013.02.003; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Hall SA, 2008, J CLIN ENDOCR METAB, V93, P3870, DOI 10.1210/jc.2008-0021; Haring R, 2010, AGING MALE, V13, P247, DOI 10.3109/13685538.2010.487553; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Isidori AM, 1999, J CLIN ENDOCR METAB, V84, P3673, DOI 10.1210/jc.84.10.3673; Jankowska EA, 2006, CIRCULATION, V114, P1829, DOI 10.1161/CIRCULATIONAHA.106.649426; KALIN MF, 1990, STEROIDS, V55, P330, DOI 10.1016/0039-128X(90)90058-J; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kapoor D, 2008, DRUG AGING, V25, P357, DOI 10.2165/00002512-200825050-00001; Katakam PVG, 2007, AM J PHYSIOL-REG I, V292, pR920, DOI 10.1152/ajpregu.00520.2006; Kaushik M, 2010, INT J CARDIOL, V142, P8, DOI 10.1016/j.ijcard.2009.10.033; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; KHAW KT, 1991, ARTERIOSCLER THROMB, V11, P489, DOI 10.1161/01.ATV.11.3.489; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Kramer CK, 2009, J CLIN ENDOCR METAB, V94, P5039, DOI 10.1210/jc.2009-1497; Kukreja RC, 2011, EXP CLIN CARDIOL, V16, pE30; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Laaksonen DE, 2005, J CLIN ENDOCR METAB, V90, P712, DOI 10.1210/jc.2004-0970; Laaksonen DE, 2003, EUR J ENDOCRINOL, V149, P601, DOI 10.1530/eje.0.1490601; Lam CSP, 2015, EUR J HEART FAIL, V17, P301, DOI 10.1002/ejhf.238; Lekli I, 2008, AM J PHYSIOL-HEART C, V294, pH859, DOI 10.1152/ajpheart.01048.2007; Li L, 2012, CLIN EXP PHARMACOL P, V39, P393, DOI 10.1111/j.1440-1681.2012.05684.x; Liu J, 2013, NUTR RES, V33, P311, DOI 10.1016/j.nutres.2013.02.005; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Ludman AJ, 2010, DIS MODEL MECH, V3, P35, DOI 10.1242/dmm.003855; Mah PM, 2010, MOL CELL ENDOCRINOL, V316, P180, DOI 10.1016/j.mce.2009.06.007; Mammi C, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/789653; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nduhirabandi F, 2011, J PINEAL RES, V50, P171, DOI 10.1111/j.1600-079X.2010.00826.x; Nettleship JE, 2009, FRONT HORM RES, V37, P91, DOI 10.1159/000176047; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Pavon N, 2012, J STEROID BIOCHEM, V132, P135, DOI 10.1016/j.jsbmb.2012.05.003; Peart JN, 2007, J MOL CELL CARDIOL, V42, P972, DOI 10.1016/j.yjmcc.2007.02.011; Ray R, 2008, MOL MED, V14, P493, DOI 10.2119/2008-00004.Ray; Rosmond R, 1996, OBES RES, V4, P245, DOI 10.1002/j.1550-8528.1996.tb00542.x; Rubio-Gayosso I, 2013, STEROIDS, V78, P362, DOI 10.1016/j.steroids.2012.12.004; Saigal CS, 2007, CANCER-AM CANCER SOC, V110, P1493, DOI 10.1002/cncr.22933; Salvador C, 2013, UROL INT, V90, P41, DOI 10.1159/000342814; Schneider HJ, 2009, CLIN ENDOCRINOL, V70, P446, DOI 10.1111/j.1365-2265.2008.03370.x; SEIDELL JC, 1990, METABOLISM, V39, P897, DOI 10.1016/0026-0495(90)90297-P; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Simon D, 1997, J CLIN ENDOCR METAB, V82, P682, DOI 10.1210/jc.82.2.682; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Sivaraman V, 2010, J CELL MOL MED, V14, P1740, DOI 10.1111/j.1582-4934.2009.00796.x; Smith JC, 2001, J CLIN ENDOCR METAB, V86, P4261, DOI 10.1210/jc.86.9.4261; Smith MR, 2008, UROLOGY, V71, P318, DOI 10.1016/j.urology.2007.08.035; Smith MR, 2006, J CLIN ENDOCR METAB, V91, P1305, DOI 10.1210/jc.2005-2507; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Sowers JR, 2003, AM J MED, V115, P37, DOI 10.1016/j.amjmed.2003.08.012; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Svartberg J, 2008, INT J IMPOT RES, V20, P378, DOI 10.1038/ijir.2008.19; Tajar A, 2012, J CLIN ENDOCR METAB, V97, P1508, DOI 10.1210/jc.2011-2513; Tchernof A, 1997, ATHEROSCLEROSIS, V133, P235, DOI 10.1016/S0021-9150(97)00125-1; Travison TG, 2008, J AM GERIATR SOC, V56, P831, DOI 10.1111/j.1532-5415.2008.01679.x; Usui C, 2010, J NUTR SCI VITAMINOL, V56, P109, DOI 10.3177/jnsv.56.109; Vermeulen A., 1999, Journal of Endocrinological Investigation, V22, P110; Wagner C, 2008, J CARDIOVASC PHARM, V52, P430, DOI 10.1097/FJC.0b013e31818c12a7; Wang C, 2010, BIOMED ENVIRON SCI, V23, P173, DOI 10.1016/S0895-3988(10)60049-9; Wang C, 2009, EUR UROL, V55, P121, DOI 10.1016/j.eururo.2008.08.033; Webb CM, 1999, CIRCULATION, V100, P1690, DOI 10.1161/01.CIR.100.16.1690; Wensley I, 2013, EXP PHYSIOL, V98, P1552, DOI 10.1113/expphysiol.2013.074948; Ye Ying, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P1235; Zmuda JM, 1997, AM J EPIDEMIOL, V146, P609, DOI 10.1093/oxfordjournals.aje.a009326	92	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138019	10.1371/journal.pone.0138019	http://dx.doi.org/10.1371/journal.pone.0138019			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366723	Green Submitted, gold, Green Published			2022-12-26	WOS:000361601100203
J	Greenwood, AK; Peichel, CL				Greenwood, Anna K.; Peichel, Catherine L.			Social Regulation of Gene Expression in Threespine Sticklebacks	PLOS ONE			English	Article							AFRICAN CICHLID FISH; SPATIAL EXPRESSION; BEHAVIOR NETWORK; HONEY-BEE; BRAIN; ZEBRAFISH; MOUSE; MICE; LIFE; TELENCEPHALON	Identifying genes that are differentially expressed in response to social interactions is informative for understanding the molecular basis of social behavior. To address this question, we described changes in gene expression as a result of differences in the extent of social interactions. We housed threespine stickleback (Gasterosteus aculeatus) females in either group conditions or individually for one week, then measured levels of gene expression in three brain regions using RNA-sequencing. We found that numerous genes in the hind-brain/cerebellum had altered expression in response to group or individual housing. However, relatively few genes were differentially expressed in either the diencephalon or telencephalon. The list of genes upregulated in fish from social groups included many genes related to neural development and cell adhesion as well as genes with functions in sensory signaling, stress, and social and reproductive behavior. The list of genes expressed at higher levels in individually-housed fish included several genes previously identified as regulated by social interactions in other animals. The identified genes are interesting targets for future research on the molecular mechanisms of normal social interactions.	[Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Peichel, CL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	cpeichel@fhcrc.org		Peichel, Catherine/0000-0002-7731-8944	National Science Foundation Division of Integrative Organismal Systems [IOS 1145866]; Direct For Biological Sciences [1145866] Funding Source: National Science Foundation	National Science Foundation Division of Integrative Organismal Systems(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the National Science Foundation Division of Integrative Organismal Systems grant IOS 1145866 to AKG and CLP (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aubin-Horth N, 2005, P ROY SOC B-BIOL SCI, V272, P1655, DOI 10.1098/rspb.2005.3125; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; Deasey S, 2012, AMINO ACIDS, V42, P1065, DOI 10.1007/s00726-011-1021-0; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dunlap KD, 2008, DEV NEUROBIOL, V68, P1420, DOI 10.1002/dneu.20673; Earley RL, 2006, PHYSIOL BEHAV, V88, P353, DOI 10.1016/j.physbeh.2006.04.002; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; Feng Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052674; Fernando CA, 2010, DEV DYNAM, V239, P1755, DOI 10.1002/dvdy.22279; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Frankel WN, 2009, GENES BRAIN BEHAV, V8, P568, DOI 10.1111/j.1601-183X.2009.00509.x; Ganz Julia, 2014, F1000Res, V3, P308, DOI 10.12688/f1000research.5595.2; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goodson JL, 2013, HORM BEHAV, V64, P103, DOI 10.1016/j.yhbeh.2013.05.006; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Hamilton SM, 2011, BEHAV BRAIN RES, V218, P29, DOI 10.1016/j.bbr.2010.11.026; Hitzemann R, 2013, GENES BRAIN BEHAV, V12, P1, DOI 10.1111/gbb.12007; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kidd MR, 2013, BEHAV ECOL SOCIOBIOL, V67, P1307, DOI 10.1007/s00265-013-1559-9; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MJ, 2007, GLYCOBIOLOGY, V17, P231, DOI 10.1093/glycob/cwl069; Klein SE, 2008, MOL CELL ENDOCRINOL, V286, P148, DOI 10.1016/j.mce.2007.08.010; Koster A, 1999, P NATL ACAD SCI USA, V96, P10444, DOI 10.1073/pnas.96.18.10444; Kroes RA, 2006, NEUROSCIENCE, V137, P37, DOI 10.1016/j.neuroscience.2005.08.076; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Levine JB, 2007, NEUROSCIENCE, V145, P42, DOI 10.1016/j.neuroscience.2006.11.063; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; Mulder J, 2010, EUR J NEUROSCI, V31, P2166, DOI 10.1111/j.1460-9568.2010.07275.x; O'Connell LA, 2013, J CHEM NEUROANAT, V47, P106, DOI 10.1016/j.jchemneu.2012.12.007; O'Connell LA, 2012, SCIENCE, V336, P1154, DOI 10.1126/science.1218889; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Puffenberger EG, 2012, HUM MUTAT, V33, P1639, DOI 10.1002/humu.22237; Reiss D, 2007, BEHAV BRAIN RES, V184, P167, DOI 10.1016/j.bbr.2007.07.010; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; Rittschof CC, 2014, P NATL ACAD SCI USA, V111, P17929, DOI 10.1073/pnas.1420369111; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Moldes I, 2002, BRAIN RES BULL, V57, P331, DOI 10.1016/S0361-9230(01)00700-6; Sanogo YO, 2012, P ROY SOC B-BIOL SCI, V279, P4929, DOI 10.1098/rspb.2012.2087; Sanogo YO, 2011, BRAIN BEHAV EVOLUT, V77, P270, DOI 10.1159/000328221; Schunter C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-167; Snell-Rood EC, 2013, ANIM BEHAV, V85, P1004, DOI 10.1016/j.anbehav.2012.12.031; STACEY NE, 1982, CAN J FISH AQUAT SCI, V39, P92, DOI 10.1139/f82-011; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse B, 2008, THE ZEBRAFISH MODEL; Torres JZ, 2011, CELL, V147, P1309, DOI 10.1016/j.cell.2011.11.020; Trainor BC, 2006, ENDOCRINOLOGY, V147, P5119, DOI 10.1210/en.2006-0511; Tseng YC, 2013, COMP BIOCHEM PHYS A, V165, P106, DOI 10.1016/j.cbpa.2013.01.025; Volkoff H, 2006, ZEBRAFISH, V3, P131, DOI 10.1089/zeb.2006.3.131; Wark AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018316; Wootton R.J., 1976, BIOL STICKLEBACKS; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	63	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137726	10.1371/journal.pone.0137726	http://dx.doi.org/10.1371/journal.pone.0137726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367311	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100123
J	Kondo, M; Das, G; Imai, R; Santana, E; Nakashita, T; Imawaka, M; Ueda, K; Ohtsuka, H; Sakai, K; Aihara, T; Kato, K; Sugimoto, M; Ueno, S; Nishizawa, Y; Aguirre, GD; Miyadera, K				Kondo, Mineo; Das, Gautami; Imai, Ryoetsu; Santana, Evelyn; Nakashita, Tomio; Imawaka, Miho; Ueda, Kosuke; Ohtsuka, Hirohiko; Sakai, Kazuhiko; Aihara, Takehiro; Kato, Kumiko; Sugimoto, Masahiko; Ueno, Shinji; Nishizawa, Yuji; Aguirre, Gustavo D.; Miyadera, Keiko			A Naturally Occurring Canine Model of Autosomal Recessive Congenital Stationary Night Blindness	PLOS ONE			English	Article							ROD BIPOLAR CELLS; METABOTROPIC GLUTAMATE-RECEPTOR; DEPOLARIZING BIPOLAR; LIGHT RESPONSE; SYNAPTIC-TRANSMISSION; RETINITIS-PIGMENTOSA; FRAMESHIFT MUTATION; MAMMALIAN RETINA; GENE-EXPRESSION; RABBIT RETINA	Congenital stationary night blindness (CSNB) is a non-progressive, clinically and genetically heterogeneous disease of impaired night vision. We report a naturally-occurring, stationary, autosomal recessive phenotype in beagle dogs with normal daylight vision but absent night vision. Affected dogs had normal retinas on clinical examination, but showed no detectable rod responses. They had "negative-type" mixed rod and cone responses in full-field ERGs. Their photopic long-flash ERGs had normal OFF-responses associated with severely reduced ON-responses. The phenotype is similar to the Schubert-Bornschein form of complete CSNB in humans. Homozygosity mapping ruled out most known CSNB candidates as well as CACNA2D4 and GNB3. Three remaining genes were excluded based on sequencing the open reading frame and intron-exon boundaries (RHO, NYX), causal to a different form of CSNB (RHO) or X-chromosome (NYX, CACNA1F) location. Among the genes expressed in the photoreceptors and their synaptic terminals, and mGluR6 cascade and modulators, reduced expression of GNAT1, CACNA2D4 and NYX was observed by qRT-PCR in both carrier (n = 2) and affected (n = 2) retinas whereas CACNA1F was down-regulated only in the affecteds. Retinal morphology revealed normal cellular layers and structure, and electron microscopy showed normal rod spherules and synaptic ribbons. No difference from normal was observed by immunohistochemistry (IHC) for antibodies labeling rods, cones and their presynaptic terminals. None of the retinas showed any sign of stress. Selected proteins of mGluR6 cascade and its modulators were examined by IHC and showed that PKC alpha weakly labeled the rod bipolar somata in the affected, but intensely labeled axonal terminals that appeared thickened and irregular. Dendritic terminals of ON-bipolar cells showed increased Goa labeling. Both PKC alpha and Go alpha labeled the more prominent bipolar dendrites that extended into the OPL in affected but not normal retinas. Interestingly, RGS11 showed no labeling in the affected retina. Our results indicate involvement of a yet unknown gene in this canine model of complete CSNB.	[Kondo, Mineo; Kato, Kumiko; Sugimoto, Masahiko] Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan; [Das, Gautami; Santana, Evelyn; Aguirre, Gustavo D.; Miyadera, Keiko] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Imai, Ryoetsu; Nakashita, Tomio; Imawaka, Miho; Ueda, Kosuke; Ohtsuka, Hirohiko] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan; [Sakai, Kazuhiko; Aihara, Takehiro] Kitayama Labes Co Ltd, Ina, Saitama, Japan; [Ueno, Shinji] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Nishizawa, Yuji] Chubu Univ, Dept Biomed Sci, Kasugai, Aichi 487, Japan	Mie University; University of Pennsylvania; Takeda Pharmaceutical Company Ltd; Nagoya University; Chubu University	Kondo, M (corresponding author), Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan.	mineo@clin.medic.mie-u.ac.jp; gda@vet.upenn.edu	Miyadera, Keiko/AAQ-8196-2020; Ueno, Shinji/M-5063-2014; Kato, Kumiko/AAE-9079-2019	Kato, Kumiko/0000-0003-4172-3443; Aguirre, Gustavo/0000-0002-5228-256X; Das, Rueben/0000-0001-9204-0605	Ministry of Education, Culture, Sports, Science and Technology of Japan [C20592603]; NIH [RO1EY-017549, RO1EY-06855]; Foundation Fighting Blindness Center grant; Career Development Award; Hope for Vision grant; Takeda Pharmaceutical Co., Ltd; Kitayama Labes Co., Ltd; NATIONAL EYE INSTITUTE [R01EY017549, P30EY001583, R01EY006855] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness Center grant; Career Development Award; Hope for Vision grant; Takeda Pharmaceutical Co., Ltd(Takeda Pharmaceutical Company Ltd); Kitayama Labes Co., Ltd; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a Grant-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp, #C20592603, MK), NIH grants (http://grants.nih.gov) RO1EY-017549 (GDA), and RO1EY-06855 (GDA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Eye Institute or the National Institutes of Health. Work was also funded by a Foundation Fighting Blindness (http://www.blindness.org) Center grant (GDA) and Career Development Award (KM), and Hope for Vision grant (http://hopeforvision.org, GDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Takeda Pharmaceutical Co., Ltd and Kitayama Labes Co., Ltd provided support in the form of salaries for authors RI, TN, MI, KU, HO and KS and TA respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguirre G D, 1998, Mol Vis, V4, P23; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, HUM GENET, V103, P124, DOI 10.1007/s004390050794; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Bellone RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078280; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Chen FS, 2010, INVEST OPHTH VIS SCI, V51, P686, DOI 10.1167/iovs.09-4084; DACHEUX RF, 1986, J NEUROSCI, V6, P331; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dhingra A, 2012, J NEUROSCI, V32, P11343, DOI 10.1523/JNEUROSCI.1436-12.2012; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Genini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085408; Genini S, 2010, INVEST OPHTH VIS SCI, V51, P6038, DOI 10.1167/iovs.10-5443; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Gregg RG, 2007, J NEUROPHYSIOL, V98, P3023, DOI 10.1152/jn.00608.2007; Koike C, 2010, CELL CALCIUM, V48, P95, DOI 10.1016/j.ceca.2010.08.004; Komaromy AM, 2013, MOL THER, V21, P1131, DOI 10.1038/mt.2013.50; Kondo M, 2000, JPN J OPHTHALMOL, V44, P20, DOI 10.1016/S0021-5155(99)00172-0; Kuznetsova T, 2012, INVEST OPHTH VIS SCI, V53, P5486, DOI 10.1167/iovs.12-10178; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Morigiwa K, 1999, J COMP NEUROL, V405, P173, DOI 10.1002/(SICI)1096-9861(19990308)405:2<173::AID-CNE3>3.0.CO;2-L; Naeem MA, 2012, INVEST OPHTH VIS SCI, V53, P1353, DOI 10.1167/iovs.11-8026; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; NARFSTROM K, 1989, BRIT J OPHTHALMOL, V73, P750, DOI 10.1136/bjo.73.9.750; Nawy S, 1999, J NEUROSCI, V19, P2938; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; Neuille M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090342; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Okawa H, 2010, J GEN PHYSIOL, V136, P443, DOI 10.1085/jgp.201010477; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; Peachey NS, 2012, J NEUROPHYSIOL, V108, P2442, DOI 10.1152/jn.00137.2012; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Rampino MAF, 2011, J NEUROSCI, V31, P13596, DOI 10.1523/JNEUROSCI.2655-11.2011; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Riazuddin SA, 2010, AM J HUM GENET, V87, P523, DOI 10.1016/j.ajhg.2010.08.013; RIGGS LA, 1954, AM J OPHTHALMOL, V38, P70, DOI 10.1016/0002-9394(54)90011-2; Ritchey ER, 2010, NEUROSCIENCE, V169, P1376, DOI 10.1016/j.neuroscience.2010.05.081; Ruether K, 2010, INVEST OPHTH VIS SCI, V51, P6051, DOI 10.1167/iovs.09-4704; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Shen Y, 2012, P NATL ACAD SCI USA, V109, P8752, DOI 10.1073/pnas.1117433109; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Shim H, 2012, J BIOL CHEM, V287, P14873, DOI 10.1074/jbc.M112.345751; Sieving P A, 1993, Trans Am Ophthalmol Soc, V91, P701; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; STRETTOI E, 1990, J COMP NEUROL, V295, P449, DOI 10.1002/cne.902950309; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Szabo V, 2007, HUM MUTAT, V28, P741, DOI 10.1002/humu.9499; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; WITZEL DA, 1978, INVEST OPHTH VIS SCI, V17, P788; Zeitz C, 2007, HUM MUTAT, V28, P771, DOI 10.1002/humu.20499; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023; Zeitz C, 2009, INVEST OPHTH VIS SCI, V50, P5919, DOI 10.1167/iovs.09-3548	71	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137072	10.1371/journal.pone.0137072	http://dx.doi.org/10.1371/journal.pone.0137072			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368928	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100047
J	Kong, LL; Wang, XB; Zhang, K; Yuan, WJ; Yang, QW; Fan, JP; Wang, P; Liu, QH				Kong, Lulu; Wang, Xiaobing; Zhang, Kun; Yuan, Wenjuan; Yang, Qiwen; Fan, Jianping; Wang, Pan; Liu, Quanhong			Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation	PLOS ONE			English	Article							MITOCHONDRIA-DEPENDENT PATHWAYS; GYNOSTEMMA-PENTAPHYLLUM MAKINO; MURINE XENOGRAFT MODEL; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; CELLS; RESISTANCE; CHEMOTHERAPY; COMBINATION; PATHOGENESIS	Objective 5-Fluorouracil (5-Fu) has been widely used as a first-line drug for colorectal cancer (CRC) treatment but limited by drug resistance and severe toxicity. The chemo-sensitizers that augment its efficiency and overcome its limitation are urgently needed. Gypenosides (Gyp), the main components from Gynostemma pentaphyllum (Thunb.) Makino, has shown potential anti-tumor property with little side-effect. Here, we carefully explored the chemo-sensitization of Gyp to potentiate the anti-tumor effect of 5-Fu in vitro and in vivo. Methodology / Principal Findings 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltertrazolium bromide tetrazolium assay and colony formation test reveal that Gyp could significantly enhance the 5-Fu-caused SW-480, SW-620 and Caco2 cells viability loss. Calcusyn analysis shows that Gyp acts synergistically with 5-Fu. Annexin V-PE/7-AAD staining indicates 5-Fu + Gyp could induce SW-480 cell apoptosis. The activations of caspase 3, caspase 9 and poly (ADP-ribose) polymerase (PARP) were involved in the process. Gyp was also found to up-regulate 5-Fu-caused phospho-p53 expression and thus augment 5-Fu-induced G0/G1 phase arrest. Gyp elevated intracellular ROS level, significantly enhanced 5-Fu-triggered DNA damage response as evidenced by flow cytometry, comet assay and the expression of Ser139-Histone H2A. X. Inhibition of ROS and p53 respectively reversed the cell death induced by 5-Fu + Gyp, suggesting the key roles of ROS and p53 in the process. Moreover, 5-Fu and Gyp in combination exhibits much superior tumor volume and weight inhibition on CT-26 xenograft mouse model in comparison to 5-Fu or Gyp alone. Immunohistochemistry analysis suggests the combinations greatly suppressed tumor proliferation. Preliminary toxicological results show that 5-Fu + Gyp treatment is relatively safe. Conclusions As a potential chemo-sensitizer, Gyp displays a splendid synergistic effect with 5-Fu to inhibit cancer cell proliferation and tumor growth. By using 5-Fu and Gyp in combination would be a promising therapeutic strategy for CRC treatment.	[Kong, Lulu; Wang, Xiaobing; Zhang, Kun; Yuan, Wenjuan; Yang, Qiwen; Fan, Jianping; Wang, Pan; Liu, Quanhong] Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Reg Sustainable Dev, Xian, Shaanxi, Peoples R China	Shaanxi Normal University	Wang, P (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Reg Sustainable Dev, Xian, Shaanxi, Peoples R China.	wangpan@snnu.edu.cn						Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Chen JC, 2006, ANTICANCER RES, V26, P4313; Chen JC, 2009, ORAL ONCOL, V45, P273, DOI 10.1016/j.oraloncology.2008.05.012; Chen MH, 2008, J ETHNOPHARMACOL, V117, P309, DOI 10.1016/j.jep.2008.02.009; Chiranthanut N, 2013, J ETHNOPHARMACOL, V149, P228, DOI 10.1016/j.jep.2013.06.027; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Circosta C, 2005, PHYTOMEDICINE, V12, P638, DOI 10.1016/j.phymed.2004.06.023; Colin DJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.486; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Douillard JY, 2003, ANN ONCOL, V14, P7, DOI 10.1093/annonc/mdg723; Fishbein AB, 2009, ARCH PHARM RES, V32, P505, DOI 10.1007/s12272-009-1405-9; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Hayano S, 2015, DEVELOPMENT, V142, P1357, DOI 10.1242/dev.118802; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Ijichi K, 2014, ANTICANCER RES, V34, P2907; Johnson KR, 1997, CLIN CANCER RES, V3, P1739; Johnston PG, 2001, ANTI-CANCER DRUG, V12, P639, DOI 10.1097/00001813-200109000-00001; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lin JJ, 2011, PHYTOMEDICINE, V18, P1075, DOI 10.1016/j.phymed.2011.03.009; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lu KW, 2012, INTEGR CANCER THER, V11, P129, DOI 10.1177/1534735411403306; Megalli S, 2005, J PHARM PHARM SCI, V8, P507; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Quan Y, 2015, MOL MED REP, V11, P2845, DOI 10.3892/mmr.2014.3095; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Santandreu FM, 2011, CELL PHYSIOL BIOCHEM, V28, P219, DOI 10.1159/000331733; Shakibaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057218; Su XM, 2014, DRUG CHEM TOXICOL, V37, P348, DOI 10.3109/01480545.2013.866135; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tudek B, 2010, AM J TRANSL RES, V2, P254; Wang QF, 2002, CANCER LETT, V183, P169, DOI 10.1016/S0304-3835(01)00828-X; Wang QF, 2007, PLANTA MED, V73, P535, DOI 10.1055/s-2007-967200; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Yan H, 2014, HUM EXP TOXICOL, V33, P522, DOI 10.1177/0960327113497771; Yan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095609; Zhang N, 2008, MOLECULES, V13, P1551, DOI 10.3390/molecules13081551	43	43	43	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137888	10.1371/journal.pone.0137888	http://dx.doi.org/10.1371/journal.pone.0137888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368019	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100168
J	Nao, N; Kajihara, M; Manzoor, R; Maruyama, J; Yoshida, R; Muramatsu, M; Miyamoto, H; Igarashi, M; Eguchi, N; Sato, M; Kondoh, T; Okamatsu, M; Sakoda, Y; Kida, H; Takada, A				Nao, Naganori; Kajihara, Masahiro; Manzoor, Rashid; Maruyama, Junki; Yoshida, Reiko; Muramatsu, Mieko; Miyamoto, Hiroko; Igarashi, Manabu; Eguchi, Nao; Sato, Masahiro; Kondoh, Tatsunari; Okamatsu, Masatoshi; Sakoda, Yoshihiro; Kida, Hiroshi; Takada, Ayato			A Single Amino Acid in the M1 Protein Responsible for the Different Pathogenic Potentials of H5N1 Highly Pathogenic Avian Influenza Virus Strains	PLOS ONE			English	Article							MATRIX PROTEIN; A VIRUS; NUCLEAR TRANSPORT; HONG-KONG; RNA; EXPRESSION; VIRULENCE; WATERFOWL; RIBONUCLEOPROTEINS; PHOSPHORYLATION	Two highly pathogenic avian influenza virus strains, A/duck/Hokkaido/WZ83/2010 ( H5N1) (WZ83) and A/duck/Hokkaido/WZ101/2010 (H5N1) (WZ101), which were isolated from wild ducks in Japan, were found to be genetically similar, with only two amino acid differences in their M1 and PB1 proteins at positions 43 and 317, respectively. We found that both WZ83 and WZ101 caused lethal infection in chickens but WZ101 killed them more rapidly than WZ83. Interestingly, ducks experimentally infected with WZ83 showed no or only mild clinical symptoms, whereas WZ101 was highly lethal. We then generated reassortants between these viruses and found that exchange of the M gene segment completely switched the pathogenic phenotype in both chickens and ducks, indicating that the difference in the pathogenicity for these avian species between WZ83 and WZ101 was determined by only a single amino acid in the M1 protein. It was also found that WZ101 showed higher pathogenicity than WZ83 in mice and that WZ83, whose M gene was replaced with that of WZ101, showed higher pathogenicity than wild-type WZ83, although this reassortant virus was not fully pathogenic compared to wild-type WZ101. These results suggest that the amino acid at position 43 of the M1 protein is one of the factors contributing to the pathogenicity of H5N1 highly pathogenic avian influenza viruses in both avian and mammalian hosts.	[Nao, Naganori; Kajihara, Masahiro; Manzoor, Rashid; Maruyama, Junki; Yoshida, Reiko; Muramatsu, Mieko; Miyamoto, Hiroko; Igarashi, Manabu; Eguchi, Nao; Sato, Masahiro; Kondoh, Tatsunari; Kida, Hiroshi; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Okamatsu, Masatoshi; Sakoda, Yoshihiro] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kida, Hiroshi; Takada, Ayato] Hokkaido Univ, Global Inst Collaborat Res & Educ, Sapporo, Hokkaido, Japan; [Takada, Ayato] Univ Zambia, Sch Vet Med, Lusaka, Zambia	Hokkaido University; Hokkaido University; Hokkaido University; University of Zambia	Takada, A (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.	atakada@czc.hokudai.ac.jp	Kida, Hiroshi/F-7244-2012; Kajihara, Masahiro/AAF-5724-2020; Maruyama, Junki/H-7993-2013; Maruyama, Junki/M-4735-2019; Igarashi, Manabu/F-6871-2012; Manzoor, Rashid/ABB-8209-2020; YOSHIDA, Reiko/F-6883-2012	Maruyama, Junki/0000-0003-0088-4793; Maruyama, Junki/0000-0003-0088-4793; 	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); KAKENHI; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA) within the framework of the Science and Technology Research Partnership for Sustainable Development (SATREPS)	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan International Cooperation Agency (JICA) within the framework of the Science and Technology Research Partnership for Sustainable Development (SATREPS)	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) (http://www.amed.go.jp/en/), KAKENHI (https://www.jsps.go.jp/english/index.html), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (http://www.mext.go.jp/english/), and partly by the Japan Science and Technology Agency (JST) (http://www.jst.go.jp/EN/index.html) and Japan International Cooperation Agency (JICA) (http://www.jica.go.jp/english/index.html) within the framework of the Science and Technology Research Partnership for Sustainable Development (SATREPS) (http://www.jst.go.jp/global/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2013, MOL IMMUNOL, V56, P358, DOI 10.1016/j.molimm.2013.05.236; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Campbell PJ, 2014, J VIROL, V88, P7569, DOI 10.1128/JVI.00119-14; Centers for Disease C Prevention., 1997, ISOLATION AVIAN INFL, V46, P1204; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021; Fan SF, 2009, VIROLOGY, V384, P28, DOI 10.1016/j.virol.2008.11.044; GREEN IJ, 1962, SCIENCE, V138, P42, DOI 10.1126/science.138.3536.42; Halder UC, 2013, J BIOL CHEM, V288, P14554, DOI 10.1074/jbc.M112.447086; Hatta M, 2001, PHILOS T R SOC B, V356, P1841, DOI 10.1098/rstb.2001.1000; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Huang XY, 2001, VIROLOGY, V287, P405, DOI 10.1006/viro.2001.1067; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Kajihara M, 2011, JPN J VET RES, V59, P89; KIDA H, 1987, VIROLOGY, V159, P109, DOI 10.1016/0042-6822(87)90353-9; KIDA H, 1980, INFECT IMMUN, V30, P547; Kishida N, 2005, ARCH VIROL, V150, P1383, DOI 10.1007/s00705-004-0473-x; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Donnell CD, 2014, J VIROL, V88, P12374, DOI 10.1128/JVI.01107-14; Okazaki K, 2000, ARCH VIROL, V145, P885, DOI 10.1007/s007050050681; ROTT R, 1982, VIROLOGY, V120, P215, DOI 10.1016/0042-6822(82)90019-8; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Shishkov AV, 1999, P NATL ACAD SCI USA, V96, P7827, DOI 10.1073/pnas.96.14.7827; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Song JS, 2011, J VIROL, V85, P2180, DOI 10.1128/JVI.01975-10; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P26, DOI 10.1111/irv.12077; WAKEFIELD L, 1989, NUCLEIC ACIDS RES, V17, P8569, DOI 10.1093/nar/17.21.8569; Wang SS, 2013, J VIROL, V87, P6182, DOI 10.1128/JVI.03024-12; Ward AC, 1997, VIRUS GENES, V14, P187, DOI 10.1023/A:1007979709403; Watanabe K, 1996, J VIROL, V70, P241, DOI 10.1128/JVI.70.1.241-247.1996; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WHITTAKER G, 1995, J VIROL, V69, P439, DOI 10.1128/JVI.69.1.439-445.1995; Whittaker G, 1996, J VIROL, V70, P2743, DOI 10.1128/JVI.70.5.2743-2756.1996; Ye ZP, 1999, J VIROL, V73, P7467, DOI 10.1128/JVI.73.9.7467-7473.1999; YE ZP, 1989, J VIROL, V63, P3586, DOI 10.1128/JVI.63.9.3586-3594.1989; ZIMMERMANN T, 1960, VIROLOGY, V11, P676, DOI 10.1016/0042-6822(60)90114-8	47	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137989	10.1371/journal.pone.0137989	http://dx.doi.org/10.1371/journal.pone.0137989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368015	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100196
J	Raba, DN; Poiana, MA; Borozan, AB; Stef, M; Radu, F; Popa, MV				Raba, Diana Nicoleta; Poiana, Mariana-Atena; Borozan, Aurica Breica; Stef, Marius; Radu, Florina; Popa, Mirela-Viorica			Investigation on Crude and High-Temperature Heated Coffee Oil by ATR-FTIR Spectroscopy along with Antioxidant and Antimicrobial Properties	PLOS ONE			English	Article							TRANSFORM-INFRARED-SPECTROSCOPY; EDIBLE OILS; OXIDATIVE STABILITY; FATTY-ACIDS; LIPID FRACTION; DITERPENES; ABSORBENCY; DPPH; EXTRACTION; SPECTRA	The coffee oil has a promising potential to be used in food industry, but an efficient use, especially in products that required high-temperature heating, depends on its chemical composition and the changes induced by processing. Since there is little information on this topic, the aim of our study was to investigate the crude green and roasted coffee oil (GCO, RCO) and heated (HGCO, HRCO) for 1 h at 200 degrees C, by Fourier Transform Infrared (FTIR) spectroscopy and in terms of antioxidant and antimicrobial properties. The results of FTIR spectroscopy revealed that no statistically significant differences (one-way ANOVA, p>0.05) in the oxidative status of GCO and RCO were found. The coffee oils heating induced significant spectral changes in the regions 3100-3600 cm(-1), 2800-3050 cm(-1) and 1680-1780 cm(-1) proved by the differences in the absorbance ratios A 3009 cm(-1)/A 2922 cm(-1), A 3009 cm(-1)/A 2853 cm(-1), A 3009 cm(-1)/A 1744 cm(-1), A 1744 cm(-1)/A 2922 cm(-1). These alterations were related to the reduction of the unsaturation degree due to primary and secondary oxidation processes of the lipid fraction. The radical scavenging ability of oils investigated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay revealed that the IC50 value of GCO was significantly lower than of RCO (p<0.05). The IC50 values of crude coffee oils were lower than those of heated samples. The antioxidant activity of oils was attributed to both antioxidant compounds with free-radical scavenging capacity and to lipids oxidation products generated by heating. In the first 6 h of incubation, the inhibitory activity of crude oils against E. coli and E. faecalis was not significantly different to the control (p>0.05). Also, HGCO and HRCO showed significantly different inhibitory potential related to the control (p<0.05). The heating induced statistically significant decreases in the effectiveness of coffee oils against the tested bacteria. GCO proved to be the most effective among investigated coffee oils against the tested bacteria.	[Raba, Diana Nicoleta; Poiana, Mariana-Atena; Radu, Florina; Popa, Mirela-Viorica] Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Food Proc Technol, Timisoara 300645, Romania; [Borozan, Aurica Breica] Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Hort & Forestry, Timisoara 300645, Romania; [Stef, Marius] West Univ Timisoara, Fac Phys, Timisoara 300223, Romania	Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; West University of Timisoara	Poiana, MA (corresponding author), Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Food Proc Technol, Calea Aradului 119, Timisoara 300645, Romania.	atenapoiana@yahoo.com	poiana, atena mariana/AAJ-9409-2020; radu, florina/AAO-8169-2021; Poiana, Mariana Atena/N-1152-2013; Stef, Marius/D-2170-2014; radu, florina/U-8575-2017; Stef, Marius/J-1623-2019	poiana, atena mariana/0000-0002-4774-4440; Stef, Marius/0000-0002-1750-0082	SUPREMIA GRUP SRL from Romania [2029/2015]	SUPREMIA GRUP SRL from Romania	The authors of this paper gratefully acknowledge the financial support in the performing of this study by SUPREMIA GRUP SRL from Romania, leader in the Romanian food ingredients, on the basis of research project No. 2029/2015, entitled: "Development of some bakery premixes based on dried fruits with high sensory and nutritional properties". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AMR, 2000, GRASAS ACEITES, V51, P74; Amarowicz R, 2009, EUR J LIPID SCI TECH, V111, P109, DOI 10.1002/ejlt.200900011; Ambrosio SR, 2008, Z NATURFORSCH C, V63, P326; American Oil Chemists' Society [AOCS], 2017, OFFICIAL METHODS REC, V7th; Anese M, 2000, ITAL J FOOD SCI, V12, P457; de Oliveira PMA, 2014, J SUPERCRIT FLUID, V95, P137, DOI 10.1016/j.supflu.2014.08.016; Bach D, 2001, BBA-BIOMEMBRANES, V1514, P318, DOI 10.1016/S0005-2736(01)00388-1; Cammerer B, 2006, EUR FOOD RES TECHNOL, V223, P469, DOI 10.1007/s00217-005-0226-4; Calligaris S, 2009, EUR J LIPID SCI TECH, V111, P1270, DOI 10.1002/ejlt.200900042; Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7; CLSI, 2011, M100S20 CLSI, P172; Czerny M, 2000, J AGR FOOD CHEM, V48, P868, DOI 10.1021/jf990609n; Dias RCE, 2014, EUR FOOD RES TECHNOL, V239, P961, DOI 10.1007/s00217-014-2293-x; Falade Ayodeji Osmund, 2015, Int J Food Sci, V2015, P806524, DOI 10.1155/2015/806524; Ferrari M, 2010, COLLOID SURFACE A, V365, P79, DOI 10.1016/j.colsurfa.2010.02.002; Frascareli EC, 2012, FOOD BIOPROD PROCESS, V90, P413, DOI 10.1016/j.fbp.2011.12.002; Gichimu B. M., 2014, Journal of Food Research, V3, P31; Guillen MD, 2005, J AGR FOOD CHEM, V53, P1093, DOI 10.1021/jf0489062; Guillen MD, 1998, J AGR FOOD CHEM, V46, P1788, DOI 10.1021/jf9705274; Guillen MD, 2002, FOOD CHEM, V77, P503, DOI 10.1016/S0308-8146(01)00371-5; Gutierrez D, 2012, APPL ENVIRON MICROB, V78, P8547, DOI 10.1128/AEM.02045-12; HARTMAN L, 1968, J AM OIL CHEM SOC, V45, P577, DOI 10.1007/BF02667175; Hashim L, 1995, FOOD RES INT, V28, P619, DOI 10.1016/0963-9969(95)00037-2; Herrera FC, 2006, J APPL MICROBIOL, V100, P527, DOI 10.1111/j.1365-2672.2005.02848.x; Jeong MK, 2012, J AM OIL CHEM SOC, V89, P1831, DOI 10.1007/s11746-012-2088-9; Jovic O, 2013, CROAT CHEM ACTA, V86, P335, DOI 10.5562/cca2377; Lago R. C. A., 2001, Boletim do Centro de Pesquisa e Processamento de Alimentos, V19, P319; Lee J, 2007, FOOD CHEM, V103, P662, DOI 10.1016/j.foodchem.2006.07.052; Wagemaker TAL, 2011, IND CROP PROD, V33, P469, DOI 10.1016/j.indcrop.2010.10.026; Martinez-Yusta M, 2014, COMPREHENSIVE REV FO, V13, P38; Moharam MA, 2010, AFR J MICROBIOL RES, V4, P1921; Moreno MCMM, 1999, TALANTA, V50, P269, DOI 10.1016/S0039-9140(99)00034-X; Nicoli MC, 1997, FOOD SCI TECHNOL-LEB, V30, P292, DOI 10.1006/fstl.1996.0181; Oliveira AL, 2011, CIENCIA TECNOLOGIA A, V25, P677; Ramadan MF, 2006, J FOOD COMPOS ANAL, V19, P838, DOI 10.1016/j.jfca.2006.02.013; RAVINDRANATH R, 1972, J SCI FOOD AGR, V23, P307, DOI 10.1002/jsfa.2740230306; Rohman A., 2011, International Food Research Journal, V18, P303; SAS Institute Inc, 2000, SAS WIND; Speer Karl, 2006, Braz. J. Plant Physiol., V18, P201, DOI 10.1590/S1677-04202006000100014; Toci AT, 2013, LWT-FOOD SCI TECHNOL, V50, P581, DOI 10.1016/j.lwt.2012.08.007; Tsukui A, 2014, FOOD CHEM, V164, P266, DOI 10.1016/j.foodchem.2014.05.039; VANDEVOORT FR, 1994, J AM OIL CHEM SOC, V71, P243, DOI 10.1007/BF02638049; Pereda MDV, 2009, J COSMET DERMATOL-US, V8, P56, DOI 10.1111/j.1473-2165.2009.00425.x; Vila MA, 2005, J AM OIL CHEM SOC, V82, P639, DOI 10.1007/s11746-005-1122-1; Vlachos N, 2006, ANAL CHIM ACTA, V573, P459, DOI 10.1016/j.aca.2006.05.034; Wagemaker T.A.L., 2012, BIOMED BIOPHARM RES, V9, P207; Wang SJ, 2007, FEMS IMMUNOL MED MIC, V51, P8, DOI 10.1111/j.1574-695X.2007.00305.x; Yeo J, 2012, FOOD SCI BIOTECHNOL, V21, P199, DOI 10.1007/s10068-012-0025-1; Yeo J, 2010, FOOD SCI BIOTECHNOL, V19, P253, DOI 10.1007/s10068-010-0036-8; YOSHIDA H, 1992, J AM OIL CHEM SOC, V69, P119, DOI 10.1007/BF02540560	50	26	27	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138080	10.1371/journal.pone.0138080	http://dx.doi.org/10.1371/journal.pone.0138080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366731	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100217
J	Sumner-Rooney, LH; Sigwart, JD				Sumner-Rooney, Lauren H.; Sigwart, Julia D.			Is the Schwabe Organ a Retained Larval Eye? Anatomical and Behavioural Studies of a Novel Sense Organ in Adult Leptochiton asellus (Mollusca, Polyplacophora) Indicate Links to Larval Photoreceptors	PLOS ONE			English	Article							NERVOUS-SYSTEM; NEURONS; LEPIDOPLEURIDA; METAMORPHOSIS; MORPHOLOGY; PATHWAYS	The discovery of a sensory organ, the Schwabe organ, was recently reported as a unifying feature of chitons in the order Lepidopleurida. It is a patch of pigmented tissue located on the roof of the pallial cavity, beneath the velum on either side of the mouth. The epithelium is densely innervated and contains two types of potential sensory cells. As the function of the Schwabe organ remains unknown, we have taken a cross-disciplinary approach, using anatomical, histological and behavioural techniques to understand it. In general, the pigmentation that characterises this sensory structure gradually fades after death; however, one particular concentrated pigment dot persists. This dot is positionally homologous to the larval eye in chiton trochophores, found in the same neuroanatomical location, and furthermore the metamorphic migration of the larval eye is ventral in species known to possess Schwabe organs. Here we report the presence of a discrete subsurface epithelial structure in the region of the Schwabe organ in Leptochiton asellus that histologically resembles the chiton larval eye. Behavioural experiments demonstrate that Leptochiton asellus with intact Schwabe organs actively avoid an upwelling light source, while Leptochiton asellus with surgically ablated Schwabe organs and a control species lacking the organ (members of the other extant order, Chitonida) do not (Kruskal-Wallis, H = 24.82, df = 3, p < 0.0001). We propose that the Schwabe organ represents the adult expression of the chiton larval eye, being retained and elaborated in adult lepidopleurans.	[Sumner-Rooney, Lauren H.; Sigwart, Julia D.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Sumner-Rooney, Lauren H.; Sigwart, Julia D.] Queens Univ Belfast, Queens Marine Lab, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Sumner-Rooney, LH (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	lsumnerrooney01@qub.ac.uk	Sigwart, Julia/J-2928-2014	Sigwart, Julia/0000-0002-3005-6246; Sumner-Rooney, Lauren/0000-0003-0196-5069	DEL Northern Ireland	DEL Northern Ireland	The authors received no specific funding for this work. A PhD studentship for LHSR was provided by DEL Northern Ireland (http://www.delni.gov.uk). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1920, AM NAT, V54, P376; Arey LB, 1919, J EXP ZOOL, V29, P157, DOI 10.1002/jez.1400290203; BOYLE P R, 1972, Marine Behaviour and Physiology, V1, P171; Boyle P.R., 1977, Oceanography mar Biol, V15, P461; BOYLE PR, 1974, CELL TISSUE RES, V153, P383; CHRISTIANSEN MARIT ELLEN, 1954, NYTT MAG ZOOL [OSLO], V2, P52; FISCHER F P, 1978, Spixiana, V1, P209; FISCHER F P, 1980, Spixiana, V3, P53; Gendre N, 2004, DEVELOPMENT, V131, P83, DOI 10.1242/dev.00879; Giraudoux P., 2013, PGIRMESS DATA ANAL E; HASZPRUNAR G, 1987, PHILOS T R SOC B, V315, P37, DOI 10.1098/rstb.1987.0002; HASZPRUNAR G, 1992, B ZOOL, V59, P1, DOI 10.1080/11250009209386641; Heath H., 1904, Proceedings of the Academy Philadelphia, P257; Kowalevsky MA., 1883, ANN DU MUSEUM DHISTO, pT1; Lord JP, 2011, J MOLLUS STUD, V77, P182, DOI 10.1093/mollus/eyr004; Naef A., 1926, ERGEBNISSE FORTSCHRI, P28; OMELICH PAUL, 1967, VELIGER, V10, P77; Pearse J.S., 1979, P27; R Core Team, 2013, R LANGUAGE ENV STAT; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; ROSEN MD, 1979, VELIGER, V22, P173; Ruthensteiner B, 2008, ZOOSYMPOSIA, V1, P63, DOI 10.11646/zoosymposia.1.1.8; Shepherd D, 1996, DEVELOPMENT, V122, P2375; Sigwart JD, 2015, STRUCTURE EVOLUTION; Sigwart JD, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-7; Sigwart JD, 2010, INVERTEBR SYST, V24, P560, DOI 10.1071/IS10028; Sigwart JD, 2009, J NAT HIST, V43, P447, DOI 10.1080/00222930802604157; Speiser DI, 2011, CURR BIOL, V21, P665, DOI 10.1016/j.cub.2011.03.033; Usui-Ishihara A, 2000, DEV BIOL, V225, P357, DOI 10.1006/dbio.2000.9838; Voronezhskaya EE, 2002, J COMP NEUROL, V444, P25, DOI 10.1002/cne.10130; Williams DW, 1999, J NEUROBIOL, V39, P275, DOI 10.1002/(SICI)1097-4695(199905)39:2<275::AID-NEU11>3.0.CO;2-0	31	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137119	10.1371/journal.pone.0137119	http://dx.doi.org/10.1371/journal.pone.0137119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366861	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100050
J	Sundin, J; Rangel, I; Repsilber, D; Brummer, RJ				Sundin, Johanna; Rangel, Ignacio; Repsilber, Dirk; Brummer, Robert-Jan			Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; DYSFUNCTION; ACTIVATION; BUTYRATE; COLITIS; CELLS; GUT	Background Microbial dysbiosis and prolonged immune activation resulting in low-grade inflammation and intestinal barrier dysfunction have been suggested to be underlying causes of post-infectious irritable bowel syndrome (PI-IBS). The aim of this study was to evaluate the difference in cytokine response between mucosal specimens of PI-IBS patients and healthy controls (HC) after ex vivo stimulation with key anaerobic bacteria. Methods Colonic biopsies from 11 PI-IBS patients and 10 HC were stimulated ex vivo with the commensal bacteria Bacteroides ovatus, Ruminococcus gnavus, Akkermansia muciniphila, Subdoligranulum variabile and Eubacterium limosum, respectively. The cytokine release (IL-1 beta, IL-2, IL-8, IL-10, IL-13, IL-17, TNF-alpha and IFN-gamma) in stimulation supernatants was analyzed using the LUMINEX assay. Comparison of cytokine release between PI-IBS patients and healthy controls was performed taking both unstimulated and bacterially stimulated mucosal specimens into account. Key Results IL-13 release from mucosal specimens without bacterial stimulation was significantly lower in PI-IBS patients compared to HC (p < 0.05). After stimulation with Subdoligranulum variabile, IL-1 beta release from PI-IBS patients was significantly increased compared to HC (p < 0.05). Stimulation with Eubacterium limosum resulted in a significantly decreased IL-10 release in HC compared to PI-IBS patients (p < 0.05) and a tendency to decreased IL-13 release in HC compared to PI-IBS patients (p = 0.07). Conclusions & Inferences PI-IBS patients differ from HC with regard to cytokine release ex vivo after stimulation with selected commensal bacteria. Hence, our results support that the pathogenesis of PI-IBS comprises an altered immune response against commensal gut microbes.	[Sundin, Johanna; Rangel, Ignacio; Repsilber, Dirk; Brummer, Robert-Jan] Univ Orebro, Fac Med & Hlth, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden	Orebro University	Sundin, J (corresponding author), Univ Orebro, Fac Med & Hlth, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden.	Johanna.sundin@oru.se			Medical Faculty, Orebro University	Medical Faculty, Orebro University	Johanna Sundin is supported by a grant from the Medical Faculty, Orebro University.	[Anonymous], 2014, COMP FIS; Barbara G, 2012, J CLIN GASTROENTEROL, V46, pS52, DOI 10.1097/MCG.0b013e318264e918; Belmonte L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042777; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Brint EK, 2011, AM J GASTROENTEROL, V106, P329, DOI 10.1038/ajg.2010.438; Brown EM, 2013, NAT IMMUNOL, V14, P660, DOI 10.1038/ni.2611; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Darkoh C, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093144, DOI 10.1371/J0URNAL.P0NE.0093144]; Degnan BA, 1997, CURR MICROBIOL, V34, P290, DOI 10.1007/s002849900184; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; FALK P, 1990, J BIOCHEM-TOKYO, V108, P466, DOI 10.1093/oxfordjournals.jbchem.a123223; Guilarte M, 2007, GUT, V56, P203, DOI 10.1136/gut.2006.100594; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; Jalanka-Tuovinen J, 2014, GUT, V63, P1737, DOI 10.1136/gutjnl-2013-305994; Kanauchi O, 2006, WORLD J GASTROENTERO, V12, P1071, DOI 10.3748/wjg.v12.i7.1071; Kanauchi O, 2010, INT J MOL MED, V25, P547, DOI 10.3892/ijmm_00000376; Kindt S, 2009, NEUROGASTROENT MOTIL, V21, P389, DOI 10.1111/j.1365-2982.2008.01220.x; Kumawat AK, 2013, J CROHNS COLITIS, V7, P694, DOI [10.1016/j.crohns.2013.04.019, 10.1016/j.crohns.2012.08.014]; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Marshall JK, 2004, ALIMENT PHARM THER, V20, P1317, DOI 10.1111/j.1365-2036.2004.02284.x; Martinez C, 2012, GUT LIVER, V6, P305, DOI 10.5009/gnl.2012.6.3.305; Matsuoka K, 2014, SEMIN IMMUNOPATHOL; McKernan DP, 2011, ALIMENT PHARM THER, V33, P1045, DOI 10.1111/j.1365-2036.2011.04624.x; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Lucas MO, 2010, REV ESP ENFERM DIG, V102, P637; Ouwerkerk JP, 2013, BEST PRACT RES CL GA, V27, P25, DOI 10.1016/j.bpg.2013.03.001; Quigley EMM, 2012, J CLIN GASTROENTEROL, V46, P356, DOI 10.1097/MCG.0b013e318247157c; Rinttila T, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-6; Rodriguez-Fandino O, 2013, NEUROGASTROENT MOTIL, V25, P872, DOI 10.1111/nmo.12204; Spiller RC, 2000, GUT, V47, P804, DOI 10.1136/gut.47.6.804; Spiller RC, 2004, BEST PRACT RES CL GA, V18, P641, DOI 10.1016/j.bpg.2004.04.002; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Sundin J, 2015, ALIMENT PHARM THER, V41, P342, DOI 10.1111/apt.13055; Sundin J, 2014, SCAND J GASTROENTERO, V49, P1068, DOI 10.3109/00365521.2014.926982	36	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0134836	10.1371/journal.pone.0134836	http://dx.doi.org/10.1371/journal.pone.0134836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366730	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100007
J	Adams, R; Nicke, B; Pohlenz, HD; Sohler, F				Adams, Robert; Nicke, Barbara; Pohlenz, Hans-Dieter; Sohler, Florian			Deciphering Seed Sequence Based Off-Target Effects in a Large-Scale RNAi Reporter Screen for E-Cadherin Expression	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SIGNALING PATHWAY; GENE-EXPRESSION; ZEB1; EMT; GROWTH; MYB; IDENTIFICATION; TRANSCRIPTS; ACTIVATION	Functional RNAi based screening is affected by large numbers of false positive and negative hits due to prevalent sequence based off-target effects. We performed a druggable genome targeting siRNA screen intended to identify novel regulators of E-cadherin (CDH1) expression, a known key player in epithelial mesenchymal transition (EMT). Analysis of primary screening results indicated a large number of false-positive hits. To address these crucial difficulties we developed an analysis method, SENSORS, which, similar to published methods, is a seed enrichment strategy for analyzing siRNA off-targets in RNAi screens. Using our approach, we were able to demonstrate that accounting for seed based off-target effects stratifies primary screening results and enables the discovery of additional screening hits. While traditional hit detection methods are prone to false positive results which are undetected, we were able to identify false positive hits robustly. Transcription factor MYBL1 was identified as a putative novel target required for CDH1 expression and verified experimentally. No siRNA pool targeting MYBL1 was present in the used siRNA library. Instead, MYBL1 was identified as a putative CDH1 regulating target solely based on the SENSORS off-target score, i.e. as a gene that is a cause for off-target effects down regulating E-cadherin expression.	[Adams, Robert; Nicke, Barbara; Pohlenz, Hans-Dieter; Sohler, Florian] Bayer Pharma AG, BPH GDD GTRG CIPL, D-13353 Berlin, Germany; [Adams, Robert] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Humboldt University of Berlin	Adams, R (corresponding author), Bayer Pharma AG, BPH GDD GTRG CIPL, Muellerstr 178, D-13353 Berlin, Germany.	robert.adams@bayer.com		Sohler, Florian/0000-0003-4276-0238	Bayer Pharma AG	Bayer Pharma AG	Bayer Pharma AG provided support for this work in the form of salaries for authors RA, BN, HDP and FS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Ellenrieder V, 2001, CANCER RES, V61, P4222; Franceschini A, 2014, P NATL ACAD SCI USA, V111, P4548, DOI 10.1073/pnas.1402353111; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henderson MC, 2011, MOL CANCER RES, V9, P724, DOI 10.1158/1541-7786.MCR-10-0436; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Hugo HJ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3580; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; Muta H, 1996, JPN J CANCER RES, V87, P843, DOI 10.1111/j.1349-7006.1996.tb02109.x; Pieraccioli M, 2013, CELL CYCLE, V12, P2309, DOI 10.4161/cc.25405; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schmidt CR, 2004, SURGERY, V136, P303, DOI 10.1016/j.surg.2004.05.004; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Swanton C, 2007, CELL CYCLE, V6, P2001, DOI 10.4161/cc.6.16.4538; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wickham H., 2009, ELEGANT GRAPHICS FOR	43	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137640	10.1371/journal.pone.0137640	http://dx.doi.org/10.1371/journal.pone.0137640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361354	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100061
J	Resni, N; Repnik, U; Kreft, ME; Sepcic, K; Macek, P; Turk, B; Veranic, P				Resni, Natasa; Repnik, Urska; Kreft, Mateja Erdani; Sepcic, Kristina; Macek, Peter; Turk, Boris; Veranic, Peter			Highly Selective Anti-Cancer Activity of Cholesterol-Interacting Agents Methyl-beta-Cyclodextrin and Ostreolysin A/Pleurotolysin B Protein Complex on Urothelial Cancer Cells	PLOS ONE			English	Article							LIPID RAFTS; MEMBRANE CHOLESTEROL; OYSTER MUSHROOM; PLASMA-MEMBRANE; BLADDER-CANCER; METABOLISM; BINDING; TUMORS; CARCINOGENESIS; THERAPEUTICS	Cholesterol content can vary distinctly between normal and cancer cells, with elevated levels in cancer cells. Here, we investigated cholesterol sequestration with methyl-beta-cyclodextrin (MCD), and pore-formation with the ostreolysin A/pleurotolysin B (OlyA/PlyB) protein complex that binds to cholesterol/sphingomyelin-rich membrane domains. We evaluated the effects on viability of T24 invasive and RT4 noninvasive human urothelial cancer cells and normal porcine urothelial (NPU) cells. Cholesterol content strongly correlated with cancerous transformation, as highest in the T24 high-grade invasive urothelial cancer cells, and lowest in NPU cells. MCD treatment induced prominent cell death of T24 cells, whereas OlyA/PlyB treatment resulted in greatly decreased viability of the RT4 low-grade noninvasive carcinoma cells. Biochemical and transmission electron microscopy analyses revealed that MCD and OlyA/PlyB induce necrotic cell death in these cancer cells, while viability of NPU cells was not significantly affected by either treatment. We conclude that MCD is more toxic for T24 high-grade invasive urothelial cancer cells, and OlyA/PlyB for RT4 low-grade noninvasive urothelial cancer cells, and neither is toxic for NPU cells. The cholesterol and cholesterol/sphingomyelin-rich membrane domains in urothelial cancer cells thus constitute a selective therapeutic target for elimination of urothelial cancer cells.	[Resni, Natasa; Kreft, Mateja Erdani; Veranic, Peter] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Repnik, Urska; Turk, Boris] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Ljubljana, Slovenia; [Sepcic, Kristina; Macek, Peter] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Veranic, P (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Vrazov Trg 2, Ljubljana, Slovenia.	peter.veranic@mf.uni-lj.si	Veranic, Peter/I-6276-2015; Maček, Peter/U-4662-2017; Sepcic, Kristina/S-5533-2018; Maček, Peter/Y-9877-2019	Veranic, Peter/0000-0003-1999-9988; Maček, Peter/0000-0001-6470-7759; Sepcic, Kristina/0000-0002-4023-5379; Maček, Peter/0000-0001-6470-7759; Kreft, Mateja Erdani/0000-0001-6486-165X; Turk, Boris/0000-0002-9007-5764	Slovenian Research Agency [P3-0108, P1-0207, P1-0140, J1-4305]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was funded by Slovenian Research Agency (http://www.arrs.gov.si/en/agencija), grants P3-0108, P1-0207, P1-0140, and J1-4305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal G, 2013, PHARM DEV TECHNOL, V18, P916, DOI 10.3109/10837450.2011.609993; Antalis CJ, 2011, CLIN EXP METASTAS, V28, P733, DOI 10.1007/s10585-011-9405-9; BENNIS A, 1993, ANN CARDIOL ANGEIOL, V42, P173; Berne S, 2002, BBA-GEN SUBJECTS, V1570, P153, DOI 10.1016/S0304-4165(02)00190-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng JL, 2006, BIOCHEM BIOPH RES CO, V351, P246, DOI 10.1016/j.bbrc.2006.10.042; Chowdhury HH, 2008, TOXICON, V51, P1345, DOI 10.1016/j.toxicon.2008.03.010; Cruz PMR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00119; DEBOER WI, 1993, INT J CANCER, V54, P1022, DOI 10.1002/ijc.2910540627; Fedida-Metula S, 2008, CARCINOGENESIS, V29, P1546, DOI 10.1093/carcin/bgn146; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Funahashi H, 2008, PANCREAS, V36, P353, DOI 10.1097/MPA.0b013e31815ccc44; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; Harikumar KG, 2013, LIPIDS, V48, P231, DOI 10.1007/s11745-012-3744-4; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Hong YM, 2008, UROLOGY, V71, P131, DOI 10.1016/j.urology.2007.08.014; Jerman UD, 2014, TISSUE ENG PART C-ME, V20, P317, DOI [10.1089/ten.TEC.2013.0298, 10.1089/ten.tec.2013.0298]; Kaufman DS, 2006, ANN ONCOL, V17, pV106, DOI 10.1093/annonc/mdj963; Kolanjiappan K, 2003, CLIN BIOCHEM, V36, P61, DOI 10.1016/S0009-9120(02)00421-6; Kreft ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038509; Kreft ME, 2010, BIOL CELL, V102, P593, DOI 10.1042/BC20100024; Lange Y, 2013, BIOCHEMISTRY-US, V52, P6950, DOI 10.1021/bi400862q; Lasic E, 2015, REV PHYSL BIOCH PHAR; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li HY, 2003, BLOOD, V101, P3628, DOI 10.1182/blood-2002-07-2283; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lindgren D, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-183; Lokar M, 2012, INT J NANOMED, V7, P1891, DOI 10.2147/IJN.S28723; Marco C, 2014, ANTITUMORAL ALKYLPHO; MAY GL, 1988, INT J CANCER, V42, P728, DOI 10.1002/ijc.2910420517; MERCHANT TE, 1995, CANCER, V76, P1715, DOI 10.1002/1097-0142(19951115)76:10<1715::AID-CNCR2820761007>3.0.CO;2-D; Ota K, 2013, BIOCHIMIE; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Rebolj K, 2006, BBA-BIOMEMBRANES, V1758, P1662, DOI 10.1016/j.bbamem.2006.06.003; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Rudling M, 1998, AM J PATHOL, V153, P1923, DOI 10.1016/S0002-9440(10)65706-9; Sandal S, 2009, CELL BIOCHEM FUNCT, V27, P155, DOI 10.1002/cbf.1549; Sauer LA, 2007, J NUTR BIOCHEM, V18, P637, DOI 10.1016/j.jnutbio.2006.12.009; Schlumberger S, 2014, FEBS LETT, V588, P35, DOI 10.1016/j.febslet.2013.10.038; SCHROEDER F, 1984, CANCER RES, V44, P3262; Schwan C, 2011, J BIOL CHEM, V286, P29356, DOI 10.1074/jbc.M111.261925; See WA, 2009, BJU INT, V103, P1714, DOI 10.1111/j.1464-410X.2008.08274.x; Sepcic K, 2004, FEBS LETT, V575, P81, DOI 10.1016/j.febslet.2004.07.093; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silvente-Poirot S, 2014, SCIENCE, V343, P1445, DOI 10.1126/science.1252787; Silvente-Poirot S, 2012, CURR OPIN PHARMACOL, V12, P673, DOI 10.1016/j.coph.2012.10.004; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Skocaj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092783; VANBLITTERSWIJK WJ, 1982, BIOCHIM BIOPHYS ACTA, V688, P495, DOI 10.1016/0005-2736(82)90361-3; Veranic P, 2009, HISTOCHEM CELL BIOL, V131, P129, DOI 10.1007/s00418-008-0492-x; Visnjar T, 2015, HISTOCHEM CELL BIOL, V143, P95, DOI 10.1007/s00418-014-1265-3; Visnjar T, 2013, IN VITRO CELL DEV-AN, V49, P196, DOI 10.1007/s11626-013-9585-5; VITOLS S, 1994, BLOOD, V84, P2689; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; Zupancic D, 2013, RADIOL ONCOL, V47, P338, DOI 10.2478/raon-2013-0052	57	43	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137878	10.1371/journal.pone.0137878	http://dx.doi.org/10.1371/journal.pone.0137878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361392	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100098
J	Singh, SP; Chand, HS; Gundavarapu, S; Saeed, AI; Langley, RJ; Tesfaigzi, Y; Mishra, NC; Sopori, ML				Singh, Shashi P.; Chand, Hitendra S.; Gundavarapu, Sravanthi; Saeed, Ali Imran; Langley, Raymond J.; Tesfaigzi, Yohannes; Mishra, Neerad C.; Sopori, Mohan L.			HIF-1 alpha Plays a Critical Role in the Gestational Sidestream Smoke-Induced Bronchopulmonary Dysplasia in Mice	PLOS ONE			English	Article							INTUBATED PREMATURE-INFANTS; HYPOXIA-INDUCIBLE FACTORS; FACTOR-KAPPA-B; CANCER-CELLS; RESPIRATORY-DISTRESS; RECEPTOR ANTAGONIST; CHILDRENS HEALTH; LUNG-FUNCTION; P53 ACTIVITY; EXPOSURE	Rationale Smoking during pregnancy increases the risk of bronchopulmonary dysplasia (BPD) and, in mice, gestational exposure to sidestream cigarette smoke (SS) induces BPD-like condition characterized by alveolar simplification, impaired angiogenesis, and suppressed surfactant protein production. Normal fetal development occurs in a hypoxic environment and nicotinic acetylcholine receptors (nAChRs) regulate the hypoxia-inducible factor (HIF)-1 alpha that controls apoptosis and angiogenesis. To understand SS-induced BPD, we hypothesized that gestational SS affected alveolar development through HIF-1 alpha. Methods Pregnant BALB/c mice were exposed to air (control) or SS throughout the gestational period and the 7-day-old lungs of the progeny were examined. Results Gestational SS increased apoptosis of alveolar and airway epithelial cells. This response was associated with increased alveolar volumes, higher levels of proapoptotic factors (FOXO3a, HIPK2, p53, BIM, BIK, and BAX) and the antiangiogenic factor (GAX), and lower levels of antiapoptotic factors (Akt-PI3K, NF-kappa B, HIF-1 alpha, and Bcl-2) in the lung. Although gestational SS increased the cells containing the proangiogenic bombesin-like-peptide, it markedly decreased the expression of its receptor GRPR in the lung. The effects of SS on apoptosis were attenuated by the nAChR antagonist mecamylamine. Conclusions Gestational SS-induced BPD is potentially regulated by nAChRs and associated with downregulation of HIF-1 alpha, increased apoptosis of epithelial cells, and increased alveolar volumes. Thus, in mice, exposure to sidestream tobacco smoke during pregnancy promotes BPD-like condition that is potentially mediated through the nAChR/HIF-1 alpha pathway.	[Singh, Shashi P.; Gundavarapu, Sravanthi; Langley, Raymond J.; Mishra, Neerad C.; Sopori, Mohan L.] Lovelace Resp Res Inst, Div Immunol, Albuquerque, NM 87108 USA; [Chand, Hitendra S.; Tesfaigzi, Yohannes] Lovelace Resp Res Inst, COPD Program, Albuquerque, NM USA; [Saeed, Ali Imran] Univ New Mexico, Pulm & Crit Care Med, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; University of New Mexico	Sopori, ML (corresponding author), Lovelace Resp Res Inst, Div Immunol, Albuquerque, NM 87108 USA.	msopori@lrri.org	Chand, Hitendra/AAE-7975-2020	Chand, Hitendra/0000-0002-0574-9307	NIH [RO1 HL 125000]; US Army Medical Research and Material Command, Fort Detrick, Maryland [GW093005]; Lovelace Respiratory Research Institute, Albuquerque, NM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command, Fort Detrick, Maryland; Lovelace Respiratory Research Institute, Albuquerque, NM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by the funds from a grant from the NIH (RO1 HL 125000), the US Army Medical Research and Material Command (GW093005), Fort Detrick, Maryland and funds from Lovelace Respiratory Research Institute, Albuquerque, NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif ME, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008308.pub2; Ali K, 2012, THER ADV RESPIR DIS, V6, P115, DOI 10.1177/1753465812436803; Ali Z, 2013, ARCH GYNECOL OBSTET, V288, P325, DOI 10.1007/s00404-013-2753-8; Alphonse RS, 2011, AM J RESP CELL MOL, V44, P146, DOI 10.1165/rcmb.2009-0182OC; Antonucci R, 2004, J PERINAT MED, V32, P272, DOI 10.1515/JPM.2004.051; Ashour K, 2006, AM J RESP CRIT CARE, V173, P1377, DOI 10.1164/rccm.200507-1014OC; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Ballard HO, 2011, PEDIATR PULM, V46, P111, DOI 10.1002/ppul.21352; Baraldi E, 2009, EARLY HUM DEV, V85, pS1, DOI 10.1016/j.earlhumdev.2009.08.002; Been JV, 2014, LANCET; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bourbia A, 2006, ARCH DIS CHILD-FETAL, V91, pF36, DOI 10.1136/adc.2003.045807; Bridges JP, 2012, DEV BIOL, V362, P24, DOI 10.1016/j.ydbio.2011.10.033; Brostrom EB, 2010, RESP MED, V104, P362, DOI 10.1016/j.rmed.2009.10.008; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Callaghan WM, 2006, PEDIATRICS, V118, P1566, DOI 10.1542/peds.2006-0860; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chakraborty D, 2012, CELL CYCLE, V11, P2427, DOI 10.4161/cc.20542; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; de Blic J, 2011, REV MAL RESPIR, V28, P187, DOI 10.1016/j.rmr.2010.10.029; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Eriksson L, 2013, PEDIAT PULMONOL; Gall S, 2014, EUR HEART J; Gough A, 2014, EUR RESPIR J, V43, P808, DOI 10.1183/09031936.00039513; Guerra S, 2013, THORAX, V68, P1021, DOI 10.1136/thoraxjnl-2013-203538; Hohla F, 2010, CELL CYCLE, V9, P1738, DOI 10.4161/cc.9.9.11347; Hori YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073875; Hylkema Machteld N, 2009, Proc Am Thorac Soc, V6, P660, DOI 10.1513/pats.200907-065DP; Iosef C, 2012, AM J PHYSIOL-LUNG C, V302, pL1023, DOI 10.1152/ajplung.00230.2011; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jeong YJ, 2013, TOXICOL APPL PHARM, V273, P542, DOI 10.1016/j.taap.2013.09.027; KERTESZ NJ, 1992, PROSTAG LEUKOTR ESS, V45, P159, DOI 10.1016/0952-3278(92)90233-9; Koksal N, 2012, EUR CYTOKINE NETW, V23, P29, DOI 10.1684/ecn.2012.0304; Levine CR, 2005, PEDIATR RES, V58, P15, DOI 10.1203/01.PDR.0000156371.89952.35; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Lv YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083312; Mao YB, 2013, ONCOL LETT, V6, P169, DOI 10.3892/ol.2013.1316; Martinez FD, 1997, CIBA F SYMP, V206, P233; Merritt TA, 2009, SEMIN FETAL NEONAT M, V14, P345, DOI 10.1016/j.siny.2009.08.009; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; Narang Indra, 2010, Chron Respir Dis, V7, P259, DOI 10.1177/1479972310375454; Nardinocchi L, 2011, AGING-US, V3, P33, DOI 10.18632/aging.100254; Nikrad M, 2005, MOL CANCER THER, V4, P443; PARKER DJP, 1992, J EPIDEMIOL COMMUN H, V46, P8, DOI 10.1136/jech.46.1.8; Patel S, 2005, CANCER RES, V65, P1414, DOI 10.1158/0008-5472.CAN-04-3431; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Petronilho Fabricia, 2007, Inflammation & Allergy Drug Targets, V6, P197; Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P457, DOI 10.2307/3454537; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Puca R, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-85; Ryan RM, 2014, AM J PHYSL LUNG CELL; Saini Y, 2008, J BIOL CHEM, V283, P33650, DOI 10.1074/jbc.M805927200; Sandberg K, 2004, PEDIATR RES, V56, P432, DOI 10.1203/01.PDR.0000136276.52104.61; Sayegh AI, 2013, PROG MOL BIOL TRANSL, V114, P343, DOI 10.1016/B978-0-12-386933-3.00010-8; SHAH SS, 2003, COCHRANE DB SYST REV; Shi DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043898; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Singh SP, 2013, ENVIRON HEALTH PERSP, V121, P957, DOI 10.1289/ehp.1306611; Singh SP, 2011, J IMMUNOL, V187, P4542, DOI 10.4049/jimmunol.1101567; Singh SP, 2009, J IMMUNOL, V183, P2115, DOI 10.4049/jimmunol.0900826; Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175; Subramaniam M, 2007, AM J RESP CRIT CARE, V176, P902, DOI 10.1164/rccm.200611-1734OC; Thomas M, 2013, PRIM CARE RESP J, V22, P101, DOI 10.4104/pcrj.2013.00025; Thomsen MS, 2012, CURR DRUG TARGETS, V13, P707, DOI 10.2174/138945012800399035; Vadivel A, 2014, AM J RESP CELL MOL, V50, P96, DOI 10.1165/rcmb.2012-0250OC; vom Hove M, 2014, J PEDIATR-US, V164, P40, DOI 10.1016/j.jpeds.2013.07.045; Wright CJ, 2011, PEDIATRICS, V128, P111, DOI 10.1542/peds.2010-3875; Wu ZX, 2009, ENVIRON HEALTH PERSP, V117, P1434, DOI 10.1289/ehp.0800511; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yamashita T, 2008, MOL CELL BIOL, V28, P1285, DOI 10.1128/MCB.01332-07; Zambrano CA, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.111; Zhang QZ, 2007, CLIN CANCER RES, V13, P4686, DOI 10.1158/1078-0432.CCR-06-2898	74	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137757	10.1371/journal.pone.0137757	http://dx.doi.org/10.1371/journal.pone.0137757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361040	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100083
J	M'Kadmi, C; Leyris, JP; Onfroy, L; Gales, C; Sauliere, A; Gagne, D; Damian, M; Mary, S; Maingot, M; Denoyelle, S; Verdie, P; Fehrentz, JA; Martinez, J; Baneres, JL; Marie, J				M'Kadmi, Celine; Leyris, Jean-Philippe; Onfroy, Lauriane; Gales, Celine; Sauliere, Aude; Gagne, Didier; Damian, Marjorie; Mary, Sophie; Maingot, Mathieu; Denoyelle, Severine; Verdie, Pascal; Fehrentz, Jean-Alain; Martinez, Jean; Baneres, Jean-Louis; Marie, Jacky			Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE SECRETAGOGUE; PROTEIN-COUPLED RECEPTORS; PHARMACOLOGICAL IN-VITRO; CONSTITUTIVE ACTIVITY; FUNCTIONAL SELECTIVITY; BODY-WEIGHT; FOOD-INTAKE; POTENT; LIGANDS; 1,2,4-TRIAZOLE	Background: GHS-R1a activates multiple signaling pathways mediating feeding and addictive behaviors. Results: Some GHS-R1a ligands activate G(q) but not G(i/o) and fail to recruit beta-arrestin2; others act as selective inverse agonists at G(q) compared with G(13). Conclusion: Synthetic ligands can selectively activate or reverse G(q)-dependent signaling at GHS-R1a. Significance: Ligand-biased signaling can be exploited for the development of selective drugs to treat GHS-R1a-mediated disorders. The G protein-coupled receptor GHS-R1a mediates ghrelin-induced growth hormone secretion, food intake, and reward-seeking behaviors. GHS-R1a signals through G(q), G(i/o), G(13), and arrestin. Biasing GHS-R1a signaling with specific ligands may lead to the development of more selective drugs to treat obesity or addiction with minimal side effects. To delineate ligand selectivity at GHS-R1a signaling, we analyzed in detail the efficacy of a panel of synthetic ligands activating the different pathways associated with GHS-R1a in HEK293T cells. Besides beta-arrestin2 recruitment and ERK1/2 phosphorylation, we monitored activation of a large panel of G protein subtypes using a bioluminescence resonance energy transfer-based assay with G protein-activation biosensors. We first found that unlike full agonists, G(q) partial agonists were unable to trigger beta-arrestin2 recruitment and ERK1/2 phosphorylation. Using G protein-activation biosensors, we then demonstrated that ghrelin promoted activation of G(q), G(i1), G(i2), G(i3), G(oa), G(ob), and G(13) but not G(s) and G(12). Besides, we identified some GHS-R1a ligands that preferentially activated G(q) and antagonized ghrelin-mediated G(i)/G(o) activation. Finally, we unambiguously demonstrated that in addition to G(q), GHS-R1a also promoted constitutive activation of G(13). Importantly, we identified some ligands that were selective inverse agonists toward G(q) but not of G(13). This demonstrates that bias at GHS-R1a signaling can occur not only with regard to agonism but also to inverse agonism. Our data, combined with other in vivo studies, may facilitate the design of drugs selectively targeting individual signaling pathways to treat only the therapeutically relevant function.	[M'Kadmi, Celine; Gagne, Didier; Damian, Marjorie; Mary, Sophie; Maingot, Mathieu; Denoyelle, Severine; Verdie, Pascal; Fehrentz, Jean-Alain; Martinez, Jean; Baneres, Jean-Louis; Marie, Jacky] Univ Montpellier, CNRS, ENSCM, IBMM,UMR 5247,Fac Pharm, F-34093 Montpellier 05, France; [Leyris, Jean-Philippe] Hop St Eloi, Inst Neurosci Montpellier, F-34091 Montpellier 05, France; [Onfroy, Lauriane; Gales, Celine; Sauliere, Aude] Univ Toulouse 3, Inst Malad Metabol & Cardiovasc, Ctr Hosp Univ Toulouse, INSERM,U1048, F-31432 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Marie, J (corresponding author), Univ Montpellier, CNRS, ENSCM, IBMM,UMR 5247,Fac Pharm, 15 Ave Charles Flahault,BP 14491, F-34093 Montpellier 05, France.	jacky.marie@univ-montp1.fr	verdie, pascal/AAM-4228-2020; Martinez, Jean/R-9421-2019	Martinez, Jean/0000-0002-9267-4621; Baneres, jean-louis/0000-0001-7078-1285; GALES, Celine/0000-0002-4938-1583	INSERM; CNRS; Universite de Montpellier, Agence Nationale de la Recherche Grant [PCV08-323163]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Montpellier, Agence Nationale de la Recherche Grant(French National Research Agency (ANR))	This work was supported by grants from INSERM, CNRS, and Universite de Montpellier, Agence Nationale de la Recherche Grant PCV08-323163. The authors declare that they have no conflicts of interest with the contents of this article.	Akamizu T, 2012, EUR J INTERN MED, V23, P197, DOI 10.1016/j.ejim.2011.12.001; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Callaghan B, 2014, PHARMACOL REV, V66, P984, DOI 10.1124/pr.113.008433; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Chollet C, 2009, J PEPT SCI, V15, P711, DOI 10.1002/psc.1177; Costantini VJA, 2011, NEUROENDOCRINOLOGY, V94, P158, DOI 10.1159/000328968; Cruz CRY, 2008, VITAM HORM, V77, P47, DOI 10.1016/S0083-6729(06)77004-2; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Delporte C., 2013, SCIENTIFICA, V2013, DOI DOI 10.1155/2013/518909; Els S, 2012, J MED CHEM, V55, P7437, DOI 10.1021/jm300414b; Evron T, 2014, J BIOL CHEM, V289, P33442, DOI 10.1074/jbc.M114.581397; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Guerlavais V, 2003, J MED CHEM, V46, P1191, DOI 10.1021/jm020985q; Halem HA, 2004, EUR J ENDOCRINOL, V151, pS71, DOI 10.1530/eje.0.151S071; Hansson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050409; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Holst B, 2006, MOL PHARMACOL, V70, P936, DOI 10.1124/mol.106.024422; Holubova M, 2013, PHYSIOL RES, V62, P435, DOI 10.33549/physiolres.932488; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Leyris JP, 2011, ANAL BIOCHEM, V408, P253, DOI 10.1016/j.ab.2010.09.030; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Mary S, 2012, P NATL ACAD SCI USA, V109, P8304, DOI 10.1073/pnas.1119881109; Maudsley S, 2012, MINI-REV MED CHEM, V12, P831, DOI 10.2174/138955712800959071; Mear Y, 2014, J CLIN ENDOCR METAB, V99, pE2463, DOI 10.1210/jc.2014-2753; Menzies JRW, 2013, ENDOCR DEV, V25, P101, DOI 10.1159/000346058; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Moulin A, 2007, CHEMMEDCHEM, V2, P1242, DOI 10.1002/cmdc.200700015; Moulin A, 2013, AMINO ACIDS, V44, P301, DOI 10.1007/s00726-012-1355-2; Mousseaux D, 2006, BRIT J PHARMACOL, V148, P350, DOI 10.1038/sj.bjp.0706727; Murphy MG, 2001, J CLIN ENDOCR METAB, V86, P1116, DOI 10.1210/jc.86.3.1116; Nass R, 2011, MOL CELL ENDOCRINOL, V340, P10, DOI 10.1016/j.mce.2011.03.021; Nelson CP, 2007, BIOCHEM PHARMACOL, V73, P737, DOI 10.1016/j.bcp.2006.09.005; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; PATCHETT AA, 1995, P NATL ACAD SCI USA, V92, P7001, DOI 10.1073/pnas.92.15.7001; Pazos Y, 2008, VITAM HORM, V77, P89, DOI 10.1016/S0083-6729(06)77005-4; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Sabbatini FM, 2010, CHEMMEDCHEM, V5, P1450, DOI 10.1002/cmdc.201000185; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Sivertsen B, 2013, BRIT J PHARMACOL, V170, P1349, DOI 10.1111/bph.12361; Sivertsen B, 2011, J BIOL CHEM, V286, P20845, DOI 10.1074/jbc.M110.173237; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yin Y, 2014, INT J MOL SCI, V15, P4837, DOI 10.3390/ijms15034837; Zhou L, 2014, CURR OPIN CELL BIOL, V27, P102, DOI 10.1016/j.ceb.2013.11.010	61	66	66	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27021	27039		10.1074/jbc.M115.659250	http://dx.doi.org/10.1074/jbc.M115.659250			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26363071	Green Published, hybrid			2022-12-26	WOS:000364794000015
J	Yang, DW; Song, DH; Kind, T; Ma, Y; Hoefkens, J; Fiehn, O				Yang, Dawei; Song, Donghui; Kind, Tobias; Ma, Yan; Hoefkens, Jens; Fiehn, Oliver			Lipidomic Analysis of Chlamydomonas reinhardtii under Nitrogen and Sulfur Deprivation	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; FATTY-ACID-COMPOSITION; SHOTGUN LIPIDOMICS; TRIACYLGLYCEROL ACCUMULATION; MEMBRANE-LIPIDS; STARVATION; PHASE; ALGAE	Chlamydomonas reinhardtii accumulates lipids under complete nutrient starvation conditions while overall growth in biomass stops. In order to better understand biochemical changes under nutrient deprivation that maintain production of algal biomass, we used a lipidomic assay for analyzing the temporal regulation of the composition of complex lipids in C. reinhardtii in response to nitrogen and sulfur deprivation. Using a chip-based nanoelectrospray direct infusion into an ion trap mass spectrometer, we measured a diversity of lipid species reported for C. reinhardtii, including PG phosphatidylglycerols, PI Phosphatidylinositols, MGDG monogalactosyldiacylglycerols, DGDG digalactosyldiacylglycerols, SQDG sulfoquinovosyldiacylglycerols, DGTS homoserine ether lipids and TAG triacylglycerols. Individual lipid species were annotated by matching mass precursors and MS/MS fragmentations to the in-house LipidBlast mass spectral database and MS2Analyzer. Multivariate statistics showed a clear impact on overall lipidomic phenotypes on both the temporal and the nutrition stress level. Homoserine-lipids were found up-regulated at late growth time points and higher cell density, while triacyclglycerols showed opposite regulation of unsaturated and saturated fatty acyl chains under nutritional deprivation.	[Yang, Dawei] Taishan Med Univ, Affiliated Liaocheng Hosp, Liaocheng Peoples Hosp, Zhong Yuan Acad Biol Med, Liaocheng 252000, Shandong, Peoples R China; [Song, Donghui] Tianjin Univ Sci & Technol, TEDA, Coll Marine Sci & Engn, Dept Marine Sci, Tianjin 300457, Peoples R China; [Kind, Tobias; Ma, Yan; Fiehn, Oliver] UC Davis Genome Ctr Metabol, Davis, CA 95616 USA; [Fiehn, Oliver] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia; [Hoefkens, Jens] Genedata Inc, Waltham, MA USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Tianjin University Science & Technology; King Abdulaziz University	Fiehn, O (corresponding author), UC Davis Genome Ctr Metabol, Davis, CA 95616 USA.	ofiehn@ucdavis.edu	Kind, Tobias/A-7553-2010	Kind, Tobias/0000-0002-1908-4916	US National Science Foundation [MCB 1139644]; Genedata Inc.	US National Science Foundation(National Science Foundation (NSF)); Genedata Inc.	The work was supported by US National Science Foundation MCB 1139644. Genedata Inc. provided support in the form of a salary for author JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Barupal DK, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-40; Bolling C, 2005, PLANT PHYSIOL, V139, P1995, DOI 10.1104/pp.105.071589; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Dean AP, 2010, BIORESOURCE TECHNOL, V101, P4499, DOI 10.1016/j.biortech.2010.01.065; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fabregas J, 2004, WORLD J MICROB BIOT, V20, P31, DOI 10.1023/B:WIBI.0000013288.67536.ed; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; GIROUD C, 1989, PLANT CELL PHYSIOL, V30, P121, DOI 10.1093/oxfordjournals.pcp.a077705; GIROUD C, 1988, PLANT CELL PHYSIOL, V29, P587; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; James GO, 2011, BIORESOURCE TECHNOL, V102, P3343, DOI 10.1016/j.biortech.2010.11.051; Khotimchenko SV, 2005, PHYTOCHEMISTRY, V66, P73, DOI 10.1016/j.phytochem.2004.10.024; Khozin-Goldberg I, 2006, PHYTOCHEMISTRY, V67, P696, DOI 10.1016/j.phytochem.2006.01.010; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kind T, 2012, J CHROMATOGR A, V1244, P139, DOI 10.1016/j.chroma.2012.04.074; Kind Tobias, 2010, Bioanal Rev, V2, P23, DOI 10.1007/s12566-010-0015-9; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Lee DY, 2012, MOL CELL PROTEOMICS, V11, P973, DOI 10.1074/mcp.M111.016733; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; Li Y, 2008, BIOTECHNOL PROGR, V24, P815, DOI 10.1021/bp070371k; Li YT, 2010, BIOTECHNOL BIOENG, V107, P258, DOI 10.1002/bit.22807; Li YT, 2010, METAB ENG, V12, P387, DOI 10.1016/j.ymben.2010.02.002; Liu BS, 2013, BIORESOURCE TECHNOL, V146, P310, DOI 10.1016/j.biortech.2013.07.088; Lopez-Lara IM, 2005, MOL PLANT MICROBE IN, V18, P973, DOI 10.1094/MPMI-18-0973; Ma Y, 2014, ANAL CHEM, V86, P10724, DOI 10.1021/ac502818e; MacDougall KM, 2011, ANAL BIOANAL CHEM, V401, P2609, DOI 10.1007/s00216-011-5376-6; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Meuser JE, 2009, J BIOTECHNOL, V142, P21, DOI 10.1016/j.jbiotec.2009.01.015; Moellering E. R., 2010, LIPIDS PHOTOSYNTHESI, P139; Paik MJ, 2009, J CHROMATOGR A, V1216, P5917, DOI 10.1016/j.chroma.2009.06.051; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Sato N, 2000, BIOCHEM SOC T, V28, P912, DOI 10.1042/0300-5127:0280912; Schiopu C, 2009, ANAL BIOANAL CHEM, V395, P2465, DOI 10.1007/s00216-009-3188-8; Schwudke D, 2007, METHOD ENZYMOL, V433, P175, DOI 10.1016/S0076-6879(07)33010-3; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Sugimoto K, 2008, BIOCHEM BIOPH RES CO, V369, P660, DOI 10.1016/j.bbrc.2008.02.058; Sugimoto K, 2007, FEBS LETT, V581, P4519, DOI 10.1016/j.febslet.2007.08.035; Sushchik NN, 2003, RUSS J PLANT PHYSL+, V50, P374, DOI 10.1023/A:1023830405898; Tatsuzawa H, 1996, J PHYCOL, V32, P598, DOI 10.1111/j.0022-3646.1996.00598.x; Urzica EI, 2013, J BIOL CHEM, V288, P30246, DOI 10.1074/jbc.M113.490425; Vieler A, 2007, CHEM PHYS LIPIDS, V150, P143, DOI 10.1016/j.chemphyslip.2007.06.224; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Welti R, 2005, HIGH THROUGHPUT LIPI, P307	48	40	44	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137948	10.1371/journal.pone.0137948	http://dx.doi.org/10.1371/journal.pone.0137948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375463	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200063
J	Balakrishnan, SR; Hashim, U; Gopinath, SCB; Poopalan, P; Ramayya, HR; Omar, MI; Haarindraprasad, R; Veeradasan, P				Balakrishnan, S. R.; Hashim, U.; Gopinath, Subash C. B.; Poopalan, P.; Ramayya, H. R.; Omar, M. Iqbal; Haarindraprasad, R.; Veeradasan, P.			A Point-of-Care Immunosensor for Human Chorionic Gonadotropin in Clinical Urine Samples Using a Cuneated Polysilicon Nanogap Lab-on-Chip	PLOS ONE			English	Article							SENSITIVE DETECTION; BETA-HCG; AMPEROMETRIC IMMUNOSENSOR; PROTEIN ADSORPTION; MICROPIPETTE TIP; CARBON NANOTUBES; PHOTOMASK DESIGN; HIGH-THROUGHPUT; BIOSENSOR; IMMUNOASSAY	Human chorionic gonadotropin (hCG), a glycoprotein hormone secreted from the placenta, is a key molecule that indicates pregnancy. Here, we have designed a cost-effective, label-free, in situ point-of-care (POC) immunosensor to estimate hCG using a cuneated 25 nm polysilicon nanogap electrode. A tiny chip with the dimensions of 20.5 x 12.5 mm was fabricated using conventional lithography and size expansion techniques. Furthermore, the sensing surface was functionalized by (3-aminopropyl) triethoxysilane and quantitatively measured the variations in hCG levels from clinically obtained human urine samples. The dielectric properties of the present sensor are shown with a capacitance above 40 nF for samples from pregnant women; it was lower with samples from non-pregnant women. Furthermore, it has been proven that our sensor has a wide linear range of detection, as a sensitivity of 835.88 mu A mIU(-1) ml(-2) cm(-2) was attained, and the detection limit was 0.28 mIU/ml (27.78 pg/ml). The dissociation constant K-d of the specific antigen binding to the anti-hCG was calculated as 2.23 +/- 0.66 mIU, and the maximum number of binding sites per antigen was B-max = 22.54 +/- 1.46 mIU. The sensing system shown here, with a narrow nanogap, is suitable for high-throughput POC diagnosis, and a single injection can obtain triplicate data or parallel analyses of different targets.	[Balakrishnan, S. R.; Hashim, U.; Gopinath, Subash C. B.; Haarindraprasad, R.; Veeradasan, P.] Univ Malaysia Perlis, Inst Nano Elect Engn INEE, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia; [Poopalan, P.] Univ Malaysia Perlis, Sch Microelect Engn, Kuala Perlis, Perlis, Malaysia; [Ramayya, H. R.] Hosp Tuanku Fauziah, Dept Obstet & Gynaecol, Kangar, Perlis, Malaysia; [Omar, M. Iqbal] Univ Malaysia Perlis, Univ Hlth Ctr, Kuala Perlis, Perlis, Malaysia	Universiti Malaysia Perlis; Universiti Malaysia Perlis; Universiti Malaysia Perlis	Hashim, U (corresponding author), Univ Malaysia Perlis, Inst Nano Elect Engn INEE, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia.	uda@unimap.edu.my	Balakrishnan, Sharma Rao/G-4561-2015; Balakrishnan, Sharma Rao/AAP-2889-2021; Gopinath, Subash/D-2953-2015; omar, Mohammad iqbal/AAD-9283-2019; Omar, ye htut @ Mohammad Iqbal/D-1610-2015	Balakrishnan, Sharma Rao/0000-0002-6796-2277; Balakrishnan, Sharma Rao/0000-0002-6796-2277; Gopinath, Subash/0000-0002-8347-4687; POOPALAN, PRABAKARAN/0000-0003-1698-0632; Omar, ye htut @ Mohammad Iqbal/0000-0001-7149-419X; Perumal, Veeradasan/0000-0003-4492-0282	Ministry of Higher Education of Malaysia (MTUN-COE) [9016-00004]	Ministry of Higher Education of Malaysia (MTUN-COE)	This study was supported by Ministry of Higher Education of Malaysia (MTUN-COE grant 9016-00004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimi P, 2011, AFRICAN REV PHYS, P4; Balakrishnan SR, 2014, SENSOR ACTUAT A-PHYS, V220, P101, DOI 10.1016/j.sna.2014.09.027; Bourinbaiar AS, 1997, LIFE SCI, V61, pPL149, DOI 10.1016/S0024-3205(97)00568-7; Cate FL, 2013, CLIN CHIM ACTA, V421, P104, DOI 10.1016/j.cca.2013.02.026; Chai R, 2008, TALANTA, V74, P1330, DOI 10.1016/j.talanta.2007.08.046; Chen J, 2005, BIOSENS BIOELECTRON, V21, P330, DOI 10.1016/j.bios.2004.10.023; Cole LA, 2012, REPROD BIOL ENDOCRIN, P10; Cole LA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-8; Davison CM, 2004, J EMERG MED, V27, P43, DOI 10.1016/j.jemermed.2004.02.009; Docoslis A, 1999, COLLOID SURFACE B, V13, P83, DOI 10.1016/S0927-7765(98)00111-8; Docoslis A, 2001, COLLOID SURFACE B, V22, P267, DOI 10.1016/S0927-7765(01)00150-3; Foo KL, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-429; Gopinath SCB, 2008, ACS NANO, V2, P1885, DOI 10.1021/nn800285p; Gopinath SCB, 2014, BIOSENS BIOELECTRON, V57, P292, DOI 10.1016/j.bios.2014.02.029; Gopinath SCB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081396; Greene DN, 2013, CLIN CHIM ACTA, V415, P317, DOI 10.1016/j.cca.2012.10.053; Gregor CR, 2011, J BIOL CHEM, V286, P25016, DOI 10.1074/jbc.M111.246637; Haarindraprasad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132755; Hsu CW, 2014, BIOSENS BIOELECTRON, V56, P204, DOI 10.1016/j.bios.2014.01.023; Hsu PY, 2009, SENSOR ACTUAT B-CHEM, V142, P273, DOI 10.1016/j.snb.2009.08.003; Jiang ZL, 2008, CLIN CHIM ACTA, V387, P24, DOI 10.1016/j.cca.2007.08.017; Kaushik A, 2014, BIOSENS BIOELECTRON, V53, P499, DOI 10.1016/j.bios.2013.09.060; Kelly LS, 2005, ANAL BIOCHEM, V338, P253, DOI 10.1016/j.ab.2004.12.011; Lei JQ, 2014, BIOSENS BIOELECTRON, V54, P72, DOI 10.1016/j.bios.2013.10.033; Li N, 2008, BIOPROC BIOSYST ENG, V31, P551, DOI 10.1007/s00449-008-0201-0; Li R, 2011, ANAL BIOCHEM, V414, P196, DOI 10.1016/j.ab.2011.03.019; Liao JY, 2007, APPL MICROBIOL BIOT, V74, P1385, DOI 10.1007/s00253-006-0778-7; Lim TK, 2001, BIOSENS BIOELECTRON, V16, P1063, DOI 10.1016/S0956-5663(01)00228-7; Liu D, 2013, SENSOR ACTUAT B-CHEM, V186, P235, DOI 10.1016/j.snb.2013.05.094; Liu JM, 2012, ANAL BIOCHEM, V431, P19, DOI 10.1016/j.ab.2012.08.007; Liu W, 2012, 2012 THIRD CYBERCRIME AND TRUSTWORTHY COMPUTING WORKSHOP (CTC 2012), P56, DOI 10.1109/CTC.2012.9; Lonappan A, 2007, MICROW OPT TECHN LET, V49, P786, DOI 10.1002/mop.22279; Viet NX, 2013, BIOSENS BIOELECTRON, V42, P592, DOI 10.1016/j.bios.2012.11.017; Oh S, 2003, PROC IEEE MICR ELECT, P52; Pan C, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028827, DOI 10.1371/J0URNAL.P0NE.0028827]; Perumal V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12231; Perumal V, 2014, J APPL BIOMED, V12, P1, DOI 10.1016/j.jab.2013.02.001; Piliarik M, 2005, BIOSENS BIOELECTRON, V20, P2104, DOI 10.1016/j.bios.2004.09.025; Prasad PV, 2007, CLIN CHIM ACTA, V376, P52, DOI 10.1016/j.cca.2006.07.013; Qin QP, 1997, J IMMUNOL METHODS, V205, P169, DOI 10.1016/S0022-1759(97)00073-2; Qureshi A, 2010, BIOSENS BIOELECTRON, V25, P2318, DOI 10.1016/j.bios.2010.03.018; Rao B. S., 2012, INT J ENHANCED RES S, V1, P1; Rao BS, 2014, ADV MATER RES-SWITZ, V925, P533, DOI 10.4028/www.scientific.net/AMR.925.533; Rao BS, 2013, ADV MATER RES-SWITZ, V795, P397, DOI 10.4028/www.scientific.net/AMR.795.397; Rao BS, 2013, ADV MATER RES-SWITZ, V795, P388, DOI 10.4028/www.scientific.net/AMR.795.388; Rao BS, 2014, ADV MATER RES-SWITZ, V832, P95, DOI 10.4028/www.scientific.net/AMR.832.95; Rao BS, 2014, ADV MATER RES-SWITZ, V832, P89, DOI 10.4028/www.scientific.net/AMR.832.89; Rao BS, 2013, 2013 IEEE REGIONAL SYMPOSIUM ON MICRO AND NANOELECTRONICS (RSM 2013), P54, DOI 10.1109/RSM.2013.6706471; Rao BS, 2013, 2013 IEEE REGIONAL SYMPOSIUM ON MICRO AND NANOELECTRONICS (RSM 2013), P17, DOI 10.1109/RSM.2013.6706462; Rao BS, 2012, IEEE EMBS CONF BIO; Sanchez S, 2008, ANAL CHEM, V80, P6508, DOI 10.1021/ac7025282; Santandreu M, 1999, ANAL CHIM ACTA, V396, P181, DOI 10.1016/S0003-2670(99)00436-5; SEVERS AH, 1993, BIOSENS BIOELECTRON, V8, P365, DOI 10.1016/0956-5663(93)80075-Z; Sharma MK, 2011, SENSOR LETT, V9, P1363, DOI 10.1166/sl.2011.1681; Tan F, 2007, BIOSENS BIOELECTRON, V22, P2945, DOI 10.1016/j.bios.2006.12.010; Tao ML, 2011, CLIN CHIM ACTA, V412, P550, DOI 10.1016/j.cca.2010.12.004; Teixeira S, 2014, SENSOR ACTUAT B-CHEM, V190, P723, DOI 10.1016/j.snb.2013.09.019; Truong LTN, 2011, TALANTA, V85, P2576, DOI 10.1016/j.talanta.2011.08.018; Wei Q, 2011, SENSOR ACTUAT B-CHEM, V153, P256, DOI 10.1016/j.snb.2010.09.073; Wu YL, 2011, SENSOR ACTUAT B-CHEM, V155, P709, DOI 10.1016/j.snb.2011.01.035; Yang GM, 2011, COLLOID SURFACE A, V389, P195, DOI 10.1016/j.colsurfa.2011.08.027; Yang HC, 2011, ELECTROCHIM ACTA, V56, P1973, DOI 10.1016/j.electacta.2010.12.003; Yang HC, 2011, COLLOID SURFACE B, V82, P463, DOI 10.1016/j.colsurfb.2010.10.003; Yang L, 2014, BIOSENS BIOELECTRON, V57, P199, DOI 10.1016/j.bios.2014.02.019; Yi MQ, 2005, BIOSENS BIOELECTRON, V20, P1320, DOI 10.1016/j.bios.2004.05.003; Yuhi T, 2006, SCI TECHNOL ADV MAT, V7, P276, DOI 10.1016/j.stam.2005.12.008; Yuhi T, 2006, J IMMUNOL METHODS, V312, P54, DOI 10.1016/j.jim.2006.02.011; Zhang GJ, 2012, ANAL CHIM ACTA, V749, P1, DOI 10.1016/j.aca.2012.08.035; Zhu QD, 2015, BIOSENS BIOELECTRON, V66, P370, DOI 10.1016/j.bios.2014.10.083	69	39	39	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137891	10.1371/journal.pone.0137891	http://dx.doi.org/10.1371/journal.pone.0137891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368287	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100169
J	Furman, BT; Peterson, BJ				Furman, Bradley T.; Peterson, Bradley J.			Sexual Recruitment in Zostera marina: Progress toward a Predictive Model	PLOS ONE			English	Article							INDIAN RIVER LAGOON; WATER-QUALITY; CYMODOCEA-NODOSA; GENETIC NEIGHBORHOOD; POSIDONIA-OCEANICA; SIMULATION-MODEL; SEED PRODUCTION; NORTH-CAROLINA; CHESAPEAKE BAY; L EELGRASS	Ecophysiological stress and physical disturbance are capable of structuring meadows through a combination of direct biomass removal and recruitment limitation; however, predicting these effects at landscape scales has rarely been successful. To model environmental influence on sexual recruitment in perennial Zostera marina, we selected a sub-tidal, light-replete study site with seasonal extremes in temperature and wave energy. During an 8-year observation period, areal coverage increased from 4.8 to 42.7%. Gains were stepwise in pattern, attributable to annual recruitment of patches followed by centrifugal growth and coalescence. Recruitment varied from 13 to 4,894 patches per year. Using a multiple linear regression approach, we examined the association between patch appearance and relative wave energy, atmospheric condition and water temperature. Two models were developed, one appropriate for the dispersal of naked seeds, and another for rafted flowers. Results indicated that both modes of sexual recruitment varied as functions of wind, temperature, rainfall and wave energy, with a regime shift in wind-wave energy corresponding to periods of rapid colonization within our site. Temporal correlations between sexual recruitment and time-lagged climatic summaries highlighted floral induction, seed bank and small patch development as periods of vulnerability. Given global losses in seagrass coverage, regions of recovery and re-colonization will become increasingly important. Lacking land-scape-scale process models for seagrass recruitment, temporally explicit statistical approaches presented here could be used to forecast colonization trajectories and to provide managers with real-time estimates of future meadow performance; i.e., when to expect a good year in terms of seagrass expansion. To facilitate use as forecasting tools, we did not use statistical composites or normalized variables as our predictors. This study, therefore, represents a first step toward linking remotely acquired environmental data to sexual recruitment, an important measure of seagrass performance that translates directly into landscape-scale coverage change.	[Furman, Bradley T.; Peterson, Bradley J.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Peterson, BJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	bradley.peterson@stonybrook.edu		Furman, Bradley/0000-0002-9284-8388	Nature Conservancy; Shinnecock Bay Restoration Program	Nature Conservancy; Shinnecock Bay Restoration Program	The authors received no specific funding for this work. Partial support for investigator salaries were provided by The Nature Conservancy and the Shinnecock Bay Restoration Program.	Becheler R, 2010, MOL ECOL, V19, P2394, DOI 10.1111/j.1365-294X.2010.04649.x; Bekkby T, 2008, ICES J MAR SCI, V65, P1093, DOI 10.1093/icesjms/fsn095; Bell SS, 1997, RESTOR ECOL, V5, P318, DOI 10.1046/j.1526-100X.1997.00545.x; Bergenius MAJ, 2005, MAR BIOL, V147, P291, DOI 10.1007/s00227-005-1575-z; Biber PD, 2008, ESTUAR COAST, V31, P177, DOI 10.1007/s12237-007-9023-6; Billingham MR, 2007, MAR BIOL, V152, P793, DOI 10.1007/s00227-007-0730-0; Brun FG, 2006, MAR ECOL PROG SER, V323, P133, DOI 10.3354/meps323133; Burdick DM, 2006, INTERACTIVE GIS BASE; Burke MK, 1996, MAR ECOL PROG SER, V137, P195, DOI 10.3354/meps137195; Cheplick Gregory P., 1998, P84, DOI 10.1017/CBO9780511525445.005; CHURCHILL AC, 1978, AQUAT BOT, V4, P83; Clarke KR, 2006, J EXP MAR BIOL ECOL, V338, P179, DOI 10.1016/j.jembe.2006.06.019; Costello CT, 2011, ESTUAR COAST, V34, P232, DOI 10.1007/s12237-010-9371-5; Cunha AH, 2009, ESTUAR COAST SHELF S, V84, P584, DOI 10.1016/j.ecss.2009.07.030; Doheny TE, 1968, CONTR DEP CONSERV WA; Downie AL, 2013, ESTUAR COAST SHELF S, V121, P8, DOI 10.1016/j.ecss.2012.12.020; Duarte CM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P271; Duarte CM, 2007, ESTUAR COAST, V30, P652, DOI 10.1007/BF02841962; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P97, DOI 10.3354/meps067097; Fonseca MS, 1998, MAR ECOL PROG SER, V171, P109, DOI 10.3354/meps171109; FONSECA MS, 1995, RESTOR ECOL, V3, P70; Fourqurean JW, 2003, ECOL APPL, V13, P474, DOI 10.1890/1051-0761(2003)013[0474:FROSDT]2.0.CO;2; Furman BT, 2015, LIMNOLOGICAL OCEANOG, V60; Gallegos CL, 1996, ESTUAR COAST SHELF S, V42, P267, DOI 10.1006/ecss.1996.0020; Goodenough AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034338; Granger S, 2003, PRACTICAL GUIDE USE, P20; Grech A, 2010, AQUAT CONSERV, V20, P437, DOI 10.1002/aqc.1107; Greve TM, 2005, AQUAT BOT, V82, P143, DOI 10.1016/j.aquabot.2005.03.004; Greve TM, 2005, MAR BIOL, V146, P849, DOI 10.1007/s00227-004-1498-0; Guidetti P, 2002, MAR ECOL-P S Z N I, V23, P51, DOI 10.1046/j.1439-0485.2002.02722.x; Hammerli A, 2003, HEREDITY, V91, P448, DOI 10.1038/sj.hdy.6800310; HARRISON PG, 1993, AQUAT BOT, V45, P63, DOI 10.1016/0304-3770(93)90053-Y; Infantes E, 2011, LIMNOL OCEANOGR, V56, P2223, DOI 10.4319/lo.2011.56.6.2223; Infantes E, 2009, BOT MAR, V52, P419, DOI 10.1515/BOT.2009.050; Jarvis JC, 2014, AQUAT BOT, V113, P32, DOI 10.1016/j.aquabot.2013.10.010; Kemp WM, 2004, ESTUARIES, V27, P363; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; Kendrick GA, 2012, BIOSCIENCE, V62, P56, DOI 10.1525/bio.2012.62.1.10; LANYON JM, 1995, AQUAT BOT, V49, P217, DOI 10.1016/0304-3770(94)00435-O; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Lee KS, 2007, MAR ECOL PROG SER, V342, P105, DOI 10.3354/meps342105; Marba N, 2003, AQUAT BOT, V77, P87, DOI 10.1016/S0304-3770(03)00079-2; March D, 2013, ESTUAR COAST SHELF S, V131, P206, DOI 10.1016/j.ecss.2013.08.009; McMahon K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0878; Mills KE, 2003, MAR ECOL PROG SER, V255, P127, DOI 10.3354/meps255127; Moore KA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P361; Morris LJ, 2004, ESTUARIES, V27, P915, DOI 10.1007/BF02803418; OLESEN B, 1994, MAR ECOL PROG SER, V106, P147, DOI 10.3354/meps106147; Orth RJ, 2000, MAR ECOL PROG SER, V200, P277, DOI 10.3354/meps200277; ORTH RJ, 1983, AQUAT BOT, V15, P117, DOI 10.1016/0304-3770(83)90023-2; PHILLIPS RC, 1983, AQUAT BOT, V16, P1, DOI 10.1016/0304-3770(83)90047-5; Plus M, 2003, AQUAT BOT, V77, P121, DOI 10.1016/S0304-3770(03)00089-5; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Reusch TBH, 1999, MAR BIOL, V133, P519, DOI 10.1007/s002270050492; Ruckelshaus MH, 1996, EVOLUTION, V50, P856, DOI 10.1111/j.1558-5646.1996.tb03894.x; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; SILBERHORN GM, 1983, AQUAT BOT, V15, P133, DOI 10.1016/0304-3770(83)90024-4; Sintes T, 2006, ESTUAR COAST, V29, P72, DOI 10.1007/BF02784700; USACE, 2004, SUBM AQ VEG SAV BED; van Katwijk MM, 2010, BIOL CONSERV, V143, P248, DOI 10.1016/j.biocon.2009.08.014; VERHAGEN JHG, 1983, MAR ECOL PROG SER, V10, P187, DOI 10.3354/meps010187; Vermaat JE, 2009, PERSPECT PLANT ECOL, V11, P137, DOI 10.1016/j.ppees.2009.01.002; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Waycott M, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P25; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wong S, 2011, ECOL INFORM, V6, P127, DOI 10.1016/j.ecoinf.2010.11.004; Zar JH, 1999, BIOSTATISTICAL ANAL; Zharova N, 2001, AQUAT BOT, V70, P135, DOI 10.1016/S0304-3770(01)00151-6; Zipperle AM, 2011, ANN BOT-LONDON, V107, P127, DOI 10.1093/aob/mcq214	70	7	7	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138206	10.1371/journal.pone.0138206	http://dx.doi.org/10.1371/journal.pone.0138206			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368792	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100242
J	Jagarlamudi, KK; Moreau, L; Westberg, S; Ronnberg, H; Eriksson, S				Jagarlamudi, Kiran Kumar; Moreau, Laura; Westberg, Sara; Ronnberg, Henrik; Eriksson, Staffan			A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; CANINE LYMPHOMA; PROLIFERATION MARKER; LYMPHOCYTIC-LEUKEMIA; PROGNOSTIC VALUE; SOLID TUMORS; ASSAY; BIOMARKER; ANTIBODY; CANCER	Thymidine kinase 1 (TK1) is a DNA precursor enzyme whose expression is closely correlated with cell proliferation and cell turnover. Sensitive serum TK1 activity assays have been used for monitoring and prognosis of hematological malignancies in both humans and dogs. Here we describe the development of a specific sandwich TK1-ELISA for the quantification of TK1 protein levels in sera from dogs with different malignancies. A combination of rabbit polyclonal anti-dog TK1 antibody and a mouse monoclonal anti-human TK1 antibody was used. Different concentrations of recombinant canine TK1 was used as standard. Clinical evaluation of the ELISA was done by using sera from 42 healthy dogs, 43 dogs with hematological tumors and 55 with solid tumors. An established [H-3]-dThd phosphorylation assay was used to determine the TK1 activity levels in the same sera. The mean TK1 activities in dogs with hematological tumors were significantly higher than those found in healthy dogs. In agreement with earlier studies, no significant difference was observed in serum TK1 activities between healthy dogs and dogs with solid tumors. However, the mean TK1 protein levels determined by new TK1-ELISA were significantly higher not only in hematological tumors but also in solid tumors compared to healthy dogs (mean +/- SD = 1.30 +/- 1.16, 0.67 +/- 0.55 and 0.27 +/- 0.10 ng/mL, respectively). Moreover, TK1-ELISA had significantly higher ability to distinguish lymphoma cases from healthy based on receiver operating characteristic analyses (area under the curve, AUC, of 0.96) to that of the activity assay (AUC, 0.84). Furthermore, fluctuations in TK1 protein levels during the course of chemotherapy in dogs with lymphoma closely associated with clinical outcome. Overall, the TK1-ELISA showed significant linear correlation with the TK1 activity assay (r(s) = 0.6, p<0.0001). Thus, the new TK1-ELISA has sufficient sensitivity and specificity for routine clinical use in veterinary oncology.	[Jagarlamudi, Kiran Kumar; Moreau, Laura; Eriksson, Staffan] Swedish Univ Agr Sci, Vet Med & Anim Sci Ctr, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Westberg, Sara] Swedish Univ Agr Sci, Univ Anim Hosp, Uppsala, Sweden; [Ronnberg, Henrik] Swedish Univ Agr Sci, Dept Clin Sci, Ctr Clin Comparat Oncol C3O, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Jagarlamudi, KK (corresponding author), Swedish Univ Agr Sci, Vet Med & Anim Sci Ctr, Dept Anat Physiol & Biochem, Uppsala, Sweden.	kirankumar.j@slu.se	Jagarlamudi, Kiran Kumar/J-6075-2013; Ronnberg, HENRIK Paul Olof/AAP-9678-2021	Ronnberg, HENRIK Paul Olof/0000-0001-6098-5364; Jagarlamudi, Kiran Kumar/0000-0003-1567-5863	Swedish Research Council; Thure. F and Karin Forsgrens Stiftelse; Faculty of Veterinary Medicine and Animal Science; Swedish University of Agricultural Sciences; companion animal insurance company AGRIA	Swedish Research Council(Swedish Research CouncilEuropean Commission); Thure. F and Karin Forsgrens Stiftelse; Faculty of Veterinary Medicine and Animal Science; Swedish University of Agricultural Sciences; companion animal insurance company AGRIA	This study was partly supported by funds from The Swedish Research Council (S.E.), Thure. F and Karin Forsgrens Stiftelse, the Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences, and the companion animal insurance company AGRIA (R.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZH, 2011, SENSORS-BASEL, V11, P11064, DOI 10.3390/s111211064; Chen ZH, 2008, ANTICANCER RES, V28, P3897; COTTER SM, 1983, J AM ANIM HOSP ASSOC, V19, P159; DORM CR, 1967, AM J VET RES, V28, P993; Elliott JW, 2013, VET COMP ONCOL, V11, P1, DOI 10.1111/j.1476-5829.2011.00296.x; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Gasparri F, 2009, EUR J CELL BIOL, V88, P779, DOI 10.1016/j.ejcb.2009.06.005; GREENLEE PG, 1990, CANCER-AM CANCER SOC, V66, P480, DOI 10.1002/1097-0142(19900801)66:3&lt;480::AID-CNCR2820660314&gt;3.0.CO;2-X; Hallek M, 1999, BLOOD, V93, P1732; HALLEK M, 1992, ANN HEMATOL, V65, P1, DOI 10.1007/BF01715117; Hanan S, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-12; He E, 2010, NUCLEOS NUCLEOT NUCL, V29, P352, DOI 10.1080/15257771003738535; He QM, 2005, ONCOL REP, V14, P1013; Jagarlamudi KK, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0228-1; Ke PY, 2003, BIOCHEM J, V370, P265, DOI 10.1042/BJ20021335; Kiupel M, 1998, J COMP PATHOL, V119, P407, DOI 10.1016/S0021-9975(98)80035-2; Kumar JK, 2013, VET J, V197, P854, DOI 10.1016/j.tvjl.2013.05.036; Li HX, 2005, ONCOL REP, V13, P145; Liu YP, 2011, EXP THER MED, V2, P1177, DOI 10.3892/etm.2011.338; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; O'Neill K L, 2001, Expert Rev Mol Diagn, V1, P428, DOI 10.1586/14737159.1.4.428; Piek CJ, 1999, VET QUART, V21, P44, DOI 10.1080/01652176.1999.9694990; Renwick MG, 2006, VET COMP ONCOL, V4, P141, DOI 10.1111/j.1476-5829.2006.00103.x; Sharif H, 2012, VET J, V194, P40, DOI 10.1016/j.tvjl.2012.03.006; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; TESKE E, 1994, VET QUART, V16, P209, DOI 10.1080/01652176.1994.9694451; Vail DM, 1997, VET CLIN PATH, V26, P66, DOI 10.1111/j.1939-165X.1997.tb00711.x; von Euler H, 2004, J VET INTERN MED, V18, P696, DOI 10.1892/0891-6640(2004)18&lt;696:STKAID&gt;2.0.CO;2; von Euler H, 2011, VET COMP ONCOL, V9, P1, DOI 10.1111/j.1476-5829.2010.00238.x; Von Euler HP, 2009, INT J ONCOL, V34, P505, DOI 10.3892/ijo_00000175; von Euler HP, 2006, RES VET SCI, V80, P17, DOI 10.1016/j.rvsc.2005.05.001; Wang NN, 2001, ANAL CELL PATHOL, V23, P11, DOI 10.1155/2001/658312; Welin M, 2004, P NATL ACAD SCI USA, V101, P17970, DOI 10.1073/pnas.0406332102; Wu CJ, 2003, J IMMUNOL METHODS, V277, P157, DOI 10.1016/S0022-1759(03)00062-0; Zanatta R, 2003, VET RES COMMUN, V27, P449, DOI 10.1023/B:VERC.0000014201.82393.67	35	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137871	10.1371/journal.pone.0137871	http://dx.doi.org/10.1371/journal.pone.0137871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366881	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000361601100162
J	Prevorovsky, M; Oravcova, M; Tvaruzkova, J; Zach, R; Folk, P; Puta, F; Bahler, J				Prevorovsky, Martin; Oravcova, Martina; Tvaruzkova, Jarmila; Zach, Robert; Folk, Petr; Puta, Frantisek; Baehler, Juerg			Fission Yeast CSL Transcription Factors: Mapping Their Target Genes and Biological Roles	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; STRESS-ACTIVATED MAPK; CYCLE-REGULATED GENES; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; CELL; EXPRESSION; PATHWAY; NOTCH	Background Cbf11 and Cbf12, the fission yeast CSL transcription factors, have been implicated in the regulation of cell-cycle progression, but no specific roles have been described and their target genes have been only partially mapped. Methodology/Principal Findings Using a combination of transcriptome profiling under various conditions and genome-wide analysis of CSL-DNA interactions, we identify genes regulated directly and indirectly by CSL proteins in fission yeast. We show that the expression of stress-response genes and genes that are expressed periodically during the cell cycle is deregulated upon genetic manipulation of cbf11 and/or cbf12. Accordingly, the coordination of mitosis and cytokinesis is perturbed in cells with genetically manipulated CSL protein levels, together with other specific defects in cell-cycle progression. Cbf11 activity is nutrient-dependent and Delta cbf11-associated defects are mitigated by inactivation of the protein kinase A (Pka1) and stress-activated MAP kinase (Sty1(p38)) pathways. Furthermore, Cbf11 directly regulates a set of lipid metabolism genes and Delta cbf11 cells feature a stark decrease in the number of storage lipid droplets. Conclusions/Significance Our results provide a framework for a more detailed understanding of the role of CSL proteins in the regulation of cell-cycle progression in fission yeast.	[Prevorovsky, Martin; Baehler, Juerg] UCL, Res Dept Genet Evolut & Environm, London, England; [Prevorovsky, Martin; Baehler, Juerg] UCL, UCL Canc Inst, London, England; [Prevorovsky, Martin; Oravcova, Martina; Tvaruzkova, Jarmila; Zach, Robert; Folk, Petr; Puta, Frantisek] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	University of London; University College London; University of London; University College London; Charles University Prague	Prevorovsky, M (corresponding author), UCL, Res Dept Genet Evolut & Environm, London, England.	prevorov@natur.cuni.cz	Převorovský, Martin/R-5191-2016; Bahler, Jurg/B-4572-2009; Princová, Jarmila/R-4583-2019; Folk, Petr/V-7545-2017; Půta, František/K-6731-2017	Převorovský, Martin/0000-0003-0277-8361; Bahler, Jurg/0000-0003-4036-1532; Princová, Jarmila/0000-0003-1656-9800; Folk, Petr/0000-0003-3813-7777; Půta, František/0000-0002-8313-878X; Zach, Robert/0000-0002-7604-1648	Wellcome Trust Senior Investigator Award [095598/Z/11/Z]; Czech Science Foundation [P305/12/P040]; Charles University Grant Agency [640413]; Charles University [SVV 260206, UNCE 204013]	Wellcome Trust Senior Investigator Award(Wellcome Trust); Czech Science Foundation(Grant Agency of the Czech Republic); Charles University Grant Agency; Charles University	This work was funded by the Wellcome Trust Senior Investigator Award #095598/Z/11/Z to JB (www.wellcome.ac.uk), the Czech Science Foundation grant P305/12/P040 to MP (www.gacr.cz), grant no. 640413 of the Charles University Grant Agency to MO (www.cuni.cz), and Charles University grants SVV 260206 and UNCE 204013 (www.cuni.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligianni S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000626; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Beltraminelli N, 1999, J CELL SCI, V112, P3103; Buck V, 2004, J CELL SCI, V117, P5623, DOI 10.1242/jcs.01473; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Bushel PR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-93; BYRNE SM, 1993, J CELL SCI, V105, P1095; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chua G, 2013, BIOCHEM SOC T, V41, P1696, DOI 10.1042/BST20130224; Davidson MK, 2004, J BIOL CHEM, V279, P50857, DOI 10.1074/jbc.M409079200; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Del Bianco C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015034; Gould KL, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P27; Gregan J, 2006, NAT PROTOC, V1, P2457, DOI 10.1038/nprot.2006.385; Gupta DR, 2011, BIOSCI BIOTECH BIOCH, V75, P1456, DOI 10.1271/bbb.110125; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; JIN M, 1995, GENETICS, V140, P457; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Knutsen JHJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017175; Kwon EJG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003104; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MAEDA T, 1994, J BIOL CHEM, V269, P9632; Marguerat S, 2006, YEAST, V23, P261, DOI 10.1002/yea.1351; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Moreno MB, 2000, YEAST, V16, P861; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Navarro FJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r36; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Oravcova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059435; Papadopoulou K, 2010, J CELL SCI, V123, P4374, DOI 10.1242/jcs.073056; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Prevorovsky M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-233; Prevorovsky M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023650; Prevorovsky M, 2009, EXP CELL RES, V315, P1533, DOI 10.1016/j.yexcr.2008.12.001; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Rostron KA, 2015, ANTON LEEUW INT J G, V108, P97, DOI 10.1007/s10482-015-0467-6; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Saitoh S, 1996, J CELL BIOL, V134, P949, DOI 10.1083/jcb.134.4.949; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; SAZER S, 1990, J CELL SCI, V97, P509; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Smith DA, 2002, J BIOL CHEM, V277, P33411, DOI 10.1074/jbc.M204593200; Takayama Y, 2007, NUCLEIC ACIDS RES, V35, P3223, DOI 10.1093/nar/gkm213; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Vachon L, 2013, GENETICS, V194, P873, DOI 10.1534/genetics.113.150870; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Wells ML, 2012, MOL CELL BIOL, V32, P4206, DOI 10.1128/MCB.00325-12; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zilahi E, 2000, FEBS LETT, V481, P105, DOI 10.1016/S0014-5793(00)01990-6	66	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137820	10.1371/journal.pone.0137820	http://dx.doi.org/10.1371/journal.pone.0137820			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366556	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100146
J	Saithong, T; Saerue, S; Kalapanulak, S; Sojikul, P; Narangajavana, J; Bhumiratana, S				Saithong, Treenut; Saerue, Samorn; Kalapanulak, Saowalak; Sojikul, Punchapat; Narangajavana, Jarunya; Bhumiratana, Sakarindr			Gene Co-Expression Analysis Inferring the Crosstalk of Ethylene and Gibberellin in Modulating the Transcriptional Acclimation of Cassava Root Growth in Different Seasons	PLOS ONE			English	Article							MANIHOT-ESCULENTA CRANTZ; DROUGHT STRESS; WATER-STRESS; PLANT HORMONES; GAS-EXCHANGE; RESPONSES; EXPRESSION; TOLERANCE; STARCH; COLD	Cassava is a crop of hope for the 21st century. Great advantages of cassava over other crops are not only the capacity of carbohydrates, but it is also an easily grown crop with fast development. As a plant which is highly tolerant to a poor environment, cassava has been believed to own an effective acclimation process, an intelligent mechanism behind its survival and sustainability in a wide range of climates. Herein, we aimed to investigate the transcriptional regulation underlying the adaptive development of a cassava root to different seasonal cultivation climates. Gene co-expression analysis suggests that AP2-EREBP transcription factor (ERF1) orthologue (D142) played a pivotal role in regulating the cellular response to exposing to wet and dry seasons. The ERF shows crosstalk with gibberellin, via ent-Kaurene synthase (D106), in the transcriptional regulatory network that was proposed to modulate the downstream regulatory system through a distinct signaling mechanism. While sulfur assimilation is likely to be a signaling regulation for dry crop growth response, calmodulin-binding protein is responsible for regulation in the wet crop. With our initiative study, we hope that our findings will pave the way towards sustainability of cassava production under various kinds of stress considering the future global climate change.	[Saithong, Treenut; Saerue, Samorn; Kalapanulak, Saowalak] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand; [Saithong, Treenut; Kalapanulak, Saowalak; Bhumiratana, Sakarindr] King Mongkuts Univ Technol Thonburi, Pilot Plant Dev & Training Inst, Syst Biol & Bioinformat Res Grp, Bangkok, Thailand; [Sojikul, Punchapat; Narangajavana, Jarunya] Mahidol Univ, Fac Sci, Ctr Cassava Mol Biotechnol, Bangkok 10400, Thailand; [Sojikul, Punchapat; Narangajavana, Jarunya] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Bhumiratana, Sakarindr] King Mongkuts Univ Technol Thonburi, Dept Chem Engn, Fac Engn, Bangkok, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; Mahidol University; Mahidol University; King Mongkuts University of Technology Thonburi	Saithong, T (corresponding author), King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand.	treenut.sai@kmutt.ac.th	Saithong, Treenut/L-1395-2019	Saithong, Treenut/0000-0003-2888-6854	Thailand Research Fund [MRG5680110]	Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by Thailand Research Fund (MRG5680110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Ahmad N, 2013, IMPACT DROUGHT STRES; Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Alves AAC, 2000, CROP SCI, V40, P131, DOI 10.2135/cropsci2000.401131x; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Arc E, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00063; Bakayoko S, 2009, AFR J AGR RES, V4, P21; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Chatakanonda P, 2003, CARBOHYD POLYM, V53, P233, DOI 10.1016/S0144-8617(03)00047-X; Chen QL, 2011, SCI CHINA EARTH SCI, V54, P1248, DOI 10.1007/s11430-011-4192-3; COCK JH, 1985, CROP SCI, V25, P265, DOI 10.2135/cropsci1985.0011183X002500020015x; CONNOR DJ, 1981, FIELD CROP RES, V4, P181, DOI 10.1016/0378-4290(81)90071-X; El-Sharkawy Mabrouk A., 2007, Braz. J. Plant Physiol., V19, P257, DOI 10.1590/S1677-04202007000400003; El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7; El-Sharkawy MA, 2012, OPEN J SOIL SCI, V2, P162, DOI [10.4236/ojss.2012.22022, DOI 10.4236/OJSS.2012.22022]; ELSHARKAWY MA, 1987, PLANT SOIL, V100, P345, DOI 10.1007/BF02370950; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hoeren FU, 1998, GENETICS, V149, P479; Iqbal N, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22478; Jia CG, 2013, J EXP BOT, V64, P637, DOI 10.1093/jxb/ers360; Kosova K, 2012, J PLANT PHYSIOL, V169, P567, DOI 10.1016/j.jplph.2011.12.013; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kumar K, 2013, RICE, V6, DOI 10.1186/1939-8433-6-27; Larrainzar E, 2014, PLANT CELL ENVIRON, V37, P2051, DOI 10.1111/pce.12285; Licausi F, 2011, NEW PHYTOL, V190, P550, DOI 10.1111/j.1469-8137.2010.03562.x; Licausi F, 2011, NEW PHYTOL, V190, P442, DOI 10.1111/j.1469-8137.2010.03451.x; Liu J, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00116, 10.3389/fpls.2014.00392]; Lokko Y, 2007, PLANT CELL REP, V26, P1605, DOI 10.1007/s00299-007-0378-8; Lopez C, 2005, PLANT MOL BIOL, V57, P393, DOI 10.1007/s11103-004-7819-3; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; Maruyama K, 2014, PLANT PHYSIOL, V164, P1759, DOI 10.1104/pp.113.231720; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Moniuszko G, 2013, J EXP BOT, V64, P5173, DOI 10.1093/jxb/ert309; Montagnac JA, 2009, COMPR REV FOOD SCI F, V8, P181, DOI 10.1111/j.1541-4337.2009.00077.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nuwamanya E., 2008, African Crop Science Journal, V16, P191; Nuwamanya E, 2012, AMBIO, V41, P262, DOI 10.1007/s13280-011-0183-z; PALTA JA, 1984, J EXP BOT, V35, P1441, DOI 10.1093/jxb/35.10.1441; Perruc E, 2004, PLANT J, V38, P410, DOI 10.1111/j.1365-313X.2004.02062.x; Ranola R. F., 2009, J ISSAAS, V15, P147; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Santisopasri V, 2001, IND CROP PROD, V13, P115, DOI 10.1016/S0926-6690(00)00058-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; Sojikul P, 2010, PHYSIOL PLANTARUM, V140, P189, DOI 10.1111/j.1399-3054.2010.01389.x; Sriroth K, 2001, EUPHYTICA, V120, P95, DOI 10.1023/A:1017511806128; Sriroth K, 1999, CARBOHYD POLYM, V38, P161, DOI 10.1016/S0144-8617(98)00117-9; Turyagyenda LF, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt007; Verelst W, 2010, PLANT SIGNAL BEHAV, V5, P473, DOI 10.4161/psb.5.4.11421; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Zhang ZY, 2007, J EXP BOT, V58, P2993, DOI 10.1093/jxb/erm151	62	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137602	10.1371/journal.pone.0137602	http://dx.doi.org/10.1371/journal.pone.0137602			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366737	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100091
J	Shushimita, S; van der Pol, P; de Bruin, RWF; Ijzermans, JNM; van Kooten, C; Dor, FJMF				Shushimita, Shushimita; van der Pol, Pieter; de Bruin, Ron W. F.; Ijzermans, Jan N. M.; van Kooten, Cees; Dor, Frank J. M. F.			Mannan-Binding Lectin Is Involved in the Protection against Renal Ischemia/Reperfusion Injury by Dietary Restriction	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CALORIE RESTRICTION; COMPLEMENT-SYSTEM; LIFE-SPAN; MECHANISMS; PATHWAYS; ACTIVATION; RAPAMYCIN; STRESS	Preoperative fasting and dietary restriction offer robust protection against renal ischemia/reperfusion injury (I/RI) in mice. We recently showed that Mannan-binding lectin (MBL), the initiator of the lectin pathway of complement activation, plays a pivotal role in renal I/RI. Based on these findings, we investigated the effect of short-term DR (30% reduction of total food intake) or three days of water only fasting on MBL in 10-12 weeks old male C57/Bl6 mice. Both dietary regimens significantly reduce the circulating levels of MBL as well as its mRNA expression in liver, the sole production site of MBL. Reconstitution of MBL abolished the protection afforded by dietary restriction, whereas in the fasting group the protection persisted. These data show that modulation of MBL is involved in the protection against renal I/RI induced by dietary restriction, and suggest that the mechanisms of protection induced by dietary restriction and fasting may be different.	[Shushimita, Shushimita; de Bruin, Ron W. F.; Ijzermans, Jan N. M.; Dor, Frank J. M. F.] Univ Med Ctr, Div Transplant Surg, Dept Surg, Erasmus MC, Rotterdam, Netherlands; [van der Pol, Pieter; van Kooten, Cees] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Dor, FJMF (corresponding author), Univ Med Ctr, Div Transplant Surg, Dept Surg, Erasmus MC, Rotterdam, Netherlands.	f.dor@erasmusmc.nl	van Kooten, Cees/E-5694-2018	van Kooten, Cees/0000-0002-6257-0899	Erasmus MC Fellowship	Erasmus MC Fellowship	This work was funded by an Erasmus MC Fellowship.	Alic N, 2011, CURR OPIN CELL BIOL, V23, P738, DOI 10.1016/j.ceb.2011.07.006; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Boros P, 2006, AM J TRANSPLANT, V6, P652, DOI 10.1111/j.1600-6143.2005.01228.x; Cefalu WT, 1997, J GERONTOL A-BIOL, V52, pB10, DOI 10.1093/gerona/52A.1.B10; Chan RK, 2006, J IMMUNOL, V177, P8080, DOI 10.4049/jimmunol.177.11.8080; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Dilova I, 2007, CELL MOL LIFE SCI, V64, P752, DOI 10.1007/s00018-007-6381-y; Fok WC, 2013, J GERONTOL A-BIOL, V68, P108, DOI 10.1093/gerona/gls127; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gorsuch WB, 2012, IMMUNOBIOLOGY, V217, P1026, DOI 10.1016/j.imbio.2012.07.024; Hansen S, 2000, J IMMUNOL, V164, P2610, DOI 10.4049/jimmunol.164.5.2610; Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Jordan JE, 2001, CIRCULATION, V104, P1413, DOI 10.1161/hc3601.095578; Ko GJ, 2010, IMMUNOL RES, V47, P78, DOI 10.1007/s12026-009-8140-7; Lameire N, 2005, LANCET, V365, P417; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Libert S, 2013, ANNU REV PHYSIOL, V75, P669, DOI 10.1146/annurev-physiol-030212-183800; Lutz J, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-27; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McCullough JW, 2013, SEMIN NEPHROL, V33, P543, DOI 10.1016/j.semnephrol.2013.08.005; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Moller-Kristensen M, 2005, SCAND J IMMUNOL, V61, P426, DOI 10.1111/j.1365-3083.2005.01591.x; Morgan T. E., 2007, V35, P83; Morrison H, 2011, CURR NEUROVASC RES, V8, P52, DOI 10.2174/156720211794520260; Oroszlan M, 2007, MOL IMMUNOL, V44, P1150, DOI 10.1016/j.molimm.2006.06.015; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Owens W, 2003, ENVIRON HEALTH PERSP, V111, P1527, DOI 10.1289/ehp.6413; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Shushimita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087772; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; van der Pol P, 2012, AM J TRANSPLANT, V12, P877, DOI 10.1111/j.1600-6143.2011.03887.x; van Ginhoven TM, 2011, CLIN TRANSPLANT, V25, P486, DOI 10.1111/j.1399-0012.2010.01313.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541	43	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137795	10.1371/journal.pone.0137795	http://dx.doi.org/10.1371/journal.pone.0137795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367533	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100139
J	Tadesse, M; Abebe, G; Abdissa, K; Aragaw, D; Abdella, K; Bekele, A; Bezabih, M; Apers, L; de Jong, BC; Rigouts, L				Tadesse, Mulualem; Abebe, Gemeda; Abdissa, Ketema; Aragaw, Dossegnaw; Abdella, Kedir; Bekele, Alemayehu; Bezabih, Mesele; Apers, Ludwig; de Jong, Bouke C.; Rigouts, Leen			GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RIFAMPIN RESISTANCE; XPERT MTB/RIF; SPECIMENS; CYTOLOGY; ETHIOPIA; BIOPSY	Introduction The diagnosis of tuberculous lymphadenitis (TBL) remains challenging. The routinely used methods (cytology and smear microscopy) have sub-optimal sensitivity. Recently, WHO recommends GeneXpert to be used as the initial diagnostic test in patients suspected of having extra-pulmonary tuberculosis (EPTB). However, this was a conditional recommendation due to very low-quality evidence available and more studies are needed. In this study we evaluated the performance of Xpert for the diagnosis of TBL on concentrated fine needle aspirates (FNA) in Southwest Ethiopia. Methods FNA was collected from presumptive TBL cases. Two smears were prepared from each aspirate and processed for cytology and conventional microscopy. The remaining aspirate was treated with N-acetyl-L-cysteine-NaOH and centrifuged for 15minutes at 3000g. The concentrated sediment was used for culture and Xpert test. Capilia TB-Neo test was used to differentiate M. tuberculosis complex (MTBC) from non-tuberculous mycobacteria (NTM). Composite bacteriological methods (culture and/or smear microscopy) were considered as a reference standard. Result Out of 143 enrolled suspects, 64.3% (92/143) were confirmed TBL cases by the composite reference standard (CRS). Xpert detected M. tuberculosis complex (MTBC) in 60.1% (86/143) of the presumptive TBL cases. The sensitivity of Xpert compared to CRS was 87.8% [95% CI: 81.0-94.5] and specificity 91.1% [95% CI: 82.8-99.4]. The sensitivity was 27.8% for smear microscopy and 80% for cytology compared to CRS. Cytology showed the lowest specificity (57.8%). Xpert was positive in 4 out of 45 culture- and smear-negative cases. Among 47 cytomorphologically non-TBL cases, 15 were positive on Xpert. More than half of Xpert-positive cases were in the range of very low cut-off threshold values (28<Ct<38). Resistance to rifampicin was identified in 4.7% (4/86) of Xpert-positive cases. Conclusion Xpert test showed a high sensitivity and specificity for the diagnosis of TBL on concentrated FNA samples. In addition, Xpert offered rapid detection of rifampicin-resistant M. tuberculosis strains from lymph node aspirates.	[Tadesse, Mulualem; Abebe, Gemeda; Abdissa, Ketema; Aragaw, Dossegnaw; Abdella, Kedir; Bekele, Alemayehu; Bezabih, Mesele] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Tadesse, Mulualem; Abebe, Gemeda; Aragaw, Dossegnaw; Abdella, Kedir] Jimma Univ, Biotechnol Res Inst, Mycobacteriol Res Ctr, Jimma, Ethiopia; [Apers, Ludwig] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [de Jong, Bouke C.; Rigouts, Leen] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Tadesse, Mulualem; Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Jimma University; Jimma University; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of Antwerp	Abebe, G (corresponding author), Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.	gemeda.abebe@ju.edu.et	de Jong, Bouke/A-3636-2013; Abebe, Gemeda/AAB-8789-2019	de Jong, Bouke/0000-0002-1017-4675; Abebe, Gemeda/0000-0002-7172-9136; Abdulsemed, Kedir Abdella/0000-0002-1480-219X	Jimma University; Flemish Universities (VLIR-OUS project)	Jimma University; Flemish Universities (VLIR-OUS project)	Funding for this work was secured from interuniversity cooperation between Jimma University and Flemish Universities (VLIR-OUS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ateah SM, 2012, SAUDI MED J, V33, P1100; Ammari FF, 2003, OTOLARYNG HEAD NECK, V128, P576, DOI 10.1016/S0194-5998(03)00121-9; Annam V, 2009, INDIAN J PATHOL MICR, V52, P349, DOI 10.4103/0377-4929.54991; [Anonymous], 2013, GLOB TUB CONTR; Biadglegne F, 2014, TUBERCULOSIS; Biadglegne F, 2013, JPN J INFECT DIS, V66, P263, DOI 10.7883/yoken.66.263; Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Boeree M, 2014, MALAWI MED J, V11, P56; Das DK, 2000, LAB MED, V31, P625, DOI 10.1309/UJ0B-VDWV-U0LE-E0QQ; Denkinger C. M, 2014, EUROPEAN RESP J; GUPTA AK, 1992, ACTA CYTOL, V36, P391; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Kidane D, 2002, J CLIN MICROBIOL, V40, P4230, DOI 10.1128/JCM.40.11.4230-4234.2002; Kurabachew M, 2004, DIAGN MICR INFEC DIS, V49, P99, DOI 10.1016/j.diagmicrobio.2004.03.010; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Mistry Y, 2012, NJMR, V2, P77; Normung DIf, 1995, MED MICR DIAGN TU 32; Penz E, 2015, INT J TUBERC LUNG D, V19, P278, DOI 10.5588/ijtld.14.0262; Prevention CfDCa, 2003, AFB MICR CHAR STRAT; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2010, 10 M; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Wright CA, 2008, DIAGN CYTOPATHOL, V36, P245, DOI 10.1002/dc.20788	26	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137471	10.1371/journal.pone.0137471	http://dx.doi.org/10.1371/journal.pone.0137471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366871	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100078
J	Wilson, MC; Scior, K				Wilson, Michelle Clare; Scior, Katrina			Implicit Attitudes towards People with Intellectual Disabilities: Their Relationship with Explicit Attitudes, Social Distance, Emotions and Contact	PLOS ONE			English	Article							ASSOCIATION TEST; LEARNING-DISABILITIES; PHYSICAL-DISABILITIES; CHALLENGING BEHAVIOR; MENTAL-RETARDATION; PUBLIC-ATTITUDES; MINORITY-GROUPS; CARE STAFF; PREJUDICE; METAANALYSIS	Implicit attitude research has expanded rapidly over the last decade and is seen as very promising as it counters biases present in much attitude research such as social desirability. However, most research in the area of intellectual disabilities has focused on explicit attitudes alone. This study examined implicit attitudes to this population and also examined their association with emotional reactions and contact, which have previously been found to have a significant influence on attitudes and stigma. A web based survey consisting of a single target Implicit Association Test, measures of explicit attitudes, social distance, and emotional reactions towards and contact with individuals with intellectual disabilities was completed by 326 adult UK residents. Implicit attitudes were not significantly associated with explicit attitudes, social distance or emotional reactions. Instead there were small to moderate associations between emotional reactions and explicit attitudes and social distance. Implicit attitudes did not vary according to participants' level of contact with individuals with intellectual disabilities, type of the contact relationship (voluntary versus involuntary), gender or educational attainment. In contrast, these participant characteristics did affect explicit attitudes and social distance. Implicit attitudes towards individuals with intellectual disabilities were somewhat negative and, unlike explicit attitudes and stigma, did not vary according to participant demographics or contact. As they may have a negative impact on the lives of people with intellectual disabilities, implicit attitudes merit increased attention in research and interventions in the intellectual disabilities field.	[Wilson, Michelle Clare] Royal Free Hosp, Dept Plast & Reconstruct Surg, London NW3 2QG, England; [Scior, Katrina] UCL, Res Dept Clin Educ & Hlth Psychol, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London	Scior, K (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.	k.scior@ucl.ac.uk		Scior, Katrina/0000-0002-4679-0090				Abbott S, 2006, J INTELLECT DISABILI, V10, P275, DOI 10.1177/1744629506067618; Akrami N, 2006, RES DEV DISABIL, V27, P605, DOI 10.1016/j.ridd.2005.07.003; Allport G. W., 1954, NATURE PREJUDICE; Angermeyer MC, 2010, EPIDEMIOL PSICHIAT S, V19, P26, DOI 10.1017/S1121189X00001573; Angermeyer MC, 2003, SOC PSYCH PSYCH EPID, V38, P526, DOI 10.1007/s00127-003-0676-6; Antonak R.F., 1988, MEASUREMENT ATTITUDE; ANTONAK RF, 1995, J INTELL DISABIL RES, V39, P316, DOI 10.1111/j.1365-2788.1995.tb00523.x; Antonak RF, 2000, DISABIL REHABIL, V22, P211; Betsch T, 2004, CONTEMPORARY PERSPECTIVES ON THE PSYCHOLOGY OF ATTITUDES, P251; Binder J, 2009, J PERS SOC PSYCHOL, V96, P843, DOI 10.1037/a0013470; Blanton H, 2006, AM PSYCHOL, V61, P27, DOI 10.1037/0003-066X.61.1.27; Bluemke M, 2008, EUR J SOC PSYCHOL, V38, P977, DOI 10.1002/ejsp.487; Bogardus Emory S., 1959, SOCIAL DISTANCE; Bohner G, 2011, ANNU REV PSYCHOL, V62, P391, DOI 10.1146/annurev.psych.121208.131609; Brewer M., 1988, ADV SOCIAL COGNITION, P1; BROMLEY J, 1995, J INTELL DISABIL RES, V39, P341, DOI 10.1111/j.1365-2788.1995.tb00526.x; Burge P, 2007, J VOCAT REHABIL, V26, P29; CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752; Corrigan PW, 2012, PSYCHIAT SERV, V63, P963, DOI 10.1176/appi.ps.201100529; Cummins RA, 2003, J APPL RES INTELLECT, V16, P145, DOI 10.1046/j.1468-3148.2003.00157.x; De Houwer J, 2001, J EXP SOC PSYCHOL, V37, P443, DOI 10.1006/jesp.2000.1464; Deal M, 2007, DISABIL SOC, V22, P93, DOI 10.1080/09687590601056667; Dillenburger K, 2011, BRIT J LEARN DISABIL, V39, P29, DOI 10.1111/j.1468-3156.2010.00613.x; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; Eagly A.H., 1998, HDB SOCIAL PSYCHOL; Emerson E, 2005, ADULTS LEARNING DIFF; Esterle M, 2008, SEX DISABIL, V26, P219, DOI 10.1007/s11195-008-9093-9; Forrester-Jones R, 2006, J APPL RES INTELLECT, V19, P285, DOI 10.1111/j.1468-3148.2006.00263.x; Gaebel W, 2008, SCHIZOPHR RES, V98, P184, DOI 10.1016/j.schres.2007.09.013; Gaertner S. L., 2000, REDUCING INTERGROUP; Gill F, 2002, PSYCHOL MED, V32, P1445, DOI 10.1017/S0033291702006608; Govan CL, 2004, J EXP SOC PSYCHOL, V40, P357, DOI 10.1016/j.jesp.2003.07.002; Greenwald A. G., 1998, J PERS SOC PSYCHOL, V74, P1646; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; HARTH R, 1971, EDUC TRAIN MENT RETA, V6, P142; Harwood J, 2005, PERS SOC PSYCHOL B, V31, P393, DOI 10.1177/0146167204271577; Hatton C, 1995, MENT HANDICAP RES, V8, P252; Henry D, 1996, MENT RETARD, V34, P149; Hergenrather K, 2007, REHABIL COUNS BULL, V50, P66, DOI 10.1177/00343552070500020501; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; ISLAM MR, 1993, PERS SOC PSYCHOL B, V19, P700, DOI 10.1177/0146167293196005; Jasinskaja-Lahti I, 2011, INT J INTERCULT REL, V35, P346, DOI 10.1016/j.ijintrel.2010.06.001; Joinson A, 1999, BEHAV RES METH INS C, V31, P433, DOI 10.3758/BF03200723; Jones C, 2003, BRIT J CLIN PSYCHOL, V42, P189, DOI 10.1348/014466503321903599; Jorm AF, 2009, AUST NZ J PSYCHIAT, V43, P183, DOI 10.1080/00048670802653349; Karpinski A, 2005, PERS SOC PSYCHOL B, V31, P949, DOI 10.1177/0146167204273007; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Kenny K., 2007, BRIT J LEARN DISABIL, V35, P221, DOI DOI 10.1111/J.1468-3156.2007.00445.X; Lane K. A., 2007, IMPLICIT MEASURES AT, P59, DOI DOI 10.1016/J.BRAT.2008.02.003; Morin D, 2013, J INTELL DISABIL RES, V57, P268, DOI 10.1111/j.1365-2788.2012.01559.x; Nosek B. A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1080/10463280701489053; Ouellette-Kuntz H, 2010, J APPL RES INTELLECT, V23, P132, DOI 10.1111/j.1468-3148.2009.00514.x; Park JH, 2003, J NONVERBAL BEHAV, V27, P65, DOI 10.1023/A:1023910408854; Parmenter, 2004, J DISABIL POLICY STU, V15, P97, DOI DOI 10.1177/10442073040150020401; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Prestwich A, 2008, BRIT J SOC PSYCHOL, V47, P575, DOI 10.1348/014466607X267470; Quarmby K, 2008, GETTING AWAY MURDER; Quarmby K, 2011, SCAPEGOAT WHY WE ARE; Rojahn J, 2008, J DEV PHYS DISABIL, V20, P389, DOI 10.1007/s10882-008-9108-6; Rose D, 2004, J APPL RES INTELLECT, V17, P219, DOI 10.1111/j.1468-3148.2004.00194.x; Scior K, 2013, J INTELL DISABIL RES, V57, P1014, DOI 10.1111/j.1365-2788.2012.01597.x; Scior K, 2013, AJIDD-AM J INTELLECT, V118, P211, DOI 10.1352/1944-7558-118.3.211; Scior K, 2011, RES DEV DISABIL, V32, P1530, DOI 10.1016/j.ridd.2011.01.044; Scior K, 2010, INTELLECT DEV DISAB, V48, P278, DOI 10.1352/1934-9556-48.4.278; Sirlopu D, 2008, J APPL SOC PSYCHOL, V38, P2710, DOI 10.1111/j.1559-1816.2008.00411.x; Slevin E, 1996, J ADV NURS, V24, P1116, DOI 10.1111/j.1365-2648.1996.tb01016.x; Slevin E, 1995, Br J Nurs, V4, P761; Staniland L, 2011, PUBLIC PERCEPTIONS D; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Swain J., 1994, EQUAL TERMS WORKING, P87; Thomas A, 2007, J REHABIL, V73, P3; TROPE Y, 1986, PSYCHOL REV, V93, P239, DOI 10.1037/0033-295X.93.3.239; Tumer RN, 2007, J PERS SOC PSYCHOL, V93, P369, DOI 10.1037/0022-3514.93.3.369; Turner RN, 2008, J PERS SOC PSYCHOL, V95, P846; White MJ, 2006, J REHABIL, V72, P33; Wigboldus D.H., 2004, SINGLE TARGET IUNPUB	77	38	38	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137902	10.1371/journal.pone.0137902	http://dx.doi.org/10.1371/journal.pone.0137902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8KS	26366575	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100174
J	You, L; Simmons, DR; Bateman, CC; Short, DPG; Kasson, MT; Rabaglia, RJ; Hulcr, J				You, Li; Simmons, David Rabern; Bateman, Craig C.; Short, Dylan P. G.; Kasson, Matthew T.; Rabaglia, Robert J.; Hulcr, Jiri			New Fungus-Insect Symbiosis: Culturing, Molecular, and Histological Methods Determine Saprophytic Polyporales Mutualists of Ambrosiodmus Ambrosia Beetles	PLOS ONE			English	Article							RIBOSOMAL DNA; COLEOPTERA; EVOLUTION; IDENTIFICATION; EUWALLACEA; DIVERSITY	Ambrosia symbiosis is an obligate, farming-like mutualism between wood-boring beetles and fungi. It evolved at least 11 times and includes many notorious invasive pests. All ambrosia beetles studied to date cultivate ascomycotan fungi: early colonizers of recently killed trees with poor wood digestion. Beetles in the widespread genus Ambrosiodmus, however, colonize decayed wood. We characterized the mycosymbionts of three Ambrosiodmus species using quantitative culturing, high-throughput metabarcoding, and histology. We determined the fungi to be within the Polyporales, closely related to Flavodon flavus. Culture-independent sequencing of Ambrosiodmus minor mycangia revealed a single operational taxonomic unit identical to the sequences from the cultured Flavodon. Histological sectioning confirmed that Ambrosiodmus possessed preoral mycangia containing dimitic hyphae similar to cultured F. cf. flavus. The Ambrosiodmus-Flavodon symbiosis is unique in several aspects: it is the first reported association between an ambrosia beetle and a basidiomycotan fungus; the mycosymbiont grows as hyphae in the mycangia, not as budding pseudo-mycelium; and the mycosymbiont is a white-rot saprophyte rather than an early colonizer: a previously undocumented wood borer niche. Few fungi are capable of turning rotten wood into complete animal nutrition. Several thousand beetle-fungus symbioses remain unstudied and promise unknown and unexpected mycological diversity and enzymatic innovations.	[You, Li; Simmons, David Rabern; Hulcr, Jiri] Univ Florida, Inst Food & Agr Sci, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Bateman, Craig C.; Hulcr, Jiri] Univ Florida, Inst Food & Agr Sci, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Short, Dylan P. G.; Kasson, Matthew T.] W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; [Rabaglia, Robert J.] ARS, Forest Hlth Protect State & Private Forestry, USDA, Washington, DC USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; West Virginia University; United States Department of Agriculture (USDA)	Hulcr, J (corresponding author), Univ Florida, Inst Food & Agr Sci, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA.	hulcr@ufl.edu	Hulcr, Jiri/AAE-4210-2019	Hulcr, Jiri/0000-0002-8706-4618; Simmons, D Rabern/0000-0002-7033-225X	USDA-FS-SRS [14-CA-11330130-032]; USDA-FS-FHP [12-CA-11420004-042]; USDA [14-8130-0377-CA]; NSF [DEB 1256968]; West Virginia Agricultural Experiment Station; University of Florida Opportunity Seed fund; Direct For Biological Sciences [1256968] Funding Source: National Science Foundation	USDA-FS-SRS; USDA-FS-FHP; USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); West Virginia Agricultural Experiment Station; University of Florida Opportunity Seed fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by USDA-FS-SRS Coop agreement 14-CA-11330130-032, USDA-FS-FHP Coop agreement 12-CA-11420004-042, USDA Farm Bill agreement 14-8130-0377-CA, NSF DEB 1256968, the West Virginia Agricultural Experiment Station, and a University of Florida Opportunity Seed fund.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; BATRA LEKH R., 1963, TRANS KANAS ACAD SCI, V66, P213, DOI 10.2307/3626562; BATRA LR, 1967, MYCOLOGIA, V59, P976, DOI 10.2307/3757271; Beaver R.A., 1989, P121; Binder M, 2013, MYCOLOGIA, V105, P1350, DOI 10.3852/13-003; BRIGHT DE, 1968, CAN ENTOMOL, V100, P1288, DOI 10.4039/Ent1001288-12; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Eichhoff WJ, 1875, SOC ENTOMOL BELGIQUE, P18195; Fraedrich SW, 2008, PLANT DIS, V92, P215, DOI 10.1094/PDIS-92-2-0215; Freeman S, 2013, MYCOLOGIA, V105, P1595, DOI 10.3852/13-066; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAPP GM, 1976, INT J INSECT MORPHOL, V5, P381, DOI 10.1016/0020-7322(76)90012-X; Harrington Thomas C., 2005, P257; Hijii N., 1991, Journal of the Japanese Forestry Society, V73, P471; Hong Ki-Jeong, 2006, Korean Journal of Applied Entomology, V45, P113; Hopkins A. D., 1915, 99 USDA, V99, P1, DOI DOI 10.5962/BHL.TITLE.65905; Hsiau PTW, 2003, SYMBIOSIS, V34, P111; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Hulcr J, 2010, EVOLUTION, V64, P3205, DOI 10.1111/j.1558-5646.2010.01055.x; Hyodo F, 2000, SOIL BIOL BIOCHEM, V32, P653, DOI 10.1016/S0038-0717(99)00192-3; Kasson MT, 2013, FUNGAL GENET BIOL, V56, P147, DOI 10.1016/j.fgb.2013.04.004; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kirkendall LR, 2015, BARK BEETLES BIOL EC, P85, DOI [DOI 10.1016/B978-0-12-417156-5.00003-4, 10.1016/B978-0-12-417156-5.00003-4]; Kolarik M, 2009, MYCOL RES, V113, P44, DOI 10.1016/j.mycres.2008.08.003; Kostovcik M, 2015, ISME J, V9, P126, DOI 10.1038/ismej.2014.115; Licht HHD, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-13; Miettinen O, 2012, CLADISTICS, V28, P251, DOI 10.1111/j.1096-0031.2011.00380.x; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rabaglia R.J., 2011, TRIOLOGY, V50, P6; Ranger CM, 2010, AGR FOREST ENTOMOL, V12, P177, DOI 10.1111/j.1461-9563.2009.00469.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RYVARDEN L, 1973, Norwegian Journal of Botany, V20, P1; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Seltzer J.L., 2013, Midsouth Entomologist, V6, P119; Six DL, 2003, CONT T ENT, P97; Stebbing E.P., 1909, INDIAN FOREST MEMOIR, V1, P13; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tagaki K., 1967, JAPANESE SOC APPL EN, V2, P168, DOI [10.1303/aez.2.168, DOI 10.1303/AEZ.2.168]; TALBOT PHB, 1977, ANNU REV PHYTOPATHOL, V15, P41, DOI 10.1146/annurev.py.15.090177.000353; Tomsovsky M, 2010, FUNGAL BIOL-UK, V114, P350, DOI 10.1016/j.funbio.2010.02.004; Vega F.E., 2015, BARK BEETLES BIOL EC, V1st; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.; Wood Stephen L., 1992, Great Basin Naturalist Memoirs, V13, P1; Zhao CL, 2014, PHYTOTAXA, V164, P17; Zwickl D. J, 2006, GENETIC ALGORITHM AP	49	45	49	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137689	10.1371/journal.pone.0137689	http://dx.doi.org/10.1371/journal.pone.0137689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367271	Green Published, gold			2022-12-26	WOS:000361601100109
J	Conner, LM; Morris, G				Conner, L. Mike; Morris, Gail			Impacts of Mesopredator Control on Conservation of Mesopredators and Their Prey	PLOS ONE			English	Article							PREDATOR REMOVAL; PUBLICATION BIAS; MAMMALIAN CARNIVORES; POPULATION-DYNAMICS; BREEDING SUCCESS; COYOTE REMOVAL; RELEASE; ABUNDANCE; BIODIVERSITY; MANAGEMENT	Declining large carnivore populations, increased habitat fragmentation, declining interests in fur trapping, and other anthropogenic factors can all lead to increased mesopredator populations and these may negatively impact biodiversity. Lethal mesopredator control potentially mitigates some of these effects but can be controversial, largely because impacts on mesopredator populations have not been evaluated. Estimating these impacts may reduce controversies while increasing our understanding of when lethal control may be beneficial. Therefore, we analyzed published mesopredator removal data to determine if mesopredator removal rates changed over time. Removals of medium,(e.g., raccoons (Procyon lotor) or red foxes (Vulpes vulpes), and large, i.e., bobcats (Lynx rufus) or coyotes (Canis latrans), mesopredators were consistent from year to year and over the duration of study (i.e., number removed during the first and last years of studies were similar). In contrast, removals of small mesopredators, e.g., weasels (Mustela spp.) or spotted skunks (Spilogale putorius), declined over the duration of study. Study area size, number of species targeted for removal, and duration of removal effort were poor predictors of removal rates. Our analyses suggest that: (1) control, as typically implemented, is unlikely to cause negative long-term impacts on populations of medium and large mesopredators but may negatively impact small mesopredators, (2) if mesopredator control benefits prey, recurring removals will generally be needed to maintain benefits, and (3) timing of removals will be important to achieve management goals. We suggest that mesopredator control efforts are frequently spatially structured harvests from continuously distributed populations. This may explain (1) why removal of small mesopredators declined over time; whereas, medium and large mesopredator removals remained consistent, and (2) why some prey failed to respond to mesopredator control efforts.	[Conner, L. Mike; Morris, Gail] Joseph W Jones Ecol Res Ctr, Newton, GA 39870 USA		Conner, LM (corresponding author), Joseph W Jones Ecol Res Ctr, Newton, GA 39870 USA.	mconner@jonesctr.org			W. Jones Ecological Research Center	W. Jones Ecological Research Center	This study was entirely funded by the Joseph W. Jones Ecological Research Center.	Allen BL, 2014, ECOL MANAG RESTOR, V15, P191, DOI 10.1111/emr.12118; Allen BL, 2013, BIOL CONSERV, V159, P158, DOI 10.1016/j.biocon.2012.12.004; Beasley JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058982; BEASOM SL, 1974, J WILDLIFE MANAGE, V38, P854, DOI 10.2307/3800056; BEKOFF M, 1977, Mammalian Species, V79, P1; Bergstrom BJ, 2014, CONSERV LETT, V7, P131, DOI 10.1111/conl.12045; Bodey TW, 2011, BIOL INVASIONS, V13, P2817, DOI 10.1007/s10530-011-9965-2; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x; Cote IM, 1997, CONSERV BIOL, V11, P395, DOI 10.1046/j.1523-1739.1997.95410.x; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cypher Brian L., 1992, Proceedings of the Vertebrate Pest Conference, V15, P42; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ellis-Felege SN, 2012, J APPL ECOL, V49, P661, DOI 10.1111/j.1365-2664.2012.02126.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fletcher K, 2010, J APPL ECOL, V47, P263, DOI 10.1111/j.1365-2664.2010.01793.x; Frey SN, 2007, J WILDLIFE MANAGE, V71, P303, DOI 10.2193/2005-417; Frey SN, 2003, WILDLIFE SOC B, V31, P727; Garrettson PR, 2001, J WILDLIFE MANAGE, V65, P398, DOI 10.2307/3803091; Gehrt SD, 2003, WILDLIFE SOC B, V31, P836; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Gordon CE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2870; Henke SE, 1999, J WILDLIFE MANAGE, V63, P1066, DOI 10.2307/3802826; Hola M, 2015, EUR J WILDLIFE RES, V61, P73, DOI 10.1007/s10344-014-0875-3; Holt AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002400; Imperio S, 2010, WILDLIFE BIOL, V16, P205, DOI 10.2981/08-051; Jennions MD, 2002, BIOL REV, V77, P211, DOI 10.1017/S1464793101005875; Kauhala K, 2004, FOLIA ZOOL, V53, P367; Kilgo JC, 2014, J WILDLIFE MANAGE, V78, P1261, DOI 10.1002/jwmg.764; King CM, 2009, BIOL CONSERV, V142, P806, DOI 10.1016/j.biocon.2008.12.010; King CM, 1989, NATURAL HIST WEASELS; Kirkwood R, 2014, WILDLIFE RES, V41, P222, DOI 10.1071/WR13196; Korpimaki E, 2002, P ROY SOC B-BIOL SCI, V269, P991, DOI 10.1098/rspb.2002.1972; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; LINT JR, 1995, WILDLIFE SOC B, V23, P164; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; McCullough DR, 1996, J WILDLIFE MANAGE, V60, P1, DOI 10.2307/3802033; Mills L. S., 2007, CONSERVATION WILDLIF; Morris G, 2011, OECOLOGIA, V167, P1005, DOI 10.1007/s00442-011-2053-6; Newsome TM, 2015, J ANIM ECOL, V84, P49, DOI 10.1111/1365-2656.12258; Palmer WE, 2005, WILDLIFE SOC B, V33, P1398, DOI 10.2193/0091-7648(2005)33[1398:EOFBAN]2.0.CO;2; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; R Core Team, 2013, R LANG ENV STAT COMP; Reiter DK, 1999, WILDLIFE SOC B, V27, P746; Remy A, 2011, J ANIM ECOL, V80, P929, DOI 10.1111/j.1365-2656.2011.01849.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rogers CM, 1998, OECOLOGIA, V116, P227, DOI 10.1007/s004420050583; Rollins D, 2001, WILDLIFE SOC B, V29, P39; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Schmidt KA, 2008, BEHAV ECOL, V19, P759, DOI 10.1093/beheco/arn034; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Summers RW, 2004, J APPL ECOL, V41, P513, DOI 10.1111/j.0021-8901.2004.00891.x; Sundell J, 2006, MAMMAL REV, V36, P107, DOI 10.1111/j.1365-2907.2006.00083.x; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; VanGilder Cory L., 2009, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V63, P11; WADE-SMITH J, 1982, Mammalian Species, P1, DOI 10.2307/3503883; Wallach AD, 2015, OIKOS, V124, P1453, DOI 10.1111/oik.01977; Whitmee S, 2013, J ANIM ECOL, V82, P211, DOI 10.1111/j.1365-2656.2012.02030.x; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	64	23	23	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137169	10.1371/journal.pone.0137169	http://dx.doi.org/10.1371/journal.pone.0137169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361211	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100024
J	Xue, X; Yang, YA; Zhang, A; Fong, KW; Kim, J; Song, B; Li, S; Zhao, JC; Yu, J				Xue, X.; Yang, Y. A.; Zhang, A.; Fong, K-W; Kim, J.; Song, B.; Li, S.; Zhao, J. C.; Yu, J.			LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer	ONCOGENE			English	Article							LONG NONCODING RNAS; HUMAN PROSTATE-CANCER; ANDROGEN RECEPTOR; PROGNOSTIC MARKER; GENE-EXPRESSION; ESTROGEN; PROGRESSION; METASTASIS; BINDING; CELLS	Tamoxifen, an estrogen receptor (ER) antagonist, is the mainstay treatment of breast cancer and the development of resistance represents a major obstacle for a cure. Although long non-coding RNAs such as HOTAIR have been implicated in breast tumorigenesis, their roles in chemotherapy resistance remain largely unknown. In this study, we report that HOTAIR (HOX antisense intergenic RNA) is upregulated in tamoxifen-resistant breast cancer tissues compared to their primary counterparts. Mechanistically, HOTAIR is a direct target of ER-mediated transcriptional repression and is thus restored upon the blockade of ER signaling, either by hormone deprivation or by tamoxifen treatment. Interestingly, this elevated HOTAIR increases ER protein level and thus enhances ER occupancy on the chromatin and potentiates its downstream gene regulation. HOTAIR overexpression is sufficient to activate the ER transcriptional program even under hormone-deprived conditions. Functionally, we found that HOTAIR overexpression increases breast cancer cell proliferation, whereas its depletion significantly impairs cell survival and abolishes tamoxifen-resistant cell growth. In conclusion, the long non-coding RNA HOTAIR is directly repressed by ER and its upregulation promotes ligand-independent ER activities and contributes to tamoxifen resistance.	[Xue, X.] Guangzhou Med Univ, Ctr Canc, Div Thorac Surg, Guangzhou, Guangdong, Peoples R China; [Xue, X.; Yang, Y. A.; Zhang, A.; Fong, K-W; Kim, J.; Song, B.; Li, S.; Zhao, J. C.; Yu, J.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol,Dept Med, 303 E Super St Lurie 5-117, Chicago, IL 60611 USA; [Yu, J.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Guangzhou Medical University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Yu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol,Dept Med, 303 E Super St Lurie 5-117, Chicago, IL 60611 USA.	jindan-yu@northwestern.edu	li, shangze/AAW-6317-2021; Kim, Jung/Q-7801-2016	Fong, Ka-wing/0000-0001-6995-0264; Yang, Angela/0000-0002-9868-7431; Kim, Jung/0000-0001-6274-2841	Office of the Provost; Northwestern University Information Technology; US Department of Defense [W81XWH-13-1-0319]; Research Scholar Award from the American Cancer Society [RSG-12-085-01]; National Institutes of Health Training Program in Oncogenesis and Developmental Biology [T32 CA080621]; National Institutes of Health/National Cancer Institute training grant [T32 CA009560]; NATIONAL CANCER INSTITUTE [T32CA080621, T32CA009560] Funding Source: NIH RePORTER	Office of the Provost; Northwestern University Information Technology; US Department of Defense(United States Department of Defense); Research Scholar Award from the American Cancer Society(American Cancer Society); National Institutes of Health Training Program in Oncogenesis and Developmental Biology; National Institutes of Health/National Cancer Institute training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Bioinformatic analysis was supported by the computational resources and staff contributions provided for the Quest high-performance computing facility at Northwestern University, which is jointly supported by the Office of the Provost, the Office for Research, and Northwestern University Information Technology. This work was supported by the the US Department of Defense W81XWH-13-1-0319 (to JY) and the Research Scholar Award RSG-12-085-01 (to JY) from the American Cancer Society. JK was supported in part by the National Institutes of Health Training Program in Oncogenesis and Developmental Biology (T32 CA080621), and YAY was supported in part by the National Institutes of Health/National Cancer Institute training grant T32 CA009560.	Bussemakers MJG, 1999, CANCER RES, V59, P5975; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Chisholm KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047998; Clarke R, 2001, PHARMACOL REV, V53, P25; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Lee GL, 2011, NAT REV UROL, V8, P123, DOI 10.1038/nrurol.2011.10; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sorensen KP, 2013, BREAST CANCER RES TR, V142, P529, DOI 10.1007/s10549-013-2776-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wu L, 2014, ONCOGENE, V33, P504, DOI 10.1038/onc.2012.602; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	36	299	320	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2746	2755		10.1038/onc.2015.340	http://dx.doi.org/10.1038/onc.2015.340			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26364613	Green Accepted			2022-12-26	WOS:000377472700008
J	Gagnon, SML; Meloncelli, PJ; Zheng, RXB; Haji-Ghassemi, O; Johal, AR; Borisova, SN; Lowary, TL; Evans, SV				Gagnon, Susannah M. L.; Meloncelli, Peter J.; Zheng, Ruixiang B.; Haji-Ghassemi, Omid; Johal, Asha R.; Borisova, Svetlana N.; Lowary, Todd L.; Evans, Stephen V.			High Resolution Structures of the Human ABO(H) Blood Group Enzymes in Complex with Donor Analogs Reveal That the Enzymes Utilize Multiple Donor Conformations to Bind Substrates in a Stepwise Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B GALACTOSYLTRANSFERASE; GROUP-A; GROUP GLYCOSYLTRANSFERASES; SPECIFICITY; TRANSFERASE; RECOGNITION; MECHANISM; ACCEPTOR; CLASSIFICATION; BIOSYNTHESIS	Homologous glycosyltransferases alpha-(1 -> 3)-N-acetylgalactosaminyltransferase (GTA) and alpha-(1 -> 3)-galactosyltransferase (GTB) catalyze the final step in ABO(H) blood group A and B antigen synthesis through sugar transfer from activated donor to the H antigen acceptor. These enzymes have a GT-A fold type with characteristic mobile polypeptide loops that cover the active site upon substrate binding and, despite intense investigation, many aspects of substrate specificity and catalysis remain unclear. The structures of GTA, GTB, and their chimeras have been determined to between 1.55 and 1.39 angstrom resolution in complex with natural donors UDP-Gal, UDP-Glc and, in an attempt to overcome one of the common problems associated with three-dimensional studies, the non-hydrolyzable donor analog UDP-phosphono-galactose (UDP-C-Gal). Whereas the uracil moieties of the donors are observed to maintain a constant location, the sugar moieties lie in four distinct conformations, varying from extended to the"tucked under" conformation associated with catalysis, each stabilized by different hydrogen bonding partners with the enzyme. Further, several structures show clear evidence that the donor sugar is disordered over two of the observed conformations and so provide evidence for stepwise insertion into the active site. Although the natural donors can both assume the tucked under conformation in complex with enzyme, UDP-C-Gal cannot. Whereas UDP-C-Gal was designed to be "isosteric" with natural donor, the small differences in structure imposed by changing the epimeric oxygen atom to carbon appear to render\ the enzyme incapable of binding the analog in the active conformation and so preclude its use as a substrate mimic in GTA and GTB.	[Gagnon, Susannah M. L.; Haji-Ghassemi, Omid; Johal, Asha R.; Borisova, Svetlana N.; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Meloncelli, Peter J.; Zheng, Ruixiang B.; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Meloncelli, Peter J.; Zheng, Ruixiang B.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Victoria; University of Alberta; University of Alberta	Evans, SV (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	svevans@uvic.ca	Lowary, Todd L/F-9608-2019	Lowary, Todd L/0000-0002-8331-8211; Evans, Stephen/0000-0002-0366-4027; Haji-Ghassemi, Omid/0000-0003-0116-005X	Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in whole or part by a grant from the Natural Sciences and Engineering Research Council of Canada, Alberta Innovates Technology Futures, and the Canadian Institutes of Health Research. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.; Recipient of a Senior Scholarship from the Michael Smith Foundation for Health Research.	Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Angulo J, 2006, J AM CHEM SOC, V128, P13529, DOI 10.1021/ja063550r; Beaton SA, 2009, CHEM COMMUN, P238, DOI 10.1039/b808078j; Blume A, 2006, J BIOL CHEM, V281, P32728, DOI 10.1074/jbc.M600424200; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Coutinho PM, 1999, ROY SOC CH, P3; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Gordon RD, 2006, J MOL BIOL, V360, P67, DOI 10.1016/j.jmb.2006.04.058; Hamasaki N, 2000, VOX SANG, V79, P191, DOI 10.1159/000056729; HEARN VM, 1968, BIOCHEM J, V109, P315, DOI 10.1042/bj1090315; Heissigerova H, 2003, GLYCOBIOLOGY, V13, P377, DOI 10.1093/glycob/cwg042; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; Johal AR, 2014, GLYCOBIOLOGY, V24, P237, DOI 10.1093/glycob/cwt098; Johal AR, 2012, ACTA CRYSTALLOGR D, V68, P268, DOI 10.1107/S0907444912001801; KABAT EA, 1949, BACTERIOL REV, V13, P189, DOI 10.1128/MMBR.13.4.189-202.1949; Kamath VP, 1999, GLYCOCONJUGATE J, V16, P599; KOBATA A, 1968, BIOCHEM BIOPH RES CO, V32, P272, DOI 10.1016/0006-291X(68)90380-X; Landsteiner K, 2001, WIEN KLIN WOCHENSCHR, V113, P768; Lee HJ, 2005, J BIOL CHEM, V280, P525, DOI 10.1074/jbc.M410245200; Letts JA, 2006, J BIOL CHEM, V281, P3625, DOI 10.1074/jbc.M507620200; Letts JA, 2007, ACTA CRYSTALLOGR D, V63, P860, DOI 10.1107/S0907444907026479; LOWARY TL, 1993, CARBOHYD RES, V249, P163, DOI 10.1016/0008-6215(93)84068-H; Marcus SL, 2003, J BIOL CHEM, V278, P12403, DOI 10.1074/jbc.M212002200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORGAN WTJ, 1959, BRIT MED BULL, V15, P109, DOI 10.1093/oxfordjournals.bmb.a069732; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Partha SK, 2010, J MOL BIOL, V403, P578, DOI 10.1016/j.jmb.2010.08.053; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Rademacher C, 2010, GLYCOCONJUGATE J, V27, P349, DOI 10.1007/s10719-010-9282-5; Schuman B, 2010, J MOL BIOL, V402, P399, DOI 10.1016/j.jmb.2010.07.036; Seto NOL, 1999, EUR J BIOCHEM, V259, P770, DOI 10.1046/j.1432-1327.1999.00086.x; Seto NOL, 2000, CARBOHYD RES, V324, P161, DOI 10.1016/S0008-6215(99)00297-9; Seto NOL, 1997, J BIOL CHEM, V272, P14133, DOI 10.1074/jbc.272.22.14133; Sindhuwinata N, 2010, GLYCOBIOLOGY, V20, P718, DOI 10.1093/glycob/cwq019; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Soya N, 2009, GLYCOBIOLOGY, V19, P1224, DOI 10.1093/glycob/cwp114; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; WATKINS WM, 1980, REV FR TRANSFUS IMMU, V23, P531, DOI 10.1016/S0338-4535(80)80157-7; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yamamoto M, 2001, J BIOL CHEM, V276, P13701, DOI 10.1074/jbc.M010805200	50	12	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27040	27052		10.1074/jbc.M115.682401	http://dx.doi.org/10.1074/jbc.M115.682401			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26374898	hybrid, Green Published			2022-12-26	WOS:000364794000016
J	Bankapalli, K; Saladi, S; Awadia, SS; Goswami, AV; Samaddar, M; D'Silva, P				Bankapalli, Kondalarao; Saladi, SreeDivya; Awadia, Sahezeel S.; Goswami, Arvind Vittal; Samaddar, Madhuja; D'Silva, Patrick			Robust Glyoxalase activity of Hsp31, a ThiJ/DJ-1/PfpI Family Member Protein, Is Critical for Oxidative Stress Resistance in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DJ-1 MUTANTS; PARKINSONS-DISEASE; MITOCHONDRIAL DYSFUNCTION; GLUTATHIONE-REDUCTASE; ESCHERICHIA-COLI; CROSS-LINKING; STATIONARY-PHASE; ALPHA-SYNUCLEIN; LENS PROTEINS; METHYLGLYOXAL	Methylglyoxal (MG) is a reactive metabolic intermediate generated during various cellular biochemical reactions, including glycolysis. The accumulation of MG indiscriminately modifies proteins, including important cellular antioxidant machinery, leading to severe oxidative stress, which is implicated in multiple neurodegenerative disorders, aging, and cardiac disorders. Although cells possess efficient glyoxalase systems for detoxification, their functions are largely dependent on the glutathione cofactor, the availability of which is self-limiting under oxidative stress. Thus, higher organisms require alternate modes of reducing the MG-mediated toxicity and maintaining redox balance. In this report, we demonstrate that Hsp31 protein, a member of the ThiJ/DJ-1/PfpI family in Saccharomyces cerevisiae, plays an indispensable role in regulating redox homeostasis. Our results show that Hsp31 possesses robust glutathione-independent methylglyoxalase activity and suppresses MG-mediated toxicity and ROS levels as compared with another paralog, Hsp34. On the other hand, glyoxalase-defective mutants of Hsp31 were found highly compromised in regulating the ROS levels. Additionally, Hsp31 maintains cellular glutathione and NADPH levels, thus conferring protection against oxidative stress, and Hsp31 relocalizes to mitochondria to provide cytoprotection to the organelle under oxidative stress conditions. Importantly, human DJ-1, which is implicated in the familial form of Parkinson disease, complements the function of Hsp31 by suppressing methylglyoxal and oxidative stress, thus signifying the importance of these proteins in the maintenance of ROS homeostasis across phylogeny.	[Bankapalli, Kondalarao; Saladi, SreeDivya; Awadia, Sahezeel S.; Goswami, Arvind Vittal; Samaddar, Madhuja; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	D'Silva, P (corresponding author), Indian Inst Sci, Dept Biochem, Biol Sci Bldg, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	Bankapalli, Kondalarao/GOH-1727-2022; Samaddar, Madhuja/AAJ-7908-2020; D'Silva, Patrick/L-6653-2019	Bankapalli, Kondalarao/0000-0002-0278-0931; Samaddar, Madhuja/0000-0001-5046-1604; Saladi, Sreedivya/0000-0001-7664-2622	Department of Science and Technology [DST/SJF/LSA-01/2011-2012]; Department of Biotechnology, India; Council of Scientific and Industrial Research, India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a Swarnajayanthi fellowship from the Department of Science and Technology (Grant ID: DST/SJF/LSA-01/2011-2012) and the Department of Biotechnology, India (to P. D.) and by a senior research fellowship from the Council of Scientific and Industrial Research, India (to K. B., A. V. G., and M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abordo EA, 1999, BIOCHEM PHARMACOL, V58, P641, DOI 10.1016/S0006-2952(99)00132-X; Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Ahmed N, 2002, BIOCHEM J, V364, P1; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Biswas S, 1997, BIOCHEM J, V323, P343, DOI 10.1042/bj3230343; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Chen P, 2015, METALLOMICS, V7, P289, DOI [10.1039/c4mt00292j, 10.1039/C4MT00292J]; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; Du J, 2000, J CELL BIOCHEM, V77, P333, DOI 10.1002/(SICI)1097-4644(20000501)77:2<333::AID-JCB15>3.0.CO;2-Q; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Goswami AV, 2012, HUM MOL GENET, V21, P3317, DOI 10.1093/hmg/dds162; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Hasim S, 2014, J BIOL CHEM, V289, P1662, DOI 10.1074/jbc.M113.505784; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Im JY, 2012, HUM MOL GENET, V21, P3013, DOI 10.1093/hmg/dds131; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; John GB, 2002, EXP CELL RES, V278, P198, DOI 10.1006/excr.2002.5586; Kasai H, 1998, CARCINOGENESIS, V19, P1459, DOI 10.1093/carcin/19.8.1459; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Kwolek-Mirek M, 2009, CELL BIOL TOXICOL, V25, P363, DOI 10.1007/s10565-008-9090-x; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Lee KW, 1999, BBA-MOL BASIS DIS, V1453, P141, DOI 10.1016/S0925-4439(98)00097-0; Li N, 2009, J BIOL CHEM, V284, P23602, DOI 10.1074/jbc.M109.024323; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Mihoub M, 2015, BIOCHEM BIOPH RES CO, V463, P1305, DOI 10.1016/j.bbrc.2015.06.111; Miller-Fleming L, 2014, P NATL ACAD SCI USA, V111, P7012, DOI 10.1073/pnas.1319221111; Mlakar A, 1996, FREE RADICAL RES, V25, P525, DOI 10.3109/10715769609149074; Morgan PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086564; Mujacic M, 2004, MOL MICROBIOL, V51, P849, DOI 10.1046/j.1365-2958.2003.03871.x; Mujacic M, 2007, APPL ENVIRON MICROB, V73, P1014, DOI 10.1128/AEM.02429-06; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; MURATA K, 1985, EUR J BIOCHEM, V151, P631, DOI 10.1111/j.1432-1033.1985.tb09151.x; NAIR S, 1991, CYTOMETRY, V12, P336, DOI 10.1002/cyto.990120408; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; RAY S, 1994, BIOCHEM J, V303, P69, DOI 10.1042/bj3030069; Richarme G, 2015, J BIOL CHEM, V290, P1885, DOI 10.1074/jbc.M114.597815; Rosca MG, 2002, AM J PHYSIOL-RENAL, V283, pF52, DOI 10.1152/ajprenal.00302.2001; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; Saha PP, 2014, J BIOL CHEM, V289, P10359, DOI 10.1074/jbc.M113.526665; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Shangari N, 2004, BIOCHEM PHARMACOL, V68, P1433, DOI 10.1016/j.bcp.2004.06.013; SHARPE JA, 1982, NEUROLOGY, V32, P1093, DOI 10.1212/WNL.32.10.1093; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Skoneczna A, 2007, FREE RADICAL BIO MED, V42, P1409, DOI 10.1016/j.freeradbiomed.2007.01.042; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Srivastava S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.355; STORZ G, 1987, P NATL ACAD SCI USA, V84, P8917, DOI 10.1073/pnas.84.24.8917; Subedi KP, 2011, MOL MICROBIOL, V81, P926, DOI 10.1111/j.1365-2958.2011.07736.x; Suh KS, 2014, FREE RADICAL RES, V48, P206, DOI 10.3109/10715762.2013.859387; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Treichel JL, 2003, NEUROTOXICOLOGY, V24, P825, DOI 10.1016/S0161-813X(03)00059-7; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Vernekar AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6301; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; Williams AC, 2004, BIOL REPROD, V71, P1309, DOI 10.1095/biolreprod.104.028407; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Wilson MA, 2014, P NATL ACAD SCI USA, V111, P6858, DOI 10.1073/pnas.1405511111; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhao QQ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-86; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	86	58	62	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26491	26507		10.1074/jbc.M115.673624	http://dx.doi.org/10.1074/jbc.M115.673624			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370081	hybrid, Green Published			2022-12-26	WOS:000364793600018
J	Borschel, WF; Cummings, KA; Tindell, LK; Popescu, GK				Borschel, William F.; Cummings, Kirstie A.; Tindell, LeeAnn K.; Popescu, Gabriela K.			Kinetic Contributions to Gating by Interactions Unique to N-methyl-D-aspartate (NMDA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE ALLOSTERIC MODULATORS; IONOTROPIC GLUTAMATE-RECEPTOR; LIGAND-BINDING CORE; SUBUNIT ARRANGEMENT; ION-CHANNEL; AMPA; ACTIVATION; DESENSITIZATION; MECHANISM; AFFINITY	Among glutamate-gated channels, NMDA receptors produce currents that subside with unusually slow kinetics, and this feature is essential to the physiology of central excitatory synapses. Relative to the homologous AMPA and kainate receptors, NMDA receptors have additional intersubunit contacts in the ligand binding domain that occur at both conserved and nonconserved sites. We examined GluN1/GluN2A single-channel currents with kinetic analyses and modeling to probe these class-specific intersubunit interactions for their role in glutamate binding and receptor gating. We found that substitutions that eliminate such interactions at non-conserved sites reduced stationary gating, accelerated deactivation, and imparted sensitivity to aniracetam, an AMPA receptor-selective positive modulator. Abolishing unique contacts at conserved sites also reduced stationary gating and accelerated deactivation. These results show that contacts specific to NMDA receptors, which brace the heterodimer interface within the ligand binding domain, stabilize actively gating receptor conformations and result in longer bursts and slower deactivations. They support the view that the strength of the heterodimer interface modulates gating in both NMDA and non-NMDA receptors and that unique interactions at this interface are responsible in part for basic differences between the kinetics of NMDA and non-NMDA currents at glutamatergic synapses.	[Borschel, William F.; Cummings, Kirstie A.; Tindell, LeeAnn K.; Popescu, Gabriela K.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, GK (corresponding author), SUNY Buffalo, Dept Biochem, 636 Biomed Res Bldg,3435 Main St, Buffalo, NY 14214 USA.	popescu@buffalo.edu	Regan, Clinton/E-6250-2012; popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002	National Institutes of Health [F31NS071782, F31NS086765, R01NS052669]; American Heart Association [EIA 0535268N]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS086765, F31NS071782, R01NS052669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants F31NS071782 (to W. F. B.), F31NS086765 (to K. A. C.), and R01NS052669 (to G. K. P.). This work was also supported by American Heart Association Grant EIA 0535268N (to G. K. P.).	Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Amico-Ruvio SA, 2010, BIOPHYS J, V98, P1160, DOI 10.1016/j.bpj.2009.12.4276; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; Borschel WF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1512; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; Dravid SM, 2008, J PHYSIOL-LONDON, V586, P4425, DOI 10.1113/jphysiol.2008.158634; FAGG GE, 1984, P NATL ACAD SCI-BIOL, V81, P6876, DOI 10.1073/pnas.81.21.6876; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; GIBB AJ, 1991, P ROY SOC B-BIOL SCI, V243, P39, DOI 10.1098/rspb.1991.0007; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Kaae BH, 2007, CHEM BIOL, V14, P1294, DOI 10.1016/j.chembiol.2007.10.012; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kussius CL, 2010, J NEUROSCI, V30, P12474, DOI 10.1523/JNEUROSCI.3337-10.2010; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Kussius CL, 2009, J NEUROSCI, V29, P6819, DOI 10.1523/JNEUROSCI.0281-09.2009; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Lu CB, 2001, EXP NEUROL, V170, P180, DOI 10.1006/exnr.2001.7686; Mitchell NA, 2007, BIOPHYS J, V92, P2392, DOI 10.1529/biophysj.106.095091; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Ptak CP, 2009, BIOCHEMISTRY-US, V48, P8594, DOI 10.1021/bi901127s; Qin F, 2004, BIOPHYS J, V87, P1657, DOI 10.1529/biophysj.103.037531; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Safferling M, 2001, BIOCHEMISTRY-US, V40, P13948, DOI 10.1021/bi011143g; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Sobolevsky AI, 2015, J PHYSIOL-LONDON, V593, P29, DOI 10.1113/jphysiol.2013.264911; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Timm DE, 2011, MOL PHARMACOL, V80, P267, DOI 10.1124/mol.110.070243; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Zhang W, 2008, NAT NEUROSCI, V11, P1373, DOI 10.1038/nn.2214	51	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26846	26855		10.1074/jbc.M115.678656	http://dx.doi.org/10.1074/jbc.M115.678656			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370091	hybrid, Green Published			2022-12-26	WOS:000364793600046
J	Cai, YH; Bhuiya, MW; Shanklin, J; Liu, CJ				Cai, Yuanheng; Bhuiya, Mohammad-Wadud; Shanklin, John; Liu, Chang-Jun			Engineering a Monolignol 4-O-Methyltransferase with High Selectivity for the Condensed Lignin Precursor Coniferyl Alcohol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ITERATIVE SATURATION MUTAGENESIS; ACID O-METHYLTRANSFERASE; SWISS-MODEL; DIRECTED EVOLUTION; STRUCTURAL BASIS; BIOSYNTHESIS; EFFICIENCY; POPLARS; ENZYMES	Lignin, a rigid biopolymer in plant cell walls, is derived from the oxidative polymerization of three monolignols. The composition of monolignol monomers dictates the degree of lignin condensation, reactivity, and thus the degradability of plant cell walls. Guaiacyl lignin is regarded as the condensed structural unit. Polymerization of lignin is initiated through the deprotonation of the para-hydroxyl group of monolignols. Therefore, preferentially modifying the para-hydroxyl of a specific monolignol to deprive its dehydrogenation propensity would disturb the formation of particular lignin subunits. Here, we test the hypothesis that specific remodeling the active site of a monolignol 4-O-methyltransferase would create an enzyme that specifically methylates the condensed guaiacyl lignin precursor coniferyl alcohol. Combining crystal structural information with combinatorial active site saturation mutagenesis and starting with the engineered promiscuous enzyme, MOMT5(T133L/E165I/F175I/F166W/H169F), we incrementally remodeled its substrate binding pocket by the addition of four substitutions, i.e. M26H, S30R, V33S, and T319M, yielding a mutant enzyme capable of discriminately etherifying the para-hydroxyl of coniferyl alcohol even in the presence of excess sinapyl alcohol. The engineered enzyme variant has a substantially reduced substrate binding pocket that imposes a clear steric hindrance thereby excluding bulkier lignin precursors. The resulting enzyme variant represents an excellent candidate for modulating lignin composition and/or structure in planta.	[Cai, Yuanheng; Bhuiya, Mohammad-Wadud; Shanklin, John; Liu, Chang-Jun] Brookhaven Natl Lab, Biol Environm & Climate Sci Dept, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Liu, CJ (corresponding author), Brookhaven Natl Lab, Biol Environm & Climate Sci Dept, Upton, NY 11973 USA.	cliu@bnl.gov		Shanklin, John/0000-0002-6774-8043	Office of Basic Energy Sciences, United States Department of Energy [DEAC0298CH10886]	Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE))	We thank Dr. Eran Pichersky, University of Michigan, for sharing the initial parental enzyme C. breweri IEMT clone. The use of the x-ray beamline X29 and X25 of the National Synchrotron Light source in Brookhaven National Laboratory was supported by the Office of Basic Energy Sciences, United States Department of Energy under Contract DEAC0298CH10886.	Acevedo-Rocha CG, 2014, METHODS MOL BIOL, V1179, P103, DOI 10.1007/978-1-4939-1053-3_7; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bhuiya MW, 2010, J BIOL CHEM, V285, P277, DOI 10.1074/jbc.M109.036673; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bommarius AS, 2011, CURR OPIN CHEM BIOL, V15, P194, DOI 10.1016/j.cbpa.2010.11.011; Bonawitz ND, 2013, CURR OPIN BIOTECH, V24, P336, DOI 10.1016/j.copbio.2012.11.004; Cabane M, 2004, PLANT PHYSIOL, V134, P586, DOI 10.1104/pp.103.031765; Cobb RE, 2013, METHODS, V60, P81, DOI 10.1016/j.ymeth.2012.03.009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Huntley SK, 2003, J AGR FOOD CHEM, V51, P6178, DOI 10.1021/jf034320o; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kille S, 2011, NAT CHEM, V3, P738, DOI [10.1038/nchem.1113, 10.1038/NCHEM.1113]; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Liu CJ, 2006, PLANT CELL, V18, P3656, DOI 10.1105/tpc.106.041376; Liu CJ, 2014, PLANT BIOTECHNOL J, V12, P1154, DOI 10.1111/pbi.12250; Louie GV, 2010, PLANT CELL, V22, P4114, DOI 10.1105/tpc.110.077578; Neutelings G, 2011, PLANT SCI, V181, P379, DOI 10.1016/j.plantsci.2011.06.012; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2006, CHEM-EUR J, V12, P6031, DOI 10.1002/chem.200600459; Reetz MT, 2005, ANGEW CHEM INT EDIT, V44, P4192, DOI 10.1002/anie.200500767; Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x; Somerville C, 2007, CURR BIOL, V17, pR115, DOI 10.1016/j.cub.2007.01.010; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wang JH, 1999, ARCH BIOCHEM BIOPHYS, V368, P172, DOI 10.1006/abbi.1999.1304; Wang JH, 1998, ARCH BIOCHEM BIOPHYS, V349, P153, DOI 10.1006/abbi.1997.0452; Zhang W, 2013, WORLD J MICROB BIOT, V29, P667, DOI 10.1007/s11274-012-1222-z; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412	36	6	6	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26715	26724		10.1074/jbc.M115.684217	http://dx.doi.org/10.1074/jbc.M115.684217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26378240	Green Published, hybrid			2022-12-26	WOS:000364793600034
J	Shehata, N; Forster, AJ; Lawrence, N; Ducharme, R; Fergusson, DA; Chasse, M; Rothwell, DM; Hebert, PC; Tinmouth, AT; Wilson, K				Shehata, Nadine; Forster, Alan J.; Lawrence, Nadine; Ducharme, Robin; Fergusson, Dean A.; Chasse, Michael; Rothwell, Deanna M.; Hebert, Paul C.; Tinmouth, Alan T.; Wilson, Kumanan			Transfusion Patterns in All Patients Admitted to the Intensive Care Unit and in Those Who Die in Hospital: A Descriptive Analysis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; BLOOD-TRANSFUSION; HEALTH-CARE; ANEMIA; MORTALITY; ICD-9-CM; SURGERY; LIFE	While it is known that the use of health care resources increases at the end of life in patients admitted to the Intensive Care Unit (ICU), the allocation of blood products at the end of life has not been described. The objective of this study was to describe overall transfusion patterns in the ICU, and specifically in patients who die in hospital. We conducted a retrospective cohort study of adult patients admitted to the ICU of a university-affiliated hospital, who were discharged or died between November 1, 2006 and June 30, 2012. During the study period, 10,642 patients were admitted at least once to the ICU. Of these patients, 4079 (38.3%) received red blood cells (RBCs), plasma or platelets in the ICU. The ICU mortality rate was 28.1% and in-hospital mortality rate was 32.3%. Among 39,591 blood product units transfused over the course of the study in the ICU (18,144 RBC units, 16,920 plasma units and 4527 platelet units), 46.2% were administered to patients who later died within the same hospitalization (41.2% of RBCs, 50.4% of plasma and 50.8% of platelets). Of all blood product units (RBCs, plasma and platelets) administered in the ICU over the study period, 11% were given within the last 24 hours before death. A large proportion of blood products used in the ICU are administered to patients who ultimately succumb to their illness in hospital, and many of these blood units are given in close proximity to death.	[Shehata, Nadine] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Shehata, Nadine] Univ Toronto, Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Shehata, Nadine] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Shehata, Nadine] Canadian Blood Serv, Toronto, ON, Canada; [Forster, Alan J.; Lawrence, Nadine; Ducharme, Robin; Fergusson, Dean A.; Chasse, Michael; Rothwell, Deanna M.; Tinmouth, Alan T.; Wilson, Kumanan] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Forster, Alan J.; Ducharme, Robin; Wilson, Kumanan] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Forster, Alan J.; Fergusson, Dean A.; Tinmouth, Alan T.; Wilson, Kumanan] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Fergusson, Dean A.; Chasse, Michael] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Fergusson, Dean A.] Univ Ottawa, Dept Surg, Ottawa, ON, Canada; [Hebert, Paul C.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Canadian Blood Services; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Universite de Montreal	Wilson, K (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	kwilson@ohri.ca	Shehata, Nadine/AAG-1124-2019; Chassé, Michaël/L-7906-2017; Chassé, Michaël/Y-7820-2019	Chassé, Michaël/0000-0001-7075-1924; Shehata, Nadine/0000-0002-9267-6256; Fergusson, Dean/0000-0002-3389-2485; Ducharme, Robin/0000-0002-5665-7429	Canadian Institute of Health Research/Canadian Blood Services New Investigator Award; Canadian Blood Services' [XT0085]	Canadian Institute of Health Research/Canadian Blood Services New Investigator Award(Canadian Institutes of Health Research (CIHR)); Canadian Blood Services'	Nadine Shehata received support from the Canadian Institute of Health Research/Canadian Blood Services New Investigator Award. This study is funded by a Canadian Blood Services' (www.blood.ca.) intramural grant XT0085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DM, 2006, TRANSFUSION, V46, P1286, DOI 10.1111/j.1537-2995.2006.00892.x; Christensen Steffen, 2011, Clin Epidemiol, V3, P203, DOI 10.2147/CLEP.S20247; Como JJ, 2004, TRANSFUSION, V44, P809, DOI 10.1111/j.1537-2995.2004.03409.x; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Lauzier F, 2007, CRIT CARE MED, V35, P1655, DOI 10.1097/01.CCM.0000269370.59214.97; Middelburg RA, 2010, TRANSFUSION, V50, P1181, DOI 10.1111/j.1537-2995.2010.02675.x; Misset B, 2008, CRIT CARE, V12, DOI 10.1186/cc6969; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reimche L, 2011, J CLIN PHARMACOL, V51, P1043, DOI 10.1177/0091270010378858; Reuben DB, 2011, JAMA-J AM MED ASSOC, V306, P430, DOI 10.1001/jama.2011.999; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; Shehata N, 2013, TRANSFUSION, V53, P1688, DOI 10.1111/trf.12007; Stanworth SJ, 2013, TRANSFUSION, V53, P1050, DOI 10.1111/j.1537-2995.2012.03866.x; Stanworth SJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10129; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Unroe KT, 2011, ARCH INTERN MED, V171, P196, DOI 10.1001/archinternmed.2010.371; van Klei WA, 2009, ANESTHESIOLOGY, V111, P717, DOI 10.1097/ALN.0b013e3181b6a761; van Walraven C, 2011, J HOSP MED, V6, P389, DOI 10.1002/jhm.917; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	23	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138427	10.1371/journal.pone.0138427	http://dx.doi.org/10.1371/journal.pone.0138427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378791	Green Submitted, Green Published, gold			2022-12-26	WOS:000361769400098
J	Gonzalez-Prieto, C; Agundez, L; Llosa, M				Gonzalez-Prieto, Coral; Agundez, Leticia; Llosa, Matxalen			Chloramphenicol Selection of IS10 Transposition in the cat Promoter Region of Widely Used Cloning Vectors	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; CONJUGATIVE RELAXASE; PLASMID; DNA; CONSTRUCTION; MUTANTS; PROTEIN; IDENTIFICATION	The widely used pSU8 family of cloning vectors is based on a p15A replicon and a chloramphenicol acetyltransferase (cat) gene conferring chloramphenicol resistance. We frequently observed an increase in the size of plasmids derived from these vectors. Analysis of the bigger molecular species shows that they have an IS10 copy inserted at a specific site between the promoter and the cat open reading frame. Promoter activity from both ends of IS10 has been reported, suggesting that the insertion events could lead to higher CAT production. Insertions were observed in certain constructions containing inserts that could lead to plasmid instability. To test the possibility that IS10 insertions were selected as a response to chloramphenicol selection, we have grown these constructs in the presence of different amounts of antibiotic and we observed that insertions arise promptly under higher chloramphenicol selective pressure. IS10 is present in many E. coli laboratory strains, so the possibility of insertion in constructions involving cat-containing vectors should be taken into account. Using lower chloramphenicol concentrations could solve this problem.	[Gonzalez-Prieto, Coral; Agundez, Leticia; Llosa, Matxalen] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; [Gonzalez-Prieto, Coral; Agundez, Leticia; Llosa, Matxalen] Inst Biomed & Biotecnol Cantabria UC CSIC SODERCA, Santander, Spain; [Agundez, Leticia] UCL, Inst Ophthalmol, Dept Genet, London, England	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of London; University College London	Llosa, M (corresponding author), Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain.	llosam@unican.es	, matxalen/ABG-5541-2020; Gonzalez-Prieto, Coral/ABD-1690-2020	, matxalen/0000-0002-4826-2240; 	Spanish Ministry of Economy and Competitiveness [BIO2013-46414-P]; University of Cantabria, Spain	Spanish Ministry of Economy and Competitiveness(Spanish Government); University of Cantabria, Spain	This work was supported by grant BIO2013-46414-P from the Spanish Ministry of Economy and Competitiveness to ML. CGP was a recipient of a predoctoral fellowship from the University of Cantabria, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031047; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLIVAR F, 1977, P NATL ACAD SCI USA, V74, P5265, DOI 10.1073/pnas.74.12.5265; CAMPBELL JL, 1978, P NATL ACAD SCI USA, V75, P2276, DOI 10.1073/pnas.75.5.2276; Cesar CE, 2007, J BACTERIOL, V189, P9037, DOI 10.1128/JB.01152-07; Cesar CE, 2006, MOL MICROBIOL, V62, P984, DOI 10.1111/j.1365-2958.2006.05437.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; de Paz HD, 2010, J BACTERIOL, V192, P2655, DOI 10.1128/JB.01692-09; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102; Eichenbaum Z, 1998, GENETICS, V149, P1173; FOSTER TJ, 1981, CELL, V23, P201, DOI 10.1016/0092-8674(81)90285-3; Francia MV, 2002, J BACTERIOL, V184, P5187, DOI 10.1128/JB.184.18.5187-5193.2002; Francia MV, 2002, MOL MICROBIOL, V45, P375, DOI 10.1046/j.1365-2958.2002.03007.x; Furuya N, 2003, J BACTERIOL, V185, P3871, DOI 10.1128/JB.185.13.3871-3877.2003; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; HALLING SM, 1982, CELL, V28, P155, DOI 10.1016/0092-8674(82)90385-3; Kobori Shungo, 2009, Open Microbiol J, V3, P146, DOI 10.2174/1874285800903010146; Kovarik A, 2001, MOL GENET GENOMICS, V266, P216, DOI 10.1007/s004380100542; Larrea D, 2013, INTERFASE MOL ENTRE; Larrea D, 2013, PLASMID, V70, P146, DOI 10.1016/j.plasmid.2013.03.006; MARTINEZ E, 1988, GENE, V68, P159, DOI 10.1016/0378-1119(88)90608-7; Martinez-Garcia E, 2003, J BACTERIOL, V185, P2046, DOI 10.1128/JB.185.6.2046-2050.2003; MATSUTANI S, 1991, J BACTERIOL, V173, P7802, DOI 10.1128/jb.173.24.7802-7809.1991; Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117; Olliver A, 2005, ANTIMICROB AGENTS CH, V49, P289, DOI 10.1128/AAC.49.1.289-301.2005; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; RODRIGUEZ H, 1992, MUTAT RES, V270, P219, DOI 10.1016/0027-5107(92)90133-M; SHEN MM, 1987, GENETICS, V116, P359; SIMONS RW, 1983, CELL, V34, P673, DOI 10.1016/0092-8674(83)90400-2; SKALITER R, 1992, MUTAT RES, V267, P139, DOI 10.1016/0027-5107(92)90118-L; Stoebel DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000671; Zechner E. L., 2000, HORIZONTAL GENE POOL, P87	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138615	10.1371/journal.pone.0138615	http://dx.doi.org/10.1371/journal.pone.0138615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375469	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200115
J	Kalarus, K; Nowicki, P				Kalarus, Konrad; Nowicki, Piotr			How Do Landscape Structure, Management and Habitat Quality Drive the Colonization of Habitat Patches by the Dryad Butterfly (Lepidoptera: Satyrinae) in Fragmented Grassland?	PLOS ONE			English	Article							CALCAREOUS GRASSLANDS; RESOURCE USE; POPULATION-DENSITY; DISPERSAL; CONSERVATION; MATRIX; OCCUPANCY; MIGRATION; WOODLAND; SCALE	Most studies dealing with species distribution patterns on fragmented landscapes focus on the characteristics of habitat patches that influence local occurrence and abundance, but they tend to neglect the question of what drives colonization of previously unoccupied patches. In a study of the dryad butterfly, we combined classical approaches derived from metapopulation theory and landscape ecology to investigate the factors driving colonization from a recent refugium. In three consecutive transect surveys, we recorded the presence and numbers of imagos in 27 patches of xerothermic grassland and 26 patches of wet meadow. Among the predictors affecting the occurrence and abundance of the dryad, we considered environmental variables reflecting (i) habitat patch quality (e.g., goldenrod cover, shrub density, vegetation height); (ii) factors associated with habitat spatial structure (patch size, patch isolation and fragmentation); and (iii) features of patch surroundings (100-m buffers around patches) that potentially pose barriers or provide corridors. Patch colonization by the dryad was strongly limited by the distance from the species refugium in the region; there was a slight positive effect of shrub density in this respect. Butterfly abundance increased in smaller and more fragmented habitat patches; it was negatively impacted by invasive goldenrod cover, and positively influenced by the density of watercourses in patch surroundings. Nectar plant availability was positively related to species abundance in xerothermic grassland, while in wet meadow the effect was the reverse. We conclude that dryad colonization of our study area is very recent, since the most important factor limiting colonization was distance from the refugium, while the habitat quality of target patches had less relevance. In order to preserve the species, conservation managers should focus on enhancing the quality of large patches and should also direct their efforts on smaller and more fragmented ones, including those with relatively low resource availability, because such habitat fragments have an important role to play for specialist species.	[Kalarus, Konrad; Nowicki, Piotr] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Jagiellonian University	Kalarus, K (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	klaus.vk5@gmail.com	Nowicki, Piotr/AFP-2530-2022	Nowicki, Piotr/0000-0002-9797-886X; Kalarus, Konrad/0000-0002-6211-1019	Polish National Science Centre [DEC-2013/11/B/NZ8/00912]; Jagiellonian University [DS/WBINOZ/INOS/761/12-13]	Polish National Science Centre; Jagiellonian University	The study was funded by the Polish National Science Centre grant DEC-2013/11/B/NZ8/00912. The fieldwork was additionally supported by the Jagiellonian University through its DS/WBINOZ/INOS/761/12-13 funds.	Akeboshi A, 2015, J INSECT CONSERV, V19, P15, DOI 10.1007/s10841-014-9732-7; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baguette M, 2000, J APPL ECOL, V37, P100, DOI 10.1046/j.1365-2664.2000.00478.x; Baum KA, 2004, ECOLOGY, V85, P2671, DOI 10.1890/04-0500; Bergerot B, 2013, POPUL ECOL, V55, P193, DOI 10.1007/s10144-012-0349-y; Bergerot B, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-5; Bommarco R, 2014, DIVERS DISTRIB, V20, P591, DOI 10.1111/ddi.12187; Boughton DA, 2000, AM NAT, V156, P131, DOI 10.1086/303380; Boughton DA, 1999, ECOLOGY, V80, P2727; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Chong KY, 2014, BIOL CONSERV, V171, P299, DOI 10.1016/j.biocon.2014.01.037; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; Clarke SA, 2011, J INSECT CONSERV, V15, P23, DOI 10.1007/s10841-010-9300-8; Collinge SK, 2003, CONSERV BIOL, V17, P178, DOI 10.1046/j.1523-1739.2003.01315.x; Concepcion ED, 2008, LANDSCAPE ECOL, V23, P135, DOI 10.1007/s10980-007-9150-2; Cozzi G, 2008, LANDSCAPE ECOL, V23, P269, DOI 10.1007/s10980-007-9178-3; Dabrowski Jerzy S., 1999, Chronmy Przyrode Ojczysta, V55, P91; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Dennis R.L.H., 2010, BUTTERFLIES BRIT LAN; Dennis RLH, 2006, BIOL CONSERV, V129, P291, DOI 10.1016/j.biocon.2005.10.043; Eastman J.R., 1997, IDRISI WINDOWS USERS; Eycott AE, 2012, LANDSCAPE ECOL, V27, P1263, DOI 10.1007/s10980-012-9781-9; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fartmann T, 2006, ANN ZOOL FENN, V43, P335; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Grill A, 2008, J INSECT CONSERV, V12, P617, DOI 10.1007/s10841-007-9098-1; Grundel R, 2007, BIOL CONSERV, V135, P135, DOI 10.1016/j.biocon.2006.10.003; Habel JC, 2011, GLOBAL CHANGE BIOL, V17, P194, DOI 10.1111/j.1365-2486.2010.02233.x; Haddad N, 2000, CONSERV BIOL, V14, P738, DOI 10.1046/j.1523-1739.2000.99041.x; Hamback PA, 2005, ECOL LETT, V8, P1057, DOI 10.1111/j.1461-0248.2005.00811.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HANSKI I, 1994, ECOLOGY, V75, P747, DOI 10.2307/1941732; Hanski I., 1999, METAPOPULATION ECOLO; Hanski I., 2009, SPATIAL ECOLOGY, P167; Hill JK, 1996, J ANIM ECOL, V65, P725, DOI 10.2307/5671; Kalarus K, 2013, J INSECT CONSERV, V17, P1221, DOI 10.1007/s10841-013-9603-7; Kalarus K, 2013, J INSECT CONSERV, V17, P777, DOI 10.1007/s10841-013-9560-1; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kindt R., 2005, WORLD; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Krauss J, 2004, BIOL CONSERV, V120, P355, DOI 10.1016/j.biocon.2004.03.007; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kuras T, 2003, POPUL ECOL, V45, P115, DOI 10.1007/s10144-003-0144-x; Legendre P., 2012, NUMERICAL ECOLOGY; Leps J, 2003, MULTIVARIATE ANAL EC; Lindman L, 2015, INSECT CONSERV DIVER, V8, P3, DOI 10.1111/icad.12087; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Matter SF, 2009, OIKOS, V118, P1461, DOI 10.1111/j.1600-0706.2009.17438.x; Moron D, 2009, BIOL CONSERV, V142, P1322, DOI 10.1016/j.biocon.2008.12.036; Nowicki P, 2008, ISR J ECOL EVOL, V54, P69, DOI 10.1560/IJEE.54.1.69; Nowicki P, 2007, BIOL CONSERV, V140, P119, DOI 10.1016/j.biocon.2007.08.001; Nowicki P, 2014, LANDSCAPE ECOL, V29, P401, DOI 10.1007/s10980-013-9971-0; Nowicki P, 2011, OECOLOGIA, V167, P657, DOI 10.1007/s00442-011-2025-x; Ockinger E, 2008, LANDSCAPE ECOL, V23, P27, DOI 10.1007/s10980-007-9167-6; Ockinger E, 2009, LANDSCAPE URBAN PLAN, V93, P31, DOI 10.1016/j.landurbplan.2009.05.021; POLLARD E, 1994, MONITORING BUTTERFLI; R Core Team, 2021, R LANGUAGE ENV STAT; Ries L, 2001, J ANIM ECOL, V70, P840, DOI 10.1046/j.0021-8790.2001.00546.x; Rosin ZM, 2012, J INSECT CONSERV, V16, P321, DOI 10.1007/s10841-011-9416-5; Schultz CB, 1998, CONSERV BIOL, V12, P284, DOI 10.1046/j.1523-1739.1998.96266.x; Schultz CB, 2005, CONSERV BIOL, V19, P887, DOI 10.1111/j.1523-1739.2005.00462.x; Schwarzwalder B, 1997, BIOL CONSERV, V82, P157, DOI 10.1016/S0006-3207(97)00023-2; Settele J, 1999, TAGFALTER DEUTSCHLAN; Shreeve TG, 2011, J INSECT CONSERV, V15, P179, DOI 10.1007/s10841-010-9336-9; Skorka P, 2007, AGR ECOSYST ENVIRON, V121, P319, DOI 10.1016/j.agee.2006.11.001; Slamova I, 2013, INSECT CONSERV DIVER, V6, P243, DOI 10.1111/j.1752-4598.2012.00212.x; Slancarova J, 2014, J INSECT CONSERV, V18, P1, DOI 10.1007/s10841-013-9607-3; Spitzer L, 2009, ECOL INDIC, V9, P1056, DOI 10.1016/j.ecolind.2008.12.006; Stefanescu C, 2011, ECOGRAPHY, V34, P353, DOI 10.1111/j.1600-0587.2010.06264.x; Suhonen J, 2014, CONSERV BIOL, V28, P783, DOI 10.1111/cobi.12231; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; THOMAS CD, 1992, OECOLOGIA, V92, P563, DOI 10.1007/BF00317850; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P1791, DOI 10.1098/rspb.2001.1693; Turlure C, 2009, OIKOS, V118, P950, DOI 10.1111/j.1600-0706.2009.17269.x; Van Swaay C.A.M., 2003, J INSECT CONSERV, V10, P5; van Swaay CAM, 2002, BIOL CONSERV, V104, P315, DOI 10.1016/S0006-3207(01)00196-3; Vandewoestijne S, 2004, BASIC APPL ECOL, V5, P581, DOI 10.1016/j.baae.2004.07.004; Vanreusel W, 2007, BIOL CONSERV, V135, P202, DOI 10.1016/j.biocon.2006.10.035; Verhagen R, 2007, THESIS U GRONINGEN N; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; WallisDeVries MF, 2002, BIOL CONSERV, V104, P265, DOI 10.1016/S0006-3207(01)00191-4; WallisDeVries MF, 2010, RESTOR ECOL, V18, P390, DOI 10.1111/j.1526-100X.2008.00447.x; Warecki Adam, 2008, Polish Journal of Entomology, V77, P191; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	85	12	12	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138557	10.1371/journal.pone.0138557	http://dx.doi.org/10.1371/journal.pone.0138557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375036	gold, Green Published			2022-12-26	WOS:000361610200112
J	Kim, JY; Choi, JY; Lee, HJ; Byun, CJ; Park, JH; Park, JH; Cho, HS; Cho, SJ; Jo, SA; Jo, I				Kim, Jee-Youn; Choi, Ji-Young; Lee, Hyeon-Ju; Byun, Catherine Jeonghae; Park, Jung-Hyun; Park, Jae Hoon; Cho, Ho-Seong; Cho, Sung-Jin; Jo, Sangmee Ahn; Jo, Inho			The Green Tea Component (-)-Epigallocatechin-3-Gallate Sensitizes Primary Endothelial Cells to Arsenite-Induced Apoptosis by Decreasing c-Jun N-Terminal Kinase-Mediated Catalase Activity	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; PROMOTES APOPTOSIS; DOWN-REGULATION; CANCER-CELLS; JNK; ABL; ACTIVATION; INHIBITION; PHOSPHORYLATION; ANGIOPOIETIN-1	The green tea component (-)-epigallocatechin-3-gallate (EGCG) has been shown to sensitize many different types of cancer cells to anticancer drug-induced apoptosis, although it protects against non-cancerous primary cells against toxicity from certain conditions such as exposure to arsenic (As) or ultraviolet irradiation. Here, we found that EGCG promotes As-induced toxicity of primary-cultured bovine aortic endothelial cells (BAEC) at doses in which treatment with each chemical alone had no such effect. Increased cell toxicity was accompanied by an increased condensed chromatin pattern and fragmented nuclei, cleaved poly(ADP-ribose) polymerase (PARP), activity of the pro-apoptotic enzymes cas-pases 3, 8 and 9, and Bax translocation into mitochondria, suggesting the involvement of an apoptotic signaling pathway. Fluorescence activated cell sorting analysis revealed that compared with EGCG or As alone, combined EGCG and As (EGCG/As) treatment significantly induced production of reactive oxygen species (ROS), which was accompanied by decreased catalase activity and increased lipid peroxidation. Pretreatment with N-acetyl-L-cysteine or catalase reversed EGCG/As-induced caspase activation and EC toxicity. EGCG/As also increased the phosphorylation of c-Jun N-terminal kinase (JNK), which was not reversed by catalase. However, pretreatment with the JNK inhibitor SP600125 reversed all of the observed effects of EGCG/As, suggesting that JNK may be the most upstream protein examined in this study. Finally, we also found that all the observed effects by EGCG/As are true for other types of EC tested. In conclusion, this is firstly to show that EGCG sensitizes non-cancerous EC to As-induced toxicity through ROS-mediated apoptosis, which was attributed at least in part to a JNK-activated decrease in catalase activity.	[Kim, Jee-Youn; Choi, Ji-Young; Lee, Hyeon-Ju; Byun, Catherine Jeonghae; Park, Jung-Hyun; Jo, Inho] Ewha Womans Univ, Sch Med, Dept Mol Med, Seoul, South Korea; [Kim, Jee-Youn] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Choi, Ji-Young; Jo, Sangmee Ahn] Dankook Univ, Dept Nanobiomed Sci, Cheonan, Chungnam, South Korea; [Choi, Ji-Young; Jo, Sangmee Ahn] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, Chungnam, South Korea; [Jo, Sangmee Ahn] Dankook Univ, Coll Pharm, Dept Pharmacol, Cheonan, Chungnam, South Korea; [Park, Jae Hoon] Kyung Hee Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Cho, Ho-Seong] Chonbuk Natl Univ, Biosafety Res Inst, Jeonju, Chonbuk, South Korea; [Cho, Ho-Seong] Chonbuk Natl Univ, Coll Vet Med, Jeonju, Chonbuk, South Korea; [Cho, Sung-Jin] Chungbuk Natl Univ, Coll Nat Sci, Dept Biol, Cheongju, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System; Dankook University; Dankook University; Dankook University; Kyung Hee University; Jeonbuk National University; Jeonbuk National University; Chungbuk National University	Jo, SA (corresponding author), Dankook Univ, Dept Nanobiomed Sci, Cheonan, Chungnam, South Korea.	smahn@dankook.ac.kr; inhojo@ewha.ac.kr	Jo, Inho/R-3581-2019	Jo, Inho/0000-0001-6060-6416	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ01052302]	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of Cooperative Research Program (PJ01052302) for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea (http://www.rda.go.kr; JYK, JYC, J-HP, HSC, SJC, IJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, ARTHRITIS RHEUM-US, V60, P1282, DOI 10.1002/art.24488; Cao C, 2003, BIOCHEMISTRY-US, V42, P10348, DOI 10.1021/bi035023f; Cao C, 2003, J BIOL CHEM, V278, P29667, DOI 10.1074/jbc.M301292200; Chen HP, 2013, J ONCOL, V2013, DOI 10.1155/2013/872957; Chen Nan-Yue, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P287; Chen SC, 2014, CARDIOVASC TOXICOL, V14, P222, DOI 10.1007/s12012-014-9246-2; Choi JY, 2013, APOPTOSIS, V18, P99, DOI 10.1007/s10495-012-0768-4; Choi JY, 2002, NEUROTOXICOLOGY, V23, P367, DOI 10.1016/S0161-813X(02)00079-7; Elbling L, 2011, TOXICOL LETT, V205, P173, DOI 10.1016/j.toxlet.2011.06.001; Eom DW, 2014, BMB REP IN PRESS; Hagen RM, 2013, INT J ONCOL, V43, P194, DOI 10.3892/ijo.2013.1920; Juneja J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026085; Katiyar S, 2007, J NUTR BIOCHEM, V18, P287, DOI 10.1016/j.jnutbio.2006.08.004; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Lee TC, 2011, TOXICOL APPL PHARM, V250, P69, DOI 10.1016/j.taap.2010.10.005; Li L, 2006, REDOX REP, V11, P173, DOI 10.1179/135100006X116682; Lu LDY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03169; Luo T, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2473; Min NY, 2012, BIOCHEM BIOPH RES CO, V421, P91, DOI 10.1016/j.bbrc.2012.03.120; Murakami T, 2005, J BIOL CHEM, V280, P31841, DOI 10.1074/jbc.M503108200; Murata Y, 2012, J NEUROSCI, V32, P8112, DOI 10.1523/JNEUROSCI.0219-12.2012; Nakagawa H, 2002, BIOCHEM BIOPH RES CO, V292, P94, DOI 10.1006/bbrc.2002.6622; Nakazato T, 2005, CLIN CANCER RES, V11, P6040, DOI 10.1158/1078-0432.CCR-04-2273; Orloff K, 2009, J TOXICOL ENV HEAL B, V12, P509, DOI 10.1080/10937400903358934; Park JS, 2009, TOXICOLOGY, V264, P26, DOI 10.1016/j.tox.2009.07.008; Park JH, 2013, NITRIC OXIDE-BIOL CH, V32, P36, DOI 10.1016/j.niox.2013.04.003; Seo J, 2014, BIOMOL THER, V22, P510, DOI 10.4062/biomolther.2014.106; Sinha Dona, 2003, Asian Pac J Cancer Prev, V4, P233; Suriyo T, 2012, TOXICOL IN VITRO, V26, P386, DOI 10.1016/j.tiv.2011.12.017; Tang CL, 2014, INT J CLIN EXP PATHO, V7, P959; Tsai KH, 2012, J CELL PHYSIOL, V227, P1347, DOI 10.1002/jcp.22847; Tsou TC, 2005, TOXICOL APPL PHARM, V208, P277, DOI 10.1016/j.taap.2005.03.001; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Wang J, 2011, MOL MED, V17, P990, DOI 10.2119/molmed.2011.00073; Wang SP, 2014, AM J CHINESE MED, V42, P1279, DOI 10.1142/S0192415X14500803; Wu XX, 2014, INT IMMUNOPHARMACOL, V23, P434, DOI 10.1016/j.intimp.2014.09.014; Yamamoto T, 2003, J PHARMACOL EXP THER, V307, P230, DOI 10.1124/jpet.103.054676; Yang EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086062; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhang TP, 2009, APOPTOSIS, V14, P1245, DOI 10.1007/s10495-009-0391-1	41	10	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138590	10.1371/journal.pone.0138590	http://dx.doi.org/10.1371/journal.pone.0138590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375285	gold, Green Submitted, Green Published			2022-12-26	WOS:000361610200113
J	Pierce, EC; LaFayette, PR; Ortega, MA; Joyce, BL; Kopsell, DA; Parrott, WA				Pierce, Emily C.; LaFayette, Peter R.; Ortega, Maria A.; Joyce, Blake L.; Kopsell, Dean A.; Parrott, Wayne A.			Ketocarotenoid Production in Soybean Seeds through Metabolic Engineering	PLOS ONE			English	Article							BETA-CAROTENE; PHYTOENE SYNTHASE; POTATO-TUBERS; ASTAXANTHIN PRODUCTION; TRANSGENIC PLANTS; BIOSYNTHESIS; GENES; EXPRESSION; PATHWAY; OVEREXPRESSION	The pink or red ketocarotenoids, canthaxanthin and astaxanthin, are used as feed additives in the poultry and aquaculture industries as a source of egg yolk and flesh pigmentation, as farmed animals do not have access to the carotenoid sources of their wild counterparts. Because soybean is already an important component in animal feed, production of these carotenoids in soybean could be a cost-effective means of delivery. In order to characterize the ability of soybean seed to produce carotenoids, soybean cv. Jack was transformed with the crtB gene from Pantoea ananatis, which codes for phytoene synthase, an enzyme which catalyzes the first committed step in the carotenoid pathway. The crtB gene was engineered together in combinations with ketolase genes (crtW from Brevundimonas sp. strain SD212 and bkt1 from Haematococcus pluvialis) to produce ketocarotenoids; all genes were placed under the control of seed-specific promoters. HPLC results showed that canthaxanthin is present in the transgenic seeds at levels up to 52 mu g/g dry weight. Transgenic seeds also accumulated other compounds in the carotenoid pathway, such as astaxanthin, lutein, beta-carotene, phytoene, alpha-carotene, lycopene, and beta-cryptoxanthin, whereas lutein was the only one of these detected in non-transgenic seeds. The accumulation of astaxanthin, which requires a beta-carotene hydroxylase in addition to a beta-carotene ketolase, in the transgenic seeds suggests that an endogenous soybean enzyme is able to work in combination with the ketolase transgene. Soybean seeds that accumulate ketocarotenoids could potentially be used in animal feed to reduce or eliminate the need for the costly addition of these compounds.	[Pierce, Emily C.; LaFayette, Peter R.; Ortega, Maria A.; Parrott, Wayne A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Pierce, Emily C.; LaFayette, Peter R.; Ortega, Maria A.; Parrott, Wayne A.] Univ Georgia, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA; [Joyce, Blake L.] Univ Arizona, Sch Plant Sci, Inst BIO5, Tucson, AZ USA; [Kopsell, Dean A.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Arizona; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Parrott, WA (corresponding author), Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA.	wparrott@uga.edu		Weiss, Emily C.P./0000-0002-9960-0270; Kopsell, Dean/0000-0002-0299-1624; Joyce, Blake/0000-0002-4784-2251	state and federal funds	state and federal funds	Research support was provided by the state and federal funds allocated to the Georgia Agricultural Experiment Stations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; Beardsworth P. M., 2004, International Poultry Production, V12, P17; Bjerkeng B, 1997, AQUACULTURE, V157, P297, DOI 10.1016/S0044-8486(97)00162-2; Brufau J, 1997, INT POULT PROD, V5, P17; Burt AJ, 2013, CROP SCI, V53, P554, DOI 10.2135/cropsci2012.02.0069; Cho EY, 2008, AM J CLIN NUTR, V87, P1837, DOI 10.1093/ajcn/87.6.1837; Cunningham FX, 2005, PLANT J, V41, P478, DOI 10.1111/j.1365-313X.2004.02309.x; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Davies B.H., 1988, HDB CHROMATOGRAPHY P, V1, P1; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Ducreux LJM, 2005, J EXP BOT, V56, P81, DOI 10.1093/jxb/eri016; Emenhiser C, 1996, J AGR FOOD CHEM, V44, P3887, DOI 10.1021/jf960104m; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fraser PD, 2002, P NATL ACAD SCI USA, V99, P1092, DOI 10.1073/pnas.241374598; Fujisawa M, 2008, J BIOSCI BIOENG, V105, P636, DOI 10.1263/jbb.105.636; Fujisawa M, 2009, J EXP BOT, V60, P1319, DOI 10.1093/jxb/erp006; Fukatsu T, 2010, SCIENCE, V328, P574, DOI 10.1126/science.1190417; Fuller Bryan, 2006, J Cosmet Dermatol, V5, P30, DOI 10.1111/j.1473-2165.2006.00220.x; GARBARINO JE, 1994, PLANT MOL BIOL, V24, P119, DOI 10.1007/BF00040579; Grashorn MA, 2002, ARCH GEFLUGELKD, V66, P258; Hasunuma T, 2008, PLANT J, V55, P857, DOI 10.1111/j.1365-313X.2008.03559.x; Jayaraj J, 2008, TRANSGENIC RES, V17, P489, DOI 10.1007/s11248-007-9120-0; Kim MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048287; Kopsell DA, 2007, J AGR FOOD CHEM, V55, P10628, DOI 10.1021/jf072793f; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Lassner MW., 1989, PLANT MOL BIOL REP, V7, P116, DOI DOI 10.1007/BF02669627; Li J, 2011, BIOTECHNOL ADV, V29, P568, DOI 10.1016/j.biotechadv.2011.04.001; Lopez AB, 2008, J EXP BOT, V59, P213, DOI 10.1093/jxb/erm299; Mann V, 2000, NAT BIOTECHNOL, V18, P888, DOI 10.1038/78515; MISAWA N, 1993, PLANT J, V4, P833, DOI 10.1046/j.1365-313X.1993.04050833.x; MONMA M, 1994, BIOSCI BIOTECH BIOCH, V58, P926, DOI 10.1271/bbb.58.926; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Morris WL, 2006, METAB ENG, V8, P253, DOI 10.1016/j.ymben.2006.01.001; Nishino H, 2002, CANCER METAST REV, V21, P257, DOI 10.1023/A:1021206826750; Nys Y, 2000, ARCH GEFLUGELKD, V64, P45; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Ravanello MP, 2003, METAB ENG, V5, P255, DOI 10.1016/j.ymben.2003.08.001; Robert F., 2007, World Poultry Science Association, Proceedings of the 16th European Symposium on Poultry Nutrition, Strasbourg, France, 26-30 August, 2007, P731; Rosa AP, 2012, POULTRY SCI, V91, P660, DOI 10.3382/ps.2011-01582; Samoylov VM, 1998, PLANT CELL REP, V18, P49, DOI 10.1007/s002990050530; Scaife MA, 2009, BIOTECHNOL BIOENG, V103, P944, DOI 10.1002/bit.22330; Schmidt MA, 2005, PLANT CELL REP, V24, P383, DOI 10.1007/s00299-005-0950-z; Schmidt MA, 2015, PLANT BIOTECHNOL J, V13, P590, DOI 10.1111/pbi.12286; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Sommer A, 1997, NUTRITION, V13, P484, DOI 10.1016/S0899-9007(97)00013-0; SUNDE ML, 1992, POULTRY SCI, V71, P709, DOI 10.3382/ps.0710709; Trick HN, 1997, PLANT TISSUE CULT BI, V3, P9; Uchiyama S, 2004, BIOL PHARM BULL, V27, P232, DOI 10.1248/bpb.27.232; Ukibe K, 2009, APPL ENVIRON MICROB, V75, P7205, DOI 10.1128/AEM.01249-09; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yoshino M, 2006, GENES GENET SYST, V81, P135, DOI 10.1266/ggs.81.135	51	22	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138196	10.1371/journal.pone.0138196	http://dx.doi.org/10.1371/journal.pone.0138196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376481	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200085
J	Saito, K; Tamaki, T; Hirata, M; Hashimoto, H; Nakazato, K; Nakajima, N; Kazuno, A; Sakai, A; Iida, M; Okami, K				Saito, Kosuke; Tamaki, Tetsuro; Hirata, Maki; Hashimoto, Hiroyuki; Nakazato, Kenei; Nakajima, Nobuyuki; Kazuno, Akihito; Sakai, Akihiro; Iida, Masahiro; Okami, Kenji			Reconstruction of Multiple Facial Nerve Branches Using Skeletal Muscle-Derived Multipotent Stem Cell Sheet-Pellet Transplantation	PLOS ONE			English	Article							COMPENSATORY HYPERTROPHIED MUSCLE; PERIPHERAL-NERVES; SCIATIC-NERVE; REGENERATION; RAT; GROWTH; INJURY; REPAIR; TUBE; RECONSTITUTION	Head and neck cancer is often diagnosed at advanced stages, and surgical resection with wide margins is generally indicated, despite this treatment being associated with poor postoperative quality of life (QOL). We have previously reported on the therapeutic effects of skeletal muscle-derived multipotent stem cells (Sk-MSCs), which exert reconstitution capacity for muscle-nerve-blood vessel units. Recently, we further developed a 3D patchtransplantation system using Sk-MSC sheet-pellets. The aim of this study is the application of the 3D Sk-MSC transplantation system to the reconstitution of facial complex nerve-vascular networks after severe damage. Mouse experiments were performed for histological analysis and rats were used for functional examinations. The Sk-MSC sheet-pellets were prepared from GFP-Tg mice and SD rats, and were transplanted into the facial resection model (ST). Culture medium was transplanted as a control (NT). In the mouse experiment, facial-nerve-palsy (FNP) scoring was performed weekly during the recovery period, and immunohistochemistry was used for the evaluation of histological recovery after 8 weeks. In rats, contractility of facial muscles was measured via electrical stimulation of facial nerves root, as the marker of total functional recovery at 8 weeks after transplantation. The ST-group showed significantly higher FNP (about three fold) scores when compared to the NT-group after 2-8 weeks. Similarly, significant functional recovery of whisker movement muscles was confirmed in the ST-group at 8 weeks after transplantation. In addition, engrafted GFP(+) cells formed complex branches of nerve-vascular networks, with differentiation into Schwann cells and perineurial/endoneurial cells, as well as vascular endothelial and smooth muscle cells. Thus, Sk-MSC sheet-pellet transplantation is potentially useful for functional reconstitution therapy of large defects in facial nerve-vascular networks.	[Saito, Kosuke; Sakai, Akihiro; Iida, Masahiro; Okami, Kenji] Tokai Univ, Sch Med, Dept Otolaryngol, Isehara, Kanagawa 2591193, Japan; [Saito, Kosuke; Tamaki, Tetsuro; Hirata, Maki; Hashimoto, Hiroyuki; Nakazato, Kenei; Nakajima, Nobuyuki; Kazuno, Akihito] Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, Isehara, Kanagawa 2591193, Japan; [Tamaki, Tetsuro] Tokai Univ, Sch Med, Dept Physiol Sci, Isehara, Kanagawa 2591193, Japan; [Hirata, Maki; Hashimoto, Hiroyuki] Tokai Univ, Sch Med, Dept Orthoped, Isehara, Kanagawa 2591193, Japan; [Nakazato, Kenei] Tokai Univ, Sch Med, Dept Gen Thorath Surg, Isehara, Kanagawa 2591193, Japan; [Nakajima, Nobuyuki] Tokai Univ, Sch Med, Dept Urol, Isehara, Kanagawa 2591193, Japan; [Sakai, Akihiro] Tokai Univ, Sch Med, Dept Surg Gastroenterol, Isehara, Kanagawa 2591193, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University	Tamaki, T (corresponding author), Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	tamaki@is.icc.u-tokai.ac.jp	Tamaki, Tetsuro/I-2615-2019	Tamaki, Tetsuro/0000-0002-9071-049X	Ministry of Education, Science and Culture of Japan [C-24592610]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research (C-24592610) from the Ministry of Education, Science and Culture of Japan (KO).	Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Costa MP, 2009, ACTA ORTOP BRAS, V17, P286, DOI 10.1590/S1413-78522009000500007; Lucena EED, 2014, J ORAL MAXIL SURG, V72, P1001, DOI 10.1016/j.joms.2013.11.006; Dubovy P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-58; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ghoreishian M, 2013, J ORAL MAXIL SURG, V71, P577, DOI 10.1016/j.joms.2012.05.025; Gordon T, 2010, J COMMUN DISORD, V43, P265, DOI 10.1016/j.jcomdis.2010.04.003; Grosheva M, 2008, BIOL CHEM, V389, P873, DOI 10.1515/BC.2008.100; Horie H, 1999, J NEUROSCI, V19, P9964; Hoshi A, 2008, TRANSPLANTATION, V85, P1617, DOI 10.1097/TP.0b013e318170572b; Husseman J, 2008, FACIAL PLAST SURG, V24, P242, DOI 10.1055/s-2008-1075840; Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029; Jungnickel J, 2006, J NEUROBIOL, V66, P940, DOI 10.1002/neu.20265; Most Sam P, 2004, Arch Facial Plast Surg, V6, P82, DOI 10.1001/archfaci.6.2.82; Nakamura K, 2003, OTOLARYNG HEAD NECK, V128, P539, DOI 10.1016/S0194-5998(02)23254-4; Nitta M, 2010, TRANSPLANTATION, V89, P1043, DOI 10.1097/TP.0b013e3181d45a7f; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81, DOI 10.1615/CritRevBiomedEng.v39.i2.20; Salomone R, 2013, MUSCLE NERVE, V48, P423, DOI 10.1002/mus.23768; Sasaki R, 2011, J TISSUE ENG REGEN M, V5, P823, DOI 10.1002/term.387; Schroder K, 2011, ANTIOXID REDOX SIGN, V15, P915, DOI 10.1089/ars.2010.3533; Shichinohe R, 2012, J PLAST RECONSTR AES, V65, P763, DOI 10.1016/j.bjps.2011.12.009; Soeda S., 2013, THE J, V3, P142, DOI [DOI 10.4172/2157-7633.1000142, 10.4172/2157-7633.1000142]; Sun F, 2011, NEUROSCI LETT, V499, P104, DOI 10.1016/j.neulet.2011.05.043; Tamaki T, 1996, ANAT REC, V246, P325; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 1996, ANAT REC, V246, P335, DOI 10.1002/(SICI)1097-0185(199611)246:3<335::AID-AR4>3.0.CO;2-X; Tamaki T, 2007, HISTOCHEM CELL BIOL, V128, P349, DOI 10.1007/s00418-007-0331-5; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Tamaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091257; Tamaki T, 2013, REGEN MED, V8, P437, DOI 10.2217/rme.13.30; Tamaki T, 2009, HISTOCHEM CELL BIOL, V132, P59, DOI 10.1007/s00418-009-0585-1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tosaki T, 2008, EXP NEUROL, V213, P381, DOI 10.1016/j.expneurol.2008.06.017; Wang XM, 2011, BRAIN RES, V1383, P71, DOI 10.1016/j.brainres.2011.01.098; Xu K, 2014, SCIENCE, V344, P1275, DOI 10.1126/science.1255149; Costa HJZR, 2013, BRAIN RES, V1510, P10, DOI 10.1016/j.brainres.2013.03.025; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x	38	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138371	10.1371/journal.pone.0138371	http://dx.doi.org/10.1371/journal.pone.0138371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372044	Green Published, gold, Green Submitted			2022-12-26	WOS:000361604400068
J	Shan, HB; Zhang, R; Li, Y; Gao, XY; Lin, SY; Luo, GY; Li, JJ; Xu, GL				Shan, Hong-Bo; Zhang, Rong; Li, Yin; Gao, Xiao-Yan; Lin, Shi-Yong; Luo, Guang-Yu; Li, Jian-Jun; Xu, Guo-Liang			Application of Endobronchial Ultrasonography for the Preoperative Detecting Recurrent Laryngeal Nerve Lymph Node Metastasis of Esophageal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DISSECTION; LYMPHADENECTOMY; EUS	Background The preoperative detection of recurrent laryngeal nerve lymph node (RLN LN) metastasis provides important information for the treatment of esophageal cancer. We investigated the possibility of applying endobronchial ultrasonography (EBUS) with conventional preoperative endoscopic ultrasonography (EUS) and computerized tomography (CT) examination to evaluate RLN LN metastasis in patients with esophageal cancer. Methods A total of 115 patients with advanced thoracic esophageal cancer underwent EBUS examinations. Patients also underwent EUS and CT imaging as reference diagnostic methods. Positron emission tomography /computed tomography (PET/CT) was also introduced in partial patients as reference method. The preoperative evaluation of RLN LN metastasis was compared with the surgical and pathological staging in 94 patients who underwent radical surgery. Results The sensitivities of the preoperative evaluations of RLN LN metastasis by EBUS, EUS and CT were 67.6%, 32.4% and 29.4%, respectively. The sensitivity of EBUS was significantly different from that of EUS or CT, especially in the detection of right RLN LNs. In addition, according to the extra data from reference method, PET/CT was not superior to EBUS or EUS in detecting RLN LN metastasis. Among all 115 patients, 21 patients who were diagnosed with tracheal invasions by EUS or EBUS avoided radical surgery. Another 94 patients who were diagnosed as negative for tracheobronchial tree invasion by EUS and EBUS had no positive findings in radical surgery. Conclusions EBUS can enhance the preoperative sensitivity of the detection of RLN LN metastasis in cases of thoracic esophageal cancer and is a useful complementary examination to conventional preoperative EUS and CT, which can alert thoracic surgeons to the possibility of a greater range of preoperative lymph node dissection. EBUS may also indicate tracheal invasion in cases of esophageal stricture.	[Shan, Hong-Bo; Zhang, Rong; Li, Yin; Gao, Xiao-Yan; Lin, Shi-Yong; Luo, Guang-Yu; Li, Jian-Jun; Xu, Guo-Liang] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou 510275, Guangdong, Peoples R China; [Shan, Hong-Bo; Zhang, Rong; Li, Yin; Gao, Xiao-Yan; Lin, Shi-Yong; Luo, Guang-Yu; Li, Jian-Jun; Xu, Guo-Liang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Shan, Hong-Bo; Zhang, Rong; Li, Yin; Gao, Xiao-Yan; Lin, Shi-Yong; Luo, Guang-Yu; Li, Jian-Jun; Xu, Guo-Liang] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Zhang, R (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou 510275, Guangdong, Peoples R China.	zhangrong@sysucc.org.cn	LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022		Science and Technology Plan Projects of Guangdong Province of China [2009B030801158, 2012B031800097, 2012B031800282]	Science and Technology Plan Projects of Guangdong Province of China	This work was supported by Science and Technology Plan Projects of Guangdong Province of China (No. 2009B030801158, 2012B031800097, 2012B031800282) for these authors: Rong Zhang, Hong-Bo Shan, Yin Li, Xiao-Yan Gao, Shi-Yong Lin, Guang-Yu Luo, Jian-Jun Li, and Guo-Liang Xu.	Austwick MR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463005; Faigel DO, 2001, GASTROINTEST ENDOSC, V53, P593, DOI 10.1067/mge.2001.114060; Garrido T, 2009, CLINICS, V64, P499, DOI 10.1590/S1807-59322009000600003; Kuge K, 2003, J THORAC CARDIOV SUR, V125, P1343, DOI 10.1016/S0022-5223(03)00036-9; Law S, 2001, DIS ESOPHAGUS, V14, P98, DOI 10.1046/j.1442-2050.2001.00164.x; Li HC, 2012, J SURG ONCOL, V105, P548, DOI 10.1002/jso.22148; Miyata M, 2006, J SURG ONCOL, V93, P437; Mizutani M, 2006, SURG RADIOL ANAT, V28, P333, DOI 10.1007/s00276-006-0115-y; Ohnishi R, 2011, ENDOSCOPY, V43, P1082, DOI 10.1055/s-0030-1256766; Pfau PR, 2007, GASTROINTEST ENDOSC, V65, P377, DOI 10.1016/j.gie.2006.12.015; Shimada H, 2009, J GASTROINTEST SURG, V13, P619, DOI 10.1007/s11605-008-0790-6; Shimizu S, 2009, INT J CLIN ONCOL, V14, P421, DOI 10.1007/s10147-009-0893-4; Shiozaki H, 2001, DIS ESOPHAGUS, V14, P191, DOI 10.1046/j.1442-2050.2001.00206.x; Takemura M, 2003, ONCOL REP, V10, P75; Tamiya M, 2013, RESPIROLOGY, V18, P834, DOI 10.1111/resp.12095; Tan ZH, 2014, J GASTROINTEST SURG, V18, P187, DOI 10.1007/s11605-013-2411-2; Taniyama Y, 2013, ANN THORAC SURG, V95, P1930, DOI 10.1016/j.athoracsur.2013.03.069	17	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137400	10.1371/journal.pone.0137400	http://dx.doi.org/10.1371/journal.pone.0137400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372339	Green Published, gold, Green Submitted			2022-12-26	WOS:000361604400021
J	Brown, AS; Mohanty, BK; Howe, PH				Brown, Andrew S.; Mohanty, Bidyut K.; Howe, Philip H.			Computational Identification of Post Translational Modification Regulated RNA Binding Protein Motifs	PLOS ONE			English	Article							EUKARYOTIC MESSENGER-RNAS; 3' UNTRANSLATED REGIONS; EVOLUTIONARY CONSERVATION; SPECIALIZED DATABASES; FUNCTIONAL ELEMENTS; PHOSPHORYLATION; SEQUENCES; ALIGNMENT; UTRSITE; GENES	RNA and its associated RNA binding proteins (RBPs) mitigate a diverse array of cellular functions and phenotypes. The interactions between RNA and RBPs are implicated in many roles of biochemical processing by the cell such as localization, protein translation, and RNA stability. Recent discoveries of novel mechanisms that are of significant evolutionary advantage between RBPs and RNA include the interaction of the RBP with the 3' and 5' untranslated region (UTR) of target mRNA. These mechanisms are shown to function through interaction of a trans-factor (RBP) and a cis-regulatory element (3' or 5' UTR) by the binding of a RBP to a regulatory-consensus nucleic acid motif region that is conserved throughout evolution. Through signal transduction, regulatory RBPs are able to temporarily dissociate from their target sites on mRNAs and induce translation, typically through a posttranslational modification (PTM). These small, regulatory motifs located in the UTR of mRNAs are subject to a loss-of-function due to single polymorphisms or other mutations that disrupt the motif and inhibit the ability to associate into the complex with RBPs. The identification of a consensus motif for a given RBP is difficult, time consuming, and requires a significant degree of experimentation to identify each motif-containing gene on a genomic scale. We have developed a computational algorithm to analyze high-throughput genomic arrays that contain differential binding induced by a PTM for a RBP of interest-RBP-PTM Target Scan (RPTS). We demonstrate the ability of this application to accurately predict a PTM-specific binding motif to an RBP that has no antibody capable of distinguishing the PTM of interest, negating the use of in-vitro exonuclease digestion techniques.	[Brown, Andrew S.; Mohanty, Bidyut K.; Howe, Philip H.] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; [Brown, Andrew S.] Kent State Univ, Dept Biomed Sci, Kent, OH 44242 USA	Medical University of South Carolina; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Howe, PH (corresponding author), Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA.	howep@musc.edu			National Cancer Institute [CA055536, CA154663, 5R01CA154663-06]; NATIONAL CANCER INSTITUTE [R01CA055536, R01CA154663, R29CA055536] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants CA055536 and CA154663 from the National Cancer Institute, 5R01CA154663-06 [http://www.nih.gov] to PHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleta JM, 1998, TRENDS BIOCHEM SCI, V23, P89, DOI 10.1016/S0968-0004(98)01185-2; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Churbanov A, 2005, NUCLEIC ACIDS RES, V33, P5512, DOI 10.1093/nar/gki847; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Huo LR, 2010, BBA-PROTEINS PROTEOM, V1804, P1954, DOI 10.1016/j.bbapap.2010.07.002; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Pesole G, 2000, NUCLEIC ACIDS RES, V28, P193, DOI 10.1093/nar/28.1.193; Pesole G, 2002, NUCLEIC ACIDS RES, V30, P335, DOI 10.1093/nar/30.1.335; Rajewsky N, 2006, COLD SPRING HARBOR S; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Shi ZH, 2012, INT J GYNECOL CANCER, V22, P1125, DOI 10.1097/IGC.0b013e3182606ac3; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson JD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-318; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Xue XY, 2014, TUMOR BIOL, V35, P7853, DOI 10.1007/s13277-014-1982-1	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137696	10.1371/journal.pone.0137696	http://dx.doi.org/10.1371/journal.pone.0137696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368004	gold, Green Submitted, Green Published			2022-12-26	WOS:000361601100112
J	Falloon, K; Juvvadi, PR; Richards, AD; Vargas-Muniz, JM; Renshaw, H; Steinbach, WJ				Falloon, Katie; Juvvadi, Praveen R.; Richards, Amber D.; Vargas-Muniz, Jose M.; Renshaw, Hilary; Steinbach, William J.			Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus	PLOS ONE			English	Article							FK506 BINDING-PROTEINS; EVOKED CA2+ RELEASE; INVASIVE ASPERGILLOSIS; CRYSTAL-STRUCTURE; CANDIDA-ALBICANS; CYCLOSPORINE-A; FKBP12-DEPENDENT INHIBITION; GALLERIA-MELLONELLA; HUMAN CALCINEURIN; SMOOTH-MUSCLE	Invasive aspergillosis, largely caused by Aspergillus fumigatus, is responsible for a growing number of deaths among immunosuppressed patients. Immunosuppressants such as FK506 (tacrolimus) that target calcineurin have shown promise for antifungal drug development. FK506-binding proteins (FKBPs) form a complex with calcineurin in the presence of FK506 (FKBP12-FK506) and inhibit calcineurin activity. Research on FKBPs in fungi is limited, and none of the FKBPs have been previously characterized in A. fumigatus. We identified four orthologous genes of FKBP12, the human FK506 binding partner, in A. fumigatus and designated them fkbp12-1, fkbp12-2, fkbp12-3, and fkbp12-4. Deletional analysis of the four genes revealed that the.fkbp12-1 strain was resistant to FK506, indicating FKBP12-1 as the key mediator of FK506-binding to calcineurin. The endogenously expressed FKBP12-1-EGFP fusion protein localized to the cytoplasm and nuclei under normal growth conditions but also to the hyphal septa following FK506 treatment, revealing its interaction with calcineurin. The FKBP12-1-EGFP fusion protein didn't localize at the septa in the presence of FK506 in the cnaA deletion background, confirming its interaction with calcineurin. Testing of all deletion strains in the Galleria mellonella model of aspergillosis suggested that these proteins don't play an important role in virulence. While the Delta fkbp12-2 and Delta fkbp12-3 strains didn't show any discernable phenotype, the Delta fkbp12-4 strain displayed slight growth defect under normal growth conditions and inhibition of the caspofungin-mediated "paradoxical growth effect" at higher concentrations of the antifungal caspofungin. Together, these results indicate that while only FKBP12-1 is the bona fide binding partner of FK506, leading to the inhibition of calcineurin in A. fumigatus, FKBP12-4 may play a role in basal growth and the caspofungin-mediated paradoxical growth response. Exploitation of differences between A. fumigatus FKBP12-1 and human FKBP12 will be critical for the generation of fungal-specific FK506 analogs to inhibit fungal calcineurin and treat invasive fungal disease.	[Falloon, Katie] Duke Univ, Sch Med, Durham, NC USA; [Juvvadi, Praveen R.; Richards, Amber D.; Steinbach, William J.] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Durham, NC 27710 USA; [Vargas-Muniz, Jose M.; Renshaw, Hilary; Steinbach, William J.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; Duke University; Duke University	Steinbach, WJ (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Durham, NC 27710 USA.	bill.steinbach@duke.edu	Vargas-Muñiz, Jose/AAQ-7152-2020	Vargas-Muñiz, Jose/0000-0003-0138-8660; Juvvadi, Praveen/0000-0002-5112-7824	National Institutes of Health [1R01AI112595]; National Science Foundation Graduate Research Fellowship Program DGF [1106401]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112595, P01AI104533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program DGF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PRJ and WJS are supported by the National Institutes of Health 1R01AI112595 (http://www.nih.gov/). JVM is supported by the National Science Foundation Graduate Research Fellowship Program DGF 1106401 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=6201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon CM, 1997, MOL CELL BIOL, V17, P5968, DOI 10.1128/MCB.17.10.5968; Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Bastidas RJ, 2012, EUKARYOT CELL, V11, P270, DOI 10.1128/EC.05284-11; Blankenship Jill R, 2003, Curr Opin Investig Drugs, V4, P192; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Calo S, 2014, NATURE; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crabol Y, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/821969; Cruz MC, 1999, MOL CELL BIOL, V19, P4101; Cruz MC, 2001, ANTIMICROB AGENTS CH, V45, P3162, DOI 10.1128/AAC.45.11.3162-3170.2001; dEnfert C, 1996, CURR GENET, V30, P76, DOI 10.1007/s002940050103; Denning DW, 1996, CLIN INFECT DIS, V23, P608, DOI 10.1093/clinids/23.3.608; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Gioti A, 2006, J MOL BIOL, V358, P372, DOI 10.1016/j.jmb.2006.01.076; Girgenrath T, 2013, J BIOL CHEM, V288, P16073, DOI 10.1074/jbc.M113.463299; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Helbig JH, 2003, BIOL CHEM, V384, P125, DOI 10.1515/BC.2003.013; HEMENWAY C, 1993, ANN NY ACAD SCI, V696, P38; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; HOFFLIN JM, 1987, ANN INTERN MED, V106, P209, DOI 10.7326/0003-4819-106-2-209; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; Juvvadi PR, 2014, MYCOPATHOLOGIA; Juvvadi PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003564; Juvvadi PR, 2008, EUKARYOT CELL, V7, P1606, DOI 10.1128/EC.00200-08; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; Kay JE, 1996, BIOCHEM J, V314, P361, DOI 10.1042/bj3140361; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee EH, 2004, J BIOL CHEM, V279, P26481, DOI 10.1074/jbc.M309574200; Lewis RE, 2008, J ANTIMICROB CHEMOTH, V61, P1140, DOI 10.1093/jac/dkn069; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MacMillan D, 2005, J CELL SCI, V118, P5443, DOI 10.1242/jcs.02657; MacMillan D, 2009, BRIT J PHARMACOL, V158, P1112, DOI 10.1111/j.1476-5381.2009.00369.x; MacMillan D, 2008, CELL CALCIUM, V43, P539, DOI 10.1016/j.ceca.2007.09.002; MacMillan D, 2013, EUR J PHARMACOL, V700, P181, DOI 10.1016/j.ejphar.2012.12.029; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Marr KA, 2015, ANN INTERN MED, V162, P81, DOI 10.7326/M13-2508; Melendez HG, 2009, FUNGAL GENET BIOL, V46, P308, DOI 10.1016/j.fgb.2008.11.011; Niu XW, 2013, GENE, V525, P77, DOI 10.1016/j.gene.2013.04.052; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; Pemberton TJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-244; Pereira PJB, 2002, EMBO REP, V3, P88, DOI 10.1093/embo-reports/kvf009; Pinto D, 2008, FUNGAL GENET BIOL, V45, P1600, DOI 10.1016/j.fgb.2008.09.011; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Shimizu K, 2001, GENETICS, V157, P591; Singh N, 2003, CLIN INFECT DIS, V36, P46, DOI 10.1086/345441; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Steinbach WJ, 2012, J INFECTION, V65, P453, DOI 10.1016/j.jinf.2012.08.003; Steinbach WJ, 2011, MED MYCOL, V49, pS77, DOI 10.3109/13693786.2010.499374; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P4922, DOI 10.1128/AAC.48.12.4922-4925.2004; Stevens DA, 2004, ANTIMICROB AGENTS CH, V48, P3407, DOI 10.1128/AAC.48.9.3407-3411.2004; Teichert S, 2006, EUKARYOT CELL, V5, P1807, DOI 10.1128/EC.00039-06; Wenzel R, 2005, J ANTIMICROB CHEMOTH, V55, P352, DOI 10.1093/jac/dkh535; Wiederhold NR, 2007, CURR OPIN INFECT DIS, V20, P574, DOI 10.1097/QCO.0b013e3282f1be7f; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x; Yao DY, 2000, J BIOL CHEM, V275, P13149, DOI 10.1074/jbc.275.17.13149	72	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137869	10.1371/journal.pone.0137869	http://dx.doi.org/10.1371/journal.pone.0137869			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366742	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100161
J	Huang, SH; Wu, SH; Lee, SS; Chang, KP; Chai, CY; Yeh, JL; Lin, SD; Kwan, AL; Wang, HMD; Lai, CS				Huang, Shu-Hung; Wu, Sheng-Hua; Lee, Su-Shin; Chang, Kao-Ping; Chai, Chee-Yin; Yeh, Jwu-Lai; Lin, Sin-Daw; Kwan, Aij-Lie; Wang, Hui-Min David; Lai, Chung-Sheng			Fat Grafting in Burn Scar Alleviates Neuropathic Pain via Anti-Inflammation Effect in Scar and Spinal Cord	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CHRONIC CONSTRICTION INJURY; OXIDATIVE STRESS; STEM-CELLS; APOPTOSIS; RATS; AKT; RADIOTHERAPY; HYPERALGESIA; CONTRIBUTES	Burn-induced neuropathic pain is complex, and fat grafting has reportedly improved neuropathic pain. However, the mechanism of fat grafting in improving neuropathic pain is unclear. Previous investigations have found that neuroinflammation causes neuropathic pain, and anti-inflammatory targeting may provide potential therapeutic opportunities in neuropathic pain. We hypothesized that fat grafting in burn scars improves the neuropathic pain through anti-inflammation. Burn-induced scar pain was confirmed using a mechanical response test 4 weeks after burn injuries, and autologous fat grafting in the scar area was performed simultaneously. After 4 weeks, the animals were sacrificed, and specimens were collected for the inflammation test, including COX-2, iNOS, and nNOS in the injured skin and spinal cord dorsal horns through immunohistochemistry and Western assays. Furthermore, pro-inflammatory cytokines (IL-1 beta and TNF-alpha) in the spinal cord were collected. Double immunofluorescent staining images for measuring p-I kappa B, p-NF kappa B, p-JNK, and TUNEL as well as Western blots of AKT, Bax/Bcl-2 for the inflammatory process, and apoptosis were analyzed. Fat grafting significantly reduced COX2, nNOS, and iNOS in the skin and spinal cord dorsal horns, as well as IL-1 beta and TNF-alpha, compared with the burn group. Moreover, regarding the anti-inflammatory effect, the apoptosis cells in the spinal cord significantly decreased after the fat grafting in the burn injury group. Fat grafting was effective in treating burn-induced neuropathic pain through the alleviation of neuroinflammation and ameliorated spinal neuronal apoptosis.	[Huang, Shu-Hung; Wu, Sheng-Hua; Kwan, Aij-Lie; Lai, Chung-Sheng] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 807, Taiwan; [Huang, Shu-Hung; Lee, Su-Shin; Kwan, Aij-Lie; Wang, Hui-Min David] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung 807, Taiwan; [Huang, Shu-Hung; Lee, Su-Shin; Chang, Kao-Ping; Lin, Sin-Daw; Lai, Chung-Sheng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Plast Surg, Dept Surg, Kaohsiung 807, Taiwan; [Huang, Shu-Hung; Lee, Su-Shin; Chang, Kao-Ping; Lin, Sin-Daw; Lai, Chung-Sheng] Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung 807, Taiwan; [Wu, Sheng-Hua] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Anesthesia, Kaohsiung 807, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Yeh, Jwu-Lai] Kaohsiung Med Univ, Dept & Grad Inst Pharmacol, Coll Med, Kaohsiung 807, Taiwan; [Wang, Hui-Min David] Kaohsiung Med Univ, Dept Fragrance & Cosmet Sci, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Wang, HMD (corresponding author), Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung 807, Taiwan.	davidw@kmu.edu.tw; chshla@kmu.edu.tw	Lee, Su-Shin/D-4722-2009; Lai, Chung-Sheng/AAL-8778-2021; Huang, Shu-Hung/AAA-3445-2021	Lee, Su-Shin/0000-0001-8675-0870; Lai, Chung-Sheng/0000-0002-1298-9325; Huang, Shu-Hung/0000-0002-2903-1703; Wang, Hui-Min/0000-0002-4692-4917; Chai, Chee-Yin/0000-0003-0486-9742; lin, sindaw/0000-0002-2269-8484	Ministry of Science and Technology, Taiwan [NSC 102-2314-B-037-014-MY2, MOST 103-2221-E-037-004, MOST 104-2622-E-037-001]; Center for Stem Cell Research, Kaohsiung Medical University [KMU-TP103G00, KMU-TP103G02-05]; Kaohsiung Medical University Hospital [KMU-Q103002, KMUH103-3R22, KMUH103-3T04]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Center for Stem Cell Research, Kaohsiung Medical University; Kaohsiung Medical University Hospital	This work was supported by grants from the Ministry of Science and Technology, Taiwan (NSC 102-2314-B-037-014-MY2, MOST 103-2221-E-037-004 and MOST 104-2622-E-037-001); Center for Stem Cell Research, Kaohsiung Medical University (KMU-TP103G00 and KMU-TP103G02-05); and Kaohsiung Medical University Hospital (KMU-Q103002, KMUH103-3R22, KMUH103-3T04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin B, 2014, AN ACAD BRAS CIENC, V86, P1821, DOI 10.1590/0001-3765201420140067; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Caviggioli F, 2011, PLAST RECONSTR SURG, V128, P349, DOI 10.1097/PRS.0b013e31821e70e7; Chen Y, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-13; Chung J, 2011, BIOL PHARM BULL, V34, P495, DOI 10.1248/bpb.34.495; Dai ZK, 2014, MOL PHARMACEUT, V11, P1621, DOI 10.1021/mp5000086; Ellis A, 2013, BRIT J ANAESTH, V111, P26, DOI 10.1093/bja/aet128; Feng M, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-98; Forbes-Duchart L, 2009, J BURN CARE RES, V30, P792, DOI 10.1097/BCR.0b013e3181b47cc2; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Hervera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043693; Hervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014321; Huang SH, 2015, ANN PLAS SURG, V74, pS99, DOI 10.1097/SAP.0000000000000462; Huang SH, 2014, PLAST RECONSTR SURG, V133, P1396, DOI 10.1097/PRS.0000000000000169; Ipaktchi K, 2006, SHOCK, V26, P201, DOI 10.1097/01.shk.0000225739.13796.f2; Keilhoff G, 2013, NEUROSCI RES, V77, P215, DOI 10.1016/j.neures.2013.08.008; Ki YW, 2013, TOXICOL LETT, V218, P235, DOI 10.1016/j.toxlet.2013.02.003; Klinger M, 2009, PLAST RECONSTR SURG, V124, P1727, DOI 10.1097/PRS.0b013e3181b98d6f; Klinger M, 2009, PLAST RECONSTR SURG, V124, P330, DOI 10.1097/PRS.0b013e3181a83842; LaBuda CJ, 2006, EUR J PAIN, V10, P505, DOI 10.1016/j.ejpain.2005.07.004; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Ma DL, 2014, ANGEW CHEM INT EDIT, V53, P9178, DOI 10.1002/anie.201404686; Maione L, 2014, AESTHET PLAST SURG, V38, P528, DOI 10.1007/s00266-014-0311-9; Makuch W, 2013, NEUROPHARMACOLOGY, V75, P445, DOI 10.1016/j.neuropharm.2013.08.031; Melenfant A, 1998, PAIN, V77, P241, DOI 10.1016/S0304-3959(98)00096-7; Mert T, 2015, INFLAMMATION, V38, P1302, DOI 10.1007/s10753-014-0101-1; Miclescu A, 2009, ACTA ANAESTH SCAND, V53, P1107, DOI 10.1111/j.1399-6576.2009.02054.x; Mohamad O, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-51; Oppeltz RF, 2012, CYTOKINE, V60, P528, DOI 10.1016/j.cyto.2012.07.003; Payne JE, 2010, J MED CHEM, V53, P7739, DOI 10.1021/jm100828n; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Svensson CI, 2010, MOL INTERV, V10, P25, DOI 10.1124/mi.10.1.6; Vaienti L, 2013, J HAND SURG-EUR VOL, V38E, P36, DOI 10.1177/1753193412441122; Wang HLS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055241, 10.1371/journal.pone.0056330]; Wang XX, 2014, NEUROPHARMACOLOGY, V79, P642, DOI 10.1016/j.neuropharm.2014.01.022; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wu SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/372819	44	32	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137563	10.1371/journal.pone.0137563	http://dx.doi.org/10.1371/journal.pone.0137563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368011	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100084
J	Lim, CAA; Awan, TH; Cruz, PCS; Chauhan, BS				Lim, Charlemagne Alexander A.; Awan, Tahir Hussain; Cruz, Pompe C. Sta.; Chauhan, Bhagirath Singh			Influence of Environmental Factors, Cultural Practices, and Herbicide Application on Seed Germination and Emergence Ecology of Ischaemum rugosum Salisb	PLOS ONE			English	Article							LIGHT SENSITIVITY; WEED; INDUCTION; DORMANCY; GROWTH; RICE; CROP	Ischaemum rugosum Salisb. (Saramolla grass) is a noxious weed of rice that is difficult to control by chemical or mechanical means once established. A study was conducted to determine the effect of light, temperature, salt, drought, flooding, rice residue mulch, burial depth, and pre-emergence herbicides on seed germination and emergence of I. rugosum. Germination was stimulated by light and inhibited under complete darkness. Optimum temperature for germination was 30/20 degrees C (97.5% germination). Germination reduced from 31 to 3.5% when the osmotic potential of the growing medium decreased from -0.1 to -0.6 MPa and no germination occurred at -0.8 MPa. Germination was 18 and 0.5% at 50 and 100 mM NaCl concentrations, respectively, but was completely inhibited at 150 mM or higher. Residue application at 1-6 t ha(-1) reduced weed emergence by 35-88% and shoot biomass by 55-95%. The efficacy of pre-emergence herbicides increased with increasing application rates and decreased with increasing rice residue mulching. The efficacy of herbicides was in the order of oxadiazon> pendimethalin> pretilachlor. At 6 t ha(-1), all herbicides, regardless of rates, did not differ from the control treatment. I. rugosum seeds buried at 2 cm or deeper did not emerge; however, they emerged by 4.5 and 0.5% at 0.5 and 1 cm depths, respectively, compared to the 39% germination for soil surface seeding. Flooding at 4 DAS or earlier reduced seedling emergence and shoot biomass while flooding at 8 DAS reduced only seedling emergence. The depth and timing of flooding independently reduced root biomass. Flooding at 4 and 6 cm depths reduced the root biomass. Relative to flooding on the day of sowing, flooding at 8 DAS increased root biomass by 89%. Similarly, flooding on the day of sowing and at 2 DAS reduced the root-shoot biomass ratio. Under the no-flood treatment, increasing rates of pretilachlor from 0.075 to 0.3 kg ai ha(-1) reduced weed emergence by 61- 79%. At the flooding depth of 2-4 cm, pretilachlor reduced weed emergence and shoot and root biomass, but the differences across rates were non-significant. Information generated in this study will be helpful in developing integrated weed management strategies for managing this weed.	[Lim, Charlemagne Alexander A.; Awan, Tahir Hussain] Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Philippines; [Lim, Charlemagne Alexander A.; Awan, Tahir Hussain; Cruz, Pompe C. Sta.] Univ Philippines, Coll Agr, Crop Sci Cluster, Los Banos, Philippines; [Chauhan, Bhagirath Singh] Univ Queensland, Queensland Alliance Agr & Food Innovat, Toowoomba, Qld, Australia	CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University; University of Queensland	Awan, TH (corresponding author), Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Philippines.	t.awan@irri.org; pompestacruz@yahoo.com	Chauhan, Bhagirath/G-8892-2014	Chauhan, Bhagirath/0000-0003-1540-4668				Abdul Shukor Juraimi, 2013, Australian Journal of Crop Science, V7, P989; Agardh VC, 2012, FEDERAL NOXIOUS WEED; Ampong-Nyarko K., 1991, HDB WEED CONTROL RIC; Anwar MP, 2012, ACTA AGR SCAND B-S P, V62, P604, DOI 10.1080/09064710.2012.681060; Awan TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090305; Awan TH, 2006, PAKISTAN J SCI, V58, P50; Ballare CL, 2000, FIELD CROP RES, V67, P149, DOI 10.1016/S0378-4290(00)00090-3; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Arnold RLB, 1988, FUNCT ECOL, V2, P311, DOI 10.2307/2389403; Benech-Arnold RL, 2000, FIELD CROP RES, V67, P105, DOI 10.1016/S0378-4290(00)00087-3; BENVENUTI S, 1995, WEED RES, V35, P343, DOI 10.1111/j.1365-3180.1995.tb01629.x; BOTHA FC, 1992, PLANT GROWTH REGUL, V11, P211, DOI 10.1007/BF00024560; Botto JF, 1998, WEED SCI, V46, P351, DOI 10.1017/S0043174500089530; Brecke BJ, 2005, P TROP SPID S TIFT G; Chauhan BS, 2006, AUST J EXP AGR, V46, P1557, DOI 10.1071/EA05291; Chauhan B. S., 2013, American Journal of Plant Sciences, V4, P1345; Chauhan BS, 2008, WEED SCI, V56, P699, DOI 10.1614/WS-08-048.1; Chauhan BS, 2007, WEED TECHNOL, V21, P53, DOI 10.1614/WT-06-016.1; Chauhan BS, 2006, WEED SCI, V54, P1032, DOI 10.1614/WS-06-060R1.1; Chauhan BS, 2006, WEED SCI, V54, P854, DOI 10.1614/WS-06-047R.1; Chauhan BS, 2006, WEED SCI, V54, P891, DOI 10.1614/WS-06-053R.1; Chauhan BS, 2013, WEED SCI, V61, P403, DOI 10.1614/WS-D-12-00147.1; Chauhan BS, 2012, WEED TECHNOL, V26, P1, DOI 10.1614/WT-D-11-00105.1; Chauhan BS, 2011, WEED SCI, V59, P119, DOI 10.1614/WS-D-10-00075.1; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2009, WEED SCI, V57, P235, DOI 10.1614/WS-08-141.1; Chauhan BS, 2008, WEED SCI, V56, P820, DOI 10.1614/WS-08-070.1; Clavijo J, 2004, COMALFI J, V31, P13; Dorji S, 2013, CANADIAN J PLANT PRO, V1, P35; Egley G. H., 1986, WEED SCI, V2, P67; Flinn JC, 1986, WEEDS ENV TROPICS, P51; Galinato MI, 1999, UPLAND RICE WEEDS S, P86; Hennig L, 2002, PLANT PHYSIOL, V128, P194, DOI 10.1104/pp.010559; Hill J. E., 2001, Rice research for food security and poverty alleviation. Proceedings of the International Rice Research Conference, Los Banos, Philippines, 31 March-3 April, 2000, P491; Holm L, 1977, WORLDS WORST WEED DO; Ismail AM, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls019; Itoh K, 1991, ISCHAEMUM RUGOSUM LI, P55; Liebman M., 2001, WEEDS SOIL ENV; Locke Martin A., 2002, Weed Biology and Management, V2, P123, DOI 10.1046/j.1445-6664.2002.00061.x; Lubigan RT, 1990, ISCHAEMUM RUGOSUM SO; Marenco Ricardo A., 1998, Revista Brasileira de Fisiologia Vegetal, V10, P107; Matsuo Mitsuhiro, 2004, Weed Biology and Management, V4, P148, DOI 10.1111/j.1445-6664.2004.00135.x; Mennan H, 2006, WEED SCI, V54, P114, DOI 10.1614/WS-05-107R1.1; Milberg P, 1997, CAN J BOT, V75, P1998, DOI 10.1139/b97-911; Opena JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092261; Pandey S, 1995, RESEARCH, V10, P73; Rengasamy P, 2002, AUST J EXP AGR, V42, P351, DOI 10.1071/EA01111; ROBERTS EH, 1981, PLANT CELL ENVIRON, V4, P97, DOI 10.1111/j.1365-3040.1981.tb01044.x; SHARMA MP, 1978, CAN J PLANT SCI, V58, P141, DOI 10.4141/cjps78-022; SHINOMURA T, 1994, PLANT PHYSIOL, V104, P363, DOI 10.1104/pp.104.2.363; Singh Y, 2008, DIRECT SEEDING RICE, P107; Tarlok Singh, 1991, Indian Journal of Weed Science, V23, P1; TAYLORSON RB, 1969, WEED SCI, V17, P48, DOI 10.1017/S0043174500030873; Wang QingYa, 2004, Rice Science, V11, P331; WESSON G, 1969, J EXP BOT, V20, P414, DOI 10.1093/jxb/20.2.414; WOOLLEY JT, 1978, PLANT PHYSIOL, V61, P597, DOI 10.1104/pp.61.4.597	56	6	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137256	10.1371/journal.pone.0137256	http://dx.doi.org/10.1371/journal.pone.0137256			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368808	gold, Green Submitted, Green Published			2022-12-26	WOS:000361601100060
J	Lubaba, CH; Hidano, A; Welburn, SC; Revie, CW; Eisler, MC				Lubaba, Caesar H.; Hidano, Arata; Welburn, Susan C.; Revie, Crawford W.; Eisler, Mark C.			Movement Behaviour of Traditionally Managed Cattle in the Eastern Province of Zambia Captured Using Two-Dimensional Motion Sensors	PLOS ONE			English	Article							LYING BEHAVIOR; DAIRY-CATTLE; INFECTIONS; SYSTEMS; MONITOR; ANEMIA; ESTRUS; COWS	Two-dimensional motion sensors use electronic accelerometers to record the lying, standing and walking activity of cattle. Movement behaviour data collected automatically using these sensors over prolonged periods of time could be of use to stakeholders making management and disease control decisions in rural sub-Saharan Africa leading to potential improvements in animal health and production. Motion sensors were used in this study with the aim of monitoring and quantifying the movement behaviour of traditionally managed Angoni cattle in Petauke District in the Eastern Province of Zambia. This study was designed to assess whether motion sensors were suitable for use on traditionally managed cattle in two veterinary camps in Petauke District in the Eastern Province of Zambia. In each veterinary camp, twenty cattle were selected for study. Each animal had a motion sensor placed on its hind leg to continuously measure and record its movement behaviour over a two week period. Analysing the sensor data using principal components analysis (PCA) revealed that the majority of variability in behaviour among studied cattle could be attributed to their behaviour at night and in the morning. The behaviour at night was markedly different between veterinary camps; while differences in the morning appeared to reflect varying behaviour across all animals. The study results validate the use of such motion sensors in the chosen setting and highlight the importance of appropriate data summarisation techniques to adequately describe and compare animal movement behaviours if association to other factors, such as location, breed or health status are to be assessed.	[Lubaba, Caesar H.; Welburn, Susan C.] Univ Edinburgh, Div Infect & Pathway Med, Ctr Infect Dis, Sch Biomed Sci,Coll Med & Vet Med, Edinburgh, Midlothian, Scotland; [Hidano, Arata; Revie, Crawford W.] Univ Prince Edward Isl, Atlantic Vet Coll, Ctr Vet Epidemiol Res, Charlottetown, PE C1A 4P3, Canada; [Eisler, Mark C.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England	University of Edinburgh; University of Prince Edward Island; University of Bristol	Hidano, A (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, EpiCtr, Palmerston North, New Zealand.	A.Hidano@massey.ac.nz	Hidano, Arata/S-1719-2019; Eisler, Mark/AAK-1119-2020; Revie, Crawford/B-5002-2011	Hidano, Arata/0000-0003-1707-5319; Eisler, Mark/0000-0001-6843-3345; Revie, Crawford/0000-0002-5018-0340	Department of Veterinary and Livestock Development, Zambia; Beit Trust	Department of Veterinary and Livestock Development, Zambia; Beit Trust	The authors acknowledge the considerable support of the Department of Veterinary and Livestock Development, Zambia for fieldwork costs. CHL acknowledges the support of the Beit Trust through a postgraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNEY DR, 1994, APPL ANIM BEHAV SCI, V40, P211, DOI 10.1016/0168-1591(94)90062-0; Billiouw M, 1999, TROP MED INT HEALTH, V4, pA28, DOI 10.1046/j.1365-3156.1999.00448.x; Blackie N, 2006, CATTLE PRACT, V14, P139; Blackie N, 2011, APPL ANIM BEHAV SCI, V134, P85, DOI 10.1016/j.applanim.2011.08.004; BUNDZA A, 1982, CAN VET J, V23, P337; Cook NB, 2005, J DAIRY SCI, V88, P3876, DOI 10.3168/jds.S0022-0302(05)73073-3; Edwards JL, 2004, J DAIRY SCI, V87, P524, DOI 10.3168/jds.S0022-0302(04)73192-6; Eisler M. C., 2004, The trypanosomiases, P253, DOI 10.1079/9780851994758.0253; Frost AR, 1997, COMPUT ELECTRON AGR, V17, P139, DOI 10.1016/S0168-1699(96)01301-4; IceRobotics, MOT SENS AN ACT AN I; Ito K, 2010, J DAIRY SCI, V93, P3553, DOI 10.3168/jds.2009-2951; KAUFMANN J, 1995, TROP ANIM HEALTH PRO, V27, P76, DOI 10.1007/BF02236314; KRZANOWSKI W. J., 2007, STAT PRINCIPLES TECH; Maule JP, REPORT TECHNICAL C D; Minjauw B., 2003, RES REPORT; Mitlohner FM, 2001, J ANIM SCI, V79, P1189; Mubanga J, 2009, THESIS U EDINBURGH; MURRAY M, 1988, ACTA TROP, V45, P389; Naessens J, 2006, INT J PARASITOL, V36, P521, DOI 10.1016/j.ijpara.2006.02.012; Robert B, 2009, COMPUT ELECTRON AGR, V67, P80, DOI 10.1016/j.compag.2009.03.002; Roelofs JB, 2005, THERIOGENOLOGY, V64, P1690, DOI 10.1016/j.theriogenology.2005.04.004; SEKONI VO, 1990, VET PARASITOL, V35, P11, DOI 10.1016/0304-4017(90)90112-O; SENGER PL, 1994, J DAIRY SCI, V77, P2745, DOI 10.3168/jds.S0022-0302(94)77217-9; Sinyangwe L, 2004, VET PARASITOL, V119, P125, DOI 10.1016/j.vetpar.2003.11.007; Tatchell R. J., 1981, Advances in the control of theileriosis. Proc. Internat. Conf., 9-13 Feb. 1981, Nairobi., P148; WALKER JW, 1985, J RANGE MANAGE, V38, P90, DOI 10.2307/3899343; Weary DM, 2009, J ANIM SCI, V87, P770, DOI 10.2527/jas.2008-1297; William R. D., 1984, MULTIVARIATE ANAL ME	28	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138125	10.1371/journal.pone.0138125	http://dx.doi.org/10.1371/journal.pone.0138125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366728	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000361601100231
J	Tenorio-Gomez, M; de Sena-Tomas, C; Perez-Martin, J				Tenorio-Gomez, Maria; de Sena-Tomas, Carmen; Perez-Martin, Jose			MRN- and 9-1-1-Independent Activation of the ATR-Chk1 Pathway during the Induction of the Virulence Program in the Phytopathogen Ustilago maydis	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; REPLICATION STRESS; REC1 GENE; CHECKPOINT; KINASE; PHOSPHORYLATION; MRC1	DNA damage response (DDR) leads to DNA repair, and depending on the extent of the damage, to further events, including cell death. Evidence suggests that cell differentiation may also be a consequence of the DDR. During the formation of the infective hypha in the phytopathogenic fungus Ustilago maydis, two DDR kinases, Atr1 and Chk1, are required to induce a G2 cell cycle arrest, which in turn is essential to display the virulence program. However, the triggering factor of DDR in this process has remained elusive. In this report we provide data suggesting that no DNA damage is associated with the activation of the DDR during the formation of the infective filament in U. maydis. We have analyzed bulk DNA replication during the formation of the infective filament, and we found no signs of impaired DNA replication. Furthermore, using RPA-GFP fusion as a surrogate marker of the presence of DNA damage, we were unable to detect any sign of DNA damage at the cellular level. In addition, neither MRN nor 9-1-1 complexes, both instrumental to transmit the DNA damage signal, are required for the induction of the above mentioned cell cycle arrest, as well as for virulence. In contrast, we have found that the claspin-like protein Mrc1, which in other systems serves as scaffold for Atr1 and Chk1, was required for both processes. We discuss possible alternative ways to trigger the DDR, independent of DNA damage, in U. maydis during virulence program activation.	[Tenorio-Gomez, Maria; de Sena-Tomas, Carmen; Perez-Martin, Jose] CSIC, Inst Biol Func & Genom, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG)	Perez-Martin, J (corresponding author), CSIC, Inst Biol Func & Genom, Salamanca, Spain.	jose.perez@csic.es	Perez-Martin, Jose/K-5117-2014	Perez-Martin, Jose/0000-0001-9849-7382; De Sena-Tomas, Carmen/0000-0002-0477-6135	Spanish government [BIO2011-27773, BIO2014-55398-R]	Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by grants from Spanish government (BIO2011-27773 and BIO2014-55398-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Becht P, 2006, J CELL SCI, V119, P4964, DOI 10.1242/jcs.03287; Berens TJ, 2012, MOL BIOL CELL, V23, P1058, DOI 10.1091/mbc.E11-10-0852; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Budirahardja Y, 2009, DEVELOPMENT, V136, P2861, DOI 10.1242/dev.021931; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; Castanheira S, 2014, PROGRAMMED CELL CYCL, DOI [10.1242/dev.113415, DOI 10.1242/DEV.113415]; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; de Sena-Tomas C, 2015, NUCLEIC ACIDS RES, V43, P2138, DOI 10.1093/nar/gkv082; de Sena-Tomas C, 2011, PLANT CELL, V23, P1654, DOI 10.1105/tpc.110.082552; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Egel R, 2005, DNA REPAIR, V4, P525, DOI 10.1016/j.dnarep.2004.11.004; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Feldbrugge M, 2004, CURR OPIN MICROBIOL, V7, P666, DOI 10.1016/j.mib.2004.10.006; Furuya K, 2010, MOL CELL BIOL, V30, P2909, DOI 10.1128/MCB.00049-10; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Garcia-Muse T, 2003, EUKARYOT CELL, V2, P494, DOI 10.1128/EC.2.3.494-500.2003; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Heimel K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001035; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Mielnichuk N, 2009, J CELL SCI, V122, P4130, DOI 10.1242/jcs.052233; Navadgi-Patil VM, 2009, DNA REPAIR, V8, P996, DOI 10.1016/j.dnarep.2009.03.011; Onel K, 1996, GENETICS, V143, P165; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Perez-Martin J., 2012, MORPHOGENESIS PATHOG, V22, P97; Perez-Martin J, 2008, PLANT SIGNAL BEHAV, V3, P480, DOI 10.4161/psb.3.7.5680; Perez-Martin J, 2011, PLANT SIGNAL BEHAV, V6, P1574, DOI 10.4161/psb.6.10.17055; Perez-Martin J, 2009, DNA REPAIR, V8, P720, DOI 10.1016/j.dnarep.2009.01.023; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Sgarlata C, 2005, J CELL SCI, V118, P3607, DOI 10.1242/jcs.02499; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; Steinberg G, 2012, J CELL BIOL, V198, P343, DOI 10.1083/jcb.201201087; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2010, BIOSCI BIOTECH BIOCH, V74, P2367, DOI 10.1271/bbb.100583; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; TSUKUDA T, 1989, GENE, V85, P335, DOI 10.1016/0378-1119(89)90426-5; Ullah Z, 2011, MOL CELL BIOL, V31, P4129, DOI 10.1128/MCB.05723-11	47	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137192	10.1371/journal.pone.0137192	http://dx.doi.org/10.1371/journal.pone.0137192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367864	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100056
J	Wang, T; Peng, SS; Krinner, G; Ryder, J; Li, Y; Dantec-Nedelec, S; Ottle, C				Wang, Tao; Peng, Shushi; Krinner, Gerhard; Ryder, James; Li, Yue; Dantec-Nedelec, Sarah; Ottle, Catherine			Impacts of Satellite-Based Snow Albedo Assimilation on Offline and Coupled Land Surface Model Simulations	PLOS ONE			English	Article							SPECTRAL ALBEDO; CLIMATE; COVER; VALIDATION; FEEDBACK; SENSITIVITY; SCHEME; AREA	Seasonal snow cover in the Northern Hemisphere is the largest component of the terrestrial cryosphere and plays a major role in the climate system through strong positive feedbacks related to albedo. The snow-albedo feedback is invoked as an important cause for the polar amplification of ongoing and projected climate change, and its parameterization across models is an important source of uncertainty in climate simulations. Here, instead of developing a physical snow albedo scheme, we use a direct insertion approach to assimilate satellite- based surface albedo during the snow season (hereafter as snow albedo assimilation) into the land surface model ORCHIDEE (ORganizing Carbon and Hydrology In Dynamic EcosystEms) and assess the influences of such assimilation on offline and coupled simulations. Our results have shown that snow albedo assimilation in both ORCHIDEE and ORCHIDEE-LMDZ (a general circulation model of Laboratoire de Meteorologie Dynamique) improve the simulation accuracy of mean seasonal (October throughout May) snow water equivalent over the region north of 40 degrees. The sensitivity of snow water equivalent to snow albedo assimilation is more pronounced in the coupled simulation than the offline simulation since the feedback of albedo on air temperature is allowed in ORCHIDEE-LMDZ. We have also shown that simulations of air temperature at 2 meters in ORCHIDEE-LMDZ due to snow albedo assimilation are significantly improved during the spring in particular over the eastern Siberia region. This is a result of the fact that high amounts of shortwave radiation during the spring can maximize its snow albedo feedback, which is also supported by the finding that the spatial sensitivity of temperature change to albedo change is much larger during the spring than during the autumn and winter. In addition, the radiative forcing at the top of the atmosphere induced by snow albedo assimilation during the spring is estimated to be -2.50 Wm(-2), the magnitude of which is almost comparable to that due to CO2 (2.83 Wm(-2)) increases since 1750. Our results thus highlight the necessity of realistic representation of snow albedo in the model and demonstrate the use of satellite-based snow albedo to improve model behaviors, which opens new avenues for constraining snow albedo feedback in earth system models.	[Wang, Tao; Peng, Shushi; Krinner, Gerhard] Univ Grenoble 1, CNRS, UMR5183, Lab Glaciol & Geophys Environm, Grenoble, France; [Wang, Tao] Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Alpine Ecol & Biodivers, Beijing 100085, Peoples R China; [Ryder, James; Dantec-Nedelec, Sarah; Ottle, Catherine] CEA CNRS UVSQ, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Li, Yue] Peking Univ, Coll Urban & Environm Sci, Sino French Inst Earth Syst Sci, Beijing 100871, Peoples R China	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Peking University	Wang, T (corresponding author), Univ Grenoble 1, CNRS, UMR5183, Lab Glaciol & Geophys Environm, Grenoble, France.	twang@lsce.ipsl.fr	Wang, Tao/ABE-7107-2020; Krinner, Gerhard/A-6450-2011; Peng, Shushi/J-4779-2014; wang, tao/H-2830-2013; Li, Yue/M-8824-2019; OTTLE, Catherine/K-3895-2012; PENG, Shushi/AAS-2603-2020; Krinner, Gerhard/AAB-8837-2022	Krinner, Gerhard/0000-0002-2959-5920; Peng, Shushi/0000-0001-5098-726X; wang, tao/0000-0003-4792-5898; Li, Yue/0000-0003-2997-6368; OTTLE, Catherine/0000-0003-1304-6414; PENG, Shushi/0000-0001-5098-726X; Krinner, Gerhard/0000-0002-2959-5920	PAGE21 project - the European Commission FP7-ENV [282700]	PAGE21 project - the European Commission FP7-ENV	This study has been supported by the PAGE21 project, funded by the European Commission FP7-ENV-2011 (grant agreement NO. 282700).	Anderson EA, 1976, 19 NOAA NWS US DEP C; Aoki T, 2011, J GEOPHYS RES-ATMOS, V116, P22; Brown R, 2006, ATMOS OCEAN, V44, P223, DOI 10.3137/ao.440302; CHALITA S, 1994, CLIM DYNAM, V10, P231, DOI 10.1007/BF00208990; Cherkauer KA, 2003, GLOBAL PLANET CHANGE, V38, P151, DOI 10.1016/S0921-8181(03)00025-0; Cohen JL, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014007; De Lannoy GJM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010588; Dutra E, 2010, J HYDROMETEOROL, V11, P899, DOI 10.1175/2010JHM1249.1; Essery R, 2013, GEOPHYS RES LETT, V40, P5521, DOI 10.1002/grl.51008; Essery R, 2009, B AM METEOROL SOC, V90, P1120, DOI 10.1175/2009BAMS2629.1; Etchevers P, 2004, ANN GLACIOL-SER, V38, P150, DOI 10.3189/172756404781814825; Flanner MG, 2011, NAT GEOSCI, V4, P151, DOI 10.1038/NGEO1062; Flanner MG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008003; Fletcher CG, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017724; Frei A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023394; He T, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2014JD021667; He T, 2014, IEEE T GEOSCI REMOTE, V52, P3428, DOI 10.1109/TGRS.2013.2272935; Hourdin F, 2006, CLIM DYNAM, V27, P787, DOI 10.1007/s00382-006-0158-0; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Krinner G, 2006, CLIM DYNAM, V27, P613, DOI 10.1007/s00382-006-0159-z; Lehning M, 2002, COLD REG SCI TECHNOL, V35, P169, DOI 10.1016/S0165-232X(02)00072-1; Liston GE, 2004, J CLIMATE, V17, P1381, DOI 10.1175/1520-0442(2004)017<1381:RSSCHI>2.0.CO;2; Livneh B, 2010, J HYDROMETEOROL, V11, P721, DOI 10.1175/2009JHM1174.1; Loranty MM, 2014, GLOBAL CHANGE BIOL, V20, P594, DOI 10.1111/gcb.12391; Malik MJ, 2012, J HYDROMETEOROL, V13, P1119, DOI 10.1175/JHM-D-11-0125.1; MARSHALL S, 1994, CLIM DYNAM, V10, P21, DOI 10.1007/BF00210334; Molotch NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019063; Muller J. -P., 2012, IEEE GEOSC REM SENS; Muller J-P, 2013, GLOBALBEDO FINAL VAL; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Niu GY, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008674; Pedersen CA, 2005, CLIM DYNAM, V25, P351, DOI 10.1007/s00382-005-0037-0; Pinty B, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009096; Qu X, 2014, CLIM DYNAM, V42, P69, DOI 10.1007/s00382-013-1774-0; Roman MO, 2010, REMOTE SENS ENVIRON, V114, P738, DOI 10.1016/j.rse.2009.11.014; Ryder J., 2014, GEOSCI MODEL DEV DIS, V7, P8649, DOI [10.5194/gmdd-7-8649-2014, DOI 10.5194/GMDD-7-8649-2014]; Su H, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013035; Sun SF, 1999, J GEOPHYS RES-ATMOS, V104, P19587, DOI 10.1029/1999JD900305; Takala M, 2011, REMOTE SENS ENVIRON, V115, P3517, DOI 10.1016/j.rse.2011.08.014; Thirel G, 2013, REMOTE SENS-BASEL, V5, P5825, DOI 10.3390/rs5115825; USACE, 1956, SNOW HYDR SUMM REP S; Vionnet V, 2012, GEOSCI MODEL DEV, V5, P773, DOI 10.5194/gmd-5-773-2012; Wang T, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/024018; Wang T, 2013, J GEOPHYS RES-ATMOS, V118, P6064, DOI 10.1002/jgrd.50395; Wang Z, 2010, J APPL METEOROL CLIM, V49, P363, DOI 10.1175/2009JAMC2134.1; WARREN SG, 1980, J ATMOS SCI, V37, P2734, DOI 10.1175/1520-0469(1980)037<2734:AMFTSA>2.0.CO;2; WISCOMBE WJ, 1980, J ATMOS SCI, V37, P2712, DOI 10.1175/1520-0469(1980)037<2712:AMFTSA>2.0.CO;2; Zaitchik BF, 2009, J HYDROMETEOROL, V10, P130, DOI 10.1175/2008JHM1042.1	48	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137275	10.1371/journal.pone.0137275	http://dx.doi.org/10.1371/journal.pone.0137275			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366564	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100062
J	Yan, PZ; Li, MC; Wei, GS; Li, H; Gao, Z				Yan, Pengze; Li, Mingcong; Wei, Guangshan; Li, Han; Gao, Zheng			Molecular Fingerprint and Dominant Environmental Factors of Nitrite-Dependent Anaerobic Methane- Oxidizing Bacteria in Sediments from the Yellow River Estuary, China	PLOS ONE			English	Article							DENITRIFYING METHANOTROPHIC BACTERIA; OXIDATION; DIVERSITY; ENRICHMENT; COOCCURRENCE; ABUNDANCE; LAKE	Nitrite-dependent anaerobic methane oxidation (n-damo) is performed by "Candidatus Methylomirabilis oxyfera" (M. oxyfera), which connects the carbon and nitrogen global nutrient cycles. In the present study, M. oxyfera- like bacteria sequences were successfully recovered from Yellow River Estuary sediments using specific primers for 16S rRNA and pmoA genes. A M. oxyfera- like sequences analysis based on the 16S rRNA gene revealed greater diversity compared with the pmoA gene; the 16S rRNA gene sequences retrieved from the Yellow River Estuary sediments belong to groups A as well as B and were mainly found in freshwater habitats. Quantitative PCR showed that 16S rRNA gene abundance varied from 9.28 +/- 0.11x10(3) to 2.10 +/- 0.13x10(5) copies g(-1) (dry weight), and the pmoA gene abundance ranged from 8.63 +/- 0.50x10(3) to 1.83 +/- 0.18x10(5) copies g(-1) (dry weight). A correlation analysis showed that the total organic carbon (TOC) and ammonium (NH4+) as well as the ratio of total phosphorus to total nitrogen (TP/TN) influenced the M. oxyfera- like bacteria distribution in the Yellow River Estuary sediments. These findings will aid in understanding the n- damo bacterial distribution pattern as well as their correlation with surrounding environmental factors in temperate estuarine ecosystems.	[Yan, Pengze; Li, Mingcong; Wei, Guangshan; Li, Han; Gao, Zheng] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Li, H (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	lihan@sdau.edu.cn; gaozheng@sdau.edu.cn	Yan, Pengze/AGZ-6962-2022	Yan, Pengze/0000-0001-8142-0944	National Natural Science Foundation Project of China [41306150]; Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province, China [BS2012HZ011]; Shandong Province Higher Educational Science and Technology Program, China [J10LC09]	National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC)); Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province, China; Shandong Province Higher Educational Science and Technology Program, China	This work was supported by the National Natural Science Foundation Project of China (No. 41306150); Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province, China (No. BS2012HZ011); A Project of Shandong Province Higher Educational Science and Technology Program, China (No. J10LC09). ZG received the three fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boetius A., 2002, OCEAN MARGIN SYSTEMS, P457, DOI [DOI 10.1007/978-3-662-05127-6_28, 10.1007/978-3-662-05127-6_28]; Chen J, 2015, APPL MICROBIOL BIOT, V99, P1463, DOI 10.1007/s00253-014-6051-6; Chen J, 2014, APPL MICROBIOL BIOT, V98, P5685, DOI 10.1007/s00253-014-5733-4; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; Deutzmann JS, 2011, APPL ENVIRON MICROB, V77, P4429, DOI 10.1128/AEM.00340-11; Dong J, 2015, APPL BIOCHEM BIOTECH, V175, P2729, DOI 10.1007/s12010-014-1456-3; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Ettwig KF, 2009, APPL ENVIRON MICROB, V75, P3656, DOI 10.1128/AEM.00067-09; Field C. B., 2014, TECHNICAL SUMMARY A, P35; Hammer O, 2001, PALEONTOLOGY ELECT, V4, P1; Han P, 2013, APPL MICROBIOL BIOT, V97, P10155, DOI 10.1007/s00253-013-5260-8; He ZF, 2015, WATER RES, V68, P554, DOI 10.1016/j.watres.2014.09.055; Hu BL, 2014, P NATL ACAD SCI USA, V111, P4495, DOI 10.1073/pnas.1318393111; Hu SH, 2009, ENV MICROBIOL REP, V1, P377, DOI 10.1111/j.1758-2229.2009.00083.x; Jetten MS, 2004, ANNU REV MICROBIOL, P58; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Kampman C, 2012, J HAZARD MATER, V227, P164, DOI 10.1016/j.jhazmat.2012.05.032; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kojima H, 2012, SYST APPL MICROBIOL, V35, P233, DOI 10.1016/j.syapm.2012.03.005; Liu Y, 2015, APPL MICROBIOL BIOT, V99, P2371, DOI 10.1007/s00253-014-6141-5; Luesken FA, 2011, APPL ENVIRON MICROB, V77, P3877, DOI 10.1128/AEM.02960-10; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen LD, 2015, APPL MICROBIOL BIOT, V99, P349, DOI 10.1007/s00253-014-6031-x; Shen LD, 2015, APPL MICROBIOL BIOT, V99, P133, DOI 10.1007/s00253-014-6200-y; Shen LD, 2014, APPL MICROBIOL BIOT, V98, P5029, DOI 10.1007/s00253-014-5556-3; Shen LD, 2014, MICROB ECOL, V67, P341, DOI 10.1007/s00248-013-0330-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang Y, 2012, FEMS MICROBIOL LETT, V336, P79, DOI 10.1111/j.1574-6968.2012.02654.x; Xia WW, 2011, ISME J, V5, P1226, DOI 10.1038/ismej.2011.5; Xu XueGong, 2002, GeoJournal, V56, P177, DOI 10.1023/A:1025175409094; Yang J, 2012, FRONT EARTH SCI-PRC, V6, P383, DOI 10.1007/s11707-012-0336-9; Zhou LL, 2014, FEMS MICROBIOL LETT, V360, P33, DOI 10.1111/1574-6968.12567; Zhu BL, 2012, APPL ENVIRON MICROB, V78, P8657, DOI 10.1128/AEM.02102-12; Zhu GB, 2015, ENV MICROBIOL REP, V7, P128, DOI 10.1111/1758-2229.12214; [朱群 Zhu Qun], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P1321	37	31	41	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137996	10.1371/journal.pone.0137996	http://dx.doi.org/10.1371/journal.pone.0137996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368535	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100198
J	Xing, R; Li, L; Chen, L; Gao, Z; Wang, H; Li, W; Cui, J; Tian, G; Liang, Q; Yu, J; Sung, JJ; Luo, G; Gao, H; Xu, X; Yang, H; Wang, J; Zhang, X; Wang, JM; Huang, J; Yu, Y; Wang, J; Lu, Y				Xing, R.; Li, L.; Chen, L.; Gao, Z.; Wang, H.; Li, W.; Cui, J.; Tian, G.; Liang, Q.; Yu, J.; Sung, J. J.; Luo, G.; Gao, H.; Xu, X.; Yang, H.; Wang, J.; Zhang, X.; Wang, J. M.; Huang, J.; Yu, Y.; Wang, J.; Lu, Y.			Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells	ONCOGENE			English	Article							LUNG-CANCER; RECEPTORS NKP30; THERAPY; NKP44; GENE	Nude mice are important in vivo model for characterization of cell malignancy behavior; however, many cancer cells fail to form tumors in it. Understanding this defective mechanism may provide novel insights into tumorigenesis and how tumor cells escape innate immunity. Whole-genome sequencing was conducted on two gastric cancer (GC) cells, BGC823 and AGS, which do and do not form tumors in nude mice, to identify their genomic differences relevant to natural killer (NK) cells. We found that the tumorigenic capacity of human GC cell lines was dependent on the recruitment and activation of NK cells in xenograft tumors. We used whole-genome sequence (WGS) on GC cell lines to identify potential genes controlling susceptibility to NK-mediated killing. The tumorigenic cell line BGC823 expressed high levels of HLA-I because of copy gain and was resistant to NK cell killing. In contrast, another cell line AGS expressing low levels of HLA-I with activated NKp30/MAPK/IL-12 (interleukin-12) or IL-2 (interleukin-2) pathway was susceptible to NK lysis. Treatment of tumor bearing mice with systemic administration of IL-12 in combination with intratumor injection of anti-HLA-I antibody significantly increased NK cell recruitment into xenograft tumors, which became sensitive to NK killing, resulting in reduced tumor progression. In human GC specimens, decreased HLA-I expression and increased NK cells surrounding tumor cells were correlated with decreased metastasis potential and better prognosis of patients. Our results provide a mechanistic basis for GC cells to escape NK lysis and a promising prospect of NK immunotherapy for GC cells.	[Xing, R.; Wang, H.; Li, W.; Cui, J.; Lu, Y.] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Lab Mol Oncol,Minist Educ, Fu Cheng Rd 52, Beijing 100142, Peoples R China; [Li, L.; Chen, L.; Gao, Z.; Tian, G.; Xu, X.; Yang, H.; Wang, J.; Zhang, X.; Wang, J.] Beijing Genom Inst Shenzhen, Shenzhen 518083, Peoples R China; [Liang, Q.; Yu, J.; Sung, J. J.] Chinese Univ Hong Kong, Shenzhen Res Inst, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Liang, Q.; Yu, J.; Sung, J. J.] Chinese Univ Hong Kong, Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Luo, G.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Luo, G.] Beijing Univ Chinese Med, Beijing, Peoples R China; [Gao, H.] Shanghai Engn Ctr Mol Med, Shanghai, Peoples R China; [Wang, J. M.; Huang, J.] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Yu, Y.] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Yu, Y.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Surg, Shanghai 200030, Peoples R China	Peking University; Beijing Genomics Institute (BGI); Chinese University of Hong Kong; Chinese University of Hong Kong; Case Western Reserve University; Beijing University of Chinese Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, Y (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Lab Mol Oncol,Minist Educ, Fu Cheng Rd 52, Beijing 100142, Peoples R China.; Wang, J (corresponding author), Beijing Genom Inst Shenzhen, Shenzhen 518083, Peoples R China.	wangj@genomics.org.cn; youyonglu@bjmu.edu.cn	Wang, Huanting/G-8399-2011; Yu, Jun/D-8569-2015; Xu, Xun/AAI-6763-2020; Huang, Jiaqiang/C-2375-2011; Sung, Joseph J. Y./R-3203-2018; Liang, Qiaoyi Jessie/G-9612-2019	Wang, Huanting/0000-0002-9887-5555; Yu, Jun/0000-0001-5008-2153; Xu, Xun/0000-0002-5338-5173; Huang, Jiaqiang/0000-0002-6610-8159; Sung, Joseph J. Y./0000-0003-3125-5199; Liang, Qiaoyi Jessie/0000-0001-8496-3442	Ministry of Science and Technology of China (863 program) [2012AA02A203, 2012AA02A504]; Beijing Nova program [XXJH2015037, Z151100000315069]; NATIONAL CANCER INSTITUTE [ZIABC010725, ZIABC010015] Funding Source: NIH RePORTER	Ministry of Science and Technology of China (863 program)(Ministry of Science and Technology, ChinaNational High Technology Research and Development Program of China); Beijing Nova program(Beijing Municipal Science & Technology Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Richard Ascione (Department of Biochemistry and Molecular Biology, Medical School of Georgetown University USA) and Dr Laurie Goodman for critical reviewing and editing of the manuscript. This work was supported by the Ministry of Science and Technology of China (863 program, grants 2012AA02A203, 2012AA02A504) and Beijing Nova program (XXJH2015037, No.Z151100000315069).	Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Cheng M, 2013, CELL MOL IMMUNOL, V10, P230, DOI 10.1038/cmi.2013.10; Farhan S, 2012, IMMUNOTHERAPY-UK, V4, P305, DOI [10.2217/IMT.11.174, 10.2217/imt.11.174]; Haraksingh RR, 2013, J MOL BIOL, V425, P3970, DOI 10.1016/j.jmb.2013.07.015; Hecht ML, 2009, J PROTEOME RES, V8, P712, DOI 10.1021/pr800747c; Hsieh CL, 2006, EUR J IMMUNOL, V36, P2170, DOI 10.1002/eji.200635982; Iliopoulou EG, 2010, CANCER IMMUNOL IMMUN, V59, P1781, DOI 10.1007/s00262-010-0904-3; Imai C, 2005, BLOOD, V106, P376, DOI 10.1182/blood-2004-12-4797; Langers I, 2012, BIOL-TARGETS THER, V6, P73, DOI 10.2147/BTT.S23976; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Ni XH, 2013, P NATL ACAD SCI USA, V110, P21083, DOI 10.1073/pnas.1320659110; Ponnampalam AP, 2008, EUR J IMMUNOL, V38, P216, DOI 10.1002/eji.200636429; Santos GC, 2007, J CLIN PATHOL, V60, P1, DOI 10.1136/jcp.2005.034389; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Srivastava BIS, 2006, LEUKEMIA RES, V30, P37, DOI 10.1016/j.leukres.2005.06.020; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Xing R, 2012, GUT, V61, P43, DOI 10.1136/gut.2010.230623	19	7	7	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 19	2016	35	20					2584	2591		10.1038/onc.2015.324	http://dx.doi.org/10.1038/onc.2015.324			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GS	26364607	Green Accepted			2022-12-26	WOS:000376165700005
J	Emmott, E; Sweeney, TR; Goodfellow, I				Emmott, Edward; Sweeney, Trevor R.; Goodfellow, Ian			A Cell-based Fluorescence Resonance Energy Transfer (FRET) Sensor Reveals Inter-and Intragenogroup Variations in Norovirus Protease Activity and Polyprotein Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORWALK VIRUS PROTEASE; NONSTRUCTURAL POLYPROTEIN; MURINE NOROVIRUS; PROTEINASE-POLYMERASE; EXPRESSION; SITES; INTERGENOGROUP; RECOMBINATION; TRANSLATION; PRECURSORS	The viral protease represents a key drug target for the development of antiviral therapeutics. Because many protease inhibitors mimic protease substrates, differences in substrate recognition between proteases may affect their sensitivity to a given inhibitor. Here we use a cell-based FRET sensor to investigate the activity of different norovirus proteases upon cleavage of various norovirus cleavage sites inserted into a linker region separating cyan fluorescent protein and yellow fluorescent protein. Using this system, we demonstrate that differences in substrate processing exist between proteases from human noroviruses (genogroups I (GI) and II) and the commonly used murine norovirus (MNV, genogroup V) model. These altered the cleavage efficiency of specific cleavage sites both within and between genogroups. The differences observed between these proteases may affect sensitivity to protease inhibitors and the suitability of MNV as a model system for testing such molecules against the human norovirus protease. Finally, we demonstrate that replacement of MNV polyprotein cleavage sites with the GI or GII equivalents, with the exception of the NS6-7 junction, leads to the production of infectious virus when the MNV NS6 protease, but not the GI or GII proteases, are present.	[Emmott, Edward; Sweeney, Trevor R.; Goodfellow, Ian] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Emmott, E (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Lab Block Level 5,Box 237,Hills Rd, Cambridge CB2 2QQ, England.	ee273@cam.ac.uk; ig299@cam.ac.uk		Emmott, Edward/0000-0002-3239-8178; Goodfellow, Ian/0000-0002-9483-510X; Sweeney, Trevor/0000-0003-4016-7326	Wellcome Trust Senior Fellowship [WT097997MA]; Wellcome Trust Marie Curie Fellowship [628373]	Wellcome Trust Senior Fellowship(Wellcome Trust); Wellcome Trust Marie Curie Fellowship	This work was funded by Wellcome Trust Senior Fellowship WT097997MA (to I. G.) and Marie Curie Fellowship 628373 (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Belliot G, 2005, J VIROL, V79, P2393, DOI 10.1128/JVI.79.4.2393-2403.2005; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Cameron CE, 2010, FUTURE MICROBIOL, V5, P867, DOI 10.2217/FMB.10.40; Chaudhry Y, 2007, J GEN VIROL, V88, P2091, DOI 10.1099/vir.0.82940-0; Felber LM, 2004, BIOTECHNIQUES, V36, P878, DOI 10.2144/04365PT04; Fernandes H, 2015, PEERJ, V3, DOI 10.7717/peerj.798; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Gamlen T, 2010, J GEN VIROL, V91, P133, DOI 10.1099/vir.0.016170-0; Herod MR, 2014, BIOCHEM J, V464, P461, DOI 10.1042/BJ20140959; Hussey RJ, 2011, BIOCHEMISTRY-US, V50, P240, DOI 10.1021/bi1008497; Hwang Seungmin, 2014, Curr Protoc Microbiol, V33, DOI 10.1002/9780471729259.mc15k02s33; Hwang YC, 2006, APPL ENVIRON MICROB, V72, P3710, DOI 10.1128/AEM.72.5.3710-3715.2006; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kankanamalage ACG, 2015, J MED CHEM, V58, P3144, DOI 10.1021/jm5019934; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Karst SM, 2015, J PATHOL, V235, P206, DOI 10.1002/path.4463; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kuyumcu-Martinez M, 2004, J VIROL, V78, P8172, DOI 10.1128/JVI.78.15.8172-8182.2004; Leen EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038723; Mandadapu SR, 2013, BIOORG MED CHEM LETT, V23, P62, DOI 10.1016/j.bmcl.2012.11.026; May J, 2014, J VIROL, V88, P10738, DOI 10.1128/JVI.01357-14; May J, 2013, VIROLOGY, V444, P218, DOI 10.1016/j.virol.2013.06.013; Muhaxhiri Z, 2013, J VIROL, V87, P4281, DOI 10.1128/JVI.02869-12; Nakamura K, 2005, J VIROL, V79, P13685, DOI 10.1128/JVI.79.21.13685-13693.2005; Nayak MK, 2008, VIROLOGY, V377, P117, DOI 10.1016/j.virol.2008.04.027; Oka T, 2005, ARCH VIROL, V150, P2539, DOI 10.1007/s00705-005-0591-0; Oka T, 2006, J GEN VIROL, V87, P3329, DOI 10.1099/vir.0.81799-0; Pathak Harsh B, 2008, J Biol Chem, V283, P30677, DOI 10.1074/jbc.M806101200; Qu L, 2014, J VIROL, V88, P10312, DOI 10.1128/JVI.01111-14; Rocha-Pereira J, 2014, ANTIMICROB AGENTS CH, V58, P4675, DOI 10.1128/AAC.02546-13; Ruether IGA, 2014, MOL CELL PROBE, V28, P204, DOI 10.1016/j.mcp.2014.04.001; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scheffler U, 2007, J GEN VIROL, V88, P2013, DOI 10.1099/vir.0.82797-0; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Sosnovtsev SV, 2002, J VIROL, V76, P7060, DOI 10.1128/JVI.76.14.7060-7072.2002; Subba-Reddy CV, 2012, J VIROL, V86, P10138, DOI 10.1128/JVI.01208-12; Takahashi D, 2013, VIRUS RES, V178, P437, DOI 10.1016/j.virusres.2013.09.008; Taube S, 2013, MBIO, V4, DOI 10.1128/mBio.00450-13; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; Waters A, 2007, VIROLOGY, V363, P11, DOI 10.1016/j.virol.2007.03.012; Wei L, 2001, J VIROL, V75, P1211, DOI 10.1128/JVI.75.3.1211-1219.2001; Zeitler CE, 2006, J VIROL, V80, P5050, DOI 10.1128/JVI.80.10.5050-5058.2006; Zhang HD, 2015, J VIROL, V89, P7722, DOI 10.1128/JVI.01137-15	48	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27841	27853		10.1074/jbc.M115.688234	http://dx.doi.org/10.1074/jbc.M115.688234			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26363064	Green Published, hybrid			2022-12-26	WOS:000365757500034
J	Lacroix, M; Rousseau, F; Guilhot, F; Malinge, P; Magistrelli, G; Herren, S; Jones, SA; Jones, GW; Scheller, J; Lissilaa, R; Kosco-Vilbois, M; Johnson, Z; Buatois, V; Ferlin, W				Lacroix, Marine; Rousseau, Francois; Guilhot, Florence; Malinge, Pauline; Magistrelli, Giovanni; Herren, Suzanne; Jones, Simon A.; Jones, Gareth W.; Scheller, Juergen; Lissilaa, Rami; Kosco-Vilbois, Marie; Johnson, Zoe; Buatois, Vanessa; Ferlin, Walter			Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-INFLAMMATORY ACTIVITIES; LIGAND-INDUCED ENDOCYTOSIS; DOWN-REGULATION; RECEPTOR; GP130; CYTOKINE; ACTIVATION; BLOCKADE; TRANSDUCTION; STIMULATION	Background: The IL-6 signaling complex consists of a hexameric structure essential for IL-6 cis- and trans-signaling. Results: mAb 25F10 targets site IIb of IL-6R and disrupts hexamer assembly to selectively block trans-signaling. Conclusion: Cis- and trans-signaling in mice utilize distinct mechanisms to mediate assembly of the IL-6R complex. Significance: Therapeutic targeting of site IIb of IL-6R provides a unique mode of action for IL-6 inhibition. The IL-6 signaling complex is described as a hexamer, formed by the association of two IL-6.IL-6 receptor (IL-6R).gp130 trimers, with gp130 being the signal transducer inducing cis- and trans-mediated signaling via a membrane-bound or soluble form of the IL-6R, respectively. 25F10 is an anti-mouse IL-6R mAb that binds to both membrane-bound IL-6R and soluble IL-6R with the unique property of specifically inhibiting trans-mediated signaling events. In this study, epitope mapping revealed that 25F10 interacts at site IIb of IL-6R but allows the binding of IL-6 to the IL-6R and the recruitment of gp130, forming a trimer complex. Binding of 25F10 to IL-6R prevented the formation of the hexameric complex obligate for trans-mediated signaling, suggesting that the cis- and trans-modes of IL-6 signaling adopt different mechanisms for receptor complex assembly. To study this phenomenon also in the human system, we developed NI-1201, a mAb that targets, in the human IL-6R sequence, the epitope recognized by 25F10 for mice. Interestingly, NI-1201, however, did not selectively inhibit human IL-6 trans-signaling, although both mAbs produced beneficial outcomes in conditions of exacerbated IL-6 as compared with a site I-directed mAb. These findings shed light on the complexity of IL-6 signaling. First, triggering cis-versus trans-mediated IL-6 signaling occurs via distinctive mechanisms for receptor complex assembly in mice. Second, the formation of the receptor complex leading to cis- and trans-signaling biology in mice and humans is different, and this should be taken into account when developing strategies to inhibit IL-6 clinically.	[Lacroix, Marine; Rousseau, Francois; Guilhot, Florence; Malinge, Pauline; Magistrelli, Giovanni; Herren, Suzanne; Kosco-Vilbois, Marie; Johnson, Zoe; Buatois, Vanessa; Ferlin, Walter] Novimmune SA, CH-1228 Plan Les Ouates, Switzerland; [Jones, Simon A.; Jones, Gareth W.] Cardiff Univ, Cardiff Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Lissilaa, Rami] Glenmark Pharmaceut SA, CH-2300 La Chaux De Fonds, Switzerland	NovImmune SA; Cardiff University; Heinrich Heine University Dusseldorf	Ferlin, W (corresponding author), Novimmune SA, 14 Chemin Aulx, CH-1228 Plan Les Ouates, Switzerland.	wferlin@novimmune.com	Scheller, Jürgen/K-5290-2015; Jones, Simon Arnett/Q-7017-2018	Johnson, Zoe/0000-0002-4120-2579; Jones, Simon Arnett/0000-0001-7297-9711; Jones, Gareth/0000-0002-0125-4841; Guilhot, Francois/0000-0001-7222-487X	Arthritis Research UK [20770, 20305] Funding Source: Medline; Versus Arthritis [20305, 20770] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)		Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Buell G, 1998, BLOOD, V92, P3521, DOI 10.1182/blood.V92.10.3521.422k50_3521_3528; Coles B, 2007, AM J PATHOL, V171, P315, DOI 10.2353/ajpath.2007.061078; DITTRICH E, 1994, J BIOL CHEM, V269, P19014; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; Ferlin W., 2011, United States Patent, Patent No. [8,034,344, 8034344]; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2015, CURR OPIN IMMUNOL, V34, P75, DOI 10.1016/j.coi.2015.02.008; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Graeve L, 1996, FEBS LETT, V399, P131, DOI 10.1016/S0014-5793(96)01305-1; Grotzinger J, 1997, PROTEINS, V27, P96; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hoge J, 2013, J IMMUNOL, V190, P703, DOI 10.4049/jimmunol.1201044; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Lissilaa R, 2010, J IMMUNOL, V185, P5512, DOI 10.4049/jimmunol.1002015; Mihara M, 2005, INT IMMUNOPHARMACOL, V5, P1731, DOI 10.1016/j.intimp.2005.05.010; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Peters M, 1998, BLOOD, V92, P3495, DOI 10.1182/blood.V92.10.3495.422k47_3495_3504; Pflanz S, 2000, J IMMUNOL, V165, P7042, DOI 10.4049/jimmunol.165.12.7042; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shaw S, 2014, MABS-AUSTIN, V6, P773, DOI 10.4161/mabs.28612; Stuhlmann-Laeisz C, 2006, MOL BIOL CELL, V17, P2986, DOI 10.1091/mbc.E05-12-1129; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Veverka V, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405597; YAWATA H, 1993, EMBO J, V12, P1705, DOI 10.1002/j.1460-2075.1993.tb05815.x; ZOHLNHOFER D, 1992, FEBS LETT, V306, P219, DOI 10.1016/0014-5793(92)81004-6	31	43	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26943	26953		10.1074/jbc.M115.682138	http://dx.doi.org/10.1074/jbc.M115.682138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26363066	hybrid, Green Published			2022-12-26	WOS:000364794000006
J	Stransky, LA; Forgac, M				Stransky, Laura A.; Forgac, Michael			Amino Acid Availability Modulates Vacuolar H+-ATPase Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; IN-VIVO; ACIDIFICATION; MECHANISM; ACTIVATION; DISSOCIATION; RAGULATOR; PATHWAY; GLUCOSE; MTORC1	Background: Reversible assembly is a major mode of V-ATPase regulation. Results: Amino acid starvation reversibly increases V-ATPase assembly. Conclusion: Amino acids are a novel regulator of V-ATPase assembly. Significance: Learning how amino acids are sensed and influence cellular physiology is important to understanding the basic processes of cellular homeostasis. The vacuolar H+-ATPase (V-ATPase) is an ATP-dependent proton pump composed of a peripheral ATPase domain (V-1) and a membrane-integral proton-translocating domain (V-0) and is involved in many normal and disease processes. An important mechanism of regulating V-ATPase activity is reversible assembly of the V-1 and V-0 domains. Increased assembly in mammalian cells occurs under various conditions and has been shown to involve PI3K. The V-ATPase is necessary for amino acid-induced activation of mechanistic target of rapamycin complex 1 (mTORC1), which is important in controlling cell growth in response to nutrient availability and growth signals. The V-ATPase undergoes amino acid-dependent interactions with the Ragulator complex, which is involved in recruitment of mTORC1 to the lysosomal membrane during amino acid sensing. We hypothesized that changes in the V-ATPase/Ragulator interaction might involve amino acid-dependent changes in V-ATPase assembly. To test this, we measured V-ATPase assembly by cell fractionation in HEK293T cells treated with and without amino acids. V-ATPase assembly increases upon amino acid starvation, and this effect is reversed upon readdition of amino acids. Lysosomes from amino acid-starved cells possess greater V-ATPase-dependent proton transport, indicating that assembled pumps are catalytically active. Amino acid-dependent changes in both V-ATPase assembly and activity are independent of PI3K and mTORC1 activity, indicating the involvement of signaling pathways distinct from those implicated previously in controlling assembly. By contrast, lysosomal neutralization blocks the amino acid-dependent change in assembly and reactivation of mTORC1 after amino acid starvation. These results identify an important new stimulus for controlling V-ATPase assembly.	[Forgac, Michael] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA	Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu	Regan, Clinton/E-6250-2012	Stransky, Laura/0000-0001-8834-936X	National Institutes of Health [GM34478, CA189321]; Sackler Families Collaborative Cancer Biology Award from Tufts University; NATIONAL CANCER INSTITUTE [F31CA189321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sackler Families Collaborative Cancer Biology Award from Tufts University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM34478 (to M. F.) and CA189321 (to L. S.) and a Sackler Families Collaborative Cancer Biology Award from Tufts University (to L. S. and M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; BLOMMAART PJE, 1993, J BIOL CHEM, V268, P1610; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kohio HP, 2013, VIROLOGY, V444, P301, DOI 10.1016/j.virol.2013.06.026; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marjuki H, 2011, CELL MICROBIOL, V13, P587, DOI 10.1111/j.1462-5822.2010.01556.x; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PUOPOLO K, 1990, J BIOL CHEM, V265, P14836; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	24	84	89	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27360	27369		10.1074/jbc.M115.659128	http://dx.doi.org/10.1074/jbc.M115.659128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378229	Green Published, hybrid			2022-12-26	WOS:000364794000042
J	Millen, SH; Watanabe, M; Komatsu, E; Yamaguchi, F; Nagasawa, Y; Suzuki, E; Monaco, H; Weiss, AA				Millen, Scott H.; Watanabe, Mineo; Komatsu, Eiji; Yamaguchi, Fuminori; Nagasawa, Yuki; Suzuki, Eri; Monaco, Haleigh; Weiss, Alison A.			Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein Function	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; BORDETELLA-PERTUSSIS; IMMUNE-RESPONSES; UNITED-STATES; WHOLE-CELL; T-CELLS; VACCINE; PERTACTIN; STRAINS; ADULTS	Whooping cough due to Bordetella pertussis is increasing in incidence, in part due to accumulation of mutations which increase bacterial fitness in highly vaccinated populations. Polymorphisms in the pertussis toxin, ptxA and ptxB genes, and the pertactin, prn genes of clinical isolates of Bordetella pertussis collected in Cincinnati from 1989 through 2005 were examined. While the ptxA and prn genotypes were variable, all 48 strains had the ptxB2 genotype; ptxB1 encodes glycine at amino acid 18 of the S2 subunit of pertussis toxin, while ptxB2 encodes serine. We investigated antigenic and functional differences of PtxB1 and PtxB2. The S2 protein was not very immunogenic. Only a few vaccinated or individuals infected with B. pertussis developed antibody responses to the S2 subunit, and these sera recognized both polymorphic forms equally well. Amino acid 18 of S2 is in a glycan binding domain, and the PtxB forms displayed differences in receptor recognition and toxicity. PtxB1 bound better to the glycoprotein, fetuin, and Jurkat T cells in vitro, but the two forms were equally effective at promoting CHO cell clustering. To investigate in vivo activity of Ptx, one mu g of Ptx was administered to DDY mice and blood was collected on 4 days after injection. PtxB2 was more effective at promoting lymphocytosis in mice.	[Millen, Scott H.; Monaco, Haleigh; Weiss, Alison A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA; [Watanabe, Mineo; Komatsu, Eiji; Yamaguchi, Fuminori; Nagasawa, Yuki; Suzuki, Eri] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, Tokyo, Japan	University System of Ohio; University of Cincinnati; Kitasato University	Weiss, AA (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA.	alison.weiss@uc.edu		Weiss, Alison/0000-0002-4726-8376; Millen, Scott/0000-0001-5072-6844	United States National Institutes of Health, Institute of Allergy and Infectious Diseases [R01AI23695]; Ministry of Education, Science, Sports and Culture [2007-19590463]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023695] Funding Source: NIH RePORTER	United States National Institutes of Health, Institute of Allergy and Infectious Diseases; Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by R01AI23695 United States National Institutes of Health, Institute of Allergy and Infectious Diseases (PI: AAW), and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C) 2007-19590463 (PI: MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bisgard KM, 2001, J INFECT DIS, V183, P1360, DOI 10.1086/319858; Bodilis H, 2013, EMERG INFECT DIS, V19, P471, DOI 10.3201/1903.121475; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Boursaux-Eude C, 1999, VACCINE, V17, P2651, DOI 10.1016/S0264-410X(99)00038-9; Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881; CHONG P, 1989, BIOCHEM CELL BIOL, V67, P387, DOI 10.1139/o89-061; CHRISTIE CDC, 1994, NEW ENGL J MED, V331, P16, DOI 10.1056/NEJM199407073310104; CUMMING DA, 1989, BIOCHEMISTRY-US, V28, P6500, DOI 10.1021/bi00441a051; GILLENIUS P, 1985, J BIOL STAND, V13, P61, DOI 10.1016/S0092-1157(85)80034-2; Guiso N, 2001, VACCINE, V19, P3248, DOI 10.1016/S0264-410X(01)00013-5; Gzyl A, 2001, VACCINE, V20, P299, DOI 10.1016/S0264-410X(01)00356-5; HEERZE LD, 1992, J BIOL CHEM, V267, P25810; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; KALININ NL, 1995, ANAL BIOCHEM, V228, P238, DOI 10.1006/abio.1995.1345; KASUGA TADAYOSHI, 1953, KITASATO ARCH EXPTL MED, V26, P121; Keitel WA, 1999, J INFECT DIS, V180, P397, DOI 10.1086/314869; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; Komatsu E, 2010, CLIN VACCINE IMMUNOL, V17, P807, DOI 10.1128/CVI.00449-09; Le T, 2004, J INFECT DIS, V190, P535, DOI 10.1086/422035; Liko J, 2013, NEW ENGL J MED, V368, P581, DOI 10.1056/NEJMc1212006; LOCHT C, 1986, NUCLEIC ACIDS RES, V14, P3251, DOI 10.1093/nar/14.8.3251; MENOZZI FD, 1991, FEMS MICROBIOL LETT, V78, P59; Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z; Millen SH, 2004, INFECT IMMUN, V72, P615, DOI 10.1128/IAI.72.1.615-620.2004; MOOI FR, 2007, PHYLOGENY EVOLUTION, P17; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; MORSE SI, 1976, J EXP MED, V143, P1483, DOI 10.1084/jem.143.6.1483; MUSSER JM, 1986, J BACTERIOL, V166, P230, DOI 10.1128/jb.166.1.230-237.1986; NICOSIA A, 1986, P NATL ACAD SCI USA, V83, P4631, DOI 10.1073/pnas.83.13.4631; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Queenan AM, 2013, NEW ENGL J MED, V368, P583, DOI 10.1056/NEJMc1209369; Schneider OD, 2007, INFECT IMMUN, V75, P4040, DOI 10.1128/IAI.00414-07; Schneider OD, 2012, BIOCHEMISTRY-US, V51, P4126, DOI 10.1021/bi3002693; Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Watanabe M, 2006, CLIN VACCINE IMMUNOL, V13, P341, DOI 10.1128/CVI.13.3.341-348.2006; Watanabe M, 2000, VACCINE, V19, P1199, DOI 10.1016/S0264-410X(00)00308-X; Weingart CL, 2000, INFECT IMMUN, V68, P7175, DOI 10.1128/IAI.68.12.7175-7179.2000; Weiss AA, 2004, INFECT IMMUN, V72, P7346, DOI 10.1128/IAI.72.12.7346-7351.2004; World Health Organization, 2011, IMM VACC BIOL PERT; Zhang SM, 2011, J BACTERIOL, V193, P4017, DOI 10.1128/JB.05184-11	45	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137379	10.1371/journal.pone.0137379	http://dx.doi.org/10.1371/journal.pone.0137379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375454	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200037
J	Nouet, J; Chevallard, C; Farre, B; Nehrke, G; Campmas, E; Stoetzel, E; El Hajraoui, MA; Nespoulet, R				Nouet, Julius; Chevallard, Corinne; Farre, Bastien; Nehrke, Gernot; Campmas, Emilie; Stoetzel, Emmanuelle; El Hajraoui, Mohamed Abdeljalil; Nespoulet, Roland			Limpet Shells from the Aterian Level 8 of El Harhoura 2 Cave (Temara, Morocco): Preservation State of Crossed-Foliated Layers	PLOS ONE			English	Article							MIDDLE STONE-AGE; MODERN HUMAN-BEHAVIOR; SOUTH-AFRICA; BLOMBOS CAVE; ACRIDINE-ORANGE; PINNACLE POINT; NORTH-AFRICA; CALCITE; GROWTH; SEA	The exploitation of mollusks by the first anatomically modern humans is a central question for archaeologists. This paper focuses on level 8 (dated around similar to 100 ka BP) of El Harhoura 2 Cave, located along the coastline in the Rabat-Temara region (Morocco). The large quantity of Patella sp. shells found in this level highlights questions regarding their origin and preservation. This study presents an estimation of the preservation status of these shells. We focus here on the diagenetic evolution of both the microstructural patterns and organic components of crossed-foliated shell layers, in order to assess the viability of further investigations based on shell layer minor elements, isotopic or biochemical compositions. The results show that the shells seem to be well conserved, with microstructural patterns preserved down to sub-micrometric scales, and that some organic components are still present in situ. But faint taphonomic degradations affecting both mineral and organic components are nonetheless evidenced, such as the disappearance of organic envelopes surrounding crossed-foliated lamellae, combined with a partial recrystallization of the lamellae. Our results provide a solid case-study of the early stages of the diagenetic evolution of crossed-foliated shell layers. Moreover, they highlight the fact that extreme caution must be taken before using fossil shells for palaeoenvironmental or geochronological reconstructions. Without thorough investigation, the alteration patterns illustrated here would easily have gone unnoticed. However, these degradations are liable to bias any proxy based on the elemental, isotopic or biochemical composition of the shells. This study also provides significant data concerning human subsistence behavior: the presence of notches and the good preservation state of limpet shells (no dissolution/recrystallization, no bioerosion and no abrasion/fragmentation aspects) would attest that limpets were gathered alive with tools by Middle Palaeolithic (Aterian) populations in North Africa for consumption.	[Nouet, Julius] Univ Paris 11, CNRS UMR GEOPS 8148, F-91405 Orsay, France; [Chevallard, Corinne] CEA Saclay, LIONS, UMR SIS2M 3299, CEA,CNRS IRAMIS, F-91191 Gif Sur Yvette, France; [Farre, Bastien] ISTO, CNRS UMR 7327, F-45071 Orleans 2, France; [Nehrke, Gernot] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Campmas, Emilie] Univ Toulouse Jean Jaures, CNRS UMR TRACES 5608, Maison Rech, F-31058 Toulouse, France; [El Hajraoui, Mohamed Abdeljalil] Inst Natl Sci Archeol & Patrimoine, Madinat Al Irfane, Rabat Hay Riyad, Morocco; [Stoetzel, Emmanuelle; Nespoulet, Roland] Museum Natl Hist Nat, Dept Prehist, CNRS UMR 7194, F-75231 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; UDICE-French Research Universities; PSL Research University Paris; Ecole des Hautes Etudes en Sciences Sociales (EHESS); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Nouet, J (corresponding author), Univ Paris 11, CNRS UMR GEOPS 8148, Batiment 504,Campus Univ, F-91405 Orsay, France.	julius.nouet@u-psud.fr	Stoetzel, Emmanuelle/ABG-2518-2020	Stoetzel, Emmanuelle/0000-0002-2724-5994; El Hajraoui, Mohamed Abdeljalil/0000-0002-6519-2264; Nehrke, Gernot/0000-0002-2851-3049; Nouet, Julius/0000-0001-5435-542X	CNRS through the interdisciplinary action AIR-Archaeometry; European Community Research Infrastructure Action under FP7 Integrating Activities Programme; mineralogy department of NHM, London; Commission consultative des recherches archeologiques a l'eatranger of Ministere des Affaires Etrangeres et Europeennes of France; Ministry of Culture of Morocco; French Agence Nationale de la Recherche; MOHMIE project [ANR-09-PEXT-004]	CNRS through the interdisciplinary action AIR-Archaeometry; European Community Research Infrastructure Action under FP7 Integrating Activities Programme; mineralogy department of NHM, London; Commission consultative des recherches archeologiques a l'eatranger of Ministere des Affaires Etrangeres et Europeennes of France; Ministry of Culture of Morocco; French Agence Nationale de la Recherche(French National Research Agency (ANR)); MOHMIE project	This research received support from CNRS through the interdisciplinary action AIR-Archaeometry and from the SYNTHESIS Project http://www.synthesis.info/ which is financed by European Community Research Infrastructure Action under FP7 Integrating Activities Programme (the authors especially thank J. Spratt, A. Ball and L. Howard from the mineralogy department of NHM, London for their support). The authors would like to thank the Institut National des Sciences de l'Archeologie et du Patrimoine (dir. A. Akerraz), the Mission archeologique El Harhoura-Temara, funded by the Commission consultative des recherches archeologiques a l'eatranger of Ministere des Affaires Etrangeres et Europeennes of France and the Ministry of Culture of Morocco. The authors also would like to thank the French Agence Nationale de la Recherche and the ANR-09-PEXT-004 MOHMIE project (dir. C. Denys) for the funding provided in the field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 1991, P 6 INT S BIOM OD OC, P29; ALEXANDERSSON ET, 1979, SEDIMENTOLOGY, V26, P845, DOI 10.1111/j.1365-3091.1979.tb00977.x; Avery G., 2008, S AFRI ARCHAEOL SOC, V10, P66, DOI [10.2307/40650020, DOI 10.2307/40650020]; Balbo A, 2011, QUATERN INT, V239, P147, DOI 10.1016/j.quaint.2011.03.032; Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; Baronnet A, 2008, MINERAL MAG, V72, P617, DOI 10.1180/minmag.2008.072.2.617; Barton N, 2012, DEV QUATER SCI, V16, P23, DOI 10.1016/B978-0-444-53821-5.00003-8; Blamart D, 2005, ERLANGEN EARTH C SER, P1005, DOI 10.1007/3-540-27673-4_50; Boggild B., 1930, KONGELIGE DANSKE, V9, P231; Bouzouggar A., 2012, MODERN ORIGINS N AFR, P93; BRADLEY DF, 1961, T NEW YORK ACAD SCI, V24, P64, DOI 10.1111/j.2164-0947.1961.tb00751.x; BRANDES G, 1990, HISTOCHEM J, V22, P106, DOI 10.1007/BF01885789; Campmas E, 2012, THESIS U BORDEAUX 1; Campmas E, 2014, J HUMAN EVO IN PRESS; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; COUTTS PJF, 1970, NATURE, V226, P874, DOI 10.1038/226874a0; Cuenca D, 2013, SERIE TESIS DOCTORAL; Cuif J., 2011, BIOMINERALS FOSSILS; Cuif J, 2003, ETAPES DECOUVERTE RA; Cuif JP, 2005, J STRUCT BIOL, V150, P319, DOI 10.1016/j.jsb.2005.03.004; CUIF JP, 1980, CR ACAD SCI D NAT, V290, P759; Cusack M, 2008, J STRUCT BIOL, V164, P96, DOI 10.1016/j.jsb.2008.06.010; Cutler Alan H., 1995, Senckenbergiana Maritima, V25, P115; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; Dauphin Y, 2008, MINERAL MAG, V72, P243, DOI 10.1180/minmag.2008.072.1.243; Dauphin Y, 2008, MICRON, V39, P891, DOI 10.1016/j.micron.2007.11.007; DEBENATH A, 1992, ANTHROPOLOGIE, V96, P711; Debenath A., 1979, B ARCHEOLOGIE MAROCA, V12, P1; Demarchi B, 2013, QUAT GEOCHRONOL, V16, P158, DOI 10.1016/j.quageo.2012.08.001; Dibble HL, 2013, J HUM EVOL, V64, P194, DOI 10.1016/j.jhevol.2012.10.010; DRISCOLL EG, 1973, PALAEOGEOGR PALAEOCL, V13, P275, DOI 10.1016/0031-0182(73)90029-1; Ehrlich H, 2010, BIOL MAT MARINE ORIG, DOI [10.1007/978/90/481/9130, DOI 10.1007/978/90/481/9130]; El Hajraoui A, 2012, VILLES SITES ARCHEOL, P194; El Hajraoui A, 2012, VILLES SITES ARCHEOL, P234; El Hajraoui M. A., 2012, PREHISTOIRE REGION R, VIII, P91; El Hajraoui M.A., 2012, VILLES SITES ARCHEOL, VIII; El Hajraoui MA, 1994, PREHISTOIRE ANTHR ME, V3, P91; Fa DA, 2002, J MOLLUS STUD, V68, P95, DOI 10.1093/mollus/68.1.95; Fa DA, 2008, QUATERNARY SCI REV, V27, P2194, DOI 10.1016/j.quascirev.2008.07.015; Friedman G, 1959, J SEDIMENT PETROL, V29, P87, DOI DOI 10.1306/74D70894-2B21-11D7-86480001020C1865D; Fuchigami Takeshi, 2005, Paleontological Research, V9, P143, DOI 10.2517/prpsj.9.143; Gautret P, 2000, ACTA PALAEONTOL POL, V45, P107; Gilis M, 2011, J STRUCT BIOL, V176, P315, DOI 10.1016/j.jsb.2011.08.008; Goldberg P, 2000, J HUM EVOL, V38, P43, DOI 10.1006/jhev.1999.0350; Hedegaard C, 2006, J MOLLUS STUD, V72, P157, DOI 10.1093/mollus/eyi062; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Jacobs Z, 2012, J HUM EVOL, V62, P377, DOI 10.1016/j.jhevol.2011.12.001; Janati-Idrissi N., 2012, QUATERNAIRE, V23, P25; Jerardino A, 2010, J HUM EVOL, V59, P412, DOI 10.1016/j.jhevol.2010.07.003; Karampelas S, 2008, THESIS U NANTES; KAUFMAN A, 1971, GEOCHIM COSMOCHIM AC, V35, P1155, DOI 10.1016/0016-7037(71)90031-7; Klein RG, 2004, P NATL ACAD SCI USA, V101, P5708, DOI 10.1073/pnas.0400528101; Kobayashi I, 2006, MAT SCI ENG C-BIO S, V26, P692, DOI 10.1016/j.msec.2005.09.101; KOTLER E, 1992, Palaios, V7, P244, DOI 10.2307/3514972; Lescinsky HL, 2002, PALAIOS, V17, P171, DOI 10.1669/0883-1351(2002)017<0171:MSEABR>2.0.CO;2; Lima FP, 2006, J BIOGEOGR, V33, P812, DOI 10.1111/j.1365-2699.2006.01457.x; Linstadter J, 2012, QUATERN INT, V274, P158, DOI 10.1016/j.quaint.2012.02.017; MacClintock C., 1967, Bulletin of the Peabody Museum of Natural History, V22, P1; Marean CW, 2011, INTERD CONTRIB ARCH, P421, DOI 10.1007/978-1-4419-8219-3_18; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; MARLOWE RL, 1995, INVERTEBR BIOL, V114, P79, DOI 10.2307/3226956; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Meibom A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028657; MERLIN JC, 1985, PURE APPL CHEM, V57, P785, DOI 10.1351/pac198557050785; Michel P, 2010, HIST BIOL, V22, P327, DOI 10.1080/08912960903570500; Mutvei H., 1969, STOCKHOLM CONTR GEOL, V20, P1; Nehrke G, 2011, BIOGEOSCIENCES, V8, P3761, DOI 10.5194/bg-8-3761-2011; Nespoulet R, 2007, ACT 4 RENC QUAT MAR, P15; Nespoulet R, 2008, AFR ARCHAEOL REV, V25, P21, DOI 10.1007/s10437-008-9025-1; Nouet J, 2012, MICRON, V43, P456, DOI 10.1016/j.micron.2011.10.027; Oujaa A, 2012, VILLES SITES ARCHEOL, P136; Oujaa A, 2012, VILLES SITES ARCHEOL, P234; Plaziat J. C., 2008, LECT NOTES EARTH SCI, P359; Pramatarova R, 2003, THESIS U HAMBURG; Ricciardi A, 1999, MAR ECOL PROG SER, V185, P21, DOI 10.3354/meps185021; Roche J, 1976, CR HEBD ACAD SCI, P45; Scerri EML, 2013, QUATERN INT, V300, P111, DOI 10.1016/j.quaint.2012.09.008; Schwenninger J, 2010, S E MEDITERRANEAN PE; Seilacher A., 1973, EVOLVING CONCEPTS SE, V21, P159; Sethmann I, 2006, J INORG BIOCHEM, V100, P88, DOI 10.1016/j.jinorgbio.2005.10.005; Sethmann I, 2005, AM MINERAL, V90, P1213, DOI 10.2138/am.2005.1833; Shopov Y.Y., 2004, INT J SPELEOL, V33, P25, DOI 10.5038/1827-806X.33.1.3; Siani G, 2001, SCIENCE, V294, P1917, DOI 10.1126/science.1063649; Sidike A, 2006, PHYS CHEM MINER, V33, P559, DOI 10.1007/s00269-006-0103-0; Steele T., 2012, PREHISTOIRE REGION R, VIII, P223; Steele TE, 2011, INTERD CONTRIB ARCH, P383, DOI 10.1007/978-1-4419-8219-3_16; Steele Teresa E., 2006, Munibe (Antropologia - Arkeologia), V57, P221; Stemmer K, 2014, J MOLLUS STUD, P1; Stoetzel E, 2012, INT J OSTEOARCHAEOL, V22, P616, DOI 10.1002/oa.1275; Stoetzel E, 2014, QUATERN INT, V320, P143, DOI 10.1016/j.quaint.2013.05.017; Stoetzel E, 2011, J HUM EVOL, V60, P1, DOI 10.1016/j.jhevol.2010.07.016; Surge D, 2008, JOINT M GEOL SOC AM; Suzuki M, 2011, CRYST GROWTH DES, V11, P4850, DOI 10.1021/cg2010997; Suzuki M, 2010, J STRUCT BIOL, V171, P223, DOI 10.1016/j.jsb.2010.04.008; TAYLOR JD, 1969, B BRIT MUSEUM NATU S, V3, P1; Uozumi S, 1971, CONTRIB DEP GEOL MIN, V1236, P447; WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G; Weiner S., 2010, MICROARCHAEOLOGY VIS; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001; WOLF MK, 1961, J HISTOCHEM CYTOCHEM, V9, P22, DOI 10.1177/9.1.22; YESNER DR, 1980, CURR ANTHROPOL, V21, P727, DOI 10.1086/202568; Zuschin M, 2003, EARTH-SCI REV, V63, P33, DOI 10.1016/S0012-8252(03)00014-X	104	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137162	10.1371/journal.pone.0137162	http://dx.doi.org/10.1371/journal.pone.0137162			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376294	Green Submitted, Green Published, gold			2022-12-26	WOS:000361610200031
J	Wang, JJ; Liu, YL; Sun, YC; Ge, W; Wang, YY; Dyce, PW; Hou, R; Shen, W				Wang, Jun-Jie; Liu, Yu-Liang; Sun, Yuan-Chao; Ge, Wei; Wang, Yong-Yong; Dyce, Paul W.; Hou, Rong; Shen, Wei			Basic Fibroblast Growth Factor Stimulates the Proliferation of Bone Marrow Mesenchymal Stem Cells in Giant Panda (Ailuropoda melanoleuca)	PLOS ONE			English	Article							GERM-CELLS; IN-VITRO; CHONDROGENIC DIFFERENTIATION; CULTURE; REGENERATION; PROGENITORS; POTENTIALS; PHENOTYPE; CHICKEN; TISSUE	It has been widely known that the giant panda (Ailuropoda melanoleuca) is one of the most endangered species in the world. An optimized platform for maintaining the proliferation of giant panda mesenchymal stemcells (MSCs) is very necessary for current giant panda protection strategies. Basic fibroblast growth factor (bFGF), a member of the FGF family, is widely considered as a growth factor and differentiation inducer within the stemcell research field. However, the role of bFGF on promoting the proliferation ofMSCs derived from giant panda bone marrow (BM) has not been reported. In this study, we aimed to investigate the role of bFGF on the proliferation of BM-MSCs derived from giant panda. MSCs were cultured for cell proliferation analysis at 24, 48 and 72 hrs following the addition of bFGF. With increasing concentrations of bFGF, cell numbers gradually increased. This was further demonstrated by performing 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) cell proliferation assay, 5-Bromo-2-deoxyUridine (BrdU) labeling and cell cycle testing. Furthermore, the percentage ofMSCs that were OCT4 positive increased slightly following treatment with 5 ng/ml bFGF. Moreover, we demonstrated that the extracellular signal-regulated kinase (ERK) signaling pathway may play an important role in the proliferation of panda MSCs stimulated by bFGF. In conclusion, this study suggests that giant panda BM-MSCs have a high proliferative capacity with the addition of 5 ng/ml bFGF in vitro.	[Wang, Jun-Jie; Sun, Yuan-Chao; Ge, Wei; Wang, Yong-Yong; Shen, Wei] Qingdao Agr Univ, Inst Reprod Sci, Qingdao 266109, Shandong, Peoples R China; [Wang, Jun-Jie; Sun, Yuan-Chao; Ge, Wei; Shen, Wei] Qingdao Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao 266109, Shandong, Peoples R China; [Liu, Yu-Liang; Hou, Rong] Chengdu Res Base Giant Panda Breeding, Chengdu 610081, Sichuan, Peoples R China; [Wang, Yong-Yong] Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Shandong, Peoples R China; [Dyce, Paul W.] Auburn Univ, Dept Anim Sci, Auburn, AL 36849 USA	Qingdao Agricultural University; Qingdao Agricultural University; Qingdao Agricultural University; Auburn University System; Auburn University	Hou, R (corresponding author), Chengdu Res Base Giant Panda Breeding, Chengdu 610081, Sichuan, Peoples R China.	hourong2000@panda.org.cn; wshen@qau.edu.cn		Ge, Wei/0000-0002-4610-7933; Dyce, Paul/0000-0002-4574-3321; Wang, Jun-Jie/0000-0002-7145-5702	Program for New Century Excellent Talents in University [NCET-12-1026]; Taishan Scholar Construction Foundation of Shandong Province; program of the Chengdu Science and Technology Bureau [12GGYB810SW-002]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Taishan Scholar Construction Foundation of Shandong Province; program of the Chengdu Science and Technology Bureau	This work was supported by Program for New Century Excellent Talents in University (NCET-12-1026) and the Taishan Scholar Construction Foundation of Shandong Province to W. Shen, and the program of the Chengdu Science and Technology Bureau (12GGYB810SW-002) to Y.L. Liu.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649; Becker AD, 2015, STEM CELLS DEV, V49, P1547; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Chen H, 2015, MOL MED REP, V12, P819, DOI 10.3892/mmr.2015.3528; Chiou M, 2006, BIOCHEM BIOPH RES CO, V343, P644, DOI 10.1016/j.bbrc.2006.02.171; Colenci R, 2014, ARCH ORAL BIOL, V59, P268, DOI 10.1016/j.archoralbio.2013.11.017; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Ito T, 2008, CYTOTECHNOLOGY, V56, P1, DOI 10.1007/s10616-007-9092-1; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Kim JH, 2011, TISSUE ENG PT A, V17, P991, DOI [10.1089/ten.tea.2010.0277, 10.1089/ten.TEA.2010.0277]; Kotobuki N, 2004, ARTIF ORGANS, V28, P33, DOI 10.1111/j.1525-1594.2004.07320.x; Lee TH, 2015, BIOCH CELL BIOL, V26, P1; Liu YL, 2013, STEM CELLS DEV, V22, P2394, DOI 10.1089/scd.2013.0102; Park HJ, 2006, MOL REPROD DEV, V73, P452, DOI 10.1002/mrd.20441; Park TS, 2000, MOL REPROD DEV, V56, P475, DOI 10.1002/1098-2795(200008)56:4&lt;475::AID-MRD5&gt;3.0.CO;2-M; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reifers F, 1998, DEVELOPMENT, V125, P2381; Shimabukuro Y, 2009, J ENDODONT, V35, P1529, DOI 10.1016/j.joen.2009.08.010; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI [10.1089/ten.tea.2009.0100, 10.1089/ten.TEA.2009.0100]; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Umezaki Y, 2015, INT J MOL SCI, V16, P13633, DOI 10.3390/ijms160613633; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; van den Bos C, 1997, Hum Cell, V10, P45; Wang L, 2010, ANN BIOMED ENG, V38, P77, DOI 10.1007/s10439-009-9841-8; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Wu JY, 2012, J ENDODONT, V38, P614, DOI 10.1016/j.joen.2012.01.014; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Xie LC, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-014-0080-6; Xin HQ, 2006, J NEUROSCI RES, V83, P1485, DOI 10.1002/jnr.20834; Yuan SH, 2013, INDIAN J MED RES, V138, P103; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	38	10	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137712	10.1371/journal.pone.0137712	http://dx.doi.org/10.1371/journal.pone.0137712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375397	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200049
J	Noubiap, JJN; Aka, PV; Nanfack, AJ; Agyingi, LA; Ngai, JN; Nyambi, PN				Noubiap, Jean Jacques N.; Aka, Peter V.; Nanfack, Aubin J.; Agyingi, Lucy A.; Ngai, Johnson N.; Nyambi, Phillipe N.			Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EQUATORIAL RAIN-FORESTS; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; RURAL VILLAGES; BLOOD-DONORS; RISK-FACTORS; INFECTION; PREVALENCE; ASSOCIATION	As people infected with the human immunodeficiency virus (HIV) in Sub-Saharan Africa live longer due to availability of antiretroviral treatment (ART), so is the rise of associated infections with their burdens on patients. But reliable data on the prevalence of co-infection with hepatitis B (HBV) or C (HCV) still remains sparse and many individuals with HIV do not know their co-infection status. This study attempted to estimate the seroprevalence and identify risk factors associated with hepatitis B and/or C co-infections in HIV-infected individuals from five Regions of Cameroon by screening 531 HIV infected subjects for the presence of HBV surface antigen (HBsAg) and antibodies to HCV (HCV-Ab). A Screening and a confirmatory Enzyme linked immunosorbent assay were used to detect presence of markers of infection. CD4 count levels were also examined. The results indicate that of the 531 participants, 68% were females and 32% males. Mean CD4 count was similar to 400 cells/mu l. Seroprevalence rates for HBsAg and HCV-Ab were 23.7%, and 7.2%, respectively. Associations assessed using logistic regression revealed that HBsAg but not HCV-Ab positivity was linked to age, lower CD4 count and residing in an urban rather than in a rural setting. This high prevalence of co-infection with HBV raises the urgent need to systematically screen all newly diagnosed HIV cases for co-infection in Cameroon and other regions of sub-Saharan Africa where HIV accounts for the majority of the global infection, so as to improve management strategies for HBV infection and ART implementation.	[Noubiap, Jean Jacques N.; Agyingi, Lucy A.; Ngai, Johnson N.] Med Diagnost Ctr, Serol Unit, Yaounde, Cameroon; [Aka, Peter V.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Nanfack, Aubin J.; Nyambi, Phillipe N.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Nanfack, Aubin J.] Univ Roma Tor Vergata, Dept Immunol & Appl Biotechnol, Fac Med & Surg, Rome, Italy; [Agyingi, Lucy A.] Univ Dschang, Fac Sci, Dschang, Cameroon; [Nyambi, Phillipe N.] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University; University of Rome Tor Vergata	Nyambi, PN (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	phillipe.nyambi@nyumc.org		Noubiap, Jean Jacques/0000-0002-7722-9757	National Institutes of Health from the National Cancer Institute [CA153726]; National Institute of Allergy and Infectious Diseases [AI083142]; FOGARTY INTERNATIONAL CENTER [D43TW009604] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [D43CA153726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083142, R01AI083142] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health grant CA153726 from the National Cancer Institute (http://www.cancer.gov/) and grant AI083142 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/) (PNN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyingi L, 2014, J MED VIROL, V86, P385, DOI 10.1002/jmv.23846; Allison RD, 2009, J INFECT DIS, V200, P619, DOI 10.1086/600107; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; Daghestani L, 1999, AM J MED, V106, P347, DOI 10.1016/S0002-9343(99)00014-5; ESKILD A, 1992, AIDS, V6, P571, DOI 10.1097/00002030-199206000-00008; Gillis J, 2014, ANTIVIR THER, V19, P309, DOI 10.3851/IMP2724; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P793, DOI 10.1046/j.1365-3156.2002.00943.x; Jauncey M, 2004, J INFECT DIS, V190, P1270, DOI 10.1086/423943; Kapembwa KC, 2011, J GLOB INFECT DIS, V3, P269, DOI 10.4103/0974-777X.83534; Kim AY, 2005, BLOOD, V105, P1170, DOI 10.1182/blood-2004-06-2336; Konings FAJ, 2004, AIDS RES HUM RETROV, V20, P105, DOI 10.1089/088922204322749558; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Laurent C, 2010, HIV MED, V11, P85, DOI 10.1111/j.1468-1293.2009.00742.x; Matthews PC, 2014, J CLIN VIROL, V61, P20, DOI 10.1016/j.jcv.2014.05.018; Measure D, 2012, HIV PREVALENCE CAMER; Muriuki Beatrice Mukami, 2013, BMC Res Notes, V6, P363, DOI 10.1186/1756-0500-6-363; Neaigus A, 2014, SEX TRANSM DIS, V41, P433, DOI 10.1097/OLQ.0000000000000144; Noubiap JJN, 2013, INT J INFECT DIS, V17, pE832, DOI 10.1016/j.ijid.2012.12.007; Nyambi P, 2002, JAIDS-J ACQ IMM DEF, V31, P506, DOI 10.1097/00126334-200212150-00008; Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004; Pattanapanyasat K, 2007, CYTOM PART B-CLIN CY, V72B, P387, DOI 10.1002/cyto.b.20167; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Reilly KH, 2014, AIDS EDUC PREV, V26, P134, DOI 10.1521/aeap.2014.26.2.134; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063303; Shirin T, 2000, J HEALTH POPUL NUTR, V18, P145; Soriano V, 2011, ENFERM INFEC MICR CL, V29, P691, DOI 10.1016/j.eimc.2011.07.003; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thio CL, 2013, AIDS, V27, P191, DOI 10.1097/QAD.0b013e32835a9984; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tremeau-Bravard A, 2012, AFR HEALTH SCI, V12, P312, DOI 10.4314/ahs.v12i3.10; Tsui JI, 2007, ARCH INTERN MED, V167, P1271, DOI 10.1001/archinte.167.12.1271; Verucchi G, 2004, INFECTION, V32, P33, DOI 10.1007/s15010-004-3063-7; Yami A, 2011, ETHIOP J HEALTH SCI, V21, P67; Zhong P, 2003, AIDS RES HUM RETROV, V19, P1167, DOI 10.1089/088922203771881284; Zhong P, 2002, JAIDS-J ACQ IMM DEF, V31, P495, DOI 10.1097/00126334-200212150-00007	41	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137375	10.1371/journal.pone.0137375	http://dx.doi.org/10.1371/journal.pone.0137375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371878	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400017
J	Jenison, RL; Reale, RA; Armstrong, AL; Oya, H; Kawasaki, H; Howard, MA				Jenison, Rick L.; Reale, Richard A.; Armstrong, Amanda L.; Oya, Hiroyuki; Kawasaki, Hiroto; Howard, Matthew A., III			Sparse Spectro-Temporal Receptive Fields Based on Multi-Unit and High-Gamma Responses in Human Auditory Cortex	PLOS ONE			English	Article							SINGLE NEURONS; REGRESSION SHRINKAGE; REVERSE-CORRELATION; GROUP-LASSO; FIRING RATE; POTENTIALS; SELECTION; REPRESENTATION; ORGANIZATION; LOCALIZATION	Spectro-Temporal Receptive Fields (STRFs) were estimated from both multi-unit sorted clusters and high-gamma power responses in human auditory cortex. Intracranial electrophysiological recordings were used to measure responses to a random chord sequence of Gammatone stimuli. Traditional methods for estimating STRFs from single-unit recordings, such as spike-triggered-averages, tend to be noisy and are less robust to other response signals such as local field potentials. We present an extension to recently advanced methods for estimating STRFs from generalized linear models (GLM). A new variant of regression using regularization that penalizes non-zero coefficients is described, which results in a sparse solution. The frequency-time structure of the STRF tends toward grouping in different areas of frequency-time and we demonstrate that group sparsity-inducing penalties applied to GLM estimates of STRFs reduces the background noise while preserving the complex internal structure. The contribution of local spiking activity to the high-gamma power signal was factored out of the STRF using the GLM method, and this contribution was significant in 85 percent of the cases. Although the GLM methods have been used to estimate STRFs in animals, this study examines the detailed structure directly from auditory cortex in the awake human brain. We used this approach to identify an abrupt change in the best frequency of estimated STRFs along posteromedial-to-anterolateral recording locations along the long axis of Heschl's gyrus. This change correlates well with a proposed transition from core to non-core auditory fields previously identified using the temporal response properties of Heschl's gyrus recordings elicited by click-train stimuli.	[Jenison, Rick L.; Reale, Richard A.; Armstrong, Amanda L.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Reale, Richard A.; Oya, Hiroyuki; Kawasaki, Hiroto; Howard, Matthew A., III] Univ Iowa, Dept Neurosurg, Iowa City, IA USA	University of Wisconsin System; University of Wisconsin Madison; University of Iowa	Jenison, RL (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	rjenison@wisc.edu	Oya, Hiroyuki/Q-2989-2018	Oya, Hiroyuki/0000-0002-1733-5478; Kawasaki, Hiroto/0000-0002-7688-9171; Howard, Matthew/0000-0003-3935-8889; Jenison, Rick/0000-0002-3712-300X	National Institutes of Health (General Clinical Research Centers Program) [R01DC04290, M01RR59]; Hoover Fund; Carver Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004290] Funding Source: NIH RePORTER	National Institutes of Health (General Clinical Research Centers Program); Hoover Fund; Carver Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the National Institutes of Health grants R01DC04290, M01RR59 General Clinical Research Centers Program), the Hoover Fund, and the Carver Trust.	Abraham G, 2013, GENET EPIDEMIOL, V37, P184, DOI 10.1002/gepi.21698; AERTSEN AMHJ, 1980, BIOL CYBERN, V38, P223, DOI 10.1007/BF00337015; Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Bach F, 2012, OPTIMIZATION SPARSIT; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; BINGHAM C, 1967, IEEE T ACOUST SPEECH, VAU15, P56, DOI 10.1109/TAU.1967.1161895; Bitterman Y, 2008, NATURE, V451, P197, DOI 10.1038/nature06476; Brugge JF, 2008, HEARING RES, V238, P12, DOI 10.1016/j.heares.2007.11.012; Brugge JF, 2009, J NEUROPHYSIOL, V102, P2358, DOI 10.1152/jn.91346.2008; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; Clarke S, 2012, SPRINGER HANDB AUDIT, V43, P11, DOI 10.1007/978-1-4614-2314-0_2; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; de Boer E., 1973, T ASME             G, V95, P265; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Domany E, 1999, PHYSICA A, V263, P158, DOI 10.1016/S0378-4371(98)00494-4; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; Eggermont JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020046; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Ergun A, 2007, IEEE T BIO-MED ENG, V54, P419, DOI 10.1109/TBME.2006.888821; Escabi MA, 2003, BIOL CYBERN, V89, P350, DOI 10.1007/S00422-003-0440-8; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gaucher Q, 2012, J PHYSIOL-PARIS, V106, P93, DOI 10.1016/j.jphysparis.2011.09.006; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Hackett Troy A, 2015, Handb Clin Neurol, V129, P27, DOI 10.1016/B978-0-444-62630-1.00002-0; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Howard MA, 1997, STEREOT FUNCT NEUROS, V68, P236, DOI 10.1159/000099931; Howard MA, 1996, J NEUROSURG, V84, P129, DOI 10.3171/jns.1996.84.1.0129; Howard MA, 1996, BRAIN RES, V724, P260, DOI 10.1016/0006-8993(96)00315-0; Howard MA, 2012, SPRINGER HANDB AUDIT, V43, P39, DOI 10.1007/978-1-4614-2314-0_3; Jenison RL, 2011, J NEUROSCI, V31, P331, DOI 10.1523/JNEUROSCI.4461-10.2011; Jenison RL, 2001, J NEUROSCI, V21, P4408, DOI 10.1523/JNEUROSCI.21-12-04408.2001; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; KRAUSZ HI, 1975, BIOL CYBERN, V19, P217, DOI 10.1007/BF02281972; Kubanek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053398; LIEGEOISCHAUVEL C, 1991, BRAIN, V114, P139; Linden JF, 2003, EVIDENCE OPTIMIZATIO; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Mairal J., 2014, SPAMS SPARSE MODELIN, P1; Mairal J, 2012, FOUND TRENDS COMPUT, V8, DOI 10.1561/0600000058; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Mizrahi A, 2014, CURR OPIN NEUROBIOL, V24, P103, DOI 10.1016/j.conb.2013.09.007; Moerel M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00225; Mukamel R, 2011, HUM BRAIN MAPP, V32, P1181, DOI 10.1002/hbm.21100; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Nourski KV, 2014, NEUROIMAGE, V101, P598, DOI 10.1016/j.neuroimage.2014.07.004; Nourski KV, 2014, CEREB CORTEX, V24, P340, DOI 10.1093/cercor/bhs314; Nourski KV, 2011, REV NEUROSCIENCE, V22, P187, DOI 10.1515/RNS.2011.016; Nourski KV, 2009, J NEUROSCI, V29, P15564, DOI 10.1523/JNEUROSCI.3065-09.2009; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Park M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002219; Pei XM, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046028; Pei XM, 2011, NEUROIMAGE, V54, P2960, DOI 10.1016/j.neuroimage.2010.10.029; Prerau MJ, 2011, NEURAL COMPUT, V23, P2537, DOI 10.1162/NECO_a_00185; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rasch MJ, 2008, J NEUROPHYSIOL, V99, P1461, DOI 10.1152/jn.00919.2007; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Ray S, 2008, J NEUROSCI, V28, P7334, DOI 10.1523/JNEUROSCI.1588-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Reddy CG, 2010, J NEUROSURG, V112, P1301, DOI 10.3171/2009.7.JNS09404; Robinson K, 1992, AUDITORY PHYSL PERCE, P429, DOI DOI 10.1016/B978-0-08-041847-6.50054-X; Sabourin J, 2015, GENET EPIDEMIOL, V39, P77, DOI 10.1002/gepi.21869; Schonwiesner M, 2015, CEREB CORTEX, V25, P3278, DOI 10.1093/cercor/bhu124; Slaney M, 1993, EFFICIENT IMPLEMENTA; Srinivasan R, 2006, ELECT FIELDS BRAIN N, pxvi; Steinschneider M, 2008, CEREB CORTEX, V18, P610, DOI 10.1093/cercor/bhm094; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tibshirani RJ, 2011, ANN STAT, V39, P1335, DOI 10.1214/11-AOS878; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Valdar W, 2012, GENET EPIDEMIOL, V36, P451, DOI 10.1002/gepi.21639; Winer J. A., 2011, THE AUDITORY CORTEX; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x	81	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137915	10.1371/journal.pone.0137915	http://dx.doi.org/10.1371/journal.pone.0137915			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367010	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100177
J	Pielecka-Fortuna, J; Kalogeraki, E; Greifzu, F; Lowel, S				Pielecka-Fortuna, Justyna; Kalogeraki, Evgenia; Greifzu, Franziska; Loewel, Siegrid			A Small Motor Cortex Lesion Abolished Ocular Dominance Plasticity in the Adult Mouse Primary Visual Cortex and Impaired Experience-Dependent Visual Improvements	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL TRANSCORTICAL DIASCHISIS; CEREBRAL-ARTERY OCCLUSION; MONOCULAR DEPRIVATION; INTRINSIC SIGNAL; CORTICAL STROKE; CRITICAL-PERIOD; MICE; BRAIN; VISION; EXCITABILITY	It was previously shown that a small lesion in the primary somatosensory cortex (S1) prevented both cortical plasticity and sensory learning in the adult mouse visual system: While 3-month-old control mice continued to show ocular dominance (OD) plasticity in their primary visual cortex (V1) after monocular deprivation (MD), age-matched mice with a small photothrombotically induced (PT) stroke lesion in S1, positioned at least 1 mm anterior to the anterior border of V1, no longer expressed OD-plasticity. In addition, in the S1-lesioned mice, neither the experience-dependent increase of the spatial frequency threshold ("visual acuity") nor of the contrast threshold ("contrast sensitivity") of the optomotor reflex through the open eye was present. To assess whether these plasticity impairments can also occur if a lesion is placed more distant from V1, we tested the effect of a PT-lesion in the secondary motor cortex (M2). We observed that mice with a small M2-lesion restricted to the superficial cortical layers no longer expressed an OD-shift towards the open eye after 7 days of MD in V1 of the lesioned hemisphere. Consistent with previous findings about the consequences of an S1-lesion, OD-plasticity in V1 of the nonlesioned hemisphere of the M2-lesioned mice was still present. In addition, the experience-dependent improvements of both visual acuity and contrast sensitivity of the open eye were severely reduced. In contrast, sham-lesioned mice displayed both an OD-shift and improvements of visual capabilities of their open eye. To summarize, our data indicate that even a very small lesion restricted to the superficial cortical layers and more than 3mm anterior to the anterior border of V1 compromised V1-plasticity and impaired learning-induced visual improvements in adult mice. Thus both plasticity phenomena cannot only depend on modality-specific and local nerve cell networks but are clearly influenced by long-range interactions even from distant brain regions.	[Pielecka-Fortuna, Justyna] Univ Gottingen, Dept Syst Neurosci, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; Univ Gottingen, Bernstein Fokus Neurotechnol, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Pielecka-Fortuna, J (corresponding author), Univ Gottingen, Dept Syst Neurosci, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	jpielec@gwdg.de			Federal Ministry of Education and Research, Germany [01GQ0921, 01GQ0810]; Alexander von Humboldt Research Fellowship; Open Access Publication Funds of the Gottingen University	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Alexander von Humboldt Research Fellowship(Alexander von Humboldt Foundation); Open Access Publication Funds of the Gottingen University	This work was supported by the Federal Ministry of Education and Research, Germany, grant numbers 01GQ0921 (F.G., E.K., J.P.-F) and 01GQ0810 (S.L.) and an Alexander von Humboldt Research Fellowship for Postdoctoral Researchers (J.P.-F.). We acknowledge support by the Open Access Publication Funds of the Gottingen University.	ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; BuchkremerRatzmann I, 1996, STROKE, V27, P1105, DOI 10.1161/01.STR.27.6.1105; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; Charbonneau V, 2012, EUR J NEUROSCI, V36, P2949, DOI 10.1111/j.1460-9568.2012.08215.x; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; Di Garbo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025285; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Fu Y, 2015, ELIFE, V4, DOI 10.7554/eLife.05558; GARCIA JH, 1975, HUM PATHOL, V6, P583, DOI 10.1016/S0046-8177(75)80043-8; Gordon JA, 1996, J NEUROSCI, V16, P3274; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Greifzu F, 2014, P NATL ACAD SCI USA, V111, P1150, DOI 10.1073/pnas.1313385111; Greifzu F, 2011, P NATL ACAD SCI USA, V108, P15450, DOI 10.1073/pnas.1016458108; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; Imbrosci B, 2015, BRAIN STRUCT FUNCT, V220, P1649, DOI 10.1007/s00429-014-0750-8; Jablonka J, 2006, ACTA NEUROBIOL EXP, V66, P261; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; Lim DH, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00011; LIU T, 1993, STROKE, V24, P1746, DOI 10.1161/01.STR.24.11.1746; Neumann-Haefelin T, 2000, J CEREBR BLOOD F MET, V20, P45, DOI 10.1097/00004647-200001000-00008; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Reinecke S, 1999, NEUROSCI LETT, V261, P85, DOI 10.1016/S0304-3940(99)00014-2; Ruscher K, 2009, J CEREBR BLOOD F MET, V29, P1796, DOI 10.1038/jcbfm.2009.96; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Silasi G, 2014, NEURON, V83, P1354, DOI 10.1016/j.neuron.2014.08.052; Stehberg J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00093; Stodieck SK, 2014, EXP GERONTOL, V60, P1, DOI 10.1016/j.exger.2014.09.007; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Vinters HV, 2000, J NEUROPATH EXP NEUR, V59, P931, DOI 10.1093/jnen/59.11.931; von Monakow C, 1914, J AM MED ASS, VLXIII, P797; WANG XK, 1994, MOL BRAIN RES, V26, P61, DOI 10.1016/0169-328X(94)90074-4; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	44	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137961	10.1371/journal.pone.0137961	http://dx.doi.org/10.1371/journal.pone.0137961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368569	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100185
J	Spadoni, JL; Rucart, P; Le Clerc, S; van Manen, D; Coulonges, C; Ulveling, D; Laville, V; Labib, T; Taing, L; Delaneau, O; Montes, M; Schuitemaker, H; Noirel, J; Zagury, JF				Spadoni, Jean-Louis; Rucart, Pierre; Le Clerc, Sigrid; van Manen, Danielle; Coulonges, Cedric; Ulveling, Damien; Laville, Vincent; Labib, Taoufik; Taing, Lieng; Delaneau, Olivier; Montes, Matthieu; Schuitemaker, Hanneke; Noirel, Josselin; Zagury, Jean-Francois			Identification of Genes Whose Expression Profile Is Associated with Non-Progression towards AIDS Using eQTLs	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HIV-1 INFECTION; MISSING HERITABILITY; BIOLOGICAL PATHWAYS; HLA GENES; T-CELLS; REVEALS; DISEASE; MHC; NONPROGRESSION	Background Many genome-wide association studies have been performed on progression towards the acquired immune deficiency syndrome (AIDS) and they mainly identified associations within the HLA loci. In this study, we demonstrate that the integration of biological information, namely gene expression data, can enhance the sensitivity of genetic studies to unravel new genetic associations relevant to AIDS. Methods We collated the biological information compiled from three databases of expression quantitative trait loci (eQTLs) involved in cells of the immune system. We derived a list of single nucleotide polymorphisms (SNPs) that are functional in that they correlate with differential expression of genes in at least two of the databases. We tested the association of those SNPs with AIDS progression in two cohorts, GRIV and ACS. Tests on permuted phenotypes of the GRIV and ACS cohorts or on randomised sets of equivalent SNPs allowed us to assess the statistical robustness of this method and to estimate the true positive rate. Results Eight genes were identified with high confidence (p = 0.001, rate of true positives 75%). Some of those genes had previously been linked with HIV infection. Notably, ENTPD4 belongs to the same family as CD39, whose expression has already been associated with AIDS progression; while DNAJB12 is part of the HSP90 pathway, which is involved in mitochondrial ribosomal proteins and a zinc finger protein, ZFP57, which could be central to the effectiveness of HIV infection. Interestingly, for six out of those eight genes, down-regulation is associated with non-progression, which makes them appealing targets to develop drugs against HIV.	[Spadoni, Jean-Louis; Rucart, Pierre; Le Clerc, Sigrid; Coulonges, Cedric; Ulveling, Damien; Laville, Vincent; Labib, Taoufik; Taing, Lieng; Montes, Matthieu; Noirel, Josselin; Zagury, Jean-Francois] Conservatoire Natl Arts & Metiers, Chaire Bioinformat, Lab Genom Bioinformat & Applicat EA 4627, Paris, France; [Schuitemaker, Hanneke] Sanquin Res, Landsteiner Lab, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Ctr Infect Dis & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Schuitemaker, Hanneke] Crucell Holland BV, NL-2333 CN Leiden, Netherlands; [Delaneau, Olivier] Univ Geneva, Fac Med, Dept Genet & Dev, CH-1211 Geneva 4, Switzerland	heSam Universite; Conservatoire National Arts & Metiers (CNAM); University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Johnson & Johnson; University of Geneva	Zagury, JF (corresponding author), Conservatoire Natl Arts & Metiers, Chaire Bioinformat, Lab Genom Bioinformat & Applicat EA 4627, Paris, France.	zagury@cnam.fr	/AAR-2792-2021; Montes, Matthieu/AAO-3578-2020	Montes, Matthieu/0000-0001-5921-460X; Delaneau, Olivier/0000-0002-3906-8446; Laville, Vincent/0000-0003-4946-698X	Agence Nationale de Recherche sur le SIDA et les Hepatites; Peptinov; Fondation pour la Recherche Medicale [ING20140129444]; Crucell Holland BV	Agence Nationale de Recherche sur le SIDA et les Hepatites; Peptinov; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Crucell Holland BV	The project was funded by Agence Nationale de Recherche sur le SIDA et les Hepatites (fellowship to PR) by Peptinov and by the Fondation pour la Recherche Medicale (to JN, grant number ING20140129444). The funder Crucell Holland BV provided support in the form of salaries for authors HS and DvM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ako-Adjei D, 2015, NUCLEIC ACIDS RES, V43, pD566, DOI 10.1093/nar/gku1126; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111; Banerjee S, 2012, EXP NEUROL, V236, P298, DOI 10.1016/j.expneurol.2012.04.013; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fellay J, 2009, ANTIVIR THER, V14, P731, DOI 10.3851/IMP1253; Flores-Villanueva PO, 2003, J IMMUNOL, V170, P1925, DOI 10.4049/jimmunol.170.4.1925; Guzman-Fulgencio M, 2013, JAIDS-J ACQ IMM DEF, V63, P178, DOI 10.1097/QAI.0b013e3182893f74; Hendel H, 1999, J IMMUNOL, V162, P6942; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Kang MG, 2015, BIOINFORMATICS, V31, P656, DOI 10.1093/bioinformatics/btu727; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Le Clerc S, 2011, JAIDS-J ACQ IMM DEF, V56, P279, DOI 10.1097/QAI.0b013e318204982b; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Limou S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00118; Limou S, 2012, J INFECT DIS, V205, P1155, DOI 10.1093/infdis/jis028; Limou S, 2010, J INFECT DIS, V202, P908, DOI 10.1086/655782; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Low JS, 2014, PARASITOLOGY, V141, P1192, DOI 10.1017/S0031182014000298; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; Morou AK, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-160; Nguyen DG, 2007, VIROLOGY, V362, P16, DOI 10.1016/j.virol.2006.11.036; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Plant K, 2014, EUR J HUM GENET, V22, P568, DOI 10.1038/ejhg.2013.244; Rappaport J, 1997, LANCET, V349, P922, DOI 10.1016/S0140-6736(05)62697-9; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Urano E, 2013, JAIDS-J ACQ IMM DEF, V64, P154, DOI 10.1097/QAI.0b013e31829a2ef8; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; van Manen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022208; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Winkler CA, 2004, JAIDS-J ACQ IMM DEF, V37, P1534, DOI 10.1097/01.qai.0000127353.01578.63; Wu JQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-18; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	54	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136989	10.1371/journal.pone.0136989	http://dx.doi.org/10.1371/journal.pone.0136989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367535	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100041
J	White, MA; Bell, PR; Cook, AG; Barnes, DG; Tischler, TR; Bassam, BJ; Elliott, DA				White, Matt A.; Bell, Phil R.; Cook, Alex G.; Barnes, David G.; Tischler, Travis R.; Bassam, Brant J.; Elliott, David A.			Forearm Range of Motion in Australovenator wintonensis (Theropoda, Megaraptoridae)	PLOS ONE			English	Article							ORNITHOLESTES-HERMANNI; FORELIMB FUNCTION; DINOSAURS; EVOLUTION; JOINT	The hypertrophied manual claws and modified manus of megaraptoran theropods represent an unusual morphological adaptation among carnivorous dinosaurs. The skeleton of Australovenator wintonensis from the Cenomanian of Australia is among the most complete of any megaraptorid. It presents the opportunity to examine the range of motion of its forearm and the function of its highly modified manus. This provides the basis for behavioural inferences, and comparison with other Gondwanan theropod groups. Digital models created from computed tomography scans of the holotype reveal a humerus range of motion that is much greater than Allosaurus, Acrocanthosaurus, Tyrannosaurus but similar to that of the dromaeosaurid Bambiraptor. During flexion, the radius was forced distally by the radial condyle of the humerus. This movement is here suggested as a mechanism that forced a medial movement of the wrist. The antebrachium possessed a range of motion that was close to dromaeosaurids; however, the unguals were capable of hyper-extension, in particular manual phalanx I-2, which is a primitive range of motion characteristic seen in allosaurids and Dilophosaurus. During flexion, digits I and II slightly converge and diverge when extended which is accentuated by hyperextension of the digits in particular the unguals. We envision that prey was dispatched by its hands and feet with manual phalanx I2 playing a dominant role. The range of motion analysis neither confirms nor refutes current phylogenetic hypotheses with regards to the placement of Megaraptoridae; however, we note Australovenator possessed, not only a similar forearm range of motion to some maniraptorans and basal coelurosaurs, but also similarities with Tetanurans (Allosauroids and Dilophosaurus).	[White, Matt A.] Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia; [White, Matt A.; Tischler, Travis R.; Bassam, Brant J.; Elliott, David A.] Australian Age Dinosaurs Museum Nat Hist, Winton, Qld 4735, Australia; [Bell, Phil R.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW 2351, Australia; [Cook, Alex G.] Univ Queensland, Sch Earth Sci, St Lucia, Qld 4072, Australia; [Barnes, David G.] Monash Univ, Monash Biomed Imaging, Clayton, Vic 3168, Australia; [Barnes, David G.] Monash Univ, Monash E Res Ctr, Clayton, Vic 3168, Australia; [Barnes, David G.] Life Sci Computat Ctr, Parkville, Vic 3052, Australia	University of Newcastle; University of New England; University of Queensland; Monash University; Monash University	White, MA (corresponding author), Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia.	fossilised@hotmail.com		White, Matt/0000-0002-4765-0356; Barnes, David/0000-0002-4594-3438				Agnolin FL, 2010, J SYST PALAEONTOL, V8, P257, DOI 10.1080/14772011003594870; ALTANGEREL P, 1993, NATURE, V362, P623, DOI 10.1038/362623a0; Barnes DG, 2008, NEW ASTRON, V13, P599, DOI 10.1016/j.newast.2008.03.008; Barnes DG, 2006, PUBL ASTRON SOC AUST, V23, P82, DOI 10.1071/AS06009; Barnes DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069446; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; BONAPARTE JF, 1985, NATL GEOGR RES, V1, P149; Bonnan MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075216; Bonnan MF, 2010, ANAT REC, V293, P2044, DOI 10.1002/ar.21266; Bryan SE, 2012, EPISODES, V35, P142, DOI 10.18814/epiiugs/2012/v35i1/013; Burnham D. A., 2000, PALEONTOLOGICAL CONT, V13, P1, DOI DOI 10.17161/PCNS.1808.3761; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Carpenter Kenneth, 2001, P90; Carrano MT, 2010, J SYSTEMATIC PALAEON, V10, P211; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; COPE ED, 1889, AM NAT, V23, P626; Currie Philip J., 2000, Geodiversitas, V22, P207; GALTON P M, 1971, Arnoldia (Rhodesia), V5, P1; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutson JD, 2013, J EXP BIOL, V216, P275, DOI 10.1242/jeb.074229; Hutson JD, 2014, ANAT REC, V297, P1228, DOI 10.1002/ar.22903; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; Kobayashi Y, 2005, LIFE O PAST, P97; Lambe LM., 1902, CONTRIBUTIONS CANADI, V2, P25; Lipkin C., 2008, TYRANNOSAURUS REX TY, P166; Manning PL, 2009, ANAT REC, V292, P1397, DOI 10.1002/ar.20986; NICHOLLS EL, 1985, PALAEONTOLOGY, V28, P643; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; Osborn HF, 1903, B AM MUS NAT HIST, V19, P459; Osborn HF, 1905, B AM MUS NAT HIST, V21, P259; Ostrom J. H., 1969, Postilla, V128, P1; Poore SO, 1997, NATURE, V387, P799, DOI 10.1038/42930; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; Senter P, 2005, PALEOBIOLOGY, V31, P373, DOI 10.1666/0094-8373(2005)031[0373:FITSFO]2.0.CO;2; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; Senter Phil, 2006, Paleobios, V26, P7; Senter Phil, 2005, Paleobios, V25, P9; Senter P, 2006, PALAEONTOLOGY, V49, P1029, DOI 10.1111/j.1475-4983.2006.00585.x; Senter Phil, 2009, Bulletin of Gunma Museum of Natural History, V13, P1; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; White MA, 2013, ALCHERINGA, V37, P435, DOI 10.1080/03115518.2013.770221; White MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068649; White MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039364	51	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137709	10.1371/journal.pone.0137709	http://dx.doi.org/10.1371/journal.pone.0137709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368529	gold, Green Submitted, Green Published			2022-12-26	WOS:000361601100114
J	Berenson, CS; Kruzel, RL; Wrona, CT; Mammen, MJ; Sethi, S				Berenson, Charles S.; Kruzel, Ragina L.; Wrona, Catherine T.; Mammen, Manoj J.; Sethi, Sanjay			Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; SINGLE-NUCLEOTIDE POLYMORPHISMS; AIRWAY BACTERIAL LOAD; NF-KAPPA-B; 4 GENE; ASSOCIATION; DISEASE; SUSCEPTIBILITY; INFLAMMATION; HAPLOTYPES	Background Dysfunctional innate responses of alveolar macrophages to nontypeable Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae contribute to morbidity in chronic obstructive pulmonary disease (COPD). Our earlier studies discovered impaired COPD alveolar macrophage responses to Toll-like receptor (TLR) ligands of nontypeable H. influenzae and provide rationale for further evaluation of TLR signaling. While the role of TLR single nucleotide polymorphisms is increasingly recognized in inflammatory diseases, TLR single nucleotide polymorphisms in COPD have only recently been explored. We hypothesized that specific TLR polymorphisms are associated with dysfunctional innate immune COPD alveolar macrophage responses and investigated polymorphisms of TLR2 (Arg753Gln), TLR4(Thr399Ile; Asp299Gly), and TLR9(T1486C; T1237C). Methods DNA was purified from cells of 1) healthy nonsmokers (n = 20); 2) COPD ex-smokers (n = 83); 3) COPD active smokers (n = 93). DNA amplifications (polymerase chain reaction) were performed for each SNP. Alveolar macrophages from each group were incubated with nontypeable H. influenzae, M. catarrhalis and S. pneumoniae. Cytokine induction of macrophage supernatants was measured and the association with TLR single nucleotide polymorphism expression was determined. Results No significant inter-group differences in frequency of any TLR SNP existed. However both TLR9 single nucleotide polymorphisms were expressed in high frequency. Among COPD ex-smokers, diminished IL-8 responsiveness to nontypeable H. influenzae, M. catarrhalis and S. pneumoniae was strongly associated with carriage of TLR9(T1237C) (p = 0.02; p = 0.008; p = 0.02), but not TLR9(T1486C). Carriage of TLR9(T1237C), but not TLR9 (T1486C), correlated with diminished FEV1% predicted (p = 0.037). Conclusion Our results demonstrate a notable association of TLR9(T1237C) expression with dysfunctional innate alveolar macrophage responses to respiratory pathogens and with severity of COPD.	[Berenson, Charles S.; Kruzel, Ragina L.] SUNY Buffalo, Sch Med, Dept Vet Affairs Western New York Healthcare Syst, Div Infect Dis, Buffalo, NY 14215 USA; [Wrona, Catherine T.; Mammen, Manoj J.; Sethi, Sanjay] SUNY Buffalo, Sch Med, Dept Vet Affairs Western New York Healthcare Syst, Div Pulm Crit Care & Sleep Med, Buffalo, NY 14215 USA; [Mammen, Manoj J.] SUNY Buffalo, Sch Med, Dept Biomed Informat, Buffalo, NY 14215 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Berenson, CS (corresponding author), SUNY Buffalo, Sch Med, Dept Vet Affairs Western New York Healthcare Syst, Div Infect Dis, Buffalo, NY 14215 USA.	berenson@buffalo.edu	Mammen, Manoj/AAH-8904-2020	Mammen, Manoj/0000-0003-0343-3234	National Institutes of Health [RO1HL082561-01]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by research grant RO1HL082561-01 (CSB, SS) from the National Institutes of Health and with support from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Berenson CS, 2006, J INFECT DIS, V194, P1375, DOI 10.1086/508428; Berenson CS, 2006, AM J RESP CRIT CARE, V174, P31, DOI 10.1164/rccm.200509-1461OC; Berenson CS, 2014, THORAX, V69, P811, DOI 10.1136/thoraxjnl-2013-203669; Berenson CS, 2013, J INFECT DIS, V208, P2036, DOI 10.1093/infdis/jit400; Berenson CS, 2005, INFECT IMMUN, V73, P2728, DOI 10.1128/IAI.73.5.2728-2735.2005; Berghofer B, 2005, CLIN EXP ALLERGY, V35, P1147, DOI 10.1111/j.1365-2222.2005.02325.x; Budulac SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043124; Carvalho A, 2008, J INFECT DIS, V197, P618, DOI 10.1086/526500; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Folwaczny M, 2004, CLIN EXP IMMUNOL, V135, P330, DOI 10.1111/j.1365-2249.2004.02383.x; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Graffelman J, 2015, J STAT SOFTW, V64, P1; Hamann L, 2004, J IMMUNOL METHODS, V285, P281, DOI 10.1016/j.jim.2003.12.005; Hill AT, 2000, AM J MED, V109, P288, DOI 10.1016/S0002-9343(00)00507-6; Ito Michiko, 2012, BMC Res Notes, V5, P36, DOI 10.1186/1756-0500-5-36; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Mailaparambil B, 2008, DIS MARKERS, V25, P59, DOI 10.1155/2008/619595; Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1016/j.jaci.2003.05.001; Murphy TF, 2006, CURR OPIN INFECT DIS, V19, P225, DOI 10.1097/01.qco.0000224815.89363.15; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Noguchi E, 2004, CLIN EXP ALLERGY, V34, P177, DOI 10.1111/j.1365-2222.2004.01839.x; Pabst S, 2013, ADV EXP MED BIOL, V756, P239, DOI 10.1007/978-94-007-4549-0_30; Pabst S, 2009, LUNG, V187, P173, DOI 10.1007/s00408-009-9144-8; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rohde G, 2006, RESP MED, V100, P892, DOI 10.1016/j.rmed.2005.08.018; Sabroe I, 2004, THORAX, V59, P81; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Schroder NWJ, 2003, J MOL MED-JMM, V81, P368, DOI 10.1007/s00109-003-0443-x; Schwartz DA, 2005, CLIN INFECT DIS, V41, pS403, DOI 10.1086/431985; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Speletas M, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/260286; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Vollmer J, 2006, INT REV IMMUNOL, V25, P155, DOI 10.1080/08830180600743107; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Yang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058444	40	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0134209	10.1371/journal.pone.0134209	http://dx.doi.org/10.1371/journal.pone.0134209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361369	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100002
J	Seoane, S; Montero, JC; Ocana, A; Pandiella, A				Seoane, S.; Montero, J. C.; Ocana, A.; Pandiella, A.			Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling node	ONCOGENE			English	Article							ADJUVANT TRASTUZUMAB; BINDING-SITES; EXPRESSION; METASTASIS; RECEPTORS; HEREGULIN; CELL; DIFFERENTIATION; TUMORIGENICITY; ACTIVATION	Advances in the treatment of breast cancer have resulted in increased survival. However, in the metastatic setting, the disease remains incurable. Therefore, understanding of the mechanisms that promote dissemination of breast cancer cells may favor the development of novel therapeutic strategies to fight those tumors. Here, we show that the ErbB ligands, Neuregulins (NRGs), promote metastatic dissemination of breast cancer cells by switching on a kinase-metalloproteinase network. Clinicopathological analyses demonstrated that NRG expression in breast tumors associated to lymph node invasion and poor patient outcome. Preclinical in vivo analyses showed that NRG expression favored in situ tumor growth, local spreading and metastatic dissemination. Genomic, biochemical and functional studies identified matrix metalloproteinases, particularly stromelysin 2 and collagenase 3, as key mediators of the NRG-induced dissemination properties of breast cancer cells. Mechanistic analyses demonstrated that NRG augmented metalloproteinase expression through a route controlled by ERK1/2 kinases. ERK1/2 increased collagenase 3 expression by controlling the activity of an SBF1-related transcription factor. In conclusion, we describe a pathway linked to breast cancer dissemination. The clinical availability of agents that target some of the components of this signalling pathway suggests that patients with tumors fed by NRGs or other factors able to activate the ERK-Collagenase 3 route may benefit from agents that act on that signalling axis.	[Seoane, S.; Montero, J. C.; Pandiella, A.] Univ Salamanca, Inst Biol Mol & Celular Canc, CSIC, CIC Campus Miguel de Unamuno,Ave Univ Coimbra, Salamanca 37007, Spain; [Ocana, A.] Complejo Hosp Univ Albacete, Med Oncol Serv, Albcete, Spain; AECC Unit, Albcete, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Pandiella, A (corresponding author), Univ Salamanca, Inst Biol Mol & Celular Canc, CSIC, CIC Campus Miguel de Unamuno,Ave Univ Coimbra, Salamanca 37007, Spain.	atanasio@usal.es	Seoane, Samuel/H-6299-2015; Montero, Juan Carlos/AAO-1780-2020; Pandiella, Atanasio/O-5180-2014	Seoane, Samuel/0000-0002-9178-0887; Montero, Juan Carlos/0000-0003-4773-053X; Pandiella, Atanasio/0000-0002-4704-8971; Ocana, Alberto/0000-0002-1067-9630	Instituto de Salud Carlos III through Spanish Cancer Centers Network Program [RD06/0020/0041, RD12/0036/0003]; Juan de la Cierva contract; Miguel Servet fellowship program	Instituto de Salud Carlos III through Spanish Cancer Centers Network Program; Juan de la Cierva contract; Miguel Servet fellowship program	Ministry of Economy and Competitiveness of Spain (BFU2009-07728 and BFU2012-39151), the Instituto de Salud Carlos III through the Spanish Cancer Centers Network Program (RD06/0020/0041 and RD12/0036/0003) and the Scientific Foundation of the Spanish Association Against Cancer (AECC). SSR was supported by a Juan de la Cierva contract. JCM is a recipient of a Miguel Servet fellowship program.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Atlas E, 2003, MOL CANCER RES, V1, P165; Cabrera N, 1996, J CELL BIOL, V132, P427, DOI 10.1083/jcb.132.3.427; Dawson SJ, 2013, EMBO J, V32, P617, DOI 10.1038/emboj.2013.19; de Alava E, 2007, J CLIN ONCOL, V25, P2656, DOI 10.1200/JCO.2006.08.6850; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kiran U, 2012, BIOINFORMATION, V8, P886, DOI 10.6026/97320630008886; Krane IM, 1996, ONCOGENE, V12, P1781; Kumler I, 2014, CANCER TREAT REV, V40, P259, DOI 10.1016/j.ctrv.2013.09.002; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LAWTON MA, 1991, PLANT MOL BIOL, V16, P235, DOI 10.1007/BF00020555; Lee CYF, 2014, CANCER RES, V74, P341, DOI 10.1158/0008-5472.CAN-13-1055; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Montero JC, 2014, ONCOGENE, V33, P148, DOI 10.1038/onc.2012.572; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Montero JC, 2007, MOL BIOL CELL, V18, P380, DOI 10.1091/mbc.E06-06-0511; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Morrison C, 2011, J BIOL CHEM, V286, P34271, DOI 10.1074/jbc.M111.222513; Ocana A, 2013, CURR PHARM DESIGN, V19, P808, DOI 10.2174/138161213804547303; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Perez EA, 2010, J CLIN ONCOL, V28, P4307, DOI 10.1200/JCO.2009.26.2154; Phillips GDL, 2014, CLIN CANCER RES, V20, P456, DOI 10.1158/1078-0432.CCR-13-0358; Pivetta E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3047; Revillion F, 2008, ANN ONCOL, V19, P73, DOI 10.1093/annonc/mdm431; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Seoane S, 2010, JNCI-J NATL CANCER I, V102, P1432, DOI 10.1093/jnci/djq315; Shah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029615; Shames DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056765; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Yuste L, 2005, CANCER RES, V65, P6801, DOI 10.1158/0008-5472.CAN-04-4023; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	41	15	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2756	2765		10.1038/onc.2015.337	http://dx.doi.org/10.1038/onc.2015.337			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26364598				2022-12-26	WOS:000377472700009
J	Yang, ZF; Wilkie-Grantham, RP; Yanagi, T; Shu, CW; Matsuzawa, S; Reed, JC				Yang, Zhifen; Wilkie-Grantham, Rachel P.; Yanagi, Teruki; Shu, Chih-Wen; Matsuzawa, Shu-ichi; Reed, John C.			ATG4B (Autophagin-1) Phosphorylation Modulates Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATG8-PE DECONJUGATION; PROTEIN LIPIDATION; LC3; BIOGENESIS; SITE; MEMBRANES; GABARAP; PATHWAY; HAMPERS; CLOSURE	Autophagy is a catabolic cellular mechanism for entrapping cellular macromolecules and organelles in intracellular vesicles and degrading their contents by fusion with lysosomes. Important roles for autophagy have been elucidated for cell survival during nutrient insufficiency, eradication of intracellular pathogens, and counteracting aging through clearance of senescent proteins and mitochondria. Autophagic vesicles become decorated with LC3, a protein that mediates their fusion with lysosomes. LC3 is a substrate of the cysteine protease ATG4B (Autophagin-1), where cleavage generates a C-terminal glycine required for LC3 conjugation to lipids in autophagosomes. ATG4B both cleaves pro-LC3 and also hydrolyzes lipids from cleaved LC3. We show here that phosphorylation of ATG4B at Ser-383 and Ser-392 increases its hydrolyase activity as measured using LC3 as a substrate. Reconstituting atg4b(-/-) cells with phosphorylation-deficient ATG4B showed a role of ATG4B phosphorylation in LC3 delipidation and autophagic flux, thus demonstrating that the cellular activity of ATG4B is modulated by phosphorylation. Proteolytic conversion of pro-LC3 to LC3-I was not significantly impacted by ATG4B phosphorylation in cells. Phosphorylation-deficient ATG4B also showed reduced interactions with the lipid-conjugated LC3 but not unconjugated LC3. Taken together, these findings demonstrate a role for Ser-383 and Ser-392 phosphorylation of ATG4B in control of autophagy.	[Yang, Zhifen; Wilkie-Grantham, Rachel P.; Yanagi, Teruki; Shu, Chih-Wen; Matsuzawa, Shu-ichi; Reed, John C.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Yang, Zhifen] Stanford Univ, Dept Radiat Oncol, Palo Alto, CA 94305 USA; [Shu, Chih-Wen] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 813, Taiwan; [Reed, John C.] Roche Innovat Ctr Basel, Pharmaceut Res & Early Dev, Roche, CH-4014 Basel, Switzerland	Sanford Burnham Prebys Medical Discovery Institute; Stanford University; Kaohsiung Veterans General Hospital; Roche Holding	Matsuzawa, S (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.	smatsuzawa@sbpdiscovery.org; John_C.Reed@roche.com	Yanagi, Teruki/D-4222-2017; Shu, Chih-Wen/AAE-9652-2019; Regan, Clinton/E-6250-2012	Yanagi, Teruki/0000-0003-2196-7600; Shu, Chih-Wen/0000-0002-7774-0002	National Institutes of Health [AI-091967]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI-091967. The authors declare that they have no conflicts of interest with the contents of this article.	Choi KM, 2011, AUTOPHAGY, V7, P1052, DOI 10.4161/auto.7.9.16451; Dai J, 2007, J PROTEOME RES, V6, P250, DOI 10.1021/pr0604155; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fujita N, 2009, AUTOPHAGY, V5, P88, DOI 10.4161/auto.5.1.7183; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Guo L, 2013, MOL CELL BIOL, V33, P3180, DOI 10.1128/MCB.00193-13; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Ketteler R, 2008, AUTOPHAGY, V4, P801, DOI 10.4161/auto.6401; Ketteler R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r64; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuang E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003007; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shu CW, 2010, AUTOPHAGY, V6, P936, DOI 10.4161/auto.6.7.13075; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yu ZQ, 2012, AUTOPHAGY, V8, P883, DOI 10.4161/auto.19652	38	67	67	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26549	26561		10.1074/jbc.M115.658088	http://dx.doi.org/10.1074/jbc.M115.658088			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26378241	Green Published, hybrid			2022-12-26	WOS:000364793600022
J	Marneweck, M; Knelange, E; Lee-Miller, T; Santello, M; Gordon, AM				Marneweck, Michelle; Knelange, Elisabeth; Lee-Miller, Trevor; Santello, Marco; Gordon, Andrew M.			Generalization of Dexterous Manipulation Is Sensitive to the Frame of Reference in Which It Is Learned	PLOS ONE			English	Article							CENTER-OF-MASS; OBJECT MANIPULATION; SENSORIMOTOR MEMORY; PRECISION GRIP; ANTICIPATORY CONTROL; FINGERTIP FORCES; GRASP STABILITY; MOTOR; REPRESENTATIONS; ADAPTATION	Studies have shown that internal representations of manipulations of objects with asymmetric mass distributions that are generated within a specific orientation are not generalizable to novel orientations, i.e., subjects fail to prevent object roll on their first grasp-lift attempt of the object following 180 degrees object rotation. This suggests that representations of these manipulations are specific to the reference frame in which they are formed. However, it is unknown whether that reference frame is specific to the hand, the body, or both, because rotating the object 180 degrees modifies the relation between object and body as well as object and hand. An alternative, untested explanation for the above failure to generalize learned manipulations is that any rotation will disrupt grasp performance, regardless if the reference frame in which the manipulation was learned is maintained or modified. We examined the effect of rotations that (1) maintain and (2) modify relations between object and body, and object and hand, on the generalizability of learned two-digit manipulation of an object with an asymmetric mass distribution. Following rotations that maintained the relation between object and body and object and hand (e.g., rotating the object and subject 180 degrees), subjects continued to use appropriate digit placement and load force distributions, thus generating sufficient compensatory moments to minimize object roll. In contrast, following rotations that modified the relation between (1) object and hand (e.g. rotating the hand around to the opposite object side), (2) object and body (e.g. rotating subject and hand 180 degrees), or (3) both (e.g. rotating the subject 180 degrees), subjects used the same, yet inappropriate digit placement and load force distribution, as those used prior to the rotation. Consequently, the compensatory moments were insufficient to prevent large object rolls. These findings suggest that representations of learned manipulation of objects with asymmetric mass distributions are specific to the body-and hand-reference frames in which they were learned.	[Marneweck, Michelle; Lee-Miller, Trevor; Gordon, Andrew M.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA; [Knelange, Elisabeth] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst, Amsterdam, North Holland, Netherlands; [Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA	Columbia University; Columbia University Teachers College; Vrije Universiteit Amsterdam; Arizona State University; Arizona State University-Tempe	Marneweck, M (corresponding author), Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA.	michelle.marneweck@uwa.edu.au		Marneweck, Michelle/0000-0002-3953-5956; Knelange, Elisabeth/0000-0002-4133-5136; Gordon, Andrew/0000-0003-1041-0479	National Science Foundation (NSF) [BCS-1153034, BCS 1152916]; Direct For Social, Behav & Economic Scie [1152916] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1153034] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by a Collaborative Research Grant BCS-1153034 (MS) and BCS 1152916 (AG) from the National Science Foundation (NSF; http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert F, 2009, NEUROSCI LETT, V463, P188, DOI 10.1016/j.neulet.2009.07.080; Berniker M, 2014, J NEUROPHYSIOL, V112, P2791, DOI 10.1152/jn.00615.2013; Berniker M, 2014, J NEUROPHYSIOL, V111, P1165, DOI 10.1152/jn.00493.2013; Bursztyn LLCD, 2008, EXP BRAIN RES, V184, P127, DOI 10.1007/s00221-007-1173-z; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Craje C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076855; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Fu QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108222; Fu QS, 2011, J NEUROSCI, V31, P13576, DOI 10.1523/JNEUROSCI.1143-11.2011; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1991, EXP BRAIN RES, V83, P483; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Gordon AM, 2004, P ANN INT IEEE EMBS, V26, P4641; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Ingram JN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002196; Ingram JN, 2010, CURR BIOL, V20, P618, DOI 10.1016/j.cub.2010.01.054; Jenmalm P, 1998, J NEUROPHYSIOL, V79, P1643, DOI 10.1152/jn.1998.79.4.1643; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Johansson RS, 1999, EXP BRAIN RES, V128, P20, DOI 10.1007/s002210050813; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Krakauer J, 1996, DIFFERENCES GEN ADAP, P899; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Miall RC, 2004, EXP BRAIN RES, V154, P201, DOI 10.1007/s00221-003-1630-2; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; Salimi I, 2003, EXP BRAIN RES, V150, P9, DOI 10.1007/s00221-003-1394-8; Salimi I, 2000, J NEUROPHYSIOL, V84, P2390, DOI 10.1152/jn.2000.84.5.2390; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Wing AM, 1998, J EXP PSYCHOL HUMAN, V24, P1571, DOI 10.1037/0096-1523.24.6.1571; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138258	10.1371/journal.pone.0138258	http://dx.doi.org/10.1371/journal.pone.0138258			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376089	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200094
J	Philip, P; Micoulaud-Franchi, JA; Lagarde, E; Taillard, J; Canel, A; Sagaspe, P; Bioulac, S				Philip, Pierre; Micoulaud-Franchi, Jean-Arthur; Lagarde, Emmanuel; Taillard, Jacques; Canel, Annick; Sagaspe, Patricia; Bioulac, Stephanie			Attention Deficit Hyperactivity Disorder Symptoms, Sleepiness and Accidental Risk in 36140 Regularly Registered Highway Drivers	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; DRIVING-RELATED RISKS; YOUNG-ADULT DRIVERS; DEFICIT/HYPERACTIVITY-DISORDER; GENERAL-POPULATION; DAYTIME SLEEPINESS; DOUBLE-BLIND; LISDEXAMFETAMINE DIMESYLATE; INTERNATIONAL SURVEY; EXTENDED-RELEASE	Background Attention Deficit Hyperactivity Disorder (ADHD) is a frequent neurodevelopmental disorder that increases accidental risk. Recent studies show that some patients with ADHD can also suffer from excessive daytime sleepiness but there are no data assessing the role of sleepiness in road safety in patients with ADHD. We conducted an epidemiological study to explore sleep complaints, inattention and driving risks among automobile drivers. Methods and Findings From August to September 2014, 491186 regular highway users were invited to participate in an Internet survey on driving habits. 36140 drivers answered a questionnaire exploring driving risks, sleep complaints, sleepiness at the wheel, ADHD symptoms (Adult ADHD Self-Report Scale) and distraction at the wheel. 1.7% of all drivers reported inattention-related driving accidents and 0.3% sleep-related driving accidents in the previous year. 1543 drivers (4.3%) reported ADHD symptoms and were more likely to report accidents than drivers without ADHD symptoms (adjusted OR = 1.24, [1.03-1.51], p < .021). 14.2% of drivers with ADHD symptoms reported severe excessive daytime sleepiness (Epworth Sleepiness Scale >15) versus 3.2% of drivers without ADHD symptoms and 20.5% reported severe sleepiness at the wheel versus 7.3%. Drivers with ADHD symptoms reported significantly more sleep-related (adjusted OR = 1.4, [1.21-1.60], p < .0001) and inattentionrelated (adjusted OR = 1.9, [1.71-2.14], p < 0001) near misses than drivers without ADHD symptoms. The fraction of near-misses attributable to severe sleepiness at the wheel was 4.24% for drivers without ADHD symptoms versus 10,35% for drivers with ADHD symptoms. Conclusion Our study shows that drivers with ADHD symptoms have more accidents and a higher level of sleepiness at the wheel than drivers without ADHD symptoms. Drivers with ADHD symptoms report more sleep-related and inattention-related near misses, thus confirming the clinical importance of exploring both attentional deficits and sleepiness at the wheel in these drivers. Road safety campaigns should be improved to better inform drivers of these accidental risks.	[Philip, Pierre; Micoulaud-Franchi, Jean-Arthur; Taillard, Jacques; Sagaspe, Patricia] CHU Bordeaux, Clin Sommeil, Serv Explorat Fonct Syst Nerveux, F-33076 Bordeaux, France; [Philip, Pierre; Micoulaud-Franchi, Jean-Arthur; Taillard, Jacques; Sagaspe, Patricia; Bioulac, Stephanie] Univ Bordeaux, CHU Pellegrin, USR CNRS SANPSY 3413, F-33000 Bordeaux, France; [Lagarde, Emmanuel] Univ Bordeaux, Equipe PPCT, ISPED, INSERM U897, F-33000 Bordeaux, France; [Canel, Annick] Assoc Soc Francaises Autoroutes, Paris, France; [Bioulac, Stephanie] Ctr Hosp Charles Perrens, Pole Univ Psychiat Enfants & Adolescents, F-33076 Bordeaux, France	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Bioulac, S (corresponding author), Univ Bordeaux, CHU Pellegrin, USR CNRS SANPSY 3413, F-33000 Bordeaux, France.	stephaniebioulac@hotmail.com	PHILIP, Pierre/AAS-8889-2020; Taillard, Jacques/H-5063-2018; Lagarde, Emmanuel/F-7132-2013	PHILIP, Pierre/0000-0003-3267-634X; Taillard, Jacques/0000-0001-9067-8189; Lagarde, Emmanuel/0000-0001-8031-7400; bioulac, stephanie/0000-0003-2618-4234; MICOULAUD-FRANCHI, Jean-Arthur/0000-0002-5203-8444; SAGASPE, Patricia/0000-0003-2845-1199	"ASFA" Association des Societes Francaises d'Autoroutes, Paris, France	"ASFA" Association des Societes Francaises d'Autoroutes, Paris, France	This work was supported by "ASFA" Association des Societes Francaises d'Autoroutes, Paris, France.	Adler LA, 2008, J CLIN PSYCHIAT, V69, P1364, DOI 10.4088/JCP.v69n0903; Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; Akerstedt T, 2010, CHRONOBIOL INT, V27, P987, DOI 10.3109/07420528.2010.489423; ALDRICH MS, 1989, SLEEP, V12, P487, DOI 10.1093/sleep/12.6.487; Alexandre C, 2013, CURR OPIN NEUROBIOL, V23, P752, DOI 10.1016/j.conb.2013.04.008; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Barkley R, 2005, ATTENTION DEFICIT HY; Barkley R.A., 2006, ADHD REP, V14, P1, DOI DOI 10.1521/ADHD.2006.14.2.1; BARKLEY RA, 1993, PEDIATRICS, V92, P212; Barkley RA, 2002, J INT NEUROPSYCH SOC, V8, P655, DOI 10.1017/S1355617702801345; Biederman J, 2006, J CLIN PSYCHIAT, V67, P524, DOI 10.4088/JCP.v67n0403; Biederman J, 2012, J PSYCHIATR RES, V46, P484, DOI 10.1016/j.jpsychires.2012.01.007; Bioulac S, 2015, J CLIN PSYCHIAT, V76, P943, DOI 10.4088/JCP.14m09087; Brown TE, 2001, ANN NY ACAD SCI, V931, P271; Caci HM, 2014, J NERV MENT DIS, V202, P324, DOI 10.1097/NMD.0000000000000126; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; Cortese S, 2008, MED HYPOTHESES, V71, P770, DOI 10.1016/j.mehy.2008.06.017; Cortese S, 2013, J AM ACAD CHILD PSY, V52, P784, DOI 10.1016/j.jaac.2013.06.001; Cox DJ, 2006, PEDIATRICS, V118, pE704, DOI 10.1542/peds.2005-2947; Cox DJ, 2012, J CLIN PSYCHOPHARM, V32, P225, DOI 10.1097/JCP.0b013e3182496dc5; Cox DJ, 2004, J AM ACAD CHILD PSY, V43, P269, DOI 10.1097/00004583-200403000-00007; Cox DJ, 2000, J NERV MENT DIS, V188, P230, DOI 10.1097/00005053-200004000-00006; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Fischer M, 2007, ACCIDENT ANAL PREV, V39, P94, DOI 10.1016/j.aap.2006.06.008; Galera C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8105; Golan N, 2004, SLEEP, V27, P261, DOI 10.1093/sleep/27.2.261; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Hvolby A, 2015, ADHD-ATTEND DEFICIT, V7, P1, DOI 10.1007/s12402-014-0151-0; Jerome L, 2006, J CAN ACAD CHILD ADO, V15, P105; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kotterba S, 2004, CLIN NEUROL NEUROSUR, V106, P275, DOI 10.1016/j.clineuro.2003.12.003; Lara C, 2009, BIOL PSYCHIAT, V65, P46, DOI 10.1016/j.biopsych.2008.10.005; Lecendreux M, 2000, J CHILD PSYCHOL PSYC, V41, P803, DOI 10.1111/1469-7610.00667; Leger D, 2008, CURR MED RES OPIN, V24, P307, DOI 10.1185/030079907X253771; Leger D, 2005, CURR MED RES OPIN, V21, P1785, DOI 10.1185/030079905X65637; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Miano S, 2006, SLEEP, V29, P797; Morgenthaler TI, 2007, SLEEP, V30, P1705, DOI 10.1093/sleep/30.12.1705; Nabi H, 2006, BRIT MED J, V333, P75, DOI 10.1136/bmj.38863.638194.AE; NadaRaja S, 1997, J AM ACAD CHILD PSY, V36, P515, DOI 10.1097/00004583-199704000-00014; Ohayon MM, 2004, ENCEPHALE, V30, P222; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P547, DOI 10.1016/S0022-3999(02)00443-9; Ohayon MM, 1997, ARCH INTERN MED, V157, P2645, DOI 10.1001/archinte.157.22.2645; Pack AI, 1995, ACCIDENT ANAL PREV, V27, P769, DOI 10.1016/0001-4575(95)00034-8; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Powell NB, 2001, LARYNGOSCOPE, V111, P887, DOI 10.1097/00005537-200105000-00024; Powell NB, 2007, SLEEP, V30, P331, DOI 10.1093/sleep/30.3.331; Reimer B, 2010, ACCIDENT ANAL PREV, V42, P842, DOI 10.1016/j.aap.2009.06.021; Reimer Bryan, 2007, Traffic Inj Prev, V8, P290, DOI 10.1080/15389580701257842; Reynolds AC, 2010, PROG BRAIN RES, V185, P91, DOI 10.1016/B978-0-444-53702-7.00006-3; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Sagaspe P, 2010, J SLEEP RES, V19, P578, DOI 10.1111/j.1365-2869.2009.00818.x; Sobanski E, 2008, J NEURAL TRANSM, V115, P347, DOI 10.1007/s00702-007-0834-1; Sobanski E, 2013, EUR PSYCHIAT, V28, P379, DOI 10.1016/j.eurpsy.2012.08.001; Sobanski E, 2012, PHARMACOPSYCHIATRY, V45, P100, DOI 10.1055/s-0031-1291319; Spencer TJ, 2007, BIOL PSYCHIAT, V61, P1380, DOI 10.1016/j.biopsych.2006.07.032; Tison F, 2005, NEUROLOGY, V65, P239, DOI 10.1212/01.wnl.0000168910.48309.4a; Verster JC, 2008, J PSYCHOPHARMACOL, V22, P230, DOI 10.1177/0269881107082946; WEINBERG WA, 1990, J PEDIATR-US, V116, P720, DOI 10.1016/S0022-3476(05)82654-X; Woods SP, 2002, ARCH CLIN NEUROPSYCH, V17, P351, DOI 10.1016/S0887-6177(01)00120-2; Woodward LJ, 2000, J AM ACAD CHILD PSY, V39, P627, DOI 10.1097/00004583-200005000-00017; Yoon SYR, 2012, SLEEP MED REV, V16, P371, DOI 10.1016/j.smrv.2011.07.001; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	67	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138004	10.1371/journal.pone.0138004	http://dx.doi.org/10.1371/journal.pone.0138004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26376078	Green Published, gold			2022-12-26	WOS:000361610200068
J	Yuan, FS; Sui, HX; Li, ZK; Yang, HF; Lu, PJ; Wang, Y; Sun, YC				Yuan, Fusong; Sui, Huaxin; Li, Zhongke; Yang, Huifang; Lu, Peijun; Wang, Yong; Sun, Yuchun			A Method of Three-Dimensional Recording of Mandibular Movement Based on Two-Dimensional Image Feature Extraction	PLOS ONE			English	Article								Background and Objective To develop a real-time recording system based on computer binocular vision and two-dimensional image feature extraction to accurately record mandibular movement in three dimensions. Methods A computer-based binocular vision device with two digital cameras was used in conjunction with a fixed head retention bracket to track occlusal movement. Software was developed for extracting target spatial coordinates in real time based on two-dimensional image feature recognition. A plaster model of a subject's upper and lower dentition were made using conventional methods. A mandibular occlusal splint was made on the plaster model, and then the occlusal surface was removed. Temporal denture base resin was used to make a 3-cm handle extending outside the mouth connecting the anterior labial surface of the occlusal splint with a detection target with intersecting lines designed for spatial coordinate extraction. The subject's head was firmly fixed in place, and the occlusal splint was fully seated on the mandibular dentition. The subject was then asked to make various mouth movements while the mandibular movement target locus point set was recorded. Comparisons between the coordinate values and the actual values of the 30 intersections on the detection target were then analyzed using paired t-tests. Results The three-dimensional trajectory curve shapes of the mandibular movements were consistent with the respective subject movements. Mean XYZ coordinate values and paired t-test results were as follows: X axis: -0.0037 +/- 0.02953, P = 0.502; Y axis: 0.0037 +/- 0.05242, P = 0.704; and Z axis: 0.0007 +/- 0.06040, P = 0.952. The t-test result showed that the coordinate values of the 30 cross points were considered statistically no significant. (P<0.05) Conclusions Use of a real-time recording system of three-dimensional mandibular movement based on computer binocular vision and two-dimensional image feature recognition technology produced a recording accuracy of approximately +/- 0.1 mm, and is therefore suitable for clinical application. Certainly, further research is necessary to confirm the clinical applications of the method.	[Yuan, Fusong; Sui, Huaxin; Yang, Huifang; Lu, Peijun; Wang, Yong; Sun, Yuchun] Peking Univ Sch & Hosp Stomatol, Ctr Digital Dent, Beijing, Peoples R China; [Yuan, Fusong; Sui, Huaxin; Yang, Huifang; Lu, Peijun; Wang, Yong; Sun, Yuchun] Peking Univ Sch & Hosp Stomatol, Fac Prosthodont, Beijing, Peoples R China; [Yuan, Fusong; Sui, Huaxin; Yang, Huifang; Lu, Peijun; Wang, Yong; Sun, Yuchun] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Yuan, Fusong; Sui, Huaxin; Yang, Huifang; Lu, Peijun; Wang, Yong; Sun, Yuchun] Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China; [Li, Zhongke] Second Artillery Engn Coll, Xian, Peoples R China	Peking University; Peking University	Wang, Y (corresponding author), Peking Univ Sch & Hosp Stomatol, Ctr Digital Dent, Beijing, Peoples R China.	kqcadc@bjmu.edu.cn; polarshining@163.com	, 孙玉春/AAX-5280-2020		National Natural Science Foundation of China [51475004]; National High Technology Research and Development Program ("863" Program) of China [2013AA040802]; Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Peking University School and Hospital of Stomatology [YS0401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Peking University School and Hospital of Stomatology	This study received support from the National Natural Science Foundation of China, grant No. 51475004; the National High Technology Research and Development Program ("863" Program) of China, grant No. 2013AA040802; Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Peking University School and Hospital of Stomatology, grant No. YS0401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang WSW, 2004, J PROSTHET DENT, V92, P83, DOI 10.1016/j.prosdent.2004.04.011; Gallo LM, 2005, CELLS TISSUES ORGANS, V180, P54, DOI 10.1159/000086199; GIBBS CH, 1971, J PROSTHET DENT, V26, P604, DOI 10.1016/0022-3913(71)90085-0; Hanssen N, 2014, INT J COMPUT DENT, V17, P65; Kordass Bernd, 2002, Dent Clin North Am, V46, P493, DOI 10.1016/S0011-8532(02)00006-X; MESSERMAN T, 1967, J PROSTHET DENT, V17, P36, DOI 10.1016/0022-3913(67)90048-0; Missaka Reinaldo, 2008, Braz. oral res., V22, P151, DOI 10.1590/S1806-83242008000200010; Miyashita K, 1998, J ORAL REHABIL, V25, P545, DOI 10.1046/j.1365-2842.1998.00273.x; Naeije M, 2002, J ORAL REHABIL, V29, P534, DOI 10.1046/j.1365-2842.2002.00895.x; PIEHSLINGER E, 1991, CRANIO, V9, P344, DOI 10.1080/08869634.1991.11678382; Pinheiro A. P., 2011, Journal of Medical Engineering & Technology, V35, P125, DOI 10.3109/03091902.2010.542270; Pinheiro AP, 2008, J APPL ORAL SCI, V16, P321, DOI 10.1590/S1678-77572008000500004; Zhang H, 2014, OCCLUSAL THEORY CLIN	13	11	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137507	10.1371/journal.pone.0137507	http://dx.doi.org/10.1371/journal.pone.0137507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375800	gold, Green Submitted, Green Published			2022-12-26	WOS:000361610200040
J	Chaar, LJ; Alves, TP; Batista, AM; Michelini, LC				Chaar, Laiali Jurdi; Alves, Tatiana Pereira; Batista Junior, Alvaro Martins; Michelini, Lisete Compagno			Early Training-Induced Reduction of Angiotensinogen in Autonomic Areas-The Main Effect of Exercise on Brain Renin-Angiotensin System in Hypertensive Rats	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; SYMPATHETIC-NERVE ACTIVITY; MESSENGER-RNA EXPRESSION; HEART-RATE-VARIABILITY; TYPE-1 AT(1) RECEPTOR; BLOOD-PRESSURE; BLOCKADE; NUCLEUS; BALANCE; RESPONSES	Background Exercise training (T) blunts functional deficits and renin-angiotensin system (RAS) hyperactivity in hypertensive individuals. There is no information on T-induced temporal changes of brain RAS. We evaluate now the simultaneous effects of T on functional responses and time course changes in the expression/activity of brain RAS components in autonomic cardiovascular- controlling areas. Methods and Results Spontaneously hypertensive rats (SHR) and age-matched normotensive controls (WKY) were trained for 0, 1, 2, 4, 8 and 12 weeks. Sedentary (S) groups served as time-controls. After arterial pressure (AP) and heart rate (HR) recordings at rest, fresh and fixed brains were harvested for qPCR and immunofluorescence assays. SHR-S vs. WKY-S exhibited higher mean AP (MAP) and HR, increased pressure variability and sympathetic activity, elevated AT(1) receptor (AT(1)) expression in nucleus tractus solitarii (NTS) and higher Mas receptor expression in the rostroventrolateral medulla (RVLM). In SHR, T promptly (T-2 on) reduced sympathetic variability to heart/vessels and largely decreased angiotensinogen expression in the paraventricular hypothalamic nucleus (PVN) and NTS, with a late RVLM reduction (T-4). AT(1) expression was only reduced at T-12 (PVN and NTS) with transient, not maintained Mas receptor changes in PVN and RVLM. These responses were accompanied by baseline MAP and HR reduction in the SHR-T (from T-4 on). In the SHR group, PVN angiotensinogen expression correlated positively with sympathetic activity, resting MAP and HR. In WKY-T, a precocious (T-2-T-12) RVLM AT(1) decrease preceded the appearance of resting bradycardia (from T-8 on). Conclusions Early and maintained reduction of angiotensinogen content in autonomic areas of the SHR is the most prominent effect of training on brain RAS. Down-regulation of PVN RAS expression is an essential factor to drive cardiovascular benefits in SHR-T, while resting bradycardia in WKY-T is correlated to RVLM AT(1) reduction.	[Chaar, Laiali Jurdi; Michelini, Lisete Compagno] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil; [Alves, Tatiana Pereira; Batista Junior, Alvaro Martins] Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Michelini, LC (corresponding author), Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil.	michelin@usp.br	Chaar, Laiali/F-3457-2013	Chaar, Laiali/0000-0002-9054-6386	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2009/03708-9, 2009/54299-1, 2011/51410-9]; Conselho Nacional de Pesquisa - CNPq [304060/2011-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the following research grants: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2009/03708-9; 2009/54299-1; 2011/51410-9), Conselho Nacional de Pesquisa - CNPq (304060/2011-9). L.C. Michelini is a research fellow from CNPq.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Arnold AC, 2013, HYPERTENS RES, V36, P5, DOI 10.1038/hr.2012.161; AVERILL DB, 1994, BRAIN RES, V665, P245, DOI 10.1016/0006-8993(94)91344-7; Bader M, 2013, PFLUG ARCH EUR J PHY, V465, P79, DOI 10.1007/s00424-012-1120-0; Baltatu O, 2001, HYPERTENSION, V37, P408, DOI 10.1161/01.HYP.37.2.408; Bezerra SMMS, 2001, HYPERTENSION, V38, P569, DOI 10.1161/hy09t1.095393; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; CAULFIELD M, 1995, J CLIN INVEST, V96, P687, DOI 10.1172/JCI118111; Cavalleri MT, 2011, AM J PHYSIOL-REG I, V301, pR958, DOI 10.1152/ajpregu.00104.2011; Felix JVC, 2007, HYPERTENSION, V50, P780, DOI 10.1161/HYPERTENSIONAHA.107.094474; Chen QH, 2003, AM J PHYSIOL-REG I, V285, pR1231, DOI 10.1152/ajpregu.00028.2003; Dias-Peixoto MF, 2012, PEPTIDES, V35, P196, DOI 10.1016/j.peptides.2012.03.022; dos Santos CM, 1998, HYPERTENSION, V31, P973; Ferrario CM, 2011, CURR OPIN NEPHROL HY, V20, P1, DOI 10.1097/MNH.0b013e3283406f57; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; FERRARIO CM, 1990, DRUGS, V39, P1, DOI 10.2165/00003495-199000392-00002; Filho AG, 2008, EXP PHYSIOL, V93, P589, DOI 10.1113/expphysiol.2007.014293; Gomes-Santos IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098012; Hu L, 2002, J APPL PHYSIOL, V92, P2153, DOI 10.1152/japplphysiol.00261.2001; Huang CL, 2006, J PHYSIOL-LONDON, V574, P597, DOI 10.1113/jphysiol.2006.107326; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KIMURA S, 1992, EMBO J, V11, P821, DOI 10.1002/j.1460-2075.1992.tb05119.x; Kleiber AC, 2010, AM J PHYSIOL-HEART C, V298, pH1546, DOI 10.1152/ajpheart.01006.2009; Kuba K, 2013, CIRC J, V77, P301, DOI 10.1253/circj.CJ-12-1544; Masson GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094927; McKinley MJ, 2003, INT J BIOCHEM CELL B, V35, P901, DOI 10.1016/S1357-2725(02)00306-0; MICHELINI LC, 1990, HYPERTENSION, V15, pI45, DOI 10.1161/01.HYP.15.2_Suppl.I45; MICHELINI LC, 1992, HYPERTENSION, V19, P159; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Nohara R, 2014, CIRC J, V78, P2022, DOI 10.1253/circj.CJ-66-0094; O'Callaghan EL, 2013, AUTON NEUROSCI-BASIC, V175, P85, DOI 10.1016/j.autneu.2013.01.010; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Petriz BD, 2013, CURR PROTEIN PEPT SC, V14, P459, DOI 10.2174/13892037113149990063; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu L, 1996, J NEUROPHYSIOL, V75, P2220, DOI 10.1152/jn.1996.75.6.2220; Sangaleti CT, 2004, HYPERTENSION, V43, P317, DOI 10.1161/01.HYP.0000112030.79692.21; SANTOS CM, 1995, AM J PHYSIOL-HEART C, V269, pH812, DOI 10.1152/ajpheart.1995.269.3.H812; Shah A, 2012, AM J PHYSIOL-HEART C, V302, pH2372, DOI 10.1152/ajpheart.00846.2011; Shan ZY, 2013, HYPERTENSION, V61, P1328, DOI 10.1161/HYPERTENSIONAHA.111.00156; Sheriff MJ, 2006, AM J PHYSIOL-REG I, V290, pR733, DOI 10.1152/ajpregu.00410.2005; Silva DMR, 2011, J APPL PHYSIOL, V111, P1272, DOI 10.1152/japplphysiol.00034.2011; Silva SD, 2015, CIRC J, V79, P1372, DOI 10.1253/circj.CJ-14-1179; Tezini GCSV, 2013, EXP GERONTOL, V48, P147, DOI 10.1016/j.exger.2012.11.009; Xia HJ, 2010, CURR HYPERTENS REP, V12, P170, DOI 10.1007/s11906-010-0105-7	44	25	27	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137395	10.1371/journal.pone.0137395	http://dx.doi.org/10.1371/journal.pone.0137395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372108	Green Submitted, Green Published, gold			2022-12-26	WOS:000361604400019
J	Zhao, T; Liu, C; Chen, LY				Zhao, Tong; Liu, Chang; Chen, Lingyi			Roles of Klf5 Acetylation in the Self-Renewal and the Differentiation of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-5; TRANSCRIPTIONAL NETWORK; EPITHELIAL-CELLS; PLURIPOTENCY; NANOG; BLASTOCYST; CIRCUITRY; KRUPPEL-LIKE-FACTOR-5; SUMOYLATION; EXPRESSION	Transcription factor Kruppel-like factor 5 (Klf5) plays important roles in the formation of the inner cell mass (ICM) and the trophectoderm during embryogenesis, as well as the self-renewal and the differentiation of mouse embryonic stem cells (ESCs). Acetylation of KLF5 has been shown to reverse the transcriptional activity of KLF5 in human epidermal cells and prostate cancer cells. Whether Klf5 acetylation contributes to the lineage specification in the blastocyst and pluripotency maintenance in ESCs remains unexplored. Here, we showed the ubiquitous expression of acetylated Klf5 in the ICM and the trophectoderm, ruling out the possibility that differential acetylation status of Klf5 leads to the lineage specification in the blastocyst. We found that K358Q mutation, mimicking acetylation, enhances the transcriptional activity of Klf5 for pluripotency genes in ESCs, and that K358Q Klf5 is more potent in pluripotency maintenance and in somatic cell reprogramming, compared to K358R Klf5. In ESCs, Klf5 acetylation, stimulated by TGF-beta signaling, is involved in enhancing Sox2 expression. Moreover, upon ESC differentiation, acetylation of Klf5 facilitates the suppression of many differentiation genes, except for that K358Q Klf5 activates Cdx2, promoting trophectodermal differentiation. In summary, our results revealed the regulatory functions of Klf5 acetylation in ESC self-renewal and differentiation.	[Zhao, Tong; Liu, Chang; Chen, Lingyi] Nankai Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Med Chem Biol, 2011 Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin 300071, Peoples R China; [Zhao, Tong; Liu, Chang; Chen, Lingyi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Chen, Lingyi] CAMS, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing, Peoples R China	Nankai University; Nankai University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Chen, LY (corresponding author), Nankai Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Med Chem Biol, 2011 Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin 300071, Peoples R China.	lingyichen@nankai.edu.cn			National Natural Science Foundation of China [31271547, 31470081]; Natural Science Foundation of Tianjin, China [14JCYBJC23600]; Program for New Century Excellent Talents [NCET-13-0293]; Nankai University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); Nankai University	LC was supported by the National Natural Science Foundation of China (Grant No. 31271547 and 31470081), the Natural Science Foundation of Tianjin, China (No. 14JCYBJC23600), and the Program for New Century Excellent Talents (NCET-13-0293). TZ was supported by the Ph.D. Candidate Research Innovation Fund of Nankai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4719; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li X, 2015, INT J CANCER, V136, P536, DOI 10.1002/ijc.29028; Lin SCJ, 2010, DEVELOPMENT, V137, P3953, DOI 10.1242/dev.054775; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Long XL, 2013, MOL CELL BIOCHEM, V382, P113, DOI 10.1007/s11010-013-1724-5; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsumura T, 2005, J BIOL CHEM, V280, P12123, DOI 10.1074/jbc.M410578200; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Yeo JC, 2014, CELL STEM CELL, V14, P864, DOI 10.1016/j.stem.2014.04.015; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310	34	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138168	10.1371/journal.pone.0138168	http://dx.doi.org/10.1371/journal.pone.0138168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372456	gold, Green Submitted, Green Published			2022-12-26	WOS:000361604400052
J	Ahmad, R; Naz, S; Afzal, MZ; Amin, SH; Breuel, T				Ahmad, Riaz; Naz, Saeeda; Afzal, Muhammad Zeshan; Amin, Sayed Hassan; Breuel, Thomas			Robust Optical Recognition of Cursive Pashto Script Using Scale, Rotation and Location Invariant Approach	PLOS ONE			English	Article								The presence of a large number of unique shapes called ligatures in cursive languages, along with variations due to scaling, orientation and location provides one of the most challenging pattern recognition problems. Recognition of the large number of ligatures is often a complicated task in oriental languages such as Pashto, Urdu, Persian and Arabic. Research on cursive script recognition often ignores the fact that scaling, orientation, location and font variations are common in printed cursive text. Therefore, these variations are not included in image databases and in experimental evaluations. This research uncovers challenges faced by Arabic cursive script recognition in a holistic framework by considering Pashto as a test case, because Pashto language has larger alphabet set than Arabic, Persian and Urdu. A database containing 8000 images of 1000 unique ligatures having scaling, orientation and location variations is introduced. In this article, a feature space based on scale invariant feature transform (SIFT) along with a segmentation framework has been proposed for overcoming the above mentioned challenges. The experimental results show a significantly improved performance of proposed scheme over traditional feature extraction techniques such as principal component analysis (PCA).	[Ahmad, Riaz; Afzal, Muhammad Zeshan; Breuel, Thomas] Univ Technol, Kaiserslautern, Germany; [Ahmad, Riaz] Shaheed Benazir Bhutto Univ, Sheringal, Pakistan; [Naz, Saeeda] Hazara Univ, Dept IT, Mansehra, Pakistan; [Naz, Saeeda] GGPGC 1, Abbottabad, Pakistan; [Amin, Sayed Hassan] Genie Technol Pvt Ltd, Lahore, Pakistan	Hazara University	Naz, S (corresponding author), Hazara Univ, Dept IT, Mansehra, Pakistan.	saeedanaz292@gmail.com	Ahmad, Riaz/R-8199-2018; Rather, R A/J-3509-2019		Higher Education Commission of Pakistan; Shaheed Benazir Bhutto University, Sheringal Dir Pakistan [SBBU/Estb/Ord/13- 315]; Genie Technologies (Pvt) Ltd	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Shaheed Benazir Bhutto University, Sheringal Dir Pakistan; Genie Technologies (Pvt) Ltd	This work is sponsored by Higher Education Commission of Pakistan and Shaheed Benazir Bhutto University, Sheringal Dir Pakistan under Award Letter No: SBBU/Estb/Ord/13- 315. Genie Technologies (Pvt) Ltd provided support in the form of a salary for author SHA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sayed Hassan Amin has contributed voluntarily in his private capacity. The specific roles of all authors are articulated in the "author contributions" section.	Ahmad Riaz, 2010, 2010 6th International Conference on Emerging Technologies (ICET), P299, DOI 10.1109/ICET.2010.5638470; Decerbo M., 2004, P 1 ACM WORKSH HARDC, P29; Durrani N, 2010, HUMAN LANGUAGE TECHN, P528; Gillies A, 1999, PROCEEDINGS OF THE S; Graves A., 2009, ADV NEURAL INFORM PR, P1; Graves A, 2009, IEEE T PATTERN ANAL, V31, P855, DOI 10.1109/TPAMI.2008.137; Guan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098806; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Husain SA, 2002, MULT C 2002 INMIC 20, P84, DOI DOI 10.1109/INMIC.2002.1310191; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Lehal G.S., 2012, P WORKSH DOC AN REC, P79; Liwicki M, 2007, PROC INT CONF DOC, P367; Lorigo LM, 2006, IEEE T PATTERN ANAL, V28, P712, DOI 10.1109/TPAMI.2006.102; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Luo YW, 2015, NEUROCOMPUTING, V156, P105, DOI 10.1016/j.neucom.2014.12.079; Margner V, 2008, LECT NOTES COMPUT SC, V4768, P82, DOI 10.1007/978-3-540-78199-8_6; Margner V, 2007, PROC INT CONF DOC, P1274; Margner V, 2005, PROC INT CONF DOC, P70, DOI 10.1109/ICDAR.2005.52; Naz S, 2015, SPRINGER J ED INF TE, P1; Naz S, 2014, PATTERN RECOGN, V47, P1229, DOI 10.1016/j.patcog.2013.09.037; Pal U, 2003, PROC INT CONF DOC, P1183; Penzl H., 1955, GRAMMAR PASHTO DESCR, V2; Ul-Hasan A, 2013, PROC INT CONF DOC, P1061, DOI 10.1109/ICDAR.2013.212; Wahab M, 2009, 2009 INTERNATIONAL C; Wei BC, 2014, IEEE MULTIMEDIA, V21, P41, DOI 10.1109/MMUL.2013.65; Yousefi MR, 2015, IS T SPIE ELECTRONIC; Zhiyi Zhang, 2009, 2009 10th International Conference on Document Analysis and Recognition (ICDAR), P763, DOI 10.1109/ICDAR.2009.27	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0133648	10.1371/journal.pone.0133648	http://dx.doi.org/10.1371/journal.pone.0133648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368566	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100003
J	Dhanapal, AP; Ray, JD; Singh, SK; Hoyos-Villegas, V; Smith, JR; Purcell, LC; King, CA; Fritschi, FB				Dhanapal, Arun Prabhu; Ray, Jeffery D.; Singh, Shardendu K.; Hoyos-Villegas, Valerio; Smith, James R.; Purcell, Larry C.; King, C. Andy; Fritschi, Felix B.			Association Mapping of Total Carotenoids in Diverse Soybean Genotypes Based on Leaf Extracts and High-Throughput Canopy Spectral Reflectance Measurements	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; GENOME-WIDE ASSOCIATION; XANTHOPHYLL CYCLE; WAVELET DECOMPOSITION; POPULATION-STRUCTURE; OPTICAL-PROPERTIES; NITROGEN-CONTENT; BETA-CAROTENE; PHOTOSYSTEM-I; CHLOROPHYLL-B	Carotenoids are organic pigments that are produced predominantly by photosynthetic organisms and provide antioxidant activity to a wide variety of plants, animals, bacteria, and fungi. The carotenoid biosynthetic pathway is highly conserved in plants and occurs mostly in chromoplasts and chloroplasts. Leaf carotenoids play important photoprotective roles and targeted selection for leaf carotenoids may offer avenues to improve abiotic stress tolerance. A collection of 332 soybean [Glycine max (L.) Merr.] genotypes was grown in two years and total leaf carotenoid content was determined using three different methods. The first method was based on extraction and spectrophotometric determination of carotenoid content (eCaro) in leaf tissue, whereas the other two methods were derived from high-throughput canopy spectral reflectance measurements using wavelet transformed reflectance spectra (tCaro) and a spectral reflectance index (iCaro). An association mapping approach was employed using 31,253 single nucleotide polymorphisms (SNPs) to identify SNPs associated with total carotenoid content using a mixed linear model based on data from two growing seasons. A total of 28 SNPs showed a significant association with total carotenoid content in at least one of the three approaches. These 28 SNPs likely tagged 14 putative loci for carotenoid content. Six putative loci were identified using eCaro, five loci with tCaro, and nine loci with iCaro. Three of these putative loci were detected by all three carotenoid determination methods. All but four putative loci were located near a known carotenoid-related gene. These results showed that carotenoid markers can be identified in soybean using extract-based as well as by high-throughput canopy spectral reflectance-based approaches, demonstrating the utility of field-based canopy spectral reflectance phenotypes for association mapping.	[Dhanapal, Arun Prabhu; Fritschi, Felix B.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Ray, Jeffery D.; Smith, James R.] USDA ARS, Crop Genet Res Unit, Stoneville, MS 38776 USA; [Singh, Shardendu K.] USDA ARS, Crop Syst & Global Change Lab, Beltsville, MD USA; [Hoyos-Villegas, Valerio] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Purcell, Larry C.; King, C. Andy] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Michigan State University; University of Arkansas System; University of Arkansas Fayetteville	Fritschi, FB (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	fritschif@missouri.edu	Dhanapal, Arun Prabhu/F-5030-2012; Purcell, Larry/AAA-5986-2022; Hoyos-Villegas, Valerio/O-6138-2018	Dhanapal, Arun Prabhu/0000-0002-9686-7260; Hoyos-Villegas, Valerio/0000-0003-1080-9148	United States Department of Agriculture-Agriculture Research Service (USDA-ARS) [6066-21220-012-00D]; United Soybean Board project [9274, 1274]; ARS [ARS-0425092] Funding Source: Federal RePORTER	United States Department of Agriculture-Agriculture Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United Soybean Board project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture-Agriculture Research Service (USDA-ARS) project number 6066-21220-012-00D and United Soybean Board project numbers 9274 and 1274. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal EM, 2013, NUTRIENTS, V5, P1169, DOI 10.3390/nu5041169; Andrade-Sanchez P, 2014, FUNCT PLANT BIOL, V41, P68, DOI 10.1071/FP13126; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackburn GA, 2007, INT J REMOTE SENS, V28, P2831, DOI 10.1080/01431160600928625; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler E, 2009, EVOLUTION LINKAGE TA; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Cazzaniga S, 2012, PLANT PHYSIOL, V159, P1745, DOI 10.1104/pp.112.201137; Cazzonelli CI, 2010, PLANT DEVELOPMENTAL BIOLOGY: BIOTECHNOLOGICAL PERSPECTIVES VOL 2, P117, DOI 10.1007/978-3-642-04670-4_7; Cazzonelli CI, 2011, FUNCT PLANT BIOL, V38, P833, DOI 10.1071/FP11192; CHAPPELLE EW, 1992, REMOTE SENS ENVIRON, V39, P239, DOI 10.1016/0034-4257(92)90089-3; Chen XY, 2011, J PLANT PHYSIOL, V168, P1828, DOI 10.1016/j.jplph.2011.05.019; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Czyczylo-Mysza I, 2013, MOL BREEDING, V32, P189, DOI 10.1007/s11032-013-9862-8; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; Davison PA, 2002, NATURE, V418, P203, DOI 10.1038/nature00861; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Dhanapal AP, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.11.0086; Dhanapal AP, 2015, THEOR APPL GENET, V128, P73, DOI 10.1007/s00122-014-2413-9; Dhanapal AP, 2013, 3 BIOTECH, V3, P481, DOI 10.1007/s13205-012-0109-x; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; ESKINS K, 1981, PLANT PHYSIOL, V67, P759, DOI 10.1104/pp.67.4.759; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fernandez-Marin B, 2011, PLANTA, V234, P579, DOI 10.1007/s00425-011-1420-1; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GAUSMAN HW, 1984, ACS SYM SER, V257, P215; Giuliano G, 2014, CURR OPIN PLANT BIOL, V19, P111, DOI 10.1016/j.pbi.2014.05.006; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gotz T, 2002, PLANT MOL BIOL, V50, P129, DOI 10.1023/A:1016072218801; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Guo J, 2012, ANN BOT-LONDON, V110, P777, DOI 10.1093/aob/mcs142; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Holland JB, 2002, PL BRED RE, V22, P9; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Hwang EY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Kannan B, 2014, SCI WORLD J, DOI 10.1155/2014/562327; Krinsky NI, 2004, CAROTENOIDS HLTH DIS, P576; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Matthews PD, 2003, J EXP BOT, V54, P2215, DOI 10.1093/jxb/erg235; MIDDLETON EM, 1993, PLANT PHYSIOL, V103, P741, DOI 10.1104/pp.103.3.741; Murchie EH, 2002, PLANT PHYSIOL, V130, P1999, DOI 10.1104/pp.011098; Murchie EH, 1999, PLANT PHYSIOL, V119, P553, DOI 10.1104/pp.119.2.553; Musa A., 2012, International Journal of Biology, V4, P130; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; Piepho HP, 2008, EUPHYTICA, V161, P209, DOI 10.1007/s10681-007-9449-8; Piepho HP, 2007, GENETICS, V177, P1881, DOI 10.1534/genetics.107.074229; Pogson B.J., 2005, PHOTOSYSTEM, P515; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roelofsen HD, 2014, ECOL EVOL, V4, P706, DOI 10.1002/ece3.932; Ryu C, 2011, FIELD CROP RES, V122, P214, DOI 10.1016/j.fcr.2011.03.013; Sandmann G, 2001, TRENDS PLANT SCI, V6, P14, DOI 10.1016/S1360-1385(00)01817-3; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Singh SK, 2013, FIELD CROP RES, V149, P20, DOI 10.1016/j.fcr.2013.04.019; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Spurgeon S.L., 1980, BIOCH ISOPRENOID COM, P1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; Vigneau N, 2011, FIELD CROP RES, V122, P25, DOI 10.1016/j.fcr.2011.02.003; Wang LY, 2014, PLANT CELL REP, V33, P1441, DOI 10.1007/s00299-014-1627-2; Wang YL, 2004, BIOPHYS J, V86, P3097, DOI 10.1016/S0006-3495(04)74358-1; Wen ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-809; White JW, 2012, FIELD CROP RES, V133, P101, DOI 10.1016/j.fcr.2012.04.003; Wongsen W., 2013, International Food Research Journal, V20, P1113; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhang JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1441-4; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	82	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137213	10.1371/journal.pone.0137213	http://dx.doi.org/10.1371/journal.pone.0137213			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368323	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100058
J	Erdman, LK; D'Acremont, V; Hayford, K; Rajwans, N; Kilowoko, M; Kyungu, E; Hongoa, P; Alamo, L; Streiner, DL; Genton, B; Kain, KC				Erdman, Laura K.; D'Acremont, Valerie; Hayford, Kyla; Rajwans, Nimerta; Kilowoko, Mary; Kyungu, Esther; Hongoa, Philipina; Alamo, Leonor; Streiner, David L.; Genton, Blaise; Kain, Kevin C.			Biomarkers of Host Response Predict Primary End-Point Radiological Pneumonia in Tanzanian Children with Clinical Pneumonia: A Prospective Cohort Study	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED PNEUMONIA; LOWER RESPIRATORY-TRACT; PUBLIC-HEALTH; DOUBLE-BLIND; BACTERIAL; PROCALCITONIN; DIAGNOSIS; EFFICACY	Background Diagnosing pediatric pneumonia is challenging in low-resource settings. The World Health Organization (WHO) has defined primary end-point radiological pneumonia for use in epidemiological and vaccine studies. However, radiography requires expertise and is often inaccessible. We hypothesized that plasma biomarkers of inflammation and endothelial activation may be useful surrogates for end-point pneumonia, and may provide insight into its biological significance. Methods We studied children with WHO-defined clinical pneumonia (n = 155) within a prospective cohort of 1,005 consecutive febrile children presenting to Tanzanian outpatient clinics. Based on x-ray findings, participants were categorized as primary end-point pneumonia (n = 30), other infiltrates (n = 31), or normal chest x-ray (n = 94). Plasma levels of 7 host response biomarkers at presentation were measured by ELISA. Associations between biomarker levels and radiological findings were assessed by Kruskal-Wallis test and multivariable logistic regression. Biomarker ability to predict radiological findings was evaluated using receiver operating characteristic curve analysis and Classification and Regression Tree analysis. Results Compared to children with normal x-ray, children with end-point pneumonia had significantly higher C-reactive protein, procalcitonin and Chitinase 3-like-1, while those with other infiltrates had elevated procalcitonin and von Willebrand Factor and decreased soluble Tie-2 and endoglin. Clinical variables were not predictive of radiological findings. Classification and Regression Tree analysis generated multi-marker models with improved performance over single markers for discriminating between groups. A model based on C-reactive protein and Chitinase 3-like-1 discriminated between end-point pneumonia and non-end-point pneumonia with 93.3% sensitivity (95% confidence interval 76.5-98.8), 80.8% specificity (72.6-87.1), positive likelihood ratio 4.9 (3.4-7.1), negative likelihood ratio 0.083 (0.022-0.32), and misclassification rate 0.20 (standard error 0.038). Conclusions In Tanzanian children with WHO-defined clinical pneumonia, combinations of host biomarkers distinguished between end-point pneumonia, other infiltrates, and normal chest x-ray, whereas clinical variables did not. These findings generate pathophysiological hypotheses and may have potential research and clinical utility.	[Erdman, Laura K.; Hayford, Kyla; Rajwans, Nimerta; Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Sandra Rotman Ctr Global Hlth,Dept Med, Toronto, ON M5G 1L7, Canada; [D'Acremont, Valerie; Genton, Blaise] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [D'Acremont, Valerie; Genton, Blaise] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Kilowoko, Mary] Amana Reg Referral Hosp, Dar Es Salaam, Tanzania; [Kyungu, Esther; Hongoa, Philipina] St Francis Hosp, Ifakara, Tanzania; [Alamo, Leonor] Univ Hosp Lausanne CHUV, Dept Radiol, Lausanne, Switzerland; [Streiner, David L.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Genton, Blaise] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Basel; Swiss Tropical & Public Health Institute; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kain, KC (corresponding author), Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Sandra Rotman Ctr Global Hlth,Dept Med, Toronto, ON M5G 1L7, Canada.	kevin.kain@uhn.ca	Erdman, Laura/ABB-6936-2021; Boillat-Blanco, Noémie/GLT-5579-2022; Streiner, David/E-6563-2011	Erdman, Laura/0000-0001-8142-825X; Streiner, David/0000-0003-0610-6271; Kain, Kevin/0000-0001-6068-1272; Hayford, Kyla/0000-0002-9872-2313	Bill and Melinda Gates Foundation [OPP1022128]; Canada Research Chair; Canadian Institutes of Health Research (CIHR) [MOP-13721, MOP-136813, MOP-115160]; Swiss National Science Foundation [3270B0-109696, IZ70Z0-124023]; K-W Rotary International; Tesari Charitable Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); K-W Rotary International; Tesari Charitable Foundation	This work was supported by the Bill and Melinda Gates Foundation (OPP1022128 to KCK; www.gatesfoundation.org); a Canada Research Chair (to KCK; www.chairs-chaires.gc.ca); Canadian Institutes of Health Research (CIHR MOP-13721, MOP-136813 and MOP-115160 to KCK, and MD/PhD Studentship to LKE; www.cihr-irsc.gc.ca); the Swiss National Science Foundation (3270B0-109696 and IZ70Z0-124023 to VD and BG; www.snf.ch); K-W Rotary International (to KCK; www.rotarykw.ca); and the Tesari Charitable Foundation (to KCK; tesarifoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronikou S, 2011, PEDIATR RADIOL, V41, P811, DOI 10.1007/s00247-011-2081-8; [Anonymous], 2001, STAND INT CHEST RAD; [Anonymous], 2005, EMERGENCY TRIAGE ASS; Arnold R, 2005, J IMMUNOL, V174, P7359, DOI 10.4049/jimmunol.174.11.7359; Baer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068419; Berg P, 2012, DAN MED J, V59; Breiman L., 1984, CLASSIFICATION REGRE; Chan CPY, 2013, ANNU REV ANAL CHEM, V6, P191, DOI 10.1146/annurev-anchem-062012-092641; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cheung YB, 2008, TROP MED INT HEALTH, V13, P603, DOI 10.1111/j.1365-3156.2008.02050.x; Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; COURTOY I, 1989, CLIN PEDIATR, V28, P261, DOI 10.1177/000992288902800604; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; de Wit M, 2013, CLIN BIOCHEM, V46, P466, DOI 10.1016/j.clinbiochem.2012.10.039; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Diez-Padrisa N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013226; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Erdman LK, 2010, PLOS ONE, V6; Esposito S, 2011, RESP MED, V105, P1939, DOI 10.1016/j.rmed.2011.09.003; FRIIS B, 1990, ACTA PAEDIATR SCAND, V79, P219, DOI 10.1111/j.1651-2227.1990.tb11442.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huang HL, 2014, CLIN INFECT DIS, V58, P1707, DOI 10.1093/cid/ciu202; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lynch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011989; Madhi SA, 2006, PEDIATR INFECT DIS J, V25, P30, DOI 10.1097/01.inf.0000195787.99199.4a; Murray J, 2014, MMWR-MORBID MORTAL W, V63, P1159; Nordenbaek C, 1999, J INFECT DIS, V180, P1722, DOI 10.1086/315050; Oved K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120012; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pittet LF, 2012, CLIN MICROBIOL INFEC, V18, P25, DOI 10.1111/j.1469-0691.2012.03938.x; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB; Vernatter J, 2013, CURR OPIN INFECT DIS, V26, P277, DOI 10.1097/QCO.0b013e3283608419; Virkki R, 2002, THORAX, V57, P438, DOI 10.1136/thorax.57.5.438; Wilkins Tyler R, 2005, Radiol Technol, V77, P106; Woods CR, 2008, PEDIATR ANN, V37, P694, DOI 10.3928/00904481-20081001-11; World Health Organization, 1991, TECHN BAS WHO REC MA; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280	48	29	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137592	10.1371/journal.pone.0137592	http://dx.doi.org/10.1371/journal.pone.0137592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366571	gold, Green Published, Green Accepted			2022-12-26	WOS:000361601100090
J	Henry, L; Biquand, V; Craig, AJFK; Hausberger, M				Henry, Laurence; Biquand, Veronique; Craig, Adrian J. F. K.; Hausberger, Martine			Sexing Adult Pale-Winged Starlings Using Morphometric and Discriminant Function Analysis	PLOS ONE			English	Article							EXTERNAL MEASUREMENTS; SEXUAL-DIMORPHISM; BIRDS; DNA; PLUMAGE	Accurate sexing of birds is vital for behavioral studies but can be a real problem in the field, especially for monomorphic species. Our goal here was to characterize the morphology of male and female monomorphic pale-winged starlings (Onychognathus nabouroup), a South African sturnid whose plumage is sexually monomorphic. Morphological measurements of genetically sexed animals indicated that males were statistically larger than females for five measurements: Mass, tail length, tarsus length and wing length. By using a Discriminant Function Analysis based on the measurements taken by one ringer, we were able to predict correctly the sex of 81.10% of the birds of data collected in the field and 77.9% of museum skins independently of year of capture and ringer. The model developed here should be useful for further field studies of this species.	[Henry, Laurence; Biquand, Veronique; Hausberger, Martine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Craig, Adrian J. F. K.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Rhodes University	Henry, L (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	Laurence.henry@univ-rennes1.fr			Centre National de la Recherche Scientifique (CNRS); National Research Foundation (NRF); Rhodes University; Rennes 1 University	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); National Research Foundation (NRF); Rhodes University; Rennes 1 University	Our studies were funded primarily by grants from the Centre National de la Recherche Scientifique (CNRS) to Martine Hausberger (France) and National Research Foundation (NRF) to Adrian Craig (South Africa) (through the CNRS PICS and LIA programs), with additional funding from Rhodes University and Rennes 1 University.	Cardoni DA, 2009, ORNITOL NEOTROP, V20, P347; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; Brady RS, 2009, J FIELD ORNITHOL, V80, P198, DOI 10.1111/j.1557-9263.2009.00209.x; CLARK RG, 1991, J FIELD ORNITHOL, V62, P132; De Beer S.J., 2001, SAFRING BIRD RINGING; Dechaume-Moncharmont FX, 2011, AUK, V128, P78, DOI 10.1525/auk.2011.10129; Feare C.J., 2009, HDB BIRDS WORLD BUSH, V14, P654; Handel CM, 2006, WILDLIFE SOC B, V34, P1094, DOI 10.2193/0091-7648(2006)34[1094:UOBSFS]2.0.CO;2; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Houdelier C, 2012, NATURWISSENSCHAFTEN, V99, P1051, DOI 10.1007/s00114-012-0987-0; Kiss JB, 2005, RINGING MIGRATION, V22, P163; Miller RA, 1938, BEHAVIOUR, V120, P262; Nisbet ICT, 1999, IBIS, V141, P307, DOI 10.1111/j.1474-919X.1999.tb07553.x; Rajchard J, 2009, VET MED-CZECH, V54, P351, DOI 10.17221/110/2009-VETMED; Robertson BC, 2006, CONSERV GENET, V7, P267, DOI 10.1007/s10592-005-9105-6; Shealer DA, 2007, WATERBIRDS, V30, P180, DOI 10.1675/1524-4695(2007)30[180:SDOABT]2.0.CO;2; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SONTAG W A JR, 1990, Bonner Zoologische Beitraege, V41, P163; Van De Pol M, 2009, IBIS, V151, P171, DOI 10.1111/j.1474-919X.2008.00891.x; van Rooij EP, 2010, ETHOLOGY, V116, P929, DOI 10.1111/j.1439-0310.2010.01808.x; Weidinger K, 1998, J ZOOL, V245, P473, DOI 10.1017/S0952836998008115; Wellbrock AHJ, 2012, J ORNITHOL, V153, P991, DOI 10.1007/s10336-012-0843-1; Wilson RR, 1999, J FIELD ORNITHOL, V70, P514; Zavalaga CB, 1997, J FIELD ORNITHOL, V68, P102	25	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0135628	10.1371/journal.pone.0135628	http://dx.doi.org/10.1371/journal.pone.0135628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367269	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100011
J	Liu, Z; Ueda, K; Kim, HJ; Sparrow, JR				Liu, Zhao; Ueda, Keiko; Kim, Hye Jin; Sparrow, Janet R.			Photobleaching and Fluorescence Recovery of RPE Bisretinoids	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; SINGLET-OXYGEN; MACULAR DEGENERATION; PHOTOOXIDATION PRODUCTS; PHOTODYNAMIC THERAPY; A2E; LIPOFUSCIN; LIGHT; INVOLVEMENT; MECHANISMS	The autofluorescence of the retina that originates primarily from lipofuscin fluorophores in retinal pigment epithelial cells, is observed to undergo photobleaching during the acquisition of fundus autofluorescence images. Bisretinoid fluorophores isolated from retinal pigment epithelial cells have the spectral characteristics consistent with their being the source of fundus autofluorescence. Clinically relevant experiments were designed to better understand conditions in the micromilieu of bisretinoid fluorophores that can influence fluorescence efficiencies, photobleaching, and subsequent fluorescence recovery of this fluorophore. The consumption of the bisretinoid A2E due to photooxidation-induced degradation was quantified in solvent systems of variable relative permittivity (formerly called dielectric constant), in micelles, and in phospholipid vesicles of varying composition. Reorganization within biphasic systems was also examined. A2E content was measured by high performance liquid chromatography (HPLC) and fluorescence intensity was quantified spectroscopically. As solvent polarity was increased, A2E fluorescent spectra exhibited red-shifted maxima and reduced intensity. A2E was depleted by light irradiation and the loss was more pronounced in less polar solvents, lower concentrations of anionic surfactant, and in gel-versus fluid-ordered phospholipid liposomes. Conditions that permit A2E aggregation promoted photooxidation/photodegradation, while movement of A2E between bisphasic systems was associated with fluorescence recovery after photobleaching. The fluorescence characteristics of A2E are subject to environmental modulation. Photooxidation and photodegradation of bisretinoid can account for fundus autofluorescence photobleaching. Return of fluorescence intensity after photobleaching likely occurs due to redistribution of A2E fractions amongst co-existing heterogeneous microdomains of the lysosomal compartment.	[Liu, Zhao; Ueda, Keiko; Kim, Hye Jin; Sparrow, Janet R.] Columbia Univ, Dept Ophthalmol, Med Ctr, New York, NY 10027 USA; [Sparrow, Janet R.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Sparrow, Janet R.] Columbia Univ, Dept Cell Biol, Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Sparrow, JR (corresponding author), Columbia Univ, Dept Ophthalmol, Med Ctr, New York, NY 10027 USA.	jrs88@cumc.columbia.edu			National Institutes of Health [EY004367, EY012951, P30EY019007]; Research to Prevent Blindness to the Department of Ophthalmology; NATIONAL EYE INSTITUTE [R01EY012951, R01EY004367, P30EY019007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness to the Department of Ophthalmology(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors acknowledge support from National Institutes of Health grants EY004367, EY012951 and P30EY019007. A grant from Research to Prevent Blindness to the Department of Ophthalmology is gratefully acknowledged. The following authors received salary from the funders. Zhao Liu: EY004367 Keiko Ueda: EY012951 Hyejin Kim: EY012951 Janet Sparrow: EY004367, EY012951. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Bonnett R, 2001, TETRAHEDRON, V57, P9513, DOI 10.1016/S0040-4020(01)00952-8; Cano M, 2011, AM J PATHOL, V179, P850, DOI 10.1016/j.ajpath.2011.04.010; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dabkowska AP, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3658382; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; Dillon J, 2004, EXP EYE RES, V79, P537, DOI 10.1016/j.exer.2004.06.024; Georgakoudi I, 1998, PHOTOCHEM PHOTOBIOL, V67, P612, DOI 10.1111/j.1751-1097.1998.tb09463.x; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Jang YP, 2005, J BIOL CHEM, V280, P39732, DOI 10.1074/jbc.M504933200; Jarvi MT, 2012, BIOPHYS J, V102, P661, DOI 10.1016/j.bpj.2011.12.043; JOHANSSON LBA, 1987, J PHYS CHEM-US, V91, P5275, DOI 10.1021/j100304a028; Kanofsky JR, 2003, PHOTOCHEM PHOTOBIOL, V77, P235, DOI 10.1562/0031-8655(2003)077<0235:SOGFA>2.0.CO;2; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; Lamb LE, 2001, J PHYS CHEM B, V105, P11507, DOI 10.1021/jp0123177; Mesquita RMRS, 2000, BIOPHYS J, V78, P3019, DOI 10.1016/S0006-3495(00)76840-8; MOAN J, 1988, J PHOTOCH PHOTOBIO B, V1, P429, DOI 10.1016/1011-1344(88)85003-6; Morgan JIW, 2008, INVEST OPHTH VIS SCI, V49, P3715, DOI 10.1167/iovs.07-1430; Morgan JIW, 2009, INVEST OPHTH VIS SCI, V50, P1350, DOI 10.1167/iovs.08-2618; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Ren RXF, 1997, J AM CHEM SOC, V119, P3619, DOI 10.1021/ja9700414; RODGERS MAJ, 1983, J AM CHEM SOC, V105, P6201, DOI 10.1021/ja00358a001; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1480, DOI 10.1039/c0pp00207k; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; WILKINSON F, 1981, J PHYS CHEM REF DATA, V10, P809, DOI 10.1063/1.555655; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Yamamoto K, 2012, INVEST OPHTH VIS SCI, V53, P3536, DOI 10.1167/iovs.12-9535; Yoon KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041309; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	32	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138081	10.1371/journal.pone.0138081	http://dx.doi.org/10.1371/journal.pone.0138081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366866	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100218
J	Nyasembe, VO; Cheseto, X; Kaplan, F; Foster, WA; Teal, PEA; Tumlinson, JH; Borgemeister, C; Torto, B				Nyasembe, Vincent O.; Cheseto, Xavier; Kaplan, Fatma; Foster, Woodbridge A.; Teal, Peter E. A.; Tumlinson, James H.; Borgemeister, Christian; Torto, Baldwyn			The Invasive American Weed Parthenium hysterophorus Can Negatively Impact Malaria Control in Africa	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; CLIMATE-CHANGE; WESTERN KENYA; BIDENS-PILOSA; FLORAL NECTAR; PLANTS; SURVIVAL; CULICIDAE; MOSQUITOS; DIPTERA	The direct negative effects of invasive plant species on agriculture and biodiversity are well known, but their indirect effects on human health, and particularly their interactions with disease-transmitting vectors, remains poorly explored. This study sought to investigate the impact of the invasive Neotropical weed Parthenium hysterophorus and its toxins on the survival and energy reserves of the malaria vector Anopheles gambiae. In this study, we compared the fitness of An. gambiae fed on three differentially attractive mosquito host plants and their major toxins; the highly aggressive invasive Neotropical weed Parthenium hysterophorus (Asteraceae) in East Africa and two other adapted weeds, Ricinus communis (Euphorbiaceae) and Bidens pilosa (Asteraceae). Our results showed that female An. gambiae fitness varied with host plants as females survived better and accumulated substantial energy reserves when fed on P. hysterophorus and R. communis compared to B. pilosa. Females tolerated parthenin and 1-phenylhepta-1, 3, 5-triyne, the toxins produced by P. hysterophorus and B. pilosa, respectively, but not ricinine produced by R. communis. Given that invasive plants like P. hysterophorus can suppress or even replace less competitive species that might be less suitable host-plants for arthropod disease vectors, the spread of invasive plants could lead to higher disease transmission. Parthenium hysterophorus represents a possible indirect effect of invasive plants on human health, which underpins the need to include an additional health dimension in risk-analysis modelling for invasive plants.	[Nyasembe, Vincent O.; Cheseto, Xavier; Borgemeister, Christian; Torto, Baldwyn] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Kaplan, Fatma; Teal, Peter E. A.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL 32608 USA; [Kaplan, Fatma] Kaplan Schiller Res LLC, Gainesville, FL 32604 USA; [Foster, Woodbridge A.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Tumlinson, James H.] Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA; [Borgemeister, Christian] Univ Bonn, Ctr Dev Res ZEF, D-53113 Bonn, Germany	International Centre of Insect Physiology & Ecology (ICIPE); United States Department of Agriculture (USDA); University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Bonn	Torto, B (corresponding author), Int Ctr Insect Physiol & Ecol, Box 30772, Nairobi, Kenya.	btorto@icipe.org	Kaplan, Fatma/AAJ-7666-2020	Kaplan, Fatma/0000-0002-9565-0211; Cheseto, Xavier/0000-0002-9779-0357	USDA/ARS - Center for Medical, Agricultural, and Veterinary Entomology; U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [RO1A1077722]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031637] Funding Source: NIH RePORTER	USDA/ARS - Center for Medical, Agricultural, and Veterinary Entomology; U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded in part by USDA/ARS - Center for Medical, Agricultural, and Veterinary Entomology; and by the U.S. National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) grant RO1A1077722.	Adkins SW, 2011, SUSTAINABLE MANAGEME, pS238; Atella GC, 2002, J EXP BIOL, V205, P3623; Atella GC, 2009, ACTA TROP, V109, P159, DOI 10.1016/j.actatropica.2008.10.004; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Batish DR, 2002, ENVIRON EXP BOT, V47, P149, DOI 10.1016/S0098-8472(01)00122-8; Brandao MGL, 1997, J ETHNOPHARMACOL, V57, P131, DOI 10.1016/S0378-8741(97)00060-3; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; BRIGGS CJ, 1995, J ANIM ECOL, V64, P403, DOI 10.2307/5900; CHAN MS, 1993, EVOL ECOL, V7, P593, DOI 10.1007/BF01237823; Chang MH, 2000, J CHIN CHEM SOC-TAIP, V47, P1131, DOI 10.1002/jccs.200000152; Clements A.N., 1992, BIOL MOSQUITOES DEV, V1, P509; Das B, 2007, PHYTOCHEMISTRY, V68, P2029, DOI 10.1016/j.phytochem.2007.05.002; Dukes JS, 2009, CAN J FOREST RES, V39, P231, DOI 10.1139/X08-171; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Gary RE, 2004, MED VET ENTOMOL, V18, P102, DOI 10.1111/j.0269-283X.2004.00483.x; Gary RE, 2005, BIOL MALARIA VECTOR, P69; Gu WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015996; Ham OBA, 2007, PHARMAZIE, V62, P226, DOI 10.1691/ph.2007.3.6628; HERZ W, 1962, J AM CHEM SOC, V84, P2601, DOI 10.1021/ja00872a027; Impoinvil DE, 2004, MED VET ENTOMOL, V18, P108, DOI 10.1111/j.0269-283X.2004.00484.x; Javaid A, 2007, PAK J BOT, V39, P2611; KANCHAN SD, 1975, CURR SCI INDIA, V44, P358; Kohl KD, 2014, ECOL LETT, V17, P1238, DOI 10.1111/ele.12329; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lee JC, 2004, ENTOMOL EXP APPL, V111, P189, DOI 10.1111/j.0013-8703.2004.00165.x; Manda H, 2007, MED VET ENTOMOL, V21, P103, DOI 10.1111/j.1365-2915.2007.00672.x; Manda H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-113; McConnachie AJ, 2011, WEED RES, V51, P71, DOI 10.1111/j.1365-3180.2010.00820.x; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-262; Nikbakhtzadeh MR, 2014, J VECTOR ECOL, V39, P372, DOI 10.1111/jvec.12113; Nyasembe VO, 2014, CURR BIOL, V24, P217, DOI 10.1016/j.cub.2013.12.022; Nyasembe VO, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-234; Okech BA, 2003, J MED ENTOMOL, V40, P657, DOI 10.1603/0022-2585-40.5.657; Orech FO, 2007, INT J FOOD SCI NUTR, V58, P522, DOI 10.1080/09637480701331163; Oudhia P., 1998, PARTHENIUM CURSE BIO, P30; PICMAN J, 1984, BIOCHEM SYST ECOL, V12, P287, DOI 10.1016/0305-1978(84)90051-6; R Development Team, 2010, R LANG ENV STAT COMP; Ramos-Lopez M, 2012, AFRIC J BIOTECH, P9; Rivero A, 1999, RES POPUL ECOL, V41, P39, DOI 10.1007/PL00011981; Shimoma F, 1998, J ORG CHEM, V63, P3758, DOI 10.1021/jo972077k; Singh HP, 2003, AGR ECOSYST ENVIRON, V95, P537, DOI 10.1016/S0167-8809(02)00202-5; Souza KMR, 2013, NAT PROD RES, V27, P364, DOI 10.1080/14786419.2012.695368; Stone CM, 2013, ECOL CONT VECTOR-BOR, V3, P35; Tamado T, 2000, WEED RES, V40, P507, DOI 10.1046/j.1365-3180.2000.00208.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; VANHANDE.E, 1972, MOSQ NEWS, V32, P458; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P302; VANHANDEL E, 1988, J AM MOSQUITO CONTR, V4, P549; Vitousek PM, 1996, AM SCI, V84, P468; Wachira SW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-312; WILLIAMS JD, 1980, WEED RES, V20, P47, DOI 10.1111/j.1365-3180.1980.tb00040.x; Witt A, 2010, IMPACTS INVASIVE PLA, P1102; Woodring Jennifer L., 1996, P51; Wu HP, 2008, BIOL CONTROL, V45, P353, DOI 10.1016/j.biocontrol.2008.01.017	55	29	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137836	10.1371/journal.pone.0137836	http://dx.doi.org/10.1371/journal.pone.0137836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367123	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100150
J	Ojelade, SA; Acevedo, SF; Kalahasti, G; Rodan, AR; Rothenfluh, A				Ojelade, Shamsideen A.; Acevedo, Summer F.; Kalahasti, Geetha; Rodan, Aylin R.; Rothenfluh, Adrian			RhoGAP18B Isoforms Act on Distinct Rho-Family GTPases and Regulate Behavioral Responses to Alcohol via Cofilin	PLOS ONE			English	Article							LOW-LEVEL; ETHANOL; DROSOPHILA; CYTOSKELETON; CONSUMPTION; DYNAMICS; CELLS; EPS8; RAC; MECHANISMS	Responses to the effects of ethanol are highly conserved across organisms, with reduced responses to the sedating effects of ethanol being predictive of increased risk for human alcohol dependence. Previously, we described that regulators of actin dynamics, such as the Rho-family GTPases Rac1, Rho1, and Cdc42, alter Drosophila's sensitivity to ethanol-induced sedation. The GTPase activating protein RhoGAP18B also affects sensitivity to ethanol. To better understand how different RhoGAP18B isoforms affect ethanol sedation, we examined them for their effects on cell shape, GTP-loading of Rho-family GTPase, activation of the actin-severing cofilin, and actin filamentation. Our results suggest that the RhoGAP18B-PA isoform acts on Cdc42, while PC and PD act via Rac1 and Rho1 to activate cofilin. In vivo, a loss-of-function mutation in the cofilin-encoding gene twinstar leads to reduced ethanol-sensitivity and acts in concert with RhoGAP18B. Different RhoGAP18B isoforms, therefore, act on distinct subsets of Rho-family GTPases to modulate cofilin activity, actin dynamics, and ethanol-induced behaviors.	[Ojelade, Shamsideen A.; Acevedo, Summer F.; Kalahasti, Geetha; Rothenfluh, Adrian] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ojelade, Shamsideen A.; Rothenfluh, Adrian] Univ Texas SW Med Ctr Dallas, Program Neurosci, Dallas, TX 75390 USA; [Rodan, Aylin R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nephrol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rothenfluh, A (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	Adrian.Rothenfluh@UTSouthwestern.edu		Acevedo, Summer/0000-0002-3206-6819; Rothenfluh, Adrian/0000-0002-3813-5723; Rodan, Aylin/0000-0001-9202-2378	National Institute of Health [DA007290, F31 AA021340, K08DK091316, R01AA019526]; Effie Marie Cain Scholarship in Biomedical Research from UT Southwestern; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK091316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019526, F31AA021340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Effie Marie Cain Scholarship in Biomedical Research from UT Southwestern; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health (nib.gov) grants to S.A.O. (T32 fellowship DA007290 and F31 AA021340), A.R.R (K08DK091316), and A.R (R01AA019526). A.R. was also supported by an Effie Marie Cain Scholarship in Biomedical Research from UT Southwestern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo SF, 2015, J NEUROSCI; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Enoch MA, 1999, PSYCHIAT CLIN N AM, V22, P289, DOI 10.1016/S0193-953X(05)70077-0; Guarnieri Douglas J, 2003, Int Rev Neurobiol, V54, P199, DOI 10.1016/S0074-7742(03)54006-5; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Knox S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000375; Lee HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001391; Malliri Angeliki, 2002, Methods Mol Biol, V189, P99; Manzo-Avalos S, 2010, INT J ENV RES PUB HE, V7, P4281, DOI 10.3390/ijerph7124281; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Meyer G, 2002, J NEUROCHEM, V83, P490, DOI 10.1046/j.1471-4159.2002.01185.x; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Ojelade SA, 2015, P NATL ACAD SCI USA, V112, pE4085, DOI 10.1073/pnas.1417222112; Ojelade SA, 2013, REV NEUROSCIENCE, V24, P471, DOI 10.1515/revneuro-2013-0017; Peru y Colon de Portugal RL, 2013, ADDICT BIOL, DOI [10.1111/adb.12105, DOI 10.1111/ADB.12105]; Popp RL, 2008, ALCOHOL, V42, P525, DOI 10.1016/j.alcohol.2008.06.006; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shuai YC, 2010, PROTEIN CELL, V1, P503, DOI 10.1007/s13238-010-0077-z; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1111/j.1530-0277.2000.tb02075.x; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Wolf FW, 2002, J NEUROSCI, V22, P11035	35	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137465	10.1371/journal.pone.0137465	http://dx.doi.org/10.1371/journal.pone.0137465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366560	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100076
J	Subramanian, A; Jhawar, J; Sarkar, RR				Subramanian, Abhishek; Jhawar, Jitesh; Sarkar, Ram Rup			Dissecting Leishmania infantum Energy Metabolism - A Systems Perspective	PLOS ONE			English	Article							SUBSTRATE LEVEL PHOSPHORYLATION; PROCYCLIC TRYPANOSOMA-BRUCEI; CONSTRAINT-BASED MODELS; FLUX BALANCE ANALYSIS; CARBOHYDRATE-METABOLISM; ENZYME-ACTIVITIES; KREBS CYCLE; MEXICANA; PROTEINS; COMPARTMENTATION	Leishmania infantum, causative agent of visceral leishmaniasis in humans, illustrates a complex lifecycle pertaining to two extreme environments, namely, the gut of the sandfly vector and human macrophages. Leishmania is capable of dynamically adapting and tactically switching between these critically hostile situations. The possible metabolic routes ventured by the parasite to achieve this exceptional adaptation to its varying environments are still poorly understood. In this study, we present an extensively reconstructed energy metabolism network of Leishmania infantum as an attempt to identify certain strategic metabolic routes preferred by the parasite to optimize its survival in such dynamic environments. The reconstructed network consists of 142 genes encoding for enzymes performing 237 reactions distributed across five distinct model compartments. We annotated the subcellular locations of different enzymes and their reactions on the basis of strong literature evidence and sequence-based detection of cellular localization signal within a protein sequence. To explore the diverse features of parasite metabolism the metabolic network was implemented and analyzed as a constraint-based model. Using a systems-based approach, we also put forth an extensive set of lethal reaction knockouts; some of which were validated using published data on Leishmania species. Performing a robustness analysis, the model was rigorously validated and tested for the secretion of overflow metabolites specific to Leishmania under varying extracellular oxygen uptake rate. Further, the fate of important non-essential amino acids in L. infantum metabolism was investigated. Stage-specific scenarios of L. infantum energy metabolism were incorporated in the model and key metabolic differences were outlined. Analysis of the model revealed the essentiality of glucose uptake, succinate fermentation, glutamate biosynthesis and an active TCA cycle as driving forces for parasite energy metabolism and its optimal growth. Finally, through our in silico knockout analysis, we could identify possible therapeutic targets that provide experimentally testable hypotheses.	[Subramanian, Abhishek; Jhawar, Jitesh; Sarkar, Ram Rup] Natl Chem Lab, CSIR, Chem Engn & Proc Dev, Pune, Maharashtra, India; [Subramanian, Abhishek; Sarkar, Ram Rup] CSIR, Acad Sci & Innovat Res AcSIR, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Sarkar, RR (corresponding author), Natl Chem Lab, CSIR, Chem Engn & Proc Dev, Pune, Maharashtra, India.	rr.sarkar@ncl.res.in	Subramanian, Abhishek/AAN-1302-2020	Subramanian, Abhishek/0000-0002-4601-5991; SARKAR, RAM RUP/0000-0001-7115-163X	Council of Scientific and Industrial Research, XII Five Year Plan Project "HOPE" [BSC0114]	Council of Scientific and Industrial Research, XII Five Year Plan Project "HOPE"	RRS is supported by a grant from Council of Scientific and Industrial Research, XII Five Year Plan Project "HOPE" (BSC0114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOINE JC, 1990, INFECT IMMUN, V58, P779, DOI 10.1128/IAI.58.3.779-787.1990; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Barrett MP, 1999, TRENDS MICROBIOL, V7, P82, DOI 10.1016/S0966-842X(98)01433-4; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; BORST P, 1986, BIOCHIM BIOPHYS ACTA, V866, P179, DOI 10.1016/0167-4781(86)90044-8; Bressi JC, 2000, J MED CHEM, V43, P4135, DOI 10.1021/jm000287a; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Brotherton MC, 2010, J PROTEOME RES, V9, P3842, DOI 10.1021/pr100048m; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chavali AK, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-27; Chavali AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.15; Colasante Claudia, 2013, F1000Res, V2, P27, DOI 10.12688/f1000research.2-27.v1; COOMBS GH, 1982, MOL BIOCHEM PARASIT, V5, P199, DOI 10.1016/0166-6851(82)90021-4; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; El Fakhry Y, 2002, PROTEOMICS, V2, P1007, DOI 10.1002/1615-9861(200208)2:8<1007::AID-PROT1007>3.0.CO;2-G; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Garami A, 2001, J BIOL CHEM, V276, P6566, DOI 10.1074/jbc.M009226200; Garami A, 2001, MOL CELL BIOL, V21, P8168, DOI 10.1128/MCB.21.23.8168-8183.2001; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghozlane Amine, 2012, Advances in Bioinformatics, V2012, P159423, DOI 10.1155/2012/159423; Gualdron-Lopez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034530; Guerra-Giraidez C, 2002, J CELL SCI, V115, P2651; HART DT, 1982, EXP PARASITOL, V54, P397, DOI 10.1016/0014-4894(82)90049-2; Joyce Andrew R, 2007, Prog Drug Res, V64, P267; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; KEEGAN F, 1990, MOL BIOCHEM PARASIT, V39, P235, DOI 10.1016/0166-6851(90)90062-Q; Lamerz AC, 2010, GLYCOBIOLOGY, V20, P872, DOI 10.1093/glycob/cwq045; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Louassini M, 1999, PARASITOL RES, V85, P300, DOI 10.1007/s004360050552; Louassini M, 1999, J PARASITOL, V85, P595, DOI 10.2307/3285729; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; MEADE JC, 1984, J PROTOZOOL, V31, P156, DOI 10.1111/j.1550-7408.1984.tb04307.x; Merlen T, 1999, AM J TROP MED HYG, V60, P41, DOI 10.4269/ajtmh.1999.60.41; MICHELS PAM, 1988, BIOL CELL, V64, P157, DOI 10.1016/0248-4900(88)90075-5; MISSET O, 1986, EUR J BIOCHEM, V157, P441, DOI 10.1111/j.1432-1033.1986.tb09687.x; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Opperdoes FR, 2001, INT J PARASITOL, V31, P482, DOI 10.1016/S0020-7519(01)00155-2; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pinney JW, 2007, TRENDS PARASITOL, V23, P548, DOI 10.1016/j.pt.2007.08.013; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Roberts SB, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-52; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Luque-Ortega JR, 2008, FASEB J, V22, P1817, DOI 10.1096/fj.07-096081; Luque-Ortega JR, 2007, ANTIMICROB AGENTS CH, V51, P1327, DOI 10.1128/AAC.01415-06; Roper JR, 2002, P NATL ACAD SCI USA, V99, P5884, DOI 10.1073/pnas.092669999; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Ter Kuile BH, 1999, J BACTERIOL, V181, P4863, DOI 10.1128/JB.181.16.4863-4872.1999; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thorleifsson SG, 2011, BIOINFORMATICS, V27, P2009, DOI 10.1093/bioinformatics/btr308; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Zar J.H., 2010, BIOSTAT ANAL; Zhang WW, 2013, EUKARYOT CELL, V12, P70, DOI 10.1128/EC.00263-12	77	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137976	10.1371/journal.pone.0137976	http://dx.doi.org/10.1371/journal.pone.0137976			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367006	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100191
J	Wang, H; Shun, MC; Dickson, AK; Engelman, AN				Wang, Hao; Shun, Ming-Chieh; Dickson, Amy K.; Engelman, Alan N.			Embryonic Lethality Due to Arrested Cardiac Development in Psip1/Hdgfrp2 Double-Deficient Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FOCAL ADHESION KINASE; HIV-1 INTEGRASE; TRANSCRIPTIONAL COACTIVATOR; GENE-EXPRESSION; CHROMATIN BINDING; CELL-ADHESION; KNOCKOUT MICE; LEDGF/P75; DOMAIN	Hepatoma-derived growth factor (HDGF) related protein 2 (HRP2) and lens epitheliumderived growth factor (LEDGF)/p75 are closely related members of the HRP2 protein family. LEDGF/p75 has been implicated in numerous human pathologies including cancer, autoimmunity, and infectious disease. Knockout of the Psip1 gene, which encodes for LEDGF/p75 and the shorter LEDGF/p52 isoform, was previously shown to cause perinatal lethality in mice. The function of HRP2 was by contrast largely unknown. To learn about the role of HRP2 in development, we knocked out the Hdgfrp2 gene, which encodes for HRP2, in both normal and Psip1 knockout mice. Hdgfrp2 knockout mice developed normally and were fertile. By contrast, the double deficient mice died at approximate embryonic day (E) 13.5. Histological examination revealed ventricular septal defect (VSD) associated with E14.5 double knockout embryos. To investigate the underlying molecular mechanism(s), RNA recovered from ventricular tissue was subjected to RNA-sequencing on the Illumina platform. Bioinformatic analysis revealed several genes and biological pathways that were significantly deregulated by the Psip1 knockout and/or Psip1/Hdgfrp2 double knockout. Among the dozen genes known to encode for LEDGF/p75 binding factors, only the expression of Nova1, which encodes an RNA splicing factor, was significantly deregulated by the knockouts. However the expression of other RNA splicing factors, including the LEDGF/p52-interacting protein ASF/SF2, was not significantly altered, indicating that deregulation of global RNA splicing was not a driving factor in the pathology of the VSD. Tumor growth factor (Tgf) beta-signaling, which plays a key role in cardiac morphogenesis during development, was the only pathway significantly deregulated by the double knockout as compared to control and Psip1 knockout samples. We accordingly speculate that deregulated Tgf-beta signaling was a contributing factor to the VSD and prenatal lethality of Psip1/Hdgfrp2 double-deficient mice.	[Engelman, Alan N.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Engelman, AN (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA.	alan_engelman@dfic.harvard.edu			US National Institutes of Health [R37 AI039394]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039394] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grant R37 AI039394 to ANE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bao CH, 2014, FUTURE ONCOL, V10, P2675, DOI 10.2217/fon.14.194; Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Briggs SF, 2014, CURR OPIN GENET DEV, V28, P78, DOI 10.1016/j.gde.2014.09.010; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Corda S, 2000, Heart Fail Rev, V5, P119, DOI 10.1023/A:1009806403194; Fassler R, 1996, J CELL SCI, V109, P2989; Gallitzendoerfer R, 2008, DEV DYNAM, V237, P1875, DOI 10.1002/dvdy.21589; Ge H, 1998, MOL CELL, V2, P751, DOI 10.1016/S1097-2765(00)80290-7; Gerard A, 2015, CELL HOST MICROBE, V17, P107, DOI 10.1016/j.chom.2014.12.002; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; HEINO J, 1989, J BIOL CHEM, V264, P21806; HEINO J, 1989, J BIOL CHEM, V264, P380; HINES KL, 1994, P NATL ACAD SCI USA, V91, P5187, DOI 10.1073/pnas.91.11.5187; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; Izumoto Y, 1997, BIOCHEM BIOPH RES CO, V238, P26, DOI 10.1006/bbrc.1997.7233; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kirchhoff S, 2000, CIRC RES, V87, P399; KULKARNI AB, 1993, AM J PATHOL, V143, P3; Kvaratskhelia M, 2014, NUCLEIC ACIDS RES, V42, P10209, DOI 10.1093/nar/gku769; Li XL, 2006, EXP CELL RES, V312, P854, DOI 10.1016/j.yexcr.2005.12.002; Llano M, 2009, CURR TOP MICROBIOL, V339, P125, DOI 10.1007/978-3-642-02175-6_7; Lu R, 2013, TRENDS BIOCHEM SCI, V38, P546, DOI 10.1016/j.tibs.2013.08.002; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; McClive P, 1998, DEV DYNAM, V212, P267, DOI 10.1002/(SICI)1097-0177(199806)212:2<267::AID-AJA11>3.0.CO;2-1; Morchikh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081217; Murai MJ, 2014, BLOOD, V124, P3730, DOI 10.1182/blood-2014-01-550079; Nishizawa Y, 2001, CELL TISSUE RES, V305, P107, DOI 10.1007/s004410100398; Park JW, 2013, METHODS MOL BIOL, V1038, P171, DOI 10.1007/978-1-62703-514-9_10; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Pradeepa MM, 2014, NUCLEIC ACIDS RES, V42, P9021, DOI 10.1093/nar/gku647; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salmon NA, 2006, GENESIS, V44, P515, DOI 10.1002/dvg.20241; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Schrijvers R, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-84; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Takehara-Kasamatsu Yuka, 2007, J Med Invest, V54, P276, DOI 10.2152/jmi.54.276; Thakar K, 2012, FEBS J, V279, P737, DOI 10.1111/j.1742-4658.2011.08464.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vadali K, 2007, IUBMB LIFE, V59, P709, DOI 10.1080/15216540701694245; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Williams TM, 2005, NUCLEIC ACIDS RES, V33, P4475, DOI 10.1093/nar/gki761; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	62	34	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137797	10.1371/journal.pone.0137797	http://dx.doi.org/10.1371/journal.pone.0137797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367869	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100140
J	Mosites, EM; Rabinowitz, PM; Thumbi, SM; Montgomery, JM; Palmer, GH; May, S; Rowhani-Rahbar, A; Neuhouser, ML; Walson, JL				Mosites, Emily M.; Rabinowitz, Peter M.; Thumbi, Samuel M.; Montgomery, Joel M.; Palmer, Guy H.; May, Susanne; Rowhani-Rahbar, Ali; Neuhouser, Marian L.; Walson, Judd L.			The Relationship between Livestock Ownership and Child Stunting in Three Countries in Eastern Africa Using National Survey Data	PLOS ONE			English	Article							UNDERNUTRITION; INCOME; DETERMINANTS; NUTRITION; GROWTH	Livestock ownership has the potential to improve child nutrition through various mechanisms, although direct evaluations of household livestock and child stunting status are uncommon. We conducted an analysis of Demographic and Health Survey (DHS) datasets from Ethiopia (2011), Kenya (2008- 2009), and Uganda (2010) among rural children under 5 years of age to compare stunting status across levels of livestock ownership. We classified livestock ownership by summing reported household numbers of goats, sheep, cattle and chickens, as well as calculating a weighted score to combine multiple species. The primary association was assessed separately by country using a log- binomial model adjusted for wealth and region, which was then stratified by child diarrheal illness, animal- source foods intake, sub- region, and wealth index. This analysis included n = 8079 children from Ethiopia, n = 3903 children from Kenya, and n = 1645 from Uganda. A ten- fold increase in household livestock ownership had significant association with lower stunting prevalence in Ethiopia (Prevalence Ratio [PR] 0.95, 95% CI 0.92- 0.98) and Uganda (PR 0.87, 95% CI 0.79- 0.97), but not Kenya (PR 1.01, 95% CI 0.96- 1.07). The weighted livestock score was only marginally associated with stunting status. The findings varied slightly by region, but not by wealth, diarrheal disease, or animal- source food intake. This analysis suggested a slightly beneficial effect of household livestock ownership on child stunting prevalence. The small effect size observed may be related to limitations of the DHS dataset or the potentially complicated relationship between malnutrition and livestock ownership, including livestock health and productivity.	[Mosites, Emily M.; Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rabinowitz, Peter M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Thumbi, Samuel M.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Thumbi, Samuel M.; Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Montgomery, Joel M.] Ctr Dis Control & Prevent, Global Dis Detect, Nairobi, Kenya; [May, Susanne] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Neuhouser, Marian L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Walson, Judd L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Washington State University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Mosites, EM (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	emily.mosites@gmail.com	Walson, Judd/R-7269-2019; Mwangi, Thumbi/L-2216-2019; Walson, Judd/HGC-4359-2022	Walson, Judd/0000-0003-4836-720X; Mwangi, Thumbi/0000-0002-5754-0556; Mosites, Emily/0000-0002-2968-9564; Rowhani-Rahbar, Ali/0000-0002-2705-4485	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007025] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2012, UG DEM HLTH SURV 201; Azzarri C., 2014, DOES LIVESTOCK OWNER; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bwibo NO, 2003, J NUTR, V133, p3936S, DOI 10.1093/jn/133.11.3936S; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Ikeda N, 2013, B WORLD HEALTH ORGAN, V91, P341, DOI 10.2471/BLT.12.113381; Jin MC, 2014, SOC SCI MED, V105, P16, DOI 10.1016/j.socscimed.2014.01.001; Kanyari PW, 2010, E AFR J PUBLIC HLTH, V7; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Keusch GT, 2013, FOOD NUTR BULL, V34, P357, DOI 10.1177/156482651303400308; MARQUIS GS, 1990, AM J PUBLIC HEALTH, V80, P146, DOI 10.2105/AJPH.80.2.146; Masibo PK, 2012, PUBLIC HEALTH NUTR, V15, P1715, DOI 10.1017/S1368980012002856; MATA L, 1992, AM J TROP MED HYG, V47, P16, DOI 10.4269/ajtmh.1992.47.16; Neumann CG, 2013, BR J NUTR, V109; Nicholson C, 2003, AAEA ANN M MONTR QUE; Semba RD, 2008, LANCET, V371; USAID, DEM HLTH SURV DAT CO; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2006, CHILD GROWTH STAND T	25	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136686	10.1371/journal.pone.0136686	http://dx.doi.org/10.1371/journal.pone.0136686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR0WB	26361393	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100014
J	Hua, G; Lv, X; He, C; Remmenga, SW; Rodabough, KJ; Dong, J; Yang, L; Lele, SM; Yang, P; Zhou, J; Karst, A; Drapkin, RI; Davis, JS; Wang, C				Hua, G.; Lv, X.; He, C.; Remmenga, S. W.; Rodabough, K. J.; Dong, J.; Yang, L.; Lele, S. M.; Yang, P.; Zhou, J.; Karst, A.; Drapkin, R. I.; Davis, J. S.; Wang, C.			YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells	ONCOGENE			English	Article							FIBROBLAST-GROWTH-FACTOR; HIPPO SIGNALING PATHWAY; OVARIAN-CANCER CELLS; TRANSCRIPTIONAL COACTIVATOR; EXPRESSION; PROLIFERATION; TRANSFORMATION; DROSOPHILA; PATHOGENESIS; SUPPRESSES	Accumulating evidence indicates that ovarian high-grade serous carcinoma (HGSC) originates from fallopian tube secretory epithelial cells (FTSECs). However, the molecular mechanisms underlying the initiation and progression of HGSC derived from FTSECs remains unclear. In this study, we found that the Hippo/Yes-associated protein (YAP) signaling pathway has a critical role in the initiation and progression of fallopian tube and ovarian HGSC. Importantly, YAP was overexpressed in inflammatory and cancerous fallopian tube tissues. Further, overexpression of wild-type YAP, or constitutively active YAP in immortalized FTSECs, induced cell proliferation, migration, colony formation and tumorigenesis. Moreover, the Hippo/YAP and the fibroblast growth factor (FGF) signaling pathways formed an autocrine/paracrine-positive feedback loop to drive the progression of the FTSEC-derived HGSC. Evidence in this study strongly suggests that combined therapy with inhibitors of YAP (such as verteporfin) and FGF receptors (such as BGJ398) can provide a novel therapeutic strategy to treat fallopian tube and ovarian HGSC.	[Hua, G.; Lv, X.; He, C.; Remmenga, S. W.; Rodabough, K. J.; Davis, J. S.; Wang, C.] Univ Nebraska Med Ctr, Dept Obstet Gynecol, Olson Ctr Womens Hlth, Omaha, NE USA; [Hua, G.; He, C.; Yang, L.] Huazhong Agr Univ, Coll Anim Sci & Technol, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [Dong, J.; Davis, J. S.; Wang, C.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA; [Lele, S. M.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Yang, P.] Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA; [Zhou, J.] Urumuqi Gen Hosp Lanzhou Mil Reg, Dept Obstet & Gynecol, Urumqi, Peoples R China; [Karst, A.; Drapkin, R. I.] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA; [Davis, J. S.] Omaha Vet Affairs Med Ctr, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; Huazhong Agricultural University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University System of Maryland; University of Maryland Baltimore; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Wang, C (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Dept Obstet Gynecol, Olson Ctr Womens Hlth, 985860 Nebraska Med Ctr, Omaha, NE 68198 USA.	chengwang@unmc.edu	Lv, Xiangmin/I-7106-2019; Davis, John S/C-3234-2014; Drapkin, Ronny/E-9944-2016	Lv, Xiangmin/0000-0001-8338-6014; Drapkin, Ronny/0000-0002-6912-6977; Davis, John/0000-0003-3468-4079	Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R00HD059985, 5P01AG029531]; Olson Center for Women's Health; Fred and Pamela Buffett Cancer Center [LB595]; Colleen's Dream Foundation; Omaha Veterans Administration Medical Center [5I01BX000512]; National Institute of Food and Agriculture [2011-67015-20076]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD059985] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD059985] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA197976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG029531] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000512] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Olson Center for Women's Health; Fred and Pamela Buffett Cancer Center; Colleen's Dream Foundation; Omaha Veterans Administration Medical Center; National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr Adam Karpf (The Pamela and Fred Cancer Center, University of Nebraska Medical Center) for providing ovarian HGSC cell lines. We acknowledge the cBioPortal for Cancer Genomics (http://cbioportal.org) for providing data sets and online analyzing tools. We also acknowledge the TCGA research Network (http://cancergenome.nih.gov) for providing data sets. This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (5R00HD059985, 5P01AG029531); the Olson Center for Women's Health (no number); the Fred and Pamela Buffett Cancer Center (LB595), the Colleen's Dream Foundation (no number), the Omaha Veterans Administration Medical Center (5I01BX000512) and the National Institute of Food and Agriculture (2011-67015-20076). We thank Melody Montgomery at the University of Nebraska Medical Center (UNMC) Research Editorial Office for the professional editing of the manuscript.	Al-Hussaini M, 2004, HISTOPATHOLOGY, V44, P109, DOI 10.1111/j.1365-2559.2004.01787.x; Ando H, 2000, HUM REPROD, V15, P1597, DOI 10.1093/humrep/15.7.1597; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Barakat RR, 2000, CANCER, V89, P383, DOI 10.1002/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T; Beaufort CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103988; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Berek JS, 2012, INT J GYNECOL OBSTET, V119, pS118, DOI 10.1016/S0020-7292(12)60025-3; Bowen NJ, 2007, GYNECOL ONCOL, V104, P331, DOI 10.1016/j.ygyno.2006.08.052; Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Casey MJ, 2000, GYNECOL ONCOL, V78, P278, DOI 10.1006/gyno.2000.5861; Cathro HP, 2002, AM J CLIN PATHOL, V117, P944, DOI 10.1309/2T1Y-7BB7-DAPE-PQ6L; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CRICKARD K, 1994, GYNECOL ONCOL, V55, P277, DOI 10.1006/gyno.1994.1290; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; De Cecco L, 2004, ONCOGENE, V23, P8171, DOI 10.1038/sj.onc.1207979; DIBLASIO AM, 1993, AM J OBSTET GYNECOL, V169, P1517, DOI 10.1016/0002-9378(93)90428-L; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dubeau L, 2013, ANN ONCOL, V24, P28, DOI 10.1093/annonc/mdt308; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fearon AE, 2013, INT J BIOCHEM CELL B, V45, P2832, DOI 10.1016/j.biocel.2013.09.017; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Fu D, 2014, ENDOCR-RELAT CANCER, V21, P297, DOI 10.1530/ERC-13-0339; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goodman MT, 2009, CANCER EPIDEM BIOMAR, V18, P132, DOI 10.1158/1055-9965.EPI-08-0771; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; He C, 2015, ONCOGENE, V34, P6040, DOI 10.1038/onc.2015.52; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Hwang H, 2004, APPL IMMUNOHISTO M M, V12, P122; Jazaeri AA, 2011, NEOPLASIA, V13, P899, DOI 10.1593/neo.11138; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Karst AM, 2012, NAT PROTOC, V7, P1755, DOI 10.1038/nprot.2012.097; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Katabuchi Hidetaka, 2003, Medical Electron Microscopy, V36, P74; Kendall SD, 2005, CANCER RES, V65, P9824, DOI 10.1158/0008-5472.CAN-05-1543; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krejci P, 2007, PEDIATR RES, V61, P267, DOI 10.1203/pdr.0b013e318030d157; Kuhn E, 2010, AM J SURG PATHOL, V34, P829, DOI 10.1097/PAS.0b013e3181dcede7; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Laury AR, 2010, AM J SURG PATHOL, V34, P627, DOI 10.1097/PAS.0b013e3181da7687; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Li T, 2010, PHARM BIOL, V48, P161, DOI 10.3109/13880200903062630; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Madore J, 2010, J PATHOL, V220, P392, DOI 10.1002/path.2659; MEYER GE, 1995, CANCER, V76, P2304, DOI 10.1002/1097-0142(19951201)76:11<2304::AID-CNCR2820761119>3.0.CO;2-N; Ono I, 2002, J DERMATOL SCI, V29, P104, DOI 10.1016/S0923-1811(02)00019-1; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Selvaggi, 2000, Arch Pathol Lab Med, V124, P477; Shan WW, 2012, CELL CYCLE, V11, P2107, DOI 10.4161/cc.20544; Sherman-Baust CA, 2014, J PATHOL, V233, P228, DOI 10.1002/path.4353; Siffroi-Fernandez S, 2005, ARCH OPHTHALMOL-CHIC, V123, P368, DOI 10.1001/archopht.123.3.368; Smith JA, 2001, BIOCHEM PHARMACOL, V62, P469, DOI 10.1016/S0006-2952(01)00690-6; Stewart SL, 2007, GYNECOL ONCOL, V107, P392, DOI 10.1016/j.ygyno.2007.09.018; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tung CS, 2009, MODERN PATHOL, V22, P1243, DOI 10.1038/modpathol.2009.92; Wang C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.397; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048299; Wang C, 2010, ENDOCRINOLOGY, V151, P2319, DOI 10.1210/en.2009-1489; Yang SP, 2013, CANCER RES, V73, P6722, DOI 10.1158/0008-5472.CAN-13-2049; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8	75	54	55	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 28	2016	35	17					2247	2265		10.1038/onc.2015.288	http://dx.doi.org/10.1038/onc.2015.288			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DK5UK	26364602	Green Submitted, Green Accepted			2022-12-26	WOS:000374986000010
J	Carnes, MU; Campbell, T; Huang, W; Butler, DG; Carbone, MA; Duncan, LH; Harbajan, SV; King, EM; Peterson, KR; Weitzel, A; Zhou, SS; Mackay, TFC				Carnes, Megan Ulmer; Campbell, Terry; Huang, Wen; Butler, Daniel G.; Carbone, Mary Anna; Duncan, Laura H.; Harbajan, Sasha V.; King, Edward M.; Peterson, Kara R.; Weitzel, Alexander; Zhou, Shanshan; Mackay, Trudy F. C.			The Genomic Basis of Postponed Senescence in Drosophila melanogaster	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; AFFECTING LIFE-SPAN; AGE-SPECIFIC PATTERNS; CAENORHABDITIS-ELEGANS; INSULIN-RECEPTOR; HUMAN LONGEVITY; OXIDATIVE STRESS; EXPRESSION ANALYSIS; IMMUNE-RESPONSE; CALORIE RESTRICTION	Natural populations harbor considerable genetic variation for lifespan. While evolutionary theory provides general explanations for the existence of this variation, our knowledge of the genes harboring naturally occurring polymorphisms affecting lifespan is limited. Here, we assessed the genetic divergence between five Drosophila melanogaster lines selected for postponed senescence for over 170 generations (O lines) and five lines from the same base population maintained at a two week generation interval for over 850 generations (B lines). On average, O lines live 70% longer than B lines, are more productive at all ages, and have delayed senescence for other traits than reproduction. We performed population sequencing of pools of individuals from all B and O lines and identified 6,394 genetically divergent variants in or near 1,928 genes at a false discovery rate of 0.068. A 2.6 Mb region at the tip of the X chromosome contained many variants fixed for alternative alleles in the two populations, suggestive of a hard selective sweep. We also assessed genome wide gene expression of O and B lines at one and five weeks of age using RNA sequencing and identified genes with significant (false discovery rate < 0.05) effects on gene expression with age, population and the age by population interaction, separately for each sex. We identified transcripts that exhibited the transcriptional signature of postponed senescence and integrated the gene expression and genetic divergence data to identify 98 (175) top candidate genes in females (males) affecting postponed senescence and increased lifespan. While several of these genes have been previously associated with Drosophila lifespan, most are novel and constitute a rich resource for future functional validation.	[Carnes, Megan Ulmer; Campbell, Terry; Huang, Wen; Butler, Daniel G.; Carbone, Mary Anna; Duncan, Laura H.; Harbajan, Sasha V.; King, Edward M.; Peterson, Kara R.; Weitzel, Alexander; Zhou, Shanshan; Mackay, Trudy F. C.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Huang, Wen; Carbone, Mary Anna; Zhou, Shanshan; Mackay, Trudy F. C.] N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA; [Carbone, Mary Anna; Zhou, Shanshan; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Mackay, TFC (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu		Carnes, Megan/0000-0002-7270-132X; Huang, Wen/0000-0001-6788-8364	National Institutes of Health [R01 AG043490, R01 GM45146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants R01 AG043490 and R01 GM45146 to TFCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen SL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002315; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Ayyadevara S, 2001, GENETICS, V157, P655; Beekman M, 2013, AGING CELL, V12, P184, DOI 10.1111/acel.12039; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; Carbone MA, 2006, CURR BIOL, V16, P912, DOI 10.1016/j.cub.2006.03.051; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Curtsinger JW, 2002, MECH AGEING DEV, V123, P81, DOI 10.1016/S0047-6374(01)00345-1; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; Deelen J, 2014, HUM MOL GENET, V23, P4420, DOI 10.1093/hmg/ddu139; Deelen J, 2013, BIOESSAYS, V35, P386, DOI 10.1002/bies.201200148; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Defossez PA, 2001, BIOESSAYS, V23, P327, DOI 10.1002/bies.1047; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Doria G, 2004, AGEING RES REV, V3, P143, DOI 10.1016/j.arr.2003.04.001; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Durham MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5338; Eikenes AH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004904; Fagan JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107311; Felix TM, 2012, GENETICS, V191, P989, DOI 10.1534/genetics.112.140640; Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Forbes SN, 2004, GENETICS, V168, P301, DOI 10.1534/genetics.103.023218; Force AG, 1995, DEV GENET, V17, P340, DOI 10.1002/dvg.1020170407; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; FRIEDMAN DB, 1988, GENETICS, V118, P75; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Ghiglione C, 2008, EMBO REP, V9, P676, DOI 10.1038/embor.2008.79; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; GRAVES JL, 1992, PHYSIOL ZOOL, V65, P268, DOI 10.1086/physzool.65.2.30158253; GRISWOLD CM, 1993, GENETICS, V134, P781; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Gundner AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097332; HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hori K, 2011, J CELL BIOL, V195, P1005, DOI 10.1083/jcb.201104146; Horn L, 2014, AGING CELL, V13, P719, DOI 10.1111/acel.12227; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Issman-Zecharya N, 2014, DEV CELL, V31, P461, DOI 10.1016/j.devcel.2014.10.013; Ivanov DK, 2015, J GERONTOL A-BIOL; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jackson AU, 2002, J GERONTOL A-BIOL, V57, pB9, DOI 10.1093/gerona/57.1.B9; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; KEIGHTLEY PD, 1993, GENET RES, V62, P195, DOI 10.1017/S0016672300031906; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kharade SV, 2005, FEBS LETT, V579, P6809, DOI 10.1016/j.febslet.2005.11.017; Khazaeli AA, 1997, J GERONTOL A-BIOL, V52, pB48, DOI 10.1093/gerona/52A.1.B48; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Lai CQ, 2007, MECH AGEING DEV, V128, P237, DOI 10.1016/j.mad.2006.12.003; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Landis GN, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r8; Lang DH, 2010, AGING CLIN EXP RES, V22, P8, DOI 10.1007/BF03324809; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Leips J, 2000, GENETICS, V155, P1773; Leips J, 2002, EXP AGING RES, V28, P361, DOI 10.1080/03610730290080399; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Ljungquist B, 1998, J GERONTOL A-BIOL, V53, pM441, DOI 10.1093/gerona/53A.6.M441; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; Magwire MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001037; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Massouras A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003055; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Matias NR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004653; MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237; Medawar P., 1952, UNSOLVED PROBLEM BIO; Mockett RJ, 2006, EXP GERONTOL, V41, P566, DOI 10.1016/j.exger.2006.03.015; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Paik D, 2012, MECH AGEING DEV, V133, P234, DOI 10.1016/j.mad.2012.02.001; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Partridge L, 2002, CURR BIOL, V12, pR544, DOI 10.1016/S0960-9822(02)01048-5; PARTRIDGE L, 1981, NATURE, V294, P580, DOI 10.1038/294580a0; Pasyukova EG, 2004, AGING CELL, V3, P297, DOI 10.1111/j.1474-9728.2004.00114.x; Pasyukova EG, 2000, GENETICS, V156, P1129; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2002, CURR OPIN GENET DEV, V12, P362, DOI 10.1016/S0959-437X(02)00310-6; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Pitt JN, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002131; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Promislow DEL, 1996, GENETICS, V143, P839; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Reis RJS, 2006, EXP GERONTOL, V41, P1046, DOI 10.1016/j.exger.2006.06.047; Remolina SC, 2012, EVOLUTION, V66, P3390, DOI 10.1111/j.1558-5646.2012.01710.x; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rollmann SM, 2006, NAT GENET, V38, P824, DOI 10.1038/ng1823; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; ROSE MR, 1992, EXP GERONTOL, V27, P241, DOI 10.1016/0531-5565(92)90048-5; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; Rosenbaum EE, 2011, NEURON, V72, P602, DOI 10.1016/j.neuron.2011.09.016; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; SAS Institute Inc, 2002, SAS 9 2 SOFTW; Schlotterer C, 2015, HEREDITY, V114, P431, DOI 10.1038/hdy.2014.86; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Service PM, 1996, BEHAV GENET, V26, P39, DOI 10.1007/BF02361157; SERVICE PM, 1988, EVOLUTION, V42, P708, DOI 10.1111/j.1558-5646.1988.tb02489.x; SERVICE PM, 1985, PHYSIOL ZOOL, V58, P380, DOI 10.1086/physzool.58.4.30156013; Shook DR, 1996, GENETICS, V142, P801; Sidyelyeva G, 2006, J BIOL CHEM, V281, P13844, DOI 10.1074/jbc.M513499200; Sidyelyeva G, 2010, CELL MOL LIFE SCI, V67, P2991, DOI 10.1007/s00018-010-0369-8; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Sun JT, 2002, GENETICS, V161, P661; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tatar M, 1996, GENETICS, V143, P849; Teotonio H, 2009, NAT GENET, V41, P251, DOI 10.1038/ng.289; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tissenbaum HA, 1998, GENETICS, V148, P703; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner TL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001336; Valenzuela RK, 2004, GENETICS, V168, P313, DOI 10.1534/genetics.103.023291; Verleyen P, 2006, J INSECT PHYSIOL, V52, P379, DOI 10.1016/j.jinsphys.2005.12.007; Vieira C, 2000, GENETICS, V154, P213; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wilson RH, 2006, GENETICS, V173, P1455, DOI 10.1534/genetics.105.055111; Wilson RH, 2013, MECH AGEING DEV, V134, P79, DOI 10.1016/j.mad.2012.11.003; WOODHEAD AD, 1985, J NATL CANCER I, V75, P1141; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zerofsky M, 2005, AGING CELL, V4, P103, DOI 10.1111/j.1474-9728.2005.00147.x; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697; ZWAAN B, 1995, EVOLUTION, V49, P635, DOI 10.2307/2410317	170	26	26	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138569	10.1371/journal.pone.0138569	http://dx.doi.org/10.1371/journal.pone.0138569			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378456	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400111
J	Ilgen, P; Grotjohann, T; Jans, DC; Kilisch, M; Hell, SW; Jakobs, S				Ilgen, Peter; Grotjohann, Tim; Jans, Daniel C.; Kilisch, Markus; Hell, Stefan W.; Jakobs, Stefan			RESOLFT Nanoscopy of Fixed Cells Using a Z-Domain Based Fusion Protein for Labelling	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; STED MICROSCOPY; LIGHT; GFP	RESOLFT super-resolution microscopy allows subdiffraction resolution imaging of living cells using low intensities of light. It relies on the light-driven switching of reversible switchable fluorescent proteins (RSFPs). So far, RESOLFT imaging was restricted to living cells, because chemical fixation typically affects the switching characteristics of RSFPs. In this study we created a fusion construct (FLASR) consisting of the RSFP rsEGFP2 and the divalent form of the antibody binding Z domain from protein A. FLASR can be used analogous to secondary antibodies in conventional immunochemistry, facilitating simple and robust sample preparation. We demonstrate RESOLFT super-resolution microscopy on chemically fixed mammalian cells. The approach may be extended to other super-resolution approaches requiring fluorescent proteins in an aqueous environment.	[Ilgen, Peter; Grotjohann, Tim; Jans, Daniel C.; Hell, Stefan W.; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Jans, Daniel C.; Jakobs, Stefan] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Kilisch, Markus] Univ Med Ctr Gottingen, Dept Mol Biol, Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen	Jakobs, S (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany.	sjakobs@gwdg.de	Jakobs, Stefan/F-4898-2012	Jakobs, Stefan/0000-0002-8028-3121; Jans, Daniel C./0000-0002-6356-9742	Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain; Max Planck Society; DFG [FOR 1086/2, SCHW 823/2-1, SR7000DC]	Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG))	This work was supported by the Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (to SJ), by the Max Planck Society, and by the DFG FOR 1086/2 (Grant SCHW 823/2-1) (MK, SPR Biosensor SR7000DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; AKERSTROM B, 1986, J BIOL CHEM, V261, P240; Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Born M., 2002, PRINCIPLES OPTICS; Bourgeois D, 2012, IUBMB LIFE, V64, P482, DOI 10.1002/iub.1023; Brakemann T, 2011, NAT BIOTECHNOL, V29, P942, DOI 10.1038/nbt.1952; Dyba M, 2003, NAT BIOTECHNOL, V21, P1303, DOI 10.1038/nbt897; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Geissbuehler S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6830; Grotjohann T, 2012, ELIFE, V1, DOI 10.7554/eLife.00248; Grotjohann T, 2011, NATURE, V478, P204, DOI 10.1038/nature10497; Grover RK, 2014, SCIENCE, V343, P656, DOI 10.1126/science.1246135; Hell SW, 2003, APPL PHYS A-MATER, V77, P859, DOI 10.1007/s00339-003-2292-4; Hell SW., 2009, SINGLE MOL SPECTROSC, P298; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Huang QL, 2006, BIOTECHNOL APPL BIOC, V43, P121, DOI 10.1042/BA20050136; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Rankin BR, 2009, OPT EXPRESS, V17, P15679, DOI 10.1364/OE.17.015679; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Testa I, 2012, NEURON, V75, P992, DOI 10.1016/j.neuron.2012.07.028; Tiwari DK, 2015, NAT METHODS, V12, P515, DOI 10.1038/nmeth.3362; Wurm CA, 2010, METHODS MOL BIOL, V591, P185, DOI 10.1007/978-1-60761-404-3_11	28	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136233	10.1371/journal.pone.0136233	http://dx.doi.org/10.1371/journal.pone.0136233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375606	Green Submitted, Green Published, gold			2022-12-26	WOS:000361610200012
J	Rho, CR; Park, MY; Kang, S				Rho, Chang Rae; Park, Mi-young; Kang, Seungbum			Effects of Granulocyte-Macrophage Colony-Stimulating (GM-CSF) Factor on Corneal Epithelial Cells in Corneal Wound Healing Model	PLOS ONE			English	Article							PARTIAL-THICKNESS BURN; GROWTH-FACTOR; C-KIT; RECEPTOR; PLANTS; MICE; MAINTENANCE; EXPRESSION; MIGRATION; CYTOKINE	Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic cytokine that activates granulocyte and macrophage cell lineages. It is also known to have an important function in wound healing. This study investigated the effect of GM-CSF in wound healing of human corneal epithelial cells (HCECs). We used human GM-CSF derived from rice cells (rice cell-derived recombinant human GM-CSF; rhGM-CSF). An in vitro migration assay was performed to investigate the migration rate of HCECs treated with various concentrations of rhGM-CSF (0.1, 1.0, and 10.0 mu g/ml). MTT assay and flow cytometric analysis were used to evaluate the proliferative effect of rhGM-CSF. The protein level of p38MAPK was analyzed by western blotting. For in vivo analysis, 100 golden Syrian hamsters were divided into four groups, and their corneas were de-epithelialized with alcohol and a blade. The experimental groups were treated with 10, 20, or 50 mu g/ml rhGM-CSF four times daily, and the control group was treated with phosphate-buffered saline. The corneal wound-healing rate was evaluated by fluorescein staining at the initial wounding and 12, 24, 36, and 48 hours after epithelial debridement. rhGM-CSF accelerated corneal epithelial wound healing both in vitro and in vivo. MTT assay and flow cytometric analysis revealed that rhGM-CSF treatment had no effects on HCEC proliferation. Western blot analysis demonstrated that the expression level of phosphorylated p38MAPK increased with rhGM-CSF treatment. These findings indicate that rhGM-CSF enhances corneal wound healing by accelerating cell migration.	[Rho, Chang Rae; Kang, Seungbum] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Rho, Chang Rae; Park, Mi-young; Kang, Seungbum] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Clin Res Inst, Taejon, South Korea	Catholic University of Korea; Catholic University of Korea	Kang, S (corresponding author), Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	john0730@catholic.ac.kr			Daejeon TechnoPark [5-2013-A0230-00001]; Clinical Research Institute [CMCDJ-P-2013-024]; Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea [CMCDJ-P-2013-024]	Daejeon TechnoPark; Clinical Research Institute; Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea	This work was supported by Daejeon TechnoPark (5-2013-A0230-00001), (http://www.cukrnd-iacf.ac.kr/index.jsp); Clinical Research Institute (CMCDJ-P-2013-024), Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea (CMCDJ-P-2013-024), (www.cmcdj.or.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; Carreno E, 2010, ACTA OPHTHALMOL, V88, pe250, DOI 10.1111/j.1755-3768.2010.01978.x; Choi JS, 2013, OCUL SURF, V11, P16, DOI 10.1016/j.jtos.2012.08.006; Fang Y, 2007, BRIT J DERMATOL, V157, P458, DOI 10.1111/j.1365-2133.2007.07979.x; Groves R W, 2000, Adv Skin Wound Care, V13, P107; Hood EE, 1999, CURR OPIN BIOTECH, V10, P382, DOI 10.1016/S0958-1669(99)80069-X; Hu XL, 2011, BURNS, V37, P729, DOI 10.1016/j.burns.2010.08.016; Imanishi J, PROG RETIN EYE RES, V200, P113; Kim HJ, 2008, BIOL PHARM BULL, V31, P290, DOI 10.1248/bpb.31.290; Klenkler B, 2007, OCUL SURF, V5, P228, DOI 10.1016/S1542-0124(12)70613-4; KRUSE FE, 1993, INVEST OPHTH VIS SCI, V34, P1963; LaFrance MW, 2008, CURR EYE RES, V33, P525, DOI 10.1080/02713680802190085; Lee HK, 2006, INVEST OPHTH VIS SCI, V47, P873, DOI 10.1167/iovs.05-0826; Yuan L, 2015, BURNS, V41, P1086, DOI 10.1016/j.burns.2014.12.004; Masucci G, 1996, MED ONCOL, V13, P149; Medrano G, 2012, METHODS MOL BIOL, V824, P535, DOI 10.1007/978-1-61779-433-9_29; METCALF D, 1987, EXP HEMATOL, V15, P1; Miele L, 1997, TRENDS BIOTECHNOL, V15, P45, DOI 10.1016/S0167-7799(97)84202-3; Miyamoto K, 2012, MOL VIS, V18, P1505; MIYAZAWA K, 1991, EXP HEMATOL, V19, P1110; NISHIDA T, 1992, INVEST OPHTH VIS SCI, V33, P2464; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; SCHULTZ GS, 1988, CORNEA, V7, P96; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Trusolino L, 1998, J CELL BIOL, V142, P1145, DOI 10.1083/jcb.142.4.1145; Wilson SE, 1999, EXP EYE RES, V68, P377, DOI 10.1006/exer.1998.0603; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2544; WILSON SE, 1992, INVEST OPHTH VIS SCI, V33, P1756; Won JH, 2013, BIOL PHARM BULL, V36, P425, DOI 10.1248/bpb.b12-00869; Yan H, 2012, BURNS, V38, P877, DOI 10.1016/j.burns.2012.02.001	30	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138020	10.1371/journal.pone.0138020	http://dx.doi.org/10.1371/journal.pone.0138020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376304	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200070
J	Dimitri, N				Dimitri, Nicola			The Economics of Epidemic Diseases	PLOS ONE			English	Article								Epidemic, infectious, diseases affect a large number of individuals across developing as well as developed countries. With reference to some very simple diffusion models, in this paper we consider how available economic resources could be optimally allocated by health authorities to mitigate, possibly eradicate, the disease. Optimality was defined as the minimization of the long run number of infected people. The main goal of the work has been to introduce a methodology for deciding if it would be best to concentrate resources to prevent contact between individuals and with an external source, or to develop a new treatment for curing the disease, or both. The analysis suggests that this depends on the cost functions, that is the available technology, for controlling the relevant parameters underlying the epidemics as well as on the available financial resources. In the case of the recent Ebola outbreak, the suggestions of the model have been consistent with the policies adopted.	Univ Siena, Dept Polit Econ & Stat, I-53100 Siena, Italy	University of Siena	Dimitri, N (corresponding author), Univ Siena, Dept Polit Econ & Stat, Via Laterina 8, I-53100 Siena, Italy.	dimitri@unisi.it						BAILEY N, 1975, MATH THEORY EPIDEMIC; Bernoulli D., 1760, MEMOIRES MATHEMATIQU, P1; Daley DJ, 1999, EPIDEMIC MODELING; Easly D., 2010, NETWORKS CROWDS MARK; Goldman SC., 2002, BE J TOP EC ANAL POL, V2, P889, DOI [10.2202/1538-0653.1007, DOI 10.2202/1538-0653.1007]; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Isham V, 2004, STOCHASTIC MOD UNPUB; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Rowthorn RE, 2009, J R SOC INTERFACE, V6, P1135, DOI 10.1098/rsif.2008.0402	12	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137964	10.1371/journal.pone.0137964	http://dx.doi.org/10.1371/journal.pone.0137964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372353	Green Published, gold, Green Submitted			2022-12-26	WOS:000361604400041
J	Hsu, JL; Lee, WJ; Liao, YC; Lirng, JF; Wang, SJ; Fuh, JL				Hsu, Jung-Lung; Lee, Wei-Ju; Liao, Yi-Chu; Lirng, Jiing-Feng; Wang, Shuu-Jiun; Fuh, Jong-Ling			Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; VERBAL-LEARNING TEST; LOBE ATROPHY; NEUROPSYCHIATRIC INVENTORY; PSYCHOLOGICAL SYMPTOMS; DEMENTIA; MRI; SCHIZOPHRENIA; DYSFUNCTION; POPULATION	Background Whether the occurrence of posterior atrophy (PA) and medial temporal lobe atrophy (MTA) was correlated with cognitive and non-cognitive symptoms in Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients are unclear. Methods Patients with probable AD and MCI from a medical center outpatient clinic received attention, memory, language, executive function evaluation and Mini-Mental Status Examination (MMSE). The severity of dementia was rated by the Clinical Dementia Rating (CDR) Sum of Box (CDR-SB). The neuropsychiatric inventory (NPI) subscale of agitation/aggression and mood symptoms was also applied. Magnetic resonance imaging (MRI) was scored visually for the MTA, PA and white matter hyperintensity (WMH) scores. Results We recruited 129 AD and 31MCI (mean age 78.8 years, 48% female) patients. MMSE scores, memory, language and executive function were all significantly decreased in individuals with AD than those with MCI (p < 0.01). MTA and PA scores reflected significant atrophy in AD compared to MCI; however, theWMHscores did not differ. The MTA scores were significantly correlated with the frontal, parieto-occipital and globalWMHscores (p < 0.01) while the PA scores showed a correlation with the parieto-occipital and temporal WMH scores (p < 0.01). After adjusting for age, education, APOE4 gene and diagnostic group covariates, the MTA scores showed a significant association with MMSE and CDR-SB, while the right side PA scores were significantly associated with NPI-agitation/aggression subscales (p < 0.01). Conclusion Regional atrophy is related to different symptoms in patients with AD or MCI. PA score is useful as a complementary measure for non-cognitive symptom.	[Hsu, Jung-Lung] Taipei Med Univ, Grad Inst Human Med, Taipei, Taiwan; [Hsu, Jung-Lung] Chang Gung Mem Hosp, Dept Neurol, Sect Dementia & Cognit Impairment, Linkou, Taiwan; [Hsu, Jung-Lung] Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei City, Taiwan; [Lee, Wei-Ju] Taichung Vet Gen Hosp, Neurol Inst, Taichung, Taiwan; [Lee, Wei-Ju; Liao, Yi-Chu; Lirng, Jiing-Feng; Wang, Shuu-Jiun; Fuh, Jong-Ling] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Lee, Wei-Ju] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan; [Wang, Shuu-Jiun] Natl Yang Ming Univ, Inst Brain Sci, Sch Med, Taipei 112, Taiwan; [Liao, Yi-Chu; Wang, Shuu-Jiun; Fuh, Jong-Ling] Natl Yang Ming Univ, Brain Res Ctr, Sch Med, Taipei 112, Taiwan; [Liao, Yi-Chu; Wang, Shuu-Jiun; Fuh, Jong-Ling] Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan; [Lirng, Jiing-Feng] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Taipei Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Wang, SJ (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan.	sjwang@vghtpe.gov.tw; jlfuh@vghtpe.gov.tw		Wang, Shuu-Jiun/0000-0001-5179-5358; Liao, Yi-Chu/0000-0002-9644-2086; Lee, Wei-Ju/0000-0002-3720-4539	Ministry of Science and Technology of Taiwan (NSC) [101-2314-B-075-037-MY2, 102-2321-B-010-030, 103-2314-B-075-063-]; Taipei Veterans General Hospital [V103E9-006, V103E3-005, V103C-083]; Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine; National Central University, Taiwan (NSC) [102-2911-I-008-001]; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan	Ministry of Science and Technology of Taiwan (NSC); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine; National Central University, Taiwan (NSC); Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	Ministry of Science and Technology of Taiwan (NSC 101-2314-B-075-037-MY2, 102-2321-B-010-030, 103-2314-B-075-063-), Taipei Veterans General Hospital (V103E9-006, V103E3-005, V103C-083), Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 102-2911-I-008-001), Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel J, 2009, AM J NEURORADIOL, V30, P1870, DOI 10.3174/ajnr.A1693; Barr A, 1996, J CLIN EXP NEUROPSYC, V18, P810, DOI 10.1080/01688639608408304; Berlow YA, 2010, INT J GERIATR PSYCH, V25, P780, DOI 10.1002/gps.2418; Bouwman FH, 2010, DEMENT GERIATR COGN, V30, P1, DOI 10.1159/000315542; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; BURKE WJ, 1988, ARCH NEUROL-CHICAGO, V45, P31, DOI 10.1001/archneur.1988.00520250037015; Cavallin L, 2012, ACTA RADIOL, V53, P318, DOI 10.1258/ar.2012.110552; Chen CS, 2012, ALZ DIS ASSOC DIS, V26, P135, DOI 10.1097/WAD.0b013e31821f5787; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Davies RR, 2009, NEURORADIOLOGY, V51, P491, DOI 10.1007/s00234-009-0521-z; Dickerson BC, 2011, J NEUROL NEUROSUR PS, V82, P45, DOI 10.1136/jnnp.2009.199505; Feczko E, 2009, NEUROBIOL AGING, V30, P420, DOI 10.1016/j.neurobiolaging.2007.07.023; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuh JL, 2005, J NEUROL NEUROSUR PS, V76, P1337, DOI 10.1136/jnnp.2004.056408; Fuh JL, 2001, INT PSYCHOGERIATR, V13, P121, DOI 10.1017/S1041610201007517; Galton CJ, 2000, BRAIN, V123, P484, DOI 10.1093/brain/123.3.484; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Hart DJ, 2003, INT J GERIATR PSYCH, V18, P1037, DOI 10.1002/gps.1013; Harting C., 2000, WMS R MANUAL; Hirono N, 2000, ARCH NEUROL-CHICAGO, V57, P861, DOI 10.1001/archneur.57.6.861; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jang JW, 2013, EUR NEUROL, V69, P229, DOI 10.1159/000345999; Kandiah N, 2014, J NEUROL SCI, V337, P162, DOI 10.1016/j.jns.2013.11.042; Koedam ELGE, 2011, EUR RADIOL, V21, P2618, DOI 10.1007/s00330-011-2205-4; Koedam ELGE, 2010, J ALZHEIMERS DIS, V19, P1401, DOI 10.3233/JAD-2010-1337; Kumari V, 2006, SCHIZOPHR RES, V84, P144, DOI 10.1016/j.schres.2006.02.017; Lanctot KL, 2004, ARCH NEUROL-CHICAGO, V61, P1731, DOI 10.1001/archneur.61.11.1731; LAUNER LJ, 1995, NEUROLOGY, V45, P747, DOI 10.1212/WNL.45.4.747; Lehmann M, 2013, NEUROBIOL AGING, V34, P73, DOI 10.1016/j.neurobiolaging.2012.03.010; Lehmann M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.003; Liao YC, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.05.009; MACK WJ, 1992, J GERONTOL, V47, pP154, DOI 10.1093/geronj/47.3.P154; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mychack P, 2001, NEUROLOGY, V56, pS11, DOI 10.1212/WNL.56.suppl_4.S11; Neill E, 2014, COGN NEUROPSYCHIATRY, V19, P81, DOI 10.1080/13546805.2013.807233; Oosterman JM, 2012, INT PSYCHOGERIATR, V24, P1474, DOI 10.1017/S1041610212000506; Pereira JB, 2014, J INTERN MED, V275, P317, DOI 10.1111/joim.12148; Prins ND, 2013, J ALZHEIMERS DIS, V36, P79, DOI 10.3233/JAD-122233; Rafii MS, 2014, AM J ALZHEIMERS DIS, V29, P159, DOI 10.1177/1533317513507373; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Shim YS, 2011, EUR NEUROL, V66, P75, DOI 10.1159/000329277; Smits LL, 2013, ALZHEIMERS DEMENTIA; Soyka M, 2011, SCHIZOPHRENIA BULL, V37, P913, DOI 10.1093/schbul/sbr103; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303; Trzepacz Paula T, 2013, Alzheimers Dement, V9, pS95, DOI 10.1016/j.jalz.2012.10.005; Trzepacz PT, 2013, AM J GERIAT PSYCHIAT, V21, P607, DOI 10.1016/j.jagp.2012.10.027; Tsai C F, 2013, East Asian Arch Psychiatry, V23, P86; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; Vanderploeg RD, 2000, CLIN NEUROPSYCHOL, V14, P318, DOI 10.1076/1385-4046(200008)14:3;1-P;FT318; Varon D, 2014, INT J GERIATRIC PSYC; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wattjes MP, 2011, INT PSYCHOGERIATR, V23, pS13, DOI 10.1017/S1041610211000913; Wechsler D., 1997, WECHSLER ADULT INTEL; Wechsler D, 1998, WECHSLER MEMORY SCAL; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	57	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137121	10.1371/journal.pone.0137121	http://dx.doi.org/10.1371/journal.pone.0137121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372372	gold, Green Published, Green Submitted			2022-12-26	WOS:000361604400011
J	Merlo, C; Trummler, M; Essig, S; Zeller, A				Merlo, Christoph; Trummler, Michael; Essig, Stefan; Zeller, Andreas			Vitamin D Deficiency in Unselected Patients from Swiss Primary Care: A Cross-Sectional Study in Two Seasons	PLOS ONE			English	Article							BODY-MASS INDEX; PAIN; 25-HYDROXYVITAMIN-D; PREVENTION; PREVALENCE; DEPENDENCY; PRODUCE; SKIN	Background As published data on 25-hydroxy-cholecalciferol (25(OH)D) Deficiency in primary care settings is scarce, we assessed the prevalence of hypovitaminosis D, potential associations with clinical symptoms, body mass index, age, Vitamin D intake, and skin type in unselected patients from primary care, and the extent of seasonal variations of serum 25(OH)D concentrations. Methodology/Principal Findings 25(OH)D was measured at the end of summer and/or winter in 1682 consecutive patients from primary care using an enzyme-linked immunosorbant assay. Clinical symptoms were assessed by self-report (visual analogue scale 0 to 10), and vitamin D deficiency was defined as 25(OH)D concentrations < 50 nmol/l. 25(OH)D deficiency was present in 995 (59.2%) patients. 25(OH)D deficient patients reported more intense muscle weakness (visual analogue scale 2.7, 95% confidence interval 2.5 to 2.9) and had a higher body mass index (25.9kg/m(2), 25.5 to 26.2) than non-deficient patients (2.5, 2.3 to 2.7; and 24.2, 23.9 to 24.5, respectively). 25(OH)D concentrations also weakly correlated with muscle weakness (Spearman's rho -0.059, 95% confidence interval -0.107 to -0.011) and body mass index (-0.156, -0.202 to -0.108). Self-reported musculoskeletal pain, fatigue, and age were not associated with deficiency, nor with concentrations. Mean 25(OH)D concentrations in patients with vitamin D containing medication were higher (60.6 +/- 22.2 nmol/l) than in patients without medication (44.8 +/- 19.2 nmol/l, p < 0.0001) but still below the targeted level of 75 nmol/l. Summer and winter 25(OH)D concentrations differed (53.4 +/- 19.9 vs. 41.6 +/- 19.3nmol/l, p < 0.0001), which was confirmed in a subgroup of 93 patients who were tested in both seasons (p = 0.01). Conclusion/Significance Nearly 60% of unselected patients from primary care met the criteria for 25(OH)D deficiency. Self-reported muscle weakness and high body mass index were associated with lower 25(OH)D levels. As expected 25(OH)D concentrations were lower in winter compared to summer.	[Merlo, Christoph; Essig, Stefan] Inst Primary & Community Care, CH-6004 Luzern, Switzerland; [Trummler, Michael] Labs Bioanalyt, CH-6006 Luzern, Switzerland; [Essig, Stefan] Swiss Parapleg Res, CH-6207 Nottwil, Switzerland; [Zeller, Andreas] Univ Basel, Ctr Primary Hlth Care, CH-4410 Liestal, Switzerland	Swiss Paraplegic Research; University of Basel	Essig, S (corresponding author), Inst Primary & Community Care, Schwanenpl 7, CH-6004 Luzern, Switzerland.	stefan.essig@iham-cc.ch		Essig, Stefan/0000-0003-3228-7010				Al Faraj S, 2003, SPINE, V28, P177, DOI 10.1097/00007632-200301150-00015; Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Arvold DS, 2009, ENDOCR PRACT, V15, P203, DOI 10.4158/EP.15.3.203; Bischoff-Ferrari HA, 2008, BONE, V42, P597, DOI 10.1016/j.bone.2007.10.026; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Bischoff-Ferrari HA, 2012, REV ENDOCR METAB DIS, V13, P71, DOI 10.1007/s11154-011-9200-6; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; Dawson-Hughes B, 2010, Osteoporos Int, V21, P1151, DOI 10.1007/s00198-010-1285-3; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; GLOTH FM, 1991, ARCH INTERN MED, V151, P1662, DOI 10.1001/archinte.151.8.1662; Hewison M, 2008, CURR OPIN INVEST DR, V9, P485; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2008, BRIT MED J, V336, P1318, DOI 10.1136/bmj.39581.411424.80; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; IDS, AC57F1AC57F22O10 IDS; Lagunova Z, 2009, ANTICANCER RES, V29, P3713, DOI 10.14341/2071-8713-4886; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Myers KJ, 2004, MAYO CLIN PROC, V79, P695, DOI 10.4065/79.5.695; Nutrition FCf, 2012, NUTR FCF EXP REP 25; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Plotnikoff GA, 2003, MAYO CLIN PROC, V78, P1463, DOI 10.4065/78.12.1463; Prabhala A, 2000, ARCH INTERN MED, V160, P1199, DOI 10.1001/archinte.160.8.1199; Rabow MW MS, 2013, CURRENT MED DIAGNOSI; Roberts WE, 2009, DERMATOL CLIN, V27, P529, DOI 10.1016/j.det.2009.08.006; Saneei P, 2013, OBES REV, V14, P393, DOI 10.1111/obr.12016; Shinchuk L, 2007, NUTR CLIN PRACT, V22, P297, DOI 10.1177/0115426507022003297; Stoll D, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13196; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Vimaleswaran Karani S, 2013, PLoS Med, V10, pe1001383, DOI 10.1371/journal.pmed.1001383; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Warner AE, 2008, JCR-J CLIN RHEUMATOL, V14, P12, DOI 10.1097/RHU.0b013e31816356a9; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004	39	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138613	10.1371/journal.pone.0138613	http://dx.doi.org/10.1371/journal.pone.0138613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372355	gold, Green Published, Green Submitted			2022-12-26	WOS:000361604400071
J	Howard, JT; O'Nan, AT; Maltecca, C; Baynes, RE; Ashwell, MS				Howard, Jeremy T.; O'Nan, Audrey T.; Maltecca, Christian; Baynes, Ronald E.; Ashwell, Melissa S.			Differential Gene Expression across Breed and Sex in Commercial Pigs Administered Fenbendazole and Flunixin Meglumine	PLOS ONE			English	Article							PHARMACOGENOMICS; CYTOCHROME-P450; POLYMORPHISM; PHARMACOKINETICS; METABOLISM; DISCOVERY; GENOMICS; ANIMALS; CLONING; TRAITS	Characterizing the variability in transcript levels across breeds and sex in swine for genes that play a role in drug metabolism may shed light on breed and sex differences in drug metabolism. The objective of the study is to determine if there is heterogeneity between swine breeds and sex in transcript levels for genes previously shown to play a role in drug metabolism for animals administered flunixin meglumine or fenbendazole. Crossbred nursery female and castrated male pigs (n = 169) spread across 5 groups were utilized. Sires (n = 15) of the pigs were purebred Duroc, Landrace, Yorkshire or Hampshire boars mated to a common sow population. Animals were randomly placed into the following treatments: no drug (control), flunixin meglumine, or fenbendazole. One hour after the second dosing, animals were sacrificed and liver samples collected. Quantitative Real-Time PCR was used to measure liver gene expression of the following genes: SULT1A1, ABCB1, CYP1A2, CYP2E1, CYP3A22 and CYP3A29. The control animals were used to investigate baseline transcript level differences across breed and sex. Post drug administration transcript differences across breed and sex were investigated by comparing animals administered the drug to the controls. Contrasts to determine fold change were constructed from a model that included fixed and random effects within each drug. Significant (P-value <0.007) basal transcript differences were found across breeds for SULT1A1, CYP3A29 and CYP3A22. Across drugs, significant (P-value <0.0038) transcript differences existed between animals given a drug and controls across breeds and sex for ABCB1, PS and CYP1A2. Significant (P <0.0038) transcript differences across breeds were found for CYP2E1 and SULT1A1 for flunixin meglumine and fenbendazole, respectively. The current analysis found transcript level differences across swine breeds and sex for multiple genes, which provides greater insight into the relationship between flunixin meglumine and fenbendazole and known drug metabolizing genes.	[Howard, Jeremy T.; O'Nan, Audrey T.; Maltecca, Christian; Ashwell, Melissa S.] N Carolina State Univ, Coll Agr & Life Sci, Dept Anim Sci, Raleigh, NC 27695 USA; [Baynes, Ronald E.] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Ctr Chem Toxicol & Res Pharmacokinet, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Ashwell, MS (corresponding author), N Carolina State Univ, Coll Agr & Life Sci, Dept Anim Sci, Raleigh, NC 27695 USA.	msashwel@ncsu.edu		maltecca, christian/0000-0002-9996-4680; Ashwell, Melissa/0000-0003-1732-1022	North Carolina Biotechnology Center [2012-MRG-1108]; Food Animal Residue Avoidance Databank (USDA) [2013-41480-21002]	North Carolina Biotechnology Center; Food Animal Residue Avoidance Databank (USDA)	Funding provided by North Carolina Biotechnology Center (grant #2012-MRG-1108) and Food Animal Residue Avoidance Databank (USDA #2013-41480-21002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerheiligen SRB, 2010, CLIN PHARMACOL THER, V88, P135, DOI 10.1038/clpt.2010.81; Bender JM, 2006, J ANIM SCI, V84, P1331, DOI 10.2527/2006.8461331x; Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004; Blowe CD, 2006, J ANIM BREED GENET, V123, P389, DOI 10.1111/j.1439-0388.2006.00620.x; Ernst CW, 2013, TRENDS GENET, V29, P215, DOI 10.1016/j.tig.2013.02.002; Evans DAP, 2001, DRUG METAB DISPOS, V29, P606; Evans WE, 2003, GUT, V52, pII10, DOI 10.1136/gut.52.suppl_2.ii10; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fink-Gremmels J, 2008, EUR J PHARMACOL, V585, P502, DOI 10.1016/j.ejphar.2008.03.013; Franke RM, 2010, CURR PHARM DESIGN, V16, P220, DOI 10.2174/138161210790112683; Fry RS, 2012, J ANIM SCI, V90, P3112, DOI 10.2527/jas.2011-4403; Gardner CR, 2012, TOXICOL SCI, V125, P607, DOI 10.1093/toxsci/kfr301; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625; Ho RH, 2008, GENOMICS, V17, P647; Hon YY, 1999, HUM MOL GENET, V8, P371, DOI 10.1093/hmg/8.2.371; Howard JT, 2014, J VET PHARMACOL THER, V37, P531, DOI 10.1111/jvp.12128; Kirchheiner J, 2005, CLIN PHARMACOL THER, V77, P1, DOI 10.1016/j.clpt.2004.08.009; Klein Kathrin, 2013, Frontiers in Genetics, V4, P12, DOI 10.3389/fgene.2013.00012; Konigsson K, 2003, ACTA VET SCAND, V44, P153, DOI 10.1186/1751-0147-44-153; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Lespine A, 2012, INT J PARASITOL-DRUG, V2, P58, DOI 10.1016/j.ijpddr.2011.10.001; Lin ZH, 2004, MAMM GENOME, V15, P218, DOI 10.1007/s00335-002-2318-4; Martinez M, 2008, J VET PHARMACOL THER, V31, P285, DOI 10.1111/j.1365-2885.2008.00964.x; McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101; Mealey KL, 2008, XENOBIOTICA, V38, P1305, DOI 10.1080/00498250802446146 ; Mealey KL, 2008, JAVMA-J AM VET MED A, V233, P921, DOI 10.2460/javma.233.6.921; MURRAY M, 1992, CHEM RES TOXICOL, V5, P60, DOI 10.1021/tx00025a010; Pacifici GM, 2004, INT J CLIN PHARM TH, V42, P488; Pairis-Garcia MD, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-165; Petersen MB, 2000, AM J VET RES, V61, P573, DOI 10.2460/ajvr.2000.61.573; Sakuma T, 2004, DRUG METAB DISPOS, V32, P376, DOI 10.1124/dmd.32.4.376; Shang HT, 2013, GENE, V524, P261, DOI 10.1016/j.gene.2013.04.007; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; STEPHENS EA, 1994, PHARMACOGENETICS, V4, P185, DOI 10.1097/00008571-199408000-00002; Vaclavikova R, 2004, DRUG METAB DISPOS, V32, P666, DOI 10.1124/dmd.32.6.666	37	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137830	10.1371/journal.pone.0137830	http://dx.doi.org/10.1371/journal.pone.0137830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366864	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100148
J	Liu, R; Liu, ZZ; Xu, Y; Liao, YQ; Hu, QH; Huang, JW; Shi, XL; Li, YH; Niu, JJ; Li, QG				Liu, Ran; Liu, Zanzan; Xu, Ye; Liao, Yiqun; Hu, Qinghua; Huang, Jianwei; Shi, Xiaolu; Li, Yinghui; Niu, Jianjun; Li, Qingge			Multicolor Melting Curve Analysis-Based Multilocus Melt Typing of Vibrio parahaemolyticus	PLOS ONE			English	Article							REAL-TIME-PCR; SEQUENCE; IDENTIFICATION; BACTERIAL; STRAINS; EBURST; O3-K6; INTERROGATION	Vibrio parahaemolyticus is the leading cause of seafood-borne gastroenteritis outbreaks. To track the source of these diseases in a timely manner, a high throughput typing method is critical. We hereby describe a novel genotyping method for V. parahaemolyticus, termed multilocus melt typing (MLMT), based on multilocus sequence typing (MLST). MLMT utilizes melting curve analysis to interrogate the allelic types of a set of informative single nucleotide polymorphisms (SNPs) derived from the housekeeping genes used in MLST. For each SNP, one allelic type generates distinct Tm values, which are converted into a binary code. Multiple SNPs thus generate a series of binary codes, forming a melt type (MT) corresponding with a sequence type (ST) of MLST. Using a set of 12 SNPs, the MLMT scheme could resolve 218 V. parahaemolyticus isolates into 50 MTs corresponding with 56 STs. The discriminatory power of MLMT and MLST was similar with Simpson's index of diversity of 0.638 and 0.646, respectively. The global (adjusted Rand index = 0.982) and directional congruence (adjusted Wallace coefficient, MT -> ST = 0.965; ST -> MT = 1.000) between the two typing approaches was high. The entire procedure of MLMT could be finished within 3 h with negligible hands on time in a real-time PCR machine. We conclude that MLMT provides a reliable and efficient approach for V. parahaemolyticus genotyping and might also find use in other pathogens.	[Liu, Ran; Liu, Zanzan; Xu, Ye; Liao, Yiqun; Li, Qingge] Xiamen Univ, Sch Life Sci, Engn Res Ctr Mol Diagnost, Minist Educ,State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Liao, Yiqun; Li, Qingge] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Fujian, Peoples R China; [Hu, Qinghua; Shi, Xiaolu; Li, Yinghui] Shenzhen Ctr Dis Control & Prevent, Shenzhen Major Infect Dis Control Key Lab, Shenzhen, Guangdong, Peoples R China; [Hu, Qinghua] Shenzhen Univ, Sch Life Sci, Shenzhen, Guangdong, Peoples R China; [Huang, Jianwei] Xiamen Ctr Dis Control & Prevent, Xiamen, Fujian, Peoples R China; [Niu, Jianjun] Xiamen Univ, Zhongshan Hosp Xiamen, Xiamen, Fujian, Peoples R China; [Li, Qingge] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China	Xiamen University; Xiamen University; Shenzhen Center for Disease Control & Prevention (SZCDC); Shenzhen University; Xiamen University; Xiamen University	Niu, JJ (corresponding author), Xiamen Univ, Zhongshan Hosp Xiamen, Xiamen, Fujian, Peoples R China.	niujianjun@xmu.edu.cn; qgli@xmu.edu.cn			National Natural Science Foundation [81271929]; Project of Science and Technology Innovation Commission of Shenzhen Municipality [JC201104220329A]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Project of Science and Technology Innovation Commission of Shenzhen Municipality	This study was partially supported by National Natural Science Foundation (http://www.nsfc.gov.cn/) No. 81271929 (to QL) and Project of Science and Technology Innovation Commission of Shenzhen Municipality (http://www.szsti.gov.cn/) No. JC201104220329A (to QL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bag PK, 1999, J CLIN MICROBIOL, V37, P2354, DOI 10.1128/JCM.37.7.2354-2357.1999; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gavilan RG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002210; Gil AI, 2007, INT J INFECT DIS, V11, P324, DOI 10.1016/j.ijid.2006.08.003; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Hu SY, 2014, J CLIN MICROBIOL, V52, P1644, DOI 10.1128/JCM.03395-13; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019206; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Huygens F, 2006, J CLIN MICROBIOL, V44, P3712, DOI 10.1128/JCM.00843-06; Jensen RV, 2013, GENOME ANNOUNC, V1, P1, DOI [10.1128/genomeA.00159-14.Copyright, DOI 10.1128/GEN0MEA.00002-12]; Letchumanan V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00705; Levesque S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016167; Liao YQ, 2013, J CLIN MICROBIOL, V51, P429, DOI 10.1128/JCM.02115-12; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Martinez-Urtaza J, 2005, EMERG INFECT DIS, V11, P1319, DOI 10.3201/eid1108.050322; Price EP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-278; Rapa RA, 2015, ENVIRON MICROBIOL, V17, P1090, DOI 10.1111/1462-2920.12512; Richardson LJ, 2011, CLIN MICROBIOL INFEC, V17, P1426, DOI 10.1111/j.1469-0691.2010.03433.x; Robertson GA, 2004, J MED MICROBIOL, V53, P35, DOI 10.1099/jmm.0.05365-0; Sanchez JA, 2004, P NATL ACAD SCI USA, V101, P1933, DOI 10.1073/pnas.0305476101; Sara Urmersbach TA, 2014, BMC MICROBIOL, V59, DOI [10.1186/1471-2180-14-59, DOI 10.1186/1471-2180-14-59]; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Severiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019539; Sheludchenko MS, 2010, APPL ENVIRON MICROB, V76, P4337, DOI 10.1128/AEM.00128-10; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Theethakaew C, 2013, APPL ENVIRON MICROB, V79, P2358, DOI 10.1128/AEM.03067-12; Tong SYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029189; Turner JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055726; Velazquez-Roman J, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00110; Xiong F, 2011, J MOL DIAGN, V13, P427, DOI 10.1016/j.jmoldx.2011.03.005; Yu Y, 2011, FOODBORNE PATHOG DIS, V8, P1169, DOI 10.1089/fpd.2011.0865	36	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136998	10.1371/journal.pone.0136998	http://dx.doi.org/10.1371/journal.pone.0136998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368129	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100043
J	Su, CH; Chen, JH; Lan, JL; Wang, YC; Tseng, CH; Hsu, CY; Huang, LC				Su, Chia-Hsien; Chen, Jiunn-Horng; Lan, Joung-Liang; Wang, Yu-Chiao; Tseng, Chun-Hung; Hsu, Chung-Yi; Huang, Lichi			Increased Risk of Coronary Heart Disease in Patients with Primary Fibromyalgia and Those with Concomitant Comorbidity-A Taiwanese Population-Based Cohort Study	PLOS ONE			English	Article							2010 CLASSIFICATION CRITERIA; CHRONIC WIDESPREAD PAIN; OF-RHEUMATOLOGY 1990; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; SYMPTOM SEVERITY; PREVALENCE; DEPRESSION; DISORDER; EPIDEMIOLOGY	Objectives Fibromyalgia has seldom been associated with coronary heart disease (CHD). The aim of this study was to evaluate the risk of CHD in patients with fibromyalgia. Methods We used a dataset of one million participants, systemically scrambled from the Taiwanese national insurance beneficiaries, to identify 61,612 patients with incident fibromyalgia (ICD-9-CM 729.0-729.1) and 184,834 reference subjects matched by sex, age and index date of diagnosis in a 1: 3 ratio from 2000 to 2005, with a mean 8.86 +/- 2.68 years of follow-up until 2011. Risk of CHD was analyzed by Cox proportional hazard modeling. Results Patients with fibromyalgia had a mean age of 44.1 +/- 16.5 years. CHD events developed in fibromyalgia patients (n = 8,280; 15.2 per 103 person-years) and reference subjects (n = 15,162; 9.26 per 103 person-years) with a significant incidence rate ratio of 1.64 (95% confidence interval: 1.61-1.68). The adjusted hazard ratio for CHD in fibromyalgia patients relative to reference subjects was 1.47 (1.43-1.51), after adjusting for age, gender, occupation, monthly income, traditional cardiovascular comorbidities, depression and anxiety. We noted that fibromyalgia and cardiovascular comorbidities had a significant interaction effect on CHD risk (p for interaction < 0.01), which was markedly enhanced in fibromyalgia patients with concomitant comorbidities relative to patients with primary fibromyalgia and reference subjects (no fibromyalgia, no comorbidity). Conclusions Our report shows that fibromyalgia patients have an independent risk for CHD development. Fibromyalgia patients with concomitant comorbidities have markedly increased CHD risk relative to those with primary fibromyalgia.	[Su, Chia-Hsien] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Su, Chia-Hsien] China Med Univ Hosp, Dept Nursing, Taichung, Taiwan; [Chen, Jiunn-Horng; Lan, Joung-Liang; Wang, Yu-Chiao; Tseng, Chun-Hung; Hsu, Chung-Yi] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Jiunn-Horng; Lan, Joung-Liang] China Med Univ Hosp, Div Rheumatol & Immunol, Dept Internal Med, Taichung, Taiwan; [Wang, Yu-Chiao] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Hsu, Chung-Yi] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Huang, Lichi] China Med Univ, Sch Nursing, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Chen, JH (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.	d91842001@ntu.edu.tw		Hsu, Chung Y./0000-0002-5632-2733	Department of Health, Executive Yuan, Taiwan [DOH 97-HP-1101, NSC97-2314-B-039-010-MY3, NSC100-2314-B-039-012, NSC101-2314-B-039-020, MOST103-2314-B-039-020]; China Medical University Hospital [1MS1, DMR-97-059, DMR-101-010, DMR-102-012]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Fund	Department of Health, Executive Yuan, Taiwan; China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Fund	This study was funded, in part, by the Department of Health, Executive Yuan, Taiwan (Grant DOH 97-HP-1101, 2008, Grant NSC97-2314-B-039-010-MY3, Grant NSC100-2314-B-039-012, Grant NSC101-2314-B-039-020, Grant MOST103-2314-B-039-020); China Medical University Hospital (Grant 1MS1, Grant DMR-97-059, Grant DMR-101-010, Grant DMR-102-012); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (Grant MOHW104-TDU-B-212-113002); Academia Sinica Taiwan Biobank, Stroke Biosignature Project (Grant BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; and Katsuzo and Kiyo Aoshima Memorial Fund. None of the funders played a role in conducting the research.	Ablin Jacob N, 2009, Clin Cardiol, V32, pE7, DOI 10.1002/clc.20308; Benjamin S, 2000, ARTHRITIS RHEUM-US, V43, P561, DOI 10.1002/1529-0131(200003)43:3<561::AID-ANR12>3.0.CO;2-O; Bureau of Health Promotion T, 2012, TAIW TOB CONTR ANN R; Buskila D, 2008, AUTOIMMUN REV, V8, P41, DOI 10.1016/j.autrev.2008.07.023; Cao HJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/362831; Chen JH, 2008, MIDTAIWAN J MED, V13, P136; Chen YJ, 2011, ARTHRITIS RHEUM-US, V63, P352, DOI 10.1002/art.30134; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cho Kyoung Im, 2010, Korean Circ J, V40, P74, DOI 10.4070/kcj.2010.40.2.74; Clark P, 1998, J RHEUMATOL, V25, P2009; Clauw DJ, 2011, MAYO CLIN PROC, V86, P907, DOI 10.4065/mcp.2011.0206; DELUZE C, 1992, BRIT MED J, V305, P1249, DOI 10.1136/bmj.305.6864.1249; Ding F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116441; Eisenlohr-Moul TA, 2015, J PAIN, V16, P247, DOI 10.1016/j.jpain.2014.12.005; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Golomb BA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003208; Horvei LD, 2014, EUR J EPIDEMIOL, V29, P821, DOI 10.1007/s10654-014-9950-z; Huang CJ, 2013, INT J CARDIOL, V168, P4711, DOI 10.1016/j.ijcard.2013.07.173; Iannuccelli C, 2012, CLIN EXP RHEUMATOL, V30, pS112; Imbierowicz K, 2003, EUR J PAIN, V7, P113, DOI 10.1016/S1090-3801(02)00072-1; Jones GT, 2015, ARTHRITIS RHEUMATOL, V67, P568, DOI 10.1002/art.38905; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kim C, 2012, RHEUMATOL INT, V32, P3435, DOI 10.1007/s00296-011-2195-1; Kim SC, 2013, ARTHRIT CARE RES, V65, P1813, DOI 10.1002/acr.22071; KRISHNAN KRR, 1985, PAIN, V22, P289, DOI 10.1016/0304-3959(85)90029-6; Lee CTC, 2013, ADDICT BEHAV, V38, P2619, DOI 10.1016/j.addbeh.2013.03.003; MAKELA M, 1991, BRIT MED J, V303, P216, DOI 10.1136/bmj.303.6796.216; Martinez-Lavin M, 1998, ARTHRITIS RHEUM-US, V41, P1966, DOI 10.1002/1529-0131(199811)41:11<1966::AID-ART11>3.0.CO;2-O; Martinez-Martinez LA, 2014, JCR-J CLIN RHEUMATOL, V20, P146, DOI 10.1097/RHU.0000000000000089; McBeth J, 2012, NAT REV RHEUMATOL, V8, P108, DOI 10.1038/nrrheum.2011.216; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Solano C, 2009, JCR-J CLIN RHEUMATOL, V15, P172, DOI 10.1097/RHU.0b013e3181a1083d; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P1378, DOI 10.1002/art.21887; Springer KW, 2003, J GEN INTERN MED, V18, P864, DOI 10.1046/j.1525-1497.2003.20918.x; Staud R, 2006, NAT CLIN PRACT RHEUM, V2, P90, DOI 10.1038/ncprheum0091; Tietjen GE, 2007, HEADACHE, V47, P857, DOI 10.1111/j.1526-4610.2007.00814.x; Toda K, 2007, SCAND J RHEUMATOL, V36, P140, DOI 10.1080/03009740600907949; Tsai PS, 2015, REGION ANESTH PAIN M, V40, P37, DOI 10.1097/AAP.0000000000000190; Vargas-Alarcon G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2316; Vincent A, 2013, ARTHRIT CARE RES, V65, P786, DOI 10.1002/acr.21896; Wen CP, 2005, TOB CONTROL, V14, pI51, DOI 10.1136/tc.2004.008011; White KP, 1999, J RHEUMATOL, V26, P1570; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140	46	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137137	10.1371/journal.pone.0137137	http://dx.doi.org/10.1371/journal.pone.0137137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366998	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100051
J	Quan, LN; Chen, X; Liu, AC; Zhang, Y; Guo, XC; Yan, SJ; Liu, Y				Quan, Lina; Chen, Xue; Liu, Aichun; Zhang, Yan; Guo, Xiuchen; Yan, Shujie; Liu, Yue			PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; HPV-ASSOCIATED HEAD; DEATH-LIGAND 1; FOLLICULAR LYMPHOMA; PROGRAMMED DEATH-1; REGULATORY T; HEPATOCELLULAR-CARCINOMA; HODGKINS-LYMPHOMA; HIGH NUMBERS; IFN-GAMMA	Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+DLBCL) is an aggressive malignancy that is largely resistant to current therapeutic regimens, and is an attractive target for immune-based therapies. Anti-programmed death-1 (PD-1) antibodies showed encouraging anti-tumor effects in both preclinical models and advanced solid and hematological malignancies, but its efficacy against EBV+DLBCL is unknown. Herein, we performed experiments using co-culture system with T cells and lymphoma cell lines including EBV+DLBCL and EBV-DLBCL [including germinal center B-cell like (GCB)-DLBCL and non-GCB-DLBCL] in vitro. We show that lymphoma cells augmented the expression of PD-1 on T cells, decreased the proliferation of T cells, and altered the secretion of multiple cytokines. However, through PD-1 blockade, these functions could be largely restored. Notbaly, the effect of PD-1 blockade on antitumor immunity was more effective in EBV+DLBCL than that in EBV-DLBCL in vitro. These results suggest that T-cell exhaustion and immune escape in microenvironment is one of the mechanisms underlying DLBCL; and PD-1 blockade could present as a efficacious immunotherapeutic treatment for EBV+DLBCL.	[Quan, Lina; Chen, Xue; Liu, Aichun; Guo, Xiuchen; Yan, Shujie; Liu, Yue] Harbin Med Univ, Canc Hosp, Dept Hematol, Harbin, Heilongjiang Pr, Peoples R China; [Zhang, Yan] Harbin Med Univ, Canc Hosp, Dept Radiotherapy, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Liu, AC (corresponding author), Harbin Med Univ, Canc Hosp, Dept Hematol, Harbin, Heilongjiang Pr, Peoples R China.	aichun2002@hotmail.com	Liu, Yue/AAU-3811-2021	Quan, Lina/0000-0001-8995-7156	Harbin Medical University Cancer Hospital [JJZD2014-08]	Harbin Medical University Cancer Hospital	This research is funded by Harbin Medical University Cancer Hospital (award number JJZD2014-08).	Andorsky DJ, 2011, CLIN CANCER RES, V17, P4232, DOI 10.1158/1078-0432.CCR-10-2660; Ansell SM, 2009, CLIN CANCER RES, V15, P6446, DOI 10.1158/1078-0432.CCR-09-1339; Armand P, 2013, J CLIN ONCOL, V31, P4199, DOI 10.1200/JCO.2012.48.3685; Badoual C, 2013, CANCER RES, V73, P128, DOI 10.1158/0008-5472.CAN-12-2606; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bryan LJ, 2015, BLOOD REV, V29, P25, DOI 10.1016/j.blre.2014.09.004; Carreras J, 2009, J CLIN ONCOL, V27, P1470, DOI 10.1200/JCO.2008.18.0513; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Chen DS, 2012, CLIN CANCER RES, V18, P6580, DOI 10.1158/1078-0432.CCR-12-1362; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fang WF, 2014, ONCOTARGET, V5, P12189, DOI 10.18632/oncotarget.2608; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; HAMILTONDUTOIT SJ, 1993, AM J PATHOL, V143, P1072; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Houot R, 2009, BLOOD, V114, P3431, DOI 10.1182/blood-2009-05-223958; Houot R, 2009, BLOOD, V113, P3546, DOI 10.1182/blood-2008-07-170274; Hui-Yuen J, 2011, JOVE-J VIS EXP, P8; IARC, 2008, WHO CLASSIFICATION T, V2; Kuchroo VK, 2014, CURR OPIN HIV AIDS, V9, P439, DOI 10.1097/COH.0000000000000088; Lu CH, 2014, JPN J CLIN ONCOL, V44, P1164, DOI 10.1093/jjco/hyu155; Lyford-Pike S, 2013, CANCER RES, V73, P1733, DOI 10.1158/0008-5472.CAN-12-2384; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; Muenst S, 2009, HUM PATHOL, V40, P1715, DOI 10.1016/j.humpath.2009.03.025; Ok CY, 2013, BLOOD, V122, P328, DOI 10.1182/blood-2013-03-489708; Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parish CR, 2010, JOVE-J VIS EXP, P12; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Wang BJ, 2011, WORLD J GASTROENTERO, V17, P3322, DOI 10.3748/wjg.v17.i28.3322; Westin JR, 2014, LANCET ONCOL, V15, P69, DOI 10.1016/S1470-2045(13)70551-5; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhou QF, 2010, J IMMUNOL, V185, P5082, DOI 10.4049/jimmunol.1001821	48	43	45	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136476	10.1371/journal.pone.0136476	http://dx.doi.org/10.1371/journal.pone.0136476			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361042	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100011
J	Treps, L; Edmond, S; Harford-Wright, E; Galan-Moya, EM; Schmitt, A; Azzi, S; Citerne, A; Bidere, N; Ricard, D; Gavard, J				Treps, L.; Edmond, S.; Harford-Wright, E.; Galan-Moya, E. M.; Schmitt, A.; Azzi, S.; Citerne, A.; Bidere, N.; Ricard, D.; Gavard, J.			Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma	ONCOGENE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; ENDOTHELIAL-CELL PERMEABILITY; BEVACIZUMAB PLUS IRINOTECAN; STEM-CELLS; RECURRENT GLIOBLASTOMA; TUMOR-GROWTH; VE-CADHERIN; ANTI-VEGF; PHASE-II; THERAPY	Glioblastoma are malignant highly vascularized brain tumours, which feature large oedema resulting from tumour-promoted vascular leakage. The pro-permeability factor Semaphorin3A (Sema3A) produced within glioblastoma has been linked to the loss of endothelial barrier integrity. Here, we report that extracellular vesicles (EVs) released by patient-derived glioblastoma cells disrupt the endothelial barrier. EVs expressed Sema3A at their surface, which accounted for in vitro elevation of brain endothelial permeability and in vivo vascular permeability, in both skin and brain vasculature. Blocking Sema3A or its receptor Neuropilin1 (NRP1) hampered EV-mediated permeability. In vivo models using ectopically and orthotopically xenografted mice revealed that Sema3A-containing EVs were efficiently detected in the blood stream. In keeping with this idea, sera from glioblastoma multiforme (GBM) patients also contain high levels of Sema3A carried in the EV fraction that enhanced vascular permeability, in a Sema3A/NRP1-dependent manner. Our results suggest that EV-delivered Sema3A orchestrates loss of barrier integrity in glioblastoma and may be of interest for prognostic purposes.	[Treps, L.; Harford-Wright, E.; Galan-Moya, E. M.; Schmitt, A.; Azzi, S.; Citerne, A.; Bidere, N.; Gavard, J.] CNRS, UMR8104, Paris, France; [Treps, L.; Harford-Wright, E.; Galan-Moya, E. M.; Schmitt, A.; Azzi, S.; Citerne, A.; Bidere, N.; Gavard, J.] INSERM, U1016, Paris, France; [Treps, L.; Harford-Wright, E.; Galan-Moya, E. M.; Schmitt, A.; Azzi, S.; Citerne, A.; Bidere, N.; Gavard, J.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Edmond, S.; Ricard, D.] Hop Instruct Armees Val de Grace, Serv Neurol, Paris, France; [Harford-Wright, E.; Bidere, N.; Gavard, J.] INSERM, U892, Nantes, France; [Harford-Wright, E.; Bidere, N.; Gavard, J.] CNRS, UMR6299, Nantes, France; [Harford-Wright, E.; Bidere, N.; Gavard, J.] Univ Nantes, Nantes, France; [Ricard, D.] CNRS, COGNAC G UMR8257, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Val-de-Grace Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Gavard, J (corresponding author), CRCNA, INSERM U892, CNRS UMR6299, 8 Quai Moncousu, F-44000 Nantes, France.	julie.gavard@inserm.fr	Treps, Lucas/AAF-2499-2020; Gavard, Julie/I-5487-2012; Bidère, Nicolas/K-8887-2015; Galan-Moya, Eva M/I-2912-2015; Gavard, Julie/I-5487-2012	Treps, Lucas/0000-0003-0735-9000; Gavard, Julie/0000-0002-7985-9007; Bidère, Nicolas/0000-0001-9177-0008; Galan-Moya, Eva M/0000-0001-5758-7592; Citerne, Antoine/0000-0002-9746-931X; Gavard, Julie/0000-0003-3107-2026	Universite Paris Descartes; Ligue nationale contre le cancer, Canceropole Ile-de-France; Fondation ARC Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale; Institut National du Cancer [INCA_6508]; Ligue nationale contre le cancer comite de Paris; Region Pays-de-la-Loire; Nantes Metropole	Universite Paris Descartes; Ligue nationale contre le cancer, Canceropole Ile-de-France; Fondation ARC Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue nationale contre le cancer comite de Paris; Region Pays-de-la-Loire(Region Pays de la Loire); Nantes Metropole(Region Pays de la Loire)	We are thankful to present and past members of the team, especially to Heloise Leclair and Armelle Le Guelte. We are grateful to Robin Lombard (Myltenyi Biotech, Paris, France) for technical assistance with the MacsQuant cytometer. We are also grateful to PO Couraud and F Niedergang's team (Institut Cochin, Paris, France) for helpful discussion and reagents. This research was funded by: Fondation pour la Recherche Medicale, Institut National du Cancer INCA_6508, Ligue nationale contre le cancer comite de Paris, Region Pays-de-la-Loire, Nantes Metropole. LT is supported by doctoral fellowship from Universite Paris Descartes. EMGM, EHW and SA are supported by post-doctoral fellowships from Ligue nationale contre le cancer, Canceropole Ile-de-France and Fondation ARC Association pour la Recherche sur le Cancer, respectively.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; Chen XB, 2014, CANCER RES, V74, P7285, DOI 10.1158/0008-5472.CAN-14-1240; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; Dwyer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045562; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Galan-Moya EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093505; Galan-Moya EM, 2011, EMBO REP, V12, P470, DOI 10.1038/embor.2011.39; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Le Guelte A, 2012, J CELL SCI, V125, P4137, DOI 10.1242/jcs.108282; Le Guelte A, 2011, BIOL CELL, V103, P593, DOI 10.1042/BC20110069; Maione F, 2012, J CLIN INVEST, V122, P1832, DOI 10.1172/JCI58976; Maione F, 2009, J CLIN INVEST, V119, P3356, DOI 10.1172/JCI36308; Narayana A, 2012, J NEUROSURG, V116, P341, DOI 10.3171/2011.9.JNS11656; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Piao YJ, 2012, NEURO-ONCOLOGY, V14, P1379, DOI 10.1093/neuonc/nos158; Shao HL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7999; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thirant C, 2012, STEM CELLS, V30, P845, DOI 10.1002/stem.1062; Vader P, 2014, TRENDS MOL MED, V20, P385, DOI 10.1016/j.molmed.2014.03.002; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Yan K, 2013, CURR OPIN NEUROL, V26, P701, DOI 10.1097/WCO.0000000000000032; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	34	74	75	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 19	2016	35	20					2615	2623		10.1038/onc.2015.317	http://dx.doi.org/10.1038/onc.2015.317			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GS	26364614				2022-12-26	WOS:000376165700008
J	Scott, MC; Sarver, AL; Tomiyasu, H; Cornax, I; Van Etten, J; Varshney, J; O'Sullivan, MG; Subramanian, S; Modiano, JF				Scott, Milcah C.; Sarver, Aaron L.; Tomiyasu, Hirotaka; Cornax, Ingrid; Van Etten, Jamie; Varshney, Jyotika; O'Sullivan, M. Gerard; Subramanian, Subbaya; Modiano, Jaime F.			Aberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY PROTEINS; YOUNG-ADULT; GENE; RB; EXPRESSION; GROWTH; HETEROZYGOSITY; INHIBITION; ADOLESCENT; P21/WAF-1	We previously identified two distinct molecular subtypes of osteosarcoma through gene expression profiling. These subtypes are associated with distinct tumor behavior and clinical outcomes. Here, we describe mechanisms that give rise to these molecular subtypes. Using bioinformatic analyses, we identified a significant association between deregulation of the retinoblastoma (RB)-E2F pathway and the molecular subtype with worse clinical outcomes. Xenotransplantation models recapitulated the corresponding behavior for each osteosarcoma subtype; thus, we used cell lines to validate the role of the RB-E2F pathway in regulating the prognostic gene signature. Ectopic RB resets the patterns of E2F regulated gene expression in cells derived from tumors with worse clinical outcomes (molecular phenotype 2) to those comparable with those observed in cells derived from tumors with less aggressive outcomes (molecular phenotype 1), providing a functional association between RB-E2F dysfunction and altered gene expression in osteosarcoma. DNA methyltransferase and histone deacetylase inhibitors similarly reset the transcriptional state of the molecular phenotype 2 cells from a state associated with RB deficiency to one seen with RB sufficiency. Our data indicate that deregulation of RB-E2F pathway alters the epigenetic landscape and biological behavior of osteosarcoma.	[Scott, Milcah C.; Sarver, Aaron L.; Tomiyasu, Hirotaka; Cornax, Ingrid; Varshney, Jyotika; O'Sullivan, M. Gerard; Subramanian, Subbaya; Modiano, Jaime F.] Univ Minnesota, Anim Canc Care & Res Program, Minneapolis, MN 55455 USA; [Scott, Milcah C.; Sarver, Aaron L.; Tomiyasu, Hirotaka; Modiano, Jaime F.] Univ Minnesota, Dept Vet Clin Sci, Minneapolis, MN 55455 USA; [Cornax, Ingrid; O'Sullivan, M. Gerard] Univ Minnesota, Dept Vet Populat Med, Minneapolis, MN 55455 USA; [Varshney, Jyotika] Univ Minnesota, Coll Vet Med, Vet Med Grad Program, Minneapolis, MN 55455 USA; [Scott, Milcah C.; Tomiyasu, Hirotaka; Cornax, Ingrid; Van Etten, Jamie; O'Sullivan, M. Gerard; Subramanian, Subbaya; Modiano, Jaime F.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Van Etten, Jamie; Varshney, Jyotika; Subramanian, Subbaya] Univ Minnesota, Sch Med, Dept Surg, Minneapolis, MN 55455 USA; [Modiano, Jaime F.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Modiano, Jaime F.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Modiano, JF (corresponding author), Univ Minnesota, Masonic Canc Ctr, 420 Delaware St,SE,MMC 806, Minneapolis, MN 55455 USA.	modiano@umn.edu	MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648; Tomiyasu, Hirotaka/0000-0001-7708-6218; Subramanian, Subbaya/0000-0002-2544-480X; Varshney, Jyotika/0000-0003-0275-1521	Morris Animal Foundation [D13CA-032]; American Cancer Society [RSG-13-381-01]; Karen Wyckoff Rein in Sarcoma Foundation [2011-1]; Zach Sobiech Fund for Osteosarcoma Research of the Children's Cancer Research Fund; Comparative Medicine Signature Program of the College of Veterinary Medicine, University of Minnesota; National Institutes of Health Comprehensive Cancer Center [P30 CA077598]; University of Minnesota; Cancer Biology Training Grant from the National Institutes of Health [T32 CA09138]; Alvin and June Perlman Chair in Animal Oncology; NATIONAL CANCER INSTITUTE [P30CA077598, T32CA009138] Funding Source: NIH RePORTER	Morris Animal Foundation; American Cancer Society(American Cancer Society); Karen Wyckoff Rein in Sarcoma Foundation; Zach Sobiech Fund for Osteosarcoma Research of the Children's Cancer Research Fund; Comparative Medicine Signature Program of the College of Veterinary Medicine, University of Minnesota; National Institutes of Health Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); Cancer Biology Training Grant from the National Institutes of Health; Alvin and June Perlman Chair in Animal Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Morris Animal Foundation Grant D13CA-032, American Cancer Society Grant RSG-13-381-01, Karen Wyckoff Rein in Sarcoma Foundation Grant 2011-1, the Zach Sobiech Fund for Osteosarcoma Research of the Children's Cancer Research Fund, and the Comparative Medicine Signature Program of the College of Veterinary Medicine, University of Minnesota. National Institutes of Health Comprehensive Cancer Center Support Grant P30 CA077598 to the Masonic Cancer Center provided support for bioinformatics, genomics, flow cytometry, bioimaging, cytogenetics, and comparative pathology services. This work was also supported by donors to the Animal Cancer Care and Research Program of the University of Minnesota, which helped support of the project The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Cancer Biology Training Grant T32 CA09138 from the National Institutes of Health.; Supported by the Alvin and June Perlman Chair in Animal Oncology. To whom correspondence should be addressed: Masonic Cancer Center, Univ. of Minnesota, 420 Delaware St., SE, MMC 806, Minneapolis, MN 55455. Tel,: 612-625-7436; Fax: 612-626-4915; E-mail: modiano@umn.edu.	Ashizawa S, 2001, J BIOL CHEM, V276, P11362, DOI 10.1074/jbc.M007992200; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; ChitkoMcKown CG, 1997, J LEUKOCYTE BIOL, V62, P430, DOI 10.1002/jlb.62.4.430; Dobson J. M., 2013, ISRN VET SCI, V2013, DOI DOI 10.1155/2013/941275); Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Feugeas O, 1996, J CLIN ONCOL, V14, P467, DOI 10.1200/JCO.1996.14.2.467; Fiorentino FP, 2013, J CELL PHYSIOL, V228, P276, DOI 10.1002/jcp.24141; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gorlick R, 2013, PEDIATR BLOOD CANCER, V60, P1009, DOI 10.1002/pbc.24429; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; Heinsohn S, 2007, INT J ONCOL, V30, P1205; Janeway KA, 2012, CLIN CANCER RES, V18, P5837, DOI 10.1158/1078-0432.CCR-12-0875; Janeway KA, 2012, CANCER-AM CANCER SOC, V118, P4597, DOI 10.1002/cncr.27414; Jubala CM, 2005, VET PATHOL, V42, P468, DOI 10.1354/vp.42-4-468; Karlsson EK, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r132; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim JH, 2014, EXP CELL RES, V323, P155, DOI 10.1016/j.yexcr.2014.02.020; Kimura M, 2004, BIOCHEM BIOPH RES CO, V316, P930, DOI 10.1016/j.bbrc.2004.01.178; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Maitra A, 2001, INT J CANCER, V95, P34, DOI 10.1002/1097-0215(20010120)95:1<34::AID-IJC1006>3.0.CO;2-V; Mann DJ, 1996, CURR BIOL, V6, P474, DOI 10.1016/S0960-9822(02)00515-8; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Modiano JF, 2006, GENE THER MOL BIOL, V10A, P31; Modiano JF, 2012, MOL THER, V20, P2234, DOI 10.1038/mt.2012.149; Modiano JF, 2000, J IMMUNOL, V165, P6693, DOI 10.4049/jimmunol.165.12.6693; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Rainusso N, 2013, CURR ONCOL REP, V15, P296, DOI 10.1007/s11912-013-0321-9; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; Ritt MG, 1998, VET PATHOL, V35, P94, DOI 10.1177/030098589803500202; Ritt MG, 2000, CANCER LETT, V158, P73, DOI 10.1016/S0304-3835(00)00507-3; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Sarver AL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-7; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; Tan ML, 2009, CANCER BIOL THER, V8, P106, DOI 10.4161/cbt.8.2.7385; Thayanithy V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043720; Thayanithy V, 2012, BONE, V50, P171, DOI 10.1016/j.bone.2011.10.012; Thomas R, 2009, CHROMOSOME RES, V17, P365, DOI 10.1007/s10577-009-9028-z; Wansleben S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.365; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Withrow SJ, 2010, ILAR J, V51, P208, DOI 10.1093/ilar.51.3.208	44	23	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28070	28083		10.1074/jbc.M115.679696	http://dx.doi.org/10.1074/jbc.M115.679696			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26378234	hybrid, Green Published			2022-12-26	WOS:000365761900004
J	Fu, X; Zhu, MJ; Dodson, MV; Du, M				Fu, Xing; Zhu, Mei-Jun; Dodson, Mike V.; Du, Min			AMP-activated Protein Kinase Stimulates Warburg-like Glycolysis and Activation of Satellite Cells during Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; AEROBIC GLYCOLYSIS; SONIC HEDGEHOG; SELF-RENEWAL; METABOLISM; DIFFERENTIATION; PROLIFERATION; PURIFICATION; PROGENITORS; EXPRESSION	Satellite cells are the major myogenic stem cells residing inside skeletal muscle and are indispensable for muscle regeneration. Satellite cells remain largely quiescent but are rapidly activated in response to muscle injury, and the derived myogenic cells then fuse to repair damaged muscle fibers or form new muscle fibers. However, mechanisms eliciting metabolic activation, an inseparable step for satellite cell activation following muscle injury, have not been defined. We found that a non-canonical Sonic Hedgehog (Shh) pathway is rapidly activated in response to muscle injury, which activates AMPK and induces a Warburg-like glycolysis in satellite cells. AMPK alpha 1 is the dominant AMPK alpha isoform expressed in satellite cells, and AMPK alpha 1 deficiency in satellite cells impairs their activation and myogenic differentiation during muscle regeneration. Drugs activating noncanonical Shh promote proliferation of satellite cells, which is abolished because of satellite cell-specific AMPK alpha 1 knock-out. Taken together, AMPK alpha 1 is a critical mediator linking noncanonical Shh pathway to Warburg-like glycolysis in satellite cells, which is required for satellite activation and muscle regeneration.	[Fu, Xing; Dodson, Mike V.; Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Fu, Xing; Dodson, Mike V.; Du, Min] Washington State Univ, Dept Pharmaceut Sci, Washington Ctr Muscle Biol, Pullman, WA 99164 USA; [Zhu, Mei-Jun] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Du, M (corresponding author), Washington State Univ, Dept Anim Sci, Washington Ctr Muscle Biol, Pullman, WA 99164 USA.	min.du@wsu.edu	Du, Min/H-4311-2011; Regan, Clinton/E-6250-2012	Du, Min/0000-0002-7232-072X; 	National Institutes of Health [1R01HD067449]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01HD067449. The authors declare that they have no conflicts of interest with the contents of this article.	Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Duprez D, 1998, DEVELOPMENT, V125, P495; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Fu X, 2013, MOL CELL BIOL, V33, P4517, DOI 10.1128/MCB.01078-13; IRINTCHEV A, 1987, CELL TISSUE RES, V249, P509; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; KATZ B, 1961, PHILOS T ROY SOC B, V243, P221, DOI 10.1098/rstb.1961.0001; Kennedy JW, 1999, DIABETES, V48, P1192, DOI 10.2337/diabetes.48.5.1192; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Kruger M, 2001, DEVELOPMENT, V128, P743; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Marcelle C, 1999, DEV BIOL, V214, P277, DOI 10.1006/dbio.1999.9389; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Nybakken K, 2002, CURR OPIN GENET DEV, V12, P503, DOI 10.1016/S0959-437X(02)00333-7; Ochocki JD, 2013, J CELL BIOL, V203, P23, DOI 10.1083/jcb.201303110; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Repele A, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-24; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Ryall JG, 2013, FEBS J, V280, P4004, DOI 10.1111/febs.12189; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vazquez-Martin A, 2013, CELL CYCLE, V12, P207, DOI 10.4161/cc.23352; Wagatsuma A, 2013, SCI WORLD J, DOI 10.1155/2013/593267; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Youn JY, 2015, CHEM BIOL, V22, P311, DOI 10.1016/j.chembiol.2015.03.004; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhao JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199372	55	49	50	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26445	26456		10.1074/jbc.M115.665232	http://dx.doi.org/10.1074/jbc.M115.665232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370082	hybrid, Green Published			2022-12-26	WOS:000364793600012
J	Hallee, S; Richard, D				Hallee, Stephanie; Richard, Dave			Evidence that the Malaria Parasite Plasmodium falciparum Putative Rhoptry Protein 2 Localizes to the Golgi Apparatus throughout the Erythrocytic Cycle	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; CELL INVASION; LIFE-CYCLE; REVEALS; EXPORT; HOST; EVENTS; PTEX; IDENTIFICATION; APICOMPLEXA	Invasion of a red blood cell by Plasmodium falciparum merozoites is an essential step in the malaria lifecycle. Several of the proteins involved in this process are stored in the apical complex of the merozoite, a structure containing secretory organelles that are released at specific times during invasion. The molecular players involved in erythrocyte invasion thus represent potential key targets for both therapeutic and vaccine-based strategies to block parasite development. In our quest to identify and characterize new effectors of invasion, we investigated the P. falciparum homologue of a P. berghei protein putatively localized to the rhoptries, the Putative rhoptry protein 2 (PbPRP2). We show that in P. falciparum, the protein colocalizes extensively with the Golgi apparatus across the asexual erythrocytic cycle. Furthermore, imaging of merozoites caught at different times during invasion show that PfPRP2 is not secreted during the process instead staying associated with the Golgi apparatus. Our evidence therefore suggests that PfPRP2 is a Golgi protein and that it is likely not a direct effector in the process of merozoite invasion.	[Hallee, Stephanie; Richard, Dave] CHU Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada	Laval University	Richard, D (corresponding author), CHU Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada.	dave.richard@crchul.ulaval.ca		Richard, Dave/0000-0003-2269-6240	National Science and Engineering Research Council of Canada [418192]; Canadian Foundation for Innovation [29837]; Banting Foundation New Investigator award; Fond de la Recherche du Quebec-Sante Junior 1 career award	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Banting Foundation New Investigator award; Fond de la Recherche du Quebec-Sante Junior 1 career award	Funding for the study was provided to D.R. by the National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), grant number 418192, the Canadian Foundation for Innovation (www.innovation.ca), grant number 29837 and the Banting Foundation New Investigator award. D.R. is supported by a Fond de la Recherche du Quebec-Sante Junior 1 career award (http://www.frqs.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Bunnik EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r128; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Counihan NA, 2013, TRENDS PARASITOL, V29, P228, DOI 10.1016/j.pt.2013.03.003; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; de Azevedo MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040981; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jimenez-Ruiz E., 2014, PARASITOLOGY, V13, P1, DOI DOI 10.1017/S0031182014000559; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Lobo CA, 2003, MOL BIOCHEM PARASIT, V128, P59, DOI 10.1016/S0166-6851(03)00050-1; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Oehring SC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r108; PERLMANN H, 1984, J EXP MED, V159, P1686, DOI 10.1084/jem.159.6.1686; Proellocks NI, 2007, INT J PARASITOL, V37, P1233, DOI 10.1016/j.ijpara.2007.03.013; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Richard D, 2011, J BIOL CHEM, V286, P11746, DOI 10.1074/jbc.M110.198499; Riglar DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2449; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Sam-Yellowe TY, 2008, EXP PARASITOL, V120, P113, DOI 10.1016/j.exppara.2008.05.001; Sam-Yellowe TY, 2004, J PROTEOME RES, V3, P995, DOI 10.1021/pr049926m; SCHOFIELD L, 1986, MOL BIOCHEM PARASIT, V18, P183, DOI 10.1016/0166-6851(86)90037-X; Sharma P, 2013, CURR OPIN MICROBIOL, V16, P432, DOI 10.1016/j.mib.2013.07.004; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Struck NS, 2008, MOL MICROBIOL, V67, P1320, DOI 10.1111/j.1365-2958.2008.06125.x; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Taraschi TF, 1998, EXP PARASITOL, V88, P184, DOI 10.1006/expr.1998.4254; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tufet-Bayona M, 2009, MOL BIOCHEM PARASIT, V166, P22, DOI 10.1016/j.molbiopara.2009.02.009; VanWye J, 1996, MOL BIOCHEM PARASIT, V83, P107, DOI 10.1016/S0166-6851(96)02759-4; Webster WAJ, 2014, J EUKARYOT MICROBIOL, V61, P655, DOI 10.1111/jeu.12176; Zuccala ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046160	49	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138626	10.1371/journal.pone.0138626	http://dx.doi.org/10.1371/journal.pone.0138626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375591	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200116
J	Palti, Y; Vallejo, RL; Gao, GT; Liu, SX; Hernandez, AG; Rexroad, CE; Wiens, GD				Palti, Yniv; Vallejo, Roger L.; Gao, Guangtu; Liu, Sixin; Hernandez, Alvaro G.; Rexroad, Caird E., III; Wiens, Gregory D.			Detection and Validation of QTL Affecting Bacterial Cold Water Disease Resistance in Rainbow Trout Using Restriction-Site Associated DNA Sequencing	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; WHOLE-GENOME DUPLICATION; ONCORHYNCHUS-MYKISS; LINKAGE MAPS; IDENTIFICATION; STRESS; FISH; ADAPTATION; DIVERGENCE; GENERATION	Bacterial cold water disease (BCWD) causes significant economic loss in salmonid aquaculture. Using microsatellite markers in a genome scan, we previously detected significant and suggestive QTL affecting phenotypic variation in survival following challenge with Flavobacterium psychrophilum, the causative agent of BCWD in rainbow trout. In this study, we performed selective genotyping of SNPs from restriction-site associated DNA (RAD) sequence data from two pedigreed families (2009070 and 2009196) to validate the major QTL from the previous work and to detect new QTL. The use of RAD SNPs in the genome scans increased the number of mapped markers from similar to 300 to similar to 5,000 per family. The significant QTL detected in the microsatellites scan on chromosome Omy8 in family 2009070 was validated explaining up to 58% of the phenotypic variance in that family, and in addition, a second QTL was also detected on Omy8. Two novel QTL on Omy11 and 14 were also detected, and the previously suggestive QTL on Omy1, 7 and 25 were also validated in family 2009070. In family 2009196, the microsatellite significant QTL on Omy6 and 12 were validated and a new QTL on Omy8 was detected, but none of the previously detected suggestive QTL were validated. The two Omy8 QTL from family 2009070 and the Omy12 QTL from family 2009196 were found to be co-localized with handling and confinement stress response QTL that our group has previously identified in a separate pedigreed family. With the currently available data we cannot determine if the co-localized QTL are the result of genes with pleiotropic effects or a mere physical proximity on the same chromosome segment. The genetic markers linked to BCWD resistance QTL were used to query the scaffolds of the rainbow trout reference genome assembly and the QTL-positive scaffold sequences were found to include 100 positional candidate genes. Several of the candidate genes located on or near the two Omy8 QTL detected in family 2009070 suggest potential linkages between stress response and the regulation of immune response in rainbow trout.	[Palti, Yniv; Vallejo, Roger L.; Gao, Guangtu; Liu, Sixin; Rexroad, Caird E., III; Wiens, Gregory D.] USDA ARS, Natl Ctr Cool & Cold Water Aquaculture, Kearneysville, WV 25430 USA; [Hernandez, Alvaro G.] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA	United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Palti, Y (corresponding author), USDA ARS, Natl Ctr Cool & Cold Water Aquaculture, 11861 Leetown Rd, Kearneysville, WV 25430 USA.	yniv.palti@ars.usda.gov	Vallejo, Roger/AAE-7591-2020; Gao, Guangtu/F-4541-2012	Vallejo, Roger/0000-0002-5399-3531; Wiens, Gregory/0000-0002-5478-7780	USDA Agricultural Research Service, CRIS Project [1930-31000-012]; ARS [ARS-0427931] Funding Source: Federal RePORTER	USDA Agricultural Research Service, CRIS Project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by USDA Agricultural Research Service, CRIS Project 1930-31000-012 (http://www.ars.usda.gov/research/projects/projects.htm?accn_no=427931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barnes M. E., 2011, The Open Fish Science Journal, V4, P40, DOI 10.2174/1874401X01104010040; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Brieuc MSO, 2014, G3-GENES GENOM GENET, V4, P447, DOI 10.1534/g3.113.009316; Campbell NR, 2014, G3-GENES GENOM GENET, V4, P2473, DOI 10.1534/g3.114.014621; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; de Koning DJ, 1999, GENETICS, V152, P1679; Gonen S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-166; Hale MC, 2013, G3-GENES GENOM GENET, V3, P1273, DOI 10.1534/g3.113.006817; Hecht BC, 2013, MOL ECOL, V22, P3061, DOI 10.1111/mec.12082; Hecht BC, 2012, G3-GENES GENOM GENET, V2, P1113, DOI 10.1534/g3.112.003137; Houston RD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-90; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Knott SA, 1997, THEOR APPL GENET, V94, P810, DOI 10.1007/s001220050482; Knott SA, 1996, THEOR APPL GENET, V93, P71, DOI 10.1007/BF00225729; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Liu SX, 2015, MAR BIOTECHNOL, V17, P328, DOI 10.1007/s10126-015-9621-4; Liu SX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088492; Marancik D, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00453; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; Narum SR, 2013, MOL ECOL, V22, P3090, DOI 10.1111/mec.12240; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; Palti Y, 2015, MOL ECOL RESOUR, V15, P662, DOI 10.1111/1755-0998.12337; Palti Y, 2006, AQUACULTURE, V255, P548, DOI 10.1016/j.aquaculture.2005.11.029; Palti Y, 2014, MOL ECOL RESOUR, V14, P588, DOI 10.1111/1755-0998.12204; Palti Y, 2012, MAR BIOTECHNOL, V14, P343, DOI 10.1007/s10126-011-9418-z; Philip AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129299; Rexroad CE, 2013, MAR BIOTECHNOL, V15, P613, DOI 10.1007/s10126-013-9512-5; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Seaton G, 2006, GRIDQTL A GRID PORTA; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; Vallejo RL, 2010, J ANIM SCI, V88, P3814, DOI 10.2527/jas.2010-2951; Vallejo RL, 2014, AQUACULTURE, V432, P139, DOI 10.1016/j.aquaculture.2014.05.003; Vallejo RL, 2014, MAR BIOTECHNOL, V16, P349, DOI 10.1007/s10126-013-9553-9; Wang TH, 2010, FISH SHELLFISH IMMUN, V29, P656, DOI 10.1016/j.fsi.2010.06.015; Wiens GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075749; Zhang H, 2012, JOURNAL OF ANIMAL SC, V3	43	60	64	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138435	10.1371/journal.pone.0138435	http://dx.doi.org/10.1371/journal.pone.0138435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376182	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200108
J	Lee, SML; Schelcher, C; Thasler, R; Schiergens, TS; Thasler, WE				Lee, Serene M. L.; Schelcher, Celine; Thasler, Reinhard; Schiergens, Tobias S.; Thasler, Wolfgang E.			Pre-Analytical Determination of the Effect of Extended Warm or Cold Ischaemia on RNA Stability in the Human Ileum Mucosa	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; C-MYC OVEREXPRESSION; FRESH-FROZEN TISSUE; BREAST-CANCER; IMPACT; TIME; DEGRADATION; BIOBANKING; INTEGRITY; QUALITY	The use of banked human tissue, obtained with informed consent after elective surgical procedures, represents a powerful model for understanding underlying mechanisms of diseases or therapeutic interventions and for establishing prognostic markers. However, donated tissues typically have varying times of warm ischaemia in situ due to blood arrest or cold ischaemia due to procurement and transportation. Hence, before using these tissues, it is important to carry out pre-analytical studies to ensure that they are representative of the in vivo state. In particular, tissues of the gastrointestinal tract have been thought to have low RNA stability. Therefore, this study aimed to determine if extended warm or cold ischaemia times and snap-freezing or banking in RNA stabilization solution affects RNA integrity or gene expression in human ileum mucosa. In short, ileum mucosa was collected for up to 1.5 h and 6 h of simulated warm or cold ischaemia respectively. Subsequently, RNA integrity and gene expressions were determined. It was found that RNA integrity remained high over the course of warm and cold ischaemia examined and there were in general no significant differences between snap-freezing and banking in RNA stabilization solution. Following the same trend, there were in general no significant changes in gene expressions measured (MYC, HIF1 alpha, CDX, HMOX1 and IL1 beta). In conclusion, RNA in the ileum mucosa is maintained at a high integrity and has stable gene expression over the examined time course of warm or cold ischaemia when banked in RNA stabilization solution or snap-frozen in liquid nitrogen. As the average warm and cold ischaemia times imposed by surgery and the process of tissue banking are shorter than the time period examined in this study, human ileum mucosa samples collected after surgeries could be used for gene expression studies.	[Lee, Serene M. L.; Schiergens, Tobias S.; Thasler, Wolfgang E.] Hosp Univ Munich, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Munich, Germany; [Schelcher, Celine; Thasler, Reinhard; Thasler, Wolfgang E.] Hosp Univ Munich, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Human Tissue & Cell Res HTCR Fdn, Biobank Adm, Munich, Germany	University of Munich; University of Munich	Thasler, WE (corresponding author), Hosp Univ Munich, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Munich, Germany.	Wolfgang.Thasler@med.uni-muenchen.de		Lee, Serene/0000-0001-5231-0607	German Federal Ministry of Education and Research (BMBF grant: M4 Munich Biotech Excellence Cluster Biobank Alliance) [01EX1020B]	German Federal Ministry of Education and Research (BMBF grant: M4 Munich Biotech Excellence Cluster Biobank Alliance)	This work was carried out with financial support from the German Federal Ministry of Education and Research (BMBF grant: M4 Munich Biotech Excellence Cluster Biobank Alliance, grant number 01EX1020B). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almeida A, 2004, ANAL BIOCHEM, V328, P101, DOI 10.1016/j.ab.2004.02.004; Bao WG, 2013, ANN SURG ONCOL, V20, P1737, DOI 10.1245/s10434-012-2440-1; Botling J, 2009, DIAGN MOL PATHOL, V18, P44, DOI 10.1097/PDM.0b013e3181857e92; Bray SE, 2010, HISTOPATHOLOGY, V56, P240, DOI 10.1111/j.1365-2559.2009.03470.x; Cho S, 2007, MOL BIOL EVOL, V24, P1259, DOI 10.1093/molbev/msm047; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gopee NV, 2007, EXP MOL PATHOL, V83, P4, DOI 10.1016/j.yexmp.2006.11.001; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Hoffmann Gaby, 2009, Comp Hepatol, V8, P3, DOI 10.1186/1476-5926-8-3; Hong Sang Hyun, 2010, J Korean Soc Coloproctol, V26, P316, DOI 10.3393/jksc.2010.26.5.316; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Ibberson D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-102; Lawson MH, 2010, J THORAC ONCOL, V5, P956, DOI 10.1097/JTO.0b013e3181ddbbe9; Lee J, 2005, FASEB J, V19, P1356, DOI 10.1096/fj.04-3552fje; Lee SML, 2013, MOL BIOTECHNOL, V53, P1, DOI 10.1007/s12033-011-9493-4; Lin DW, 2006, J CLIN ONCOL, V24, P3763, DOI 10.1200/JCO.2005.05.1458; MAESTRO R, 1991, BRIT J CANCER, V63, P185, DOI 10.1038/bjc.1991.45; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Rudloff U, 2010, ANN SURG ONCOL, V17, P2229, DOI 10.1245/s10434-010-0959-6; Schlomm T, 2008, EUR UROL, V53, P333, DOI 10.1016/j.eururo.2007.03.075; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sewart S, 2009, INT J ONCOL, V35, P381, DOI 10.3892/ijo_00000350; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; Strand C, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-38; Thasler Wolfgang E., 2003, Cell and Tissue Banking, V4, P49, DOI 10.1023/A:1026392429112; Thasler WE, 2013, LANGENBECK ARCH SURG, V398, P487, DOI 10.1007/s00423-013-1060-y; Thompson KL, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-57; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VIEL A, 1990, J CANCER RES CLIN, V116, P288, DOI 10.1007/BF01612905; Wolfe LM, 2014, PLACENTA, V35, P645, DOI 10.1016/j.placenta.2014.05.005	33	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138214	10.1371/journal.pone.0138214	http://dx.doi.org/10.1371/journal.pone.0138214			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371767	gold, Green Published, Green Submitted			2022-12-26	WOS:000361604400056
J	Aubin, K; Safoine, M; Proulx, M; Audet-Casgrain, MA; Cote, JF; Tetu, FA; Roy, A; Fradette, J				Aubin, Kim; Safoine, Meryem; Proulx, Maryse; Audet-Casgrain, Marie-Alice; Cote, Jean-Francois; Tetu, Felix-Andre; Roy, Alphonse; Fradette, Julie			Characterization of In Vitro Engineered Human Adipose Tissues: Relevant Adipokine Secretion and Impact of TNF-alpha	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INFLAMMATION-RELATED ADIPOKINES; HEPATOCYTE GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; HUMAN ADIPOCYTES; CARDIOVASCULAR-DISEASE; REGENERATIVE MEDICINE; ORGANOTYPIC CULTURE; METABOLIC DISEASE; 3T3-L1 ADIPOCYTES	Representative modelling of human adipose tissue functions is central to metabolic research. Tridimensional models able to recreate human adipogenesis in a physiological tissue-like context in vitro are still scarce. We describe the engineering of white adipose tissues reconstructed from their cultured adipose-derived stromal precursor cells. We hypothesize that these reconstructed tissues can recapitulate key functions of AT under basal and pro-inflammatory conditions. These tissues, featuring human adipocytes surrounded by stroma, were stable and metabolically active in long-term cultures (at least 11 weeks). Secretion of major adipokines and growth factors by the reconstructed tissues was determined and compared to media conditioned by human native fat explants. Interestingly, the secretory profiles of the reconstructed adipose tissues indicated an abundant production of leptin, PAI-1 and angiopoietin-1 proteins, while higher HGF levels were detected for the human fat explants. We next demonstrated the responsiveness of the tissues to the proinflammatory stimulus TNF-alpha, as reflected by modulation of MCP-1, NGF and HGF secretion, while VEGF and leptin protein expression did not vary. TNF-alpha exposure induced changes in gene expression for adipocyte metabolism-associated mRNAs such as SLC2A4, FASN and LIPE, as well as for genes implicated in NF-kappa B activation. Finally, this model was customized to feature adipocytes representative of progressive stages of differentiation, thereby allowing investigations using newly differentiated or more mature adipocytes. In conclusion, we produced tridimensional tissues engineered in vitro that are able to recapitulate key characteristics of subcutaneous white adipose tissue. These tissues are produced from human cells and their neo-synthesized matrix elements without exogenous or synthetic biomaterials. Therefore, they represent unique tools to investigate the effects of pharmacologically active products on human stromal cells, extracellular matrix and differentiated adipocytes, in addition to compounds modulating adipogenesis from precursor cells.	[Aubin, Kim; Safoine, Meryem; Proulx, Maryse; Audet-Casgrain, Marie-Alice; Cote, Jean-Francois; Fradette, Julie] Univ Laval, Ctr Rech Organogenese Expt, LOEX, Quebec City, PQ, Canada; [Aubin, Kim; Safoine, Meryem; Proulx, Maryse; Fradette, Julie] CHU Quebec, Res Ctr, Div Regenerat Med, Quebec City, PQ, Canada; [Tetu, Felix-Andre] Clin Chirurg Esthet Felix Andre Tetu, Quebec City, PQ, Canada; [Tetu, Felix-Andre; Roy, Alphonse] CHU Quebec, Quebec City, PQ, Canada; [Roy, Alphonse] Clin Chirurg Plast Alphonse Roy, Quebec City, PQ, Canada; [Fradette, Julie] Univ Laval, Fac Med, Dept Surg, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Laval University	Fradette, J (corresponding author), Univ Laval, Ctr Rech Organogenese Expt, LOEX, Quebec City, PQ, Canada.	Julie.fradette@chg.ulaval.ca		Fradette, Julie/0000-0002-1851-5112	National Science and Engineering Research Council (NSERC) [326987]; Canadian Institutes of Health Research (CIHR) [111233]; Centre de recherche du CHU de Quebec du Fonds de recherche du Quebec-Sante (FRQ-S); Reseau TheCell du FRQ-S; Fonds de recherche du Quebec-Nature et technologies (FRQNT); CIHR; Laval University Faculty of Medicine; NSERC; FRQ-S; Canadian Federation of University Women (CFUW)	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Centre de recherche du CHU de Quebec du Fonds de recherche du Quebec-Sante (FRQ-S); Reseau TheCell du FRQ-S; Fonds de recherche du Quebec-Nature et technologies (FRQNT); CIHR(Canadian Institutes of Health Research (CIHR)); Laval University Faculty of Medicine; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQ-S; Canadian Federation of University Women (CFUW)	This work was supported by the National Science and Engineering Research Council (NSERC, grant #326987) and in part by the Canadian Institutes of Health Research (CIHR, grant #111233, Figs 3 and 4) awarded to JF. We acknowledge the support of the Centre de recherche du CHU de Quebec du Fonds de recherche du Quebec-Sante (FRQ-S) and of the Reseau TheCell du FRQ-S. The confocal imaging system was obtained through the Fonds des leaders program from Canada Foundation for Innovation (CFI) to JF. KA received a studentship from Fonds de recherche du Quebec-Nature et technologies (FRQNT). MS received studentships from CIHR and Laval University Faculty of Medicine. MP received studentships from NSERC, FRQ-S and the Canadian Federation of University Women (CFUW). JF is a FRQ-S career award scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin K, 2015, ACTA BIOMATER, V11, P333, DOI 10.1016/j.actbio.2014.09.044; Bauer-Kreisel P, 2010, ADV DRUG DELIVER REV, V62, P798, DOI 10.1016/j.addr.2010.04.003; Bellas E, 2013, TISSUE ENG PART C-ME, V19, P745, DOI [10.1089/ten.tec.2012.0620, 10.1089/ten.TEC.2012.0620]; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Choi JH, 2010, TISSUE ENG PART B-RE, V16, P413, DOI [10.1089/ten.teb.2009.0544, 10.1089/ten.TEB.2009.0544]; Crandall DL, 2000, J CLIN ENDOCR METAB, V85, P2609, DOI 10.1210/jc.85.7.2609; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Ferrante AW, 2013, DIABETES OBES METAB, V15, P34, DOI 10.1111/dom.12154; Finck BN, 2002, AM J PHYSIOL-REG I, V282, pR1429, DOI 10.1152/ajpregu.00569.2001; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Fortier GM, 2013, J TISSUE ENG REGEN M, V7, P292, DOI 10.1002/term.522; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Gesta S, 2003, HORM METAB RES, V35, P158, DOI 10.1055/s-2003-39070; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Good Manuela, 2006, Diab Vasc Dis Res, V3, P26, DOI 10.3132/dvdr.2006.003; Goralski KB, 2007, CAN J PHYSIOL PHARM, V85, P113, DOI 10.1139/Y06-092; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hube F, 1999, EUR J CLIN INVEST, V29, P672, DOI 10.1046/j.1365-2362.1999.00520.x; Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469; Kirchgessner TG, 1997, J CLIN INVEST, V100, P2777, DOI 10.1172/JCI119824; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Labbe B, 2011, METHODS MOL BIOL, V702, P429, DOI 10.1007/978-1-61737-960-4_31; Lafontan M, 2012, AM J PHYSIOL-CELL PH, V302, pC327, DOI 10.1152/ajpcell.00168.2011; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; MacLaren R, 2008, ADV EXP MED BIOL, V632, P1, DOI 10.1007/978-0-387-78952-1_1; Mahadik Sujata R, 2013, J Assoc Physicians India, V61, P244; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Maury E, 2009, J CLIN ENDOCR METAB, V94, P1393, DOI 10.1210/jc.2008-2196; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; NAKAMURA Y, 1995, BIOCHEM BIOPH RES CO, V215, P483, DOI 10.1006/bbrc.1995.2490; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Peeraully MR, 2004, AM J PHYSIOL-ENDOC M, V287, pE331, DOI 10.1152/ajpendo.00076.2004; Philips BJ, 2012, EXPERT OPIN BIOL TH, V12, P155, DOI 10.1517/14712598.2012.644533; Poloni A, 2012, STEM CELLS, V30, P965, DOI 10.1002/stem.1067; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Sonoda E, 2008, ENDOCRINOLOGY, V149, P4794, DOI 10.1210/en.2008-0525; SUGIHARA H, 1986, DIFFERENTIATION, V31, P42, DOI 10.1111/j.1432-0436.1986.tb00381.x; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Toda S, 2009, ORGANOGENESIS, V5, P50, DOI 10.4161/org.5.2.8347; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Tsuji Wakako, 2014, World J Stem Cells, V6, P312, DOI 10.4252/wjsc.v6.i3.312; Vallee M, 2009, PATHOL BIOL, V57, P309, DOI 10.1016/j.patbio.2008.04.010; Vermette M, 2007, BIOMATERIALS, V28, P2850, DOI 10.1016/j.biomaterials.2007.02.030; Wang BH, 2005, AM J PHYSIOL-ENDOC M, V288, pE731, DOI 10.1152/ajpendo.00475.2004; Wang BH, 2006, PFLUG ARCH EUR J PHY, V452, P418, DOI 10.1007/s00424-006-0055-8; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yao R, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045005; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	68	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137612	10.1371/journal.pone.0137612	http://dx.doi.org/10.1371/journal.pone.0137612			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367137	gold, Green Submitted, Green Published			2022-12-26	WOS:000361601100094
J	Gregory, A; Mehrmohammadi, M; Denis, M; Bayat, M; Stan, DL; Fatemi, M; Alizad, A				Gregory, Adriana; Mehrmohammadi, Mohammad; Denis, Max; Bayat, Mahdi; Stan, Daniela L.; Fatemi, Mostafa; Alizad, Azra			Effect of Calcifications on Breast Ultrasound Shear Wave Elastography: An Investigational Study	PLOS ONE			English	Article							BI-RADS CLASSIFICATION; VIBRO-ACOUSTOGRAPHY; DIFFERENTIAL-DIAGNOSIS; KIDNEY-STONES; MICROCALCIFICATIONS; MASSES; LESIONS; BENIGN; TISSUE; CANCER	Purpose To investigate the effects of macrocalcifications and clustered microcalcifications associated with benign breast masses on shear wave elastography (SWE). Methods SuperSonic Imagine (SSI) and comb-push ultrasound shear elastography (CUSE) were performed on three sets of phantoms to investigate how calcifications of different sizes and distributions influence measured elasticity. To demonstrate the effect in vivo, three female patients with benign breast masses associated with mammographically-identified calcifications were evaluated by CUSE. Results Apparent maximum elasticity (E-max) estimates resulting from individual macrocalcifications (with diameters of 2mm, 3mm, 5mm, 6mm, 9mm, 11mm, and 15mm) showed values over 50 kPa for all cases, which represents more than 100% increase over background (similar to 21kPa). We considered a 2cm-diameter circular region of interest for all phantom experiments. Mean elasticity (E-mean) values varied from 26 kPa to 73 kPa, depending on the macrocalcification size. Highly dense clusters of microcalcifications showed higher E-max values than clusters of microcalcification with low concentrations, but the difference in E-mean values was not significant. Conclusions Our results demonstrate that the presence of large isolated macrocalcifications and highly concentrated clusters of microcalcifications can introduce areas with apparent high elasticity in SWE. Considering that benign breast masses normally have significantly lower elasticity values than malignant tumors, such areas with high elasticity appearing due to presence of calcification in benign breast masses may lead to misdiagnosis.	[Gregory, Adriana; Mehrmohammadi, Mohammad; Denis, Max; Bayat, Mahdi; Fatemi, Mostafa; Alizad, Azra] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN USA; [Stan, Daniela L.; Alizad, Azra] Mayo Clin, Dept Internal Med, Coll Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Alizad, A (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN USA.	Alizad.Azra@mayo.edu		Fatemi, Mostafa/0000-0002-6603-9077; Mehrmohammadi, Mohammad/0000-0002-9264-9354	Mayo Clinic; NATIONAL CANCER INSTITUTE [R01CA168575] Funding Source: NIH RePORTER	Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Mayo Clinic has financial interest in the technology described here.	Alizad A, 2005, TECHNOL CANCER RES T, V4, P151, DOI 10.1177/153303460500400204; Alizad A, 2004, IEEE T MED IMAGING, V23, P307, DOI 10.1109/TMI.2004.824241; Alizad A, 2004, J ULTRAS MED, V23, P267, DOI 10.7863/jum.2004.23.2.267; Alizad A, 2006, ULTRASONICS, V44, pE217, DOI 10.1016/j.ultras.2006.06.021; Alizad A, 2014, BMC MED IMAGING, V14, DOI 10.1186/s12880-014-0040-1; Alizad A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3323; Anwar, 2011, INT J PATHOL, V9, P63, DOI DOI 10.4103/IJU.IJU_363_16; Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Bai M, 2012, J ULTRAS MED, V31, P289, DOI 10.7863/jum.2012.31.2.289; Baker R, 2010, BRIT J CANCER, V103, P1034, DOI 10.1038/sj.bjc.6605873; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bercoff J, 2003, ULTRASOUND MED BIOL, V29, P1387, DOI 10.1016/S0301-5629(03)00978-5; Berg W. A., 2012, RADIOLOGY, P1; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Chang JM, 2013, AM J ROENTGENOL, V201, pW347, DOI 10.2214/AJR.12.10416; Chang JM, 2011, BREAST CANCER RES TR, V129, P89, DOI 10.1007/s10549-011-1627-7; Chang JM, 2011, RADIOLOGY, V259, P59, DOI 10.1148/radiol.10101414; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Cox RF, 2012, BRIT J CANCER, V106, P525, DOI 10.1038/bjc.2011.583; Craciun II, 2002, BREAST CALCIFICATI 1; Demetri-Lewis A, 2012, AM J ROENTGENOL, V198, pW325, DOI 10.2214/AJR.10.5732; Denis M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119398; Ellis I., 2002, BREAST CALCIFICATION, P1; Evans A, 2012, BRIT J CANCER, V107, P224, DOI 10.1038/bjc.2012.253; Evans A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2787; FANDOSMORERA A, 1988, RADIOLOGY, V169, P325, DOI 10.1148/radiology.169.2.2845471; Farshid G, 2011, BRIT J CANCER, V105, P1669, DOI 10.1038/bjc.2011.466; Fatemi M, 1998, SCIENCE, V280, P82, DOI 10.1126/science.280.5360.82; Fatemi M, 2002, IEEE T MED IMAGING, V21, P1, DOI 10.1109/42.981229; Fink M, 2010, PHYS TODAY, V63, P28, DOI 10.1063/1.3326986; Harris JE, 2014, MEDSCAPE; Heimbach D, 2000, J UROLOGY, V164, P537, DOI 10.1016/S0022-5347(05)67419-8; Ianculescu V, 2014, EUR J RADIOL, V83, P773, DOI 10.1016/j.ejrad.2014.01.021; Joon Park RSL, 2007, BIOMATERIALS INTRO; Ko KH, 2014, EUR RADIOL, V24, P305, DOI 10.1007/s00330-013-3034-4; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Lee EJ, 2013, EUR RADIOL, V23, P1803, DOI 10.1007/s00330-013-2782-5; Lee SH, 2013, EUR RADIOL, V23, P1015, DOI 10.1007/s00330-012-2686-9; Li GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076322; Manglaviti G, 2011, AM J ROENTGENOL, V197, pW76, DOI 10.2214/AJR.10.5217; Mehrmohammadi M., 2014, IEEE T MED IMAGING, P1; Mehrmohammadi M, 2014, ULTRASOUND MED BIOL, V40, P2819, DOI 10.1016/j.ultrasmedbio.2014.07.005; Morgan MP, 2005, J MAMMARY GLAND BIOL, V10, P181, DOI 10.1007/s10911-005-5400-6; Mosli HA, 2013, RES REP UROL, V5, P11, DOI 10.2147/RRU.S39581; Olgun DC, 2014, DIAGN INTERV RADIOL, V20, P239, DOI 10.5152/dir.2014.13306; Orlando MTD, 2008, POWDER DIFFR, V23, pS59, DOI 10.1154/1.2903738; da Silva SFR, 2010, ACTA CIR BRAS, V25, P444, DOI 10.1590/S0102-86502010000500011; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Schaefer FKW, 2011, EUR J RADIOL, V77, P450, DOI 10.1016/j.ejrad.2009.08.026; Scimeca M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-286; SEWELL CW, 1995, RADIOL CLIN N AM, V33, P1067; SICKLES EA, 1986, RADIOLOGY, V160, P289, DOI 10.1148/radiology.160.2.3726103; Song PF, 2013, IEEE T MED IMAGING, V32, P1435, DOI 10.1109/TMI.2013.2257831; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Xiao Y, 2013, ENG MED BIOL SOC EMB; Yao M, 2014, BIOMED RES INT, V2014, P7; Youk JH, 2013, EUR RADIOL, V23, P2695, DOI 10.1007/s00330-013-2873-3	58	27	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137898	10.1371/journal.pone.0137898	http://dx.doi.org/10.1371/journal.pone.0137898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368939	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100173
J	Heuner, M; Silinski, A; Schoelynck, J; Bouma, TJ; Puijalon, S; Troch, P; Fuchs, E; Schroder, B; Schroder, U; Meire, P; Temmerman, S				Heuner, Maike; Silinski, Alexandra; Schoelynck, Jonas; Bouma, Tjeerd J.; Puijalon, Sara; Troch, Peter; Fuchs, Elmar; Schroeder, Boris; Schroeder, Uwe; Meire, Patrick; Temmerman, Stijn			Ecosystem Engineering by Plants on Wave-Exposed Intertidal Flats Is Governed by Relationships between Effect and Response Traits	PLOS ONE			English	Article							SALT-MARSH; SPECIES INTERACTIONS; VEGETATION; STRESS; LIGNIN; FLOW; MACROPHYTES; SERVICES; DRAG; BIODIVERSITY	In hydrodynamically stressful environments, some species-known as ecosystem engineers-are able to modify the environment for their own benefit. Little is known however, about the interaction between functional plant traits and ecosystem engineering. We studied the responses of Scirpus tabernaemontani and Scirpus maritimus to wave impact in full-scale flume experiments. Stem density and biomass were used to predict the ecosystem engineering effect of wave attenuation. Also the drag force on plants, their bending angle after wave impact and the stem biomechanical properties were quantified as both responses of stress experienced and effects on ecosystem engineering. We analyzed lignin, cellulose, and silica contents as traits likely effecting stress resistance (avoidance, tolerance). Stem density and biomass were strong predictors for wave attenuation, S. maritimus showing a higher effect than S. tabernaemontani. The drag force and drag force per wet frontal area both differed significantly between the species at shallow water depths (20 cm). At greater depths (35 cm), drag forces and bending angles were significantly higher for S. maritimus than for S. tabernaemontani. However, they do not differ in drag force per wet frontal area due to the larger plant surface of S. maritimus. Stem resistance to breaking and stem flexibility were significantly higher in S. tabernaemontani, having a higher cellulose concentration and a larger cross-section in its basal stem parts. S. maritimus had clearly more lignin and silica contents in the basal stem parts than S. tabernaemontani. We concluded that the effect of biomass seems more relevant for the engineering effect of emergent macrophytes with leaves than species morphology: S. tabernaemontani has avoiding traits with minor effects on wave attenuation; S. maritimus has tolerating traits with larger effects. This implies that ecosystem engineering effects are directly linked with traits affecting species stress resistance and responding to stress experienced.	[Heuner, Maike; Fuchs, Elmar] Fed Inst Hydrol, Dept Ecol Interact, Koblenz, Germany; [Heuner, Maike] Tech Univ Berlin, Geoinformat Environm Planning Lab, Berlin, Germany; [Silinski, Alexandra; Schoelynck, Jonas; Meire, Patrick; Temmerman, Stijn] Univ Antwerp, Ecosyst Management Res Grp, Dept Biol, Antwerp, Belgium; [Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res, Ctr Estuarine & Marine Ecol, Yerseke, Netherlands; [Puijalon, Sara] Univ Lyon 1, CNRS, UMR LEHNA 5023, ENTPE, F-69622 Villeurbanne, France; [Troch, Peter] Univ Ghent, Dept Civil Engn, B-9000 Ghent, Belgium; [Schroeder, Boris] Tech Univ Carolo Wilhelmina Braunschweig, Environm Syst Anal, Inst Geoecol, D-38106 Braunschweig, Germany; [Schroeder, Boris] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Schroeder, Uwe] Fed Inst Hydrol, Dept Vegetat Studies & Landscape Management, Koblenz, Germany	Technical University of Berlin; University of Antwerp; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ghent University; Braunschweig University of Technology	Heuner, M (corresponding author), Fed Inst Hydrol, Dept Ecol Interact, Koblenz, Germany.	heuner@bafg.de	Troch, Peter/L-2463-2017; Schroder, Boris/B-7211-2009; Schröder, Boris/N-7250-2019; Puijalon, Sara/ABA-6520-2020; Temmerman, Stijn/C-5521-2009	Troch, Peter/0000-0003-3274-0874; Schroder, Boris/0000-0002-8577-7980; Schröder, Boris/0000-0002-8577-7980; Puijalon, Sara/0000-0002-1942-7958; Bouma, Tjeerd/0000-0001-7824-7546; Schoelynck, Jonas/0000-0003-0166-280X; Temmerman, Stijn/0000-0003-3346-9115	KLIWAS; FWO Scientific Research Community; Research Foundation Flanders (FWO); Port of Antwerp	KLIWAS; FWO Scientific Research Community; Research Foundation Flanders (FWO)(FWO); Port of Antwerp	This study was supprted by KLIWAS (Impacts of climate change on waterways and navigation - Searching for options of adaptation, (www.kliwas.de/KLIWAS/EN/)) - MH; FWO Scientific Research Community on "The functioning of river ecosystems through plant-flow-soil interactions" - AS and MH Personal grant of Research Foundation Flanders (FWO, www.fwo.be/) - AS and JS; Port of Antwerp (www.portofantwerp.com) - AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2014, COAST ENG, V83, P82, DOI 10.1016/j.coastaleng.2013.10.004; Asaeda T, 2005, FRESHWATER BIOL, V50, P1991, DOI 10.1111/j.1365-2427.2005.01445.x; Balke T, 2013, J APPL ECOL, V50, P740, DOI 10.1111/1365-2664.12067; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Bertness MD, 2006, ATLANTIC SHORELINES; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Bouma TJ, 2010, ECOLOGY, V91, P2696, DOI 10.1890/09-0690.1; Bouma TJ, 2009, MAR ECOL PROG SER, V388, P293, DOI 10.3354/meps08130; Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Crain CM, 2005, ECOLOGY, V86, P2695, DOI 10.1890/04-1517; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Cuddington K, 2009, AM NAT, V173, P488, DOI 10.1086/597216; DENNY MW, 1994, J EXP BIOL, V194, P97; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Fittschen T, 2003, WELLENMESSUNGEN UNTE; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Gilad E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098105; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; He Q, 2014, ECOLOGY, V95, P1437, DOI 10.1890/13-2226.1; Henry PY, 2013, COAST ENG, V78, P13, DOI 10.1016/j.coastaleng.2013.03.004; Jung HJG, 1999, J AGR FOOD CHEM, V47, P2005, DOI 10.1021/jf981250q; Kaufman PB, 1999, NATURAL PRODUCTS PLA, P343; Knutson PL, 1982, WAVE DAMPING SPARTIN; Koivisto M, 2011, MAR BIOL, V158, P945, DOI 10.1007/s00227-010-1621-3; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Levitt J, 1972, RESPONSES PLANTS ENV; MCLAUGHLIN EC, 1980, J MATER SCI, V15, P89, DOI 10.1007/BF00552431; Moller I, 2006, ESTUAR COAST SHELF S, V69, P337, DOI 10.1016/j.ecss.2006.05.003; Moller I, 1999, ESTUAR COAST SHELF S, V49, P411, DOI 10.1006/ecss.1999.0509; Nepf HM, 1999, WATER RESOUR RES, V35, P479, DOI 10.1029/1998WR900069; Pages JF, 2012, FUNCT ECOL, V26, P1015, DOI 10.1111/j.1365-2435.2012.02038.x; Paul M, 2012, MAR ECOL PROG SER, V444, P31, DOI 10.3354/meps09489; Pollen-Bankhead N, 2011, ECOL ENG, V37, P1779, DOI 10.1016/j.ecoleng.2011.06.027; Puijalon S, 2011, NEW PHYTOL, V191, P1141, DOI 10.1111/j.1469-8137.2011.03763.x; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Schoelynck J, 2013, LIMNOLOGICA, V43, P371, DOI 10.1016/j.limno.2013.05.003; Schoelynck J, 2010, NEW PHYTOL, V186, P385, DOI 10.1111/j.1469-8137.2009.03176.x; Silinski A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118687; TAYLOR GE, 1978, NEW PHYTOL, V80, P523, DOI 10.1111/j.1469-8137.1978.tb01584.x; Temmerman S, 2007, GEOLOGY, V35, P631, DOI 10.1130/G23502A.1; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Traill LW, 2010, J ANIM ECOL, V79, P937, DOI 10.1111/j.1365-2656.2010.01695.x; Usherwood JR, 1997, J EXP BOT, V48, P1469, DOI 10.1093/jxb/48.7.1469; van Wesenbeeck BK, 2008, OIKOS, V117, P152, DOI 10.1111/j.2007.0030-1299.16245.x; Vandenbruwaene W, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001788; VANSOEST PJ, 1963, J ASSOC OFF AGR CHEM, V46, P829; Vieira DAN, 2012, HYDROL PROCESS, V26, P2225, DOI 10.1002/hyp.8262; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2; Ysebaert T, 2011, WETLANDS, V31, P1043, DOI 10.1007/s13157-011-0240-1; Zhang CB, 2014, GEOMORPHOLOGY, V206, P196, DOI 10.1016/j.geomorph.2013.09.024	54	32	32	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138086	10.1371/journal.pone.0138086	http://dx.doi.org/10.1371/journal.pone.0138086			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367004	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100219
J	Makino, Y; Konoshita, T; Omori, A; Maegawa, N; Nakaya, T; Ichikawa, M; Yamamoto, K; Wakahara, S; Ishizuka, T; Onoe, T; Nakamura, H				Makino, Yasukazu; Konoshita, Tadashi; Omori, Atsuhito; Maegawa, Nobuhiro; Nakaya, Takahiro; Ichikawa, Mai; Yamamoto, Katsushi; Wakahara, Shigeyuki; Ishizuka, Tamotsu; Onoe, Tamehito; Nakamura, Hiroyuki		Genomic Dis Outcome Consortium	A Genetic Variant in the Distal Enhancer Region of the Human Renin Gene Affects Renin Expression	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; PLASMA-RENIN; ESSENTIAL-HYPERTENSION; DELETION POLYMORPHISM; DIABETIC-NEPHROPATHY; RISK-FACTOR; SYSTEM; DETERMINANTS; MORTALITY; PRORENIN	Background The high heritability of plasma renin activity was confirmed in recent investigations. A variation located near the strong enhancer of the human renin gene (REN), C-5312T, has been shown to have different transcription activity levels depending on its allele: the 5312T allele shows transcription levels that are 45% greater than those of the 5312C allele. The purpose of this study was to confirm the hypothesis that variations in the enhancer region of the REN gene are involved in regulating renal expression of renin. Methods Sixty-four subjects with biopsy-proven renal diseases were included in this study (male/female: 35/29, age 41.9 +/- 20.9 years, SBP/DBP 123.1 +/- 23.7/73.4 +/- 14.8 mmHg, s-Cr 0.93 +/- 0.63 mg/dl). A genetic variant of REN, C-5312T, was assayed by PCR-RFLP and the Taq-Man method. Total RNAs from a small part of the renal cortex were reverse-transcribed and amplified for REN and GAPDH with a real-time PCR system. Results Logarithmically transformed expression values of the relative ratio of REN to GAPDH (10(-3)) were as follows (mean +/- SE): CC (26 cases), 0.016 +/- 0.005; CT (33 cases), 0.047 +/- 0.021 (p = 0.41 vs. CC); TT (5 cases), 0.198 +/- 0.194 (p = 0.011 vs. CC, p < 0.031 vs. CT). Thus, significant differences in REN expression were observed among the genetic variants. Conclusion The results suggest that variants in the enhancer region of the human renin gene have an effect on the expression levels of renin in renal tissue; this observation is in good accordance with the results of the transcriptional assay.	[Makino, Yasukazu; Konoshita, Tadashi; Omori, Atsuhito; Maegawa, Nobuhiro; Nakaya, Takahiro; Ichikawa, Mai; Yamamoto, Katsushi; Wakahara, Shigeyuki; Ishizuka, Tamotsu] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 910, Japan; [Onoe, Tamehito] Kanazawa Univ, Grad Sch Med Sci, Dept Internal Med, Div Rheumatol, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa, Japan	University of Fukui; Kanazawa University; Kanazawa University	Konoshita, T (corresponding author), Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 910, Japan.	konosita@u-fukui.ac.jp			Ministry of Education, Science and Culture of Japan [08770879, 09770843, 14571020, 22590909, 25461245]; National Research Foundation/Japan Science and Technology Agency (NRF/JST) [J110000349]; Strategic International Research Cooperative Program (SICP)	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Research Foundation/Japan Science and Technology Agency (NRF/JST); Strategic International Research Cooperative Program (SICP)	This work was supported by grant-in-aids 08770879, 09770843, 14571020, 22590909 and 25461245 from the Ministry of Education, Science and Culture of Japan and a grant from National Research Foundation/Japan Science and Technology Agency (NRF/JST) (Project number: J110000349) and Strategic International Research Cooperative Program (SICP).	BORENSZTEIN P, 1994, CIRC RES, V74, P764, DOI 10.1161/01.RES.74.5.764; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; CAULFIELD M, 1994, NEW ENGL J MED, V330, P1629, DOI 10.1056/NEJM199406093302301; Corvol P, 1997, PATHOL BIOL, V45, P229; Daimon M, 2012, METABOLISM, V61, P504, DOI 10.1016/j.metabol.2011.08.004; Deinum J, 1999, NEPHROL DIAL TRANSPL, V14, P1904, DOI 10.1093/ndt/14.8.1904; Fogarty DG, 1996, DIABETES, V45, P1204, DOI 10.2337/diabetes.45.9.1204; Frossard PM, 1998, HYPERTENS RES-CLIN E, V21, P221, DOI 10.1291/hypres.21.221; Fuchs S, 2002, J HYPERTENS, V20, P2391, DOI 10.1097/00004872-200212000-00018; Germain S, 1996, BIOCHEM J, V316, P107, DOI 10.1042/bj3160107; Germain S, 1998, J BIOL CHEM, V273, P25292, DOI 10.1074/jbc.273.39.25292; HACKENTHAL E, 1990, PHYSIOL REV, V70, P1067, DOI 10.1152/physrev.1990.70.4.1067; HARDEN PN, 1995, LANCET, V345, P1540, DOI 10.1016/S0140-6736(95)91088-3; Hasimu B, 2003, HYPERTENSION, V41, P308, DOI 10.1161/01.HYP.0000049762.77830.89; Ichikawa M, 2014, ACTA DIABETOL, V51, P595, DOI 10.1007/s00592-014-0561-7; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; JEUNEMAITRE X, 1992, HUM GENET, V88, P301; KLEMM SA, 1994, KIDNEY INT, V46, P1591, DOI 10.1038/ki.1994.455; Konoshita T, 2006, DIABETES CARE, V29, P848, DOI 10.2337/diacare.29.04.06.dc05-1873; Konoshita T, 2004, J CELL BIOCHEM, V93, P327, DOI 10.1002/jcb.20151; Konoshita T, 2001, AM J KIDNEY DIS, V37, P113, DOI 10.1053/ajkd.2001.20595; Konoshita T, 1996, KIDNEY INT, V50, P1515, DOI 10.1038/ki.1996.466; Konoshita T, 2007, J CELL BIOCHEM, V102, P1043, DOI 10.1002/jcb.21341; Konoshita T, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000354; Konoshita T, 2013, INT J CARDIOL, V166, P448, DOI 10.1016/j.ijcard.2011.10.133; Konoshita T, 2011, CURR HYPERTENS REP, V13, P356, DOI 10.1007/s11906-011-0212-0; Konoshita T, 2010, J HYPERTENS, V28, P2156, DOI 10.1097/HJH.0b013e32833d01dd; Konoshita T, 2009, DIABETES CARE, V32, P1485, DOI 10.2337/dc09-0348; Kotchen TA, 2000, HYPERTENSION, V36, P7, DOI 10.1161/01.HYP.36.1.7; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; MERCURE C, 1995, J BIOL CHEM, V270, P16355, DOI 10.1074/jbc.270.27.16355; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; SOUBRIER F, 1990, HYPERTENSION, V16, P712, DOI 10.1161/01.HYP.16.6.712; Tomaschitz A, 2011, EUR HEART J, V32, P2642, DOI 10.1093/eurheartj/ehr150; Waeber B, 1996, J CARDIOVASC PHARM, V27, pS36; Wakahara S, 2007, ENDOCRINOLOGY, V148, P2453, DOI 10.1210/en.2006-1287	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137469	10.1371/journal.pone.0137469	http://dx.doi.org/10.1371/journal.pone.0137469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366736	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100077
J	Paul, D; Dasgupta, A; De, RK				Paul, Debjyoti; Dasgupta, Abhijit; De, Rajat K.			Exploring the Altered Dynamics of Mammalian Central Carbon Metabolic Pathway in Cancer Cells: A Classical Control Theoretic Approach	PLOS ONE			English	Article							PYRUVATE-KINASE M2; ISOFORM; PROMOTE; ENZYME; PKM2	Background In contrast with normal cells, most of the cancer cells depend on aerobic glycolysis for energy production in the form of adenosine triphosphate (ATP) bypassing mitochondrial oxidative phosphorylation. Moreover, compared to normal cells, cancer cells exhibit higher consumption of glucose with higher production of lactate. Again, higher rate of glycolysis provides the necessary glycolytic intermediary precursors for DNA, protein and lipid synthesis to maintain high active proliferation of the tumor cells. In this scenario, classical control theory based approach may be useful to explore the altered dynamics of the cancer cells. Since the dynamics of the cancer cells is different from that of the normal cells, understanding their dynamics may lead to development of novel therapeutic strategies. Method We have developed a model based on the state space equations of classical control theory along with an order reduction technique to mimic the actual dynamic behavior of mammalian central carbon metabolic (CCM) pathway in normal cells. Here, we have modified Michaelis Menten kinetic equation to incorporate feedback mechanism along with perturbations and cross talks associated with a metabolic pathway. Furthermore, we have perturbed the proposed model to reduce the mitochondrial oxidative phosphorylation. Thereafter, we have connected proportional-integral (PI) controller(s) with the model for tuning it to behave like the CCM pathway of a cancer cell. This methodology allows one to track the altered dynamics mediated by different enzymes. Results and Discussions The proposed model successfully mimics all the probable dynamics of the CCM pathway in normal cells. Moreover, experimental results demonstrate that in cancer cells, a coordination among enzymes catalyzing pentose phosphate pathway and intermediate glycolytic enzymes along with switching of pyruvate kinase (M2 isoform) plays an important role to maintain their altered dynamics.	[Paul, Debjyoti] Indian Stat Inst, Kolkata 700108, W Bengal, India; [Dasgupta, Abhijit; De, Rajat K.] Indian Stat Inst, Machine Intelligence Unit, Kolkata 700108, W Bengal, India	Indian Statistical Institute; Indian Statistical Institute Kolkata; Indian Statistical Institute; Indian Statistical Institute Kolkata	De, RK (corresponding author), Indian Stat Inst, Machine Intelligence Unit, 203 BT Rd, Kolkata 700108, W Bengal, India.	rajat@isical.ac.in	Dasgupta, Abhijit/W-7750-2019	Dasgupta, Abhijit/0000-0001-6062-9896; Dasgupta, Abhijit/0000-0002-6302-3512				ACERENZA L, 1989, J THEOR BIOL, V137, P423, DOI 10.1016/S0022-5193(89)80038-4; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Cascante M, 2002, NAT BIOTECHNOL, V20, P243, DOI 10.1038/nbt0302-243; Chang R., 2005, PHYS CHEM BIOSCIENCE; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; De RK, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012500199; De RK, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-65; Famili I, 2003, BIOPHYS J, V85, P16, DOI 10.1016/S0006-3495(03)74450-6; Gerdtzen ZP, 2004, METAB ENG, V6, P140, DOI 10.1016/j.ymben.2003.11.003; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huang LQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092949; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kholodenko BN, 1997, J PHYS CHEM B, V101, P2070, DOI 10.1021/jp962336u; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Mazurek S, 2012, BIOMED RES-INDIA, V23, P133; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Morris K. A., 2000, INTRO FEEDBACK CONTR; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Panja S, 2013, IEEE ACM T COMPUT BI, V10, P858, DOI 10.1109/TCBB.2013.82; Qian H, 2003, EUR J BIOCHEM, V270, P415, DOI 10.1046/j.1432-1033.2003.03357.x; Rao CV, 2004, 7 INT S DYN CONTR PR, V7; Resendis-Antonio O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012383; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wildermuth MC, 2000, GENOME BIOL, V1; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137728	10.1371/journal.pone.0137728	http://dx.doi.org/10.1371/journal.pone.0137728			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367460	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100124
J	Skryhan, K; Cuesta-Seijo, JA; Nielsen, MM; Marri, L; Mellor, SB; Glaring, MA; Jensen, PE; Palcic, MM; Blennow, A				Skryhan, Katsiaryna; Cuesta-Seijo, Jose A.; Nielsen, Morten M.; Marri, Lucia; Mellor, Silas B.; Glaring, Mikkel A.; Jensen, Poul E.; Palcic, Monica M.; Blennow, Andreas			The Role of Cysteine Residues in Redox Regulation and Protein Stability of Arabidopsis thaliana Starch Synthase 1	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; FERREDOXIN/THIOREDOXIN SYSTEM; THIOREDOXIN REDUCTASE; GLYCOGEN-SYNTHASE; ESCHERICHIA-COLI; BETA-AMYLASE; PLANT; LEAVES; METABOLISM; LIGHT	Starch biosynthesis in Arabidopsis thaliana is strictly regulated. In leaf extracts, starch synthase 1 (AtSS1) responds to the redox potential within a physiologically relevant range. This study presents data testing two main hypotheses: 1) that specific thiol-disulfide exchange in AtSS1 influences its catalytic function 2) that each conserved Cys residue has an impact on AtSS1 catalysis. Recombinant AtSS1 versions carrying combinations of cysteine-to-serine substitutions were generated and characterized in vitro. The results demonstrate that AtSS1 is activated and deactivated by the physiological redox transmitters thioredoxin f1 (Trxf1), thioredoxin m4 (Trxm4) and the bifunctional NADPH-dependent thioredoxin reductase C (NTRC). AtSS1 displayed an activity change within the physiologically relevant redox range, with a midpoint potential equal to -306 mV, suggesting that AtSS1 is in the reduced and active form during the day with active photosynthesis. Cys164 and Cys545 were the key cysteine residues involved in regulatory disulfide formation upon oxidation. A C164S_C545S double mutant had considerably decreased redox sensitivity as compared to wild type AtSS1 (30% vs 77%). Michaelis-Menten kinetics and molecular modeling suggest that both cysteines play important roles in enzyme catalysis, namely, Cys545 is involved in ADP-glucose binding and Cys164 is involved in acceptor binding. All the other single mutants had essentially complete redox sensitivity (98-99%). In addition of being part of a redox directed activity "light switch", reactivation tests and low heterologous expression levels indicate that specific cysteine residues might play additional roles. Specifically, Cys265 in combination with Cys164 can be involved in proper protein folding or/and stabilization of translated protein prior to its transport into the plastid. Cys442 can play an important role in enzyme stability upon oxidation. The physiological and phylogenetic relevance of these findings is discussed.	[Skryhan, Katsiaryna; Mellor, Silas B.; Glaring, Mikkel A.; Jensen, Poul E.; Blennow, Andreas] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen Plant Sci Ctr, DK-1871 Frederiksberg C, Denmark; [Cuesta-Seijo, Jose A.; Nielsen, Morten M.; Marri, Lucia; Palcic, Monica M.] Carlsberg Lab, DK-1799 Copenhagen V, Denmark; [Palcic, Monica M.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of Copenhagen; University of Victoria	Blennow, A (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen Plant Sci Ctr, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	abl@plen.ku.dk	Jensen, Poul Erik/A-4862-2014; Mellor, Silas/D-8037-2015	Jensen, Poul Erik/0000-0001-6524-7723; Cuesta-Seijo, Jose Antonio/0000-0002-3755-9305; Mellor, Silas/0000-0002-3364-5804	University of Copenhagen; Carlsberg Foundation; VILLUM Center of Excellence "Plant Plasticity"; Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies [12-131834]	University of Copenhagen; Carlsberg Foundation(Carlsberg Foundation); VILLUM Center of Excellence "Plant Plasticity"; Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies	Funding was provided by a stipend from the University of Copenhagen, http://www.ku.dk/, providing a stipend for KS; Carlsberg Foundation, http://www.carlsbergfondet.dk/, funding salaries and materials for JAC-S MMN LM; the VILLUM Center of Excellence "Plant Plasticity", Salary and materials for SBM; "Plant Power: Light-Driven Synthesis of Complex Terpenoids Using Cytochrome P450s" (12-131834) funded by the Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies, salary and materials for SBM.	Antal TK, 2013, PHOTOSYNTH RES, V117, P1, DOI 10.1007/s11120-013-9945-8; Baier M, 2005, J EXP BOT, V56, P1449, DOI 10.1093/jxb/eri161; Ballicora MA, 2000, J BIOL CHEM, V275, P1315, DOI 10.1074/jbc.275.2.1315; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; Balsera M, 2014, ANTIOXID REDOX SIGN, V21, P1327, DOI 10.1089/ars.2013.5817; Blennow A, 2013, CEREAL CHEM, V90, P274, DOI 10.1094/CCHEM-01-13-0010-FI; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; Blennow A, 2010, BIOCATAL BIOTRANSFOR, V28, P3, DOI 10.3109/10242420903408211; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Cuesta-Seijo JA, 2013, ACTA CRYSTALLOGR D, V69, P1013, DOI 10.1107/S090744491300440X; Delvalle D, 2005, PLANT J, V43, P398, DOI 10.1111/j.1365-313X.2005.02462.x; Dietz KJ, 2011, PLANT PHYSIOL, V155, P1477, DOI 10.1104/pp.110.170043; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geigenberger P, 2005, J EXP BOT, V56, P1469, DOI 10.1093/jxb/eri178; Geigenberger P, 2014, ANTIOXID REDOX SIGN, V21, P1389, DOI 10.1089/ars.2014.6018; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Glaring MA, 2012, PLANT PHYSIOL BIOCH, V58, P89, DOI 10.1016/j.plaphy.2012.06.017; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Hadrich N, 2012, PLANT J, V70, P231, DOI 10.1111/j.1365-313X.2011.04860.x; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; HUTCHISON RS, 1995, METHOD ENZYMOL, V252, P220; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kirchsteiger K, 2012, PLANT CELL, V24, P1534, DOI 10.1105/tpc.111.092304; Kotting O, 2010, CURR OPIN PLANT BIOL, V13, P321, DOI 10.1016/j.pbi.2010.01.003; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Meyer AJ, 2008, J PLANT PHYSIOL, V165, P1390, DOI 10.1016/j.jplph.2007.10.015; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Michelet L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00470; Mikkelsen R, 2005, P NATL ACAD SCI USA, V102, P1785, DOI 10.1073/pnas.0406674102; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Momma M, 2012, BIOSCI BIOTECH BIOCH, V76, P1591, DOI 10.1271/bbb.120305; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Onda Y., 2013, INT J CELL BIOL, V2013; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Reichmann D, 2013, CURR OPIN STRUC BIOL, V23, P436, DOI 10.1016/j.sbi.2013.02.006; Santelia D, 2015, CURR OPIN PLANT BIOL, V25, P1, DOI 10.1016/j.pbi.2015.04.003; Sanz-Barrio R, 2013, PLANT BIOTECHNOL J, V11, P618, DOI 10.1111/pbi.12052; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Seung D, 2013, J BIOL CHEM, V288, P33620, DOI 10.1074/jbc.M113.514794; Sheng F, 2009, BIOCHEMISTRY-US, V48, P10089, DOI 10.1021/bi900916t; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Silver DM, 2013, FEBS J, V280, P538, DOI 10.1111/j.1742-4658.2012.08546.x; Smith AM, 2012, STARCH-STARKE, V64, P421, DOI 10.1002/star.201100163; Sparla F, 2006, PLANT PHYSIOL, V141, P840, DOI 10.1104/pp.106.079186; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Thormahlen I, 2013, PLANT CELL ENVIRON, V36, P16, DOI 10.1111/j.1365-3040.2012.02549.x; Toivola J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00389; Valerio C, 2011, J EXP BOT, V62, P545, DOI 10.1093/jxb/erq288; Yep A, 2004, J BIOL CHEM, V279, P8359, DOI 10.1074/jbc.M312686200; Zeeman SC, 1998, PLANT J, V15, P357, DOI 10.1046/j.1365-313X.1998.00213.x	57	35	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136997	10.1371/journal.pone.0136997	http://dx.doi.org/10.1371/journal.pone.0136997			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367870	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100042
J	Tahita, MC; Tinto, H; Erhart, A; Kazienga, A; Fitzhenry, R; VanOvermeir, C; Rosanas-Urgell, A; Ouedraogo, JB; Guiguemde, RT; Van Geertruyden, JP; D'Alessandro, U				Tahita, Marc C.; Tinto, Halidou; Erhart, Annette; Kazienga, Adama; Fitzhenry, Robert; VanOvermeir, Chantal; Rosanas-Urgell, Anna; Ouedraogo, Jean-Bosco; Guiguemde, Robert T.; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto			Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine	PLOS ONE			English	Article							FALCIPARUM DIHYDROFOLATE-REDUCTASE; DIHYDROPTEROATE SYNTHASE GENE; PLASMODIUM-FALCIPARUM; POINT MUTATIONS; MALARIA; RESISTANCE; SYNTHETASE; EFFICACY; POLICY; LINE	Background The emergence and spread of drug resistance represents one of the biggest challenges for malaria control in endemic regions. Sulfadoxine-pyrimethamine (SP) is currently deployed as intermittent preventive treatment in pregnancy (IPTp) to prevent the adverse effects of malaria on the mother and her offspring. Nevertheless, its efficacy is threatened by SP resistance which can be estimated by the prevalence of dihydropteroate synthase (dhps) and dihydrofolate reductase (dhfr) mutations. This was measured among pregnant women in the health district of Nanoro, Burkina Faso. Methods From June to December 2010, two hundred and fifty six pregnant women in the second and third trimester, attending antenatal care with microscopically confirmed malaria infection were invited to participate, regardless of malaria symptoms. A blood sample was collected on filter paper and analyzed by PCR-RFLP for the alleles 51, 59, 108, 164 in the pfdhfr gene and 437, 540 in the pfdhps gene. Results The genes were successfully genotyped in all but one sample (99.6%; 255/256) for dhfr and in 90.2% (231/256) for dhps. The dhfr C59R and S108N mutations were the most common, with a prevalence of 61.2%(156/255) and 55.7%(142/255), respectively; 12.2%(31/255) samples had also the dhfr N51I mutation while the I164L mutation was absent. The dhps A437G mutation was found in 34.2%(79/231) isolates, but none of them carried the codon K540E. The prevalence of the dhfr double mutations NRNI and the triple mutations IRNI was 35.7% (91/255) and 11.4% (29/255), respectively. Conclusion Though the mutations in the pfdhfr and pfdhps genes were relatively common, the prevalence of the triple pfdhfr mutation was very low, indicating that SP as IPTp is still efficacious in Burkina Faso.	[Tahita, Marc C.; Tinto, Halidou; Ouedraogo, Jean-Bosco] IRSS, DRO, Bobo Dioulasso, Burkina Faso; [Tahita, Marc C.; Tinto, Halidou; Kazienga, Adama; Ouedraogo, Jean-Bosco; Guiguemde, Robert T.] IRSS CRUN, Clin Res Unit Nanoro, Nanoro, Burkina Faso; [Tahita, Marc C.; Tinto, Halidou; Guiguemde, Robert T.] Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso; [Tahita, Marc C.; Erhart, Annette; Fitzhenry, Robert; VanOvermeir, Chantal; Rosanas-Urgell, Anna; D'Alessandro, Umberto] Inst Trop Med, Malariol Unit, B-2000 Antwerp, Belgium; [Tahita, Marc C.; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Guiguemde, Robert T.] Inst Super Sci Sante INSSA, Bobo Dioulasso, Burkina Faso; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England; [D'Alessandro, Umberto] MRC Unit, Banjul, Gambia	Centre Muraz; Institute of Tropical Medicine (ITM); University of Antwerp; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Tahita, MC (corresponding author), IRSS, DRO, Bobo Dioulasso, Burkina Faso.	marctahita@yahoo.fr	Van geertruyden, Jean-Pierre/S-3254-2019; Kazienga, Adama/HGB-6079-2022; Van geertruyden, Jean-Pierre/K-6425-2014; Rosanas-Urgell, Anna/D-3193-2015; Tahita, Marc/AAG-6549-2019	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Rosanas-Urgell, Anna/0000-0002-0432-5203; Tahita, Marc/0000-0003-2158-0182; Tinto, Halidou/0000-0002-0472-3586; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Kazienga, Adama/0000-0002-6093-9648				Artimovich E, 2015, J INFECT DIS, V212, P694, DOI 10.1093/infdis/jiv078; Aziken ME, 2011, INT J GYNECOL OBSTET, V112, P30, DOI 10.1016/j.ijgo.2010.07.027; Bacon DJ, 2009, ANTIMICROB AGENTS CH, V53, P2042, DOI 10.1128/AAC.01677-08; Basco LK, 1998, AM J TROP MED HYG, V58, P374, DOI 10.4269/ajtmh.1998.58.374; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; Coulibaly SO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-41; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; Cuzin-Ouattara N, 1999, T ROY SOC TROP MED H, V93, P473, DOI 10.1016/S0035-9203(99)90343-7; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014; Geiger C, 2014, TROP MED INT HEALTH, V19, P690, DOI 10.1111/tmi.12305; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Maiga OM, 2011, CLIN INFECT DIS, V53, P215, DOI 10.1093/cid/cir374; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Omar SA, 2001, T ROY SOC TROP MED H, V95, P315, DOI 10.1016/S0035-9203(01)90250-0; Pearce RJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000055; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; Pfeiffer K, 2008, TROP MED INT HEALTH, V13, P418, DOI 10.1111/j.1365-3156.2008.02017.x; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Programme National de Lutte contre le Paludisme (PNLP), 2010, DIR NAT PRIS CHARG P; Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2; Sicuri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013407; Tahita MC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-464; Tinto H, 2007, AM J TROP MED HYG, V76, P608, DOI 10.4269/ajtmh.2007.76.608; Tinto H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-113; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; Wang P, 1997, MOL BIOCHEM PARASIT, V89, P161, DOI 10.1016/S0166-6851(97)00114-X; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; Zhou ZY, 2008, ANTIMICROB AGENTS CH, V52, P739, DOI 10.1128/AAC.00975-07	35	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137440	10.1371/journal.pone.0137440	http://dx.doi.org/10.1371/journal.pone.0137440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368675	Green Accepted, Green Published, gold			2022-12-26	WOS:000361601100073
J	Wang, TH; Zhang, Y; Chin, FYL; Ting, HF; Tsin, YH; Poon, SH				Wang, Tianhao; Zhang, Yong; Chin, Francis Y. L.; Ting, Hing-Fung; Tsin, Yung H.; Poon, Sheung-Hung			A Simple Algorithm for Finding All k-Edge-Connected Components	PLOS ONE			English	Article								The problem of finding k-edge-connected components is a fundamental problem in computer science. Given a graph G = (V, E), the problem is to partition the vertex set V into {V-1, V-2, ..., V-h}, where each V-i is maximized, such that for any two vertices x and y in V-i, there are k edge-disjoint paths connecting them. In this paper, we present an algorithm to solve this problem for all k. The algorithm preprocesses the input graph to construct an Auxiliary Graph to store information concerning edge-connectivity among every vertex pair in O(Fn) time, where F is the time complexity to find the maximum flow between two vertices in graph G and n = vertical bar V vertical bar. For any value of k, the k-edge-connected components can then be determined by traversing the auxiliary graph in O(n) time. The input graph can be a directed or undirected, simple graph or multigraph. Previous works on this problem mainly focus on fixed value of k.	[Zhang, Yong] Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr High Performance Comp, Shenzhen, Peoples R China; [Wang, Tianhao] Fudan Univ, Software Sch, Shanghai 200433, Peoples R China; [Zhang, Yong] Hebei Univ, Coll Math & Informat Sci, Baoding, Peoples R China; [Chin, Francis Y. L.; Ting, Hing-Fung] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Chin, Francis Y. L.] Hang Seng Management Coll, Hong Kong, Hong Kong, Peoples R China; [Tsin, Yung H.] Univ Windsor, Sch Comp Sci, Windsor, ON N9B 3P4, Canada; [Poon, Sheung-Hung] Inst Teknol Brunei, Sch Comp & Informat, Gadong, Brunei	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Fudan University; Hebei University; University of Hong Kong; Hang Seng University of Hong Kong; University of Windsor; University of Technology Brunei	Zhang, Y (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr High Performance Comp, Shenzhen, Peoples R China.	yzhang.hku@gmail.com	Wang, Tianhao/AAU-5463-2021	Poon, Sheung-Hung/0000-0002-1777-9394	National Natural Science Foundation of China [11171086, 61433012, U1435215]; Research Grants Council of Hong Kong [HKU 7114/13E, HKU 7164/12E, HKU 7111/12E]; Natural Sciences and Engineering Research Council of Canada; NSERC [7811-2009]; Natural Science Foundation of Hebei Province [A2013201218]; Chinese Academy of Sciences research grant [KGZD-EW-103-5(9)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Chinese Academy of Sciences research grant	This work is supported by National Natural Science Foundation of China (No. 11171086, 61433012, U1435215), Research Grants Council of Hong Kong (No. HKU 7114/13E, HKU 7164/12E, HKU 7111/12E), Natural Sciences and Engineering Research Council of Canada, NSERC 7811-2009, Natural Science Foundation of Hebei Province (No. A2013201218), and Chinese Academy of Sciences research grant (No. KGZD-EW-103-5(9)).	Chang L., 2013, SIGMOD, P205; Ford L. R. J., 1962, FLOWS NETWORKS; Ford LR, 1956, CAN J MATH, V8, P399, DOI [10.4153/CJM-1956-045-5, 10.4153/CJM-1956-045-5., DOI 10.4153/CJM-1956-045-5]; Galil Z., 1991, SIGACT News, V22, P57, DOI 10.1145/122413.122416; GOLDBERG AV, 1988, J ACM, V35, P921, DOI 10.1145/48014.61051; GOMORY RE, 1961, J SOC IND APPL MATH, V9, P551, DOI 10.1137/0109047; GUSFIELD D, 1990, SIAM J COMPUT, V19, P143, DOI 10.1137/0219009; GUSFIELD D, 1991, NETWORKS, V21, P505, DOI 10.1002/net.3230210503; Matula D. W., 1987, P FOCS; NAGAMOCHI H, 1992, ALGORITHMICA, V7, P583, DOI 10.1007/BF01758778; Nagamochi H., 1992, JAPAN J IND APPL MAT, V9, P163, DOI DOI 10.1007/BF03167564; SCHNORR CP, 1979, SIAM J COMPUT, V8, P265, DOI 10.1137/0208019; Stoer M, 1997, J ACM, V44, P585, DOI 10.1145/263867.263872; Tarjan R. E., 1974, Information Processing Letters, V2, P160, DOI 10.1016/0020-0190(74)90003-9; Tsin YH, 2007, THEOR COMPUT SYST, V40, P125, DOI 10.1007/s00224-005-1269-4; Tsin YH, 2009, J DISCRET ALGORITHMS, V7, P130, DOI 10.1016/j.jda.2008.04.003; Watanabe T., 1992, IEICE T FUND ELECTR, VE76-A, P513; Zhou RG, 2012, COMM COM INF SC, V321, P480	18	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136264	10.1371/journal.pone.0136264	http://dx.doi.org/10.1371/journal.pone.0136264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368134	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100015
J	Hudson, MB; Smuder, AJ; Nelson, WB; Wiggs, MP; Shimkus, KL; Fluckey, JD; Szeto, HH; Powers, SK				Hudson, Matthew B.; Smuder, Ashley J.; Nelson, W. Bradley; Wiggs, Michael P.; Shimkus, Kevin L.; Fluckey, James D.; Szeto, Hazel H.; Powers, Scott K.			Partial Support Ventilation and Mitochondrial-Targeted Antioxidants Protect against Ventilator-Induced Decreases in Diaphragm Muscle Protein Synthesis	PLOS ONE			English	Article							PROLONGED MECHANICAL VENTILATION; CRITICALLY-ILL PATIENTS; OXIDATIVE STRESS; RAT DIAPHRAGM; MASS-SPECTROMETRY; KINASE-B; DYSFUNCTION; ATROPHY; WEAKNESS; ACTIVATION	Mechanical ventilation (MV) is a life-saving intervention in patients in respiratory failure. Unfortunately, prolonged MV results in the rapid development of diaphragm atrophy and weakness. MV-induced diaphragmatic weakness is significant because inspiratory muscle dysfunction is a risk factor for problematic weaning from MV. Therefore, developing a clinical intervention to prevent MV-induced diaphragm atrophy is important. In this regard, MV-induced diaphragmatic atrophy occurs due to both increased proteolysis and decreased protein synthesis. While efforts to impede MV-induced increased proteolysis in the diaphragm are well-documented, only one study has investigated methods of preserving diaphragmatic protein synthesis during prolonged MV. Therefore, we evaluated the efficacy of two therapeutic interventions that, conceptually, have the potential to sustain protein synthesis in the rat diaphragm during prolonged MV. Specifically, these experiments were designed to: 1) determine if partial-support MV will protect against the decrease in diaphragmatic protein synthesis that occurs during prolonged full-support MV; and 2) establish if treatment with a mitochondrial-targeted antioxidant will maintain diaphragm protein synthesis during full-support MV. Compared to spontaneously breathing animals, full support MV resulted in a significant decline in diaphragmatic protein synthesis during 12 hours of MV. In contrast, diaphragm protein synthesis rates were maintained during partial support MV at levels comparable to spontaneous breathing animals. Further, treatment of animals with a mitochondrial-targeted antioxidant prevented oxidative stress during full support MV and maintained diaphragm protein synthesis at the level of spontaneous breathing animals. We conclude that treatment with mitochondrial-targeted antioxidants or the use of partial-support MV are potential strategies to preserve diaphragm protein synthesis during prolonged MV.	[Hudson, Matthew B.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Smuder, Ashley J.; Wiggs, Michael P.; Powers, Scott K.] Univ Florida, Ctr Exercise Sci, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA; [Nelson, W. Bradley] Ohio Dominican Univ, Dept Nat Sci, Columbus, OH USA; [Shimkus, Kevin L.; Fluckey, James D.] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA; [Szeto, Hazel H.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; University of Florida; Ohio Dominican University; Texas A&M University System; Texas A&M University College Station; Cornell University	Hudson, MB (corresponding author), Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA.	mbhudson@temple.edu	Nelson, Brad/P-8771-2016	Nelson, Brad/0000-0003-0793-2006	National Institute of Health [R01AR064189]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064189] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by the National Institute of Health (grant #R01AR064189) awarded to SKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agten A, 2011, CRIT CARE MED, V39, P777, DOI 10.1097/CCM.0b013e318206cca9; Alirezaei M, 2001, J NEUROCHEM, V76, P1080, DOI 10.1046/j.1471-4159.2001.00105.x; Betters JL, 2004, AM J RESP CRIT CARE, V170, P1179, DOI 10.1164/rccm.200407-939OC; Bodine SC, 2006, MED SCI SPORT EXER, V38, P1950, DOI 10.1249/01.mss.0000233797.24035.35; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Bruells CS, 2013, ANESTHESIOLOGY, V119, P652, DOI 10.1097/ALN.0b013e31829b3692; CALDER AG, 1992, RAPID COMMUN MASS SP, V6, P421, DOI 10.1002/rcm.1290060704; Eskandar N, 2007, CRIT CARE CLIN, V23, P263, DOI 10.1016/j.ccc.2006.12.002; Falk DJ, 2011, CHEST, V139, P816, DOI 10.1378/chest.09-2787; Futier E, 2008, CRIT CARE, V12, DOI 10.1186/cc7010; Gayan-Ramirez G, 2003, INTENS CARE MED, V29, P825, DOI 10.1007/s00134-003-1688-0; Hooijman PE, 2015, AM J RESP CRIT CARE, V191, P1126, DOI 10.1164/rccm.201412-2214OC; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V307, pC314, DOI 10.1152/ajpcell.00395.2013; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Hudson MB, 2012, CRIT CARE MED, V40, P1254, DOI 10.1097/CCM.0b013e31823c8cc9; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Klawitter PF, 2004, J APPL PHYSIOL, V96, P89, DOI 10.1152/japplphysiol.00237.2003; Laghi F, 2003, AM J RESP CRIT CARE, V168, P10, DOI 10.1164/rccm.2206020; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Maes K, 2007, AM J RESP CRIT CARE, V175, P1134, DOI 10.1164/rccm.200609-1342OC; McClung JM, 2007, J PHYSIOL-LONDON, V585, P203, DOI 10.1113/jphysiol.2007.141119; McClung JM, 2009, CRIT CARE MED, V37, P1373, DOI 10.1097/CCM.0b013e31819cef63; MORTOLA JP, 1983, J APPL PHYSIOL, V55, P250, DOI 10.1152/jappl.1983.55.1.250; Nelson WB, 2012, CRIT CARE MED, V40, P1857, DOI 10.1097/CCM.0b013e318246bb5d; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Patterson BW, 1997, METABOLISM, V46, P943, DOI 10.1016/S0026-0495(97)90084-6; Pham FH, 2000, CIRC RES, V86, P1252, DOI 10.1161/01.RES.86.12.1252; Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC; Powers SK, 2013, AM J PHYSIOL-REG I, V305, pR464, DOI 10.1152/ajpregu.00231.2013; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Powers SK, 2011, FREE RADICAL BIO MED, V51, P942, DOI 10.1016/j.freeradbiomed.2010.12.009; Rollier H, 1998, AM J RESP CRIT CARE, V157, P833, DOI 10.1164/ajrccm.157.3.9512103; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Shanely RA, 2004, AM J RESP CRIT CARE, V170, P994, DOI 10.1164/rccm.200304-575OC; Smuder AJ, 2014, ANESTHESIOLOGY, V121, P115, DOI 10.1097/ALN.0000000000000245; Smuder AJ, 2012, CRIT CARE MED, V40, P927, DOI 10.1097/CCM.0b013e3182374a84; Smuder AJ, 2012, J APPL PHYSIOL, V112, P501, DOI 10.1152/japplphysiol.01086.2011; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Supinski GS, 2013, CRIT CARE, V17, DOI 10.1186/cc12792; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Vassilakopoulos T, 2004, AM J RESP CRIT CARE, V169, P336, DOI 10.1164/rccm.200304-489CP; Vassilakopoulos T, 1996, Monaldi Arch Chest Dis, V51, P489; Whidden MA, 2010, J APPL PHYSIOL, V108, P1376, DOI 10.1152/japplphysiol.00098.2010; Whidden MA, 2009, J APPL PHYSIOL, V106, P385, DOI 10.1152/japplphysiol.91106.2008; Zhao KS, 2005, BIOCHEM PHARMACOL, V70, P1796, DOI 10.1016/j.bcp.2005.08.022; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	46	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137693	10.1371/journal.pone.0137693	http://dx.doi.org/10.1371/journal.pone.0137693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361212	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100072
J	Kuling, IA; Smeets, JBJ; Lammertse, P; Onneweer, B; Mugge, W				Kuling, Irene A.; Smeets, Jeroen B. J.; Lammertse, Piet; Onneweer, Bram; Mugge, Winfred			Delays in Admittance-Controlled Haptic Devices Make Simulated Masses Feel Heavier	PLOS ONE			English	Article							PERCEPTION; WEIGHT	In an admittance-controlled haptic device, input forces are used to calculate the movement of the device. Although developers try to minimize delays, there will always be delays between the applied force and the corresponding movement in such systems, which might affect what the user of the device perceives. In this experiment we tested whether these delays in a haptic human-robot interaction influence the perception of mass. In the experiment an admittance-controlled manipulator was used to simulate various masses. In a staircase design subjects had to decide which of two virtual masses was heavier after gently pushing them leftward with the right hand in mid-air (no friction, no gravity). The manipulator responded as quickly as possible or with an additional delay (25 or 50 ms) to the forces exerted by the subject on the handle of the haptic device. The perceived mass was similar to 10% larger for a delay of 25 ms and similar to 20% larger for a delay of 50 ms. Based on these results, we estimated that the delays that are present in nowadays admittance-controlled haptic devices (up to 20ms) will give an increase in perceived mass which is smaller than the Weber fraction for mass (similar to 10% for inertial mass). Additional analyses showed that the subjects' decision on mass when the perceptual differences were small did not correlate with intuitive variables such as force, velocity or a combination of these, nor with any other measured variable, suggesting that subjects did not have a consistent strategy during guessing or used other sources of information, for example the efference copy of their pushes.	[Kuling, Irene A.; Smeets, Jeroen B. J.; Mugge, Winfred] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Lammertse, Piet] Moog BV, Nieuw Vennep, Netherlands; [Onneweer, Bram] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands	Vrije Universiteit Amsterdam; Delft University of Technology	Kuling, IA (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	i.a.kuling@vu.nl	Kuling, Irene/ABC-4022-2021; Smeets, Jeroen/B-4198-2008	Kuling, Irene/0000-0003-3556-0393; Smeets, Jeroen/0000-0002-3794-0579	Dutch Technology Foundation STW; Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs, Agriculture and Innovation; STW [12160]	Dutch Technology Foundation STW(Technologiestichting STW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs, Agriculture and Innovation; STW(Technologiestichting STW)	This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs, Agriculture and Innovation. STW grant 12160. Moog B.V. provided support in the form of salaries for author PL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abbink DA, 2012, COGN TECHNOL WORK, V14, P19, DOI 10.1007/s10111-011-0192-5; Bloch M. A. -M., 1885, CR HEBD ACAD SCI, V37, P493; Boessenkool H, 2013, IEEE T HAPTICS, V6, P2, DOI [10.1109/ToH.2012.22, 10.1109/TOH.2012.22]; Di Luca M, 2011, BRAIN RES BULL, V85, P245, DOI 10.1016/j.brainresbull.2010.02.009; Honda T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00760; Kahrimanovic M, 2011, IEEE T HAPTICS, V4, P316, DOI [10.1109/TOH.2011.22, 10.1109/ToH.2011.22]; Kambara H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00040; Keetels M, 2012, EXP BRAIN RES, V219, P431, DOI 10.1007/s00221-012-3081-0; Mulder M, 2012, HUMAN FACTORS J HUMA, V54, P681; Mulder M, 2008, IEEE SYS MAN CYBERN, P804, DOI 10.1109/ICSMC.2008.4811377; Murray DJ, 1999, PERCEPT PSYCHOPHYS, V61, P1681, DOI 10.3758/BF03213127; Plaisier MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042518; Pressman A, 2007, INT J ROBOT RES, V26, P1191, DOI 10.1177/0278364907082611; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; ROSS HE, 1987, Q J EXP PSYCHOL-A, V39, P77, DOI 10.1080/02724988743000042; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Tiest WMB, 2010, ATTEN PERCEPT PSYCHO, V72, P1144, DOI 10.3758/APP.72.4.1144; Tzafestas CS, 2013, PRESENCE-TELEOP VIRT, V22, P323, DOI 10.1162/PRES_a_00162; Wolfe H. K., 1898, PSYCHOL REV, V5, P25, DOI [DOI 10.1037/H0073342, 10.1037/h0073342]	19	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0138023	10.1371/journal.pone.0138023	http://dx.doi.org/10.1371/journal.pone.0138023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361353	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100109
J	Menzel-Severing, J; Petsch, C; Tourtas, T; Polisetti, N; Klenke, J; Skerl, K; Wullner, C; Donitzky, C; Kruse, FE; Kremers, J; Hammer, CM				Menzel-Severing, Johannes; Petsch, Corinna; Tourtas, Theofilos; Polisetti, Naresh; Klenke, Joerg; Skerl, Katrin; Wuellner, Christian; Donitzky, Christof; Kruse, Friedrich E.; Kremers, Jan; Hammer, Christian M.			Evaluation of a 345 nm Femtosecond Laser for Corneal Surgery with Respect to Intraocular Radiation Hazard	PLOS ONE			English	Article							INCISION LENTICULE EXTRACTION; CLASSIFICATION-SYSTEM III; PHOTOCHEMICAL DAMAGE; LENS OPACITY; CROSS-LINKING; NUCLEAR; SAFETY; MYOPIA; OPACIFICATION; RIBOFLAVIN	Purpose We report our findings from a preclinical safety study designed to assess potential side effects of corneal ultraviolet femtosecond laser treatment on lens and retina. Methods Refractive lenticules (-5 dpt) with a diameter of 6 mm were created in the right cornea of eight Dutch Belted rabbits. Radiant exposure was 0.5 J/cm(2) in two animals and 18 J/cm(2) in six animals. The presence of lens opacities was assessed prior to and up to six months following laser application using Scheimpflug images (Pentacam, Oculus) and backscatter analysis (Opacity Lensmeter 702, Interzeag). Ganzfeld flash and flicker electroretinogram (ERG) recordings were obtained from both eyes prior to and up to six weeks following laser application. At the study endpoint, retinas were examined by light microscopy. Results Independent of energy dose applied, no cataract formation could be observed clinically or with either of the two objective methods used. No changes in ERG recordings over time and no difference between treated and untreated eye were detected. Histologically, retinal morphology was preserved and retinal pigment epithelium as well as photoreceptor inner and outer segments appeared undamaged. Quantitative digital image analysis did not reveal cell loss in inner or outer nuclear layers. Conclusions Our analysis confirms theoretical considerations suggesting that ultraviolet femtosecond laser treatment of the cornea is safe for intraocular tissues. Transmitted light including stray light induces no photochemical effects in lens or retina at energy levels much higher than required for the clinical purpose. These conclusions cannot be applied to eyes with preexisting retinal damage, as these may be more vulnerable to light.	[Menzel-Severing, Johannes; Petsch, Corinna; Tourtas, Theofilos; Polisetti, Naresh; Kruse, Friedrich E.; Kremers, Jan; Hammer, Christian M.] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany; [Klenke, Joerg; Skerl, Katrin; Wuellner, Christian; Donitzky, Christof] WaveLight GmbH, Erlangen, Germany; [Hammer, Christian M.] Univ Erlangen Nurnberg, Dept Anat 2, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Menzel-Severing, J (corresponding author), Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany.	johannes.menzel-severing@uk-erlangen.de	Kremers, Jan/X-3125-2019	Kremers, Jan/0000-0002-9293-7380; Polisetti, Naresh/0000-0001-8669-0388; Tourtas, Theofilos/0000-0002-3465-9837	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [01EX1011B]; Wavelight GmbH	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); Wavelight GmbH	This study was funded by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF), project grant no. 01EX1011B. The funder Wavelight GmbH provided support in the form of equipment (prototype femtosecond laser) and salaries for authors JoK, KS, CW and CD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ainsbury EA, 2009, RADIAT RES, V172, P1, DOI 10.1667/RR1688.1; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776; Cejka C, 2013, PHOTOCHEM PHOTOBIOL, V89, P474, DOI 10.1111/php.12010; Coroneo M, 2011, EYE CONTACT LENS, V37, P214, DOI 10.1097/ICL.0b013e318223394e; Gupta M, 2013, J CATARACT REFR SURG, V39, P1818, DOI 10.1016/j.jcrs.2013.05.052; HAM WT, 1976, NATURE, V260, P153, DOI 10.1038/260153a0; Hammer CM, 2015, J CATARACT REFR SURG, V41, P1279, DOI 10.1016/j.jcrs.2014.11.046; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Hayashi LC, 2003, SCI TOTAL ENVIRON, V302, P53, DOI 10.1016/S0048-9697(02)00320-0; HOPPELER T, 1988, CURR EYE RES, V7, P849, DOI 10.3109/02713688808997242; Horn Folkert K., 2001, Documenta Ophthalmologica, V103, P105, DOI 10.1023/A:1012263922188; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Konig K, 2005, European Patent, Patent No. [1787607 A1, 1787607A1]; Kopf D, 2002, WO Patent, Patent No. [2,002,060,020, 2002060020]; LAWWILL T, 1973, INVEST OPHTH VISUAL, V12, P45; Le Harzic R, 2009, J REFRACT SURG, V25, P383, DOI 10.3928/1081597X-20090401-08; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; McKinlay AF, 2004, HEALTH PHYS, V87, P171; MIZUNO T, 1990, OPHTHALMIC RES, V22, P36, DOI 10.1159/000267062; Noell W K, 1966, Invest Ophthalmol, V5, P450; Pei X, 2008, BRIT J OPHTHALMOL, V92, P1471, DOI 10.1136/bjo.2007.136978; Schumacher S, 2008, J REFRACT SURG, V24, P991, DOI 10.3928/1081597X-20081101-24; Seiler T, 2014, OPHTHALMOLOGE, V111, P539, DOI 10.1007/s00347-013-2993-9; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Sliney DH, 2002, INT J TOXICOL, V21, P501, DOI 10.1080/10915810290169927; Sliney DH, 2000, HDB OPTICS, VIII; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Sutton GL, 2010, CLIN EXP OPHTHALMOL, V38, P192, DOI 10.1111/j.1442-9071.2010.02227.x; Trost A, 2013, INVEST OPHTH VIS SCI, V54, P7854, DOI 10.1167/iovs.13-12580; TUFT SJ, 1990, BRIT J OPHTHALMOL, V74, P78, DOI 10.1136/bjo.74.2.78; Ullrich K, 2012, J CATARACT REFR SURG, V38, P2100, DOI 10.1016/j.jcrs.2012.07.033; Vestergaard A, 2012, J CATARACT REFR SURG, V38, P2003, DOI 10.1016/j.jcrs.2012.07.021; Wang MM, 2015, CLIN EXP OPHTHALMOL, V43, P156, DOI 10.1111/ceo.12392; Werner L, 2010, J CATARACT REFR SURG, V36, P1392, DOI 10.1016/j.jcrs.2010.02.018; Wu JM, 2006, SURV OPHTHALMOL, V51, P461, DOI 10.1016/j.survophthal.2006.06.009; ZUCLICH JA, 1989, HEALTH PHYS, V56, P671, DOI 10.1097/00004032-198905000-00012	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137638	10.1371/journal.pone.0137638	http://dx.doi.org/10.1371/journal.pone.0137638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361228	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100060
J	Wei, Q; Chen, ZH; Wang, L; Zhang, T; Duan, L; Behrens, C; Wistuba, II; Minna, JD; Gao, B; Luo, JH; Liu, ZP				Wei, Q.; Chen, Z-H; Wang, L.; Zhang, T.; Duan, L.; Behrens, C.; Wistuba, I. I.; Minna, J. D.; Gao, B.; Luo, J-H; Liu, Z. P.			LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells	ONCOGENE			English	Article							CANCER; MAINTENANCE; MIGRATION	Lung cancer is the leading cause of cancer-related death in the United States, and metastatic behavior is largely responsible for this mortality. Mutations in multiple 'driver' oncogenes and tumor suppressors are known to contribute to the lung tumorigenesis and in some cases represent therapeutic targets. Leucine Zipper Transcription Factor-like 1 (LZTFL1) is located in the chromosome region 3p21.3 where allelic loss and genetic alterations occur early and frequently in lung cancers. Previously, we found that LZTFL1 is downregulated in epithelial tumors, including lung cancer, and functions as a tumor suppressor in gastric cancers. However, the functional role of LZTFL1 in lung oncogenesis is undefined. We show here that downregulation of LZTFL1 expression in non-small cell lung cancer is associated with recurrence and poor survival, whereas re-expression of LZTFL1 in lung tumor cells inhibited extravasation/colonization of circulating tumor cells to the lung and inhibited tumor growth in vivo. Mechanistically, we found that LZTFL1 is expressed in ciliated human bronchial epithelial cells (HBECs) and its expression correlates with HBEC differentiation. LZTFL1 inhibits transforming growth factor beta-activated mitogen-activated protein kinase and hedgehog signaling. Alteration of intracellular levels of LZTFL1 resulted in changes of expression of genes associated with epithelial-to-mesenchymal transition (EMT). We conclude that LZTFL1 inhibits lung tumorigenesis, possibly by maintaining epithelial cell differentiation and/or inhibition of signalings that lead to EMT and suggest that reactivation of LZTFL1 expression in tumor cells may be a novel lung cancer therapeutic approach.	[Wei, Q.; Chen, Z-H; Wang, L.; Zhang, T.; Duan, L.; Minna, J. D.; Liu, Z. P.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, 6000 Harry Hines Blvd, Dallas, TX 75235 USA; [Wei, Q.] Zhejiang Univ, Sir Run Run Shaw Hosp Coll Med, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Wei, Q.] Zhejiang Univ, Sir Run Run Shaw Hosp Coll Med, Inst Clin Med, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Z-H; Luo, J-H] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Behrens, C.; Wistuba, I. I.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Behrens, C.; Wistuba, I. I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Minna, J. D.; Gao, B.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75235 USA; [Minna, J. D.; Gao, B.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75235 USA; [Liu, Z. P.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Zhejiang University; Zhejiang University; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, ZP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 6000 Harry Hines Blvd, Dallas, TX 75235 USA.; Luo, JH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.; Liu, ZP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75235 USA.	luojunh@mail.sysu.edu.cn; Zhi-Ping.Liu@UTsouthwestern.edu			NIHRO1; CPRIT-MIRA [RP120717-P1]; National Natural Science Foundation of China [81101581]; National Cancer Institute Specialized Program of Research Excellence in Lung Cancer Grant [P50CA70907]; Cancer Center Support Grant by National Cancer Institute of the National Institutes of Health [5P30CA142543]; NATIONAL CANCER INSTITUTE [P30CA142543, P50CA070907] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109471] Funding Source: NIH RePORTER	NIHRO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT-MIRA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Cancer Institute Specialized Program of Research Excellence in Lung Cancer Grant; Cancer Center Support Grant by National Cancer Institute of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by NIHRO1 and CPRIT-MIRA RP120717-P1 (to ZPL), National Natural Science Foundation of China No. 81101581 (to QW), National Cancer Institute Specialized Program of Research Excellence in Lung Cancer Grant P50CA70907 (to JDM) and Cancer Center Support Grant by the National Cancer Institute of the National Institutes of Health under award number 5P30CA142543.	Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Fortier AM, 2013, J BIOL CHEM, V288, P11555, DOI 10.1074/jbc.M112.428920; Gao X, 2013, P NATL ACAD SCI USA, V110, P9356, DOI 10.1073/pnas.1307589110; Gomperts BN, 2013, CANCER PREV RES, V6, P4, DOI 10.1158/1940-6207.CAPR-12-0470; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Jia YF, 2015, ARCH TOXICOL, V89, P179, DOI 10.1007/s00204-014-1433-1; Kenny PM, 2008, J CLIN ONCOL, V26, P233, DOI 10.1200/JCO.2006.07.7230; Kiss H, 2001, GENOMICS, V73, P10, DOI 10.1006/geno.2000.6498; Kugler MC, 2015, AM J RESP CELL MOL, V52, P1, DOI 10.1165/rcmb.2014-0132TR; Look DC, 2001, AM J PATHOL, V159, P2055, DOI 10.1016/S0002-9440(10)63057-X; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Mendoza A, 2010, J CLIN INVEST, V120, P2979, DOI 10.1172/JCI40252; Minna JD, 2002, CANCER J, V8, pS41; Nanjundan M, 2010, J THORAC ONCOL, V5, P1894, DOI 10.1097/JTO.0b013e3181f2a266; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Sato M, 2012, RESPIROLOGY, V17, P1048, DOI 10.1111/j.1440-1843.2012.02173.x; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Wang LB, 2014, J CANCER RES CLIN, V140, P1997, DOI 10.1007/s00432-014-1753-9; Watanabe H, 2014, J CLIN INVEST, V124, P1636, DOI 10.1172/JCI71545; Wei Q, 2010, CANCER RES, V70, P2942, DOI 10.1158/0008-5472.CAN-09-3826; Xiao Dakai, 2010, J Thorac Dis, V2, P154, DOI 10.3978/j.issn.2072-1439.2010.02.03.7; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	31	27	27	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 19	2016	35	20					2655	2663		10.1038/onc.2015.328	http://dx.doi.org/10.1038/onc.2015.328			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GS	26364604	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000376165700012
J	Bardwell, AJ; Bardwell, L				Bardwell, A. Jane; Bardwell, Lee			Two Hydrophobic Residues Can Determine the Specificity of Mitogen-activated Protein Kinase Docking Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; HIGH-AFFINITY BINDING; MAP KINASES; SITES; SUBSTRATE; JNK; MECHANISMS; INHIBITOR; PATHWAYS; MOTIFS	MAPKs bind to many of their upstream regulators and downstream substrates via a short docking motif (the D-site) on their binding partner. MAPKs that are in different families (e.g. ERK, JNK, and p38) can bind selectively to D-sites in their authentic substrates and regulators while discriminating against D-sites in other pathways. Here we demonstrate that the short hydrophobic region at the distal end of the D-site plays a critical role in determining the high selectivity of JNK MAPKs for docking sites in their cognate MAPK kinases. Changing just 1 or 2 key hydrophobic residues in this submotif is sufficient to turn a weak JNK-binding D-site into a strong one, or vice versa. These specificity-determining differences are also found in the D-sites of the ETS family transcription factors Elk-1 and Net. Moreover, swapping two hydrophobic residues between these D-sites switches the relative efficiency of Elk-1 and Net as substrates for ERK versus JNK, as predicted. These results provide new insights into docking specificity and suggest that this specificity can evolve rapidly by changes to just 1 or 2 amino acids.	[Bardwell, A. Jane; Bardwell, Lee] Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92697 USA	University of California System; University of California Irvine	Bardwell, L (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.	bardwell@uci.edu	Bardwell, Lee/I-8284-2019	Bardwell, Lee/0000-0002-2393-8363	National Institutes of Health, NIGMS [R01 GM60366, R01 GM84332, P50 GM76516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060366, P50GM076516, R01GM084332] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grants R01 GM60366, R01 GM84332, and P50 GM76516. The authors declare that they have no conflicts of interest with the contents of this article.	Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Bardwell AJ, 2003, BIOCHEM J, V370, P1077, DOI 10.1042/BJ20021806; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Barsyte-Lovejoy D, 2002, J BIOL CHEM, V277, P9896, DOI 10.1074/jbc.M108145200; Bhaduri S, 2011, CURR BIOL, V21, P1615, DOI 10.1016/j.cub.2011.08.033; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; BRANDT RB, 1987, BIOCHEM MED METAB B, V37, P344, DOI 10.1016/0885-4505(87)90046-6; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Callaway K, 2007, BIOCHEMISTRY-US, V46, P9187, DOI 10.1021/bi700206u; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Deschenes-Simard X, 2013, GENE DEV, V27, P900, DOI 10.1101/gad.203984.112; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Ducret C, 2000, ONCOGENE, V19, P5063, DOI 10.1038/sj.onc.1203892; Ember B, 2008, BIOCHEMISTRY-US, V47, P3076, DOI 10.1021/bi701852z; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Futran AS, 2013, CURR BIOL, V23, pR972, DOI 10.1016/j.cub.2013.09.033; Gaestel M, 2009, CURR PHARM DESIGN, V15, P2471, DOI 10.2174/138161209788682299; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Gogl G, 2013, ACTA CRYSTALLOGR D, V69, P486, DOI 10.1107/S0907444912051062; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Grewal S, 2006, CELL SIGNAL, V18, P123, DOI 10.1016/j.cellsig.2005.04.001; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hancock CN, 2006, MED CHEM, V2, P213, DOI 10.2174/157340606776056151; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Ho DT, 2003, J BIOL CHEM, V278, P32662, DOI 10.1074/jbc.M304229200; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Koivomagi M, 2011, MOL CELL, V42, P610, DOI 10.1016/j.molcel.2011.05.016; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Laudet V, 1999, ONCOGENE, V18, P1351, DOI 10.1038/sj.onc.1202444; Laughlin JD, 2012, STRUCTURE, V20, P2174, DOI 10.1016/j.str.2012.09.021; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Morrison Deborah K, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a011254; Niu LH, 2007, BIOCHEMISTRY-US, V46, P4775, DOI 10.1021/bi602423e; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Peti W, 2013, PROTEIN SCI, V22, P1698, DOI 10.1002/pro.2374; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Sakaguchi A, 2004, J BIOCHEM, V136, P7, DOI 10.1093/jb/mvh097; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; Tanoue T, 2002, J BIOL CHEM, V277, P22942, DOI 10.1074/jbc.M202096200; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Whisenant TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000908; Wozniak MA, 2012, CURR BIOL, V22, P2017, DOI 10.1016/j.cub.2012.08.050; Wu ZG, 1997, MOL CELL BIOL, V17, P7407, DOI 10.1128/MCB.17.12.7407; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	73	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26661	26674		10.1074/jbc.M115.691436	http://dx.doi.org/10.1074/jbc.M115.691436			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370088	hybrid, Green Published			2022-12-26	WOS:000364793600030
J	Blasic, JR; Worcester, DL; Gawrisch, K; Gurnev, P; Mihailescu, M				Blasic, Joseph R.; Worcester, David L.; Gawrisch, Klaus; Gurnev, Philip; Mihailescu, Mihaela			Pore Hydration States of KcsA Potassium Channels in Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILAYER STRUCTURE DETERMINATION; NEUTRON-DIFFRACTION DATA; X-RAY; CRYSTAL-STRUCTURE; JOINT REFINEMENT; VOLUME CHANGES; WATER; CONDUCTION; MECHANISM; SITE	Water-filled hydrophobic cavities in channel proteins serve as gateways for transfer of ions across membranes, but their properties are largely unknown. We determined water distributions along the conduction pores in two tetrameric channels embedded in lipid bilayers using neutron diffraction: potassium channel KcsA and the transmembrane domain of M2 protein of influenza A virus. For the KcsA channel in the closed state, the distribution of water is peaked in the middle of the membrane, showing water in the central cavity adjacent to the selectivity filter. This water is displaced by the channel blocker tetrabutylammonium. The amount of water associated with the channel was quantified, using neutron diffraction and solid state NMR. In contrast, the M2 proton channel shows a V-shaped water profile across the membrane, with a narrow constriction at the center, like the hourglass shape of its internal surface. These two types of water distribution are therefore very different in their connectivity to the bulk water. The water and protein profiles determined here provide important evidence concerning conformation and hydration of channels in membranes and the potential role of pore hydration in channel gating.	[Blasic, Joseph R.; Mihailescu, Mihaela] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Worcester, David L.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Worcester, David L.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Gawrisch, Klaus] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20892 USA; [Gurnev, Philip] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Gurnev, Philip] NICHHD, NIH, Bethesda, MD 20892 USA	University of California System; University of California Irvine; National Institute of Standards & Technology (NIST) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Massachusetts System; University of Massachusetts Amherst; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mihailescu, M (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	emihailescu@ibbr.umd.edu			National Research Council; NIST Biomanufacturing Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM086685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003] Funding Source: NIH RePORTER	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); NIST Biomanufacturing Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Crina Nimigean for providing the KcsA plasmid and Jun Wang and William F. DeGrado for the M2 peptide. We also thank Kenton Swartz, Dmitriy Krepkiy (NINDS, National Institutes of Health), and Stephen H. White (University of California, Irvine) for helpful discussions. We acknowledge the National Research Council for the postdoctoral fellowship awarded to J. B. We acknowledge the National Institute of Standards and Technology, U.S. Department of Commerce, in providing the neutron research facilities and the support provided by NIST Biomanufacturing Initiative. The identification of any commercial product or trade name does not imply endorsement or recommendation by the National Institute of Standards and Technology.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Balannik V, 2010, BIOCHEMISTRY-US, V49, P696, DOI 10.1021/bi901799k; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; BULDT G, 1978, NATURE, V271, P182, DOI 10.1038/271182a0; Cao Y, 2011, NATURE, V473, P50, DOI 10.1038/nature09939; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ERNST JA, 1995, SCIENCE, V267, P1813, DOI 10.1126/science.7892604; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hilser VJ, 2011, NATURE, V469, P166, DOI 10.1038/469166a; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Myles DAA, 2006, CURR OPIN STRUC BIOL, V16, P630, DOI 10.1016/j.sbi.2006.08.010; Nucci NV, 2011, NAT STRUCT MOL BIOL, V18, P245, DOI 10.1038/nsmb.1955; OTTING G, 1995, ACCOUNTS CHEM RES, V28, P171, DOI 10.1021/ar00052a002; Santos JS, 2012, J BIOL CHEM, V287, P43063, DOI 10.1074/jbc.M112.415091; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Taraphder S, 2003, J AM CHEM SOC, V125, P3931, DOI 10.1021/ja016860c; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Vaitheeswaran S, 2004, P NATL ACAD SCI USA, V101, P17002, DOI 10.1073/pnas.0407968101; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Wang J, 2011, CURR OPIN STRUC BIOL, V21, P68, DOI 10.1016/j.sbi.2010.12.002; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; WIENER MC, 1991, BIOPHYS J, V60, P568, DOI 10.1016/S0006-3495(91)82086-0; WIENER MC, 1991, BIOPHYS J, V59, P174, DOI 10.1016/S0006-3495(91)82209-3; WIENER MC, 1991, BIOPHYS J, V59, P162, DOI 10.1016/S0006-3495(91)82208-1; Wikstrom M, 1998, CURR OPIN STRUC BIOL, V8, P480, DOI 10.1016/S0959-440X(98)80127-9; WORCESTER DL, 1976, J MOL BIOL, V100, P359, DOI 10.1016/S0022-2836(76)80068-X; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0; ZIMMERBERG J, 1990, BIOPHYS J, V57, P1049, DOI 10.1016/S0006-3495(90)82623-0	43	5	5	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26765	U472		10.1074/jbc.M115.661819	http://dx.doi.org/10.1074/jbc.M115.661819			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370089	hybrid, Green Published			2022-12-26	WOS:000364793600038
J	Shrestha, Y; Wirshing, HH; Harasewych, MG				Shrestha, Yesha; Wirshing, Herman H.; Harasewych, M. G.			The Genus Cerion (Gastropoda: Cerionidae) in the Florida Keys	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PARTITIONING SCHEMES; PULMONATA CERIONIDAE; NATURAL-HISTORY; LAND; PHYLOGEOGRAPHY; HYBRIDIZATION; RECORD	The systematic relationships and phylogeography of Cerion incanum, the only species of Cerion native to the Florida Keys, are reviewed based on partial sequences of the mitochondrial COI and 16S genes derived from 18 populations spanning the range of this species and including the type localities of all four described subspecies. Our samples included specimens of Cerion casablancae, a species introduced to Indian Key in 1912, and a population of C. incanum x C. casablancae hybrids descended from a population of C. casablancae introduced onto Bahia Honda Key in the same year. Molecular data did not support the partition of C. incanum into subspecies, nor could populations be apportioned reliably into subspecies based on morphological features used to define the subspecies. Phylogenetic analyses affirmed the derived relationship of C. incanum relative to other cerionids, and indicated a Bahamian origin for the Cerion fauna of southern Florida. Relationships among the populations throughout the Keys indicate that the northernmost populations, closest to the Tomeu paleoislands that had been inhabited by Cerion petuchi during the Calabrian Pleistocene, are the oldest. The range of Cerion incanum expanded as the archipelago that is the Florida Keys was formed since the lower Tarantian Pleistocene by extension from the northeast to the southwest, with new islands populated as they were formed. The faunas of the High Coral Keys in the northeast and the Oolite Keys in the southwest, both with large islands that host multiple discontinuous populations of Cerion, are each composed of well supported clades that are characterized by distinctive haplotypes. In contrast, the fauna of the intervening Low Coral Keys consist of a heterogeneous series of populations, some with haplotypes derived from the High Coral Keys, others from the Oolite Keys. Individuals from the C. incanum x C. casablancae hybrid population inhabiting the southeastern coast of Bahia Honda Key were readily segregated based on their mitogenome lineage, grouping either with C. incanum or with C. casablancae from Indian Key. Hybrids with C. casablancae mitogenomes had haplotypes that were more divergent from their parent mitogenome than were hybrids with C. incanum mitogenomes.	[Shrestha, Yesha] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA; [Wirshing, Herman H.; Harasewych, M. G.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA	George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History	Harasewych, MG (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	Harasewych@si.edu		Shrestha, Yesha/0000-0002-9714-8516; Wirshing, Herman H./0000-0003-4926-4237	Harasewych lab	Harasewych lab	General research funds from the Harasewych lab supported field work in the Florida Keys and laboratory expenses. The authors received no grant funding for this work.	Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bartsch P., 1912, CARNEGIE I WASHINGTO, V11, P129; Bartsch P, 1931, ANN REPORT TORTUGAS, V30, P373; Bartsch P., 1920, DEP MARINE BIOL CARN, VXVI, P1; Bartsch P, 1949, AM MALACOLOGICAL UNI, V1948, P2; Binney A, 1851, TERRESTIAL AIR BREAT, V1, p[153, 162]; Binney WG, 1859, BOSTON J NATURAL HIS, V4, p[i, 1]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clench W. J., 1938, Bulletin of the Museum of Comparative Zoology, V80, P481; Clench W. J., 1957, Bulletin of the Museum of Comparative Zoology, V116, P121; Dall W. H., 1905, P23; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Goodfriend GA, 1996, SCIENCE, V274, P1894, DOI 10.1126/science.274.5294.1894; Gould S.J., 1983, Natural History, V92, P10; GOULD S J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P321; GOULD S J, 1978, Bulletin of the Museum of Comparative Zoology, V148, P371; GOULD S J, 1986, Bulletin of the American Museum of Natural History, V182, P389; Harasewych MG, 2006, NAUTILUS, V120, P94; Harasewych MG, 2015, J MOLLUS STUD, V81, P66, DOI 10.1093/mollus/eyu062; Harasewych MG, 2014, NAUTILUS, V128, P18; Harasewych MG, 2012, NAUTILUS, V126, P119; Harasewych MG, 2011, NAUTILUS, V125, P173; Harasewych MG., 2009, CERION WEB BASED RES; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leidy J, 1851, TERRESTRIAL AIR BREA, V1, P198; Mayr E, 1956, GEOGRAPHIC VAIRATION, V1806, P1; Palumbi Stephen R., 1996, P205; Petuch E.J., 2007, GEOLOGY EVERGLADES A; Pilsbry H. A., 1907, Proceedings of the Academy of Natural Sciences of Philadelphia, V59; Pilsbry HA, 1946, ACAD NATURAL SCI PHI, V2, P158; Pilsbry HA, 1902, FAMILY CERIONIDAE 2, V2, P215; Pilsbry HA, 1899, P ACAD NAT SCI PHILA, V1898, P477; Prevot V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060736; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rambaut A, 2009, TRACER VERSION 1 5 0; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schilthuizen M, 1999, P ROY SOC B-BIOL SCI, V266, P2181, DOI 10.1098/rspb.1999.0906; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Woodruff D.S., 1981, P171; WOODRUFF DS, 1978, MALACOLOGIA, V17, P223; WOODRUFF DS, 1980, BIOL J LINN SOC, V14, P389, DOI 10.1111/j.1095-8312.1980.tb00115.x; WOODRUFF DS, 1989, BIOL J LINN SOC, V36, P281, DOI 10.1111/j.1095-8312.1989.tb00495.x; WOODRUFF DS, 1987, EVOLUTION, V41, P1022, DOI 10.1111/j.1558-5646.1987.tb05874.x	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137325	10.1371/journal.pone.0137325	http://dx.doi.org/10.1371/journal.pone.0137325			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378443	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400013
J	Angione, C; Costanza, J; Carapezza, G; Lio, P; Nicosia, G				Angione, Claudio; Costanza, Jole; Carapezza, Giovanni; Lio, Pietro; Nicosia, Giuseppe			Multi-Target Analysis and Design of Mitochondrial Metabolism	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; PARETO OPTIMALITY; IMMUNE ALGORITHM; NETWORK BIOLOGY; IDENTIFIABILITY; EXPRESSION; FRAMEWORK; CALCIUM; HEART; LIFE	Analyzing and optimizing biological models is often identified as a research priority in biomedical engineering. An important feature of a model should be the ability to find the best condition in which an organism has to be grown in order to reach specific optimal output values chosen by the researcher. In this work, we take into account a mitochondrial model analyzed with flux-balance analysis. The optimal design and assessment of these models is achieved through single-and/or multi-objective optimization techniques driven by epsilondominance and identifiability analysis. Our optimization algorithm searches for the values of the flux rates that optimize multiple cellular functions simultaneously. The optimization of the fluxes of the metabolic network includes not only input fluxes, but also internal fluxes. A faster convergence process with robust candidate solutions is permitted by a relaxed Pareto dominance, regulating the granularity of the approximation of the desired Pareto front. We find that the maximum ATP production is linked to a total consumption of NADH, and reaching the maximum amount of NADH leads to an increasing request of NADH from the external environment. Furthermore, the identifiability analysis characterizes the type and the stage of three monogenic diseases. Finally, we propose a new methodology to extend any constraint-based model using protein abundances.	[Angione, Claudio; Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Costanza, Jole] Ist Italiano Tecnol, Ctr Genom Sci IIT SEMM, Milan, Italy; [Carapezza, Giovanni; Nicosia, Giuseppe] Univ Catania, Dept Math & Comp Sci, Catania, Italy	University of Cambridge; Istituto Italiano di Tecnologia - IIT; University of Catania	Angione, C (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	claudio.angione@cl.cam.ac.uk	P. Lió, Pietro Lio/AAV-3358-2021; Nicosia, Giuseppe/AAD-1625-2019; Nicosia, Giuseppe/F-1161-2011	P. Lió, Pietro Lio/0000-0002-0540-5053; Nicosia, Giuseppe/0000-0002-0650-3157; Nicosia, Giuseppe/0000-0002-0650-3157; Costanza, Jole/0000-0002-0290-3970; Angione, Claudio/0000-0002-3140-7909	FP7-Health-F5 (MIMOmics) [305280]	FP7-Health-F5 (MIMOmics)	PL has received funding from (FP7-Health-F5-2012) under grant agreement no. 305280 (MIMOmics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angione C, 2013, IEEE ACM T COMPUT BI, V10, P1032, DOI 10.1109/TCBB.2013.95; Angione C, 2013, MOL BIOSYST, V9, P2554, DOI 10.1039/c3mb25558a; Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8; Brandes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036947; BREIMAN L, 1985, J AM STAT ASSOC, V80, P580, DOI 10.2307/2288473; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Carapezza G, 2013, ACS SYNTH BIOL, V2, P274, DOI 10.1021/sb300102k; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Costanza J, 2012, BIOINFORMATICS, V28, P3097, DOI 10.1093/bioinformatics/bts590; Cutello V, 2006, J R SOC INTERFACE, V3, P139, DOI 10.1098/RSIF.2005.0083; Cutello V, 2007, J COMB OPTIM, V14, P9, DOI 10.1007/s10878-006-9036-2; Cutello V, 2007, IEEE T EVOLUT COMPUT, V11, P101, DOI 10.1109/TEVC.2006.880328; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Dumas ME, 2012, MOL BIOSYST, V8, P2494, DOI 10.1039/c2mb25167a; Esteves AR, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/693761; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hengl S, 2007, BIOINFORMATICS, V23, P2612, DOI 10.1093/bioinformatics/btm382; Ingalls, 2013, MATH MODELING SYSTEM; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Johnston DS, 2009, PHARMACOGENOMICS, V10, P1645, DOI [10.2217/pgs.09.112, 10.2217/PGS.09.112]; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581; Laumanns M, 2002, EVOL COMPUT, V10, P263, DOI 10.1162/106365602760234108; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Lun DS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.57; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; Navid A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-150; Nicosia G, 2008, BIOPHYS J, V95, P4988, DOI 10.1529/biophysj.107.124016; NUUTILA P, 1992, J CLIN INVEST, V89, P1767, DOI 10.1172/JCI115780; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Palsson B, 2015, SYSTEMS BIOLOGY: CONSTRAINT-BASED RECONSTRUCTION AND ANALYSIS, pXV; Pavone M, 2012, J GLOBAL OPTIM, V53, P769, DOI 10.1007/s10898-011-9736-8; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Sherry AD, 1998, AM J PHYSIOL-HEART C, V274, pH591, DOI 10.1152/ajpheart.1998.274.2.H591; Shi P, 2010, BIOCHIM BIOPHYS ACTA, V1802; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Smith AC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-102; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Stracquadanio G, 2011, COMPUT CHEM ENG, V35, P464, DOI 10.1016/j.compchemeng.2010.04.005; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Tyo KEJ, 2010, METAB ENG, V12, P187, DOI 10.1016/j.ymben.2009.10.005	48	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0133825	10.1371/journal.pone.0133825	http://dx.doi.org/10.1371/journal.pone.0133825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376088	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200003
J	Frebortova, J; Greplova, M; Seidl, MF; Heyl, A; Frebort, I				Frebortova, Jitka; Greplova, Marta; Seidl, Michael F.; Heyl, Alexander; Frebort, Ivo			Biochemical Characterization of Putative Adenylate Dimethylallyltransferase and Cytokinin Dehydrogenase from Nostoc sp PCC 7120	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TRANSFER-RNA; PHYLOGENETIC ANALYSES; ESCHERICHIA-COLI; PLANT-GROWTH; EXPRESSION; PROTEIN; BIOSYNTHESIS; ARABIDOPSIS; EVOLUTION	Cytokinins, a class of phytohormones, are adenine derivatives common to many different organisms. In plants, these play a crucial role as regulators of plant development and the reaction to abiotic and biotic stress. Key enzymes in the cytokinin synthesis and degradation in modern land plants are the isopentyl transferases and the cytokinin dehydrogenases, respectively. Their encoding genes have been probably introduced into the plant lineage during the primary endosymbiosis. To shed light on the evolution of these proteins, the genes homologous to plant adenylate isopentenyl transferase and cytokinin dehydrogenase were amplified from the genomic DNA of cyanobacterium Nostoc sp. PCC 7120 and expressed in Escherichia coli. The putative isopentenyl transferase was shown to be functional in a biochemical assay. In contrast, no enzymatic activity was detected for the putative cytokinin dehydrogenase, even though the principal domains necessary for its function are present. Several mutant variants, in which conserved amino acids in land plant cytokinin dehydrogenases had been restored, were inactive. A combination of experimental data with phylogenetic analysis indicates that adenylate-type isopentenyl transferases might have evolved several times independently. While the Nostoc genome contains a gene coding for protein with characteristics of cytokinin dehydrogenase, the organism is not able to break down cytokinins in the way shown for land plants.	[Frebortova, Jitka] Palacky Univ, Fac Sci, Dept Chem Biol & Genet, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Greplova, Marta; Frebort, Ivo] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Mol Biol, CR-77147 Olomouc, Czech Republic; [Seidl, Michael F.] Wageningen Univ, Lab Phytopathol, NL-6700 AP Wageningen, Netherlands; [Heyl, Alexander] Free Univ Berlin, Dahlem Ctr Plant Sci, Inst Biol Appl Genet, Berlin, Germany	Palacky University Olomouc; Palacky University Olomouc; Wageningen University & Research; Free University of Berlin	Frebortova, J (corresponding author), Palacky Univ, Fac Sci, Dept Chem Biol & Genet, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic.	jitka.frebortova@upol.cz; alexander.heyl@fu-berlin.de	Seidl, Michael F./ABD-6042-2021; Frébortová, Jitka/H-2435-2014; Heyl, Alexander/ABD-2145-2020; Frébort, Ivo/G-6382-2018	Frébortová, Jitka/0000-0002-2909-9337; Frébort, Ivo/0000-0002-4032-4961; Seidl, Michael F/0000-0002-5218-2083	Czech Science Foundation [P501/12/0161]; National Program of Sustainability I from the Ministry of Education, Youth and Sports, Czech Republic [LO1204]; Operational Program Education for Competitiveness - European Social Fund [CZ.1.07/2.3.00/20.0165]; Dahlem Centre of Plant Sciences	Czech Science Foundation(Grant Agency of the Czech Republic); National Program of Sustainability I from the Ministry of Education, Youth and Sports, Czech Republic; Operational Program Education for Competitiveness - European Social Fund(European Social Fund (ESF)); Dahlem Centre of Plant Sciences	This study was supported by research grant P501/12/0161 from the Czech Science Foundation (www.gacr.cz) to IF and by grant LO1204 from the National Program of Sustainability I from the Ministry of Education, Youth and Sports, Czech Republic (www.msmt.cz). JF and IF were partly supported by the Operational Program Education for Competitiveness - European Social Fund (project CZ.1.07/2.3.00/20.0165 to IF; www.msmt.cz) and the work of AH was supported by the Dahlem Centre of Plant Sciences (www.dcps.fu-berlin.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYOSHI DE, 1984, P NATL ACAD SCI-BIOL, V81, P5994, DOI 10.1073/pnas.81.19.5994; Akiyoshi DE, 1989, NUCLEIC ACIDS RES, V17, P88; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; BARNES MF, 1980, PHYTOCHEMISTRY, V19, P409, DOI 10.1016/0031-9422(80)83190-6; BARRY GF, 1984, P NATL ACAD SCI-BIOL, V81, P4776, DOI 10.1073/pnas.81.15.4776; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beres T, 2012, ANAL CHIM ACTA, V751, P176, DOI 10.1016/j.aca.2012.08.049; Beres T, 2010, ANAL BIOANAL CHEM, V398, P2071, DOI 10.1007/s00216-010-4126-5; Bilyeu KD, 2001, PLANT PHYSIOL, V125, P378, DOI 10.1104/pp.125.1.378; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen XJS, 2001, J MOL BIOL, V307, P173, DOI 10.1006/jmbi.2000.4464; Chu HM, 2010, NUCLEIC ACIDS RES, V38, P1738, DOI 10.1093/nar/gkp1093; Clark ED, 2001, CURR OPIN BIOTECH, V12, P202, DOI 10.1016/S0958-1669(00)00200-7; CRESPI M, 1992, EMBO J, V11, P795, DOI 10.1002/j.1460-2075.1992.tb05116.x; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fiore MF, 2000, J MICROBIOL METH, V39, P159, DOI 10.1016/S0167-7012(99)00110-4; Frebort I, 2002, ANAL BIOCHEM, V306, P1, DOI 10.1006/abio.2002.5670; Frebort I, 2011, J EXP BOT, V62, P2431, DOI 10.1093/jxb/err004; Frebortova J, 2007, BIOL PLANTARUM, V51, P673, DOI 10.1007/s10535-007-0141-6; Galuszka P, 2001, EUR J BIOCHEM, V268, P450, DOI 10.1046/j.1432-1033.2001.01910.x; Galuszka P, EUR J BIOCH, V204, P3990; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Goble AM, 2011, ACS CHEM BIOL, V6, P1036, DOI 10.1021/cb200198c; Gruhn N, 2014, PLANT PHYSIOL, V165, P227, DOI 10.1104/pp.113.228080; Gruhn N, 2013, CURR OPIN PLANT BIOL, V16, P569, DOI 10.1016/j.pbi.2013.09.001; Gu RL, 2010, J PLANT GROWTH REGUL, V29, P428, DOI 10.1007/s00344-010-9155-y; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Hussain A, 2010, CURR MICROBIOL, V61, P361, DOI 10.1007/s00284-010-9620-7; Joseph RE, 2008, PROTEIN EXPRES PURIF, V60, P194, DOI 10.1016/j.pep.2008.04.001; Joshi MV, 2007, MOL PLANT MICROBE IN, V20, P751, DOI 10.1094/MPMI-20-7-0751; Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5; Kamada-Nobusada T, 2009, PHYTOCHEMISTRY, V70, P444, DOI 10.1016/j.phytochem.2009.02.007; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KLINE LK, 1969, BIOCHEMISTRY-US, V8, P4361, DOI 10.1021/bi00839a021; Koenig RL, 2002, J BACTERIOL, V184, P1832, DOI 10.1128/JB.184.7.1832-1842.2002; Kowalska M, 2010, PHYTOCHEMISTRY, V71, P1970, DOI 10.1016/j.phytochem.2010.08.013; Krall L, 2002, FEBS LETT, V527, P315, DOI 10.1016/S0014-5793(02)03258-1; LICHTER A, 1995, J BACTERIOL, V177, P4457, DOI 10.1128/jb.177.15.4457-4465.1995; Lindner AC, 2014, J EXP BOT, V65, P2533, DOI 10.1093/jxb/eru142; Lisitskaya TB, 2013, RUSS J GEN CHEM+, V83, P2765, DOI 10.1134/S1070363213130252; Malito E, 2004, J MOL BIOL, V341, P1237, DOI 10.1016/j.jmb.2004.06.083; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Novak O, 2003, ANAL CHIM ACTA, V480, P207, DOI 10.1016/S0003-2670(03)00025-4; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; PERSSON BC, 1994, BIOCHIMIE, V76, P1152, DOI 10.1016/0300-9084(94)90044-2; Pertry I, 2010, MOL PLANT MICROBE IN, V23, P1164, DOI 10.1094/MPMI-23-9-1164; Pospisilova H, 2008, BIOSCIENCE REP, V28, P335, DOI 10.1042/BSR20080081; POWELL GK, 1986, NUCLEIC ACIDS RES, V14, P2555, DOI 10.1093/nar/14.6.2555; RIPPKA R, 1971, ARCH MIKROBIOL, V76, P341, DOI 10.1007/BF00408530; Samanovic MI, 2015, MOL CELL, V57, P984, DOI 10.1016/j.molcel.2015.01.024; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Soderberg T, 2001, BIOCHEMISTRY-US, V40, P1734, DOI 10.1021/bi002149t; Spichal L, 2012, FUNCT PLANT BIOL, V39, P267, DOI 10.1071/FP11276; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stirk WA, 1999, J PHYCOL, V35, P89, DOI 10.1046/j.1529-8817.1999.3510089.x; Sugawara H, 2008, P NATL ACAD SCI USA, V105, P2734, DOI 10.1073/pnas.0707374105; Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200; TAYA Y, 1978, NATURE, V271, P545, DOI 10.1038/271545a0; Voller J, 2010, PHYTOCHEMISTRY, V71, P1350, DOI 10.1016/j.phytochem.2010.04.018; von Schwartzenberg K, 2009, ANNU PLANT REV, V36, P246, DOI 10.1111/b.9781405181891.2009.000010.x; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; WHITTY CD, 1974, CAN J BIOCHEM CELL B, V52, P789, DOI 10.1139/o74-112; Zalabak D, 2014, PLANT PHYSIOL BIOCH, V74, P283, DOI 10.1016/j.plaphy.2013.11.020	69	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138468	10.1371/journal.pone.0138468	http://dx.doi.org/10.1371/journal.pone.0138468			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376297	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200109
J	Hartvig, I; Czako, M; Kjaer, ED; Nielsen, LR; Theilade, I				Hartvig, Ida; Czako, Mihaly; Kjaer, Erik Dahl; Nielsen, Lene Rostgaard; Theilade, Ida			The Use of DNA Barcoding in Identification and Conservation of Rosewood (Dalbergia spp.)	PLOS ONE			English	Article							PLANTS; DISCRIMINATE; TAXONOMY; ORIGIN; SPACER; ACACIA; WOOD	The genus Dalbergia contains many valuable timber species threatened by illegal logging and deforestation, but knowledge on distributions and threats is often limited and accurate species identification difficult. The aim of this study was to apply DNA barcoding methods to support conservation efforts of Dalbergia species in Indochina. We used the recommended rbcL, matK and ITS barcoding markers on 95 samples covering 31 species of Dalbergia, and tested their discrimination ability with both traditional distance-based as well as different model-based machine learning methods. We specifically tested whether the markers could be used to solve taxonomic confusion concerning the timber species Dalbergia oliveri, and to identify the CITES-listed Dalbergia cochinchinensis. We also applied the barcoding markers to 14 samples of unknown identity. In general, we found that the barcoding markers discriminated among Dalbergia species with high accuracy. We found that ITS yielded the single highest discrimination rate (100%), but due to difficulties in obtaining high-quality sequences from degraded material, the better overall choice for Dalbergia seems to be the standard rbcL+matK barcode, as this yielded discrimination rates close to 90% and amplified well. The distance-based method TaxonDNA showed the highest identification rates overall, although a more complete specimen sampling is needed to conclude on the best analytic method. We found strong support for a monophyletic Dalbergia oliveri and encourage that this name is used consistently in Indochina. The CITES-listed Dalbergia cochinchinensis was successfully identified, and a species-specific assay can be developed from the data generated in this study for the identification of illegally traded timber. We suggest that the use of DNA barcoding is integrated into the work flow during floristic studies and at national herbaria in the region, as this could significantly increase the number of identified specimens and improve knowledge about species distributions.	[Hartvig, Ida; Kjaer, Erik Dahl; Nielsen, Lene Rostgaard] Univ Copenhagen, Dept Geosci & Nat Resource Management, Forest Genet & Divers, Frederiksberg, Denmark; [Czako, Mihaly] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Theilade, Ida] Univ Copenhagen, Dept Food & Resource Econ, Global Dev, Frederiksberg, Denmark	University of Copenhagen; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Copenhagen	Hartvig, I (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Forest Genet & Divers, Frederiksberg, Denmark.	ihla@ign.ku.dk	Theilade, Ida/A-6498-2010; Czako, Mihaly/AAB-6956-2020; Theilade, Ida/N-5882-2019; Czako, Mihaly/Q-9025-2019; Kjaer, Erik D/D-6534-2017; Hartvig, Ida/E-4080-2015; Nielsen, Lene/E-6769-2015	Theilade, Ida/0000-0003-3502-1277; Theilade, Ida/0000-0003-3502-1277; Czako, Mihaly/0000-0003-4655-3674; Kjaer, Erik D/0000-0001-8624-1611; Hartvig, Ida/0000-0002-1509-6864; Nielsen, Lene/0000-0002-7214-8691	University of Copenhagen scholarship	University of Copenhagen scholarship	This work was part of Ida Hartvig's PhD project funded by a University of Copenhagen scholarship. The authors received no specific funding for this work.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral W, 2004, FOREST GENETIC RESOU, V1, P37; [Anonymous], 2015, IUCN RED LIST THREAT; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Aubriot X, 2013, MOL ECOL RESOUR, V13, P57, DOI 10.1111/1755-0998.12028; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bentham G., 1860, P LINN SOC LONDON, P1; Bosser J, 2002, LEGUMINOSAE MADAGASC; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Chen D, 2010, FLORA CHINA, V10; Cohen W. W., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P115; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; DeCarvalho AM, 1997, BRITTONIA, V49, P87, DOI 10.2307/2807701; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Evans TD, 2013, EVIDENCE BASED CONSE, P157, DOI DOI 10.4324/9780203128466; FA CTSP, 2004, CAMB TREE SPEC MON; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071710; Finkeldey R, 2010, APPL MICROBIOL BIOT, V85, P1251, DOI 10.1007/s00253-009-2328-6; Gagnepain F, 1913, FLORE GEN INDOCHINE, V2; Gao T, 2011, PLANTA MED, V77, P92, DOI 10.1055/s-0030-1250050; Gasson P, 2010, ANN BOT-LONDON, V105, P45, DOI 10.1093/aob/mcp270; Gillett JB, 1971, FLORA TROPICAL E AFR; Gu J, 2011, J SYST EVOL, V49, P213, DOI 10.1111/j.1759-6831.2011.00136.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holtken AM, 2012, HOLZFORSCHUNG, V66, P97, DOI 10.1515/HF.2011.142; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Jiao LC, 2014, HOLZFORSCHUNG, V68, P487, DOI 10.1515/hf-2013-0129; John GH, 1993, 11 C UNC ART INT; Kelchner SA, 1997, MOL PHYLOGENET EVOL, V8, P385, DOI 10.1006/mpev.1997.0432; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kim HM, 2014, MOL ECOL RESOUR, V14, P499, DOI 10.1111/1755-0998.12207; Krawczyk K, 2014, MOL ECOL RESOUR, V14, P272, DOI 10.1111/1755-0998.12175; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Layton KKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095003; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552; Lock J, 1994, LEGUMES INDOCHINA CH; Lowe AJ, 2011, IAWA J, V32, P251, DOI 10.1163/22941932-90000055; Maddison W., 2018, MESQUITE MODULAR SYS; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M, 2000, MOL EVOLUTION PHYLOG; Nevill PG, 2013, MOL ECOL RESOUR, V13, P1033, DOI 10.1111/1755-0998.12060; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Niyomdham C, 1997, LEGUMINOSEAE PAPILIO; Ogden Rob, 2010, Endangered Species Research, V9, P255, DOI 10.3354/esr00141; Phillips OL, 2003, J TROP ECOL, V19, P629, DOI 10.1017/S0266467403006035; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Prain D., 1904, ANN ROYAL BOT GARDEN, V10, P1; Puillandre N, 2012, MOL ECOL RESOUR, V12, P396, DOI 10.1111/j.1755-0998.2011.03105.x; Quinlan R, 1993, C4 5 PROGRAMS MACHIN; Ribeiro RA, 2007, SYST BOT, V32, P762, DOI 10.1600/036364407783390700; Saha S, 2013, PHYTOPHARMACOL, V4, P291; Schrire B, 2005, LEGUMES WORLD; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Stech M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053134; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Thothathri K, 1987, TAXONOMIC REVISION T; UNEP-WCMC, 2014, NONCITES TIMB SPEC S; Van Sam H, 2004, BLUMEA, V49, P201; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Vatanparast M, 2013, S AFR J BOT, V89, P143, DOI 10.1016/j.sajb.2013.07.001; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Webb CO, 2010, BIODIVERS CONSERV, V19, P955, DOI 10.1007/s10531-010-9817-x; Weitschek E, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-4; Weitschek E, 2013, MOL ECOL RESOUR, V13, P1043, DOI 10.1111/1755-0998.12073; Yu M, 2015, TESTING 3 PROPOSED D; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x	84	72	74	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138231	10.1371/journal.pone.0138231	http://dx.doi.org/10.1371/journal.pone.0138231			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375850	gold, Green Submitted, Green Published			2022-12-26	WOS:000361610200092
J	Jemberu, WT; Mourits, MCM; Hogeveen, H				Jemberu, Wudu T.; Mourits, M. C. M.; Hogeveen, H.			Farmers' Intentions to Implement Foot and Mouth Disease Control Measures in Ethiopia	PLOS ONE			English	Article							HEALTH BELIEF MODEL; RISK-MANAGEMENT; PERCEPTIONS; ATTITUDES; CATTLE; MOTIVATORS; EFFICACY; ADOPTION	The objectives of this study were to explore farmers' intentions to implement foot and mouth disease (FMD) control in Ethiopia, and to identify perceptions about the disease and its control measures that influence these intentions using the Health Belief Model (HBM) framework. Data were collected using questionnaires from 293 farmers in three different production systems. The influence of perceptions on the intentions to implement controlmeasures were analyzed using binary logistic regression. The effect of socio-demographic and husbandry variables on perceptions that were found to significantly influence the intentions were analyzed using ordinal logistic regression. Almost all farmers (99%) intended to implement FMD vaccination free of charge. The majority of farmers in the pastoral (94%) and market oriented (92%) systems also had the intention to implement vaccination with charge but only 42% of the crop-livestockmixed farmers had the intention to do so. Only 2% of pastoral and 18% of crop-livestock mixed farmers had the intention to implement herd isolation and animal movement restriction continuously. These proportions increased to 11% for pastoral and 50% for crop-livestock mixed farmers when the measure is applied only during an outbreak. The majority of farmers in the market oriented system (>80%) had the intention to implement herd isolation and animal movement restriction measure, both continuously and during an outbreak. Among the HBM perception constructs, perceived barrier was found to be the only significant predictor of the intention to implement vaccination. Perceived susceptibility, perceived benefit and perceived barrier were the significant predictors of the intention for herd isolation and animalmovement restriction measure. In turn, the predicting perceived barrier on vaccination control varied significantly with the production systemand the age of farmers. The significant HBM perception predictors on herd isolation and animalmovement restriction control were significantly influenced only by the type of production system. The results of this study indicate that farmers' intentions to apply FMD controlmeasures are variable among production systems, an insight which is relevant in the development of future control programs. Promotion programs aimed at increasing farmers' motivation to participate in FMD control by charged vaccination or animal movement restriction should give attention to the perceived barriers influencing the intentions to apply these measures.	[Jemberu, Wudu T.; Mourits, M. C. M.; Hogeveen, H.] Wageningen Univ, Business Econ Grp, NL-6700 AP Wageningen, Netherlands; [Jemberu, Wudu T.] Univ Gondar, Fac Vet Med, Dept Vet Epidemiol & Publ Hlth, Gondar, Ethiopia; [Hogeveen, H.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	Wageningen University & Research; University of Gondar; Utrecht University	Jemberu, WT (corresponding author), Wageningen Univ, Business Econ Grp, NL-6700 AP Wageningen, Netherlands.	Wudu.Jemberu@wur.nl	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Jemberu, Wudu Temesgen/0000-0002-3769-307X; Mourits, Monique/0000-0001-5213-2927; Hogeveen, Henk/0000-0002-9443-1412	University of Gondar Ethiopia; Nuffic (Netherlands organization for international cooperation in higher education)	University of Gondar Ethiopia; Nuffic (Netherlands organization for international cooperation in higher education)	The study was funded by University of Gondar Ethiopia: www.uog.edu.et/en/ and Nuffic (Netherlands organization for international cooperation in higher education) https://www.nuffic.nl/en.	ADESINA AA, 1995, AGR ECON, V13, P1, DOI 10.1016/0169-5150(95)01142-8; Alarcon P, 2014, PREV VET MED, V116, P223, DOI 10.1016/j.prevetmed.2013.08.004; Ayelet G, 2012, REV SCI TECH OIE, V31, P789; Bruijnis M, 2013, LIVEST SCI, V155, P103, DOI 10.1016/j.livsci.2013.04.005; Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906; Champion VL., 2008, HLTH BEHAV HLTH ED T, V4th ed., P45; CSA, 2013, REPORT LIVESTOCK CHA, V570; Delabbio JL, 2005, J AQUAT ANIM HEALTH, V17, P153, DOI 10.1577/H04-005.1; Delgado AH, 2014, PREV VET MED, V117, P505, DOI 10.1016/j.prevetmed.2014.09.011; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Ellis-Iversen J, 2010, PREV VET MED, V93, P276, DOI 10.1016/j.prevetmed.2009.11.005; Fandamu P, 2006, TROP ANIM HEALTH PRO, V38, P9, DOI 10.1007/s11250-006-4341-4; FAO/OIE, 2012, GLOB FOOT MOUTH DIS; Field A, 2013, DISCOVERING STAT USI; Garforth CJ, 2013, PREV VET MED, V110, P456, DOI 10.1016/j.prevetmed.2013.02.018; Glanz K., 2008, HLTH BEHAV HLTH ED T; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Howley P., 2012, Journal of Agricultural Science (Toronto), V4, P171, DOI 10.5539/jas.v4n6p171; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jemberu WT, 2016, TRANSBOUND EMERG DIS, V63, pE246, DOI 10.1111/tbed.12338; Jemberu WT, 2014, PREV VET MED, V116, P26, DOI 10.1016/j.prevetmed.2014.06.004; MoARD, 2007, LIV DEV MAST PLAN ST; Paton DJ, 2011, PHILOS T R SOC B, V366, P2774, DOI 10.1098/rstb.2011.0107; Roeder PL, 2007, REV SCI TECH OIE, V26, P253, DOI 10.20506/rst.26.1.1738; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [DOI 10.1080/14792772143000003, 10.1080/14792772143000003]; Tanner-Smith EE, 2010, SOC THEOR HEALTH, V8, P95, DOI 10.1057/sth.2009.23; Thomson G. R., 2014, TCPETH3401B3; Valeeva NI, 2011, PREV VET MED, V102, P284, DOI 10.1016/j.prevetmed.2011.08.005	28	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138363	10.1371/journal.pone.0138363	http://dx.doi.org/10.1371/journal.pone.0138363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375391	Green Submitted, gold, Green Published			2022-12-26	WOS:000361610200101
J	van den Broek, E; Dijkstra, MJJ; Krijgsman, O; Sie, D; Haan, JC; Traets, JJH; van de Wiel, MA; Nagtegaal, ID; Punt, CJA; Carvalho, B; Ylstra, B; Abeln, S; Meijer, GA; Fijneman, RJA				van den Broek, Evert; Dijkstra, Maurits J. J.; Krijgsman, Oscar; Sie, Daoud; Haan, Josien C.; Traets, Joleen J. H.; van de Wiel, Mark A.; Nagtegaal, Iris D.; Punt, Cornelis J. A.; Carvalho, Beatriz; Ylstra, Bauke; Abeln, Sanne; Meijer, Gerrit A.; Fijneman, Remond J. A.			High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer	PLOS ONE			English	Article							MACRODOMAIN-CONTAINING PROTEINS; BRAF MUTATION; CHEMOTHERAPY; ABERRATIONS; EXPRESSION; STAT3; CAIRO	Background Cancer is caused by somatic DNA alterations such as gene point mutations, DNA copy number aberrations (CNA) and structural variants (SVs). Genome-wide analyses of SVs in large sample series with well-documented clinical information are still scarce. Consequently, the impact of SVs on carcinogenesis and patient outcome remains poorly understood. This study aimed to perform a systematic analysis of genes that are affected by CNA-associated chromosomal breaks in colorectal cancer (CRC) and to determine the clinical relevance of recurrent breakpoint genes. Methods Primary CRC samples of patients with metastatic disease from CAIRO and CAIRO2 clinical trials were previously characterized by array-comparative genomic hybridization. These data were now used to determine the prevalence of CNA-associated chromosomal breaks within genes across 352 CRC samples. In addition, mutation status of the commonly affected APC, TP53, KRAS, PIK3CA, FBXW7, SMAD4, BRAF and NRAS genes was determined for 204 CRC samples by targeted massive parallel sequencing. Clinical relevance was assessed upon stratification of patients based on gene mutations and gene breakpoints that were observed in >3% of CRC cases. Results In total, 748 genes were identified that were recurrently affected by chromosomal breaks (FDR < 0.1). MACROD2 was affected in 41% of CRC samples and another 169 genes showed breakpoints in >3% of cases, indicating that prevalence of gene breakpoints is comparable to the prevalence of well-known gene point mutations. Patient stratification based on gene breakpoints and point mutations revealed one CRC subtype with very poor prognosis. Conclusions We conclude that CNA-associated chromosomal breaks within genes represent a highly prevalent and clinically relevant subset of SVs in CRC.	[van den Broek, Evert; Krijgsman, Oscar; Sie, Daoud; Haan, Josien C.; Traets, Joleen J. H.; Carvalho, Beatriz; Ylstra, Bauke; Meijer, Gerrit A.; Fijneman, Remond J. A.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Dijkstra, Maurits J. J.; Abeln, Sanne] Vrije Univ Amsterdam, Dept Comp Sci, Amsterdam, Netherlands; [van de Wiel, Mark A.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van de Wiel, Mark A.] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands; [Nagtegaal, Iris D.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Punt, Cornelis J. A.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Fijneman, RJA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands.	R.Fijneman@nki.nl	Fijneman, Remond/X-4199-2019; Carvalho, Beatriz/GXA-0720-2022; Ylstra, Bauke/D-2906-2012; Nagtegaal, Iris D/A-2448-2014	Fijneman, Remond/0000-0003-2076-5521; Ylstra, Bauke/0000-0001-9479-3010; Nagtegaal, Iris D/0000-0003-0887-4127; van de Wiel, Mark/0000-0003-4780-8472; Sie, Daoud/0000-0001-6762-2582; Meijer, Gerrit/0000-0003-0330-3130; Abeln, Sanne/0000-0002-2779-7174	VUmc-Cancer Center Amsterdam; Dutch Cancer Society [KWF-2007-3832]; Center for Translational Molecular Medicine, DeCoDe project [03O-101]; Dutch Colorectal Cancer Group (DCCG)	VUmc-Cancer Center Amsterdam; Dutch Cancer Society(KWF Kankerbestrijding); Center for Translational Molecular Medicine, DeCoDe project; Dutch Colorectal Cancer Group (DCCG)	This study was financially supported by grants from the VUmc-Cancer Center Amsterdam (E. van den Broek) and the Dutch Cancer Society (KWF-2007-3832), and performed within the framework of the Center for Translational Molecular Medicine, DeCoDe project (grant 03O-101) and the Dutch Colorectal Cancer Group (DCCG). These funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Drusco A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/984505; Edwards PAW, 2010, J PATHOL, V220, P244, DOI 10.1002/path.2632; Feijs KLH, 2013, NAT REV MOL CELL BIO, V14, P443, DOI 10.1038/nrm3601; Gilbert PB, 2005, J R STAT SOC C-APPL, V54, P143, DOI 10.1111/j.1467-9876.2005.00475.x; Haan JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6457; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hu MM, 2014, P NATL ACAD SCI USA, V111, P1509, DOI 10.1073/pnas.1318227111; Ibrahem S, 2014, INT J EXP PATHOL, V95, P392, DOI 10.1111/iep.12102; Jankevicius G, 2013, NAT STRUCT MOL BIOL, V20, P508, DOI 10.1038/nsmb.2523; Knijn N, 2011, BRIT J CANCER, V104, P1020, DOI 10.1038/bjc.2011.26; Koopman M, 2007, LANCET, V370, P135, DOI 10.1016/S0140-6736(07)61086-1; Krijgsman O, 2014, BBA-MOL CELL RES, V1843, P2698, DOI 10.1016/j.bbamcr.2014.08.001; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Kumar R, 2010, CANCER RES, V70, P6598, DOI 10.1158/0008-5472.CAN-10-0907; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Mekenkamp LJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086833; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Polgar B, 2003, J IMMUNOL, V171, P5956, DOI 10.4049/jimmunol.171.11.5956; Romero I, 2012, J PATHOL, V227, P367, DOI 10.1002/path.4029; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sie D, 2014, CELL ONCOL, V37, P353, DOI 10.1007/s13402-014-0196-2; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; Venderbosch S, 2014, CLIN CANCER RES, V20, P5322, DOI 10.1158/1078-0432.CCR-14-0332; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yang Z, 2013, CELL IMMUNOL, V285, P1, DOI 10.1016/j.cellimm.2013.07.015; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104	33	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138141	10.1371/journal.pone.0138141	http://dx.doi.org/10.1371/journal.pone.0138141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375816	Green Submitted, Green Published, gold			2022-12-26	WOS:000361610200079
J	Fan, B; Dun, SH; Gu, JQ; Guo, Y; Ikuyama, S				Fan, Bin; Dun, Sai-Hong; Gu, Jian-Qiu; Guo, Yang; Ikuyama, Shoichiro			Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-kappa B and AP-1 Activation	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; ADHESION MOLECULE EXPRESSION; NITRIC-OXIDE SYNTHASE; FRENCH MARITIME PINE; GENE-EXPRESSION; DOPAMINERGIC-NEURONS; TRANSCRIPTION FACTOR; LIPID-ACCUMULATION; CELLS; NEURODEGENERATION	Over activation of microglia results in the production of proinflammatory agents that have been implicated in various brain diseases. Pycnogenol is a patented extract from French maritime pine bark (Pinus pinaster Aiton) with strong antioxidant and anti-inflammatory potency. The present study investigated whether pycnogenol may be associated with the production of proinflammatory mediators in lipopolysaccharide-stimulated BV2 (mouse-derived) microglia. It was found that pycnogenol treatment was dose-dependently associated with significantly less release of nitricoxide (NO), TNF-alpha, IL-6 and IL-1 beta, and lower levels of intercellular adhesion molecule1 (ICAM-1) and perilipin 2 (PLIN2). Furthermore, this effect was replicated in primary brain microglia. Levels of inducible NO synthase mRNA and protein were attenuated, whereas there was no change in the production of the anti-inflammatory cytokine IL-10. Further evidence indicated that pycnogenol treatment led to the suppression of NF-kappa B activation through inhibition of p65 translocation into the nucleus and inhibited DNA binding of AP-1, suggesting that these proinflammatory factors are associated with NF-kappa B and AP-1. We conclude that pycnogenol exerts anti-inflammatory effects through inhibition of the NF-kappa B and AP-1pathway, and may be useful as a therapeutic agent in the prevention of diseases caused by over activation of microglia.	[Fan, Bin; Dun, Sai-Hong; Guo, Yang] China Med Univ, Shengjing Hosp, Dept Neurol, Shenyang 110004, Peoples R China; [Gu, Jian-Qiu] PR China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang 110001, Peoples R China; [Ikuyama, Shoichiro] Oita San Ai Med Ctr, Dept Clin Invest, Oita 8701151, Japan; [Ikuyama, Shoichiro] Oita San Ai Med Ctr, Dept Endocrine Metab & Rheumat Dis, Oita 8701151, Japan	China Medical University	Fan, B (corresponding author), China Med Univ, Shengjing Hosp, Dept Neurol, Shenyang 110004, Peoples R China.	fanbin@hotmail.co.jp			National Natural Science Foundation of China Youth Fund Project [81100216]; Scientific Research Foundation for the Returned Scholars, State Education Ministry [2013693]; Research Fund for the Doctoral Program of Higher Education of Liaoning Province [20131148]	National Natural Science Foundation of China Youth Fund Project; Scientific Research Foundation for the Returned Scholars, State Education Ministry; Research Fund for the Doctoral Program of Higher Education of Liaoning Province	This work is supported by Grant 81100216 from the National Natural Science Foundation of China Youth Fund Project; Grant 2013693 from the Scientific Research Foundation for the Returned Scholars, State Education Ministry; Grand 20131148 from Research Fund for the Doctoral Program of Higher Education of Liaoning Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1993, ACTA NEUROPATHOL, V85, P628, DOI 10.1007/BF00334673; BELL MD, 1995, J NEUROCYTOL, V24, P695, DOI 10.1007/BF01179819; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Carr RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097118; Cho KJ, 2001, ANN NY ACAD SCI, V928, P141; Choi YH, 2009, PHYTOTHER RES, V23, P1691, DOI 10.1002/ptr.2812; Dang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102522; Dinarello CA, 1999, J INFECT DIS, V179, pS294, DOI 10.1086/513856; Fan B, 2013, METABOLISM, V62, P1168, DOI 10.1016/j.metabol.2013.02.013; Fan B, 2009, AM J PHYSIOL-ENDOC M, V297, pE112, DOI 10.1152/ajpendo.00119.2009; Feldmann M, 1998, Int Rev Immunol, V17, P217, DOI 10.3109/08830189809084493; Fiebich BL, 2002, J NEUROIMMUNOL, V132, P18, DOI 10.1016/S0165-5728(02)00279-5; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099; Gu JQ, 2010, AM J PHYSIOL-ENDOC M, V299, pE593, DOI 10.1152/ajpendo.00159.2010; Gu JQ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1390, DOI 10.1152/ajpendo.90543.2008; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Jeong YH, 2013, BIOMOL THER, V21, P332, DOI 10.4062/biomolther.2013.069; Khan MM, 2013, NEUROCHEM INT, V62, P379, DOI 10.1016/j.neuint.2013.01.029; Khatchadourian A, 2012, BBA-MOL CELL BIOL L, V1821, P607, DOI 10.1016/j.bbalip.2012.01.007; Kim DH, 2006, EXP MOL MED, V38, P417, DOI 10.1038/emm.2006.49; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kitayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025234; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Maimoona A, 2011, J ETHNOPHARMACOL, V133, P261, DOI 10.1016/j.jep.2010.10.041; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Mukaida N, 1996, J LEUKOCYTE BIOL, V59, P145, DOI 10.1002/jlb.59.2.145; Nuotio K, 2007, STROKE, V38, P1791, DOI 10.1161/STROKEAHA.106.478867; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; Peng Q, 2000, CELL MOL LIFE SCI, V57, P834, DOI 10.1007/s000180050045; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Roshak AK, 1996, J BIOL CHEM, V271, P31496, DOI 10.1074/jbc.271.49.31496; Saliou C, 2001, FREE RADICAL BIO MED, V30, P154, DOI 10.1016/S0891-5849(00)00445-7; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Straub BK, 2013, HISTOPATHOLOGY, V62, P617, DOI 10.1111/his.12038; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wang MJ, 2002, EUR J NEUROSCI, V16, P2103, DOI 10.1046/j.1460-9568.2002.02290.x; XIE QW, 1994, J BIOL CHEM, V269, P4705; Ye SM, 2001, J NEUROIMMUNOL, V117, P87, DOI 10.1016/S0165-5728(01)00316-2	48	24	25	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137837	10.1371/journal.pone.0137837	http://dx.doi.org/10.1371/journal.pone.0137837			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367267	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100151
J	Jayasundara, N; Kozal, JS; Arnold, MC; Chan, SSL; Di Giulio, RT				Jayasundara, Nishad; Kozal, Jordan S.; Arnold, Mariah C.; Chan, Sherine S. L.; Di Giulio, Richard T.			High-Throughput Tissue Bioenergetics Analysis Reveals Identical Metabolic Allometric Scaling for Teleost Hearts and Whole Organisms	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; BODY-MASS; MITOCHONDRIAL DYSFUNCTION; GENERAL-MODEL; BRAIN; CELLS; SIZE; DISEASE; BIOLOGY; FISH	Organismal metabolic rate, a fundamental metric in biology, demonstrates an allometric scaling relationship with body size. Fractal-like vascular distribution networks of biological systems are proposed to underlie metabolic rate allometric scaling laws from individual organisms to cells, mitochondria, and enzymes. Tissue-specific metabolic scaling is notably absent from this paradigm. In the current study, metabolic scaling relationships of hearts and brains with body size were examined by improving on a high-throughput whole-organ oxygen consumption rate (OCR) analysis method in five biomedically and environmentally relevant teleost model species. Tissue-specific metabolic scaling was compared with organismal routine metabolism (RMO2), which was measured using whole organismal respirometry. Basal heart OCR and organismal RMO2 scaled identically with body mass in a species-specific fashion across all five species tested. However, organismal maximum metabolic rates (MMO2) and pharmacologically-induced maximum cardiac metabolic rates in zebrafish Danio rerio did not show a similar relationship with body mass. Brain metabolic rates did not scale with body size. The identical allometric scaling of heart and organismal metabolic rates with body size suggests that hearts, the power generator of an organism's vascular distribution network, might be crucial in determining teleost metabolic rate scaling under routine conditions. Furthermore, these findings indicate the possibility of measuring heart OCR utilizing the high-throughput approach presented here as a proxy for organismal metabolic rate-a useful metric in characterizing organismal fitness. In addition to heart and brain OCR, the current approach was also used to measure whole liver OCR, partition cardiac mitochondrial bioenergetic parameters using pharmacological agents, and estimate heart and brain glycolytic rates. This high-throughput whole-organ bioenergetic analysis method has important applications in toxicology, evolutionary physiology, and biomedical sciences, particularly in the context of investigating pathogenesis of mitochondrial diseases.	[Jayasundara, Nishad; Kozal, Jordan S.; Arnold, Mariah C.; Di Giulio, Richard T.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Chan, Sherine S. L.] Med Univ S Carolina, Charleston, SC 29425 USA	Duke University; Medical University of South Carolina	Jayasundara, N (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	Nishad.Jayasundara@duke.edu	Jayasundara, Nishad/AAR-7871-2021	Jayasundara, Nishad/0000-0003-2485-6893	National Institutes of Environmental Health (Duke University Superfund Research Center) [P42-ES010356]; Duke University Program in Environmental Health Training grant [T32-ES021432]; Office of Research Support; Nicholas School of the Environment, Duke University; NIH [P20RR024485/P20 GM103542, R21DA037706, R01GM111672]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010356, T32ES021432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111672, P20GM103542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA037706] Funding Source: NIH RePORTER	National Institutes of Environmental Health (Duke University Superfund Research Center); Duke University Program in Environmental Health Training grant; Office of Research Support; Nicholas School of the Environment, Duke University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Di Giulio lab is supported by National Institutes of Environmental Health awards P42-ES010356 (Duke University Superfund Research Center) and Duke University Program in Environmental Health Training grant (T32-ES021432). Purchase of the XFe24 Extracellular Flux Analyzer was supported by funds provided by the Office of Research Support and the Nicholas School of the Environment, Duke University. The Chan lab is supported by NIH awards P20RR024485/P20 GM103542, R21DA037706, and R01GM111672.	Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; da Silva JKL, 2006, PHYS LIFE REV, V3, P229, DOI 10.1016/j.plrev.2006.08.001; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Driedzic William R., 1992, P219; DRIEDZIC WR, 1987, AM J PHYSIOL, V252, pR930, DOI 10.1152/ajpregu.1987.252.5.R930; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HEUSNER AA, 1987, ANNU REV PHYSIOL, V49, P121; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; HOCHACHKA PW, 2014, BIOCH ADAPTATION; HOPPELER H, 1984, RESP PHYSIOL, V55, P131, DOI 10.1016/0034-5687(84)90018-5; Karbowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026709; Karbowski J, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-18; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Kitambi Satish Srinivas, 2012, BMC Physiology, V12, P3, DOI 10.1186/1472-6793-12-3; Kleiber M, 1932, HILGARDIA, V6; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Little AG, 2014, J EXP BIOL, V217, P718, DOI 10.1242/jeb.096602; Lucas J, 2014, J FISH BIOL, V84, P1171, DOI 10.1111/jfb.12306; MCNAB BK, 1989, AM NAT, V133, P157, DOI 10.1086/284907; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; REIDY SP, 1995, J FISH BIOL, V47, P377, DOI 10.1111/j.1095-8649.1995.tb01907.x; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; SIDELL BD, 1987, PHYSIOL ZOOL, V60, P221, DOI 10.1086/physzool.60.2.30158646; SOMERO GN, 1980, PHYSIOL ZOOL, V53, P322, DOI 10.1086/physzool.53.3.30155794; Stackley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025652; Steele SL, 2014, TRANSL RES, V163, P79, DOI 10.1016/j.trsl.2013.08.008; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Zar J. H., 1984, BIOSTAT ANAL, V2, P292; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571	46	17	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137710	10.1371/journal.pone.0137710	http://dx.doi.org/10.1371/journal.pone.0137710			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368567	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100115
J	Philipson, CW; Bassaganya-Riera, J; Viladomiu, M; Kronsteiner, B; Abedi, V; Hoops, S; Michalak, P; Kang, L; Girardin, SE; Hontecillas, R				Philipson, Casandra W.; Bassaganya-Riera, Josep; Viladomiu, Monica; Kronsteiner, Barbara; Abedi, Vida; Hoops, Stefan; Michalak, Pawel; Kang, Lin; Girardin, Stephen E.; Hontecillas, Raquel			Modeling the Regulatory Mechanisms by Which NLRX1 Modulates Innate Immune Responses to Helicobacter pylori Infection	PLOS ONE			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; INFLAMMATORY CASPASES; DENDRITIC CELLS; COMPLEX; GASTRITIS; STRAINS; HOST; GENE; MAVS	Helicobacter pylori colonizes half of the world's population as the dominant member of the gastric microbiota resulting in a lifelong chronic infection. Host responses toward the bacterium can result in asymptomatic, pathogenic or even favorable health outcomes; however, mechanisms underlying the dual role of H. pylori as a commensal versus pathogenic organism are not well characterized. Recent evidence suggests mononuclear phagocytes are largely involved in shaping dominant immunity during infection mediating the balance between host tolerance and succumbing to overt disease. We combined computational modeling, bioinformatics and experimental validation in order to investigate interactions between macrophages and intracellular H. pylori. Global transcriptomic analysis on bone marrow-derived macrophages (BMDM) in a gentamycin protection assay at six time points unveiled the presence of three sequential host response waves: an early transient regulatory gene module followed by sustained and late effector responses. Kinetic behaviors of pattern recognition receptors (PRRs) are linked to differential expression of spatiotemporal response waves and function to induce effector immunity through extracellular and intracellular detection of H. pylori. We report that bacterial interaction with the host intracellular environment caused significant suppression of regulatory NLRC3 and NLRX1 in a pattern inverse to early regulatory responses. To further delineate complex immune responses and pathway crosstalk between effector and regulatory PRRs, we built a computational model calibrated using time-series RNAseq data. Our validated computational hypotheses are that: 1) NLRX1 expression regulates bacterial burden in macrophages; and 2) early host response cytokines down-regulate NLRX1 expression through a negative feedback circuit. This paper applies modeling approaches to characterize the regulatory role of NLRX1 in mechanisms of host tolerance employed by macrophages to respond to and/or to co-exist with intracellular H. pylori.	[Philipson, Casandra W.; Bassaganya-Riera, Josep; Viladomiu, Monica; Kronsteiner, Barbara; Abedi, Vida; Hoops, Stefan; Michalak, Pawel; Kang, Lin; Hontecillas, Raquel] Virginia Tech, Virginia Bioinformat Inst, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA 24061 USA; [Philipson, Casandra W.; Bassaganya-Riera, Josep; Viladomiu, Monica; Kronsteiner, Barbara; Abedi, Vida; Hoops, Stefan; Hontecillas, Raquel] Virginia Tech, Virginia Bioinformat Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA USA; [Bassaganya-Riera, Josep] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Girardin, Stephen E.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Toronto	Hontecillas, R (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA 24061 USA.	rmagarzo@vt.edu	Kang, Lin/AAA-2260-2019; Viladomiu, Monica/GNM-6447-2022; Philipson, Casandra/AAY-5746-2021	Kang, Lin/0000-0002-9186-9574; Kronsteiner-Dobramysl, Barbara/0000-0003-0867-2867; Abedi, Vida/0000-0001-7689-933X	National Institute of Allergy and Infectious Diseases Contract [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory	National Institute of Allergy and Infectious Diseases Contract(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory	This work was supported in part by National Institute of Allergy and Infectious Diseases Contract (www.niaid.nih.gov) No. HHSN272201000056C to JB-R and funds from the Nutritional Immunology and Molecular Medicine Laboratory (www.nimml.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Allen IC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00169; Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; [Anonymous], 2007, GASTROENTEROLOGY, V133, P6; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050069; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blaser MJ, 2008, CANCER PREV RES, V1, P308, DOI 10.1158/1940-6207.CAPR-08-0170; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Blaser MJ, 2008, GUT; Carbo A, 2014, MBIO, V5, DOI 10.1128/mBio.01243-14; Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Castano-Rodriguez N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00336; Castano-Rodriguez N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098899; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Chionh YT, 2015, MUCOSAL IMMUNOL, V8, P68, DOI 10.1038/mi.2014.43; Chow WH, 1998, CANCER RES, V58, P588; Chu YT, 2010, INFECT IMMUN, V78, P4157, DOI 10.1128/IAI.00524-10; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; Davis BK, 2014, INFLAMM BOWEL DIS, V20, P2412, DOI 10.1097/MIB.0000000000000151; Deen NS, 2015, HELICOBACTER, V20, P449, DOI 10.1111/hel.12223; Dennis MD, 2015, J BIOL CHEM, V290, P3865, DOI 10.1074/jbc.M114.623058; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; Eftang LL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-9; Engler DB, 2014, P NATL ACAD SCI USA, V111, P11810, DOI 10.1073/pnas.1410579111; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Gobert AP, 2014, J IMMUNOL, V193, P3013, DOI 10.4049/jimmunol.1401075; Hagar JA, 2015, CELL RES, V25, P149, DOI 10.1038/cr.2014.128; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Indramohan M, 2012, INFECT IMMUN, V80, P4099, DOI 10.1128/IAI.00589-12; Jaworska J, 2014, P NATL ACAD SCI USA, V111, pE2110, DOI 10.1073/pnas.1322118111; Kang MJ, 2015, J CLIN INVEST, V125, P2458, DOI 10.1172/JCI71747; Kronsteiner B, 2014, GUT MICROBES, V5, P357, DOI 10.4161/gmic.28899; Kronsteiner B, 2013, INFECT IMMUN, V81, P3803, DOI 10.1128/IAI.00660-13; Kurokawa K, 2012, J BIOL CHEM, V287, P13170, DOI 10.1074/jbc.M111.292235; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Lender N, 2014, ALIMENT PHARM THER, V40, P24, DOI 10.1111/apt.12790; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lord CA, 2009, J IMMUNOL, V182, P2948, DOI 10.4049/jimmunol.0801692; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Manuzak J, 2012, CLIN VACCINE IMMUNOL, V19, P1207, DOI 10.1128/CVI.00282-12; Mayerle J, 2013, JAMA-J AM MED ASSOC, V309, P1912, DOI 10.1001/jama.2013.4350; McCune A, 2003, EUR J GASTROEN HEPAT, V15, P637, DOI 10.1097/00042737-200306000-00010; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mendes Pedro, 2009, V500, P17, DOI 10.1007/978-1-59745-525-1_2; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Muller A, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-25; Mustapha P, 2014, INFECT IMMUN, V82, P2881, DOI 10.1128/IAI.01517-13; Nanda Shreeya, 2011, Nat Rev Gastroenterol Hepatol, V8, P299, DOI 10.1038/nrgastro.2011.77; Pachathundikandi SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019614; Pernitzsch SR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00014; QIAGEN, INGENUITY PATHWAY AN; Qiao SX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8014; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rebsamen M, 2011, CELL DEATH DIFFER, V18, P1387, DOI 10.1038/cdd.2011.64; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Sayi A, 2011, J IMMUNOL, V186, P878, DOI 10.4049/jimmunol.1002269; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Soares F, 2013, INNATE IMMUN-LONDON, V19, P438, DOI 10.1177/1753425912467383; Sonnenberg A, 2010, GASTROENTEROLOGY, V139, P1894, DOI 10.1053/j.gastro.2010.08.018; STOLTE M, 1992, LANCET, V339, P745, DOI 10.1016/0140-6736(92)90645-J; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074595; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vaezi MF, 2000, AM J GASTROENTEROL, V95, P2206, DOI 10.1111/j.1572-0241.2000.02305.x; van Doorn NEM, 1999, INFECT IMMUN, V67, P3040, DOI 10.1128/IAI.67.6.3040-3046.1999; Vieth M, 2000, DIGESTION, V62, P225, DOI 10.1159/000007820; Wang YH, 2009, EXP BIOL MED, V234, P171, DOI 10.3181/0808-RM-252; Wang YC, 2014, J IMMUNOL, V193, P4149, DOI 10.4049/jimmunol.1400594; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Wendelsdorf KV, 2012, IEEE T NANOBIOSCI, V11, P273, DOI 10.1109/TNB.2012.2211891; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Yokota SI, 2007, FEMS IMMUNOL MED MIC, V51, P140, DOI 10.1111/j.1574-695X.2007.00288.x; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	85	25	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137839	10.1371/journal.pone.0137839	http://dx.doi.org/10.1371/journal.pone.0137839			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367386	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100152
J	Sahner, J; Budi, SW; Barus, H; Edy, N; Meyer, M; Corre, MD; Polle, A				Sahner, Josephine; Budi, Sri Wilarso; Barus, Henry; Edy, Nur; Meyer, Marike; Corre, Marife D.; Polle, Andrea			Degradation of Root Community Traits as Indicator for Transformation of Tropical Lowland Rain Forests into Oil Palm and Rubber Plantations	PLOS ONE			English	Article							ALUMINUM RESISTANCE; SOIL CARBON; LAND-USE; LITTER DECOMPOSITION; CENTRAL SULAWESI; ORGANIC-ACIDS; CONVERSION; TOLERANCE; PLANTS; CONSEQUENCES	Conversion of tropical forests into intensely managed plantations is a threat to ecosystem functions. On Sumatra, Indonesia, oil palm (Elaeis guineensis) plantations are rapidly expanding, displacing rain forests and extensively used rubber (Hevea brasiliensis) agroforests. Here, we tested the influence of land use systems on root traits including chemical traits (carbon, nitrogen, mineral nutrients, potentially toxic elements [aluminium, iron] and performance traits (root mass, vitality, mycorrhizal colonization). Traits were measured as root community-weighed traits (RCWTs) in lowland rain forests, in rubber agro-forests mixed with rain forest trees, in rubber and oil palm plantations in two landscapes (Bukit Duabelas and Harapan, Sumatra). We hypothesized that RCWTs vary with land use system indicating increasing transformation intensity and loss of ecosystem functions. The main factors found to be related to increasing transformation intensity were declining root vitality and root sulfur, nitrogen, carbon, manganese concentrations and increasing root aluminium and iron concentrations as well as increasing spore densities of arbuscular mycorrhizas. Mycorrhizal abundance was high for arbuscular and low for ectomycorrhizas and unrelated to changes in RCWTs. The decline in RCWTs showed significant correlations with soil nitrogen, soil pH and litter carbon. Thus, our study uncovered a relationship between deteriorating root community traits and loss of ecosystem functionality and showed that increasing transformation intensity resulted in decreasing root nutrition and health. Based on these results we suggest that land management that improves root vitality may enhance the ecological functions of intense tropical production systems.	[Sahner, Josephine; Edy, Nur; Polle, Andrea] Univ Gottingen, Dept Forest Bot & Tree Physiol, Busgen Inst, D-37073 Gottingen, Germany; [Budi, Sri Wilarso] IPB Darmaga, Fac Forestry, Dept Sylviculture, Bogor, Indonesia; [Barus, Henry; Edy, Nur] Tadulako Univ, Fac Agr, Dept Agrotechnol, Palu, Indonesia; [Meyer, Marike] Univ Gottingen, Inst Geog, D-37073 Gottingen, Germany; [Corre, Marife D.] Univ Gottingen, Dept Soil Sci Trop & Subtrop Ecosyst, Busgen Inst, D-37073 Gottingen, Germany	University of Gottingen; Universitas Tadulako; University of Gottingen; University of Gottingen	Polle, A (corresponding author), Univ Gottingen, Dept Forest Bot & Tree Physiol, Busgen Inst, D-37073 Gottingen, Germany.	apolle@gwdg.de	Budi, Sri Wilarso/ABH-5213-2020; Edy, Nur/C-7648-2017	Edy, Nur/0000-0001-9013-5141; Barus, Henry/0000-0003-2351-2132; Budi, Sri Wilarso/0000-0002-3477-4261; Corre, Marife D./0000-0003-0359-2104; Polle, Andrea/0000-0001-8697-6394	Deutsche Forschungsgemeinschaft [CRC990]; Erasmus Mundus [EURASIA2]; Georg-August Universitat Gottingen [CRC990]; Deutsche Forschungsgemeinschaft; Georg-August Universitat Gottingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Erasmus Mundus; Georg-August Universitat Gottingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg-August Universitat Gottingen	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), CRC990: Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia) project B07 (AP) and Project A05 (MDC); Erasmus Mundus, EURASIA2 (http://www.eurasia2.cz/page/erasmus-mundus) (NE); Georg-August Universitat Gottingen CRC990 internal research grants awarded to counterparts and stakeholders in the frame of Access and Benefit Sharing (ABS) of the Convention of Biological Diversity (CBD) (http://www.uni-goettingen.de/de/310995.html) (SWB); and Deutsche Forschungsgemeinschaft and Georg-August Universitat Gottingen open access publication fund (http://www.sub.uni-goettingen.de/en/electronicpublishing/open-access/open-access-publicationfunding/) (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118732; Barnes AD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6351; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Brunner I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00172; Carlson KM, 2012, P NATL ACAD SCI USA, V109, P7559, DOI 10.1073/pnas.1200452109; Carrasco LR, 2014, SCIENCE, V346, P38, DOI 10.1126/science.1256685; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cristancho R, 2007, PALMAS, P24; Cristancho RJA, 2011, PLANT BIOLOGY, V13, P333, DOI 10.1111/j.1438-8677.2010.00378.x; Dechert G, 2004, PLANT SOIL, V265, P197, DOI 10.1007/s11104-005-0885-8; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Erasmi S, 2010, ENVIRON SCI ENG, P269, DOI 10.1007/978-3-642-00493-3_12; Fankem H, 2006, AFR J BIOTECHNOL, V5, P2450; FAO, 2011, STAT WORLDS FOR; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/nclimate2177, 10.1038/NCLIMATE2177]; Finegan B, 2015, J ECOL, V103, P191, DOI 10.1111/1365-2745.12346; Fornara DA, 2009, J ECOL, V97, P48, DOI 10.1111/j.1365-2745.2008.01453.x; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Godbold DL, 2006, PLANT SOIL, V281, P15, DOI 10.1007/s11104-005-3701-6; GOUYON A, 1993, AGROFOREST SYST, V22, P181, DOI 10.1007/BF00705233; Habib MT, 2013, PLANT ROOTS: THE HIDDEN HALF, 4TH EDITION; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Horst WJ, 2010, ANN BOT-LONDON, V106, P185, DOI 10.1093/aob/mcq053; JANSEN S, 2004, EVOLUTION PLANT PHYS, P467; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Katabuchi M, 2012, J ECOL, V100, P643, DOI [10.1111/J.1365-2745.2011.01937.x, 10.1111/j.1365-2745.2011.01937.x]; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; Lang C, 2011, MYCORRHIZA, V21, P297, DOI 10.1007/s00572-010-0338-y; Leuschner C, 2013, AGROFOREST SYST, V87, P1173, DOI 10.1007/s10457-013-9628-7; Lovelock CE, 2003, OECOLOGIA, V135, P268, DOI 10.1007/s00442-002-1166-3; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Masunaga T, 1998, SOIL SCI PLANT NUTR, V44, P347, DOI 10.1080/00380768.1998.10414456; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MELILLO JM, 1989, PLANT SOIL, V115, P189, DOI 10.1007/BF02202587; Ministry of Agriculture, 2010, AR PROD CAT PROD OIL; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Murdiyarso D, 2002, J VEG SCI, V13, P429, DOI 10.1111/j.1654-1103.2002.tb02067.x; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Nguyen NT, 2003, TREE PHYSIOL, V23, P1041, DOI 10.1093/treephys/23.15.1041; OHMS RE, 1957, PHYTOPATHOLOGY, V47, P751; Orwin KH, 2010, J ECOL, V98, P1074, DOI 10.1111/j.1365-2745.2010.01679.x; Pena R, 2014, ISME J, V8, P321, DOI 10.1038/ismej.2013.158; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; Prieto I, 2015, J ECOL, V103, P361, DOI 10.1111/1365-2745.12351; Rout GR, 2001, AGRONOMIE, V21, P3, DOI 10.1051/agro:2001105; Ryan PR, 2010, FUNCT PLANT BIOL, V37, P275, DOI 10.1071/FP09261; Schroth G, 2002, FOREST ECOL MANAG, V163, P131, DOI 10.1016/S0378-1127(01)00537-0; Seguel A, 2013, MYCORRHIZA, V23, P167, DOI 10.1007/s00572-013-0479-x; Smiley GL, 2008, AGROFOREST SYST, V73, P219, DOI 10.1007/s10457-008-9144-3; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Squire G., 2005, EXP AGR, V41, P121, DOI [10.1017/S001447970422244X, DOI 10.1017/S001447970422244X]; Tata HL, 2008, P IND STUD SCI M 200; vanNoordwijk M, 1997, GEODERMA, V79, P187, DOI 10.1016/S0016-7061(97)00042-6; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Wyatt TT, 2013, ADV APPL MICROBIOL, V85, P43, DOI 10.1016/B978-0-12-407672-3.00002-2	60	27	29	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138077	10.1371/journal.pone.0138077	http://dx.doi.org/10.1371/journal.pone.0138077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366576	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100216
J	Wernerehl, RW; Givnish, TJ				Wernerehl, Robert W.; Givnish, Thomas J.			Relative Roles of Soil Moisture, Nutrient Supply, Depth, and Mechanical Impedance in Determining Composition and Structure of Wisconsin Prairies	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; RAINFALL GRADIENT; GRASSLAND ECOSYSTEM; TALLGRASS PRAIRIE; ROOT ELONGATION; WATER-STRESS; PLANTS; LEAF; PATTERNS; CLIMATE	Ecologists have long classified Midwestern prairies based on compositional variation assumed to reflect local gradients in moisture availability. The best known classification is based on Curtis' continuum index (CI), calculated using the presence of indicator species thought centered on different portions of an underlying moisture gradient. Direct evidence of the extent to which CI reflects differences in moisture availability has been lacking, however. Many factors that increase moisture availability (e.g., soil depth, silt content) also increase nutrient supply and decrease soil mechanical impedance; the ecological effects of the last have rarely been considered in any ecosystem. Decreased soil mechanical impedance should increase the availability of soil moisture and nutrients by reducing the root costs of retrieving both. Here we assess the relative importance of soil moisture, nutrient supply, and mechanical impedance in determining prairie composition and structure. We used leaf delta C-13 of C-3 plants as a measure of growing-season moisture availability, cation exchange capacity (CEC) x soil depth as a measure of mineral nutrient availability, and penetrometer data as a measure of soil mechanical impedance. Community composition and structure were assessed in 17 remnant prairies in Wisconsin which vary little in annual precipitation. Ordination and regression analyses showed that delta C-13 increased with CI toward "drier" sites, and decreased with soil depth and% silt content. Variation in delta C-13 among remnants was 2.0 parts per thousand, comparable to that along continental gradients from ca. 500-1500 mm annual rainfall. As predicted, LAI and average leaf height increased significantly toward "wetter" sites. CI accounted for 54% of compositional variance but delta C-13 accounted for only 6.2%, despite the strong relationships of delta C-13 to CI and CI to composition. Compositional variation reflects soil fertility and mechanical impedance more than moisture availability. This study is the first to quantify the effects of soil mechanical impedance on community ecology.	[Wernerehl, Robert W.] Massachusetts State Botanist, Nat Heritage & Endangered Species Program, Westborough, MA 01581 USA; [Givnish, Thomas J.] Univ Wisconsin, Dept Bot, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Wernerehl, RW (corresponding author), Massachusetts State Botanist, Nat Heritage & Endangered Species Program, Westborough, MA 01581 USA.	robert.wernerehl@state.ma.us			Hertel Gift Fund of the University of Wisconsin-Madison; Davis Fund of the UW-Madison Department of Botany	Hertel Gift Fund of the University of Wisconsin-Madison; Davis Fund of the UW-Madison Department of Botany	Support was provided by the Hertel Gift Fund of the University of Wisconsin-Madison and the Davis Fund of the UW-Madison Department of Botany.	ANDERSON RC, 1984, OECOLOGIA, V64, P111, DOI 10.1007/BF00377552; [Anonymous], 2015, PC ORD MULTIVARIATE; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; Bowling DR, 2002, OECOLOGIA, V131, P113, DOI 10.1007/s00442-001-0851-y; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Carr SC, 2009, J BIOGEOGR, V36, P1600, DOI 10.1111/j.1365-2699.2009.02085.x; Casper BB, 2012, OECOLOGIA, V169, P85, DOI 10.1007/s00442-011-2183-x; COMSTOCK JP, 1992, P NATL ACAD SCI USA, V89, P7747, DOI 10.1073/pnas.89.16.7747; Corbett E, 2006, J TORREY BOT SOC, V133, P267, DOI 10.3159/1095-5674(2006)133[267:LAOIAW]2.0.CO;2; CURTIS JT, 1949, ECOLOGY, V30, P83, DOI 10.2307/1932279; CURTIS JT, 1955, ECOLOGY, V36, P558, DOI 10.2307/1931295; Curtis JT, 1959, VEGETATION WISCONSIN; DAWSON TE, 1993, ECOLOGY, V74, P798, DOI 10.2307/1940807; Devices Decagon, 2008, ACCUPAR PAR LAI CEPT; Di Luzio M, 2008, J APPL METEOROL CLIM, V47, P475, DOI 10.1175/2007JAMC1356.1; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Dybzinski R, 2007, AM NAT, V170, P305, DOI 10.1086/519857; EHLERINGER JR, 1988, OECOLOGIA, V76, P562, DOI 10.1007/BF00397870; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Flanagan LB, 1997, OECOLOGIA, V111, P481, DOI 10.1007/s004420050261; Givnish TJ, 2014, ECOLOGY, V95, P2991, DOI 10.1890/14-0240.1; Givnish Thomas J., 1995, P3, DOI 10.1016/B978-012276460-8/50003-5; GIVNISH TJ, 1982, AM NAT, V120, P353, DOI 10.1086/283995; Gonfiantini R., 1995, REFERENCE INTERCOMPA, P13, DOI DOI 10.1029/2001JD001156; Grace JB., 2015, STRUCTURAL EQUATION; Guix-Herard N, 2007, EUR J AGRON, V27, P187, DOI 10.1016/j.eja.2007.03.005; Hartman G, 2010, OECOLOGIA, V162, P837, DOI 10.1007/s00442-009-1514-7; Henderson RA, 1998, PLANT SPECIES COMPOS; Hopkins E., 2009, TEMPERATURE PRECIPIT; Howe HF, 2006, ECOLOGY, V87, P3007, DOI 10.1890/0012-9658(2006)87[3007:MADEOM]2.0.CO;2; Knapp AK, 2004, FRONT ECOL ENVIRON, V2, P483, DOI 10.1890/1540-9295(2004)002[0483:GIETNA]2.0.CO;2; KNIGHT DH, 1965, ECOLOGY, V46, P744, DOI 10.2307/1935018; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Lai CT, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006436; Leach MK, 1996, SCIENCE, V273, P1555, DOI 10.1126/science.273.5281.1555; Leng X, 2013, J VEG SCI, V24, P138, DOI 10.1111/j.1654-1103.2012.01439.x; Mckenzie BM, 2013, PLANT CELL ENVIRON, V36, P1085, DOI 10.1111/pce.12037; MCNULTY SG, 1995, ECOLOGY, V76, P1581, DOI 10.2307/1938159; Miller JM, 2001, FUNCT ECOL, V15, P222, DOI 10.1046/j.1365-2435.2001.00508.x; Mueller KE, 2013, GLOBAL CHANGE BIOL, V19, P1249, DOI 10.1111/gcb.12096; NELSON DC, 1983, AM MIDL NAT, V109, P367, DOI 10.2307/2425417; Nippert JB, 2007, OECOLOGIA, V153, P261, DOI 10.1007/s00442-007-0745-8; Nippert JB, 2007, ENVIRON EXP BOT, V60, P412, DOI 10.1016/j.envexpbot.2006.12.012; Nippert JB, 2012, PLANT SOIL, V355, P385, DOI 10.1007/s11104-011-1112-4; Nippert JB, 2009, ACTA OECOL, V35, P400, DOI 10.1016/j.actao.2009.01.010; Partch ML, 1949, THESIS U WISCONSIN M; Partch ML, 1962, MINN ACAD SCI, V30, P38; PEET R K, 1988, P233; Peters J, 2013, WISCONSIN PROCEDURES; Prentice IC, 2011, NEW PHYTOL, V190, P169, DOI 10.1111/j.1469-8137.2010.03579.x; Santesteban LG, 2014, ACTA HORTIC, V1038, P677, DOI 10.17660/ActaHortic.2014.1038.86; Schulze ED, 1998, AUST J PLANT PHYSIOL, V25, P413, DOI 10.1071/PP97113; Schulze ED, 2006, TREE PHYSIOL, V26, P479, DOI 10.1093/treephys/26.4.479; Sherry RA, 2008, GLOBAL CHANGE BIOL, V14, P2923, DOI 10.1111/j.1365-2486.2008.01703.x; STEWART GR, 1995, AUST J PLANT PHYSIOL, V22, P51, DOI 10.1071/PP9950051; TILMAN D, 1988; Tracy SR, 2012, ANN BOT-LONDON, V110, P511, DOI 10.1093/aob/mcs031; Turner CL, 1997, ECOLOGY, V78, P1832, DOI 10.1890/0012-9658(1997)078[1832:SNAPRT]2.0.CO;2; Turner NC, 2008, PHYSIOL PLANTARUM, V132, P440, DOI 10.1111/j.1399-3054.2007.01027.x; UMBANHOWAR CE, 1992, AM MIDL NAT, V127, P268, DOI 10.2307/2426533; Valentine TA, 2012, ANN BOT-LONDON, V110, P259, DOI 10.1093/aob/mcs118; Vereecken H, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006829; von Fischer JC, 2008, GLOBAL CHANGE BIOL, V14, P1141, DOI 10.1111/j.1365-2486.2008.01552.x; Wang N, 2013, PLANT BIOLOGY, V15, P144, DOI 10.1111/j.1438-8677.2012.00605.x; Warren JM, 2011, OECOLOGIA, V166, P899, DOI 10.1007/s00442-011-1953-9; Weng ES, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000539; WHITE JA, 1984, VEGETATIO, V57, P65, DOI 10.1007/BF00047300	70	11	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137963	10.1371/journal.pone.0137963	http://dx.doi.org/10.1371/journal.pone.0137963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368936	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100187
J	Westrop, GD; Williams, RAM; Wang, LJ; Zhang, T; Watson, DG; Silva, AM; Coombs, GH				Westrop, Gareth D.; Williams, Roderick A. M.; Wang, Lijie; Zhang, Tong; Watson, David G.; Silva, Ana Marta; Coombs, Graham H.			Metabolomic Analyses of Leishmania Reveal Multiple Species Differences and Large Differences in Amino Acid Metabolism	PLOS ONE			English	Article							INTERACTION LIQUID-CHROMATOGRAPHY; GLOBAL BIOCHEMICAL APPROACH; MASS-SPECTROMETRY; INDOLEAMINE 2,3-DIOXYGENASE; VISCERAL LEISHMANIASIS; TRYPTOPHAN CATABOLISM; PROTOZOAN PARASITE; OSMOTIC-STRESS; HOST IMMUNITY; DONOVANI	Comparative genomic analyses of Leishmania species have revealed relatively minor heterogeneity amongst recognised housekeeping genes and yet the species cause distinct infections and pathogenesis in their mammalian hosts. To gain greater information on the biochemical variation between species, and insights into possible metabolic mechanisms underpinning visceral and cutaneous leishmaniasis, we have undertaken in this study a comparative analysis of the metabolomes of promastigotes of L. donovani, L. major and L. mexicana. The analysis revealed 64 metabolites with confirmed identity differing 3-fold or more between the cell extracts of species, with 161 putatively identified metabolites differing similarly. Analysis of the media from cultures revealed an at least 3-fold difference in use or excretion of 43 metabolites of confirmed identity and 87 putatively identified metabolites that differed to a similar extent. Strikingly large differences were detected in their extent of amino acid use and metabolism, especially for tryptophan, aspartate, arginine and proline. Major pathways of tryptophan and arginine catabolism were shown to be to indole-3-lactate and arginic acid, respectively, which were excreted. The data presented provide clear evidence on the value of global metabolomic analyses in detecting species-specific metabolic features, thus application of this technology should be a major contributor to gaining greater understanding of how pathogens are adapted to infecting their hosts.	[Westrop, Gareth D.; Williams, Roderick A. M.; Wang, Lijie; Zhang, Tong; Watson, David G.; Silva, Ana Marta; Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Williams, Roderick A. M.] Univ West Scotland, Inst Biomed & Environm Hlth Res, Paisley, Renfrew, Scotland; [Silva, Ana Marta] Univ Porto, Inst Biol Mol & Celular, P-4100 Porto, Portugal	University of Strathclyde; University of West Scotland; Universidade do Porto	Coombs, GH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	graham.coombs@strath.ac.uk	Williams, Roderick/V-4317-2019; Silva, Ana/J-5017-2013	Williams, Roderick/0000-0001-5065-9768; Silva, Ana/0000-0002-1840-1473; Westrop, Gareth/0000-0002-8011-6219	Scottish Universities Life Sciences Alliance (SULSA)	Scottish Universities Life Sciences Alliance (SULSA)	This work was funded by the Scottish Universities Life Sciences Alliance (SULSA; www.sulsa.ac.uk) to DGW and GHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu NK, 1997, FEMS MICROBIOL LETT, V156, P43, DOI 10.1016/S0378-1097(97)00401-1; Berg M, 2013, MOL MICROBIOL, V90, P428, DOI 10.1111/mmi.12374; Blum JJ, 1996, BIOL CELL, V87, P9, DOI 10.1016/S0248-4900(97)89833-4; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; Burchmore RJS, 2001, INT J PARASITOL, V31, P1311, DOI 10.1016/S0020-7519(01)00259-4; Creek DJ, 2012, BIOINFORMATICS, V28, P1048, DOI 10.1093/bioinformatics/bts069; Creek DJ, 2012, MOL BIOCHEM PARASIT, V181, P73, DOI 10.1016/j.molbiopara.2011.10.003; Creek DJ, 2011, ANAL CHEM, V83, P8703, DOI 10.1021/ac2021823; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Donovan MJ, 2012, PARASITE IMMUNOL, V34, P464, DOI 10.1111/j.1365-3024.2012.01380.x; Downing T, 2012, INFECT GENET EVOL, V12, P149, DOI 10.1016/j.meegid.2011.11.005; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Gazanion E, 2011, MOL MICROBIOL, V82, P21, DOI 10.1111/j.1365-2958.2011.07799.x; Genestra M, 2003, MED MICROBIOL IMMUN, V192, P217, DOI 10.1007/s00430-003-0176-z; Genestra M, 2006, ARCH MICROBIOL, V185, P348, DOI 10.1007/s00203-006-0105-9; Ginger ML, 2000, EUR J BIOCHEM, V267, P2555, DOI 10.1046/j.1432-1327.2000.01261.x; GREEN SJ, 1990, J IMMUNOL, V144, P278; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Inbar E, 2013, BIOCHEM J, V449, P555, DOI 10.1042/BJ20121262; Jankevics A, 2012, METABOLOMICS, V8, pS29, DOI 10.1007/s11306-011-0341-0; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Kamleh A, 2008, RAPID COMMUN MASS SP, V22, P1912, DOI 10.1002/rcm.3564; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kloehn J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004683; LEELAYOOVA S, 1992, J PROTOZOOL, V39, P350, DOI 10.1111/j.1550-7408.1992.tb01329.x; Leroux A, 2006, MOL BIOCHEM PARASIT, V149, P74, DOI 10.1016/j.molbiopara.2006.04.010; Liu X, 2009, CURR CANCER DRUG TAR, V9, P938, DOI 10.2174/156800909790192374; Liu XD, 2010, BLOOD, V115, P3520, DOI 10.1182/blood-2009-09-246124; Lye LF, 2011, MOL BIOCHEM PARASIT, V175, P58, DOI 10.1016/j.molbiopara.2010.09.004; Makala LHC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-5; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; McGaha TL, 2012, IMMUNOL REV, V249, P135, DOI 10.1111/j.1600-065X.2012.01149.x; Mellor AL, 2003, J IMMUNOL, V170, P5809, DOI 10.4049/jimmunol.170.12.5809; Mieulet V, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000934; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Moreno MA, 2014, INT J PARASITOL-DRUG, V4, P347, DOI 10.1016/j.ijpddr.2014.06.001; Munder M, 2009, EUR J IMMUNOL, V39, P2161, DOI 10.1002/eji.200839041; Nowicki C, 2008, COMP BIOCHEM PHYS A, V151, P381, DOI 10.1016/j.cbpa.2007.03.010; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Rojas-Bernabe A, 2014, PARASITOLOGY, V141, P788, DOI 10.1017/S0031182013002187; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; SACKS DL, 1995, J EXP MED, V181, P685, DOI 10.1084/jem.181.2.685; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Saunders EC, 2010, PARASITOLOGY, V137, P1303, DOI 10.1017/S0031182010000077; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Scott DA, 2008, J BIOL CHEM, V283, P155, DOI 10.1074/jbc.M708014200; Silva AM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001451; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Szkop M, 2012, FOLIA MICROBIOL, V57, P1, DOI 10.1007/s12223-011-0089-y; t'Kindt R, 2010, ANAL BIOANAL CHEM, V398, P2059, DOI 10.1007/s00216-010-4139-0; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; tKindt R, 2010, PLOS NEGLECT TROP D, V4, P11; Vieira LL, 1996, BIOCHEM J, V319, P691, DOI 10.1042/bj3190691; Vincent IM, 2015, J BIOMOL SCREEN, V20, P44, DOI 10.1177/1087057114551519; Vincent IM, 2014, INT J PARASITOL-DRUG, V4, P20, DOI 10.1016/j.ijpddr.2013.11.002; Vouldoukis I, 1996, ANTIMICROB AGENTS CH, V40, P253, DOI 10.1128/AAC.40.1.253; Wanasen N, 2008, IMMUNOL RES, V41, P15, DOI 10.1007/s12026-007-8012-y; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Xu H, 2008, IMMUNOL LETT, V121, P1, DOI 10.1016/j.imlet.2008.08.008; Zhang R, 2014, J CHROMATOGR A, V1362, P168, DOI 10.1016/j.chroma.2014.08.039; Zhang T, 2012, ANAL CHEM, V84, P1994, DOI 10.1021/ac2030738; Zhang WW, 2010, MOL MICROBIOL, V77, P505, DOI 10.1111/j.1365-2958.2010.07230.x; Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045; Zhang YJJ, 2013, CELL MICROBIOL, V15, P1079, DOI 10.1111/cmi.12140	75	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136891	10.1371/journal.pone.0136891	http://dx.doi.org/10.1371/journal.pone.0136891			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368322	Green Accepted, Green Published, gold			2022-12-26	WOS:000361601100030
J	Whitmore, LS; Ye, P				Whitmore, Leanne S.; Ye, Ping			Dissecting Germ Cell Metabolism through Network Modeling	PLOS ONE			English	Article							RETINOIC ACID METABOLISM; BINDING-PROTEIN-I; SERTOLI-CELLS; GLOBAL RECONSTRUCTION; TARGETED DISRUPTION; INSULIN-RESISTANCE; SPERMATOGENIC WAVE; MICE; DIFFERENTIATION; EXPRESSION	Metabolic pathways are increasingly postulated to be vital in programming cell fate, including stemness, differentiation, proliferation, and apoptosis. The commitment to meiosis is a critical fate decision for mammalian germ cells, and requires a metabolic derivative of vitamin A, retinoic acid (RA). Recent evidence showed that a pulse of RA is generated in the testis of male mice thereby triggering meiotic commitment. However, enzymes and reactions that regulate this RA pulse have yet to be identified. We developed a mouse germ cell-specific metabolic network with a curated vitamin A pathway. Using this network, we implemented flux balance analysis throughout the initial wave of spermatogenesis to elucidate important reactions and enzymes for the generation and degradation of RA. Our results indicate that primary RA sources in the germ cell include RA import from the extracellular region, release of RA from binding proteins, and metabolism of retinal to RA. Further, in silico knockouts of genes and reactions in the vitamin A pathway predict that deletion of Lipe, hormone-sensitive lipase, disrupts the RA pulse thereby causing spermatogenic defects. Examination of other metabolic pathways reveals that the citric acid cycle is the most active pathway. In addition, we discover that fatty acid synthesis/oxidation are the primary energy sources in the germ cell. In summary, this study predicts enzymes, reactions, and pathways important for germ cell commitment to meiosis. These findings enhance our understanding of the metabolic control of germ cell differentiation and will help guide future experiments to improve reproductive health.	[Whitmore, Leanne S.; Ye, Ping] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Ye, Ping] Avera Canc Inst, Dept Mol & Expt Med, Sioux Falls, SD 57105 USA	Washington State University	Ye, P (corresponding author), Washington State Univ, Sch Mol Biosci, POB 647520, Pullman, WA 99164 USA.	Ping.Ye@avera.org			National Institutes of Health (NIH) [R03HD079723]; NIH [T32GM008336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD079723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (NIH) research grant R03HD079723 to PY. LSW was supported, in part, by NIH training grant T32GM008336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MG, 2013, CELL MOL LIFE SCI, V70, P777, DOI 10.1007/s00018-012-1079-1; Amory JK, 2011, J ANDROL, V32, P111, DOI 10.2164/jandrol.110.010751; Anderson JE, 2009, FERTIL STERIL, V91, P2466, DOI 10.1016/j.fertnstert.2008.03.022; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Busada JT, 2015, DEV BIOL, V397, P140, DOI 10.1016/j.ydbio.2014.10.020; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chung SR, 2001, ENDOCRINOLOGY, V142, P4272, DOI 10.1210/en.142.10.4272; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; DEBRUIJN DRH, 1994, DIFFERENTIATION, V58, P141; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Drumond AL, 2011, REPRODUCTION, V142, P145, DOI 10.1530/REP-10-0431; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Evans E, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.118034; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Hao T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-393; Hermo L, 2008, MOL REPROD DEV, V75, P565, DOI 10.1002/mrd.20800; Hogarth CA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126326; Hogarth CA, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105346; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; LAMPRON C, 1995, DEVELOPMENT, V121, P539; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MORALES C, 1987, ENDOCRINOLOGY, V121, P432, DOI 10.1210/endo-121-1-432; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nogiec C, 2015, MOL METAB, V4, P151, DOI 10.1016/j.molmet.2014.12.012; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Singh K, 2013, REPROD SCI, V20, P622, DOI 10.1177/1933719112459232; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sugimoto R, 2012, MECH DEVELOP, V128, P610, DOI 10.1016/j.mod.2011.12.003; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Tong MH, 2013, P NATL ACAD SCI USA, V110, P543, DOI 10.1073/pnas.1214883110; VANPELT AMM, 1990, BIOL REPROD, V43, P363, DOI 10.1095/biolreprod43.3.363; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953	49	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137607	10.1371/journal.pone.0137607	http://dx.doi.org/10.1371/journal.pone.0137607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367011	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100093
J	Wood, SW; Prior, LD; Stephens, HC; Bowman, DMJS				Wood, Sam W.; Prior, Lynda D.; Stephens, Helen C.; Bowman, David M. J. S.			Macroecology of Australian Tall Eucalypt Forests: Baseline Data from a Continental-Scale Permanent Plot Network	PLOS ONE			English	Article							TREE MORTALITY-RATES; CLIMATE-CHANGE; CARBON STOCKS; GLOBAL-CHANGE; FIRE; TEMPERATE; DROUGHT; BIOMASS; GROWTH; WORLDS	Tracking the response of forest ecosystems to climate change demands large (>= 1 ha) monitoring plots that are repeatedly measured over long time frames and arranged across macro-ecological gradients. Continental scale networks of permanent forest plots have identified links between climate and carbon fluxes by monitoring trends in tree growth, mortality and recruitment. The relationship between tree growth and climate in Australia has been recently articulated through analysis of data from smaller forest plots, but conclusions were limited by (a) absence of data on recruitment and mortality, (b) exclusion of non-eucalypt species, and (c) lack of knowledge of stand age or disturbance histories. To remedy these gaps we established the Ausplots Forest Monitoring Network: a continental scale network of 48 1 ha permanent plots in highly productive tall eucalypt forests in the mature growth stage. These plots are distributed across cool temperate, Mediterranean, subtropical and tropical climates (mean annual precipitation 850 to 1900 mm per year; mean annual temperature 6 to 21 degrees C). Aboveground carbon stocks (AGC) in these forests are dominated by eucalypts (90% of AGC) whilst non-eucalypts in the understorey dominated species diversity and tree abundance (84% of species; 60% of stems). Aboveground carbon stocks were negatively related to mean annual temperature, with forests at the warm end of the temperature range storing approximately half the amount of carbon as forests at the cool end of the temperature range. This may reflect thermal constraints on tree growth detected through other plot networks and physiological studies. Through common protocols and careful sampling design, the Ausplots Forest Monitoring Network will facilitate the integration of tall eucalypt forests into established global forest monitoring initiatives. In the context of projections of rapidly warming and drying climates in Australia, this plot network will enable detection of links between climate and growth, mortality and carbon dynamics of eucalypt forests.	[Wood, Sam W.; Prior, Lynda D.; Stephens, Helen C.; Bowman, David M. J. S.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Wood, Sam W.; Stephens, Helen C.; Bowman, David M. J. S.] Terr Ecosyst Res Network, Brisbane, Qld, Australia	University of Tasmania	Wood, SW (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	swwood@utas.edu.au	Bowman, David M.J.S./A-2930-2011; Prior, Lynda/A-7460-2012	Bowman, David M.J.S./0000-0001-8075-124X; Prior, Lynda/0000-0002-5511-2320; Stephens, Helen/0000-0001-8112-3931	Terrestrial Ecosystem Research Network (TERN)	Terrestrial Ecosystem Research Network (TERN)	The establishment of the Ausplots Forest Monitoring Network was funded by the Terrestrial Ecosystem Research Network (TERN; www.tern.org.au). All authors involved in the study design, data collection, data analysis and manuscript preparation were supported by TERN.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Ashton D.H., 1994, AUSTR VEGETATION, P157; ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P247, DOI 10.1016/0378-1127(94)90114-7; Bond-Lamberty B, 2007, NATURE, V450, P89, DOI 10.1038/nature06272; Bond-Lamberty B, 2014, GLOBAL CHANGE BIOL, V20, P216, DOI 10.1111/gcb.12404; Bowman DMJS, 2014, GLOBAL ECOL BIOGEOGR, V23, P925, DOI 10.1111/geb.12171; Bowman DMJS, 2014, GLOBAL CHANGE BIOL, V20, P1008, DOI 10.1111/gcb.12433; Bradford MG, 2014, J TROP FOR SCI, V26, P543; Bradshaw F. J., 1997, Australian Forestry, V60, P178; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brouwers N, 2013, LANDSCAPE ECOL, V28, P69, DOI 10.1007/s10980-012-9815-3; BURGMAN MA, 1994, FOREST ECOL MANAG, V67, P319, DOI 10.1016/0378-1127(94)90026-4; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butt N, 2013, ECOL EVOL, V3, P5011, DOI 10.1002/ece3.873; Cochrane MA, 2008, AMBIO, V37, P522, DOI 10.1579/0044-7447-37.7.522; Condit R, 2014, FOREST ECOL MANAG, V316, P21, DOI 10.1016/j.foreco.2013.09.011; Crous KY, 2013, GLOBAL CHANGE BIOL, V19, P3790, DOI 10.1111/gcb.12314; Cruz MG, 2012, FOREST ECOL MANAG, V284, P269, DOI 10.1016/j.foreco.2012.02.035; Curtis JT, 1959, VEGETATION WISCONSIN; Dean C, 2012, PLANT BIOSYST, V146, P223, DOI 10.1080/11263504.2011.638332; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Fahey TJ, 2010, FRONT ECOL ENVIRON, V8, P245, DOI 10.1890/080169; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fedrigo M, 2014, FOREST ECOL MANAG, V334, P129, DOI 10.1016/j.foreco.2014.08.025; Florence R., 1996, ECOLOGY SILVICULTURE, DOI DOI 10.1071/9780643100893; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Haberle SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097925; Hammill KA, 2006, INT J WILDLAND FIRE, V15, P213, DOI 10.1071/WF05051; Harrington Graham N., 2000, Proceedings of the Royal Society of Queensland, V109, P59; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horton BM, 2013, FOREST ECOL MANAG, V302, P329, DOI 10.1016/j.foreco.2013.04.006; Hughes L, 1996, GLOBAL ECOL BIOGEOGR, V5, P128, DOI 10.2307/2997395; Hutchinson M, 2014, ANUCLIM VERSION 6 1; Hutchinson MF, 2005, GLOBAL ECOL BIOGEOGR, V14, P197, DOI [10.1111/j.1466-822X.2005.00154.x, 10.1111/j.1466-822x.2005.00154.x]; Illian J, 2008, STAT ANAL MODELLING; Keith H, 2000, REV ALLOMETRIC RELAT; Keith H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107126; Keith H, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00051.1; Keith H, 2010, GLOBAL CHANGE BIOL, V16, P2971, DOI 10.1111/j.1365-2486.2009.02146.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Kirkpatrick J.B., 1988, WET EUCALYPT FORESTS; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Lindenmayer D, 2009, FOREST PATTERN AND ECOLOGICAL PROCESS: A SYNTHESIS OF 25 YEARS OF RESEARCH, P1; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Liu YC, 2014, GLOBAL ECOL BIOGEOGR, V23, P323, DOI 10.1111/geb.12113; Lutz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036131; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Marthews T., 2012, MEASURING TROPICAL F; Matusick G, 2013, EUR J FOREST RES, V132, P497, DOI 10.1007/s10342-013-0690-5; May B., 2012, TASMANIAN FOREST CAR; Monserud RA, 1996, FOREST ECOL MANAG, V80, P57, DOI 10.1016/0378-1127(95)03638-5; Montreal Process Implementation Group for Australia and National Forest Inventory Steering Committee, 2013, AUSTR STAT FOR REP 2; Mueller-Dombois D., 1974, AIMS METHODS VEGETAT; Murphy S., 2014, VALIDATING ABOVE GRO; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Phillips O., 2009, RAINFOR FIELD MANUAL; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Popescu SC, 2011, PHOTOGRAMM ENG REM S, V77, P217; Popkin G, 2015, NATURE, V523, P20, DOI 10.1038/523020a; Prior L.D., 2011, USING PERMANENT FORE; PRIOR LD, 2014, FRONT PLANT SCI, V5; Prior LD, 2014, GLOBAL CHANGE BIOL, V20, P2793, DOI 10.1111/gcb.12540; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; Sileshi GW, 2014, FOREST ECOL MANAG, V329, P237, DOI 10.1016/j.foreco.2014.06.026; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Tng DYP, 2012, NEW PHYTOL, V196, P1001, DOI 10.1111/j.1469-8137.2012.04359.x; Tng DYP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084378; Turner PAM, 2009, FOREST ECOL MANAG, V258, P366, DOI 10.1016/j.foreco.2009.04.021; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Vertessy RA, 1996, TREE PHYSIOL, V16, P221; Weiskittel AR, 2011, FOREST GROWTH AND YIELD MODELING, P1, DOI 10.1002/9781119998518; Wiegand T., 2013, HDB SPATIAL POINT PA; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Williams J. E., 1997, EUCALYPT ECOLOGY IND; Williamson G, 2014, ENV CHANGE BIOL TOOL; Wood SW, 2010, FOREST ECOL MANAG, V260, P438, DOI 10.1016/j.foreco.2010.04.037; Wood SW, 2015, AUSPLOTS FOREST MONI; Wood SW, 2014, BIODIVERSITY ENV CHA, P531	88	25	26	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137811	10.1371/journal.pone.0137811	http://dx.doi.org/10.1371/journal.pone.0137811			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368919	Green Submitted, gold, Green Published			2022-12-26	WOS:000361601100145
J	Joly, AL; Deepti, A; Seignez, A; Goloudina, A; Hebrard, S; Schmitt, E; Richaud, S; Fourmaux, E; Hammann, A; Collura, A; Svrcek, M; Jego, G; Robinet, E; Solary, E; Demidov, O; Kohli, E; Garrido, C				Joly, A-L; Deepti, A.; Seignez, A.; Goloudina, A.; Hebrard, S.; Schmitt, E.; Richaud, S.; Fourmaux, E.; Hammann, A.; Collura, A.; Svrcek, M.; Jego, G.; Robinet, E.; Solary, E.; Demidov, O.; Kohli, E.; Garrido, C.			The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development	ONCOGENE			English	Article							NEURAL PROGENITOR CELLS; ER STRESS; T-CELLS; SENSITIVITY; MOLECULES; THERAPY; TARGET; HSP70; RISK	Graft versus host disease (GvHD), which is the primary complication of allogeneic bone marrow transplantation, can alter the intestinal barrier targeted by activated donor T-cells. Chemical inhibition of the stress protein HSP90 was demonstrated in vitro to inhibit T-cell activation and to modulate endoplasmic reticulum (ER) stress to which intestinal cells are highly susceptible. Since the HSP90 inhibitor 17-allylamino-demethoxygeldanamycin (17AAG) is developed in clinics, we explored here its ability to control intestinal acute GvHD in vivo in two mouse GvHD models (C57BL/6 -> BALB/c and FVB/N -> Lgr5-eGFP), ex vivo in intestine organoids and in vitro in intestinal epithelial cultures. We show that 17AAG decreases GvHD-associated mortality without impairing graft versus leukemia effect. While 17AAG effect in T-cell activation is just moderate at the dose used in vivo, we observe a striking intestinal integrity protection. At the intestine level, the drug promotes the splicing of the transcription factor X-box binding protein 1 (XBP1), which is a key component of the ER stress. This effect is associated with a decrease in intestinal damage and an increase in Lgr5(+) stem cells, Paneth cells and defensins production. The importance of XBP1 splicing control is further confirmed in cultured cells and organoids of primary intestinal epithelium where XBP1 is either shRNA depleted or inhibited with toyocamycin. In conclusion, 17AAG has a protective effect on the epithelial intestinal barrier in mouse models of acute GvHD. This compound deserves to be tested in the therapeutic control of acute GvHD.	[Joly, A-L; Deepti, A.; Seignez, A.; Goloudina, A.; Hebrard, S.; Schmitt, E.; Richaud, S.; Fourmaux, E.; Hammann, A.; Jego, G.; Demidov, O.; Kohli, E.; Garrido, C.] INSERM, UMR 866, Equipe Labellisee Ligue Natl Canc, F-21079 Dijon, France; [Joly, A-L; Deepti, A.; Seignez, A.; Goloudina, A.; Hebrard, S.; Schmitt, E.; Richaud, S.; Fourmaux, E.; Hammann, A.; Jego, G.; Demidov, O.; Kohli, E.; Garrido, C.] Lab Excellence LipSTIC, Dijon, France; [Joly, A-L; Deepti, A.; Seignez, A.; Goloudina, A.; Hebrard, S.; Schmitt, E.; Richaud, S.; Fourmaux, E.; Hammann, A.; Jego, G.; Demidov, O.; Kohli, E.; Garrido, C.] Univ Bourgogne, Dijon, France; [Seignez, A.] CHU, Dijon, France; [Collura, A.; Svrcek, M.] INSERM, UMR S938, Ctr Rech St Antoine, Paris, France; [Robinet, E.] INSERM, U748, Inst Virol, Strasbourg, France; [Robinet, E.] Inst Hosp Univ Strasbourg, Strasbourg, France; [Solary, E.] Inst Gustave Roussy, INSERM, UMR1009, F-94805 Villejuif, France; [Solary, E.] Univ Paris 11, Villejuif, France; [Garrido, C.] Anticanc Ctr George Francois Leclerc, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Garrido, C (corresponding author), INSERM, Fac Med & Pharm, UMR866, 7 Blvd Jeanne dArc, F-21079 Dijon, France.	cgarrido@u-bourgogne.fr	Garrido, Carolina/GWM-5557-2022; Garrido, carmen/G-1633-2018; Demidov, Oleg/AAC-4462-2021; Demidov, Oleg/U-2050-2017; Goloudina, Anastasia/T-4989-2019; jego, gaetan/N-7226-2018	Garrido, carmen/0000-0003-1368-1493; Demidov, Oleg/0000-0003-4323-7174; Demidov, Oleg/0000-0003-4323-7174; jego, gaetan/0000-0003-0376-9299; Solary, Eric/0000-0002-8629-1341; deepti, ayswaria/0000-0001-7159-6911	Institut National du Cancer; Agence Nationale de la Recherche; Ligue Nationale Contre le Cancer; Association pour la Recherche sur le Cancer; FEDER; La Ligue Nationale Contre le Cancer; Conseil Regional de Bourgogne	Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); FEDER(European Commission); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte)	We thank J Haiech (University of Strasbourg), P Saas and B Gaugler (INSERM U1098, Besancon, France), for helpful discussions. We thank P Saas, H Clevers (Hubrecht Institute, The Netherlands) and A Jevnikar (Ontario, CA) for providing A20-luc cells, Lgr5-eGFP mice and IEC 4-1, respectively, and A Bouchot and JF Merlin (INSERM U866, Dijon, France) for excellent technical assistance. This work was supported by grants from the Institut National du Cancer, Agence Nationale de la Recherche, Ligue Nationale Contre le Cancer ('Labeled teams' to CG and ES), the Association pour la Recherche sur le Cancer (labeled team to CG and OD), and FEDER. CG team belongs to the LabEx LipSTIC and GR-Ex. ALJ has a doctoral fellowship from La Ligue Nationale Contre le Cancer and AD by the 'Conseil Regional de Bourgogne'.	Aucagne R, 2011, J CLIN INVEST, V121, P2361, DOI 10.1172/JCI45213; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Biamonte MA, 2010, J MED CHEM, V53, P3, DOI 10.1021/jm9004708; Bradley E, 2014, J CELL COMMUN SIGNAL, V8, P353, DOI 10.1007/s12079-014-0247-5; Cawley K, 2011, METHOD ENZYMOL, V490, P31, DOI 10.1016/B978-0-12-385114-7.00002-7; Choi SW, 2014, NAT REV CLIN ONCOL, V11, P536, DOI 10.1038/nrclinonc.2014.102; Collins CB, 2013, MUCOSAL IMMUNOL, V6, P960, DOI 10.1038/mi.2012.134; Contassot E, 1998, TRANSPLANTATION, V65, P1365, DOI 10.1097/00007890-199805270-00014; Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Couturier M, 2013, LEUKEMIA, V27, P1527, DOI 10.1038/leu.2013.39; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Elo MA, 2005, BBA-MOL CELL RES, V1743, P115, DOI 10.1016/j.bbamcr.2004.09.004; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, CURR OPIN GASTROEN, V26, P318, DOI 10.1097/MOG.0b013e32833a9ff1; Levine JE, 2013, BLOOD, V122, P1505, DOI 10.1182/blood-2013-02-485813; Li XC, 1997, CELL IMMUNOL, V175, P58, DOI 10.1006/cimm.1996.1050; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Mjahed H, 2012, EXP CELL RES, V318, P1946, DOI 10.1016/j.yexcr.2012.05.012; Moser C, 2009, ANTICANCER RES, V29, P2031; Murphy S, 2011, LEUKEMIA LYMPHOMA, V52, P1844, DOI 10.3109/10428194.2011.580476; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Pelicano H, 2006, LEUKEMIA, V20, P610, DOI 10.1038/sj.leu.2404140; Penack O, 2010, BLOOD, V115, P1865, DOI 10.1182/blood-2009-09-242784; Rerole AL, 2011, CANCER RES, V71, P484, DOI 10.1158/0008-5472.CAN-10-1443; Ri M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.26; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Stuehler C, 2009, BLOOD, V114, P2829, DOI 10.1182/blood-2009-06-224600; Takashima S, 2011, J EXP MED, V208, P285, DOI 10.1084/jem.20101559; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; Wang GH, 2011, J NEUROCHEM, V117, P703, DOI 10.1111/j.1471-4159.2011.07239.x; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929	43	16	17	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2842	2851		10.1038/onc.2015.242	http://dx.doi.org/10.1038/onc.2015.242			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26364610				2022-12-26	WOS:000377473700004
J	Zhou, L; Liu, XD; Sun, M; Zhang, X; German, P; Bai, S; Ding, Z; Tannir, N; Wood, CG; Matin, SF; Karam, JA; Tamboli, P; Sircar, K; Rao, P; Rankin, EB; Laird, DA; Hoang, AG; Walker, CL; Giaccia, AJ; Jonasch, E				Zhou, L.; Liu, X-D; Sun, M.; Zhang, X.; German, P.; Bai, S.; Ding, Z.; Tannir, N.; Wood, C. G.; Matin, S. F.; Karam, J. A.; Tamboli, P.; Sircar, K.; Rao, P.; Rankin, E. B.; Laird, D. A.; Hoang, A. G.; Walker, C. L.; Giaccia, A. J.; Jonasch, E.			Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma	ONCOGENE			English	Article							RECEPTOR TYROSINE KINASES; CABOZANTINIB XL184; C-MET; GROWTH; EXPRESSION; CANCER; ANGIOGENESIS; PROGRESSION; METASTASIS; ACTIVATION	Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance to sunitinib, an antiangiogenic small molecule, and to exploit this mechanism therapeutically. We hypothesized that sunitinib-induced upregulation of the prometastatic MET and AXL receptors is associated with resistance to sunitinib and with more aggressive tumor behavior. In the present study, tissue microarrays containing sunitinib-treated and untreated RCC tissues were stained with MET and AXL antibodies. The low malignant RCC cell line 786-O was chronically treated with sunitinib and assayed for AXL, MET, epithelial-mesenchymal transition (EMT) protein expression and activation. Co-culture experiments were used to examine the effect of sunitinib pretreatment on endothelial cell growth. The effects of AXL and MET were evaluated in various cell-based models by short hairpin RNA or inhibition by cabozantinib, the multi-tyrosine kinases inhibitor that targets vascular endothelial growth factor receptor, MET and AXL. Xenograft mouse models tested the ability of cabozantinib to rescue sunitinib resistance. We demonstrated that increased AXL and MET expression was associated with inferior clinical outcome in patients. Chronic sunitinib treatment of RCC cell lines activated both AXL and MET, induced EMT-associated gene expression changes, including upregulation of Snail and beta-catenin, and increased cell migration and invasion. Pretreatment with sunitinib enhanced angiogenesis in 786-0/human umbilical vein endothelial cell co-culture models. The suppression of AXL or MET expression and the inhibition of AXL and MET activation using cabozantinib both impaired chronic sunitinib treatment-induced prometastatic behavior in cell culture and rescued acquired resistance to sunitinib in xenograft models. In summary, chronic sunitinib treatment induces the activation of AXL and MET signaling and promotes prometastatic behavior and angiogenesis. The inhibition of AXL and MET activity may overcome resistance induced by prolonged sunitinib therapy in metastatic RCC.	[Zhou, L.; Liu, X-D; Sun, M.; Zhang, X.; German, P.; Bai, S.; Ding, Z.; Tannir, N.; Jonasch, E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1155 Hermann Pressler Dr, Houston, TX 77030 USA; [Wood, C. G.; Matin, S. F.; Karam, J. A.] Univ Texas MD Anderson Canc Ctr, Div Surg, Dept Urol, Houston, TX 77030 USA; [Tamboli, P.; Sircar, K.; Rao, P.; Hoang, A. G.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Rankin, E. B.; Giaccia, A. J.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Laird, D. A.] Exelixis Inc, San Francisco, CA USA; [Walker, C. L.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Stanford University; Exelixis, Inc.; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Jonasch, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1155 Hermann Pressler Dr, Houston, TX 77030 USA.	ejonasch@mdanderson.org		Liu, xiande/0000-0002-9639-0458	Exelixis; Renee Kaye Cure Fur Cancer Foundation; Monteleone Family Foundation; UT MD Anderson Cancer Center P30 Cancer Center Support Grant; NATIONAL CANCER INSTITUTE [R01CA198291, P01CA067166, P30CA016672, R01CA143811] Funding Source: NIH RePORTER	Exelixis; Renee Kaye Cure Fur Cancer Foundation; Monteleone Family Foundation; UT MD Anderson Cancer Center P30 Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Exelixis, Renee Kaye Cure Fur Cancer Foundation, the Monteleone Family Foundation and the UT MD Anderson Cancer Center P30 Cancer Center Support Grant.	Bentzien F, 2013, THYROID, V23, P1569, DOI 10.1089/thy.2013.0137; Betsunoh H, 2007, CANCER SCI, V98, P491, DOI 10.1111/j.1349-7006.2007.00412.x; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Chinchar E, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-12; Choueiri TK, 2014, ANN ONCOL, V25, P1603, DOI 10.1093/annonc/mdu184; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; Domblides C, 2013, EXPERT OPIN EMERG DR, V18, P495, DOI 10.1517/14728214.2013.858697; Ellison AR, 2003, J STEROID BIOCHEM, V86, P15, DOI 10.1016/S0960-0760(03)00257-7; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gibney GT, 2013, ANN ONCOL, V24, P343, DOI 10.1093/annonc/mds463; Griffioen AW, 2012, CLIN CANCER RES, V18, P3961, DOI 10.1158/1078-0432.CCR-12-0002; Gujral TS, 2013, ONCOGENE, V32, P3470, DOI 10.1038/onc.2012.378; Gustafsson A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007575; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Harshman LC, 2013, CANCER J, V19, P316, DOI 10.1097/PPO.0b013e31829e3c9a; Ho MY, 2012, MOL CANCER RES, V10, P1109, DOI 10.1158/1541-7786.MCR-12-0160; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Horie S, 1999, J UROLOGY, V161, P990, DOI 10.1016/S0022-5347(01)61834-2; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Jonasch E, 2010, CANCER-AM CANCER SOC, V116, P57, DOI 10.1002/cncr.24685; Jonasch E, 2009, J CLIN ONCOL, V27, P4076, DOI 10.1200/JCO.2008.21.3660; Kanesvaran Ravindran, 2014, J Carcinog, V13, P3, DOI 10.4103/1477-3163.127638; Kim J, 2009, CLIN CANCER RES, V15, P81, DOI 10.1158/1078-0432.CCR-08-0170; Kumar R, 2009, BRIT J CANCER, V101, P1717, DOI 10.1038/sj.bjc.6605366; Leconet W, 2014, ONCOGENE, V33, P5405, DOI 10.1038/onc.2013.487; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pao-Chun L, 2009, J BIOL CHEM, V284, P34954, DOI 10.1074/jbc.M109.072660; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Plimack ER, 2009, CANCER-AM CANCER SOC, V115, P1859, DOI 10.1002/cncr.24211; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Rankin EB, 2014, P NATL ACAD SCI USA, V111, P13373, DOI 10.1073/pnas.1404848111; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Singhal E, 2011, INT J BIOCHEM CELL B, V43, P1134, DOI 10.1016/j.biocel.2011.04.006; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; THOENES W, 1986, PATHOL RES PRACT, V181, P125, DOI 10.1016/S0344-0338(86)80001-2; Tsavachidou-Fenner D, 2010, ANN ONCOL, V21, P1599, DOI 10.1093/annonc/mdp600; WEIDNER N, 1995, AM J PATHOL, V147, P9; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zhang Y, 2010, IDRUGS, V13, P112; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	47	252	259	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2687	2697		10.1038/onc.2015.343	http://dx.doi.org/10.1038/onc.2015.343			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26364599	Green Accepted			2022-12-26	WOS:000377472700003
J	Deschemin, JC; Noordine, ML; Remot, A; Willemetz, A; Afif, C; Canonne-Hergaux, F; Langella, P; Karim, Z; Vaulont, S; Thomas, M; Nicolas, G				Deschemin, Jean-Christophe; Noordine, Marie-Louise; Remot, Aude; Willemetz, Alexandra; Afif, Clement; Canonne-Hergaux, Francois; Langella, Philippe; Karim, Zoubida; Vaulont, Sophie; Thomas, Muriel; Nicolas, Gael			The microbiota shifts the iron sensing of intestinal cells	FASEB JOURNAL			English	Article						microbes; iron transporters; iron storage; ferroportin	GUT MICROBIOTA; COLONIC EPITHELIUM; EXPRESSION; INFLAMMATION; PROTEINS; MUCOSA; SUPPLEMENTATION; FERROPORTIN; METABOLISM; ABSORPTION	The amount of iron in the diet directly influences the composition of the microbiota. Inversely, the effects of the microbiota on iron homeostasis have been little studied. So, we investigate whether the microbiota itself may alter host iron sensing. Duodenal cytochrome b and divalent metal transporter 1, involved in apical iron uptake, are 8- and 10-fold, respectively, more abundant in the duodenum of germ-free (GF) mice than in mice colonized with a microbiota. In contrast, the luminal exporter ferroportin is 2-fold less abundant in GF. The overall signature of microbiota on iron-related proteins is similar in the colon. The colonization does not modify systemic parameters as plasma transferrin saturation (20%), plasma ferritin (150ng/L), and liver (85 mu g/g) iron load. Commensal organisms (Bacteroides thetaiotaomicron VPI-5482 and Faecalibacterium prausnitzii A2-165) and a probiotic strain (Streptococcus thermophilus LMD-9) led to up to 12-fold induction of ferritin in colon. Our data suggest that the intestinal cells of GF mice are depleted of iron and that following colonization, the epithelial cells favor iron storage. This study is the first to demonstrate that gut microbes induce a specific iron-related protein signature, highlighting new aspects of the crosstalk between the microbiota and the intestinal epithelium.-Deschemin, J.-C., Noordine, M.-L., Remot, A., Willemetz, A., Afif, C., Canonne-Hergaux, F., Langella, P., Karim, Z., Vaulont, S., Thomas, M., Nicolas, G. The microbiota shifts the iron sensing of intestinal cells. FASEB J. 30, 252-261 (2016). www.fasebj.org	[Deschemin, Jean-Christophe; Willemetz, Alexandra; Vaulont, Sophie] INSERM, Inst Cochin, U1016, Paris, France; [Deschemin, Jean-Christophe; Willemetz, Alexandra; Vaulont, Sophie] CNRS, Unite Mixte Rech 8104, Paris, France; [Deschemin, Jean-Christophe; Willemetz, Alexandra; Vaulont, Sophie] Univ Paris 05, Paris, France; [Nicolas, Gael] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Deschemin, Jean-Christophe; Willemetz, Alexandra; Karim, Zoubida; Vaulont, Sophie; Nicolas, Gael] Lab Excellence GR Ex, Paris, France; [Noordine, Marie-Louise; Remot, Aude; Afif, Clement; Langella, Philippe; Thomas, Muriel] INRA, F-78350 Jouy En Josas, France; [Noordine, Marie-Louise; Remot, Aude; Afif, Clement; Langella, Philippe; Thomas, Muriel] AgroParisTech, Jouy En Josas, France; [Noordine, Marie-Louise; Remot, Aude; Afif, Clement; Langella, Philippe; Thomas, Muriel] Commensal & Probiot Host Interact Lab, Unite Mixte Rech 1319, Microbiol Alimentat Serv Sante, Jouy En Josas, France; [Canonne-Hergaux, Francois] Ctr Physiopathol Toulouse Purpan, INSERM, U1043, Toulouse, France; [Canonne-Hergaux, Francois] Univ Toulouse 3, Univ Toulouse, Ctr Physiopathol Toulouse Purpan, F-31062 Toulouse, France; [Canonne-Hergaux, Francois] CNRS, U5282, Toulouse, France; [Karim, Zoubida; Nicolas, Gael] Ctr Rech Inflammat, INSERM, U1149, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Thomas, M (corresponding author), INRA, Unite Mixte Rech 1319, Microbiol Alimentat Serv Sante, F-78350 Jouy En Josas, France.	muriel.thomas@jouy.inra.fr; gael.nicolas@inserm.fr	thomas, muriel/HDO-3887-2022; Canonne-Hergaux, Francois/L-5363-2016; Langella, Philippe/N-8368-2017; Vaulont, Sophie/O-6732-2017; CANONNE-HERGAUX, François/AAC-2073-2020; NICOLAS, Gaël/X-9555-2019; NICOLAS, Gaël/D-7611-2013; Thomas, Muriel/D-9164-2015	Canonne-Hergaux, Francois/0000-0002-0621-2157; Langella, Philippe/0000-0001-5960-4341; CANONNE-HERGAUX, François/0000-0002-0621-2157; NICOLAS, Gaël/0000-0002-1671-8274; NICOLAS, Gaël/0000-0002-1671-8274; Deschemin, Jean-Christophe/0000-0002-1256-8459; Thomas, Muriel/0000-0002-7608-3274; Remot, Aude/0000-0001-9896-3216; KARIM, Zoubida/0000-0002-3724-5592	French National Research Agency "Blanc" program [2010 1130 01]; Laboratory of Excellence GR-Ex - "Investissements d'avenir" program of the French National Research Agency [ANR-11-LABX-0051, ANR-11-IDEX-0005-02]; Institut National de la Recherche Agronomique; European Union [267196]	French National Research Agency "Blanc" program(French National Research Agency (ANR)); Laboratory of Excellence GR-Ex - "Investissements d'avenir" program of the French National Research Agency(French National Research Agency (ANR)); Institut National de la Recherche Agronomique; European Union(European Commission)	The authors thank Nicolas Sorhaindo (Centre de Recherche sur l'Inflammation) for plasma determinations. The authors also thank the staff of the Anaxem (Microbiologie de l'Alimentation au Service de la Sante) animal facility. This study was supported by grants from the French National Research Agency "Blanc" program (2010 1130 01) and from the Laboratory of Excellence GR-Ex (ANR-11-LABX-0051), which is funded by the "Investissements d'avenir" program of the French National Research Agency (ANR-11-IDEX-0005-02). A.R. was supported by an Institut National de la Recherche Agronomique young scientist contract (Contrat Jeune Scientifique Institut National de la Recherche Agronomique) and the European Union, in the framework of the Marie-Curie FP7 COFUND People Program, through the award of an AgreenSkills fellowship under grant agreement number 267196. J.-C.D., M.-L.N., A.R. ,A.W., C.A., G.N., and M.T. carried out experiments. F.C.-H. and A.W. participated in the analysis of Western blotting, and F.C.-H. provided divalent metal transporter 1 antibody. Z.K. participated in the analysis of iron, ferritin, and transferrin dosages. P.L., S.V., M.T., and G.N. conceived the study and participated in its design, coordination, and financial support. G.N. and M.T. wrote the manuscript. M.T. and G.N. share co-senior authorship of this article. All authors read and approved the final manuscript. The authors declare no conflicts of interest.	Blachier F, 2007, CAN J PHYSIOL PHARM, V85, P185, DOI 10.1139/Y07-007; Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Buhnik-Rosenblau K, 2012, BIOMETALS, V25, P883, DOI 10.1007/s10534-012-9555-5; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Cherbuy C, 2004, EUR J BIOCHEM, V271, P87, DOI 10.1046/j.1432-1033.2003.03908.x; CHERBUY C, 1995, GASTROENTEROLOGY, V109, P1890, DOI 10.1016/0016-5085(95)90756-4; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Deschemin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061050; Dostal A, 2014, BRIT J NUTR, V112, P547, DOI 10.1017/S0007114514001160; Dostal A, 2012, J NUTR, V142, P271, DOI 10.3945/jn.111.148643; El Aidy S, 2013, GUT, V62, P1306, DOI 10.1136/gutjnl-2011-301955; El Aidy S, 2013, ISME J, V7, P743, DOI 10.1038/ismej.2012.142; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; Frazer DM, 2007, AM J PHYSIOL-GASTR L, V293, pG525, DOI 10.1152/ajpgi.00579.2006; Fuqua BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098792; Galy B, 2013, CELL REP, V3, P844, DOI 10.1016/j.celrep.2013.02.026; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Guo XC, 2014, CHEMOSPHERE, V112, P1, DOI 10.1016/j.chemosphere.2014.03.068; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460, DOI 10.2174/138161211798072463; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kortman GAM, 2014, FEMS MICROBIOL REV, V38, P1202, DOI 10.1111/1574-6976.12086; Lacroix C, 2015, CURR OPIN BIOTECH, V32, P149, DOI 10.1016/j.copbio.2014.12.009; Marciano R, 2015, BRIT J NUTR, V113, P901, DOI 10.1017/S0007114514004334; Miquel S, 2015, MBIO, V6, DOI 10.1128/mBio.00300-15; Moulouel B, 2013, KIDNEY INT, V84, P756, DOI 10.1038/ki.2013.142; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; PIZARRO F, 1987, AM J CLIN NUTR, V45, P484, DOI 10.1093/ajcn/45.2.484; REDDY BS, 1972, J NUTR, V102, P101, DOI 10.1093/jn/102.1.101; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; Shanmugam NKN, 2014, J IMMUNOL, V193, P1398, DOI 10.4049/jimmunol.1400278; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028789; Tomas J, 2015, ISME J, V9, P46, DOI 10.1038/ismej.2014.111; Tomas J, 2013, FASEB J, V27, P645, DOI 10.1096/fj.12-216861; Tomas Julie, 2012, Animal Health Research Reviews, V13, P54, DOI 10.1017/S1466252312000072; Tompkins GR, 2001, CURR MICROBIOL, V43, P38, DOI 10.1007/s002840010257; Turpin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057711; Vazquez-Gutierrez P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-014-0334-z; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Wilkinson N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00176; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Yang FM, 2002, J BIOL CHEM, V277, P39786, DOI 10.1074/jbc.M201485200	49	57	60	2	62	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					252	261		10.1096/fj.15-276840	http://dx.doi.org/10.1096/fj.15-276840			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26370847				2022-12-26	WOS:000367621000025
J	Pedram, A; Razandi, M; Blumberg, B; Levin, ER				Pedram, Ali; Razandi, Mahnaz; Blumberg, Bruce; Levin, Ellis Robert			Membrane and nuclear estrogen receptor a collaborate to suppress adipogenesis but not triglyceride content	FASEB JOURNAL			English	Article						BMSCs; preadipocytes; adipocyte hypertrophy; kinase activation; ChREBP	BODY-FAT DISTRIBUTION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; OBESOGEN TRIBUTYLTIN; REPLACEMENT THERAPY; GLUCOSE-METABOLISM; PRENATAL EXPOSURE; ALPHA; BETA	Estrogen and estrogen receptor (ER)-alpha suppress visceral fat development through actions in several organs via unclear mechanisms that we sought to identify. Using mice that express only nuclear ER-alpha [nuclear-only ER-alpha (NOER) mice] or plasma membrane ER-alpha[membrane-only ER-alpha (MOER) mice], we found that 10-wk-old mice that lacked either receptor pool showed extensive abdominal visceral fat deposition and weight gain compared with wild-type (WT) mice. Differentiation of cultured bone marrow stem cells (BMSCs) into the adipocyte lineage was suppressed by 17-beta-estradiol (E2) in WT female mice but not in NOER or MOER mice. This finding correlated with E2 inhibition of prominent differentiation genes in WT BMSCs. In contrast, triglyceride content in differentiated BMSCs or 3T3-L1 cells was suppressed as a result of membrane ER-alpha signaling through several kinases to inhibit carbohydrate response element-binding protein-alpha and -beta. We concluded that extranuclear and nuclear ER-alpha collaborate to suppress adipocyte development, but inhibition of lipid synthesis in mature cells does not involve nuclear ER-alpha.-Pedram, A., Razandi, M., Blumberg, B., Levin, E. R. Membrane and nuclear estrogen receptor a collaborate to suppress adipogenesis but not triglyceride content. FASEB J. 30, 230-240 (2016). www.fasebj.org	[Pedram, Ali; Razandi, Mahnaz; Levin, Ellis Robert] Vet Affairs Med Ctr, Div Endocrinol, Long Beach, CA USA; [Blumberg, Bruce] Univ Calif Irvine, Dept Dev & Cell Biol, Long Beach, CA 90822 USA; [Levin, Ellis Robert] Univ Calif Irvine, Dept Med, Long Beach, CA 90822 USA; [Levin, Ellis Robert] Univ Calif Irvine, Dept Biochem, Long Beach, CA 90822 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Levin, ER (corresponding author), Univ Calif Irvine, Long Beach Vet Affairs Med Ctr, Med Serv 111-I,5901 E 7th St, Long Beach, CA 90822 USA.	ellis.levin@va.gov			Research Service of the Department of Veteran's Affairs; U.S. National Institutes of Health [CA-10036]; Institute of Cancer Research; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002316] Funding Source: NIH RePORTER	Research Service of the Department of Veteran's Affairs(US Department of Veterans Affairs); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a grant from the Research Service of the Department of Veteran's Affairs (to E.R.L), and Grant CA-10036 from the U.S. National Institutes of Health, Institute of Cancer Research (to E.R.L.). A.P. and M.R. performed the research, and E.R.L. and B.B. designed the research and analyzed the data. E.R.L. wrote the paper. B.B. is a named inventor on U.S. patents 5,861,274; 6,200,802; 6,815,168; and 7,250,273 related to PPAR-gamma. The remaining authors declare no conflicts of interest.	Anderson LA, 2001, J CLIN ENDOCR METAB, V86, P5045, DOI 10.1210/jc.86.10.5045; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414; HAARBO J, 1991, METABOLISM, V40, P1323, DOI 10.1016/0026-0495(91)90037-W; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Harris HA, 2002, ENDOCRINOLOGY, V143, P4172, DOI 10.1210/en.2002-220403; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hong JN, 2011, INT J ONCOL, V39, P1443, DOI 10.3892/ijo.2011.1162; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kirchner S, 2010, MOL ENDOCRINOL, V24, P526, DOI 10.1210/me.2009-0261; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lapid K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6196; Levin ER, 2014, AM J PHYSIOL-ENDOC M, V307, pE133, DOI 10.1152/ajpendo.00626.2013; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Monsenego J, 2012, J HEPATOL, V56, P632, DOI 10.1016/j.jhep.2011.10.008; Okura T, 2003, INT J OBESITY, V27, P1020, DOI 10.1038/sj.ijo.0802378; Pedram A, 2005, J BIOL CHEM, V280, P26339, DOI 10.1074/jbc.M414409200; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pedram A, 2014, DEV CELL, V29, P482, DOI 10.1016/j.devcel.2014.04.016; Pedram A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004013; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; Pedram A, 2009, J BIOL CHEM, V284, P3488, DOI 10.1074/jbc.M806249200; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Razandi M, 2013, ONCOGENE, V32, P3274, DOI 10.1038/onc.2012.335; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Seidlova-Wuttke D, 2008, BONE, V43, P849, DOI 10.1016/j.bone.2008.07.237; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Tiano JP, 2012, ENDOCRINOLOGY, V153, P2997, DOI 10.1210/en.2011-1980; Trogden BG, 2009, BIOORG MED CHEM LETT, V19, P485, DOI 10.1016/j.bmcl.2008.11.043; UTIAN WH, 1987, AM J OBSTET GYNECOL, V156, P1280, DOI 10.1016/0002-9378(87)90164-5; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Yonezawa R, 2012, AM J PHYSIOL-ENDOC M, V303, pE445, DOI 10.1152/ajpendo.00638.2011	39	58	59	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					230	240		10.1096/fj.15-274878	http://dx.doi.org/10.1096/fj.15-274878			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26373802	Green Published, Green Submitted			2022-12-26	WOS:000367621000023
J	Lee, JG; Heur, M				Lee, Jeong Goo; Heur, Martin			WNT10B Enhances Proliferation through beta-Catenin and RAC1 GTPase in Human Corneal Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MAMMARY EPITHELIAL-CELLS; MESENCHYMAL TRANSFORMATION; RHO-GTPASES; SIGNALING PATHWAY; CYCLIN D1; PHOSPHATIDYLINOSITOL 3-KINASE; VERTEBRATE GASTRULATION; CANCER CELLS; CROSS-TALK	The cornea is the anterior, transparent tissue of the human eye that serves as its main refractive element. Corneal endothelial cells are arranged as a monolayer on the posterior surface of the cornea and function as a pump to counteract the leakiness of its basement membrane. Maintaining the cornea in a slightly dehydrated state is critical for the maintenance of corneal transparency. Adult human corneal endothelial cells are G(1)-arrested, even in response to injury, leading to an age-dependent decline in endothelial cell density. Corneal edema and subsequent vision loss ensues when endothelial cell density decreases below a critical threshold. Vision loss secondary to corneal endothelial dysfunction is a common indication for transplantation in developed nations. An impending increase in demand for and a current global shortage of donor corneas will necessitate the development of treatments for vision loss because of endothelial dysfunction that do not rely on donor corneas. Wnt ligands regulate many critical cellular functions, such as proliferation, making them attractive candidates for modulation in corneal endothelial dysfunction. We show that WNT10B causes nuclear transport and binding of RAC1 and beta-catenin in human corneal endothelial cells, leading to the activation of Cyclin D1 expression and proliferation. Our findings indicate that WNT10B promotes proliferation in human corneal endothelial cells by simultaneously utilizing both beta-catenin-dependent and -independent pathways and suggest that its modulation could be used to treat vision loss secondary to corneal endothelial dysfunction.	[Lee, Jeong Goo; Heur, Martin] Univ So Calif, Keck Sch Med, Inst Eye, Los Angeles, CA 90033 USA	University of Southern California	Heur, M (corresponding author), USCEye Inst, 1450 San Pablo St,Rm 4802, Los Angeles, CA 90033 USA.	heur@usc.edu			Kehle family; NATIONAL EYE INSTITUTE [K08EY021485] Funding Source: NIH RePORTER	Kehle family; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the Kehle family for their generous support.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cajanek L, 2013, MOL CELL BIOL, V33, P59, DOI 10.1128/MCB.00745-12; Chahdi A, 2013, J BIOL CHEM, V288, P34019, DOI 10.1074/jbc.M113.480103; Chen Y, 2006, SEMIN CELL DEV BIOL, V17, P712, DOI 10.1016/j.semcdb.2006.11.005; Chim CS, 2007, LEUKEMIA, V21, P2527, DOI 10.1038/sj.leu.2404939; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Djalilian AR, 2006, CORNEA, V25, P709, DOI 10.1097/01.ico.0000208815.02120.90; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; GEROSKI DH, 1984, INVEST OPHTH VIS SCI, V25, P1056; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Grandy D, 2009, J BIOL CHEM, V284, P16256, DOI 10.1074/jbc.M109.009647; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamilton G, 2014, MAR DRUGS, V12, P1377, DOI 10.3390/md12031377; Hatou S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0286; Hirata-Tominaga K, 2013, STEM CELLS, V31, P1396, DOI 10.1002/stem.1390; Honda N, 2009, ARCH OPHTHALMOL-CHIC, V127, P1321, DOI 10.1001/archophthalmol.2009.253; Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; Katoh M, 2007, INT J MOL MED, V19, P699; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Ko MK, 2005, INVEST OPHTH VIS SCI, V46, P4495, DOI 10.1167/iovs.05-0818; KREUTZIGER GO, 1976, EXP EYE RES, V23, P285, DOI 10.1016/0014-4835(76)90129-9; Lee HT, 2004, J BIOL CHEM, V279, P32325, DOI 10.1074/jbc.M405208200; Lee JG, 2007, J BIOL CHEM, V282, P6444, DOI 10.1074/jbc.M607808200; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P2358, DOI 10.1167/iovs.05-1490; Lee JG, 2014, MOL CELL BIOL, V34, P3535, DOI 10.1128/MCB.01572-13; Lee JG, 2013, BIOL CELL, V105, P175, DOI 10.1111/boc.201200077; Lee JG, 2012, INVEST OPHTH VIS SCI, V53, P1530, DOI 10.1167/iovs.11-9102; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P8216, DOI 10.1167/iovs.11-8213; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P417, DOI 10.1167/iovs.10-6140; Lee JG, 2009, INVEST OPHTH VIS SCI, V50, P2067, DOI 10.1167/iovs.08-3135; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P1376, DOI 10.1167/iovs.05-1223; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moore JE, 2002, INVEST OPHTH VIS SCI, V43, P2905; Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255; Numata R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088169; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Okumura N, 2014, CORNEA, V33, pS37, DOI 10.1097/ICO.0000000000000229; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P318, DOI 10.1167/iovs.13-12225; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Polakis P, 2000, GENE DEV, V14, P1837; Randall RM, 2012, J ORTHOP RES, V30, P1906, DOI 10.1002/jor.22152; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Rossol-Allisone J, 2009, CELL SIGNAL, V21, P1559, DOI 10.1016/j.cellsig.2009.05.010; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Song JS, 2010, INVEST OPHTH VIS SCI, V51, P822, DOI 10.1167/iovs.09-4240; Stump RJW, 2003, DEV BIOL, V259, P48, DOI 10.1016/S0012-1606(03)00179-9; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang JD, 2012, HUM PATHOL, V43, P1044, DOI 10.1016/j.humpath.2011.08.013; Zhu YT, 2014, J CELL BIOL, V206, P799, DOI 10.1083/jcb.201404032	72	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26752	26764		10.1074/jbc.M115.677245	http://dx.doi.org/10.1074/jbc.M115.677245			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370090	Green Published, hybrid			2022-12-26	WOS:000364793600037
J	John, G; Louis, C; Berner, A; Genne, D				John, Gregor; Louis, Celine; Berner, Amandine; Genne, Daniel			Tobacco Stained Fingers and Its Association with Death and Hospital Admission: A Retrospective Cohort Study	PLOS ONE			English	Article							SMOKING; ALCOHOL; READMISSION; MORTALITY; OUTCOMES; FRAILTY; PNEUMONIA; DRINKING; HISTORY; RISK	Background Among smokers, the presence of tobacco stains on fingers has recently been associated with a high prevalence of tobacco related conditions and alcohol abuse. Objective we aimed to explore tobacco stains as a marker of death and hospital readmission. Method Seventy-three smokers presenting tobacco-tar staining on their fingers and 70 control smokers were followed during a median of 5.5 years in a retrospective cohort study. We used the Kaplan-Meier survival analysis and the log-rank test to compare mortality and hospital readmission rates among smokers with and smokers without tobacco stains. Multivariable Cox models were used to adjust for confounding factors: age, gender, pack-year unit smoked, cancer, harmful alcohol use and diabetes. The number of hospital admissions was compared through a negative binomial regression and adjusted for the follow-up time, diabetes, and alcohol use. Results Forty-three patients with tobacco-stained fingers died compared to 26 control smokers (HR 1.6; 95% CI: 1.0 to 2.7; p 0.048). The association was not statistically significant after adjustment. Patients with tobacco-stained fingers needed a readmission earlier than smokers without stains (HR 2.1; 95% CI: 1.4 to 3.1; p<0.001), and more often (incidence rate ratio (IRR) 1.6; 95% CI: 1.1 to 2.1). Associations between stains and the first hospital readmission (HR 1.6; 95% CI: 1.0 to 2.5), and number of readmissions (IRR 1.5; 95% CI: 1.1 to 2.1) persisted after adjustment for confounding factors. Conclusions Compared to other smokers, those presenting tobacco-stained fingers have a high unadjusted mortality rate and need early and frequent hospital readmission even when controlling for confounders.	[John, Gregor; Louis, Celine; Berner, Amandine] Hop Neuchatelois, Dept Internal Med, CH-2300 La Chaux De Fonds, Switzerland; [John, Gregor] Univ Hosp Geneva, Dept Internal Med Geriatr & Rehabil, CH-1205 Geneva, Switzerland; [Genne, Daniel] Ctr Hosp Bienne, Dept Internal Med, CH-2501 Biel, Switzerland	University of Geneva	John, G (corresponding author), Hop Neuchatelois, Dept Internal Med, CH-2300 La Chaux De Fonds, Switzerland.	Gregor.John@h-ne.ch	Berner, Amandine/AHC-8435-2022; Genne, Daniel/O-2305-2014; John, Gregor/AAJ-6424-2021	John, Gregor/0000-0002-1548-7339				Abrams L, 2000, Nurs Stand, V14, P59; Abrams P, 2000, AM J MANAG CARE, V6, pS580; Bisson EF, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00020; Burke RE, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-423; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Dawson DA, 2000, DRUG ALCOHOL DEPEN, V59, P235, DOI 10.1016/S0376-8716(99)00130-1; El Solh AA, 2004, J AM GERIATR SOC, V52, P2010, DOI 10.1111/j.1532-5415.2004.52556.x; Evangelista LS, 2000, AM J CARDIOL, V86, P1339, DOI 10.1016/S0002-9149(00)01238-8; FRIEDMAN GD, 1991, DRUG ALCOHOL DEPEN, V27, P283, DOI 10.1016/0376-8716(91)90011-M; Guessous Idris, 2014, J Aging Res, V2014, P198603, DOI 10.1155/2014/198603; Hubbard RE, 2009, J NUTR HEALTH AGING, V13, P468, DOI 10.1007/s12603-009-0085-y; John G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003304; Jorgensen CC, 2013, ACTA ANAESTH SCAND, V57, P631, DOI 10.1111/aas.12086; Jurschik P, 2012, ARCH GERONTOL GERIAT, V55, P625, DOI 10.1016/j.archger.2012.07.002; Kobayashi M, 2010, INT J PSYCHIAT MED, V40, P247, DOI 10.2190/PM.40.3.b; Kulaylat AN, 2015, COLORECTAL DIS; Lawder R, 2011, PUBLIC HEALTH, V125, P533, DOI 10.1016/j.puhe.2011.05.007; Leow JJ, 2014, CAN J UROL, V21, P7537; Long J.S., 2006, REGRESSION MODELS CA; Nelson JA, 2015, HERNIA, V19, P125, DOI 10.1007/s10029-014-1329-2; NIL R, 1984, PHARMACOL BIOCHEM BE, V20, P583, DOI 10.1016/0091-3057(84)90308-3; Prochaska JJ, 2014, AM J PUBLIC HEALTH, V104, P1557, DOI 10.2105/AJPH.2013.301403; Qiao Q, 2000, EUR HEART J, V21, P1621, DOI 10.1053/euhj.2000.2151; Rigotti NA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub2; Shen L, 2013, AM HEART J, V166, P1056, DOI 10.1016/j.ahj.2013.09.011; Sule S, 2011, CLIN CARDIOL, V34, P35, DOI 10.1002/clc.20872; The Criteria Committee of the New York Heart Association, 1994, NOM CRIT DAGN DIS HE; Wang CX, 2013, J GERONTOL A-BIOL, V68, P338, DOI 10.1093/gerona/gls166; Wood D, 1960, PROJECT WHEAT 1; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; World Health Organization (WHO), 2011, REP GLOB TOB EP; Yadav D, 2012, AM J GASTROENTEROL, V107, P1096, DOI 10.1038/ajg.2012.126	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138211	10.1371/journal.pone.0138211	http://dx.doi.org/10.1371/journal.pone.0138211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8NH	26375287	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200087
J	Pope, LC; Riginos, C; Ovenden, J; Keyse, J; Blomberg, SP				Pope, Lisa C.; Riginos, Cynthia; Ovenden, Jennifer; Keyse, Jude; Blomberg, Simon P.			Population Genetic Diversity in the Australian 'Seascape': A Bioregion Approach	PLOS ONE			English	Article							SPECIES RICHNESS; GLOBAL PATTERNS; CLIMATE-CHANGE; BIODIVERSITY; SIZE; CONSERVATION; DIVERGENCE; PREDICTORS; EVOLUTION; FRAMEWORK	Genetic diversity within species may promote resilience to environmental change, yet little is known about how such variation is distributed at broad geographic scales. Here we develop a novel Bayesian methodology to analyse multi-species genetic diversity data in order to identify regions of high or low genetic diversity. We apply this method to co-distributed taxa from Australian marine waters. We extracted published summary statistics of population genetic diversity from 118 studies of 101 species and > 1000 populations from the Australian marine economic zone. We analysed these data using two approaches: a linear mixed model for standardised data, and a mixed beta-regression for unstandardised data, within a Bayesian framework. Our beta-regression approach performed better than models using standardised data, based on posterior predictive tests. The best model included region (Integrated Marine and Coastal Regionalisation of Australia (IMCRA) bioregions), latitude and latitude squared. Removing region as an explanatory variable greatly reduced model performance (delta DIC 23.4). Several bioregions were identified as possessing notably high genetic diversity. Genetic diversity increased towards the equator with a 'hump' in diversity across the range studied (-9.4 to -43.7 degrees S). Our results suggest that factors correlated with both region and latitude play a role in shaping intra-specific genetic diversity, and that bioregion can be a useful management unit for intra-specific as well as species biodiversity. Our novel statistical model should prove useful for future analyses of within species genetic diversity at broad taxonomic and geographic scales.	[Pope, Lisa C.; Riginos, Cynthia; Keyse, Jude; Blomberg, Simon P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Ovenden, Jennifer] Univ Queensland, Mol Fisheries Lab, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Pope, LC (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	l.pope@uq.edu.au	Riginos, Cynthia/G-3320-2010; Pope, Lisa C/A-7533-2011; Ovenden, Jennifer/A-3717-2010; Blomberg, Simone P/B-7613-2008	Riginos, Cynthia/0000-0002-5485-4197; Pope, Lisa C/0000-0002-1791-3979; Ovenden, Jennifer/0000-0001-7538-1504; Blomberg, Simone P/0000-0003-1062-0839	University of Queensland, UQ Postdoctoral Research Fellowships for Women	University of Queensland, UQ Postdoctoral Research Fellowships for Women	LP was funded to perform this work by The University of Queensland, UQ Postdoctoral Research Fellowships for Women, part-time (http://www.uq.edu.au/research/research-management/uq-postdoctoral-research-fellowships-for-women). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2013, EVOL ECOL, V27, P133, DOI 10.1007/s10682-012-9587-x; [Anonymous], 2014, R LANG ENV STAT COMP; April J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070296; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barr LM, 2013, MAR POLICY, V42, P39, DOI 10.1016/j.marpol.2013.01.012; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Begg GA, 1999, FISH RES, V43, P35, DOI 10.1016/S0165-7836(99)00065-X; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Campbell AK, 2003, J APPL ECOL, V40, P193, DOI 10.1046/j.1365-2664.2003.00803.x; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Coyle T, 1997, STOCK IDENTIFICATION, P173; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Figueroa-Zuniga JI, 2012, ARXIV12012375V4; Flood M, 2012, STATUS KEY FISH STOC; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Gaither MR, 2013, J BIOGEOGR, V40, P1638, DOI 10.1111/jbi.12126; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gelman A., 2004, BAYESIAN DATA ANAL, V2nd, P157; Gelman A., 2021, BAYESIAN DATA ANAL; Gillman LN, 2014, J BIOGEOGR, V41, P39, DOI 10.1111/jbi.12173; Gillman LN, 2009, P R SOC B, V276, P3353, DOI 10.1098/rspb.2009.0674; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Harrisson KA, 2014, EVOL APPL, V7, P1008, DOI 10.1111/eva.12149; Hawkins BA, 2001, TRENDS ECOL EVOL, V16, P470, DOI 10.1016/S0169-5347(01)02197-8; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Keyse J, 2014, B MAR SCI, V90, P47, DOI 10.5343/bms.2012.1107; Kimura M., 1983, NEUTRAL THEORY MOL E; Last PR, 2011, J BIOGEOGR, V38, P1484, DOI 10.1111/j.1365-2699.2011.02484.x; Last PR, 2010, BIOL CONSERV, V143, P1675, DOI 10.1016/j.biocon.2010.04.008; Lawson AB, 2003, WINBUGS BASICS DIS M; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mapstone B. D., 2010, NATL CLIMATE CHANGE; Marshall JL, 2006, ACTA OECOL, V29, P33, DOI 10.1016/j.actao.2005.07.008; Martin PR, 2004, EVOLUTION, V58, P938; McCallum AW, 2013, MAR ECOL-EVOL PERSP, V34, P298, DOI 10.1111/maec.12016; McCusker MR, 2010, MOL ECOL, V19, P4852, DOI 10.1111/j.1365-294X.2010.04822.x; Miller MJ, 2010, ECOL LETT, V13, P576, DOI 10.1111/j.1461-0248.2010.01454.x; Mirams AGK, 2011, CORAL REEFS, V30, P937, DOI 10.1007/s00338-011-0767-x; Murtagh F, 2011, WARDS HIERARCHICAL C; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; NEI M, 1981, GENETICS, V97, P145; NEI M, 1978, GENETICS, V89, P583; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; O'Corry-Crowe G, 2008, ECOL APPL, V18, pS56, DOI 10.1890/06-0795.1; O'Hara TD, 2011, CURR BIOL, V21, P226, DOI 10.1016/j.cub.2011.01.002; Oksanen J., **DATA OBJECT**; Ovenden JR, 2013, FISH FISH, V16, P125, DOI DOI 10.1111/FAF.12052; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pinsky ML, 2014, MOL ECOL, V23, P29, DOI 10.1111/mec.12509; Pope LC, 2015, MOL ECOL, V24, P3802, DOI 10.1111/mec.13254; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Romiguier J, 2014, NATURE, V515, P261, DOI 10.1038/nature13685; RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785; Ryman N, 2014, MOL ECOL RESOUR, V14, P87, DOI 10.1111/1755-0998.12154; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Taberlet P, 2012, ECOL LETT, V15, P1439, DOI 10.1111/ele.12004; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; United Nations, 2012, FUTURE WE WANT; Vandergast AG, 2011, MOL ECOL RESOUR, V11, P158, DOI 10.1111/j.1755-0998.2010.02904.x; Vellend M, 2003, AM NAT, V162, P358, DOI 10.1086/377189; Vellend M, 2014, MOL ECOL, V23, P2890, DOI 10.1111/mec.12756; Volkmann L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088945; Vucetich JA, 2003, CONSERVATION GENETIC, V45; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Whitlock R, 2014, J ECOL, V102, P857, DOI 10.1111/1365-2745.12240; Wilcox B. A., 1984, NATL PARKS CONSERVAT, P18; Woolley SNC, 2013, DIVERS DISTRIB, V19, P1506, DOI 10.1111/ddi.12119	83	13	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136275	10.1371/journal.pone.0136275	http://dx.doi.org/10.1371/journal.pone.0136275			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375711	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200013
J	Shiferaw, MB; Hailu, HA; Fola, AA; Derebe, MM; Kebede, AT; Kebede, AA; Emiru, MA; Gelaw, ZD				Shiferaw, Melashu Balew; Hailu, Hiwot Amare; Fola, Abebe Alemu; Derebe, Mulatu Melese; Kebede, Aimro Tadese; Kebede, Abayneh Admas; Emiru, Manamnot Agegne; Gelaw, Zelalem Dessie			Tuberculosis Laboratory Diagnosis Quality Assurance among Public Health Facilities in West Amhara Region, Ethiopia	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; ACID-FAST BACILLI	Introduction Reliable smear microscopy is an important component of Directly Observed Treatment Scheme (DOTS) strategy for TB control program in countries with limited resources. Despite external quality assessment is established in Ethiopia, there is lower TB detection rate (48%) in Amhara region compared to the World Health Organization (WHO) estimate (70%). This highlights the quality of smear microscopy needs to be evaluated. Therefore, the aim of this study was to assess the quality of sputum smear microscopy performance among health center laboratories in West Amhara region, Ethiopia. Materials and Methods A cross sectional study was conducted from July 08, 2013 to July 07, 2014. Data were collected from 201 public health center laboratories using a structured questionnaire. Slides were collected based on Lot Quality Assurance Sampling (LQAS) method and rechecked blindly by trained laboratory technologists. The data were entered into EPI info V. 7 and smear quality indicators and AFB results were analyzed by SPSS version 20. Results Among 201 laboratories enrolled in this study, 47 (23.4%) laboratories had major errors. Forty one (20.4%) laboratories had a total of 67 false negative and 29 (14.4%) laboratories had a total of 68 false positive results. Specimen quality, smear thickness and evenness were found poor in 134 (66.7%), 133 (66.2%) and 126 (62.7%) laboratories, respectively. Unavailability of microscope lens cleaning solution (AOR: 2.90; 95% CI: 1.25-6.75; P: 0.013) and dirty smears (AOR: 2.65; 95% CI: 1.14-6.18; P: 0.024) were correlated with false negative results whereas no previous EQA participation (AOR: 3.43; 95% CI: 1. 39-8.45; P: 0.007) was associated with false positive results. Conclusion The performance of health facilities for sputum smear microscopy was relatively poor in West Amhara region. Hence, strengthening the EQA program and technical support on sputum smear microscopy are recommended to ensure quality tuberculosis diagnostic service.	[Shiferaw, Melashu Balew; Hailu, Hiwot Amare; Derebe, Mulatu Melese; Kebede, Aimro Tadese; Emiru, Manamnot Agegne; Gelaw, Zelalem Dessie] Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia; [Fola, Abebe Alemu] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Kebede, Abayneh Admas] Amhara Reg State Hlth Bur, Bahir Dar, Ethiopia	Walter & Eliza Hall Institute	Shiferaw, MB (corresponding author), Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia.	bmelashu@gmail.com	Shiferaw, Melashu/GPT-3320-2022; Fola, Abebe/AAV-8048-2021	Shiferaw, Melashu Balew/0000-0002-5066-0758				Ajaykumar T, 2006, NTI B, V42, P15; Amhara Regional Health Bureau, 2013, TUB ANN REP; Basra D, 2006, East Afr Med J, V83, P306; Ethiopian Health and Nutrition Research Institute, 2009, AFB SMEAR MICR MAN; Ethiopian Health and Nutrition Research Institute Federal Ministry of Health, 2009, GUID QUAL ASS SMEAR; Farnia P, 2003, TANAFFOS, V2, P29; Federal Ministry of Health, 2012, GUID CLIN PROGR MAN; Jha K, 2011, SAARC J TUBER LUNG D, V8, P20; Kusznierz GF, 2004, INT J TUBERC LUNG D, V8, P1234; Lan NTN, 1999, INT J TUBERC LUNG D, V3, P55; PHL CDC IUATLD KNCV RIT, 2002, EXT QUAL ASS AFB SME; Rohit Sarin, 2002, Indian Journal of Tuberculosis, V49, P143; Selvakumar N, 2005, J CLIN MICROBIOL, V43, P913, DOI 10.1128/JCM.43.2.913-915.2005; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2003, QUAL ASS SPUT MICR D; World Health Organization Stop TB Partnership, 2006, STOP TB STRAT BUILD; Wu MH, 2009, INT J TUBERC LUNG D, V13, P606	19	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138488	10.1371/journal.pone.0138488	http://dx.doi.org/10.1371/journal.pone.0138488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376438	Green Submitted, Green Published, gold			2022-12-26	WOS:000361610200110
J	Chen, MJ; Lu, YQ; Simpson, NE; Beveridge, MJ; Elshikha, AS; Akbar, MA; Tsai, HY; Hinske, S; Qin, JL; Grunwitz, CR; Chen, TN; Brantly, ML; Song, SH				Chen, Mong-Jen; Lu, Yuanqing; Simpson, Nicholas E.; Beveridge, Mark J.; Elshikha, Ahmed S.; Akbar, Mohammad Ahsanul; Tsai, Hsin-Yin; Hinske, Stephanie; Qin, Junling; Grunwitz, Christian R.; Chen, Tina; Brantly, Mark L.; Song, Sihong			In Situ Transplantation of Alginate Bioencapsulated Adipose Tissues Derived Stem Cells (ADSCs) via Hepatic Injection in a Mouse Model	PLOS ONE			English	Article							HEPATOCYTE-LIKE CELLS; LIVER FIBROSIS; DIFFERENTIATION; MICROSPHERES; REPOPULATION; ENGRAFTMENT; GENERATION; DISEASE; VIVO	Objective Adipose tissue derived stem cells (ADSCs) transplantation has recently gained widespread enthusiasm, particularly in the perspective to use them as potential alternative cell sources for hepatocytes in cell based therapy, mainly because of their capability of hepatogenic differentiation in vitro and in vivo. But some challenges remain to be addressed, including whether ADSCs can be provided effectively to the target organ and whether subsequent proliferation of transplanted cells can be achieved. To date, intrasplenic injection is the conventional method to deliver ADSCs into the liver; however, a number of donor cells retained in the spleen has been reported. In this study, our objective is to evaluate a novel route to transplant ADSCs specifically to the liver. We aimed to test the feasibility of in situ transplantation of ADSCs by injecting bioencapsulated ADSCs into the liver in mouse model. Methods The ADSCs isolated from human alpha 1 antitrypsin (M-hAAT) transgenic mice were used to allow delivered ADSCs be readily identified in the liver of recipient mice, and alginate was selected as a cell carrier. We first evaluated whether alginate microspheres are implantable into the liver tissue by injection and whether ADSCs could migrate from alginate microspheres (study one). Once proven, we then examined the in vivo fate of ADSCs loaded microspheres in the liver. Specifically, we evaluated whether transplanted, undifferentiated ASDCs could be induced by the local microenvironment toward hepatogenic differentiation and the distribution of surviving ADSCs in major tissue organs (study two). Results Our results indicated ADSCs loaded alginate microspheres were implantable into the liver. Both degraded and residual alginate microspheres were observed in the liver up to three weeks. The viable ADSCs were detectable surrounding degraded and residual alginate microspheres in the liver and other major organs such as bone marrow and the lungs. Importantly, transplanted ADSCs underwent hepatogenic differentiation to become cells expressing albumin in the liver. These findings improve our understanding of the interplay between ADSCs (donor cells), alginate (biomaterial), and local microenvironment in a hepatectomized mouse model, and might improve the strategy of in situ transplantation of ADSCs in treating liver diseases.	[Chen, Mong-Jen; Lu, Yuanqing; Elshikha, Ahmed S.; Akbar, Mohammad Ahsanul; Tsai, Hsin-Yin; Hinske, Stephanie; Qin, Junling; Grunwitz, Christian R.; Chen, Tina; Song, Sihong] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA; [Simpson, Nicholas E.; Beveridge, Mark J.; Brantly, Mark L.] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Song, SH (corresponding author), Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA.	shsong@ufl.edu	Brantly, Mark/AAH-2922-2020					Allen KJ, 2004, J GASTROEN HEPATOL, V19, P1283, DOI 10.1111/j.1440-1746.2004.03451.x; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Chen MJ, 2014, HUM GENE THER METHOD, V25, P72, DOI 10.1089/hgtb.2013.011; De Vree JML, 2000, GASTROENTEROLOGY, V119, P1720, DOI 10.1053/gast.2000.20222; Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Grompe M, 1999, Hum Cell, V12, P171; Harn HJ, 2012, CELL TRANSPLANT, V21, P2753, DOI 10.3727/096368912X652959; Jain E, 2014, HEPATOL INT, V8, P185, DOI 10.1007/s12072-013-9503-7; Ji R, 2012, BIOMATERIALS, V33, P8995, DOI 10.1016/j.biomaterials.2012.08.058; Joseph B, 2006, HEPATOLOGY, V44, P1411, DOI 10.1002/hep.21416; KAHN D, 1984, J SURG RES, V37, P290, DOI 10.1016/0022-4804(84)90191-4; Kim SJ, 2011, J KOREAN SURG SOC, V81, P176, DOI 10.4174/jkss.2011.81.3.176; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Li H, 2011, J HEPATOL, V54, P930, DOI 10.1016/j.jhep.2010.07.051; Li KG, 2004, BIOTECHNOL LETT, V26, P879, DOI 10.1023/B:bile.0000025896.61490.6d; Li YS, 2013, CELL TRANSPLANT, V22, P685, DOI 10.3727/096368912X655163; Lin N, 2010, CELL PROLIFERAT, V43, P427, DOI 10.1111/j.1365-2184.2010.00692.x; Meier RPH, 2015, J HEPATOL, V62, P634, DOI 10.1016/j.jhep.2014.10.030; Meier RPH, 2013, STEM CELL RES, V11, P1348, DOI 10.1016/j.scr.2013.08.011; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Moshaverinia A, 2013, BIOMATERIALS, V34, P6572, DOI 10.1016/j.biomaterials.2013.05.048; Moya ML, 2012, J MATER SCI-MATER M, V23, P903, DOI 10.1007/s10856-012-4575-9; Moyer HR, 2010, ANN PLAS SURG, V65, P497, DOI 10.1097/SAP.0b013e3181d37713; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; Simpson NE, 2004, BIOMATERIALS, V25, P2603, DOI 10.1016/j.biomaterials.2003.09.046; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Stock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7; Sugii S, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.199; Waelzlein JH, 2009, CURR OPIN NEPHROL HY, V18, P481, DOI 10.1097/MNH.0b013e3283318e1c; Yao R, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025007; Yin LB, 2015, MOL MED REP, V11, P1722, DOI 10.3892/mmr.2014.2935; Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078; Zhao YS, 2010, TISSUE ENG PART C-ME, V16, P653, DOI 10.1089/ten.TEC.2009.0053; Zhou P, 2011, LIVER TRANSPLANT, V17, P418, DOI 10.1002/lt.22270	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138184	10.1371/journal.pone.0138184	http://dx.doi.org/10.1371/journal.pone.0138184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372641	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400054
J	Hodkinson, DJ; Veggeberg, R; Wilcox, SL; Scrivani, S; Burstein, R; Becerra, L; Borsook, D				Hodkinson, Duncan J.; Veggeberg, Rosanna; Wilcox, Sophie L.; Scrivani, Steven; Burstein, Rami; Becerra, Lino; Borsook, David			Primary Somatosensory Cortices Contain Altered Patterns of Regional Cerebral Blood Flow in the Interictal Phase of Migraine	PLOS ONE			English	Article							HUMAN BRAIN; ARTERIAL; CORTEX; ALLODYNIA; PAIN; PATHOPHYSIOLOGY; QUESTIONNAIRE; SENSITIZATION; POPULATION; MECHANISMS	The regulation of cerebral blood flow (CBF) is a complex integrated process that is critical for supporting healthy brain function. Studies have demonstrated a high incidence of alterations in CBF in patients suffering from migraine with and without aura during different phases of attacks. However, the CBF data collected interictally has failed to show any distinguishing features or clues as to the underlying pathophysiology of the disease. In this study we used the magnetic resonance imaging (MRI) technique-arterial spin labeling (ASL)-to non-invasively and quantitatively measure regional CBF (rCBF) in a case-controlled study of interictal migraine. We examined both the regional and global CBF differences between the groups, and found a significant increase in rCBF in the primary somatosensory cortex (S1) of migraine patients. The CBF values in S1 were positively correlated with the headache attack frequency, but were unrelated to the duration of illness or age of the patients. Additionally, 82% of patients reported skin hypersensitivity (cutaneous allodynia) during migraine, suggesting atypical processing of somatosensory stimuli. Our results demonstrate the presence of a disease-specific functional deficit in a known region of the trigemino-cortical pathway, which may be driven by adaptive or maladaptive functional plasticity. These findings may in part explain the altered sensory experiences reported between migraine attacks.	[Hodkinson, Duncan J.; Veggeberg, Rosanna; Wilcox, Sophie L.; Scrivani, Steven; Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Boston Childrens Hosp, Ctr Pain & Brain,Dept Anesthesiol Perioperat & Pa, Boston, MA 02163 USA; [Scrivani, Steven] Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Boston, MA 02114 USA; [Burstein, Rami] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Anesthesia & Crit Care, Boston, MA 02215 USA; [Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Dept Psychiat, McLean Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; McLean Hospital	Hodkinson, DJ (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Ctr Pain & Brain,Dept Anesthesiol Perioperat & Pa, Boston, MA 02163 USA.	duncan.hodkinson@childrens.harvard.edu			National Institutes of Health [RO1 NS073977, K24 NS064050]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by National Institutes of Health (RO1 NS073977 and K24 NS064050).	Akerman S, 2011, NAT REV NEUROSCI, V12, P570, DOI 10.1038/nrn3057; Alsop DC, 2014, MAGN RESON MED, DOI [10.1002/mrm.25197, DOI 10.1002/MRM.25197]; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Ashkenazi A, 2007, CEPHALALGIA, V27, P325, DOI 10.1111/j.1468-2982.2007.01291.x; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Asllani I, 2008, MAGN RESON MED, V60, P1362, DOI 10.1002/mrm.21670; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bartolini M, 2005, FUNCT NEUROL, V20, P209; Bashir A, 2013, NEUROLOGY, V81, P1260, DOI 10.1212/WNL.0b013e3182a6cb32; Bigal ME, 2008, NEUROLOGY, V70, P1525, DOI 10.1212/01.wnl.0000310645.31020.b1; Brennan KC, 2010, CURR OPIN NEUROL, V23, P266, DOI 10.1097/WCO.0b013e32833821c1; Burstein R, 2015, J NEUROSCI, V35, P6619, DOI 10.1523/JNEUROSCI.0373-15.2015; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Cavestri R, 1995, Minerva Med, V86, P257; Chappell MA, 2011, MAGN RESON MED, V65, P1173, DOI 10.1002/mrm.22641; Coppola G, 2007, Cephalalgia, V27, P1427, DOI 10.1111/j.1468-2982.2007.01500.x; Coppola G, 2005, BRAIN, V128, P98, DOI 10.1093/brain/awh334; Coppola G, 2009, NEUROBIOL LEARN MEM, V92, P249, DOI 10.1016/j.nlm.2008.07.006; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; DaSilva AFM, 2007, NEUROREPORT, V18, P301, DOI 10.1097/WNR.0b013e32801776bb; Donahue MJ, 2006, NMR BIOMED, V19, P1043, DOI 10.1002/nbm.1075; Ferrari MD, 2015, LANCET NEUROL, V14, P65, DOI 10.1016/S1474-4422(14)70220-0; Friberg L, 1994, Eur J Neurol, V1, P35, DOI 10.1111/j.1468-1331.1994.tb00048.x; Goadsby Peter J, 2013, Handb Clin Neurol, V117, P193, DOI 10.1016/B978-0-444-53491-0.00016-X; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Golay Xavier, 2004, Top Magn Reson Imaging, V15, P10, DOI 10.1097/00002142-200402000-00003; Hansen JM, 2015, CEPHALALGIA INT J HE, DOI [10.1177/0333102415584601, DOI 10.1177/0333102415584601]; Hendrikse J, 2012, NEUROIMAG CLIN N AM, V22, P259, DOI 10.1016/j.nic.2012.02.003; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hickmott PW, 2005, NAT NEUROSCI, V8, P140, DOI 10.1038/nn1384; Hodkinson DJ, 2015, PAIN, V156, P1301, DOI 10.1097/j.pain.0000000000000176; Hodkinson DJ, 2013, NEUROIMAGE-CLIN, V3, P301, DOI 10.1016/j.nicl.2013.09.004; Jakubowski M, 2005, NEUROLOGY, V65, P1419, DOI 10.1212/01.wnl.0000183358.53939.38; Jenkins BG, 2012, NEUROIMAGE, V62, P1072, DOI 10.1016/j.neuroimage.2012.03.075; Kim JH, 2014, CEPHALALGIA, V34, P1125, DOI 10.1177/0333102414531155; LEVINE SR, 1987, CEPHALALGIA, V7, P245, DOI 10.1046/j.1468-2982.1987.0704245.x; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liang XY, 2014, NEUROIMAGE, V87, P265, DOI 10.1016/j.neuroimage.2013.11.013; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Lord LD, 2013, J CEREBR BLOOD F MET, V33, P1347, DOI 10.1038/jcbfm.2013.94; Lu HZ, 2006, MAGN RESON MED, V56, P546, DOI 10.1002/mrm.20976; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Maleki N, 2012, CEPHALALGIA, V32, P607, DOI 10.1177/0333102412445622; Noseda R, 2011, J NEUROSCI, V31, P14204, DOI 10.1523/JNEUROSCI.3285-11.2011; Penfield W, 1937, BRAIN, V60, P383; Petr J, 2013, MAGN RESON MED, V70, P1535, DOI 10.1002/mrm.24601; Prescot A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-34; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reyngoudt H, 2012, CEPHALALGIA, V32, P845, DOI 10.1177/0333102412452048; ROBERTSON WM, 1989, NEUROLOGY, V39, P947, DOI 10.1212/WNL.39.7.947; Schwedt TJ, 2013, CURR OPIN NEUROL, V26, P248, DOI 10.1097/WCO.0b013e328360edb1; Soriani S, 1997, HEADACHE, V37, P31, DOI 10.1046/j.1526-4610.1997.3701031.x; Strassman AM, 1996, NATURE, V384, P560, DOI 10.1038/384560a0; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Valentini E, 2012, NEUROIMAGE, V59, P1571, DOI 10.1016/j.neuroimage.2011.08.069; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403	59	34	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137971	10.1371/journal.pone.0137971	http://dx.doi.org/10.1371/journal.pone.0137971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372461	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400042
J	Contreras-Bolton, C; Parada, V				Contreras-Bolton, Carlos; Parada, Victor			Automatic Combination of Operators in a Genetic Algorithm to Solve the Traveling Salesman Problem	PLOS ONE			English	Article							INVER-OVER OPERATOR; LOCAL SEARCH; MUTATION OPERATORS; PARAMETER CONTROL; EVOLUTIONARY; CROSSOVER; OPTIMIZATION	Genetic algorithms are powerful search methods inspired by Darwinian evolution. To date, they have been applied to the solution of many optimization problems because of the easy use of their properties and their robustness in finding good solutions to difficult problems. The good operation of genetic algorithms is due in part to its two main variation operators, namely, crossover and mutation operators. Typically, in the literature, we find the use of a single crossover and mutation operator. However, there are studies that have shown that using multi-operators produces synergy and that the operators are mutually complementary. Using multi-operators is not a simple task because which operators to use and how to combine them must be determined, which in itself is an optimization problem. In this paper, it is proposed that the task of exploring the different combinations of the crossover and mutation operators can be carried out by evolutionary computing. The crossover and mutation operators used are those typically used for solving the traveling salesman problem. The process of searching for good combinations was effective, yielding appropriate and synergic combinations of the crossover and mutation operators. The numerical results show that the use of the combination of operators obtained by evolutionary computing is better than the use of a single operator and the use of multi-operators combined in the standard way. The results were also better than those of the last operators reported in the literature.	[Contreras-Bolton, Carlos; Parada, Victor] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile	Universidad de Santiago de Chile	Parada, V (corresponding author), Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile.	victor.parada@usach.cl	Parada, Victor/M-5840-2014; Contreras-Bolton, Carlos/D-9624-2016; Parada, Victor/AHD-6455-2022	Contreras-Bolton, Carlos/0000-0001-9549-4143; Parada, Victor/0000-0002-8649-5694	Complex Engineering Systems Institute [P-05-004-F]; CONICYT [FBO16]; ECOS/CONICYT [C13E04]	Complex Engineering Systems Institute; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); ECOS/CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	The authors would like to thank the Complex Engineering Systems Institute: P-05-004-F, CONICYT: FBO16, ECOS/CONICYT: C13E04.	Acan A, 2003, IEEE C EVOL COMPUTAT, P256, DOI 10.1109/CEC.2003.1299583; Albayrak M, 2011, EXPERT SYST APPL, V38, P1313, DOI 10.1016/j.eswa.2010.07.006; [Anonymous], 1991, HDB GENETIC ALGORITH; Applegate D.L., 2007, TRAVELING SALESMAN P, DOI DOI 10.1515/9781400841103; BANZHAF W, 1990, BIOL CYBERN, V64, P7, DOI 10.1007/BF00203625; Bolton CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058551; Davis L, 1985, P IJCAI, V85, P162; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Eiben AE, 2007, STUD COMPUT INTELL, V54, P19; Eiben A. E., 2010, 2010 Fourth IEEE International Conference on Self-Adaptive and Self-Organizing Systems Workshop (SASOW), P147, DOI 10.1109/SASOW.2010.31; Eiben AE, 1999, IEEE T EVOLUT COMPUT, V3, P124, DOI 10.1109/4235.771166; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Elaoud S., 2010, ELECT NOTES DISCRETE, V36, P939, DOI DOI 10.1016/J.ENDM.2010.05.119; Elsayed SM, 2011, COMPUT OPER RES, V38, P1877, DOI 10.1016/j.cor.2011.03.003; Esquivel SC, 1997, PROCEEDINGS OF 1997 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION (ICEC '97), P103, DOI 10.1109/ICEC.1997.592277; FLOOD MM, 1956, OPER RES, V4, P61, DOI 10.1287/opre.4.1.61; Fogel D. B., 1990, Proceedings of the Fourth Annual Parallel Processing Symposium, P318; FOGEL DB, 1993, CYBERNET SYST, V24, P27, DOI 10.1080/01969729308961697; FOGEL DB, 1988, BIOL CYBERN, V60, P139, DOI 10.1007/BF00202901; Freisleben B, 1996, IEEE C EVOL COMPUTAT, P616, DOI 10.1109/ICEC.1996.542671; Garcia S, 2009, J HEURISTICS, V15, P617, DOI 10.1007/s10732-008-9080-4; Gen M., 1997, GENETIC ALGORITHMS E; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Goldberg D. E, 1985, P 1 INT C GEN ALG TH; Grefenstette J., 1985, PROC 1 INT C GENET A, V160, P160; Grefenstette J.J., 1987, INCORPORATING PROBLE, P42; GREFENSTETTE JJ, 1986, IEEE T SYST MAN CYB, V16, P122, DOI 10.1109/TSMC.1986.289288; Holland J.H., 1975, ADAPTATION NATURAL A; Hong I, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION, VOLS 1 AND 2, P245, DOI 10.1109/ICEC.1995.489153; Hong TP, 2001, APPL INTELL, V16, P7, DOI 10.1023/A:1012815625611; Hong TP, 1998, J INF SCI ENG, V14, P369; Hong TP, 2000, J HEURISTICS, V6, P439, DOI 10.1023/A:1009642825198; Jong D., 1975, ANAL BEHAV CLASS GEN; Karp R. M., 1972, P COMPL COMP COMP, P85; Koza JR, 1992, GENETIC PROGRAMMING; Larranaga P, 1999, ARTIF INTELL REV, V13, P129, DOI 10.1023/A:1006529012972; LIN S, 1965, AT&T TECH J, V44, P2245, DOI 10.1002/j.1538-7305.1965.tb04146.x; Louis SJ, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P385; Martin O., 1991, Complex Systems, V5, P299; MARTIN O, 1992, OPER RES LETT, V11, P219, DOI 10.1016/0167-6377(92)90028-2; Michalewicz Z., 1994, GENETIC ALGORITHMS D; MORTON G, 1955, J ROY STAT SOC B, V17, P185; MUHLENBEIN H, 1988, PARALLEL COMPUT, V7, P65, DOI 10.1016/0167-8191(88)90098-1; MUHLENBEIN H, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P416; MUHLENBEIN H, 1991, LECT NOTES ARTIF INT, V565, P398; Murata T, 1996, IEEE C EVOL COMPUTAT, P170, DOI 10.1109/ICEC.1996.542355; Ngyen H. D., 2002, IPSJ T MATH MODELING, V43, P165; Oliver I. M., 1987, Genetic Algorithms and their Applications: Proceedings of the Second International Conference on Genetic Algorithms, P224; Osaba E, 2014, STUD COMPUT INTELL, V512, P113, DOI 10.1007/978-3-319-01692-4_9; Osaba E, 2013, 2013 IEEE 8TH INTERNATIONAL SYMPOSIUM ON APPLIED COMPUTATIONAL INTELLIGENCE AND INFORMATICS (SACI 2013), P17, DOI 10.1109/SACI.2013.6608960; Poli R., 2008, FIELD GUIDE GENETIC; Ray SS, 2004, INT C PATT RECOG, P497, DOI 10.1109/ICPR.2004.1334276; Reinelt G., 1991, ORSA Journal on Computing, V3, P376, DOI 10.1287/ijoc.3.4.376; Reinelt G., 1994, TRAVELING SALESMAN C; Schaffer J. D., 1987, Genetic Algorithms and their Applications: Proceedings of the Second International Conference on Genetic Algorithms, P36; Sengoku Y. I. H., 1998, PROC AROB 3, P283; SYSWERDA G, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P2; Syswerda G., 1991, HDB GENETIC ALGORITH, P332; Tao G, 1998, LECT NOTES COMPUT SC, V1498, P803, DOI 10.1007/BFb0056922; Tasgetiren MF, 2013, LECT NOTES COMPUT SC, V8297, P1, DOI 10.1007/978-3-319-03753-0_1; Tsai HK, 2002, IEEE C EVOL COMPUTAT, P1290, DOI 10.1109/CEC.2002.1004429; Wang CX, 2005, LECT NOTES COMPUT SC, V3611, P1269; Wang YT, 2011, COMPUT MATH APPL, V62, P2743, DOI 10.1016/j.camwa.2011.06.063; Wang YT, 2012, LECT NOTES ARTIF INT, V6839, P17; WHITLEY D, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P133; Yoon HS, 2002, IEEE T EVOLUT COMPUT, V6, P212, DOI 10.1109/4235.996022; Zhang L, 2006, INT J ADV MANUF TECH, V27, P580, DOI 10.1007/s00170-004-2223-3	67	27	27	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137724	10.1371/journal.pone.0137724	http://dx.doi.org/10.1371/journal.pone.0137724			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367182	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100122
J	Feldblum, PJ; Okech, J; Ochieng, R; Hart, C; Kiyuka, G; Lai, JJ; Veena, V				Feldblum, Paul J.; Okech, Jairus; Ochieng, Rolex; Hart, Catherine; Kiyuka, Grace; Lai, Jaim Jou; Veena, Valentine			Longer-Term Follow-Up of Kenyan Men Circumcised Using the ShangRing Device	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; HIV PREVENTION	Objectives To ascertain clinical sequelae, client satisfaction and sexual behavior 2+ years after male circumcision using the ShangRing device. Methods We enrolled 199 men from the Kenya sites (Homa Bay district) participating in a 2012 study of the ShangRing device used in routine male circumcision services (N = 552). We enrolled men who had had the ShangRing placed successfully, and over-sampled men who had had an adverse event and/or were HIV-positive during the field study. In the present study, each participant was examined and interviewed by a study clinician, and penile photographs were taken to document longer-term cosmetic results and any abnormal findings. Results 194 men were included in the analysis. The mean and median times between circumcision and the longer-term follow-up visit in this study were 31.8 and 32 months, respectively. Four men (2.1%) had signs/symptoms of a sexually transmitted infection (STI). Virtually all (99.5%) of the men were very satisfied with the appearance of their circumcised penis, and all would recommend a ShangRing circumcision to friends or family members. The most prevalent reported advantage of the circumcision was the ease of bathing and enhanced cleanliness of the penis (75.8%). 94.3% of the men did not cite a single negative feature of their circumcision. 87.5% of men reported more sexual pleasure post-MC, the most common reason being more prolonged intercourse. The majority of men (52.6%) reported one sexual partner post-MC, but more than a quarter of the men (28.1%) reported an increased number of partners post-MC. Less than half of the men (44.3%) reported using condoms half of the time or more, but the great majority of condom users stated that condom use was much easier post-MC, and 76.9% of users said they used condoms more after circumcision than before. Conclusions This study supports the safety and acceptability of ShangRing male circumcision during 2-3 years of follow-up. It should allay worries that the ShangRing procedure could lead to delayed complications later than the observation period of most clinical studies.	[Feldblum, Paul J.; Hart, Catherine; Lai, Jaim Jou] FHI 360, Durham, NC 27701 USA; [Okech, Jairus; Ochieng, Rolex; Kiyuka, Grace] Homa Bay Dist Hosp, Homa Bay, Kenya; [Veena, Valentine] FHI 360, Nairobi, Kenya	FHI 360	Feldblum, PJ (corresponding author), FHI 360, Durham, NC 27701 USA.	pfeldblum@fhi360.org			Bill and Melinda Gates Foundation [OPPGH5166]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by Grant OPPGH5166, Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Barone MA, 2014, TRANSL ANDROL UROL, V3, P113, DOI 10.3978/j.issn.2223-4683.2014.01.09; Cao DH, 2015, UROLOGY, V85, P799, DOI 10.1016/j.urology.2014.12.007; Cheng Y, 2014, CHINESE MED J-PEKING, V127, P1879, DOI 10.3760/cma.j.issn.0366-6999.20133135; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Krieger JN, 2008, J SEX MED, V5, P2610, DOI 10.1111/j.1743-6109.2008.00979.x; Mehta SD, 2013, AIDS, V27, P2899, DOI 10.1097/01.aids.0000432444.30308.2d; Morris BJ, 2013, J SEX MED, V10, P2644, DOI 10.1111/jsm.12293; Samuelson J, 2013, JAIDS-J ACQ IMM DEF, V64, P127, DOI 10.1097/QAI.0b013e3182a61dd3; Sokal DC, 2014, JAIDS-J ACQ IMM DEF, V67, P430, DOI 10.1097/QAI.0000000000000321; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO, 2013, GUID US DEV AD MAL C; WHO, 2015, WHO PREQ MAL CIRC DE; World Health Organization, 2013, WHO PREQ MAL CIRC DE	14	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137510	10.1371/journal.pone.0137510	http://dx.doi.org/10.1371/journal.pone.0137510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367141	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100080
J	Korsa, MG; Browning, GF; Coppo, MJC; Legione, AR; Gilkerson, JR; Noormohammadi, AH; Vaz, PK; Lee, SW; Devlin, JM; Hartley, CA				Korsa, Mesula G.; Browning, Glenn F.; Coppo, Mauricio J. C.; Legione, Alistair R.; Gilkerson, James R.; Noormohammadi, Amir H.; Vaz, Paola K.; Lee, Sang-Won; Devlin, Joanne M.; Hartley, Carol A.			Protection Induced in Broiler Chickens following Drinking-Water Delivery of Live Infectious Laryngotracheitis Vaccines against Subsequent Challenge with Recombinant Field Virus	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; POLYMERASE-CHAIN-REACTION; UNITED-STATES; EYE-DROP; VACCINATION; STRAIN; RESTRICTION; REPLICATION; VIRULENCE; POULTRY	Infectious laryngotracheitis virus (ILTV) causes acute upper respiratory tract disease in chickens. Attenuated live ILTV vaccines are often used to help control disease, but these vaccines have well documented limitations, including retention of residual virulence, incomplete protection, transmission of vaccine virus to unvaccinated birds and reversion to high levels of virulence following bird-to-bird passage. Recently, two novel ILTV field strains (class 8 and 9 ILTV viruses) emerged in Australia due to natural recombination between two genotypically distinct commercial ILTV vaccines. These recombinant field strains became dominant field strains in important poultry producing areas. In Victoria, Australia, the recombinant class 9 virus largely displaced the previously predominant class 2 ILTV strain. The ability of ILTV vaccines to protect against challenge with the novel class 9 ILTV strain has not been studied. Here, the protection induced by direct (drinking-water) and indirect (contact) exposure to four different ILTV vaccines against challenge with class 9 ILTV in commercial broilers was studied. The vaccines significantly reduced, but did not prevent, challenge virus replication in vaccinated chickens. Only one vaccine significantly reduced the severity of tracheal pathology after direct drinking-water vaccination. The results indicate that the current vaccines can be used to help control class 9 ILTV, but also indicate that these vaccines have limitations that should be considered when designing and implementing disease control programs.	[Korsa, Mesula G.; Browning, Glenn F.; Coppo, Mauricio J. C.; Legione, Alistair R.; Gilkerson, James R.; Noormohammadi, Amir H.; Vaz, Paola K.; Lee, Sang-Won; Devlin, Joanne M.; Hartley, Carol A.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia; [Lee, Sang-Won] Konkuk Univ, Coll Vet Med, Seoul, South Korea	University of Melbourne; Konkuk University	Devlin, JM (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia.	devlinj@unimelb.edu.au	Legione, Alistair/L-9102-2015; Browning, Glenn Francis/P-4459-2014; Vaz, Paola K./D-8713-2015; Legione, Alistair/AAX-6064-2020	Legione, Alistair/0000-0003-2407-4496; Browning, Glenn Francis/0000-0002-0903-2469; Vaz, Paola K./0000-0001-6877-7383; Legione, Alistair/0000-0003-2407-4496; Devlin, Joanne/0000-0003-0400-9670; Korsa, Mesula G/0000-0001-9334-4790; Hartley, Carol/0000-0001-6174-7341; Gilkerson, James/0000-0003-1801-4817; Coppo, Mauricio/0000-0002-4344-9532; NOORMOHAMMADI, AMIR/0000-0003-3459-2692	Rural Industries Research and Development Corporation (RIRDC) [PRJ-008792]; Australian Research Council (ARC) [DP130103991]; ARC Future Fellowship [FT140101287]	Rural Industries Research and Development Corporation (RIRDC)(Rural Industries R&D Corp); Australian Research Council (ARC)(Australian Research Council); ARC Future Fellowship(Australian Research Council)	This work was supported by the Rural Industries Research and Development Corporation (RIRDC, PRJ-008792) and by the Australian Research Council (ARC, DP130103991). JMD is supported by an ARC Future Fellowship (FT140101287). The ARC had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The RIRDC contributed to the study design and approved the manuscript for publication, but had no role in data collection and analysis or preparation of the manuscript.	BAGUST TJ, 1986, AVIAN PATHOL, V15, P581, DOI 10.1080/03079458608436317; Bagust TJ, 2000, REV SCI TECH OIE, V19, P483, DOI 10.20506/rst.19.2.1229; Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Coppo MJC, 2012, AVIAN PATHOL, V41, P99, DOI 10.1080/03079457.2011.643222; Coppo MJC, 2011, AVIAN PATHOL, V40, P411, DOI 10.1080/03079457.2011.588686; Cover M.S., 1960, AVIAN DIS, V4, P467; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Devlin JM, 2007, VACCINE, V25, P3561, DOI 10.1016/j.vaccine.2007.01.080; Devlin JM, 2011, VACCINE, V29, P5699, DOI 10.1016/j.vaccine.2011.06.002; Fuchs W, 2007, VET RES, V38, P261, DOI 10.1051/vetres:200657; Fulton RM, 2000, AVIAN DIS, V44, P8, DOI 10.2307/1592502; Gharaibeh S, 2013, POULTRY SCI, V92, P2333, DOI 10.3382/ps.2013-03249; GUY JS, 1990, AVIAN DIS, V34, P106, DOI 10.2307/1591340; GUY JS, 1991, AVIAN DIS, V35, P348, DOI 10.2307/1591188; Ingram DR, 2000, J APPL POULTRY RES, V9, P501, DOI 10.1093/japr/9.4.501; Jones RC, 2010, BRIT POULTRY SCI, V51, P1, DOI 10.1080/00071660903541378; Koenen ME, 2002, VET IMMUNOL IMMUNOP, V89, P47, DOI 10.1016/S0165-2427(02)00169-1; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120282; Lee SW, 2014, AVIAN DIS, V58, P147, DOI 10.1637/10508-013113-ResNote.1; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; Mutinda WU, 2014, TROP ANIM HEALTH PRO, V46, P603, DOI 10.1007/s11250-013-0533-x; Neff C, 2008, AVIAN DIS, V52, P278, DOI 10.1637/8168-110107-Reg.1; Oldoni I, 2008, AVIAN DIS, V52, P59, DOI 10.1637/8054-070607-Reg; Oldoni I, 2009, AVIAN PATHOL, V38, P47, DOI 10.1080/03079450802632031; PURCELL DA, 1974, AUST VET J, V50, P419, DOI 10.1111/j.1751-0813.1974.tb05357.x; ROBERTSON GM, 1981, AUST VET J, V57, P119, DOI 10.1111/j.1751-0813.1981.tb00472.x; Rodriguez-Avila A, 2008, AVIAN PATHOL, V37, P287, DOI 10.1080/03079450802043742	28	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137719	10.1371/journal.pone.0137719	http://dx.doi.org/10.1371/journal.pone.0137719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366738	Green Published, gold			2022-12-26	WOS:000361601100119
J	Li, JY; Hu, JP				Li, Jiying; Hu, Jianping			Using Co-Expression Analysis and Stress-Based Screens to Uncover Arabidopsis Peroxisomal Proteins Involved in Drought Response	PLOS ONE			English	Article							PLANT PEROXISOMES; GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; NONHOST RESISTANCE; PROTEOME ANALYSIS; BETA-OXIDATION; DEFENSE; MUTANT; PHOTORESPIRATION	Peroxisomes are essential organelles that house a wide array of metabolic reactions important for plant growth and development. However, our knowledge regarding the role of peroxisomal proteins in various biological processes, including plant stress response, is still incomplete. Recent proteomic studies of plant peroxisomes significantly increased the number of known peroxisomal proteins and greatly facilitated the study of peroxisomes at the systems level. The objectives of this study were to determine whether genes that encode peroxisomal proteins with related functions are co-expressed in Arabidopsis and identify peroxisomal proteins involved in stress response using in silico analysis and mutant screens. Using microarray data from online databases, we performed hierarchical clustering analysis to generate a comprehensive view of transcript level changes for Arabidopsis peroxisomal genes during development and under abiotic and biotic stress conditions. Many genes involved in the same metabolic pathways exhibited co-expression, some genes known to be involved in stress response are regulated by the corresponding stress conditions, and function of some peroxisomal proteins could be predicted based on their co-expression pattern. Since drought caused expression changes to the highest number of genes that encode peroxisomal proteins, we subjected a subset of Arabidopsis peroxisomal mutants to a drought stress assay. Mutants of the LON2 protease and the photorespiratory enzyme hydroxypyruvate reductase 1 (HPR1) showed enhanced susceptibility to drought, suggesting the involvement of peroxisomal quality control and photorespiration in drought resistance. Our study provided a global view of how genes that encode peroxisomal proteins respond to developmental and environmental cues and began to reveal additional peroxisomal proteins involved in stress response, thus opening up new avenues to investigate the role of peroxisomes in plant adaptation to environmental stresses.	[Li, Jiying; Hu, Jianping] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Li, Jiying] Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA; [Hu, Jianping] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Hu, JP (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	huji@msu.edu			Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [DE-FG02-91ER20021]	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (DE-FG02-91ER20021; http://energy.gov/) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaran E, 2014, PLANT PHYSIOL, V165, P1302, DOI 10.1104/pp.114.239004; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Cassin-Ross G, 2014, PLANT PHYSIOL, V166, P1546, DOI 10.1104/pp.114.250183; Cassin-Ross G, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29464; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Coca M, 2010, PLANT J, V63, P526, DOI 10.1111/j.1365-313X.2010.04255.x; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; del Rio LA, 2011, ARCH BIOCHEM BIOPHYS, V506, P1, DOI 10.1016/j.abb.2010.10.022; Desai M, 2008, PLANT PHYSIOL, V146, P1117, DOI 10.1104/pp.107.113555; Farmer LM, 2013, PLANT CELL, V25, P4085, DOI 10.1105/tpc.113.113407; Gehan MA, 2015, CURR OPIN PLANT BIOL, V24, P39, DOI 10.1016/j.pbi.2015.01.004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goto-Yamada S, 2014, PLANT CELL PHYSIOL, V55, P482, DOI 10.1093/pcp/pcu017; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaur Navneet, 2013, Subcell Biochem, V69, P195, DOI 10.1007/978-94-007-6889-5_11; Kaur N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00103; Kaur Navneet, 2009, Arabidopsis Book, V7, pe0123, DOI 10.1199/tab.0123; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Lingard MJ, 2009, PLANT PHYSIOL, V151, P1354, DOI 10.1104/pp.109.142505; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Ma CL, 2006, PLANT PHYSIOL, V141, P47, DOI 10.1104/pp.105.073841; Maeda K, 2009, MOL PLANT MICROBE IN, V22, P1331, DOI 10.1094/MPMI-22-11-1331; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; Okinaka Y, 2002, MOL PLANT MICROBE IN, V15, P1213, DOI 10.1094/MPMI.2002.15.12.1213; Pandey N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-216; Pieuchot L, 2012, ANNU REV MICROBIOL, V66, P237, DOI 10.1146/annurev-micro-092611-150126; Pracharoenwattana I, 2008, TRENDS PLANT SCI, V13, P522, DOI 10.1016/j.tplants.2008.07.003; Quan S, 2013, PLANT PHYSIOL, V163, P1518, DOI 10.1104/pp.113.223453; Quan S, 2010, PLANT SIGNAL BEHAV, V5, P151, DOI 10.4161/psb.5.2.10412; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Reumann S, 2004, PLANT PHYSIOL, V135, P783, DOI 10.1104/pp.103.035584; Reumann S, 2009, PLANT PHYSIOL, V150, P125, DOI 10.1104/pp.109.137703; Rochon D, 2014, VIROLOGY, V452, P133, DOI 10.1016/j.virol.2013.12.035; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinclair AM, 2009, PLANT J, V59, P231, DOI 10.1111/j.1365-313X.2009.03863.x; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorhagen K, 2013, PLANT BIOLOGY, V15, P723, DOI 10.1111/j.1438-8677.2012.00723.x; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Taler D, 2004, PLANT CELL, V16, P172, DOI 10.1105/tpc.016352; Warnes GR, 2015, GPLOTS VARIOUS R PRO; Westphal L, 2008, PLANT CELL, V20, P824, DOI 10.1105/tpc.107.056895; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xiong LM, 2002, J BIOL CHEM, V277, P8588, DOI 10.1074/jbc.M109275200; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	52	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137762	10.1371/journal.pone.0137762	http://dx.doi.org/10.1371/journal.pone.0137762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368942	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100131
J	Li, XL; Menade, M; Kozlov, G; Hu, ZP; Dai, Z; McPherson, PS; Brais, B; Gehring, K				Li, Xinlu; Menade, Marie; Kozlov, Guennadi; Hu, Zheping; Dai, Zheng; McPherson, Peter S.; Brais, Bernard; Gehring, Kalle			High-Throughput Screening for Ligands of the HEPN Domain of Sacsin	PLOS ONE			English	Article							RECESSIVE SPASTIC ATAXIA; CHARLEVOIX-SAGUENAY ARSACS; FLUORESCENCE POLARIZATION; PROTEIN SACSIN; BINDING SITES; MUTATIONS; CHAPERONE; DEFECTS; COMMON	Sacsin is a large protein implicated in the neurodevelopmental and neurodegenerative disease autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), which features the loss of Purkinje neurons in the cerebellum. Although the domain architecture of sacsin suggests that it is a neuronal chaperone assisting in protein quality control, the precise function of sacsin remains elusive. Using fluorescence polarization (FP) assays, we confirmed that the HEPN domain of sacsin binds to nucleotides with low micromolar affinities. FP competition assays with a variety of nucleotides and nucleotide analogs revealed that the binding is primarily mediated by the phosphate groups of nucleotides. A highthroughput screen subsequently identified novel small molecule ligands of HEPN, providing new chemical probes for cell culture studies and drug development. Together, the results are consistent with the HEPN domain contributing to the functional activity of sacsin by binding to nucleotides or other multiply charged anionic compounds in neurons.	[Li, Xinlu; Menade, Marie; Kozlov, Guennadi; Hu, Zheping; Dai, Zheng; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Li, Xinlu; Menade, Marie; Kozlov, Guennadi; Hu, Zheping; Dai, Zheng; Gehring, Kalle] Grp Rech Axe Struct Prot, Montreal, PQ, Canada; [McPherson, Peter S.; Brais, Bernard] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019; Brais, Bernard/Y-3910-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; 	Bionanomachines NSERC CREATE scholarship; Fondation de l'Ataxie de Charlevoix-Saguenay; Marcelle and Jean Coutu Foundation; Canadian Institutes of Health Research Emerging Team Grant on Rare Diseases [126526]	Bionanomachines NSERC CREATE scholarship; Fondation de l'Ataxie de Charlevoix-Saguenay; Marcelle and Jean Coutu Foundation; Canadian Institutes of Health Research Emerging Team Grant on Rare Diseases	XL is a recipient of a Bionanomachines NSERC CREATE scholarship. This research was supported by the Fondation de l'Ataxie de Charlevoix-Saguenay (www.arsacs.com), the Marcelle and Jean Coutu Foundation, and a Canadian Institutes of Health Research Emerging Team Grant on Rare Diseases (126526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Anderrson JF, 2011, J MOL BIOL, V411, P870, DOI 10.1016/j.jmb.2011.06.016; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Baell JB, 2010, FUTURE MED CHEM, V2, P1529, DOI [10.4155/fmc.10.237, 10.4155/FMC.10.237]; BLACK CB, 1994, COORDIN CHEM REV, V135, P165, DOI 10.1016/0010-8545(94)80068-5; Bouchard JP, 1998, NEUROMUSCULAR DISORD, V8, P474, DOI 10.1016/S0960-8966(98)00055-8; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Erlandsen H, 2004, PROTEINS, V54, P806, DOI 10.1002/prot.10631; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Grynberg M, 2003, TRENDS BIOCHEM SCI, V28, P224, DOI 10.1016/S0968-0004(03)00060-4; Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884; Lariviere R, 2015, HUM MOL GENET, V24, P727, DOI 10.1093/hmg/ddu491; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Romano A, 2013, HUM MUTAT, V34, P525, DOI 10.1002/humu.22269; Synofzik M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-41; Turek-Etienne TC, 2003, J BIOMOL SCREEN, V8, P176, DOI 10.1177/1087057103252304	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137298	10.1371/journal.pone.0137298	http://dx.doi.org/10.1371/journal.pone.0137298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366743	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100063
J	Min, J; Zhang, QQ; Qiu, XL; Zhu, MH; Yu, HY; Gao, SS				Min, Jie; Zhang, Qianqian; Qiu, Xiaoli; Zhu, Minhao; Yu, Haiyang; Gao, Shanshan			Investigation on the Tribological Behavior and Wear Mechanism of Five Different Veneering Porcelains	PLOS ONE			English	Article							DENTAL CERAMICS; HUMAN ENAMEL; NORMAL FORCE; FRICTION; COEFFICIENT; MODES	Objectives The primary aim of this research was to investigate the wear behavior and wear mechanism of five different veneering porcelains. Methods Five kinds of veneering porcelains were selected in this research. The surface microhardness of all the samples was measured with a microhardness tester. Wear tests were performed on a ball-on-flat PLINT fretting wear machine, with lubrication of artificial saliva at 37 degrees C. The friction coefficients were recorded by the testing system. The microstructure features, wear volume, and damage morphologies were recorded and analyzed with a confocal laser scanning microscope and a scanning electron microscope. The wear mechanism was then elucidated. Results The friction coefficients of the five veneering porcelains differ significantly. No significant correlation between hardness and wear volume was found for these veneering porcelains. Under lubrication of artificial saliva, the porcelain with higher leucite crystal content exhibited greater wear resistance. Additionally, leucite crystal size and distribution in glass matrix influenced wear behavior. The wear mechanisms for these porcelains were similar: abrasive wear dominates the early stage, whereas delamination was the main damage mode at the later stage. Furthermore, delamination was more prominent for porcelains with larger crystal sizes. Significance Wear compatibility between porcelain and natural teeth is important for dental restorative materials. Investigation on crystal content, size, and distribution in glass matrix can provide insight for the selection of dental porcelains in clinical settings.	[Min, Jie; Zhang, Qianqian; Qiu, Xiaoli; Yu, Haiyang; Gao, Shanshan] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Zhu, Minhao] Southwest Jiaotong Univ, State Key Lab Tract Power, Chengdu, Peoples R China; [Qiu, Xiaoli] Second Peoples Hosp Nanning City, Dept Stomatol, Guangxi, Peoples R China	Sichuan University; Southwest Jiaotong University	Gao, SS (corresponding author), Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.	christina12357@163.com			National Natural Science Foundation of China [81100777]; Research Fund for the Doctoral Program of Higher Education of China [20110181120076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the National Natural Science Foundation of China (81100777), Research Fund for the Doctoral Program of Higher Education of China (20110181120076).	Cattell MJ, 2001, DENT MATER, V17, P21, DOI 10.1016/S0109-5641(00)00046-4; Cozza RC, 2009, WEAR, V267, P61, DOI 10.1016/j.wear.2009.01.055; Cozza RC, 2014, TRIBOL INT, V70, P52, DOI 10.1016/j.triboint.2013.09.010; Dahl B L, 1994, Quintessence Int, V25, P561; Elmaria A, 2006, J PROSTHET DENT, V96, P345, DOI 10.1016/j.prosdent.2006.09.002; Ghazal M, 2008, DENT MATER, V24, P502, DOI 10.1016/j.dental.2007.04.012; Giordano R A, 1996, Compend Contin Educ Dent, V17, P779; He YJ, 1996, J AM CERAM SOC, V79, P3090, DOI 10.1111/j.1151-2916.1996.tb08081.x; Ho WF, 2011, CERAM INT, V37, P1169, DOI 10.1016/j.ceramint.2010.11.027; Kalin M, 2003, WEAR, V255, P669, DOI 10.1016/S0043-1648(03)00069-3; Kim MJ, 2012, J DENT, V40, P979, DOI 10.1016/j.jdent.2012.08.004; Lee H H, 1997, Dent Mater J, V16, P134; Mackert Jr JR, 1996, J DENT RES, V75, P126; Oscar BL, 2005, J AM CERAM SOC, V88, P2159; Park S, 2008, DENT MATER, V24, P1477, DOI 10.1016/j.dental.2008.03.007; Sednda T, 1999, J AM CERAM SOC, V82, P1505; SEGHI RR, 1991, J DENT RES, V70, P221, DOI 10.1177/00220345910700031301; Sinmazisik G, 2006, DENT MATER, V22, P735, DOI 10.1016/j.dental.2005.08.007; Soler VC, 2010, MAT SCI ENG A-STRUCT, V527, P1730; Suh MS, 2008, WEAR, V264, P800, DOI 10.1016/j.wear.2006.12.079; Susmel L, 2014, INT J FATIGUE, V58, P94, DOI 10.1016/j.ijfatigue.2013.05.007; Tanaka R, 2010, ARCH ORAL BIOL, V55, P300, DOI 10.1016/j.archoralbio.2010.02.009; Wang L, 2012, J EUR CERAM SOC, V32, P2599, DOI 10.1016/j.jeurceramsoc.2012.03.021; Yap AUJ, 1997, J ORAL REHABIL, V24, P574, DOI 10.1046/j.1365-2842.1997.00528.x; Yoshimura HN, 2005, J AM CERAM SOC, V88, P1680, DOI 10.1111/j.1551-2916.2005.00334.x; Yu HY, 2006, WEAR, V261, P611, DOI 10.1016/j.wear.2006.01.024; Zhang Y, 2008, J AM CERAM SOC, V91, P1678, DOI 10.1111/j.1551-2916.2008.02312.x; [No title captured]	28	9	10	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137566	10.1371/journal.pone.0137566	http://dx.doi.org/10.1371/journal.pone.0137566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368532	Green Submitted, gold, Green Published			2022-12-26	WOS:000361601100086
J	Saccenti, E; Nieuwenhuijse, D; Koehorst, JJ; dos Santos, VAPM; Schaap, PJ				Saccenti, Edoardo; Nieuwenhuijse, David; Koehorst, Jasper J.; dos Santos, Vitor A. P. Martins; Schaap, Peter J.			Assessing the Metabolic Diversity of Streptococcus from a Protein Domain Point of View	PLOS ONE			English	Article							EVOLUTION; GENES; MODEL	Understanding the diversity and robustness of the metabolism of bacteria is fundamental for understanding how bacteria evolve and adapt to different environments. In this study, we characterised 121 Streptococcus strains and studied metabolic diversity from a protein domain perspective. Metabolic pathways were described in terms of the promiscuity of domains participating in metabolic pathways that were inferred to be functional. Promiscuity was defined by adapting existing measures based on domain abundance and versatility. The approach proved to be successful in capturing bacterial metabolic flexibility and species diversity, indicating that it can be described in terms of reuse and sharing functional domains in different proteins involved in metabolic activity. Additionally, we showed striking differences among metabolic organisation of the pathogenic serotype 2 Streptococcus suis and other strains.	[Saccenti, Edoardo; Nieuwenhuijse, David; Koehorst, Jasper J.; dos Santos, Vitor A. P. Martins; Schaap, Peter J.] Univ Wageningen & Res Ctr, Lab Syst & Synthet Biol, Wageningen, Netherlands	Wageningen University & Research	Saccenti, E (corresponding author), Univ Wageningen & Res Ctr, Lab Syst & Synthet Biol, Wageningen, Netherlands.	esaccenti@gmail.com; peter.schaap@wur.nl	Koehorst, Jasper Jan/Z-1697-2019	Koehorst, Jasper Jan/0000-0001-8172-8981; Schaap, Peter/0000-0002-4346-6084; Saccenti, Edoardo/0000-0001-8284-4829; martins dos santos, vitor/0000-0002-2352-9017	European Commission-funded FP7 project INFECT [305340]	European Commission-funded FP7 project INFECT	This work was supported by the European Commission-funded FP7 project INFECT (Contract No. 305340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attwood TK, 2012, PRINTS DATABASE FINE; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; Basu MK, 2009, BRIEF BIOINFORM, V10, P205, DOI 10.1093/bib/bbn057; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Carvalho SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068277; Caspi R, 2014, NUCLEIC ACIDS RES, V42; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Cochrane G, 2012, NUCL ACIDS RES; D'Ari R, 1998, BIOESSAYS, V20, P181, DOI 10.1002/(SICI)1521-1878(199802)20:2<181::AID-BIES10>3.3.CO;2-6; De Leeuw J., 2011, MULTIDIMENSIONAL SCA; De Lima Morais DA, 2011, NUCLEIC ACIDS RES, V39; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Downs DM, 2006, ANNU REV MICROBIOL, V60, P533, DOI 10.1146/annurev.micro.60.080805.142308; Eddy Sean R, 2009, Genome Inform, V23, P205; Fiebig A, INT J MED MICROBIOL; Finn RD, 2014, PFAM PROTIEN FAMILIE; Graham K., 2004, W3C RECOMMENDATION, V10, P1; Guzman GI, 2015, P NATL ACAD SCI USA, V112, P929, DOI 10.1073/pnas.1414218112; Haft DH, 2013, NUCLEIC ACIDS RES, V41; Harris S., 2013, SPARQL 1 1 QUERY LAN; Hunter S, 2012, NUCLEIC ACIDS RES, V40; Husson F, 2006, COMPUT STAT DATA AN, V50, P358, DOI 10.1016/j.csda.2004.08.005; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kim J, 2007, BIOCHEMISTRY-US, V46, P12501, DOI 10.1021/bi7014629; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Lee B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S5; Lees J, 2012, NUCLEIC ACIDS RES, V40; Leimena MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-530; Letunic I., 2012, NUCLEIC ACIDS RES, P40; Levering J, 2011, SYSTEMS BIOL CENTRAL; Liu ML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-253; Mi H, 2013, NUCLEIC ACIDS RES, V41; Mohanty S, 2013, MOL BIOSYST, V9, P1708, DOI 10.1039/c3mb25481j; Morgat A, 2012, NUCLEIC ACIDS RES, V40; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Notebaart RA, 2014, P NATL ACAD SCI USA, V111, P11762, DOI 10.1073/pnas.1406102111; Pedruzzi I, 2013, NUCLEIC ACIDS RES, V41; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41; Sinha S, 1999, P NATL ACAD SCI USA, V96, P13074, DOI 10.1073/pnas.96.23.13074; Smith HE, 1999, J CLIN MICROBIOL, V37, P3146, DOI 10.1128/JCM.37.10.3146-3152.1999; Tordai H, 2005, FEBS J, V272, P5064, DOI 10.1111/j.1742-4658.2005.04917.x; Vogel C, 2005, J MOL BIOL, V346, P355, DOI 10.1016/j.jmb.2004.11.050; Weiner J, 2006, FEBS J, V273, P2037, DOI 10.1111/j.1742-4658.2006.05220.x; Weiner J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-285; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Zhang AD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-523	60	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137908	10.1371/journal.pone.0137908	http://dx.doi.org/10.1371/journal.pone.0137908			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366735	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100175
J	van Oeffelen, AAM; Rittersma, S; Vaartjes, I; Stronks, K; Bots, ML; Agyemang, C				van Oeffelen, Aloysia A. M.; Rittersma, Saskia; Vaartjes, Ilonca; Stronks, Karien; Bots, Michiel L.; Agyemang, Charles			Are There Ethnic Inequalities in Revascularisation Procedure Rate after an ST-Elevation Myocardial Infarction?	PLOS ONE			English	Article							INVASIVE CARDIAC PROCEDURES; RACIAL-DIFFERENCES; PRIMARY ANGIOPLASTY; CORONARY-DISEASE; DISPARITIES; PREVALENCE; MANAGEMENT; MORTALITY; VETERANS; SURVIVAL	Background Previously, ethnic inequalities in prognosis after a first acute myocardial infarction were observed in the Netherlands. This might be due to differences in revascularisation rate between ethnic minority groups and ethnic Dutch. Therefore, we investigated inequalities in revascularisation rate after occurrence of an ST-elevation myocardial infarction (STEMI) between first generation ethnic minority groups (henceforth, migrants) and ethnic Dutch. Methods All STEMI events between 2006 and 2011 were identified in a subset of the Achmea Health Database, which records medical care to persons insured at the Achmea health insurance company, a major health insurance company in the central part of the Netherlands. Ethnic Dutch and migrants from Suriname (Hindustani Surinamese and non-Hindustani Surinamese), Morocco, and Turkey were included (n = 1,765). Multivariable Cox proportional hazards regression analyses were used to identify ethnic inequalities in revascularisation rate (percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG)) after a STEMI event. Results On average, 73.2% of STEMI events were followed by a revascularisation procedure. After adjustment for confounders (age, sex, degree of urbanization) no significant differences in revascularisation rate were found between the ethnic Dutch population and Hindustani Surinamese (HR: 1.04; 0.85-1.27), non-Hindustani Surinamese (HR: 0.98; 0.63-1.51), Moroccan (HR: 0.94; 0.77-1.14), and Turkish migrants (HR: 1.04; 0.88-1.24). Additional adjustment for comorbidity and neighborhood income did not change our findings. Conclusion Our study suggests no ethnic inequalities in revascularisation rate after a STEMI event. This finding is in agreement with the universally accessible health care system in the Netherlands.	[van Oeffelen, Aloysia A. M.; Vaartjes, Ilonca; Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Rittersma, Saskia] Univ Med Ctr Utrecht, Dept Cardiol, NL-3508 GA Utrecht, Netherlands; [Stronks, Karien; Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1100 DD Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	van Oeffelen, AAM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands.	L.vanOeffelen@umcutrecht.nl		Stronks, Karien/0000-0002-0921-2232	Dutch Heart Foundation [2010B296]	Dutch Heart Foundation(Netherlands Heart Foundation)	This work was supported by the Dutch Heart Foundation [grant number 2010B296]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2005, J HYPERTENS, V23, P1971, DOI 10.1097/01.hjh.0000186835.63996.d4; Bansal N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003415; Boelman L, 2012, EUR J PSYCHIAT, V26, P236, DOI 10.4321/S0213-61632012000400003; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Chan MY, 2009, CIRCULATION, V119, P3110, DOI 10.1161/CIRCULATIONAHA.108.799981; Cram P, 2009, J NATL MED ASSOC, V101, P1132, DOI 10.1016/S0027-9684(15)31109-3; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Echols MR, 2007, AM J CARDIOL, V99, P315, DOI 10.1016/j.amjcard.2006.08.031; Feder G, 2002, BRIT MED J, V324, P511, DOI 10.1136/bmj.324.7336.511; Freund KM, 2012, J WOMENS HEALTH, V21, P126, DOI 10.1089/jwh.2010.2580; Iribarren C, 2005, ARCH INTERN MED, V165, P2105, DOI 10.1001/archinte.165.18.2105; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kendall H, 2013, EUR J PREV CARDIOL, V20, P737, DOI 10.1177/2047487312447844; Kessels W, 2008, REGIONAAL INKOMENSON; Mandelzweig L, 2006, EUR HEART J, V27, P2285, DOI 10.1093/eurheartj/ehl196; Mindell J, 2008, J PUBLIC HEALTH-UK, V30, P45, DOI 10.1093/pubmed/fdm077; Peniston RL, 2000, AM HEART J, V139, P840, DOI 10.1016/S0002-8703(00)90016-4; Quadri G, 2013, ACTA CARDIOL, V68, P151, DOI 10.1080/AC.68.2.2967272; Sedlis SP, 1997, J CLIN EPIDEMIOL, V50, P899, DOI 10.1016/S0895-4356(97)00089-9; Smeets HM, 2011, J CLIN EPIDEMIOL, V64, P424, DOI 10.1016/j.jclinepi.2010.04.023; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stenestrand U, 2002, LANCET, V359, P1805, DOI 10.1016/S0140-6736(02)08710-X; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Thomas KL, 2010, AM HEART J, V160, P744, DOI 10.1016/j.ahj.2010.06.014; Ting HH, 2008, AM J CARDIOL, V101, P286, DOI 10.1016/j.amjcard.2007.09.084; Trevelyan J, 2001, INT J CARDIOL, V77, P275, DOI 10.1016/S0167-5273(00)00444-7; US Census Bureau, 2010, INC POV HLTH INS COV; van Oeffelen AAM, 2014, HEART, V100, P1436, DOI 10.1136/heartjnl-2013-305444; Whittle J, 2006, J AM COLL CARDIOL, V47, P2034, DOI 10.1016/j.jacc.2005.12.059; Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277	31	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136415	10.1371/journal.pone.0136415	http://dx.doi.org/10.1371/journal.pone.0136415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368504	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100016
J	Gunasekara, SM; Hicks, MN; Park, J; Brooks, CL; Serate, J; Saunders, CV; Grover, SK; Goto, JJ; Lee, JW; Youn, H				Gunasekara, Sanjiva M.; Hicks, Matt N.; Park, Jin; Brooks, Cory L.; Serate, Jose; Saunders, Cameron V.; Grover, Simranjeet K.; Goto, Joy J.; Lee, Jin-Won; Youn, Hwan			Directed Evolution of the Escherichia coli cAMP Receptor Protein at the cAMP Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE ACTIVATOR PROTEIN; VIRULENCE FACTOR REGULATOR; CYCLIC-AMP; TRANSCRIPTION ACTIVATION; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; DNA-BINDING; SUGGESTS; CAP	The Escherichia coli cAMP receptor protein (CRP) requires cAMP binding to undergo a conformational change for DNA binding and transcriptional regulation. Two CRP residues, Thr(127) and Ser(128), are known to play important roles in cAMP binding through hydrogen bonding and in the cAMP-induced conformational change, but the connection between the two is not completely clear. Here, we simultaneously randomized the codons for these two residues and selected CRP mutants displaying high CRP activity in a cAMP-producing E. coli. Many different CRP mutants satisfied the screening condition for high CRP activity, including those that cannot form any hydrogen bonds with the incoming cAMP at the two positions. In vitro DNA-binding analysis confirmed that these selected CRP mutants indeed display high CRP activity in response to cAMP. These results indicate that the hydrogen bonding ability of the Thr(127) and Ser(128) residues is not critical for the cAMP-induced CRP activation. However, the hydrogen bonding ability of Thr(127) and Ser(128) was found to be important in attaining high cAMP affinity. Computational analysis revealed that most natural cAMP-sensing CRP homologs have Thr/Ser, Thr/Thr, or Thr/Asn at positions 127 and 128. All of these pairs are excellent hydrogen bonding partners and they do not elevate CRP activity in the absence of cAMP. Taken together, our analyses suggest that CRP evolved to have hydrogen bonding residues at the cAMP pocket residues 127 and 128 for performing dual functions: preserving high cAMP affinity and keeping CRP inactive in the absence of cAMP.	[Gunasekara, Sanjiva M.; Hicks, Matt N.; Saunders, Cameron V.; Grover, Simranjeet K.; Youn, Hwan] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA; [Park, Jin] Calif State Univ Fresno, Dept Comp Sci, Fresno, CA 93740 USA; [Brooks, Cory L.; Goto, Joy J.] Calif State Univ Fresno, Dept Chem, Fresno, CA 93740 USA; [Serate, Jose] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Lee, Jin-Won] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Lee, Jin-Won] Hanyang Univ, Inst Nat Sci, Seoul 133791, South Korea	California State University System; California State University Fresno; California State University System; California State University Fresno; California State University System; California State University Fresno; University of Wisconsin System; University of Wisconsin Madison; Hanyang University; Hanyang University	Youn, H (corresponding author), 2555 East San Ramon Ave M-S SB73, Fresno, CA 93740 USA.	hyoun@csufresno.edu	LEE, JIN-WON/L-1116-2016	LEE, JIN-WON/0000-0002-1201-8254	National Institutes of Health from the NIAID [R15AI101919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI101919] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R15AI101919 from the NIAID (to H. Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arce-Rodriguez A, 2012, ENVIRON MICROBIOL, V14, P702, DOI 10.1111/j.1462-2920.2011.02622.x; Baichoo N, 1999, J MOL BIOL, V290, P37, DOI 10.1006/jmbi.1999.2858; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; CHENG XD, 1995, BIOCHEMISTRY-US, V34, P10816, DOI 10.1021/bi00034a014; Cordes TJ, 2011, J BACTERIOL, V193, P4069, DOI 10.1128/JB.00666-10; Derouaux A, 2004, BIOCHEM BIOPH RES CO, V325, P983, DOI 10.1016/j.bbrc.2004.10.143; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; EBRIGHT RH, 1985, J MOL BIOL, V182, P91, DOI 10.1016/0022-2836(85)90030-0; Forcada-Nadal A, 2014, FEBS LETT, V588, P2270, DOI 10.1016/j.febslet.2014.05.010; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; GRONENBORN AM, 1988, BIOCHEM J, V253, P801, DOI 10.1042/bj2530801; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Hogema BM, 1998, MOL MICROBIOL, V28, P755, DOI 10.1046/j.1365-2958.1998.00833.x; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Kumar S, 2000, PROTEIN SCI, V9, P10; Lee Eun Ju, 1994, Nucleic Acids Research, V22, P2894, DOI 10.1093/nar/22.15.2894; Leu SF, 1999, BIOCHEMISTRY-US, V38, P6222, DOI 10.1021/bi982938z; Lyell NL, 2013, J BACTERIOL, V195, P5051, DOI 10.1128/JB.00751-13; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NotleyMcRobb L, 1997, MICROBIOL-SGM, V143, P1909, DOI 10.1099/00221287-143-6-1909; Nussinov R, 2014, TRENDS PHARMACOL SCI, V35, P256, DOI 10.1016/j.tips.2014.03.006; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Phillips R., 2009, PHYS BIOL CELL; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reddy MCM, 2009, J BIOL CHEM, V284, P36581, DOI 10.1074/jbc.M109.041343; Ryu MH, 2015, PROTEINS, V83, P799, DOI 10.1002/prot.24769; Serate J, 2011, J BACTERIOL, V193, P4859, DOI 10.1128/JB.00352-11; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; Townsend PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113265; Villarreal JM, 2011, MICROBIOL-SGM, V157, P636, DOI 10.1099/mic.0.046045-0; Youn H, 2006, J BIOL CHEM, V281, P1119, DOI 10.1074/jbc.M509421200; Youn H, 2008, J BACTERIOL, V190, P4532, DOI 10.1128/JB.00074-08; Youn H, 2007, J BIOL CHEM, V282, P3632, DOI 10.1074/jbc.M606602200	40	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26587	26596		10.1074/jbc.M115.678474	http://dx.doi.org/10.1074/jbc.M115.678474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26378231	Green Published, hybrid			2022-12-26	WOS:000364793600025
J	Mora, M; Adam, V; Palomera, E; Blesa, S; Diaz, G; Buquet, X; Serra-Prat, M; Martin-Escudero, JC; Palanca, A; Chaves, JF; Puig-Domingo, M				Mora, Mireia; Adam, Victoria; Palomera, Elisabet; Blesa, Sebastian; Diaz, Gonzalo; Buquet, Xavier; Serra-Prat, Mateu; Carlos Martin-Escudero, Juan; Palanca, Ana; Felipe Chaves, Javier; Puig-Domingo, Manuel		Mataro Aging Study Grp	Ghrelin Gene Variants Influence on Metabolic Syndrome Components in Aged Spanish Population	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; LEU72MET POLYMORPHISM; INSULIN SENSITIVITY; ASSOCIATION; FAT; PREPROGHRELIN; HYPERTENSION; CHOLESTEROL; OBESTATIN	Background The role of genetic variations within the ghrelin gene on cardiometabolic profile and nutritional status is still not clear in humans, particularly in elderly people. Objectives We investigated six SNPs of the ghrelin gene and their relationship with metabolic syndrome (MS) components. Subjects and Methods 824 subjects (413 men/411 women, age 77.31 +/- 5.04) participating in the Mataro aging study (n = 310) and the Hortega study (n = 514) were analyzed. Anthropometric variables, ghrelin, lipids, glucose and blood pressure levels were measured, and distribution of SNPs -994CT (rs26312), -604GA (rs27647), -501AC (rs26802), R51Q (rs34911341), M72L (rs696217) and L90G (rs4684677) of the ghrelin gene evaluated. Genotypes were determined by multiplex PCR and SNaPshot minisequencing. MS (IDF criteria) was found in 54.9%. Results No association between any of the SNPs and levels of total fasting circulating ghrelin levels was found. C/A-A/A genotype of M72L was associated with increased risk of central obesity according to IDF criteria, while G/A-G/G genotypes of -604GA with reduced risk. A/Agenotype of -501AC polymorphism was associated to decreased BMI. In relation to lipid profile, the same genotypes of -604GA were associated with increased total cholesterol and LDL-cholesterol and -501AC with reduced triglycerides. There were no associations with systolic or diastolic blood pressure levels or with hypertension, glucose levels or diabetes and ghrelin polymorphisms. However, G/G genotype of -604GA was associated with glucose >100 mg/dL. Haplotype analysis showed that only one haplotype is associated with increased risk of waist circumference and central obesity. The analysis of subjects by gender showed an important and different association of these polymorphisms regarding MS parameters. Conclusion Ghrelin gene variants -604GA, -501AC and M72L are associated with certain components of MS, in particular to BMI and lipid profile in elderly Spanish subjects.	[Mora, Mireia; Diaz, Gonzalo] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain; [Adam, Victoria; Blesa, Sebastian; Felipe Chaves, Javier] Hosp Clinic Valencia INCLIVA, Genotyping & Genet Diag Unit, Res Fdn, Valencia, Spain; [Palomera, Elisabet; Serra-Prat, Mateu] Hosp Mataro, Res Unit, Mataro, Spain; [Palomera, Elisabet; Serra-Prat, Mateu] Hosp Mataro, Ciberhep, Mataro, Spain; [Diaz, Gonzalo] Hosp Clin Valladolid, Valladolid, Spain; [Buquet, Xavier] Hosp Mataro, Serv Biochem, Mataro, Spain; [Carlos Martin-Escudero, Juan] Univ Valladolid, Hosp Rio Hortega, Dept Internal Med, Valladolid, Spain; [Puig-Domingo, Manuel] Hosp Badalona Germans Trias & Pujol, Dept Endocrinol & Nutr, Badalona, Spain; [Felipe Chaves, Javier] CIBER Diabet & Associated Metab Dis CIBERDEM, Barcelona, Spain; [Puig-Domingo, Manuel] Ctr Invest Biomed Enfermedades Raras CIBER ER, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; Hospital del Rio Hortega; Universidad de Valladolid; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Puig-Domingo, M (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Endocrinol & Nutr, Badalona, Spain.	mpuigd@gmail.com	Blesa, Sebastián/AAC-3857-2019; Puig-Domingo, Manel/S-2169-2019; Chaves-Martinez, Felipe Javier/ABC-3294-2021; Palanca, Ana/E-1541-2018; Mora, Mireia/R-6696-2018	Blesa, Sebastián/0000-0002-5219-0796; Puig-Domingo, Manel/0000-0002-6744-7195; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; Palanca, Ana/0000-0003-3513-4458; Martin-Escudero, Juan Carlos/0000-0002-6209-6509; Mora, Mireia/0000-0002-5887-5016; PALOMERA FANEGAS, ELISABET/0000-0002-4384-5746; Serra-Prat, Mateu/0000-0002-6554-9913	Fondo Investigaciones Sanitarias [07/0601, PI11/00726]; CIBER de Diabetes y Enfermedades Metabolicas Relacionadas (CIBERDEM); CIBERDEM is an initiative by Carlos III Health Institute in Madrid; Spanish Health Ministry; Valencian Government [PROMETEO/2009/029, AP-091/11, ACOMP/2013/039]	Fondo Investigaciones Sanitarias(Instituto de Salud Carlos III); CIBER de Diabetes y Enfermedades Metabolicas Relacionadas (CIBERDEM); CIBERDEM is an initiative by Carlos III Health Institute in Madrid; Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Valencian Government	Fondo Investigaciones Sanitarias Grants 07/0601 And PI11/00726, by CIBER de Diabetes y Enfermedades Metabolicas Relacionadas (CIBERDEM); CIBERDEM is an initiative by Carlos III Health Institute in Madrid and the Spanish Health Ministry, by PROMETEO/2009/029, AP-091/11, and ACOMP/2013/039 from the Valencian Government.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Ando T, 2007, AM J CLIN NUTR, V86, P25, DOI 10.1093/ajcn/86.1.25; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Berthold HK, 2010, HYPERTENS RES, V33, P155, DOI 10.1038/hr.2009.194; Bertoli S, 2006, EUR J ENDOCRINOL, V155, P321, DOI 10.1530/eje.1.02220; Bing C, 2005, DIABETIC MED, V22, P1157, DOI 10.1111/j.1464-5491.2005.01575.x; Chen CY, 2000, PHARMACOL REV, V61, P430; Choi HJ, 2006, J CLIN ENDOCR METAB, V91, P4657, DOI 10.1210/jc.2005-2549; del Giudice EM, 2004, INT J OBESITY, V28, P447, DOI 10.1038/sj.ijo.0802572; Garcia EA, 2009, EUR J ENDOCRINOL, V161, P307, DOI 10.1530/EJE-09-0122; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Hubacek JA, 2007, FOLIA BIOL-PRAGUE, V53, P202; Hubacek JA, 2008, METABOLISM, V57, P1016, DOI 10.1016/j.metabol.2008.04.004; Korbonits M, 2002, J CLIN ENDOCR METAB, V87, P4005, DOI 10.1210/jc.87.8.4005; Li WJ, 2008, CHINESE MED J-PEKING, V121, P1666, DOI 10.1097/00029330-200809010-00015; Liao N, 2013, GENE, V517, P179, DOI 10.1016/j.gene.2012.12.094; Liu J, 2012, GENE, V504, P309, DOI 10.1016/j.gene.2012.03.025; Mager U, 2006, DIABETIC MED, V23, P685, DOI 10.1111/j.1464-5491.2006.01870.x; Mager U, 2006, AM J HYPERTENS, V19, P920, DOI 10.1016/j.amjhyper.2006.02.017; Martin GR, 2008, OBESITY, V16, P908, DOI 10.1038/oby.2007.125; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Mora M, 2014, AGING CLIN EXP RES, V26, P161, DOI 10.1007/s40520-014-0203-5; Mora M, 2013, CLIN ENDOCRINOL, V78, P882, DOI 10.1111/j.1365-2265.2012.04489.x; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Puig-Domingo M, 2008, AGING CLIN EXP RES, V20, P439; Rigamonti AE, 2002, J ENDOCRINOL, V175, pR1, DOI 10.1677/joe.0.175R001; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Rozen S, 2003, BIOINFORMATICS METHO, P365; Serra-Prat M, 2007, J ENDOCRINOL INVEST, V30, P484, DOI 10.1007/BF03346332; Serra-Prat M, 2009, CLIN ENDOCRINOL, V70, P227, DOI 10.1111/j.1365-2265.2008.03307.x; Serra-Prat M, 2009, AM J CLIN NUTR, V89, P1410, DOI 10.3945/ajcn.2008.27076; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; St-Pierre DH, 2007, J CLIN ENDOCR METAB, V92, P264, DOI 10.1210/jc.2006-1603; Steinle NI, 2005, J CLIN ENDOCR METAB, V90, P6672, DOI 10.1210/jc.2005-0549; Strum K, 2003, J CLIN ENDOCR METAB, V88, P3747, DOI 10.1210/jc.2002-021656; Ukkola O, 2002, OBES RES, V10, P782, DOI 10.1038/oby.2002.106; Ukkola O, 2006, ANN MED, V38, P274, DOI 10.1080/07853890600622192; Vivenza D, 2004, EUR J ENDOCRINOL, V151, P127, DOI 10.1530/eje.0.1510127; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Xu LL, 2008, BIOMED ENVIRON SCI, V21, P188, DOI 10.1016/S0895-3988(08)60027-6; Zavarella S, 2008, INT J OBESITY, V32, P663, DOI 10.1038/sj.ijo.0803766; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhu JF, 2010, IRISH J MED SCI, V179, P345, DOI 10.1007/s11845-010-0494-2	43	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136931	10.1371/journal.pone.0136931	http://dx.doi.org/10.1371/journal.pone.0136931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375586	gold, Green Submitted, Green Published			2022-12-26	WOS:000361610200025
J	Oltolina, F; Zamperone, A; Colangelo, D; Gregoletto, L; Reano, S; Pietronave, S; Merlin, S; Talmon, M; Novelli, E; Diena, M; Nicoletti, C; Musaro, A; Filigheddu, N; Follenzi, A; Prat, M				Oltolina, Francesca; Zamperone, Andrea; Colangelo, Donato; Gregoletto, Luca; Reano, Simone; Pietronave, Stefano; Merlin, Simone; Talmon, Maria; Novelli, Eugenio; Diena, Marco; Nicoletti, Carmine; Musaro, Antonio; Filigheddu, Nicoletta; Follenzi, Antonia; Prat, Maria			Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; IN-VITRO; MONOCLONAL-ANTIBODIES; ENDOTHELIAL-CELLS; REPAIR; HEART; MIGRATION; MUSCLE; MULTIPOTENT	A major obstacle to an effective myocardium stem cell therapy has always been the delivery and survival of implanted stem cells in the heart. Better engraftment can be achieved if cells are administered as cell aggregates, which maintain their extra-cellular matrix (ECM). We have generated spheroid aggregates in less than 24 h by seeding human cardiac progenitor cells (hCPCs) onto methylcellulose hydrogel-coated microwells. Cells within spheroids maintained the expression of stemness/mesenchymal and ECM markers, growth factors and their cognate receptors, cardiac commitment factors, and metalloproteases, as detected by immunofluorescence, q-RT-PCR and immunoarray, and expressed a higher, but regulated, telomerase activity. Compared to cells in monolayers, 3D spheroids secreted also bFGF and showed MMP2 activity. When spheroids were seeded on culture plates, the cells quickly migrated, displaying an increased wound healing ability with or without pharmacological modulation, and reached confluence at a higher rate than cells from conventional monolayers. When spheroids were injected in the heart wall of healthy mice, some cells migrated from the spheroids, engrafted, and remained detectable for at least 1 week after transplantation, while, when the same amount of cells was injected as suspension, no cells were detectable three days after injection. Cells from spheroids displayed the same engraftment capability when they were injected in cardiotoxin-injured myocardium. Our study shows that spherical in vivo ready-to-implant scaffold-less aggregates of hCPCs able to engraft also in the hostile environment of an injured myocardium can be produced with an economic, easy and fast protocol.	[Oltolina, Francesca; Zamperone, Andrea; Colangelo, Donato; Gregoletto, Luca; Pietronave, Stefano; Merlin, Simone; Talmon, Maria; Follenzi, Antonia; Prat, Maria] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Reano, Simone; Filigheddu, Nicoletta] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Novelli, Eugenio; Diena, Marco] Clin S Gaudenzio, Dept Cardiac Surg, Novara, Italy; [Nicoletti, Carmine; Musaro, Antonio] DAHFMO, Inst Pasteur Cenci Bolognetti, Rome, Italy; [Nicoletti, Carmine; Musaro, Antonio] Univ Roma La Sapienza, IIM, Unit Histol & Med Embryol, I-00185 Rome, Italy; [Follenzi, Antonia; Prat, Maria] Ctr Biotecnol Ric Med Applicata BRMA, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Fondazione Cenci Bolognetti; Sapienza University Rome	Prat, M (corresponding author), Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy.	mprat@med.unipmn.it	Filigheddu, Nicoletta/N-7219-2015; Musarò, Antonio/K-9598-2016; Colangelo, Donato/ABB-2772-2020; Musaro, Antonio/P-2953-2019	Filigheddu, Nicoletta/0000-0002-3848-611X; Musarò, Antonio/0000-0002-2944-9739; Colangelo, Donato/0000-0003-2277-3226; Musaro, Antonio/0000-0002-2944-9739; Merlin, Simone/0000-0001-5209-3921; Reano, Simone/0000-0002-5059-3620; NICOLETTI, Carmine/0000-0001-5896-2040; Follenzi, Antonia/0000-0001-9780-300X; Talmon, Maria/0000-0002-3914-5034	European Commission: Starting Consolidator ERC Grant [261178 CGT-HA]; AIRC [13166]; Clinica S. Gaudenzio - Novara (Gruppo Policlinico di Monza)	European Commission: Starting Consolidator ERC Grant; AIRC(Fondazione AIRC per la ricerca sul cancro); Clinica S. Gaudenzio - Novara (Gruppo Policlinico di Monza)	Funding was provided by a grant of the European Commission: Starting Consolidator ERC Grant n. 261178 CGT-HA, "Cell and gene therapy foe Hemophilia", http://erc.europa.eu/starting-grants and a grant from AIRC: IG n. 13166, "Development of engineered magnetic nanoparticles for cancer therapy", http://www.airc.it to A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S.P. was supported by a fellowship from Clinica S. Gaudenzio - Novara (Gruppo Policlinico di Monza).	Anversa P, 2005, BASIC RES CARDIOL, V100, P482, DOI 10.1007/s00395-005-0554-3; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; BUSSOLINO F, 1991, J CLIN INVEST, V87, P986, DOI 10.1172/JCI115107; Cao ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082949; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cheng K, 2012, STEM CELLS, V30, P2835, DOI 10.1002/stem.1184; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Colangelo D, 2005, CURR MED CHEM, V12, P3091, DOI 10.2174/092986705774933416; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Di Scipio F, 2014, BBA-GEN SUBJECTS, V1840, P2152, DOI 10.1016/j.bbagen.2014.03.005; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Forte G, 2011, STEM CELLS, V29, P2051, DOI 10.1002/stem.763; Giardini MA, 2014, PROG MOL BIOL TRANSL, V125, P1, DOI 10.1016/B978-0-12-397898-1.00001-3; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hindi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072121; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Keith MCL, 2015, CIRC RES, V116, P1216, DOI 10.1161/CIRCRESAHA.116.305557; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kutys ML, 2013, EXP CELL RES, V319, P2434, DOI 10.1016/j.yexcr.2013.05.030; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee WY, 2011, BIOMATERIALS, V32, P5558, DOI 10.1016/j.biomaterials.2011.04.031; Lee WY, 2009, BIOMATERIALS, V30, P5505, DOI 10.1016/j.biomaterials.2009.07.006; Leor J, 2000, CIRCULATION, V102, P56; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Madonna R, 2011, EUR HEART J, V32, P1190, DOI 10.1093/eurheartj/ehq450; Malliaras K, 2014, STEM CELL TRANSL MED, V3, P2, DOI 10.5966/sctm.2013-0104; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x; Mosqueira D, 2014, ACS NANO, V8, P2033, DOI 10.1021/nn4058984; Mu XD, 2011, AM J PATHOL, V179, P931, DOI 10.1016/j.ajpath.2011.05.004; Nabel Elizabeth G, 2012, Trans Am Clin Climatol Assoc, V123, P221; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; Ni AG, 2014, STEM CELLS DEV, V23, P3065, DOI 10.1089/scd.2014.0064; Pavo N, 2014, J MOL CELL CARDIOL, V75, P12, DOI 10.1016/j.yjmcc.2014.06.016; Pietronave S, 2014, STEM CELLS DEV, V23, P888, DOI 10.1089/scd.2013.0375; Pietronave S, 2010, AM J PHYSIOL-HEART C, V298, pH1155, DOI 10.1152/ajpheart.01323.2008; Potapova IA, 2007, STEM CELLS, V25, P1761, DOI 10.1634/stemcells.2007-0022; Prat M, 1998, J CELL SCI, V111, P237; Ratajczak MZ, 2012, ADV MED SCI-POLAND, V57, P1, DOI 10.2478/v10039-012-0020-z; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Samsonraj RM, 2013, GENE, V519, P348, DOI 10.1016/j.gene.2013.01.039; Santini MP, 2007, CIRC RES, V100, P1732, DOI 10.1161/CIRCRESAHA.107.148791; Shirvaikar N, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/685267; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Taghavi S, 2013, AM J TRANSL RES, V5, P404; Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Valente M, 2014, STEM CELLS DEV, V23, P2263, DOI 10.1089/scd.2014.0197; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wang CC, 2009, STEM CELLS, V27, P724, DOI 10.1634/stemcells.2008-0944; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Wu KH, 2006, EUR J CARDIO-THORAC, V30, P770, DOI 10.1016/j.ejcts.2006.08.003; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yamaguchi Y, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/s12896-014-0105-9; Yang MJ, 2007, BIOMACROMOLECULES, V8, P2746, DOI 10.1021/bm0704166; Yeh YC, 2010, BIOMATERIALS, V31, P6444, DOI 10.1016/j.biomaterials.2010.04.069; Zakharova L, 2010, CARDIOVASC RES, V87, P40, DOI 10.1093/cvr/cvq027; Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023	66	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137999	10.1371/journal.pone.0137999	http://dx.doi.org/10.1371/journal.pone.0137999			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375957	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200067
J	Galan-Cobo, A; Ramirez-Lorca, R; Serna, A; Echevarria, M				Galan-Cobo, Ana; Ramirez-Lorca, Reposo; Serna, Ana; Echevarria, Miriam			Overexpression of AQP3 Modifies the Cell Cycle and the Proliferation Rate of Mammalian Cells in Culture	PLOS ONE			English	Article							PLASMA-MEMBRANE; WATER CHANNELS; AQUAPORIN 5; EXPRESSION; APOPTOSIS; PROMOTES; HYPOXIA; GROWTH; ADAPTATION; ESOPHAGEAL	Abnormal AQP3 overexpression in tumor cells of different origins has been reported and a role for this enhanced AQP3 expression in cell proliferation and tumor processess has been indicated. To further understand the role AQP3 plays in cell proliferation we explore the effect that stable over expression of AQP3 produces over the proliferation rate and cell cycle of mammalian cells. The cell cycle was analyzed by flow cytometry with propidium iodide (PI) and the cell proliferation rate measured through cell counting and BrdU staining. Cells with overexpression of AQP3 (AQP3-o) showed higher proliferation rate and larger percentage of cells in phases S and G2/M, than wild type cells (wt). Evaluation of the cell response against arresting the cell cycle with Nocodazole showed that AQP3-o exhibited a less modified cell cycle pattern and lower Annexin V specific staining than wt, consistently with a higher resistance to apoptosis of AQP3-overexpressing cells. The cell volume and complexity were also larger in AQP3-o compared to wt cells. After transcriptomic analysis, RT-qPCR was performed to highlight key molecules implicated in cell proliferation which expression may be altered by overexpression of AQP3 and the comparative analysis between both type of cells showed significant changes in the expression of Zeb2, Jun, JunB, NF-k beta, Cxcl9, Cxcl10, TNF, and TNF receptors. We conclude that the role of AQP3 in cell proliferation seems to be connected to increments in the cell cycle turnover and changes in the expression levels of relevant genes for this process. Larger expression of AQP3 may confer to the cell a more tumor like phenotype and contributes to explain the presence of this protein in many different tumors.	[Galan-Cobo, Ana; Ramirez-Lorca, Reposo; Serna, Ana; Echevarria, Miriam] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS,Dept Fisiol Med & Biofis, Seville, Spain; [Echevarria, Miriam] Inst Salud Carlos III, CIBERES, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Echevarria, M (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS,Dept Fisiol Med & Biofis, Seville, Spain.	irusta@us.es	IBIS, TERAPIA CELULA/P-3297-2015; Reposo, Ramirez-Lorca/D-7907-2014; Echevarría, Miriam/E-6682-2010; Serna Gallego, Ana/M-3379-2014	Echevarría, Miriam/0000-0002-4758-9428; Ramirez Lorca, Reposo/0000-0002-1594-0404; Serna Gallego, Ana/0000-0002-7142-0315; Galan Cobo, Ana/0000-0002-0988-1823	Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa; Red de Terapia Celular; Instituto de Salud Carlos III [Exp. PI12/01882, Exp. PS09/00605]; La Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa [P08-CTS-03574]; Consejeria de Salud [PI0018-2014, PI0298-2010]	Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa(Junta de Andalucia); Red de Terapia Celular; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); La Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa(Junta de Andalucia); Consejeria de Salud	The authors thank "Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa" for the postdoctoral contract that supported AGC and "Red de Terapia Celular" for the postdoctoral contract that supported RRL. This work was funded by grants from the "Instituto de Salud Carlos III" (Exp. PI12/01882 and Exp. PS09/00605), and by grants from "La Junta de Andalucia, Consejeria de Innovacion Ciencia y Empresa" (P08-CTS-03574) and Consejeria de Salud (PI0018-2014) to RRL and (PI0298-2010) to ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghouleh I, 2013, CARDIOVASC RES, V97, P134, DOI 10.1093/cvr/cvs295; Almasalmeh A, 2014, FEBS J, V281, P647, DOI 10.1111/febs.12653; Beswick RW, 2006, LEUKEMIA RES, V30, P427, DOI 10.1016/j.leukres.2005.08.009; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002594; Di Giusto G, 2012, J CELL BIOCHEM, V113, P3721, DOI 10.1002/jcb.24246; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Flamenco P, 2009, BIOL CELL, V101, P237, DOI 10.1042/BC20080050; Galan-Cobo A, 2016, J CELL PHYSIOL, V231, P243, DOI 10.1002/jcp.25078; Galan-Cobo A, 2013, GENE, V522, P18, DOI 10.1016/j.gene.2013.03.075; Gao L, 2004, FEBS LETT, V569, P256, DOI 10.1016/j.febslet.2004.06.004; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Huang YM, 2010, CANCER BIOL THER, V9, P1000, DOI 10.4161/cbt.9.12.11705; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kang SK, 2008, AM J PATHOL, V173, P518, DOI 10.2353/ajpath.2008.071198; Ko SBH, 2002, AM J PHYSIOL-GASTR L, V282, pG324, DOI 10.1152/ajpgi.00198.2001; Kusayama M, 2011, CANCER SCI, V102, P1128, DOI 10.1111/j.1349-7006.2011.01927.x; Lee M, 2012, MOL ENDOCRINOL, V26, P1394, DOI 10.1210/me.2012-1055; Liu YL, 2007, HUM PATHOL, V38, P171, DOI 10.1016/j.humpath.2006.07.015; Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984; Marinelli RA, 1999, AM J PHYSIOL-GASTR L, V276, pG280, DOI 10.1152/ajpgi.1999.276.1.G280; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Onori P, 2010, INT J CANCER, V127, P43, DOI 10.1002/ijc.25028; Papadopoulos MC, 2015, BBA-BIOMEMBRANES, V1848, P2576, DOI 10.1016/j.bbamem.2014.09.001; Pedersen SF, 2013, FRONT PHYSIOL, V4; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rivarola V, 2010, J CELL PHYSIOL, V224, P405, DOI 10.1002/jcp.22136; Serna A, 2014, J CELL PHYSIOL, V229, P1787, DOI 10.1002/jcp.24632; Shimizu H, 2014, J GASTROENTEROL, V49, P655, DOI 10.1007/s00535-013-0827-9; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140	41	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137692	10.1371/journal.pone.0137692	http://dx.doi.org/10.1371/journal.pone.0137692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367709	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100111
J	Langos, D; Kulik, L; Ruiz-Lambides, A; Widdig, A				Langos, Doreen; Kulik, Lars; Ruiz-Lambides, Angelina; Widdig, Anja			Does Male Care, Provided to Immature Individuals, Influence Immature Fitness in Rhesus Macaques?	PLOS ONE			English	Article							LIFETIME REPRODUCTIVE SUCCESS; MONKEYS MACACA-MULATTA; PATERNAL CARE; SOCIAL RELATIONSHIPS; BARBARY MACAQUES; DOMINANCE RANK; ADAPTIVE VALUE; ENERGY-INTAKE; BODY-FAT; PRIMATE	Among many mammals, maternal care strongly impacts infant survival; however, less is known about whether adult males also affect infant fitness. Paternal care is expected when providing care enhances offspring survival and reproduction, which likewise increases fathers' fitness. Males might also care for unrelated immature individuals to increase their mating probability with the immature individuals' mothers. Studies in multimale primate groups showed that sires enhance food access for offspring and provide protection in conflicts. Furthermore, fathers' presence during infancy has been suggested to accelerate offspring sexual maturation. However, no study has yet directly linked the degree of father-offspring bonds to offspring fitness in primates. We previously reported father-offspring affiliation in rhesus macaques, pronounced during early infancy and independent of mothers' presence. The present study aims at investigating whether affiliation with fathers or other males affects proxies of immature fitness (body mass gain, body fat and testis size). First, we combined behavioral, genetic and morphometric data from 55 subjects of one group. Second, using demographic and genetic data, we investigated for 92 individuals of the population whether mother-and father-offspring co-residence during immaturity influenced offspring lifetime reproductive success (LRS). Our results show that focal rank and higher amounts of affiliation with high-ranking males during infancy tend to positively impact body mass gain of female, but not male focal animals. In contrast, body mass gain of male focal individuals, but not females', appeared to be higher when affiliation of male immature individuals was evenly distributed across their adult male partners. Moreover, we found mothers', but not fathers', presence during immaturity to predict offspring LRS. Our results suggest that male-immature affiliation, but not father-offspring co-residence, potentially impacts proxies of immature fitness. However, future studies should investigate the underlying mechanisms of male-immature relationships and their impact on immature fitness in more detail.	[Langos, Doreen; Kulik, Lars; Ruiz-Lambides, Angelina; Widdig, Anja] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Jr Res Grp Primate Kin Select, D-04103 Leipzig, Germany; [Langos, Doreen; Kulik, Lars; Ruiz-Lambides, Angelina; Widdig, Anja] Univ Leipzig, Inst Biol, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [Ruiz-Lambides, Angelina] Univ Puerto Rico, Caribbean Primate Res Ctr, Punta Santiago, PR 00741 USA	Max Planck Society; Leipzig University; University of Puerto Rico; University of Puerto Rico Mayaguez	Widdig, A (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Jr Res Grp Primate Kin Select, Deutsch Pl 6, D-04103 Leipzig, Germany.	anja.widdig@eva.mpg.de			German Research Foundation (DFG) [WI 1801/1-1, 1-2, 2-1, 3-1]; KKGS Stiftung; Elsa-Neumann Stiftung; DAAD; Research Academy of Leipzig; National Center for Research Resources (NCRR) [8 P40 OD012217-25]; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; Medical Sciences Campus of the University of Puerto Rico; University of Leipzig; KKGS; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD012217] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); KKGS Stiftung; Elsa-Neumann Stiftung; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Research Academy of Leipzig; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Sciences Campus of the University of Puerto Rico; University of Leipzig; KKGS; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The following funding was awarded to AW: German Research Foundation (DFG) (grant numbers WI 1801/1-1, 1-2, 2-1, 3-1) (http://www.dfg.de/en/index.jsp). The following funding was awarded to DL: 1. KKGS Stiftung (http://www.kkgs-stiftung.de/index.html), 2. Elsa-Neumann Stiftung (http://www.hu-berlin.de/forschung/szf/wiss_nachwuchs/wn_nafoeg_html), 3. DAAD (https://www.daad.de/en/index.html), and 4. Research Academy of Leipzig (http://www.zv.unileipzig.de/en/research/ral/information-about-researchacademy-leipzig/funding-opportunities. html). The population of Cayo Santiago was supported by grant number 8 P40 OD012217-25 from the National Center for Research Resources (NCRR), the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health and the Medical Sciences Campus of the University of Puerto Rico. Additionally, funding was received through a PhD grant of the University of Leipzig (awarded to LK and DL), as well as from the KKGS, Elsa-Neumann Stiftung and the DAAD (awarded to DL). The authors thank the Max-Planck Institute for Evolutionary Anthropology, Leipzig, for hosting of the Jr. Research Group of Primate Kin Selection and for their logistic support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 1996, ANIM BEHAV, V51, P733, DOI 10.1006/anbe.1996.0077; Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; ALBERTS SC, 1995, AM NAT, V145, P279, DOI 10.1086/285740; ALBERTS SC, 1995, BEHAV ECOL SOCIOBIOL, V36, P397, DOI 10.1007/BF00177335; Alberts SC, 2012, BEHAV ECOL, V23, P699, DOI 10.1093/beheco/ars052; Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Altmann J, 1980, BABOON MOTHERS AND I; Alvergne A, 2009, ANIM BEHAV, V78, P61, DOI 10.1016/j.anbehav.2009.03.019; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Asher GW, 2013, ANIM REPROD SCI, V143, P79, DOI 10.1016/j.anireprosci.2013.10.013; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bates D, 2011, R PACKAGE VERSION 0; Belachew T, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-125; Berard J, 1999, PRIMATES, V40, P159, DOI 10.1007/BF02557708; BERCOVITCH FB, 1993, BEHAV ECOL SOCIOBIOL, V33, P313; Bercovitch FB, 1998, AM J PRIMATOL, V46, P135, DOI 10.1002/(SICI)1098-2345(1998)46:2<135::AID-AJP3>3.3.CO;2-A; BERCOVITCH FB, 1993, AM J PRIMATOL, V30, P163, DOI 10.1002/ajp.1350300208; Bercovitch FB, 2003, NATURWISSENSCHAFTEN, V90, P309, DOI 10.1007/s00114-003-0436-1; BERCOVITCH FB, 1990, MG PRIMATOL, V13, P59; BERCOVITCH FB, 1992, PATERNITY IN PRIMATES : GENETIC TESTS AND THEORIES, P225; Bercovitch FB, 1997, PRIMATES, V38, P247, DOI 10.1007/BF02381613; Berk R, 2008, J QUANT CRIMINOL, V24, P269, DOI 10.1007/s10940-008-9048-4; Blomquist GE, 2013, AM J PRIMATOL, V75, P238, DOI 10.1002/ajp.22117; Blumstein DT, 2001, ETHOLOGY, V107, P655, DOI 10.1046/j.1439-0310.2001.00699.x; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Cameron JL, 1997, SEMIN REPROD ENDOCR, V15, P37, DOI 10.1055/s-2008-1067966; Cawthon Lang KA, 2005, PRIMATE FACTSHEETS R; Chapais Bernard, 1992, P29; Charpentier MJE, 2008, P NATL ACAD SCI USA, V105, P1988, DOI 10.1073/pnas.0711219105; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Colvin J, 1983, PRIMATE SOCIAL RELAT, P190; Crean AJ, 2014, TRENDS ECOL EVOL, V29, P554, DOI 10.1016/j.tree.2014.07.009; Crockford C, 2008, HORM BEHAV, V53, P254, DOI 10.1016/j.yhbeh.2007.10.007; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; Diaz-Munoz SL, 2011, ANIM BEHAV, V82, P563, DOI 10.1016/j.anbehav.2011.06.013; Dixson AF, 1997, HORM BEHAV, V31, P126, DOI 10.1006/hbeh.1997.1374; Dobson AJ, 2002, AN INTRODUCTION TO G; DRICKAMER LC, 1974, FOLIA PRIMATOL, V21, P61, DOI 10.1159/000155596; Dubuc C, 2014, BEHAV ECOL, V25, P878, DOI 10.1093/beheco/aru052; Dubuc C, 2012, HORM BEHAV, V61, P696, DOI 10.1016/j.yhbeh.2012.03.003; Elo AE, 1978, THE RATING OF CHESS; FEDIGAN LM, 1986, FOLIA PRIMATOL, V47, P143, DOI 10.1159/000156271; Fernandez-Duque E, 2009, ANNU REV ANTHROPOL, V38, P115, DOI 10.1146/annurev-anthro-091908-164334; Fooden J, 2000, FIELDIANA ZOOL, V96, P1, DOI DOI 10.5962/BHL.TITLE.7192; Foster EA, 2012, SCIENCE, V337, P1313, DOI 10.1126/science.1224198; Fox CW, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P159; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; Geary DC, 2000, PSYCHOL BULL, V126, P55, DOI 10.1037/0033-2909.126.1.55; Gende SM, 2004, CAN J ZOOL, V82, P75, DOI 10.1139/Z03-226; Goodall J, 1986, THE CHIMPANZEES OF G; Gouzoules S., 1987, P299; GRAFEN A, 1980, ANIM BEHAV, V28, P967, DOI 10.1016/S0003-3472(80)80160-6; Griffin AS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001520; GUST DA, 1993, HORM BEHAV, V27, P318, DOI 10.1006/hbeh.1993.1024; Hastie TJ, 1991, STATISTICAL MODELS I; HECTOR ACK, 1989, ANIM BEHAV, V38, P262, DOI 10.1016/S0003-3472(89)80088-0; HILL DA, 1986, PRIMATES, V27, P425, DOI 10.1007/BF02381888; Hinde RA, 1983, PRIMATE SOCIAL RELAT, P160; HOOGLAND JL, 1982, BEHAV ECOL SOCIOBIOL, V11, P155, DOI 10.1007/BF00300058; Hrdy SB, 1999, MOTHER NATURE A HIST; Hrdy SB, 1981, THE WOMAN THAT NEVER; Huchard E, 2013, BEHAV ECOL, V24, P229, DOI 10.1093/beheco/ars158; Jolly CJ, 2003, INT J PRIMATOL, V24, P125, DOI 10.1023/A:1021402730111; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kaar P, 1996, P ROY SOC B-BIOL SCI, V263, P1475, DOI 10.1098/rspb.1996.0215; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KEDDYHECTOR AC, 1992, AM ZOOL, V32, P62; Kessler MJ, 2015, AM J PRIMATOL, V77, P211, DOI 10.1002/ajp.22323; Kessler MJ, 1986, THE CAYO SANTIAGO MA; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; Kleiman D.G., 1981, P347; Kulik L, 2015, INT J PRIMATOL, V36, P353, DOI 10.1007/s10764-015-9826-4; Kulik L, 2012, MOL ECOL, V21, P699, DOI 10.1111/j.1365-294X.2011.05250.x; Langos D, 2013, MOL ECOL, V22, P3638, DOI 10.1111/mec.12328; Le Boeuf BJ, 1990, REPROD SUCCESS, P344; LINDBURG DG, 1969, SCIENCE, V166, P1176, DOI 10.1126/science.166.3909.1176; Lindburg DG, 1971, PRIMATE BEHAVIOR DEV, P1, DOI Academic Press; Lukas D, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0418; MAESTRIPIERI D, 1994, PRIMATES, V35, P443, DOI 10.1007/BF02381953; Maestripieri Dario, 2009, P256; Manly BFJ, 1997, RANDOMIZATION BOOTST; MANSON JH, 1992, ANIM BEHAV, V44, P405, DOI 10.1016/0003-3472(92)90051-A; Marriott B.M., 1988, Bulletin de la Societe Herpetologique de France, V11, P125; Marriott B.M., 1989, Puerto Rico Health Sciences Journal, V8, P87; Mateo JM, 2009, MATERNAL EFFECTS IN; MATSUBAYASHI K, 1983, Primates, V24, P521, DOI 10.1007/BF02381685; Meelis E, 1994, STAT ANAL; Menard N, 2001, CR ACAD SCI III-VIE, V324, P601, DOI 10.1016/S0764-4469(01)01339-7; Mitani JC, 2012, THE EVOLUTION OF PRI; MORI A, 1979, Primates, V20, P371, DOI 10.1007/BF02373390; Moscovice LR, 2010, ANIM BEHAV, V79, P1007, DOI 10.1016/j.anbehav.2010.01.013; Moscovice LR, 2009, BEHAV ECOL SOCIOBIOL, V63, P1471, DOI 10.1007/s00265-009-0781-y; Murray CM, 2006, BEHAV ECOL, V17, P1020, DOI 10.1093/beheco/arl042; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Onyango PO, 2013, HORM BEHAV, V63, P430, DOI 10.1016/j.yhbeh.2012.11.014; Ostner J, 2013, ANIM BEHAV, V86, P623, DOI 10.1016/j.anbehav.2013.07.004; Packer C, 1990, REPROD SUCCESS, P363; Palombit RA, 1997, ANIM BEHAV, V54, P599, DOI 10.1006/anbe.1996.0457; Palombit Ryne, 2009, P377; Palombit Ryne A., 2000, P239, DOI 10.1017/CBO9780511542312.013; Palombit Ryne A., 2000, P123, DOI 10.1017/CBO9780511542312.008; Pan Y, 2008, EPIDEMIOL INFECT, V136, P421, DOI 10.1017/S095026880700831X; Paul A, 1996, ANIM BEHAV, V51, P155, DOI 10.1006/anbe.1996.0013; Paul A, 1999, PRIMATES, V40, P33, DOI 10.1007/BF02557700; Pereira M.E., 1985, Monographs in Primatology, P217; PEREIRA ME, 1995, AM J PRIMATOL, V37, P143, DOI 10.1002/ajp.1350370207; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Potter DM, 2006, J BIOPHARM STAT, V16, P327, DOI 10.1080/10543400600609585; Price TA, 2012, CURR BIOL, V22, pR135, DOI 10.1016/j.cub.2012.01.020; Queller DC, 1997, P ROY SOC B-BIOL SCI, V264, P1555, DOI 10.1098/rspb.1997.0216; Quinn GP, 2002, EXPERIMENTAL DESIGN; Reinhold K, 2002, J HERED, V93, P400, DOI 10.1093/jhered/93.6.400; RIDLEY M, 1978, ANIM BEHAV, V26, P904, DOI 10.1016/0003-3472(78)90156-2; Rogerson PA, 2001, STAT METHODS; SAPOLSKY RM, 1991, PSYCHONEUROENDOCRINO, V16, P281, DOI 10.1016/0306-4530(91)90015-L; SAPOLSKY RM, 1990, BIOL PSYCHIAT, V28, P862, DOI 10.1016/0006-3223(90)90568-M; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schwartz S.M., 1989, Puerto Rico Health Sciences Journal, V8, P103; Setchell JM, 2005, BEHAV ECOL SOCIOBIOL, V58, P474, DOI 10.1007/s00265-005-0946-2; Sheppard P, 2012, BIOL LETTERS, V8, P237, DOI 10.1098/rsbl.2011.0747; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; SILK J, 1993, INT J PRIMATOL, V14, P95, DOI 10.1007/BF02196505; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Silk JB, 2014, EVOL ANTHROPOL, V23, P83, DOI 10.1002/evan.21402; Smuts BB, 1992, FATHER CHILD RELATIO; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Stearns SC, 1992, THE EVOLUTION OF LIF; Stoehr Andrew M., 1999, Animal Behaviour Forum, V57, pF22, DOI 10.1006/anbe.1998.1016; Surbeck M, 2011, P ROY SOC B-BIOL SCI, V278, P590, DOI 10.1098/rspb.2010.1572; Swedell L., 2011, PRIMATES PERSPECTIVE, V2, P241; Swedell L, DOMINANCE IN BABOONS; Trivers R., 1972, SEXUAL SELECTION DES, P139; TRIVERS RL, 1974, AM ZOOL, V14, P249; TURNQUIST JE, 1989, AM J PRIMATOL, V19, P1, DOI 10.1002/ajp.1350190102; van Schaik Carel, 1996, Evolutionary Anthropology, V5, P152, DOI 10.1002/(SICI)1520-6505(1996)5:5<152::AID-EVAN3>3.3.CO;2-9; Vancata V, 2000, VAR EVO, V8, P83; Vessey SH, 1973, PRIMATES, V14, P359, DOI [10.1007/BF01731357, DOI 10.1007/BF01731357]; Vogel ER, 2005, BEHAV ECOL SOCIOBIOL, V58, P333, DOI 10.1007/s00265-005-0960-4; WALKER ML, 1984, AM J PHYS ANTHROPOL, V63, P323, DOI 10.1002/ajpa.1330630309; WESTNEAT DF, 1993, BEHAV ECOL, V4, P66, DOI 10.1093/beheco/4.1.66; Whitten P.L., 1987, P343; Widdig A, 2004, P ROY SOC B-BIOL SCI, V271, P819, DOI 10.1098/rspb.2003.2666; Widdig A, 2001, P NATL ACAD SCI USA, V98, P13769, DOI 10.1073/pnas.241210198; Widdig A, 2015, AM J PRIMATOL, DOI DOI 10.1002/AJP.22401/ABSTRACT; WILSON ME, 1983, AM J PHYS ANTHROPOL, V61, P103, DOI 10.1002/ajpa.1330610111; Wittig RM, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0118695, DOI 10.1371/J0URNAL.P0NE.0118695]; Wittig RM, 2008, HORM BEHAV, V54, P170, DOI 10.1016/j.yhbeh.2008.02.009; WRIGHT PC, 1990, INT J PRIMATOL, V11, P89, DOI 10.1007/BF02192783; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zehr JL, 2005, BIOL REPROD, V72, P1087, DOI 10.1095/biolreprod.104.027755	155	11	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137841	10.1371/journal.pone.0137841	http://dx.doi.org/10.1371/journal.pone.0137841			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367536	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100153
J	Macedo, AA; Silva, APC; Mol, JPS; Costa, LF; Garcia, LNN; Araujo, MS; Martins, OA; Paixao, TA; Santos, RL				Macedo, Auricelio A.; Silva, Ana P. C.; Mol, Juliana P. S.; Costa, Luciana F.; Garcia, Luize N. N.; Araujo, Marcio S.; Martins Filho, Olindo A.; Paixao, Tatiane A.; Santos, Renato L.			The abcEDCBA-Encoded ABC Transporter and the virB Operon-Encoded Type IV Secretion System of Brucella ovis Are Critical for Intracellular Trafficking and Survival in Ovine Monocyte-Derived Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; MURINE MACROPHAGES; ABORTUS; AGROBACTERIUM; REPLICATION; INFECTION; HOMOLOG	Brucella ovis infection is associated with epididymitis, orchitis and infertility in rams. Most of the information available on B. ovis and host cell interaction has been generated using murine macrophages or epithelial cell lines, but the interaction between B. ovis and primary ovine macrophages has not been studied. The aim of this study was to evaluate the role of the B. ovis abcEDCBA-encoded ABC transporter and the virB operon-encoded Type IV Secretion System (T4SS) during intracellular survival of B. ovis in ovine peripheral blood monocyte-derived macrophages. Delta abcBA and Delta virB2 mutant strains were unable to survive in the intracellular environment when compared to the WT B. ovis at 48 hours post infection (hpi). In addition, these mutant strains cannot exclude the lysosomal marker LAMP1 from its vacuolar membrane, and their vacuoles do not acquire the endoplasmic reticulum marker calreticulin, which takes place in the WT B. ovis containing vacuole. Higher levels of nitric oxide production were observed in macrophages infected with WT B. ovis at 48 hpi when compared to macrophages infected with the Delta abcBA or Delta virB2 mutant strains. Conversely, higher levels of reactive oxygen species were detected in macrophages infected with the Delta abcBA or Delta virB2 mutant strains at 48 hpi when compared to macrophages infected with the WT strain. Our results demonstrate that B. ovis is able to persist and multiply in ovine macrophages, while Delta abcBA and Delta virB2 mutations prevent intracellular multiplication, favor phagolysosome fusion, and impair maturation of the B. ovis vacuole towards an endoplasmic reticulum-derived compartment.	[Macedo, Auricelio A.; Silva, Ana P. C.; Mol, Juliana P. S.; Garcia, Luize N. N.; Santos, Renato L.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil; [Costa, Luciana F.; Paixao, Tatiane A.] Univ Fed Minas Gerais, Dept Patol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Araujo, Marcio S.; Martins Filho, Olindo A.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Santos, RL (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil.	rsantos@vet.ufmg.br	Araujo, Marcio Sobreira Silva/ABE-7105-2021; Martins-Filho, Olindo Assis/ABE-6278-2021; de Lima Santos, Renato/A-1134-2008	Araujo, Marcio Sobreira Silva/0000-0002-7532-3360; Martins-Filho, Olindo Assis/0000-0002-5494-4889; de Lima Santos, Renato/0000-0002-4830-0470; Mol, Juliana/0000-0002-6946-8213	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Work in RLS lab is supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil), and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil). AAM, OAMF, and RLS have fellowships from CNPq (Brazil).	ADAMS LB, 1991, J IMMUNOL, V147, P1642; ADAMS LB, 1990, J IMMUNOL, V144, P2725; Blasco J. M., 1990, Animal brucellosis., P351; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; BURGESS GW, 1982, VET MICROBIOL, V7, P551, DOI 10.1016/0378-1135(82)90049-9; CARPENTER TE, 1987, J AM VET MED ASSOC, V190, P977; Carvalho CA, 2012, SMALL RUMINANT RES, V102, P213, DOI 10.1016/j.smallrumres.2011.08.004; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Celli J, 2015, CELL MICROBIOL, V17, P951, DOI 10.1111/cmi.12452; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; Copin R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002575; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Descoteaux A, 1999, BBA-MOL BASIS DIS, V1455, P341, DOI 10.1016/S0925-4439(99)00065-4; Eskra L, 2003, INFECT IMMUN, V71, P1125, DOI 10.1128/IAI.71.3.1125-1133.2003; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Gross A, 1998, INFECT IMMUN, V66, P1309, DOI 10.1128/IAI.66.4.1309-1316.1998; JIANG XS, 1993, CELL IMMUNOL, V151, P309, DOI 10.1006/cimm.1993.1241; Kikuchi H, 2006, FEMS MICROBIOL LETT, V259, P120, DOI 10.1111/j.1574-6968.2006.00253.x; Lewis AM, 2015, MOL MICROBIOL, V96, P651, DOI 10.1111/mmi.12962; LIEW FY, 1990, J IMMUNOL, V144, P4794; Macedo AA, 2013, VET IMMUNOL IMMUNOP, V151, P294, DOI 10.1016/j.vetimm.2012.12.001; MAUEL J, 1991, J LEUKOCYTE BIOL, V49, P73, DOI 10.1002/jlb.49.1.73; Mol JPS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108606; Moreira AP, 2010, CELL IMMUNOL, V263, P196, DOI 10.1016/j.cellimm.2010.03.016; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Poester FP, 2013, REV SCI TECH OIE, V32, P105; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Rocco NM, 2011, INFECT IMMUN, V79, P2385, DOI 10.1128/IAI.01249-10; Sa JC, 2012, VET MICROBIOL, V159, P130, DOI 10.1016/j.vetmic.2012.03.029; Santos RL, 2013, PESQUI VET BRASIL, V33, P759, DOI 10.1590/S0100-736X2013000600012; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Silva APC, 2013, VET MICROBIOL, V167, P546, DOI 10.1016/j.vetmic.2013.09.003; Silva TMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114532; Silva TMA, 2011, INFECT IMMUN, V79, P1706, DOI 10.1128/IAI.01109-10; SORENSEN AL, 1994, APMIS, V102, P265, DOI 10.1111/j.1699-0463.1994.tb04874.x; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; STEINER M, 1994, HISTOCHEM J, V26, P934; SUMMERSGILL JT, 1992, J LEUKOCYTE BIOL, V52, P625, DOI 10.1002/jlb.52.6.625; Sun YH, 2002, INFECT IMMUN, V70, P4826, DOI 10.1128/IAI.70.9.4826-4832.2002; Thoen C. O., 1993, P236; Tsolis RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005519; Wang M, 2001, MICROB PATHOGENESIS, V31, P221, DOI 10.1006/mpat.2001.0463; Xavier MN, 2010, VET MICROBIOL, V145, P158, DOI 10.1016/j.vetmic.2010.02.037; Xavier MN, 2009, CIENC RURAL, V39, P2252, DOI 10.1590/S0103-84782009005000167	51	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138131	10.1371/journal.pone.0138131	http://dx.doi.org/10.1371/journal.pone.0138131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366863	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100232
J	Ruairuen, W; Fochesatto, GJ; Sparrow, EB; Schnabel, W; Zhang, MC; Kim, Y				Ruairuen, Watcharee; Fochesatto, Gilberto J.; Sparrow, Elena B.; Schnabel, William; Zhang, Mingchu; Kim, Yongwon			Evapotranspiration Cycles in a High Latitude Agroecosystem: Potential Warming Role	PLOS ONE			English	Article							ENERGY-BALANCE CLOSURE; SURFACE FLUX MEASUREMENTS; WATER-BALANCE; EDDY COVARIANCE; ARCTIC TUNDRA; PRIESTLEY-TAYLOR; PENMAN-MONTEITH; CLIMATE-CHANGE; BOREAL FOREST; BOUNDARY-LAYER	As the acreages of agricultural lands increase, changes in surface energetics and evapotranspiration (ET) rates may arise consequently affecting regional climate regimes. The objective of this study was to evaluate summertime ET dynamics and surface energy processes in a subarctic agricultural farm in Interior Alaska. The study includes micrometeorological and hydrological data. Results covering the period from June to September 2012 and 2013 indicated consistent energy fractions: LE/R-net (67%), G/R-net (6%), H/R-net (27%) where LE is latent heat flux, R-net is the surface net radiation, G is ground heat flux and H is the sensible heat flux. Additionally actual surface evapotranspiration from potential evaporation was found to be in the range of 59 to 66%. After comparing these rates with those of most prominent high latitude ecosystems it is argued here that if agroecosystem in high latitudes become an emerging feature in the land-use, the regional surface energy balance will significantly shift in comparison to existing Arctic natural ecosystems.	[Ruairuen, Watcharee; Sparrow, Elena B.; Zhang, Mingchu] Univ Alaska Fairbanks, Sch Nat Resources & Extens, Fairbanks, AK 99775 USA; [Fochesatto, Gilberto J.] Univ Alaska Fairbanks, Inst Geophys, Dept Atmospher Sci, Fairbanks, AK 99775 USA; [Fochesatto, Gilberto J.] Univ Alaska Fairbanks, Coll Nat Sci & Math, Fairbanks, AK 99775 USA; [Schnabel, William] Univ Alaska Fairbanks, Inst Northern Engn, Water & Environm Res Ctr, Fairbanks, AK 99775 USA; [Sparrow, Elena B.; Kim, Yongwon] Univ Alaska Fairbanks, Int Arctic Res Ctr, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Fochesatto, GJ (corresponding author), Univ Alaska Fairbanks, Inst Geophys, Dept Atmospher Sci, Fairbanks, AK 99775 USA.	foch@gi.alaska.edu	Kim, Yongwon/F-4683-2010	Kim, Yongwon/0000-0002-6513-4777; Ruairuen, Watcharee/0000-0003-3448-5686	Suratthani Rajabhat University, Thailand PhD Scholarship; Alaska EPSCOR [NSF-OIA-1208927]; Geophysical Institute University of Alaska Fairbanks; International Arctic Research Center; JAMSTEC-IARC Collaboration Study (JICS) project by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC); Office Of The Director [1208927] Funding Source: National Science Foundation	Suratthani Rajabhat University, Thailand PhD Scholarship; Alaska EPSCOR; Geophysical Institute University of Alaska Fairbanks; International Arctic Research Center; JAMSTEC-IARC Collaboration Study (JICS) project by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	Watcharee Ruairuen was funded by Suratthani Rajabhat University, Thailand PhD Scholarship and the Alaska EPSCOR (NSF-OIA-1208927 for Alaska Adapting to Changing Environments). Gilberto J. Fochesatto was funded by the Geophysical Institute University of Alaska Fairbanks. Elena B. Sparrow was supported by the International Arctic Research Center and the Alaska EPSCOR (NSF-OIA-1208927 for Alaska Adapting to Changing Environments). Yongwon Kim was partially supported under the JAMSTEC-IARC Collaboration Study (JICS) project by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC).	Adegoke JO, 2007, AGR FOREST METEOROL, V142, P203, DOI 10.1016/j.agrformet.2006.07.013; Adegoke JO, 2003, MON WEATHER REV, V131, P556, DOI 10.1175/1520-0493(2003)131<0556:IOIOMS>2.0.CO;2; Alaska Climate Research Center (ACRC), CLIMATE NORMAL; Alfieri JG, 2012, ADV WATER RESOUR, V50, P62, DOI 10.1016/j.advwatres.2012.07.008; Allen R. G., 2005, Irrigation and Drainage Systems, V19, P251, DOI 10.1007/s10795-005-5187-z; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Alves I, 2000, AGR WATER MANAGE, V42, P371, DOI 10.1016/S0378-3774(99)00041-4; Anadranistakis M., 2000, AGR WATER MANAGE, V42, P371; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Baldocchi DD, 1997, AGR FOREST METEOROL, V83, P147, DOI 10.1016/S0168-1923(96)02335-0; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Beringer J, 2005, AGR FOREST METEOROL, V131, P143, DOI 10.1016/j.agrformet.2005.05.006; BEVEN K, 1979, J HYDROL, V44, P169, DOI 10.1016/0022-1694(79)90130-6; BLANKEN PD, 1995, INT J CLIMATOL, V15, P97, DOI 10.1002/joc.3370150110; Boike J, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000540; BOLLE HJ, 1990, SOILS AND THE GREENHOUSE EFFECT, P329; Bolton WR, 2004, IAHS-AISH P, V290, P213; Braley WA, 1980, THESIS; Bunn A.G., 2007, EOS T AM GEOPHYS UN, V88, P333, DOI [10.1029/2007EO340001, DOI 10.1029/2007EO340001]; Chapin F. S., 2005, ECOSYSTEMS HUMAN WEL, P717; Chapin F. S., 2014, 3 NATL CLIMATE ASSES, P514, DOI [10.7930/J00Z7150, DOI 10.7930/J00Z7150]; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapin FS, 2011, PRINCIPLES OF TERRES; Cook BI, 2011, CLIM DYNAM, V37, P1587, DOI 10.1007/s00382-010-0932-x; CULF AD, 1993, AGR FOREST METEOROL, V66, P65, DOI 10.1016/0168-1923(93)90082-S; Doorenbos J, 1986, FAO IRRIGATION AND D; DUGAS WA, 1993, AGR FOREST METEOROL, V67, P115, DOI 10.1016/0168-1923(93)90053-K; Dugas WA, 1991, AGR FOREST METEOROL, V56, P12; Eaton AK, 2001, J CLIMATE, V14, P3692, DOI 10.1175/1520-0442(2001)014<3692:SEBOTW>2.0.CO;2; Engstrom RN, 2002, J AM WATER RESOUR AS, V38, P1647, DOI 10.1111/j.1752-1688.2002.tb04371.x; Eugster W, 2000, GLOBAL CHANGE BIOL, V6, P84, DOI 10.1046/j.1365-2486.2000.06015.x; Euskirchen ES, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00202.1; Euskirchen ES, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD005793; Euskirchen ES, 2006, GLOBAL CHANGE BIOL, V12, P731, DOI 10.1111/j.1365-2486.2006.01113.x; Evans JP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006671; Farahani HJ, 2007, T ASABE, V50, P1627, DOI 10.13031/2013.23965; FLINT AL, 1991, AGR FOREST METEOROL, V56, P247, DOI 10.1016/0168-1923(91)90094-7; Fochesatto GJ, 2015, METEOROL ATMOS PHYS, V127, P369, DOI 10.1007/s00703-013-0274-4; Foken T, 2008, ECOL APPL, V18, P1351, DOI 10.1890/06-0922.1; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Goyal M., 2014, EVAPOTRANSPIRATION P; Grunwald T, 2007, TELLUS B, V59, P387, DOI 10.1111/j.1600-0889.2007.00259.x; Haddeland I, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026047; Hammond T, 1996, ECOSCIENCE, V3, P490, DOI 10.1080/11956860.1996.11682368; Harazono Y, 1998, HYDROL PROCESS, V12, P2163, DOI 10.1002/(SICI)1099-1085(19981030)12:13/14&lt;2163::AID-HYP727&gt;3.0.CO;2-Y; Hatch E., 2011, THESIS; Heusinkveld BG, 2004, AGR FOREST METEOROL, V122, P21, DOI 10.1016/j.agrformet.2003.09.005; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Holloway PS, 1993, GEORGESON BOTANICAL; Irmak S, 2008, AGR FOREST METEOROL, V148, P1034, DOI 10.1016/j.agrformet.2008.02.001; Ishii Y, 2004, IAHS-AISH P, V290, P50; Jalota SK, 2002, AGR WATER MANAGE, V57, P75, DOI 10.1016/S0378-3774(02)00049-5; Juday GP, 2005, ARCTIC CLIMATE IMPAC, P782; KANE DL, 1990, NORD HYDROL, V21, P253; Kane DL, 2004, IAHS-AISH P, V290, P224; Kane DL, 2004, IAHS-AISH P, V290, P1; Knight CW, 2004, AEFF BULLETIN, V111; Langer M, 2011, CRYOSPHERE, V5; Lei HM, 2010, AGR FOREST METEOROL, V150, P581, DOI 10.1016/j.agrformet.2010.01.022; Lewan E, 1996, WATER RESOUR RES, V32, P2067, DOI 10.1029/96WR00803; Li S, 2008, AGR WATER MANAGE, V95, P1214, DOI 10.1016/j.agwat.2008.04.014; Liljedahl AK, 2011, BIOGEOSCIENCES, V8, P3375, DOI 10.5194/bg-8-3375-2011; Liu S, 2010, HYDROL EARTH SYST SC, V14, P573, DOI 10.5194/hess-14-573-2010; Lloyd CR, 2001, THEOR APPL CLIMATOL, V70, P19, DOI 10.1007/s007040170003; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Loring PA, 2009, ENVIRON SCI POLICY, V12, P466, DOI 10.1016/j.envsci.2008.10.006; Lu JB, 2003, J AM WATER RESOUR AS, V39, P887, DOI 10.1111/j.1752-1688.2003.tb04413.x; Lui H, 2005, J GEOPHYS RES-ATMOS, V110, DOI [10.1029/2004JD005158, DOI 10.1029/2004JD005158]; Lund M, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.21631; Ma Y, 2009, HYDROL EARTH SYST SC, V13, P1103, DOI 10.5194/hess-13-1103-2009; Mahrt L, 1998, J ATMOS OCEAN TECH, V15, P416, DOI 10.1175/1520-0426(1998)015<0416:FSEFAA>2.0.CO;2; MALEK E, 1993, J HYDROL, V146, P209, DOI 10.1016/0022-1694(93)90276-F; Marsh P, 2004, IAHS-AISH P, V290, P205; Martinez-Cob A, 2010, AGR WATER MANAGE, V97, P410, DOI 10.1016/j.agwat.2009.10.013; Mayfield JA, 2013, J APPL METEOROL CLIM, V52, P953, DOI 10.1175/JAMC-D-12-01.1; McFadden JP, 1998, J GEOPHYS RES-ATMOS, V103, P28947, DOI 10.1029/98JD02400; Meyers TP, 2004, AGR FOREST METEOROL, V125, P105, DOI 10.1016/j.agrformet.2004.03.001; Moderow U, 2009, THEOR APPL CLIMATOL, V98, P397, DOI 10.1007/s00704-009-0175-0; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Monteith J. L, 1973, PRINCIPLES OF ENVIRO; MOORE KE, 1994, J GEOPHYS RES-ATMOS, V99, P1937, DOI 10.1029/93JD01442; Mulligan D., 2004, SOIL SURVEY OF THE G, P101; Nakai T, 2013, POLAR SCI, V7, P136, DOI 10.1016/j.polar.2013.03.003; NOAA Climatological Data, 2013, CLIMATOLOGICAL DATA, V5; NOAA Climatological Data, 2012, CLIMATOLOGICAL DATA, V4; Ortega-Farias S, 2004, IRRIGATION SCI, V23, P1, DOI 10.1007/s00271-003-0087-1; Overland JE, 2004, CLIMATIC CHANGE, V63, P291, DOI 10.1023/B:CLIM.0000018512.40506.d2; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Ozdogan M, 2010, J HYDROMETEOROL, V11, P171, DOI 10.1175/2009JHM1116.1; Parent AC, 2012, AGR WATER MANAGE, V113, P45, DOI 10.1016/j.agwat.2012.06.014; Patric JH, 1968, U S DEPARTMENT OF AG; Pielke RA, 2007, TELLUS B, V59, P587, DOI 10.1111/j.1600-0889.2007.00251.x; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Quinton WL, 2004, IAHS-AISH P, V290, P186; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; Rouse WR, 2000, GLOBAL CHANGE BIOL, V6, P59, DOI 10.1046/j.1365-2486.2000.06013.x; Rouse WR, 1997, WATER RESOUR RES, V13, P909; Sanchez JM, 2010, HYDROL EARTH SYST SC, V14, P1487, DOI 10.5194/hess-14-1487-2010; Segal M, 1998, J APPL METEOROL, V37, P325, DOI 10.1175/1520-0450-37.3.325; Serreze MC, 2006, CLIMATIC CHANGE, V76, P241, DOI 10.1007/s10584-005-9017-y; Serreze MC, 2000, J CLIMATE, V13, P182, DOI 10.1175/1520-0442(2000)013<0182:ROMAPF>2.0.CO;2; Seuna P, 2004, IAHS-AISH P, V290, P111; Sharratt BS, 1998, SOIL TILL RES, V46, P225, DOI 10.1016/S0167-1987(98)00102-0; SHARRATT BS, 1992, ARCTIC, V45, P124; Shulski M, 2007, THE CLIMATE OF ALASK; Slingo JM, 2005, PHILOS T R SOC B, V360, P1983, DOI 10.1098/rstb.2005.1755; Smith NV, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004472; STANNARD DI, 1994, WATER RESOUR RES, V30, P1227, DOI 10.1029/93WR03037; Starkenburg D, 2014, J GEOPHYS RES, V20, P1348; STATSGO, 2011, STATE SOIL GEOGRAPHI; Stevenson KT, 2014, ARCTIC, V67, P296, DOI 10.14430/arctic4408; STEWART RB, 1977, J APPL METEOROL, V16, P649, DOI 10.1175/1520-0450(1977)016&lt;0649:SOTPAT&gt;2.0.CO;2; Stow DA, 2004, REMOTE SENS ENVIRON, V89, P281, DOI 10.1016/j.rse.2003.10.018; Stoy PC, 2006, GLOBAL CHANGE BIOL, V12, P2115, DOI 10.1111/j.1365-2486.2006.01244.x; Sumner DM, 2005, J HYDROL, V308, P81, DOI 10.1016/j.jhydrol.2004.10.023; Sun G, 2002, J HYDROL, V263, P92, DOI 10.1016/S0022-1694(02)00064-1; Sun HY, 2006, AGR WATER MANAGE, V85, P211, DOI 10.1016/j.agwat.2006.04.008; Suyker AE, 2008, AGR FOREST METEOROL, V148, P417, DOI 10.1016/j.agrformet.2007.10.005; Suyker AE, 2009, AGR FOREST METEOROL, V149, P443, DOI 10.1016/j.agrformet.2008.09.010; SWANK WT, 1974, SCIENCE, V185, P857, DOI 10.1126/science.185.4154.857; Tanana Valley Irrigation Study Team, 1972, REPORT OF A FEDERAL; Thorne G, 2004, IAHS-AISH P, V290, P164; Twine TE, 2000, AGR FOREST METEOROL, V103, P279, DOI 10.1016/S0168-1923(00)00123-4; Vasilenko NG, 2004, IAHS-AISH P, V290, P65; Vourlitis GL, 1999, ECOLOGY, V80, P686, DOI 10.1890/0012-9658(1999)080[0686:ECMOCA]2.0.CO;2; Wagle P, 2014, ECOHYDROLOGY, V7, P64, DOI 10.1002/eco.1322; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Wendler G, 2009, ARCTIC, V62, P295; Wever LA, 2002, AGR FOREST METEOROL, V112, P31, DOI 10.1016/S0168-1923(02)00041-2; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Wolken JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00288.1; Yan HF, 2015, METEOROL ATMOS PHYS, V127, P305, DOI 10.1007/s00703-015-0369-1; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Zhuravin SA, 2004, IAHS-AISH P, V290, P78	135	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137209	10.1371/journal.pone.0137209	http://dx.doi.org/10.1371/journal.pone.0137209			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368123	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100057
J	Schultz, ST; Kruschel, C; Bakran-Petricioli, T; Petricioli, D				Schultz, Stewart T.; Kruschel, Claudia; Bakran-Petricioli, Tatjana; Petricioli, Donat			Error, Power, and Blind Sentinels: The Statistics of Seagrass Monitoring	PLOS ONE			English	Article							POSIDONIA-OCEANICA MEADOWS; BENTHIC HABITATS; UNDERWATER VIDEOGRAPHY; MANAGEMENT; VIDEO; COVER; TOOL; SEA; BAY; BIODIVERSITY	We derive statistical properties of standard methods for monitoring of habitat cover worldwide, and criticize them in the context of mandated seagrass monitoring programs, as exemplified by Posidonia oceanica in the Mediterranean Sea. We report the novel result that cartographic methods with non-trivial classification errors are generally incapable of reliably detecting habitat cover losses less than about 30 to 50%, and the field labor required to increase their precision can be orders of magnitude higher than that required to estimate habitat loss directly in a field campaign. We derive a universal utility threshold of classification error in habitat maps that represents the minimum habitat map accuracy above which direct methods are superior. Widespread government reliance on blind-sentinel methods for monitoring seafloor can obscure the gradual and currently ongoing losses of benthic resources until the time has long passed for meaningful management intervention. We find two classes of methods with very high statistical power for detecting small habitat cover losses: 1) fixed-plot direct methods, which are over 100 times as efficient as direct random-plot methods in a variable habitat mosaic; and 2) remote methods with very low classification error such as geospatial underwater videography, which is an emerging, lowcost, non-destructive method for documenting small changes at millimeter visual resolution. General adoption of these methods and their further development will require a fundamental cultural change in conservation and management bodies towards the recognition and promotion of requirements of minimal statistical power and precision in the development of international goals for monitoring these valuable resources and the ecological services they provide.	[Schultz, Stewart T.; Kruschel, Claudia] Univ Zadar, Dept Ecol Agr & Aquaculture, Zadar 23000, Croatia; [Bakran-Petricioli, Tatjana] Univ Zagreb, Dept Biol, Fac Sci, Zagreb 10000, Croatia; [Petricioli, Donat] DIIV Ltd, Sali 23281, Croatia	University of Zadar; University of Zagreb	Schultz, ST (corresponding author), Univ Zadar, Dept Ecol Agr & Aquaculture, Zadar 23000, Croatia.	sschultz@unizd.hr	Kruschel, Claudia/AAX-1772-2020; Bakran-Petricioli, Tatjana/AAU-3594-2020	Bakran-Petricioli, Tatjana/0000-0002-3368-4248	Croatian Science Foundation; COREBIO; European Commission grant COCONET	Croatian Science Foundation; COREBIO; European Commission grant COCONET	This work was funded by the Croatian Science Foundation, grant COREBIO (SS), and the European Commission grant COCONET (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Coauthor DP donated his expertise for this project, and is director of the commercial firm D.I.I.V., which had no role in the funding of this project.	[Anonymous], 2000, BIOL MAR MEDITERR; Ardizzone G, 2006, MAR ECOL-EVOL PERSP, V27, P299, DOI 10.1111/j.1439-0485.2006.00128.x; Baggett LP, 2014, OYSTER REEF HABITAT; Bakran-Petricioli T, 2006, ECOL MODEL, V191, P96, DOI 10.1016/j.ecolmodel.2005.08.014; Ball David, 2007, Parks Victoria Technical Series, V37, pi; Bonacorsi M, 2013, MEDITERR MAR SCI, V14, P193, DOI 10.12681/mms.334; Borfecchia F, 2013, INT J REMOTE SENS, V34, P4680, DOI 10.1080/01431161.2013.781701; Borg JA, 2009, MEDITERR MAR SCI, V10, P45, DOI 10.12681/mms.108; Borg JA, 2006, MAR ECOL-EVOL PERSP, V27, P320, DOI 10.1111/j.1439-0485.2006.00085.x; Boudouresque C.-F., 2012, PROTECTION CONSERVAT; Calvo S, 2003, INT J REMOTE SENS, V24, P2703, DOI 10.1080/0143116031000066882; Coles RG, 2001, GLOBAL SEAGRASS RESE; De Falco G, 2000, GEO-MAR LETT, V20, P50, DOI 10.1007/s003670000030; De Falco G, 2010, CONT SHELF RES, V30, P1941, DOI 10.1016/j.csr.2010.09.006; Dekker AG, 2005, REMOTE SENS ENVIRON, V97, P415, DOI 10.1016/j.rse.2005.02.017; Di Maida G, 2011, ICES J MAR SCI, V68, P12, DOI 10.1093/icesjms/fsq130; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; Durell SEALD, 2005, BIOL CONSERV, V121, P289, DOI 10.1016/j.biocon.2004.05.005; Ehrhold A, 2006, ICES J MAR SCI, V63, P1604, DOI 10.1016/j.icesjms.2006.06.010; FAIRWEATHER PG, 1991, AUST J MAR FRESH RES, V42, P555, DOI 10.1071/MF9910555; Ferguson RL, 1997, AQUAT BOT, V58, P241, DOI 10.1016/S0304-3770(97)00038-7; Field SA, 2004, ECOL LETT, V7, P669, DOI 10.1111/j.1461-0248.2004.00625.x; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Field SA, 2007, AUSTRAL ECOL, V32, P485, DOI 10.1111/j.1442-9993.2007.01715.x; Fonseca M.S., 1998, GUIDELINES CONSERVAT; Foody GM, 2010, REMOTE SENS ENVIRON, V114, P2271, DOI 10.1016/j.rse.2010.05.003; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Fox DR, 2001, ENVIRONMETRICS, V12, P437, DOI 10.1002/env.470; Gaeckle J., 2011, PUGET SOUND SUBMERGE; Gardner T., 2010, MONITORING FOREST BI; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Gerrodette T, 2002, B MAR SCI, V70, P657; Gerrodette T, 2011, MAR ECOL-EVOL PERSP, V32, P404, DOI 10.1111/j.1439-0485.2011.00466.x; Gladstone W, 2014, ESTUAR COAST SHELF S, V136, P53, DOI 10.1016/j.ecss.2013.10.023; GREEN RH, 1993, AUST J ECOL, V18, P81, DOI 10.1111/j.1442-9993.1993.tb00436.x; Grizzle RE, 2008, J COASTAL RES, V24, P103, DOI 10.2112/06-0672.1; Guala I., 2014, MONITORING PROTOCOL; Guala I, 2012, MONITORING POSIDONIA; Guala I, 2014, MONITORING ACTIVITES; Holmer M, 2003, MAR POLLUT BULL, V46, P1372, DOI 10.1016/S0025-326X(03)00396-5; Ierodiaconou D, 2011, CONT SHELF RES, V31, pS28, DOI 10.1016/j.csr.2010.01.012; Irving AD, 2013, MAR POLLUT BULL, V66, P176, DOI 10.1016/j.marpolbul.2012.10.017; Jordan A, 2005, AQUAT CONSERV, V15, P51, DOI 10.1002/aqc.657; Kendall MS, 2005, J COASTAL RES, V21, P1154, DOI 10.2112/03-0101R.1; Kendrick GA, 2002, AQUAT BOT, V73, P75, DOI 10.1016/S0304-3770(02)00005-0; Kiparissis S, 2011, BIOL INVASIONS, V13, P669, DOI 10.1007/s10530-010-9858-9; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Leriche A, 2004, ESTUAR COAST SHELF S, V59, P353, DOI 10.1016/j.ecss.2003.09.007; Lindenmayer D.B., 2003, FOREST SUSTAINABILIT; Lindenmayer D, 2012, BIODIVERSITY MONITORING IN AUSTRALIA, P193; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P285, DOI 10.1111/j.1442-9993.2011.02314.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lirman D, 2008, J COASTAL RES, V24, P135, DOI 10.2112/04-0428.1; Royo CLY, 2010, ENVIRON MONIT ASSESS, V171, P365, DOI 10.1007/s10661-009-1284-z; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; Marba N, 2005, ESTUARIES, V28, P53, DOI 10.1007/BF02732753; Marba N, 1996, MAR ECOL PROG SER, V133, P203, DOI 10.3354/meps133203; Marba N, 2014, BIOL CONSERV, V176, P183, DOI 10.1016/j.biocon.2014.05.024; Marba N, 2013, HYDROBIOLOGIA, V704, P265, DOI 10.1007/s10750-012-1403-7; March D, 2013, AQUAT BOT, V106, P14, DOI 10.1016/j.aquabot.2012.12.005; Matta E, 2014, INT GEOSCI REMOTE SE, P5152, DOI 10.1109/IGARSS.2014.6947658; McDonald JI, 2006, J ENVIRON MANAGE, V80, P148, DOI 10.1016/j.jenvman.2005.08.021; McKenzie LJ, SEAGRASS WATCH MANUL; McKenzie LJ, 2010, REEF RESCUE MARINE M; McKenzie LJ, 2014, DEV WET TOPICS WQIP; Meehan AJ, 2005, ESTUARIES, V28, P462, DOI 10.1007/BF02693927; Montefalcone M, 2013, AQUAT BOT, V104, P204, DOI 10.1016/j.aquabot.2011.05.009; Montefalcone M, 2009, ECOL INDIC, V9, P595, DOI 10.1016/j.ecolind.2008.09.013; Norris JG, 1997, AQUAT BOT, V58, P269, DOI 10.1016/S0304-3770(97)00040-5; Ooi JLS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086782; Pergent G., 1995, M SOG E MARSEILLE, V54, P3; Pergent-Martini C, 2005, ECOL INDIC, V5, P213, DOI 10.1016/j.ecolind.2005.02.004; Pierre D, 2011, MAR POLLUT BULL, V62, P284, DOI 10.1016/j.marpolbul.2010.10.012; Puhr K, 2014, SCI TOTAL ENVIRON, V470, P364, DOI 10.1016/j.scitotenv.2013.09.103; R Core Team, 2021, R LANGUAGE ENV STAT; Sabol BM, 2002, ESTUARIES, V25, P133, DOI 10.1007/BF02696057; Sanchez-Carnero N, 2012, ESTUAR COAST SHELF S, V115, P334, DOI 10.1016/j.ecss.2012.09.015; Sandulli R., 1998, Oebalia, P3; Santos RO, 2012, CAN J FISH AQUAT SCI, V69, P1380, DOI [10.1139/f2012-018, 10.1139/F2012-018]; Schultz ST, 2008, AQUAT BOT, V88, P228, DOI 10.1016/j.aquabot.2007.10.009; Schultz ST, 2011, AQUAT BOT, V95, P117, DOI 10.1016/j.aquabot.2011.04.004; SFWMD, 2007, ENV MON REP GUID; Short FT, 2014, MAR POLLUT BULL, V83, P408, DOI 10.1016/j.marpolbul.2014.03.036; Somaschini A, 1998, SCI MAR, V62, P27; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Stevens T, 2004, BIOL CONSERV, V119, P351, DOI 10.1016/j.biocon.2003.12.001; Stuart A, 1998, KENDALLS ADV THEORY, V1; USACE, 2015, 2013 REG COMP MIT MO; Vandermeulen H, 2014, HELGOLAND MAR RES, V68, P559, DOI 10.1007/s10152-014-0412-5; Vassallo P, 2013, MAR POLLUT BULL, V75, P157, DOI 10.1016/j.marpolbul.2013.07.044; Vlachopoulou EI, 2013, OCEAN COAST MANAGE, V76, P105, DOI 10.1016/j.ocecoaman.2013.02.008; Vos P, 2000, ENVIRON MONIT ASSESS, V61, P317, DOI 10.1023/A:1006139412372; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; Zampoukas N, 2012, MONITORING MARINE ST; Zampoukas N, 2011, REV METHODOLOGICAL S; Zapata-Ramirez PA, 2013, ADV OCEANOGR LIMNOL, V4, P102, DOI DOI 10.1080/19475721.2013.849758; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zawada DG, 2008, REV BIOL TROP, V56, P51	99	5	5	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138378	10.1371/journal.pone.0138378	http://dx.doi.org/10.1371/journal.pone.0138378			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367863	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100252
J	Sun, HZ; Ge, WJ; Gao, X; Wang, SS; Jiang, SJ; Hu, Y; Yu, M; Hu, SS				Sun, Haizhu; Ge, Wenjie; Gao, Xin; Wang, Shaoshan; Jiang, Shijian; Hu, Ying; Yu, Miao; Hu, Shaoshan			Apoptosis-Promoting Effects of Hematoporphyrin Monomethyl Ether-Sonodynamic Therapy (HMME-SDT) on Endometrial Cancer	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; CELL-DEATH; ULTRASOUND; CALCIUM; MITOCHONDRIA; INDUCTION	Objective The aim of the present study was to examine the apoptosis-promoting effects and mechanisms of hematoporphyrin monomethyl ether (HMME)-sonodynamic therapy (SDT) on endometrial cancer cells in vitro. Methods Endometrial cancer cell samples were divided into four groups: 1) untreated control group, 2) HMME group, 3) pure ultrasound group, and 4) HMME combined with ultrasound, i.e. SDT group. CCK-8 method was utilized to assess the inhibiting effect of SDT on the proliferation of endometrial cancer cells. Optical microscope and field emission transmission electron microscopy were used to characterize the morphology changes of the cancer cells induced by the treatments. Apoptosis rate, reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were examined by flow cytometer. Fluorescence intensity measured by laser scanning confocal microscopy was used to explore the variation of intracellular calcium ion (Ca2+) concentration. Apoptosis-related proteins involved in both intrinsic and extrinsic apoptosis signallings were analyzed by western blot. Results SDT can effectively induce the apoptosis of endometrial cancer cells. Compared with ultrasound which is known as an effective anti-tumor method, SDT leads to a significant improvement on suppression of cell viability and induction of apoptosis, together with more remarkable modifications on the morphology and substructure in both ultrasound sensitive and resistant endometrial cancer cells. Further studies reveals that SDT promotes ROS production, induces loss of MMP and increases intracellular Ca2+ concentration more efficiently than HMME or ultrasound alone. SDT groups also show a rather high expression of apoptosis- promoting proteins, including Bax, Fas and Fas-L, and a significant low expression of apoptosis- suspending proteins including Bcl-2 and Survivin. Meanwhile, both cleaved caspse-3 and caspase-8 are dramatically enhanced in SDT groups. Multiple pathways has been proposed in the process, including the intrinsic activation by excessive ROS and overloaded Ca2+, silencing survivin gene, and the extrinsic pathway mediated by the death receptor. Conclusion Given its considerable effectivity in both ultrasound sensitive and resistant cells, SDT may therefore be a promising therapeutic method for treating endometrial cancers.	[Sun, Haizhu; Gao, Xin; Hu, Shaoshan] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150001, Peoples R China; [Wang, Shaoshan; Yu, Miao] Harbin Inst Technol, Sch Chem Engn & Technol, State Key Lab Urban Water Resource & Environm, Harbin 150001, Peoples R China; [Sun, Haizhu] Harbin Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Harbin 150001, Peoples R China; [Ge, Wenjie; Jiang, Shijian; Hu, Ying] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China	Harbin Medical University; Harbin Institute of Technology; Harbin Medical University; Harbin Institute of Technology	Hu, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.	shaoshanhu@126.com; huying@hit.edu.cn; miaoyu_che@hit.edu.cn	Hu, Ying/ABG-2935-2021	Hu, Ying/0000-0003-2469-5604; Yu, Miao/0000-0001-8820-9594	National Natural Science Foundation of China [30872650]; Program for New Century Excellent Talents in University of China [NCET-09-0131]; Recruitment Program of Global Young Experts, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Recruitment Program of Global Young Experts, China	This work was financially supported by the National Natural Science Foundation of China (Grant No. 30872650); Program for New Century Excellent Talents in University of China (Grant No. NCET-09-0131); MY acknowledges financial support from the Recruitment Program of Global Young Experts, China.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Ando H, 2006, CANCER LETT, V242, P37, DOI 10.1016/j.canlet.2005.10.032; Ashush H, 2000, CANCER RES, V60, P1014; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Chen HJ, 2014, DRUG DISCOV TODAY, V19, P502, DOI 10.1016/j.drudis.2014.01.010; Dellinger TH, 2009, EXPERT REV ANTICANC, V9, P905, DOI [10.1586/era.09.54, 10.1586/ERA.09.54]; Ding XM, 2004, CANCER LETT, V216, P43, DOI 10.1016/j.canlet.2004.07.005; Furusawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029012; Guan HT, 2006, WORLD J GASTROENTERO, V12, P2901, DOI 10.3748/wjg.v12.i18.2901; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kumar B, 2012, BIOCHEM BIOPH RES CO, V417, P903, DOI 10.1016/j.bbrc.2011.12.072; Lei TC, 2012, PHOTODIAGN PHOTODYN, V9, P232, DOI 10.1016/j.pdpdt.2012.01.003; Li YC, 2009, NEUROCHEM RES, V34, P418, DOI 10.1007/s11064-008-9799-1; Masgras I, 2012, J BIOL CHEM, V287, P9845, DOI 10.1074/jbc.M111.250357; Rosenthal I, 2004, ULTRASON SONOCHEM, V11, P349, DOI 10.1016/j.ultsonch.2004.03.004; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Tang W, 2010, ULTRASONICS, V50, P567, DOI 10.1016/j.ultras.2009.12.001; Tang W, 2009, ULTRASONICS, V49, P786, DOI 10.1016/j.ultras.2009.06.002; Tarkowski R, 2003, INT J GYNECOLOGICAL, V13, P72; Vyssokikh MY, 2002, MOL BIOL REP, V29, P93, DOI 10.1023/A:1020383108620; Wang B, 2013, FREE RADICAL BIO MED, V65, P882, DOI 10.1016/j.freeradbiomed.2013.08.173; Wang HY, 2010, BIOMATERIALS, V31, P413, DOI 10.1016/j.biomaterials.2009.09.066; Wood AKW, 2015, ULTRASOUND MED BIOL, V41, P905, DOI 10.1016/j.ultrasmedbio.2014.11.019; YUMITA N, 1989, JPN J CANCER RES, V80, P219, DOI 10.1111/j.1349-7006.1989.tb02295.x; Zhang L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/696107; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003; Zhou YJ, 2009, TOXICOL IN VITRO, V23, P288, DOI 10.1016/j.tiv.2008.12.009	28	20	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137980	10.1371/journal.pone.0137980	http://dx.doi.org/10.1371/journal.pone.0137980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367393	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100194
J	Zhang, P; Liu, KP; Zhao, B; Li, YC				Zhang, Peng; Liu, Keping; Zhao, Bo; Li, Yuanchun			A Computationally Inexpensive Optimal Guidance via Radial-Basis-Function Neural Network for Autonomous Soft Landing on Asteroids	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; INDIRECT OPTIMIZATION; REGRESSION; APPROXIMATION; NAVIGATION; SYSTEMS	Optimal guidance is essential for the soft landing task. However, due to its high computational complexities, it is hardly applied to the autonomous guidance. In this paper, a computationally inexpensive optimal guidance algorithm based on the radial basis function neural network (RBFNN) is proposed. The optimization problem of the trajectory for soft landing on asteroids is formulated and transformed into a two-point boundary value problem (TPBVP). Combining the database of initial states with the relative initial co-states, an RBFNN is trained offline. The optimal trajectory of the soft landing is determined rapidly by applying the trained network in the online guidance. The Monte Carlo simulations of soft landing on the Eros433 are performed to demonstrate the effectiveness of the proposed guidance algorithm.	[Zhang, Peng; Li, Yuanchun] Jilin Univ, Dept Control Sci & Engn, Changchun 130023, Jilin, Peoples R China; [Liu, Keping; Li, Yuanchun] Changchun Univ Technol, Dept Control Engn, Changchun, Jilin, Peoples R China; [Zhao, Bo] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China	Jilin University; Changchun University of Technology; Chinese Academy of Sciences; Institute of Automation, CAS	Li, YC (corresponding author), Jilin Univ, Dept Control Sci & Engn, Changchun 130023, Jilin, Peoples R China.	liyc@ccut.edu.cn	Li, Yuan/GXV-1310-2022		National Basic Research Program of China (973 Program) [2012CB720000]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 Program) Grant 2012CB720000.	Bencherif MA, 2015, IEEE GEOSCI REMOTE S, V12, P527, DOI 10.1109/LGRS.2014.2349538; Broomhead D. S., 1988, Complex Systems, V2, P321; Cheng T, 2007, AUTOMATICA, V43, P482, DOI 10.1016/j.automatica.2006.09.021; Deng ZH, 2014, IEEE T CYBERNETICS, V44, P2585, DOI 10.1109/TCYB.2014.2311014; Furfaro R, 2013, J GUID CONTROL DYNAM, V36, P1075, DOI 10.2514/1.58246; GIROSI F, 1990, BIOL CYBERN, V63, P169, DOI 10.1007/BF00195855; GUELMAN M, 1994, J GUID CONTROL DYNAM, V17, P15, DOI 10.2514/3.21153; Guibout VM, 2004, J GUID CONTROL DYNAM, V27, P693, DOI 10.2514/1.11164; He YL, 2015, ENG APPL ARTIF INTEL, V41, P65, DOI 10.1016/j.engappai.2015.02.001; Hossain MA, 2013, ENG APPL ARTIF INTEL, V26, P1230, DOI 10.1016/j.engappai.2012.10.007; Huang GB, 2005, IEEE T NEURAL NETWOR, V16, P57, DOI 10.1109/TNN.2004.836241; Huang XY, 2004, ACTA ASTRONAUT, V54, P763, DOI 10.1016/j.actaastro.2003.09.001; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P548, DOI 10.1109/TCYB.2014.2330844; Lantoine G, 2008, ADV ASTRONAUT SCI, V129, P447; Li S, 2006, AEROSP SCI TECHNOL, V10, P239, DOI 10.1016/j.ast.2005.12.003; Liu KP, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/510618; Mai-Duy N, 2003, APPL MATH MODEL, V27, P197, DOI 10.1016/S0307-904X(02)00101-4; Medagam PV, 2009, P AMER CONTR CONF, P355, DOI 10.1109/ACC.2009.5160105; Miller JK, 2002, ICARUS, V155, P3, DOI 10.1006/icar.2001.6753; Ranieri CL, 2006, J GUID CONTROL DYNAM, V29, P1360, DOI 10.2514/1.19539; Ranieri CL, 2009, J GUID CONTROL DYNAM, V32, P445, DOI 10.2514/1.38170; Romain G, 2001, CELEST MECH DYN ASTR, V79, P235, DOI 10.1023/A:1017555515763; Scheeres Daniel J., 2014, 2014 American Control Conference, P1584, DOI 10.1109/ACC.2014.6858821; Scheeres DJ, 2000, J GUID CONTROL DYNAM, V23, P466, DOI 10.2514/2.4552; Wang H, 2014, RESEARCH OF ASTEROID, P26; Werner R. A., 1996, Celestial Mechanics and Dynamical Astronomy, V65, P313, DOI 10.1007/BF00053511; Zhang P, 2013, CHIN CONTR CONF, P5000; Zhang ZX, 2012, J FRANKLIN I, V349, P493, DOI 10.1016/j.jfranklin.2011.07.007	29	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137792	10.1371/journal.pone.0137792	http://dx.doi.org/10.1371/journal.pone.0137792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367382	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100138
J	Kalda, M; Peterson, P; Vendelin, M				Kalda, Mari; Peterson, Pearu; Vendelin, Marko			Cross-Bridge Group Ensembles Describing Cooperativity in Thermodynamically Consistent Way	PLOS ONE			English	Article							CARDIAC-MUSCLE; ACTIVATION; MODEL; TROPOMYOSIN; FORCE; ATP; CONTRACTION; CONSUMPTION; FILAMENTS; STRESS	The aim of this work is to incorporate cooperativity into Huxley-type cross-bridge model in thermodynamically consistent way. While the Huxley-type models assume that cross-bridges act independently from each other, we take into account that each cross-bridge is influenced by its neighbors and cooperativity is induced by tropomyosin movement. For that, we introduce ensembles of cross-bridge groups connected by elastic tropomyosin. By taking into account that the mechanical displacement of tropomyosin induces free energy change of the cross-bridge group ensemble, we develop the formalism for thermodynamically consistent description of the cooperativity in muscle contraction. An example model was composed to test the approach. The model parameters were found by optimization from the linear relation between oxygen consumption and stress-strain area as well as experimentally measured stress dynamics of rat trabecula. We have found a good agreement between the optimized model solution and experimental data. Simulations also showed that it is possible to study cooperativity with the approach developed in this work.	[Kalda, Mari; Peterson, Pearu; Vendelin, Marko] Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, EE-12618 Tallinn, Estonia	Tallinn University of Technology	Vendelin, M (corresponding author), Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, Akad Tee 21, EE-12618 Tallinn, Estonia.	markov@sysbio.ioc.ee	Kalda, Mari/AAF-1693-2020; Vendelin, Marko/AAE-7137-2020	Kalda, Mari/0000-0002-4705-7237; Vendelin, Marko/0000-0002-6459-0391; Peterson, Pearu/0000-0001-7328-4305	European Union through the European Regional Development Fund (CENS Estonian Center of Excellence in Research)	European Union through the European Regional Development Fund (CENS Estonian Center of Excellence in Research)	This research was supported by the European Union through the European Regional Development Fund (CENS Estonian Center of Excellence in Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BROWN PN, 1989, SIAM J SCI STAT COMP, V10, P1038, DOI 10.1137/0910062; Campbell SG, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002156; Campbell SG, 2010, BIOPHYS J, V98, P2254, DOI 10.1016/j.bpj.2010.02.010; de Tombe PP, 2003, J BIOMECH, V36, P721, DOI 10.1016/S0021-9290(02)00450-5; DELHAAS T, 1994, J PHYSIOL-LONDON, V477, P481, DOI 10.1113/jphysiol.1994.sp020209; Dobesh DP, 2002, AM J PHYSIOL-HEART C, V282, pH1055, DOI 10.1152/ajpheart.00667.2001; EISENBERG E, 1980, BIOPHYS J, V29, P195, DOI 10.1016/S0006-3495(80)85126-5; Gibbs CL, 1995, CARDIOVASC RES, V30, P627, DOI 10.1016/S0008-6363(95)00161-1; Hill T L, 1975, Prog Biophys Mol Biol, V29, P105; Hill T.L., 1974, Progress Biophys Molec Biol, V28, P267, DOI 10.1016/0079-6107(74)90020-0; HISANO R, 1987, CIRC RES, V61, P318, DOI 10.1161/01.RES.61.3.318; JANSSEN PML, 1995, AM J PHYSIOL-HEART C, V269, pH676, DOI 10.1152/ajpheart.1995.269.2.H676; Kalda M, 2013, COMPUTER MODELS BIOM, P91; KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962; Mansson A, 2010, BIOPHYS J, V98, P1237, DOI 10.1016/j.bpj.2009.12.4285; More J. J., 1984, SOURCES DEV MATH SOF; PATE E, 1989, J MUSCLE RES CELL M, V10, P181, DOI 10.1007/BF01739809; Peterson P, 2009, INT J COMPUT SCI ENG, V4, P296, DOI 10.1504/IJCSE.2009.029165; Powell M.J.D., 1970, NUMERICAL METHODS NO, P87; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; Rice JJ, 2004, PROG BIOPHYS MOL BIO, V85, P179, DOI 10.1016/j.pbiomolbio.2004.01.011; Rice JJ, 2003, BIOPHYS J, V84, P897, DOI 10.1016/S0006-3495(03)74907-8; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; Smith DA, 2003, BIOPHYS J, V84, P3168, DOI 10.1016/S0006-3495(03)70041-1; SUGA H, 1990, PHYSIOL REV, V70, P247, DOI 10.1152/physrev.1990.70.2.247; Tanner BCW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002506; TAYLOR TW, 1993, AM J PHYSIOL, V264, pH994, DOI 10.1152/ajpheart.1993.264.3.H994; TAYLOR TW, 1993, J BIOMECH, V26, P1217, DOI 10.1016/0021-9290(93)90069-Q; van der Velden J, 1998, J PHYSIOL-LONDON, V507, P497, DOI 10.1111/j.1469-7793.1998.497bt.x; Vendelin M, 2000, ANN BIOMED ENG, V28, P629, DOI 10.1114/1.1305910; Vendelin M, 2002, AM J PHYSIOL-HEART C, V283, pH1072, DOI 10.1152/ajpheart.00874.2001; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3; ZAHALAK GI, 1990, J BIOMECH ENG-T ASME, V112, P52, DOI 10.1115/1.2891126; ZOU GZ, 1994, BIOPHYS J, V67, P11, DOI 10.1016/S0006-3495(94)80475-8	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137438	10.1371/journal.pone.0137438	http://dx.doi.org/10.1371/journal.pone.0137438			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361396	Green Published, gold			2022-12-26	WOS:000361043100038
J	Kono, Y; Kohn, JR				Kono, Yoshiaki; Kohn, Joshua R.			Range and Frequency of Africanized Honey Bees in California (USA)	PLOS ONE			English	Article							APIS-MELLIFERA L.; MITOCHONDRIAL-DNA; EUROPEAN HONEYBEES; GENETIC-STRUCTURE; TROPICAL YUCATAN; UNITED-STATES; HYBRIDIZATION; POPULATIONS; IDENTIFICATION; HYMENOPTERA	Africanized honey bees entered California in 1994 but few accounts of their northward expansion or their frequency relative to European honey bees have been published. We used mitochondrial markers and morphometric analyses to determine the prevalence of Africanized honeybees in San Diego County and their current northward progress in California west of the Sierra Nevada crest. The northernmost African mitotypes detected were approximately 40 km south of Sacramento in California's central valley. In San Diego County, 65% of foraging honey bee workers carry African mitochondria and the estimated percentage of Africanized workers using morphological measurements is similar (61%). There was no correlation between mitotype and morphology in San Diego County suggesting Africanized bees result from bidirectional hybridization. Seventy percent of feral hives, but only 13% of managed hives, sampled in San Diego County carried the African mitotype indicating that a large fraction of foraging workers in both urban and rural San Diego County are feral. We also found a single nucleotide polymorphism at the DNA barcode locus COI that distinguishes European and African mitotypes. The utility of this marker was confirmed using 401 georeferenced honey bee sequences from the worldwide Barcode of Life Database. Future censuses can determine whether the current range of the Africanized form is stable, patterns of introgression at nuclear loci, and the environmental factors that may limit the northern range of the Africanized honey bee.	[Kono, Yoshiaki; Kohn, Joshua R.] Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kohn, JR (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA.	jkohn@ucsd.edu			Agouron Foundation; UCSD; Direct For Education and Human Resources [1140640, 1446563] Funding Source: National Science Foundation	Agouron Foundation; UCSD; Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	Y.K. was partially supported by a grant from the Agouron Foundation. JRK received support from UCSD. No additional funding sources for this study.	Balling SS, 1978, J KANSAS ENTOMOL SYS, V51, P857; Chapman NC, 2015, MOL ECOL RESOUR, V15, P1346, DOI 10.1111/1755-0998.12411; Clarke KE, 2002, EVOLUTION, V56, P1462; CROZIER RH, 1993, GENETICS, V133, P97; CROZIER YC, 1991, EXPERIENTIA, V47, P968, DOI 10.1007/BF01929894; DALY HV, 1991, APIDOLOGIE, V22, P591, DOI 10.1051/apido:19910603; Diniz NM, 2003, GENET MOL BIOL, V26, P47, DOI 10.1590/S1415-47572003000100008; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRANCA FOS, 1994, Q J MED, V87, P269; Franck P, 2001, HEREDITY, V86, P420, DOI 10.1046/j.1365-2540.2001.00842.x; Galindo-Cardona A, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-65; GARNERY L, 1993, EXPERIENTIA, V49, P1016, DOI 10.1007/BF02125651; Harrison JF, 2006, INTEGR COMP BIOL, V46, P1110, DOI 10.1093/icb/icl046; Kerr W.E., 1967, S AFR BEE J, V39, P3; Lazaneo V, 2002, U CALIFORNIA AGR NAT, V8068; MICHENER CD, 1975, ANNU REV ENTOMOL, V20, P399, DOI 10.1146/annurev.en.20.010175.002151; Nielsen DI, 2000, ANN ENTOMOL SOC AM, V93, P1, DOI 10.1603/0013-8746(2000)093[0001:IPCRBM]2.0.CO;2; Pinto MA, 2007, ANN ENTOMOL SOC AM, V100, P289, DOI 10.1603/0013-8746(2007)100[289:HBHAOA]2.0.CO;2; Pinto MA, 2005, GENETICS, V170, P1653, DOI 10.1534/genetics.104.035030; Pinto MA, 2004, EVOLUTION, V58, P1047, DOI 10.1111/j.0014-3820.2004.tb00438.x; Pinto MA, 2003, ANN ENTOMOL SOC AM, V96, P679, DOI 10.1603/0013-8746(2003)096[0679:IOAHBH]2.0.CO;2; Quezada-Euan JJG, 1998, APIDOLOGIE, V29, P555, DOI 10.1051/apido:19980608; Quezada-Euan JJG, 2000, APIDOLOGIE, V31, P443, DOI 10.1051/apido:2000135; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RINDERER T E, 1986, Bulletin of the Entomological Society of America, V32, P226; RINDERER TE, 1993, APIDOLOGIE, V24, P569, DOI 10.1051/apido:19930605; RINDERER TE, 1991, SCIENCE, V253, P309, DOI 10.1126/science.253.5017.309; RINDERER TE, 1993, SCI AM, V269, P84, DOI 10.1038/scientificamerican1293-84; Rivera-Marchand B, 2008, CARIBB J SCI, V44, P264; Rivera-Marchand B, 2012, EVOL APPL, V5, P746, DOI 10.1111/j.1752-4571.2012.00252.x; Ruttner F., 1988, Biogeography and taxonomy of honeybees.; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Segura JAL, 2000, GENET MOL BIOL, V23, P317; SHEPPARD WS, 1991, NATURE, V349, P782, DOI 10.1038/349782a0; SMITH DR, 1989, NATURE, V339, P213, DOI 10.1038/339213a0; SOUTHWICK EE, 1990, COMP BIOCHEM PHYS A, V97, P1, DOI 10.1016/0300-9629(90)90713-3; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Szalanski AL, 2010, J APICULT RES, V49, P177, DOI 10.3896/IBRA.1.49.2.06; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR OR, 1984, BEE WORLD, V65, P38, DOI 10.1080/0005772X.1984.11098769; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; WINSTON ML, 1992, ANNU REV ENTOMOL, V37, P173, DOI 10.1146/annurev.en.37.010192.001133	43	29	30	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137407	10.1371/journal.pone.0137407	http://dx.doi.org/10.1371/journal.pone.0137407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361047	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100035
J	Wilky, BA; Kim, C; McCarty, G; Montgomery, EA; Kammers, K; DeVine, LR; Cole, RN; Raman, V; Loeb, DM				Wilky, B. A.; Kim, C.; McCarty, G.; Montgomery, E. A.; Kammers, K.; DeVine, L. R.; Cole, R. N.; Raman, V.; Loeb, D. M.			RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma	ONCOGENE			English	Article							CELL-GROWTH; PROTEIN; TRANSLATION; TUMOR; RESISTANCE; STRATEGY; SURVIVAL; FUSION	RNA helicase DDX3 has oncogenic activity in breast and lung cancers and is required for translation of complex mRNA transcripts, including those encoding key cell-cycle regulatory proteins. We sought to determine the expression and function of DDX3 in sarcoma cells, and to investigate the antitumor activity of a novel small molecule DDX3 inhibitor, RK-33. Utilizing various sarcoma cell lines, xenografts and human tissue microarrays, we measured DDX3 expression at the mRNA and protein levels, and evaluated cytotoxicity of RK-33 in sarcoma cell lines. To study the role of DDX3 in Ewing sarcoma, we generated stable DDX3-knockdown Ewing sarcoma cell lines using DDX3-specific small hairpin RNA (shRNA), and assessed oncogenic activity. DDX3-knockdown and RK-33-treated Ewing sarcoma cells were compared with wild-type cells using an isobaric mass-tag quantitative proteomics approach to identify target proteins impacted by DDX3 inhibition. Overall, we found high expression of DDX3 in numerous human sarcoma subtypes compared with non-malignant mesenchymal cells, and knockdown of DDX3 by RNA interference inhibited oncogenic activity in Ewing sarcoma cells. Treatment with RK-33 was preferentially cytotoxic to sarcoma cells, including chemotherapy-resistant Ewing sarcoma stem cells, while sparing non-malignant cells. Sensitivity to RK-33 correlated with DDX3 protein expression. Growth of human Ewing sarcoma xenografts expressing high DDX3 was inhibited by RK-33 treatment in mice, without overt toxicity. DDX3 inhibition altered the Ewing sarcoma cellular proteome, especially proteins involved in DNA replication, mRNA translation and proteasome function. These data support further investigation of the role of DDX3 in sarcomas, advancement of RK-33 to Ewing sarcoma clinical trials and development of RNA helicase inhibition as a novel anti-neoplastic strategy.	[Wilky, B. A.; Kim, C.; McCarty, G.; Raman, V.; Loeb, D. M.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Montgomery, E. A.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Kammers, K.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [DeVine, L. R.; Cole, R. N.] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD USA; [Raman, V.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Wilky, BA (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, 1120 NW 14th St,Suite 610E, Miami, FL 33136 USA.	b.wilky@med.miami.edu		Wilky, Breelyn/0000-0001-5080-497X	NIH [R01 CA138212, T32 CA009071-31, P30 CA006973, HHSN268201000032C]; Alex's Lemonade Stand Foundation, LLC; Conquer Cancer Foundation/ASCO Young Investigator Award - WWWW Foundation, Inc. (QuadW); Giant Food Children's Cancer Research Fund; Heather Brooke Foundation; German Research Foundation [KA 3884/1-1]; Flight Attendant Medical Research Institute (FAMRI); Alpha Omega Alpha Postgraduate Award; NATIONAL CANCER INSTITUTE [R01CA138212, P30CA006973, T32CA009071] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation, LLC; Conquer Cancer Foundation/ASCO Young Investigator Award - WWWW Foundation, Inc. (QuadW); Giant Food Children's Cancer Research Fund; Heather Brooke Foundation; German Research Foundation(German Research Foundation (DFG)); Flight Attendant Medical Research Institute (FAMRI); Alpha Omega Alpha Postgraduate Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to thank Jeffrey Toretsky (Georgetown University), Jonathan Powell (JHU), Lee Helman (NIH), Chand Khanna (Pediatric Oncology Branch NCI) and Nita Ahuja (JHU) for providing cell lines and xenografts. They also credit Richard Jones, MD, Milada Vala and Gabriel Ghaiur, MD, PhD (JHU) for assistance with hematopoietic stem cells experiments; Hao Zhang, PhD (JHU) for assistance with flow cytometry; and Enrico Capobianco at the Center for Computational Analysis at the University of Miami for assistance with STRING networking. This work was supported by grants from the NIH (R01 CA138212 (DL),T32 CA009071-31 (BW), P30 CA006973 and HHSN268201000032C) (RC); a 2013 Reach Award from Alex's Lemonade Stand Foundation, LLC (DL); a Conquer Cancer Foundation/ASCO 2012 Young Investigator Award sponsored by WWWW Foundation, Inc. (QuadW) (BW); additional funding provided from the Giant Food Children's Cancer Research Fund (DL), the Heather Brooke Foundation (DL), German Research Foundation (KA 3884/1-1) (KK), Flight Attendant Medical Research Institute (FAMRI) (VR), and a 2012 Alpha Omega Alpha Postgraduate Award (BW).	Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943; Bol GM, 2012, CANC RES CHICAGO IL; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Bol GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063548; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Chang PC, 2006, ONCOGENE, V25, P1991, DOI 10.1038/sj.onc.1209239; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Fukumura J, 2003, J BIOCHEM, V134, P71, DOI 10.1093/jb/mvg126; Garbelli A, 2011, CURR MED CHEM, V18, P3015, DOI 10.2174/092986711796391688; Geissler R, 2012, NUCLEIC ACIDS RES, V40, P4998, DOI 10.1093/nar/gks070; Gonzalez-Nieto D, 2012, BLOOD, V119, P5144, DOI 10.1182/blood-2011-07-368506; HAZELTON BJ, 1987, CANCER RES, V47, P4501; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Italiano A, 2012, GENE CHROMOSOME CANC, V51, P207, DOI 10.1002/gcc.20945; Italiano A, 2011, CANCER-AM CANCER SOC, V117, P1049, DOI 10.1002/cncr.25538; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Kondaskar A, 2011, ACS MED CHEM LETT, V2, P252, DOI 10.1021/ml100281b; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; Lai MC, 2010, MOL CELL BIOL, V30, P5444, DOI 10.1128/MCB.00560-10; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Miao XY, 2013, INT J CLIN EXP PATHO, V6, P179; NYGREN P, 1991, INT J CANCER, V48, P598, DOI 10.1002/ijc.2910480419; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Sison EAR, 2013, BRIT J HAEMATOL, V160, P785, DOI 10.1111/bjh.12205; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Specht K, 2014, GENE CHROMOSOME CANC, V53, P622, DOI 10.1002/gcc.22172; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Sun MN, 2013, BBA-MOL CELL RES, V1833, P1489, DOI 10.1016/j.bbamcr.2013.02.026; Sun MN, 2011, BBA-MOL CELL RES, V1813, P438, DOI 10.1016/j.bbamcr.2011.01.003; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Velikodvorskaya T, 2010, CANCER RES, V70, P663; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Wu DW, 2014, ONCOGENE, V33, P1515, DOI 10.1038/onc.2013.107	39	39	40	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 19	2016	35	20					2574	2583		10.1038/onc.2015.336	http://dx.doi.org/10.1038/onc.2015.336			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GS	26364611				2022-12-26	WOS:000376165700004
J	Song, TY; Zheng, YM; Vincent, PA; Cai, DS; Rosenberg, P; Wang, YX				Song, Tengyao; Zheng, Yun-Min; Vincent, Peter A.; Cai, Dongsheng; Rosenberg, Paul; Wang, Yong-Xiao			Canonical transient receptor potential 3 channels activate NF-kappa B to mediate allergic airway disease via PKC-alpha/I kappa B-alpha and calcineurin/I kappa B-beta pathways	FASEB JOURNAL			English	Article						ion channel; signaling pathway; AIAD	SMOOTH-MUSCLE-CELLS; PULMONARY ARTERIAL-HYPERTENSION; KINASE-C-ALPHA; PROTEIN-KINASE; LENTIVIRAL VECTORS; FUNCTIONAL-ROLE; ASTHMA; INHIBITION; EXPRESSION; TRPC3	The purpose of this study was to determine the role of canonical transient receptor potential 3 (TRPC3) channel in allergen-induced airway disease (AIAD) and its underlying signaling mechanisms. The procedures included (1) intravenous injection of lentiviral TRPC3 channel or nonsilencing short hairpin ribonucleic acid (shRNA) to make the channel knockdown (KD) or control mice, (2) allergen sensitization/challenge to induce AIAD, (3) patch-clamp recording and Ca2+ imaging to examine the channel activity, and (4) gene manipulations and other methods to determine the underlying signaling mechanisms. The findings are that (1) intravenous or intranasal delivery of TRPC3 channel lentiviral shRNAs or blocker 1-[4-[(2,3,3-trichloro-1-oxo-2-propen-1-yl) amino] phenyl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid prevents AIAD in mice, (2) TRPC3 channel KD and overexpression, respectively, blocks and augments protein kinase C-alpha/nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibitor-alpha (PKC-alpha/I kappa B-alpha)-mediated or calcineurin/I kappa B-beta-dependent, NF-kappa B-dependent allergen-induced airway smooth muscle cell (ASMC) hyperproliferation and cyclin D1 (an important cell proliferation molecule) induction, and (3) the changes of the major molecules of the PKC-alpha/I kappa B alpha- and calcineurin/I kappa B-beta-dependent NF-kappa B signaling pathways are also observed in asthmatic human ASMCs. The conclusions are that TRPC3 channels plays an essential role in AIAD via the PKC-alpha/I kappa B-alpha- and calcineurin/I kappa B-beta-dependent NF-kappa B signaling pathways, and lentiviral shRNA or inhibitor of TRPC3 channels may become novel and effective treatments for AIAD.-Song, T., Zheng, Y.-M., Vincent, P. A., Cai, D., Rosenberg, P., Wang, Y.-X. Canonical transient receptor potential 3 channels activate NF-kB to mediate allergic airway disease via PKC-alpha/I kappa B-alpha and calcineurin/I kappa B-beta pathways. FASEB J. 30, 214-229 (2016). www.fasebj.org	[Song, Tengyao; Zheng, Yun-Min; Vincent, Peter A.; Wang, Yong-Xiao] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Rosenberg, Paul] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Albany Medical College; Yeshiva University; Albert Einstein College of Medicine; Duke University	Wang, YX (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave, Albany, NY 12208 USA.	wangy@mail.amc.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL071000, HL108232]; American Heart Association [0340160N, 0630236N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075190, R01HL071000, R01HL122865, R01HL108232] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL071000 and HL108232 (to Y.-X.W.), as well as American Heart Association Established Investigator Awards 0340160N (to Y.-X.W.) and 0630236N (to Y.-M.Z.). The authors thank Dennis Metzger, Ph.D., for assisting with experiments with the FlexiVent system and Qinghua Liu, M.D., Ph.D. for providing help with initial experiments.	[Anonymous], 2014, CALCIUM SIGNALING AI; Bai Y, 2006, AM J PHYSIOL-LUNG C, V291, pL208, DOI 10.1152/ajplung.00494.2005; Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Barnes PJ, 2012, SEMIN RESP CRIT CARE, V33, P685, DOI 10.1055/s-0032-1326965; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Du CL, 2010, EXP LUNG RES, V36, P201, DOI 10.3109/01902140903290022; Furuya Y, 2014, J VIROL, V88, P9166, DOI 10.1128/JVI.00265-14; Grimm S, 1996, J CELL BIOL, V134, P13, DOI 10.1083/jcb.134.1.13; Hai CM, 2007, CURR MED CHEM, V14, P67, DOI 10.2174/092986707779313507; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Herron CR, 2011, AM J PHYSIOL-HEART C, V300, pH36, DOI 10.1152/ajpheart.00812.2010; Jansen L. J., 2014, CALCIUM SIGNALING AI, P195; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kumar P, 2011, CURR GENE THER, V11, P144, DOI 10.2174/156652311794940782; Lam Hilaire C, 2011, J Vis Exp, DOI 10.3791/2513; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Liu QH, 2009, P NATL ACAD SCI USA, V106, P11418, DOI 10.1073/pnas.0813307106; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Poteser M, 2011, P NATL ACAD SCI USA, V108, P10556, DOI 10.1073/pnas.1106183108; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; Said SI, 2010, EUR RESPIR J, V35, P730, DOI 10.1183/09031936.00097109; Smedlund K, 2010, CIRC RES, V106, P1479, DOI 10.1161/CIRCRESAHA.109.213314; Song T., 2014, CALCIUM SIGNALING AI, P393; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Vertegaal ACO, 2000, CELL SIGNAL, V12, P759, DOI 10.1016/S0898-6568(00)00133-9; Walczak-Drzewiecka A, 2008, J IMMUNOL, V181, P1665, DOI 10.4049/jimmunol.181.3.1665; Wang YX, 2011, ADV EXP MED BIOL, V704, P731, DOI 10.1007/978-94-007-0265-3_38; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; Xiao JH, 2010, AM J RESP CELL MOL, V43, P17, DOI 10.1165/rcmb.2009-0091OC; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458	31	19	20	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					214	229		10.1096/fj.15-274860	http://dx.doi.org/10.1096/fj.15-274860			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26373801	Green Published			2022-12-26	WOS:000367621000022
J	Molina, R; Redondo, P; Lopez-Mendez, B; Villate, M; Merino, N; Blanco, FJ; Valton, J; Grizot, S; Duchateau, P; Prieto, J; Montoya, G				Molina, Rafael; Redondo, Pilar; Lopez-Mendez, Blanca; Villate, Maider; Merino, Nekane; Blanco, Francisco J.; Valton, Julien; Grizot, Silvestre; Duchateau, Phillipe; Prieto, Jesus; Montoya, Guillermo			Crystal Structure of the Homing Endonuclease I-CvuI Provides a New Template for Genome Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA endonuclease; enzyme; genetics; protein-DNA interaction; X-ray crystallography; gene targeting; homing endonucleases	PROTEIN-DNA INTERACTIONS; HOMOLOGOUS RECOMBINATION; MOLECULAR-BASIS; SYSTEM; SITE; FEATURES; COMPLEX; BINDING	Homing endonucleases recognize and generate a DNA double-strand break, which has been used to promote gene targeting. These enzymes recognize long DNA stretches; they are highly sequence-specific enzymes and display a very low frequency of cleavage even in complete genomes. Although a large number of homing endonucleases have been identified, the landscape of possible target sequences is still very limited to cover the complexity of the whole eukaryotic genome. Therefore, the finding and molecular analysis of homing endonucleases identified but not yet characterized may widen the landscape of possible target sequences. The previous characterization of protein-DNA interaction before the engineering of new homing endonucleases is essential for further enzyme modification. Here we report the crystal structure of I-CvuI in complex with its target DNA and with the target DNA of I-CreI, a homologue enzyme widely used in genome engineering. To characterize the enzyme cleavage mechanism, we have solved the I-CvuI DNA structures in the presence of non-catalytic (Ca2+) and catalytic ions (Mg2+). We have also analyzed the metal dependence of DNA cleavage using Mg2+ ions at different concentrations ranging from non-cleavable to cleavable concentrations obtained from in vitro cleavage experiments. The structure of I-CvuI homing endonuclease expands the current repertoire for engineering custom specificities, both by itself as a new scaffold alone and in hybrid constructs with other related homing endonucleases or other DNA-binding protein templates.	[Molina, Rafael; Redondo, Pilar; Prieto, Jesus; Montoya, Guillermo] Spanish Natl Canc Res Ctr CNIO, Macromol Crystallog Grp, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Lopez-Mendez, Blanca] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Prot Struct & Funct Programme, DK-2200 Copenhagen, Denmark; [Villate, Maider; Merino, Nekane; Blanco, Francisco J.] CIC BioGUNE, Struct Biol Unit, Derio 48160, Spain; [Blanco, Francisco J.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain; [Valton, Julien; Grizot, Silvestre; Duchateau, Phillipe] CELLECTIS SA, F-75013 Paris, France	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Copenhagen; CIC bioGUNE; Basque Foundation for Science	Prieto, J (corresponding author), Spanish Natl Canc Res Ctr CNIO, Macromol Crystallog Grp, Struct Biol & Biocomp Programme, C Melchor Fernandez Almagro 3, Madrid 28029, Spain.	jprieto@cnio.es; guillermo.montoya@cpr.ku.dk	Blanco, Francisco J/D-4401-2009; Molina, Rafael/AAG-6552-2019; Molina, Rafael/L-6203-2016; Redondo, Pilar/L-7612-2014	Blanco, Francisco J/0000-0003-2545-4319; Molina, Rafael/0000-0002-6443-4989; Molina, Rafael/0000-0002-6443-4989; Redondo, Pilar/0000-0002-6723-0818; Valton, Julien/0000-0003-0826-5401; GRIZOT, Sylvestre/0000-0002-0670-0687	Novo Nordisk Foundation [NNF14CC0001]; Novo Nordisk Foundation Center for Protein Research [PI Guillermo Montoya] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Foundation Center for Protein Research	We thank the Swiss Light Source and XALOC beamline staff from the Spanish Synchrotron Radiation Facility for their support. The Novo Nordisk Foundation Center for Protein Research is supported financially by the Novo Nordisk Foundation (Grant NNF14CC0001).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Chevalier B, 2004, BIOCHEMISTRY-US, V43, P14015, DOI 10.1021/bi048970c; Chevalier BS, 2001, NAT STRUCT BIOL, V8, P312, DOI 10.1038/86181; CHOULIKA A, 1994, CR ACAD SCI III-VIE, V317, P1013; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; Marcaida MJ, 2010, CELL MOL LIFE SCI, V67, P727, DOI 10.1007/s00018-009-0188-y; Marciada MJ, 2008, P NATL ACAD SCI USA, V105, P16888, DOI 10.1073/pnas.0804795105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina R, 2015, NAT STRUCT MOL BIOL, V22, P65, DOI 10.1038/nsmb.2932; Molina R, 2012, NUCLEIC ACIDS RES, V40, P6936, DOI 10.1093/nar/gks320; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Prieto J, 2008, J BIOL CHEM, V283, P4364, DOI 10.1074/jbc.M706323200; Prieto J, 2012, CRIT REV BIOCHEM MOL, V47, P207, DOI 10.3109/10409238.2011.652358; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Redondo P, 2014, ACTA CRYSTALLOGR F, V70, P256, DOI 10.1107/S2053230X1400065X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Seligman LM, 1997, GENETICS, V147, P1653; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Wang JS, 1997, NUCLEIC ACIDS RES, V25, P3767, DOI 10.1093/nar/25.19.3767	28	2	2	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28727	28736		10.1074/jbc.M115.678342	http://dx.doi.org/10.1074/jbc.M115.678342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26363068	Green Published, hybrid			2022-12-26	WOS:000365762300016
J	Payne, KAP; Fisher, K; Sjuts, H; Dunstan, MS; Bellina, B; Johannissen, L; Barran, P; Hay, S; Rigby, SEJ; Leys, D				Payne, Karl A. P.; Fisher, Karl; Sjuts, Hanno; Dunstan, Mark S.; Bellina, Bruno; Johannissen, Linus; Barran, Perdita; Hay, Sam; Rigby, Stephen E. J.; Leys, David			Epoxyqueuosine Reductase Structure Suggests a Mechanism for Cobalamin-dependent tRNA Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RES; IRON-SULFUR CLUSTER; ESCHERICHIA-COLI; REPEAT PROTEINS; NUCLEOSIDE Q; QUEUOSINE; BIOSYNTHESIS; VITAMIN-B-12; PURIFICATION; DISCOVERY	Queuosine (Q) is a hypermodified RNA base that replaces guanine in the wobble positions of 5'-GUN-3' tRNA molecules. Q is exclusively made by bacteria, and the corresponding queuine base is a micronutrient salvaged by eukaryotic species. The final step in Q biosynthesis is the reduction of the epoxide precursor, epoxyqueuosine, to yield the Q cyclopentene ring. The epoxyqueuosine reductase responsible, QueG, shares distant homology with the cobalamin-dependent reductive dehalogenase (RdhA), however the role played by cobalamin in QueG catalysis has remained elusive. Wereport the solution and structural characterization of Streptococcus thermophilus QueG, revealing the enzyme harbors a redox chain consisting of two [4Fe-4S] clusters and a cob(II) alamin in the base-off form, similar to RdhAs. In contrast to the shared redox chain architecture, the QueG active site shares little homology with RdhA, with the notable exception of a conserved Tyr that is proposed to function as a proton donor during reductive dehalogenation. Docking of an epoxyqueuosine substrate suggests the QueG active site places the substrate cyclopentane moiety in close proximity of the cobalt. Both the Tyr and a conserved Asp are implicated as proton donors to the epoxide leaving group. This suggests that, in contrast to the unusual carbon-halogen bond chemistry catalyzed by RdhAs, QueG acts via Co-C bond formation. Our study establishes the common features of Class III cobalamin-dependent enzymes, and reveals an unexpected diversity in the reductive chemistry catalyzed by these enzymes.	[Payne, Karl A. P.; Fisher, Karl; Sjuts, Hanno; Dunstan, Mark S.; Bellina, Bruno; Johannissen, Linus; Barran, Perdita; Hay, Sam; Rigby, Stephen E. J.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	University of Manchester	Payne, KAP (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Princess St 131, Manchester M1 7DN, Lancs, England.	karl.payne@manchester.ac.uk; david.leys@manchester.ac.uk	Barran, Perdita/AAY-6303-2021; Hay, Sam/D-5974-2012	Hay, Sam/0000-0003-3274-0938; payne, karl/0000-0002-6331-6374; bellina, bruno/0000-0001-5763-7676; Dunstan, Mark/0000-0002-9416-5505; Barran, Perdita/0000-0002-7720-586X	European Research Council [DEHALORES206080]; BBSRC [BB/M007316/1]; BBSRC [BB/H021523/1, BB/L015048/1, BB/L002655/1, BB/E013007/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L002655/1, BB/E013007/1, BB/C00521X/1, BB/H021523/1, BB/L015048/1, BB/M007316/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Research Council Grant DEHALORES206080 and by BBSRC Grant BB/M007316/1 (both to D. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BAYSTON JH, 1970, BIOCHEMISTRY-US, V9, P2164, DOI 10.1021/bi00812a020; Beveridge R, 2014, ANAL CHEM, V86, P10979, DOI 10.1021/ac5027435; Biedendieck R, 2007, BIOTECHNOL BIOENG, V96, P525, DOI 10.1002/bit.21145; Bommer M, 2014, SCIENCE, V346, P455, DOI 10.1126/science.1258118; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Fergus C, 2015, NUTRIENTS, V7, P2897, DOI 10.3390/nu7042897; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; FREY B, 1988, J BACTERIOL, V170, P2078, DOI 10.1128/jb.170.5.2078-2082.1988; Futagami T, 2008, CHEM REC, V8, P1, DOI 10.1002/tcr.20134; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; HAGEN WR, 1985, J MAGN RESON, V61, P220, DOI 10.1016/0022-2364(85)90077-0; HARADA F, 1972, BIOCHEMISTRY-US, V11, P301, DOI 10.1021/bi00752a024; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KASAI H, 1975, NUCLEIC ACIDS RES, V2, P1931, DOI 10.1093/nar/2.10.1931; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; LINDAHL PA, 1987, J BIOL CHEM, V262, P14945; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; Miles ZD, 2015, BIOCHEMISTRY-US, V54, P4927, DOI 10.1021/acs.biochem.5b00335; Miles ZD, 2011, P NATL ACAD SCI USA, V108, P7368, DOI 10.1073/pnas.1018636108; Moore SJ, 2013, P NATL ACAD SCI USA, V110, P14906, DOI 10.1073/pnas.1308098110; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OKADA N, 1979, J BIOL CHEM, V254, P3061; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Rubinson EH, 2012, CURR OPIN STRUC BIOL, V22, P101, DOI 10.1016/j.sbi.2011.11.005; Sjuts H, 2012, PROTEIN EXPRES PURIF, V85, P224, DOI 10.1016/j.pep.2012.08.007; SLANY RK, 1993, BIOCHEMISTRY-US, V32, P7811, DOI 10.1021/bi00081a028; SWEENEY WV, 1980, ANNU REV BIOCHEM, V49, P139, DOI 10.1146/annurev.bi.49.070180.001035; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Urvoas A, 2010, J MOL BIOL, V404, P307, DOI 10.1016/j.jmb.2010.09.048; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	34	26	26	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27572	27581		10.1074/jbc.M115.685693	http://dx.doi.org/10.1074/jbc.M115.685693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26378237	Green Published, hybrid			2022-12-26	WOS:000365757500013
J	Borges-Pereira, L; Budu, A; McKnight, CA; Moore, CA; Vella, SA; Triana, MAH; Liu, J; Garcia, CRS; Pace, DA; Moreno, SNJ				Borges-Pereira, Lucas; Budu, Alexandre; McKnight, Ciara A.; Moore, Christina A.; Vella, Stephen A.; Triana, Miryam A. Hortua; Liu, Jing; Garcia, Celia R. S.; Pace, Douglas A.; Moreno, Silvia N. J.			Calcium Signaling throughout the Toxoplasma gondii Lytic Cycle A STUDY USING GENETICALLY ENCODED CALCIUM INDICATORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CA2+; PARASITOPHOROUS VACUOLE; MICRONEME SECRETION; PROTEIN SECRETION; CONOID EXTRUSION; PHOSPHOLIPASE-C; HOST-CELLS; TACHYZOITES; STORES; THAPSIGARGIN	Background: Ca2+ signaling is important for the lytic cycle of T. gondii. Results: Genetically encoded Ca2+ indicators revealed cytosolic Ca2+ changes in real time. Conclusion: New approach highlights important features of the lytic cycle. Significance: Ca2+ influx leads to signaling that results in enhancement of important lytic cycle features. Toxoplasma gondii is an obligate intracellular parasite that invades host cells, creating a parasitophorous vacuole where it communicates with the host cell cytosol through the parasitophorous vacuole membrane. The lytic cycle of the parasite starts with its exit from the host cell followed by gliding motility, conoid extrusion, attachment, and invasion of another host cell. Here, we report that Ca2(+) oscillations occur in the cytosol of the parasite during egress, gliding, and invasion, which are critical steps of the lytic cycle. Extracellular Ca2(+) enhances each one of these processes. We used tachyzoite clonal lines expressing genetically encoded calcium indicators combined with host cells expressing transiently expressed calcium indicators of different colors, and we measured Ca2(+) changes in both parasites and host simultaneously during egress. We demonstrated a link between cytosolic Ca2(+) oscillations in the host and in the parasite. Our approach also allowed us to measure two new features of motile parasites, which were enhanced by Ca2(+) influx. This is the first study showing, inreal time, Ca2(+) signals preceding egress and their direct link with motility, an essential virulence trait.	[Triana, Miryam A. Hortua; Liu, Jing; Garcia, Celia R. S.; Pace, Douglas A.; Moreno, Silvia N. J.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Moore, Christina A.; Moreno, Silvia N. J.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Moreno, SNJ (corresponding author), Univ Georgia, Dept Cellular Biol, 350A Paul Coverdell Ctr, Athens, GA 30602 USA.	smoreno@uga.edu	Regan, Clinton/E-6250-2012; Garcia, Celia R. S./A-4093-2011; Budu, Alexandre/F-6498-2013; Borges Pereira, Lucas/F-3503-2016	Garcia, Celia R. S./0000-0003-2825-1701; Budu, Alexandre/0000-0002-7110-9754; Hortua Triana, Miryam Andrea/0000-0001-5964-8512	National Institutes of Health [AI-110027, AI-096836, AI060546]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil; CNPq (Ciencia sem Fronteiras) [243462/2012-3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060546, R01AI096836, R21AI110027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Ciencia sem Fronteiras); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-110027 and AI-096836 (to S. N. J. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil, during his stay at University of Georgia.; Supported by a research fellowship from CNPq (Ciencia sem Fronteiras) Project 243462/2012-3.; Supported in part by National Institutes of Health Training Grant AI060546 to the Center for Tropical and Emerging Global Diseases, University of Georgia.	Alves E, 2011, J BIOL CHEM, V286, P5905, DOI 10.1074/jbc.M110.188474; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Billups B, 2002, J NEUROSCI, V22, P5840; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Case RM, 2007, CELL CALCIUM, V42, P345, DOI 10.1016/j.ceca.2007.05.001; Chini EN, 2005, BIOCHEM J, V389, P269, DOI 10.1042/BJ20041971; Choi S, 2001, BRIT J PHARMACOL, V132, P641, DOI 10.1038/sj.bjp.0703856; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Fang JM, 2006, BIOCHEM J, V394, P417, DOI 10.1042/BJ20051393; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Del Carmen MG, 2009, CELL MICROBIOL, V11, P967, DOI 10.1111/j.1462-5822.2009.01304.x; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Leybaert L, 2012, PHYSIOL REV, V92, P1359, DOI 10.1152/physrev.00029.2011; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Lukyanenko V, 1999, J PHYSIOL-LONDON, V521, P575, DOI 10.1111/j.1469-7793.1999.00575.x; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; MONDRAGON R, 1994, J EUKARYOT MICROBIOL, V41, P330, DOI 10.1111/j.1550-7408.1994.tb06086.x; Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x; Moreno SNJ, 1998, BIOCHEM J, V330, P853; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Pace DA, 2014, J BIOL CHEM, V289, P19637, DOI 10.1074/jbc.M114.565390; Passos APD, 1998, BIOCHEM BIOPH RES CO, V245, P155, DOI 10.1006/bbrc.1998.8338; Pernas L, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001845; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; Silverman JA, 1998, J BIOL CHEM, V273, P12352, DOI 10.1074/jbc.273.20.12352; Stommel EW, 1997, EXP PARASITOL, V87, P88, DOI 10.1006/expr.1997.4187; Striepen B, 1998, MOL BIOCHEM PARASIT, V92, P325, DOI 10.1016/S0166-6851(98)00011-5; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tian Lin, 2012, Cold Spring Harb Protoc, V2012, P647, DOI 10.1101/pdb.top069609; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; TSUKAMOTO A, 1993, CELL BIOL INT, V17, P969, DOI 10.1006/cbir.1993.1021; VERCESI AE, 1993, J BIOL CHEM, V268, P8564; Vieira MCF, 2000, MOL BIOCHEM PARASIT, V106, P157, DOI 10.1016/S0166-6851(99)00182-6; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	48	42	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26914	26926		10.1074/jbc.M115.652511	http://dx.doi.org/10.1074/jbc.M115.652511			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26374900	hybrid, Green Published			2022-12-26	WOS:000364794000004
J	Abdelgawad, A; Hermes, R; Damiani, A; Lamglait, B; Czirjak, GA; East, M; Aschenborn, O; Wenker, C; Kasem, S; Osterrieder, N; Greenwood, AD				Abdelgawad, Azza; Hermes, Robert; Damiani, Armando; Lamglait, Benjamin; Czirjak, Gabor A.; East, Marion; Aschenborn, Ortwin; Wenker, Christian; Kasem, Samy; Osterrieder, Nikolaus; Greenwood, Alex D.			Comprehensive Serology Based on a Peptide ELISA to Assess the Prevalence of Closely Related Equine Herpesviruses in Zoo and Wild Animals	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; TYPE-1 EHV-1; EXPERIMENTAL-INFECTION; GAZELLE HERPESVIRUS-1; SERENGETI ECOSYSTEM; EQUUS-BURCHELLI; ZEBRA; ANTIBODIES; VIRUS; ENCEPHALITIS	Equine herpesvirus type 1 (EHV-1) causes respiratory disorders and abortion in equids while EHV-1 regularly causes equine herpesvirus myeloencephalopathy (EHM), a stroke-like syndrome following endothelial cell infection in horses. Both EHV-1 and EHV-9 infections of non-definitive hosts often result in neuronal infection and high case fatality rates. Hence, EHV-1 and EHV-9 are somewhat unusual herpesviruses and lack strict host specificity, and the true extent of their host ranges have remained unclear. In order to determine the seroprevalence of EHV-1 and EHV-9, a sensitive and specific peptide-based ELISA was developed and applied to 428 sera from captive and wild animals representing 30 species in 12 families and five orders. Members of the Equidae, Rhinocerotidae and Bovidae were serologically positive for EHV-1 and EHV-9. The prevalence of EHV-1 in the sampled wild zebra populations was significantly higher than in zoos suggesting captivity may reduce exposure to EHV-1. Furthermore, the seroprevalence for EHV-1 was significantly higher than for EHV-9 in zebras. In contrast, EHV-9 antibody prevalence was high in captive and wild African rhinoceros species suggesting that they may serve as a reservoir or natural host for EHV-9. Thus, EHV-1 and EHV-9 have a broad host range favoring African herbivores and may have acquired novel natural hosts in ecosystems where wild equids are common and are in close contact with other perissodactyls.	[Abdelgawad, Azza; Hermes, Robert; Czirjak, Gabor A.; East, Marion; Greenwood, Alex D.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Damiani, Armando; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany; [Lamglait, Benjamin] Reserve Africaine Sigean, Sigean, France; [Aschenborn, Ortwin] Bwabwata Ecol Inst, Susuwe, Zambezi Region, Namibia; [Wenker, Christian] Zoo Basel, Basel, Switzerland; [Kasem, Samy] Kafrelsheikh Univ, Fac Vet Med, Dept Virol, Kafrelsheikh, Egypt	Leibniz Institut fur Zoo und Wildtierforschung; Free University of Berlin; Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Greenwood, AD (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	greenwood@izw-berlin.de	Kasem, Samy/AAF-9650-2019; Greenwood, Alex/GWU-8292-2022; Kasem, Samy/AAA-3910-2021; Czirják, Gábor Árpád/F-5440-2011	Kasem, Samy/0000-0002-8730-7333; Kasem, Samy/0000-0002-8730-7333; Czirják, Gábor Árpád/0000-0001-9488-0069; Osterrieder, Nikolaus/0000-0002-5313-2176	Leibniz Gemeinschaft [SAW-2015-IZW-1 440]	Leibniz Gemeinschaft	AA, GAC, ME, OA, NO and ADG were supported by a grant from the Leibniz Gemeinschaft SAW-2015-IZW-1 440. Benjamin Lamglait is an employee of the Reserve Africaine de Sigean, a commercial entity. The funder provided support in the form of salaries for authors [BL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgawad A, 2014, VET MICROBIOL, V169, P102, DOI 10.1016/j.vetmic.2013.12.011; BARNARD BJH, 1993, ONDERSTEPOORT J VET, V60, P111; BARNARD BJH, 1993, ONDERSTEPOORT J VET, V60, P175; Becker SD, 2007, LAB ANIM-UK, V41, P229, DOI 10.1258/002367707780378203; Blunden AS, 1998, J COMP PATHOL, V119, P485, DOI 10.1016/S0021-9975(98)80043-1; Borchers K, 2005, J WILDLIFE DIS, V41, P80, DOI 10.7589/0090-3558-41.1.80; Borchers K, 2008, J VET MED SCI, V70, P1377, DOI 10.1292/jvms.70.1377; Carvalho R, 2000, ARQ BRAS MED VET ZOO, P52; CHOWDHURY SI, 1988, VIRUS RES, V11, P127, DOI 10.1016/0168-1702(88)90038-X; CRABB BS, 1993, J VIROL, V67, P6332, DOI 10.1128/JVI.67.10.6332-6338.1993; CRANDELL RA, 1988, AM J VET RES, V49, P1807; CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258; El-Nahass E, 2011, J COMP PATHOL; Fischer-Tenhagen C, 2000, J WILDLIFE DIS, V36, P316, DOI 10.7589/0090-3558-36.2.316; Fukushi H, 1997, VIROLOGY, V227, P34, DOI 10.1006/viro.1996.8296; Fukushi H, 2000, J NEUROVIROL, V6, P314, DOI 10.3109/13550280009030757; Ghanem Y, 2008, ARCH VIROL, V153, P2297, DOI 10.1007/s00705-008-0247-y; Gilbert AT, 2013, ECOHEALTH, V10, P298, DOI 10.1007/s10393-013-0856-0; Goltenboth R, 1996, P AM ASS ZOO VETS PU, P18; Greenwood AD, 2012, CURR BIOL, V22, P1727, DOI 10.1016/j.cub.2012.07.035; Kasem S, 2008, EMERG INFECT DIS, V14, P1948, DOI 10.3201/eid1412.080801; Lang A, 2013, J VIROL METHODS, V193, P667, DOI 10.1016/j.jviromet.2013.07.044; Ma GG, 2013, VET MICROBIOL, V167, P123, DOI 10.1016/j.vetmic.2013.06.018; Narita M, 2000, VET PATHOL, V37, P476, DOI 10.1354/vp.37-5-476; Office International des Epizooties, 2008, MAN DIAGN TESTS VACC, P894; Perkins GA, 2013, AM J VET RES, V74, P248, DOI 10.2460/ajvr.74.2.248; Pusterla N, 2009, VET J, V179, P230, DOI 10.1016/j.tvjl.2007.09.018; REBHUN WC, 1988, J AM VET MED ASSOC, V192, P953; Reed SM, 2004, VET CLIN N AM-EQUINE, V20, P631, DOI 10.1016/j.cveq.2004.09.001; Schrenzel MD, 2008, EMERG INFECT DIS, V14, P1616, DOI 10.3201/eid1410.080703; Stobel K, 2002, INT J MED MICROBIOL, V291, P88; Taniguchi A, 2000, J VET MED SCI, V62, P215, DOI 10.1292/jvms.62.215; Taniguchi A, 2000, ARCH VIROL, V145, P2619, DOI 10.1007/s007050070011; van Maanen C, 2002, VET QUART, V24, P57, DOI 10.1080/01652176.2002.9695126; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Wohlsein P, 2011, VET MICROBIOL, V149, P456, DOI 10.1016/j.vetmic.2010.11.024; Wright P F, 1993, Rev Sci Tech, V12, P435; Yanai T, 2003, VET PATHOL, V40, P263, DOI 10.1354/vp.40-3-263; Yanai T, 2003, J COMP PATHOL, V128, P113, DOI 10.1053/jcpa.2002.0613; Yasunaga S, 1998, J VET MED SCI, V60, P1133, DOI 10.1292/jvms.60.1133	40	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138370	10.1371/journal.pone.0138370	http://dx.doi.org/10.1371/journal.pone.0138370			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378452	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400090
J	Shinchi, H; Yuki, N; Ishida, H; Hirata, K; Wakao, M; Suda, Y				Shinchi, Hiroyuki; Yuki, Nobuhiro; Ishida, Hideharu; Hirata, Koichi; Wakao, Masahiro; Suda, Yasuo			Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barre Syndrome	PLOS ONE			English	Article							ABO BLOOD-GROUP; NATURAL ANTIBODIES; LINKER LENGTH; LECTIN; LIPOPOLYSACCHARIDE; OLIGOSACCHARIDES; EPITOPES; ANTIGENS; LIGANDS; BINDING	Sugar chain binding antibodies have gained substantial attention as biomarkers due to their crucial roles in various disorders. In this study, we developed simple and quick detection method of anti-sugar chain antibodies in sera using our previously developed sugar chain-immobilized fluorescent nanoparticles (SFNPs) for the point-of-care diagnostics. Sugar chain structure on SFNPs was modified with the sugar moieties of the GM1 ganglioside via our original linker molecule to detect anti-GM1 antibodies. The structures and densities of the sugar moieties immobilized on the nanoparticles were evaluated in detail using lectins and sera containing anti-GM1 antibodies from patients with Guillain-Barre syndrome, a neurological disorder, as an example of disease involving anti-sugar chain antibodies. When optimized SFNPs were added to sera from patients with Guillain-Barre syndrome, fluorescent aggregates were able to visually detect under UV light in three hours. The sensitivity of the detection method was equivalent to that of the current ELISA method used for the diagnosis of Guillain-Barre syndrome. These results suggest that our method using SFNPs is suitable for the point-of-care diagnostics of diseases involving anti-sugar chain antibodies.	[Shinchi, Hiroyuki; Wakao, Masahiro; Suda, Yasuo] Kagoshima Univ, Dept Chem Biotechnol & Chem Engn, Kagoshima 8900065, Japan; [Yuki, Nobuhiro; Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi 3210293, Japan; [Yuki, Nobuhiro] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia; [Ishida, Hideharu] Gifu Univ, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; [Suda, Yasuo] SUDx Biotec Corp, Kagoshima 8900013, Japan	Kagoshima University; Dokkyo Medical University; University of Sydney; Gifu University	Suda, Y (corresponding author), Kagoshima Univ, Dept Chem Biotechnol & Chem Engn, 1-21-40 Kohrimoto, Kagoshima 8900065, Japan.	ysuda@eng.kagoshimau.ac.jp		Shinchi, Hiroyuki/0000-0001-5204-9170	Japan Society for the Promotion of Science [23300356]; Japan Science and Technology Agency [V07-05, AS2416907P, AS251Z02372P, 16-057]; Japan Ministry of Health, Labor, and Welfare [H21-Nano-Ippan-002]; Singapore National Medical Research Council [IRG 10nov086, CSA/047/2012]; Yong Loo Lin School of Medicine [R-172-000-264-733]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Singapore National Medical Research Council(National Medical Research Council, Singapore); Yong Loo Lin School of Medicine(National University of Singapore)	This study was supported in part by grants from the Japan Society for the Promotion of Science (23300356 to YS, http://www.jsps.go.jp/english/), the Japan Science and Technology Agency (V07-05 and AS2416907P to YS and AS251Z02372P and 16-057 to MW, http://www.jst.go.jp/EN/), the Japan Ministry of Health, Labor, and Welfare (H21-Nano-Ippan-002 to YS, http://www.mhlw.go.jp/english/), the Singapore National Medical Research Council (IRG 10nov086 and CSA/047/2012 to NY, http://www.nmrc.gov.sg/content/nmrc_internet/home.html), and Yong Loo Lin School of Medicine (start-up grant, R-172-000-264-733 to NY, http://medicine.nus.edu.sg/corporate/). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The SUDx-bitec Corporation provided support in the form of travel expenses for YS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Alaedini A, 2002, J NEUROL SCI, V196, P41, DOI 10.1016/S0022-510X(02)00022-9; Barrientos AG, 2009, CARBOHYD RES, V344, P1474, DOI 10.1016/j.carres.2009.04.029; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; Houseman BT, 1999, ANGEW CHEM INT EDIT, V38, P782, DOI 10.1002/(SICI)1521-3773(19990315)38:6<782::AID-ANIE782>3.0.CO;2-N; Huflejt ME, 2009, MOL IMMUNOL, V46, P3037, DOI 10.1016/j.molimm.2009.06.010; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; ILYAS AA, 1988, ANN NEUROL, V23, P440, DOI 10.1002/ana.410230503; Imamura A, 2008, GLYCOCONJUGATE J, V25, P269, DOI 10.1007/s10719-007-9102-8; Janshoff A, 1996, EUR BIOPHYS J BIOPHY, V25, P105, DOI 10.1007/s002490050022; Kimoto K, 2006, NEUROLOGY, V67, P1837, DOI 10.1212/01.wnl.0000244468.22377.6b; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; KORNBERG AJ, 1994, ANN NEUROL, V35, P234, DOI 10.1002/ana.410350217; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lawrie CH, 2006, INT J CANCER, V118, P3161, DOI 10.1002/ijc.21762; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Pochechueva T, 2011, ANALYST, V136, P560, DOI 10.1039/c0an00758g; Reynolds M, 2012, CHEM-EUR J, V18, P4264, DOI 10.1002/chem.201102034; SANDRIN MS, 1994, IMMUNOL REV, V141, P169, DOI 10.1111/j.1600-065X.1994.tb00877.x; SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391; Sato M, 2009, J BIOCHEM, V146, P33, DOI 10.1093/jb/mvp041; Shewmake TA, 2008, BIOMACROMOLECULES, V9, P3057, DOI 10.1021/bm800529b; Shinchi H, 2012, CHEM-ASIAN J, V7, P2678, DOI 10.1002/asia.201200362; SIMM S, 1979, Ginekologia Polska, V50, P1029; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wakao M, 2008, BIOORG MED CHEM LETT, V18, P2499, DOI 10.1016/j.bmcl.2008.01.069; WANG WT, 1984, ANAL BIOCHEM, V141, P366, DOI 10.1016/0003-2697(84)90057-5; WATANABE A, 1975, ANN NY ACAD SCI, V259, P95, DOI 10.1111/j.1749-6632.1975.tb25406.x; Watkins WM, 2001, TRANSFUSION MED, V11, P243, DOI 10.1046/j.1365-3148.2001.00321.x; WEIGEL PH, 1979, J BIOL CHEM, V254, P830; WERNER TC, 1972, P NATL ACAD SCI USA, V69, P795, DOI 10.1073/pnas.69.4.795; Willison HJ, 1999, EUR J NEUROL, V6, P71, DOI 10.1046/j.1468-1331.1999.610071.x; Woller EK, 2003, J AM CHEM SOC, V125, P8820, DOI 10.1021/ja0352496; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; YUKI N, 1992, BIOMED RES-TOKYO, V13, P451, DOI 10.2220/biomedres.13.451; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525	42	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137966	10.1371/journal.pone.0137966	http://dx.doi.org/10.1371/journal.pone.0137966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378448	gold, Green Published, Green Submitted			2022-12-26	WOS:000361769400041
J	Yeomans, MR; Brace, A				Yeomans, Martin R.; Brace, Aaron			Cued to Act on Impulse: More Impulsive Choice and Risky Decision Making by Women Susceptible to Overeating after Exposure to Food Stimuli	PLOS ONE			English	Article							3-FACTOR EATING QUESTIONNAIRE; ORBITOFRONTAL CORTEX; BULIMIA-NERVOSA; TASK BART; OBESE WOMEN; BEHAVIORAL MEASURES; INHIBITORY CONTROL; DIETARY RESTRAINT; DOPAMINE RELEASE; FUTURE REWARDS	There is increasing evidence that individual differences in tendency to overeat relate to impulsivity, possibly by increasing reactivity to food-related cues in the environment. This study tested whether acute exposure to food cues enhanced impulsive and risky responses in women classified on tendency to overeat, indexed by scores on the three factor eating questionnaire disinhibition (TFEQ-D), restraint (TFEQ-R) and hunger scales. Ninety six healthy women completed two measures of impulsive responding (delayed discounting, DDT and a Go No-Go, GNG, task) and a measure of risky decision making (the balloon analogue risk task, BART) as well as questionnaire measures of impulsive behaviour either after looking at a series of pictures of food or visually matched controls. Impulsivity (DDT) and risk-taking (BART) were both positively associated with TFEQ-D scores, but in both cases this effect was exacerbated by prior exposure to food cues. No effects of restraint were found. TFEQ-D scores were also related to more commission errors on the GNG, while restrained women were slower on the GNG, but neither effect was modified by cue exposure. Overall these data suggest that exposure to food cues act to enhance general impulsive responding in women at risk of overeating and tentatively suggest an important interaction between tendency for impulsive decision making and food cues that may help explain a key underlying risk factor for overeating.	[Yeomans, Martin R.; Brace, Aaron] Univ Sussex, Sch Psychol, Brighton BN1 9QH, E Sussex, England	University of Sussex	Yeomans, MR (corresponding author), Univ Sussex, Sch Psychol, Brighton BN1 9QH, E Sussex, England.	martin@sussex.ac.uk	Yeomans, Martin/A-5291-2012	Yeomans, Martin/0000-0003-1436-1483				Ames SL, 2014, APPETITE, V81, P180, DOI 10.1016/j.appet.2014.06.013; Appelhans BM, 2011, OBESITY, V19, P2175, DOI 10.1038/oby.2011.57; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Blundell J, 2010, OBESITY PREVENTION: THE ROLE OF BRAIN AND SOCIETY ON INDIVIDUAL BEHAVIOR, P231, DOI 10.1016/B978-0-12-374387-9.00018-0; Bond MJ, 2001, INT J OBESITY, V25, P900, DOI 10.1038/sj.ijo.0801611; Carrard I, 2012, EAT BEHAV, V13, P13, DOI 10.1016/j.eatbeh.2011.10.004; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Claes Laurence, 2006, Eat Behav, V7, P196, DOI 10.1016/j.eatbeh.2006.05.001; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Davis C, 2010, APPETITE, V54, P208, DOI 10.1016/j.appet.2009.11.002; Dietrich A., 2014, FRONTIERS PSYCHOL, V5; Dougherty DM, 2005, BEHAV RES METHODS, V37, P82, DOI 10.3758/BF03206401; Engel SG, 2005, INT J EAT DISORDER, V38, P244, DOI 10.1002/eat.20169; Epstein LH, 2012, APPETITE, V58, P157, DOI 10.1016/j.appet.2011.09.025; Epstein LH, 2010, PHYSIOL BEHAV, V100, P438, DOI 10.1016/j.physbeh.2010.04.029; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Guerrieri R, 2007, APPETITE, V49, P66, DOI 10.1016/j.appet.2006.11.008; Hendrick OM, 2012, OBESITY, V20, P1796, DOI 10.1038/oby.2011.180; Hopko DR, 2006, J PSYCHOPATHOL BEHAV, V28, P95, DOI 10.1007/s10862-006-7487-5; Ito R, 2000, J NEUROSCI, V20, P7489; Jansen A, 2009, BEHAV RES THER, V47, P105, DOI 10.1016/j.brat.2008.10.016; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Kemps E, 2010, J CLIN EXP NEUROPSYC, V32, P515, DOI 10.1080/13803390903264122; King BM, 2013, AM PSYCHOL, V68, P88, DOI 10.1037/a0030684; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Lattimore P, 2015, APPETITE, V90, P248, DOI 10.1016/j.appet.2015.02.020; Leitch MA, 2013, APPETITE, V69, P54, DOI 10.1016/j.appet.2013.05.007; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Loeber S, 2013, APPETITE, V71, P32, DOI 10.1016/j.appet.2013.07.008; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; Lyke JA, 2004, INT J EAT DISORDER, V36, P229, DOI 10.1002/eat.20025; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Meule A, 2011, EAT BEHAV, V12, P152, DOI 10.1016/j.eatbeh.2011.01.006; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Nederkoorn C, 2004, PERS INDIV DIFFER, V37, P1651, DOI 10.1016/j.paid.2004.02.020; Nederkoorn C, 2009, INT J OBESITY, V33, P905, DOI 10.1038/ijo.2009.98; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Nederkoorn C, 2006, APPETITE, V47, P253, DOI 10.1016/j.appet.2006.05.008; Nicola SM, 2005, NEUROSCIENCE, V135, P1025, DOI 10.1016/j.neuroscience.2005.06.088; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Rolls ET, 2006, PHILOS T R SOC B, V361, P1123, DOI 10.1098/rstb.2006.1852; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sellitto M, 2010, J NEUROSCI, V30, P16429, DOI 10.1523/JNEUROSCI.2516-10.2010; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Speakman JR, 2012, DIS MODEL MECH, V5, P569, DOI 10.1242/dmm.010553; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; van den Berg L, 2011, INT J OBESITY, V35, P1301, DOI 10.1038/ijo.2011.116; Van den Eynde F, 2012, J CLIN EXP NEUROPSYC, V34, P67, DOI 10.1080/13803395.2011.621891; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Wiederman MW, 1996, INT J EAT DISORDER, V20, P359, DOI 10.1002/(SICI)1098-108X(199612)20:4<359::AID-EAT3>3.0.CO;2-M; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Yeomans MR, 2008, APPETITE, V50, P469, DOI 10.1016/j.appet.2007.10.002; Zeeb FD, 2010, PSYCHOPHARMACOLOGY, V211, P87, DOI 10.1007/s00213-010-1871-2	62	25	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0137626	10.1371/journal.pone.0137626	http://dx.doi.org/10.1371/journal.pone.0137626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS0RH	26378459	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000361769400020
J	Eshoo, MW; Carolan, HE; Massire, C; Chou, DM; Crowder, CD; Rounds, MA; Phillipson, CA; Schutzer, SE; Ecker, DJ				Eshoo, Mark W.; Carolan, Heather E.; Massire, Christian; Chou, Danny M.; Crowder, Chris D.; Rounds, Megan A.; Phillipson, Curtis A.; Schutzer, Steven E.; Ecker, David J.			Survey of Ixodes pacificus Ticks in California Reveals a Diversity of Microorganisms and a Novel and Widespread Anaplasmataceae Species	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; CANDIDATUS NEOEHRLICHIA-MIKURENSIS; BURGDORFERI SENSU-LATO; BORRELIA-BURGDORFERI; PHYLOGENETIC ANALYSIS; RAPID IDENTIFICATION; LYME-DISEASE; INFECTION; EHRLICHIA; PATHOGENS	Ixodes pacificus ticks can harbor a wide range of human and animal pathogens. To survey the prevalence of tick-borne known and putative pathogens, we tested 982 individual adult and nymphal I. pacificus ticks collected throughout California between 2007 and 2009 using a broad-range PCR and electrospray ionization mass spectrometry (PCR/ESI-MS) assay designed to detect a wide range of tick-borne microorganisms. Overall, 1.4% of the ticks were found to be infected with Borrelia burgdorferi, 2.0% were infected with Borrelia miyamotoi and 0.3% were infected with Anaplasma phagocytophilum. In addition, 3.0% were infected with Babesia odocoilei. About 1.2% of the ticks were co-infected with more than one pathogen or putative pathogen. In addition, we identified a novel Anaplasmataceae species that we characterized by sequencing of its 16S rRNA, groEL, gltA, and rpoB genes. Sequence analysis indicated that this organism is phylogenetically distinct from known Anaplasma species with its closest genetic near neighbors coming from Asia. The prevalence of this novel Anaplasmataceae species was as high as 21% at one site, and it was detected in 4.9% of ticks tested statewide. Based upon this genetic characterization we propose that this organism be called 'Candidatus Cryptoplasma californiense'. Knowledge of this novel microbe will provide awareness for the community about the breadth of the I. pacificus microbiome, the concept that this bacterium could be more widely spread; and an opportunity to explore whether this bacterium also contributes to human or animal disease burden.	[Eshoo, Mark W.; Carolan, Heather E.; Massire, Christian; Chou, Danny M.; Crowder, Chris D.; Rounds, Megan A.; Phillipson, Curtis A.; Ecker, David J.] Ibis Biosci, Carlsbad, CA 92008 USA; [Schutzer, Steven E.] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Eshoo, MW (corresponding author), Ibis Biosci, Carlsbad, CA 92008 USA.	mark.eshoo@abbott.com		Ecker, David/0000-0003-4350-9037	National Institutes of Health [2R44AI077156]; Abbott; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI077156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott(Abbott Laboratories); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant number 2R44AI077156 and Abbott.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; BURGDORFER W, 1985, AM J TROP MED HYG, V34, P925, DOI 10.4269/ajtmh.1985.34.925; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Crowder CD, 2014, EMERG INFECT DIS, V20, P1678, DOI 10.3201/eid2010.131583; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Crowder CD, 2010, J MED ENTOMOL, V47, P89, DOI 10.1603/033.047.0112; Crowder CD, 2012, AM J VET RES, V73, P854, DOI 10.2460/ajvr.73.6.854; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Duncan DD, 2013, LETT APPL MICROBIOL, V56, P128, DOI 10.1111/lam.12022; Ecker D, 2006, J ASS LAB AUTOM, P341; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; Eshoo MW, 2014, VECTOR-BORNE ZOONOT, V14, P584, DOI 10.1089/vbz.2013.1498; Eshoo MW, 2013, EXPERT REV MOL DIAGN, V13, P875, DOI 10.1586/14737159.2013.850418; Eshoo MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036825; Eshoo MW, 2010, J CLIN MICROBIOL, V48, P472, DOI 10.1128/JCM.01669-09; Fritzen C, 2014, J PARASITOL, V100, P106, DOI 10.1645/12-158.1; Grant-Klein RJ, 2010, MOL CELL PROBE, V24, P219, DOI 10.1016/j.mcp.2010.04.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Inokuma H, 2001, J CLIN MICROBIOL, V39, P3031, DOI 10.1128/JCM.39.9.3031-3039.2001; Jiang J, 2005, ANN NY ACAD SCI, V1063, P337, DOI 10.1196/annals.1355.054; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Lane RS, 2013, TICKS TICK-BORNE DIS, V4, P377, DOI 10.1016/j.ttbdis.2013.02.005; Lane RS, 2010, TICKS TICK-BORNE DIS, V1, P159, DOI 10.1016/j.ttbdis.2010.09.004; LANE RS, 1991, J MED ENTOMOL, V28, P719, DOI 10.1093/jmedent/28.5.719; Li H, 2015, LANCET INFECT DIS, V15, P663, DOI 10.1016/S1473-3099(15)70051-4; Marques A, 2014, CLIN INFECT DIS, V58, P937, DOI 10.1093/cid/cit939; 오재영, 2009, Journal of Bacteriology and Virology, V39, P257; MURRAY RGE, 1995, INT J SYST BACTERIOL, V45, P186, DOI 10.1099/00207713-45-1-186; Naitou H, 2006, MICROBIOL IMMUNOL, V50, P45, DOI 10.1111/j.1348-0421.2006.tb03769.x; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Palomar AM, 2012, TICKS TICK-BORNE DIS, V3, P318, DOI 10.1016/j.ttbdis.2012.10.025; Pattullo KM, 2013, J VET DIAGN INVEST, V25, P535, DOI 10.1177/1040638713491746; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Reis C, 2011, VECTOR-BORNE ZOONOT, V11, P907, DOI 10.1089/vbz.2010.0103; Rounds MA, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.49; Rounds MA, 2012, J MED ENTOMOL, V49, P843, DOI 10.1603/ME12038; Rudenko N, 2009, J CLIN MICROBIOL, V47, P3875, DOI 10.1128/JCM.01050-09; Sampath R, 2005, EMERG INFECT DIS, V11, P373, DOI 10.3201/eid1103.040629; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Sarih MH, 2005, J CLIN MICROBIOL, V43, P1127, DOI 10.1128/JCM.43.3.1127-1132.2005; Schoelkopf L, 2005, J WILDLIFE DIS, V41, P683, DOI 10.7589/0090-3558-41.4.683; Stefancikova A, 2008, FOLIA MICROBIOL, V53, P493, DOI 10.1007/s12223-008-0077-z; Steiner FE, 2006, J MED ENTOMOL, V43, P437, DOI 10.1603/0022-2585(2006)043[0437:DOAPAB]2.0.CO;2; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; TULLY JG, 1995, INT J SYST BACTERIOL, V45, P23, DOI 10.1099/00207713-45-1-23; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Whitehouse CA, 2012, LETT APPL MICROBIOL, V54, P313, DOI 10.1111/j.1472-765X.2012.03214.x; Ybanez AP, 2014, J VET MED SCI, V76, P307, DOI 10.1292/jvms.13-0411	53	32	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0135828	10.1371/journal.pone.0135828	http://dx.doi.org/10.1371/journal.pone.0135828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375033	Green Submitted, Green Published, gold			2022-12-26	WOS:000361610200008
J	Mambres, DH; Machelart, A; Vanderwinden, JM; De Trez, C; Ryffel, B; Letesson, JJ; Muraille, E				Mambres, Delphine Hanot; Machelart, Arnaud; Vanderwinden, Jean-Marie; De Trez, Carl; Ryffel, Bernhard; Letesson, Jean-Jacques; Muraille, Eric			In Situ Characterization of Splenic Brucella melitensis Reservoir Cells during the Chronic Phase of Infection in Susceptible Mice	PLOS ONE			English	Article							DENDRITIC CELLS; MACROPHAGE POLARIZATION; ABORTUS INFECTION; FOAMY MACROPHAGES; EXPRESSION; ARGINASE; TH2; CHOLESTEROL; METABOLISM; GRANULOMAS	Brucella are facultative intracellular Gram-negative coccobacilli that chronically infect humans as well as domestic and wild-type mammals, and cause brucellosis. Alternatively activated macrophages (M2a) induced by IL-4/IL-13 via STAT6 signaling pathways have been frequently described as a favorable niche for long-term persistence of intracellular pathogens. Based on the observation that M2a-like macrophages are induced in the spleen during the chronic phase of B. abortus infection in mice and are strongly infected in vitro, it has been suggested that M2a macrophages could be a potential in vivo niche for Brucella. In order to test this hypothesis, we used a model in which infected cells can be observed directly in situ and where the differentiation of M2a macrophages is favored by the absence of an IL-12-dependent Th1 response. We performed an in situ analysis by fluorescent microscopy of the phenotype of B. melitensis infected spleen cells from intranasally infected IL-12p40(-/-) BALB/c mice and the impact of STAT6 deficiency on this phenotype. Most of the infected spleen cells contained high levels of lipids and expressed CD11c and CD205 dendritic cell markers and Arginase1, but were negative for the M2a markers Fizz1 or CD301. Furthermore, STAT6 deficiency had no effect on bacterial growth or the reservoir cell phenotype in vivo, leading us to conclude that, in our model, the infected cells were not Th2-induced M2a macrophages. This characterization of B. melitensis reservoir cells could provide a better understanding of Brucella persistence in the host and lead to the design of more efficient therapeutic strategies.	[Mambres, Delphine Hanot; Machelart, Arnaud; Letesson, Jean-Jacques; Muraille, Eric] Univ Namur, Lab Immunol & Microbiol, Unite Rech Biol Microorganismes, Namur, Belgium; [Vanderwinden, Jean-Marie] Univ Libre Bruxelles, Neurophysiol Lab, Brussels, Belgium; [De Trez, Carl] Vrije Univ Brussel, Vlaams Interuniv Inst Biotechnol, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Ryffel, Bernhard] CNRS, UMR7355, F-45071 Orleans, France; [Ryffel, Bernhard] Univ Orleans, Expt & Mol Immunol & Neurogenet, Orleans, France; [Ryffel, Bernhard] IDM, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Muraille, Eric] Univ Libre Bruxelles, Parasitol Lab, Brussels, Belgium	University of Namur; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Cape Town; Universite Libre de Bruxelles	Muraille, E (corresponding author), Univ Namur, Lab Immunol & Microbiol, Unite Rech Biol Microorganismes, Namur, Belgium.	emuraille@hotmail.com	Jean-Jacques, LETESSON/AHB-6921-2022; Machelart, Arnaud/L-3539-2019; Mrl, Eric/ABC-5458-2021	Machelart, Arnaud/0000-0002-4444-0011; Muraille, Eric/0000-0003-1250-5228; LETESSON, Jean-Jacques/0000-0002-5838-0224; De Trez, Carl/0000-0002-3899-1968	Fonds National de la Recherche Scientifique (FNRS) (Belgium) [FRSM FNRS 3.4.600.06.F]; Communaute Francaise de Belgique (Action de Recherches Concertees) [08/13-015]; Belgian Science Policy Office; Agence Nationale pour la Recherche [ANR 2007 MIME-103-02]; "Fondation pour la Recherche Medicale" (FRM allergy) [DAL 2007 0822007]; "Fonds Europeen de Developpement Regional" (FEDER Asthme) [1575-32168]; Le Studium, Orleans; FRS-FNRS (Belgium); FRIA (Belgium); Interuniversity Attraction Poles Programme	Fonds National de la Recherche Scientifique (FNRS) (Belgium)(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique (Action de Recherches Concertees); Belgian Science Policy Office(Belgian Federal Science Policy Office); Agence Nationale pour la Recherche(French National Research Agency (ANR)); "Fondation pour la Recherche Medicale" (FRM allergy); "Fonds Europeen de Developpement Regional" (FEDER Asthme); Le Studium, Orleans; FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); FRIA (Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office)	This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS) (convention FRSM FNRS 3.4.600.06.F, Belgium), Communaute Francaise de Belgique (Action de Recherches Concertees 08/13-015) and by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. E.M. is a Research Associate from the FRS-FNRS (Belgium). B.R. is supported by the "Agence Nationale pour la Recherche" (ANR 2007 MIME-103-02), "Fondation pour la Recherche Medicale" (FRM allergy DAL 2007 0822007), "Fonds Europeen de Developpement Regional" (FEDER Asthme 1575-32168) and Le Studium, Orleans (BR). D.H.M. holds PhD grants from the FRS-FNRS (Belgium). A.M. holds PhD grants from the FRIA (Belgium).	Archambaud C, 2010, EUR J IMMUNOL, V40, P3458, DOI 10.1002/eji.201040497; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Caire-Brandli I, 2014, INFECT IMMUN, V82, P476, DOI 10.1128/IAI.01196-13; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Copin R, 2007, J IMMUNOL, V178, P5182, DOI 10.4049/jimmunol.178.8.5182; Copin R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002575; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Eisele NA, 2013, CELL HOST MICROBE, V14, P171, DOI 10.1016/j.chom.2013.07.010; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048; Eng TR, 1989, PREV VET MED, V7, P311, DOI [10.1016/0167-5877(89)90014-7, DOI 10.1016/0167-5877(89)90014-7]; Ferrero MC, 2014, INFECT IMMUN, V82, P626, DOI 10.1128/IAI.01237-13; Grandl M, 2010, CYTOM PART A, V77A, P231, DOI 10.1002/cyto.a.20828; Hasko G, 2000, SHOCK, V14, P144, DOI 10.1097/00024382-200014020-00012; Hespel C, 2012, EUR J IMMUNOL, V42, P2535, DOI 10.1002/eji.201242480; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Iniesta V, 2002, PARASITE IMMUNOL, V24, P113, DOI 10.1046/j.1365-3024.2002.00444.x; Jablonska J, 2007, INFECT IMMUN, V75, P462, DOI 10.1128/IAI.00443-06; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kiss M, 2013, J ALLERGY CLIN IMMUN, V132, P264, DOI 10.1016/j.jaci.2013.05.044; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Maya-Monteiro CM, 2008, J BIOL CHEM, V283, P2203, DOI 10.1074/jbc.M706706200; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027; Oliveira SC, 2011, EXPERT REV VACCINES, V10, P1291, DOI [10.1586/erv.11.110, 10.1586/ERV.11.110]; Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873; Pei JW, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00115; Pessanha AP, 2012, FEMS IMMUNOL MED MIC, V66, P265, DOI 10.1111/j.1574-695X.2012.01012.x; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Rodriguez-Sosa M, 2002, J IMMUNOL, V168, P3135, DOI 10.4049/jimmunol.168.7.3135; Ronneau S, 2016, CRIT REV MICROBIOL, V42, P507, DOI 10.3109/1040841X.2014.962480; Santos RL, 2011, J BIOMED BIOTECHNOL, V2011; Sathe P, 2008, MUCOSAL IMMUNOL, V1, P425, DOI 10.1038/mi.2008.56; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Takeda K, 1996, J IMMUNOL, V157, P3220; Vitry MA, 2012, INFECT IMMUN, V80, P4271, DOI 10.1128/IAI.00761-12; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Watarai M, 2002, INFECT IMMUN, V70, P4818, DOI 10.1128/IAI.70.9.4818-4825.2002; Xavier MN, 2013, CELL HOST MICROBE, V14, P159, DOI 10.1016/j.chom.2013.07.009; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759	52	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137835	10.1371/journal.pone.0137835	http://dx.doi.org/10.1371/journal.pone.0137835			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376185	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200056
J	Marton, J; Albert, D; Wiltshire, SA; Park, R; Bergen, A; Qureshi, S; Malo, D; Burelle, Y; Vidal, SM				Marton, Jennifer; Albert, Danica; Wiltshire, Sean A.; Park, Robin; Bergen, Arthur; Qureshi, Salman; Malo, Danielle; Burelle, Yan; Vidal, Silvia M.			Cyclosporine A Treatment Inhibits Abcc6-Dependent Cardiac Necrosis and Calcification following Coxsackievirus B3 Infection in Mice	PLOS ONE			English	Article							CAUSE PSEUDOXANTHOMA ELASTICUM; VIRAL MYOCARDITIS; CELL-DEATH; PERMEABILITY TRANSITION; B3-INDUCED MYOCARDITIS; ABCC6; VIRUS; APOPTOSIS; MOUSE; GENE	Coxsackievirus type B3 (CVB3) is a cardiotropic enterovirus. Infection causes cardiomyocyte necrosis and myocardial inflammation. The damaged tissue that results is replaced with fibrotic or calcified tissue, which can lead to permanently altered cardiac function. The extent of pathogenesis among individuals exposed to CVB3 is dictated by a combination of host genetics, viral virulence, and the environment. Here, we aimed to identify genes that modulate cardiopathology following CVB3 infection. 129S1 mice infected with CVB3 developed increased cardiac pathology compared to 129X1 substrain mice despite no difference in viral burden. Linkage analysis identified a major locus on chromosome 7 (LOD: 8.307, P<0.0001) that controlled the severity of cardiac calcification and necrosis following infection. Sub-phenotyping and genetic complementation assays identified Abcc6 as the underlying gene. Microarray expression profiling identified genotype-dependent regulation of genes associated with mitochondria. Electron microscopy examination showed elevated deposition of hydroxyapatite-like material in the mitochondrial matrices of infected Abcc6 knockout (Abcc6-/-) mice but not in wildtype littermates. Cyclosporine A (CsA) inhibits mitochondrial permeability transition pore opening by inhibiting cyclophilin D (CypD). Treatment of Abcc6 -/- mice with CsA reduced cardiac necrosis and calcification by more than half. Furthermore, CsA had no effect on the CVB3-induced phenotype of doubly deficient CypD-/-Abcc6-/- mice. Altogether, our work demonstrates that mutations in Abcc6 render mice more susceptible to cardiac calcification following CVB3 infection. Moreover, we implicate CypD in the control of cardiac necrosis and calcification in Abcc6-deficient mice, whereby CypD inhibition is required for cardioprotection.	[Marton, Jennifer; Albert, Danica; Wiltshire, Sean A.; Park, Robin; Malo, Danielle; Vidal, Silvia M.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Marton, Jennifer; Albert, Danica; Wiltshire, Sean A.; Park, Robin; Malo, Danielle; Vidal, Silvia M.] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada; [Bergen, Arthur] Netherlands Inst Neurosci, Dept Ophthalmogenet, Amsterdam, Netherlands; [Qureshi, Salman] McGill Univ, Ctr Host Resistance, Montreal, PQ, Canada; [Qureshi, Salman] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Burelle, Yan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); McGill University; McGill University; Universite de Montreal	Vidal, SM (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	silvia.vidal@mcgill.ca	Burelle, Yan/AAF-8104-2021	Burelle, Yan/0000-0001-9379-146X; Park, Robin/0000-0002-3004-3285; Bergen, Arthur/0000-0002-6333-9576; Malo, Danielle/0000-0003-3980-6610	Canadian Institutes of Health Research [MOP-86592, HSD-63192]; Fonds de Recherche en Sante du Quebec; Tier 1 Canada Research Chair in Host Responses to Virus Infections	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Tier 1 Canada Research Chair in Host Responses to Virus Infections	These studies were supported by the Canadian Institutes of Health Research grants MOP-86592 and HSD-63192: http://www.cihr-irsc.gc.ca/. J.M. is supported by the Fonds de Recherche en Sante du Quebec: http://www.frqs.gouv.qc.ca/. S.M.V. is supported by a Tier 1 Canada Research Chair in Host Responses to Virus Infections: http://www.chairs-chaires.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherrahrou Z, 2008, J BIOL CHEM, V283, P7608, DOI 10.1074/jbc.M708290200; Aly M, 2007, GENES IMMUN, V8, P193, DOI 10.1038/sj.gene.6364374; Aziz KU, 2010, CARDIOL YOUNG, V20, P509, DOI 10.1017/S1047951110000594; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barnabei MS, 2010, PHYSIOL GENOMICS, V42A, P103, DOI 10.1152/physiolgenomics.00071.2010; Belinsky MG, 2002, CANCER RES, V62, P6172; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Calandria C, 2004, VIRUS RES, V104, P39, DOI 10.1016/j.virusres.2004.02.042; Chau DHW, 2007, APOPTOSIS, V12, P513, DOI 10.1007/s10495-006-0013-0; Cox KL, 1996, CLIN INVEST MED, V19, P389; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; ESTRIN M, 1987, EUR HEART J, V8, P259, DOI 10.1093/eurheartj/8.suppl_J.259; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Flisiak R, 2010, EXPT CLIN HEPATOLOGY, V6, P11; Gorgels TGMF, 2005, HUM MOL GENET, V14, P1763, DOI 10.1093/hmg/ddi183; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; HERZUM M, 1991, EUR HEART J, V12, P200, DOI 10.1093/eurheartj/12.suppl_D.200; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Jensen KJ, 2013, CELL HOST MICROBE, V13, P67, DOI 10.1016/j.chom.2012.11.009; Jiang QJ, 2010, AM J PATHOL, V176, P1855, DOI 10.2353/ajpath.2010.090983; Jiang QJ, 2009, J INVEST DERMATOL, V129, P348, DOI 10.1038/jid.2008.212; KAWAI C, 1978, JPN CIRC J, V42, P43, DOI 10.1253/jcj.42.43; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; Marcil M, 2006, AM J PHYSIOL-HEART C, V290, pH1549, DOI 10.1152/ajpheart.00913.2005; Martin LJ, 2012, CIRC RES, V111, P516, DOI 10.1161/CIRCRESAHA.112.276667; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; Matsuzaki Y, 2005, J INVEST DERMATOL, V125, P900, DOI 10.1111/j.0022-202X.2005.23897.x; MCCAFFREY FM, 1991, AM J DIS CHILD, V145, P177, DOI 10.1001/archpedi.1991.02160020069020; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Mungrue IN, 2011, ARTERIOSCL THROM VAS, V31, P2806, DOI 10.1161/ATVBAHA.111.237420; Nguyen TTM, 2013, CIRC RES, V113, P1308, DOI 10.1161/CIRCRESAHA.113.301867; OCONNELL JB, 1986, CIRCULATION, V73, P353, DOI 10.1161/01.CIR.73.2.353; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ruf Nico, 2005, Hum Mutat, V25, P98, DOI 10.1002/humu.9297; Schrader J, 2011, NEW ENGL J MED, V364, P1578, DOI 10.1056/NEJMc1102515; Si XN, 2005, J VIROL, V79, P8014, DOI 10.1128/JVI.79.13.8014-8023.2005; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Wiltshire SA, 2011, J IMMUNOL, V186, P6398, DOI 10.4049/jimmunol.1100159; WOLFGRAM LJ, 1986, J IMMUNOL, V136, P1846; Yajima T, 2011, FUTURE MICROBIOL, V6, P551, DOI [10.2217/FMB.11.40, 10.2217/fmb.11.40]; Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022; Zhang HFM, 2010, J VIROL, V84, P8446, DOI 10.1128/JVI.01416-09	54	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138222	10.1371/journal.pone.0138222	http://dx.doi.org/10.1371/journal.pone.0138222			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375467	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200089
J	Pedersen, PJ; Thomsen, KB; Olander, ER; Hauser, F; Tejada, MD; Poulsen, KL; Grubb, S; Buhl, R; Calloe, K; Klaerke, DA				Pedersen, Philip Juul; Thomsen, Kirsten Brolin; Olander, Emma Rie; Hauser, Frank; Tejada, Maria de los Angeles; Poulsen, Kristian Lundgaard; Grubb, Soren; Buhl, Rikke; Calloe, Kirstine; Klaerke, Dan Arne			Molecular Cloning and Functional Expression of the Equine K+ Channel K(V)11.1 (Ether a Go-Go-Related/KCNH2 Gene) and the Regulatory Subunit KCNE2 from Equine Myocardium	PLOS ONE			English	Article							LONG QT SYNDROME; POTASSIUM CHANNELS; SUDDEN-DEATH; HERG; RECTIFIER; PROTEIN; FAMILY; KCNQ1; TRAFFICKING; MODULATION	The KCNH2 and KCNE2 genes encode the cardiac voltage-gated K+ channel K(V)11.1 and its auxiliary beta subunit KCNE2. K(V)11.1 is critical for repolarization of the cardiac action potential. In humans, mutations or drug therapy affecting the K(V)11.1 channel are associated with prolongation of the QT intervals on the ECG and increased risk of ventricular tachyarrhythmia and sudden cardiac death-conditions known as congenital or acquired Long QT syndrome (LQTS), respectively. In horses, sudden, unexplained deaths are a well-known problem. We sequenced the cDNA of the KCNH2 and KCNE2 genes using RACE and conventional PCR on mRNA purified from equine myocardial tissue. Equine K(V)11.1 and KCNE2 cDNA had a high homology to human genes (93 and 88%, respectively). Equine and human K(V)11.1 and K(V)11.1/KCNE2 were expressed in Xenopus laevis oocytes and investigated by two-electrode voltage-clamp. Equine K(V)11.1 currents were larger compared to human K(V)11.1, and the voltage dependence of activation was shifted to more negative values with V-1/2 = -14.2 +/- 1.1 mV and -17.3 +/- 0.7, respectively. The onset of inactivation was slower for equine K(V)11.1 compared to the human homolog. These differences in kinetics may account for the larger amplitude of the equine current. Furthermore, the equine K(V)11.1 channel was susceptible to pharmacological block with terfenadine. The physiological importance of K(V)11.1 was investigated in equine right ventricular wedge preparations. Terfenadine prolonged action potential duration and the effect was most pronounced at slow pacing. In conclusion, these findings indicate that horses could be disposed to both congenital and acquired LQTS.	[Pedersen, Philip Juul; Thomsen, Kirsten Brolin; Olander, Emma Rie; Tejada, Maria de los Angeles; Poulsen, Kristian Lundgaard; Grubb, Soren; Calloe, Kirstine; Klaerke, Dan Arne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg C, Denmark; [Hauser, Frank] Univ Copenhagen, Fac Sci, Dept Biol, Ctr Funct & Comparat Insect Genom, Copenhagen, Denmark; [Buhl, Rikke] Univ Copenhagen, Fac Hlth & Med Sci, Dept Large Anim Sci, Taastrup, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Calloe, K (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg C, Denmark.	kirstinec@sund.ku.dk	Calloe, Kirstine/H-8643-2016; Hauser, Frank/M-2952-2014	Calloe, Kirstine/0000-0002-1777-7938; Hauser, Frank/0000-0001-5563-2345; Grubb, Soren/0000-0002-6710-9655; Buhl, Rikke/0000-0002-8201-0186	Foreningen Kustos af 1881; Danish Strategic Research Foundation; Fraenkel Foundation; Medical Research Council; Lundbeck Foundation; National Danish Foundation for Advanced Technology	Foreningen Kustos af 1881; Danish Strategic Research Foundation(Danske Strategiske Forskningsrad (DSF)); Fraenkel Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); National Danish Foundation for Advanced Technology	Work in the authors' labs was funded by grants from Foreningen Kustos af 1881, the Danish Strategic Research Foundation, the Fraenkel Foundation, the Medical Research Council, the Lundbeck Foundation and the National Danish Foundation for Advanced Technology.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Buhl R, 2013, J EQUINE VET SCI, V33, P590, DOI 10.1016/j.jevs.2012.09.009; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Eldstrom J, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002092; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Finley MR, 2003, J VET INTERN MED, V17, P473, DOI 10.1892/0891-6640(2003)017&lt;0473:SAFBFT&gt;2.3.CO;2; Finley MR, 2002, AM J PHYSIOL-HEART C, V283, pH126, DOI 10.1152/ajpheart.00622.2001; Grunnet M, 2001, PFLUG ARCH EUR J PHY, V441, P544, DOI 10.1007/s004240000447; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Jonsson MKB, 2012, J MOL CELL CARDIOL, V53, P369, DOI 10.1016/j.yjmcc.2012.06.011; Kallergis EM, 2012, SCI WORLD J, DOI 10.1100/2012/212178; Kamiya K, 2008, J PHARMACOL SCI, V108, P301, DOI 10.1254/jphs.08102FP; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Ke Y, 2014, J BIOL CHEM, V289, P13782, DOI 10.1074/jbc.M113.531277; Kiryu K, 1999, J VET MED SCI, V61, P921, DOI 10.1292/jvms.61.921; Larsen AP, 2010, PFLUG ARCH EUR J PHY, V460, P803, DOI 10.1007/s00424-010-0855-8; Liu WL, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9085; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lyle CH, 2011, EQUINE VET J, V43, P324, DOI 10.1111/j.2042-3306.2010.00164.x; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Pedersen PJ, 2013, J VET CARDIOL, V15, P23, DOI 10.1016/j.jvc.2012.08.002; Pedersen PJ, 2014, J VET CARDIOL OFF J; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; Rosati B, 2008, PHYSIOL GENOMICS, V35, P262, DOI 10.1152/physiolgenomics.00159.2007; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Saenen JB, 2006, BIOPHYS J, V91, P4381, DOI 10.1529/biophysj.106.087247; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Stoebner R, 2012, CURR SPORT MED REP, V11, P70, DOI 10.1249/JSR.0b013e31824cf347; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Ware WA, 2015, J VET INTERN MED, V29, P561, DOI 10.1111/jvim.12550; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weerapura M, 2002, J PHYSIOL-LONDON, V540, P15, DOI 10.1113/jphysiol.2001.013296; Zhang M, 2012, AM J PHYSIOL-HEART C, V302, pH910, DOI 10.1152/ajpheart.00691.2011	46	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138320	10.1371/journal.pone.0138320	http://dx.doi.org/10.1371/journal.pone.0138320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376488	Green Submitted, Green Published, gold			2022-12-26	WOS:000361610200098
J	Wang, QQ; Zhang, W; Yang, RD; Huang, YX; Zhang, L; Ning, PS; Cheng, XJ; Schwebel, DC; Hu, GQ; Yao, HY				Wang, Qiqi; Zhang, Wei; Yang, Rendong; Huang, Yuanxiu; Zhang, Lin; Ning, Peishan; Cheng, Xunjie; Schwebel, David C.; Hu, Guoqing; Yao, Hongyan			Common Traffic Violations of Bus Drivers in Urban China: An Observational Study	PLOS ONE			English	Article							ACCIDENTS; BEHAVIOR; MODEL; FLOW	Objective To report common traffic violations in bus drivers and the factors that influence those violations in urban China. Methods We conducted an observational study to record three types of traffic violations among bus drivers in Changsha City, China: illegal stopping at bus stations, violating traffic light signals, and distracted driving. The behaviors of bus drivers on 32 routes (20% of bus routes in the city) were observed. A two-level Poisson regression examined factors that predicted bus driver violations. Results The incidence of illegal stopping at bus stations was 20.2%. Illegal stopping was less frequent on weekends, sunny days, and at stations with cameras, with adjusted incidence rate ratios (IRRs) of 0.81, 0.65 and 0.89, respectively. The incidence of violating traffic light signals was 2.2%, and was lower on cloudy than sunny days (adjusted IRR: 0.60). The incidence of distracted driving was 3.3%. The incidence of distracted driving was less common on cloudy days, rainy or snowy days, and foggy/windy/dusty days compared to sunny days, with adjusted IRRs of 0.54, 0.55 and 0.07, respectively. Conclusion Traffic violations are common in bus drivers in urban China and they are associated with the date, weather, and presence of traffic cameras at bus station. Further studies are recommended to understand the behavioral mechanisms that may explain bus driver violations and to develop feasible prevention measures.	[Wang, Qiqi; Yao, Hongyan] Chinese Ctr Dis Control & Prevent, Off Epidemiol, Beijing, Peoples R China; [Zhang, Wei; Yang, Rendong; Zhang, Lin; Ning, Peishan; Cheng, Xunjie; Hu, Guoqing] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Huang, Yuanxiu] Changsha Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, Coll Arts & Sci, Birmingham, AL 35294 USA	Chinese Center for Disease Control & Prevention; Central South University; University of Alabama System; University of Alabama Birmingham	Hu, GQ (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	huguoqing009@gmail.com; yaohy@chinacdc.cn	Schwebel, David/GXH-9944-2022	Hu, Guoqing/0000-0002-5002-8015				Aeron-Thomas AS, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003862.pub2; Edwards J. B., 1999, TRANSPORT RES F-TRAF, V2, P1, DOI [10.1016/S1369-8478(99)00003-0, DOI 10.1016/S1369-8478(99)00003-0]; Gao GF, 2005, P 4 AS PAC TRANSP SU, P637; Levine N, 1995, ACCIDENT ANAL PREV, V27, P785, DOI 10.1016/0001-4575(95)00038-0; Li H., 2010, THESIS CENTRAL S U; Ministry of Transport of PRC, STAT B TRANSP DEV CH; Mirza S, 1999, ACCIDENT ANAL PREV, V31, P329, DOI 10.1016/S0001-4575(98)00025-6; SATTERTHWAITE SP, 1976, ACCIDENT ANAL PREV, V8, P87, DOI 10.1016/0001-4575(76)90002-6; Sharma S, 2015, PHYSICA A, V421, P401, DOI 10.1016/j.physa.2014.11.003; Tang TQ, 2014, PHYSICA A, V413, P583, DOI 10.1016/j.physa.2014.07.035; Tang TQ, 2012, COMMUN THEOR PHYS, V58, P583, DOI 10.1088/0253-6102/58/4/24; Tang TQ, 2012, NONLINEAR DYNAM, V67, P2255, DOI 10.1007/s11071-011-0143-y; The Peoples' Government of Changsha City, ANN REP TRAFF SIT CH; Wang DQ, 2004, CHINESE J DIS CONTRO, V8, P519; World Health Organization, 2013, GLOB STAT REP ROAD S; Yan FF, 2016, ACCIDENT ANAL PREV, V95, P381, DOI 10.1016/j.aap.2015.06.006; Zeng YZ, 2015, PHYSICA A, V424, P113, DOI 10.1016/j.physa.2015.01.010; Zhang G, 2014, MOD PHYS LETT B, V28, DOI 10.1142/S0217984914501917; Zheng YL, 2006, P BEIJ INT TRAFF SAF, P216	19	8	8	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137954	10.1371/journal.pone.0137954	http://dx.doi.org/10.1371/journal.pone.0137954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372105	Green Published, gold, Green Submitted			2022-12-26	WOS:000361604400039
J	Dou, WB; Zhang, MY; Zhang, XJ; Li, Y; Chen, HY; Li, SW; Lu, M; Dai, JP; Constans, JM				Dou, Weibei; Zhang, Mingyu; Zhang, Xiaojie; Li, Yuan; Chen, Hongyan; Li, Shaowu; Lu, Min; Dai, Jianping; Constans, Jean-Marc			Convex-Envelope Based Automated Quantitative Approach to Multi-Voxel H-1-MRS Applied to Brain Tumor Analysis	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; CEREBRAL GLIOMA GRADE; NONINVASIVE EVALUATION; PREDICTIVE VALUES; DIFFUSION; TIME; QUANTIFICATION; SPECIFICITY; SENSITIVITY	Background Magnetic Resonance Spectroscopy (MRS) can measure in vivo brain tissue metabolism that exhibits unique biochemical characteristics in brain tumors. For clinical application, an efficient and versatile quantification method of MRS would be an important tool for medical research, particularly for exploring the scientific problem of tumor monitoring. The objective of our study is to propose an automated MRS quantitative approach and assess the feasibility of this approach for glioma grading, prognosis and boundary detection. Methods An automated quantitative approach based on a convex envelope (AQoCE) is proposed in this paper, including preprocessing, convex-envelope based baseline fitting, bias correction, sectional baseline removal, and peak detection, in a total of 5 steps. Some metabolic ratios acquired by this quantification are selected for statistical analysis. An independent sample t-test and the Kruskal-Wallis test are used for distinguishing low-grade gliomas (LGG) and high-grade gliomas (HGG) and for detecting the tumor, peritumoral and contralateral areas, respectively. Seventy-eight cases of pre-operative brain gliomas with pathological reports are included in this study. Results Cho/NAA, Cho/Cr and Lip-Lac/Cr (LL/Cr) calculated by AQoCE in the tumor area differ significantly between LGG and HGG, with p <= 0.005. Using logistic regression combining Cho/NAA, Cho/Cr and LL/Cr to generate a ROC curve, AQoCE achieves a sensitivity of 92.9%, a specificity of 72.2%, and an area under ROC curve (AUC) of 0.860. Moreover, both Cho/NAA and Cho/Cr in the AQoCE approach show a significant difference (p <= 0.019) between tumoral, peritumoral, and contralateral areas. The comparison between the results of AQoCE and Siemens MRS processing software are also discussed in this paper. Conclusions The AQoCE approach is an automated method of residual water removal and metabolite quantification. It can be applied to multi-voxel H-1-MRS for evaluating brain glioma grading and demonstrating characteristics of brain glioma metabolism. It can also detect infiltration in the peritumoral area. Under the limited clinical data used, AQoCE is significantly more versatile and efficient compared to the reference approach of Siemens.	[Dou, Weibei; Zhang, Xiaojie; Li, Yuan; Lu, Min] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China; [Zhang, Mingyu; Chen, Hongyan; Dai, Jianping] Capital Med Univ, Beijing Tian Tan Hosp, Dept Radiol, Beijing, Peoples R China; [Zhang, Mingyu; Li, Shaowu; Dai, Jianping] Beijing Neurosurg Inst, Beijing, Peoples R China; [Constans, Jean-Marc] Univ Hosp, Serv Neuroradiol, Amiens, France	Tsinghua University; Capital Medical University; Beijing Neurosurgical Institute; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Dou, WB (corresponding author), Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China.	douwb@tsinghua.edu.cn; daijianping_2008@126.com	Zhang, mingyu/HGB-1069-2022; Dou, Weibei/K-6044-2012	Dou, Weibei/0000-0001-8555-2776; Constans, Jean-Marc/0000-0002-6751-4378	Natural Science Foundation of China [NSFC-61171002, NSFC-60372023]; Tsinghua University Initiative Scientific Research Program [20131089382]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program	This work was supported by the Natural Science Foundation of China (NSFC-61171002 and NSFC-60372023) and Tsinghua University Initiative Scientific Research Program (Grant No. 20131089382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Brandao LA, 2004, MR SPECTROSCOPY BRAI, P91; Caseiras GB, 2010, EUR J RADIOL, V73, P215, DOI 10.1016/j.ejrad.2008.11.005; Chi P., 2011, BIOINF BIOM ENG ICBB, P1; Cudalbu C, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104034; De Edeleny FS, 2000, NAT MED, V6, P1287, DOI 10.1038/81401; Di Costanzo A, 2008, EUR RADIOL, V18, P1727, DOI 10.1007/s00330-008-0938-5; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Grams AE, 2014, OPEN J RADIOLOGY, V4, P182, DOI DOI 10.4236/0JRAD.2014.42024; Guillevin R, 2011, BRIT J CANCER, V104, P1854, DOI 10.1038/bjc.2011.174; Guillevin R, 2008, J NEURO-ONCOL, V87, P181, DOI 10.1007/s11060-007-9508-y; Guzman-De-Villoria JA, 2014, CANCER IMAGING, V14, DOI 10.1186/s40644-014-0035-8; Hlaihel C, 2010, J NEURO-ONCOL, V97, P73, DOI 10.1007/s11060-009-9991-4; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Kwock L, 2006, LANCET ONCOL, V7, P859, DOI 10.1016/S1470-2045(06)70905-6; Law M, 2003, AM J NEURORADIOL, V24, P1989; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Liu ZL, 2012, J INT MED RES, V40, P76, DOI 10.1177/147323001204000108; Majos C, 2009, EUR RADIOL, V19, P2049, DOI 10.1007/s00330-009-1357-y; McKnight TR, 2002, J NEUROSURG, V97, P794, DOI 10.3171/jns.2002.97.4.0794; Metwally LIA, 2014, EGYPT J RADIOL NUC M, V45, P211, DOI 10.1016/j.ejrnm.2013.07.004; Mierisova S, 2001, NMR BIOMED, V14, P247, DOI 10.1002/nbm.697; Nakajima T, 2009, NEUROL MED-CHIR, V49, P394, DOI 10.2176/nmc.49.394; Pedersen CL, 2013, CLIN NEUROL NEUROSUR, V115, P1, DOI 10.1016/j.clineuro.2012.07.002; Pijnappel W, 1992, J MAGN RESON, V97, P97, DOI DOI 10.1016/0022-2364(92)90241-X; Preul MC, 1996, NAT MED, V2, P323, DOI 10.1038/nm0396-323; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Ratiney H, 2004, MAGN RESON MATER PHY, V16, P284, DOI 10.1007/s10334-004-0037-9; Sahin N, 2013, NEURORADIOL J, V26, P531, DOI 10.1177/197140091302600506; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Server A, 2011, EUR J RADIOL, V80, P462, DOI 10.1016/j.ejrad.2010.07.017; Server A, 2010, ACTA RADIOL, V51, P316, DOI 10.3109/02841850903482901; Stadlbauer A, 2006, RADIOLOGY, V238, P958, DOI 10.1148/radiol.2382041896; van den Boogaart A, 1997, MAGN RESON CHEM, V35, pS146, DOI 10.1002/(SICI)1097-458X(199712)35:13<S146::AID-OMR196>3.0.CO;2-X; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; VanHuffel S, 1997, SIAM PROC S, P307; Wang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112577; Zeng QS, 2011, MAGN RESON IMAGING, V29, P25, DOI 10.1016/j.mri.2010.07.017	39	7	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137850	10.1371/journal.pone.0137850	http://dx.doi.org/10.1371/journal.pone.0137850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367871	gold, Green Submitted, Green Published			2022-12-26	WOS:000361601100154
J	Gray, EM; Diaz-Vazquez, G; Veatch, SL				Gray, Erin M.; Diaz-Vazquez, Gladys; Veatch, Sarah L.			Growth Conditions and Cell Cycle Phase Modulate Phase Transition Temperatures in RBL-2H3 Derived Plasma Membrane Vesicles	PLOS ONE			English	Article							BASOPHILIC LEUKEMIA-CELLS; LIQUID-ORDERED DOMAINS; LATERAL DIFFUSION; HISTAMINE-RELEASE; CORTICAL ACTIN; MAST-CELLS; PROTEINS; PROLIFERATION; CHOLESTEROL; CERAMIDE	Giant plasma membrane vesicle (GPMV) isolated from a flask of RBL-2H3 cells appear uniform at physiological temperatures and contain coexisting liquid-ordered and liquid-disordered phases at low temperatures. While a single GPMV transitions between these two states at a well-defined temperature, there is significant vesicle-to-vesicle heterogeneity in a single preparation of cells, and average transition temperatures can vary significantly between preparations. In this study, we explore how GPMV transition temperatures depend on growth conditions, and find that average transition temperatures are negatively correlated with average cell density over 15 degrees C in transition temperature and nearly three orders of magnitude in average surface density. In addition, average transition temperatures are reduced by close to 10 degrees C when GPMVs are isolated from cells starved of serum overnight, and elevated transition temperatures are restored when serum-starved cells are incubated in serum-containing media for 12h. We also investigated variation in transition temperature of GPMVs isolated from cells synchronized at the G1/S border through a double Thymidine block and find that average transition temperatures are systematically higher in GPMVs produced from G1 or M phase cells than in GPMVs prepared from S or G1 phase cells. Reduced miscibility transition temperatures are also observed in GPMVs prepared from cells treated with TRAIL to induce apoptosis or sphingomyelinase, and in some cases a gel phase is observed at temperatures above the miscibility transition in these vesicles. We conclude that at least some variability in GPMV transition temperature arises from variation in the local density of cells and asynchrony of the cell cycle. It is hypothesized that GPMV transition temperatures are a proxy for the magnitude of lipid-mediated membrane heterogeneity in intact cell plasma membranes at growth temperatures. If so, these results suggest that cells tune their plasma membrane composition in order to control the magnitude of membrane heterogeneity in response to different growth conditions.	[Gray, Erin M.; Diaz-Vazquez, Gladys; Veatch, Sarah L.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Veatch, SL (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.	sveatch@umich.edu	Veatch, Sarah L/G-9512-2016	Veatch, Sarah L/0000-0002-9317-2308	REU from the NSF [NSF 12-569]; NIH [R00GM87810, R01GM110052]; startup funds through the University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087810, R01GM110052] Funding Source: NIH RePORTER	REU from the NSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); startup funds through the University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GDV was supported through an REU from the NSF (NSF 12-569). Research was funded through grants from the NIH (R00GM87810 and R01GM110052) and startup funds through the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Arumugam S, 2015, BIOPHYS J, V108, P1104, DOI 10.1016/j.bpj.2014.12.050; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Chen BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049232; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Del Piccolo N, 2012, ANAL CHEM, V84, P8650, DOI [10.1021/ac301776j, 10.1021/ac301776J]; DELAAT SW, 1980, P NATL ACAD SCI-BIOL, V77, P1526; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Frechin M, 2015, NATURE, V523, P88, DOI 10.1038/nature14429; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Gniadecki R, 2004, BIOCHEM BIOPH RES CO, V320, P165, DOI 10.1016/j.bbrc.2004.05.145; Gray E, 2013, BIOPHYS J, V105, P2751, DOI 10.1016/j.bpj.2013.11.005; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3466, DOI 10.1021/bi00283a025; Honigmann A, 2014, ELIFE, V3, DOI 10.7554/eLife.01671; ISERSKY C, 1975, J EXP MED, V141, P1147, DOI 10.1084/jem.141.5.1147; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; JACOBSON K, 1984, J CELL BIOL, V99, P1624, DOI 10.1083/jcb.99.5.1624; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Jolly PS, 2005, BLOOD, V105, P4736, DOI 10.1182/blood-2004-12-4686; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental KR, 2015, METHODS MOL BIOL, V1232, P65, DOI 10.1007/978-1-4939-1752-5_6; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Machta BB, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.138101; Machta BB, 2011, BIOPHYS J, V100, P1668, DOI 10.1016/j.bpj.2011.02.029; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; MEYER C, 1983, J IMMUNOL, V131, P911; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SLOTTE JP, 1990, BIOCHIM BIOPHYS ACTA, V1030, P251, DOI 10.1016/0005-2736(90)90301-4; Sot J, 2008, FEBS LETT, V582, P3230, DOI 10.1016/j.febslet.2008.08.016; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Tserkovnyak Y, 2006, P NATL ACAD SCI USA, V103, P15002, DOI 10.1073/pnas.0606992103; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Zhao J, 2013, BIOPHYS J, V104, P825, DOI 10.1016/j.bpj.2012.12.047; Zhou Y, 2013, J BIOL CHEM, V288, P35660, DOI 10.1074/jbc.M113.519116	49	30	30	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137741	10.1371/journal.pone.0137741	http://dx.doi.org/10.1371/journal.pone.0137741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368288	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100127
J	Lee, YN; Kim, MC; Lee, YT; Hwang, HS; Lee, J; Kim, C; Kang, SM				Lee, Yu-Na; Kim, Min-Chul; Lee, Young-Tae; Hwang, Hye Suk; Lee, Jongsang; Kim, Cheol; Kang, Sang-Moo			Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; CONJUGATE VACCINES; MATRIX PROTEIN-2; FC-RECEPTOR; IMMUNOGENICITY; VACCINATION; IMMUNITY; DOMAIN; ECTODOMAIN; PARTICLES	The influenza M2 ectodomain (M2e) is well conserved across human influenza A subtypes, but there are few residue changes among avian and swine origin influenza A viruses. We expressed a tandem repeat construct of heterologous M2e sequences (M2e5x) derived from human, swine, and avian origin influenza A viruses using the yeast expression system. Intramuscular immunization of mice with AS04-adjuvanted M2e5x protein vaccines was effective in inducing M2e-specific antibodies reactive to M2e peptide and native M2 proteins on the infected cells with human, swine, or avian influenza virus, mucosal and systemic memory cellular immune responses, and cross-protection against H3N2 virus. Importantly, M2e5x immune sera were found to confer protection against different subtypes of H1N1 and H5N1 influenza A viruses in naive mice. Also, M2e5x-immune complexes of virus-infected cells stimulated macrophages to secrete cytokines via Fc receptors, indicating a possible mechanism of protection. The present study provides evidence that M2e5x proteins produced in yeast cells could be developed as a potential universal influenza vaccine.	[Lee, Yu-Na; Kim, Min-Chul; Lee, Young-Tae; Hwang, Hye Suk; Kang, Sang-Moo] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Kim, Min-Chul] Anim & Plant Quarantine Agcy, Anyang, Gyeonggi Do, South Korea; [Lee, Jongsang; Kim, Cheol] BEAMS Biotechnol Co Ltd, Seongnam, Gyeonggi Do, South Korea	University System of Georgia; Georgia State University; Animal & Plant Quarantine Agency	Kang, SM (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	skang24@gsu.edu			NIH/NIAID [AI105170, AI093772, AI119366]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105170, R01AI093772, R21AI119366] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID grants AI105170 (SMK), AI093772 (SMK), and AI119366 (SMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BEAMS Biotechnology Co. Ltd. provided support in the form of salaries for authors JL and CK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Andersson AMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046395; Boland G, 2004, VACCINE, V23, P316, DOI 10.1016/j.vaccine.2004.06.006; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Chung EY, 2006, CELL RES, V16, P154, DOI 10.1038/sj.cr.7310021; Cox MMJ, 2009, BIOLOGICALS, V37, P182, DOI 10.1016/j.biologicals.2009.02.014; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Haynes JR, 2009, VACCINE, V27, P530, DOI 10.1016/j.vaccine.2008.11.011; Heinen PP, 2002, J GEN VIROL, V83, P1851, DOI 10.1099/0022-1317-83-8-1851; Hilleman MR, 2000, VACCINE, V18, P1436, DOI 10.1016/S0264-410X(99)00434-X; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Husain M, 2014, INFECT GENET EVOL, V28, P304, DOI 10.1016/j.meegid.2014.10.016; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kim EH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-104; Kim MC, 2014, MOL THER, V22, P1364, DOI 10.1038/mt.2014.33; Kim MC, 2013, ANTIVIR RES, V99, P328, DOI 10.1016/j.antiviral.2013.06.010; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Krammer F, 2010, TRENDS MOL MED, V16, P313, DOI 10.1016/j.molmed.2010.05.002; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; Lee YN, 2014, IMMUNOLOGY, V143, P300, DOI 10.1111/imm.12310; Lee YN, 2014, VACCINE, V32, P4578, DOI 10.1016/j.vaccine.2014.06.040; Lee YN, 2011, VIROLOGY, V417, P57, DOI 10.1016/j.virol.2011.05.005; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu WL, 2005, MICROBES INFECT, V7, P171, DOI 10.1016/j.micinf.2004.10.006; Liu WL, 2004, VACCINE, V23, P366, DOI 10.1016/j.vaccine.2004.05.028; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Mancardi DA, 2008, J CLIN INVEST, V118, P3738, DOI 10.1172/JCI36452; Margine I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051559; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Park JW, 2014, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2014-1; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; Shi L, 2007, CLIN PHARMACOL THER, V81, P259, DOI 10.1038/sj.clpt.6100055; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; Sivakumar SM, 2011, SAUDI PHARM J, V19, P197, DOI 10.1016/j.jsps.2011.06.003; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Song JM, 2010, VIROLOGY, V405, P165, DOI 10.1016/j.virol.2010.05.034; Talbot HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014442; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Wong KK, 2012, J INFECT DIS, V206, pS68, DOI 10.1093/infdis/jis585; ZEBEDEE SL, 1989, NUCLEIC ACIDS RES, V17, P2870, DOI 10.1093/nar/17.7.2870; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005	62	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137822	10.1371/journal.pone.0137822	http://dx.doi.org/10.1371/journal.pone.0137822			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366729	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100147
J	Phay, M; Welzel, AT; Williams, AD; McWilliams-Koeppen, HP; Blinder, V; O'Malley, TT; Solomon, A; Walsh, DM; O'Nuallain, B				Phay, Monichan; Welzel, Alfred T.; Williams, Angela D.; McWilliams-Koeppen, Helen P.; Blinder, Veronika; O'Malley, Tiernan T.; Solomon, Alan; Walsh, Dominic M.; O'Nuallain, Brian			IgG Conformer's Binding to Amyloidogenic Aggregates	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; ALZHEIMERS-DISEASE; BETA-PROTEIN; MOUSE MODEL; HUMAN PLASMA; ANTIBODIES; PEPTIDE; RECEPTOR; VIRUS; RAGE	Amyloid-reactive IgGs isolated from pooled blood of normal individuals (pAbs) have demonstrated clinical utility for amyloid diseases by in vivo targeting and clearing amyloidogenic proteins and peptides. We now report the following three novel findings on pAb conformer's binding to amyloidogenic aggregates: 1) pAb aggregates have greater activity than monomers (HMW species > dimers > monomers), 2) pAbs interactions with amyloidogenic aggregates at least partially involves unconventional (non-CDR) interactions of F(ab) regions, and 3) pAb's activity can be easily modulated by trace aggregates generated during sample processing. Specifically, we show that HMW aggregates and dimeric pAbs present in commercial preparations of pAbs, intravenous immunoglobulin (IVIg), had up to similar to 200-and similar to 7-fold stronger binding to aggregates of A beta and transthyretin (TTR) than the monomeric antibody. Notably, HMW aggregates were primarily responsible for the enhanced anti-amyloid activities of A beta- and Cibacron blue-isolated IVIg IgGs. Human pAb conformer's binding to amyloidogenic aggregates was retained in normal human sera, and mimicked by murine pAbs isolated from normal pooled plasmas. An unconventional (non-CDR) component to pAb's activity was indicated from control human mAbs, generated against non-amyloid targets, binding to aggregated A beta and TTR. Similar to pAbs, HMW and dimeric mAb conformers bound stronger than their monomeric forms to amyloidogenic aggregates. However, mAbs had lower maximum binding signals, indicating that pAbs were required to saturate a diverse collection of binding sites. Taken together, our findings strongly support further investigations on the physiological function and clinical utility of the inherent anti-amyloid activities of monomeric but not aggregated IgGs.	[Phay, Monichan; Blinder, Veronika; O'Malley, Tiernan T.; Walsh, Dominic M.; O'Nuallain, Brian] Brigham & Womens Hosp, Harvard Inst Med, Lab Neurodegenerat Res, Boston, MA 02115 USA; [Welzel, Alfred T.; O'Nuallain, Brian] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Williams, Angela D.; McWilliams-Koeppen, Helen P.; Solomon, Alan; O'Nuallain, Brian] Univ Tennessee, Grad Sch Med, Human Immunol & Canc Program, Knoxville, TN USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University College Dublin; University of Tennessee System; University of Tennessee Health Science Center	O'Nuallain, B (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Lab Neurodegenerat Res, 75 Francis St, Boston, MA 02115 USA.	briano_nuallain@hotmail.com			Baxter BioScience (Baxter International Inc., Deerfield, IL); SENS Research Foundation	Baxter BioScience (Baxter International Inc., Deerfield, IL); SENS Research Foundation	These studies were funded by an investigator initiated research grant (IIRG) from Baxter BioScience (Baxter International Inc., Deerfield, IL) (BO), and by a research grant from the SENS Research Foundation (BO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis PW, 2014, J BIOL CHEM, V289, P7200, DOI 10.1074/jbc.M113.492215; Ahmadi M, 2015, PHARM RES-DORDR, V32, P1383, DOI 10.1007/s11095-014-1541-x; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Ballow M, 2014, CURR OPIN ALLERGY CL, V14, P509, DOI 10.1097/ACI.0000000000000116; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bevacizumab, 2005, DRUGS IN R D, V3, P28; Brannstrom K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090857; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Buchacher Andrea, 2006, Biotechnology Journal, V1, P148, DOI 10.1002/biot.200500037; BURTON DR, 1990, TRENDS BIOCHEM SCI, V15, P64, DOI 10.1016/0968-0004(90)90178-E; BURTON DR, 1985, MOL IMMUNOL, V22, P161, DOI 10.1016/0161-5890(85)90151-8; Buxbaum JN, 2012, J MOL BIOL, V421, P142, DOI 10.1016/j.jmb.2012.01.024; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeVincenzo JP, 2004, J INFECT DIS, V190, P975, DOI 10.1086/423213; DODEL R, 2010, 2010 DRUGS, V70, P513, DOI DOI 10.2165/11533070-000000000-00000; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Dolado I, 2005, J COMB CHEM, V7, P246, DOI 10.1021/cc049849s; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.X, 10.1111/j.1365-2249.2009.04022.x]; Ermolenko DN, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1233, DOI 10.1007/s10541-005-0069-4; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gever J, 2013, ALZHEIMERS DISEASE I; Giacomelli CE, 2005, MACROMOL BIOSCI, V5, P401, DOI 10.1002/mabi.200400189; Golde TE, 2009, CNS NEUROL DISORD-DR, V8, P31, DOI 10.2174/187152709787601830; Haggqvist B, 1999, P NATL ACAD SCI USA, V96, P8669, DOI 10.1073/pnas.96.15.8669; HUANG D, 1993, J NEUROIMMUNOL, V48, P199, DOI 10.1016/0165-5728(93)90192-2; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kaveri SV, 2012, AUTOIMMUN REV, V11, P792, DOI 10.1016/j.autrev.2012.02.006; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Li QY, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-22; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Loeffler DA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-70; Luo JH, 2013, CHEM COMMUN, V49, P6507, DOI 10.1039/c3cc42325e; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; Maftei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068996; Maftei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044516; Magga J, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-90; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; MCCARTHY D, 1981, J IMMUNOL METHODS, V41, P63, DOI 10.1016/0022-1759(81)90274-X; MCGEER PL, 1994, TOHOKU J EXP MED, V174, P269, DOI 10.1620/tjem.174.269; NEEPER M, 1992, J BIOL CHEM, V267, P14998; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2008, BIOCHEMISTRY-US, V47, P12254, DOI 10.1021/bi801767k; O'Nuallain B, 2006, J IMMUNOL, V176, P7071, DOI 10.4049/jimmunol.176.11.7071; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; O'Nuallain B, 2010, J CLIN IMMUNOL, V30, pS37, DOI 10.1007/s10875-010-9413-6; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paul S, 2006, IMMUNOL LETT, V103, P8, DOI 10.1016/j.imlet.2005.10.003; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2010, J CLIN IMMUNOL, V30, pS43, DOI 10.1007/s10875-010-9414-5; Phay M, 2014, REJUV RES, V17, P97, DOI 10.1089/rej.2013.1524; Pinney JH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000098; Planque SA, 2014, J BIOL CHEM, V289, P13243, DOI 10.1074/jbc.M114.557231; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; Rahman MM, 2015, ACS CHEM BIOL, V10, P766, DOI 10.1021/cb5008663; Rajagopalan K, 1996, P NATL ACAD SCI USA, V93, P6019, DOI 10.1073/pnas.93.12.6019; Rapezzi C, 2010, NAT REV CARDIOL, V7, P398, DOI 10.1038/nrcardio.2010.67; REEVES JP, 1995, HYBRIDOMA, V14, P235, DOI 10.1089/hyb.1995.14.235; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Savelieff MG, 2013, ACS CHEM BIOL, V8, P856, DOI 10.1021/cb400080f; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Seite JF, 2008, AUTOIMMUN REV, V7, P435, DOI 10.1016/j.autrev.2008.04.012; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; SILVERMAN GJ, 1995, J CLIN INVEST, V96, P417, DOI 10.1172/JCI118051; Solomon A, 2003, CANCER BIOTHER RADIO, V18, P853, DOI 10.1089/108497803322702824; Solomon B, 2007, CURR OPIN MOL THER, V9, P79; St-Amour I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-54; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008; Szabo P, 2008, AUTOIMMUN REV, V7, P415, DOI 10.1016/j.autrev.2008.03.007; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; VIDAL MA, 1980, J IMMUNOL METHODS, V35, P169, DOI 10.1016/0022-1759(80)90161-1; Wall JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052686; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Welzel AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050317; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yu Z, 2013, J PHARM SCI-US, V102, P4284, DOI 10.1002/jps.23746; Zilka N, 2008, J ALZHEIMERS DIS, V15, P169	91	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137344	10.1371/journal.pone.0137344	http://dx.doi.org/10.1371/journal.pone.0137344			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367058	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100065
J	Rout, SP; Charles, CJ; Doulgeris, C; McCarthy, AJ; Rooks, DJ; Loughnane, JP; Laws, AP; Humphreys, PN				Rout, Simon P.; Charles, Christopher J.; Doulgeris, Charalampos; McCarthy, Alan J.; Rooks, Dave J.; Loughnane, J. Paul; Laws, Andrew P.; Humphreys, Paul N.			Anoxic Biodegradation of Isosaccharinic Acids at Alkaline pH by Natural Microbial Communities	PLOS ONE			English	Article							GEN. NOV.; GLUCOISOSACCHARINIC ACID; BLACK LIQUOR; FERMENTATION; DEGRADATION; REPOSITORY; COMPLEXATION; METHANOGENS; STABILITY; CELLULOSE	One design concept for the long-term management of the UK's intermediate level radioactive wastes (ILW) is disposal to a cementitious geological disposal facility (GDF). Under the alkaline (10.0 < pH > 13.0) anoxic conditions expected within a GDF, cellulosic wastes will undergo chemical hydrolysis. The resulting cellulose degradation products (CDP) are dominated by alpha- and beta-isosaccharinic acids (ISA), which present an organic carbon source that may enable subsequent microbial colonisation of a GDF. Microcosms established from neutral, near-surface sediments demonstrated complete ISA degradation under methanogenic conditions up to pH 10.0. Degradation decreased as pH increased, with beta-ISA fermentation more heavily influenced than alpha-ISA. This reduction in degradation rate was accompanied by a shift in microbial population away from organisms related to Clostridium sporosphaeroides to a more diverse Clostridial community. The increase in pH to 10.0 saw an increase in detection of Alcaligenes aquatilis and a dominance of hydrogenotrophic methanogens within the Archaeal population. Methane was generated up to pH 10.0 with acetate accumulation at higher pH values reflecting a reduced detection of acetoclastic methanogens. An increase in pH to 11.0 resulted in the accumulation of ISA, the absence of methanogenesis and the loss of biomass from the system. This study is the first to demonstrate methanogenesis from ISA by near surface microbial communities not previously exposed to these compounds up to and including pH 10.0.	[Rout, Simon P.; Charles, Christopher J.; Doulgeris, Charalampos; Laws, Andrew P.; Humphreys, Paul N.] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [McCarthy, Alan J.; Rooks, Dave J.; Loughnane, J. Paul] Univ Liverpool, Inst Integrat Biol, Microbiol Res Grp, Liverpool L69 3BX, Merseyside, England	University of Huddersfield; University of Liverpool	Humphreys, PN (corresponding author), Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England.	p.n.humphreys@hud.ac.uk	Doulgeris, Charalampos/K-5363-2019; Doulgeris, Charalampos/Q-5016-2019	Humphreys, Paul/0000-0003-3431-7930; Rout, Simon/0000-0001-5778-6145; Doulgeris, Charalampos/0000-0002-4825-2296	EPSRC [EP/I036354/1]; Radioactive Waste Management (RWM); Natural Environment Research Council (NERC); NERC [NE/H007563/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I036354/1] Funding Source: researchfish; Natural Environment Research Council [NE/H007563/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Radioactive Waste Management (RWM); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	PH was funded by the EPSRC under grant EP/I036354/1 https://www.epsrc.ac.uk and Radioactive Waste Management (RWM) as part of the C14-BIG project. Further information regarding the C14-BIG project can be found at: www.hud.ac.uk/c14-big. The molecular ecology components of this research were supported by the Natural Environment Research Council (NERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 2006, J SOLUTION CHEM, V35, P1173, DOI 10.1007/s10953-006-9048-7; Almond M, 2012, CARBOHYD RES, V363, P51, DOI 10.1016/j.carres.2012.09.019; [Anonymous], 1999, 576681999 BSI; [Anonymous], 2005, 148532005 BSI ISO; Askarieh MM, 2000, WASTE MANAGE, V20, P93, DOI 10.1016/S0956-053X(99)00275-5; Avis J, 2014, NUCL TECHNOL, V187, P175, DOI 10.13182/NT13-83; BAILEY MJ, 1986, APPL MICROBIOL BIOT, V24, P493; Bassil NM, 2015, ISME J, V9, P310, DOI 10.1038/ismej.2014.125; Bracke G, 2008, J CONTAM HYDROL, V102, P210, DOI 10.1016/j.jconhyd.2008.09.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choung S, 2014, ANN NUCL ENERGY, V71, P6, DOI 10.1016/j.anucene.2014.03.021; Cowper M, SERCO CONTRACTORS RE; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duro L, 2014, APPL GEOCHEM, V49, P192, DOI 10.1016/j.apgeochem.2014.04.015; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Elberson MA, 1997, INT J SYST BACTERIOL, V47, P1258, DOI 10.1099/00207713-47-4-1258; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Garnova ES, 2004, EXTREMOPHILES, V8, P309, DOI 10.1007/s00792-004-0390-7; Grant WD, 2002, AEATERRA0301 U LEIC; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hsiao CL, 2009, INT J HYDROGEN ENERG, V34, P7173, DOI 10.1016/j.ijhydene.2009.06.028; Huang L, 2014, BIORESOURCE TECHNOL, V153, P87, DOI 10.1016/j.biortech.2013.11.049; Humphreys P. N., 2010, SERCOTAS002274001; Jeon BS, 2010, APPL MICROBIOL BIOT, V88, P1161, DOI 10.1007/s00253-010-2827-5; Keith-Roach MJ, 2008, SCI TOTAL ENVIRON, V396, P1, DOI 10.1016/j.scitotenv.2008.02.030; Kotelnikova S, 1998, INT J SYST BACTERIOL, V48, P357, DOI 10.1099/00207713-48-2-357; Lawson PA, 2014, INT J SYST EVOL MICR, V64, P198, DOI 10.1099/ijs.0.053728-0; Libert M, 2011, PHYS CHEM EARTH, V36, P1616, DOI 10.1016/j.pce.2011.10.010; MAESTROJUAN GM, 1991, INT J SYST BACTERIOL, V41, P267, DOI 10.1099/00207713-41-2-267; Milodowski A., 2013, HARPUR HILL SITE ITS; NDA, 2010, NEAR FIELD EV STAT R; NDA, 2011, 2010 UK RAD WAST INV; NDA, 2012, CARBON 14 PROJECT PH; NIEMELA K, 1990, J CHEM TECHNOL BIOT, V48, P17; Nolla-Ardevol V, 2012, J BIOTECHNOL, V161, P167, DOI 10.1016/j.jbiotec.2012.04.003; PEKAROVICOVA A, 1991, J CHEM TECHNOL BIOT, V52, P539; Rizk S, 1963, JOURNAL OF APPLIED B, V26, P20; Rizoulis A, 2012, MINERAL MAG, V76, P3261, DOI 10.1180/minmag.2012.076.8.39; Rizoulis A, 2016, GEOMICROBIOL J, V33, P73, DOI 10.1080/01490451.2014.961107; Rout SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107433; Rout SP, 2015, PLOS ONE, V10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaw PB, 2012, CARBOHYD RES, V349, P6, DOI 10.1016/j.carres.2011.11.022; STAMS AJM, 1984, ARCH MICROBIOL, V137, P329, DOI 10.1007/BF00410730; STRAND SE, 1984, APPL ENVIRON MICROB, V47, P268, DOI 10.1128/AEM.47.2.268-271.1984; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; Van Soest PJ, 1970, ARS USDA HDB, V379; Van Trappen S, 2005, INT J SYST EVOL MICR, V55, P2571, DOI 10.1099/ijs.0.63849-0; WANG SH, 1993, HOLZFORSCHUNG, V47, P141, DOI 10.1515/hfsg.1993.47.2.141; Warwick P, 2003, RADIOCHIM ACTA, V91, P233, DOI 10.1524/ract.91.4.233.19971; Wilkins MJ, 2007, GEOBIOLOGY, V5, P293, DOI 10.1111/j.1472-4669.2007.00101.x; Williamson AJ, 2013, APPL ENVIRON MICROB, V79, P3320, DOI 10.1128/AEM.03063-12; WORAKIT S, 1986, INT J SYST BACTERIOL, V36, P380, DOI 10.1099/00207713-36-3-380; WU WM, 1992, APPL MICROBIOL BIOT, V38, P282, DOI 10.1007/BF00174484; Xing DF, 2006, INT J SYST EVOL MICR, V56, P755, DOI 10.1099/ijs.0.63926-0; Zhu JX, 2011, INT J SYST EVOL MICR, V61, P2974, DOI 10.1099/ijs.0.027540-0	57	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137682	10.1371/journal.pone.0137682	http://dx.doi.org/10.1371/journal.pone.0137682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367005	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000361601100107
J	Shibasaki, M; Wang, JG; Figueiredo, JL; New, SEP; Quillard, T; Goettsch, C; Koga, J; Sonoki, H; Matsumoto, J; Aikawa, M; Aikawa, E				Shibasaki, Manabu; Wang, Jian-Guo; Figueiredo, Jose-Luiz; New, Sophie E. P.; Quillard, Thibaut; Goettsch, Claudia; Koga, Jun-ichiro; Sonoki, Hiroyuki; Matsumoto, Jiro; Aikawa, Masanori; Aikawa, Elena			Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; COA REDUCTASE INHIBITOR; VASCULAR CALCIFICATION; OSTEOPONTIN EXPRESSION; IN-VIVO; STATINS; CHOLESTEROL; MACROPHAGES; SIMVASTATIN; PHOSPHATE	Objectives Chronic renal disease (CRD) accelerates atherosclerosis and cardiovascular calcification. Statins reduce low-density lipoprotein-cholesterol levels in patients with CRD, however, the benefits of statins on cardiovascular disease in CRD remain unclear. This study has determined the effects of pitavastatin, the newest statin, on arterial inflammation and calcification in atherogenic mice with CRD. Methods and Results CRD was induced by 5/6 nephrectomy in cholesterol-fed apolipoprotein E-deficient mice. Mice were randomized into three groups: control mice, CRD mice, and CRD mice treated with pitavastatin. Ultrasonography showed that pitavastatin treatment significantly attenuated luminal stenosis in brachiocephalic arteries of CRD mice. Near-infrared molecular imaging and correlative Mac3 immunostaining demonstrated a significant reduction in macrophage accumulation in pitavastatin-treated CRD mice. Pitavastatin treatment reduced levels of osteopontin in plasma and atherosclerotic lesions in CRD mice, but did not produce a significant reduction in calcification in atherosclerotic plaques as assesses by histology. CRD mice had significantly higher levels of phosphate in plasma than did control mice, which did not change by pitavastatin. In vitro, pitavastatin suppressed the expression of osteopontin in peritoneal macrophages stimulated with phosphate or calcium/phosphate in concentrations similar to those found in human patients with CRD. Conclusion Our study provides in vivo evidence that pitavastatin reduces inflammation within atherosclerotic lesions in CRD mice.	[Shibasaki, Manabu; Wang, Jian-Guo; Figueiredo, Jose-Luiz; New, Sophie E. P.; Goettsch, Claudia; Sonoki, Hiroyuki; Matsumoto, Jiro; Aikawa, Masanori; Aikawa, Elena] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Med, Sch Med,CICS, Boston, MA 02115 USA; [Quillard, Thibaut; Koga, Jun-ichiro; Aikawa, Masanori; Aikawa, Elena] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Med, Sch Med,Ctr Excellence Vasc Biol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Aikawa, E (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Med, Sch Med,CICS, Boston, MA 02115 USA.	eaikawa@partners.org	Goettsch, Claudia/AAD-9658-2019; Aikawa, Elena/L-6173-2019; Quillard, Thibaut/K-8150-2015	Quillard, Thibaut/0000-0002-8096-2597; Goettsch, Claudia/0000-0002-7973-1329; Aikawa, Masanori/0000-0002-9275-2079; Aikawa, Elena/0000-0001-7835-2135	Kowa Company, Ltd. (Tokyo, Japan); National Institutes of Health [R01HL107550, R01HL114805, R01HL109506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109506, R01HL114805, R01HL107550] Funding Source: NIH RePORTER	Kowa Company, Ltd. (Tokyo, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a research grant from Kowa Company, Ltd. (Tokyo, Japan, to M.A.) and the National Institutes of Health grants (R01HL107550 to M.A. and R01HL114805; R01HL109506 to E.A.). Kowa had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Aikawa M, 2001, CIRCULATION, V103, P276; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Bot I, 2011, ATHEROSCLEROSIS, V214, P295, DOI 10.1016/j.atherosclerosis.2010.11.008; Cheng XW, 2011, J HYPERTENS, V29, P542, DOI 10.1097/HJH.0b013e328341cedf; Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Ellam TJ, 2012, ATHEROSCLEROSIS, V220, P310, DOI 10.1016/j.atherosclerosis.2011.09.002; Fatherazi S, 2009, J DENT RES, V88, P39, DOI 10.1177/0022034508328072; Fujii M, 2007, KIDNEY INT, V72, P473, DOI 10.1038/sj.ki.5002366; Fukumoto Y, 2001, CIRCULATION, V103, P993; Haynes R, 2014, J AM SOC NEPHROL, V25, P1825, DOI 10.1681/ASN.2013090965; HIROTA S, 1993, AM J PATHOL, V143, P1003; Ivanovski O, 2008, J UROLOGY, V179, P1631, DOI 10.1016/j.juro.2007.11.042; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kadoglou NPE, 2014, CLIN DRUG INVEST, V34, P165, DOI 10.1007/s40261-013-0157-y; Kalaitzidis RG, 2011, AM J NEPHROL, V34, P195, DOI 10.1159/000330355; Kimata H, 1998, XENOBIO METABOL DISP, V13, P484, DOI DOI 10.2133/DMPK.13.484; Koga J, 2009, ARTERIOSCL THROM VAS, V29, P458, DOI 10.1161/ATVBAHA.109.183772; Kon V, 2011, NAT REV NEPHROL, V7, P45, DOI 10.1038/nrneph.2010.157; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Levin A, 2012, NAT REV NEPHROL, V8, P70, DOI 10.1038/nrneph.2011.195; Liaw L, 1997, ARTERIOSCL THROM VAS, V17, P188, DOI 10.1161/01.ATV.17.1.188; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Matsui Y, 2003, ARTERIOSCL THROM VAS, V23, P1029, DOI 10.1161/01.ATV.0000074878.29805.D0; Matter CM, 2009, EUR HEART J, V30, P2566, DOI 10.1093/eurheartj/ehp419; Mazhar AR, 2001, KIDNEY INT, V60, P324, DOI 10.1046/j.1523-1755.2001.00803.x; Moody WE, 2012, ATHEROSCLEROSIS, V223, P86, DOI 10.1016/j.atherosclerosis.2012.01.043; Nakamachi T, 2007, DIABETES, V56, P1662, DOI 10.2337/db06-1177; Ogawa D, 2005, CIRC RES, V96, P59, DOI 10.1161/01.RES.0000163630.86796.17; Otto CM, 2008, NEW ENGL J MED, V359, P1395, DOI 10.1056/NEJMe0807001; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085; Saito Y, 2009, VASC HEALTH RISK MAN, V5, P921; Sata M, 2004, HYPERTENSION, V43, P1214, DOI 10.1161/01.HYP.0000126186.29571.41; Scalia R, 2001, CIRCULATION, V103, P2598; Schwarz U, 2000, NEPHROL DIAL TRANSPL, V15, P218, DOI 10.1093/ndt/15.2.218; Shao JS, 2011, ARTERIOSCL THROM VAS, V31, P1821, DOI 10.1161/ATVBAHA.111.230011; Sparrow CP, 2001, ARTERIOSCL THROM VAS, V21, P115, DOI 10.1161/01.ATV.21.1.115; Swaminathan S, 2011, KIDNEY INT, V80, P453, DOI 10.1038/ki.2011.178; Takemoto M, 2001, BRIT J PHARMACOL, V133, P83, DOI 10.1038/sj.bjp.0704046; Thukkani AK, 2013, AM J NUCL MED MOLEC, V3, P217; Towler DA, 2008, IBMS BONEKEY, V5, P41, DOI DOI 10.1138/20080298; Zhao W, 2011, J IMMUNOL, V186, P3173, DOI 10.4049/jimmunol.1003626; Zheng CY, 2013, EUR HEART J, V34, P615, DOI 10.1093/eurheartj/ehs271	50	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138047	10.1371/journal.pone.0138047	http://dx.doi.org/10.1371/journal.pone.0138047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367531	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100209
J	Langhagen, T; Albers, L; Heinen, F; Straube, A; Filippopulos, F; Landgraf, MN; Gerstl, L; Jahn, K; von Kries, R				Langhagen, Thyra; Albers, Lucia; Heinen, Florian; Straube, Andreas; Filippopulos, Filipp; Landgraf, Mirjam N.; Gerstl, Lucia; Jahn, Klaus; von Kries, Ruediger			Period Prevalence of Dizziness and Vertigo in Adolescents	PLOS ONE			English	Article							MIGRAINE; COMMUNITY; SYMPTOMS; CLASSIFICATION; EPIDEMIOLOGY; CHILDREN	Objectives To assess the period prevalence and severity of dizziness and vertigo in adolescents. Methods In 1661 students in 8th-10th grade in twelve grammar schools in Munich, Germany information on vertigo/dizziness was assessed by a questionnaire in the class room setting. Three month prevalence of dizziness/vertigo was estimated; symptoms were categorized as orthostatic dizziness, spinning vertigo, swaying vertigo or unspecified dizziness. Duration of symptoms and impact on daily life activities were assessed. Results 72.0% (95%-CI = [69.8-74.2]; N = 1196) of the students (mean age 14.5 +/- 1.1) reported to suffer fromat least one episode of dizziness or vertigo in the last three months. Most adolescents ticked to have symptoms of orthostatic dizziness (52.0%, 95%-CI = [49.5-54.4], N = 863). The period prevalence for the other types of vertigo were spinning vertigo: 11.6%, 95%-CI = [10.1-13.3], N = 193; swaying vertigo: 12.2%, 95%-CI = [10.6-13.8], N = 202; and unspecified dizziness: 15.2%, 95%-CI = [13.5-17.1], N = 253. About 50% of students with spinning vertigo and swaying vertigo also report to have orthostatic dizziness. Most vertigo/dizziness types were confined to less than one minute on average. The proportion of students with any dizziness/vertigo accounting for failure attending school, leisure activities or obliging them to stay in bed were more pronounced for spinning or swaying vertigo. Conclusion Dizziness and vertigo in grammar school students appear to be as common as in adults. In face of the high period prevalence and clinical relevance of dizziness/vertigo in adolescents there is a need for prevention strategies. Risk factors for dizziness/vertigo need to be assessed to allow for conception of an intervention programme.	[Langhagen, Thyra; Heinen, Florian; Landgraf, Mirjam N.; Gerstl, Lucia] Univ Munich, Hauner Childrens Hosp, Dept Paediat Neurol & Dev Med, Munich, Germany; [Langhagen, Thyra; Heinen, Florian; Straube, Andreas; Filippopulos, Filipp; Landgraf, Mirjam N.; Gerstl, Lucia; Jahn, Klaus] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Albers, Lucia; von Kries, Ruediger] Univ Munich, Div Epidemiol, Inst Social Paediat & Adolescents Med, Munich, Germany; [Straube, Andreas; Filippopulos, Filipp; Jahn, Klaus] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Jahn, Klaus] Schon Klin Bad Aibling, Bad Aibling, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Langhagen, T (corresponding author), Univ Munich, Hauner Childrens Hosp, Dept Paediat Neurol & Dev Med, Munich, Germany.	Thyra.Langhagen@med.uni-muenchen.de	Jahn, Klaus/AAC-4969-2021; Jahn, Klaus/F-9902-2010; Heinen, Florian/B-6594-2015	Jahn, Klaus/0000-0002-1669-3652; Heinen, Florian/0000-0002-3872-6136	DMKG (German Headache Society); German Federal Ministry of Education and Research [01 EO1401]	DMKG (German Headache Society); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was supported by an unrestricted fund of the DMKG (German Headache Society) and by the German Federal Ministry of Education and Research (Grant code 01 EO1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers L, 2014, EUR J NEUROL; Best C, 2006, J NEUROL NEUROSUR PS, V77, P658, DOI 10.1136/jnnp.2005.072934; Best C, 2009, J NEUROL, V256, P58, DOI 10.1007/s00415-009-0038-8; Bisdorff A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00029; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; Ishiyama A, 2000, ANN OTO RHINOL LARYN, V109, P377, DOI 10.1177/000348940010900407; Kizlauskas M, 2009, DIE ENTWICKLUNG DER; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Lempert T, 2014, REV NEUROL-FRANCE, V170, P401, DOI 10.1016/j.neurol.2013.05.010; Murdin L, 2015, OTOL NEUROTOL, V36, P387, DOI 10.1097/MAO.0000000000000691; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Neuhauser HK, 2008, ARCH INTERN MED, V168, P2118, DOI 10.1001/archinte.168.19.2118; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Niemensivu R, 2006, INT J PEDIATR OTORHI, V70, P259, DOI 10.1016/j.ijporl.2005.06.015; Radtke A, 2002, NEUROLOGY, V59, P1700, DOI 10.1212/01.WNL.0000036903.22461.39; Radtke A, 2011, CLIN AUTON RES, V21, P161, DOI 10.1007/s10286-010-0114-2; Russell G, 1999, INT J PEDIATR OTORHI, V49, pS105, DOI 10.1016/S0165-5876(99)00143-3; Thijs RD, 2006, NEUROLOGY, V66, P1034, DOI 10.1212/01.wnl.0000204186.43597.66; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Wiltink J, 2009, J PSYCHOSOM RES, V66, P417, DOI 10.1016/j.jpsychores.2008.09.012; Wu JS, 2008, HYPERTENS RES, V31, P897, DOI 10.1291/hypres.31.897; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131	22	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136512	10.1371/journal.pone.0136512	http://dx.doi.org/10.1371/journal.pone.0136512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361225	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100012
J	Prince, SA; Reed, JL; Mark, AE; Blanchard, CM; Grace, SL; Reid, RD				Prince, Stephanie A.; Reed, Jennifer L.; Mark, Amy E.; Blanchard, Christopher M.; Grace, Sherry L.; Reid, Robert D.			A Comparison of Accelerometer Cut-Points among Individuals with Coronary Artery Disease	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIAC REHABILITATION; CARDIORESPIRATORY FITNESS; SECONDARY PREVENTION; FUNCTIONAL-CAPACITY; AEROBIC CAPACITY; HEART-DISEASE; EXERCISE; VALIDATION; GUIDELINES	Background Accurate assessment of physical activity among coronary artery disease patients is important for assessing adherence to interventions. The study compared moderate-to-vigorous physical intensity activity and relationships with cardiometabolic health/fitness indicators using accelerometer cut-points developed for coronary artery disease patients versus those developed in younger and middle-aged adults. Methods A total of 231 adults with coronary artery disease wore an Actigraph GT3X accelerometer for >= 4 days (>= 10 hours/day). Moderate-to-vigorous intensity physical activity between cut-points was compared using Bland-Altman analyses. Partial spearman correlations assessed relationships between moderate-to-vigorous intensity physical activity from each cut-point with markers of cardiometabolic health and fitness while controlling for age and sex. Results Average time spent in bouts of moderate-to-vigorous intensity physical activity using coronary artery disease cut-points was significantly higher than the young (mean difference: 13.0 +/- 12.8 minutes/day) or middle-aged (17.0 +/- 15.2 minutes/day) cut-points. Young and middle-aged cut-points were more strongly correlated with body mass index, waist circumference and systolic blood pressure, while coronary artery disease cut-points had stronger relationships with triglycerides, high-density and low-density lipoproteins. All were similarly correlated with measures of fitness. Conclusion Researchers need to exert caution when deciding on which cut-points to apply to their population. Further work is needed to validate which cut-points provide a true reflection of moderate-to-vigorous intensity physical activity and to examine relationships among patients with varying fitness.	[Prince, Stephanie A.; Reed, Jennifer L.; Reid, Robert D.] Univ Ottawa, Inst Heart, Div Prevent & Rehabil, Ottawa, ON, Canada; [Mark, Amy E.] Inst Clin Evaluat Serv, Ottawa, ON, Canada; [Blanchard, Christopher M.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Grace, Sherry L.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Grace, Sherry L.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; Dalhousie University; York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Prince, SA (corresponding author), Univ Ottawa, Inst Heart, Div Prevent & Rehabil, Ottawa, ON, Canada.	sprinceware@ottawaheart.ca	Reed, Jennifer/J-8086-2019; Grace, Sherry L/H-1388-2013; Prince, Stephanie A./J-9361-2019	Reed, Jennifer/0000-0001-8006-8555; Grace, Sherry L/0000-0001-7063-3610; Prince, Stephanie A./0000-0001-6729-5649	Gordon E. Allen Post-Doctoral Fellowship; Strategic Endowed Research Fellowship from the UOHI Foundation; Canadian Institutes of Health Research Fellowship; UOHI; Heart and Stroke Foundation of Ontario [6838, 000109]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER	Gordon E. Allen Post-Doctoral Fellowship; Strategic Endowed Research Fellowship from the UOHI Foundation; Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); UOHI; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	SAP was funded by a Gordon E. Allen Post-Doctoral Fellowship and is currently funded by a Strategic Endowed Research Fellowship from the UOHI Foundation and a Canadian Institutes of Health Research Fellowship. JLR held a Jan and Ian Craig Endowed Fellowship from the UOHI. AEM held a Health Services/Population Health Post-Doctoral Research Fellowship Award from the Heart and Stroke Foundation of Ontario (grant FPDL # 6838). The ECO-PCR study was funded by the Heart and Stroke Foundation of Ontario (Grant # 000109).	Ades PA, 2006, CIRCULATION, V113, P2706, DOI 10.1161/CIRCULATIONAHA.105.606624; American College of Sports Medicine, 2009, ACSMS GUID EX TEST P; BUSKIRK ER, 1987, FASEB J, V46, P1824; Carson V, 2014, PREV MED, V65, P23, DOI 10.1016/j.ypmed.2014.04.005; Colley RC, 2011, HLTH REP, V22, P7; Davidson MH, 2004, PROG CARDIOVASC DIS, V47, P73, DOI 10.1016/j.pcad.2004.04.007; DeFina LF, 2015, PROG CARDIOVASC DIS, V57, P324, DOI 10.1016/j.pcad.2014.09.008; Durstine J L, 1994, Exerc Sport Sci Rev, V22, P477; Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Grace SL, 2014, PROG CARDIOVASC DIS, V56, P530, DOI 10.1016/j.pcad.2013.09.010; HARTUNG GH, 1981, AM HEART J, V101, P181, DOI 10.1016/0002-8703(81)90664-5; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Humphrey R, 2014, PROG CARDIOVASC DIS, V56, P551, DOI 10.1016/j.pcad.2013.08.004; Kissel CK, 2012, CAN J CARDIOL, V28, P251, DOI 10.1016/j.cjca.2011.12.008; Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409; Lavie CJ, 2009, MAYO CLIN PROC, V84, P373, DOI [10.4065/84.4.373, 10.1016/S0025-6196(11)60548-X]; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Menezes AR, 2014, PROG CARDIOVASC DIS, V56, P522, DOI 10.1016/j.pcad.2013.09.018; Myers J, 2015, PROG CARDIOVASC DIS, V57, P306, DOI 10.1016/j.pcad.2014.09.011; Ozemek C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-53; Parker BA, 2010, EUR J APPL PHYSIOL, V110, P235, DOI 10.1007/s00421-010-1506-7; PATTERSON JA, 1972, AM J CARDIOL, V30, P757, DOI 10.1016/0002-9149(72)90151-8; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Statistics Canada, PHYS ACT LEIS TIM 20; Stone JA, 2009, CANADIAN GUIDELINES, P1; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; WEBER KT, 1987, CIRCULATION, V76, P40; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2011, GLOB STAT REP ALC HL	36	20	20	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137759	10.1371/journal.pone.0137759	http://dx.doi.org/10.1371/journal.pone.0137759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361345	gold, Green Submitted, Green Published			2022-12-26	WOS:000361043100085
J	Liu, X; Dai, FY; Guo, E; Li, K; Ma, L; Tian, L; Cao, Y; Zhang, GZ; Palli, SR; Li, S				Liu, Xi; Dai, Fangyin; Guo, Enen; Li, Kang; Ma, Li; Tian, Ling; Cao, Yang; Zhang, Guozheng; Palli, Subba R.; Li, Sheng			20-Hydroxyecdysone (20E) Primary Response Gene E93 Modulates 20E Signaling to Promote Bombyx Larval-Pupal Metamorphosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; TISSUE-SPECIFIC REGULATION; CUTICLE PROTEIN GENE; FAT-BODY; JUVENILE-HORMONE; WING DISCS; DROSOPHILA DEVELOPMENT; STEROID REGULATION; PIPSQUEAK PROTEIN; NUCLEAR RECEPTOR	Background: 20-Hydroxyecdysone (20E) and juvenile hormone (JH) coordinately control insect molting and metamorphosis. Results: Induced by 20E and suppressed by JH, E93 acts through GAGA-containing motifs and up-regulates a subset of 20E response genes. Conclusion: E93 transcriptionally modulates 20E signaling to promote Bombyx metamorphosis. Significance: Our study helps in understanding the complicated molecular mechanisms of insect metamorphosis. As revealed in a previous microarray study to identify genes regulated by 20-hydroxyecdysone (20E) and juvenile hormone (JH) in the silkworm, Bombyx mori, E93 expression in the fat body was markedly low prior to the wandering stage but abundant during larval-pupal metamorphosis. Induced by 20E and suppressed by JH, E93 expression follows this developmental profile in multiple silkworm alleles. The reduction of E93 expression by RNAi disrupted 20E signaling and the 20E-induced autophagy, caspase activity, and cell dissociation in the fat body. Reducing E93 expression also decreased the expression of the 20E-induced pupal-specific cuticle protein genes and prevented growth and differentiation of the wing discs. Importantly, the two HTH domains in E93 are critical for inducing the expression of a subset of 20E response genes, including EcR, USP, E74, Br-C, and Atg1. By contrast, the LLQHLL and PLDLSAK motifs in E93 inhibit its transcriptional activity. E93 binds to the EcR-USP complex via a physical association with USP through its LLQHLL motif; and this association is enhanced by 20E-induced EcR-USP interaction, which attenuates the transcriptional activity of E93. E93 acts through the two HTH domains to bind to GAGA-containing motifs present in the Atg1 promoter region for inducing gene expression. In conclusion, E93 transcriptionally modulates 20E signaling to promote Bombyx larval- pupal metamorphosis.	[Liu, Xi; Guo, Enen; Li, Kang; Ma, Li; Tian, Ling; Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Liu, Xi; Dai, Fangyin] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Liu, Xi; Dai, Fangyin] Southwest Univ, Coll Biotechnol, Chongqing 400715, Peoples R China; [Guo, Enen; Li, Kang; Cao, Yang] South China Agr Univ, Lab Insect Mol Biol & Biotechnol, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China; [Zhang, Guozheng] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang 212018, Peoples R China; [Palli, Subba R.] Univ Kentucky, Coll Agr, Dept Entomol, Lexington, KY 40546 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Southwest University - China; Southwest University - China; South China Agricultural University; Chinese Academy of Agricultural Sciences; University of Kentucky	Li, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	lisheng01@sibs.ac.cn	PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247	National Science Foundation of China [31330072, 31472042, 31201747]; 973 program Grant [2012CB114605]; National Program for the Development of New Transgenic Species of China [2014ZX08010-016B]; 863 Program Grant [2013AA102507]; State Key Laboratory of Silkworm Genome Biology [20120003]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program Grant(National Basic Research Program of China); National Program for the Development of New Transgenic Species of China; 863 Program Grant; State Key Laboratory of Silkworm Genome Biology	This study was supported by National Science Foundation of China Grant 31330072, 973 program Grant 2012CB114605, and National Program for the Development of New Transgenic Species of China Grant 2014ZX08010-016B (to S. L.), National Science Foundation of China Grants 31472042 (to L. T.) and 31201747 (to L. M.), 863 Program Grant 2013AA102507 (to F. D.), and State Key Laboratory of Silkworm Genome Biology Grant 20120003 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali MS, 2013, GENE, V512, P337, DOI 10.1016/j.gene.2012.09.126; BAEHRECKE EH, 1995, DEV BIOL, V171, P85, DOI 10.1006/dbio.1995.1262; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Benyajati C, 1997, NUCLEIC ACIDS RES, V25, P3345, DOI 10.1093/nar/25.16.3345; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; Deng H, 2011, INSECT MOL BIOL, V20, P45, DOI 10.1111/j.1365-2583.2010.01041.x; Deng HM, 2012, P NATL ACAD SCI USA, V109, P12598, DOI 10.1073/pnas.1203149109; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Khurad AM, 2009, IN VITRO CELL DEV-AN, V45, P414, DOI 10.1007/s11626-009-9197-2; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lee CY, 2002, DEV BIOL, V252, P138, DOI 10.1006/dbio.2002.0838; Lee CY, 2002, DEV BIOL, V250, P101, DOI 10.1006/dbio.2002.0784; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lehmann M, 1998, J BIOL CHEM, V273, P28504, DOI 10.1074/jbc.273.43.28504; Li K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12114; Liu HH, 2014, INSECT BIOCHEM MOLEC, V45, P30, DOI 10.1016/j.ibmb.2013.11.005; Liu HH, 2013, INSECT BIOCHEM MOLEC, V43, P1068, DOI 10.1016/j.ibmb.2013.09.001; Moeller ME, 2013, DEVELOPMENT, V140, P4730, DOI 10.1242/dev.099739; Mou XC, 2012, P NATL ACAD SCI USA, V109, P2949, DOI 10.1073/pnas.1117559109; Noji T, 2003, INSECT BIOCHEM MOLEC, V33, P671, DOI 10.1016/S0965-1748(03)00048-1; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Schwendemann A, 2002, P NATL ACAD SCI USA, V99, P12883, DOI 10.1073/pnas.202341499; Siegmund T, 2002, DEV GENES EVOL, V212, P152, DOI 10.1007/s00427-002-0219-2; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Tian L, 2012, ARCH INSECT BIOCHEM, V79, P207, DOI 10.1002/arch.20457; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Urena E, 2014, P NATL ACAD SCI USA, V111, P7024, DOI 10.1073/pnas.1401478111; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P624, DOI 10.1016/j.ibmb.2009.06.007; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P615, DOI 10.1016/j.ibmb.2009.06.008; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; Xiang YH, 2010, DEV BIOL, V344, P800, DOI 10.1016/j.ydbio.2010.05.510; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zitnan D, 2007, GEN COMP ENDOCR, V153, P88, DOI 10.1016/j.ygcen.2007.04.002	46	64	71	10	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27370	27383		10.1074/jbc.M115.687293	http://dx.doi.org/10.1074/jbc.M115.687293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378227	hybrid, Green Published			2022-12-26	WOS:000364794000043
J	Miyazawa, T; Takahashi, S; Kawata, A; Panthee, S; Hayashi, T; Shimizu, T; Nogawa, T; Osada, H				Miyazawa, Takeshi; Takahashi, Shunji; Kawata, Akihiro; Panthee, Suresh; Hayashi, Teruo; Shimizu, Takeshi; Nogawa, Toshihiko; Osada, Hiroyuki			Identification of Middle Chain Fatty Acyl-CoA Ligase Responsible for the Biosynthesis of 2-Alkylmalonyl-CoAs for Polyketide Extender Unit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; ESCHERICHIA-COLI K-12; LUNG-CANCER CELLS; MYCOBACTERIUM-TUBERCULOSIS; REVEROMYCIN-A; MYCOLIC ACIDS; STREPTOMYCES; PATHWAY; SYNTHASE; BONE	Background: Fatty acyl-CoA ligases involved in polyketide biosynthesis remain uncharacterized. Results: RevS classified in fatty acyl-AMP ligase clade was the middle chain fatty acyl-CoA ligase. Conclusion: RevS was responsible for 2-alkylmalonyl-CoA biosynthesis through enzyme coupling with RevT carboxylase/reductase. Significance: 2-Alkylmalonyl-CoA biosynthesis was strongly supported by the function of RevR and RevS, which utilized fatty acids derived from de novo biosynthesis and degradation products, respectively. Understanding the biosynthetic mechanism of the atypical polyketide extender unit is important for the development of bioactive natural products. Reveromycin (RM) derivatives produced by Streptomyces sp. SN-593 possess several aliphatic extender units. Here, we studied the molecular basis of 2-alkyl-malonyl- CoA formation by analyzing the revR and revS genes, which form a transcriptional unit with the revT gene, a crotonyl-CoA carboxylase/reductase homolog. We mainly focused on the uncharacterized adenylate-forming enzyme (RevS). revS gene disruption resulted in the reduction of all RM derivatives, whereas reintroduction of the gene restored the yield of RMs. Although RevS was classified in the fatty acyl-AMP ligase clade based on phylogenetic analysis, biochemical characterization revealed that the enzyme catalyzed the middle chain fatty acyl-CoA ligase (FACL) but not the fatty acyl-AMP ligase activity, suggesting the molecular evolution for acyl-CoA biosynthesis. Moreover, we examined the in vitro conversion of fatty acid into 2-alkylmalonyl-CoA using purified RevS and RevT. The coupling reaction showed efficient conversion of hexenoic acid into butylmalonyl-CoA. RevS efficiently catalyzed C8-C10 middle chain FACL activity; therefore, we speculated that the acyl-CoA precursor was truncated via beta-oxidation and converted into (E)-2-enoyl-CoA, a RevT substrate. To determine whether the beta-oxidation process is involved between the RevS and RevT reaction, we performed the feeding experiment using [1,2,3,4-C-13] octanoic acid. C-13 NMR analysis clearly demonstrated incorporation of the [3,4-C-13] octanoic acid moiety into the structure of RM-A. Our results provide insight into the role of uncharacterized RevS homologs that may catalyze middle chain FACL to produce a unique polyketide extender unit.	[Miyazawa, Takeshi; Takahashi, Shunji; Panthee, Suresh; Hayashi, Teruo; Shimizu, Takeshi; Nogawa, Toshihiko; Osada, Hiroyuki] RIKEN, Ctr Sustainable Resource Sci, Chem Biol Res Grp, Saitama 3510198, Japan; [Miyazawa, Takeshi; Kawata, Akihiro; Osada, Hiroyuki] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan	RIKEN; Saitama University	Takahashi, S (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Chem Biol Res Grp, Saitama 3510198, Japan.	shunjitaka@riken.jp	Takahashi, Shunji/N-6921-2015; Nogawa, Toshihiko/ABG-2652-2020; Osada, Hiroyuki/N-4305-2014; Panthee, Suresh/H-2754-2013; Osada, Hiroyuki/AAY-6254-2020; Takahashi, Shunji/GLT-3245-2022; Nogawa, Toshihiko/C-4095-2017	Takahashi, Shunji/0000-0003-1684-9298; Panthee, Suresh/0000-0003-4021-7936; Takahashi, Shunji/0000-0003-1684-9298; Nogawa, Toshihiko/0000-0003-1270-5270	Japan Society for the Promotion of Science KAKENHI [24380052]; Ministry of Economy, Trade and Industry, Japan; "Science and technology research promotion program for agriculture, forestry, fisheries and food industry"	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Economy, Trade and Industry, Japan; "Science and technology research promotion program for agriculture, forestry, fisheries and food industry"	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 24380052, by a grant for "Project Focused on Developing Key Technology of Discovering and Manufacturing Drug for Next-generation Treatment and Diagnosis" from the Ministry of Economy, Trade and Industry, Japan, and by "Science and technology research promotion program for agriculture, forestry, fisheries and food industry." The authors declare that they have no conflicts of interest with the contents of this article.	Arabolaza A, 2008, APPL ENVIRON MICROB, V74, P2573, DOI 10.1128/AEM.02638-07; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Cacho RA, 2012, J AM CHEM SOC, V134, P16781, DOI 10.1021/ja307220z; Chang CC, 2015, J AM CHEM SOC, V137, P4183, DOI 10.1021/jacs.5b00728; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dehesh K, 1996, PLANT PHYSIOL, V110, P203, DOI 10.1104/pp.110.1.203; Dias DA, 2012, METABOLITES, V2, DOI 10.3390/metabo2020303; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Eustaquio AS, 2009, P NATL ACAD SCI USA, V106, P12295, DOI 10.1073/pnas.0901237106; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hansen DB, 2007, J AM CHEM SOC, V129, P6366, DOI 10.1021/ja070890j; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hayashi T, 2011, CHEMBIOCHEM, V12, P2166, DOI 10.1002/cbic.201100344; He X, 2006, J MED CHEM, V49, P6308, DOI 10.1021/jm060715y; Hiraoka K, 2008, CANCER SCI, V99, P1595, DOI 10.1111/j.1349-7006.2008.00880.x; HOSAKA K, 1979, EUR J BIOCHEM, V93, P197, DOI 10.1111/j.1432-1033.1979.tb12811.x; Khare G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008387; Kieser T., 2000, PRACTICAL STREPTOMYC, P232; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Lechner A, 2013, ACS SYNTH BIOL, V2, P379, DOI 10.1021/sb3001062; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Liu Z, 2013, J BIOL CHEM, V288, P18473, DOI 10.1074/jbc.M113.466912; Mares J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111904; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Mo S, 2011, J AM CHEM SOC, V133, P976, DOI 10.1021/ja108399b; Morsczeck C, 2001, BBA-GENE STRUCT EXPR, V1521, P59, DOI 10.1016/S0167-4781(01)00287-1; Muguruma H, 2005, CLIN CANCER RES, V11, P8822, DOI 10.1158/1078-0432.CCR-05-1335; Nakamura H, 2012, J AM CHEM SOC, V134, P18518, DOI 10.1021/ja308318p; OLUKOSHI ER, 1994, MICROBIOL-SGM, V140, P931, DOI 10.1099/00221287-140-4-931; Onaka H, 2003, J ANTIBIOT, V56, P950, DOI 10.7164/antibiotics.56.950; OSADA H, 1991, J ANTIBIOT, V44, P259, DOI 10.7164/antibiotics.44.259; PADMAKUMAR R, 1993, ANAL BIOCHEM, V214, P318, DOI 10.1006/abio.1993.1494; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Quade N, 2012, NAT CHEM BIOL, V8, P117, DOI 10.1038/nchembio.734; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Ross C, 2014, ANGEW CHEM INT EDIT, V53, P7794, DOI 10.1002/anie.201403344; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; Steenbergen JN, 2005, J ANTIMICROB CHEMOTH, V55, P283, DOI 10.1093/jac/dkh546; Takahashi S, 2011, NAT CHEM BIOL, V7, P461, DOI [10.1038/NCHEMBIO.583, 10.1038/nchembio.583]; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; TSAY JT, 1992, J BIOL CHEM, V267, P6807; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989; Vats A, 2012, J BIOL CHEM, V287, P30677, DOI 10.1074/jbc.M112.384966; Wilkinson B, 2007, NAT CHEM BIOL, V3, P379, DOI 10.1038/nchembio.2007.7; Wilson MC, 2012, NAT PROD REP, V29, P72, DOI 10.1039/c1np00082a; Winter JM, 2012, CURR OPIN BIOTECH, V23, P736, DOI 10.1016/j.copbio.2011.12.016; Wittmann M, 2008, FEBS J, V275, P5343, DOI 10.1111/j.1742-4658.2008.06664.x; Wong FT, 2012, CURR OPIN CHEM BIOL, V16, P117, DOI 10.1016/j.cbpa.2012.01.018; Woo JT, 2006, P NATL ACAD SCI USA, V103, P4729, DOI 10.1073/pnas.0505663103; Xu Z, 2007, J AM CHEM SOC, V129, P6022, DOI 10.1021/ja069045b; Xu ZL, 2011, ANGEW CHEM INT EDIT, V50, P4667, DOI 10.1002/anie.201008265; Xu ZL, 2009, J BIOTECHNOL, V140, P107, DOI 10.1016/j.jbiotec.2008.10.013; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Zhang ZN, 2011, J MOL BIOL, V406, P313, DOI 10.1016/j.jmb.2010.12.011	67	12	13	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26994	27011		10.1074/jbc.M115.677195	http://dx.doi.org/10.1074/jbc.M115.677195			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378232	Green Published, hybrid			2022-12-26	WOS:000364794000010
J	Zhu, LJ; Wang, ZK; Wang, WW; Wang, CL; Hua, SS; Su, ZQ; Brako, L; Garcia-Barrio, M; Ye, ML; Wei, X; Zou, HF; Ding, X; Liu, LF; Liu, X; Yao, XB				Zhu, Lijuan; Wang, Zhikai; Wang, Wenwen; Wang, Chunli; Hua, Shasha; Su, Zeqi; Brako, Larry; Garcia-Barrio, Minerva; Ye, Mingliang; Wei, Xuan; Zou, Hanfa; Ding, Xia; Liu, Lifang; Liu, Xing; Yao, Xuebiao			Mitotic Protein CSPP1 Interacts with CENP-H Protein to Coordinate Accurate Chromosome Oscillation in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETOCHORE-MICROTUBULE DYNAMICS; AURORA-B KINASE; SPINDLE MICROTUBULES; JOUBERT SYNDROME; PROGRESSION; SEGREGATION; CENTROMERE; MUTATIONS; COMPLEX; CILIA	Mitotic chromosome segregation is orchestrated by the dynamic interaction of spindle microtubules with the kinetochores. During chromosome alignment, kinetochore-bound microtubules undergo dynamic cycles between growth and shrinkage, leading to an oscillatory movement of chromosomes along the spindle axis. Although kinetochore protein CENP-H serves as a molecular control of kinetochore-microtubule dynamics, the mechanistic link between CENP-H and kinetochore microtubules (kMT) has remained less characterized. Here, we show that CSPP1 is a kinetochore protein essential for accurate chromosome movements in mitosis. CSPP1 binds to CENP-H in vitro and in vivo. Suppression of CSPP1 perturbs proper mitotic progression and compromises the satisfaction of spindle assembly checkpoint. In addition, chromosome oscillation is greatly attenuated in CSPP1-depleted cells, similar to what was observed in the CENP-H-depleted cells. Importantly, CSPP1 depletion enhances velocity of kinetochore movement, and overexpression of CSPP1 decreases the speed, suggesting that CSPP1 promotes kMT stability during cell division. Specific perturbation of CENP-H/CSPP1 interaction using a membrane-permeable competing peptide resulted in a transient mitotic arrest and chromosome segregation defect. Based on these findings, we propose that CSPP1 cooperates with CENP-H on kinetochores to serve as a novel regulator of kMT dynamics for accurate chromosome segregation.	[Zhu, Lijuan; Wang, Zhikai; Wang, Wenwen; Hua, Shasha; Liu, Xing; Yao, Xuebiao] Univ Sci & Technol China, Lab Cellular Dynam, Hefei 230027, Peoples R China; [Wang, Zhikai; Wang, Wenwen; Brako, Larry; Garcia-Barrio, Minerva; Liu, Xing] Morehouse Sch Med, Atlanta, GA 30310 USA; [Wang, Zhikai; Wang, Wenwen; Brako, Larry; Garcia-Barrio, Minerva; Liu, Xing] Atlanta Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Wang, Chunli; Ye, Mingliang; Zou, Hanfa] Chinese Acad Sci, Natl Chromatog Res & Anal Ctr, Dalian 116023, Peoples R China; [Su, Zeqi; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Wang, Wenwen; Hua, Shasha; Wei, Xuan; Liu, Lifang] Airforce Gen Hosp, Beijing 100036, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Chinese Academy of Sciences; Beijing University of Chinese Medicine	Liu, LF (corresponding author), Airforce Gen Hosp, Beijing 100036, Peoples R China.	lfliubj@hotmail.com; xing1017@ustc.edu.cn; yaoxb@ustc.edu.cn	liu, li/HGC-0900-2022; WANG, WENWEN/AAF-1080-2020; Yao, Xuebiao/P-5771-2014; Liu, Xing/H-2989-2018; Regan, Clinton/E-6250-2012	WANG, WENWEN/0000-0002-1545-4369; Liu, Xing/0000-0002-7480-5085; 	Chinese 973 Project [2012CB917204, 2012CB945002, 2002CB713700]; Anhui Province Key Project [08040102005]; International Collaboration Grant [2009DFA31010]; Chinese Natural Science Foundation [90508002, 31301120, 91129714, 31301121, 31071184, 81270466, 90913016, 31501095, MOE20113402130010]; Fundamental Research Funds for Central Universities [WK2060190018]; Anhui Provincial Natural Science Foundation [1508085SMC213]; China Postdoctoral Science Foundation [2014M560517]; National Institutes of Health [DK56292, CA164133, G12RR03034]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	Chinese 973 Project(National Basic Research Program of China); Anhui Province Key Project; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Chinese 973 Project Grants 2012CB917204, 2012CB945002, and 2002CB713700, Anhui Province Key Project Grant 08040102005, International Collaboration Grant 2009DFA31010, Chinese Natural Science Foundation Grants 90508002, 31301120, 91129714, 31301121, 31071184, 81270466, 90913016, 31501095, and MOE20113402130010, Fundamental Research Funds for Central Universities Grant WK2060190018, Anhui Provincial Natural Science Foundation Grant 1508085SMC213, China Postdoctoral Science Foundation Grant 2014M560517, and National Institutes of Health Grants DK56292, CA164133, and G12RR03034. The authors declare that they have no conflicts of interest with the contents of this article.	Akizu N, 2014, AM J HUM GENET, V94, P80, DOI 10.1016/j.ajhg.2013.11.015; Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Bakhoum SF, 2012, CURR OPIN CELL BIOL, V24, P64, DOI 10.1016/j.ceb.2011.11.012; Cao D, 2015, J BIOL CHEM, V290, P23766, DOI 10.1074/jbc.M115.673517; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Dumont S, 2012, SCIENCE, V337, P355, DOI 10.1126/science.1221886; Ems-McClung SC, 2013, CURR BIOL, V23, P2491, DOI 10.1016/j.cub.2013.10.054; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Mikami Y, 2005, MOL CELL BIOL, V25, P1958, DOI 10.1128/MCB.25.5.1958-1970.2005; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Patzke S, 2005, ONCOGENE, V24, P1159, DOI 10.1038/sj.onc.1208267; Patzke S, 2006, J CELL PHYSIOL, V209, P199, DOI 10.1002/jcp.20725; Patzke S, 2010, MOL BIOL CELL, V21, P2555, DOI 10.1091/mbc.E09-06-0503; Shaheen R, 2014, AM J HUM GENET, V94, P73, DOI 10.1016/j.ajhg.2013.11.010; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Sternemalm J, 2014, BRIT J CANCER, V111, P326, DOI 10.1038/bjc.2014.297; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tuz K, 2014, AM J HUM GENET, V94, P62, DOI 10.1016/j.ajhg.2013.11.019; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Ward T, 2013, J BIOL CHEM, V288, P15771, DOI 10.1074/jbc.M112.448886; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yao XB, 2009, CELL RES, V19, P152, DOI 10.1038/cr.2009.7; Yuan K, 2009, J BIOL CHEM, V284, P23072, DOI 10.1074/jbc.M109.001990; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	42	11	11	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27053	27066		10.1074/jbc.M115.658534	http://dx.doi.org/10.1074/jbc.M115.658534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378239	Green Published, hybrid			2022-12-26	WOS:000364794000017
J	Gregory, NS; Whitley, PE; Sluka, KA				Gregory, Nicholas S.; Whitley, Phillip E.; Sluka, Kathleen A.			Effect of Intramuscular Protons, Lactate, and ATP on Muscle Hyperalgesia in Rats	PLOS ONE			English	Article							RHEUMATOID KNEE-JOINTS; THERMAL HYPERALGESIA; POSTOPERATIVE PAIN; DYNAMIC EXERCISE; TISSUE ACIDOSIS; SKELETAL-MUSCLE; SENSORY NEURONS; ACIDIC SALINE; ION CHANNELS; NA+ CHANNEL	Chronic muscle pain is a significant health problem leading to disability[1]. Muscle fatigue can exacerbate muscle pain. Metabolites, including ATP, lactate, and protons, are released during fatiguing exercise and produce pain in humans. These substances directly activate purinergic (P2X) and acid sensing ion channels (ASICs) on muscle nociceptors, and when combined, produce a greater increase in neuron firing than when given alone. Whether the enhanced effect of combining protons, lactate, and ATP is the sum of individual effects (additive) or more than the sum of individual effects (synergistic) is unknown. Using a rat model of muscle nociceptive behavior, we tested each of these compounds individually over a range of physiologic and supra-physiologic concentrations. Further, we combined all three compounds in a series of dilutions and tested their effect on muscle nociceptive behavior. We also tested a non-hydrolyzable form of ATP (alpha,beta-meATP) alone and in combination with lactate and acidic pH. Surprisingly, we found no dose-dependent effect on muscle nociceptive behavior for protons, lactate, or ATP when given alone. We similarly found no effect after application of each two-metabolite combination. Only pH 4 saline and alpha,beta-meATP produced hyperalgesia when given alone. When all 3 substances were combined, however, ATP (2.4 mu m), lactate (10mM), and acidic pH (pH 6.0) produced an enhanced effect greater than the sum of the effects of the individual components, i.e. synergism. alpha,beta me ATP (3nmol), on the other hand, showed no enhanced effects when combined with lactate (10mM) or acidic pH (pH 6.0), i.e. additive. These data suggest that combining fatigue metabolites in muscle produces a synergistic effect on muscle nociception.	[Gregory, Nicholas S.; Sluka, Kathleen A.] Univ Iowa, Grad Program Neurosci, Iowa City, IA 52242 USA; [Sluka, Kathleen A.] Univ Iowa, Dept Phys Therapy & Rehabil Sci, Iowa City, IA USA; [Whitley, Phillip E.] CFD Res Corp, Huntsville, AL USA	University of Iowa; University of Iowa; CFD Research Corporation	Sluka, KA (corresponding author), Univ Iowa, Grad Program Neurosci, Iowa City, IA 52242 USA.	kathleen-sluka@uiowa.edu		Whitley, Phillip/0000-0001-9202-5085; Sluka, Kathleen/0000-0003-0207-8728; Gregory, Nicholas/0000-0001-9392-6504	United States Navy Small Business Innovative Research Contract [N68335-13-C-0062]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045549] Funding Source: NIH RePORTER	United States Navy Small Business Innovative Research Contract; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the United States Navy Small Business Innovative Research Contract N68335-13-C-0062 (KS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CFD Research Corporation provided support in the form of a salary for author PEW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BANGSBO J, 1993, J PHYSIOL-LONDON, V462, P115, DOI 10.1113/jphysiol.1993.sp019546; Birdsong WT, 2010, NEURON, V68, P739, DOI 10.1016/j.neuron.2010.09.029; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; GOLDIE I, 1970, ACTA ORTHOP SCAND, V41, P354, DOI 10.3109/17453677008991521; GOLDIE I, 1969, ACTA ORTHOP SCAND, V40, P634, DOI 10.3109/17453676908989529; Gregory NS, 2013, PAIN, V154, P2668, DOI 10.1016/j.pain.2013.07.047; Gregory NS, 2015, MOL NEUROBIOL; Gregory NS, 2014, CURR TOP BEHAV NEURO; Hamamoto DT, 1998, PAIN, V74, P225, DOI 10.1016/S0304-3959(97)00185-1; Hanna RL, 2004, J APPL PHYSIOL, V96, P1166, DOI 10.1152/japplphysiol.01020.2003; Hilliges M, 2002, PAIN, V98, P59, DOI 10.1016/S0304-3959(01)00469-9; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Institute of Medicine (IOM), 2011, REL PAIN AM BLUEPR T; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jankowski MP, 2012, PAIN, V153, P410, DOI 10.1016/j.pain.2011.10.042; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Juel C, 2004, AM J PHYSIOL-ENDOC M, V286, pE245, DOI 10.1152/ajpendo.00303.2003; Kido K, 2013, ANESTHESIOLOGY, V119, P1186, DOI 10.1097/ALN.0b013e31829bd791; Kim TJ, 2007, J PAIN, V8, P59, DOI 10.1016/j.jpain.2006.06.003; Kwon SG, 2014, NEUROPHARMACOLOGY, V79, P368, DOI 10.1016/j.neuropharm.2013.12.005; Kwon SG, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-2; Law LAF, 2008, PAIN, V140, P254, DOI 10.1016/j.pain.2008.08.014; Light AR, 2008, J NEUROPHYSIOL, V100, P1184, DOI 10.1152/jn.01344.2007; Lin C-CJ, 2011, P NATL ACAD SCI US; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Mork H, 2003, EUR J PAIN, V7, P145, DOI 10.1016/S1090-3801(02)00096-4; Pollak KA, 2014, EXP PHYSIOL, V99, P368, DOI 10.1113/expphysiol.2013.075812; PORRECA F, 1990, EUR J PHARMACOL, V179, P463, DOI 10.1016/0014-2999(90)90190-H; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Reinohl J, 2003, NEUROSCI LETT, V338, P25, DOI 10.1016/S0304-3940(02)01360-5; Reitz M, 2009, CEPHALALGIA, V29, P58, DOI 10.1111/j.1468-2982.2008.01700.x; SAHLIN K, 1976, PFLUG ARCH EUR J PHY, V367, P143, DOI 10.1007/BF00585150; Schiavuzzo JG, 2015, NEUROSCIENCE, V285, P24, DOI 10.1016/j.neuroscience.2014.11.020; Seo HS, 2011, NEUROPHARMACOLOGY, V60, P580, DOI 10.1016/j.neuropharm.2010.12.009; Shinoda M, 2008, PAIN, V134, P148, DOI 10.1016/j.pain.2007.04.006; Skyba DA, 2002, PAIN, V98, P69, DOI 10.1016/S0304-3959(01)00471-7; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; Sluka KA, 2007, PAIN, V129, P102, DOI 10.1016/j.pain.2006.09.038; Sluka KA, 2010, PAIN, V148, P188, DOI 10.1016/j.pain.2009.07.001; Tallarida RJ., 2000, DRUG SYNERGISM DOSE; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; VICTOR RG, 1988, J CLIN INVEST, V82, P1301, DOI 10.1172/JCI113730; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Woo YC, 2004, ANESTHESIOLOGY, V101, P468, DOI 10.1097/00000542-200408000-00029; Yokoyama T, 2007, J PAIN, V8, P692, DOI 10.1016/j.jpain.2007.05.008	50	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138576	10.1371/journal.pone.0138576	http://dx.doi.org/10.1371/journal.pone.0138576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378796	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400112
J	Nemutlu, E; Gupta, A; Zhang, S; Viqar, M; Holmuhamedov, E; Terzic, A; Jahangir, A; Dzeja, P				Nemutlu, Emirhan; Gupta, Anu; Zhang, Song; Viqar, Maria; Holmuhamedov, Ekhson; Terzic, Andre; Jahangir, Arshad; Dzeja, Petras			Decline of Phosphotransfer and Substrate Supply Metabolic Circuits Hinders ATP Cycling in Aging Myocardium	PLOS ONE			English	Article							O-18-ASSISTED P-31 NMR; ADENYLATE KINASE; HEART-FAILURE; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL DYSFUNCTION; ENERGY-METABOLISM; CELL ENERGETICS; PROTECTIVE ROLE; FAILING ATRIAL; KNOCKOUT HEART	Integration of mitochondria with cytosolic ATP-consuming/ATP-sensing and substrate supply processes is critical for muscle bioenergetics and electrical activity. Whether age-dependent muscle weakness and increased electrical instability depends on perturbations in cellular energetic circuits is unknown. To define energetic remodeling of aged atrial myocardium we tracked dynamics of ATP synthesis-utilization, substrate supply, and phosphotransfer circuits through adenylate kinase (AK), creatine kinase (CK), and glycolytic/ glycogenolytic pathways using O-18 stable isotope-based phosphometabolomic technology. Samples of intact atrial myocardium from adult and aged rats were subjected to O-18-labeling procedure at resting basal state, and analyzed using the O-18-assisted HPLC-GC/MS technique. Characteristics for aging atria were lower inorganic phosphate Pi[O-18], y-ATP[O-18], 3-ADP[O-18], and creatine phosphate CrP[O-18] O-18-labeling rates indicating diminished ATP utilization-synthesis and AK and CK phosphotransfer fluxes. Shift in dynamics of glycolytic phosphotransfer was reflected in the diminished G6P[O-18] turnover with relatively constant glycogenolytic flux or G1 P[O-18] O-18-labeling. Labeling of G3P[O-18], an indicator of G3Pshuttle activity and substrate supply to mitochondria, was depressed in aged myocardium. Aged atrial myocardium displayed reduced incorporation of O-18 into second (O-18(2)), third (O-18(3)), and fourth (O-18(4)) positions of Pi[O-18] and a lower Pi[O-18]/y-ATP[O-18]-labeling ratio, indicating delayed energetic communication and ATP cycling between mitochondria and cellular ATPases. Adrenergic stress alleviated diminished CK flux, AK catalyzed 3-ATP turnover and energetic communication in aging atria. Thus, O-18-assisted phosphometabolomics uncovered simultaneous phosphotransfer through AK, CK, and glycolytic pathways and G3P substrate shuttle deficits hindering energetic communication and ATP cycling, which may underlie energetic vulnerability of aging atrial myocardium.	[Nemutlu, Emirhan; Gupta, Anu; Zhang, Song; Viqar, Maria; Terzic, Andre; Dzeja, Petras] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Holmuhamedov, Ekhson; Jahangir, Arshad] Aurora Univ Wisconsin Med Grp, Aurora Hlth Care, Ctr Integrat Res Cardiovasc Aging, Milwaukee, WI USA	Mayo Clinic	Dzeja, P (corresponding author), Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA.	arshad.jahangir@aurora.org; dzeja.petras@mayo.edu	Jahangir, Arshad/M-7916-2016; Nemutlu, Emirhan/D-3218-2013; Holmuhamedov, Ekhson L/P-5228-2016	Nemutlu, Emirhan/0000-0002-7337-6215; Holmuhamedov, Ekhson L/0000-0002-0809-350X	National Institutes of Health [R01HL 85744, U24DK100469]; Marriott Heart Disease Research Program; Marriott Foundation; Mayo Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK100469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marriott Heart Disease Research Program; Marriott Foundation; Mayo Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (R01HL 85744 and U24DK100469 Mayo Clinic Metabolomics Resource Core), Marriott Heart Disease Research Program, Marriott Foundation, and Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MR, 2002, J BIOL CHEM, V277, P24427, DOI 10.1074/jbc.M201777200; AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Aon MA, 2006, BBA-MOL BASIS DIS, V1762, P232, DOI 10.1016/j.bbadis.2005.06.008; Ausma J, 2000, CARDIOVASC RES, V47, P788, DOI 10.1016/S0008-6363(00)00139-5; Bak MI, 1998, J MOL CELL CARDIOL, V30, P661, DOI 10.1006/jmcc.1997.0633; Carley AN, 2014, CIRC RES, V114, P717, DOI 10.1161/CIRCRESAHA.114.301863; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Cha YM, 2006, AM J PHYSIOL-HEART C, V290, pH1686, DOI 10.1152/ajpheart.00384.2005; Cha YM, 2003, AM J PHYSIOL-HEART C, V284, pH1313, DOI 10.1152/ajpheart.00337.2002; Cha YM, 2007, J CARDIOVASC ELECTR, V18, P1015, DOI 10.1111/j.1540-8167.2007.00926.x; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Corradi D, 2011, J CARDIOVASC ELECTR, V22, P223, DOI 10.1111/j.1540-8167.2010.01887.x; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dzeja P P, 2000, Curr Cardiol Rep, V2, P212, DOI 10.1007/s11886-000-0071-9; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Dzeja PP, 2007, J BIOL CHEM, V282, P31366, DOI 10.1074/jbc.M705268200; Dzeja PP, 2011, J PHYSIOL-LONDON, V589, P5193, DOI 10.1113/jphysiol.2011.212829; Dzeja PP, 1996, J BIOL CHEM, V271, P12847, DOI 10.1074/jbc.271.22.12847; Dzeja PP, 1999, MOL CELL BIOCHEM, V201, P33, DOI 10.1023/A:1007016703229; Dzeja PP, 1998, MOL CELL BIOCHEM, V184, P169, DOI 10.1023/A:1006859632730; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Dzeja PP, 1998, FASEB J, V12, P523, DOI 10.1096/fasebj.12.7.523; Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Huang JH, 2009, IUBMB LIFE, V61, P201, DOI 10.1002/iub.164; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Ingwall JS, 2004, J MOL CELL CARDIOL, V37, P613, DOI 10.1016/j.yjmcc.2004.05.020; Jahangir A, 2001, MECH AGEING DEV, V122, P1073, DOI 10.1016/S0047-6374(01)00242-1; Kane GC, 2004, DIABETES, V53, pS169, DOI 10.2337/diabetes.53.suppl_3.S169; Kanski J, 2005, AM J PHYSIOL-HEART C, V288, pH371, DOI 10.1152/ajpheart.01030.2003; KARL DM, 1985, APPL ENVIRON MICROB, V50, P706, DOI 10.1128/AEM.50.3.706-709.1985; Kuiper JWP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005030; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; London B, 2007, CIRCULATION, V116, P2260, DOI 10.1161/CIRCULATIONAHA.107.703330; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mihm MJ, 2001, CIRCULATION, V104, P174, DOI 10.1161/01.CIR.104.2.174; Mirza M, 2011, J INTERV CARD ELECTR, V31, P197, DOI 10.1007/s10840-011-9560-6; Montaigne D, 2013, J AM COLL CARDIOL, V62, P1466, DOI 10.1016/j.jacc.2013.03.061; Nemutlu E, 2012, PHYSL GENOMICS; Nemutlu E, 2012, ANAL BIOANAL CHEM, V403, P697, DOI 10.1007/s00216-012-5899-5; Nemutlu E, 2012, PHYSIOL GENOMICS, V44, P386, DOI 10.1152/physiolgenomics.00152.2011; NEUBAUER S, 1992, CIRCULATION, V86, P302, DOI 10.1161/01.CIR.86.1.302; Nichtova Z, 2012, GEN PHYSIOL BIOPHYS, V31, P141, DOI 10.4149/gpb_2012_015; Olson LK, 1996, J BIOL CHEM, V271, P16544, DOI 10.1074/jbc.271.28.16544; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Peart JN, 2014, EXP GERONTOL, V50, P72, DOI 10.1016/j.exger.2013.11.015; Picard M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7259; PODEROSO JJ, 1995, CRIT CARE MED, V23, P1726, DOI 10.1097/00003246-199510000-00018; Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010; Pucar D, 2004, MOL CELL BIOCHEM, V256, P281, DOI 10.1023/B:MCBI.0000009875.30308.7a; Pucar D, 2002, AM J PHYSIOL-HEART C, V283, pH776, DOI 10.1152/ajpheart.00116.2002; Pucar D, 2000, J BIOL CHEM, V275, P41424, DOI 10.1074/jbc.M007903200; Pucar D, 2001, J BIOL CHEM, V276, P44812, DOI 10.1074/jbc.M104425200; Roosimaa M, 2013, MITOCHONDRION, V13, P399, DOI 10.1016/j.mito.2012.12.005; ROSSI A, 1975, J MOL CELL CARDIOL, V7, P891, DOI 10.1016/0022-2828(75)90150-9; Saks V, 2006, J PHYSIOL-LONDON, V571, P253, DOI 10.1113/jphysiol.2005.101444; Saks V, 2012, J MOL CELL CARDIOL, V52, P419, DOI 10.1016/j.yjmcc.2011.07.015; Scholz TD, 1997, J MOL CELL CARDIOL, V29, P1605, DOI 10.1006/jmcc.1997.0394; Sharma S, 2014, CARDIOVASCULAR PATHO; Shen WQ, 2005, J MOL CELL CARDIOL, V39, P537, DOI 10.1016/j.yjmcc.2005.05.003; Shibayama J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057821; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Taegtmeyer H, 2005, ANN NY ACAD SCI, V1047, P208, DOI 10.1196/annals.1341.019; Tsuboi M, 2001, EUR J CLIN INVEST, V31, P489, DOI 10.1046/j.1365-2362.2001.00844.x; Valdivia CR, 2009, AM J PHYSIOL-HEART C, V297, pH1446, DOI 10.1152/ajpheart.00513.2009; van Horssen R, 2009, J BIOL CHEM, V284, P1620, DOI 10.1074/jbc.M806974200; Van Norstrand DW, 2007, CIRCULATION, V116, P2253, DOI 10.1161/CIRCULATIONAHA.107.704627; Wang QS, 2010, NEUROCHEM RES, V35, P13, DOI 10.1007/s11064-009-0023-8; Yang JH, 2008, J BIOL CHEM, V283, P36321, DOI 10.1074/jbc.M804794200; Yaniv Y, 2013, TRENDS ENDOCRIN MET, V24, P495, DOI 10.1016/j.tem.2013.06.001; ZELEZNIKAR RJ, 1991, J BIOL CHEM, V266, P15110; Zhang S, 2014, SPRINGER SER BIOPHYS, V16, P145, DOI 10.1007/978-3-642-38505-6_6; Zilversmit DB, 1943, J GEN PHYSIOL, V26, P325, DOI 10.1085/jgp.26.3.325; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	76	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0136556	10.1371/journal.pone.0136556	http://dx.doi.org/10.1371/journal.pone.0136556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378442	Green Published, gold, Green Submitted			2022-12-26	WOS:000361769400006
J	Mei, L; Tang, YC; Li, M; Yang, PC; Liu, ZQ; Yuan, JL; Zheng, PY				Mei, Lu; Tang, Youcai; Li, Ming; Yang, Pingchang; Liu, Zhiqiang; Yuan, Jieli; Zheng, Pengyuan			Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; SERUM-CHOLESTEROL; GENE-EXPRESSION; DISEASE; RECEPTOR; OBESITY; DIET; 7-ALPHA-HYDROXYLASE; STEATOHEPATITIS	Non-alcoholic fatty liver disease (NAFLD) has become a common liver disease in recent decades. No effective treatment is currently available. Probiotics and natural functional food may be promising therapeutic approaches to this disease. The present study aims to investigate the efficiency of the anthraquinone from Cassia obtusifolia L. (AC) together with cholesterol- lowering probiotics (P) to improve high-fat diet (HFD)-induced NAFLD in rat models and elucidate the underlying mechanism. Cholesterol-lowering probiotics were screened out by MRS-cholesterol broth with ammonium ferric sulfate method. Male Sprague-Dawley rats were fed with HFD and subsequently administered with AC and/or P. Lipid metabolism parameters and fat synthesis related genes in rat liver, as well as the diversity of gut microbiota were evaluated. The results demonstrated that, compared with the NAFLD rat, the serumlipid levels of treated rats were reduced effectively. Besides, cholesterol 7 alpha-hydroxylase (CYP7A1), low density lipoprotein receptor (LDL-R) and farnesoid X receptor (FXR) were up-regulated while the expression of 3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMGCR) was reduced. The expression of peroxisome proliferator activated receptor (PPAR)-alpha protein was significantly increased while the expression of PPAR-gamma and sterol regulatory element binding protein- 1c (SREBP-1c) was down-regulated. In addition, compared with HFD group, in AC, P and AC+P group, the expression of intestinal tight-junction protein occludin and zonula occluden-1 (ZO-1) were up-regulated. Furthermore, altered gut microbiota diversity after the treatment of probiotics and AC were analysed. The combination of cholesterol-lowering probiotics and AC possesses a therapeutic effect on NAFLD in rats by up-regulating CYP7A1, LDL-R, FXR mRNA and PPAR-a protein produced in the process of fat metabolism while down-regulating the expression of HMGCR, PPAR-gamma and SREBP-1c, and through normalizing the intestinal dysbiosis and improving the intestinal mucosal barrier function.	[Mei, Lu; Tang, Youcai; Zheng, Pengyuan] Zhengzhou Univ, Affiliated Hosp 2, Dept Gastroenterol, Zhengzhou 450052, Peoples R China; [Mei, Lu; Li, Ming; Yuan, Jieli] Dalian Med Univ, Sch Basic Med Sci, Dept Microecol, Dalian, Peoples R China; [Zheng, Pengyuan] Zhengzhou Univ, Med Microecol & Clin Nutr Res Inst, Zhengzhou 450052, Peoples R China; [Liu, Zhiqiang] ENT Hosp, Shenzhen ENT Inst, Longgang Cent Hosp, Shenzhen, Peoples R China; [Yang, Pingchang] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	Zhengzhou University; Dalian Medical University; Zhengzhou University; McMaster University	Yuan, JL (corresponding author), Dalian Med Univ, Sch Basic Med Sci, Dept Microecol, Dalian, Peoples R China.	zgwst@126.com; medp7123@126.com	Yang, Ping-Chang/K-4669-2019; zheng, pengyuan/ABE-9595-2020	zheng, pengyuan/0000-0003-1647-0253; Tang, Youcai/0000-0003-2087-6029	National Science & Technology Pillar Program [2012BAI35B02, 2012BAI35B03]; 973 Program of China [2011CB512006]; National Natural Science Foundation of China [81370494, 31070799]; Science and Technology Department key research projects of Henan province [102102310400]; Science and technology innovation and outstanding talents funds of Henan province [134200510022]; National High Technology Research and Development Program of China 863 Program [2014AA022200]; Research Fund for the Doctoral Program of Higher Education, China (RFDP) [20132105120012]	National Science & Technology Pillar Program; 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department key research projects of Henan province; Science and technology innovation and outstanding talents funds of Henan province; National High Technology Research and Development Program of China 863 Program(National High Technology Research and Development Program of China); Research Fund for the Doctoral Program of Higher Education, China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This study was supported by grants from National Science & Technology Pillar Program during the Twelve Five-year Plan Period (2012BAI35B02, 2012BAI35B03), 973 Program (2011CB512006) of China, the National Natural Science Foundation of China (No. 81370494, 31070799), Science and Technology Department key research projects of Henan province (102102310400), Science and technology innovation and outstanding talents funds of Henan province (134200510022), the National High Technology Research and Development Program of China 863 Program (2014AA022200), and the Research Fund for the Doctoral Program of Higher Education, China (RFDP, 20132105120012).	ABBOTT RD, 1988, ARTERIOSCLEROSIS, V8, P207, DOI 10.1161/01.ATV.8.3.207; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Astrup A, 2014, AM J CLIN NUTR, V99, p1235S, DOI 10.3945/ajcn.113.073015; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cordero A, 2008, AM J CARDIOL, V102, P424, DOI 10.1016/j.amjcard.2008.03.079; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhanasekaran M, 2009, PHYTOMEDICINE, V16, P891, DOI 10.1016/j.phymed.2009.02.006; Eckard C, 2013, THER ADV GASTROENTER, V6, P249, DOI 10.1177/1756283X13484078; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Khoury D, 2013, CRITICAL RE IN PRESS; FENG HW, 1973, CLIN CHEM, V19, P121; Finelli C, 2012, WORLD J GASTROENTERO, V18, P6790, DOI 10.3748/wjg.v18.i46.6790; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001; Han KH, 2005, BRIT J NUTR, V94, P902, DOI 10.1079/BJN20051598; Hashimoto E, 2011, J GASTROENTEROL, V46, P63, DOI 10.1007/s00535-010-0311-8; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Jang DS, 2007, BIOL PHARM BULL, V30, P2207, DOI 10.1248/bpb.30.2207; Ju MS, 2010, FOOD CHEM TOXICOL, V48, P2037, DOI 10.1016/j.fct.2010.05.002; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816; Lesmana CRA, 2009, J DIGEST DIS, V10, P201, DOI 10.1111/j.1751-2980.2009.00386.x; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105577; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Liong MT, 2007, NUTR REV, V65, P316, DOI 10.1111/j.1753-4887.2007.tb00309.x; Luo Xianqin, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1654; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Moore JB, 2010, P NUTR SOC, V69, P211, DOI 10.1017/S0029665110000030; Patil UK, 2004, J ETHNOPHARMACOL, V90, P249, DOI 10.1016/j.jep.2003.10.007; Andrade MER, 2015, CLIN NUTR, V34, P1080, DOI 10.1016/j.clnu.2015.01.012; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; SHANMUGASUNDARAM KR, 1986, AM J CLIN NUTR, V44, P805, DOI 10.1093/ajcn/44.6.805; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Tarantino G, 2009, EUR J GASTROEN HEPAT, V21, P504, DOI 10.1097/MEG.0b013e3283229b40; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tzeng TF, 2013, FOOD CHEM TOXICOL, V51, P194, DOI 10.1016/j.fct.2012.09.024; Wagnerberger S, 2013, J NUTR BIOCHEM, V24, P531, DOI 10.1016/j.jnutbio.2012.01.014; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Xu ZJ, 2010, DIGEST DIS SCI, V55, P931, DOI 10.1007/s10620-009-0815-3	48	44	63	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138078	10.1371/journal.pone.0138078	http://dx.doi.org/10.1371/journal.pone.0138078			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375281	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200074
J	Rosier, E; Loix, S; Develter, W; Van de Voorde, W; Tytgat, J; Cuypers, E				Rosier, E.; Loix, S.; Develter, W.; Van de Voorde, W.; Tytgat, J.; Cuypers, E.			The Search for a Volatile Human Specific Marker in the Decomposition Process	PLOS ONE			English	Article							2-DIMENSIONAL GAS-CHROMATOGRAPHY; FLIGHT MASS-SPECTROMETRY; ORGANIC-COMPOUNDS PRESENT; HUMAN REMAINS; ODOR ANALYSIS; TIME; HEADSPACE; PRODUCTS; SOIL	In this study, a validated method using a thermal desorber combined with a gas chromatograph coupled to mass spectrometry was used to identify the volatile organic compounds released during decomposition of 6 human and 26 animal remains in a laboratory environment during a period of 6 months. 452 compounds were identified. Among them a human specific marker was sought using principle component analysis. We found a combination of 8 compounds (ethyl propionate, propyl propionate, propyl butyrate, ethyl pentanoate, pyridine, diethyl disulfide, methyl(methylthio) ethyl disulfide and 3-methylthio-1-propanol) that led to the distinction of human and pig remains from other animal remains. Furthermore, it was possible to separate the pig remains from human remains based on 5 esters (3-methylbutyl pentanoate, 3-methylbutyl 3-methylbutyrate, 3-methylbutyl 2-methylbutyrate, butyl pentanoate and propyl hexanoate). Further research in the field with full bodies has to corroborate these results and search for one or more human specific markers. These markers would allow a more efficiently training of cadaver dogs or portable detection devices could be developed.	[Rosier, E.; Loix, S.; Tytgat, J.; Cuypers, E.] Univ Leuven KU Leuven, Dept Pharmaceut & Pharmacol Sci Toxicol & Pharmac, Leuven, Belgium; [Develter, W.; Van de Voorde, W.] Univ Leuven KU Leuven, Div Forens Biomed Sci, Imaging & Pathol Dept, Leuven, Belgium	KU Leuven; KU Leuven	Cuypers, E (corresponding author), Univ Leuven KU Leuven, Dept Pharmaceut & Pharmacol Sci Toxicol & Pharmac, Leuven, Belgium.	eva.cuypers@pharm.kuleuven.be	Cuypers, Eva/AAK-9134-2021	Tytgat, Jan/0000-0003-1778-6022; Cuypers, Eva/0000-0002-6411-2461				Brasseur C, 2012, J CHROMATOGR A, V1255, P163, DOI 10.1016/j.chroma.2012.03.048; Cablk ME, 2012, FORENSIC SCI INT, V220, P118, DOI 10.1016/j.forsciint.2012.02.007; DeGreeff LE, 2011, ANAL BIOANAL CHEM, V401, P1295, DOI 10.1007/s00216-011-5167-0; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Dekeirsschieter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039005; Dent BB, 2004, ENVIRON GEOL, V45, P576, DOI 10.1007/s00254-003-0913-z; Etschmann MMW, 2008, APPL MICROBIOL BIOT, V80, P579, DOI 10.1007/s00253-008-1573-4; Forbes SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113681; Forbes SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095107; Hoffman EM, 2009, FORENSIC SCI INT, V186, P6, DOI 10.1016/j.forsciint.2008.12.022; Hudson DT, 2009, J FORENSIC SCI, V54, P1270, DOI 10.1111/j.1556-4029.2009.01153.x; Kasper J, 2012, FORENSIC SCI INT, V223, P64, DOI 10.1016/j.forsciint.2012.08.001; Moreira N, 2002, ANAL CHIM ACTA, V458, P157, DOI 10.1016/S0003-2670(01)01618-X; Paczkowski S, 2011, APPL MICROBIOL BIOT, V91, P917, DOI 10.1007/s00253-011-3417-x; Perrault KA, 2015, ANAL METHODS-UK, V7, P690, DOI 10.1039/c4ay02321h; Perrault KA, 2015, J SEP SCI, V38, P73, DOI 10.1002/jssc.201400935; Rosier E, 2014, ANAL BIOANAL CHEM, V406, P3611, DOI 10.1007/s00216-014-7741-8; Stadler S, 2013, ANAL CHEM, V85, P998, DOI 10.1021/ac302614y; Stadler S, 2012, J CHROMATOGR A, V1255, P202, DOI 10.1016/j.chroma.2012.04.001; Statheropoulos M, 2007, SCI TOTAL ENVIRON, V385, P221, DOI 10.1016/j.scitotenv.2007.07.003; Statheropoulos M, 2005, FORENSIC SCI INT, V153, P147, DOI 10.1016/j.forsciint.2004.08.015; Statheropoulos M, 2011, FORENSIC SCI INT, V210, P154, DOI 10.1016/j.forsciint.2011.02.023; Swann LM, 2010, ANAL CHIM ACTA, V682, P9, DOI 10.1016/j.aca.2010.09.052; Vass AA, 2004, J FORENSIC SCI, V49, P760; Vass AA, 2008, J FORENSIC SCI, V53, P384, DOI 10.1111/j.1556-4029.2008.00680.x; Vass AA, 2012, FORENSIC SCI INT, V222, P234, DOI 10.1016/j.forsciint.2012.06.006	26	27	27	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137341	10.1371/journal.pone.0137341	http://dx.doi.org/10.1371/journal.pone.0137341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375029	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200034
J	Bertrand, S; Aldea, D; Oulion, S; Subirana, L; de Lera, AR; Somorjai, I; Escriva, H				Bertrand, Stephanie; Aldea, Daniel; Oulion, Silvan; Subirana, Lucie; de Lera, Angel R.; Somorjai, Ildiko; Escriva, Hector			Evolution of the Role of RA and FGF Signals in the Control of Somitogenesis in Chordates	PLOS ONE			English	Article							RETINOIC ACID CONTROLS; LEFT-RIGHT ASYMMETRY; BRANCHIOSTOMA-LANCEOLATUM; DEVELOPMENTAL EXPRESSION; CIONA-INTESTINALIS; POSTERIOR AXIS; AMPHIOXUS; GENE; SEGMENTATION; CLOCK	During vertebrate development, the paraxial mesoderm becomes segmented, forming somites that will give rise to dermis, axial skeleton and skeletal muscles. Although recently challenged, the "clock and wavefront" model for somitogenesis explains how interactions between several cell-cell communication pathways, including the FGF, RA, Wnt and Notch signals, control the formation of these bilateral symmetric blocks. In the cephalochordate amphioxus, which belongs to the chordate phylum together with tunicates and vertebrates, the dorsal paraxial mesendoderm also periodically forms somites, although this process is asymmetric and extends along the whole body. It has been previously shown that the formation of the most anterior somites in amphioxus is dependent upon FGF signalling. However, the signals controlling somitogenesis during posterior elongation in amphioxus are still unknown. Here we show that, contrary to vertebrates, RA and FGF signals act independently during posterior elongation and that they are not mandatory for posterior somites to form. Moreover, we show that RA is not able to buffer the left/right asymmetry machinery that is controlled through the asymmetric expression of Nodal pathway actors. Our results give new insights into the evolution of the somitogenesis process in chordates. They suggest that RA and FGF pathways have acquired specific functions in the control of somitogenesis in vertebrates. We propose that the "clock and wavefront" system was selected specifically in vertebrates in parallel to the development of more complex somite-derived structures but that it was not required for somitogenesis in the ancestor of chordates.	[Bertrand, Stephanie; Aldea, Daniel; Oulion, Silvan; Subirana, Lucie; Somorjai, Ildiko; Escriva, Hector] Univ Paris 06, BIOM, Observ Oceanol Banyuls Mer, UMR 7232, F-66650 Banyuls Sur Mer, France; [de Lera, Angel R.] Univ Vigo, CINBIO, Fac Quim, Dept Quim Organ, Vigo 36310, Spain; [de Lera, Angel R.] Invest Biomed Vigo IBIV, Vigo 36310, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universidade de Vigo; CINBIO	Bertrand, S (corresponding author), Univ Paris 06, BIOM, Observ Oceanol Banyuls Mer, UMR 7232, F-66650 Banyuls Sur Mer, France.	stephanie.bertrand@obs-banyuls.fr; hector.escriva@obs-banyuls.fr	Escriva, Hector/K-8325-2013; Aldea, Daniel/L-4040-2015; Bertrand, Stephanie/D-8482-2014	Escriva, Hector/0000-0001-7577-5028; Aldea, Daniel/0000-0001-5101-0194; Bertrand, Stephanie/0000-0002-0689-0126; Somorjai, Ildiko/0000-0001-5243-6664; Subirana, Lucie/0000-0002-9942-1125	ANR [BLAN 1716 01]; MASTS (Marine Alliance for Science and Technology Scotland)	ANR(French National Research Agency (ANR)); MASTS (Marine Alliance for Science and Technology Scotland)	The laboratory of HE is supported by the ANR BLAN 1716 01. IMLS's laboratory is currently supported by MASTS (Marine Alliance for Science and Technology Scotland).	Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Beaster-Jones L, 2008, DEV GENES EVOL, V218, P599, DOI 10.1007/s00427-008-0257-5; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; Boorman CJ, 2002, EVOL DEV, V4, P354, DOI 10.1046/j.1525-142X.2002.02021.x; Canestro C, 2007, DEV BIOL, V305, P522, DOI 10.1016/j.ydbio.2007.02.032; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dias AS, 2014, SCIENCE, V343, P791, DOI 10.1126/science.1247575; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Escriva H, 2002, DEVELOPMENT, V129, P2905; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; Hirakow R, 1994, Kaibogaku Zasshi, V69, P1; HIRAKOW R, 1991, J MORPHOL, V207, P37, DOI 10.1002/jmor.1052070106; Holland LZ, 2000, DEV GENES EVOL, V210, P522, DOI 10.1007/s004270000089; Holland LZ, 1996, MOL ZOOLOGY ADV STRA; HOLLAND PWH, 1992, DEVELOPMENT, V116, P653; Hubaud A, 2014, NAT REV MOL CELL BIO, V15, P709, DOI 10.1038/nrm3891; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Keyte AL, 2014, SEMIN CELL DEV BIOL, V34, P99, DOI 10.1016/j.semcdb.2014.06.015; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; Le Petillon Y, 2013, GENE EXPR PATTERNS, V13, P377, DOI 10.1016/j.gep.2013.07.005; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Lin HC, 2006, DEV DYNAM, V235, P3396, DOI 10.1002/dvdy.20971; Maden M, 2000, INT J DEV BIOL, V44, P151; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; Martinez-Morales PL, 2011, J CELL BIOL, V194, P489, DOI 10.1083/jcb.201011077; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; MORII M, 1993, J BIOL CHEM, V268, P21553; Morris SC, 2012, BIOL REV, V87, P480, DOI 10.1111/j.1469-185X.2012.00220.x; Nagatomo K, 2003, GENE EXPR PATTERNS, V3, P273, DOI 10.1016/S1567-133X(03)00051-6; Nagatomo K, 2003, MECH DEVELOP, V120, P363, DOI 10.1016/S0925-4773(02)00441-0; Namigai EKO, 2014, GENESIS, V52, P458, DOI 10.1002/dvg.22748; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Onai T, 2010, DEV BIOL, V344, P377, DOI 10.1016/j.ydbio.2010.05.016; Osborne PW, 2009, DEV BIOL, V327, P252, DOI 10.1016/j.ydbio.2008.11.027; Oulion Silvan, 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/298147; Pascual-Anaya J, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-28; Pasini A, 2013, PLOS ONE, V7; Passamaneck YJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000714; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Qian GH, 2013, GENE EXPR PATTERNS, V13, P445, DOI 10.1016/j.gep.2013.08.003; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; Schubert M, 2000, GENESIS, V27, P1; Schubert M, 2005, DEVELOPMENT, V132, P61, DOI 10.1242/dev.01554; Schubert M, 2001, DEV BIOL, V240, P262, DOI 10.1006/dbio.2001.0460; Schubert M, 2006, DEV BIOL, V296, P190, DOI 10.1016/j.ydbio.2006.04.457; Shimeld SM, 2006, DEV DYNAM, V235, P1543, DOI 10.1002/dvdy.20792; Sirbu IO, 2008, DEV DYNAM, V237, P1627, DOI 10.1002/dvdy.21570; Somorjai I, 2008, DEV GENES EVOL, V218, P703, DOI 10.1007/s00427-008-0256-6; Soukup V, 2015, EVODEVO, V6, DOI 10.1186/2041-9139-6-5; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Watanabe H, 2014, NATURE, V515, P112, DOI 10.1038/nature13666; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Wu HR, 2011, DEV BIOL, V353, P147, DOI 10.1016/j.ydbio.2011.02.014; Yu JK, 2002, EVOL DEV, V4, P418, DOI 10.1046/j.1525-142X.2002.02030.x; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	65	28	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136587	10.1371/journal.pone.0136587	http://dx.doi.org/10.1371/journal.pone.0136587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371756	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400006
J	Rosenbaum, JT; Choi, D; Wong, A; Wilson, DJ; Grossniklaus, HE; Harrington, CA; Dailey, RA; Ng, JD; Steele, EA; Czyz, CN; Foster, JA; Tse, D; Alabiad, C; Dubovy, S; Parekh, PK; Harris, GJ; Kazim, M; Patel, PJ; White, VA; Dolman, PJ; Edward, DP; Alkatan, HM; al Hussain, H; Selva, D; Yeatts, RP; Korn, BS; Kikkawa, DO; Stauffer, P; Planck, SR				Rosenbaum, James T.; Choi, Dongseok; Wong, Amanda; Wilson, David J.; Grossniklaus, Hans E.; Harrington, Christina A.; Dailey, Roger A.; Ng, John D.; Steele, Eric A.; Czyz, Craig N.; Foster, Jill A.; Tse, David; Alabiad, Chris; Dubovy, Sander; Parekh, Prashant K.; Harris, Gerald J.; Kazim, Michael; Patel, Payal J.; White, Valerie A.; Dolman, Peter J.; Edward, Deepak P.; Alkatan, Hind M.; al Hussain, Hailah; Selva, Dinesh; Yeatts, R. Patrick; Korn, Bobby S.; Kikkawa, Don O.; Stauffer, Patrick; Planck, Stephen R.			The Role of the Immune Response in the Pathogenesis of Thyroid Eye Disease: A Reassessment	PLOS ONE			English	Article							ORBITAL ADIPOSE-TISSUE; GRAVES OPHTHALMOPATHY; GENE-EXPRESSION; ORBITOPATHY; OVEREXPRESSION; CYTOKINES; PROFILES; ALPHA; FAT	Background Although thyroid eye disease is a common complication of Graves' disease, the pathogenesis of the orbital disease is poorly understood. Most authorities implicate the immune response as an important causal factor. We sought to clarify pathogenesis by using gene expression microarray. Methods An international consortium of ocular pathologists and orbital surgeons contributed formalin fixed orbital biopsies. RNA was extracted from orbital tissue from 20 healthy controls, 25 patients with thyroid eye disease (TED), 25 patients with nonspecific orbital inflammation (NSOI), 7 patients with sarcoidosis and 6 patients with granulomatosis with polyangiitis (GPA). Tissue was divided into a discovery set and a validation set. Gene expression was quantified using Affymetrix U133 Plus 2.0 microarrays which include 54,000 probe sets. Results Principal component analysis showed that gene expression from tissue from patients with TED more closely resembled gene expression from healthy control tissue in comparison to gene expression characteristic of sarcoidosis, NSOI, or granulomatosis with polyangiitis. Unsupervised cluster dendrograms further indicated the similarity between TED and healthy controls. Heat maps based on gene expression for cytokines, chemokines, or their receptors showed that these inflammatory markers were associated with NSOI, sarcoidosis, or GPA much more frequently than with TED. Conclusion This is the first study to compare gene expression in TED to gene expression associated with other causes of exophthalmos. The juxtaposition shows that inflammatory markers are far less characteristic of TED relative to other orbital inflammatory diseases.	[Rosenbaum, James T.; Choi, Dongseok; Wong, Amanda; Wilson, David J.; Dailey, Roger A.; Ng, John D.; Steele, Eric A.; Stauffer, Patrick; Planck, Stephen R.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Rosenbaum, James T.; Planck, Stephen R.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Rosenbaum, James T.; Planck, Stephen R.] Legacy Hlth Syst, Devers Eye Inst, Portland, OR USA; [Choi, Dongseok] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Grossniklaus, Hans E.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Harrington, Christina A.] Oregon Hlth & Sci Univ, Integrated Genom Lab, Portland, OR 97201 USA; [Czyz, Craig N.] Oregon Hlth & Sci Univ, Div Ophthalmol, Portland, OR 97201 USA; [Foster, Jill A.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Tse, David; Alabiad, Chris; Dubovy, Sander; Parekh, Prashant K.] Univ Miami, Dept Ophthalmol, Miami, FL USA; [Harris, Gerald J.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Kazim, Michael; Patel, Payal J.] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [White, Valerie A.; Dolman, Peter J.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Edward, Deepak P.; Alkatan, Hind M.; al Hussain, Hailah] King Khalid Eye Specialist Hosp, Res Dept, Riyadh, Saudi Arabia; [Selva, Dinesh] Royal Adelaide Hosp, Ophthalmol Network, Adelaide, SA 5000, Australia; [Yeatts, R. Patrick] Wake Forrest Univ, Dept Ophthalmol, Winston Salem, NC USA; [Korn, Bobby S.; Kikkawa, Don O.] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA	Oregon Health & Science University; Oregon Health & Science University; Devers Eye Institute; Legacy Health; Oregon Health & Science University; Emory University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Miami; Medical College of Wisconsin; Columbia University; University of British Columbia; King Khaled Eye Specialist Hospital; Royal Adelaide Hospital; University of California System; University of California San Diego	Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	rosenbaj@ohsu.edu	ALKATAN, HIND M/AAU-3752-2021; Tse, David/GMW-9987-2022	ALKATAN, HIND M/0000-0002-9968-4099; Choi, Dongseok/0000-0002-1552-4072; Czyz, Craig/0000-0001-6357-8019	National Institutes of Health USA [EY020249, EY010572, RR024140]; Research to Prevent Blindness (Casey Eye Institute, OHSU); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; MAS Family Foundation; NATIONAL EYE INSTITUTE [P30EY010572, R01EY020249] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (Casey Eye Institute, OHSU); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; MAS Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by funding from National Institutes of Health USA Grants (www.nih.gov), EY020249 (JTR), EY010572 (JTR) and RR024140 (E.S. Orwoll); and Research to Prevent Blindness (www.rpbusa.org) (Casey Eye Institute, OHSU), the Stan and Madelle Rosenfeld Family Trust (JTR), the William and Mary Bauman Foundation (JTR), the MAS Family Foundation (JTR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2014, AUTOIMMUN REV, V13, P1160, DOI 10.1016/j.autrev.2014.08.025; Beck IM, 2013, EUR J PHARMACOL, V715, P1, DOI 10.1016/j.ejphar.2013.06.032; Chen MH, 2008, INVEST OPHTH VIS SCI, V49, P4760, DOI 10.1167/iovs.08-2020; Du P, 2014, INT J GENOMICS, V2014, DOI [10.1155/2014/537969, DOI 10.1155/2014/537969]; Ezra DG, 2012, J CLIN PATHOL, V65, P608, DOI 10.1136/jclinpath-2012-200719; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kumar S, 2005, J CLIN ENDOCR METAB, V90, P4730, DOI 10.1210/jc.2004-2239; Kumar S, 2003, J CLIN ENDOCR METAB, V88, P4246, DOI 10.1210/jc.2003-030380; Lantz M, 2005, J CLIN ENDOCR METAB, V90, P4784, DOI 10.1210/jc.2004-2275; Li B, 2014, J CLIN ENDOCR METAB, V99, P3363, DOI 10.1210/jc.2014-1257; Li R, 2014, GENE, V538, P150, DOI 10.1016/j.gene.2013.12.027; Linquist RA, 2014, ORBIT, V33, P363, DOI 10.3109/01676830.2014.937877; MARDIA KV, 1978, COMMUN STAT A-THEOR, V7, P1233, DOI 10.1080/03610927808827707; Minakaran N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009226.pub2; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Niyazoglu M, 2014, GENE, V547, P226, DOI 10.1016/j.gene.2014.06.038; Planck T, 2011, THYROID, V21, P663, DOI 10.1089/thy.2010.0217; Ponto KA, 2014, CLIN EXP IMMUNOL, V178, P57, DOI 10.1111/cei.12395; Rosenbaum JT, 2015, EXP MOL PATHOL, V99, P271, DOI 10.1016/j.yexmp.2015.07.002; Rosenbaum JT, 2015, EXP MOL PATHOL, V98, P225, DOI 10.1016/j.yexmp.2015.01.009; Salvi M, 2014, CURR OPIN ENDOCRINOL, V21, P409, DOI 10.1097/MED.0000000000000097; Shan Shannon J C, 2014, J Neuroophthalmol, V34, P177, DOI 10.1097/WNO.0000000000000132; Stan MN, 2015, J CLIN ENDOCR METAB, V100, P432, DOI 10.1210/jc.2014-2572; Stone JH, 2012, SEMIN DIAGN PATHOL, V29, P177, DOI 10.1053/j.semdp.2012.08.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wei HF, 2014, ENDOCR J, V61, P1087, DOI 10.1507/endocrj.EJ14-0246; Wong AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109847; Zhang L, 2014, J CLIN ENDOCR METAB, V99, pE1183, DOI 10.1210/jc.2013-4182	29	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137654	10.1371/journal.pone.0137654	http://dx.doi.org/10.1371/journal.pone.0137654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371757	Green Submitted, Green Published, gold			2022-12-26	WOS:000361604400026
J	Scacchetti, PC; Utsunomia, R; Pansonato-Alves, JC; Silva, GJD; Vicari, MR; Artoni, RF; Oliveira, C; Foresti, F				Scacchetti, Priscilla Cardim; Utsunomia, Ricardo; Pansonato-Alves, Jose Carlos; da Costa Silva, Guilherme Jose; Vicari, Marcelo Ricardo; Artoni, Roberto Ferreira; Oliveira, Claudio; Foresti, Fausto			Repetitive DNA Sequences and Evolution of ZZ/ZW Sex Chromosomes in Characidium (Teleostei: Characiformes)	PLOS ONE			English	Article							DETERMINING MECHANISMS; COASTAL DRAINAGES; CRENUCHIDAE; SYSTEM; DIVERSIFICATION; DIFFERENTIATION; FISHES; LINKAGE; PISCES; BRAZIL	Characidium constitutes an interesting model for cytogenetic studies, since a large degree of karyotype variation has been detected in this group, like the presence/absence of sex and supernumerary chromosomes and variable distribution of repetitive sequences in different species/populations. In this study, we performed a comparative cytogenetic analysis in 13 Characidium species collected at different South American river basins in order to investigate the karyotype diversification in this group. Chromosome analyses involved the karyotype characterization, cytogenetic mapping of repetitive DNA sequences and cross-species chromosome painting using a W-specific probe obtained in a previous study from Characidium gomesi. Our results evidenced a conserved diploid chromosome number of 2n = 50, and almost all the species exhibited homeologous ZZ/ZW sex chromosomes in different stages of differentiation, except C. cf. zebra, C. tenue, C. xavante and C. stigmosum. Notably, some ZZ/ZW sex chromosomes showed 5S and/or 18S rDNA clusters, while no U2 snDNA sites could be detected in the sex chromosomes, being restricted to a single chromosome pair in almost all the analyzed species. In addition, the species Characidium sp. aff. C. vidali showed B chromosomes with an inter-individual variation of 1 to 4 supernumerary chromosomes per cell. Notably, these B chromosomes share sequences with theWspecific probe, providing insights about their origin. Results presented here further confirm the extensive karyotype diversity within Characidium in contrast with a conserved diploid chromosome number. Such chromosome differences seem to constitute a significant reproductive barrier, since several sympatric Characidium species had been described during the last few years and no interespecific hybrids were found.	[Scacchetti, Priscilla Cardim; Utsunomia, Ricardo; Pansonato-Alves, Jose Carlos; da Costa Silva, Guilherme Jose; Oliveira, Claudio; Foresti, Fausto] Univ Estadual Paulista UNESP, Inst Biociencias Botucatu IBB, Dept Morfol, Botucatu, SP, Brazil; [Vicari, Marcelo Ricardo; Artoni, Roberto Ferreira] Univ Estadual Ponta Grossa, Dept Biol Estrut Mol Genet, Ponta Grossa, PR, Brazil	Universidade Estadual Paulista; Universidade Estadual de Ponta Grossa	Scacchetti, PC (corresponding author), Univ Estadual Paulista UNESP, Inst Biociencias Botucatu IBB, Dept Morfol, Botucatu, SP, Brazil.	pcardim@ibb.unesp.br	Fapesp, Biota/F-8655-2017; Vicari, Marcelo Ricardo/I-2299-2015; Artoni, Roberto Ferreira/N-1693-2019; Oliveira, Claudio/D-7713-2012; Utsunomia, Ricardo/O-8955-2015	Fapesp, Biota/0000-0002-9887-8449; Vicari, Marcelo Ricardo/0000-0003-3913-9889; Artoni, Roberto Ferreira/0000-0002-2528-9846; Oliveira, Claudio/0000-0002-7010-8880; Utsunomia, Ricardo/0000-0003-4565-6065	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) from Brazil; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) from Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) from Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) from Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil.	Merlo MA, 2010, GENES GENET SYST, V85, P341, DOI 10.1266/ggs.85.341; BUCKUP PA, 1993, ZOOL J LINN SOC-LOND, V108, P225; Buckup PA., 2003, CHECK LIST FRESHWATE, P87; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Centofante L, 2003, HEREDITAS, V138, P213, DOI 10.1034/j.1601-5223.2003.01714.x; Centofante L, 2001, CARYOLOGIA, V54, P253, DOI 10.1080/00087114.2001.10589233; FORESTI F, 1981, CYTOGENET CELL GENET, V31, P137, DOI 10.1159/000131639; Henning F, 2008, CYTOGENET GENOME RES, V121, P55, DOI 10.1159/000124382; Koubova M, 2014, CHROMOSOME RES, V22, P441, DOI 10.1007/s10577-014-9430-z; Leitao RP, 2014, COPEIA, P14, DOI 10.1643/CI-12-137; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Machado TC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-65; Maistro Edson Luis, 2004, Cytologia (Tokyo), V69, P181, DOI 10.1508/cytologia.69.181; Maistro EL, 1998, GENETICA, V104, P1, DOI 10.1023/A:1003242020259; Manchado M, 2006, GENOME, V49, P79, DOI 10.1139/G05-068; Mank JE, 2006, BIOL J LINN SOC, V87, P83, DOI 10.1111/j.1095-8312.2006.00558.x; Miyazawa C. S., 1994, Cytologia (Tokyo), V59, P73; Netto-Ferreira AL, 2013, ZOOTAXA, V3664, P361, DOI 10.11646/zootaxa.3664.3.6; Noleto RB, 2009, J FISH BIOL, V75, P448, DOI 10.1111/j.1095-8649.2009.02342.x; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Palacios-Gimenez OM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-167; Alves JCP, 2010, NEOTROP ICHTHYOL, V8, P77, DOI 10.1590/S1679-62252010000100010; Pansonato-Alves JC, 2011, J FISH BIOL, V78, P183, DOI 10.1111/j.1095-8649.2010.02847.x; Pansonato-Alves JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107169; Pansonato-Alves JC, 2011, GENET MOL BIOL, V34, P208, DOI 10.1590/S1415-47572011005000005; Parise-Maltempi PP, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-60; Pazian MF, 2013, GENETICA, V141, P1, DOI 10.1007/s10709-013-9701-1; Pelliccia F, 2001, GENOME, V44, P331, DOI 10.1139/gen-44-3-331; PENDAS AM, 1994, CYTOGENET CELL GENET, V67, P31, DOI 10.1159/000133792; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pokorna M, 2009, ZOOL J LINN SOC-LOND, V156, P168, DOI 10.1111/j.1096-3642.2008.00481.x; Pucci MB, 2014, BIOL J LINN SOC, V111, P541, DOI 10.1111/bij.12218; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Scacchetti PC, 2015, CYTOGENET GENOME RES, V146, P136, DOI 10.1159/000437165; Scacchetti PC, 2015, GENETICA, V143, P263, DOI 10.1007/s10709-014-9812-3; Schemberger MO, 2011, GENETICA, V139, P1499, DOI 10.1007/s10709-012-9649-6; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Utsunomia R, 2014, CYTOGENET GENOME RES, V142, P286, DOI 10.1159/000362258; Vicari MR, 2008, GENETICA, V134, P311, DOI 10.1007/s10709-007-9238-2; Vicoso B, 2013, NATURE, V499, P332, DOI 10.1038/nature12235; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zanata AM, 2014, NEOTROP ICHTHYOL, V12, P333, DOI 10.1590/1982-0224-20130168	44	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137231	10.1371/journal.pone.0137231	http://dx.doi.org/10.1371/journal.pone.0137231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372604	gold, Green Published, Green Submitted			2022-12-26	WOS:000361604400013
J	Smith, D; Aherrera, A; Lopez, A; Neptune, E; Winickoff, JP; Klein, JD; Chen, G; Lazarus, P; Collaco, JM; McGrath-Morrow, SA				Smith, Dani; Aherrera, Angela; Lopez, Armando; Neptune, Enid; Winickoff, Jonathan P.; Klein, Jonathan D.; Chen, Gang; Lazarus, Philip; Collaco, Joseph M.; McGrath-Morrow, Sharon A.			Adult Behavior in Male Mice Exposed to E-Cigarette Nicotine Vapors during Late Prenatal and Early Postnatal Life	PLOS ONE			English	Article							C57BL/6J MICE; SMOKE EXPOSURE; TERATOGENICITY; HYPERACTIVITY; PERFORMANCE; COTININE; ANXIETY; BRAIN; RISK; TIME	Nicotine exposure has been associated with an increased likelihood of developing attention deficit hyperactivity disorder (ADHD) in offspring of mothers who smoked during pregnancy. The goal of this study was to determine if exposure to E-cigarette nicotine vapors during late prenatal and early postnatal life altered behavior in adult mice. Methods Timed-pregnant C57BL/6J mice were exposed to 2.4% nicotine in propylene glycol (PG) or 0% nicotine/PG once a day from gestational day 15 until delivery. After delivery, offspring and mothers were exposed to E-cigarette vapors for an additional 14 days from postnatal day 2 through 16. Following their last exposure serum cotinine levels were measured in female juvenile mice. Male mice underwent behavioral testing at 14 weeks of age to assess sensorimotor, affective, and cognitive functional domains. Results Adult male mice exposed to 2.4% nicotine/PG E-cigarette vapors had significantly more head dips in the zero maze test and higher levels of rearing activity in the open field test compared to 0% nicotine/ PG exposed mice and untreated controls. In the water maze test after reversal training, the 2.4% nicotine/ PG mice spent more than 25% of time in the new location whereas the other groups did not. Conclusion Adult male mice exhibited increased levels of activity in the zero maze and open field tests when exposed to E-cigarette vapor containing nicotine during late prenatal and early postnatal life. These findings indicate that nicotine exposure from E-cigarettes may cause persistent behavioral changes when exposure occurs during a period of rapid brain growth.	[Smith, Dani] Johns Hopkins Univ, Dept Psychol & Brain Sci, Neurogenet & Behav Ctr, Baltimore, MD USA; [Aherrera, Angela; Lopez, Armando; Collaco, Joseph M.; McGrath-Morrow, Sharon A.] Johns Hopkins Univ, Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD 21218 USA; [Lopez, Armando; Neptune, Enid] Johns Hopkins Med Inst, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Winickoff, Jonathan P.; Klein, Jonathan D.; Collaco, Joseph M.; McGrath-Morrow, Sharon A.] Amer Acad Pediat, Julius B Richmond Ctr Excellence, Elk Grove Village, IL USA; [Winickoff, Jonathan P.] Massachusetts Gen Hosp, Div Gen Pediat, Boston, MA 02114 USA; [Winickoff, Jonathan P.] Harvard Univ, Sch Med, Boston, MA USA; [Chen, Gang; Lazarus, Philip] Washington State Univ, Dept Pharmacol, Pullman, WA 99164 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; American Academy of Pediatrics; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington State University	McGrath-Morrow, SA (corresponding author), Johns Hopkins Univ, Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD 21218 USA.	smcgrath@jhmi.edu		Klein, Jonathan/0000-0003-4185-1998	Flight Attendant Medical Research Institute; National Institutes of Health, NIH [RHL114800A]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025460] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by a Center of Excellence Grant to the American Academy of Pediatrics from the Flight Attendant Medical Research Institute (SAM, JMC, JDK, JPW); and National Institutes of Health, NIH RHL114800A (SAM).	Ajarem JS, 1998, PHARMACOL BIOCHEM BE, V59, P313, DOI 10.1016/S0091-3057(97)00408-5; Alkam T, 2013, PSYCHOPHARMACOLOGY, V230, P451, DOI 10.1007/s00213-013-3175-9; Allison C, 2013, NEUROPHARMACOLOGY, V64, P314, DOI 10.1016/j.neuropharm.2012.06.055; Ballbe M, 2014, ENVIRON RES, V135, P76, DOI 10.1016/j.envres.2014.09.005; Bergvall N, 2006, PEDIATRICS, V117, pE460, DOI 10.1542/peds.2005-0737; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Damaj MI, 2001, J PHARMACOL EXP THER, V296, P132; de Chazeron I, 2008, PULM PHARMACOL THER, V21, P485, DOI 10.1016/j.pupt.2007.11.001; Eppolito AK, 2010, NEUROTOXICOL TERATOL, V32, P336, DOI 10.1016/j.ntt.2009.12.009; Eriksson P, 2000, BRAIN RES, V853, P41, DOI 10.1016/S0006-8993(99)02231-3; Etter JF, 2014, ADDICTION, V109, P825, DOI 10.1111/add.12475; Flores-Montoya MG, 2015, J APPL TOXICOL, V35, P759, DOI 10.1002/jat.3064; Herrmann M, 2008, CURR OPIN PEDIATR, V20, P184, DOI 10.1097/MOP.0b013e3282f56165; Ivorra C, 2014, DRUG ALCOHOL DEPEN, V134, P275, DOI 10.1016/j.drugalcdep.2013.10.017; Levin ED, 2013, BIOCHEM PHARMACOL, V86, P1145, DOI 10.1016/j.bcp.2013.07.021; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Lv JX, 2008, NEUROTOXICOLOGY, V29, P722, DOI 10.1016/j.neuro.2008.04.015; Marchenko Y, 2006, STATA J, V6, P1; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Ortega LA, 2013, BEHAV BRAIN RES, V238, P134, DOI 10.1016/j.bbr.2012.10.032; Paavonen EJ, 2007, PEDIATRICS, V120, P778, DOI 10.1542/peds.2007-0540; Paz R, 2007, NEUROPSYCHOPHARMACOL, V32, P693, DOI 10.1038/sj.npp.1301066; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Ross EJ, 2015, NEUROPSYCHOPHARMACOL, V40, P61, DOI 10.1038/npp.2014.147; Schneider T, 2012, PSYCHOPHARMACOLOGY, V223, P401, DOI 10.1007/s00213-012-2728-7; Vaglenova J, 2004, BEHAV BRAIN RES, V150, P159, DOI 10.1016/j.bbr.2003.07.005; Wainwright PE, 2007, DEV PSYCHOBIOL, V49, P664, DOI 10.1002/dev.20245; WEITZMAN M, 1992, PEDIATRICS, V90, P342; Yochum C, 2014, EXP NEUROL, V254, P145, DOI 10.1016/j.expneurol.2014.01.016	29	61	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137953	10.1371/journal.pone.0137953	http://dx.doi.org/10.1371/journal.pone.0137953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372012	Green Published, gold, Green Submitted			2022-12-26	WOS:000361604400038
J	Di Giacomo, G; Campello, S; Corrado, M; Di Giambattista, L; Cirotti, C; Filomeni, G; Gentile, G				Di Giacomo, Giuseppina; Campello, Silvia; Corrado, Mauro; Di Giambattista, Livia; Cirotti, Claudia; Filomeni, Giuseppe; Gentile, Gabriele			Mature Erythrocytes of Iguana iguana (Squamata, Iguanidae) Possess Functional Mitochondria	PLOS ONE			English	Article							RED-BLOOD-CELLS; ELECTRON-MICROSCOPE; OXYGEN-BINDING; HEMOGLOBIN; METABOLISM; CROCODYLUS; EVOLUTION	Electron microscopy analyses of Iguana iguana blood preparations revealed the presence of mitochondria within erythrocytes with well-structured cristae. Fluorescence microscopy analyses upon incubation with phalloidin-FITC, Hoechst 33342 and mitochondrial transmembrane potential (Delta psi(m))-sensitive probe MitoTracker Red indicated that mitochondria i) widely occur in erythrocytes, ii) are polarized, and iii) seem to be preferentially confined at a "perinuclear" region, as confirmed by electron microscopy. The analysis of NADH-dependent oxygen consumption showed that red blood cells retain the capability to consume oxygen, thereby providing compelling evidence that mitochondria of Iguana erythrocytes are functional and capable to perform oxidative phosphorylation.	[Di Giacomo, Giuseppina; Campello, Silvia; Di Giambattista, Livia; Cirotti, Claudia; Filomeni, Giuseppe; Gentile, Gabriele] Univ Roma Tor Vergata, Dipartimento Biol, Rome, Italy; [Campello, Silvia; Corrado, Mauro] IRCCS Fdn Santa Lucia, Rome, Italy; [Corrado, Mauro] Ist Veneto Med Mol, Ist Telethon Dulbecco, Padua, Italy; [Filomeni, Giuseppe] Danish Canc Soc, Res Ctr, Cell Stress & Survival Unit, Copenhagen, Denmark	University of Rome Tor Vergata; IRCCS Santa Lucia; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; Danish Cancer Society	Filomeni, G (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, Rome, Italy.	filomeni@bio.uniroma2.it; gabriele.gentile@uniroma2.it	cirotti, claudia/AAN-7789-2020; Gentile, Gabriele/E-8945-2013; Campello, Silvia/AAB-3399-2019	cirotti, claudia/0000-0001-6267-8034; Gentile, Gabriele/0000-0002-1045-6816; Filomeni, Giuseppe/0000-0002-2719-1412; campello, silvia/0000-0003-0536-2484				BARTLETT GR, 1980, AM ZOOL, V20, P103; BEAM KG, 1979, J CELL BIOL, V83, P1, DOI 10.1083/jcb.83.1.1; BOUTILIER RG, 1989, CAN J ZOOL, V67, P2986, DOI 10.1139/z89-421; BRASCH K, 1974, J CELL SCI, V15, P659; Bratosin D, 2004, BIOCHIMIE, V86, P183, DOI 10.1016/j.biochi.2004.03.003; Damsgaard C, 2013, AM J PHYSIOL-REG I, V305, pR961, DOI 10.1152/ajpregu.00284.2013; DAVIES HG, 1961, J BIOPHYS BIOCHEM CY, V9, P671, DOI 10.1083/jcb.9.3.671; EDDY FB, 1977, J FISH BIOL, V10, P87, DOI 10.1111/j.1095-8649.1977.tb04044.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; GRIGG GC, 1993, J EXP BIOL, V175, P15; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARRIS JR, 1971, J ULTRA MOL STRUCT R, V36, P8, DOI 10.1016/S0022-5320(71)80085-0; Herman JK, 1996, J EXP BIOL, V199, P2061; HUNTER AS, 1957, J CELL COMPAR PHYSL, V49, P479, DOI 10.1002/jcp.1030490307; Janke A, 2001, P ROY SOC B-BIOL SCI, V268, P623, DOI 10.1098/rspb.2000.1402; LESSLER MA, 1962, RADIAT RES, V17, P111, DOI 10.2307/3571300; Malone CL, 2000, MOL PHYLOGENET EVOL, V17, P269, DOI 10.1006/mpev.2000.0836; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Nikinmaa M., 1990, VERTEBRATE RED BLOOD; OGO SH, 1993, J COMP PHYSIOL B, V163, P614, DOI 10.1007/BF00302122; Olsson M, 2008, BIOL LETTERS, V4, P186, DOI 10.1098/rsbl.2007.0611; Phillips MCL, 2000, J EXP BIOL, V203, P1039; Pica A, 2001, COMP BIOCHEM PHYS B, V128, P213, DOI 10.1016/S1096-4959(00)00312-2; Rozas J, 2009, BIOINFORMATICS; RUCKNAGEL KP, 1988, BIOL CHEM H-S, V369, P1143, DOI 10.1515/bchm3.1988.369.2.1143; Snyder GK, 1999, AM ZOOL, V39, P189; Stier A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-33; Thrall M. A., 2012, Veterinary hematology and clinical chemistry, P61; TIIHONEN K, 1991, J EXP BIOL, V161, P509; TOOZE J, 1967, J CELL SCI, V2, P617; Weber RE, 2007, RESP PHYSIOL NEUROBI, V158, P132, DOI 10.1016/j.resp.2007.05.001; YASUZUMI G, 1960, Z ZELLFORSCH MIK ANA, V51, P325; ZENTGRAF H, 1971, J BIOL CHEM, V246, P2986; Zhang ZW, 2011, IUBMB LIFE, V63, P560, DOI 10.1002/iub.490	35	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136770	10.1371/journal.pone.0136770	http://dx.doi.org/10.1371/journal.pone.0136770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367118	gold, Green Submitted, Green Published			2022-12-26	WOS:000361601100024
J	Lai, YJ; Chang, GJ; Yeh, YH; Pang, JHS; Huang, CC; Chen, WJ				Lai, Ying-Ju; Chang, Gwo-Jyh; Yeh, Yung-Hsin; Pang, Jong-Hwei S.; Huang, Chung-Chi; Chen, Wei-Jan			Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase	PLOS ONE			English	Article							INHALED ILOPROST; SILDENAFIL; EXPRESSION; PRESENILIN; NOTCH; HYPERTHYROIDISM; VASODILATATION; OVEREXPRESSION; NICASTRIN; INDUCTION	Gamma-secretase-mediated Notch3 signaling is involved in smooth muscle cell (SMC) hyper-activity and proliferation leading to pulmonary arterial hypertension (PAH). In addition, Propylthiouracil (PTU), beyond its anti-thyroid action, has suppressive effects on atherosclerosis and PAH. Here, we investigated the possible involvement of gammasecretase- mediated Notch3 signaling in PTU-inhibited PAH. In rats with monocrotalineinduced PAH, PTU therapy improved pulmonary arterial hypertrophy and hemodynamics. In vitro, treatment of PASMCs from monocrotaline-treated rats with PTU inhibited their proliferation and migration. Immunocyto, histochemistry, and western blot showed that PTU treatment attenuated the activation of Notch3 signaling in PASMCs from monocrotalinetreated rats, which was mediated via inhibition of gamma-secretase expression especially its presenilin enhancer 2 (Pen-2) subunit. Furthermore, over-expression of Pen-2 in PASMCs from control rats increased the capacity of migration, whereas knockdown of Pen2 with its respective siRNA in PASMCs from monocrotaline-treated rats had an opposite effect. Transfection of PASMCs from monocrotaline-treated rats with Pen-2 siRNA blocked the inhibitory effect of PTU on PASMC proliferation and migration, reflecting the crucial role of Pen-2 in PTU effect. We present a novel cell-signaling paradigm in which overexpression of Pen-2 is essential for experimental pulmonary arterial hypertension to promote motility and growth of smooth muscle cells. Propylthiouracil attenuates experimental PAH via suppression of the gamma-secretase-mediated Notch3 signaling especially its presenilin enhancer 2 (Pen-2) subunit. These findings provide a deep insight into the pathogenesis of PAH and a novel therapeutic strategy.	[Lai, Ying-Ju; Huang, Chung-Chi] Chang Gung Univ, Coll Med, Dept Resp Therapy, Tao Yuan, Taiwan; [Chang, Gwo-Jyh; Pang, Jong-Hwei S.] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Yeh, Yung-Hsin; Chen, Wei-Jan] Chang Gung Mem Hosp, Cardiovasc Div, Tao Yuan, Taiwan; [Huang, Chung-Chi] Chang Gung Mem Hosp, Div Thorac Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, WJ (corresponding author), Chang Gung Mem Hosp, Cardiovasc Div, Tao Yuan, Taiwan.	wjchen@adm.cgmh.org.tw	Yeh, Yung-Hsin/ABD-9351-2021	Lai, Ying-Ju/0000-0001-9750-7649	Chang Gung Medical Research Program [CMRPD1B001-3, CMRPG3A0571-3]; National Science Council, Taiwan [NSC 101-2314-B-182-076-MY3]	Chang Gung Medical Research Program; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grants from Chang Gung Medical Research Program [CMRPD1B001-3 (to YJL) and CMRPG3A0571-3 (to YHY)] and National Science Council, Taiwan [NSC 101-2314-B-182-076-MY3 (to YJL)]. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe JI, 2010, ARTERIOSCL THROM VAS, V30, P667, DOI 10.1161/ATVBAHA.109.202713; Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Al Husseini A, 2013, EUR RESPIR J, V41, P104, DOI 10.1183/09031936.00196511; Alva JA, 2004, CURR OPIN HEMATOL, V11, P278, DOI 10.1097/01.moh.0000130309.44976.ad; Campbell WA, 2006, J NEUROCHEM, V96, P1423, DOI 10.1111/j.1471-4159.2006.03648.x; Chen WJ, 2008, ATHEROSCLEROSIS, V196, P383, DOI 10.1016/j.atherosclerosis.2006.11.018; Chen WJ, 2010, BASIC RES CARDIOL, V105, P19, DOI 10.1007/s00395-009-0045-z; Chen WJ, 2009, BASIC RES CARDIOL, V104, P60, DOI 10.1007/s00395-008-0746-8; Chen WJ, 2004, CIRCULATION, V110, P1313, DOI 10.1161/01.CIR.0000140764.15398.F3; Claeysen S, 2012, CELL SIGNAL, V24, P1831, DOI 10.1016/j.cellsig.2012.05.008; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Garcia-Mayor RV, 2010, MED CHEM, V6, P239, DOI 10.2174/1573406411006040239; Ghofrani HA, 2002, ANN INTERN MED, V136, P515, DOI 10.7326/0003-4819-136-7-200204020-00008; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; HICKS M, 1992, BIOCHEM PHARMACOL, V43, P439, DOI 10.1016/0006-2952(92)90561-V; Holmes O, J NEUROCHEM IN PRESS; Humbert M, 1998, EUR RESPIR J, V11, P554; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Lai YJ, 2008, AM J RESP CRIT CARE, V178, P188, DOI 10.1164/rccm.200710-1519OC; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Mao GZ, 2012, J NEUROCHEM, V123, P837, DOI 10.1111/jnc.12016; Marvisi M, 2006, EUR J INTERN MED, V17, P267, DOI 10.1016/j.ejim.2005.11.023; Mechanick JI, 1997, THYROID DIS, P253; Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112; Montani D, 2010, EUR HEART J, V31, P1898, DOI 10.1093/eurheartj/ehq170; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Nam SH, 2011, INT J MOL MED, V28, P961, DOI 10.3892/ijmm.2011.767; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; OPPENHEIMER JH, 1985, J CLIN INVEST, V75, P147, DOI 10.1172/JCI111667; Ozdem S, 2000, PHARMACOLOGY, V61, P31, DOI 10.1159/000028377; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; RICH S, 1991, J AM COLL CARDIOL, V18, P1323, DOI 10.1016/0735-1097(91)90556-O; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Sun CK, 2009, CIRC J, V73, P1722, DOI 10.1253/circj.CJ-09-0074; Tomita T, 2013, J BIOL CHEM, V288, P14673, DOI 10.1074/jbc.R113.463281; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Wight JL, 1992, NATL I HEART NOCTURN, V170, P109; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117	45	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137426	10.1371/journal.pone.0137426	http://dx.doi.org/10.1371/journal.pone.0137426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367462	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100068
J	Lee, J; Narang, S; Martinez, J; Rao, G; Rao, A				Lee, Joonsang; Narang, Shivali; Martinez, Juan; Rao, Ganesh; Rao, Arvind			Spatial Habitat Features Derived from Multiparametric Magnetic Resonance Imaging Data Are Associated with Molecular Subtype and 12-Month Survival Status in Glioblastoma Multiforme	PLOS ONE			English	Article							TUMOR HETEROGENEITY; POINT PATTERNS; CANCER; IMAGES; DYNAMICS; MODELS; EGFR	One of the most common and aggressive malignant brain tumors is Glioblastoma multi-forme. Despite the multimodality treatment such as radiation therapy and chemotherapy (temozolomide: TMZ), the median survival rate of glioblastoma patient is less than 15 months. In this study, we investigated the association between measures of spatial diversity derived from spatial point pattern analysis of multiparametric magnetic resonance imaging (MRI) data with molecular status as well as 12-month survival in glioblastoma. We obtained 27 measures of spatial proximity (diversity) via spatial point pattern analysis of multiparametric T1 post-contrast and T2 fluid-attenuated inversion recovery MRI data. These measures were used to predict 12-month survival status (<= 12 or > 12 months) in 74 glioblastoma patients. Kaplan-Meier with receiver operating characteristic analyses was used to assess the relationship between derived spatial features and 12-month survival status as well as molecular subtype status in patients with glioblastoma. Kaplan-Meier survival analysis revealed that 14 spatial features were capable of stratifying overall survival in a statistically significant manner. For prediction of 12-month survival status based on these diversity indices, sensitivity and specificity were 0.86 and 0.64, respectively. The area under the receiver operating characteristic curve and the accuracy were 0.76 and 0.75, respectively. For prediction of molecular subtype status, proneural subtype shows highest accuracy of 0.93 among all molecular subtypes based on receiver operating characteristic analysis. We find that measures of spatial diversity from point pattern analysis of intensity habitats from T1 post-contrast and T2 fluid-attenuated inversion recovery images are associated with both tumor subtype status and 12-month survival status and may therefore be useful indicators of patient prognosis, in addition to providing potential guidance for molecularly-targeted therapies in Glioblastoma multiforme.	[Lee, Joonsang; Narang, Shivali; Rao, Arvind] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Martinez, Juan; Rao, Ganesh] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Rao, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	aruppore@mdanderson.org		Lee, Joonsang/0000-0001-9694-4425	NIH/NCI Cancer Center [NCI P30 CA016672]; UTMDACC Institution Research Grant; UTMDACC Brain SPORE Career Development Award; NIH [K08NS070928]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070928] Funding Source: NIH RePORTER	NIH/NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UTMDACC Institution Research Grant; UTMDACC Brain SPORE Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by NIH/NCI Cancer Center Support Grant (NCI P30 CA016672), UTMDACC Institution Research Grant, and UTMDACC Brain SPORE Career Development Award to Arvind Rao, and NIH award (K08NS070928) to Ganesh Rao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Affronti ML, 2009, CANCER, V115, P3501, DOI 10.1002/cncr.24398; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2007, LECT NOTES MATH, V1892, P1; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; CHEN CC, 1989, IEEE T MED IMAGING, V8, P133, DOI 10.1109/42.24861; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Eo SH, 2013, ARXIV13064615; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; Grove O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118261; Held K, 1997, IEEE T MED IMAGING, V16, P878, DOI 10.1109/42.650883; Illian J, 2008, STAT ANAL MODELLING; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jiao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027323; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Mazurowski MA, 2013, NEURO-ONCOLOGY, V15, P1389, DOI 10.1093/neuonc/nos335; McAuliffe MJ, 2001, COMP MED SY, P381; Miles KA, 2009, RADIOLOGY, V250, P444, DOI 10.1148/radiol.2502071879; Moeur M., 1993, Forest Science, V39, P756; Rajala T, 2012, ENVIRON ECOL STAT, V19, P545, DOI 10.1007/s10651-012-0200-9; Reynolds DA., 2009, ENCY BIOMETRICS, P659, DOI DOI 10.1007/978-0-387-73003-5_196; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Van Lieshout MNM, 1999, SCAND J STAT, V26, P511, DOI 10.1111/1467-9469.00165; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Zhou M, 2014, TRANSL ONCOL, V7, P5, DOI 10.1593/tlo.13730	29	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136557	10.1371/journal.pone.0136557	http://dx.doi.org/10.1371/journal.pone.0136557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368923	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100019
J	Lim, SM; Choi, J; Chang, JH; Sohn, J; Jacobson, K; Policht, F; Schulz, J; Cho, BC; Kim, SH				Lim, Sun Min; Choi, Junjeong; Chang, Jong Hee; Sohn, Jinyoung; Jacobson, Kristine; Policht, Frank; Schulz, John; Cho, Byoung Chul; Kim, Se Hoon			Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme	PLOS ONE			English	Article							TARGETING ROS1; TEMOZOLOMIDE; IDENTIFICATION; INACTIVATION; BEVACIZUMAB; LANDSCAPE; FUSIONS; TUMORS; MGMT; FIG	Glioblastoma multiforme (GBM) is the most aggressive type of brain tumor, and the prognosis remains poor. Rearrangement of ROS1 gene, which was shown to have an oncogenic potential, was previously discovered in GBM cell lines. In this pilot study, we aimed to identify the incidence of ROS1 rearrangement in GBM patient tissues to explore novel biomarkers for therapeutic strategy. Formalin-fixed and paraffin-embedded (FFPE) tissue sections from 109 patients with GBM were screened for ROS1 rearrangement by anti-ROS immunohistochemistry (IHC) and ROS1 break-apart fluorescent in situ hybridization (FISH) assays. O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation and Isocitrate dehydrogenase 1 (IDH1) mutation status were also assessed. All samples were interpreted by two experienced pathologists who were blinded to the clinical data. A total of 109 samples were collected and all samples were examined for ROS1 rearrangement by IHC and FISH assays, and none was found to harbor ROS1 rearrangement. MGMT gene methylation was found in 42 (39.2%) cases, and IDH1 mutation was found in 6 (5.5%) cases. In this study, ROS1 rearrangement was not identified in GBM patients, and thus it is difficult to classify ROS1 rearrangement as a novel molecular subset in GBM patients for now.	[Lim, Sun Min; Cho, Byoung Chul] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea; [Choi, Junjeong] Yonsei Univ, Coll Pharm, Dept Pharm, Seoul 120749, South Korea; [Chang, Jong Hee] Yonsei Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Sohn, Jinyoung] JEUK Co Ltd, JE UK Inst Canc Res, Gumi, Kyungbuk, South Korea; [Jacobson, Kristine; Policht, Frank; Schulz, John] Abbott Mol Diagnost, Des Plaines, IL USA; [Kim, Se Hoon] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, BC (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea.	cbc1971@yuhs.ac; PAXCO70@yuhs.ac		Kim, Se Hoon/0000-0001-7516-7372; Cho, Byoung Chul/0000-0002-5562-270X; Chang, Jong Hee/0000-0003-1509-9800	Novartis Pharmaceuticals; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C1186]; JEUK Co., Ltd; Abbott Molecular Diagnostics	Novartis Pharmaceuticals(Novartis); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; JEUK Co., Ltd; Abbott Molecular Diagnostics	This work was funded by the Novartis Pharmaceuticals and a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C1186 to BCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jinyoung Sohn is employed by JEUK Co., Ltd. John Schulz is employed by Abbott Molecular Diagnostics. JEUK Co., Ltd and Abbott Molecular Diagnostics provided support in the form of salaries for authors Jinyoung Sohn and John Schulz respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; BIRCHMEIER C, 1990, P NATL ACAD SCI USA, V87, P4799, DOI 10.1073/pnas.87.12.4799; BIRCHMEIER C, 1987, P NATL ACAD SCI USA, V84, P9270, DOI 10.1073/pnas.84.24.9270; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin LP, 2012, J THORAC ONCOL, V7, P1625, DOI 10.1097/JTO.0b013e31826baf83; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Esteller M, 1999, CANCER RES, V59, P793; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Horbinski C, 2009, J NEUROPATH EXP NEUR, V68, P1319, DOI 10.1097/NEN.0b013e3181c391be; Kim HR, 2013, ANN ONCOL, V24, P2364, DOI 10.1093/annonc/mdt220; Kim YS, 2012, INT J RADIAT ONCOL, V84, P661, DOI 10.1016/j.ijrobp.2011.12.086; Lee J, 2013, CANCER-AM CANCER SOC, V119, P1627, DOI 10.1002/cncr.27967; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Ou SHI, 2012, EXPERT REV ANTICANC, V12, P447, DOI [10.1586/ERA.12.17, 10.1586/era.12.17]; Ou SH, 2013, 15 WORLD C LUNG CANC; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Saborowski A, 2013, P NATL ACAD SCI USA, V110, P19513, DOI 10.1073/pnas.1311707110; SHARMA S, 1989, ONCOGENE RES, V5, P91; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Tanaka S, 2013, NAT REV CLIN ONCOL, V10, P14, DOI 10.1038/nrclinonc.2012.204; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020	30	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137678	10.1371/journal.pone.0137678	http://dx.doi.org/10.1371/journal.pone.0137678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366867	gold, Green Published, Green Submitted			2022-12-26	WOS:000361601100106
J	Ribeiro, R; Otte, J; Madeira, S; Hutchings, GH; Boinas, F				Ribeiro, Rita; Otte, Joachim; Madeira, Sara; Hutchings, Geoff H.; Boinas, Fernando			Experimental Infection of Ornithodoros erraticus sensu stricto with Two Portuguese African Swine Fever Virus Strains. Study of Factors Involved in the Dynamics of Infection in Ticks	PLOS ONE			English	Article							EXPERIMENTAL TRANSMISSION; MOUBATA-PORCINUS; DOMESTIC PIGS; ARGASID TICK; BONE-MARROW; ACARI; VECTOR; MODEL	African swine fever (ASF) is a frequently devastating hemorrhagic disease of domestic pigs and wild boar and Ornithodoros erraticus sensu stricto argasid ticks are the only biological vectors of African swine fever virus (ASFV) known to occur in Europe. Recently this disease emerged in Eastern Europe and Russian Federation, showing a huge potential for a rapid spread between countries. There is some risk of re-emergence of ASF in the countries where these ticks exist, that can contribute for the persistence of infection and compromise control measures. In this study we aimed to identify factors that determine the probability of infection and its dynamics in the tick vector Ornithodoros erraticus sensu stricto, with two Portuguese strains of ASFV. Our results suggest that these ticks have a high likelihood of excreting the two haemadsorbing ASF viruses of different host origins and that, in field surveys, the analysis of adults and 5th nymphal stage can provide the best chance of detecting virus infection. The results also indicate that infection of pigs with highly virulent ASF viruses will promote higher rates of infection and a higher likelihood for virus excretion by ticks. Nevertheless, there is also a risk, although lower, that ticks can become infected on pigs that have overcome the acute phase of infection, which was simulated in our study by membrane feeding ticks with low titres of virus. We believe these results can be valuable in designing and interpreting the results of ASF control programmes, and future work can also be undertaken as our dataset is released under open access, to perform studies in risk assessment for ASFV persistence in a region where O. erraticus sensu stricto ticks are present.	[Ribeiro, Rita; Madeira, Sara; Boinas, Fernando] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, P-1699 Lisbon, Portugal; [Otte, Joachim] FAO Reg Off Asia & Pacific, Bangkok 10200, Thailand; [Hutchings, Geoff H.] AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England	Universidade de Lisboa; Food & Agriculture Organization of the United Nations (FAO); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute	Boinas, F (corresponding author), Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, P-1699 Lisbon, Portugal.	fboinas@fmv.ulisboa.pt	Boinas, Fernando/AAD-9779-2022	Boinas, Fernando/0000-0001-6259-4404; Madeira, Sara/0000-0001-5804-9745; Ribeiro, Rita/0000-0002-9976-3731	Commission of the Economic Communities -Directorate General VI project [ATS/4]; Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN Permanent Commission scholarship [PO/86/00]	Commission of the Economic Communities -Directorate General VI project; Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN Permanent Commission scholarship	Fernando Boinas was funded by Commission of the Economic Communities -Directorate General VI project ATS/4 and by a Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN Permanent Commission scholarship (ref PO/86/00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, OFFICIAL J EUROPEAN, V31; Arias M, 2002, TRENDS IN EMERGING VIRAL INFECTIONS OF SWINE, P133; Arnot LF, 2009, ONDERSTEPOORT J VET, V76, P385; Basto AP, 2006, J GEN VIROL, V87, P1863, DOI 10.1099/vir.0.81765-0; Bastos ADS, 2009, MED VET ENTOMOL, V23, P399, DOI 10.1111/j.1365-2915.2009.00828.x; Bastos ADS, 2003, ARCH VIROL, V148, P693, DOI 10.1007/s00705-002-0946-8; Boinas F, 2014, J VECTOR ECOL, V39, P238, DOI 10.1111/jvec.12098; Boinas FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020383; Boinas FJS, 1994, THESIS U READING REA; Boinas FS, 2004, J GEN VIROL, V85, P2177, DOI 10.1099/vir.0.80058-0; Boorman J, 1975, Lab Pract, V24, P90; Boshoff CI, 2007, VET MICROBIOL, V121, P45, DOI 10.1016/j.vetmic.2006.11.007; Burrage TG, 2013, VIRUS RES, V173, P131, DOI 10.1016/j.virusres.2012.10.010; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Diaz AV, 2012, EMERG INFECT DIS, V18, P1026, DOI 10.3201/eid1806.111728; ENDRIS RG, 1994, J MED ENTOMOL, V31, P373, DOI 10.1093/jmedent/31.3.373; ENDRIS RG, 1991, J MED ENTOMOL, V28, P854, DOI 10.1093/jmedent/28.6.854; Goddard J, 2008, INFECT DIS ARTHROPOD, DOI DOI 10.1007/978-1-60327-400-5; GomezVillamandos JC, 1997, VET PATHOL, V34, P97, DOI 10.1177/030098589703400202; GREIG A, 1972, ARCH GES VIRUSFORSCH, V39, P240, DOI 10.1007/BF01241546; GROOCOCK CM, 1980, AM J VET RES, V41, P591; Guglielmone AA, 2010, ARGASIDAE LXODIDAE N; HARESNAPE JM, 1989, EPIDEMIOL INFECT, V102, P507, DOI 10.1017/S0950268800030223; HELMY N, 1983, J PARASITOL, V69, P229, DOI 10.2307/3281305; HESS WR, 1989, J MED ENTOMOL, V26, P314, DOI 10.1093/jmedent/26.4.314; HESS WR, 1987, VET PARASITOL, V26, P145, DOI 10.1016/0304-4017(87)90084-7; Jori F, 2009, ECOHEALTH, V6, P296, DOI 10.1007/s10393-009-0248-7; Kleiboeker SB, 1999, J VIROL, V73, P8587, DOI 10.1128/JVI.73.10.8587-8598.1999; Kleiboeker Steven B., 2001, Animal Health Research Reviews, V2, P121; Leitao A, 2001, J GEN VIROL, V82, P513, DOI 10.1099/0022-1317-82-3-513; MALMQUIST WA, 1960, AM J VET RES, V21, P104; MELLOR PS, 1985, RES VET SCI, V39, P353, DOI 10.1016/S0034-5288(18)31726-0; Nuttall PA, 2009, FRONT BIOSCI-LANDMRK, V14, P2466, DOI 10.2741/3390; OLEAGA A, 1990, J PARASITOL, V76, P874, DOI 10.2307/3282808; OSBORNE RW, 1985, TROP ANIM HEALTH PRO, V17, P31, DOI 10.1007/BF02356130; PLOWRIGH.W, 1974, RES VET SCI, V17, P106, DOI 10.1016/S0034-5288(18)33716-0; PLOWRIGHT W, 1968, J HYG-CAMB, V66, P117, DOI 10.1017/S0022172400040997; Plowright W, 1970, Res Vet Sci, V11, P582; PLOWRIGHT W, 1970, ARCH GES VIRUSFORSCH, V31, P33, DOI 10.1007/BF01241664; Plowright W, 1977, VECTOR TRANSMISSION, P575; PLOWRIGHT W, 1994, INFECT DIS LIVESTOCK, P567; Plowright W, 1968, J HYG LOND, V1, P117; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rennie L, 2000, MED VET ENTOMOL, V14, P355, DOI 10.1046/j.1365-2915.2000.00251.x; Rowlands RJ, 2009, VIROLOGY, V393, P319, DOI 10.1016/j.virol.2009.07.040; SANCHEZBOTIJA A, 1963, B OFF INT EPIZOOT, V60, P895; Sonenshine D. E., 1993, ECOLOGY NIDICOLOUS T, V2; Tendeiro J., 1962, Bol Pecuario Lisboa, V30, P1; Thomson G, 1983, RELATIONSHIP AFRICAN, P85; Trape JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078473; Travassos Santos Dias JA, 1994, I INVESTIG CIENTIFIC, P128; WALTON GA, 1979, RECENT ADV ACAROL, V11, P491; Wilkinson PJ, 1989, P M HELD U EX EX, P80; Wilkinson PJ, 1983, AGR AFR SWIN FEV P C, P74; Wilson AJ, 2013, PREV VET MED, V110, P45, DOI 10.1016/j.prevetmed.2013.02.006; 2010, EFSA J, V8	56	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137718	10.1371/journal.pone.0137718	http://dx.doi.org/10.1371/journal.pone.0137718			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366570	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100118
J	Wang, ZH; Liu, NC; Shi, TG; Zhou, G; Wang, ZZ; Gan, JJ; Guo, T; Qian, HB; Bao, NR; Zhao, JN				Wang, Zhenheng; Liu, Naicheng; Shi, Tongguo; Zhou, Gang; Wang, Zhenzhen; Gan, Jingjing; Guo, Ting; Qian, Hongbo; Bao, Nirong; Zhao, Jianning			ER Stress Mediates TiAl6V4 Particle-Induced Peri-Implant Osteolysis by Promoting RANKL Expression in Fibroblasts	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSMISSION ELECTRON-MICROSCOPY; NF-KAPPA-B; WEAR DEBRIS; PERIPROSTHETIC OSTEOLYSIS; OSTEOCLAST DIFFERENTIATION; OXIDATIVE STRESS; HIP; TISSUE; NANOPARTICLES	Wear particle-induced osteolysis is a major cause of aseptic loosening, which is one of the most common reasons for total hip arthroplasty (THA) failure. Previous studies have shown that the synovial fibroblasts present in the periprosthetic membrane are important targets of wear debris during osteolysis. However, the interaction mechanisms between the wear debris and fibroblasts remain largely unknown. In the present study, we investigated the effect of ER (endoplasmic reticulum) stress induced by TiAl6V4 particles (TiPs) in human synovial fibroblasts and calvarial resorption animal models. The expression of ER stress markers, including IRE1-alpha, GRP78/Bip and CHOP, were determined by western blot in fibroblasts that had been treated with TiPs for various times and concentration. To address whether ER stress was involved in the expression of RANKL, the effects of ER stress blockers (including 4-PBA and TUDCA) on the expression of RANKL in TiPs-treated fibroblasts were examined by real-time PCR, western blot and ELISA. Osteoclastogenesis was assessed by tartrate resistant acid phosphatase (TRAP) staining. Our study demonstrated that ER stress markers were markedly upregulated in TiPs-treated fibroblasts. Blocking ER stress significantly reduced the TiPs-induced expression of RANKL both in vitro and in vivo. Moreover, the inhibition of ER stress ameliorated wear particle-induced osteolysis in animal models. Taken together, these results suggested that the expression of RANKL induced by TiPs was mediated by ER stress in fibroblasts. Therefore, down regulating the ER stress of fibroblasts represents a potential therapeutic approach for wear particle-induced periprosthetic osteolysis.	[Qian, Hongbo] Nanjing Univ, Sch Med, Dept Orthopaed, Jinling Hosp, Nanjing 210093, Jiangsu, Peoples R China; Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Qian, HB (corresponding author), Nanjing Univ, Sch Med, Dept Orthopaed, Jinling Hosp, Nanjing 210093, Jiangsu, Peoples R China.	qianrenyang@vip.163.com; bnrbnr@sina.com; zhaojianning.0207@163.com	Shi, Tongguo/AAS-3460-2021	Shi, Tongguo/0000-0002-5382-2775	Department of Orthopedics Clinical Research Center of Jiangsu Province, China [BL2012002]	Department of Orthopedics Clinical Research Center of Jiangsu Province, China	This work was supported by the Department of Orthopedics Clinical Research Center of Jiangsu Province, China (BL2012002) (Jianning Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz EB, 2001, BIOMATERIALS, V22, P2835, DOI 10.1016/S0142-9612(01)00027-8; Brown C, 2007, J MATER SCI-MATER M, V18, P819, DOI 10.1007/s10856-006-0015-z; Cartiera MS, 2009, BIOMATERIALS, V30, P2790, DOI 10.1016/j.biomaterials.2009.01.057; Chen R, 2014, ACS NANO, V8, P2562, DOI 10.1021/nn406184r; Dong L, 2008, J ORTHOP RES, V26, P1114, DOI 10.1002/jor.20607; Doorn PF, 1998, J BIOMED MATER RES, V42, P103, DOI 10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.3.CO;2-D; Fujii J, 2011, HIP INT, V21, P231, DOI 10.5301/HIP.2011.7977; Gallo J, 2013, INNATE IMMUN-LONDON, V19, P213, DOI 10.1177/1753425912451779; Horiki M, 2004, J BONE MINER METAB, V22, P346, DOI 10.1007/s00774-003-0493-8; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hou CC, 2013, INT J NANOMED, V8, P2689, DOI 10.2147/IJN.S47208; Jiang YP, 2013, ACTA ORTHOP BELG, V79, P1; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Koreny T, 2006, ARTHRITIS RHEUM, V54, P3221, DOI 10.1002/art.22134; Landgraeber S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/185150; Lin TH, 2014, ACTA BIOMATER, V10, P1, DOI 10.1016/j.actbio.2013.09.034; Liu XQ, 2014, BIOMATERIALS, V35, P5721, DOI 10.1016/j.biomaterials.2014.04.006; Lochner K, 2011, INT J MOL MED, V28, P1055, DOI 10.3892/ijmm.2011.778; Mediero A, 2015, ARTHRITIS RHEUMATOL, V67, P849, DOI 10.1002/art.38971; Nine MJ, 2014, MATERIALS, V7, P980, DOI 10.3390/ma7020980; O'Neill SC, 2013, BONE JOINT J, V95B, P1022, DOI 10.1302/0301-620X.95B8.31229; Papageorgiou I, 2007, BIOMATERIALS, V28, P2946, DOI 10.1016/j.biomaterials.2007.02.034; Ramage SC, 2007, J BONE JOINT SURG AM, V89A, P841, DOI 10.2106/JBJS.F.00655; Ren WP, 2003, BIOMATERIALS, V24, P4819, DOI 10.1016/S0142-9612(03)00384-3; Sakai H, 2002, ANN RHEUM DIS, V61, P103, DOI 10.1136/ard.61.2.103; Sheng L, 2015, J BIOMED MATER RES A, V103, P1141, DOI 10.1002/jbm.a.35263; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tsai YY, 2011, ACS NANO, V5, P9354, DOI 10.1021/nn2027775; Tsutsumi R, 2009, J BONE MINER RES, V24, P1753, DOI [10.1359/JBMR.090412, 10.1359/jbmr.090412]; Ulrich SD, 2008, INT ORTHOP, V32, P597, DOI 10.1007/s00264-007-0364-3; Visentin M, 2004, BIOMATERIALS, V25, P5531, DOI 10.1016/j.biomaterials.2004.01.001; Wang H, 2013, GENE THER, V20, P128, DOI 10.1038/gt.2012.1; Wang KK, 2011, J MOL CELL BIOL, V3, P360, DOI 10.1093/jmcb/mjr021; Wang L, 2014, METHODS, V67, P394, DOI 10.1016/j.ymeth.2014.01.007; Wang R, 2013, BIOMATERIALS, V34, P2611, DOI 10.1016/j.biomaterials.2013.01.025; Wei XC, 2005, J BONE MINER RES, V20, P1136, DOI 10.1359/JBMR.050206; Xu J, 2012, EXP DIABETES RES; Yang SY, 2002, ARTHRITIS RHEUM, V46, P2514, DOI 10.1002/art.10527; Yang X, 2015, TOXICOL LETT, V234, P40, DOI 10.1016/j.toxlet.2015.02.004; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324; Zhai ZJ, 2014, BIOMATERIALS, V35, P6299, DOI 10.1016/j.biomaterials.2014.04.044; Zhang T, 2009, BIOMATERIALS, V30, P6102, DOI 10.1016/j.biomaterials.2009.07.032; Zijlstra WP, 2012, J ORTHOP RES, V30, P740, DOI 10.1002/jor.21581	45	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137774	10.1371/journal.pone.0137774	http://dx.doi.org/10.1371/journal.pone.0137774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366858	Green Submitted, gold, Green Published			2022-12-26	WOS:000361601100134
J	Zhang, GX; Jin, LQ; Hu, JL; Rodemer, W; Selzer, ME				Zhang, Guixin; Jin, Li-qing; Hu, Jianli; Rodemer, William; Selzer, Michael E.			Antisense Morpholino Oligonucleotides Reduce Neurofilament Synthesis and Inhibit Axon Regeneration in Lamprey Reticulospinal Neurons	PLOS ONE			English	Article							SPINAL-CORD-INJURY; LARVAL SEA LAMPREY; GROWTH CONES; IN-VIVO; FUNCTIONAL REGENERATION; BEHAVIORAL RECOVERY; TRANSECTED LAMPREY; LOCOMOTOR RECOVERY; PROJECTION NEURONS; XENOPUS-LAEVIS	The sea lamprey has been used as a model for the study of axonal regeneration after spinal cord injury. Previous studies have suggested that, unlike developing axons in mammal, the tips of regenerating axons in lamprey spinal cord are simple in shape, packed with neurofilaments (NFs), and contain very little F-actin. Thus it has been proposed that regeneration of axons in the central nervous system of mature vertebrates is not based on the canonical actin-dependent pulling mechanism of growth cones, but involves an internal protrusive force, perhaps generated by the transport or assembly of NFs in the distal axon. In order to assess this hypothesis, expression of NFs was manipulated by antisense morpholino oligonucleotides (MO). A standard, company-supplied MO was used as control. Axon retraction and regeneration were assessed at 2, 4 and 9 weeks after MOs were applied to a spinal cord transection (TX) site. Antisense MO inhibited NF180 expression compared to control MO. The effect of inhibiting NF expression on axon retraction and regeneration was studied by measuring the distance of axon tips from the TX site at 2 and 4 weeks post-TX, and counting the number of reticulospinal neurons (RNs) retrogradely labeled by fluorescently-tagged dextran injected caudal to the injury at 9 weeks post-TX. There was no statistically significant effect of MO on axon retraction at 2 weeks post-TX. However, at both 4 and 9 weeks post-TX, inhibition of NF expression inhibited axon regeneration.	[Zhang, Guixin; Jin, Li-qing; Hu, Jianli; Rodemer, William; Selzer, Michael E.] Shriners Hosp Pediat Res Ctr, Ctr Neural Repair & Rehabil, Philadelphia, PA 19140 USA; [Selzer, Michael E.] Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA 19122 USA	Shriners Hospitals Children Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Selzer, ME (corresponding author), Shriners Hosp Pediat Res Ctr, Ctr Neural Repair & Rehabil, 3500 North Broad St, Philadelphia, PA 19140 USA.	mselzer@temple.edu		Hu, Jianli/0000-0002-3022-1950; Rodemer, William/0000-0001-5091-4343	National Institutes of Health [R01 NS14837, R01 NS38537]; Shriners Research Foundation [SHC-85220]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038537, R01NS014837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health, R01 NS14837 and R01 NS38537 to MES (http://www.nih.gov) and Shriners Research Foundation, SHC-85220 to MES (http://www.mheresearchfoundation.org/MHE_Shriners_Hospital_Directory.html).	Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Chan WKH, 2003, CELL MOTIL CYTOSKEL, V54, P195, DOI 10.1002/cm.10084; Chen E, 2004, CURR PHARM BIOTECHNO, V5, P409, DOI 10.2174/1389201043376652; COHEN AH, 1988, TRENDS NEUROSCI, V11, P227, DOI 10.1016/0166-2236(88)90131-2; COHEN AH, 1986, P NATL ACAD SCI USA, V83, P2763, DOI 10.1073/pnas.83.8.2763; DAVIS GR, 1993, BRAIN RES, V602, P131, DOI 10.1016/0006-8993(93)90252-I; DAVIS GR, 1994, EXP NEUROL, V127, P94, DOI 10.1006/exnr.1994.1083; DAVIS GR, 1993, EXP BRAIN RES, V97, P83; GORGELS TGMF, 1991, J COMP NEUROL, V306, P95, DOI 10.1002/cne.903060108; Hall GF, 1997, J NEUROCYTOL, V26, P733, DOI 10.1023/A:1018562331003; Hall GF, 2000, CELL MOTIL CYTOSKEL, V46, P166, DOI 10.1002/1097-0169(200007)46:3<166::AID-CM2>3.0.CO;2-8; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; JACOBS AJ, 1995, MOL BRAIN RES, V29, P43, DOI 10.1016/0169-328X(94)00227-6; Jacobs AJ, 1996, J COMP NEUROL, V364, P383; Jacobs AJ, 1997, J NEUROSCI, V17, P5206; Jin LQ, 2011, BRAIN RES, V1370, P16, DOI 10.1016/j.brainres.2010.11.037; Jin LQ, 2009, J COMP NEUROL, V515, P295, DOI 10.1002/cne.22057; Jin LQ, 2005, J COMP NEUROL, V483, P403, DOI 10.1002/cne.20459; Jones SL, 2006, J NEUROBIOL, V66, P1630, DOI 10.1002/neu.20309; LANNERS HN, 1980, J NEUROCYTOL, V9, P733, DOI 10.1007/BF01205016; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; LASEK RJ, 1985, ANN NY ACAD SCI, V455, P462, DOI 10.1111/j.1749-6632.1985.tb50429.x; Lee JK, 2012, EXP NEUROL, V235, P33, DOI 10.1016/j.expneurol.2011.05.001; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Lin WC, 1996, DEV BIOL, V179, P197, DOI 10.1006/dbio.1996.0251; Lin WC, 1995, J NEUROSCI, V15, P8331; LURIE DI, 1994, J COMP NEUROL, V344, P559, DOI 10.1002/cne.903440406; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MCKERRACHER L, 1990, J NEUROSCI, V10, P641; NORDLANDER RH, 1987, J COMP NEUROL, V263, P485, DOI 10.1002/cne.902630403; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Pijak DS, 1996, J COMP NEUROL, V368, P569; PLEASURE SJ, 1989, J NEUROSCI, V9, P698; SCALIA F, 1985, J COMP NEUROL, V231, P323, DOI 10.1002/cne.902310304; SELZER ME, 1978, J PHYSIOL-LONDON, V277, P395, DOI 10.1113/jphysiol.1978.sp012280; Shifman MI, 2008, J COMP NEUROL, V510, P269, DOI 10.1002/cne.21789; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; SWAIN GP, 1994, EXP NEUROL, V126, P256, DOI 10.1006/exnr.1994.1063; SWAIN GP, 1993, J COMP NEUROL, V336, P194, DOI 10.1002/cne.903360204; WOOD MR, 1979, SCIENCE, V206, P344, DOI 10.1126/science.482943; Yuan AD, 2003, J NEUROSCI, V23, P9452; Zhang GX, 2011, J COMP NEUROL, V519, P3657, DOI 10.1002/cne.22673; Zhang GX, 2005, NEUROREHAB NEURAL RE, V19, P46, DOI 10.1177/1545968305274577; Zhang GX, 2004, J COMP NEUROL, V471, P188, DOI 10.1002/cne.20026; Zhang L, 1999, J COMP NEUROL, V410, P612, DOI 10.1002/(SICI)1096-9861(19990809)410:4<612::AID-CNE8>3.0.CO;2-R; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	51	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137670	10.1371/journal.pone.0137670	http://dx.doi.org/10.1371/journal.pone.0137670			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366578	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100104
J	Bakker, PJ; Scantlebery, AM; Butter, LM; Claessen, N; Teske, GJD; van der Poll, T; Florquin, S; Leemans, JC				Bakker, Pieter J.; Scantlebery, Angelique M.; Butter, Loes M.; Claessen, Nike; Teske, Gwendoline J. D.; van der Poll, Tom; Florquin, Sandrine; Leemans, Jaklien C.			TLR9 Mediates Remote Liver Injury following Severe Renal Ischemia Reperfusion	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-9; ISCHEMIA/REPERFUSION INJURY; INFLAMMATORY RESPONSES; KIDNEY INJURY; ACTIVATION; TOLL-LIKE-RECEPTOR-9; PROGRESSION; INHIBITION; EXPRESSION; INNATE	Ischemia reperfusion injury is a common cause of acute kidney injury and is characterized by tubular damage. Mitochondrial DNA is released upon severe tissue injury and can act as a damage-associated molecular pattern via the innate immune receptor TLR9. Here, we investigated the role of TLR9 in the context of moderate or severe renal ischemia reperfusion injury using wild-type C57BL/6 mice or TLR9KO mice. Moderate renal ischemia induced renal dysfunction but did not decrease animal well-being and was not regulated by TLR9. In contrast, severe renal ischemia decreased animal well-being and survival in wildtype mice after respectively one or five days of reperfusion. TLR9 deficiency improved animal well-being and survival. TLR9 deficiency did not reduce renal inflammation or tubular necrosis. Rather, severe renal ischemia induced hepatic injury as seen by increased plasma ALAT and ASAT levels and focal hepatic necrosis which was prevented by TLR9 deficiency and correlated with reduced circulating mitochondrial DNA levels and plasma LDH. We conclude that TLR9 does not mediate renal dysfunction following either moderate or severe renal ischemia. In contrast, our data indicates that TLR9 is an important mediator of hepatic injury secondary to ischemic acute kidney injury.	[Bakker, Pieter J.; Scantlebery, Angelique M.; Butter, Loes M.; Claessen, Nike; Teske, Gwendoline J. D.; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Bakker, PJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	pieterjeroenbakker@gmail.com	Leemans, Jaklien/AAM-4958-2020	Florquin, Sandrine/0000-0002-9676-1722; Scantlebery, Angelique/0000-0001-9303-6042	Dutch Kidney Foundation [C06.6023]; Netherlands Organization for Scientific Research [91712386]	Dutch Kidney Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by grants from the Dutch Kidney Foundation to author PJB (C06.6023) and the Netherlands Organization for Scientific Research to authors LMB and JCL (91712386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anders HJ, 2004, FASEB J, V18, P534, DOI 10.1096/fj.03-0646fje; Anders HJ, 2003, J AM SOC NEPHROL, V14, P317, DOI 10.1097/01.ASN.0000042169.23931.73; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Benigni A, 2007, ARTHRITIS RHEUM, V56, P1569, DOI 10.1002/art.22524; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; Grams ME, 2012, KIDNEY INT, V81, P942, DOI 10.1038/ki.2011.241; Hekimoglu AT, 2013, KOREAN J PHYSIOL PHA, V17, P169, DOI 10.4196/kjpp.2013.17.2.169; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Itagaki K, 2011, SHOCK, V36, P548, DOI 10.1097/SHK.0b013e3182369fb2; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Kadkhodaee M, 2009, WORLD J GASTROENTERO, V15, P1113, DOI 10.3748/wjg.15.1113; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Li XZ, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2013.02.016; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Papadimitraki ED, 2009, LUPUS, V18, P831, DOI 10.1177/0961203309103054; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Serteser M, 2002, J SURG RES, V107, P234, DOI 10.1006/jsre.2002.6513; Stasiak KL, 2003, CONTEMP TOP LAB ANIM, V42, P13; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; van Loo PLP, 1997, LAB ANIM, V31, P318, DOI 10.1258/002367797780596211; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	35	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137511	10.1371/journal.pone.0137511	http://dx.doi.org/10.1371/journal.pone.0137511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361210	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100048
J	dos Reis, IC; Honorio, NA; de Barros, FSM; Barcellos, C; Kitron, U; Camara, DCP; Pereira, GR; Keppeler, EC; da Silva-Nunes, M; Codeco, CT				dos Reis, Izabel Cristina; Honorio, Nildimar Alves; Monteiro de Barros, Fabio Saito; Barcellos, Christovam; Kitron, Uriel; Portela Camara, Daniel Cardoso; Pereira, Glaucio Rocha; Keppeler, Erlei Cassiano; da Silva-Nunes, Monica; Codeco, Claudia Torres			Epidemic and Endemic Malaria Transmission Related to Fish Farming Ponds in the Amazon Frontier	PLOS ONE			English	Article							ANOPHELES-DARLINGI; BRAZILIAN AMAZON; DEFORESTATION; HABITAT; VECTOR	Fish farming in the Amazon has been stimulated as a solution to increase economic development. However, poorly managed fish ponds have been sometimes associated with the presence of Anopheles spp. and consequently, with malaria transmission. In this study, we analyzed the spatial and temporal dynamics of malaria in the state of Acre (and more closely within a single county) to investigate the potential links between aquaculture and malaria transmission in this region. At the state level, we classified the 22 counties into three malaria endemicity patterns, based on the correlation between notification time series. Furthermore, the study period (2003-2013) was divided into two phases (epidemic and post-epidemic). Higher fish pond construction coincided both spatially and temporally with increased rate of malaria notification. Within one malaria endemic county, we investigated the relationship between the geolocation of malaria cases (2011-2012) and their distance to fish ponds. Entomological surveys carried out in these ponds provided measurements of anopheline abundance that were significantly associated with the abundance of malaria cases within 100 m of the ponds (P < 0.005; r = 0.39). These results taken together suggest that fish farming contributes to the maintenance of high transmission levels of malaria in this region.	[dos Reis, Izabel Cristina; Codeco, Claudia Torres] Fiocruz MS, Programa Comp Cient, BR-21045900 Rio De Janeiro, RJ, Brazil; [dos Reis, Izabel Cristina; Honorio, Nildimar Alves; Portela Camara, Daniel Cardoso] Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, BR-20001 Rio De Janeiro, RJ, Brazil; [Monteiro de Barros, Fabio Saito] Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil; [Barcellos, Christovam] Fiocruz MS, Inst Comunicacao & Informacao Cient & Tecnol Saud, Lab Informacao Saude, BR-21045900 Rio De Janeiro, RJ, Brazil; [Kitron, Uriel] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Keppeler, Erlei Cassiano] Univ Floresta, Ctr Multidiscipinar Campus Floresta, Univ Fed Acre, Cruzeiro Do Sul, Acre, Brazil; [Honorio, Nildimar Alves; Pereira, Glaucio Rocha] Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores, DIRAC, VPAAPS,IOC, BR-21045900 Rio De Janeiro, RJ, Brazil; [da Silva-Nunes, Monica] Univ Fed Acre, Ctr Ciencias Saude & Desporto, Rio Branco, Acre, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz; Emory University; Fundacao Oswaldo Cruz; Universidade Federal do Acre (UFAC)	dos Reis, IC (corresponding author), Fiocruz MS, Programa Comp Cient, BR-21045900 Rio De Janeiro, RJ, Brazil.	izabio2005@gmail.com	Câmara, Daniel C. P./S-3504-2018; Barcellos, Christovam/G-6856-2012; da Silva-Nunes, Monica/A-1885-2008; Barcellos, Christovam/GQA-5106-2022	Câmara, Daniel C. P./0000-0002-5439-4477; Barcellos, Christovam/0000-0002-1161-2753; Barcellos, Christovam/0000-0002-1161-2753	Brazilian Council for Scientific and Technological Development [484027/2012-3, 479977/2008-9, 471295/2011-6, 552746/2011-8]; Carlos Chagas Filho Foundation for the Support of Research in the State of Rio de Janeiro [E-26/111.500/2011]; Agency for Support and Evaluation of Graduate Education (Science without Borders program) [3341-13-5]; Universidade Federal do Acre; Fundacao de tecnologia do estado do Acre [04/2012]; Fundacao de Amparo a pesquisa no estado do Acre [14/2013]	Brazilian Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for the Support of Research in the State of Rio de Janeiro; Agency for Support and Evaluation of Graduate Education (Science without Borders program); Universidade Federal do Acre; Fundacao de tecnologia do estado do Acre; Fundacao de Amparo a pesquisa no estado do Acre	Funding was provided by Brazilian Council for Scientific and Technological Development (Grants 484027/2012-3 to NAH, 479977/2008-9 to CTC, 471295/2011-6 to MdSN and Climate and Health Observatory 552746/2011-8 to CB), Carlos Chagas Filho Foundation for the Support of Research in the State of Rio de Janeiro (Grants E-26/111.500/2011 to CTC); Agency for Support and Evaluation of Graduate Education (Grants 3341-13-5 from Science without Borders program to ICdR); Universidade Federal do Acre, Fundacao de tecnologia do estado do Acre (Grant n. 04/2012 to MdSN), and Fundacao de Amparo a pesquisa no estado do Acre Grant n. 14/2013 to MdSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2006, J VECTOR ECOL, V31, P145, DOI 10.3376/1081-1710(2006)31[145:EEOOBI]2.0.CO;2; ACRE. Secretaria de Estado de Meio Ambiente-SEMA, 2012, PROGR ARB URB EST AC; Anjos LHCS, 2013, 9 REUN BRAS CLASS CO; Barreto P, 2005, I HOMEM MEIO AMBIENT, V3, P1; Barros FSM, 2011, B ENTOMOL RES, V101, P643, DOI 10.1017/S0007485311000265; Braz Rui Moreira, 2014, Rev. bras. epidemiol., V17, P615, DOI 10.1590/1809-4503201400030004; Brochero Helena, 2006, Biomed., V26, P269; Chavent M, 2012, J STAT SOFTW, V50, P1; Cohen J, 2010, MALARIA J, V9, P1, DOI [10.1186/1475-2875-9-S1-S1, DOI 10.1186/1475-2875-9-S1-S1.PUBMED:20043863]; de Castro MC, 2007, HEALTH PLACE, V13, P368, DOI 10.1016/j.healthplace.2006.03.006; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; Costa KMD, 2010, REV PANAM SALUD PUBL, V28, P353, DOI 10.1590/S1020-49892010001100005; de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228; Duarte RBA, 2007, HIST SUCESSO AGRONEG; Saraiva MDG, 2009, REV SOC BRAS MED TRO, V42, P515, DOI 10.1590/S0037-86822009000500008; Maheu-Giroux M, 2010, ACTA TROP, V115, P112, DOI 10.1016/j.actatropica.2010.02.011; Matthys B, 2006, AM J TROP MED HYG, V75, P1223, DOI 10.4269/ajtmh.2006.75.1223; Minitry of Health Brazil, 2006, TECHN REP SIVEP MAL; Minitry of Health Brazil, 2010, SIST INF VIG EP MAL; Monteiro de Barros Fabio Saito, 2007, Memorias do Instituto Oswaldo Cruz, V102, P299; Oliveira- Ferreira J, 2010, MAL J, V9, P2; Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785; OpenStreetMap, 2012, OPENSTREETMAP FREE W; Pan American Health Organization and World Health Organization, 2011, MAL CHAMP AM 2011 FI, V11; Pan American Health Organization and World Health Organization, 2013, EST ACR HOM COM CAMP, V11; R Development Core Team, 2014, R LANG ENV STAT COMP; REZENDE F. J. W., 2008, AMAZONIA CIENCIA DES, V4, P167; Rodrigues I. B., 2008, Revista de Patologia Tropical, V37, P161; Sawyer DR, 1988, FRONTIER MALARIA AMA; Service M, 1993, MOSQUITO ECOLOGY FIE; Simpson JM, 2006, THESIS COLUMBIA U; Stefani A, 2013, MALARIA J, V12, P1; Suarez-Mutis MC, 2007, CAD SAUDE PUBLICA, V23, P795, DOI 10.1590/S0102-311X2007000400007; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3	36	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137521	10.1371/journal.pone.0137521	http://dx.doi.org/10.1371/journal.pone.0137521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361330	Green Published, gold			2022-12-26	WOS:000361043100049
J	Shi, DW; Shen, S; Fan, XL; Chen, SH; Wang, DY; Li, CG; Wu, X; Li, LL; Bai, DT; Zhang, CT; Wang, JZ				Shi, Dawei; Shen, Shu; Fan, Xingliang; Chen, Suhong; Wang, Dayan; Li, Changgui; Wu, Xing; Li, Lili; Bai, Dongting; Zhang, Chuntao; Wang, Junzhi			Evaluation of Commercial Diagnostic Assays for the Specific Detection of Avian Influenza A (H7N9) Virus RNA Using a Quality-Control Panel and Clinical Specimens in China	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; HUMAN INFECTION; A(H7N9) VIRUS; FERRETS; ORIGIN; PCR	A novel avian influenza A H7N9-subtype virus emerged in China in 2013 and threatened global public health. Commercial kits that specifically detect avian influenza A (H7N9) virus RNA are urgently required to prepare for the emergence and potential pandemic of this novel influenza virus. The safety and effectiveness of three commercial molecular diagnostic assays were evaluated using a quality-control panel and clinical specimens collected from over 90 patients with confirmed avian influenza A (H7N9) virus infections. The analytical performance evaluation showed that diverse influenza H7N9 viruses can be detected with high within-and between-lot reproducibility and without cross-reactivity to other influenza viruses (H1N1 pdm09, seasonal H1N1, H3N2, H5N1 and influenza B). The detection limit of all the commercial assays was 2.83 Log(10) copies/mu l [0.7 Log(10)T-CID50/mL of avian influenza A (H7N9) virus strain A/Zhejiang/DTID-ZJU01/2013], which is comparable to the method recommended by the World Health Organization (WHO). In addition, using a WHO-Chinese National Influenza Center (CNIC) method as a reference for clinical evaluation, positive agreement of more than 98% was determined for all of the commercial kits, while negative agreement of more than 99% was observed. In conclusion, our findings provide comprehensive evidence for the high performance of three commercial diagnostic assays and suggest the application of these assays as rapid and effective diagnostic tools for avian influenza A (H7N9) virus in the routine clinical practice of medical laboratories.	[Shi, Dawei; Shen, Shu; Fan, Xingliang; Li, Changgui; Wu, Xing; Li, Lili; Bai, Dongting; Zhang, Chuntao; Wang, Junzhi] Natl Inst Food & Drug Control, Key Lab, Minist Hlth Res Qual & Standardizat Biotech Prod, Beijing, Peoples R China; [Fan, Xingliang; Li, Changgui; Wu, Xing; Wang, Junzhi] WHO Collaborating Ctr Standardizat & Evaluat Biol, Beijing, Peoples R China; [Chen, Suhong] Beijing Inst Radiat Med, Beijing, Peoples R China; [Wang, Dayan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Chinese Natl Influenza Ctr, Beijing, Peoples R China; [Wang, Dayan] WHO Collaborating Ctr Reference & Res Influenza, Beijing, Peoples R China	National Institute of Food & Drug Control - China; Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, CT (corresponding author), Natl Inst Food & Drug Control, Key Lab, Minist Hlth Res Qual & Standardizat Biotech Prod, Beijing, Peoples R China.	zhangct2@126.com; wangjunzhi2013@126.com			Ministry of Science and Technology of the People's Republic of China [KJYJ-2013-01-03]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work is supported by the grant (KJYJ-2013-01-03) from Ministry of Science and Technology of the People's Republic of China (www.most.gov.cn) to BDT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Chantratita W, 2008, MOL CELL PROBE, V22, P287, DOI 10.1016/j.mcp.2008.06.005; Chen E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.43.20616; Chen Y, 2014, EMERG INFECT DIS, V21; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Corman VM, 2013, EUROSURVEILLANCE, V18, P10; Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ge YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069941; Hatchette TF, 2013, J CLIN MICROBIOL, V51, P3835, DOI 10.1128/JCM.01808-13; Kalthoff D, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.10.20731; Kang KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092306; Kang XP, 2014, J VIROL METHODS, V206, P140, DOI 10.1016/j.jviromet.2014.01.026; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Li Y, 2013, J VIROL METHODS, V194, P194, DOI 10.1016/j.jviromet.2013.08.021; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu J, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0271-x; Lu J, 2014, EMERG INFECT DIS, V20, P1582, DOI 10.3201/eid2009.140250; Meng Z, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.6.20699; Nie K, 2013, CLIN MICROBIOL INFEC, V19, pE372, DOI 10.1111/1469-0691.12263; Quidel Corpoation, 2013, QUID LYR INFL A SUBT; ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W; The National Food Drug Administration of China, 2013, NOT NATL FOOD DRUG A; US Food and Drug Administration, 2014, LETT EM US AUTH EUA; Wang D, 2014, EUROSURVEILLANCE, V2013, P19, DOI DOI 10.2807/1560-7917.ES2014.19.25.20836; Wang SQ, 2002, ANAL BIOCHEM, V309, P206, DOI 10.1016/S0003-2697(02)00317-2; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; WHO, 2013, REAL TIM RT PCR PROT; World Health Organization, 2014, HUM INF AV INFL A H7; World Health Organization, 2013, LAB PROC SER DET AV; World Health Organization, 2013, SER DET AV INFL A H7; Xiao XC, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.25.20837; Zhang JH, 2013, J CLIN MICROBIOL, V51, P3760, DOI 10.1128/JCM.01907-13; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844; Zhu ZW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056662, 10.1371/journal.pone.0080028]	36	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137862	10.1371/journal.pone.0137862	http://dx.doi.org/10.1371/journal.pone.0137862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361351	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100097
J	Qiao, Y; Lin, SJ; Chen, Y; Voon, DCC; Zhu, F; Chuang, LSH; Wang, T; Tan, P; Lee, SC; Yeoh, KG; Sudol, M; Ito, Y				Qiao, Y.; Lin, S. J.; Chen, Y.; Voon, D. C-C; Zhu, F.; Chuang, L. S. H.; Wang, T.; Tan, P.; Lee, S. C.; Yeoh, K. G.; Sudol, M.; Ito, Y.			RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer	ONCOGENE			English	Article							TUMOR-SUPPRESSOR RUNX3; HIPPO PATHWAY; WW DOMAIN; PROMOTES METASTASIS; SIGNALING PATHWAY; EPITHELIAL-CELLS; BREAST-CANCER; SIZE-CONTROL; PROTEIN; GROWTH	Runt-related transcription factor 3 (RUNX3) is a well-documented tumour suppressor that is frequently inactivated in gastric cancer. Here, we define a novel mechanism by which RUNX3 exerts its tumour suppressor activity involving the TEAD-YAP complex, a potent positive regulator of proliferative genes. We report that the TEAD-YAP complex is not only frequently hyperactivated in liver and breast cancer, but also confers a strong oncogenic activity in gastric epithelial cells. The increased expression of TEAD-YAP in tumour tissues significantly correlates with poorer overall survival of gastric cancer patients. Strikingly, RUNX3 physically interacts with the N-terminal region of TEAD through its Runt domain. This interaction markedly reduces the DNA-binding ability of TEAD that attenuates the downstream signalling of TEAD-YAP complex. Mutation of RUNX3 at Arginine 122 to Cysteine, which was previously identified in gastric cancer, impairs the interaction between RUNX3 and TEAD. Our data reveal that RUNX3 acts as a tumour suppressor by negatively regulating the TEAD-YAP oncogenic complex in gastric carcinogenesis.	[Qiao, Y.; Chen, Y.; Voon, D. C-C; Chuang, L. S. H.; Wang, T.; Tan, P.; Lee, S. C.; Ito, Y.] Natl Univ Singapore, Canc Sci Inst Singapore, 14 Med Dr,12-01 Ctr Translat Med,MD6, Singapore 117599, Singapore; [Lin, S. J.; Tan, P.] Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Singapore, Singapore; [Zhu, F.; Lee, S. C.] Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Haematol & Oncol, Singapore, Singapore; [Tan, P.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Tan, P.] Natl Canc Ctr, Cellular & Mol Res, Singapore, Singapore; [Yeoh, K. G.; Sudol, M.] Natl Univ Singapore, NUS Yong Loo Lin Sch Med, Singapore 117599, Singapore; [Sudol, M.] Mechanobiol Inst MBI, Singapore, Singapore; [Sudol, M.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Ito, Y (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, 14 Med Dr,12-01 Ctr Translat Med,MD6, Singapore 117599, Singapore.	csiitoy@nus.edu.sg	Lee, Soo Chin/S-9111-2016	Lee, Soo Chin/0000-0002-5835-6419; Voon, Dominic Chih-Cheng/0000-0002-2963-9305	Singapore National Research Foundation under its Translational and Clinical Research Flagship Programme; Singapore Ministry of Health's National Medical Research Council [NMRC/TCR/001/2007, NMRC/TCR/009-NUHS/2013]; NUS-Medical School, MBI; IMCB A*STAR; National Research Foundation Singapore; Singapore Ministry of Education under its Research Centres of Excellence initiative	Singapore National Research Foundation under its Translational and Clinical Research Flagship Programme(National Research Foundation, Singapore); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); NUS-Medical School, MBI; IMCB A*STAR; National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under its Research Centres of Excellence initiative(Ministry of Education, Singapore)	This research is supported by the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centres of Excellence initiative. The study was also supported by the Singapore National Research Foundation under its Translational and Clinical Research Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (Grants NMRC/TCR/001/2007 and NMRC/TCR/009-NUHS/2013). M Sudol was supported by seed grants from The NUS-Medical School, MBI and IMCB A*STAR. We are grateful to Professor Stefano Piccolo for providing us the 8xGTIIC-luciferase plasmid via Addgene. We also thank Professor Kunliang Guan for providing us myc-TEAD1 plasmid via Addgene. We acknowledge valuable comments on the manuscript from Dr Megan Finch-Edmondson.	Anbanandam A, 2006, P NATL ACAD SCI USA, V103, P17225, DOI 10.1073/pnas.0607171103; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Brusgard JL, 2015, ONCOTARGET IN PRESS; Chakraborty PK, 2014, CANCER RES, V74, P3489, DOI 10.1158/0008-5472.CAN-13-2708; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Cinghu S, 2012, J CELL PHYSIOL, V227, P1071, DOI 10.1002/jcp.22820; Dembele D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-14; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fan XY, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-92; Fukumoto Y, 2011, J BIOL CHEM, V286, P43537, DOI 10.1074/jbc.M111.308858; Huang B, 2012, ONCOGENE, V31, P527, DOI 10.1038/onc.2011.252; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Jiang CG, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-122; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Karagiannis GS, 2012, ONCOTARGET, V3, P267, DOI 10.18632/oncotarget.451; Koh CP, 2013, LEUKEMIA, V27, P1793, DOI 10.1038/leu.2013.200; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lee YS, 2013, CANCER CELL, V24, P603, DOI 10.1016/j.ccr.2013.10.003; Li H, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0539-5; Li P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-52; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lim B, 2014, CARCINOGENESIS, V35, P1020, DOI 10.1093/carcin/bgt409; Lin MT, 2005, CLIN CANCER RES, V11, P5809, DOI 10.1158/1078-0432.CCR-04-2639; Lin YT, 2012, EXP CELL RES, V318, P1877, DOI 10.1016/j.yexcr.2012.05.005; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Min B, 2012, J CELL PHYSIOL, V227, P839, DOI 10.1002/jcp.22887; Oh YS, 2013, CELL, V152, P831, DOI 10.1016/j.cell.2013.01.014; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Rho SB, 2008, CANCER LETT, V271, P306, DOI 10.1016/j.canlet.2008.06.020; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; SUDOL M, 1994, ONCOGENE, V9, P2145; Tsang YH, 2010, ONCOGENE, V29, P5643, DOI 10.1038/onc.2010.304; Tsutsumi R, 2013, DEV CELL, V26, P658, DOI 10.1016/j.devcel.2013.08.013; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Voon DCC, 2012, STEM CELLS, V30, P2088, DOI 10.1002/stem.1183; Wang CQ, 2014, CELL REP, V8, P767, DOI 10.1016/j.celrep.2014.06.046; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yamada C, 2010, J BIOL CHEM, V285, P16693, DOI 10.1074/jbc.M109.055525; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	59	57	58	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 19	2016	35	20					2664	2674		10.1038/onc.2015.338	http://dx.doi.org/10.1038/onc.2015.338			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GS	26364597				2022-12-26	WOS:000376165700013
J	Billesbolle, CB; Kruger, MB; Shi, L; Quick, M; Li, Z; Stolzenberg, S; Kniazeff, J; Gotfryd, K; Mortensen, JS; Javitch, JA; Weinstein, H; Loland, CJ; Gether, U				Billesbolle, Christian B.; Kruger, Mie B.; Shi, Lei; Quick, Matthias; Li, Zheng; Stolzenberg, Sebastian; Kniazeff, Julie; Gotfryd, Kamil; Mortensen, Jonas S.; Javitch, Jonathan A.; Weinstein, Harel; Loland, Claus J.; Gether, Ulrik			Substrate-induced Unlocking of the Inner Gate Determines the Catalytic Efficiency of a Neurotransmitter:Sodium Symporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATION; BETA(2) ADRENERGIC-RECEPTOR; CONFORMATIONAL-CHANGES; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; BACTERIAL HOMOLOG; BINDING-SITE; MONOAMINE TRANSPORTERS; ALTERNATING ACCESS; SODIUM SYMPORTERS	Neurotransmitter: sodium symporters (NSSs) mediate reuptake of neurotransmitters from the synaptic cleft and are targets for several therapeutics and psychostimulants. The prokaryotic NSS homologue, LeuT, represents a principal structural model for Na+ coupled transport catalyzed by these proteins. Here, we used site-directed fluorescence quenching spectroscopy to identify in LeuTa substrate-induced conformational rearrangement at the inner gate conceivably leading to formation of a structural intermediate preceding transition to the in ward-open conformation. The substrate induced, Na+-dependent change required an intact primary substrate-binding site and involved increased water exposure of the cytoplasmic end of transmembrane segment 5. The findings were supported by simulations predicting disruption of an intracellular interaction network leading to a discrete rotation of transmembrane segment 5 and the adjacent intracellular loop 2. The magnitude of the spectroscopic response correlated inversely with the transport rate for different substrates, suggesting that stability of the intermediate represents an unrecognized rate-limiting barrier in the NSS transport mechanism.	[Billesbolle, Christian B.; Kruger, Mie B.; Kniazeff, Julie; Gotfryd, Kamil; Mortensen, Jonas S.; Loland, Claus J.; Gether, Ulrik] Univ Copenhagen, Panum Inst, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Shi, Lei; Li, Zheng; Stolzenberg, Sebastian; Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	University of Copenhagen; Cornell University; Cornell University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Gether, U (corresponding author), Univ Copenhagen, Mol Neuropharmacol & Genet Lab, Dept Neurosci & Pharmacol, Fac Hlth & Med Sci,Panum Inst 18 6, DK-2200 Copenhagen N, Denmark.	gether@sund.ku.dk	Shi, Lei/AAV-1321-2020; Mortensen, Jonas Sigurd/AAP-6768-2020; Regan, Clinton/E-6250-2012; WEINSTEIN, HAREL/O-8245-2019; Mortensen, Jonas S/R-1655-2017; Gourdon, Pontus/E-1076-2014; Loland, Claus/E-5975-2014	Shi, Lei/0000-0002-4137-096X; Mortensen, Jonas Sigurd/0000-0002-6743-276X; WEINSTEIN, HAREL/0000-0003-3473-9818; Gourdon, Pontus/0000-0002-8631-3539; Javitch, Jonathan/0000-0001-7395-2967; Loland, Claus/0000-0002-1773-1446; Gotfryd, Kamil/0000-0002-0299-0779; Gether, Ulrik/0000-0002-0020-3807; Kniazeff, Julie/0000-0002-0426-0999	National Institutes of Health [P01 DA 12408, DA022413, DA17293]; Danish Council for Independent Research-Sapere Aude Program; Lundbeck Foundation Center for Biomembranes in Nanomedicine; UNIK Center for Synthetic Biology; European Community [HEALTH-F4-2007-201924]; Carlsberg Foundation; Bikuben Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research-Sapere Aude Program; Lundbeck Foundation Center for Biomembranes in Nanomedicine; UNIK Center for Synthetic Biology; European Community(European Commission); Carlsberg Foundation(Carlsberg Foundation); Bikuben Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DA 12408 (to U. G. and H. W.), DA022413 (to J. A. J.), and DA17293 (to J. A. J.). This work was also supported by the Danish Council for Independent Research-Sapere Aude Program (to C. J. L.), the Lundbeck Foundation Center for Biomembranes in Nanomedicine (to U. G.), the UNIK Center for Synthetic Biology (to U. G. and C. J. L.), the European Community's Seventh Framework Programme FP7/2007-2013 HEALTH-F4-2007-201924 (to U. G.), The Carlsberg Foundation (to C. J. L.), and the Bikuben Foundation (to C. B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Dayan O, 2014, J BIOL CHEM, V289, P28172, DOI 10.1074/jbc.M114.589721; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; GETHER U, 1995, J BIOL CHEM, V270, P28268; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Larsen MB, 2011, J NEUROSCI, V31, P6605, DOI 10.1523/JNEUROSCI.0576-11.2011; LeVine MV, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003603; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rasmussen SGF, 2001, J BIOL CHEM, V276, P4717, DOI 10.1074/jbc.M008067200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Vastermark A, 2014, PROTEINS, V82, P336, DOI 10.1002/prot.24401; Venkatesan P, 1998, P NATL ACAD SCI USA, V95, P9802, DOI 10.1073/pnas.95.17.9802; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang QD, 1997, BIOCHEMISTRY-US, V36, P14120, DOI 10.1021/bi9716433; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963; Zhang Y, 2010, J MOL RECOGNIT, V23, P360, DOI 10.1002/jmr.1002; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	57	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26725	26738		10.1074/jbc.M115.677658	http://dx.doi.org/10.1074/jbc.M115.677658			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26363074	hybrid, Green Published			2022-12-26	WOS:000364793600035
J	Liu, X; Chen, Z; Ouyang, G; Song, TS; Liang, HG; Liu, W; Xiao, WH				Liu, Xing; Chen, Zhu; Ouyang, Gang; Song, Tieshan; Liang, Huageng; Liu, Wei; Xiao, Wuhan			ELL Protein-associated Factor 2 (EAF2) Inhibits Transforming Growth Factor beta Signaling through a Direct Interaction with Smad3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; NUCLEAR EXPORT; TRANSCRIPTIONAL ACTIVITY; II RECEPTORS; COACTIVATORS; EXPRESSION; CBP/P300; TRANSLOCATION; TRANSDUCTION; CONVERGENCE	A series of in vitro and in vivo studies has shown that EAF2 can affect multiple signaling pathways involved in cellular processes. However, the molecular mechanisms underlying its effects have remained elusive. Here we report the discovery of a new functional link between EAF2 and TGF-beta signaling. Promoter reporter assays indicated that EAF2 suppresses Smad3 transcriptional activity, resulting in inhibition of TGF-beta signaling. Coimmunoprecipitation assays showed that EAF2 specifically interacts with Smad3 in vitro and in vivo but not with other Smad proteins. In addition, we observed that EAF2 binding does not alter Smad3 phosphorylation but causes Smad3 cytoplasmic retention, competes with Smad4 for binding to Smad3, and prevents p300-Smad3 complex formation. Furthermore, we demonstrated that EAF2 suppresses both TGF-beta -induced G(1) cell cycle arrest and TGF-beta -induced cell migration. This study identifies and characterizes a novel repressor of TGF-beta signaling.	[Liu, Xing; Chen, Zhu; Ouyang, Gang; Liu, Wei; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China; [Chen, Zhu] Maternal & Child Hlth Hosp Hubei Prov, Dept Reprod, Wuhan 430070, Peoples R China; [Song, Tieshan] Hubei Univ Sci & Technol, Xianning 437100, Peoples R China; [Liang, Huageng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, Wuhan 430030, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Hubei University of Science & Technology; Huazhong University of Science & Technology	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022		CAS Major Scientific and Technological Project [XDA08010208]; NSFC (National Natural Science Foundation of China) [31461163003, 31071212, 91019008, 31401072, 81160266/H1603]	CAS Major Scientific and Technological Project; NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC))	This work is supported by CAS Major Scientific and Technological Project XDA08010208 and NSFC (National Natural Science Foundation of China) Grants 31461163003, 31071212, and 91019008 (to W. X.), 31401072 (to X. L.), and 81160266/H1603 (to T. S.). The authors declared that they have no conflict of interest to this work.	Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen Z, 2014, MOL CELL BIOL, V34, P1085, DOI 10.1128/MCB.00718-13; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Dai FY, 2007, MOL CELL BIOL, V27, P6183, DOI 10.1128/MCB.00132-07; Dai FY, 2011, EMBO REP, V12, P1175, DOI 10.1038/embor.2011.174; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Imoto S, 2008, BIOCHEM BIOPH RES CO, V370, P359, DOI 10.1016/j.bbrc.2008.03.116; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kim RH, 2000, GENE DEV, V14, P1605; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Liu JX, 2013, DEVELOPMENT, V140, P1067, DOI 10.1242/dev.086157; Liu JX, 2009, J BIOL CHEM, V284, P16679, DOI 10.1074/jbc.M109.009654; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Mori N, 2001, BLOOD, V97, P2137, DOI 10.1182/blood.V97.7.2137; OKADOME T, 1994, J BIOL CHEM, V269, P30753; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Simone F, 2001, BLOOD, V98, P201, DOI 10.1182/blood.V98.1.201; Suh JH, 2006, J BIOL CHEM, V281, P39169, DOI 10.1074/jbc.M605947200; Sun HQ, 2010, J BIOL CHEM, V285, P4243, DOI 10.1074/jbc.M109.079533; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; VIVIEN D, 1995, J BIOL CHEM, V270, P7134, DOI 10.1074/jbc.270.13.7134; Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2003, CANCER RES, V63, P4698; Xiao WH, 2009, CANCER RES, V69, P2599, DOI 10.1158/0008-5472.CAN-08-2595; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; Yanagi Y, 1999, J BIOL CHEM, V274, P12971, DOI 10.1074/jbc.274.19.12971; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200	53	7	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25933	25945		10.1074/jbc.M115.663542	http://dx.doi.org/10.1074/jbc.M115.663542			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26370086	Green Published, hybrid			2022-12-26	WOS:000363527300016
J	Tourmente, M; Roldan, ERS				Tourmente, Maximiliano; Roldan, Eduardo R. S.			Mass-Specific Metabolic Rate Influences Sperm Performance through Energy Production in Mammals	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE-S; GLYCOLYTIC-ENZYMES; MOUSE SPERMATOZOA; BODY-MASS; FIBROUS SHEATH; SIZE; COMPETITION; MOTILITY; PHOSPHORYLATION; CAPACITATION	Mass-specific metabolic rate, the rate at which organisms consume energy per gram of body weight, is negatively associated with body size in metazoans. As a consequence, small species have higher cellular metabolic rates and are able to process resources at a faster rate than large species. Since mass-specific metabolic rate has been shown to constrain evolution of sperm traits, and most of the metabolic activity of sperm cells relates to ATP production for sperm motility, we hypothesized that mass-specific metabolic rate could influence sperm energetic metabolism at the cellular level if sperm cells maintain the metabolic rate of organisms that generate them. We compared data on sperm straight-line velocity, mass-specific metabolic rate, and sperm ATP content from 40 mammalian species and found that the mass-specific metabolic rate positively influences sperm swimming velocity by (a) an indirect effect of sperm as the result of an increased sperm length, and (b) a direct effect independent of sperm length. In addition, our analyses show that species with higher mass-specific metabolic rate have higher ATP content per sperm and higher concentration of ATP per mu m of sperm length, which are positively associated with sperm velocity. In conclusion, our results suggest that species with high mass-specific metabolic rate have been able to evolve both long and fast sperm. Moreover, independently of its effect on the production of larger sperm, the mass-specific metabolic rate is able to influence sperm velocity by increasing sperm ATP content in mammals.	[Tourmente, Maximiliano; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Roldan, ERS (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Tourmente, Maximiliano/I-2852-2019	Roldan, Eduardo R.S./0000-0002-7545-4248; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Economy and Competitiveness	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was funded by the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MF, 2007, AM J PHYSIOL-REG I, V292, pR2115, DOI 10.1152/ajpregu.00568.2006; Bunch DO, 1998, BIOL REPROD, V58, P834, DOI 10.1095/biolreprod58.3.834; Calder W.A., 1984, SIZE FUNCTION LIFE H; Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Cooper TG., 2012, EPIDIDYMIS SPERM MAT; COUTURE P, 1995, AM J PHYSIOL-REG I, V268, pR641, DOI 10.1152/ajpregu.1995.268.3.R641; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; DU JY, 1994, J REPROD FERTIL, V101, P37, DOI 10.1530/jrf.0.1010037; Else PL, 1985, AM J PHYSIOL, V248, pR1; EMMETT B, 1981, RESP PHYSIOL, V45, P261, DOI 10.1016/0034-5687(81)90010-4; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; FRASER LR, 1981, J REPROD FERTIL, V61, P25, DOI 10.1530/jrf.0.0610025; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garrett LJA, 2008, J ANDROL, V29, P449, DOI 10.2164/jandrol.107.003533; Gatti JL, 2004, ANIM REPROD SCI, V82-3, P321, DOI 10.1016/j.anireprosci.2004.05.011; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomendio M, 2011, P ROY SOC B-BIOL SCI, V278, P3135, DOI 10.1098/rspb.2011.0275; HALANGK W, 1985, BIOMED BIOCHIM ACTA, V44, P411; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HEUSNER AA, 1991, J EXP BIOL, V160, P25; HOCHACHKA PW, 1988, CAN J ZOOL, V66, P1128, DOI 10.1139/z88-165; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; JEULIN C, 1992, CELL MOTIL CYTOSKEL, V21, P210, DOI 10.1002/cm.970210305; Kamp G, 1996, EXPERIENTIA, V52, P487, DOI 10.1007/BF01919321; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; Konarzewski M, 2013, J COMP PHYSIOL B, V183, P27, DOI 10.1007/s00360-012-0698-z; KREBS HA, 1950, BIOCHIM BIOPHYS ACTA, V4, P249, DOI 10.1016/0006-3002(50)90032-1; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; Lupold S, 2013, EVOLUTION, V67, P3052, DOI 10.1111/evo.12132; Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Orme C. D. L., 2013, CAPER PACKAGE COMP A; Parapanov R, 2008, REPROD FERT DEVELOP, V20, P431, DOI 10.1071/RD07207; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; Ramm SA, 2010, BIOL LETTERS, V6, P219, DOI 10.1098/rsbl.2009.0635; RIKMENSPOEL R, 1978, BIOPHYS J, V23, P177, DOI 10.1016/S0006-3495(78)85442-3; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rosnow RL, 2003, CAN J EXP PSYCHOL, V57, P221, DOI 10.1037/h0087427; Ruiz-Pesini E, 2007, CURR TOP DEV BIOL, V77, P3, DOI 10.1016/S0070-2153(06)77001-6; Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104; Schmidt-Nielsen K., 1990, ANIMAL PHYSL ADAPTAT; SCHOCH G, 1990, EUR J CLIN NUTR, V44, P647; Smithson M, 2002, CONFIDENCE INTERVALS; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Tourmente M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021244; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Travis AJ, 1998, MOL BIOL CELL, V9, P263, DOI 10.1091/mbc.9.2.263; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; Turner N, 2005, AM J PHYSIOL-REG I, V288, pR301, DOI 10.1152/ajpregu.00297.2004; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; WATERLOW JC, 1984, Q J EXP PHYSIOL CMS, V69, P409, DOI 10.1113/expphysiol.1984.sp002829; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2013, J COMP PHYSIOL B, V183, P1, DOI 10.1007/s00360-012-0676-5; Yeung CH, 2002, J ANDROL, V23, P522	66	15	15	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138185	10.1371/journal.pone.0138185	http://dx.doi.org/10.1371/journal.pone.0138185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371474	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400055
J	Ichijo, M; Ishibashi, S; Li, FY; Yui, DS; Miki, K; Mizusawa, H; Yokota, T				Ichijo, Masahiko; Ishibashi, Satoru; Li, Fuying; Yui, Daishi; Miki, Kazunori; Mizusawa, Hidehiro; Yokota, Takanori			Sphingosine-1-Phosphate Receptor-1 Selective Agonist Enhances Collateral Growth and Protects against Subsequent Stroke	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE ISCHEMIC-STROKE; FLUID SHEAR-STRESS; SPHINGOSINE 1-PHOSPHATE; CEREBRAL-ISCHEMIA; ACTIVATION; MICE; FTY720; EDG-1; FATE	Background and Purpose Collateral growth after acute occlusion of an intracranial artery is triggered by increasing shear stress in preexisting collateral pathways. Recently, sphingosine-1-phosphate receptor-1 (S1PR1) on endothelial cells was reported to be essential in sensing fluid shear stress. Here, we evaluated the expression of S1PR1 in the hypoperfused mouse brain and investigated the effect of a selective S1PR1 agonist on leptomeningeal collateral growth and subsequent ischemic damage after focal ischemia. Methods In C57Bl/6 mice (n = 133) subjected to unilateral common carotid occlusion (CCAO) and sham surgery. The first series examined the time course of collateral growth, cell proliferation, and S1PR1 expression in the leptomeningeal arteries after CCAO. The second series examined the relationship between pharmacological regulation of S1PR1 and collateral growth of leptomeningeal anastomoses. Animals were randomly assigned to one of the following groups: LtCCAO and daily intraperitoneal (ip) injection for 7 days of an S1PR1 selective agonist (SEW2871, 5 mg/kg/day); sham surgery and daily ip injection for 7 days of SEW2871 after surgery; LtCCAO and daily ip injection for 7 days of SEW2871 and an S1PR1 inverse agonist (VPC23019, 0.5 mg/kg); LtCCAO and daily ip injection of DMSO for 7 days after surgery; and sham surgery and daily ip injection of DMSO for 7 days. Leptomeningeal anastomoses were visualized 14 days after LtCCAO by latex perfusion method, and a set of animals underwent subsequent permanent middle cerebral artery occlusion (pMCAO) 7days after the treatment termination. Neurological functions 1hour, 1, 4, and 7days and infarction volume 7days after pMCAO were evaluated. Results In parallel with the increase in S1PR1 mRNA levels, S1PR1 expression colocalized with endothelial cellmarkers in the leptomeningeal arteries, increased markedly on the side of the CCAO, and peaked 7 days after CCAO. Mitotic cell numbers in the leptomeningeal arteries increased after CCAO. Administration of the S1PR1 selective agonist significantly increased cerebral blood flow (CBF) and the diameter of leptomeningeal collateral vessels (42.9 +/- 2.6 mu m) compared with the controls (27.6 +/- 5.7 mu m; P < 0.01). S1PR1 inverse agonist administration diminished the effect of the S1PR1 agonist (P < 0.001). After pMCAO, S1PR1 agonist pretreated animals showed significantly smaller infarct volume (17.5% +/- 4.0% vs. 7.7% +/- 4.0%, P < 0.01) and better functional recovery than vehicle-treated controls. Conclusions These results suggest that S1PR1 is one of the principal regulators of leptomeningeal collateral recruitment at the site of increased shear stress and provide evidence that an S1PR1 selective agonist has a role in promoting collateral growth and preventing of ischemic damage and neurological dysfunction after subsequent stroke in patients with intracranial major artery stenosis or occlusion.	[Ichijo, Masahiko; Ishibashi, Satoru; Li, Fuying; Yui, Daishi; Yokota, Takanori] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Tokyo, Japan; [Miki, Kazunori] Tokyo Med & Dent Univ, Dept Endovasc Surg, Tokyo, Japan; [Mizusawa, Hidehiro] Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan; [Yokota, Takanori] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Center for Neurology & Psychiatry - Japan; Tokyo Medical & Dental University (TMDU)	Ishibashi, S (corresponding author), Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Tokyo, Japan.	t-ishibashi.nuro@tmd.ac.jp		Yokota, Takanori/0000-0002-6490-3263				Bang OY, 2008, J NEUROL NEUROSUR PS, V79, P625, DOI 10.1136/jnnp.2007.132100; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Gu YJ, 2000, ARTIF ORGANS, V24, P43, DOI 10.1046/j.1525-1594.2000.06351.x; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Hecht N, 2012, STROKE, V43, P3052, DOI 10.1161/STROKEAHA.112.653204; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Igarashi J, 2000, J BIOL CHEM, V275, P32363, DOI 10.1074/jbc.M003075200; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kitagawa K, 2005, STROKE, V36, P2270, DOI 10.1161/01.STR.0000181075.77897.0e; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Liebeskind DS, 2014, STROKE, V45, P759, DOI 10.1161/STROKEAHA.113.004072; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Montrose DC, 2013, J LIPID RES, V54, P843, DOI 10.1194/jlr.M034108; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Pipp F, 2004, ARTERIOSCL THROM VAS, V24, P1664, DOI 10.1161/01.ATV.0000138028.14390.e4; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Samarska IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097196; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Smith WS, 2009, STROKE, V40, P3834, DOI 10.1161/STROKEAHA.109.561787; Sugiyama Y, 2011, STROKE, V42, P770, DOI 10.1161/STROKEAHA.110.597799; Tarbell JM, 2014, ANNU REV BIOMED ENG, V16, P505, DOI 10.1146/annurev-bioeng-071813-104908; Todo K, 2008, STROKE, V39, P1875, DOI 10.1161/STROKEAHA.107.503433; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952	32	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138029	10.1371/journal.pone.0138029	http://dx.doi.org/10.1371/journal.pone.0138029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367258	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100207
J	Ishizuka, M; Miyazaki, Y; Masuo, M; Suhara, K; Tateishi, T; Yasui, M; Inase, N				Ishizuka, Masahiro; Miyazaki, Yasunari; Masuo, Masahiro; Suhara, Kozo; Tateishi, Tomoya; Yasui, Makito; Inase, Naohiko			Interleukin-17A and Neutrophils in a Murine Model of Bird-Related Hypersensitivity Pneumonitis	PLOS ONE			English	Article							PIGEON-BREEDERS LUNG; SIGLEC-F; ALLERGIC ALVEOLITIS; CYCLOSPORINE-A; FANCIERS LUNG; T-CELLS; INNATE; INFLAMMATION; FIBROSIS; MICE	Hypersensitivity pneumonitis (HP) is an immune mediated lung disease induced by the repeated inhalation of a wide variety of antigens. Bird-related hypersensitivity pneumonitis (BRHP) is one of the most common forms of HP in human and results from the inhalation of avian antigens. The findings of a recent clinical analysis suggest that in addition to Th1 factors, the levels of interleukin(IL)-17 and IL-17-associated transcripts are increased in the setting of HP, and that both IL-17A and neutrophils are crucial for the development of pulmonary inflammation in murine models of HP. Our objectives were to investigate the roles of IL-17A and neutrophils in granuloma-forming inflammation in an acute HP model. We developed a mouse model of acute BRHP using pigeon dropping extract. We evaluated the process of granuloma formation and the roles of both IL-17A and neutrophils in a model. We found that the neutralization of IL-17A by the antibody attenuated granuloma formation and the recruitment of neutrophils, and also decreased the expression level of chemokine(C-XC motif) ligand 5 (CXCL5) in the acute HP model. We confirmed that most of the neutrophils in the acute HP model exhibited immunoreactivity to the anti-IL-17 antibody. We have identified the central roles of both IL-17A and neutrophils in the pathogenesis of granuloma formation in acute HP. We have also assumed that neutrophils are an important source of IL-17A in an acute HP model, and that the IL-17A-CXCL5 pathway may be responsible for the recruitment of neutrophils.	[Ishizuka, Masahiro; Miyazaki, Yasunari; Masuo, Masahiro; Suhara, Kozo; Tateishi, Tomoya; Yasui, Makito; Inase, Naohiko] Tokyo Med & Dent Univ, Dept Resp Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Miyazaki, Y (corresponding author), Tokyo Med & Dent Univ, Dept Resp Med, Tokyo, Japan.	miyazaki.pilm@tmd.ac.jp	Miyazaki, Yasunari/B-7847-2015	Miyazaki, Yasunari/0000-0002-9073-9815; Tateishi, Tomoya/0000-0001-5402-3185	Ministry of Health, Labor and Welfare, Japan; Japan Agency for Medical Research and development, AMED; Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This project was supported by a grant to the Diffuse Lung Diseases Research Group from the Ministry of Health, Labor and Welfare, Japan (N.I.). This research is partially supported by the Practical Research Project for Rare Intractable Diseases from Japan Agency for Medical Research and development, AMED. This study is partially supported by a grant from the Ministry of Health, Labour and Welfare of Japan awarded to the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on intractable diseases.	Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Butler NS, 2002, J IMMUNOL, V169, P3700, DOI 10.4049/jimmunol.169.7.3700; COLEMAN A, 1988, AM J SURG PATHOL, V12, P514, DOI 10.1097/00000478-198807000-00002; Costabel U, 2012, CLIN CHEST MED, V33, P151, DOI 10.1016/j.ccm.2011.12.004; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DENIS M, 1992, AM J RESP CELL MOL, V6, P68, DOI 10.1165/ajrcmb/6.1.68; DENIS M, 1992, AM J RESP CELL MOL, V6, P183, DOI 10.1165/ajrcmb/6.2.183; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; FINK JN, 1984, J ALLERGY CLIN IMMUN, V74, P1, DOI 10.1016/0091-6749(84)90077-0; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gudmundsson G, 1997, J CLIN INVEST, V99, P2386, DOI 10.1172/JCI119420; Gudmundsson G, 1998, J IMMUNOL, V161, P991; Hasan SA, 2013, J ALLERGY CLIN IMMUN, V131, P1663, DOI 10.1016/j.jaci.2013.01.015; Hoshino A, 2008, J AUTOIMMUN, V31, P79, DOI 10.1016/j.jaut.2008.03.006; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Joshi AD, 2009, AM J RESP CRIT CARE, V179, P705, DOI 10.1164/rccm.200811-1700OC; Lacasse Y, 2009, INT ARCH ALLERGY IMM, V149, P161, DOI 10.1159/000189200; Liu YH, 2011, J IMMUNOL, V186, P3197, DOI 10.4049/jimmunol.1002016; Mitaka K, 2011, INT ARCH ALLERGY IMM, V154, P264, DOI 10.1159/000321114; Nance S, 2005, EUR J IMMUNOL, V35, P1928, DOI 10.1002/eji.200425762; Ohtani Y, 2000, CHEST, V118, P1382, DOI 10.1378/chest.118.5.1382; Ohtani Y, 1999, INTERNAL MED, V38, P896, DOI 10.2169/internalmedicine.38.896; Pardo A, 2000, AM J RESP CRIT CARE, V161, P1698, DOI 10.1164/ajrccm.161.5.9907065; Patnode ML, 2013, J BIOL CHEM, V288, P26533, DOI 10.1074/jbc.M113.485409; Pickens SR, 2011, ANGIOGENESIS, V14, P443, DOI 10.1007/s10456-011-9227-z; SALVAGGIO JE, 1993, RESP MED, V87, P495, DOI 10.1016/0954-6111(93)90004-J; Schuyler M, 2000, J LAB CLIN MED, V136, P29, DOI 10.1067/mlc.2000.107694; Schuyler M, 1997, CELL IMMUNOL, V177, P169, DOI 10.1006/cimm.1997.1107; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; SELMAN M, 1987, CLIN IMMUNOL IMMUNOP, V44, P63, DOI 10.1016/0090-1229(87)90052-3; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; Suzukawa M, 2013, J IMMUNOL, V190, P5939, DOI 10.4049/jimmunol.1203455; TAKIZAWA H, 1988, J ALLERGY CLIN IMMUN, V81, P391, DOI 10.1016/0091-6749(88)90907-4; TAKIZAWA H, 1992, AM REV RESPIR DIS, V146, P479, DOI 10.1164/ajrccm/146.2.479; TODD A, 1991, CLIN EXP IMMUNOL, V85, P453; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255	42	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137978	10.1371/journal.pone.0137978	http://dx.doi.org/10.1371/journal.pone.0137978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367130	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100192
J	Jiang, YF; Pun, RYK; Peariso, K; Holland, KD; Lian, QQ; Danzer, SC				Jiang, Yifei; Pun, Raymund Y. K.; Peariso, Katrina; Holland, Katherine D.; Lian, Qingquan; Danzer, Steve C.			Olfactory Bulbectomy Leads to the Development of Epilepsy in Mice	PLOS ONE			English	Article							SPONTANEOUS RECURRENT SEIZURES; TEMPORAL-LOBE EPILEPSY; PILOCARPINE MODEL; GRANULE CELLS; DEPRESSION; RAT; BEHAVIOR; BRAIN; EPILEPTOGENESIS; COMORBIDITIES	There is a clear link between epilepsy and depression. Clinical data demonstrate a 30-35% lifetime prevalence of depression in patients with epilepsy, and patients diagnosed with depression have a three to sevenfold higher risk of developing epilepsy. Traditional epilepsy models partially replicate the clinical observations, with the demonstration of depressive traits in epileptic animals. Studies assessing pro-epileptogenic changes in models of depression, however, are more limited. Here, we examined whether a traditional rodent depression model-bilateral olfactory bulbectomy-predisposes the animals towards the development of epilepsy. Past studies have demonstrated increased neuronal excitability after bulbectomy, but continuous seizure monitoring had not been conducted. For the present study, we monitored control and bulbectomized animals by video-EEG 24/7 for approximately two weeks following the surgery to determine whether they develop spontaneous seizures. All seven bulbectomized mice exhibited seizures during the monitoring period. Seizures began about one week after surgery, and occurred in clusters with severity increasing over the monitoring period. These results suggest that olfactory bulbectomy could be a useful model of TBI-induced epilepsy, with advantages of relatively rapid seizure onset and a high number of individuals developing the disease. The model may also be useful for investigating the mechanisms underlying the bidirectional relationship between epilepsy and depression.	[Jiang, Yifei; Lian, Qingquan] Wenzhou Med Univ, Dept Anesthesia, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Jiang, Yifei; Pun, Raymund Y. K.; Danzer, Steve C.] Cincinnati Childrens Hosp Med Ctr, Dept Anesthesia, Cincinnati, OH USA; [Peariso, Katrina] Univ Cincinnati, Med Ctr, Div Neurocrit Care, Cincinnati, OH 45267 USA; [Holland, Katherine D.] Cincinnati Childrens Hosp Med Ctr, Dept Neurol, Cincinnati, OH 45229 USA; [Danzer, Steve C.] Univ Cincinnati, Dept Anesthesia, Cincinnati, OH USA; [Danzer, Steve C.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA	Wenzhou Medical University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Lian, QQ (corresponding author), Wenzhou Med Univ, Dept Anesthesia, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China.	lianqingquanmz@163.com; steve.danzer@cchmc.org	Peariso, Katrina/Y-1516-2019; Peariso, Katrina/AAQ-2090-2021	Peariso, Katrina/0000-0003-1616-8329; 	National Institutes of Health;  [1R01-NS-062806];  [2R01-NS-065020]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065020, R01NS062806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health in the form of grant awards to SD; award numbers 1R01-NS-062806 and 2R01-NS-065020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI Y, 1972, JPN J PHARMACOL, V22, P447, DOI 10.1254/jjp.22.447; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; CAIN DP, 1978, BEHAV BIOL, V22, P264, DOI 10.1016/S0091-6773(78)92320-9; Castro OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046044; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; Epps SA, 2013, BIOCHEM PHARMACOL, V85, P135, DOI 10.1016/j.bcp.2012.08.016; Epps SA, 2012, NEUROPSYCHOPHARMACOL, V37, P2756, DOI 10.1038/npp.2012.141; Fox J., 2006, MOUSE BIOMEDICAL RES; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Haut SR, 2005, NEUROLOGY, V65, P1313, DOI 10.1212/01.wnl.0000180685.84547.7f; Hesdorffer DC, 2006, ANN NEUROL, V59, P35, DOI 10.1002/ana.20685; Hester MS, 2014, EPILEPSY BEHAV, V38, P105, DOI 10.1016/j.yebeh.2013.12.022; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; Islam MR, 2014, NEUROSCIENCE, V272, P116, DOI 10.1016/j.neuroscience.2014.04.046; Jarosik J, 2007, EXP NEUROL, V204, P20, DOI 10.1016/j.expneurol.2006.09.008; Kanner AM, 2014, EPILEPSY BEHAV, V38, P3, DOI 10.1016/j.yebeh.2014.06.027; Kelly JP, 1999, EUR NEUROPSYCHOPHARM, V9, P101, DOI 10.1016/S0924-977X(98)00010-8; LEONARD CM, 1975, J COMP NEUROL, V162, P467, DOI 10.1002/cne.901620405; Lin JJ, 2012, LANCET, V380, P1180, DOI 10.1016/S0140-6736(12)61455-X; Loscher W, 1996, PROG NEUROBIOL, V50, P427, DOI 10.1016/S0301-0082(96)00036-6; Machado DG, 2012, PHARMACOL BIOCHEM BE, V103, P220, DOI 10.1016/j.pbb.2012.08.024; MILLAN MH, 1986, BRAIN RES, V398, P204, DOI 10.1016/0006-8993(86)91271-0; Morales-Medina JC, 2013, J CHEM NEUROANAT, V52, P80, DOI 10.1016/j.jchemneu.2013.07.001; NAKANISHI H, 1990, BRAIN RES, V532, P69, DOI 10.1016/0006-8993(90)91743-Z; OTMAKHOVA NA, 1992, PHYSIOL BEHAV, V52, P441, DOI 10.1016/0031-9384(92)90329-Z; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Powell KL, 2014, EPILEPSIA, V55, P1959, DOI 10.1111/epi.12840; Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Restrepo D, 2014, EPILEPSY BEHAV, V38, P37, DOI 10.1016/j.yebeh.2013.08.036; Roche M, 2008, PHARMACOL REP, V60, P404; Romeas T, 2009, PSYCHOPHARMACOLOGY, V205, P293, DOI 10.1007/s00213-009-1539-y; Sankar R, 2010, EPILEPSIA, V51, P81, DOI 10.1111/j.1528-1167.2010.02867.x; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; WATANABE S, 1982, PHYSIOL BEHAV, V28, P687, DOI 10.1016/0031-9384(82)90052-X; WATANABE S, 1980, TOHOKU J EXP MED, V130, P41, DOI 10.1620/tjem.130.41; Watson JB, 1907, PSYCHOL REV MONOGRAP, V8, pi; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138178	10.1371/journal.pone.0138178	http://dx.doi.org/10.1371/journal.pone.0138178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368332	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100240
J	Kindgren, P; Dubreuil, C; Strand, A				Kindgren, Peter; Dubreuil, Carole; Strand, Asa			The Recovery of Plastid Function Is Required for Optimal Response to Low Temperatures in Arabidopsis	PLOS ONE			English	Article							CHELATASE H-SUBUNIT; MG-PROTOPORPHYRIN IX; COLD-REGULATED GENES; ABSCISIC-ACID; CHLOROPLAST DEVELOPMENT; FREEZING TOLERANCE; NUCLEUS COMMUNICATION; MAGNESIUM-CHELATASE; SIGNAL-TRANSDUCTION; PROTEIN-SYNTHESIS	Cold acclimation is an essential response in higher plants to survive freezing temperatures. Here, we report that two independent mutant alleles of the H-subunit of Mg-chelatase, CHLH, gun5-1 and cch in Arabidopsis are sensitive to low temperatures. Plants were grown in photoperiodic conditions and exposed to low temperatures for short-and long-term periods. Tetrapyrrole biosynthesis was initially significantly inhibited in response to low temperature but recovered in wild type (Col-0), although the tetrapyrrole levels were lower in cold compared to control conditions. The gun5-1 and cch alleles showed an inability to recover chlorophyll biosynthesis in addition to a significant decrease in freezing tolerance. We found that the impaired plastid function in the CHLH mutant plants resulted in compromised de novo protein synthesis at low temperatures. The expression of the transcription factors CBF1-3 was super-induced in gun5-1 and cch mutant alleles but expression levels of their target genes, COR15a, COR47 and COR78 were similar or even lower compared to Col-0. In addition, the protein levels of COR15a were lower in gun5-1 and cch and a general defect in protein synthesis could be seen in the gun5-1 mutant following a 35S labelling experiment performed at low temperature. Taken together, our results demonstrate the importance of a functional chloroplast for the cold acclimation process and further suggest that impaired plastid function could result in inhibition of protein synthesis at low temperature.	[Kindgren, Peter; Dubreuil, Carole; Strand, Asa] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden	Umea University	Kindgren, P (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen Plant Sci Ctr, Frederiksberg C, Denmark.	peter.kindgren@plen.ku.dk	Kindgren, Peter/ABF-7599-2020; Kindgren, Peter/H-4649-2015	Kindgren, Peter/0000-0003-0947-2648	Swedish research foundation, VR	Swedish research foundation, VR(Swedish Research Council)	This work was supported by a grant from the Swedish research foundation, VR, www.vr.se (to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Adhikari ND, 2009, J BIOL CHEM, V284, P24783, DOI 10.1074/jbc.M109.025205; Baldi P, 2001, J PLANT PHYSIOL, V158, P1541, DOI 10.1078/0176-1617-00591; Barajas-Lopez JD, 2013, BBA-MOL CELL RES, V1833, P425, DOI 10.1016/j.bbamcr.2012.06.020; Baron KN, 2012, PLANT SCI, V188, P48, DOI 10.1016/j.plantsci.2012.03.001; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Crosatti C, 2013, PHYSIOL PLANTARUM, V147, P55, DOI 10.1111/j.1399-3054.2012.01689.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dal Bosco C, 2003, PLANT PHYSIOL, V131, P793, DOI 10.1104/pp.014530; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Franklin KA, 2007, NAT GENET, V39, P1410, DOI 10.1038/ng.2007.3; GILMOUR SJ, 1988, PLANT PHYSIOL, V87, P745, DOI 10.1104/pp.87.3.745; Guo Y, 2002, P NATL ACAD SCI USA, V99, P7786, DOI 10.1073/pnas.112040099; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; HERRIN DL, 1992, J BIOL CHEM, V267, P8260; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Keskitalo J, 2005, PLANT PHYSIOL, V139, P1635, DOI 10.1104/pp.105.066845; Kindgren P, 2012, MOL PLANT, V5, P901, DOI 10.1093/mp/ssr112; Kindgren P, 2012, PLANT J, V70, P279, DOI 10.1111/j.1365-313X.2011.04865.x; Kindgren P, 2011, PHYSIOL PLANTARUM, V141, P310, DOI 10.1111/j.1399-3054.2010.01440.x; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; KRISHNA P, 1995, PLANT PHYSIOL, V107, P915, DOI 10.1104/pp.107.3.915; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Li W, 2008, J BIOL CHEM, V283, P461, DOI 10.1074/jbc.M706692200; Liu XY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-287; Maibam P, 2013, INT J MOL SCI, V14, P11527, DOI 10.3390/ijms140611527; Maruta T, 2012, J BIOL CHEM, V287, P11717, DOI 10.1074/jbc.M111.292847; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Mei C, 2014, J EXPT BOT; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Mohanty S, 2006, PLANTA, V224, P692, DOI 10.1007/s00425-006-0248-6; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Nakayama K, 2007, PLANT PHYSIOL, V144, P513, DOI 10.1104/pp.106.094581; Nelson CJ, 2014, PLANT PHYSIOL, V166, P91, DOI 10.1104/pp.114.243014; Pesaresi P, 2006, PLANT CELL, V18, P970, DOI 10.1105/tpc.105.039073; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Renaut J, 2004, PLANT BIOLOGY, V6, P81, DOI 10.1055/s-2004-815733; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Stitt M, 2002, CURR OPIN PLANT BIOL, V5, P199, DOI 10.1016/S1369-5266(02)00258-3; STITT M, 1989, METHOD ENZYMOL, V174, P518; Strand A, 1999, PLANT PHYSIOL, V119, P1387, DOI 10.1104/pp.119.4.1387; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Tewari AK, 1998, PLANT PHYSIOL, V117, P851, DOI 10.1104/pp.117.3.851; Thalhammer A, 2014, PLANT PHYSIOL, V166, P190, DOI 10.1104/pp.114.245399; Thomashow MF, 1997, ACTA PHYSIOL PLANT, V19, P497, DOI 10.1007/s11738-997-0046-1; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tokuhisa JG, 1998, PLANT CELL, V10, P699, DOI 10.1105/tpc.10.5.699; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Wu FQ, 2009, PLANT PHYSIOL, V150, P1940, DOI 10.1104/pp.109.140731	61	14	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0138010	10.1371/journal.pone.0138010	http://dx.doi.org/10.1371/journal.pone.0138010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366569	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100202
J	Kong, Y; Liang, XJ; Liu, L; Zhang, DD; Wan, C; Gan, ZJ; Yuan, LD				Kong, Yan; Liang, Xijun; Liu, Lin; Zhang, Dongdong; Wan, Chao; Gan, Zhenji; Yuan, Liudi			High Throughput Sequencing Identifies MicroRNAs Mediating alpha-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model	PLOS ONE			English	Article							PROTECTS DOPAMINERGIC-NEURONS; DIETARY SUPPLEMENTATION; CLIMBING ABILITY; GABA(B) RECEPTOR; LEAF EXTRACT; OVEREXPRESSION; EXPRESSION; NEUROTOXICITY; DYSFUNCTION; MIR-137	Parkinson's disease (PD) is a prevalent neurodegenerative disorder with pathological features including death of dopaminergic neurons in the substantia nigra and intraneuronal accumulations of Lewy bodies. As the main component of Lewy bodies, alpha-synuclein is implicated in PD pathogenesis by aggregation into insoluble filaments. However, the detailed mechanisms underlying alpha-synuclein induced neurotoxicity in PD are still elusive. MicroRNAs are similar to 20nt small RNA molecules that fine-tune gene expression at posttranscriptional level. A plethora of miRNAs have been found to be dysregulated in the brain and blood cells of PD patients. Nevertheless, the detailed mechanisms and their in vivo functions in PD still need further investigation. By using Drosophila PD model expressing alpha-synuclein A30P, we examined brain miRNA expression with high-throughput small RNA sequencing technology. We found that five miRNAs (dme-miR-133-3p, dme-miR-137-3p, dme-miR-13b-3p, dme-miR-932-5p, dme-miR-1008-5p) were upregulated in PD flies. Among them, miR-13b, miR-133, miR-137 are brain enriched and highly conserved from Drosophila to humans. KEGG pathway analysis using DIANA miR-Path demonstrated that neuroactive-ligand receptor interaction pathway was most likely affected by these miRNAs. Interestingly, miR-137 was predicted to regulate most of the identified targets in this pathway, including dopamine receptor (DopR, D2R), gamma-aminobutyric acid (GABA) receptor (GABA-B-R1, GABA-B-R3) and N-methyl-D-aspartate (NMDA) receptor (Nmdar2). The validation experiments showed that the expression of miR-137 and its targets was negatively correlated in PD flies. Further experiments using luciferase reporter assay confirmed that miR-137 could act on specific sites in 3' UTR region of D2R, Nmdar2 and GABA-B-R3, which downregulated significantly in PD flies. Collectively, our findings indicate that a-synuclein could induce the dysregulation of miRNAs, which target neuroactive ligand-receptor interaction pathway in vivo. We believe it will help us further understand the contribution of miRNAs to alpha-synuclein neurotoxicity and provide new insights into the pathogenesis driving PD.	[Kong, Yan; Yuan, Liudi] Southeast Univ, Sch Med, Dept Biochem & Mol Biol, Nanjing 210009, Jiangsu, Peoples R China; [Liang, Xijun; Liu, Lin; Gan, Zhenji] Nanjing Univ, MOE, Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Zhang, Dongdong; Wan, Chao; Yuan, Liudi] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China; Nanjing University; Southeast University - China	Kong, Y (corresponding author), Southeast Univ, Sch Med, Dept Biochem & Mol Biol, Nanjing 210009, Jiangsu, Peoples R China.	kongyancn@163.com; yld@seu.edu.cn	KONG, YAN/AGT-7798-2022	Jiang, Bing-Hua/0000-0003-4526-2031; Gan, Zhenji/0000-0001-5940-207X	Specialized Research Fund for the Doctoral Program of Higher Education, Ministry of Education, China [20120092120065]; National Natural Science Foundation of China [31200804]; Jiangsu Natural Science Foundation [BK20140600]	Specialized Research Fund for the Doctoral Program of Higher Education, Ministry of Education, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was funded by the Specialized Research Fund for the Doctoral Program of Higher Education, Ministry of Education, China (20120092120065), www.sdns.cutech.edu.cn; the National Natural Science Foundation of China (31200804), www.nsfc.gov.cn; and the Jiangsu Natural Science Foundation (BK20140600), www.jstd.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002425; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Barkholt P, 2012, NEUROSCIENCE, V208, P85, DOI 10.1016/j.neuroscience.2012.02.004; Barone MC, 2011, DIS MODEL MECH, V4, P701, DOI 10.1242/dmm.007575; Botella JA, 2008, NEUROBIOL DIS, V30, P65, DOI 10.1016/j.nbd.2007.11.013; Bouleau S, 2015, J ALZHEIMERS DIS, V45, P1015, DOI 10.3233/JAD-142802; Buttner S, 2014, CELL CYCLE, V13, P3903, DOI 10.4161/15384101.2014.973309; Buttner S, 2013, EMBO J, V32, P3041, DOI 10.1038/emboj.2013.228; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Cardo LF, 2013, J NEUROL, V260, P1420, DOI 10.1007/s00415-013-6900-8; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen LA, 2015, J NEUROSCI, V35, P890, DOI 10.1523/JNEUROSCI.0089-14.2015; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Czapski GA, 2013, FEBS LETT, V587, P3135, DOI 10.1016/j.febslet.2013.07.053; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Desplats P, 2012, J BIOL CHEM, V287, P31691, DOI 10.1074/jbc.M112.354522; Devine MJ, 2012, J NEUROSCI, V32, P16071, DOI 10.1523/JNEUROSCI.4224-12.2012; Dorval V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085510; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Du GP, 2010, MOL BIOL CELL, V21, P2128, DOI 10.1091/mbc.E10-03-0200; Dulovic M, 2014, NEUROBIOL DIS, V63, P1, DOI 10.1016/j.nbd.2013.11.002; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Gao SS, 2015, INT J BIOCHEM CELL B, V64, P25, DOI 10.1016/j.biocel.2015.03.006; Geekiyanage H, 2011, J NEUROSCI, V31, P14820, DOI 10.1523/JNEUROSCI.3883-11.2011; Gispert S, 2015, MOL NEUROBIOL, V52, P57, DOI 10.1007/s12035-014-8844-0; Golpich M, 2015, PHARMACOL RES, V97, P16, DOI 10.1016/j.phrs.2015.03.010; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Haywood AFM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-14; Hillman R, 2012, NEUROSCI LETT, V516, P167, DOI 10.1016/j.neulet.2012.03.034; Huang AH, 2014, GENET EPIDEMIOL, V38, P300, DOI 10.1002/gepi.21803; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251; Jin HJ, 2011, J NEUROSCI, V31, P2035, DOI 10.1523/JNEUROSCI.5634-10.2011; Johnston T, 2003, BRIT J PHARMACOL, V139, P1480, DOI 10.1038/sj.bjp.0705372; Kabaria S, 2015, FEBS LETT, V589, P319, DOI 10.1016/j.febslet.2014.12.014; Khan S, 2012, INT J NEUROSCI, V122, P704, DOI 10.3109/00207454.2012.709893; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kohno R, 2004, BIOCHEM BIOPH RES CO, V318, P113, DOI 10.1016/j.bbrc.2004.04.012; Kong Y, 2014, CURR ALZHEIMER RES, V11, P882; Lee FKM, 2009, J NEUROCHEM, V110, P208, DOI 10.1111/j.1471-4159.2009.06124.x; Liu SM, 2007, EUR J NEUROSCI, V25, P3583, DOI 10.1111/j.1460-9568.2007.05569.x; Long JG, 2009, REJUV RES, V12, P321, DOI 10.1089/rej.2009.0877; Lu JH, 2012, AUTOPHAGY, V8, P98, DOI 10.4161/auto.8.1.18313; Luo J, 2014, HUM MOL GENET, V23, P6567, DOI 10.1093/hmg/ddu377; Sanchez-Simon FM, 2010, MOL PHARMACOL, V78, P935, DOI 10.1124/mol.110.066837; Maheshwari M, 2014, HUM MOL GENET, V23, P2737, DOI 10.1093/hmg/ddt667; Margis R, 2011, J BIOTECHNOL, V152, P96, DOI 10.1016/j.jbiotec.2011.01.023; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Miura E, 2014, NEUROBIOL DIS, V71, P1, DOI 10.1016/j.nbd.2014.07.014; Musgrove REJ, 2013, NEUROTOX RES, V23, P358, DOI 10.1007/s12640-012-9352-5; Nalls MA, 2014, HUM MOL GENET, V23, P831, DOI 10.1093/hmg/ddt465; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pendleton RG, 2002, J PHARMACOL EXP THER, V300, P91, DOI 10.1124/jpet.300.1.91; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Price DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014020; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Shaltiel-Karyo R, 2013, J BIOL CHEM, V288, P17579, DOI 10.1074/jbc.M112.434787; Shaltiel-Karyo R, 2012, BBA-GEN SUBJECTS, V1820, P1628, DOI 10.1016/j.bbagen.2012.04.021; Siddique YH, 2014, CHIN J NAT MEDICINES, V12, P777, DOI 10.1016/S1875-5364(14)60118-7; Siddique YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/606928; Siddique Yasir Hasan, 2014, Journal of Dietary Supplements, V11, P121, DOI 10.3109/19390211.2013.859207; Siddique YH, 2013, FOOD CHEM TOXICOL, V55, P29, DOI 10.1016/j.fct.2012.12.028; Siddique Yasir Hasan, 2012, Journal of Dietary Supplements, V9, P1, DOI 10.3109/19390211.2011.630716; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; St Laurent R, 2013, NEUROSCIENCE, V246, P382, DOI 10.1016/j.neuroscience.2013.04.037; Strazisar M, 2015, MOL PSYCHIATR, V20, P472, DOI 10.1038/mp.2014.53; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Tenreiro S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004302; Todd AM, 2008, GENOME, V51, P1040, DOI 10.1139/G08-085; Valles A, 2014, J PSYCHIATR NEUROSCI, V39, P312, DOI 10.1503/jpn.130269; Van der Perren A, 2015, NEUROBIOL AGING, V36, P1559, DOI 10.1016/j.neurobiolaging.2015.01.014; Verma P, 2015, NAT NEUROSCI, V18, P379, DOI 10.1038/nn.3935; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wang B, 2015, BIOCHEM CELL BIOL, V93, P351, DOI 10.1139/bcb-2015-0015; Wang SX, 2014, P NATL ACAD SCI USA, V111, pE3976, DOI 10.1073/pnas.1411694111; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wright Carrie, 2013, Frontiers in Genetics, V4, P58, DOI 10.3389/fgene.2013.00058; Wu N, 2010, J NEUROSCI RES, V88, P1764, DOI 10.1002/jnr.22327; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Yin JW, 2014, INT J MOL SCI, V15, P3262, DOI 10.3390/ijms15023262; Yu YM, 2011, EUR J NEUROSCI, V33, P1587, DOI 10.1111/j.1460-9568.2011.07643.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhao LX, 2013, NEURAL REGEN RES, V8, P2441, DOI 10.3969/j.issn.1673-5374.2013.26.005	94	81	85	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137432	10.1371/journal.pone.0137432	http://dx.doi.org/10.1371/journal.pone.0137432			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361355	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100037
J	Musayev, FN; Zarate-Perez, F; Bishop, C; Burgner, JW; Escalante, CR				Musayev, Faik N.; Zarate-Perez, Francisco; Bishop, Clayton; Burgner, John W., II; Escalante, Carlos R.			Structural Insights into the Assembly of the Adeno-associated Virus Type 2 Rep68 Protein on the Integration Site AAVS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEIC-ACID STRUCTURES; NUCLEOTIDE-SEQUENCE; BINDING-PROTEIN; DNA RECOGNITION; HUMAN GENOME; ORIGIN; VISUALIZATION; REPLICATION; HELICASE; RECOMBINATION	Adeno-associated virus (AAV) is the only eukaryotic virus with the property of establishing latency by integrating site-specifically into the human genome. The integration site known as AAVS1 is located in chromosome 19 and contains multiple GCTC repeats that are recognized by the AAV non-structural Rep proteins. These proteins are multifunctional, with an N-terminal origin-binding domain (OBD) and a helicase domain joined together by a short linker. As a first step to understand the process of site-specific integration, we proceeded to characterize the recognition and assembly of Rep68 onto the AAVS1 site. We first determined the x-ray structure of AAV-2 Rep68 OBD in complex with the AAVS1 DNA site. Specificity is achieved through the interaction of a glycine-rich loop that binds the major groove and an alpha-helix that interacts with a downstream minor groove on the same face of the DNA. Although the structure shows a complex with three OBD molecules bound to the AAVS1 site, we show by using analytical centrifugation and electron microscopy that the full-length Rep68 forms a heptameric complex. Moreover, we determined that a minimum of two direct repeats is required to form a stable complex and to melt DNA. Finally, we show that although the individual domains bind DNA poorly, complex assembly requires oligomerization and cooperation between its OBD, helicase, and the linker domains.	[Musayev, Faik N.] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23298 USA; [Zarate-Perez, Francisco; Bishop, Clayton; Burgner, John W., II; Escalante, Carlos R.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Escalante, CR (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, 1220 East Broad St, Richmond, VA 23298 USA.	cescalante@vcu.edu	ZARATE PEREZ, FRANCISCO/ABF-1106-2021; Regan, Clinton/E-6250-2012; Musayev, Faik/AAY-2010-2020	ZARATE PEREZ, FRANCISCO/0000-0001-7014-6804; 	National Institutes of Health [R01-GM092854]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM092854. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Berns KI, 1996, CURR TOP MICROBIOL, V218, P1; BERNS KI, 1995, BIOESSAYS, V17, P237, DOI 10.1002/bies.950170310; Chandler M, 2013, NAT REV MICROBIOL, V11, P525, DOI 10.1038/nrmicro3067; Chang YP, 2013, CELL REP, V3, P1117, DOI 10.1016/j.celrep.2013.03.002; Chiorini JA, 1999, J VIROL, V73, P4293, DOI 10.1128/JVI.73.5.4293-4298.1999; CHIORINI JA, 1994, J VIROL, V68, P7448, DOI 10.1128/JVI.68.11.7448-7457.1994; COLEMAN RA, 1995, J BIOL CHEM, V270, P13850, DOI 10.1074/jbc.270.23.13850; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng DM, 2006, J MOL BIOL, V358, P38, DOI 10.1016/j.jmb.2006.01.029; FIFE KH, 1977, VIROLOGY, V78, P475, DOI 10.1016/0042-6822(77)90124-6; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; Gonzalez-Prieto C, 2013, TRENDS BIOTECHNOL, V31, P41, DOI 10.1016/j.tibtech.2013.02.002; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Grimm D, 2006, J VIROL, V80, P426, DOI 10.1128/JVI.80.1.426-439.2006; HAUSWIRTH WW, 1977, VIROLOGY, V78, P488, DOI 10.1016/0042-6822(77)90125-8; Henckaerts E, 2009, P NATL ACAD SCI USA, V106, P7571, DOI 10.1073/pnas.0806821106; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; Hickman AB, 2004, MOL CELL, V13, P403, DOI 10.1016/S1097-2765(04)00023-1; Huser D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000985; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; James JA, 2003, STRUCTURE, V11, P1025, DOI 10.1016/S0969-2126(03)00152-7; KIM JG, 1987, J MOL BIOL, V196, P149, DOI 10.1016/0022-2836(87)90517-1; Kim R, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-45; KOTIN RM, 1991, GENOMICS, V10, P831, DOI 10.1016/0888-7543(91)90470-Y; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; Li L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r101; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Linden RM, 1996, P NATL ACAD SCI USA, V93, P7966, DOI 10.1073/pnas.93.15.7966; Linden RM, 1996, P NATL ACAD SCI USA, V93, P11288, DOI 10.1073/pnas.93.21.11288; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Maggin JE, 2012, J VIROL, V86, P3337, DOI 10.1128/JVI.06775-11; Mansilla-Soto J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000513; Musayev FN, 2015, BIOCHEMISTRY-US, V54, P5907, DOI 10.1021/acs.biochem.5b00610; Otwinowski Z, 1997, METHODS ENZYMOL, V276, P307; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponnazhagan S, 1997, HUM GENE THER, V8, P275, DOI 10.1089/hum.1997.8.3-275; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Smith RH, 1997, J VIROL, V71, P4461, DOI 10.1128/JVI.71.6.4461-4471.1997; SNYDER RO, 1990, CELL, V60, P105, DOI 10.1016/0092-8674(90)90720-Y; SPEAR IS, 1977, J VIROL, V24, P627, DOI 10.1128/JVI.24.2.627-634.1977; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; Surosky RT, 1997, J VIROL, V71, P7951, DOI 10.1128/JVI.71.10.7951-7959.1997; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Xu ZX, 2009, GENE THER, V16, P589, DOI 10.1038/gt.2009.9; Young SM, 2000, J VIROL, V74, P3953, DOI 10.1128/JVI.74.9.3953-3966.2000; Young SM, 2001, P NATL ACAD SCI USA, V98, P13525, DOI 10.1073/pnas.241508998; Zarate-Perez F, 2013, J VIROL, V87, P1232, DOI 10.1128/JVI.02441-12; Zarate-Perez F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002764	57	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27487	27499		10.1074/jbc.M115.669960	http://dx.doi.org/10.1074/jbc.M115.669960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26370092	hybrid, Green Published			2022-12-26	WOS:000365757500005
J	Feng, Y; Chen, HL; Cai, JY; Zou, L; Yan, D; Xu, GQ; Li, D; Chao, W				Feng, Yan; Chen, Hongliang; Cai, Jiayan; Zou, Lin; Yan, Dan; Xu, Ganqiong; Li, Dan; Chao, Wei			Cardiac RNA Induces Inflammatory Responses in Cardiomyocytes and Immune Cells via Toll-like Receptor 7 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENTIAL BIOMARKER; MESSENGER-RNA; CIRCULATING MICRORNAS; PATTERN-RECOGNITION; MYOCARDIAL INJURY; DENDRITIC CELLS; NECROTIC CELLS; NUCLEIC-ACIDS; CUTTING EDGE; STRANDED-RNA	We have recently reported that extracellular RNA (exRNA) released from necrotic cells induces cytokine production in cardiomyocytes and immune cells and contributes to myocardial ischemia/reperfusion injury. However, the signaling mechanism by which exRNA exhibits its pro-inflammatory effect is unknown. Here we hypothesize that exRNA directly induces inflammation through specific Toll-like receptors (TLRs). To test the hypothesis, we treated rat neonatal cardiomyocytes, mouse bone marrow-derived macrophages (BMDM), or mouse neutrophils with RNA (2.5-10 mu g/ml) isolated from rat cardiomyocytes or the hearts from mouse, rat, and human. We found that cellular RNA induced production of several cytokines such as macrophage inflammatory protein-2 (MIP-2), ILs, TNF alpha, and the effect was completely diminished by RNase, but not DNase. The RNA-induced cytokine production was partially inhibited in cells treated with TLR7 antagonist or genetically deficient in TLR7. Deletion of myeloid differentiation primary response protein 88 (MyD88), a downstream adapter of TLRs including TLR7, abolished the RNA-induced MIP-2 production. Surprisingly, genetic deletion of TLR3 had no impact on the RNA-induced MIP-2 response. Importantly, extracellular RNA released from damaged cardiomyocytes also induced cytokine production. Finally, mice treated with 50 mu g of RNA intraperitoneal injection exhibited acute peritonitis as evidenced by marked neutrophil and monocyte migration into the peritoneal space. Together, these data demonstrate that exRNA of cardiac origin exhibits a potent pro-inflammatory property in vitro and in vivo and that exRNA induces cytokine production through TLR7-MyD88 signaling.	[Feng, Yan; Chen, Hongliang; Cai, Jiayan; Zou, Lin; Yan, Dan; Xu, Ganqiong; Li, Dan; Chao, Wei] Harvard Univ, Sch Med, Dept Anesthesia Crit Care & Pain Med, Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Feng, Y (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, 149 13th St,Rm 4-212, Charlestown, MA 02129 USA.	yfeng@mgh.harvard.edu; wchao@mgh.harvard.edu	Regan, Clinton/E-6250-2012	Chao, Wei/0000-0002-2505-1360	National Institutes of Health [R01-GM080906, R01-GM097259]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080906, R01GM097259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01-GM080906 and R01-GM097259 (to W. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baiersdorfer M, 2010, EXP CELL RES, V316, P3489, DOI 10.1016/j.yexcr.2010.07.022; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Brencicova E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00037; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Cabrera-Fuentes HA, 2014, THROMB HAEMOSTASIS, V112, P1110, DOI 10.1160/TH14-08-0703; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ding XF, 2012, MOL MED REP, V5, P1428, DOI 10.3892/mmr.2012.838; Dinger ME, 2008, J MOL ENDOCRINOL, V40, P151, DOI 10.1677/JME-07-0160; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Feng Y, 2008, AM J PHYSIOL-HEART C, V295, pH1311, DOI 10.1152/ajpheart.00119.2008; Feng Y, 2011, ANESTHESIOLOGY, V115, P555, DOI 10.1097/ALN.0b013e31822a22f7; Feng Y, 2010, AM J PHYSIOL-CELL PH, V299, pC760, DOI 10.1152/ajpcell.00155.2010; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Koski GK, 2004, J IMMUNOL, V172, P3989, DOI 10.4049/jimmunol.172.7.3989; Lee H, 2006, BIOCHEM BIOPH RES CO, V350, P742, DOI 10.1016/j.bbrc.2006.09.108; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Li Y, 2011, J BIOL CHEM, V286, P31308, DOI 10.1074/jbc.M111.246124; Lim DM, 2011, AM J PHYSIOL-GASTR L, V301, pG91, DOI 10.1152/ajpgi.00471.2010; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Matsumoto M, 2011, REV MED VIROL, V21, P67, DOI 10.1002/rmv.680; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; Miura N, 2008, CLIN MED INSIGHTS-ON, V2, P511; Pun JCS, 2014, MOL CLIN ONCOL, V2, P817, DOI 10.3892/mco.2014.321; Sueoka E, 2005, LUNG CANCER, V48, P77, DOI 10.1016/j.lungcan.2004.10.007; Wang HY, 2014, J SURG ONCOL, V109, P574, DOI 10.1002/jso.23526; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang SJ, 2011, ARCH DERMATOL RES, V303, P771, DOI 10.1007/s00403-011-1170-8; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zhu C, 2014, BRIT J CANCER, V110, P2291, DOI 10.1038/bjc.2014.119; Zou L, 2010, CRIT CARE MED, V38, P1335, DOI 10.1097/CCM.0b013e3181d99e67	48	39	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26688	26698		10.1074/jbc.M115.661835	http://dx.doi.org/10.1074/jbc.M115.661835			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26363072	hybrid, Green Published			2022-12-26	WOS:000364793600032
J	Wolkow, A; Ferguson, SA; Vincent, GE; Larsen, B; Aisbett, B; Main, LC				Wolkow, Alexander; Ferguson, Sally A.; Vincent, Grace E.; Larsen, Brianna; Aisbett, Brad; Main, Luana C.			The Impact of Sleep Restriction and Simulated Physical Firefighting Work on Acute Inflammatory Stress Responses	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; C-REACTIVE PROTEIN; BLOOD-CELL COUNT; ANTIINFLAMMATORY CYTOKINES; WILDFIRE SUPPRESSION; CAPILLARY BLOOD; HEART-DISEASE; HEALTHY-MEN; INTERLEUKIN-6; DEPRIVATION	Objectives This study investigated the effect restricted sleep has on wildland firefighters' acute cytokine levels during 3 days and 2 nights of simulated physical wildfire suppression work. Methods Firefighters completed multiple days of physical firefighting work separated by either an 8-h (Control condition; n = 18) or 4-h (Sleep restriction condition; n = 17) sleep opportunity each night. Blood samples were collected 4 times a day (i.e., 06: 15, 11: 30, 18: 15, 21: 30) from which plasma cytokine levels (IL-6, IL-8, IL-1 beta, TNF-alpha, IL-4, IL-10) were measured. Results The primary findings for cytokine levels revealed a fixed effect for condition that showed higher IL-8 levels among firefighters who received an 8-h sleep each night. An interaction effect demonstrated differing increases in IL-6 over successive days of work for the SR and CON conditions. Fixed effects for time indicated that IL-6 and IL-4 levels increased, while IL-1 beta, TNF-alpha and IL-8 levels decreased. There were no significant effects for IL-10 observed. Conclusion Findings demonstrate increased IL-8 levels among firefighters who received an 8-h sleep when compared to those who had a restricted 4-h sleep. Firefighters' IL-6 levels increased in both conditions which may indicate that a 4-h sleep restriction duration and/or period (i.e., 2 nights) was not a significant enough stressor to affect this cytokine. Considering the immunomodulatory properties of IL-6 and IL-4 that inhibit pro-inflammatory cytokines, the rise in IL-6 and IL-4, independent of increases in IL-1 beta and TNF-alpha, could indicate a non-damaging response to the stress of simulated physical firefighting work. However, given the link between chronically elevated cytokine levels and several diseases, further research is needed to determine if firefighters' IL-8 and IL-6 levels are elevated following repeated fire-fighting deployments across a fire season and over multiple fire seasons.	[Wolkow, Alexander; Vincent, Grace E.; Larsen, Brianna; Aisbett, Brad; Main, Luana C.] Deakin Univ, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia; [Wolkow, Alexander; Ferguson, Sally A.; Vincent, Grace E.; Larsen, Brianna; Aisbett, Brad] Bushfire Cooperat Res Ctr, East Melbourne, Vic 3002, Australia; [Ferguson, Sally A.] Cent Queensland Univ, Appleton Inst, Wayville, Qld 5034, Australia	Deakin University; Central Queensland University	Wolkow, A (corresponding author), Deakin Univ, Ctr Phys Act & Nutr Res, 221 Burwood Hwy, Burwood, Vic 3125, Australia.	awolkow@deakin.edu.au	Main, L.C./L-2359-2015; Aisbett, Brad/E-5178-2011	Main, L.C./0000-0002-9576-9466; Aisbett, Brad/0000-0001-8077-0272; Wolkow, Alexander/0000-0001-7845-3104; Ferguson, Sally/0000-0002-9682-7971; Larsen, Brianna/0000-0003-0885-795X; Vincent, Grace/0000-0002-7036-7823	Bushfire Co-operative Research Centre	Bushfire Co-operative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The authors (AW, SAF, GEV, BL, BA and LCM) received funding for this study from the Bushfire Co-operative Research Centre, http://www.bushfirecrc.com/. The funders provided financial and logistical support for the study, but had no role in the study design, data collection or preparation of the manuscript.	Abedelmalek S, 2013, CHRONOBIOL INT, V30, P502, DOI 10.3109/07420528.2012.742102; Aisbett B, 2012, APPL ERGON, V43, P916, DOI 10.1016/j.apergo.2011.12.013; Akerstedt T, 2010, CHRONOBIOL INT, V27, P975, DOI 10.3109/07420528.2010.489001; [Anonymous], 2017, GUIDE REML GENSTAT; [Anonymous], 2011, P BUSHF CRC AFAC C S; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Axelsson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082291; Baune BT, 2011, AGE, V33, P209, DOI 10.1007/s11357-010-9165-5; Bishop NC, 2001, INT J SPORT NUTR EXE, V11, P503, DOI 10.1123/ijsnem.11.4.503; Boudjeltia KZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028230; Boyum A, 1996, SCAND J IMMUNOL, V43, P228, DOI 10.1046/j.1365-3083.1996.d01-32.x; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Bruunsgaard H, 2005, J LEUKOCYTE BIOL, V78, P819, DOI 10.1189/jlb.0505247; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cater H, 2007, AUSTR FIR AUTH COUNC; Chrousos GP, 2000, INT J OBESITY, V24, pS50, DOI 10.1038/sj.ijo.0801278; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Corsini E, 2014, PHARMACOL RES, V81, P10, DOI 10.1016/j.phrs.2014.01.002; Cuddy JS, 2007, MED SCI SPORT EXER, V39, P1004, DOI 10.1249/mss.0b013e318040b2fb; Cullen T, 2015, CYTOKINE, V71, P397, DOI 10.1016/j.cyto.2014.10.011; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Elenkov IJ, 2008, NEUROCHEM INT, V52, P40, DOI 10.1016/j.neuint.2007.06.037; Eriksson M, 2007, CLIN EXP IMMUNOL, V150, P469, DOI 10.1111/j.1365-2249.2007.03515.x; FAO, 2004, REP HUM EN REQ; Faraut B, 2011, BRAIN BEHAV IMMUNITY, V25; Farhangi MA, 2013, J HEALTH POPUL NUTR, V31, P58; Faulkner SH, 2014, EUR J APPL PHYSIOL, V114, P1207, DOI 10.1007/s00421-014-2851-8; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; FRY RW, 1994, BRIT J SPORT MED, V28, P241, DOI 10.1136/bjsm.28.4.241; Glass DC., 2014, AUSTR FIREFIGHTERS H; Gundersen Y, 2006, EUR J APPL PHYSIOL, V97, P151, DOI 10.1007/s00421-006-0150-8; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Huang CJ, 2010, INT J PSYCHOPHYSIOL, V75, P312, DOI 10.1016/j.ijpsycho.2009.12.013; Inoue T, 2008, INT J CARDIOL, V124, P319, DOI 10.1016/j.ijcard.2007.02.012; Kales SN, 2007, NEW ENGL J MED, V356, P1207, DOI 10.1056/NEJMoa060357; Laskowski R, 2011, J HUM KINET, V30, P65, DOI 10.2478/v10078-011-0074-1; Lundeland B, 2012, SCAND J CLIN LAB INV, V72, P547, DOI 10.3109/00365513.2012.705017; Main L, 2013, AUSTR FIR AUTH COUNC; Miles MP, 2006, INT J SPORT NUTR EXE, V16, P36, DOI 10.1123/ijsnem.16.1.36; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; National Health and Medical Research Council, 2013, AUSTR DIET GUID; Nguyen HP, 2010, PLOS CURRENTS, V2; Nieman DC, 2014, BRAIN BEHAV IMMUN, V39, P180, DOI 10.1016/j.bbi.2013.09.004; Ohshita K, 2004, DIABETES CARE, V27, P491, DOI 10.2337/diacare.27.2.491; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Padgett D, 2003, TRENDS IMMUNOLOGY, V24; Pandey AK, 2011, BIOCHEM BIOPH RES CO, V410, P242, DOI 10.1016/j.bbrc.2011.05.123; PAUL WE, 1991, BLOOD, V77, P1859; Pedersen B, 2008, PHYSL REV; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Pejovic S, 2013, AM J PHYSIOL-ENDOC M, V305, pE890, DOI 10.1152/ajpendo.00301.2013; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Phillips M, 2011, AUSTR FIR AUTH BUSHF; Phillips M, 2012, APPL ERGON, V43, P435, DOI 10.1016/j.apergo.2011.06.018; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Raines J, 2013, APPL ERGON, V44, P404, DOI 10.1016/j.apergo.2012.10.002; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ruby BC, 2002, MED SCI SPORT EXER, V34, P1048, DOI 10.1097/00005768-200206000-00023; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Starkie R, 2003, FASEB J, V17, P884, DOI 10.1096/fj.02-0670fje; Tauler P, 2013, MED SCI SPORT EXER, V45, P1269, DOI 10.1249/MSS.0b013e3182857c8a; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; US Fire Administration National Fire Programs National Fallen Firefighters Foundation., 2014, FIREF FAT US 2013; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Verbyla AP, 1999, J ROY STAT SOC C-APP, V48, P269, DOI 10.1111/1467-9876.00154; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vgontzas AN, 2002, METABOLISM, V51, P887, DOI 10.1053/meta.2002.33357; Vincent G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115329; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Wolkow A, 2014, 4 INT C HLTH WELLN S; Wolkow A, 2014, ARCH ENVIRON OCCUP H, V69, P112, DOI 10.1080/19338244.2012.750588; Wu H, 2010, PHYSIOL RES, V59, P821, DOI 10.33549/physiolres.931895; Yehuda S, 2009, J INTERF CYTOK RES, V29, P393, DOI 10.1089/jir.2008.0080; Zhou X, 2010, CURR OPIN CLIN NUTR, V13, P541, DOI 10.1097/MCO.0b013e32833cf3bc	78	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138128	10.1371/journal.pone.0138128	http://dx.doi.org/10.1371/journal.pone.0138128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378783	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000361769400056
J	Martinez-Heras, E; Varriano, F; Prckovska, V; Laredo, C; Andorra, M; Martinez-Lapiscina, EH; Calvo, A; Lampert, E; Villoslada, P; Saiz, A; Prats-Galino, A; Llufriu, S				Martinez-Heras, Eloy; Varriano, Federico; Prckovska, Vesna; Laredo, Carlos; Andorra, Magi; Martinez-Lapiscina, Elena H.; Calvo, Anna; Lampert, Erika; Villoslada, Pablo; Saiz, Albert; Prats-Galino, Alberto; Llufriu, Sara			Improved Framework for Tractography Reconstruction of the Optic Radiation	PLOS ONE			English	Article							DIFFUSION TENSOR TRACTOGRAPHY; WHITE-MATTER TRACTS; HUMAN BRAIN; MULTIPLE-SCLEROSIS; FIBER TRACTOGRAPHY; MRI; RESOLUTION; SEGMENTATION; CONNECTIVITY; DEGENERATION	The optic radiation (OR) is one of the major components of the visual system and a key structure at risk in white matter diseases such as multiple sclerosis (MS). However, it is challenging to perform track reconstruction of the OR using diffusion MRI due to a sharp change of direction in the Meyer's loop and the presence of kissing and crossing fibers along the pathway. As such, we aimed to provide a highly precise and reproducible framework for tracking the OR from thalamic and visual cortex masks. The framework combined the generation of probabilistic streamlines by high order fiber orientation distributions estimated with constrained spherical deconvolution and an automatic post-processing based on anatomical exclusion criteria (AEC) to compensate for the presence of anatomically implausible streamlines. Specifically, those ending in the contralateral hemisphere, cerebrospinal fluid or grey matter outside the visual cortex were automatically excluded. We applied the framework to two distinct high angular resolution diffusion- weighted imaging (HARDI) acquisition protocols on one cohort, comprised of ten healthy volunteers and five MS patients. The OR was successfully delineated in both HARDI acquisitions in the healthy volunteers and MS patients. Quantitative evaluation of the OR position was done by comparing the results with histological reference data. Compared with histological mask, the OR reconstruction into a template (OR-TCT) was highly precise (percentage of voxels within the OR-TCT correctly defined as OR), ranging from 0.71 to 0.83. The sensitivity (percentage of voxels in histological reference mask correctly defined as OR in OR-TCT) ranged from 0.65 to 0.81 and the accuracy (measured by F1 score) was 0.73 to 0.77 in healthy volunteers. When AEC was not applied the precision and accuracy decreased. The absolute agreement between both HARDI datasets measured by the intraclass correlation coefficient was 0.73. This improved framework allowed us to reconstruct the OR with high reliability and accuracy independently of the acquisition parameters. Moreover, the reconstruction was possible even in the presence of tissue damage due to MS. This framework could also be applied to other tracts with complex configuration.	[Martinez-Heras, Eloy; Prckovska, Vesna; Andorra, Magi; Martinez-Lapiscina, Elena H.; Lampert, Erika; Villoslada, Pablo; Saiz, Albert; Llufriu, Sara] Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain; [Martinez-Heras, Eloy; Prckovska, Vesna; Laredo, Carlos; Andorra, Magi; Martinez-Lapiscina, Elena H.; Lampert, Erika; Villoslada, Pablo; Saiz, Albert; Llufriu, Sara] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Varriano, Federico; Prats-Galino, Alberto] Univ Barcelona, Fac Med, Lab Surg NeuroAnat LSNA, Barcelona 7, Spain; [Laredo, Carlos] Hosp Clin Barcelona, Dept Neurosci, Comprehens Stroke Ctr, Barcelona, Spain; [Calvo, Anna] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Med Imaging Platform, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Llufriu, S (corresponding author), Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain.	SLLUFRIU@clinic.ub.es	Llufriu, Sara/K-2987-2014; Llufriu, Sara/T-6761-2019; Martinez-Heras, Eloy/AAN-1849-2020; Martínez-Lapiscina, Elena H/L-1161-2014; Prats-Galino, Alberto/J-6319-2013; Villoslada, Pablo/AAF-9547-2019; Laredo, Carlos/AAB-4456-2019; Andorra, Magi/D-8726-2015	Llufriu, Sara/0000-0003-4273-9121; Martinez-Heras, Eloy/0000-0001-9937-3162; Martínez-Lapiscina, Elena H/0000-0003-4272-0826; Prats-Galino, Alberto/0000-0002-2710-6433; Laredo, Carlos/0000-0002-4626-6360; Lampert, Erika/0000-0001-9406-5371; Varriano, Federico/0000-0001-6742-4746; Andorra, Magi/0000-0002-0491-3144	Asociacion Esclerosis Multiple Isla de Menorca (AEMIM); FP7 Marie Curie Intra-European Fellowship, project acronym: ConnectMS [328060]	Asociacion Esclerosis Multiple Isla de Menorca (AEMIM); FP7 Marie Curie Intra-European Fellowship, project acronym: ConnectMS	This work was partially funded by a donation from the Asociacion Esclerosis Multiple Isla de Menorca (AEMIM, http://www.esclerosismultiple.com/) to AS. It was also funded by the FP7 Marie Curie Intra-European Fellowship, project acronym: ConnectMS, project number: 328060 to VP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Alvarez I, 2014, BRAIN STRUCTURE FUNC; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bastiani M, 2012, NEUROIMAGE, V62, P1732, DOI 10.1016/j.neuroimage.2012.06.002; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Benjamin CFA, 2014, HUM BRAIN MAPP, V35, P683, DOI 10.1002/hbm.22204; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Clatworthy PL, 2010, NEUROIMAGE, V49, P2001, DOI 10.1016/j.neuroimage.2009.10.083; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/nmeth.2482, 10.1038/NMETH.2482]; Dayan M, 2015, BRAIN STRUCT FUNCT, V220, P291, DOI 10.1007/s00429-013-0655-y; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Fernandez-Miranda JC, 2008, NEUROSURGERY, V62, P989, DOI [10.1227/01.NEU.0000297076.98175.67, 10.1227/01.neu.0000333767.05328.49]; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Girard G, 2014, NEUROIMAGE, V98, P266, DOI 10.1016/j.neuroimage.2014.04.074; Goga C, 2015, J NEUROSURG, V122, P1253, DOI 10.3171/2014.12.JNS14281; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hodaie M, 2010, NEUROSURGERY, V66, P788, DOI 10.1227/01.NEU.0000367613.09324.DA; Hofer S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00015; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Jones DK, 2010, DIFFUSION MRI THEORY; Kim M, 2006, NEUROIMAGE, V32, P1243, DOI 10.1016/j.neuroimage.2006.06.006; Klein E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055455; Kolbe S, 2012, HUM BRAIN MAPP, V33, P2047, DOI 10.1002/hbm.21343; Kovalev VA, 2003, NEUROIMAGE, V19, P895, DOI 10.1016/S1053-8119(03)00140-X; Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Lilja Y, 2015, QUANT IMAG MED SURG, V5, P288, DOI 10.3978/j.issn.2223-4292.2015.01.08; Lilja Y, 2014, EPILEPSY RES, V108, P481, DOI 10.1016/j.eplepsyres.2014.01.017; Llufriu S, 2014, MULT SCLER J, V20, P424, DOI 10.1177/1352458513503722; Mandelstam SA, 2012, AM J NEURORADIOL, V33, P1204, DOI 10.3174/ajnr.A2652; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Martinez-Lapiscina EH, 2014, MULTIPLE SCLEROSIS H; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2009, CURR OPIN NEUROL, V22, P362, DOI 10.1097/WCO.0b013e32832d954b; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Rocca MA, 2013, MULT SCLER J, V19, P1610, DOI 10.1177/1352458513485146; Schreiber J, 2014, NEUROIMAGE, V90, P163, DOI 10.1016/j.neuroimage.2014.01.002; Sdika M, 2009, HUM BRAIN MAPP, V30, P1060, DOI 10.1002/hbm.20566; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.9.15; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Smith RE, 2015, NEUROIMAGE, V104, P253, DOI 10.1016/j.neuroimage.2014.10.004; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Tax CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101524; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tournier J.-.D., 2010, IMPROVED PROBABILIST; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Winston GP, 2011, EPILEPSY RES, V97, P124, DOI 10.1016/j.eplepsyres.2011.07.019; Wu WT, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822efcae; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	60	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137064	10.1371/journal.pone.0137064	http://dx.doi.org/10.1371/journal.pone.0137064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376179	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200030
J	Ostrbenk, A; Kocjan, BJ; Hosnjak, L; Li, JJ; Deng, QJ; Sterbenc, A; Poljak, M				Ostrbenk, Anja; Kocjan, Bostjan J.; Hosnjak, Lea; Li, Jingjing; Deng, Qiuju; Sterbenc, Anja; Poljak, Mario			Identification of a Novel Human Papillomavirus, Type HPV199, Isolated from a Nasopharynx and Anal Canal, and Complete Genomic Characterization of Papillomavirus Species Gamma-12	PLOS ONE			English	Article							RENAL-TRANSPLANT RECIPIENTS; MULTIPLE SEQUENCE ALIGNMENT; HEALTHY SKIN; NUCLEAR-LOCALIZATION; ANOGENITAL HAIRS; BINDING DOMAIN; CAPSID PROTEIN; PCR ASSAY; DNA; DIVERSITY	The novel human papillomavirus type 199 (HPV199) was initially identified in a nasopharyngeal swab sample obtained from a 25 year-old immunocompetent male. The complete genome of HPV199 is 7,184 bp in length with a GC content of 36.5%. Comparative genomic characterization of HPV199 and its closest relatives showed the classical genomic organization of Gammapapillomaviruses (Gamma-PVs). HPV199 has seven major open reading frames (ORFs), encoding five early (E1, E2, E4, E6, and E7) and two late (L1 and L2) proteins, while lacking the E5 ORF. The long control region (LCR) of 513 bp is located between the L1 and E6 ORFs. Phylogenetic analysis additionally confirmed that HPV-199 clusters into the Gamma-PV genus, species Gamma-12, additionally containing HPV127, HV132, HPV148, HPV165, and three putative HPV types: KC5, CG2 and CG3. HPV199 is most closely related to HPV127 (nucleotide identity 77%). The complete viral genome sequence of additional HPV199 isolate was determined from anal canal swab sample. Two HPV199 complete viral sequences exhibit 99.4% nucleotide identity. To the best of our knowledge, this is the first member of Gamma-PV with complete nucleotide sequences determined from two independent clinical samples. To evaluate the tissue tropism of the novel HPV type, 916 clinical samples were tested using HPV199 type-specific real-time PCR: HPV199 was detected in 2/76 tissue samples of histologically confirmed common warts, 2/108 samples of eyebrow hair follicles, 2/137 anal canal swabs obtained from individuals with clinically evident anal pathology, 4/184 nasopharyngeal swabs and 3/411 cervical swabs obtained from women with normal cervical cytology. Although HPV199 was found in 1.4% of cutaneous and mucosal samples only, it exhibits dual tissue tropism. According to the results of our study and literature data, dual tropism of all Gamma-12 members is highly possible.	[Ostrbenk, Anja; Kocjan, Bostjan J.; Hosnjak, Lea; Sterbenc, Anja; Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Li, Jingjing; Deng, Qiuju] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China	University of Ljubljana; Peking University	Poljak, M (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	mario.poljak@mf.uni-lj.si			Slovenian Research Agency (ARRS); Young Researcher Training Program; CoheaHr Project (European Commission) [603019]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); Young Researcher Training Program; CoheaHr Project (European Commission)	This work is the result of PhD research and is financially supported by the Slovenian Research Agency (ARRS), which funded AO through the Young Researcher Training Program, and in part by the CoheaHr Project (European Commission FP7 Program, grant number: 603019) (MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Bao YM, 2014, ARCH VIROL, V159, P3293, DOI 10.1007/s00705-014-2197-x; Bergvall M, 2013, VIROLOGY, V445, P35, DOI 10.1016/j.virol.2013.07.020; Bernard HU, 2013, VIROLOGY, V445, P197, DOI 10.1016/j.virol.2013.04.035; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Boxman ILA, 1999, J CLIN MICROBIOL, V37, P2270, DOI 10.1128/JCM.37.7.2270-2273.1999; Boxman ILA, 1997, J INVEST DERMATOL, V108, P712, DOI 10.1111/1523-1747.ep12292090; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; Buck CB, 2013, VIROLOGY, V445, P169, DOI 10.1016/j.virol.2013.05.038; Bzhalava D, 2015, VIROLOGY, V476, P341, DOI 10.1016/j.virol.2014.12.028; Chen Z, 2007, J GEN VIROL, V88, P2952, DOI 10.1099/vir.0.83178-0; Chen ZG, 2007, VIROLOGY, V360, P447, DOI 10.1016/j.virol.2006.10.022; Chouhy D, 2013, J GEN VIROL, V94, P524, DOI 10.1099/vir.0.048157-0; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; Doorbar J., 1996, HUMAN PAPILLOMAVIRUS, P58; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Forslund O, 2003, J VIROL METHODS, V110, P129, DOI 10.1016/S0166-0934(03)00109-5; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harwood CA, 1999, J CLIN MICROBIOL, V37, P3545, DOI 10.1128/JCM.37.11.3545-3555.1999; HEINZEL PA, 1995, J CLIN MICROBIOL, V33, P1746, DOI 10.1128/JCM.33.7.1746-1754.1995; Hosnjak L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119154; KASHER MS, 1988, J VIROL, V62, P3295, DOI 10.1128/JVI.62.9.3295-3300.1988; Kocjan Bogtjan J., 2005, Infection Genetics and Evolution, V5, P255, DOI 10.1016/j.meegid.2004.05.009; Kocjan BJ, 2010, J VIROL METHODS, V163, P492, DOI 10.1016/j.jviromet.2009.10.024; Kocjan BJ, 2009, VIROLOGY, V391, P274, DOI 10.1016/j.virol.2009.06.030; Kohler A, 2009, BRIT J DERMATOL, V161, P528, DOI 10.1111/j.1365-2133.2009.09297.x; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Komlos KF, 2013, ACTA DERMATOVEN ALP, V21, P31, DOI 10.2478/v10162-012-0028-x; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022414; Li JJ, 2013, J VIROL METHODS, V193, P633, DOI 10.1016/j.jviromet.2013.06.026; Li JJ, 2012, J VIROL, V86, P11936, DOI 10.1128/JVI.01988-12; Ma YF, 2014, J VIROL, V88, P4786, DOI 10.1128/JVI.00093-14; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Milosevic M, 2010, CENT EUR J MED, V5, P698, DOI 10.2478/s11536-010-0019-4; Mitsuishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079592; Narechania A, 2004, J GEN VIROL, V85, P1243, DOI 10.1099/vir.0.19765-0; Nelson LM, 2000, J CELL BIOCHEM, V79, P225, DOI 10.1002/1097-4644(20001101)79:2<225::AID-JCB60>3.0.CO;2-A; Nobre RJ, 2009, J VIROL, V83, P2907, DOI 10.1128/JVI.02490-08; Nordin P, 2007, ACTA DERM-VENEREOL, V87, P219, DOI 10.2340/00015555-0235; O'Connor M, 1995, HUMAN PAPILLOMAVIRUS, pIII21; OBALEK S, 1992, J INVEST DERMATOL, V98, P936, DOI 10.1111/1523-1747.ep12460892; Odar K, 2014, J CELL MOL MED, V18, P635, DOI 10.1111/jcmm.12211; Ogawa T, 2007, J GEN VIROL, V88, P1934, DOI 10.1099/vir.0.82794-0; Platt AR, 2007, BIOTECHNIQUES, V43, P58, DOI 10.2144/000112499; Poljak M, 2011, J CLIN MICROBIOL, V49, P1721, DOI 10.1128/JCM.00012-11; Poljak M, 2009, J INFECT DIS, V199, P1270, DOI 10.1086/597619; Potocnik M, 2006, J MED VIROL, V78, P1673, DOI 10.1002/jmv.20753; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Roman A, 2013, VIROLOGY, V445, P138, DOI 10.1016/j.virol.2013.04.013; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; SHAMANIN V, 1994, J GEN VIROL, V75, P1149, DOI 10.1099/0022-1317-75-5-1149; Sichero L, 2015, CLIN MICROBIOL INFEC, V21, P502, DOI 10.1016/j.cmi.2014.12.023; Sichero L, 2013, VIROLOGY, V443, P214, DOI 10.1016/j.virol.2013.04.024; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terai M, 2002, J INFECT DIS, V185, P1794, DOI 10.1086/340824; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; Torres M, 2015, J CLIN VIROL, V67, P47, DOI 10.1016/j.jcv.2015.04.005; Ure AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089342; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; van Duin M, 2002, INT J CANCER, V98, P590, DOI 10.1002/ijc.10232; Venuti A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-140; Wang JW, 2013, VIROLOGY, V445, P175, DOI 10.1016/j.virol.2013.04.017; ZHOU J, 1991, VIROLOGY, V185, P625, DOI 10.1016/0042-6822(91)90533-H; Zou NX, 2000, J VIROL, V74, P3761, DOI 10.1128/JVI.74.8.3761-3770.2000	69	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138628	10.1371/journal.pone.0138628	http://dx.doi.org/10.1371/journal.pone.0138628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375679	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200117
J	Rainard, P; Cunha, P; Ledresseur, M; Staub, C; Touze, JL; Kempf, F; Gilbert, FB; Foucras, G				Rainard, Pascal; Cunha, Patricia; Ledresseur, Marion; Staub, Christophe; Touze, Jean-Luc; Kempf, Florent; Gilbert, Florence B.; Foucras, Gilles			Antigen-Specific Mammary Inflammation Depends on the Production of IL-17A and IFN-gamma by Bovine CD4+T Lymphocytes	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; INTERFERON-GAMMA; EPITHELIAL-CELLS; MUCOSAL IMMUNITY; GUINEA-PIGS; T-CELLS; GLAND; MASTITIS; NEUTROPHILS; TUBERCULOSIS	Intramammary infusion of the antigen used to sensitize cows by the systemic route induces a local inflammation associated with neutrophil recruitment. We hypothesize that this form of delayed type hypersensitivity, which may occur naturally during infections or could be induced intentionally by vaccination, can impact the outcome of mammary gland infections. We immunized cows with ovalbumin to identify immunological correlates of antigen-specific mammary inflammation. Intraluminal injection of ovalbumin induced a mastitis characterized by a prompt tissue reaction (increase in teat wall thickness) and an intense influx of leukocytes into milk of 10 responder cows out of 14 immunized animals. The magnitude of the local inflammatory reaction, assessed through milk leukocytosis, correlated with antibody titers, skin thickness test, and production of IL-17A and IFN-gamma in a whole-blood antigen stimulation assay (WBA). The production of these two cytokines significantly correlated with the magnitude of the milk leukocytosis following the ovalbumin intramammary challenge. The IL-17A and IFN-gamma production in the WBA was dependent on the presence of CD4+ cells in blood samples. In vitro stimulation of peripheral blood lymphocytes with ovalbumin followed by stimulation with PMA/ionomycin allowed the identification by flow cytometry of CD4+ T cells producing either IL-17A, IFN-gamma, or both cytokines. The results indicate that the antigen-specific WBA, and specifically IL-17A and IFN-gamma production by circulating CD4+ cells, can be used as a predictor of mammary hypersensitivity to protein antigens. This prompts further studies aiming at determining how Th17 and/or Th1 lymphocytes modulate the immune response of the mammary gland to infection.	[Rainard, Pascal; Cunha, Patricia; Ledresseur, Marion; Kempf, Florent; Gilbert, Florence B.] INRA, UMR1282, Infectiol & Sante Publ, F-37380 Nouzilly, France; [Staub, Christophe] INRA, UEPAO, Unite Expt Physiol Anim, UE1297, F-37380 Nouzilly, France; [Rainard, Pascal; Cunha, Patricia; Ledresseur, Marion; Touze, Jean-Luc; Kempf, Florent; Gilbert, Florence B.] Univ Tours, Tours, France; [Touze, Jean-Luc] INRA, UMR0085, Physiol Reprod & Comportement, F-37380 Nouzilly, France; [Foucras, Gilles] Univ Toulouse, ENVT, INP, Toulouse, France; [Foucras, Gilles] INRA, UMR1225, Interact Hote Agents Pathogenes, F-31931 Toulouse, France	INRAE; INRAE; Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE	Rainard, P (corresponding author), INRA, UMR1282, Infectiol & Sante Publ, F-37380 Nouzilly, France.	pascal.rainard@tours.inra.fr	FOUCRAS, Gilles/A-3061-2014	FOUCRAS, Gilles/0000-0002-0363-0337; Rainard, Pascal/0000-0002-5477-2626	Region Centre (Mamimmunotypage project) [2012 00073634]; National Institute for Agricultural Research (INRA)	Region Centre (Mamimmunotypage project)(Region Centre-Val de Loire); National Institute for Agricultural Research (INRA)	This work was funded by the Region Centre (Mamimmunotypage project, Convention 2012 00073634, www.regioncentre.fr) and by the National Institute for Agricultural Research (INRA, www.paris.inra.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013418; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; Bougarn S, 2010, CLIN VACCINE IMMUNOL, V17, P1797, DOI 10.1128/CVI.00268-10; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Bruno DR, 2010, VET IMMUNOL IMMUNOP, V138, P15, DOI 10.1016/j.vetimm.2010.06.009; Chessel D., 2004, R NEWS, V4, P5; COLDITZ IG, 1982, RES VET SCI, V33, P146, DOI 10.1016/S0034-5288(18)32327-0; CRAVEN N, 1985, VET IMMUNOL IMMUNOP, V10, P71, DOI 10.1016/0165-2427(85)90039-X; DECUENINCK BJ, 1979, INT ARCH ALLER A IMM, V59, P394, DOI 10.1159/000232286; DECUENINCK BJ, 1982, AM J VET RES, V43, P1696; Dray S, 2008, COMPUT STAT DATA AN, V52, P2228, DOI 10.1016/j.csda.2007.07.015; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Geherin SA, 2013, VET IMMUNOL IMMUNOP, V155, P87, DOI 10.1016/j.vetimm.2013.06.008; Gilbert FB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-40; Gunther J, 2011, INFECT IMMUN, V79, P695, DOI 10.1128/IAI.01071-10; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Herbelin C, 1997, J DAIRY SCI, V80, P2025, DOI 10.3168/jds.S0022-0302(97)76147-2; Jungersen G, 2012, VET IMMUNOL IMMUNOP, V148, P48, DOI 10.1016/j.vetimm.2011.05.010; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kumar P, 2013, CURR OPIN IMMUNOL, V25, P373, DOI 10.1016/j.coi.2013.03.011; Lind M, 2015, INNATE IMMUN-LONDON, V21, P322, DOI 10.1177/1753425914539820; LUTJE V, 1991, VET IMMUNOL IMMUNOP, V28, P275, DOI 10.1016/0165-2427(91)90120-2; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; NONNECKE BJ, 1984, AM J REPROD IMMUNOL, V6, P9, DOI 10.1111/j.1600-0897.1984.tb00101.x; Oviedo-Boyso J, 2007, J INFECTION, V54, P399, DOI 10.1016/j.jinf.2006.06.010; Pareek Ravi, 2005, Journal of Applied Genetics, V46, P171; PLASTRIDGE WN, 1958, J DAIRY SCI, V41, P1141, DOI 10.3168/jds.S0022-0302(58)91071-3; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Rainard P, 1997, VET RES, V28, P231; Rainard P, 2010, CLIN VACCINE IMMUNOL, V17, P848, DOI 10.1128/CVI.00447-09; Rainard P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063471; Rinaldi M, 2010, FUNCT INTEGR GENOMIC, V10, P21, DOI 10.1007/s10142-009-0133-z; Riollet C, 2006, J INTERF CYTOK RES, V26, P141, DOI 10.1089/jir.2006.26.141; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; Schiller I, 2010, VET REC, V167, P322, DOI 10.1136/vr.c3403; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Soltani MH, 2012, IRAN J IMMUNOL, V9, P168; STEINBECK MJ, 1986, CELL IMMUNOL, V98, P137, DOI 10.1016/0008-8749(86)90274-1; Tao WJ, 2007, VET IMMUNOL IMMUNOP, V120, P201, DOI 10.1016/j.vetimm.2007.06.019; TARGOWSKI SP, 1975, AM J VET RES, V36, P1561; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Wedlock DN, 2002, VET IMMUNOL IMMUNOP, V86, P79, DOI 10.1016/S0165-2427(02)00017-X; Wu WH, 2012, AM J RESP CRIT CARE, V186, P420, DOI 10.1164/rccm.201202-0182OC; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	46	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137755	10.1371/journal.pone.0137755	http://dx.doi.org/10.1371/journal.pone.0137755			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375594	Green Published, gold, Green Submitted			2022-12-26	WOS:000361610200051
J	Wang, L; Groenewald, M; Wang, QM; Boekhout, T				Wang, Long; Groenewald, Marizeth; Wang, Qi-Ming; Boekhout, Teun			Reclassification of Saccharomycodes sinensis, Proposal of Yueomyces sinensis gen. nov., comb. nov within Saccharomycetaceae (Saccharomycetales, Saccharomycotina)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; YEASTS; GENERA	The phylogenetic position of Saccharomycodes sinensis has been debated by yeast taxonomists. In this study, a multigene phylogenetic analysis based on four regions, namely the 18S ribosomal DNA (rDNA), the D1/D2 domains of the 26S rDNA, the second largest subunit of RNA polymerase II gene (RPB2) and translation elongation factor 1-alpha gene (EF1-alpha), were performed to address the phylogenetic placement of S. sinensis. Our result indicated that S. sinensis belongs to Saccharomycetaceae instead of Saccharomycodaceae, and forms a single species lineage divergent from the other genera within Saccharomycetaceae. Yueomyces gen. nov. (MycoBank No. MB 811648) is proposed in the Saccharomycetaceae with Y. sinensis comb. nov. (MycoBank No. MB 811649, type strain CGMCC 2.01395(T) = IFO 10111(T) = CBS 7075(T)) as the type species.	[Wang, Long; Wang, Qi-Ming] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Groenewald, Marizeth; Boekhout, Teun] CBS KNAW Fungal Biodivers Ctr, Yeast Div, Utrecht, Netherlands	Chinese Academy of Sciences; Institute of Microbiology, CAS; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Wang, QM (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	wangqm@im.ac.cn	Boekhout, Teunis/ABF-2538-2020; Groenewald, Marizeth/G-4976-2012	Boekhout, Teunis/0000-0002-0476-3609; Groenewald, Marizeth/0000-0003-0835-5925	Youth Innovation Promotion Association of the Chinese Academy of Sciences [2012078]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-6]	Youth Innovation Promotion Association of the Chinese Academy of Sciences; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This study was supported by grants no. 2012078 from the Youth Innovation Promotion Association of the Chinese Academy of Sciences and by no. KSCX2-EW-J-6 from the Knowledge Innovation Program of the Chinese Academy of Sciences.	Boundy-Mills K, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P747, DOI 10.1016/B978-0-444-52149-1.00062-8; Cannon PF, 2007, FUNGAL FAMILIES WORL; Kudryavtsev VI, 1960, SYSTEMATIK HEFEN, V270; Kurtzman C.P., 1998, YEASTS TAXONOMIC STU; Kurtzman CP, 2013, FEMS YEAST RES, V13, P23, DOI 10.1111/1567-1364.12006; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P887, DOI 10.1016/B978-0-444-52149-1.00078-1; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P293, DOI 10.1016/B978-0-444-52149-1.00013-6; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lumbsch H. T., 2007, MYCONET, V13, P1, DOI DOI 10.3158/1557.1; McNeill J, 2012, REGNUM VEG, V154, P1; Miller M. W., 1998, P372, DOI 10.1016/B978-044481312-1/50049-6; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Smith MT, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P629, DOI 10.1016/B978-0-444-52149-1.00049-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132653; Wang QM, 2014, PERSOONIA, V33, P41, DOI 10.3767/003158514X682313; Wang QM, 2008, FEMS YEAST RES, V8, P799, DOI 10.1111/j.1567-1364.2008.00403.x; YAMADA Y, 1992, J GEN APPL MICROBIOL, V38, P585, DOI 10.2323/jgam.38.585; Yamazaki T, 2005, J GEN APPL MICROBIOL, V51, P35, DOI 10.2323/jgam.51.35; Yue J.-Z., 1977, ACTA MICROBIOL SIN, V17, P89	22	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136987	10.1371/journal.pone.0136987	http://dx.doi.org/10.1371/journal.pone.0136987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375944	Green Submitted, Green Published, gold			2022-12-26	WOS:000361610200028
J	Zhou, XL; Ding, HX; Wu, WQ; Zhang, YT				Zhou, Xiaolin; Ding, Hongxia; Wu, Wanqing; Zhang, Yuanting			A Real-Time Atrial Fibrillation Detection Algorithm Based on the Instantaneous State of Heart Rate	PLOS ONE			English	Article							STROKE SEVERITY; RISK	Atrial fibrillation (AF), the most frequent cause of cardioembolic stroke, is increasing in prevalence as the population ages, and presents with a broad spectrum of symptoms and severity. The early identification of AF is an essential part for preventing the possibility of blood clotting and stroke. In this work, a real-time algorithm is proposed for accurately screening AF episodes in electrocardiograms. This method adopts heart rate sequence, and it involves the application of symbolic dynamics and Shannon entropy. Using novel recursive algorithms, a low-computational complexity can be obtained. Four publicly-accessible sets of clinical data (Long-Term AF, MIT-BIH AF, MIT-BIH Arrhythmia, and MIT-BIH Normal Sinus Rhythm Databases) were used for assessment. The first database was selected as a training set; the receiver operating characteristic (ROC) curve was performed, and the best performance was achieved at the threshold of 0.639: the sensitivity (Se), specificity (Sp), positive predictive value (PPV) and overall accuracy (ACC) were 96.14%, 95.73%, 97.03% and 95.97%, respectively. The other three databases were used for independent testing. Using the obtained decision-making threshold (i.e., 0.639), for the second set, the obtained parameters were 97.37%, 98.44%, 97.89% and 97.99%, respectively; for the third database, these parameters were 97.83%, 87.41%, 47.67% and 88.51%, respectively; the Sp was 99.68% for the fourth set. The latest methods were also employed for comparison. Collectively, results presented in this study indicate that the combination of symbolic dynamics and Shannon entropy yields a potent AF detector, and suggest this method could be of practical use in both clinical and out-of-clinical settings.	[Zhou, Xiaolin; Ding, Hongxia; Wu, Wanqing; Zhang, Yuanting] Chinese Acad Sci, Shenzhen Inst Adv Technol, CAS CUHK Res Ctr Biosensors & Med Instruments, Shenzhen, Guangdong, Peoples R China; [Zhou, Xiaolin; Ding, Hongxia; Wu, Wanqing; Zhang, Yuanting] Chinese Acad Sci, Key Lab Hlth Informat, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China; [Zhang, Yuanting] Chinese Univ Hong Kong, Dept Elect Engn, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong	Zhou, XL (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, CAS CUHK Res Ctr Biosensors & Med Instruments, Shenzhen, Guangdong, Peoples R China.	xl.zhou@siat.ac.cn; wq.wu@siat.ac.cn	zhou, xiaolin/GNP-3201-2022	ZHANG, Yuanting/0000-0003-4150-5470	National Natural Science Foundation of China [61401453]; STS Key Health Program of Chinese Academy of Sciences [KFJEW-STS-097, KFJ-EW-STS-095]; External Cooperation Program of the Chinese Academy of Sciences [GJHZ1212]; Guangdong Innovation Research Team Fund for Low-Cost Healthcare Technologies in China; Key Lab for Health Informatics of Chinese Academy of Sciences; Enhancing Program of Key Laboratories of Shenzhen City [ZDSY20120617113021359]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); STS Key Health Program of Chinese Academy of Sciences; External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Guangdong Innovation Research Team Fund for Low-Cost Healthcare Technologies in China; Key Lab for Health Informatics of Chinese Academy of Sciences; Enhancing Program of Key Laboratories of Shenzhen City	This work was supported in part by the National Natural Science Foundation of China (no. 61401453), the STS Key Health Program of Chinese Academy of Sciences (no. KFJEW-STS-097 and KFJ-EW-STS-095), the External Cooperation Program of the Chinese Academy of Sciences (GJHZ1212), the Guangdong Innovation Research Team Fund for Low-Cost Healthcare Technologies in China, and the Key Lab for Health Informatics of Chinese Academy of Sciences, the Enhancing Program of Key Laboratories of Shenzhen City (no. ZDSY20120617113021359).	Babaeizadeh S, 2009, J ELECTROCARDIOL, V42, P522, DOI 10.1016/j.jelectrocard.2009.06.006; Dash S, 2009, ANN BIOMED ENG, V37, P1701, DOI 10.1007/s10439-009-9740-z; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Huang C, 2011, IEEE T BIO-MED ENG, V58, P1113, DOI 10.1109/TBME.2010.2096506; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Larburu N, 2011, COMPUT CARDIOL CONF, V38, P265; Larburu N, 2011, THESIS PUBLIC U NAVA; Lee J, 2013, IEEE T BIO-MED ENG, V60, P2783, DOI 10.1109/TBME.2013.2264721; Lee J, 2013, IEEE T BIO-MED ENG, V60, P203, DOI 10.1109/TBME.2012.2208112; Lian J, 2011, AM J CARDIOL, V107, P1494, DOI 10.1016/j.amjcard.2011.01.028; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; Mathew ST, 2009, EUR J INTERN MED, V20, P672, DOI 10.1016/j.ejim.2009.07.011; Park J, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-38; Petrenas A., 2015, COMPUT BIOL MED, V60, P2783; Petrutiu S, 2006, IEEE ENG MED BIOL, V25, P24, DOI 10.1109/EMB-M.2006.250505; Voss A, 1996, CARDIOVASC RES, V31, P419; WHO (World Health Organization), ATLAS HEART DIS STRO; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yaghouby F, 2012, EXPERT SYST, V29, P183, DOI 10.1111/j.1468-0394.2010.00571.x; Yaghouby F, 2010, COMPUT BIOL MED, V40, P919, DOI 10.1016/j.compbiomed.2010.10.004; Zhou XL, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-18	24	48	50	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136544	10.1371/journal.pone.0136544	http://dx.doi.org/10.1371/journal.pone.0136544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376341	gold, Green Published, Green Submitted			2022-12-26	WOS:000361610200018
J	Chen, N; Liu, Y; Cheng, YJ; Liu, L; Yan, Z; Tao, LX; Guo, XH; Luo, YX; Yan, AS				Chen, Ning; Liu, Yun; Cheng, Yijie; Liu, Long; Yan, Zhe; Tao, Lixin; Guo, Xiuhua; Luo, Yanxia; Yan, Aoshuang			Technology Resource, Distribution, and Development Characteristics of Global Influenza Virus Vaccine: A Patent Bibliometric Analysis	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; NANOTECHNOLOGY; PUBLICATIONS; PATTERNS	Influenza virus vaccine (IVV) is a promising research domain that is closely related to global health matters, which has been acknowledged not only by scientists and technology developers, but also by policy-makers. Meanwhile, patents encompass valuable technological information and reflect the latest technological inventions as well as the innovative capability of a nation. However, little research has examined this up- and-coming research field using patent bibliometric method. Thus, this paper (a) designs the technology classification system and search strategy for the identification of IVV; and (b) presents a longitudinal analysis of the global IVV development based on the European Patent Office (EPO) patents. Bibliometric analysis is used to rank countries, institutions, inventors and technology subfields contributing to IVV technical progress. The results show that the global trends of IVV are a multi-developing feature of variety but an uneven technical resource distribution. Although the synthetic peptide vaccine is a comparatively young field, it already demonstrates the powerful vitality and the enormous development space. With the worldwide competition increasing, all nations especially China should be looking to increase devotion, enhance capability and regard effectiveness of technological innovation.	[Chen, Ning; Liu, Long; Tao, Lixin; Guo, Xiuhua; Luo, Yanxia; Yan, Aoshuang] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Chen, Ning; Liu, Long; Tao, Lixin; Guo, Xiuhua; Luo, Yanxia; Yan, Aoshuang] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Chen, Ning; Yan, Aoshuang] Beijing Municipal Sci & Technol Commiss, Beijing, Peoples R China; [Liu, Yun; Cheng, Yijie; Yan, Zhe] Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China	Capital Medical University; Beijing Municipal Science & Technology Commission; Beijing Institute of Technology	Liu, Y (corresponding author), Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.	liuyun@bit.edu.cn; lyx100@ccmu.edu.cn; Yanas@139.com	TAO, Li/HIR-4254-2022		National Natural Science Foundation of China [71273030]; National International S&T Cooperation Program [2012DFG11750]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National International S&T Cooperation Program	This paper was funded by the project of National Natural Science Foundation of China (No. 71273030) and the project of National International S&T Cooperation Program (No. 2012DFG11750).	Blind K, 2009, RES POLICY, V38, P428, DOI 10.1016/j.respol.2008.12.003; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Cheng YJ, 2014, PORTL INT CONF MANAG, P1373; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Dekker T, 2012, J ENVIRON ECON MANAG, V64, P45, DOI 10.1016/j.jeem.2011.11.005; Du J, 2014, J CANCER RES THER, V10, P27, DOI 10.4103/0973-1482.139750; Dubourg L, 2008, SURF COAT TECH, V202, P5863, DOI 10.1016/j.surfcoat.2008.06.122; Gambaryan AS, 1999, VIROLOGY, V258, P232, DOI 10.1006/viro.1999.9732; Guan JC, 2007, SCIENTOMETRICS, V72, P403, DOI 10.1007/s11192-007-1741-1; Harhoff D, 2003, RES POLICY, V32, P1343, DOI 10.1016/S0048-7333(02)00124-5; Huang MC, 2011, SCIENTOMETRICS, V88, P805, DOI 10.1007/s11192-011-0400-3; Meyer M, 1998, SCIENTOMETRICS, V42, P195, DOI 10.1007/BF02458355; Narin F, 1996, SCIENTOMETRICS, V36, P293, DOI 10.1007/BF02129596; Partei O D OT, 2004, EUR PAT OFF BIOT LAW; Piergiovanni R, 2013, SCIENTOMETRICS, V94, P497, DOI 10.1007/s11192-012-0711-z; Porter AL, 2008, J NANOPART RES, V10, P715, DOI 10.1007/s11051-007-9266-y; Shaw A, 2012, VACCINE, V30, P4927, DOI 10.1016/j.vaccine.2012.04.095; Wareing MD, 2001, VACCINE, V19, P3320, DOI 10.1016/S0264-410X(01)00045-7; WINNER EP, 1980, J PATENT TRADEMARK, V62, P419; Ye XT, 2012, INT J TECHNOL MANAGE, V59, P255, DOI 10.1504/IJTM.2012.047246; Yesil-Celiktas O, 2010, IND ENG CHEM RES, V49, P7017, DOI 10.1021/ie100115x	22	6	6	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136953	10.1371/journal.pone.0136953	http://dx.doi.org/10.1371/journal.pone.0136953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR8LR	26372160	gold, Green Published, Green Submitted			2022-12-26	WOS:000361604400009
J	Guo, GY; Xu, K; Zhang, XM; Zhu, JL; Lu, MY; Chen, FL; Liu, LP; Xi, ZY; Bachmair, A; Chen, QS; Fu, YF				Guo, Guangyu; Xu, Kun; Zhang, Xiaomei; Zhu, Jinlong; Lu, Mingyang; Chen, Fulu; Liu, Linpo; Xi, Zhang-Ying; Bachmair, Andreas; Chen, Qingshan; Fu, Yong-Fu			Extensive Analysis of GmFTL and GmCOL Expression in Northern Soybean Cultivars in Field Conditions	PLOS ONE			English	Article							FLOWERING-LOCUS-T; TIME GENE CONSTANS; MAP-BASED CLONING; MOLECULAR-BASIS; GLYCINE-MAX; FT PROTEIN; ARABIDOPSIS; MATURITY; EVOLUTION; PHOTOPERIOD	The FLOWERING LOCUS T (FT) gene is a highly conserved florigen gene among flowering plants. Soybean genome encodes six homologs of FT, which display flowering activity in Arabidopsis thaliana. However, their contributions to flowering time in different soybean cultivars, especially in field conditions, are unclear. We employed six soybean cultivars with different maturities to extensively investigate expression patterns of GmFTLs (Glycine max FT-like) and GmCOLs (Glycine max CO-like) in the field conditions. The results show that GmFTL3 is an FT homolog with the highest transcript abundance in soybean, but other GmFTLs may also contribute to flower induction with different extents, because they have more or less similar expression patterns in developmental-, leaf-, and circadian-specific modes. And four GmCOL genes (GmCOL1/2/5/13) may confer to the expression of GmFTL genes. Artificial manipulation of GmFTL expression by transgenic strategy (overexpression and RNAi) results in a distinct change in soybean flowering time, indicating that GmFTLs not only impact on the control of flowering time, but have potential applications in the manipulation of photoperiodic adaptation in soybean. Additionally, transgenic plants show that GmFTLs play a role in formation of the first flowers and in vegetative growth.	[Guo, Guangyu; Chen, Qingshan] Northeast Agr Univ, Coll Agr, Harbin, Peoples R China; [Xu, Kun; Zhang, Xiaomei; Zhu, Jinlong; Lu, Mingyang; Chen, Fulu; Liu, Linpo; Fu, Yong-Fu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Xu, Kun; Lu, Mingyang] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Xi, Zhang-Ying] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China; [Bachmair, Andreas] Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Biochem & Cell Biol, A-1030 Vienna, Austria	Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Henan Agricultural University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Chen, QS (corresponding author), Northeast Agr Univ, Coll Agr, Harbin, Peoples R China.	qshchen@126.com; fufu19cn@163.com		Bachmair, Andreas/0000-0001-7731-1841	Transgenic Projects [2014ZX08004-005, 2014ZX08009-001]; Project 863 [2013AA102602]; National Natural Science Foundation [31371703, 31301200, 31371629]; Austrian Science Fund [P25488]	Transgenic Projects; Project 863(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by Transgenic Projects (2014ZX08004-005 and 2014ZX08009-001), by Project 863 (2013AA102602), and by the National Natural Science Foundation (31371703, 31301200, and 31371629). A.B. was supported by the Austrian Science Fund (grant P25488).	Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; [Anonymous], 2004, SOYBEANS IMPROVEMENT; Ballerini ES, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00081; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Chardon F, 2005, J MOL EVOL, V61, P579, DOI 10.1007/s00239-004-0179-4; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; D'Aloia M, 2011, PLANT J, V65, P972, DOI 10.1111/j.1365-313X.2011.04482.x; Fan CM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-9; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hiraoka K, 2013, PLANT CELL PHYSIOL, V54, P352, DOI 10.1093/pcp/pcs168; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jiang BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106042; Jiang BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077474; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Karlgren A, 2011, PLANT PHYSIOL, V156, P1967, DOI 10.1104/pp.111.176206; Kim MY, 2011, BREEDING SCI, V61, P445, DOI 10.1270/jsbbs.61.445; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Kong FJ, 2014, CROP SCI, V54, P2529, DOI 10.2135/cropsci2014.03.0228; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Lagercrantz U, 2000, MOL BIOL EVOL, V17, P1499, DOI 10.1093/oxfordjournals.molbev.a026249; Langewisch T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094150; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079036; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu H, 2009, J PLANT PHYSIOL, V166, P278, DOI 10.1016/j.jplph.2008.06.003; Liu LY, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00164; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Matsoukas IG, 2012, PLANT CELL PHYSIOL, V53, P1827, DOI 10.1093/pcp/pcs130; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Nan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097669; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; OGAWA Y, 1990, PLANT CELL PHYSIOL, V31, P129; Olhoft PM, 2006, METH MOL B, V343, P385; Owen FV, 1927, GENETICS, V12, P519; PATON DM, 1971, AUST J BIOL SCI, V24, P609, DOI 10.1071/BI9710609; Paz MM, 2006, PLANT CELL REP, V25, P206, DOI 10.1007/s00299-005-0048-7; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Serrano G, 2009, CURR BIOL, V19, P359, DOI 10.1016/j.cub.2009.01.044; Simpson GG, 2003, BIOESSAYS, V25, P829, DOI 10.1002/bies.10330; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Thomas B, 1997, PHOTOPERIODISM PLANT, P355; Thomas B., 1997, PHOTOPERIODISM PLANT, P11; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; Wang K, AGROBACTERIUM MEDIAT, P1; Wang Z, 2015, PLANT CELL, V27, P323, DOI 10.1105/tpc.114.135103; Watanabe S, 2011, BREEDING SCI, V61, P531, DOI 10.1270/jsbbs.61.531; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Xi WY, 2009, PLANT SIGNAL BEHAV, V4, P1142, DOI 10.4161/psb.4.12.9901; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yoo SJ, 2013, PLANT CELL PHYSIOL, V54, P119, DOI 10.1093/pcp/pcs158; Zhai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097636	74	13	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0136601	10.1371/journal.pone.0136601	http://dx.doi.org/10.1371/journal.pone.0136601			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26371882	Green Submitted, Green Published, gold			2022-12-26	WOS:000361604400007
J	Juratli, MA; Siegel, ER; Nedosekin, DA; Sarimollaoglu, M; Jamshidi-Parsian, A; Cai, CZ; Menyaev, YA; Suen, JY; Galanzha, EI; Zharov, VP				Juratli, Mazen A.; Siegel, Eric R.; Nedosekin, Dmitry A.; Sarimollaoglu, Mustafa; Jamshidi-Parsian, Azemat; Cai, Chengzhong; Menyaev, Yulian A.; Suen, James Y.; Galanzha, Ekaterina I.; Zharov, Vladimir P.			In Vivo Long-Term Monitoring of Circulating Tumor Cells Fluctuation during Medical Interventions	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BREAST-CANCER; BLOOD; BIOPSY; DISSEMINATION; MAMMOGRAPHY; RESECTION; SURGERY; GROWTH	The goal of this research was to study the long-term impact of medical interventions on circulating tumor cell (CTC) dynamics. We have explored whether tumor compression, punch biopsy or tumor resection cause dissemination of CTCs into peripheral blood circulation using in vivo fluorescent flow cytometry and breast cancer-bearing mouse model inoculated with MDA-MB-231-Luc2-GFP cells in the mammary gland. Two weeks after tumor inoculation, three groups of mice were the subject of the following interventions: (1) tumor compression for 15 minutes using 400 g weight to approximate the pressure during mammography; (2) punch biopsy; or (3) surgery. The CTC dynamics were determined before, during and six weeks after these interventions. An additional group of tumor-bearing mice was used as control and did not receive an intervention. The CTC dynamics in all mice were monitored weekly for eight weeks after tumor inoculation. We determined that tumor compression did not significantly affect CTC dynamics, either during the procedure itself (P = 0.28), or during the 6-week follow-up. In the punch biopsy group, we observed a significant increase in CTC immediately after the biopsy (P = 0.02), and the rate stayed elevated up to six weeks after the procedure in comparison to the tumor control group. The CTCs in the group of mice that received a tumor resection disappeared immediately after the surgery (P = 0.03). However, CTC recurrence in small numbers was detected during six weeks after the surgery. In the future, to prevent these side effects of medical interventions, the defined dynamics of intervention-induced CTCs may be used as a basis for initiation of aggressive anti-CTC therapy at time-points of increasing CTC number.	[Juratli, Mazen A.; Nedosekin, Dmitry A.; Sarimollaoglu, Mustafa; Jamshidi-Parsian, Azemat; Cai, Chengzhong; Menyaev, Yulian A.; Galanzha, Ekaterina I.; Zharov, Vladimir P.] UAMS, Arkansas Nanomed Ctr, Little Rock, AR 72205 USA; [Juratli, Mazen A.] Univ Hosp Frankfurt, Dept Gen & Visceral Surg, Frankfurt, Germany; [Siegel, Eric R.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Suen, James Y.; Zharov, Vladimir P.] Univ Arkansas Med Sci, Dept Otolaryngol Head & Neck Surg, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Little Rock; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Juratli, MA (corresponding author), UAMS, Arkansas Nanomed Ctr, Little Rock, AR 72205 USA.	mjuratli@uams.edu	Juratli, Mazen/ABH-2883-2021; Juratli, Mazen/AAJ-3277-2021; Juratli, Mazen/AAH-7970-2019	Juratli, Mazen/0000-0002-1793-0672; Zharov, Vladimir/0000-0003-4773-0548; Siegel, Eric/0000-0001-9824-6612; Menyaev, Yulian/0000-0001-5861-3641; Sarimollaoglu, Mustafa/0000-0003-0246-9702	National Institutes of Health [R01 EB017217, R01 CA131164]; FDA [HHSF223201400079C]; EPSCOR from the NSF [1457888]; Translational Reserach Institute (TRI) at UAMS; Deutsche Forschungsgemeinschaft (DFG-German Research Foundation Grant) [JU 2814/1-1]; Arkansas Breast Cancer Research Program Grant [ABCRP-FY13]; NATIONAL CANCER INSTITUTE [R01CA131164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA(United States Department of Health & Human Services); EPSCOR from the NSF; Translational Reserach Institute (TRI) at UAMS; Deutsche Forschungsgemeinschaft (DFG-German Research Foundation Grant)(German Research Foundation (DFG)); Arkansas Breast Cancer Research Program Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants R01 EB017217 and R01 CA131164 from the National Institutes of Health, HHSF223201400079C from the FDA, 1457888 EPSCOR from the NSF, from the Translational Reserach Institute (TRI) at UAMS, Deutsche Forschungsgemeinschaft (DFG-German Research Foundation Grant, JU 2814/1-1), and by the Arkansas Breast Cancer Research Program Grant ABCRP-FY13.	Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Bonadonna G, 2005, BRIT MED J, V330, P217, DOI 10.1136/bmj.38314.622095.8F; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; Fornvik D, 2013, BREAST CANCER RES TR, V141, P187, DOI 10.1007/s10549-013-2674-z; Georgakoudi I, 2004, CANCER RES, V64, P5044, DOI 10.1158/0008-5472.CAN-04-1058; HANSEN E, 1995, ARCH SURG-CHICAGO, V130, P387; Hatada T, 2000, J AM COLL SURGEONS, V190, P299, DOI 10.1016/S1072-7515(99)00300-2; Hayashi N, 1999, SURGERY, V125, P369, DOI 10.1067/msy.1999.96536; Hogg P, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120222; Hu XC, 2000, ONCOLOGY-BASEL, V59, P217, DOI 10.1159/000012164; Juratli MA, 2014, CANCERS, V6, P128, DOI 10.3390/cancers6010128; Juratli MA, 2014, HEAD NECK-J SCI SPEC, V36, P1207, DOI 10.1002/hed.23439; Katharina Pachmann, 2011, Cancers (Basel), V3, P2540, DOI 10.3390/cancers3022540; Louha M, 1999, HEPATOLOGY, V29, P879, DOI 10.1002/hep.510290348; Menyaev YA, 2013, BIOMED OPT EXPRESS, V4, P3030, DOI 10.1364/BOE.4.003030; Nedosekin DA, 2013, J BIOPHOTONICS, V6, P425, DOI 10.1002/jbio.201200047; Novak J, 2004, OPT LETT, V29, P77, DOI 10.1364/OL.29.000077; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Sarimollaoglu M, 2014, PHOTOACOUSTICS, V2, P1, DOI 10.1016/j.pacs.2013.11.002; Shibue T, 2011, SEMIN CANCER BIOL, V21, P99, DOI 10.1016/j.semcancer.2010.12.003; Tyzzer EE, 1913, J MED RES, V28, P309; WATMOUGH DJ, 1993, J BIOMED ENG, V15, P121, DOI 10.1016/0141-5425(93)90040-6; WATMOUGH DJ, 1992, LANCET, V340, P122, DOI 10.1016/0140-6736(92)90451-8; Weitz J, 1998, CLIN CANCER RES, V4, P343; Yamaguchi K, 2000, ANN SURG, V232, P58, DOI 10.1097/00000658-200007000-00009	26	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137613	10.1371/journal.pone.0137613	http://dx.doi.org/10.1371/journal.pone.0137613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367280	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100095
J	Komalapriya, C; Kaloriti, D; Tillmann, AT; Yin, ZK; Herrero-de-Dios, C; Jacobsen, MD; Belmonte, RC; Cameron, G; Haynes, K; Grebogi, C; de Moura, APS; Gow, NAR; Thiel, M; Quinn, J; Brown, AJP; Romano, MC				Komalapriya, Chandrasekaran; Kaloriti, Despoina; Tillmann, Anna T.; Yin, Zhikang; Herrero-de-Dios, Carmen; Jacobsen, Mette D.; Belmonte, Rodrigo C.; Cameron, Gary; Haynes, Ken; Grebogi, Celso; de Moura, Alessandro P. S.; Gow, Neil A. R.; Thiel, Marco; Quinn, Janet; Brown, Alistair J. P.; Romano, M. Carmen			Integrative Model of Oxidative Stress Adaptation in the Fungal Pathogen Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HYDROGEN-PEROXIDE; TRANSCRIPTION FACTOR; ALTERNATIVE-PATHWAYS; SIGNALING PATHWAYS; OSMOTIC-STRESS; GLUTATHIONE; CELL; MAPK; H2O2	The major fungal pathogen of humans, Candida albicans, mounts robust responses to oxidative stress that are critical for its virulence. These responses counteract the reactive oxygen species (ROS) that are generated by host immune cells in an attempt to kill the invading fungus. Knowledge of the dynamical processes that instigate C. albicans oxidative stress responses is required for a proper understanding of fungus-host interactions. Therefore, we have adopted an interdisciplinary approach to explore the dynamical responses of C. albicans to hydrogen peroxide (H2O2). Our deterministic mathematical model integrates two major oxidative stress signalling pathways (Cap1 and Hog1 pathways) with the three major antioxidant systems (catalase, glutathione and thioredoxin systems) and the pentose phosphate pathway, which provides reducing equivalents required for oxidative stress adaptation. The model encapsulates existing knowledge of these systems with new genomic, proteomic, transcriptomic, molecular and cellular datasets. Our integrative approach predicts the existence of alternative states for the key regulators Cap1 and Hog1, thereby suggesting novel regulatory behaviours during oxidative stress. The model reproduces both existing and new experimental observations under a variety of scenarios. Time-and dose-dependent predictions of the oxidative stress responses for both wild type and mutant cells have highlighted the different temporal contributions of the various antioxidant systems during oxidative stress adaptation, indicating that catalase plays a critical role immediately following stress imposition. This is the first model to encapsulate the dynamics of the transcriptional response alongside the redox kinetics of the major antioxidant systems during H2O2 stress in C. albicans.	[Komalapriya, Chandrasekaran; Grebogi, Celso; de Moura, Alessandro P. S.; Thiel, Marco; Romano, M. Carmen] Univ Aberdeen, Inst Complex Syst & Math Biol, Aberdeen, Scotland; [Komalapriya, Chandrasekaran; Kaloriti, Despoina; Tillmann, Anna T.; Yin, Zhikang; Herrero-de-Dios, Carmen; Jacobsen, Mette D.; Belmonte, Rodrigo C.; Gow, Neil A. R.; Brown, Alistair J. P.; Romano, M. Carmen] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [Cameron, Gary] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Haynes, Ken] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Quinn, Janet] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Exeter; Newcastle University - UK	Brown, AJP (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland.	al.brown@abdn.ac.uk; m.romano@abdn.ac.uk	GOW, Neil/AAS-5323-2021; Quinn, Janet/AAR-9957-2021; Herrero, Carmen/N-4724-2018	GOW, Neil/0000-0002-2776-5850; Brown, Alistair JP/0000-0003-1406-4251; Herrero, Carmen/0000-0002-2042-8480; Komalapriya, Chandrasekaran/0000-0002-9289-1693; Romano, M. Carmen/0000-0002-6261-2147; Quinn, Janet/0000-0002-8732-7676; Grebogi, Celso/0000-0002-9811-4617	CRISP project (Combinatorial Responses In Stress Pathways); UK Biotechnology and Biological Research Council [BB/F00513X/1, BB/F005210/1-2]; BBSRC [BB/K016393/1, BB/K017365/1]; Wellcome Trust [080088, 097377]; European Research Council [ERC-2009-AdG-249793]; BBSRC [BB/F005210/2, BB/F00513X/1, BB/F005210/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K016393/1, BB/K017365/1, BB/F005210/2, BB/F00513X/1, BB/F005210/1] Funding Source: researchfish	CRISP project (Combinatorial Responses In Stress Pathways); UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the CRISP project (Combinatorial Responses In Stress Pathways), which was funded by the UK Biotechnology and Biological Research Council (www.bbsrc.ac.uk): AJPB, KH, CG, ADM, NARG, MT, MCR. (Research Grants; BB/F00513X/1, BB/F005210/1-2). AJPB and JQ received additional support from the BBSRC (Research Grants; BB/K016393/1; BB/K017365/1). NARG and AJPB were also supported by the Wellcome Trust (www.wellcome.ac.uk), (Grants: 080088; 097377). AJPB was also supported by the European Research Council (http://erc.europa.eu/), (STRIFE Advanced Grant; ERC-2009-AdG-249793). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora NJ, 2010, ANTIOXID REDOX SIGN, V13, P731, DOI 10.1089/ars.2009.2968; Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Ask M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-87; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Branco MR, 2004, J BIOL CHEM, V279, P6501, DOI 10.1074/jbc.M311818200; Brown AJP, 2012, STRESS RESPONSES CAN; Brown AJP, 2014, TRENDS MICROBIOL, V22, P614, DOI 10.1016/j.tim.2014.07.001; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Cheetham J, 2007, MOL BIOL CELL, V18, P4603, DOI 10.1091/mbc.E07-06-0581; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Day AM, 2010, J BIOL CHEM, V285, P7505, DOI 10.1074/jbc.M109.040840; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Flohe L, 2013, BBA-GEN SUBJECTS, V1830, P3139, DOI 10.1016/j.bbagen.2012.10.020; Gilchrist CA, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-151, 10.5402/2012/538694]; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Gulshan K, 2011, J BIOL CHEM, V286, P34071, DOI 10.1074/jbc.M111.251298; de Dios CH, 2010, CURR PROTEIN PEPT SC, V11, P693; Jamieson DJ, 1996, FEMS MICROBIOL LETT, V138, P83, DOI 10.1111/j.1574-6968.1996.tb08139.x; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kaloriti D, 2014, MBIO, V5, DOI 10.1128/mBio.01334-14; Kaloriti D, 2012, MED MYCOL, V50, P699, DOI 10.3109/13693786.2012.672770; Ke RA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002879; Kim BJ, 2005, DEV BIOL, V284, P387, DOI 10.1016/j.ydbio.2005.05.034; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Kowald A, 2006, J THEOR BIOL, V238, P828, DOI 10.1016/j.jtbi.2005.06.034; Kowald A, 2004, ANN NY ACAD SCI, V1019, P370, DOI 10.1196/annals.1297.065; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miramon P, 2014, MED MYCOL, V52, P223, DOI 10.1093/mmy/myt021; Moller MNL-JJDA, 2008, INTERACTION REACTIVE; Nicholls P, 2001, ADV INORG CHEM, V51, P51; Nicholls S, 2004, EUKARYOT CELL, V3, P1111, DOI 10.1128/EC.3.5.1111-1123.2004; Nikolaou E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-44; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; Patterson MJ, 2013, ANTIOXID REDOX SIGN, V19, P2244, DOI 10.1089/ars.2013.5199; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Radmaneshfar E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068067; Raftos JE, 2010, J BIOL CHEM, V285, P23557, DOI 10.1074/jbc.M109.067017; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604; Reed MC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-8; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; Rodaki A, 2006, EUKARYOT CELL, V5, P1371, DOI 10.1128/EC.00115-06; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; Schaber J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.53; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schulze J, 2009, DTSCH ARZTEBL INT, V106, P837, DOI 10.3238/arztebl.2009.0837; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Smith DA, 2010, FEMS MICROBIOL LETT, V306, P1, DOI 10.1111/j.1574-6968.2010.01937.x; Steghens JP, 2003, J CHROMATOGR B, V798, P343, DOI 10.1016/j.jchromb.2003.10.007; Tillmann AT, 2013, NITROSATIVE COMBINAT; Urban C, 2005, MOL MICROBIOL, V57, P1318, DOI 10.1111/j.1365-2958.2005.04771.x; Wang Y, 2006, FREE RADICAL BIO MED, V40, P1201, DOI 10.1016/j.freeradbiomed.2005.11.019; Watson WH, 2003, FEBS LETT, V543, P144, DOI 10.1016/S0014-5793(03)00430-7; Wijeratne SSK, 2005, J AGR FOOD CHEM, V53, P8768, DOI 10.1021/jf0512003; Wysong DR, 1998, INFECT IMMUN, V66, P1953, DOI 10.1128/IAI.66.5.1953-1961.1998; Yin ZK, 2009, PROTEOMICS, V9, P4686, DOI 10.1002/pmic.200800958; Zhang XT, 2000, MOL MICROBIOL, V36, P618, DOI 10.1046/j.1365-2958.2000.01877.x; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101; Zi ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009522; Znaidi S, 2009, EUKARYOT CELL, V8, P806, DOI 10.1128/EC.00002-09	80	37	38	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137750	10.1371/journal.pone.0137750	http://dx.doi.org/10.1371/journal.pone.0137750			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368573	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100129
J	Lee, SH; Hayano, K; Zhu, AX; Sahani, DV; Yoshida, H				Lee, Sang Ho; Hayano, Koichi; Zhu, Andrew X.; Sahani, Dushyant V.; Yoshida, Hiroyuki			Water-Exchange-Modified Kinetic Parameters from Dynamic Contrast-Enhanced MRI as Prognostic Biomarkers of Survival in Advanced Hepatocellular Carcinoma Treated with Antiangiogenic Monotherapy	PLOS ONE			English	Article							TRACER KINETICS; BLOOD-VOLUME; HEPATIC METASTASES; T-1-WEIGHTED MRI; SHUTTER-SPEED; PERFUSION; HYPOXIA; BRAIN; CT; QUANTIFICATION	Background To find prognostic biomarkers in pretreatment dynamic contrast-enhanced MRI (DCE-MRI) water-exchange-modified (WX) kinetic parameters for advanced hepatocellular carcinoma (HCC) treated with antiangiogenic monotherapy. Methods Twenty patients with advanced HCC underwent DCE-MRI and were subsequently treated with sunitinib. Pretreatment DCE-MRI data on advanced HCC were analyzed using five different WX kinetic models: the Tofts-Kety (WX-TK), extended TK (WX-ETK), two compartment exchange, adiabatic approximation to tissue homogeneity (WX-AATH), and distributed parameter (WX-DP) models. The total hepatic blood flow, arterial flow fraction (gamma), arterial blood flow (BFA), portal blood flow, blood volume, mean transit time, permeability-surface area product, fractional interstitial volume (v(I)), extraction fraction, mean intracellular water molecule lifetime (tau(C)), and fractional intracellular volume (v(C)) were calculated. After receiver operating characteristic analysis with leave-one-out cross-validation, individual parameters for each model were assessed in terms of 1-year-survival (1YS) discrimination using Kaplan-Meier analysis, and association with overall survival (OS) using univariate Cox regression analysis with permutation testing. Results The WX-TK-model-derived. (P = 0.022) and v(I) (P = 0.010), and WX-ETK-model-derived tC (P = 0.023) and v(C) (P = 0.042) were statistically significant prognostic biomarkers for 1YS. Increase in the WX-DP-model-derived BFA (P = 0.025) and decrease in the WX-TK, WX-ETK, WX-AATH, and WX-DP-model-derived v(C) (P = 0.034, P = 0.038, P = 0.028, P = 0.041, respectively) were significantly associated with an increase in OS. Conclusions The WX-ETK-model-derived v(C) was an effective prognostic biomarker for advanced HCC treated with sunitinib.	[Lee, Sang Ho; Yoshida, Hiroyuki] Massachusetts Gen Hosp, Dept Radiol, Imaging Res 3D, Boston, MA 02114 USA; [Lee, Sang Ho; Yoshida, Hiroyuki] Harvard Univ, Sch Med, Boston, MA USA; [Hayano, Koichi; Sahani, Dushyant V.] Massachusetts Gen Hosp, Dept Radiol, Div Abdominal Imaging & Intervent, Boston, MA USA; [Zhu, Andrew X.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Yoshida, H (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Imaging Res 3D, Boston, MA 02114 USA.	yoshida.hiro@mgh.harvard.edu	Hayano, Koichi/Z-2895-2019; Lee, Sang Ho/B-9149-2017	Hayano, Koichi/0000-0003-4733-8220; Lee, Sang Ho/0000-0002-4634-4904	National Institutes of Health [R21CA187877]; NATIONAL CANCER INSTITUTE [R21CA187877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Part of this work was supported by the National Institutes of Health grant (http://grants.nih.gov/grants/oer.htm) of R21CA187877 (PI: Yoshida). National Institutes of Health had a role in supporting, through the above grant, the development of the software that implemented kinetic models used for the analysis of the DCE-MRI data in this study. The majority of the study presented in manuscript was done under the "work made for hire" by the affiliated institution (MGH), which is, by nature, not an explicit funding dedicated to the study. Thus, there is no explicit funding other than what was stated.	Bains LJ, 2010, MAGN RESON MED, V64, P595, DOI 10.1002/mrm.22430; Barsky D, 1997, MAGNET RESON MED, V37, P666, DOI 10.1002/mrm.1910370507; Bhujwalla ZM, 2003, CLIN CANCER RES, V9, P355; Brix G, 1999, RADIOLOGY, V210, P269, DOI 10.1148/radiology.210.1.r99ja46269; Brix G, 2010, EUR J NUCL MED MOL I, V37, pS30, DOI 10.1007/s00259-010-1448-7; Buckley DL., 2005, MEASURING CONTRAST A, P69, DOI [10.1007/3-540-26420-5_5, DOI 10.1007/3-540-26420-5_5]; Bultman EM, 2014, J MAGN RESON IMAGING, V39, P853, DOI 10.1002/jmri.24238; Cunningham SD., 2011, LONGITUDINAL DATA AN, P43; Czabanka M, 2009, INT J CANCER, V124, P1293, DOI 10.1002/ijc.24019; Donahue KM, 1997, JMRI-J MAGN RESON IM, V7, P102, DOI 10.1002/jmri.1880070114; Gordon MJ, 1999, BIOTECHNOL BIOENG, V65, P459, DOI 10.1002/(SICI)1097-0290(19991120)65:4<459::AID-BIT10>3.0.CO;2-O; Haider MA, 2005, INT J RADIAT ONCOL, V62, P1100, DOI 10.1016/j.ijrobp.2004.12.064; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Huang W, 2011, RADIOLOGY, V261, P394, DOI 10.1148/radiol.11102413; Jain R, 2011, AM J NEURORADIOL, V32, P388, DOI 10.3174/ajnr.A2280; Kim YR, 2002, MAGNET RESON MED, V47, P1110, DOI 10.1002/mrm.10175; Koh T S, 2008, IEEE Trans Biomed Eng, V55, P340, DOI 10.1109/TBME.2007.910682; Koh TS, 2011, MAGN RESON MED, V66, P886, DOI 10.1002/mrm.22868; Koh TS, 2011, MAGN RESON MED, V65, P250, DOI 10.1002/mrm.22596; Koh TS, 2008, RADIOLOGY, V249, P307, DOI 10.1148/radiol.2483071958; Koh TS, 2011, J MAGN RESON IMAGING, V34, P1262, DOI 10.1002/jmri.22795; Landis CS, 2000, MAGNET RESON MED, V44, P563, DOI 10.1002/1522-2594(200010)44:4<563::AID-MRM10>3.0.CO;2-#; Landis CS, 1999, MAGNET RESON MED, V42, P467, DOI 10.1002/(SICI)1522-2594(199909)42:3<467::AID-MRM9>3.0.CO;2-0; Larsson HBW, 2001, MAGNET RESON MED, V46, P272, DOI 10.1002/mrm.1188; Larsson HBW, 2009, MAGN RESON MED, V62, P1270, DOI 10.1002/mrm.22136; Li X, 2005, MAGN RESON MED, V54, P1351, DOI [10.1002/mrm.20684, 10.1002/mrm.20864]; Li X, 2010, J MAGN RESON, V206, P190, DOI 10.1016/j.jmr.2010.07.004; Markwardt CB, 2009, ASTR SOC P, V411, P251; Miyazaki K, 2012, RADIOLOGY, V263, P139, DOI 10.1148/radiol.12110770; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; More JJ, 1980, USER GUIDE FOR MINPA; Orton MR, 2008, PHYS MED BIOL, V53, P1225, DOI 10.1088/0031-9155/53/5/005; Osawa Y, 2009, ESSENTIALS OF APOPTOSIS, SECOND EDITION, P547, DOI 10.1007/978-1-60327-381-7_24; Paudyal R, 2013, J MAGN RESON IMAGING, V37, P435, DOI 10.1002/jmri.23837; R Core Team, 2013, R A LANGUAGE AND ENV; Sahani DV, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-51; Simon R, 2007, CANCER INFORM, V3, P11; Simon RM, 2011, BRIEF BIOINFORM, V12, P203, DOI 10.1093/bib/bbr001; Sourbron S, 2007, PHYS MED BIOL, V52, P6761, DOI 10.1088/0031-9155/52/22/014; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; Springer CS, 2014, NMR BIOMED, V27, P760, DOI 10.1002/nbm.3111; St Lawrence KS, 1998, J CEREBR BLOOD F MET, V18, P1365, DOI 10.1097/00004647-199812000-00011; Taouli B, 2013, AM J ROENTGENOL, V201, P795, DOI 10.2214/AJR.12.9798; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Turetschek K, 2004, J MAGN RESON IMAGING, V20, P138, DOI 10.1002/jmri.20049; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu XZ, 2007, J GASTROEN HEPATOL, V22, P1178, DOI 10.1111/j.1440-1746.2007.04997.x; Yankeelov TE, 2003, MAGNET RESON MED, V50, P1151, DOI 10.1002/mrm.10624; Yopp AC, 2011, ANN SURG ONCOL, V18, P2192, DOI 10.1245/s10434-011-1570-1; Zhang J, 2014, MAGN RESON MED, V72, P534, DOI 10.1002/mrm.24927; Zhao YD, 2008, CANCER INFORM, V6, P9; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30; Zhu AX, 2009, J CLIN ONCOL, V27, P3027, DOI 10.1200/JCO.2008.20.9908	55	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136725	10.1371/journal.pone.0136725	http://dx.doi.org/10.1371/journal.pone.0136725			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366997	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100023
J	Chen, JG; Yang, HQ; Zhang, DD; Xu, D; Luo, J; Wang, JF				Chen, Jingan; Yang, Haiquan; Zhang, David Dian; Xu, Dan; Luo, Jing; Wang, Jingfu			A Particular River-Whiting Phenomenon Caused by Discharge of Hypolimnetic Water from a Stratified Reservoir	PLOS ONE			English	Article								A particular river-whiting phenomenon occurred in the early 2000s in the Xiaoche River and since then it has been reoccurring from June to November each year. Residents were surprised by this phenomenon and worried about it. This study was designed to reveal the forming mechanism of the river-whiting phenomenon. A comparison of T, EC, ORP, DO, TDS and delta S-34 in the culvert water and discharge pipe water with that in the water column of Aha Reservoir strongly indicated that the culvert water and discharge pipe water derived primarily from the hypolimnetic reservoir water. When the hypolimnetic water enriched in SO42- and H2S, through seepage from the penstock, flows into the Xiaoche River, the water's supersaturation degree with respect to CaSO4 is increased as a result of increased temperature and DO, thus colloid CaSO4 can be formed. This is the essential cause of the river-whiting phenomenon. The sources of high concentrations of SO42- and H2S in hypolimnetic water include not only direct SO42- and H2S input of acid mine drainage as a result of irrational coal mining in the watershed, but also the sulfur-enriched surface sediments which may release H2S through the sulfate reduction processes. The contaminated sediment has acted as an important contamination source for sulfur to the overlying water in Aha Reservoir. There are more than 50,000 large dams in the world until now. With the increase of reservoir age and the persistent accumulation of pollutants within the reservoir system, discharged hypolimnetic water may contain high levels of pollutants and lead to unpredicted disasters. More investigations are needed to illuminate the water quality condition of discharge water from reservoirs and estimate its impacts on the downstream ecoenvironment.	[Chen, Jingan; Yang, Haiquan; Xu, Dan; Wang, Jingfu] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang 550002, Peoples R China; [Zhang, David Dian] Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China; [Luo, Jing] Guizhou Univ, Coll Resources & Environm Engn, Guiyang 550025, Peoples R China	Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; University of Hong Kong; Guizhou University	Chen, JG (corresponding author), Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang 550002, Peoples R China.	chenjingan@vip.skleg.cn		Yang, Haiquan/0000-0003-4826-8199	Natural Science Foundation of China [U1302231, 41173125]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (Grant Nos. U1302231, 41173125) for data collection and analysis.	Canavan CM, 2000, SCI TOTAL ENVIRON, V260, P159, DOI 10.1016/S0048-9697(00)00560-X; Chen J, 2013, INVESTIGATION REPORT; Chen ZL, 1996, CHINESE SCI BULL, V41, P1359; Cibils Martina L, 2013, J LIMNOL, V72, P79, DOI 10.4081/jlimnol.2013.e7; Feng XB, 2011, APPL GEOCHEM, V26, P213, DOI 10.1016/j.apgeochem.2010.11.021; Guizhou Normal University, 2009, INV REP WHIT TURB WA; Li KF, 2013, ENVIRON REV, V21, P127, DOI 10.1139/er-2012-0051; Luo S, 2003, THESIS CHINESE ACAD; Nichols S, 2006, HYDROBIOLOGIA, V572, P255, DOI 10.1007/s10750-005-0995-6; Petts G.E., 1984, IMPOUNDED RIVERS PER, DOI [10.1177/030913338601000116., DOI 10.1016/0006-3207(85)90110-7]; Qianzhong Morning Post, 2011, QIANZHONG MORNING PO; Rosenberg DM, 2000, BIOSCIENCE, V50, P746, DOI 10.1641/0006-3568(2000)050[0746:GSEEOH]2.0.CO;2; Song LT, 2011, ACTA GEOCHIM, V30, P444, DOI 10.1007/s11631-011-0530-6; Song LT, 2011, CHEM GEOL, V280, P170, DOI 10.1016/j.chemgeo.2010.11.006; Wan G. J., 2001, EARTH SCI FRONTIERS, V8, P353; Wan X, 1997, LAKE SCI, V9, P129; Wang F, 2003, THESIS CHINESE ACAD; Wang Fu-shun, 2005, Huanjing Kexue, V26, P135; Wang Y C, 1998, GEOLOGY GEOCHEMISTRY, V1, p94 ; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; Wu N, 2010, AQUAT SCI, V72, P117, DOI 10.1007/s00027-009-0121-3	21	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137860	10.1371/journal.pone.0137860	http://dx.doi.org/10.1371/journal.pone.0137860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361219	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100096
J	Huang, L; Liu, QF; Zhang, LJ; Zhang, Q; Hu, L; Li, CY; Wang, SN; Li, JN; Zhang, YF; Yu, HB; Wang, Y; Zhong, ZH; Xiong, T; Xia, XS; Wang, XJ; Yu, L; Deng, GH; Cai, XH; Cui, SJ; Weng, CJ				Huang, Li; Liu, Qinfang; Zhang, Lijie; Zhang, Quan; Hu, Liang; Li, Changyao; Wang, Shengnan; Li, Jiangnan; Zhang, Yuanfeng; Yu, Huibin; Wang, Yan; Zhong, Zhaohua; Xiong, Tao; Xia, Xueshan; Wang, Xiaojun; Yu, Li; Deng, Guohua; Cai, Xuehui; Cui, Shangjin; Weng, Changjiang			Encephalomyocarditis Virus 3C Protease Relieves TRAF Family Member-associated NF-kappa B Activator (TANK) Inhibitory Effect on TRAF6-mediated NF-kappa B Signaling through Cleavage of TANK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN; NEGATIVE REGULATOR; PHOSPHORYLATION; EXPRESSION; MECHANISM; APOPTOSIS; RESPONSES; PATHWAY; LIGAND; REGION	TRAF family member-associated NF-kappa B activator (TANK) is a negative regulator of canonical NF-kappa B signaling in the Toll-like receptor-and B-cell receptor-mediated signaling pathways. However, functions of TANK in viral infection-mediated NF-kappa B activation remain unclear. Here, we reported that TANK was cleaved by encephalomyocarditis virus 3C at the 197 and 291 glutamine residues, which depends on its cysteine protease activity. In addition, encephalomyocarditis virus 3C impaired the ability of TANK to inhibit TRAF6-mediated NF-kappa B signaling. Interestingly, we found that several viral proteases encoded by the foot and mouth disease virus, porcine reproductive and respiratory syndrome virus, and equine arteritis virus also cleaved TANK. Our results suggest that TANK is a novel target of some viral proteases, indicating that some positive RNA viruses have evolved to utilize their major proteases to regulate NF-kappa B activation.	[Huang, Li; Liu, Qinfang; Zhang, Lijie; Zhang, Quan; Hu, Liang; Li, Changyao; Wang, Shengnan; Li, Jiangnan; Zhang, Yuanfeng; Yu, Huibin; Wang, Yan; Wang, Xiaojun; Yu, Li; Deng, Guohua; Cai, Xuehui; Cui, Shangjin; Weng, Changjiang] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Heilongjiang, Peoples R China; [Zhang, Quan; Xiong, Tao] Yangtze Univ, Coll Life Sci, Jingzhou 434100, Peoples R China; [Wang, Yan; Xia, Xueshan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650093, Peoples R China; [Zhong, Zhaohua] Harbin Med Univ, Dept Microbiol, Harbin 150081, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Yangtze University; Kunming University of Science & Technology; Harbin Medical University	Cui, SJ (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Heilongjiang, Peoples R China.	cuishangjin@caas.cn; wengcj@hvri.ac.cn	weng, changjiang/HHR-8479-2022; Zhong, Zhaohua/N-1659-2019; Hu, Liang/HHM-7463-2022; YU, HUIBIN/AHB-5025-2022	Zhong, Zhaohua/0000-0002-0778-5053; Hu, Liang/0000-0002-9386-6406; YU, HUIBIN/0000-0002-2430-272X; Huang, Lan/0000-0001-9594-4722; Liu, Qinfang/0000-0003-2930-3892; Wang, Xiaojun/0000-0003-4521-4099	National Natural Science Foundation of China [31172333, 31300139]; State Key Laboratory of Veterinary Biotechnological Foundation [SKLVBP201432]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Veterinary Biotechnological Foundation	This work was supported by the National Natural Science Foundation of China Grants 31172333 and 31300139 (to C. J. W. and L. H.) and State Key Laboratory of Veterinary Biotechnological Foundation Grant SKLVBP201432 (to L. H.). The authors declare that they have no conflict of interest with the contents of this article.	Bonif M, 2006, BIOCHEM J, V394, P593, DOI 10.1042/BJ20051659; Carocci M, 2012, VIRULENCE, V3, P351, DOI 10.4161/viru.20573; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chiu YH, 2009, CHEM REV, V109, P1549, DOI 10.1021/cr800554j; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hall DJ, 1996, J VIROL, V70, P5954, DOI 10.1128/JVI.70.9.5954-5961.1996; Huang C, 2014, J VIROL, V88, P10934, DOI 10.1128/JVI.01396-14; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Jakus PB, 2013, J NUTR BIOCHEM, V24, P819, DOI 10.1016/j.jnutbio.2012.04.017; Jiang JY, 2010, PROTEIN CELL, V1, P1106, DOI 10.1007/s13238-010-0141-8; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kobayashi M, 2012, J VIROL, V86, P10686, DOI 10.1128/JVI.00896-12; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li D, 2013, J VIROL, V87, P2072, DOI 10.1128/JVI.02807-12; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Loiarro M, 2013, CL LYMPH MYELOM LEUK, V13, P222, DOI 10.1016/j.clml.2013.02.003; Loiarro M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/674363; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Loughran G, 2011, P NATL ACAD SCI USA, V108, pE1111, DOI 10.1073/pnas.1102932108; Maruyama K, 2012, J BIOL CHEM, V287, P29114, DOI 10.1074/jbc.M112.347799; Matsumura T, 2003, IMMUNOLOGY, V109, P127, DOI 10.1046/j.1365-2567.2003.01627.x; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Muroi M, 2008, J LEUKOCYTE BIOL, V83, P702, DOI 10.1189/jlb.0907629; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Schwarz EM, 1998, J VIROL, V72, P5654, DOI 10.1128/JVI.72.7.5654-5660.1998; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shi HX, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002057; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Sun JY, 2005, PROTEIN EXPRES PURIF, V42, P122, DOI 10.1016/j.pep.2005.03.009; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Tian XS, 2009, J MOL BIOL, V392, P977, DOI 10.1016/j.jmb.2009.07.062; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Wang D, 2012, J VIROL, V86, P9311, DOI 10.1128/JVI.00722-12; Wang Z, 2012, MOL BIOL REP, V39, P10013, DOI 10.1007/s11033-012-1870-y; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Xue M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-191; Zaragoza C, 2006, P NATL ACAD SCI USA, V103, P19051, DOI 10.1073/pnas.0606019103; Zhang YN, 2011, AUTOPHAGY, V7, P613, DOI 10.4161/auto.7.6.15267; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	54	41	45	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27618	27632		10.1074/jbc.M115.660761	http://dx.doi.org/10.1074/jbc.M115.660761			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26363073	Green Published, hybrid			2022-12-26	WOS:000365757500017
J	Singh, DR; Ahmed, F; King, C; Gupta, N; Salotto, M; Pasquale, EB; Hristova, K				Singh, Deo R.; Ahmed, Fozia; King, Christopher; Gupta, Nisha; Salotto, Matt; Pasquale, Elena B.; Hristova, Kalina			EphA2 Receptor Unliganded Dimers Suppress EphA2 Pro-tumorigenic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; ENERGY-TRANSFER; ACTIVATION; LIGAND; CELLS; DIMERIZATION; EPHRINA1; CONSEQUENCES; INHIBITION; COMPLEXES	Background: The EphA2 receptor tyrosine kinase can promote cell migration and cancer malignancy in the absence of ligand binding. Results: We uncover a correlation between unliganded dimerization and tumorigenic signaling. Conclusion: EphA2 pro-tumorigenic signaling is likely mediated by the EphA2 monomer. Significance: A therapeutic strategy that aims at the stabilization of EphA2 dimers may be beneficial for the treatment of cancers linked to EphA2 overexpression. The EphA2 receptor tyrosine kinase promotes cell migration and cancer malignancy through a ligand- and kinase-independent distinctive mechanism that has been linked to high Ser-897 phosphorylation and low tyrosine phosphorylation. Here, we demonstrate that EphA2 forms dimers in the plasma membrane of HEK293T cells in the absence of ephrin ligand binding, suggesting that the current seeding mechanism model of EphA2 activation is incomplete. We also characterize a dimerization-deficient EphA2 mutant that shows enhanced ability to promote cell migration, concomitant with increased Ser-897 phosphorylation and decreased tyrosine phosphorylation compared with EphA2 wild type. Our data reveal a correlation between unliganded dimerization and tumorigenic signaling and suggest that EphA2 pro-tumorigenic activity is mediated by the EphA2 monomer. Thus, a therapeutic strategy that aims at the stabilization of EphA2 dimers may be beneficial for the treatment of cancers linked to EphA2 overexpression.	[Singh, Deo R.; Ahmed, Fozia; Gupta, Nisha; Salotto, Matt; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [King, Christopher; Hristova, Kalina] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Pasquale, Elena B.] Sanford Burnham Prebys Med Discovery Inst, San Diego, CA 92037 USA	Johns Hopkins University; Johns Hopkins University; Sanford Burnham Prebys Medical Discovery Institute	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 Charles St, Baltimore, MD 21218 USA.	kh@jhu.edu	Regan, Clinton/E-6250-2012; Singh, Deo/AAI-7013-2020; Singh, Deo/J-9773-2017	King, Christopher/0000-0002-2400-5717; Singh, Deo/0000-0001-9027-1813	National Science Foundation [MCB 1157687]; National Science Foundation Graduate Research Fellowship [DGE-1232825]; National Institutes of Health [GM068619, CA138390]; NATIONAL CANCER INSTITUTE [P30CA030199, P01CA138390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB 1157687, National Science Foundation Graduate Research Fellowship DGE-1232825 (to C. K.), and National Institutes of Health Grants GM068619 (to K. H.) and CA138390 (to E. B. P.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; Adler J, 2010, NAT METHODS, V7, P170, DOI 10.1038/nmeth0310-170; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Beauchamp A, 2012, MOL CELL BIOL, V32, P3253, DOI 10.1128/MCB.06791-11; Biener G, 2014, INT J MOL SCI, V15, P261, DOI 10.3390/ijms15010261; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Del Piccolo N, 2015, BIOPHYS J, V108, P272, DOI 10.1016/j.bpj.2014.11.3460; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145; Funk SD, 2012, ARTERIOSCL THROM VAS, V32, P686, DOI 10.1161/ATVBAHA.111.242792; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; Liu Y, 2014, NUCL MED BIOL, V41, P450, DOI 10.1016/j.nucmedbio.2014.03.020; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Miao H, 2015, ONCOGENE, V34, P558, DOI 10.1038/onc.2013.590; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Miura K, 2009, MOL BIOL CELL, V20, P1949, DOI 10.1091/mbc.E08-06-0549; Nasreen N, 2007, CANCER LETT, V258, P215, DOI 10.1016/j.canlet.2007.09.005; Paraiso KHT, 2015, CANCER DISCOV, V5, P264, DOI 10.1158/2159-8290.CD-14-0293; Parmryd I, 2013, FEBS J, V280, P2775, DOI 10.1111/febs.12209; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pratt RL, 2002, ONCOGENE, V21, P7690, DOI 10.1038/sj.onc.1205758; Raicu V, 2007, J BIOL PHYS, V33, P109, DOI 10.1007/s10867-007-9046-z; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Rong BX, 2011, CURR CANCER DRUG TAR, V11, P1082, DOI 10.2174/156800911798073050; Sarabipour S, 2015, J MOL BIOL, V427, P1705, DOI 10.1016/j.jmb.2015.02.013; Schick S, 2010, BIOPHYS J, V99, P1810, DOI 10.1016/j.bpj.2010.07.026; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Wakayama Y, 2011, J BIOL CHEM, V286, P44243, DOI 10.1074/jbc.M111.267047; Wimmer-Kleikamp SH, 2008, BLOOD, V112, P721, DOI 10.1182/blood-2007-11-121681; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110	42	44	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27271	27279		10.1074/jbc.M115.676866	http://dx.doi.org/10.1074/jbc.M115.676866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26363067	hybrid, Green Published			2022-12-26	WOS:000364794000035
J	Kerbert, AJC; Verbeke, L; Chiang, FWT; Laleman, W; van der Reijden, JJ; van Duijn, W; Nevens, F; Wolterbeek, R; van Hoek, B; Verspaget, HW; Coenraad, MJ				Kerbert, Annarein J. C.; Verbeke, Len; Chiang, Fang W. T.; Laleman, Wim; van der Reijden, Johan J.; van Duijn, Wim; Nevens, Frederik; Wolterbeek, Ron; van Hoek, Bart; Verspaget, Hein W.; Coenraad, Minneke J.			Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis	PLOS ONE			English	Article							ANTIDIURETIC-HORMONE; HEPATORENAL-SYNDROME; PIG PITUITARIES; PLASMA COPEPTIN; POSTERIOR LOBE; RENAL-FUNCTION; GLYCOPEPTIDE; MODEL; VASOPRESSIN; DIAGNOSIS	Background Advanced liver cirrhosis is associated with systemic hemodynamic derangement leading to the development of severe complications associated with increased mortality. Copeptin is a stable cleavage product of the precursor of arginine vasopressin, a key-regulator in hemodynamic homeostasis. Copeptin is currently considered a reliable prognostic marker in a wide variety of diseases other than cirrhosis. The present study aimed to assess copeptin, both experimentally and clinically, as a potential biomarker of hemodynamic derangement and to evaluate its prognostic significance in cirrhosis. Materials and Methods Two studies were executed: 1) in 18 thioacetamide-induced cirrhotic rats and 5 control rats, plasma copeptin and hemodynamic measurements were performed, 2) in 61 cirrhotic patients, serum copeptin concentration was measured in samples collected at time of registration at the waiting list for liver transplantation. In 46 patients, also a second copeptin measurement was performed during follow-up while registered at the waiting list for liver transplantation. To determine the association of serum copeptin and clinical data with outcome, Cox proportional hazard regression analysis and Kaplan Meier analysis were performed. Results Plasma copeptin concentration was significantly higher in cirrhotic rats than in controls (1.6 +/- 0.5 vs. 0.9 +/- 0.1 pmol/L, p< 0.01) and was negatively correlated to the mean arterial blood pressure (r = -0.574, p = 0.013). In cirrhotic patients, serum copeptin concentration was high [11.0 (5.2-24.0) pmol/L] and increased significantly during the time of registration at the waiting list for liver transplantation. MELD and MELD-sodium score were significantly correlated to serum copeptin [MELD: (r = 0.33, p = 0.01), MELD-sodium: (r = 0.29, p = 0.02)], also at time of the second copeptin measurement [MELD and MELD-sodium: r = 0.39, p< 0.01]. In cirrhotic humans, serum copeptin concentration was significantly associated with outcome, independently of the MELD and MELD-sodium score. Patients with a low serum copeptin concentration at time of registration at the liver transplant waiting list had significantly better transplant-free survival rates at 3, 6 and 12 months of follow-up as compared to those with a high serum copeptin concentration (Log-rank: p< 0.01, p< 0.01 and p = 0.02 respectively). Conclusions Circulating copeptin levels are elevated in rats and humans with cirrhosis. Copeptin is independently associated with outcome in cirrhotic patients awaiting liver transplantation.	[Kerbert, Annarein J. C.; Chiang, Fang W. T.; van der Reijden, Johan J.; van Duijn, Wim; van Hoek, Bart; Verspaget, Hein W.; Coenraad, Minneke J.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Verbeke, Len; Laleman, Wim; Nevens, Frederik] Univ Hosp Gasthuisberg, Dept Liver & Biliopancreat Dis, Leuven, Belgium; [Wolterbeek, Ron] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; KU Leuven; University Hospital Leuven; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kerbert, AJC (corresponding author), Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands.	j.c.kerbert@lumc.nl; rn.j.coenraad@lumc.nl	van Hoek, Bart/AAU-8953-2020; Coenraad, Minneke/AAU-1684-2020; Kerbert, J.C./AAN-7747-2020; Laleman, Wim/H-7272-2019	Coenraad, Minneke/0000-0002-3434-4421; Kerbert, J.C./0000-0001-9845-2176; Laleman, Wim/0000-0002-0842-7813; van Hoek, Bart/0000-0001-6527-764X	Leiden University Medical Center [8219-70550]	Leiden University Medical Center	Support was provided by a research grant from the Leiden University Medical Center (number: 8219-70550). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balanescu S, 2011, J CLIN ENDOCR METAB, V96, P1046, DOI 10.1210/jc.2010-2499; BAUMANN G, 1976, J CLIN INVEST, V57, P1109, DOI 10.1172/JCI108377; Bhandari SS, 2009, CLIN SCI, V116, P257, DOI 10.1042/CS20080140; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; BOSCH J, 1980, GASTROENTEROLOGY, V78, P92; Dobsa L, 2013, BIOCHEM MEDICA, V23, P172, DOI 10.11613/BM.2013.021; Fernandez-Esparrach G, 2001, J HEPATOL, V34, P46, DOI 10.1016/S0168-8278(00)00011-8; GINES A, 1993, GASTROENTEROLOGY, V105, P229, DOI 10.1016/0016-5085(93)90031-7; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; HOLWERDA DA, 1972, EUR J BIOCHEM, V28, P340, DOI 10.1111/j.1432-1033.1972.tb01919.x; HOLWERDA DA, 1972, EUR J BIOCHEM, V28, P334, DOI 10.1111/j.1432-1033.1972.tb01918.x; Kimer N, 2014, EUR J CLIN INVEST, V44, P441, DOI 10.1111/eci.12249; Krag A, 2010, GUT, V59, P105, DOI 10.1136/gut.2009.180570; Laleman W, 2006, EUR J CLIN INVEST, V36, P242, DOI 10.1111/j.1365-2362.2006.01620.x; Lippi G, 2012, CLIN CHEM LAB MED, V50, P243, DOI 10.1515/cclm-2011-0845; LLACH J, 1988, GASTROENTEROLOGY, V94, P482, DOI 10.1016/0016-5085(88)90441-6; Miller WL, 2013, AM J CARDIOL, V111, P880, DOI 10.1016/j.amjcard.2012.11.053; Montgomery A, 2005, CARDIOVASC INTER RAD, V28, P307, DOI 10.1007/s00270-004-0145-y; Moreno JP, 2013, LIVER INT, V33, P843, DOI 10.1111/liv.12175; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Neuhold S, 2008, J AM COLL CARDIOL, V52, P266, DOI 10.1016/j.jacc.2008.03.050; Nigro N, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13270; Przybylowski P, 2010, TRANSPL P, V42, P1808, DOI 10.1016/j.transproceed.2010.03.138; ROBERTSON GL, 1976, J CLIN ENDOCR METAB, V42, P613, DOI 10.1210/jcem-42-4-613; Robertson GL, 2001, ENDOCRIN METAB CLIN, V30, P671, DOI 10.1016/S0889-8529(05)70207-3; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; SMYTH DG, 1979, BIOCHEM BIOPH RES CO, V87, P1006, DOI 10.1016/S0006-291X(79)80007-8; Szinnai G, 2007, J CLIN ENDOCR METAB, V92, P3973, DOI 10.1210/jc.2007-0232; von Haehling S, 2012, INT J CARDIOL, V162, P27, DOI 10.1016/j.ijcard.2011.12.105; Wiese S, 2014, LIVER INT, V34, pE19, DOI 10.1111/liv.12428; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	32	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2015	10	9							e0138264	10.1371/journal.pone.0138264	http://dx.doi.org/10.1371/journal.pone.0138264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0RH	26378453	Green Published, Green Submitted, gold			2022-12-26	WOS:000361769400076
J	Bagcioglu, M; Zimmermann, B; Kohler, A				Bagcioglu, Murat; Zimmermann, Boris; Kohler, Achim			A Multiscale Vibrational Spectroscopic Approach for Identification and Biochemical Characterization of Pollen	PLOS ONE			English	Article							MULTIPLICATIVE SIGNAL CORRECTION; RAMAN; IR; MICROSPECTROSCOPY; QUANTIFICATION; DISCRIMINATION; CLASSIFICATION; SPECTRA; TOOL	Background Analysis of pollen grains reveals valuable information on biology, ecology, forensics, climate change, insect migration, food sources and aeroallergens. Vibrational (infrared and Raman) spectroscopies offer chemical characterization of pollen via identifiable spectral features without any sample pretreatment. We have compared the level of chemical information that can be obtained by different multiscale vibrational spectroscopic techniques. Methodology Pollen from 15 different species of Pinales (conifers) were measured by seven infrared and Raman methodologies. In order to obtain infrared spectra, both reflectance and transmission measurements were performed on ground and intact pollen grains (bulk measurements), in addition, infrared spectra were obtained by microspectroscopy of multigrain and single pollen grain measurements. For Raman microspectroscopy measurements, spectra were obtained from the same pollen grains by focusing two different substructures of pollen grain. The spectral data from the seven methodologies were integrated into one data model by the Consensus Principal Component Analysis, in order to obtain the relations between the molecular signatures traced by different techniques. Results The vibrational spectroscopy enabled biochemical characterization of pollen and detection of phylogenetic variation. The spectral differences were clearly connected to specific chemical constituents, such as lipids, carbohydrates, carotenoids and sporopollenins. The extensive differences between pollen of Cedrus and the rest of Pinaceae family were unambiguously connected with molecular composition of sporopollenins in pollen grain wall, while pollen of Picea has apparently higher concentration of carotenoids than the rest of the family. It is shown that vibrational methodologies have great potential for systematic collection of data on ecosystems and that the obtained phylogenetic variation can be well explained by the biochemical composition of pollen. Out of the seven tested methodologies, the best taxonomical differentiation of pollen was obtained by infrared measurements on bulk samples, as well as by Raman microspectroscopy measurements of the corpus region of the pollen grain. Raman microspectroscopy measurements indicate that measurement area, as well as the depth of focus, can have crucial influence on the obtained data.	[Bagcioglu, Murat; Zimmermann, Boris; Kohler, Achim] Norwegian Univ Life Sci, Fac Environm Sci & Technol, Dept Math Sci & Technol, As, Norway; [Kohler, Achim] Nofima AS, As, Norway	Norwegian University of Life Sciences; Nofima	Bagcioglu, M (corresponding author), Norwegian Univ Life Sci, Fac Environm Sci & Technol, Dept Math Sci & Technol, As, Norway.	murat.bagcioglu@nmbu.no	Zimmermann, Boris/N-8297-2014; Bağcıoğlu, Murat/N-7791-2019; Zimmermann, Boris/GVS-6235-2022; Bağcıoğlu, Murat/P-5549-2014	Zimmermann, Boris/0000-0001-5046-520X; Bağcıoğlu, Murat/0000-0003-0575-9246; Zimmermann, Boris/0000-0001-5046-520X; Bağcıoğlu, Murat/0000-0003-0575-9246; Kohler, Achim/0000-0001-5759-1989	European Commission [328289]; Ministry of Education, Sciences and Sports of the Republic of Croatia [098-0982904-2927]; Nofima AS	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Education, Sciences and Sports of the Republic of Croatia; Nofima AS(Nofima)	This work was supported by the European Commission through the Seventh Framework Programme (FP7-PEOPLE-2012-IEF project No. 328289) (BZ,AK); The Ministry of Education, Sciences and Sports of the Republic of Croatia (project No. 098-0982904-2927) (BZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nofima AS provided support in the form of a salary for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "Author Contributions" section.	Afseth NK, 2012, CHEMOMETR INTELL LAB, V117, P92, DOI 10.1016/j.chemolab.2012.03.004; Benton M. J., 2009, INTRO PALEOBIOLOGY F, P608; Blokker P, 2006, PLANT ECOL, V182, P197, DOI 10.1007/s11258-005-9026-y; Bocker U, 2007, APPL SPECTROSC, V61, P1032, DOI 10.1366/000370207782217707; Boyain-Goitia AR, 2003, APPL OPTICS, V42, P6119, DOI 10.1364/AO.42.006119; de Oliveira VE, 2010, J RAMAN SPECTROSC, V41, P642, DOI 10.1002/jrs.2493; Dell'Anna R, 2009, ANAL BIOANAL CHEM, V394, P1443, DOI 10.1007/s00216-009-2794-9; Fraser WT, 2012, NEW PHYTOL, V196, P397, DOI 10.1111/j.1469-8137.2012.04301.x; Garcia-Asua G, 1998, TRENDS PLANT SCI, V3, P445, DOI 10.1016/S1360-1385(98)01329-6; Glauser AL, 2014, REV PALAEOBOT PALYNO, V210, P62, DOI 10.1016/j.revpalbo.2014.07.005; Gottardini E, 2007, AEROBIOLOGIA, V23, P211, DOI 10.1007/s10453-007-9065-z; Hassani S, 2010, CHEMOMETR INTELL LAB, V104, P140, DOI 10.1016/j.chemolab.2010.08.008; Ivleva NP, 2005, ANAL BIOANAL CHEM, V381, P261, DOI 10.1007/s00216-004-2942-1; Kano H, 2006, CHEM LETT, V35, P1124, DOI 10.1246/cl.2006.1124; Karaman I, 2015, METABOLOMICS, V11, P367, DOI 10.1007/s11306-014-0698-y; Kohler A, 2005, APPL SPECTROSC, V59, P707, DOI 10.1366/0003702054280649; Kohler A, 2007, INTERPRETING SEVERAL, P333; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Lomax BH, 2012, EARTH PLANET SC LETT, V353, P22, DOI 10.1016/j.epsl.2012.07.039; Lukacs R, 2015, ANALYST, V140, P3273, DOI [10.1039/c5an00401b, 10.1039/C5AN00401B]; Martens H., 1992, MULTIVARIATE CALIBRA; MERLIN JC, 1985, PURE APPL CHEM, V57, P785, DOI 10.1351/pac198557050785; Mirabella Francis M. Jr., 1993, V15, P17; Mularczyk-Oliwa M, 2012, SPECTROCHIM ACTA A, V97, P246, DOI 10.1016/j.saa.2012.05.063; Newsham KK, 2009, GLOBAL CHANGE BIOL, V15, P2574, DOI 10.1111/j.1365-2486.2009.01944.x; Pappas CS, 2003, APPL SPECTROSC, V57, P23, DOI 10.1366/000370203321165160; Perisic N, 2013, FOOD CHEM, V138, P679, DOI 10.1016/j.foodchem.2012.10.117; Pummer BG, 2013, J RAMAN SPECTROSC, V44, P1654, DOI 10.1002/jrs.4395; Robledo-Arnuncio JJ, 2005, HEREDITY, V94, P13, DOI 10.1038/sj.hdy.6800542; Schulte F, 2008, ANAL CHEM, V80, P9551, DOI 10.1021/ac801791a; Sivaguru M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039129; Terrab A, 2008, AM J BOT, V95, P1262, DOI 10.3732/ajb.0800010; Westerhuis JA, 1998, J CHEMOMETR, V12, P301, DOI 10.1002/(SICI)1099-128X(199809/10)12:5<301::AID-CEM515>3.0.CO;2-S; Willis KJ, 2011, NEW PHYTOL, V192, P553, DOI 10.1111/j.1469-8137.2011.03815.x; Zimmermann B, 2015, PLANTA, V242, P1237, DOI 10.1007/s00425-015-2380-7; Zimmermann B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124240; Zimmermann B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095417; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723; Zimmermann B, 2010, APPL SPECTROSC, V64, P1364, DOI 10.1366/000370210793561664; Zuk M, 2011, SPECTROCHIM ACTA A, V78, P1080, DOI 10.1016/j.saa.2010.12.054	40	45	46	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137899	10.1371/journal.pone.0137899	http://dx.doi.org/10.1371/journal.pone.0137899			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376486	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000361610200059
J	Lopes-Pires, ME; Naime, ACA; Cardelli, NJA; Anjos, DJ; Antunes, E; Marcondes, S				Elisa Lopes-Pires, M.; Antunes Naime, Ana C.; Almeida Cardelli, Nadia J.; Anjos, Debora J.; Antunes, Edson; Marcondes, Sisi			PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INTACT HUMAN PLATELETS; PROTEIN-KINASE-C; PHOSPHORYLATION; SRC; LIPOPOLYSACCHARIDE; ADHESION; ACTIVATION; ALPHA-IIB-BETA-3; INHIBITION	Sepsis severity has been positively correlated with platelet dysfunction, which may be due to elevations in nitric oxide (NO) and cGMP levels. Protein kinase C, Src kinases, PI3K and AKT modulate platelet activity in physiological conditions, but no studies evaluated the role of these enzymes in platelet aggregation in sepsis. In the present study we tested the hypothesis that in sepsis these enzymes positively modulate upstream the NO-cGMP pathway resulting in platelet inhibition. Rats were injected with lipopolysaccharide (LPS, 1 mg/kg, i.p.) and blood was collected after 6 h. Platelet aggregation was induced by ADP (10 mu M). Western blotting assays were carried out to analyze c-Src and AKT activation in platelets. Intraplatelet cGMP levels were determined by enzyme immunoassay kit. Phosphorylation of c-SRC at Tyr416 was the same magnitude in platelets of control and LPS group. Incubation of the non-selective Src inhibitor PP2 (10 mu M) had no effect on platelet aggregation of LPS-treated rats. LPS increased intraplatelet cGMP levels by 5-fold compared with control group, which was accompanied by 76% of reduction in ADP-induced platelet aggregation. The guanylyl cyclase inhibitor ODQ (25 mu M) and the PKG inhibitor Rp-8-Br-PETcGMPS (25 mu M) fully reversed the inhibitory effect of LPS on platelet aggregation. Likewise, the PKC inhibitor GF109203X (10 mu M) reversed the inhibition by LPS of platelet aggregation and decreased cGMP levels in platelets. AKT phosphorylation at Thr308 was significantly higher in platelets of LPS compared with control group, which was not reduced by PI3K inhibition. The AKT inhibitor API-1 (20 mu M) significantly increased aggregation and reduced cGMP levels in platelets of LPS group. However, the PI3K inhibitor wortmannin and LY29004 had no effect on platelet aggregation of LPS-treated rats. Therefore, inhibition of ADP-induced platelet aggregation after LPS injection is mediated by cGMP/PKG-dependent mechanisms, and PKC and AKT act upstream upregulating this pathway.	[Elisa Lopes-Pires, M.; Antunes Naime, Ana C.; Almeida Cardelli, Nadia J.; Anjos, Debora J.; Antunes, Edson; Marcondes, Sisi] Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil	Universidade Estadual de Campinas	Marcondes, S (corresponding author), Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil.	sisimp@fcm.unicamp.br	ANTUNES, EDSON/F-6731-2012	ANTUNES, EDSON/0000-0003-2201-8247	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/17003-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	S. Marcondes received a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grant 2010/17003-4). M.E. Lopes Pires received a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP).	Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11816; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Bergandi L, 2010, CLIN RES CARDIOL, V99, P557, DOI 10.1007/s00392-010-0157-3; Butt E, 2001, J BIOL CHEM, V276, P7108, DOI 10.1074/jbc.M009234200; Cavallini L, 1996, J BIOL CHEM, V271, P5545, DOI 10.1074/jbc.271.10.5545; Chung SH, 2000, J BIOL CHEM, V275, P25286, DOI 10.1074/jbc.M004204200; Cicala C, 1996, LIFE SCI, V60, pPL31, DOI 10.1016/S0024-3205(96)00607-8; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dong HP, 2005, SHOCK, V24, P239, DOI 10.1097/01.shk.0000174019.10311.80; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Lopes-Pires ME, 2012, PLATELETS, V23, P195, DOI 10.3109/09537104.2011.603065; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Galler AB, 2006, HISTOCHEM CELL BIOL, V125, P457, DOI 10.1007/s00418-005-0091-z; Gambaryan S, 2008, J THROMB HAEMOST, V6, P1376, DOI 10.1111/j.1538-7836.2008.03014.x; Gratacap MP, 2011, ADV ENZYME REGUL, V51, P106, DOI 10.1016/j.advenzreg.2010.09.011; Hartwig J H, 1997, Curr Opin Hematol, V4, P351; HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Jackson SP, 2004, BIOCHEM SOC T, V32, P387, DOI 10.1042/BST0320387; Kim D, 2010, J BIOL CHEM, V285, P8383, DOI 10.1074/jbc.M109.094060; Kim S, 2011, J BIOL CHEM, V286, P24170, DOI 10.1074/jbc.M110.212274; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lin WN, 2008, TOXICOL APPL PHARM, V228, P256, DOI 10.1016/j.taap.2007.11.026; Liu J, 2008, J THROMB HAEMOST, V6, P1035, DOI 10.1111/j.1538-7836.2008.02958.x; Liu YQ, 2013, BIOCHEM PHARMACOL, V86, P914, DOI 10.1016/j.bcp.2013.07.009; Lu WJ, 2014, THROMB RES, V133, P1088, DOI 10.1016/j.thromres.2014.03.042; Lundahl TH, 1998, PLATELETS, V9, P223, DOI 10.1080/09537109876735; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Monti M, 2010, J MOL CELL CARDIOL, V48, P746, DOI 10.1016/j.yjmcc.2009.11.002; Naseem KM, 2008, J THROMB HAEMOST, V6, P1373, DOI 10.1111/j.1538-7836.2008.03035.x; Newman DK, 2009, J THROMB HAEMOST, V7, P195, DOI 10.1111/j.1538-7836.2009.03369.x; Niu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047356; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Ognibene DT, 2010, HYPERTENS RES, V33, P899, DOI 10.1038/hr.2010.102; Polgar J, 2003, J BIOL CHEM, V278, P44369, DOI 10.1074/jbc.M307864200; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P5193, DOI 10.1073/pnas.87.13.5193; Riba R, 2006, J THROMB HAEMOST, V4, P2636, DOI 10.1111/j.1538-7836.2006.02195.x; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318; Signorello MG, 2011, CURR NEUROVASC RES, V8, P200; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Smolinska MJ, 2008, MOL IMMUNOL, V45, P990, DOI 10.1016/j.molimm.2007.07.026; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; Yaguchi A, 2004, J THROMB HAEMOST, V2, P2096, DOI 10.1111/j.1538-7836.2004.01009.x; Yamakawa K, 2013, J TRAUMA ACUTE CARE, V74, P411, DOI 10.1097/TA.0b013e31827a34cf; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296	52	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0137901	10.1371/journal.pone.0137901	http://dx.doi.org/10.1371/journal.pone.0137901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375024	Green Submitted, Green Published, gold			2022-12-26	WOS:000361610200060
J	Fuchs, SC; Pakter, HM; Maestri, MK; Beltrami-Moreira, M; Gus, M; Moreira, LB; Oliveira, MM; Fuchs, FD				Fuchs, Sandra C.; Pakter, Helena M.; Maestri, Marcelo K.; Beltrami-Moreira, Marina; Gus, Miguel; Moreira, Leila B.; Oliveira, Manuel M.; Fuchs, Flavio D.			Are Retinal Vessels Calibers Influenced by Blood Pressure Measured at the Time of Retinography Acquisition?	PLOS ONE			English	Article							VASCULAR CALIBER; MICROVASCULAR ABNORMALITIES; VENULAR DIAMETER; ARTERIOLAR; RISK; HYPERTENSION; ASSOCIATION; POPULATION; RATIO; METAANALYSIS	Background Retinal arterial narrowing is associated with higher office blood pressure (BP) and ambulatory blood pressure monitoring, and increased incidence of cardiovascular disease, but it is still unknown if the vessel caliber is associated with BP measured at the time of retinography acquisition. Methods Retinal arteriolar and venular calibers were measured by the microdensitometric method in 448 patients with hypertension. Participants underwent 24-hours ambulatory blood pressure (24-h ABP) monitoring simultaneously with the retinography acquisition. Association between arteriolar and venular calibers with increase of 10 mmHg in the mean 24-hours, daily, and nightly BP, and with BP measured at the time of retinography, was evaluated by ANOVA and multivariate analyses. Results Mean 24-hours, daytime and nighttime systolic and diastolic BP were inversely associated with the arteriolar caliber, but not with the venular caliber. Arteriolar caliber decreased -0.8 (95% CI -1.4 to -0.2) mu m per 10-mmHg increase in 24-hours mean systolic BP, adjusted for age, gender, fellow vessel, and duration of hypertension (P = 0.01). The corresponding decreasing in arteriolar caliber by 10 mmHg of increasing in mean diastolic BP was -1.1 mu m(-2.0 to -0.2, P = 0.02). The decrease of arteriolar caliber by the same increasing of BP measured at the time of retinography was lower and not statistically significant, particularly for mean diastolic BP and outer arterioles calibers: -1.0 (-1.8 to -0.2) mu m in the daytime BP average versus -0.3 (-0.9 to 0.3) at the moment of retinography acquisition. Conclusions These findings suggest that the caliber of arteriolar retinal vessels in patients with uncontrolled hypertension are not significantly influenced by blood pressure measured at the time of retinography acquisition.	[Fuchs, Sandra C.; Pakter, Helena M.; Moreira, Leila B.] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Epidemiol, BR-90035003 Porto Alegre, RS, Brazil; [Fuchs, Sandra C.; Beltrami-Moreira, Marina; Gus, Miguel; Moreira, Leila B.; Fuchs, Flavio D.] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Cardiol, BR-90035003 Porto Alegre, RS, Brazil; [Fuchs, Sandra C.; Beltrami-Moreira, Marina; Gus, Miguel; Moreira, Leila B.; Fuchs, Flavio D.] Univ Fed Rio Grande do Sul, HCPA, BR-90035003 Porto Alegre, RS, Brazil; [Maestri, Marcelo K.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Ophthalmol, BR-90035003 Porto Alegre, RS, Brazil; [Oliveira, Manuel M.] Univ Fed Rio Grande do Sul, Inst Informat, BR-91501970 Porto Alegre, RS, Brazil; [Fuchs, Flavio D.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, CNPq, Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Fuchs, SC (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Epidemiol, R Ramiro Barcelos 2600, BR-90035003 Porto Alegre, RS, Brazil.	scfuchs@terra.com.br	Beltrami Moreira, Marina/AGW-5591-2022; MOREIRA, LEILA LEILA B/AAC-2240-2019; Oliveira, Manuel M/H-1508-2011; Fuchs, Sandra C/T-2670-2019; Fuchs, Flávio D/L-5078-2016; Beltrami Moreira, Marina/ADG-6570-2022	Beltrami Moreira, Marina/0000-0001-7449-9789; MOREIRA, LEILA LEILA B/0000-0002-4730-7988; Oliveira, Manuel M/0000-0003-4957-9984; Messinger Pakter, Helena/0000-0003-4569-116X; fuchs, flavio/0000-0002-1191-0523	National Counsel of Technological and Scientific Development (CNPq) [485831/2007-4]; Brazilian Federal Agency for the Improvement of Higher Education (CAPES); Hospital de Cl~nicas de Porto Alegre-FIPE [GPPG 04-465]; CNPq fellowship [305613/2007-3]	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for the Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Hospital de Cl~nicas de Porto Alegre-FIPE; CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by National Counsel of Technological and Scientific Development (CNPq, Grant number: 485831/2007-4), the Brazilian Federal Agency for the Improvement of Higher Education (CAPES) and the Hospital de Cl~nicas de Porto Alegre-FIPE (Protocol GPPG 04-465), RS, Brazil. Manuel M. Oliveira acknowledges a CNPq fellowship (305613/2007-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Ding J, 2014, J HYPERTENS, V32, P207, DOI 10.1097/HJH.0b013e32836586f4; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Duncan BB, 2002, BRIT J OPHTHALMOL, V86, P1002, DOI 10.1136/bjo.86.9.1002; Fuchs SC, 2012, J HYPERTENS, V30, P75, DOI 10.1097/HJH.0b013e32834e5a4f; Garcia-Ortiz L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006144; Grosso A, 2006, BLOOD PRESSURE, V15, P308, DOI 10.1080/08037050600996792; Hatanaka Y, 2005, P ANN INT IEEE EMBS, P286, DOI 10.1109/IEMBS.2005.1616400; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, HYPERTENSION, V47, P189, DOI 10.1161/01.HYP.0000199104.61945.33; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Kawasaki R, 2009, J HYPERTENS, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; Keith NM, 1939, AM J MED SCI, V197, P332, DOI 10.1097/00000441-193903000-00006; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; LATIES AM, 1967, ARCH OPHTHALMOL-CHIC, V77, P405, DOI 10.1001/archopht.1967.00980020407021; Li HQ, 2005, IEEE T BIO-MED ENG, V52, P1352, DOI 10.1109/TBME.2005.847402; Liew G, 2007, INVEST OPHTH VIS SCI, V48, P52, DOI 10.1167/iovs.06-0672; Maestri MM, 2007, AM J HYPERTENS, V20, P501, DOI 10.1016/j.amjhyper.2006.10.012; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; Pakter HM, 2011, INVEST OPHTH VIS SCI, V52, P810, DOI 10.1167/iovs.10-5876; Pakter HM, 2005, AM J HYPERTENS, V18, P417, DOI 10.1016/j.amjhyper.2004.10.011; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Pose-Reino A, 2005, J HYPERTENS, V23, P843, DOI 10.1097/01.hjh.0000163154.35577.8e; Relan D, 2014, IEEE ENG MED BIO, P142, DOI 10.1109/EMBC.2014.6943549; Ruggeri A, 2007, P ANN INT IEEE EMBS, P6464; Salvetti M, 2014, HYPERTENSION, V63, P1110, DOI 10.1161/HYPERTENSIONAHA.113.03004; Smith W, 2004, HYPERTENSION, V44, P442, DOI 10.1161/01.HYP.0000140772.40322.ec; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Tanabe Y, 2010, MICROCIRCULATION, V17, P94, DOI 10.1111/j.1549-8719.2009.00006.x; Torres FS, 2013, ATHEROSCLEROSIS, V229, P134, DOI 10.1016/j.atherosclerosis.2013.04.019; Tramontan L, 2011, IEEE T BIO-MED ENG, V58, P818, DOI 10.1109/TBME.2010.2085001; Tramontan L, 2008, IEEE ENG MED BIO, P3550, DOI 10.1109/IEMBS.2008.4649972; Triantafyllou A, 2014, AM J HYPERTENS, V27, P1472, DOI 10.1093/ajh/hpu074; Trucco E., 2015, BIOMEDICAL IMAGE UND; Trucco E, 2013, 4 IEEE BIOS BIOR C I; Wang JJ, 2008, AM J EPIDEMIOL, V168, P80, DOI 10.1093/aje/kwn100; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2004, BMJ-BRIT MED J, V329, P79, DOI 10.1136/bmj.38124.682523.55; Wong TY, 2004, AM J OPHTHALMOL, V137, P1050, DOI 10.1016/j.ajo.2004.01.035; Wong TY, 2004, ANN INTERN MED, V140, P248, DOI 10.7326/0003-4819-140-4-200402170-00006; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Zhu PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106551	44	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0136678	10.1371/journal.pone.0136678	http://dx.doi.org/10.1371/journal.pone.0136678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26375034	Green Published, gold			2022-12-26	WOS:000361610200021
J	Nigam, N; Grover, A; Goyal, S; Katiyar, SP; Bhargava, P; Wang, PC; Sundar, D; Kaul, SC; Wadhwa, R				Nigam, Nupur; Grover, Abhinav; Goyal, Sukriti; Katiyar, Shashank P.; Bhargava, Priyanshu; Wang, Pi-Chao; Sundar, Durai; Kaul, Sunil C.; Wadhwa, Renu			Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells	PLOS ONE			English	Article							BAX CONFORMATIONAL-CHANGE; TRAIL-INDUCED APOPTOSIS; XIAP INHIBITOR EMBELIN; MITOCHONDRIAL PATHWAY; HEPATOCELLULAR-CARCINOMA; HUMAN CARCINOGENESIS; GLUCOSE DEPRIVATION; LINKED INHIBITOR; DIABETIC-RATS; UP-REGULATION	Embelin, a natural quinone found in the fruits of Embelia ribes, is commonly used in Ayurvedic home medicine for a variety of therapeutic potentials including anti-inflammation, antifever, anti-bacteria and anti-cancer. Molecular mechanisms of these activities and cellular targets have not been clarified to-date. We demonstrate that the embelin inhibits mortalin-p53 interactions, and activates p53 protein in tumor cells. We provide bioinformatics, molecular docking and experimental evidence to the binding affinity of embelin with mortalin and p53. Binding of embelin with mortalin/p53 abrogates their complex resulted in nuclear translocation and transcriptional activation function of p53 causing growth arrest in cancer cells. Furthermore, analyses of growth factors and metastatic signaling using antibody membrane array revealed their downregulation in embelin-treated cells. We also found that the embelin causes transcriptional attenuation of mortalin and several other proteins involved in metastatic signaling in cancer cells. Based on these molecular dynamics and experimental data, it is concluded that the anticancer activity of embelin involves targeting of mortalin, activation of p53 and inactivation of metastatic signaling.	[Nigam, Nupur; Bhargava, Priyanshu; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, DBT AIST Int Lab Adv Biomed DAILAB, Drug Discovery & Assets Innovat Lab, Tsukuba, Ibaraki, Japan; [Nigam, Nupur; Bhargava, Priyanshu; Wang, Pi-Chao] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Grover, Abhinav; Goyal, Sukriti] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Katiyar, Shashank P.; Sundar, Durai] Indian Inst Technol IIT Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Jawaharlal Nehru University, New Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, DBT AIST Int Lab Adv Biomed DAILAB, Drug Discovery & Assets Innovat Lab, Tsukuba, Ibaraki, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Bhargava, Priyanshu/AAQ-1548-2020; Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192; bhargava, priyanshu/0000-0003-3598-4890; Katiyar, Shashank/0000-0002-8496-5103; Sundar, Durai/0000-0002-6549-6663	National Institute of Advanced Industrial Science & Technology (AIST) Special Research Grant	National Institute of Advanced Industrial Science & Technology (AIST) Special Research Grant	The study was supported by National Institute of Advanced Industrial Science & Technology (AIST) Special Research Grant.	Ahn KS, 2007, MOL PHARMACOL, V71, P209, DOI 10.1124/mol.106.028787; Aird KM, 2008, MOL CANCER THER, V7, P38, DOI 10.1158/1535-7163.MCT-07-0370; Ando K, 2014, GASTRIC CANCER, V17, P255, DOI 10.1007/s10120-013-0279-1; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bolton EE, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-32; Chen J, 2014, INT J ONCOL, V44, P247, DOI 10.3892/ijo.2013.2161; Chen X, 2011, ANAT REC, V294, P1344, DOI 10.1002/ar.21433; Cheng YJ, 2010, EUR J PHARMACOL, V627, P75, DOI 10.1016/j.ejphar.2009.11.003; CHITRA M, 1994, CHEMOTHERAPY, V40, P109, DOI 10.1159/000239181; Chitra M, 2003, FITOTERAPIA, V74, P401, DOI 10.1016/S0367-326X(03)00066-2; Dai Y, 2009, CANCER RES, V69, P4776, DOI 10.1158/0008-5472.CAN-08-4754; Deocaris CC, 2013, CURR PHARM DESIGN, V19, P418; Deshmukh PT, 2013, J ASIAN NAT PROD RES, V15, P158, DOI 10.1080/10286020.2012.758634; Dhanjal JK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-775; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Gandhi GR, 2013, BBA-GEN SUBJECTS, V1830, P2243, DOI 10.1016/j.bbagen.2012.10.016; Hu R, 2015, TUMOR BIOL, V36, P769, DOI 10.1007/s13277-014-2702-6; Joshi R, 2007, CHEM-BIOL INTERACT, V167, P125, DOI 10.1016/j.cbi.2007.02.004; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kumar GK, 2011, EUR J PHARMACOL, V662, P63, DOI 10.1016/j.ejphar.2011.04.037; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Li Y, 2013, ONCOL LETT, V5, P1005, DOI 10.3892/ol.2012.1084; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; MAKAWITI DW, 1990, FEBS LETT, V266, P26, DOI 10.1016/0014-5793(90)81497-C; Melson AJ, 2012, ADDICTION, V107, P1883, DOI [10.1111/j.1360-0443.2012.03956.x, 10.1111/j.1360-0443.2012.03988.x]; Modak R, 2013, ACS CHEM BIOL, V8, P1311, DOI 10.1021/cb4000597; Mori T, 2007, J SURG RES, V142, P281, DOI 10.1016/j.jss.2007.03.068; Naik SR, 2013, PHYTOMEDICINE, V20, P797, DOI 10.1016/j.phymed.2013.03.003; Narayanaswamy R, 2014, ADV PHARM BULL, V4, P543, DOI 10.5681/apb.2014.080; Qu MY, 2012, NEUROSCI RES, V72, P94, DOI 10.1016/j.neures.2011.09.009; Rozenberg P, 2013, INT J CANCER, V133, P514, DOI 10.1002/ijc.28029; Ryu J, 2014, J BIOL CHEM, V289, P24832, DOI 10.1074/jbc.M114.565929; Siegelin MD, 2009, NEUROCHEM INT, V55, P423, DOI 10.1016/j.neuint.2009.04.011; Singh D, 2009, BASIC CLIN PHARMACOL, V105, P243, DOI 10.1111/j.1742-7843.2009.00429.x; Sreepriya M, 2005, FITOTERAPIA, V76, P549, DOI 10.1016/j.fitote.2005.04.014; Taghiyev A, 2012, EXP THER MED, V4, P649, DOI 10.3892/etm.2012.637; Thippeswamy BS, 2011, NEUROTOX RES, V20, P379, DOI 10.1007/s12640-011-9258-7; Vaishnavi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044419; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Spoel D, 2012, BIOINFORMATICS, V28, P752, DOI 10.1093/bioinformatics/bts020; Wadhwa R, 2003, EMBO REP, V4, P595, DOI 10.1038/sj.embor.embor855; Wadhwa R, 2002, CANCER RES, V62, P4434; Wadhwa R, 2000, CANCER RES, V60, P6818; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Wang AP, 2013, ONCOL REP, V29, P2473, DOI 10.3892/or.2013.2369; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Xue ZY, 2014, MOL NEUROBIOL, V49, P1087, DOI 10.1007/s12035-013-8583-7; Yang L, 2008, ACTA BIOCH BIOPH SIN, V40, P339, DOI 10.1111/j.1745-7270.2008.00409.x; Yang L, 2011, J MOL BIOL, V414, P654, DOI 10.1016/j.jmb.2011.09.009; Yoo JY, 2010, J GENE MED, V12, P586, DOI 10.1002/jgm.1471; Zhou XL, 2015, INFLAMMATION	58	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138192	10.1371/journal.pone.0138192	http://dx.doi.org/10.1371/journal.pone.0138192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376435	Green Submitted, gold, Green Published			2022-12-26	WOS:000361610200084
J	Sirohi, K; Kumari, A; Radha, V; Swarup, G				Sirohi, Kapil; Kumari, Asha; Radha, Vegesna; Swarup, Ghanshyam			A Glaucoma-Associated Variant of Optineurin, M98K, Activates Tbk1 to Enhance Autophagosome Formation and Retinal Cell Death Dependent on Ser177 Phosphorylation of Optineurin	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; COPY NUMBER VARIATIONS; BINDING KINASE 1; NORMAL-TENSION GLAUCOMA; NF-KAPPA-B; GANGLION-CELLS; RGC-5 CELLS; GENE; RECEPTOR; TANK	Certain missense mutations in optineurin/ OPTN and amplification of TBK1 are associated with normal tension glaucoma. A glaucoma-associated variant of OPTN, M98K, induces autophagic degradation of transferrin receptor (TFRC) and death in retinal cells. Here, we have explored the role of Tbk1 in M98K-OPTN-induced autophagy and cell death, and the effect of Tbk1 overexpression in retinal cells. Cell death induced by M98K-OPTN was dependent on Tbk1 as seen by the effect of Tbk1 knockdown and blocking of Tbk1 activity by a chemical inhibitor. Inhibition of Tbk1 also restores M98K-OPTN-induced transferrin receptor degradation. M98K-OPTN-induced autophagosome formation, autophagy and cell death were dependent on its phosphorylation at S177 by Tbk1. Knockdown of OPTN reduced starvation-induced autophagosome formation. M98K-OPTN expressing cells showed higher levels of Tbk1 activation and enhanced phosphorylation at Ser177 compared to WT-OPTN expressing cells. M98K-OPTN-induced activation of Tbk1 and its ability to be phosphorylated better by Tbk1 was dependent on ubiquitin binding. Phosphorylated M98K-OPTN localized specifically to autophagosomes and endogenous Tbk1 showed increased localization to autophagosomes in M98K-OPTN expressing cells. Overexpression of Tbk1 induced cell death and caspase-3 activation that were dependent on its catalytic activity. Tbk1-induced cell death possibly involves autophagy, as shown by the effect of Atg5 knockdown, and requirement of autophagic function of OPTN. Our results show that phosphorylation of Ser177 plays a crucial role in M98K-OPTN-induced autophagosome formation, autophagy flux and retinal cell death. In addition, we provide evidence for cross talk between two glaucoma associated proteins and their inter-dependence to mediate autophagy- dependent cell death.	[Sirohi, Kapil; Kumari, Asha; Radha, Vegesna; Swarup, Ghanshyam] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Radha, V (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	vradha@ccmb.res.in; gshyam@ccmb.res.in	Sirohi, Kapil/GVT-2867-2022; Sirohi, Kapil/N-6676-2019	Sirohi, Kapil/0000-0001-5039-2848; Sirohi, Kapil/0000-0001-5039-2848; Swarup, Ghanshyam/0000-0002-8098-0509	Council of Scientific and Industrial Research, Government of India [BSC-0115, BSC-0208]; Department of Science and Technology, Government of India [SR/S2/JCB-41/2010]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by grants (BSC-0115 and BSC-0208) to GS from the Council of Scientific and Industrial Research, Government of India. GS gratefully acknowledges the Department of Science and Technology, Government of India for J C Bose National Fellowship grant SR/S2/JCB-41/2010.	Agudo-Barriuso M, 2013, CURR OPIN PHARMACOL, V13, P5, DOI 10.1016/j.coph.2012.09.006; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Awadalla MS, 2015, AM J OPHTHALMOL, V159, P124, DOI 10.1016/j.ajo.2014.09.044; Ayala-Lugo RM, 2007, MOL VIS, V13, P151; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chalasani ML, 2009, OPHTHALMIC RES, V42, P176, DOI 10.1159/000232400; Chalasani MLS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095758; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Choi SS, 2011, BRIT J OPHTHALMOL, V95, P131, DOI 10.1136/bjo.2010.183756; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Davis LK, 2011, INVEST OPHTH VIS SCI, V52, P7122, DOI 10.1167/iovs.10-5606; Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109; Fernaandez-Saanchez L, 2014, INVEST OPHTH VIS SCI, V55, P6059, DOI 10.1167/iovs.14-14421; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 2014, OPHTHALMIC GENET, V35, P35, DOI 10.3109/13816810.2013.768674; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Gupta V, 2006, J CELL SCI, V119, P1703, DOI 10.1242/jcs.02885; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Helgason E, 2013, FEBS LETT, V587, P1230, DOI 10.1016/j.febslet.2013.01.059; Journo C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000521; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Kachaner D, 2012, MOL CELL, V45, P553, DOI 10.1016/j.molcel.2011.12.030; Kim JK, 2013, NEOPLASIA, V15, P1064, DOI 10.1593/neo.13402; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kumar A, 2007, MOL VIS, V13, P667; Marchlik E, 2010, J LEUKOCYTE BIOL, V88, P1171, DOI 10.1189/jlb.0210071; May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200; Minegishi Y, 2013, HUM MOL GENET, V22, P3559, DOI 10.1093/hmg/ddt210; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Muppirala M, 2011, BIOL CELL, V103, P333, DOI 10.1042/BC20110006; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sadasivam S, 2005, ONCOGENE, V24, P627, DOI 10.1038/sj.onc.1208201; Shen XA, 2011, J BIOL CHEM, V286, P3618, DOI 10.1074/jbc.M110.175810; Sippl C, 2014, ADV EXP MED BIOL, V801, P145, DOI 10.1007/978-1-4614-3209-8_19; Sippl C, 2011, EXP EYE RES, V93, P669, DOI 10.1016/j.exer.2011.08.011; Sirohi K, 2013, AUTOPHAGY, V9, P510, DOI 10.4161/auto.23458; Sripriya S, 2006, MOL VIS, V12, P816; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Swarup G, 2004, J BIOSCIENCES, V29, P129, DOI 10.1007/BF02703408; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tucker Budd A, 2014, J Stem Cell Res Ther, V3, P161; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Turturro S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-99; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Wood JPM, 2010, INVEST OPHTH VIS SCI, V51, P3774, DOI 10.1167/iovs.09-4305; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Yu T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/979105; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	73	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0138289	10.1371/journal.pone.0138289	http://dx.doi.org/10.1371/journal.pone.0138289			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	26376340	Green Published, Green Submitted, gold			2022-12-26	WOS:000361610200096
J	Areces, F; Gonzalez-Millan, C; Salinero, JJ; Abian-Vicen, J; Lara, B; Gallo-Salazar, C; Ruiz-Vicente, D; Del Coso, J				Areces, Francisco; Gonzalez-Millan, Cristina; Jose Salinero, Juan; Abian-Vicen, Javier; Lara, Beatriz; Gallo-Salazar, Cesar; Ruiz-Vicente, Diana; Del Coso, Juan			Changes in Serum Free Amino Acids and Muscle Fatigue Experienced during a Half-Ironman Triathlon	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE; INCREMENTAL EXERCISE; SUSTAINED EXERCISE; SKELETAL-MUSCLE; SUPPLEMENTATION; PERFORMANCE; DAMAGE; TRYPTOPHAN; METABOLISM; INCREASES	The aim of this study was to investigate the relationship between changes in serum free amino acids, muscle fatigue and exercise-induced muscle damage during a half-ironman triathlon. Twenty-six experienced triathletes (age = 37.0 +/- 6.8 yr; experience = 7.4 +/- 3.0 yr) competed in a real half-ironman triathlon in which sector times and total race time were measured by means of chip timing. Before and after the race, a countermovement jump and a maximal isometric force test were performed, and blood samples were withdrawn to measure serum free amino acids concentrations, and serum creatine kinase levels as a blood marker of muscle damage. Total race time was 320 +/- 37 min and jump height (-16.3 +/- 15.2%, P < 0.001) and isometric force (-14.9 +/- 9.8%; P = 0.007) were significantly reduced after the race in all participants. After the race, the serum concentration of creatine kinase increased by 368 +/- 187% (P < 0.001). In contrast, the serum concentrations of essential (-27.1 +/- 13.0%; P < 0.001) and non-essential amino acids (-24.4 +/- 13.1%; P < 0.001) were significantly reduced after the race. The tryptophan/ BCAA ratio increased by 42.7 +/- 12.7% after the race. Pre-to-post changes in serum free amino acids did not correlate with muscle performance variables or post-race creatine kinase concentration. In summary, during a half-ironman triathlon, serum amino acids concentrations were reduced by >20%. However, neither the changes in serum free amino acids nor the tryptophan/ BCAA ratio were related muscle fatigue or muscle damage during the race.	[Areces, Francisco; Gonzalez-Millan, Cristina; Jose Salinero, Juan; Abian-Vicen, Javier; Lara, Beatriz; Gallo-Salazar, Cesar; Ruiz-Vicente, Diana; Del Coso, Juan] Camilo Jose Cela Univ, Sports Sci Inst, Exercise Physiol Lab, Madrid, Spain	Camilo Jose Cela University	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Sports Sci Inst, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Ruiz-Vicente, Diana/AAH-3689-2019; Areces, Francisco/ABH-3023-2020; GALLO, CESAR/O-4823-2019; Abián-Vicén, Javier/I-8509-2012; Salinero, Juan J./GLT-1243-2022; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012; Del Coso, Juan/AAC-7117-2020; Lara, Beatriz/AAQ-5269-2021	Areces, Francisco/0000-0003-2996-4156; GALLO, CESAR/0000-0001-8676-4658; Abián-Vicén, Javier/0000-0001-9635-3289; Salinero, Juan J./0000-0003-4153-5100; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Del Coso, Juan/0000-0002-5785-984X; Lara, Beatriz/0000-0001-5516-4852; Gonzalez-Millan, Cristina/0000-0002-3371-9420				Anthony JC, 2000, J NUTR, V130, P2413; Areces F, 2014, AMINO ACIDS, V46, P1169, DOI 10.1007/s00726-014-1677-3; Assenza A, 2004, J ANIM PHYSIOL AN N, V88, P172, DOI 10.1111/j.1439-0396.2004.00493.x; Blomstrand E, 2006, J NUTR, V136, p544S, DOI 10.1093/jn/136.2.544S; BLOMSTRAND E, 1988, ACTA PHYSIOL SCAND, V133, P115, DOI 10.1111/j.1748-1716.1988.tb08388.x; Buerger-Mendonca M, 2008, ANN HEPATOL, V7, P245, DOI 10.1016/S1665-2681(19)31855-1; Chang CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121866; CHAOULOFF F, 1989, J NEURAL TRANSM-GEN, V78, P121, DOI 10.1007/BF01252498; Cheuvront SN, 2004, J APPL PHYSIOL, V97, P1275, DOI 10.1152/japplphysiol.00357.2004; Coombes JS, 2000, J SPORT MED PHYS FIT, V40, P240; Crowe MJ, 2006, EUR J APPL PHYSIOL, V97, P664, DOI 10.1007/s00421-005-0036-1; Del Coso J, 2014, J SPORT SCI, V32, P1680, DOI 10.1080/02640414.2014.915425; Del Coso J, 2014, EUR J APPL PHYSIOL, V114, P587, DOI 10.1007/s00421-013-2789-2; Del Coso J, 2013, APPL PHYSIOL NUTR ME, V38, P286, DOI 10.1139/apnm-2012-0241; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Del Coso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043280; DOHM GL, 1987, MED SCI SPORT EXER, V19, pS166; Fernstrom JD, 2006, J NUTR, V136, p553S, DOI 10.1093/jn/136.2.553S; Gleeson M, 2005, J NUTR, V135, p1591S, DOI 10.1093/jn/135.6.1591S; Greer BK, 2007, INT J SPORT NUTR EXE, V17, P595, DOI 10.1123/ijsnem.17.6.595; Greer BK, 2011, J STRENGTH COND RES, V25, P539, DOI 10.1519/JSC.0b013e3181bf443a; Howatson G, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-20; Hsu MC, 2011, CHINESE J PHYSIOL, V54, P71, DOI 10.4077/CJP.2011.AMK075; Jeukendrup AE, 2011, J SPORT SCI, V29, pS91, DOI 10.1080/02640414.2011.610348; Knechtle B, 2011, J INT SOC SPORT NUTR, V8, DOI 10.1186/1550-2783-8-6; Koba T, 2007, J SPORT MED PHYS FIT, V47, P316; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Garcia-Manso JM, 2011, J SPORT SCI, V29, P619, DOI 10.1080/02640414.2010.548822; Margaritis I, 1999, J SPORT MED PHYS FIT, V39, P133; Matsumoto K, 2009, J NUTR SCI VITAMINOL, V55, P52, DOI 10.3177/jnsv.55.52; Maughan RJ, 2012, P NUTR SOC, V71, P112, DOI 10.1017/S0029665111003211; Meeusen R, 2007, INT J SPORT NUTR EXE, V17, pS37, DOI 10.1123/ijsnem.17.s1.s37; Millet GP, 2007, INTJ SPORT PHYSIOL, V2, P315, DOI 10.1123/ijspp.2.3.315; Mueller SM, 2013, EUR J APPL PHYSIOL, V113, P2343, DOI 10.1007/s00421-013-2670-3; Nelson AR, 2012, MED SCI SPORT EXER, V44, P57, DOI 10.1249/MSS.0b013e3182290371; Newsholme EA, 2006, J NUTR, V136, p274S, DOI 10.1093/jn/136.1.274S; Nosaka K, 2006, INT J SPORT NUTR EXE, V16, P620, DOI 10.1123/ijsnem.16.6.620; Roelands B, 2013, SPORTS MED, V43, P301, DOI 10.1007/s40279-013-0030-4; Shimomura Y, 2006, J NUTR, V136, p529S, DOI 10.1093/jn/136.2.529S; Smriga M, 2006, J NUTR, V136, p548S, DOI 10.1093/jn/136.2.548S; Stepanyan V, 2014, APPL PHYSIOL NUTR ME, V39, P1029, DOI 10.1139/apnm-2013-0566; Suzuki K, 2006, EUR J APPL PHYSIOL, V98, P525, DOI 10.1007/s00421-006-0296-4; Tang FC, 2006, J AM COLL NUTR, V25, P188, DOI 10.1080/07315724.2006.10719531; VANHALL G, 1995, J PHYSIOL-LONDON, V486, P789, DOI 10.1113/jphysiol.1995.sp020854; VARNIER M, 1994, EUR J APPL PHYSIOL O, V69, P26, DOI 10.1007/BF00867923; Williams, 2001, AMINO ACID ANAL PROT	46	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0138376	10.1371/journal.pone.0138376	http://dx.doi.org/10.1371/journal.pone.0138376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372162	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400069
J	Hapca, S; Baveye, PC; Wilson, C; Lark, RM; Otten, W				Hapca, Simona; Baveye, Philippe C.; Wilson, Clare; Lark, Richard Murray; Otten, Wilfred			Three-Dimensional Mapping of Soil Chemical Characteristics at Micrometric Scale by Combining 2D SEM-EDX Data and 3D X-Ray CT Images	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY IMAGES; ANISOTROPIC SHRINKAGE; QUANTITATIVE-ANALYSIS; NEXAFS SPECTROSCOPY; CARBON DISTRIBUTION; SPATIAL PREDICTION; POROUS-MEDIA; SPECIATION; MICROTOMOGRAPHY; MICROORGANISMS	There is currently a significant need to improve our understanding of the factors that control a number of critical soil processes by integrating physical, chemical and biological measurements on soils at microscopic scales to help produce 3D maps of the related properties. Because of technological limitations, most chemical and biological measurements can be carried out only on exposed soil surfaces or 2-dimensional cuts through soil samples. Methods need to be developed to produce 3D maps of soil properties based on spatial sequences of 2D maps. In this general context, the objective of the research described here was to develop a method to generate 3D maps of soil chemical properties at the microscale by combining 2D SEM-EDX data with 3D X-ray computed tomography images. A statistical approach using the regression tree method and ordinary kriging applied to the residuals was developed and applied to predict the 3D spatial distribution of carbon, silicon, iron, and oxygen at the microscale. The spatial correlation between the X-ray grayscale intensities and the chemical maps made it possible to use a regression-tree model as an initial step to predict the 3D chemical composition. For chemical elements, e.g., iron, that are sparsely distributed in a soil sample, the regression-tree model provides a good prediction, explaining as much as 90% of the variability in some of the data. However, for chemical elements that are more homogenously distributed, such as carbon, silicon, or oxygen, the additional kriging of the regression tree residuals improved significantly the prediction with an increase in the R-2 value from 0.221 to 0.324 for carbon, 0.312 to 0.423 for silicon, and 0.218 to 0.374 for oxygen, respectively. The present research develops for the first time an integrated experimental and theoretical framework, which combines geostatistical methods with imaging techniques to unveil the 3-D chemical structure of soil at very fine scales. The methodology presented in this study can be easily adapted and applied to other types of data such as bacterial or fungal population densities for the 3D characterization of microbial distribution.	[Hapca, Simona; Otten, Wilfred] Abertay Univ, Sch Sci Engn & Technol, Dundee DD1 1HG, Scotland; [Baveye, Philippe C.] Rensselaer Polytech Inst, Dept Civil & Environm Engn, Lab Soil & Water Engn, Troy, NY USA; [Baveye, Philippe C.] Univ Paris Saclay, AgroParisTech, Unite EcoSYS, F-78850 Thiverval Grignon, France; [Wilson, Clare] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Lark, Richard Murray] British Geol Survey, Nottingham NG12 5GG, England	Rensselaer Polytechnic Institute; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; University of Stirling; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey	Hapca, S (corresponding author), Abertay Univ, Sch Sci Engn & Technol, 40 Bell St, Dundee DD1 1HG, Scotland.	s.hapca@abertay.ac.uk	Otten, Wilfried/H-7168-2019; Lark, Richard/G-6744-2012; Wilson, Clare/J-7060-2012	Otten, Wilfried/0000-0002-3847-9825; Lark, Richard/0000-0003-2571-8521; Wilson, Clare/0000-0002-0287-8576; Baveye, Philippe/0000-0002-8432-6141	Scottish Alliance for Geoscience, Environment and Society (SAGES); NERC at Abertay, and by the Kodak Endowment in Environmental Engineering at RPI [NE/H01263X/1]; Natural Environment Research Council [NE/H01263X/1, bgs05013] Funding Source: researchfish; NERC [bgs05013, NE/H01263X/1] Funding Source: UKRI	Scottish Alliance for Geoscience, Environment and Society (SAGES); NERC at Abertay, and by the Kodak Endowment in Environmental Engineering at RPI; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	PB, WO and CW were supported by the Scottish Alliance for Geoscience, Environment and Society (SAGES). The work was supported by NERC (grant NE/H01263X/1) at Abertay, and by the Kodak Endowment in Environmental Engineering at RPI. The Abertay University is a charity registered in Scotland, No: SC016040.	ALEXANDER M, 1964, ANNU REV MICROBIOL, V18, P217, DOI 10.1146/annurev.mi.18.100164.001245; Baveye PC, 2010, GEODERMA, V157, P51, DOI 10.1016/j.geoderma.2010.03.015; Bleuet P, 2010, TRAC-TREND ANAL CHEM, V29, P518, DOI 10.1016/j.trac.2010.02.011; Cazelles K, 2013, ECOL MODEL, V248, P165, DOI 10.1016/j.ecolmodel.2012.08.008; Clode PL, 2009, PLANT PHYSIOL, V151, P1751, DOI 10.1104/pp.109.141499; DeLeo PC, 1997, J MICROBIOL METH, V30, P193, DOI 10.1016/S0167-7012(97)00065-1; EICKHORST T, 2008, MICROSC MICROANAL, V14, P754, DOI DOI 10.1017/S1431927608083025; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1284, DOI 10.1016/j.soilbio.2007.06.019; Elliot TR, 2007, GEODERMA, V141, P60, DOI 10.1016/j.geoderma.2007.05.001; Garnier P, 1997, SOIL SCI, V162, P410, DOI 10.1097/00010694-199706000-00003; Gebhardt S, 2012, SOIL TILL RES, V125, P96, DOI 10.1016/j.still.2012.06.017; Hapca SM, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0172; Hapca SM, 2011, GEODERMA, V164, P146, DOI 10.1016/j.geoderma.2011.05.018; Hastie T., 2009, ELEMENTS STAT LEARNI; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; Houston AN, 2013, GEODERMA, V207, P154, DOI 10.1016/j.geoderma.2013.05.017; Houston AN, 2013, COMPUT GEOSCI-UK, V54, P239, DOI 10.1016/j.cageo.2012.11.016; Iassonov P, 2010, VADOSE ZONE J, V9, P187, DOI 10.2136/vzj2009.0042; Iassonov P, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR008087; Jacobson AR, 2007, ENVIRON SCI TECHNOL, V41, P6343, DOI 10.1021/es070707m; Kravchenko A, 2011, ECOL APPL, V21, P1202, DOI 10.1890/10-0525.1; Lark RM, 2006, EUR J SOIL SCI, V57, P787, DOI 10.1111/j.1365-2389.2005.00768.x; Long HL, 2009, SEDIMENT GEOL, V220, P116, DOI 10.1016/j.sedgeo.2009.07.003; Moreau E, 1999, GEODERMA, V92, P55, DOI 10.1016/S0016-7061(99)00025-7; Okabe H, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066135; Otten W, 2004, SOIL BIOL BIOCHEM, V36, P203, DOI 10.1016/j.soilbio.2003.09.006; Pajor R, 2010, BIOGEOSCIENCES, V7, P3731, DOI 10.5194/bg-7-3731-2010; Peng X, 2007, EUR J SOIL SCI, V58, P98, DOI 10.1111/j.1365-2389.2006.00808.x; Prado B, 2009, AGR WATER MANAGE, V96, P1377, DOI 10.1016/j.agwat.2009.04.012; Prietzel J, 2010, J SYNCHROTRON RADIAT, V17, P166, DOI 10.1107/S0909049509049917; Rau C, 2003, NUCL INSTRUM METH B, V200, P444, DOI 10.1016/S0168-583X(02)01737-8; Remeysen K, 2008, MAR PETROL GEOL, V25, P486, DOI 10.1016/j.marpetgeo.2007.07.008; Schluter S, 2014, WATER RESOUR RES, V50, P3615, DOI 10.1002/2014WR015256; Schumacher M, 2005, ENVIRON SCI TECHNOL, V39, P9094, DOI 10.1021/es050099f; Shokri N, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4861755; Sleutel S, 2008, COMPUT GEOSCI-UK, V34, P931, DOI 10.1016/j.cageo.2007.10.006; Solomon D, 2009, SOIL SCI SOC AM J, V73, P1817, DOI 10.2136/sssaj2008.0228; Stein ML, 1999, SPRINGER SERIES STAT, Vxvii, P247; Strawn DG, 2008, ENVIRON SCI TECHNOL, V42, P37, DOI 10.1021/es071605z; Strawn DG, 2009, ENVIRON POLLUT, V157, P2813, DOI 10.1016/j.envpol.2009.04.018; Taina IA, 2008, CAN J SOIL SCI, V88, P1, DOI 10.4141/CJSS06027; Thieme J, 2010, J SYNCHROTRON RADIAT, V17, P149, DOI 10.1107/S0909049509049905; Thullner M, 2008, BIOTECHNOL BIOENG, V99, P1337, DOI 10.1002/bit.21708; Van Geet M, 2000, SEDIMENT GEOL, V132, P25, DOI 10.1016/S0037-0738(99)00127-X; Van Loo D, 2014, GEODERMA, V213, P485, DOI 10.1016/j.geoderma.2013.08.036; Wan J, 2007, GEOCHIM COSMOCHIM AC, V71, P5439, DOI 10.1016/j.gca.2007.07.030; Webster R., 2007, GEOSTATISTICS ENV SC, P315, DOI 10.1002/9780470517277; Willson CS, 2012, GEOTECH TEST J, V35, P911, DOI 10.1520/GTJ20120075; Wilson CA, 2008, J ARCHAEOL SCI, V35, P412, DOI 10.1016/j.jas.2007.04.006; Yao YB, 2009, INT J COAL GEOL, V80, P113, DOI 10.1016/j.coal.2009.08.001	50	35	37	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137205	10.1371/journal.pone.0137205	http://dx.doi.org/10.1371/journal.pone.0137205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372473	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000361604400012
J	Kwok, KO; Davoudi, B; Riley, S; Pourbohloul, B				Kwok, Kin On; Davoudi, Bahman; Riley, Steven; Pourbohloul, Babak			Early real-time estimation of the basic reproduction number of emerging or reemerging infectious diseases in a community with heterogeneous contact pattern: Using data from Hong Kong 2009 H1N1 Pandemic Influenza as an illustrative example	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; AGENT; SARS	Emerging and re-emerging infections such as SARS ( 2003) and pandemic H1N1 ( 2009) have caused concern for public health researchers and policy makers due to the increased burden of these diseases on health care systems. This concern has prompted the use of mathematical models to evaluate strategies to control disease spread, making these models invaluable tools to identify optimal intervention strategies. A particularly important quantity in infectious disease epidemiology is the basic reproduction number, R-0. Estimation of this quantity is crucial for effective control responses in the early phase of an epidemic. In our previous study, an approach for estimating the basic reproduction number in real time was developed. This approach uses case notification data and the structure of potential transmission contacts to accurately estimate R-0 from the limited amount of information available at the early stage of an outbreak. Based on this approach, we extend the existing methodology; the most recent method features intra- and inter-age groups contact heterogeneity. Given the number of newly reported cases at the early stage of the outbreak, with parsimony assumptions on removal distribution and infectivity profile of the diseases, experiments to estimate real time R-0 under different levels of intra- and inter-group contact heterogeneity using two age groups are presented. We show that the new method converges more quickly to the actual value of R-0 than the previous one, in particular when there is high-level intra- group and inter-group contact heterogeneity. With the age specific contact patterns, number of newly reported cases, removal distribution, and information about the	[Kwok, Kin On; Riley, Steven] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China; [Davoudi, Bahman; Pourbohloul, Babak] British Columbia Ctr Dis Control, Div Math Modeling, Vancouver, BC, Canada; [Riley, Steven] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London SW7 2AZ, England; [Pourbohloul, Babak] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of Hong Kong; Imperial College London; University of British Columbia	Pourbohloul, B (corresponding author), British Columbia Ctr Dis Control, Div Math Modeling, Vancouver, BC, Canada.	babak.p@ubc.ca	Kwok, Kin On/A-5074-2018	Kwok, Kin On/0000-0002-2804-5433; Riley, Steven/0000-0001-7904-4804	Canadian Institutes of Health Research [PTL-97126]; Michael Smith Foundation for Health Research [CI-SSH-00931(06-1)]; British Columbia Ministry of Health (Pandemic Preparedness Modeling Project); Medical Research Council (UK) [MR/J008761/1]; Wellcome Trust [093488/Z/10/Z]; National Institute for Health Research (UK, Health Protection Research Unit); Fogarty International Centre (FluScape) [R01 TW008246-01]; Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SARResearch Grants Council, Hong Kong [110642, PHE 21]; Research Grants Council, Hong Kong [776810]; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721] Funding Source: NIH RePORTER; MRC [MR/K010174/1, MR/J008761/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B, MR/J008761/1] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); British Columbia Ministry of Health (Pandemic Preparedness Modeling Project); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (UK, Health Protection Research Unit); Fogarty International Centre (FluScape); Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SARResearch Grants Council, Hong Kong; Research Grants Council, Hong Kong(Hong Kong Research Grants Council); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	BP would like to acknowledge the support of the Canadian Institutes of Health Research (Grant No. PTL-97126), the Michael Smith Foundation for Health Research (Grant No. CI-SSH-00931(06-1)), and the British Columbia Ministry of Health (Pandemic Preparedness Modeling Project). SR thanks the Medical Research Council (UK, Project Grant MR/J008761/1), Wellcome Trust (Project Award 093488/Z/10/Z) and the National Institute for Health Research (UK, Health Protection Research Unit). KOK would like to acknowledge the support by R01 TW008246-01 from Fogarty International Centre (FluScape); the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (RFCID Number: 110642 and PHE 21) and Research Grants Council, Hong Kong (Grant No. 776810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Davoudi B, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031005; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Glass K, 2012, EPIDEMIOLOGY, V23, P86, DOI 10.1097/EDE.0b013e31823a44a5; Kwok KO, 2014, P ROYAL SOC B; Kwok KO, 2014, TEMPORAL PATTERNS HU; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Noel PA, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026101; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Wallinga J, 2010, P NATL ACAD SCI; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216	20	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137959	10.1371/journal.pone.0137959	http://dx.doi.org/10.1371/journal.pone.0137959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372219	Green Published, Green Submitted, gold			2022-12-26	WOS:000361604400040
J	Xiang, Y; Wu, XQ; Zhou, AD				Xiang, Yang; Wu, Xiao-Qin; Zhou, Ai-Dong			Bacterial Diversity and Community Structure in the Pine Wood Nematode Bursaphelenchus xylophilus and B-mucronatus with Different Virulence by High-Throughput Sequencing of the 16S rDNA	PLOS ONE			English	Article							ENDOPHYTIC BACTERIA; PATHOGENICITY	Bursaphelenchus xylophilus is the pathogen of pine wilt disease. Bursaphelenchus mucronatus is similar to B. xylophilus in morphology. Both species share a common niche, but they are quite different in pathogenicity. Presently, the role of bacteria in pine wilt disease development has been widely speculated. The diversity of bacteria associated with B. xylophilus and B. mucronatus with different virulence remains unclear. In this study, virulence of four B. xylophilus and four B. mucronatus strains were evaluated by inoculating Pinus thunbergii. High-throughput sequencing targeted 16S rDNA of different virulence nematode strains was carried out. The associated bacterial community structures of the eight strains were analyzed. The results showed that 634,051 high-quality sequences were obtained from the eight nematode strains. The number of OTUs of bacteria associated with B. mucronatus was generally greater than those of B. xylophilus. The richness of the community of bacteria associated with high virulent B. xylophilus ZL1 and AmA3 was higher than moderately virulent B. xylophilus AA3, HE2, and all B. mucronatus strains. While the diversity of bacteria associated with B. mucronatus was higher than B. xylophilus. Stenotrophomonas, Pseudomonadaceae_Unclassified or Rhizobiaceae_Unclassified were predominant in the nematode strains with different virulence. Oxalobacteraceae and Achromobacter were found more abundant in the low virulent B. xylophilus and non-virulent B. mucronatus strains.	[Xiang, Yang; Wu, Xiao-Qin; Zhou, Ai-Dong] Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Xiang, Yang; Wu, Xiao-Qin; Zhou, Ai-Dong] Nanjing Forestry Univ, Jiangsu Key Lab Prevent & Management Invas Specie, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University; Nanjing Forestry University	Wu, XQ (corresponding author), Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.	xqwu@njfu.edu.cn			National Natural Science Foundation of China [31270683]; Southern China Collaborative Innovation Center of Sustainable Forestry; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Southern China Collaborative Innovation Center of Sustainable Forestry; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (NO. 31270683), Southern China Collaborative Innovation Center of Sustainable Forestry, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke A, 1991, SCAND J FOREST RES, V6, P407, DOI 10.1080/02827589109382678; Braasch Helen, 1997, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V49, P209; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheng H. R. (et al.), 1983, Forest Pest and Disease, P1; Cheng XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01869; Chi SY, 2003, THESIS NANJING FORES; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fang ZD, 1998, METHODS RES PLANT DI; FUTAI K, 1980, APPL ENTOMOL ZOOL, V15, P115, DOI 10.1303/aez.15.115; Ju Yunwei, 2008, Journal of Northeast Forestry University, V36, P84; Kanzaki N, 2006, NEMATOLOGY, V8, P485, DOI 10.1163/156854106778613994; Kawazu K, 1997, JAPANESE J NEMATOLOG, V27; Kawazu K, 1999, WHAT FACTORS GOVERN, P42; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; KIYOHARA T, 1990, FOREST SCI, V36, P1061; Li H, 2008, THESIS GHENT U; Liu X.L., 2007, THESIS NANJING FORES; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; MAMIYA Y, 1979, NEMATOLOGICA, V25, P353, DOI 10.1163/187529279X00091; MCNAMARA D G, 1988, Bulletin OEPP, V18, P353, DOI 10.1111/j.1365-2338.1988.tb00386.x; Nascimento FX, 2014, ENV MICROBIOLOGY REP, DOI 10:1111/1758-2229.12202.; Paiva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079705; PPQ New Pest Advisory Group, 2001, NPGA DAT BURS MUCR P; Proenca DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105190; Proenca DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015191; Proenca DN, 2011, BACTERIA ARCHAEA COM; Shen PY, 1995, FOREST PEST DIS, V4, P1; Shinya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067377; Tan JJ., 2008, CHINA FORESTRY SCI T, V22, P23; Tian XL, 2010, THESIS NW A F U; Tian XL, 2011, CURR MICROBIOL, V62, P117, DOI 10.1007/s00284-010-9681-7; TOMMINEN J, 1993, EUR J FOREST PATHOL, V23, P236; Vicente CSL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-299; Vicente CSL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046661; Vicente CSL, 2011, ANTON LEEUW INT J G, V100, P477, DOI 10.1007/s10482-011-9602-1; Wu GuangChao, 2006, Acta Agriculturae Shanghai, V22, P61; Wu XQ, 2013, INT J BIOL SCI, V9, P34, DOI 10.7150/ijbs.5071; Yuan Weimin, 2011, Weishengwu Xuebao, V51, P1071; [岳秀娟 Yue Xiujuan], 2004, [微生物学通报, Microbiology], V31, P108; [张治宇 Zhang Zhiyu], 2002, [南京农业大学学报, Journal of Nanjing Agricultural University], V25, P43; Zhang ZY, 2004, J NANJING AGR U, V27, P46; Zhang ZY, 2001, J SHENYANG AGR U, V32, P28; Zhao BoGuang, 2005, Journal of Nanjing Forestry University (Natural Sciences Edition), V29, P1; Zhao YX, 2003, J SW FORESTRY COLL, V23, P62	45	24	26	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2015	10	9							e0137386	10.1371/journal.pone.0137386	http://dx.doi.org/10.1371/journal.pone.0137386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8LR	26372013	Green Published, gold, Green Submitted			2022-12-26	WOS:000361604400018
J	Henao-Tamayo, M; Shanley, CA; Verma, D; Zilavy, A; Stapleton, MC; Furney, SK; Podell, B; Orme, IM				Henao-Tamayo, Marcela; Shanley, Crystal A.; Verma, Deepshikha; Zilavy, Andrew; Stapleton, Margaret C.; Furney, Synthia K.; Podell, Brendan; Orme, Ian M.			The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis	PLOS ONE			English	Article							W-BEIJING STRAINS; GUINEA-PIGS; PROTECTIVE EFFICACY; RHESUS MACAQUES; SOUTH-AFRICA; TB VACCINE; IMMUNITY; MODEL; RATES	To date, most new vaccines against Mycobacterium tuberculosis, including new recombinant versions of the current BCG vaccine, have usually been screened against the laboratory strains H37Rv or Erdman. In this study we took advantage of our recent work in characterizing an increasingly large panel of newly emerging clinical isolates [from the United States or from the Western Cape region of South Africa], to determine to what extent vaccines would protect against these [mostly high virulence] strains. We show here that both BCG Pasteur and recombinant BCG Aeras-422 [used here as a good example of the new generation BCG vaccines] protected well in both mouse and guinea pig low dose aerosol infection models against the majority of clinical isolates tested. However, Aeras-422 was not effective in a long term survival assay compared to BCG Pasteur. Protection was very strongly expressed against all of the Western Cape strains tested, reinforcing our viewpoint that any attempt at boosting BCG would be very difficult to achieve statistically. This observation is discussed in the context of the growing argument made by others that the failure of a recent vaccine trial disqualifies the further use of animal models to predict vaccine efficacy. This viewpoint is in our opinion completely erroneous, and that it is the fitness of prevalent strains in the trial site area that is the centrally important factor, an issue that is not being addressed by the field.	[Henao-Tamayo, Marcela; Shanley, Crystal A.; Verma, Deepshikha; Zilavy, Andrew; Stapleton, Margaret C.; Furney, Synthia K.; Podell, Brendan; Orme, Ian M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	Colorado State University	Orme, IM (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	ian.orme@colostate.edu	Henao-Tamayo, Marcela/D-8189-2017; Podell, Brendan/D-8396-2017	Henao-Tamayo, Marcela/0000-0002-4249-9650; Podell, Brendan/0000-0003-2548-8826	National Institutes of Health [AI106779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI106779 to IMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018523; Brennan MJ, 2012, INT J TUBERC LUNG D, V16, P1566, DOI 10.5588/ijtld.12.0569; Falzon Dennis, 2013, Lancet Respir Med, V1, pe9, DOI 10.1016/S2213-2600(12)70056-5; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Johnson LF, 2015, AIDS, V29, P1401, DOI 10.1097/QAD.0000000000000721; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Kato-Maeda M, 2012, CLIN VACCINE IMMUNOL, V19, P1227, DOI 10.1128/CVI.00250-12; Kupferschmidt K, 2011, SCIENCE, V334, P1488, DOI 10.1126/science.334.6062.1488; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; McShane H, 2014, TUBERCULOSIS, V94, P105, DOI 10.1016/j.tube.2013.11.003; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Ordway DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1527, DOI 10.1128/CVI.05127-11; Orme I, 2014, TUBERCULOSIS, V94, P717, DOI 10.1016/j.tube.2014.08.004; Orme IM, 2013, DRUGS, V73, P1015, DOI 10.1007/s40265-013-0081-8; Orme IM, 2011, FUTURE MICROBIOL, V6, P161, DOI 10.2217/FMB.10.168; Palanisamy GS, 2009, TUBERCULOSIS, V89, P203, DOI 10.1016/j.tube.2009.01.005; Podell BK, 2014, AM J PATHOL, V184, P1104, DOI 10.1016/j.ajpath.2013.12.015; Ramirez-Avila L, 2015, INT J STD AIDS, V26, P704, DOI 10.1177/0956462414551234; Shang SB, 2011, TUBERCULOSIS, V91, P378, DOI 10.1016/j.tube.2011.06.001; Shanley CA, 2013, VACCINE, V31, P5934, DOI 10.1016/j.vaccine.2013.10.044; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Walker NF, 2013, FUTURE VIROL, V8, P57, DOI 10.2217/FVL.12.123; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; World Health Organization, 2014, GLOB TUB REP	28	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136500	10.1371/journal.pone.0136500	http://dx.doi.org/10.1371/journal.pone.0136500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368806	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100018
J	Li, JJ; Ding, Q; Wang, FD; Zhang, YH; Li, HY; Gao, JW				Li, Jingjuan; Ding, Qian; Wang, Fengde; Zhang, Yihui; Li, Huayin; Gao, Jianwei			Integrative Analysis of mRNA and miRNA Expression Profiles of the Tuberous Root Development at Seedling Stages in Turnips	PLOS ONE			English	Article							POTATO IPOMOEA-BATATAS; DIGITAL GENE-EXPRESSION; BRASSICA-RAPA L.; SWEET-POTATO; STORAGE ROOT; TRANSCRIPTOME ANALYSIS; THICKENING GROWTH; DOWN-REGULATION; FOLDING LEAVES; MICRORNAS	The tuberous root of Brassica rapa L. (turnip) is an important modified organ for nutrition storage. A better understanding of the molecular mechanisms involved in the process of tuberous root development is of great value in both economic and biological context. In this study, we analyzed the expression profiles of both mRNAs and miRNAs in tuberous roots at an early stage before cortex splitting (ES), cortex splitting stage (CSS), and secondary root thickening stage (RTS) in turnip based on high-throughput sequencing technology. A large number of differentially expressed genes (DEGs) and several differentially expressed miRNAs (DEMs) were identified. Based on the DEG analysis, we propose that metabolism is the dominant pathway in both tuberous root initiation and secondary thickening process. The plant hormone signal transduction pathway may play a predominant role in regulating tuberous root initiation, while the starch and sucrose metabolism may be more important for the secondary thickening process. These hypotheses were partially supported by sequential DEM analyses. Of all DEMs, miR156a, miR157a, and miR172a exhibited relatively high expression levels, and were differentially expressed in both tuberous root initiation and the secondary thickening process with the expression profiles negatively correlated with those of their target genes. Our results suggest that these miRNAs play important roles in tuberous root development in turnips.	[Li, Jingjuan; Ding, Qian; Wang, Fengde; Zhang, Yihui; Li, Huayin; Gao, Jianwei] Shandong Acad Agr Sci, Inst Vegetables & Flowers, Shandong Key Lab Greenhouse Vegetable Biol, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences	Gao, JW (corresponding author), Shandong Acad Agr Sci, Inst Vegetables & Flowers, Shandong Key Lab Greenhouse Vegetable Biol, Jinan, Shandong, Peoples R China.	jianweigao3@yahoo.com	Wang, Fengde/HCI-6590-2022		Modern Agriculture Industrial Technology System Funding of Shandong Province, China [SDAIT-02-022-04]; National Natural Science Foundation of China [31401869]; China Postdoctoral Science Foundation [2013M541948]; Shandong Postdoctoral Science Foundation Funded Project, China [201303030]	Modern Agriculture Industrial Technology System Funding of Shandong Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Postdoctoral Science Foundation Funded Project, China	This study was supported by Modern Agriculture Industrial Technology System Funding of Shandong Province, China (SDAIT-02-022-04, http://cyjstx.sdny.gov.cn/). The role of funder: study design, decision to publish, and preparation of the manuscript. National Natural Science Foundation of China (31401869, http://www.nsfc.gov.cn/). The role of funder: study design, data collection and analysis, and preparation of the manuscript. China Postdoctoral Science Foundation Funded Project (2013M541948, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx). The role of funder: study design, data collection and analysis, and preparation of the manuscript. Shandong Postdoctoral Science Foundation Funded Project, China (201303030, http://www.sdhrss.gov.cn/cm/). The role of funder: study design, data collection and analysis, and preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bari A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/307145; Bhogale S, 2014, PLANT PHYSIOL, V164, P1011, DOI 10.1104/pp.113.230714; Choi SR, 2007, THEOR APPL GENET, V115, P777, DOI 10.1007/s00122-007-0608-z; Covarrubias AA, 2010, PLANT CELL ENVIRON, V33, P481, DOI 10.1111/j.1365-3040.2009.02048.x; Curtis IS, 2003, TRENDS PLANT SCI, V8, P305, DOI 10.1016/S1360-1385(03)00127-4; Dini I, 2009, FOOD CHEM, V113, P411, DOI 10.1016/j.foodchem.2008.07.053; Eguchi Toshihiko, 2011, Environmental Control in Biology, V49, P47; Fan MX, 2011, J PLANT GROWTH REGUL, V30, P11, DOI 10.1007/s00344-010-9163-y; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gupta AK, 2001, ACTA PHYSIOL PLANT, V23, P31, DOI 10.1007/s11738-001-0019-8; Jiang JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-72; Khan GA, 2011, PLANT MOL BIOL, V77, P47, DOI 10.1007/s11103-011-9793-x; Kim B, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-218; Kim SH, 2005, J PLANT BIOL, V48, P387, DOI 10.1007/BF03030580; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Ku AT, 2008, ANN BOT-LONDON, V102, P57, DOI 10.1093/aob/mcn067; Legnani G, 2001, NEW PHYTOL, V149, P449, DOI 10.1046/j.1469-8137.2001.00055.x; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005436; Luo XingLu, 2011, Journal of Agricultural Science (Toronto), V3, P64; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Martin A, 2009, DEVELOPMENT, V136, P2873, DOI 10.1242/dev.031658; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Noh SA, 2013, J EXP BOT, V64, P129, DOI 10.1093/jxb/ers236; Noh SA, 2010, J EXP BOT, V61, P1337, DOI 10.1093/jxb/erp399; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rouhier H, 2001, PLANT CELL PHYSIOL, V42, P583, DOI 10.1093/pcp/pce071; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Solis J, 2014, J AM SOC HORTIC SCI, V139, P317, DOI 10.21273/JASHS.139.3.317; Song XM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-71; Sorin C, 2014, NEW PHYTOL, V202, P1197, DOI 10.1111/nph.12735; Sun P, 2010, MOL BIOL REP, V37, P1069, DOI 10.1007/s11033-009-9834-6; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tanaka M, 2005, J PLANT PHYSIOL, V162, P91, DOI 10.1016/j.jplph.2004.06.003; Tanaka M, 2008, J PLANT PHYSIOL, V165, P1726, DOI 10.1016/j.jplph.2007.11.009; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Wang FD, 2013, GENE, V532, P222, DOI 10.1016/j.gene.2013.09.039; Wang FD, 2012, MOL GENET GENOMICS, V287, P555, DOI 10.1007/s00438-012-0699-3; Wang FD, 2012, GENOMICS, V99, P299, DOI 10.1016/j.ygeno.2012.02.005; Wang JY, 2011, GENOME, V54, P1029, DOI [10.1139/G11-069, 10.1139/g11-069]; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang QingMei, 2006, Agricultural Sciences in China, V5, P919, DOI 10.1016/S1671-2927(07)60005-4; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Yang J, 2011, J INTEGR PLANT BIOL, V53, P193, DOI 10.1111/j.1744-7909.2010.01018.x; Yao Y, 2013, ADV MATER RES-SWITZ, V726-731, P4529, DOI 10.4028/www.scientific.net/AMR.726-731.4529; Yasunori K, 2001, PLANT PROD SCI, V4, P131; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337	55	20	21	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137983	10.1371/journal.pone.0137983	http://dx.doi.org/10.1371/journal.pone.0137983			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367742	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100195
J	Liu, M; Lam, MKH; Zhang, QF; Elderfield, R; Barclay, WS; Shaw, PC				Liu, Ming; Lam, Mandy Ka-Han; Zhang, Qinfen; Elderfield, Ruth; Barclay, Wendy S.; Shaw, Pang-Chui			The Functional Study of the N-Terminal Region of Influenza B Virus Nucleoprotein	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; NUCLEAR-LOCALIZATION; RNA-BINDING; REDUCED SENSITIVITY; REPLICATION; PROTEIN; ARCHITECTURE; EXPRESSION	Influenza nucleoprotein (NP) is a major component of the ribonucleoprotein (vRNP) in influenza virus, which functions for the transcription and replication of viral genome. Compared to the nucleoprotein of influenza A (ANP), the N-terminal region of influenza B nucleoprotein (BNP) is much extended. By virus reconstitution, we found that the first 38 residues are essential for viral growth. We further illustrated the function of BNP by mini-genome reconstitution, fluorescence microscopy, electron microscopy, light scattering and gel shift. Results show that the N terminus is involved in the formation of both higher homo-oligomers of BNP and BNP-RNA complex.	[Liu, Ming; Lam, Mandy Ka-Han; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Zhang, Qinfen] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Elderfield, Ruth; Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Virol Sect, London, England	Chinese University of Hong Kong; Sun Yat Sen University; Imperial College London	Shaw, PC (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	pcshaw@cuhk.edu.hk		Barclay, Wendy/0000-0002-3948-0895	General Research Fund grant from the Research Grants Council of Hong Kong (PCS) [CUHK473810]; Area of Excellence Scheme of the University Grants Committee of Hong Kong [AoE/M-12/06]; University Grants Council of Hong Kong [SEG CUHK08]	General Research Fund grant from the Research Grants Council of Hong Kong (PCS); Area of Excellence Scheme of the University Grants Committee of Hong Kong; University Grants Council of Hong Kong	This research was supported by a General Research Fund grant (CUHK473810) from the Research Grants Council of Hong Kong (PCS), http://www.ugc.edu.hk/eng/rgc/index.htm, and an Area of Excellence Scheme of the University Grants Committee of Hong Kong (Grant AoE/M-12/06) (PCS). Equipment used was obtained through a Special Equipment Grant (SEG CUHK08) from the University Grants Council of Hong Kong, http://www.ugc.edu.hk/eng/ugc/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Ariza A, 2013, NUCLEIC ACIDS RES, V41, P5912, DOI 10.1093/nar/gkt268; Escuret V, 2008, J CLIN VIROL, V41, P25, DOI 10.1016/j.jcv.2007.10.019; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hatta M, 2003, J VIROL, V77, P6050, DOI 10.1128/JVI.77.10.6050-6054.2003; Jackson D, 2002, J VIROL, V76, P11744, DOI 10.1128/JVI.76.22.11744-11747.2002; Jackson D, 2011, J GEN VIROL, V92, P1, DOI 10.1099/vir.0.026187-0; Jambrina E, 1997, VIROLOGY, V235, P209, DOI 10.1006/viro.1997.8682; Kawai N, 2006, CLIN INFECT DIS, V43, P439, DOI 10.1086/505868; Macville M, 1999, CANCER RES, V59, P141; MOWSHOWITZ SL, 1980, ARCH VIROL, V63, P159, DOI 10.1007/BF01320774; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Ng AKL, 2012, J VIROL, V86, P6758, DOI 10.1128/JVI.00073-12; Niu FF, 2013, P NATL ACAD SCI USA, V110, P9054, DOI 10.1073/pnas.1300035110; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rainsford EW, 2010, J VIROL, V84, P1741, DOI 10.1128/JVI.01803-09; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sherry L, 2014, J VIROL, V88, P12326, DOI 10.1128/JVI.01542-14; Stevens MP, 1998, J VIROL, V72, P5307, DOI 10.1128/JVI.72.6.5307-5312.1998; Wanitchang A, 2013, VIROLOGY, V443, P59, DOI 10.1016/j.virol.2013.04.025; Yang Yinhua, 2014, Biodesign, V2, P91; Zhao B, 2015, CLIN MICROBIOL INFEC, V21, P694, DOI 10.1016/j.cmi.2015.03.009	25	9	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137802	10.1371/journal.pone.0137802	http://dx.doi.org/10.1371/journal.pone.0137802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368391	Green Published, Green Submitted, gold			2022-12-26	WOS:000361601100142
J	Soltysiak, KA; van Schaik, EJ; Samuel, JE				Soltysiak, Kelly A.; van Schaik, Erin J.; Samuel, James E.			Surfactant Protein D Binds to Coxiella burnetii and Results in a Decrease in Interactions with Murine Alveolar Macrophages	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; LEGIONELLA-PNEUMOPHILA; MYCOBACTERIUM-TUBERCULOSIS; KLEBSIELLA-PNEUMONIAE; PULMONARY COLLECTINS; LUNG COLLECTINS; CELL-LINE; Q-FEVER; MH-S	Coxiella burnetii is a Gram-negative, obligate intracellular bacterium and the causative agent of Q fever. Infections are usually acquired after inhalation of contaminated particles, where C. burnetii infects its cellular target cells, alveolar macrophages. Respiratory pathogens encounter the C-type lectin surfactant protein D (SP-D) during the course of natural infection. SP-D is a component of the innate immune response in the lungs and other mucosal surfaces. Many Gram-negative pulmonary pathogens interact with SP-D, which can cause aggregation, bactericidal effects and aid in bacterial clearance. Here we show that SP-D binds to C. burnetii in a calcium-dependent manner with no detectable bacterial aggregation or bactericidal effects. Since SP-D interactions with bacteria often alter macrophage interactions, it was determined that SP-D treatment resulted in a significant decrease in C. burnetii interactions to a mouse alveolar macrophage model cell line MH-S indicating SP-D causes a significant decrease in phagocytosis. The ability of SP-D to modulate macrophage activation by C. burnetii was tested and it was determined that SP-D does not alter the correlates measured for macrophage activation. Taken together these studies support those demonstrating limited activation of alveolar macrophages with C. burnetii and demonstrate interactions with SP-D participate in reduction of phagocyte attachment and phagocytosis.	[Soltysiak, Kelly A.; van Schaik, Erin J.; Samuel, James E.] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Samuel, JE (corresponding author), Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA.	jsamuel@medicine.tamhsc.edu			National Institutes of Health [AI088430, AI090142]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088430, R01AI090142, R56AI090142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institutes of Health AI088430 awarded to JS; and by National Institutes of Health AI090142 awarded to JS [http://grants.nih.gov/grants/oer.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit M, 2008, EUR J IMMUNOL, V38, P1065, DOI 10.1002/eji.200738067; Bufler P, 2003, AM J RESP CELL MOL, V28, P249, DOI 10.1165/rcmb.4896; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen C, 2013, NAT REV MICROADVANCE; Ferguson JS, 2002, J IMMUNOL, V168, P1309, DOI 10.4049/jimmunol.168.3.1309; Ferguson JS, 1999, J IMMUNOL, V163, P312; Graham JG, 2013, CELL MICROBIOL, V15, P1012, DOI 10.1111/cmi.12096; Griese M, 2005, PEDIATR PULM, V40, P378, DOI 10.1002/ppul.20295; Hogenkamp A, 2007, MOL IMMUNOL, V44, P3517, DOI 10.1016/j.molimm.2007.03.013; Howe D, 2010, INFECT IMMUN, V78, P3465, DOI 10.1128/IAI.00406-10; Jounblat R, 2004, INFECT IMMUN, V72, P709, DOI 10.1128/IAI.72.2.709-716.2004; Keisari Y, 2001, J LEUKOCYTE BIOL, V70, P135; Khamri W, 2005, INFECT IMMUN, V73, P7677, DOI 10.1128/IAI.73.11.7677-7686.2005; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kurimura Y, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380287; LIM BL, 1994, BIOCHEM BIOPH RES CO, V202, P1674, DOI 10.1006/bbrc.1994.2127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsunaga K, 2001, AM J RESP CELL MOL, V24, P326, DOI 10.1165/ajrcmb.24.3.4359; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Narasaki CT, 2012, ADV EXP MED BIOL, V984, P65, DOI 10.1007/978-94-007-4315-1_4; Oberley RE, 2004, LUNG CELLULAR MOL PH, V287, P296; Ofek I, 2001, INFECT IMMUN, V69, P24, DOI 10.1128/IAI.69.1.24-33.2001; Omsland A, 2011, APPL ENVIRON MICROB, V77, P3720, DOI 10.1128/AEM.02826-10; ORIORDAN DM, 1995, J CLIN INVEST, V95, P2699, DOI 10.1172/JCI117972; PERSSON A, 1990, J BIOL CHEM, V265, P5755; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Samuel JE, 2009, CURRENT PROTOCOLS MI; Sano H, 2006, RESPIROLOGY, V11, pS46, DOI 10.1111/j.1440-1843.2006.00808.x; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Schaeffer LM, 2004, INFECT IMMUN, V72, P7124, DOI 10.1128/IAI.72.12.7124-7130.2004; Wu HFM, 2005, AM J PHYSIOL-LUNG C, V288, pL585, DOI 10.1152/ajplung.00305.2004; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yan L, 2004, FEMS MICROBIOL LETT, V230, P147, DOI 10.1016/S0378-1097(03)00883-8; Yokota S, 2012, INFECT IMMUN, V80, P2956, DOI 10.1128/IAI.00345-12	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0136699	10.1371/journal.pone.0136699	http://dx.doi.org/10.1371/journal.pone.0136699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26366725	Green Submitted, Green Published, gold			2022-12-26	WOS:000361601100021
J	Wu, LN; Ci, YS; Chu, JW; Zhang, HS				Wu, Lina; Ci, Yusheng; Chu, Jiangwei; Zhang, Hongsheng			The Influence of Intersections on Fuel Consumption in Urban Arterial Road Traffic: A Single Vehicle Test in Harbin, China	PLOS ONE			English	Article							HYBRID ELECTRIC BUS; ENERGY EFFICIENCY; POWER MANAGEMENT; PREDICTION; STOPS	The calculating method for fuel consumption (FC) was put forward and calibrated and the characteristics of the fuel consumption on intersections were analyzed based on 18 groups of vehicular operating data which were acquired from the test experiment of a single vehicle along the urban arterial roads in Harbin, China. The results obtained show that 50.36% of the fuel consumption for the test vehicle was used at the area of intersections compared with 28.9% of the influencing distance and 68.5% of the running time; and 78.4% of them was burnt at the stages of acceleration and idling. Meanwhile, the type (c) of the vehicular operating status was illustrated to be the worst way of reducing fuel consumption, the causes were analyzed and four improvement strategies were put forward.	[Wu, Lina] Heilongjiang Inst Technol, Coll Automobile & Traff Engn, Harbin, Heilongjiang, Peoples R China; [Wu, Lina; Chu, Jiangwei] Northeast forestry Univ, Coll Traff, Harbin, Heilongjiang, Peoples R China; [Ci, Yusheng] Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin 150006, Heilongjiang, Peoples R China; [Zhang, Hongsheng] Harbin Inst Technol, Sch Mechatron Engn, Harbin 150006, Heilongjiang, Peoples R China	Heilongjiang Institute of Technology; Northeast Forestry University - China; Harbin Institute of Technology; Harbin Institute of Technology	Ci, YS (corresponding author), Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin 150006, Heilongjiang, Peoples R China.	ciyusheng1999@126.com			Scientific Research Fund of Heilongjiang Provincial Education Department of China [12541650]	Scientific Research Fund of Heilongjiang Provincial Education Department of China	This work was financially supported by the Scientific Research Fund of Heilongjiang Provincial Education Department of China (No. 12541650).	Ahn K, 2002, J TRANSP ENG, V128, P182, DOI 10.1061/(ASCE)0733-947X(2002)128:2(182); Asadi B, 2011, IEEE T CONTR SYST T, V19, P707, DOI 10.1109/TCST.2010.2047860; Bie YM, 2012, J TRANSP ENG, V138, P12, DOI 10.1061/(ASCE)TE.1943-5436.0000310; Evans LE, 1976, TRANSPORT SCI, V10, P213; Feng YQ, 2011, J HARBIN I TECHNOLOG, V18, P79; HERMAN R, 1985, TRANSPORT SCI, V19, P1, DOI 10.1287/trsc.19.1.1; Hu XS, 2015, IEEE-ASME T MECH, V20, P457, DOI 10.1109/TMECH.2014.2336264; Hu XS, 2015, APPL ENERG, V137, P913, DOI 10.1016/j.apenergy.2014.05.013; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2013, APPL ENERG, V111, P1001, DOI 10.1016/j.apenergy.2013.06.056; Lai WT, 2015, TRANSPORT RES D-TR E, V34, P155, DOI 10.1016/j.trd.2014.10.003; Li L, 2006, IEEE T VEH TECHNOL, V55, P1712, DOI 10.1109/TVT.2006.878730; Li L, 2015, IEEE T VEH TECHNOL, V64, P2792, DOI 10.1109/TVT.2014.2352357; Li Zhenlei, 2010, China Mechanical Engineering, V21, P110; Luo XH, 1997, J BEIJING I CIVIL EN, V13, P25; Mahler G, 2014, IEEE T INTELL TRANSP, V15, P2516, DOI 10.1109/TITS.2014.2319306; McIlroy RC, 2015, ERGONOMICS, V58, P866, DOI 10.1080/00140139.2014.997807; Rakha H, 2003, J TRANSP ENG, V129, P23, DOI 10.1061/(ASCE)0733-947X(2003)129:1(23); Staubach M, 2014, TRANSPORT RES F-TRAF, V27, P11, DOI 10.1016/j.trf.2014.09.006; Sun C, 2015, IEEE T CONTR SYST T, V23, P1075, DOI 10.1109/TCST.2014.2361294; Xia HT, 2013, J INTELL TRANSPORT S, V17, P31, DOI 10.1080/15472450.2012.712494; Xiang QJ, 2004, J HIGHWAY TRANSPORTA, V21, P100; Yang C, 2015, IET CONTROL THEORY A, V9, P270, DOI 10.1049/iet-cta.2014.0321; Zhang R, 2015, IET INTELL TRANSP SY, V9, P488, DOI 10.1049/iet-its.2014.0145; [张卫华 Zhang Weihua], 2002, [东南大学学报. 自然科学版, Journal of southeast university], V32, P249; Zheng CH, 2013, INT J HYDROGEN ENERG, V38, P5192, DOI 10.1016/j.ijhydene.2013.02.048	26	10	10	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137477	10.1371/journal.pone.0137477	http://dx.doi.org/10.1371/journal.pone.0137477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26367012	Green Published, gold			2022-12-26	WOS:000361601100079
J	Zhang, XZ; Zhang, YW; Meng, QX; Li, N; Ren, LP				Zhang, Xinzhuang; Zhang, Yawei; Meng, Qingxiang; Li, Ning; Ren, Liping			Evaluation of Beef by Electronic Tongue System TS-5000Z: Flavor Assessment, Recognition and Chemical Compositions According to Its Correlation with Flavor	PLOS ONE			English	Article							MEAT QUALITY; GROUND-BEEF; TAURINE; CATTLE	The aim of this study was to assess the ability of electronic tongue system TS-5000Z to evaluate meat quality based on flavor assessment, recognition and correlation with the meat chemical composition. Meat was sampled from eighteen beef cattle including 6 Wagyu breed cattle, 6 Angus breed cattle and 6 Simmental breed cattle. Chemical composition including dry matter, crude protein, fat, ash, cholesterol and taurine and flavor of the meat were measured. The results showed that different breed cattle had different chemical compositions and flavor, which contains sourness, umami, saltiness, bitterness, astringency, aftertaste from astringency, aftertaste from bitterness and aftertaste from umami, respectively. A principal component analysis (PCA) showed an easily visible separation between different breeds of cattle and indicated that TS-5000Z made a rapid identification of different breeds of cattle. In addition, TS-5000Z seemed to be used to predict the chemical composition according to its correlation with the flavor. In conclusion, TS-5000Z would be used as a rapid analytical tool to evaluate the beef quality both qualitatively and quantitatively, based on flavor assessment, recognition and chemical composition according to its correlation with flavor.	[Zhang, Xinzhuang; Zhang, Yawei; Meng, Qingxiang; Ren, Liping] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Li, Ning] Ying Sheng Hengtai Technol Co LTD, Beijing, Peoples R China	China Agricultural University	Ren, LP (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	renlp@cau.edu.cn	Meng, Q./GSI-6185-2022	Zhang, Yawei/0000-0002-0571-8383	Beijing municipal government [201202910411136]	Beijing municipal government	This study was supported by a grant from the Beijing municipal government (201202910411136).	Andersen HJ, 2005, MEAT SCI, V70, P543, DOI 10.1016/j.meatsci.2004.07.015; AOAC, 1999, OFFICIAL METHODS ANA; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Beullens K, 2008, SENSOR ACTUAT B-CHEM, V131, P10, DOI 10.1016/j.snb.2007.12.024; Calkins CR, 2007, MEAT SCI, V77, P63, DOI 10.1016/j.meatsci.2007.04.016; Chabanet C, 2013, MEAT SCI, V94, P253, DOI 10.1016/j.meatsci.2012.09.023; Chung KY, 2006, MEAT SCI, V73, P432, DOI 10.1016/j.meatsci.2006.01.002; Cram A, 2009, INT J PHARMACEUT, V365, P1, DOI 10.1016/j.ijpharm.2008.09.015; Dang YL, 2015, LWT-FOOD SCI TECHNOL, V60, P1179, DOI 10.1016/j.lwt.2014.09.014; Delwiche J, 2004, FOOD QUAL PREFER, V15, P137, DOI 10.1016/S0950-3293(03)00041-7; Escuder-Gilabert L, 2010, ANAL CHIM ACTA, V665, P15, DOI 10.1016/j.aca.2010.03.017; FISCHER U, 1994, AM J ENOL VITICULT, V45, P6; Guhmann M, 2012, INT J PHARMACEUT, V438, P81, DOI 10.1016/j.ijpharm.2012.08.047; Inoue H, 2003, ANAL BIOCHEM, V319, P138, DOI 10.1016/S0003-2697(03)00277-X; LEFEBVRE N, 1994, MEAT SCI, V36, P371, DOI 10.1016/0309-1740(94)90133-3; Legin A, 2003, ANAL CHIM ACTA, V484, P33, DOI 10.1016/S0003-2670(03)00301-5; Priolo A, 2001, ANIM RES, V50, P185, DOI 10.1051/animres:2001125; Rule DC, 2002, J ANIM SCI, V80, P1202; Silva J, 2012, INT J FOOD SCI TECH, V47, P1630; Stapleton PP, 1997, CLIN NUTR, V16, P103, DOI 10.1016/S0261-5614(97)80234-8; Togersen G, 2003, MEAT SCI, V63, P515, DOI 10.1016/S0309-1740(02)00113-4; Vlasov Y, 2002, ANAL BIOANAL CHEM, V373, P136, DOI 10.1007/s00216-002-1310-2; Woertz K, 2011, J PHARMACEUT BIOMED, V55, P272, DOI 10.1016/j.jpba.2011.02.002; Woertz K, 2010, J PHARMACEUT BIOMED, V51, P497, DOI 10.1016/j.jpba.2009.09.029; Xie XX, 2012, ASIAN AUSTRAL J ANIM, V25, P824, DOI 10.5713/ajas.2011.11462; Yamamoto K, 2013, SEMIN CELL DEV BIOL, V24, P240, DOI 10.1016/j.semcdb.2012.08.005; Zhang M, 2004, AMINO ACIDS, V26, P203, DOI 10.1007/s00726-003-0002-3	27	29	31	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2015	10	9							e0137807	10.1371/journal.pone.0137807	http://dx.doi.org/10.1371/journal.pone.0137807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KS	26368555	Green Published, gold, Green Submitted			2022-12-26	WOS:000361601100143
J	Komaba, S; Coluccio, LM				Komaba, Shigeru; Coluccio, Lynne M.			Myosin 1b Regulates Amino Acid Transport by Associating Transporters with the Apical Plasma Membrane of Kidney Cells	PLOS ONE			English	Article							MOLECULAR-CLONING; HARTNUP DISORDER; RAT-LIVER; L-CYSTINE; I-ALPHA; ACTIN; SYSTEM; GENE; IDENTIFICATION; COLLECTRIN	Amino acid transporters (AATers) in the brush border of the apical plasma membrane (APM) of renal proximal tubule (PT) cells mediate amino acid transport (AAT). We found that the membrane-associated class I myosin myosin 1b (Myo1b) localized at the apical brush border membrane of PTs. In opossum kidney (OK) 3B/2 epithelial cells, which are derived from PTs, expressed rat Myo1b-GFP colocalized in patched microvilli with expressed mouse V5-tagged SIT1 (SIT1-V5), which mediates neutral amino acid transport in OK cells. Lentivirus-mediated delivery of opossum Myo1b-specific shRNA resulted in knockdown (kd) of Myo1b expression, less SIT1-V5 at the APM as determined by localization studies, and a decrease in neutral AAT as determined by radioactive uptake assays. Myo1b kd had no effect on Pi transport or noticeable change in microvilli structure as determined by rhodamine phalloidin staining. The studies are the first to define a physiological role for Myo1b, that of regulating renal AAT by modulating the association of AATers with the APM.	[Komaba, Shigeru; Coluccio, Lynne M.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University	Coluccio, LM (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.	coluccio@bu.eduj			National Institutes of Health [1R01 DC 08793]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by National Institutes of Health Grant 1R01 DC 08793 to LMC (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Almeida CG, 2011, NAT CELL BIOL, V13, P779, DOI 10.1038/ncb2262; Bacic D, 2001, PFLUG ARCH EUR J PHY, V443, P306, DOI 10.1007/s004240100695; Balish MF, 1999, ARCH BIOCHEM BIOPHYS, V370, P285, DOI 10.1006/abbi.1999.1409; Benesh AE, 2010, MOL BIOL CELL, V21, P970, DOI 10.1091/mbc.E09-07-0638; Blaine J, 2009, AM J PHYSIOL-CELL PH, V297, pC1339, DOI 10.1152/ajpcell.00260.2009; Boguslavsky S, 2012, MOL BIOL CELL, V23, P4065, DOI 10.1091/mbc.E12-04-0263; Bohmer C, 2005, BIOCHEM J, V389, P745; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Broer S, 2008, PHYSIOLOGY, V23, P95, DOI 10.1152/physiol.00045.2007; Broer S, 2009, IUBMB LIFE, V61, P591, DOI 10.1002/iub.210; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cechova S, 2013, CIRCULATION, V128, P1770, DOI 10.1161/CIRCULATIONAHA.113.003301; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; COLUCCIO LM, 1989, J CELL BIOL, V108, P495, DOI 10.1083/jcb.108.2.495; COLUCCIO LM, 2008, PROTEINS CELL REGULA, V7, P95; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; Fernandez E, 2003, J AM SOC NEPHROL, V14, P837, DOI 10.1097/01.ASN.0000057852.35075.AC; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; GSTRAUNTHALER G, 1985, AM J PHYSIOL, V248, pF536, DOI 10.1152/ajprenal.1985.248.4.F536; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Herve JC, 2014, BBA-BIOMEMBRANES, V1838, P511, DOI 10.1016/j.bbamem.2013.10.014; HOSHIMARU M, 1987, J BIOL CHEM, V262, P14625; Huling JC, 2012, AM J PHYSIOL-RENAL, V302, pF401, DOI 10.1152/ajprenal.00457.2011; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; Ito M, 2010, AM J PHYSIOL-RENAL, V299, pF243, DOI 10.1152/ajprenal.00189.2009; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Komaba S, 2010, J BIOL CHEM, V285, P27686, DOI 10.1074/jbc.M109.087270; Kowalczuk S, 2005, BIOCHEM J, V386, P417, DOI 10.1042/BJ20050100; KOYAMA H, 1978, IN VITRO CELL DEV B, V14, P239; Kravtsov DV, 2012, TRAFFIC, V13, P1072, DOI 10.1111/j.1600-0854.2012.01368.x; Kuroda H, 2009, J VIROL METHODS, V157, P113, DOI 10.1016/j.jviromet.2008.11.021; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Liang MY, 1999, KIDNEY INT, V56, P2304, DOI 10.1046/j.1523-1755.1999.00787.x; Malakauskas SM, 2007, AM J PHYSIOL-RENAL, V292, pF533, DOI 10.1152/ajprenal.00325.2006; MALMSTROM K, 1986, AM J PHYSIOL, V251, pC23, DOI 10.1152/ajpcell.1986.251.1.C23; MALSTROM K, 1987, BIOCHIM BIOPHYS ACTA, V902, P269, DOI 10.1016/0005-2736(87)90305-1; MATSUDAIRA PT, 1979, J CELL BIOL, V83, P667, DOI 10.1083/jcb.83.3.667; Mazzolini R, 2012, P NATL ACAD SCI USA, V109, P1530, DOI 10.1073/pnas.1108411109; McConnell RE, 2007, J CELL BIOL, V177, P671, DOI 10.1083/jcb.200701144; Mora C, 1996, J BIOL CHEM, V271, P10569, DOI 10.1074/jbc.271.18.10569; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Nickel A, 2010, AMINO ACIDS, V38, P753, DOI 10.1007/s00726-009-0280-5; Pfister MF, 1997, J BIOL CHEM, V272, P20125, DOI 10.1074/jbc.272.32.20125; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Ristic Z, 2006, AM J PHYSIOL-RENAL, V290, pF880, DOI 10.1152/ajprenal.00319.2005; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; RUPPERT C, 1995, J CELL SCI, V108, P3775; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; STATES B, 1991, AM J PHYSIOL, V261, pC8, DOI 10.1152/ajpcell.1991.261.1.C8; STATES B, 1990, J CELL PHYSIOL, V143, P555, DOI 10.1002/jcp.1041430321; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Takanaga H, 2005, J BIOL CHEM, V280, P8974, DOI 10.1074/jbc.M413027200; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; TEITELBAUM AP, 1984, ENDOCRINOLOGY, V114, P980, DOI 10.1210/endo-114-3-980; Tokuo H, 2013, MOL BIOL CELL, V24, P2820, DOI 10.1091/mbc.E12-12-0884; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Verrey F, 2005, ANNU REV PHYSIOL, V67, P557, DOI 10.1146/annurev.physiol.67.031103.153949; Verrey F, 2009, PFLUG ARCH EUR J PHY, V458, P53, DOI 10.1007/s00424-009-0638-2; Walmsley SJ, 2010, AM J PHYSIOL-RENAL, V298, pF1323, DOI 10.1152/ajprenal.00711.2009; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396; Zhang H, 2001, J BIOL CHEM, V276, P17132, DOI 10.1074/jbc.M006723200; Zhang YL, 2007, BIOCHEM BIOPH RES CO, V363, P1, DOI 10.1016/j.bbrc.2007.08.136	77	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0138012	10.1371/journal.pone.0138012	http://dx.doi.org/10.1371/journal.pone.0138012			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361046	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100107
